S-1/A

0001193125-15-184231.txt : 20150513 0001193125-15-184231.hdr.sgml : 20150513 20150512173119 ACCESSION NUMBER: 0001193125-15-184231 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 21 FILED AS OF DATE: 20150513 DATE AS OF CHANGE: 20150512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invuity, Inc. CENTRAL INDEX KEY: 0001393020 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: CA FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-203505 FILM NUMBER: 15855636 BUSINESS ADDRESS: STREET 1: 444 DE HARO STREET CITY: San Francisco STATE: CA ZIP: 94107 BUSINESS PHONE: 415-655-2100 MAIL ADDRESS: STREET 1: 444 DE HARO STREET CITY: San Francisco STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: Spotlight Surgical Inc DATE OF NAME CHANGE: 20070313 S-1/A 1 d852944ds1a.htm S-1/A S-1/A

As filed with the Securities and Exchange Commission on May 12, 2015.

Registration No. 333-203505

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Amendment No. 1

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

INVUITY, INC.

(Exact name of registrant as specified in its charter)


Delaware	3841	04-3803169
(State or other jurisdiction of incorporation or organization)	(Primary Standard Industrial Classification Code Number)	(I.R.S. Employer Identification Number)

444 De Haro Street

San Francisco, CA 94107

(415) 655-2100

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Philip Sawyer

President and Chief Executive Officer

Invuity, Inc.

444 De Haro Street

San Francisco, CA 94107

(415) 655-2100

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Copies to:

Steven E. Bochner

Allison B. Spinner

Wilson Sonsini Goodrich & Rosati, P.C.

650 Page Mill Road

Palo Alto, California 94304

(650) 493-9300

Brett Robertson

Vice President of Corporate Development and

General Counsel

Invuity, Inc.

444 De Haro Street

San Francisco, California 94107

(415) 655-2100

B. Shayne Kennedy

Drew Capurro

Latham & Watkins LLP

650 Town Center Drive, 20th Floor

Costa Mesa, California 92626

(714) 540-1235

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective.

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box: ¨

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer ¨		Accelerated filer ¨
Non-accelerated filer x (Do not check if a smaller reporting company)		Smaller reporting company ¨

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

LOGO

The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted. Subject to Completion, dated May 12, 2015 [logo] Invuity registered mark [blank] Shares INVUITY, INC. Common Stock $[blank] per share Invuity, Inc. is offering [blank] shares. We anticipate that the initial public offering price will be between $[blank] and $[blank] per share. This is our initial public offering and no public marker currently exists for our shares. We intend to apply to be listed on the NASDAQ Global Market under the trading symbol: “IVTY.” This investment involves risks. See “Risk Factors” beginning on page 12. We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, and as such, have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. Per Share Total Initial public offering price $ $ Underwriting discounts and commissions(1) $ $ Proceeds to Invuity, Inc., before expenses $ $ (1) See “Underwriting” for additional information regarding underwriting compensation. We have granted to the underwriters an option to purchase up to [blank] additional shares of common stock from us at the initial public offering price, less the underwriting discounts and commissions, for 30 days after the date of this prospectus. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. The underwriters expect to deliver the shares of common stock to investors on or about [blank], 2015. Piper Jaffray Leerink Partners Stifel William Blair The date of this prospectus is [blank], 2015.

LOGO

INVUITY intelligent photonics. ™ Surgery. Redefined.

LOGO

Eikon™ Illuminated Retractor System Waveguide XT™ System Saber Yankauer™ Breiten™ Illuminated Retractor System A new solution for intracavity visualization.

LOGO

CERVICAL Breiten™ Saber Frazier™ Eika™ Waveguide XT™ BREAST RECONSTRUCTION Eikon™Saber Yankauer™LUMBARSaber Frazier™ Saber Yankauer™ Eikon™ Waveguide XT™TRAUMA/TUMORSaber Yankauer™ Saber Frazier™ Eivector™ Eipex™ Eikon™THYROIDEika™ Eikon™SHOULDERSaber Yankauer™ Eivector™ Eipex™BREASTEikon™ Saber Yankauer™ Eika™HIPSaber Yankauer™ Eivector™ Eipex™ Other SpecialtiesNeurosurgery; Gynecology; Urology; Ear, Nose and Throat; Craniomaxillofacial; CardiothoracicA portfolio of devices to address a broad spectrum of surgical procedures.Eipex™Saber Eikon™ Eivector™ Frazier™Waveguide Saber Eika™ Breiten™ XT™ System Yankauer™Drop-In Handheld Retractor

TABLE OF CONTENTS


	Page
Prospectus Summary		1
Risk Factors		13
Special Note Regarding Forward-Looking Statements		43
Market and Industry Data		45
Use of Proceeds		46
Dividend Policy		47
Capitalization		48
Dilution		50
Selected Financial Data		53
Management’s Discussion and Analysis of Financial Condition and Results of Operations		55
Business		70
Management		97
Executive Compensation		106
Certain Relationships and Related Party Transactions		117
Principal Stockholders		123
Description of Capital Stock		126
Shares Eligible for Future Sale		131
Material U.S. Federal Income Tax Consequences to Non-U.S. Holders		133
Underwriting		137
Legal Matters		146
Experts		146
Additional Information		146
Index to Financial Statements		F-1

Until , 2015, all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

You should rely only on the information contained in this prospectus or any related free writing prospectus we may authorize to be delivered to you. We have not, and the underwriters have not, authorized any other person to provide you with different information. We and the underwriters take no responsibility for, and can provide no assurances as to the reliability of, any information that others may give you. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the offer or sale is not permitted. The information in this prospectus is only accurate as of the date of this prospectus, regardless of the time or delivery of this prospectus and any sale of our common stock.

Trademarks

Invuity, Inc. and our logo, as well as Intelligent Photonics, are our trademarks and are used in this prospectus. This prospectus also includes trademarks, tradenames and service marks that are the property of other organizations. Solely for convenience, our trademarks and tradenames referred to in this prospectus appear without the ^® and ^™ symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights, or the right of the applicable licensor to these trademarks and tradenames. Additionally, we do not intend for our use or display of other companies’ trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies.

Investors Outside of the United States

Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about, and to observe any restrictions relating to, this offering and the distribution of this prospectus outside of the United States.

PROSPECTUS SUMMARY

This prospectus summary highlights information contained elsewhere in this prospectus. This prospectus summary is not complete and does not contain all of the information that you should consider before making a decision to invest in our common stock. You should carefully read this entire prospectus, including the information provided under the headings “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and the related notes, before investing in our common stock. Unless otherwise stated in this prospectus, references to “Invuity,” “we,” “us,” “our” or “the Company” refer to Invuity, Inc.

Invuity

We are a commercial-stage medical technology company pioneering the use of advanced photonics to provide surgeons with improved direct visualization of surgical cavities during minimally invasive and minimal access surgical procedures. We integrate our Intelligent Photonics technology platform into our single-use and reusable advanced surgical devices to address some of the critical intracavity illumination and visualization challenges facing surgeons today. We utilize our proprietary Intelligent Photonics technology to develop optical waveguides that direct and shape thermally cool, brilliant light into broad, uniform and volumetric illumination of the surgical target. We believe that improving a surgeon’s ability to see critical anatomical structures can lead to better clinical and aesthetic outcomes, improved patient safety and reduced surgical time and healthcare costs. We sold our devices to approximately 400 hospitals in the first quarter of 2015, as compared to approximately 200 hospitals in the same quarter of 2014. Based on the number of single-use units we have shipped as of March 31, 2015, we estimate that our devices have been used in over 92,000 surgical procedures. We are also using our Intelligent Photonics technology to develop new devices and modalities to broaden the application and adoption of open minimally invasive and minimal access procedures and enable new advanced surgical techniques.

Photonics is the science and technological applications of light. We have applied advanced principles of photonics to develop our Intelligent Photonics technology platform, which enables the transmission, management and manipulation of light in surgical procedures. Our initial application of this technology is integrated into our family of proprietary optical waveguides. Our waveguides are sophisticated devices that rely on the principles of optics to shape and direct light. They are coupled to a modified fiber optic cable and are designed to work with the standard xenon or LED light sources typically found and utilized in the operating room. Our optical waveguides are incorporated into surgical devices, including our customized line of illuminated surgical retractors, handheld illuminated aspiration devices and drop-in intracavity illuminators. Our handheld illuminated aspiration devices and drop-in intracavity illuminators are single-use products. Our retractors are reusable, but utilize a single-use optical waveguide, which we sell separately because a new waveguide must be used for each procedure.

The fundamental attributes of our optical waveguides include a solid core optical-grade polymer, total internal reflection of light waves, light mixing and extraction by a complex geometry of refractive microstructures or microlenses. The solid core optical-grade polymer waveguide is coupled to a fiber optic cable in order to facilitate the efficient transfer of light. This unique coupling results in our waveguides capturing maximum light with minimal heat build-up. Our waveguides use critical angles and the properties of total internal reflection to retain and transmit maximum light as it travels through the device. In addition, each waveguide utilizes various novel optical methods to mix light during the total internal reflection transmission process to enable more uniform light extraction across its output surface. The output surface consists of a complex geometry of refractive microstructures or microlenses that extract, direct and shape volumetric illumination into the surgical cavity while virtually eliminating shadows and glare. This complex geometric structure extracts and directs light at numerous different angles to enable illumination of the surgical target, even if blood or debris accumulates on the surface of

the waveguide. The uniform distribution of light extraction from the microstructures or microlenses throughout the entire output surface of the waveguide, as well as the proprietary solid core optical-grade polymer and patented design of our waveguides, results in thermally cool illumination.

In the last several years, we have transitioned from a focus on research and development to the commercialization of our device portfolio. As of March 31, 2015, we market eight families of illuminated surgical devices, consisting of over 40 devices. We market and sell our devices in the United States primarily through a direct salesforce, which has grown from 16 sales representatives as of December 31, 2012, to 43 as of March 31, 2015. We have plans to increase sales by further expanding this commercial organization. We believe this expansion will allow us to further penetrate and grow our market by demonstrating the benefits of our devices to additional surgeons and hospitals. Our revenue increased from $7.2 million in 2013 to $13.1 million in 2014. We had a net loss of $12.1 million and $20.7 million in the years ended December 31, 2013 and 2014, respectively. Our revenue increased from $2.2 million during the three months ended March 31, 2014 to $4.4 million during the three months ended March 31, 2015. In 2014 and the three months ended March 31, 2015, approximately 80% and 74% of our revenue, respectively, was generated from the sale of single-use devices. We had a net loss of $4.7 million and $9.0 million during the three months ended March 31, 2014 and 2015, respectively. As of March 31, 2015, we had an accumulated deficit of $77.1 million.

Our Market Opportunity

Advances in medical technology have resulted in growing adoption of minimally invasive and minimal access surgical procedures. The increased utilization of these procedures by surgeons is primarily driven by their significant benefits compared to conventional open surgery, including:

•

smaller incisions resulting in less scarring and fewer complications;

•

less trauma to the organs, muscles, nerves, and tissue;

•

less bleeding and reduced need for blood transfusions;

•

fewer surgical infections;

•

shortened hospital stays, potentially reducing hospital costs;

•

less postoperative pain and reduced need for associated narcotics;

•

faster recovery time; and

•

improved aesthetic outcomes.

Minimally invasive surgery refers to surgery performed through one or more small incisions as compared to conventional open surgery procedures. Some minimally invasive procedures, such as endoscopic, laparoscopic and arthroscopic procedures, use small tubes, tiny cameras and surgical instruments to access, visualize and perform the surgery. Though these procedures have several of the benefits described above, surgeons are only able to view the surgical target through a tiny camera, which can cause reduced depth perception and field of vision, diminished hand-eye coordination, limited mobility of the surgical instruments, and reduced tactile feedback. These limitations can increase the cognitive and physical load on the surgeon and, consequently, increase the possibility of surgical error. Other procedures also use smaller incisions than conventional open surgery but still enable the surgeon direct visualization of the surgical target and the ability to use traditional surgical instruments. We refer to these procedures as open minimally invasive and minimal access procedures. We believe that open minimally invasive and minimal access procedures provide many of the benefits described above. However, the small incisions used in these procedures inherently reduce a surgeon’s ability to directly see the surgical target, particularly deep within the surgical cavity, which can impact surgical precision, procedural efficiency and patient safety.

We estimate that approximately 40% of all surgical procedures in the United States are open minimally invasive and minimal access. Based on the benefits of these procedures over conventional open surgery, we believe this percentage will continue to grow. We have initially targeted our sales and marketing efforts to surgeons in the following specialties: orthopedics, spine, breast oncology, plastics, and thyroid. However, our current illuminated surgical devices have a broader indication for use and can be marketed to other specialties with limited or no additional regulatory clearance. We intend to target other surgical specialties including trauma; cardiothoracic; ear, nose and throat; gynecology; urology; general surgery; neurosurgery and craniomaxilliofacial procedures. We currently estimate the annual total addressable market for our devices in these surgical specialties in the United States to be approximately $2.0 billion, based on the estimate of our average revenue per procedure.

Traditional Illumination Devices and Their Limitations

Lighting is a critical element of every open surgical procedure. Traditional surgical lighting options in the operating room include overhead lighting systems, surgical headlights and on-field fiber optic lighting systems. We are aware of various publications identifying limitations of these devices, including limitations that present particular challenges when the surgical field is accessed through the small incisions used in open minimally invasive and minimal access procedures.

Overhead Lighting Systems

The most common illumination method in the operating room setting today is overhead lighting systems. Overhead lighting systems consist of lighting fixtures that are positioned above the surgical field. Overhead lighting systems are frequently inadequate for surgery in deeper cavities due to the creation of significant shadows within the surgical field and the inability of the light to reach the depths of the incision.

Surgical Headlights

On-field Fiber Optic Lighting Systems

Due to the limitations of overhead lighting systems and surgical headlights, on-field fiber optic lighting systems have been developed in an effort to provide intracavity lighting of the surgical field. On-field fiber optic lighting systems consist of a fiber optic cable attached to a fiber optic retractor. However, traditional on-field fiber optic systems have inherent limitations and risks. With traditional fiber optic retractors, light is directed in a straight line in the shape of a cone from the end of the fiber optic. To avoid the light being absorbed by the retractor, the fiber is typically located as close as possible to the distal end. Placing the fiber on the distal end of the retractor puts it in close proximity to the patient’s tissue, which can create a very bright, narrow spot of light that can create hot spots on the patient’s tissue and create glare in the surgeon’s line of vision. In addition, traditional on-field fiber optic lighting systems represent a thermal hazard in the operating room creating the risk of burns to patients, surgeons and hospital staff and operating room fires.

Market Need for Advanced Intracavity Illumination and Visualization Devices

Given the limitations of traditional surgical lighting options in the operating room, we believe there is a significant opportunity to enhance intracavity illumination and visualization during open minimally invasive and minimal access procedures. In addition, we believe that an advanced illumination and visualization technology could broaden the application and adoption of less invasive surgical techniques.

Our Solution

We utilize our Intelligent Photonics technology platform to develop surgical devices designed to overcome the significant limitations of traditional surgical lighting options in the operating room. Based on surgeon feedback, surgeon observation and bench testing, we believe our technology may provide the following benefits:

•

Enhanced illumination and visualization of the surgical field. Our devices are designed to provide enhanced intracavity illumination and visualization of the surgical field during open minimally invasive and minimal access surgeries. The proprietary complex geometry of refractive microstructures or microlenses along the surface of our optical waveguides allow for the extraction of light in a manner that distributes light at different angles in a broad, uniform and volumetric pattern that is intended to reduce shadows, glare and excessive heat that are commonly associated with traditional surgical lighting options. In bench testing comparing light distribution and thermal profile of our Eikon retractor to a traditional fiber optic retractor, we found our Eikon retractor system had approximately five times the illumination area with a thermal profile below the risk of burn.

•

Improved surgical precision during open minimally invasive and minimal access procedures. Our technology is designed to improve intracavity visualization to allow surgeons to identify, differentiate and avoid vital anatomical structures. We believe this enables surgeons to dissect with great precision, while also allowing them to differentiate tissue planes, identify and avoid nerves and blood vessels, and quickly locate and control bleeding vessels to achieve rapid hemostasis. With this precise visualization, we believe surgeons may be able to use smaller, and in some cases fewer, incisions.

•

Reduced risks to patients and surgeons. Our technology is developed with design elements to help create thermally cool illumination as well as ergonomics to improve ease of use while performing a procedure. By improving visualization, our devices may also decrease the risk of unintended retained foreign objects by improving the surgeon’s ability to see and dispose of such objects that might have otherwise been left in the surgical cavity inadvertently. Additionally, by being directly incorporated into a variety of illuminated surgical retractors, handheld illuminated aspiration devices, and drop-in intracavity illuminators, we believe our technology may help to decrease surgeon fatigue by reducing or eliminating the need for surgical headlights, thereby helping to reduce some of the associated head, neck and shoulder fatigue, frequent headaches, neck pain and injury to the cervical spine.

•

Enhanced operating room efficiency. We believe our technology improves operating room workflow by reducing the need for perioperative repositioning of traditional surgical lighting options. Many open minimally invasive and minimal access procedures are time sensitive and the treatment area requires constant attention of the surgeon and operating team. Because our optical waveguides are directly connected to the surgical instrument that is used to access the deep surgical cavity, we believe surgeons are able to clearly illuminate the surgical target and effectively focus on performing the procedure.

•

Economic value proposition to healthcare systems. We believe our devices have the potential to substantially reduce procedure costs as well as create incremental revenue

opportunities. We believe the improved efficiency of the operating room workflow and the related reduced procedure and anesthesia time can translate to meaningful cost savings for the hospital. In addition, we believe the reduction in procedure times may also create additional capacity in the operating room for surgeons to perform more procedures, which we believe can create incremental revenue for the hospital. A retrospective analysis conducted by a healthcare consulting firm in 2015 demonstrated a 31-minute reduction in anesthesia time, on average, in nipple-sparing mastectomy procedures using our devices.

Our Strategy

Our goal is to be the global leader in providing advanced photonics systems to surgeons across a broad array of surgical specialties. The key elements of our strategy include:

•

Establish our Intelligent Photonics technology as the standard illumination technology used in open minimally invasive and minimal access procedures. We intend to continue to educate and train surgeons on the advantages of our Intelligent Photonics technology compared to traditional operating room lighting options. We believe the benefits of our Intelligent Photonics technology should also enable the broader application and adoption of open minimally invasive and minimal access procedures and help enable new advanced surgical techniques.

•

Expand our sales organization to support growth. We plan to continue to expand our direct sales organization in the United States to help facilitate further adoption among existing hospital accounts as well as broaden awareness of our Intelligent Photonics technology to new hospitals. As of March 31, 2015, we had 43 direct sales representatives.

•

Focus on key opinion leader surgeons to facilitate adoption. We are working in collaboration with key opinion leader surgeons in various surgical specialties to explore new product development and clinical applications for our technology and generate surgeon awareness of the clinical and economic value of our technology.

•

Introduce our Intelligent Photonics technology in markets outside the United States. While our current commercial plan is to focus our direct sales efforts on continued penetration of the U.S. market, we plan to continue to monitor opportunities to develop a presence internationally.

Our Products

We currently market eight families of illuminated surgical devices, consisting of over 40 devices. Our Intelligent Photonics technology is integrated into each of these device families. Our device portfolio includes reusable illuminated surgical retractors that include a single-use waveguide, single-use handheld illuminated aspiration devices and single-use drop-in intracavity illuminators. Our optical waveguides are integrated into these customized devices to deliver improved visualization of the surgical cavity without generating excessive heat.

Risks Related to Our Business

Our ability to successfully operate our business is subject to numerous risks, including, without limitation, those that are generally associated with operating in the medical device industry. Some of the principal risks relating to our business and our ability to execute our business strategy include:

•

We have a history of significant operating losses and expect to incur losses in the future. If we do not achieve and sustain profitability, our financial condition and stock price could suffer.

•

All of our revenue is generated from devices incorporating our Intelligent Photonics technology, and any decline in the sales of these devices or failure to gain market acceptance of these devices will negatively impact our business.

•

If we are unable to convince hospital facilities to approve the use of our devices, our sales may decrease.

•

We must demonstrate to surgeons and hospitals the merits of our devices compared to those of our competitors.

•

We have limited experience marketing and selling our devices, and if we fail to develop and retain our direct sales force and independent sales agents, our business could suffer.

•

We operate in a highly competitive market segment. If our competitors are better able to market and develop devices than we are able to market or develop devices, our business will be adversely impacted.

•

Our ability to sell our devices at prices necessary to support our current business strategies depends on demonstrating that the benefits of devices incorporating our Intelligent Photonics technology outweigh the increased cost of such devices compared to other surgical illumination methods.

•

It is difficult to forecast future performance and our financial results may vary from forecasts and may fluctuate from quarter to quarter.

•

If our intellectual property rights are not adequately protected, our business will be negatively affected.

•

We have identified a material weakness in our internal control over financial reporting. If our remediation of this material weakness is not effective, or if we experience additional material weaknesses in the future or otherwise fail to maintain an effective system of internal control over financial reporting in the future, we may not be able to accurately or timely report our financial condition or results of operations, which may adversely affect investor confidence in us and, as a result, the value of our common stock.

•

If we fail to obtain and maintain necessary regulatory clearances or approvals for our devices, or if clearances or approvals for future devices and indications are delayed or not issued, our commercial operations would be harmed.

Implications of Being an Emerging Growth Company

As a company with less than $1.0 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of specified reduced reporting requirements and is relieved of certain other significant requirements that are otherwise generally applicable to public companies. As an emerging growth company:

•

We are permitted to present only two years of audited financial statements and only two years of related Management’s Discussion and Analysis of Financial Condition and Results of Operations in this prospectus.

•

We are exempt from the requirement to obtain an attestation report from our independent registered public accounting firm on our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002.

•

We are permitted to provide less extensive disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements.

•

We are not required to give our stockholders non-binding advisory votes on executive compensation or golden parachute arrangements.

We may take advantage of these provisions until the last day of the fiscal year following the fifth anniversary of the completion of this offering. However, if certain events occur prior to the end of such five-year period, including (i) if we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, (ii) our annual gross revenue equals or exceeds $1.0 billion or (iii) we issue more than $1.0 billion of non-convertible debt in any three-year period, we will cease to be an emerging growth company prior to the end of such five-year period.

We may choose to take advantage of some or all of these reduced burdens. We have taken advantage of reduced reporting requirements in this prospectus. Accordingly, the information contained herein may be different from the information you receive from our competitors that are public companies, or other public companies in which you have made an investment.

In addition, the JOBS Act provides that an emerging growth company may take advantage of an extended transition period for complying with new or revised accounting standards. We have irrevocably elected not to avail ourselves of this exemption and, therefore, we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

Corporate Information

We were incorporated in California in 2004 as Spotlight Surgical, Inc. We changed our name to Invuity, Inc. in 2007. We plan to reincorporate in Delaware prior to the completion of this offering. Our principal executive offices are located at 444 De Haro Street, San Francisco, California, 94107, and our telephone number is (415) 655-2100. Our website is www.invuity.com. Information contained on, or that can be accessed through, our website is not incorporated by reference into this prospectus, and you should not consider information on our website to be part of this prospectus.

THE OFFERING



Issuer		Invuity, Inc.

Shares of common stock offered by us		shares.

Shares of common stock to be outstanding immediately after this offering		shares (or shares, if the underwriters exercise in full their option to purchase additional shares).

Option to purchase additional shares		We have granted the underwriters an option to purchase up to additional shares of common stock from us. The underwriters can exercise this option at any time within 30 days from the date of this prospectus.

Use of proceeds		We intend to use the net proceeds received from this offering primarily to expand sales and marketing activities and research and development efforts, and for working capital and general corporate purposes. We may also use a portion of the net proceeds from this offering to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. See “Use of Proceeds” on page 45 of this prospectus for a more complete description of the intended use of proceeds from this offering.

Risk factors		Investing in our common stock involves risks. See the section entitled “Risk Factors” beginning on page 13 of this prospectus and other information included in this prospectus for a discussion of factors you should carefully consider before deciding to invest in our common stock.

Directed share program		At our request, the underwriters have reserved for sale at the initial public offering price up to shares of common stock, or approximately % of the shares offered by this prospectus, for our employees, directors and other persons associated with us. Any directed shares purchased by our officers and directors will be subject to the 180-day lock-up restriction described in the “Underwriting” section of this prospectus. Any other participants in the directed share program will not be subject to any lock-up arrangements with any underwriter with respect to the directed shares sold to them. The number of shares of common stock available for sale to the general public in the offering will be reduced by the number of shares sold pursuant to the directed share program. Any directed shares not so purchased will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. The directed share program will be arranged through .

Proposed NASDAQ Global Market symbol		“IVTY.”

The number of shares of our common stock to be outstanding after this offering is based on 158,438,759 shares of our common stock outstanding as of March 31, 2015, including convertible preferred stock on an as-converted basis, and excludes:

•

25,145,974 shares of common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of March 31, 2015, with a weighted-average exercise price of $0.14 per share;

•

7,114,305 shares of common stock issuable upon the exercise of options to purchase shares of our common stock which were issued in April and May 2015, with a weighted-average exercise price of $0.61 per share;

•

65,353 shares of common stock issuable upon the exercise of warrants outstanding as of March 31, 2015 with a weighted-average exercise price of $0.07 per share;

•

2,489,601 shares of common stock issuable upon conversion of convertible preferred stock issuable upon the exercise of warrants outstanding as of March 31, 2015 with a weighted-average exercise price of $0.72 per share;

•

shares of common stock reserved for future grants under our stock-based compensation plans, consisting of:

•

12,634,964 shares of common stock reserved for future grants under our 2005 Stock Incentive Plan as of March 31, 2015, which shares will be added to the shares to be reserved under our 2015 Equity Incentive Plan, which will become effective upon completion of this offering;

•

shares of common stock reserved for future grants under our 2015 Equity Incentive Plan, which will become effective upon completion of this offering; and

•

any shares that become available under our 2015 Equity Incentive Plan, pursuant to provisions thereof that automatically increase the share reserve under such plan each year, as more fully described in “Executive Compensation—Employee Benefit and Stock Plans.”

Except as otherwise indicated, all information in this prospectus assumes:

•

our reincorporation into Delaware;

•

a for reverse stock split of our common stock and convertible preferred stock;

•

the filing and effectiveness of our amended and restated certificate of incorporation and the adoption of our amended and restated bylaws upon the completion of this offering;

•

the automatic conversion of all shares of our convertible preferred stock outstanding as of March 31, 2015 into an aggregate of 145,085,870 shares of common stock upon the completion of this offering;

•

the automatic conversion of all outstanding warrants exercisable for shares of our convertible preferred stock as of March 31, 2015 into warrants exercisable for shares of common stock upon the completion of this offering;

•

no exercise of outstanding options or warrants subsequent to March 31, 2015; and

•

no exercise of the underwriters’ option to purchase additional shares.

SUMMARY FINANCIAL DATA

The following tables set forth a summary of our historical financial data as of and for the periods indicated. We have derived the summary statements of operations data for the years ended December 31, 2013 and 2014 from our audited financial statements included elsewhere in this prospectus. We have derived the summary statements of operations data for the three months ended March 31, 2014 and 2015, and the summary balance sheet data as of March 31, 2015, from our unaudited interim financial statements included elsewhere in this prospectus. We have prepared the unaudited interim financial statements on the same basis as the audited financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments that we consider necessary for a fair statement of the financial information set forth in those statements. Our historical results are not necessarily indicative of our future results and our interim results are not necessarily indicative of results to be expected for the full year ending December 31, 2015, or any other period. The following summary financial data should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes included elsewhere in this prospectus.


	Year Ended December 31,						Three Months Ended March 31,
	2013			2014			2014			2015
	(In thousands, except share and per share data)
Statements of Operations Data:
Revenue	$	7,186		$	13,103		$	2,154		$	4,442
Cost of goods sold		2,294			4,871			747			1,731

Gross profit		4,892			8,232			1,407			2,711

Operating expenses:
Selling, general and administrative		12,402			22,803			4,574			8,923
Research and development		4,445			5,181			1,203			1,900

Total operating expenses		16,847			27,984			5,777			10,823

Loss from operations		(11,955	)		(19,752	)		(4,370	)		(8,112	)
Interest expense		(284	)		(1,402	)		(370	)		(369	)
Interest and other income (expense), net		130			492			28			(551	)

Net loss	$	(12,109	)	$	(20,662	)	$	(4,712	)	$	(9,032	)

Net loss per common share, basic and diluted⁽¹⁾	$	(1.03	)	$	(1.70	)	$	(0.40	)	$	(0.69	)

Weighted-average shares used to compute net loss per common share, basic and diluted⁽¹⁾		11,713,408			12,178,182			11,915,715			13,017,592

Pro forma net loss per common share, basic and diluted (unaudited)⁽¹⁾				$	(0.17	)				$	(0.06	)

Weighted-average shares used to compute pro forma net loss per common share, basic and diluted (unaudited)⁽¹⁾					123,522,788						144,976,946

⁽¹⁾

See Notes 2, 12 and 13 to our financial statements included elsewhere in this prospectus for an explanation of the calculations of our basic and diluted net loss per common share, pro forma basic and diluted net loss per common share, and the weighted-average number of shares used in the computation of the per share amounts.


	March 31, 2015
	Actual			Pro Forma⁽¹⁾			Pro Forma As Adjusted⁽²⁾⁽³⁾
	(In thousands)
Balance Sheet Data:
Cash and cash equivalents	$	25,251		$	25,251		$
Working capital		28,230			28,230
Total assets		46,151			46,151
Convertible preferred stock warrant liability		640			—
Long-term debt—related party		14,382			14,382
Convertible preferred stock		96,524			—
Accumulated deficit		(77,069	)		(77,069	)
Total stockholders’ (deficit) equity		(74,668	)		22,496

⁽¹⁾

Reflects (i) the automatic conversion of the outstanding shares of our convertible preferred stock as of March 31, 2015 into 145,085,870 shares of our common stock upon the completion of this offering and (ii) the automatic conversion of warrants to purchase shares of convertible preferred stock into warrants to purchase shares of common stock upon the completion of this offering and the related reclassification of our convertible preferred stock warrant liability to additional paid-in capital.

⁽²⁾

Reflects the pro forma adjustments described in footnote (1) and the sale and issuance of shares of our common stock by us in this offering, at the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

⁽³⁾

Each $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) our pro forma as adjusted cash and cash equivalents, working capital, total assets and total stockholders’ equity by approximately $ million, assuming that the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Each increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase (decrease) the amount of our pro forma as adjusted cash and cash equivalents, working capital, total assets and total stockholders’ equity by approximately $ million, assuming an initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

RISK FACTORS

Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information contained in this prospectus, including our financial statements and the related notes thereto, before making a decision to invest in our common stock. The realization of any of the following risks could materially and adversely affect our business, financial condition, operating results and prospects. In that event, the price of our common stock could decline, and you could lose part or all of your investment.

Risks Related to Our Business and Industry

We have a history of significant operating losses and expect to incur losses in the future. If we do not achieve and sustain profitability, our financial condition and stock price could suffer.

We have experienced significant operating losses, and we expect to continue to incur operating losses for the next several years as we implement additional initiatives designed to grow our business, including, among other things, increasing sales and developing new devices. We incurred net losses of $12.1 million and $20.7 million for the years ended December 31, 2013 and 2014, respectively, and $4.7 million and $9.0 million for the three months ended March 31, 2014 and 2015, respectively. As of March 31, 2015, our accumulated deficit was $77.1 million. Our prior losses, combined with expected future losses, have had and will continue to have, for the foreseeable future, an adverse effect on our stockholders’ deficit and working capital. To date, we have financed our operations primarily through private placements of our equity securities, certain debt-related financing arrangements and from sales of our approved devices. We have devoted substantially all of our resources to research and development of our devices, sales and marketing activities and certain clinical and quality assurance initiatives. Our ability to generate sufficient revenue from our existing devices or from any of our device candidates in development, and to transition to profitability and generate consistent positive cash flows is uncertain. We will need to generate significant sales to achieve profitability, and we might not be able to do so. If our revenue grows more slowly than we anticipate, or if our operating expenses are higher than we expect, we may not be able to achieve profitability as anticipated, or ever, our financial condition will suffer and our stock price could decline. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods.

We have focused heavily on the development and commercialization of devices using our Intelligent Photonics technology platform for the illumination of certain open minimally invasive and minimal access surgeries. For the years ended December 31, 2013 and December 31, 2014 and the three months ended March 31, 2015, our revenue was $7.2 million, $13.1 million and $4.4 million, respectively, and was derived entirely from sales of devices incorporating our Intelligent Photonics technology. Because we expect our revenue to be derived entirely from sales of these devices for the foreseeable future, our ability to execute our growth strategy and become profitable will depend not only upon an increase in the number of hospitals using our devices, but also an increase in the number of specialties using our devices within those hospitals in which our devices are utilized. Intelligent Photonics technology, and the devices that incorporate it, fail to achieve and maintain wide market acceptance for any reason, our business may be adversely affected, as we will be severely constrained in our ability to fund our operations and to develop and commercialize improvements to existing product lines and new product lines.

If we are unable to convince hospital facilities to approve the use of our devices, our sales may decrease.

In the United States, in order for surgeons to use our devices, the hospital facilities where these surgeons treat patients will typically require us to receive approval from the facility’s value analysis committee, or VAC. VACs typically review the comparative effectiveness and cost of medical devices used in the facility. The makeup and evaluation processes for VACs vary considerably, and it can be a lengthy, costly and time-consuming effort to obtain approval by the relevant VAC. For example, even if we have an agreement with a hospital system for purchase of our devices, in most cases, we must obtain VAC approval by each hospital within the system to sell at that particular hospital. Additionally, hospitals typically require separate VAC approval for each specialty in which our device is used, which may result in multiple VAC approval processes within the same hospital even if such device has already been approved for use by a different specialty group. We often need VAC approval for each different device to be used by the surgeons in that specialty. In addition, hospital facilities and group purchasing organizations, or GPOs, which manage purchasing for multiple facilities, may also require us to enter into a purchasing agreement and satisfy numerous elements of their administrative procurement process, which can also be a lengthy, costly, and time-consuming effort. If we do not receive access to hospital facilities in a timely manner, or at all, via these VAC and purchasing contract processes, or otherwise, or if we are unable to secure contracts in a timely manner, or at all, our operating costs will increase, our sales may decrease, and our operating results may be harmed. Furthermore, we may expend significant effort in these costly and time-consuming processes and still may not obtain VAC approval or a purchase contract from such hospitals or GPOs.

We must demonstrate to surgeons and hospitals the merits of our devices to facilitate greater adoption of our devices.

Surgeons play a significant role in determining the devices used in the operating room and in assisting in obtaining approval by the relevant VAC. Educating surgeons on the benefits of our devices requires a significant commitment by our marketing team and sales organization. Surgeons and hospitals may be slow to change their practices because of perceived risks arising from the use of new devices, lack of experience using new devices, lack of clinical data supporting the benefits of such devices or the cost of new devices. We cannot predict when, or if ever, there will be widespread adoption of our devices by surgeons and hospitals. If we are unable to educate surgeons and hospitals about the advantages of devices incorporating our Intelligent Photonics technology, as compared to other surgical illumination methods which do not incorporate this technology, we may face challenges in obtaining approval by the relevant VAC, and we will not achieve significantly greater market acceptance of our devices, gain momentum in our sales activities, significantly grow our market share or grow our revenue, and our business and financial condition will be adversely affected.

We have limited experience marketing and selling our devices, and if we fail to develop and retain our direct salesforce and independent sales agents, our business could suffer.

We began selling our first FDA-cleared device in March 2009. As a result, we have limited experience marketing and selling our devices. We currently sell our devices through our direct sales representatives only in the United States. Our direct salesforce works with independent sales agents or agencies, whom we refer to as independent sales agents, who assist us in educating targeted surgeons. We increased the number of our direct sales representatives from 16 as of December 31, 2012 to 43 as of March 31, 2015. Our operating results are dependent upon the sales and marketing efforts of our direct sales representatives. If our direct salesforce fails to adequately promote, market and sell our devices, our sales may suffer.

As we launch new devices and increase our current marketing efforts with respect to existing devices and expand into new geographies, our future success will depend largely on our ability to continue to hire, train, retain and motivate skilled sales personnel with significant technical knowledge of our devices. We have made, and intend to continue to make, a significant investment in recruiting and training sales

representatives. There is significant competition for sales personnel experienced in relevant medical device sales. Once hired, the training process is lengthy because of the significant education required to achieve the level of competency surgeons expect from sales representatives with respect to understanding our devices. Upon completion of the training, our sales representatives typically require lead time in the field to grow their network of accounts and achieve the productivity levels we expect them to reach. If we are unable to attract, motivate, develop and retain a sufficient number of qualified sales personnel, or if our sales representatives do not achieve the productivity levels we expect them to reach, our revenue will not grow at the rate we expect and our financial performance will suffer. Also, to the extent we hire personnel from our competitors, we may have to wait until applicable non-competition provisions have expired before deploying such personnel in restricted territories or incur costs to relocate personnel outside of such territories, and we may be subject to allegations that these new hires have been improperly solicited, or that they have divulged to us proprietary or other confidential information of their former employers.

The medical device industry is highly competitive. Our success depends, in part, upon our ability to maintain a competitive position in the development of technologies and devices for surgical illumination and visualization. Any device we develop will have to compete for market acceptance and market share. We believe that the primary competitive factors in the surgical illumination and visualization market segment are clinical safety and effectiveness, price, surgeon experience and comfort with use of particular illumination systems, reliability and durability, ease of use, device support and service, salesforce experience and relationships. We face significant competition in the United States and internationally in the surgical illumination and visualization market, and we expect the intensity of competition will increase over time. Surgeons and hospitals typically use traditional overhead lighting, headlights and fiber-optic lighting products, and if we cannot convince surgeons and hospitals of the benefits of using our devices in addition to, or as an alternative to, traditional overhead lighting and headlights, or, of the benefits of using our devices instead of using competing fiber-optic lighting products, our business may be harmed. Some of our main competitors are Lumitex, Inc., Scintillant (Engineered Medical Solutions Co. LLC), Stryker Corporation, TeDan Surgical Innovations, LLC and Black & Black Surgical, Inc. and other general surgical instrument companies that supply traditional fiber optic retractors. Many of the companies developing or marketing competing products enjoy several competitive advantages, including:

•

more established sales and marketing programs and distribution networks;

•

long established relationships with surgeons and hospitals;

•

contractual relationships with customers;

•

products that have already received approval from the relevant VACs;

•

greater financial and human resources for product development, sales and marketing;

•

greater name recognition;

•

the ability to offer rebates or bundle multiple product offerings to offer greater discounts or incentives; and

•

greater experience in and resources for conducting research and development, clinical studies, manufacturing, preparing regulatory submissions, obtaining regulatory clearance or approval for products and marketing approved products.

devices or technologies that render our technology or devices obsolete or less competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific, and management personnel. If our competitors are more successful than us in these matters, our business may be harmed.

Hospital and other healthcare provider customers that purchase our devices typically bill various third-party payors to cover all or a portion of the costs and fees associated with the surgical procedures in which our devices are used and bill patients for any deductibles or copayments. Supplies used in surgery, such as our devices, are typically not separately reimbursed by third-party payors, but are rather included in the overall reimbursement for the procedure involved. Because there is no separate reimbursement for medical devices and supplies used in surgical procedures, the additional cost associated with the use of our devices can impact the profit margin of the hospital or surgery center where the surgery is performed. If reimbursement is inadequate, hospitals may choose to use less expensive instruments or devices that do not include illumination. Some of our target customers may be unwilling to adopt our devices in light of the additional associated cost. Our success depends on our ability to convince such cost-restricted customers that the potential benefits of using our devices, such as reduced surgery time, reduced surgery blood transfusion, and reduced post-surgery complications, outweigh the additional cost of such devices.

It is difficult to forecast future performance and our financial results may vary from forecasts and may fluctuate from quarter to quarter.

Our limited operating history and commercial experience make it difficult for us to predict future performance and growth as such forecasts are limited and subject to a number of uncertainties, including our ability to market our devices successfully, our ability to maintain or obtain regulatory clearances, unexpected or serious complications related to our devices or other factors discussed in these risk factors. A number of factors over which we have limited control may contribute to fluctuations in our financial results. These factors include, without limitation:

•

surgeon and hospital acceptance of our devices;

•

the productivity of our sales representatives;

•

the introduction of new devices and technologies or acquisitions by us or our competitors;

•

fluctuations in our expenses associated with expanding our operations and operating as a public company;

•

the timing, expense and results of research and development activities and obtaining future regulatory clearances and approvals;

•

buying patterns of the distributors that serve our military customers;

•

supplier, manufacturing or quality problems with our devices; and

•

changes in our pricing policies or in the pricing policies of our competitors or suppliers.

Additionally, we may experience seasonal variations in revenue. For example, our revenue tends to be the lowest in the first quarter as the result of the resetting of annual patient healthcare insurance plan deductibles and by hospitals and military facilities working off their inventories of products purchased in the fourth quarter. Revenue in the fourth quarter tends to be the highest as demand may be impacted by the desire of patients to spend their remaining balances in their flexible spending accounts or because they have met their annual deductibles under their health insurance plans. In addition, in the fourth quarter, our results can be impacted by the budgeting and buying patterns of hospitals and military facilities.

The loss of one or more of our key customers could slow our revenue growth or cause our revenue to decline.

A material portion of our total revenue in any given period may come from a relatively small number of customers. Sales to one customer accounted for 12% of our total revenue in each of 2013 and 2014, and sales to another customer accounted for 13% of our total revenue in 2013. We do not expect sales to these customers to increase significantly in the future, and as our revenue increases, we expect sales to these customers to decrease as a percent of revenue. There were no sales to any customer in excess of 10% of our total revenue for the three months ended March 31, 2015. However the loss of any of our key customers for any reason, or a change in our relationship with any of our key customers may cause a significant decrease in our total revenue.

Our manufacturing operations are dependent upon third-party suppliers, making us vulnerable to supply problems and price fluctuations, which could harm our business.

We rely on a number of suppliers who manufacture certain components of our devices, including specialty machining for our retractors and molding for our waveguides and handheld components. We do not have long-term supply agreements with most of our suppliers, and, in many cases, we purchase components on a purchase order basis. Our suppliers may encounter problems during manufacturing for a variety of reasons, including failure to follow specific protocols and procedures, failure to comply with applicable regulations, equipment malfunction and environmental factors, any of which could delay or impede their ability to meet our demand. Our reliance on these third-party suppliers also subjects us to other risks that could harm our business, including:

•

we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers’ needs higher priority than ours;

•

we may not be able to obtain an adequate supply in a timely manner or on commercially reasonable terms;

•

price fluctuations due to a lack of long-term supply arrangements with our suppliers for components;

•

our suppliers, especially new suppliers, may make errors in manufacturing that could negatively affect the efficacy or safety of our devices or cause delays in shipment;

•

we may have difficulty locating and qualifying alternative suppliers;

•

switching components or suppliers may require device redesign and possibly premarket submission to the FDA;

•

the failure of our suppliers to comply with strictly enforced regulatory requirements, which could result in disruption of supply and/or increased expenses;

•

the occurrence of a fire, natural disaster or other catastrophe impacting one or more of our suppliers may affect the supplier’s ability to deliver components to us in a timely manner; and

•

our suppliers may encounter financial hardships unrelated to our demand, which could inhibit their ability to fulfill our orders and meet our requirements.

In addition, we rely on single- and limited-source suppliers for several of our components and sub-assemblies. For example, the optical molding for our waveguides is provided by one supplier. These components are critical to our devices and there are relatively few alternative sources of supply. We do not carry a significant inventory of these components. Identifying and qualifying additional or replacement suppliers for any of these components or sub-assemblies used in our devices could involve significant time and cost.

Although we could temporarily assemble some of these components internally, we may incur greater costs, delay production or divert attention from other critical projects until we find an alternate source. Any interruption or delay in obtaining components from our third-party suppliers, or our inability to obtain components from qualified alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to switch to competing devices.

We are required to maintain high levels of inventory, which could consume a significant amount of our resources and reduce our cash flows.

We need to maintain substantial levels of inventory to protect ourselves from supply interruptions. In addition, because of the broad choice of devices we offer the many surgeon specialists who use our devices, we must maintain sufficient inventory on hand to ensure each order is filled when received. As a result of our substantial inventory levels, we are subject to the risk that a substantial portion of our inventory becomes obsolete, which could have a material adverse effect on our earnings and cash flows due to the resulting costs associated with the inventory impairment charges and costs required to replace such inventory. We may need to write off inventory for other reasons as well. For example, our gross margin decreased from 68% for the year ended December 31, 2013 to 63% for the year ended December 31, 2014, primarily due to the impact of inventory write-offs for unrecoverable trunk stock inventory provided to direct sales representatives and independent sales agents and related increase to cost of goods sold.

We have no clinical data to support the clinical and cost benefits of use of our devices, which could be a barrier to further surgeon adoption of our devices.

For FDA purposes, our devices are classified as Class I, Class II exempt or Class II devices. Class I and Class II exempt devices do not require a 510(k) premarket notification. Our Class II devices, which require a 510(k) premarket notification, are not in a category that require clinical studies to obtain clearance for marketing. As a result the FDA has not required, and we have not developed, clinical data supporting the safety and efficacy of our devices. Therefore, we currently lack clinical data supporting the benefits and cost effectiveness of our devices compared to other illumination solutions. As a result, surgeons may be slow to adopt or recommend our devices, and we may encounter difficulty obtaining approval from VACs. Further, any clinical studies that we initiate or the clinical experience of surgeons may indicate that our devices do not provide advantages over our competitors’ surgical illumination devices or that our devices do not deliver sufficient benefits to justify their cost. Such results could slow the adoption of our devices and significantly reduce our sales, which could harm our business and reputation.

We may need to conduct clinical studies in the future to support new device regulatory clearances or approvals, gain acceptance of our products in hospitals or to secure approval of the use of our devices in some foreign countries. Clinical testing is time-consuming and expensive and carries uncertain outcomes. The initiation and completion of any of these studies may be prevented, delayed or halted for numerous reasons. Moreover, we cannot assure you that the results of any clinical trials would support the promoted benefits of our devices. Failure or perceived failures in any clinical trials will delay and may prevent our device development and regulatory clearance or approval processes, damage our business prospects and negatively affect our reputation and competitive position.

Our long-term growth depends on our ability to develop and commercialize additional devices.

The medical device industry is highly competitive and subject to rapid change and technological advancements. Therefore, it is important to our business that we continue to enhance our device offerings and introduce new devices. Developing new devices is expensive and time-consuming and could divert management’s attention away from our core business. Even if we are successful in developing additional devices, the success of any new device offering or enhancements to existing devices will depend on several factors, including our ability to:

•

properly identify and anticipate surgeon and patient needs;

•

develop and introduce new devices or device enhancements in a timely manner;

•

develop an effective and dedicated sales and marketing team;

•

avoid infringing upon the intellectual property rights of third-parties;

•

demonstrate, if required, the safety and efficacy of new devices with data from preclinical studies and clinical trials;

•

obtain the necessary regulatory clearances or approvals for new devices or device enhancements;

•

be fully FDA-compliant with marketing of new devices or modified devices;

•

provide adequate training to potential users of our devices; and

•

receive adequate coverage and reimbursement for procedures performed with our devices.

If we are unsuccessful in developing and commercializing additional devices in other areas, our ability to increase our revenue may be impaired.

We may face product liability claims that could result in costly litigation and significant liabilities, and we may not be able to maintain adequate product liability insurance.

Our business exposes us to the risk of product liability claims that are inherent in the testing, manufacturing and marketing of medical devices. This risk exists even if a device is cleared or approved for commercial sale by the FDA and manufactured in facilities licensed and regulated by the FDA or an applicable foreign regulatory authority. Manufacturing and marketing of our commercial devices, and clinical testing of our devices under development, may expose us to product liability and other tort claims. Additionally, regardless of the merit or eventual outcome, product liability claims may result in:

•

litigation costs;

•

distraction of management’s attention from our primary business;

•

impairment of our business reputation;

•

the inability to commercialize our devices;

•

decreased demand for our devices or devices in development, if cleared or approved;

•

device recall or withdrawal from the market;

•

withdrawal of clinical trial participants;

•

substantial monetary awards to patients or other claimants; or

•

loss of revenue.

Although we have, and intend to maintain, liability insurance, the coverage limits of our insurance policies may not be adequate, and one or more successful claims brought against us may have a material adverse effect on our business and results of operations. If we are unable to obtain insurance in the future at an acceptable cost or on acceptable terms with adequate coverage, we will be exposed to significant liabilities.

Our ability to maintain our competitive position depends on our ability to attract, integrate and retain highly qualified personnel.

We believe that our continued success depends to a significant extent upon the efforts and abilities of our executive officers and other key personnel. Our executive officers and other key personnel are critical to the strategic direction and overall management of our company as well as our research and development process. All of our executive officers and other employees are at-will employees, and therefore may terminate employment with us at any time with no advance notice. The loss of any of our executive

officers and other key personnel could adversely affect our business, financial condition and operating results. Our Chief Financial Officer, Michael Gandy, has informed us of his intention to resign from his position to pursue other interests. We are actively engaged in a process to identify and hire a new Chief Financial Officer. While Mr. Gandy has indicated that he will continue in his current role until we have hired his replacement, we cannot assure you that we will be able to identify and hire an appropriate candidate in a timely manner or on terms reasonable to us or at all. Any delay in hiring a new Chief Financial Officer could significantly disrupt our business and operations. In addition, many members of our management team have only joined us in the last year as part of our investment in the expansion of our business, including our Vice President of Research and Development and Vice President of Operations. Our productivity may be adversely affected if we do not integrate and train our new employees quickly and effectively.

We invest significant time and expense in training our employees, which increases their value to competitors who may seek to recruit them. Many of our competitors have greater resources than we have. We do not carry any “key person” insurance policies. The replacement of any of our key personnel likely would involve significant time and costs and may significantly delay or prevent the achievement of our business objectives and would harm our business.

In addition, many of our employees have become or will soon become vested in a substantial amount of stock or number of stock options. Our employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the options, or if the exercise prices of the options that they hold are significantly below the market price of our common stock. Further, our employees’ ability to exercise those options and sell their stock in a public market after the closing of this offering may result in a higher than normal turnover rate.

If we fail to properly manage our anticipated growth, our business could suffer.

We have been growing rapidly in recent periods and have a relatively short history of operating as a commercial company. For example, we increased the number of employees from 49 at December 31, 2012 to 116 at March 31, 2015. We intend to continue to grow and may experience periods of rapid growth and expansion. Future growth will impose significant added responsibilities on management, including the need to identify, recruit, train and integrate additional employees. In addition, rapid and significant growth will place a strain on our administrative personnel, information technology systems and other operational infrastructure. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals. To achieve our revenue goals, we must continue to hire, train, retain and motivate skilled personnel.

In order to manage our operations and growth we will need to continue to improve our operational and management controls, reporting and information technology systems and financial internal control procedures. If we are unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our operating results and business could suffer.

We must also successfully increase production output to meet expected customer demand. In the future, we may experience difficulties with production yields and quality control, component supply, and shortages of qualified personnel, among other problems. These problems could result in delays in product availability and increases in expenses. Any such delay or increased expense could adversely affect our ability to generate revenues.

Our ability to achieve profitability will depend, in part, on our ability to reduce the per unit manufacturing cost of our current devices and attain a low per unit manufacturing cost for our future devices.

Currently, the gross profit generated from the sale of our devices is not sufficient to cover our operating expenses. To achieve profitability, we need to, among other things, reduce the per unit manufacturing cost of our current devices and attain low per unit manufacturing costs for our future devices. This cannot be achieved without improving manufacturing efficiency and increasing our manufacturing volume to leverage manufacturing overhead costs. If we are unable to improve manufacturing efficiency and reduce manufacturing overhead costs per unit, our ability to achieve profitability will be constrained. Any increase in manufacturing volumes is dependent upon a corresponding increase in sales. The occurrence of one or more factors that negatively impact the manufacturing or sales of our devices or reduce our manufacturing efficiency may prevent us from achieving our desired decrease in manufacturing costs, which would prevent us from attaining profitability.

If our facilities are damaged or become inoperable, we will be unable to continue to research, develop and manufacture our devices and, as a result, there will be an adverse impact on our business until we are able to secure a new facility.

We have recently transitioned all of our internal manufacturing, development and management activities to a new single location in San Francisco, California. Our facility and equipment would be costly to replace and could require substantial lead time to repair or replace. The facility may be harmed or rendered inoperable by natural or man-made disasters, including, but not limited to, earthquakes, flooding, fire, vandalism and power outages, which may render it difficult or impossible for us to perform our research, development, manufacturing and commercialization activities for some period of time. While we have taken precautions to safeguard our facilities, including through insurance and health and safety protocols, the inability to perform those activities may result in the inability to continue manufacturing our devices during such periods and the loss of customers or harm to our reputation. We also possess insurance for damage to our property and the disruption of our business, but this insurance may not be sufficient to cover all of our potential losses and this insurance may not continue to be available to us on acceptable terms, or at all.

We have no prior experience selling devices that are sold outside of the United States. If we commercialize any devices outside of the United States, a variety of risks associated with international operations could adversely impact our net sales, results of operations and financial condition.

We currently sell our devices in the United States but expect to expand sales to Europe and other regions directly and through distributors which will require us to identify and develop relationships with distributors who will focus on marketing our devices.

The sale and shipment of our devices across international borders, as well as the purchase of components from international sources, subjects us to U.S. and foreign governmental trade, import and export, and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly impact us include various anti-bribery laws, including the U.S. Foreign Corrupt Practices Act and anti-boycott laws, as well as export controls laws. Any failure to comply with applicable legal and regulatory obligations could impact us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments, restrictions on certain business activities and exclusion or debarment from government contracting. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our shipping and sales activities.

Additionally, the countries into which we expand our sales in the future may have different practices than the United States regarding the use of disposable medical devices. In the United States, our single-use optical waveguides for use with reusable retractors, single-use handheld illuminated aspiration devices and single-use drop-in intracavity illuminators are not reused whereas surgeons in some countries may reuse our single-use devices. Customers in these countries may be less willing to purchase our single-use devices as they were not designed to be reusable, or they may purchase fewer of our single-use devices than U.S. customers purchase because they choose to reuse our devices rather than purchasing additional single-use devices from us.

International operations will expose us and our distributors to risks inherent in operating in foreign jurisdictions. These risks include:

•

difficulties in enforcing or defending intellectual property rights;

•

pricing pressure that we may experience internationally;

•

a shortage of high-quality sales people and distributors;

•

third-party reimbursement policies that may require some of the patients who receive our devices to directly absorb medical costs or that may necessitate the reduction of the selling prices of our devices;

•

competitive disadvantage with established businesses and customer relationships;

•

the imposition of additional U.S. and foreign governmental controls or regulations;

•

economic instability;

•

changes in duties and tariffs, license obligations and other non-tariff barriers to trade;

•

the imposition of restrictions on the activities of foreign agents, representatives and distributors;

•

scrutiny of foreign tax authorities which could result in significant fines, penalties and additional taxes being imposed on us;

•

laws and business practices favoring local companies;

•

longer payment cycles;

•

foreign currency exchange rate fluctuations;

•

difficulties in maintaining consistency with our internal guidelines;

•

difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;

•

the imposition of costly and lengthy new export licensing requirements;

•

the imposition of U.S. or international sanctions against a country, company, person or entity with whom we do business that would restrict or prohibit continued business with the sanctioned country, company, person or entity; and

•

the imposition of new trade restrictions.

If we experience any of these risks, our sales in international countries may be harmed and our results of operations would suffer.

Our operations involve the use of hazardous and toxic materials, and we must comply with environmental, health and safety laws and regulations, which can be expensive, and could have an adverse impact on our business.

Our operations use or generate small volumes of hazardous or toxic materials. We are therefore subject to a variety of federal, state and local regulations relating to the use, handling, storage, disposal and human exposure to hazardous and toxic materials. Liability under environmental laws can be joint and several and without regard to comparative fault, and environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations, which could have an adverse impact on our business. Although we believe that our activities conform in all material respects with environmental, health and safety laws, there can be no assurance that violations of environmental, health and safety laws will not occur in the future as a result of human error, accident, equipment failure or other causes. The failure to comply with past, present or future laws could result in the imposition of fines, third-party property damage and personal injury claims, investigation and remediation costs, the suspension of production or a cessation of operations. We also expect that our operations will be affected by other new environmental and health and safety laws and regulations on an ongoing basis. Although we cannot predict the ultimate impact of any such new laws and regulations, they will likely result in additional costs, and may require us to change how we manufacture our devices, which could have an adverse impact on our business.

We may acquire other companies or technologies, which could divert our management’s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.

We may in the future seek to acquire or invest in companies or technologies that we believe could complement or expand our platform, enhance our technical capabilities or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. We may not be able to identify desirable acquisition targets or be successful in entering into an agreement with any particular target or obtain the expected benefits of any acquisition or investment.

To date, the growth in our business has been organic, and we have no experience in acquiring other businesses. In any acquisition, we may not be able to successfully integrate acquired personnel, operations and technologies, or effectively manage the combined business following the acquisition. Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash or the incurrence of debt, which could harm our operating results. In addition, if an acquired company or technology fails to meet our expectations, or if we are unable to integrate any acquired company or technology, our operating results, business and financial condition may suffer.

Failure to protect our information technology infrastructure against cyber-based attacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.

We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, attacks by computer hackers, failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors

or catastrophic events. We are not aware of any breaches of our information technology infrastructure. Despite the precautionary measures we have taken to prevent breakdowns in our information technology and telephone systems, if our systems suffer severe damage or disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may suffer.

Risks Related to Our Intellectual Property

If our intellectual property rights are not adequately protected, our business will be negatively affected.

Our success depends in large part on our intellectual property rights, including patents, trademarks, trade secrets, copyrights and know-how. The steps we have taken and may take in the future to protect our intellectual property may not adequately prevent misappropriation or ensure that others will not develop competitive technologies or devices. We cannot assure you that our competitors will not successfully challenge the validity or ownership of our patents or design products that avoid infringement of our proprietary rights with respect to our technology. There can be no assurance that other companies are not investigating or developing other similar technologies, that any patents will be issued from any application pending or filed by us, or that, if patents are issued, that the issued claims will be sufficiently broad to deter or prohibit others from marketing similar devices. We may also not be able to detect infringement of our patents by third parties. In addition, we cannot assure you that any patents issued to us will not be challenged, invalidated or circumvented, or that the rights under those patents will provide a competitive advantage to us or that our devices and technology will be adequately covered by our patents and other intellectual property. Additionally, as our patents expire, we may be unsuccessful in extending their protection through adjustments in patent term. The expiration of, or the failure to maintain or extend our patents, could have a material adverse effect on us.

Furthermore, we do not have any patent rights in certain foreign countries in which a market may exist in the future, and the laws of many foreign countries may not protect our intellectual property rights to the same extent as the laws of the United States. The scope of our patent claims may vary between countries, as individual countries have distinctive patent laws. Thus, we may not be able to stop a competitor from marketing and selling in certain foreign countries devices that are the same as or similar to our devices.

We also own trade secrets and confidential information that we try to protect by entering into invention assignment and confidentiality agreements with our employees and other parties. However, these agreements may not be honored or, if breached, we may not have sufficient remedies to protect our confidential or proprietary information. Further, our competitors may independently learn our trade secrets and develop similar or superior technologies. To the extent that our consultants, key employees or others apply technological information to our projects that they develop independently or others develop, disputes may arise regarding the ownership of proprietary rights to such information, and such disputes may not be resolved in our favor. If we are unable to protect our intellectual property adequately, our business and commercial prospects will suffer.

The medical device industry is characterized by extensive patent litigation, and we could become subject to litigation that could be costly, result in the diversion of management’s attention, require us to pay significant damages or royalty payments or prevent us from marketing and selling our existing or future devices.

Our success depends in part on not infringing the patents or violating the other proprietary rights of others. Significant litigation regarding patent rights occurs in the medical industry. It is possible that U.S. and foreign patents and pending patent applications controlled by third parties may be alleged to cover our devices. Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent,

limit or otherwise interfere with our ability to make, use and sell our devices. We may receive in the future, particularly as a public company, communications from patent holders, including non-practicing entities, alleging infringement of patents or other intellectual property rights or misappropriation of trade secrets, or offering licenses to such intellectual property. At any given time, we may be involved as either a plaintiff or a defendant in a number of patent infringement actions, the outcomes of which may not be known for prolonged periods of time. Such intellectual property litigation is typically costly and time-consuming. Litigation proceedings, if instituted against us, could divert our management’s and technical team’s attention and resources. Adverse determinations in any such litigation could result in significant liabilities to third parties or injunctions, or could require us to seek licenses from third parties and, if such licenses are not available on commercially reasonable terms, prevent us from manufacturing, selling or using certain devices, any one of which could have a material adverse effect on us. In addition, some licenses may be nonexclusive, which could provide our competitors access to the same technologies. Third parties could also obtain patents that may require us to either redesign products or, if possible, negotiate licenses from such third parties. Such licenses may materially increase our expenses.

The large number of patents, the rapid rate of new patent applications and issuances, the complexities of the technologies involved and the uncertainty of litigation significantly increase the risks related to any patent litigation. Any potential intellectual property litigation also could force us to do one or more of the following:

•

stop selling, making, or using devices that use the disputed intellectual property;

•

obtain a license from the intellectual property owner to continue selling, making, licensing, or using devices, which license may require substantial royalty payments and may not be available on reasonable terms, or at all;

•

incur significant legal expenses;

•

pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing;

•

pay the attorney fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing; and

•

redesign those devices that contain the allegedly infringing intellectual property, which could be costly, disruptive and/or infeasible.

If any of the foregoing occurs, we may have to withdraw existing devices from the market or may be unable to commercialize one or more of our devices, all of which could have a material adverse effect on our business, results of operations and financial condition. Any litigation or claim against us, even those without merit, may cause us to incur substantial costs and could place a significant strain on our financial resources, divert the attention of management from our core business and harm our reputation. Further, as the number of participants in the industry grows, the possibility of intellectual property infringement claims against us increases.

In addition, we may be required to indemnify our customers, distributors and OEM partners with respect to infringement by our devices of the proprietary rights of third parties. Third parties may assert infringement claims against our customers or distributors which may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers or distributors or may be required to obtain licenses for the devices they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our devices.

Risks Related to Our Capital Structure

We may be required to obtain additional funds in the future, and these funds may not be available on acceptable terms or at all.

Our operations have consumed substantial amounts of cash since inception, and we anticipate our expenses will increase as we seek to continue to grow our business and transition to operating as a public company. We believe that our growth will depend, in part, on our ability to fund our commercialization efforts and our efforts to develop new technologies for surgical illumination and visualization, and technology complementary to our current devices. Our existing resources may not allow us to conduct all of these activities that we believe would be beneficial for our future growth. As a result, we may need to seek funds in the future and if we are unable to raise funds on favorable terms, or at all, we may not be able to support our commercialization efforts or increase our research and development activities and the growth of our business may be negatively impacted. As a result, we may be unable to compete effectively. For the three months ended March 31, 2015, our net cash used in operating activities was $6.9 million, and was $13.9 million and $19.8 million for the years ended December 31, 2013 and 2014, respectively. As of March 31, 2015, we had working capital of $28.2 million, which included $25.3 million in cash and cash equivalents. Our cash requirements in the future may be significantly different from our current estimates and depend on many factors, including:

•

the results of our commercialization efforts for our existing and future devices, including international expansion;

•

the rate at which we continue to grow our direct salesforce and increase our marketing activities;

•

the establishment of high volume manufacturing;

•

the need for additional capital to fund future development programs;

•

the costs involved in obtaining and enforcing patents or any litigation by third parties regarding intellectual property; and

•

our success in entering into collaborative relationships with other parties.

To finance these activities, we may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third-parties, it may be necessary to relinquish some rights to our technologies or our devices, or grant licenses on terms that are not favorable to us.

Furthermore, we cannot be certain that additional funding will be available on acceptable terms, if at all. If we do not have, or are not able to obtain, sufficient funds, we may have to reduce marketing, customer support or other resources devoted to our existing devices, delay development or commercialization of our devices in development, license to third parties the rights to commercialize devices or technologies that we would otherwise seek to commercialize or cease operations. Any of these actions could harm our operating results.

We may not be able to generate sufficient cash to service our indebtedness, which currently consists of our term loan with HealthCare Royalty Partners and line of credit with Silicon Valley Bank.

As of March 31, 2015, we owed an aggregate principal amount of $15.0 million, and accrued interest of $21,000, to HealthCare Royalty Partners, pursuant to a term loan agreement, which we refer to as the HCRP loan agreement.

In addition, in February 2015, we entered into a $7.5 million loan and security agreement with Silicon Valley Bank, which we refer to as the SVB credit facility. SVB has a first priority security in our cash and cash equivalents, accounts receivable and inventory, and HCRP has a second priority security in these assets and a first priority interest in our remaining assets. As of March 31, 2015, we had not drawn down on the SVB credit facility. Pursuant to the terms of the SVB credit facility, we can borrow up to 80% of certain qualified accounts receivables at a per annum interest rate equal to the prime rate as published by the Wall Street Journal plus 0.75%. In addition, the credit facility states that if we maintain a net cash balance, defined as unrestricted cash held with SVB less any borrowings on the revolving line of credit, of more than $3.0 million, then all collections will be deposited in our operating account. If the net cash balance is below $3.0 million, then all collections will be held in an SVB-controlled account and applied to reduce the loan balance.

Our ability to make scheduled payments or to refinance our debt obligations depends on numerous factors, including the amount of our cash balances and our actual and projected financial and operating performance. These amounts and our performance are subject to certain financial and business factors, as well as prevailing economic and competitive conditions, some of which may be beyond our control. We may be unable to maintain a level of cash balances or cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on our existing or future indebtedness. If our cash flows and capital resources are insufficient to fund our debt service obligations, we may be forced to reduce or delay capital expenditures, sell assets or operations, seek additional capital or restructure or refinance our indebtedness. Our future working capital, borrowings or equity financing could be unavailable to repay or refinance the amounts outstanding under the loan agreements, and even if they were, these actions may be insufficient to permit us to meet our scheduled debt service obligations. In addition, in the event of our breach of either the HCRP loan agreement or the SVB credit facility, we may not be allowed to draw additional amounts under the other agreement, and we may be required to repay any outstanding amounts earlier than anticipated. In the event of a liquidation, HealthCare Royalty Partners and Silicon Valley Bank would be repaid all outstanding principal, premium, if any, and interest prior to distribution of assets to unsecured creditors, and the holders of our common stock would receive a portion of any liquidation proceeds only if all of our creditors, including HealthCare Royalty Partners and Silicon Valley Bank, were first repaid in full.

The HCRP loan agreement and the SVB credit facility each contain restrictive covenants that may limit our operating flexibility.

The HCRP loan agreement and the SVB credit facility each contain certain restrictive covenants that, among other things, either limit our ability to incur, or require a mandatory prepayment in the event we incur, additional indebtedness or liens, merge with or acquire other companies, consummate a change of control, engage in new lines of business, make certain investments, pay dividends, transfer or dispose of assets, amend certain material agreements or enter into various specified transactions. We therefore may not be able to engage in any of the foregoing transactions unless we obtain the consent of our lenders or prepay the outstanding amounts under the HCRP loan agreement and SVB credit facility, which could require us to pay additional prepayment penalties.

Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations; in addition, we may be unable to use a substantial part of our net operating losses if we don’t attain profitability in an amount necessary to offset such losses.

As of December 31, 2014, we had net operating loss, or NOL, carryforwards for federal and state income tax purposes of approximately $60.9 million and $53.8 million, respectively. In general, under Section 382 of the Internal Revenue Code of 1986, as amended, or Section 382, a corporation that undergoes an “ownership change” is subject to limitations on its ability to utilize its pre-change NOLs to offset future taxable income. Our existing NOLs may be subject to limitations arising from previous ownership changes, and if we undergo an ownership change in connection with or after this offering, our ability to utilize NOLs could be further limited by Section 382. Future changes in our stock ownership, some of which are outside of our control, could also result in an ownership change under Section 382. Furthermore, we may be unable to use a substantial part of our NOLs if we do not attain profitability in an amount sufficient to offset such losses. Any limitation on using NOLs could result in our retaining less cash after payment of U.S. federal and state income taxes during any year in which we have taxable income than we would be entitled to retain if such NOLs were available as an offset against such income for U.S. federal income and state tax reporting purposes, which could materially and adversely affect our results of operations.

Risks Related to Government Regulation

Our business is subject to extensive governmental regulation that could make it more expensive and time consuming for us to introduce new or improved devices.

Our devices are medical devices and must comply with regulatory requirements imposed by the FDA in the United States and similar agencies in foreign jurisdictions. While our current devices are classified as Class I, Class II exempt, or Class II medical devices in the United States and are not subject to premarket clearance or approval by the FDA, these requirements could change and new devices may be subject to more extensive regulation. Premarket clearance or approval has become more stringent overt time and can involve lengthy and detailed laboratory and clinical testing procedures and an extensive agency review process, and other costly and time-consuming procedures. It often takes several years to satisfy these requirements depending on the complexity and novelty of the device. We also are subject to numerous additional licensing and regulatory requirements relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances.

Government regulation may impede our ability to develop and manufacture our existing and future devices. Government regulation also could delay our marketing of new devices for a considerable period of time and impose costly procedures on our activities. The FDA and other regulatory agencies may not approve or clear any of our future devices on a timely basis, if at all. Any delay in obtaining, or failure to obtain, such approvals or clearances could negatively impact our marketing of any future devices and reduce our device revenues.

Our devices remain subject to strict regulatory controls on manufacturing, marketing and use. We may be forced to modify or recall a device after release in response to regulatory action or unanticipated difficulties encountered in general use. Any such action could have a material adverse effect on the reputation of our devices and on our business and financial position.

Further, regulations may change, and any additional regulation could limit or restrict our ability to use any of our technologies, which could harm our business. We could also be subject to new international, federal, state or local regulations that could affect our research and development programs and harm our business in unforeseen ways. If this happens, we may have to incur significant costs to comply with such laws and regulations, which will harm our results of operations.

Our devices are medical devices that are subject to extensive regulation by FDA in the United States and by regulatory agencies in other countries where we plan to do business. Government regulations specific to medical devices are wide-ranging and govern, among other things:

•

device design, development and manufacture;

•

laboratory, preclinical and clinical testing, labeling, packaging, storage and distribution;

•

premarketing clearance and approval;

•

record keeping;

•

device marketing, promotion and advertising, sales and distribution; and

•

post-marketing surveillance, including reporting of deaths and serious injuries and recalls and correction and removals.

Before a new medical device, or a new intended use for, an existing device can be marketed in the United States, a company must first submit and receive either 510(k) clearance or premarketing approval from the FDA, unless an exemption applies. In the 510(k) clearance process, the FDA must determine that a proposed device is “substantially equivalent” to a device legally on the market, known as a “predicate” device, with respect to intended use, technology and safety and effectiveness, in order to clear the proposed device for marketing. Clinical data is sometimes required to support substantial equivalence. The PMA pathway requires an applicant to demonstrate the safety and effectiveness of the device based on extensive data, including, but not limited to, technical, preclinical, clinical trial, manufacturing and labeling data. The PMA process is typically required for devices that are deemed to pose the greatest risk, such as life-sustaining, life-supporting or implantable devices. Products that are approved through a PMA application generally need FDA approval before they can be modified. Similarly, some modifications made to products cleared through a 510(k) may require a new 510(k). Either process can be expensive, lengthy and unpredictable. We may not be able to obtain the necessary clearances or approvals or may be unduly delayed in doing so, which could harm our business. Furthermore, even if we are granted regulatory clearances or approvals, they may include significant limitations on the indicated uses for the device, which may limit the market for the device. Although we have obtained 510(k) clearance to market our sterilization trays, our clearance can be revoked if safety or efficacy problems develop.

In addition, we are required to timely file various reports with the FDA, including reports required by the medical device reporting regulations, or MDRs, that require that we report to the regulatory authorities if our devices may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur. If these reports are not filed timely, regulators may impose sanctions and sales of our devices may suffer, and we may be subject to product liability or regulatory enforcement actions, all of which could harm our business. Six MDRs for our devices have been filed, which includes a discontinued reusable aspiration device that we voluntarily recalled in 2012, four reports in 2012 of device breakage and one report in 2014 relating to tissue irritation.

If we initiate a correction or removal for one of our devices to reduce a risk to health posed by the device, we would be required to submit a publically available Correction and Removal report to the FDA and in many cases, similar reports to other regulatory agencies. This report could be classified by the FDA as a device recall which could lead to increased scrutiny by the FDA, other international regulatory agencies and our customers regarding the quality and safety of our devices. Furthermore, the submission

of these reports has been and could be used by competitors against us in competitive situations and cause customers to delay purchase decisions or cancel orders and would harm our reputation. The only Correction and Removal report that we have submitted to the FDA is in connection with the discontinued reusable aspiration device that we voluntarily recalled in 2012.

The FDA and the Federal Trade Commission, or FTC, also regulate the advertising and promotion of our devices to ensure that the claims we make are consistent with our regulatory clearances, that there are adequate and reasonable data to substantiate the claims and that our promotional labeling and advertising is neither false nor misleading in any respect. If the FDA or FTC determines that any of our advertising or promotional claims are misleading, not substantiated or not permissible, we may be subject to enforcement actions, including Warning Letters, and we may be required to revise our promotional claims and make other corrections or restitutions.

FDA and state authorities have broad enforcement powers. Our failure to comply with applicable regulatory requirements could result in enforcement action by the FDA or state agencies, which may include any of the following sanctions:

•

adverse publicity, warning letters, fines, injunctions, consent decrees and civil penalties;

•

repair, replacement, refunds, recall or seizure of our devices;

•

operating restrictions, partial suspension or total shutdown of production;

•

refusing our requests for 510(k) clearance or premarket approval of new devices, new intended uses or modifications to existing devices;

•

withdrawing 510(k) clearance or premarket approvals that have already been granted; and

•

criminal prosecution.

If any of these events were to occur, our business and financial condition would be harmed.

The misuse of our devices may harm our image in the marketplace, result in injuries that lead to product liability suits, which could be costly to our business, or result in costly investigations and FDA sanctions if we are deemed to have engaged in such promotion.

Surgeons may misuse our devices or use improper techniques if they are not adequately trained, potentially leading to injury and an increased risk of product liability. If our devices are misused or used with improper technique, we may become subject to costly litigation by our customers or their patients. Product liability claims could divert management’s attention from our core business, be expensive to defend, and result in sizable damage awards against us that may not be covered by insurance. Any of these events could significantly harm our business and results of operations and cause our stock price to decline.

Our devices may in the future be subject to recalls or voluntary market withdrawals that could harm our reputation, business and financial results.

The FDA and similar foreign governmental authorities have the authority to require the recall of commercialized devices in the event of material deficiencies or defects in the design, manufacture or labeling of the device that could affect patient safety or in the event that a product poses an unacceptable risk to health. In the case of the FDA, the authority to require a recall must be based on an FDA finding that there is a reasonable probability that the device would cause serious adverse health consequences or death. Further, under the FDA’s MDR regulations, we are required to report to the FDA any incident in which our product may have caused or contributed to a death or serious injury or in which our product malfunctioned and, if the malfunction were to recur, would likely cause or contribute to death or serious injury. Manufacturers may, under their own initiative, conduct a device notification or recall to inform surgeons of changes to instructions for use or of a deficiency, or of a suspected deficiency, found in a

device. For example, in 2012, we conducted a voluntary recall relating to a fiber optic aspiration device that we no longer sell. A government-mandated recall or voluntary recall by us or one of our distributors could occur as a result of component failures, manufacturing errors, design or labeling defects or other issues.

Repeated product malfunctions may result in a voluntary or involuntary product recall, which could divert managerial and financial resources, impair our ability to manufacture our products in a cost-effective and timely manner and have an adverse effect on our reputation, financial condition and operating results. Depending on the corrective action we take to redress a product’s deficiencies or defects, the FDA may require, or we may decide, that we will need to obtain new approvals or clearances for the device before we may market or distribute the corrected device. Seeking such approvals or clearances may delay our ability to replace the recalled devices in a timely manner. Moreover, if we do not adequately address problems associated with our devices, we may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative penalties, or civil or criminal fines. We may also be required to bear other costs or take other actions that may have a negative impact on our sales as well as face significant adverse publicity or regulatory consequences, which could harm our business, including our ability to market our products in the future.

Any adverse event involving our products could result in future voluntary corrective actions, such as recalls or customer notifications, or regulatory agency action, which could include inspection, mandatory recall or other enforcement action. Recalls, which include certain notifications and corrections as well as removals, of any of our devices, could divert managerial and financial resources and could have an adverse effect on our financial condition, harm our reputation with customers, and reduce our ability to achieve expected revenues.

Material modifications to our devices may require new 510(k) clearances or premarket approvals or may require us to recall or cease marketing our devices until clearances or approvals are obtained.

Material modifications to the intended use or technological characteristics of our devices will require new 510(k) clearances or premarket approvals or require us to recall or cease marketing the modified devices until these clearances or approvals are obtained. Based on FDA published guidelines, the FDA requires device manufacturers to initially make and document a determination of whether or not a modification requires a new approval, supplement, or clearance; however, the FDA can review a manufacturer’s decision. Any modification to an FDA-cleared device that would significantly affect it safety or efficacy or that would constitute a major change in its intended use would constitute a material modification and would require a new 510(k) clearance or possibly a premarket approval. We may not be able to obtain additional 510(k) clearances or premarket approvals for new devices or for modifications to, additional indications for, our devices in a timely fashion, or at all. Delays in obtaining required future clearances would harm our ability to introduce new or enhanced devices in a timely manner, which in turn would harm our future growth. We have made modifications to our devices in the past and will make additional modifications in the future that we believe do not or will not require additional clearances or approvals. If the FDA disagrees and requires new clearances or approvals for the modifications, we may be required to recall and to stop selling or marketing our devices as modified, which could harm our operating results and require us to redesign our platform devices. In these circumstances, we may also be subject to significant enforcement actions such as significant regulatory fines or penalties. Furthermore, the FDA’s ongoing review of the 510(k) program may make it more difficult for us to modify our previously cleared products, either by imposing stricter requirements on when a new 510(k) for a modification to a previously cleared product must be submitted, or applying more onerous review criteria to such submissions. Specifically, on July 9, 2012, the FDA Safety and Innovation Act of 2012 was enacted which, among other requirements, obligates the FDA to prepare a report for Congress on the FDA’s approach for determining when a new 510(k) will be required for modifications or changes to a previously cleared device. The FDA recently submitted this report and suggested that manufacturers

continue to adhere to the FDA’s 1997 Guidance on this topic when making a determination as to whether or not a new 510(k) is required for a change or modification to a device. However, the practical impact of the FDA’s continuing scrutiny of these issues remains unclear.

If we or our suppliers fail to comply with the FDA’s Quality System Regulation, our manufacturing operations could be delayed or shut down and our sales could suffer.

Our manufacturing processes and those of our third-party suppliers are required to comply with the FDA’s Quality System Regulation, which covers the procedures and documentation of the design, testing, production, control, quality assurance, labeling, packaging, sterilization, storage and shipping of our devices. We are also subject to similar state requirements and licenses. In addition, we must engage in extensive recordkeeping and reporting and must make available our manufacturing facilities and records for periodic announced and unannounced inspections by governmental agencies, including the FDA, state authorities and comparable agencies in other countries. If we fail a Quality System inspection, our operations could be disrupted and our manufacturing interrupted. Failure to take adequate and prompt corrective action in response to an adverse Quality System inspection could result in, among other things, a partial or total shut-down of our manufacturing operations, significant fines, consent decrees, injunctions, untitled letters, warning letters, injunctions, customer notifications or repair, replacement, refunds, recall, detention or seizure of our products, suspension of marketing clearances and approvals, seizures or recalls of our devices, operating restrictions, refusal to grant export approval for our products, refusing or delaying our requests for 510(k) clearance or pre-market approval of new products or modified products, withdrawing 510(k) clearances or pre-market approvals that have already been granted, and criminal prosecutions, any of which would cause our business to suffer. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements, which may result in manufacturing delays for our devices and cause revenues to decline.

We have registered with the FDA as a medical device manufacturer and have obtained a manufacturing license from the California Department of Health Services, or CDHS. The FDA has broad post-market and regulatory enforcement powers. We are subject to announced and unannounced inspections by FDA and the Food and Drug Branch of CDHS to determine our compliance with the QSR and other regulations, and these inspections may include the manufacturing facilities of our suppliers. We passed the most recent audit by the Food and Drug Branch of CDHS in February 2015, and the inspection revealed no minor or major issues. However, we cannot assure you that we will pass future inspections by the FDA or other regulatory bodies.

We may be subject to federal, state and foreign healthcare laws and regulations, and a finding of failure to comply with such laws and regulations could have a material adverse effect on our business.

Our operations are, and will continue to be, directly and indirectly affected by various federal, state or foreign healthcare laws, including, but not limited to, those described below. These laws include:

•

the federal Anti-Kickback Statute, which prohibits, among other things, persons from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal healthcare programs, such as the Medicare and Medicaid programs. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it to have committed a violation; in addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act;

•

federal false claims laws which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, claims for payment from Medicare,

Medicaid or other federal third-party payors that are false or fraudulent. Suits filed under the False Claims Act, known as “qui tam” actions, can be brought by any individual on behalf of the government and such individuals, commonly known as “whistleblowers”, may share in any amounts paid by the entity to the government in fines or settlement. When an entity is determined to have violated the False Claims Act, it may be required to pay up to three times the actual damages sustained by the government, plus civil penalties for each separate false claim;

•

the federal Civil Monetary Penalties Law, which prohibits, among other things, offering or transferring remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary’s decision to order or receive items or services reimbursable by the government from a particular provider or supplier;

•

federal criminal laws that prohibit executing a scheme to defraud any federal healthcare benefit program or making false statements relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation;

•

the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act, which governs the conduct of certain electronic healthcare transactions and protects the security and privacy of protected health information;

•

the federal Physician Payment Sunshine Act, which requires manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children’s Health Insurance Program (with certain exceptions) to report annually to CMS information related to payments or other “transfers of value” made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and requires applicable manufacturers and group purchasing organizations to report annually to the government ownership and investment interests held by the physicians described above and their immediate family members and payments or other “transfers of value” to such physician owners. Manufacturers are required to submit reports to CMS by the 90^th day of each calendar year. Failure to submit the required information may result in civil monetary penalties up to an aggregate of $150,000 per year (and up to an aggregate of $1 million per year for “knowing failures”) for all payments, transfers of value or ownership or investment interests not reported in an annual submission, and may result in liability under other federal laws or regulations;

•

the U.S. Foreign Corrupt Practices Act, or the FCPA, which prohibits corporations and individuals from paying, offering to pay or authorizing the payment of anything of value to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity; the UK Bribery Act, which prohibits both domestic and international bribery, as well as bribery across both public and private sectors; and bribery provisions contained in the German Criminal Code, which, pursuant to draft legislation being prepared by the German government, may make the corruption and corruptibility of physicians in private practice and other healthcare professionals a criminal offense; and

•

analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers; state laws that require device companies to comply with the industry’s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require device manufacturers to report information related to payments and other transfers of value

to physicians and other healthcare providers or marketing expenditures; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.

The risk of our being found in violation of these laws is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available under such laws, it is possible that some of our business activities, including our relationships with surgeons and other healthcare providers, some of whom recommend, purchase and/or prescribe our devices, group purchasing organizations and our independent sales agents and distributors, could be subject to challenge under one or more of such laws. We are also exposed to the risk that our employees, independent contractors, principal investigators, consultants, vendors, independent sales agents and distributors may engage in fraudulent or other illegal activity. While we have policies and procedures in place prohibiting such activity, misconduct by these parties could include, among other infractions or violations, intentional, reckless and/or negligent conduct or unauthorized activity that violates FDA regulations, including those laws that require the reporting of true, complete and accurate information to the FDA, manufacturing standards, federal and state healthcare fraud and abuse laws and regulations, laws that require the true, complete and accurate reporting of financial information or data or other commercial or regulatory laws or requirements. It is not always possible to identify and deter misconduct by our employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations.

If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us now or in the future, we may be subject to penalties, including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental health care programs, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our financial results. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management’s attention from the operation of our business.

We may fail to obtain foreign regulatory approvals to market our devices in other countries.

We do not have any direct sales outside of the United States; our corporate partners, however, manufacture and sell certain of our devices outside of the United States and have already obtained the necessary regulatory approvals to manufacture and sell certain of our devices outside of the United States. Sales of our devices outside the United States are subject to foreign regulatory requirements that vary widely from country to country. In addition, the FDA regulates the exports of medical devices from the United States. Complying with international regulatory requirements can be an expensive and a time-consuming process and clearance or approval is not certain. The time required to obtain clearances or approvals, if required by other countries, may be longer than required for FDA clearances or approvals, and requirements for such clearances or approvals may significantly differ from FDA requirements. In certain countries we may rely upon third-party or third-party distributors to obtain all required regulatory clearances or approvals, and these distributors may be unable to obtain or maintain such clearances or approvals. Our distributors in these countries may also incur significant costs in attempting to obtain and in maintaining foreign regulatory approvals or qualifications, which could increase the difficulty of attracting and retaining qualified distributors. If these distributors experience delays in receiving necessary qualifications, clearances or approvals to market our devices outside the United States, or if they fail to receive those qualifications, clearances or approvals, we may be unable to market our devices in certain international markets effectively, or at all, which will adversely affect our results of operations and financial condition generally.

Healthcare policy changes, including recent federal legislation to reform the U.S. healthcare system, may have a material adverse effect on us.

In March 2010, President Obama signed the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or PPACA. The PPACA includes, among other things, a deductible 2.3% excise tax on any entity that manufactures or imports medical devices offered for sale in the United States, with limited exceptions, effective January 1, 2013. This excise tax has resulted in an increase in the tax burden on our industry, and if any efforts we undertake to offset the excise tax are unsuccessful, the increased tax burden could have an adverse effect on our results of operations and cash flows. Other elements of the PPACA, including comparative effectiveness research, an independent payment advisory board, payment system reforms including shared savings pilots and other provisions, may significantly affect the payment for, and the availability of, healthcare services and may result in fundamental changes to federal healthcare reimbursement programs, any of which may adversely affect numerous aspects of our business.

In addition, other legislative changes have been proposed and adopted in the United States since the PPACA was enacted. On August 2, 2011, the Budget Control Act of 2011 among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation’s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect in April 2013, and, due to subsequent legislative amendments to the statute, will remain in effect through 2024 unless additional Congressional action is taken. On January 2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012, or the ATRA, which, among other things, further reduced Medicare payments to several providers, including hospitals.

We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare devices and services, which could result in reduced demand for our devices or additional pricing pressures.

Risks Related to this Offering and Ownership of our Common Stock

Our common stock has never been publicly traded, and we expect that the price of our common stock will fluctuate substantially.

Before this offering, there has been no public market for our common stock, and we cannot be certain that an active trading market for our common stock will develop or be sustained following this offering. The lack of an active market may impair the value of your shares, or your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. An inactive market may also impair our ability to raise capital to continue to fund operations by selling shares and may impair our ability to acquire other companies or products by using our shares as consideration. Upon closing of this offering, we anticipate that our common stock will be listed on the NASDAQ Global Market. If we fail to satisfy the continued listing standards of the NASDAQ Global Market, however, we could be de-listed, which would negatively impact the price of our common stock.

The trading price of our common stock is likely to be volatile and could fluctuate widely regardless of our operating performance. As a result of this volatility, you may not be able to sell your common stock at or above the initial public offering price, if at all. The initial public offering price for our common stock will be determined through negotiations between the underwriters and us and may vary substantially from the market price of our common stock following this offering. In addition, the market price of our common stock is likely to be highly volatile and may fluctuate substantially in response to, among other things, the risk factors described in this prospectus and other factors, many of which are beyond our control, including:

•

actual or anticipated quarterly variations in our or our competitors’ results of operations;

•

variance in our financial performance from the financial projects we may provide to the public, any changes in these projections or our failure to meet these projections;

•

changes in operating performance and stock market valuations of other technology companies generally, or those in the medical device industry in particular;

•

announcements of significant new devices or device enhancements by us or our competitors;

•

changes in our pricing policies or the pricing policies of our competitors;

•

changes in analysts’ estimates, investors’ perceptions, recommendations by securities analysts or our failure to achieve analysts’ estimates;

•

legislation or regulatory policies, practices or actions affecting our business;

•

lawsuits threatened or filed against us;

•

the sale of our common stock or other securities in the future by us or our stockholders, including upon expiration of market standoff or contractual lock-up agreements;

•

developments or disputes concerning our intellectual property or other proprietary rights;

•

announcements related to patents issued to us or our competitors and to litigation;

•

recruitment or departure of key personnel, including changes in our board of directors and management;

•

changes in market valuation or earnings of our competitors;

•

the trading volume of our common stock;

•

changes in the estimation of the future size and growth rate of our markets;

•

general market conditions and other factors unrelated to our operating performance or the operating performance of our competitors; and

•

developments in our industry.

In addition, the market prices of the stock of many new issuers in the medical device industry and of other companies with smaller market capitalizations like us have been volatile and from time to time have experienced significant share price and trading volume changes unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have filed securities class action litigation following periods of market volatility. If we were to become involved in securities litigation, it could subject us to substantial costs, divert resources and the attention of management from our business, and adversely affect our business, results of operations, financial condition, reputation and cash flows. These factors may materially and adversely affect the market price of our common stock.

A substantial number of additional shares may be sold into the public market in the near future, which may cause the market price of our common stock to decline significantly, even if our business is doing well.

Sales of a substantial amount of common stock in the public market, or the perception that these sales may occur, could adversely affect the market price of our common stock. Based upon the number of shares outstanding as of March 31, 2015, immediately upon completion of this offering, we will have shares of common stock outstanding, assuming no exercise of our outstanding options and warrants. This includes the shares we are selling in this offering, which may be resold in the public market immediately, except for any shares held or purchased in this offering by our affiliates, as defined in Rule 144 under the Securities Act. The remaining shares of common stock outstanding after this offering will be restricted as a result of applicable securities laws, lock-up or market standoff agreements, or other contractual restrictions that restrict transfers for at least 180 days after the date of

this prospectus. However, Piper Jaffray & Co. and Leerink Partners LLC may, in their sole discretion, release all or some portion of the shares subject to lock-up agreements with the underwriters prior to expiration of the lock-up period. As restrictions on resale expire, the market price could drop significantly if the holders of these restricted shares sell them or are perceived by the market as intending to sell them. For a more detailed description, see the sections of this prospectus entitled “Shares Eligible for Future Sale” and “Underwriting.” In addition, shares of our common stock purchased by our officers and directors in the directed share program will be subject to the 180-day contractual lock-up agreement with the underwriters.

After this offering, the holders of shares of common stock and holders of warrants to purchase shares of common stock, based on shares outstanding as of March 31, 2015, have the right, subject to some conditions, to require us file registration statements under the Securities Act covering their shares or to include their shares in registration statements that we may file for ourselves or our stockholders pursuant to a stockholders agreement between such holders and us. If such holders, by exercising their registration rights, sell a large number of shares, they could adversely affect the market price for our common stock. If we file a registration statement for the purpose of selling additional shares to raise capital and are required to include shares held by these holders pursuant to the exercise of their registration rights, our ability to raise capital may be impaired.

We also intend to file a registration statement under the Securities Act to register all shares subject to options outstanding or reserved for future issuance under our equity incentive plans. Our 2015 Equity Incentive Plan provides for annual automatic increases in the shares reserved for issuance under the plan without stockholder approval, which would result in additional dilution to our stockholders. Once we register these shares, they can be freely sold in the public market upon issuance and vesting, subject to any applicable lock-up period or other restrictions provided under the terms of the applicable plan and/or the option agreements entered into with option holders.

Our directors, officers and principal stockholders will continue to have significant voting power after this offering and may take actions that may not be in the best interests of our other stockholders.

Upon completion of this offering, our directors and executive officers and stockholders holding more than 5% of our capital stock and their affiliates will beneficially own, in the aggregate, approximately % of our outstanding common stock (assuming no exercise of the underwriters’ option to purchase additional shares and no purchases of shares by such persons in the directed share program) and as purchasers by such parties in our directed share program. To the extent our existing stockholders purchase additional shares in this offering or otherwise, this ownership concentration would increase. As a result, if these stockholders were to choose to act together, they would be able to control the management and affairs of our company and most matters and exercise significant influence over most matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, such as a merger or other sale of our company or its assets. This concentration of ownership could limit your ability to influence corporate matters and may have the effect of delaying or preventing a third party from acquiring control over us. For information regarding the ownership of our outstanding stock by our executive officers and directors and their affiliates, see the section of this prospectus entitled “Principal Stockholders.”

If securities or industry analysts do not publish research or reports about our business, or if they issue a negative opinion regarding our common stock, the price of our common stock and trading volume could decline.

The trading market for our common stock will be influenced by the research reports and opinions that securities or industry analysts publish about our business, our market and our competitors. We are pioneering the use of advanced photonics in surgical illumination and thus, analysts may be less likely to publish reports and opinions about our industry. Therefore, we may be required to educate analysts on

the nature of our industry in order to obtain research coverage, and such efforts may not be successful. We do not have any control over these analysts. We do not currently have and may never obtain research coverage by these analysts. Investors have numerous investment opportunities and may limit their investments to publicly traded companies that receive thorough research coverage. If no analysts commence coverage of us or if one or more analysts who cover us downgrade our shares, cease to cover us or fail to publish reports in a regular manner, our share price would likely decline, or we could lose visibility in the financial markets, which could cause a significant and prolonged decline in our stock price due to lack of investor awareness. There is no guarantee that the equity research organizations affiliated with the underwriters of this offering will elect to initiate or sustain research coverage of us, nor whether such research, if initiated, will be positive towards our stock price or our business prospects.

New investors purchasing our common stock will experience substantial and immediate dilution as a result of this offering.

Investors purchasing common stock in this offering will pay a price per share that substantially exceeds the pro forma as adjusted net tangible book value per share. As a result, investors purchasing common stock in this offering will incur immediate dilution of $ in pro forma as adjusted net tangible book value per share of common stock, based on an assumed initial public offering price of $ per share, the midpoint of the estimated offering price range set forth on the cover page of this prospectus. In addition, we have issued options and warrants to acquire common stock at prices significantly below the initial public offering price. The number of shares available for issuance under our 2015 Equity Incentive Plan will increase annually without further stockholder approval. To the extent such options and warrants are ultimately exercised, investors will incur additional dilution. For more information, see the section of this prospectus entitled “Dilution.”

We have broad discretion in the use of proceeds from this offering and may not use the proceeds effectively.

We intend to use the net proceeds received from this offering primarily to fund sales and marketing activities, research and development efforts, working capital and general corporate purposes. We also may use a portion of the net proceeds from this offering to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. Within those categories, our management will have broad discretion over the use and investment of the net proceeds of this offering and may spend these proceeds in ways in which you may not agree. Accordingly, investors in this offering will need to rely upon the judgment of our management with respect to the use of proceeds with only limited information concerning management’s specific intentions. The failure of our management to apply these funds effectively could result in unfavorable returns and uncertainty about our prospects, each of which could cause the price of our common stock to decline.

The requirements of being a public company may strain our resources, divert management’s attention and affect our ability to attract and retain executive management and qualified board members.

As a public company, we will be subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act, the Sarbanes-Oxley Act, the Dodd-Frank Act, the listing requirements of the NASDAQ Global Market and other applicable securities laws, rules and regulations. Despite recent reforms made possible by the JOBS Act, compliance with these laws, rules and regulations will nonetheless increase our legal and financial compliance costs, make some activities more difficult, time-consuming or costly and increase demand on our systems and resources, particularly after we are no longer an “emerging growth company.” The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. In order to maintain and, if required, improve our disclosure controls and procedures and internal control over financial reporting to meet this standard,

significant resources and management oversight may be required. As a result, management’s attention may be diverted from other business concerns and our costs and expenses will increase, which could harm our business and operating results. We may need to hire more employees in the future or engage outside consultants to comply with these requirements, which will increase our costs and expenses.

In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be harmed.

We will incur additional compensation costs in the event that we decide to pay our executive officers cash compensation closer to that of executive officers of other public medical device companies, which would increase our general and administrative expense and could harm our profitability. Any future equity awards will also increase our compensation expense. We also expect that being a public company and compliance with applicable rules and regulations will make it more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified executive officers and members of our board of directors, particularly to serve on our audit committee and compensation committee.

As a result of disclosure of information in this prospectus and in filings required of a public company, our business and financial condition will become more visible, which could be advantageous to our competitors and clients and could result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and operating results could be harmed, and even if the claims are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm our business, brand, reputation and operating results.

As a public company, we will be required to maintain internal control over financial reporting and to report any material weaknesses in such internal controls. Section 404 of the Sarbanes-Oxley Act requires that we evaluate and determine the effectiveness of our internal control over financial reporting and, beginning with our second annual report following this offering, which will be our year ending December 31, 2016, provide a management report on internal control over financial reporting. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis.

In connection with the audit of our financial statements as of and for the year ended December 31, 2014, we identified a material weakness in our internal control over financial reporting. The material weakness related to a lack of effective controls to adequately restrict access and segregate duties. Specifically, certain personnel had the ability to prepare and post journal entries without an independent review performed by someone without this ability. Upon identifying this material weakness, we performed additional procedures to evaluate the impact on our financial statements. Based on these procedures, we believe the material weakness did not result in any material misstatements to the financial statements. However, this material weakness could result in a misstatement of our accounts or disclosures that would result in a material misstatement of our financial statements that would not be prevented or detected. We are implementing measures designed to improve our internal control over financial reporting to remediate this material weakness, including the following:

•

We amended accounting system access rights so that there are finance personnel without journal entry access who can perform review activities.

•

We are formalizing our internal control documentation and strengthening supervisory reviews by our management.

•

We are in the process of adding accounting personnel and segregating duties amongst accounting personnel.

We cannot assure you that the measures we have taken to date, and are continuing to implement, will be sufficient to remediate the material weakness we have identified or avoid potential future material weaknesses. If the steps we take do not correct the material weakness in a timely manner, we will be unable to conclude that we maintain effective internal control over financial reporting. Accordingly, there could continue to be a reasonable possibility that a material misstatement of our financial statements would not be prevented or detected on a timely basis.

In addition to the remediation efforts related to the material weakness described above, we are in the process of designing and implementing the internal control over financial reporting required to comply with Section 404 of the Sarbanes Oxley Act. This process will be time consuming, costly and complicated. If during the evaluation and testing process, we identify one or more other material weaknesses in our internal control over financial reporting, our management will be unable to assert that our internal control over financial reporting is effective. Even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may conclude that there are material weaknesses with respect to our internal controls or the level at which our internal controls are documented, designed, implemented or reviewed. If we are unable to assert that our internal control over financial reporting is effective, or when required in the future, if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock could be adversely affected, and we could become subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory authorities, which could require additional financial and management resources.

We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

We are an “emerging growth company” as defined under federal securities laws. For as long as we continue to be an emerging growth company, we may take advantage of certain exemptions from reporting requirements that are applicable to other public companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive

compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile or decline.

We could be an emerging growth company until as late as December 31, 2020, the fiscal year-end following the fifth anniversary of the completion of this offering, although circumstances could cause us to lose that status at the earliest of (i) the end of the fiscal year in which the market value of our common stock that is held by non-affiliates is at least $700.0 million as of the last business day of our most recently completed second fiscal quarter, (ii) the end of the fiscal year in which we have total annual gross revenues of $1.0 billion or more during such fiscal year, or (iii) the date on which we issue more than $1.0 billion in non-convertible debt in a three-year period.

Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.

Upon the closing of this offering, we will become subject to the periodic reporting requirements of the Exchange Act. We designed our disclosure controls and procedures to provide reasonable assurance that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met.

These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected.

Anti-takeover provisions in our amended and restated certificate of incorporation and amended and restated bylaws and Delaware law could discourage a takeover and may prevent attempts by our stockholders to replace or remove current management.

Our amended and restated certificate of incorporation and amended and restated bylaws will contain provisions that might discourage, delay or prevent a merger, acquisition or change of control, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions include:

•

a classified board of directors;

•

advance notice requirements applicable to stockholders for matters to be brought before a meeting of stockholders and requirements as to the form and content of a stockholder’s notice;

•

a supermajority stockholder vote requirement for amending certain provisions of our certificate of incorporation and bylaws;

•

the right to issue preferred stock without stockholder approval, which could be used to dilute the stock ownership of a potential hostile acquirer;

•

allowing stockholders to remove directors only for cause and only with a supermajority stockholder vote;

•

a requirement that the authorized number of directors may be changed only by resolution of the board of directors;

•

allowing all vacancies, including newly created directorships, to be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum, except as otherwise required by law;

•

a requirement that our stockholders may only take action at annual or special meetings of our stockholders and not by written consent; and

•

limiting the persons that can call special meetings of our stockholders to our board of directors, the chairperson of our board of directors, the chief executive officer or the president (in the absence of a chief executive officer).

These provisions might discourage, delay or prevent a change in control of our company or a change in our management. The existence of these provisions could adversely affect the voting power of holders of common stock and limit the price that investors might be willing to pay in the future for shares of our common stock. In addition, we will be governed by the provisions of Section 203 of the Delaware General Corporation Law, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested” stockholder. For more information, see the section of this prospectus entitled “Description of Capital Stock.”

Our issuance of preferred stock could adversely affect holders of our common stock.

Pursuant to our amended and restated certificate of incorporation, our board will be authorized to issue up to shares of preferred stock without any action on the part of our stockholders. Our board will also have the power, without stockholder approval, to set the terms of any series of preferred stock that may be issued, including voting rights, except that shares of preferred stock may not have more than one vote per share, dividend rights, preferences over our common stock with respect to dividends or in the event of a dissolution, liquidation or winding up and other terms. In the event that we issue preferred stock in the future that has preference over our common stock with respect to payment of dividends or upon our liquidation, dissolution or winding up, or if we issue preferred stock that is convertible into our common stock at greater than a one-to-one ratio, the voting and other rights of the holders of our common stock or the market price of our common stock could be adversely affected.

We have not paid dividends in the past and do not expect to pay dividends in the future on our common stock, and any return on investment may be limited to the value of our common stock.

We have never paid cash dividends and we currently intend to retain any future earnings and do not anticipate paying cash dividends in the foreseeable future. We are not legally or contractually required to pay dividends and both the HCRP loan agreement and the SVB credit facility contain restrictions on our ability to pay cash dividends. The declaration and payment of all future dividends, if any, will be at the sole discretion our board of directors, which retains the right to change our dividend policy at any time, and may be limited by our debt arrangements in place from time to time. The payment of dividends will depend on our earnings, capital requirements, financial condition, prospects and other factors our board of directors may deem relevant. If we do not pay dividends, our common stock may be less valuable because stockholders must rely on sales of their common stock after price appreciation, which may never occur, to realize any future gains on their investment.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus, including the sections entitled “Prospectus Summary,” “Risk Factors,” “Use of Proceeds,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Business” contains forward-looking statements. The words “believe,” “may,” “will,” “potentially,” “estimate,” “continue,” “anticipate,” “intend,” “could,” “would,” “project,” “plan,” “expect” and similar expressions that convey uncertainty of future events or outcomes are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements concerning the following:

•

our expectations regarding the potential market size and widespread adoption of our devices, including applications in additional surgical specialties;

•

our ability to demonstrate to surgeons and hospitals the merits of our devices and timely obtain approval by hospitals to sell our devices;

•

developments and projections relating to our competitors or our industry;

•

the expected growth in our business and our organization, including outside of the United States;

•

our financial performance, our estimates of our expenses, ongoing losses, future revenue, capital requirements and our needs for, or ability to obtain, additional financing;

•

our ability to retain and recruit key personnel, including the continued development and expansion of a sales and marketing infrastructure;

•

our ability to obtain an adequate supply of components for our devices from our third-party suppliers;

•

our ability to identify and develop new and planned devices;

•

our ability to obtain and maintain intellectual property protection for our devices or avoid claims of infringement;

•

our compliance with extensive government regulation;

•

our expected uses of the net proceeds from this offering;

•

the volatility of our share price; and

•

our expectations regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act under the federal securities laws.

These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in “Risk Factors” and elsewhere in this prospectus. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in our forward-looking statements.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events and circumstances described in the forward-looking statements will be achieved or occur. Moreover, neither we nor any other person

assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual results or to changes in our expectations, except as required by law.

You should read this prospectus and the documents that we reference in this prospectus and have filed with the Securities and Exchange Commission, or the SEC, as exhibits to the registration statement of which this prospectus is a part with the understanding that our actual future results, levels of activity, performance, and events and circumstances may be materially different from what we expect.

MARKET AND INDUSTRY DATA

Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate, including our general expectations and market position, market opportunity, and market size, is based on information from various sources, on assumptions we have made based on such data and other similar sources, and on our knowledge of the markets for our solutions and services. This information involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market position, market opportunity and market size information included in this prospectus is generally reliable, such information is inherently imprecise. In addition, projections, assumptions and estimates of our future performance and the future performance of the industry in which we operate is necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Risk Factors” and elsewhere in this prospectus. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

USE OF PROCEEDS

We estimate that the net proceeds from our sale of shares of common stock in this initial public offering at an assumed initial public offering price of $ per share, the midpoint of the estimated offering price range reflected on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, will be approximately $ million, or $ million if the underwriters exercise in full their option to purchase additional shares.

A $1.00 increase (decrease) in the assumed initial public offering price would increase (decrease) the net proceeds to us from this offering by $ million, assuming the number of shares offered by us, as reflected on the cover page of this prospectus, remains the same and after deducting the estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Each 1,000,000 share increase (decrease) in the number of shares offered by us, as set forth on the cover of this prospectus, would increase (decrease) the net proceeds to us by approximately $ million, at the assumed initial public offering price of $ per share, and after deducting estimated underwriting discount and commissions and estimated offering expenses payable by us.

The principal purposes of this offering are to increase our capitalization and financial flexibility, create a public market for our stock, thereby enabling access to the public equity markets by our stockholders and employees, and increase our visibility in the marketplace. We intend to use approximately $ million of the net proceeds received from this offering to expand sales and marketing activities, approximately $ million to expand research and development efforts, and the remainder of the net proceeds from this offering for working capital and general corporate purposes. At this time, we cannot quantify the amounts we intend to expend on any of these activities.

We may also use a portion of our net proceeds to acquire or invest in complementary products, technologies or businesses, although we have no present commitments to complete any such transaction. The amounts and timing of our expenditures will depend upon numerous factors, including the rate of adoption of our devices, the expenses we incur in selling and marketing our devices, the scope of research and development efforts, the timing and success of clinical trials we may commence in the future, and the timing of regulatory submissions.

Accordingly, our management will have broad discretion over the use of the net proceeds from this offering. Pending the use of the proceeds from this offering, we intend to invest the net proceeds in short-term, interest-bearing, investment-grade securities, certificates of deposit or government securities.

DIVIDEND POLICY

We have never declared or paid cash dividends on our common stock. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any dividends on our common stock in the foreseeable future, if at all. Both our loan agreement with HealthCare Royalty Partners, or HCRP, and our credit facility with Silicon Valley Bank, or SVB, restrict our ability to pay cash dividends on our capital stock. In addition to the restrictions imposed by the HCRP loan agreement and the SVB credit facility, as well as any limitations set forth by the terms of any future debt or preferred securities or future credit facility, any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, general business conditions and other factors that our board of directors may deem relevant.

CAPITALIZATION

The following table sets forth our cash and cash equivalents and capitalization as of March 31, 2015 on:

•

an actual basis;

•

a pro forma basis, giving effect to (i) the automatic conversion of the outstanding shares of our convertible preferred stock as of March 31, 2015 into 145,085,870 shares of our common stock upon completion of this offering, (ii) the automatic conversion of warrants to purchase shares of our convertible preferred stock into warrants to purchase shares of common stock upon the completion of this offering and the related reclassification of our convertible preferred stock warrant liability to additional paid-in capital; and (iii) the effectiveness of our amended and restated certificate of incorporation; and

•

a pro forma as adjusted basis, giving effect to (i) the pro forma adjustments set forth above and (ii) the sale and issuance of shares of our common stock by us in this offering, based upon the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

You should read this information together with the section of this prospectus entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes included elsewhere in this prospectus.


	March 31, 2015
	Actual			Pro Forma			Pro Forma as Adjusted⁽¹⁾
	(In thousands, except share and per share data)
Cash and cash equivalents	$	25,251		$	25,251		$

Convertible preferred stock warrant liability	$	640		$	—
Long-term debt—related party		14,382			14,382
Convertible preferred stock, no par value—145,445,475 shares authorized; 141,574,456 shares issued and outstanding, actual; no shares authorized, issued and outstanding, pro forma and pro forma as adjusted		96,524			—
Stockholders’ (deficit) equity:
Preferred stock, no par value—no shares authorized, issued and outstanding, actual; $ par value— shares authorized, no shares issued and outstanding, pro forma and pro forma as adjusted		—			—
Common stock, no par value—210,610,000 shares authorized; 13,352,889 shares issued and outstanding, actual; $ par value per share— shares authorized, 158,438,759 shares issued and outstanding, pro forma; and shares issued and outstanding, pro forma as adjusted		233			96,757
Additional paid-in capital		2,168			2,808
Accumulated deficit		(77,069	)		(77,069	)

Total stockholders’ (deficit) equity		(74,668	)		22,496

Total capitalization	$	36,878		$	36,878

footnotes on following page

⁽¹⁾

Each $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders’ equity and total capitalization by approximately $ million, assuming that the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions payable by us. Each increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase (decrease) the amount of our pro-forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders’ equity and total capitalization by approximately $ million, assuming an initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.

The number of shares of our common stock reflected in the discussion and table above is based on 158,438,759 shares of our common stock outstanding as of March 31, 2015, including convertible preferred stock on an as-converted basis, and excludes the following:

•

25,145,974 shares of our common stock issuable upon the exercise of options to purchase shares of our common stock outstanding as of March 31, 2015, with a weighted-average exercise price of $0.14 per share;

•

65,353 shares of common stock issuable upon the exercise of warrants outstanding as of March 31, 2015 with a weighted-average exercise price of $0.07 per share;

•

shares of common stock reserved for future grants under our stock-based compensation plans, consisting of:

•

shares of common stock reserved for future grants under our 2015 Equity Incentive Plan, which will become effective upon completion of this offering, and

•

any shares that become available under our 2015 Equity Incentive Plan pursuant to provisions thereof that automatically increase the share reserve under such plan each year, as more fully described in “Executive Compensation—Employee Benefit and Stock Plans.”

DILUTION

If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the initial public offering price per share of our common stock in this offering and the pro forma as adjusted net tangible book value per share of our common stock immediately after this offering.

As of March 31, 2015, our historical net tangible book value (deficit) was approximately $(76.0) million, or ($5.69) per share of common stock. Historical net tangible book value (deficit) per share represents our total tangible assets, less deferred initial public offering costs, less total liabilities, less convertible preferred stock, divided by the number of our outstanding shares of common stock.

As of March 31, 2015, our pro forma net tangible book value was approximately $ million, or $ per share of common stock. Our pro forma net tangible book value per share represents our total tangible assets less total liabilities, divided by the number of our outstanding shares of common stock as of March 31, 2015, assuming the automatic conversion of all outstanding shares of our convertible preferred stock into 145,085,870 shares of our common stock, which conversion will occur upon the completion of the offering, the automatic conversion of warrants to purchase shares of our convertible preferred stock into warrants to purchase shares of common stock upon the completion of this offering and the related reclassification of our convertible preferred stock warrant liability to additional paid-in capital.

After giving further effect to the sale of shares of our common stock in this offering, at the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of March 31, 2015 would have been approximately $ million, or $ per share. This represents an immediate increase in pro forma as adjusted net tangible book value of $ per share to our existing stockholders and an immediate dilution of $ per share to investors purchasing common stock in this offering.

The following table illustrates this dilution to new investors on a per share basis:


Assumed initial public offering price per share		$
Historical net tangible book value (deficit) per share as of March 31, 2015	$
Pro forma increase in net tangible book value (deficit) per share

Pro forma net tangible book value per share as of March 31, 2015
Increase in pro forma net tangible book value per share attributable to investors purchasing shares in this offering

Pro forma as adjusted net tangible book value per share, after giving effect to this offering

Dilution in pro forma as adjusted net tangible book value per share to investors purchasing shares in this offering		$

A $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) our pro forma as adjusted net tangible book value by approximately $ per share and the dilution per share to new investors in this offering by $ per share, assuming the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions payable by us.

Similarly, a 1,000,000 increase (decrease) in the number of shares of our common stock offered by us would increase (decrease) our pro forma as adjusted net tangible book value by approximately $ per share and the dilution per share to new investors in this offering by $ per share, assuming the assumed initial public offering price remains the same and after deducting underwriting discounts and commissions payable by us.

If the underwriters exercise their option to purchase additional shares in this offering in full, the pro forma as adjusted net tangible book value per share of our common stock would be $ per share, and the dilution in pro forma net tangible book value per share to investors purchasing shares in this offering would be $ per share.

The following table summarizes, on the pro forma basis described above, the difference between existing stockholders and new investors with respect to the number of shares of common stock purchased from us, the total consideration paid to us, and the average price per share paid, before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us:


	Shares Purchased				Total Consideration				Average Price Per Share
	Number	Percent			Amount	Percent			Average Price Per Share
Existing stockholders				%	$			%	$
Investors purchasing shares in this offering

Total			100.0	%	$		100.0	%

A $1.00 increase (decrease) in the assumed initial public offering price of $ per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) total consideration paid by new investors and total consideration paid by all stockholders by approximately $ million, assuming that the number of shares of our common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions payable by us.

Similarly, a 1,000,000 increase (decrease) in the number of shares of our common stock offered by us would increase (decrease) the shares purchased by new investors and total shares purchased by all stockholders by 1,000,000, would increase (decrease) the percentage of shares purchased by new investors by %, and would increase (decrease) the total consideration paid by new investors and total consideration paid by all stockholders by approximately $ million, assuming the assumed initial public offering price remains the same and after deducting underwriting discounts and commissions payable by us.

If the underwriters exercise their option to purchase additional shares in this offering in full, our existing stockholders would own % and our new investors would own % of the total number of shares of our common stock outstanding upon the completion of this offering.

The number of shares of our common stock reflected in the discussion and tables above is based on 158,438,759 shares of our common stock outstanding as of March 31, 2015, including convertible preferred stock on an as-converted basis, and excludes the following:

•

65,353 shares of common stock issuable upon the exercise of warrants outstanding as of March 31, 2015 with a weighted-average exercise price of $0.07 per share;

•

shares of common stock reserved for future grants under our stock-based compensation plans, consisting of:

•

12,634,964 shares of common stock reserved for future grants under our 2005 Stock Incentive Plan as of March 31, 2105, which shares will be added to the shares to be reserved under our 2015 Equity Incentive Plan, which will become effective upon completion of this offering,

•

shares of common stock reserved for future grants under our 2015 Equity Incentive Plan, which will become effective upon completion of this offering, and

•

To the extent that any outstanding options to purchase shares of our common stock or warrants to purchase shares of our common stock or convertible preferred stock are exercised or new awards are granted under our equity compensation plans, there will be further dilution to investors participating in this offering.

SELECTED FINANCIAL DATA

The following selected statement of operations data for the years ended December 31, 2013 and 2014 and the balance sheet data as of December 31, 2013 and 2014 have been derived from our audited financial statements included elsewhere in this prospectus. The statements of operations data for the three months ended March 31, 2014 and 2015, and the balance sheet data as of March 31, 2015, are derived from our unaudited interim financial statements included elsewhere in this prospectus. We have prepared the unaudited interim financial statements on the same basis as the audited financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments that we consider necessary for a fair statement of the financial information set forth in those statements. Our historical results are not necessarily indicative of our future results and our interim results are not necessarily indicative of results to be expected for the full year ending December 31, 2015, or any other period. You should read the following selected financial and other data below in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes included elsewhere in this prospectus.


	Year Ended December 31,						Three Months Ended March 31,
	2013			2014			2014			2015
	(In thousands, except share and per share data)
Statements of Operations Data:
Revenue	$	7,186		$	13,103		$	2,154		$	4,442
Cost of goods sold		2,294			4,871			747			1,731

Gross profit		4,892			8,232			1,407			2,711

Operating expenses:
Selling, general and administrative		12,402			22,803			4,574			8,923
Research and development		4,445			5,181			1,203			1,900

Total operating expenses		16,847			27,984			5,777			10,823

Loss from operations		(11,955	)		(19,752	)		(4,370	)		(8,112	)
Interest expense		(284	)		(1,402	)		(370	)		(369	)
Interest and other income (expense), net		130			492			28			(551	)

Net loss	$	(12,109	)	$	(20,662	)	$	(4,712	)	$	(9,032	)

Net loss per common share, basic and diluted⁽¹⁾	$	(1.03	)	$	(1.70	)	$	(0.40	)	$	(0.69	)

Weighted-average shares used to compute net loss per common share, basic and diluted⁽¹⁾		11,713,408			12,178,182			11,915,715			13,017,592

Pro forma net loss per common share, basic and diluted (unaudited)⁽¹⁾				$	(0.17	)				$	(0.06	)

Weighted-average shares used to compute pro forma net loss per common share, basic and diluted (unaudited)⁽¹⁾					123,522,788						144,976,946

⁽¹⁾

See Notes 2, 12 and 13 to our financial statements included elsewhere in this prospectus for an explanation of the calculations of our basic and diluted net loss per common share, pro forma basic and diluted net loss per common share and the weighted-average number of shares used in the computation of the per share amounts.


	December 31,						March 31,
	2013			2014			2015
		(In thousands)
Balance Sheet Data:
Cash and cash equivalents	$	4,953		$	6,048		$	25,251
Working capital		8,486			10,366			28,230
Total assets		12,053			25,324			46,151
Convertible preferred stock warrant liability		86			136			640
Total long-term debt		2,477			9,347			14,382
Convertible preferred stock		52,949			73,755			96,524
Accumulated deficit		(47,375	)		(68,037	)		(77,069	)
Total shareholders’ deficit		(45,906	)		(65,827	)		(74,668	)

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

You should read the following discussion and analysis of our financial condition and results of operations together with “Selected Financial Data” and the financial statements and related notes included elsewhere in this prospectus. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed in “Risk Factors” and in other parts of this prospectus.

Overview

Photonics is the science and technological applications of light. We have applied advanced principles of photonics to develop our Intelligent Photonics technology platform, which enables the transmission, management and manipulation of light in surgical procedures. Our initial application of this technology is integrated into our family of proprietary optical waveguides. Our waveguides are sophisticated devices that rely on the principles of optics to shape and direct light. They are coupled to a modified fiber optic cable and are designed to work with the standard xenon or LED light sources typically found and utilized in the operating room. Our optical waveguides are incorporated into surgical devices, including our customized line of illuminated surgical retractors, handheld illuminated aspiration devices and a drop-in intracavity illuminator. Our handheld illuminated aspiration devices and drop-in intracavity illuminators are single-use products. Our retractor devices are reusable, but utilize a single-use optical waveguide, which we sell separately because a new waveguide must be used for each procedure.

We currently sell our devices in the United States, primarily through a direct sales force. We increased the number of our direct sales representatives from 16 as of December 31, 2012 to 39 as of December 31, 2014 and to 43 as of March 31, 2015, and we expect to continue to expand our direct salesforce and marketing organization to further penetrate and expand the market by demonstrating the benefits of our Intelligent Photonics technology platform to surgeons. Our direct salesforce works with independent sales agents or agencies, whom we refer to as independent sales agents, who assist us in educating targeted surgeons. Although our sales and marketing efforts are directed at surgeons because they are the primary users of our technology, the hospitals where surgical procedures are performed are our customers, as they typically are responsible for making the decisions to purchase our devices. We have a diverse customer base of hospitals in the United States. One customer accounted for 12% of our total revenue in each of 2013 and 2014, and another customer accounted for 13% of our total revenue in 2013. There were no sales to any customer in excess of 10% of our total revenue for the three months ended March 31, 2015. Our currently marketed devices are commonly treated as general supplies utilized

in surgery. As a result, the hospital or surgical center receives a single reimbursement from the third-party payor that is intended to cover the overall cost of treatment, including the cost of devices used during the procedure, as well as the overhead cost associated with the facility where the procedure is performed. There is no separate reimbursement for our devices.

In addition to marketing and selling our existing products, we are engaged in ongoing research and development. Our research and development efforts are focused on developing new devices and modalities to broaden the application and adoption of open minimally invasive and minimal access procedures and enable new advanced surgical techniques. Our manufacturing involves the combined utilization of our internal manufacturing resources and expertise, approved suppliers and contract manufacturers. We outsource the manufacture of components, subassemblies and certain finished devices that are produced to our specifications and shipped to our facilities in San Francisco, California for final assembly or inspection, and certification. Finished products are stored at and distributed from our facility. We expect our existing facility to meet expected demand for the foreseeable future.

Our revenue increased from $7.2 million in 2013 to $13.1 million in 2014. We incurred a net loss of $12.1 million and $20.7 million for the years ended December 31, 2013 and 2014, respectively. For the three months ended March 31, 2015, our revenue was $4.4 million and we incurred a net loss of $9.0 million compared to revenue of $2.2 million and a net loss of $4.7 million for the three months ended March 31, 2014. We expect to continue to incur losses for the next several years as we expand our organization to support planned sales growth, while also continuing to invest in development of new devices and modalities. As of March 31, 2015, we had an accumulated deficit of $77.1 million. We have increased our number of employees from 49 on December 31, 2012 to 116 employees as of March 31, 2015. Our primary sources of capital to date have been from sales of our devices, private placements of our convertible preferred securities and amounts borrowed under certain debt financing arrangements.

Components of Our Results of Operations

Revenue

All of our revenue is currently derived from sales of our devices in the United States. We earn revenue from the sale of our devices primarily through our direct salesforce as complemented by our independent sales agents. Recent revenue growth has been driven by, and we expect our revenue to continue to increase in the future as a result of, the growth of our sales and marketing infrastructure and increased surgeon awareness of the benefits of our Intelligent Photonics technology platform over traditional surgical lighting options in the operating room. We expect our revenue to fluctuate from quarter to quarter due to a variety of factors, including:

•

surgeon and hospital acceptance of our devices;

•

the productivity of our sales representatives;

•

the introduction of new devices and technologies or acquisitions by us or our competitors;

•

the timing, expense and results of research and development activities and obtaining future regulatory clearances and approvals;

•

buying patterns of the distributors that serve our military customers;

•

supplier, manufacturing or quality problems with our devices; and

•

changes in our pricing policies or in the pricing policies of our competitors or suppliers.

Additionally, we have experienced seasonality in the first and fourth quarters of the year. Revenue tends to be the lowest in the first quarter as the result of the resetting of annual patient healthcare insurance plan deductibles and by hospitals and military facilities working off their inventories of products purchased in the fourth quarter. Revenue in the fourth quarter tends to be the highest as demand may be impacted by the

desire of patients to spend their remaining balances in their flexible spending accounts or because they have met their annual deductibles under their health insurance plans. In addition, in the fourth quarter, our results can be impacted by the budgeting and buying patterns of hospitals and military facilities.

Cost of Goods Sold and Gross Margin

Cost of goods sold consists primarily of material costs, manufacturing overhead, direct labor and third-party services, such as sterilization. Manufacturing overhead represents a significant portion of cost of goods sold and includes the cost of quality assurance, material procurement, inventory control, facilities, equipment and operations supervision and management. We expect overhead costs as a percentage of revenue to decrease as our production volume increases and our production process becomes more efficient. Cost of goods sold also includes depreciation expense for production equipment and certain direct costs such as shipping cost, as well as a 2.3% excise tax on the sale of medical devices in the United States. We expect cost of goods sold to increase in absolute dollars primarily as, and to the extent, our revenue grows.

We calculate gross margin as gross profit divided by revenue. Our gross margin has been and will continue to be affected by a variety of factors, primarily production volumes, manufacturing costs and product yields, and the implementation of cost-reduction strategies. We expect our gross margin to increase over the long term as our production volume increases and as we spread the fixed portion of our manufacturing overhead costs over a larger number of units produced, thereby reducing our per unit manufacturing costs. However, our gross margin will likely fluctuate from quarter to quarter in the near term.

Selling, General and Administrative Expenses

Our selling, general and administrative, or SG&A, expenses consist primarily of compensation for executive, finance, sales, legal and administrative personnel, including sales commissions and stock-based compensation. Other significant SG&A expenses include independent sales agent commissions, conferences, trade shows, promotional activities, professional fees for legal and accounting services, consulting fees, insurance costs and travel expenses.

We expect SG&A expenses to continue to increase in absolute dollars as we expect to hire additional direct sales representatives and expand our commercial infrastructure to both drive and support our planned revenue growth. We also expect to incur additional SG&A expenses as a result of operating as a public company, including expenses related to compliance with the rules and regulations of the Securities and Exchange Commission and those of any national securities exchange on which our securities are traded, additional insurance expenses, investor relations activities and other administrative and professional services.

Research and Development Expenses

Our research and development, or R&D, expenses consist primarily of product research, engineering, product development, quality assurance and depreciation. These expenses include personnel costs, including stock-based compensation expense, consulting services, laboratory materials and supplies and an allocation of related facilities costs. We expect our R&D costs to increase in absolute dollars as we hire additional personnel to develop new devices and device enhancements. We expense R&D costs as they are incurred.

Interest Expense

Interest expense consists of cash and non-cash components. The cash component of interest expense is attributable to our borrowings under our loan agreements. The non-cash component consists of interest expense recognized from the amortization of debt discounts derived from the issuance of warrants and debt issuance costs capitalized on our balance sheets.

Interest and Other Income (Expense), Net

Interest and other income (expense), net consists primarily of the fair value remeasurement related to our outstanding convertible preferred stock warrants, which are accounted for as a liability and marked-to-market at each reporting period, and interest income from interest earned on our cash, cash equivalents and marketable securities.

Results of Operations


	Three Months Ended March 31,						$ Change			% Change
	2014			2015			$ Change			% Change
	(In thousands)
Revenue	$	2,154		$	4,442		$	2,288			106
Cost of goods sold		747			1,731			984			132

Gross profit		1,407			2,711			1,304			93

Gross margin		65	%		61	%
Operating expenses:
Selling, general and administrative		4,574			8,923			4,349			95
Research and development		1,203			1,900			697			58

Total operating expenses		5,777			10,823			5,046			87

Loss from operations		(4,370	)		(8,112	)		(3,742	)		86
Interest expense		(370	)		(369	)		1			*
Interest and other income (expense), net		28			(551	)		(579	)		*

Net loss	$	(4,712	)	$	(9,032	)	$	(4,320	)		92

*	Not meaningful

Comparison of the Three Months Ended March 31, 2014 and 2015

Revenue

Revenue increased $2.3 million, or 106%, to $4.4 million during the three months ended March 31, 2015, compared to $2.2 million during the three months ended March 31, 2014. The growth in revenue was attributable to an increase in unit sales. The increase in units was driven by the increased number of customers to whom we sold devices. The number of our direct sales representatives increased from 35 as of March 31, 2014 to 43 as of March 31, 2015 and the number of customers purchasing our devices increased from approximately 200 in the first quarter of 2014 to approximately 400 in the first quarter of 2015.

Cost of Goods Sold and Gross Margin

Cost of goods sold increased $1.0 million, or 132%, to $1.7 million during the three months ended March 31, 2015, compared to $0.7 million during the three months ended March 31, 2014. The increase in cost of goods sold was primarily due to the increase in the number of devices sold as we expanded our sales and marketing efforts and increased our device sales. The increase in cost of goods sold was also attributable to higher overhead costs related to our new leased facility in San Francisco as well as idle capacity costs of $0.2 million related to the move of our production team and operations to the new leased facility in mid-March 2015.

Gross margin for the three months ended March 31, 2015 decreased to 61%, compared to 65% for the three months ended March 31, 2014. The decrease in gross margin was primarily due to the impact of idle capacity costs.

Selling, General and Administrative Expenses

SG&A expenses increased $4.3 million, or 95%, to $8.9 million during the three months ended March 31, 2015, compared to $4.6 million during the three months ended March 31, 2014. The increase in SG&A expenses was attributable to a $1.4 million increase in personnel-related expenses, excluding sales commissions, as a result of increased headcount, a $0.7 million increase in marketing, advertising and promotion related expenses, a $0.6 million increase in professional service fees, primarily as a result of an increase in legal, accounting and recruiting services due to the growth in our operations, a $0.5 million increase in commissions to direct sales representatives, and a $0.3 million increase in independent sales agent commissions. The increase in SG&A expenses was also attributable to an increase in facility related costs of $0.8 million primarily related to rent expense and depreciation for our new leased facility.

Research and Development Expenses

R&D expenses increased $0.7 million, or 58%, to $1.9 million during the three months ended March 31, 2015, compared to $1.2 million during the three months ended March 31, 2014. The increase in R&D expenses was primarily attributable to a $0.7 million increase in personnel-related expenses as a result of increased headcount.

Interest and Other Income (Expense), Net

Interest and other income (expense), net changed $0.6 million to ($0.6) million expense during the three months ended March 31, 2015, compared to income of $28,000 during the three months ended March 31, 2014. The change was primarily due to the fair value re-measurement and related increase of the liability related to our outstanding convertible preferred stock warrants. We recorded an out-of-period adjustment to increase the fair value of the convertible preferred stock warrant liability, which was incorrectly valued at December 31, 2014 due to an error in the expected term assumption. The correction of this error resulted in an increase to expense of $370,000 for the three months ended March 31, 2015 and a corresponding increase to the convertible preferred stock warrant liability.


	Year Ended December 31,						$ Change			% Change
	2013			2014			$ Change			% Change
	(In thousands)
Revenue	$	7,186		$	13,103		$	5,917			82
Cost of goods sold		2,294			4,871			2,577			112

Gross profit		4,892			8,232			3,340			68

Gross margin		68	%		63	%

Operating expenses:
Selling, general and administrative^(a)		12,402			22,803			10,401			84
Research and development^(a)		4,445			5,181			736			17

Total operating expenses		16,847			27,984			11,137			66

Loss from operations		(11,955	)		(19,752	)		(7,797	)		65
Interest expense		(284	)		(1,402	)		(1,118	)		*
Interest and other income, net		130			492			362			*

Net loss	$	(12,109	)	$	(20,662	)	$	(8,553	)		71

*	Not meaningful

^(a)

We have revised the statement of operations for the year ended December 31, 2014 to correct the classification between research and development expenses and selling, general and administrative expenses due to an erroneous allocation of departmental expenses, which resulted in an increase to research and development expenses of $564,000, with a corresponding decrease to selling, general and administrative expenses.

Comparison of the Years Ended December 31, 2013 and 2014

Revenue

Revenue increased $5.9 million, or 82%, to $13.1 million during the year ended December 31, 2014, compared to $7.2 million during the year ended December 31, 2013. The growth in revenue was attributable to an increase in unit sales. The increase in units was driven by the expansion of our direct salesforce, which increased the number of customers to whom we sold devices. The number of our direct sales representatives increased from 18 as of December 31, 2013 to 39 as of December 31, 2014 and the number of customers ordering our devices increased from approximately 150 in the fourth quarter of 2013 to approximately 350 in the fourth quarter of 2014.

Cost of Goods Sold and Gross Margin

Cost of goods sold increased $2.6 million, or 112%, to $4.9 million during the year ended December 31, 2014, compared to $2.3 million during the year ended December 31, 2013. The increase in cost of goods sold was primarily due to the increase in the number of devices sold as we expanded our sales and marketing efforts and increased our device sales. The increase in cost of goods sold was also attributable to charges totaling $0.7 million, which primarily consisted of write-offs of unrecoverable trunk stock inventory provided to direct sales representatives and independent sales agents. We have made improvements in our processes and procedures related to the tracking of our trunk stock inventory to reduce the likelihood of future significant trunk stock write-offs.

Gross margin for the year ended December 31, 2014 decreased to 63%, compared to 68% for the year ended December 31, 2013. The decrease in gross margin was primarily due to the impact of the write-off of inventory and related increase to cost of goods sold.

Selling, General and Administrative Expenses

SG&A expenses increased $10.4 million, or 84%, to $22.8 million during the year ended December 31, 2014, compared to $12.4 million during the year ended December 31, 2013. The increase in SG&A expenses was attributable to a $5.7 million increase in personnel-related expenses, excluding sales commissions, as a result of increased headcount, a $2.0 million increase in commissions to direct sales representatives, a $1.1 million increase in independent sales agent commissions, a $0.8 million increase in marketing, advertising and promotion-related expenses and a $0.8 million increase in professional service fees, primarily as a result of an increase in legal, accounting and recruiting services due to the growth in our operations.

Research and Development Expenses

R&D expenses increased $0.7 million, or 17%, to $5.2 million during the year ended December 31, 2014, compared to $4.4 million during the year ended December 31, 2013. The increase in R&D expenses was primarily attributable to a $0.3 million increase in personnel-related expenses as a result of increased headcount, a $0.3 million increase in supplies and testing expenses in development activities and a $0.1 million increase in recruiting fees.

Interest Expense

Interest expense increased $1.1 million to $1.4 million during the year ended December 31, 2014 from $0.3 million during the year ended December 31, 2013. In February 2014, we drew down $10.0 million from our loan with HealthCare Royalty Partners, or HCRP, and utilized a portion of the proceeds to repay the outstanding balance of our then outstanding loan with Silicon Valley Bank, or SVB. The extinguishment of the SVB loan resulted in the recognition of additional interest expense of $0.2 million comprising an early repayment penalty and the unamortized balances of debt discount and balloon interest payment. In addition, the higher principal amount of our HCRP loan together with the higher interest rate of 12.5% per year contributed to increased interest costs in 2014.

Interest and Other Income, Net

Interest and other income, net increased $0.4 million to $0.5 million during the year ended December 31, 2014, compared to $0.1 million during the year ended December 31, 2013. The increase in interest and other income, net was primarily related to the fair value remeasurement of the liability related to our outstanding convertible preferred stock warrants.

Liquidity and Capital Resources

Overview

As of March 31, 2015, we had cash and cash equivalents of $25.3 million and an accumulated deficit of $77.1 million, compared to cash, cash equivalents and short-term investments of $6.0 million and an accumulated deficit of $68.0 million as of December 31, 2014. We have financed our operations primarily through sales of our convertible preferred securities, debt financings and the sale of our devices. As of March 31, 2015, we have raised $96.5 million from private placements of our convertible preferred securities, including proceeds from convertible notes, and had $14.4 million of borrowings outstanding under our loan agreements. We have additional availability under our accounts receivable credit facility that we entered into in February 2015 that permits the borrowing of the lesser of $7.5 million or an amount representing up to 80% of eligible accounts receivable.

We believe that our existing cash and cash equivalents as of March 31, 2015, and borrowings available under our accounts receivable credit facility with SVB that we entered into in the first quarter of 2015, will be sufficient to meet our anticipated cash requirements through at least December 31, 2015 and, after giving effect to the net proceeds of this offering, through at least December 31, 2016. Our expected future capital requirements may depend on many factors including customer expansion, the expansion of our salesforce, and the timing and extent of spending on the development of our technology to increase our product portfolio. We may need additional funding to fund our operations but additional funds may not be available to us on acceptable terms on a timely basis, if at all. We may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we raise additional funds through collaboration and licensing arrangements with third-parties, it may be necessary to relinquish some rights to our technologies or our devices, or grant licenses on terms that are not favorable to us.

Furthermore, we cannot be certain that additional funding will be available on acceptable terms, if at all. If we are unable to raise additional capital or generate sufficient cash from operations to adequately fund our operations, we will need to curtail planned activities to reduce costs. Doing so will likely harm our ability to execute on our business plan.

Cash Flows

The following table summarizes our cash flows for the periods indicated:


	Year Ended December 31,						Three Months Ended March 31
(in thousands)	2013			2014			2014			2015
Net cash (used in) provided by:
Operating activities	$	(13,897	)	$	(19,818	)	$	(4,608	)	$	(6,941	)
Investing activities		15,496			(7,271	)		(15,128	)		(1,467	)
Financing activities		(451	)		28,184			28,132			27,611

Net increase in cash and cash equivalents	$	1,148		$	1,095		$	8,396			$19,203

Net Cash Used in Operating Activities

During the three months ended March 31, 2015, net cash used in operating activities was $6.9 million, which consisted of a net loss of $9.0 million, adjusted by non-cash charges of $1.2 million and a net increase of $0.9 million in our net operating assets. The non-cash charges primarily consist of stock-based compensation of $0.2 million, depreciation and amortization of $0.4 million and a $0.5 million loss from the revaluation of the convertible preferred stock warrant liability. The change in our net operating assets and liabilities was primarily due to a $0.7 million increase in accounts payable and accrued liabilities as a result of an increase in our operations and related growth in headcount and a decrease of $1.1 million of prepaid expenses and other assets primarily due to the receipt of tenant improvement allowance from our landlord in the first quarter of 2015. This change was partially offset by an increase of $0.9 million in accounts receivable due to the increase in revenue and the timing of collections.

During the three months ended March 31, 2014, net cash used in operating activities was $4.6 million, which consisted of a net loss of $4.7 million, adjusted by non-cash charges of $0.2 million and a net increase of $0.1 million in our net operating assets. The non-cash charges primarily consist of depreciation and amortization of $0.1 million and stock-based compensation of $0.1 million. The change in our net operating assets and liabilities was primarily the result of a $0.2 million increase in accounts payable due to the growth in our operations.

During the year ended December 31, 2014, net cash used in operating activities was $19.8 million, which consisted of a net loss of $20.7 million, adjusted by non-cash charges of $0.9 million and a net change of $0.1 million in our net operating assets. The non-cash charges primarily consist of stock-based compensation of $0.7 million, depreciation and amortization of $0.3 million, amortization of the premium on marketable securities of $0.2 million, an increase in the provision for doubtful accounts of $0.1 million and non-cash interest expense of $0.1 million, offset by a $0.5 million gain from the revaluation of the convertible preferred stock warrant liability. The increase in our net operating assets and liabilities was primarily due to a $1.0 million increase in accrued liabilities as a result of an increase in our operations and related growth in headcount and an increase of $2.9 million in deferred rent related to our new facility lease. This increase was partially offset by a $1.4 million increase in accounts receivable as a result of an increase in revenue and timing of collections, an increase in prepaid expenses and other current assets of $1.9 million primarily as a result of the tenant allowance receivable in 2014 and a $0.8 million increase in inventory as a result of an increase in production to support the expected growth in future revenue.

During the year ended December 31, 2013, net cash used in operating activities was $13.9 million, which consisted of a net loss of $12.1 million, adjusted by non-cash charges of $0.6 million and a net increase of $2.4 million in our net operating assets. The non-cash charges primarily consist of depreciation and amortization of $0.2 million, stock-based compensation of $0.3 million, amortization of the premium on

marketable securities of $0.2 million, and non-cash interest expense of $0.1 million, partially offset by the gain from the revaluation of the convertible preferred stock warrant liability of $0.2 million. The net decrease in our net operating assets and liabilities was primarily the result of a $2.4 million increase in inventory as a result of the expected growth in revenue, a $0.7 million increase in accounts receivable as a result of an increase in revenue and a $0.2 million increase in other assets as a result of capitalized issuance costs for the Series E convertible preferred stock that was issued in February 2014. These changes were offset by a $0.9 million increase in accounts payable and accrued liabilities as a result of an increase in operations and company growth.

Net Cash Provided by (Used in) Investing Activities

During the three months ended March 31, 2015, net cash used in investing activities was $1.5 million, which consisted of capital expenditures to purchase property and equipment in connection with the new facility lease entered into in December 2014.

During the three months ended March 31, 2014, net cash used in investing activities was $15.1 million, which consisted of $15.9 million for the purchase of marketable securities and $0.1 million of capital expenditures to purchase property and equipment, offset by $0.9 million in proceeds from the maturities of marketable securities.

During the year ended December 31, 2014, net cash used in investing activities was $7.3 million, which consisted of cash outflows of $17.5 million for purchases of marketable securities, $6.8 million of capital expenditures to purchase property and equipment in connection with the new facility lease entered into in December 2014 and a $1.1 million increase in restricted cash for the security deposit on our new leased facility, offset by sales and maturities of marketable securities of $18.1 million. The purchase of property and equipment is primarily related to the expansion of our facilities, purchases of office furniture and equipment, leasehold improvements, computer software and manufacturing equipment.

During the year ended December 31, 2013, net cash provided by investing activities was $15.5 million, which consisted of $18.1 million from the sale and maturities of marketable securities, offset by purchases of marketable securities of $2.2 million and $0.5 million of capital expenditures to purchase property and equipment.

Net Cash Provided by (Used in) Financing Activities

During the three months ended March 31, 2015, net cash provided by financing activities was $27.6 million, consisting of net proceeds of $22.8 million from the issuance of our convertible preferred stock and net proceeds of $5.0 million from borrowings under our long-term debt facility partially offset by $0.2 million of payments of deferred initial public offering costs.

During the three months ended March 31, 2014, net cash provided by financing activities was $28.1 million, consisting of net proceeds of $20.8 million from the issuance of our convertible preferred stock and net proceeds of $9.8 million from the issuance of long-term debt, partially offset by $2.5 million in payments on long-term debt.

During the year ended December 31, 2014, net cash provided by financing activities was $28.2 million consisting of net proceeds of $20.8 million from the issuance of convertible preferred stock, net proceeds of $9.8 million from the issuance of long-term debt and proceeds of $0.1 million from the issuance of common stock upon exercise of stock options, partially offset by $2.5 million in payments on long-term debt.

During the year ended December 31, 2013, net cash used in financing activities was $0.5 million consisting of $3.0 million in payments on long-term debt, offset by proceeds of $2.5 million from the issuance of long-term debt.

Indebtedness

In February 2014, we entered into a loan agreement with HCRP, a related party due to its equity ownership interest in us, for an aggregate principal amount of up to $15.0 million in two separate tranches. We drew down the first tranche of $10.0 million upon execution of the HCRP loan agreement and drew down the second tranche of $5.0 million in March 2015. Interest is payable quarterly at a fixed rate of 12.5% per annum with interest-only payments to be made from the effective date of the loan until March 31, 2017. Thereafter, we will make principal and interest payments until the maturity of the loan on December 31, 2020. We are permitted to make a voluntary prepayment in full, but not in part, prior to December 31, 2020, which prepayment must be made together with accrued and unpaid fixed interest on the amount prepaid and any additional amounts due in respect thereof, including an additional percentage of the aggregate loan amount or outstanding principal amount, depending on the date of prepayment. Our obligations under the HCRP loan agreement are secured by a first priority security interest in all of our assets, other than bank accounts, accounts receivable and inventory. The HCRP loan agreement imposes customary affirmative and restrictive covenants, including with respect to fundamental transactions, the incurrence of additional indebtedness or liens and the payment of cash dividends, but does not include any financial covenants. The HCRP loan agreement provides that an event of default will occur if, among other triggers, there occurs any circumstance that could reasonably be expected to result in a material adverse effect on our business, operations or condition, or on our ability to perform our obligations under the loan. The HCRP loan agreement also includes customary representations and warranties, other events of default and termination provisions. As of March 31, 2015, we were in compliance with all covenants.

Also in February 2015, we entered into an accounts receivable credit facility with SVB that permits the borrowing of the lesser of $7.5 million or an amount representing up to 80% of eligible accounts receivable. The SVB credit facility matures in February 2018 and our obligations under the SVB credit facility are secured by a first priority security interest in our bank accounts, accounts receivable, and inventory. Interest on borrowed amounts is payable monthly at the prime rate plus 0.75%. The SVB credit facility imposes customary affirmative and restrictive covenants, including with respect to fundamental transactions, changes to our business, the incurrence of additional indebtedness or liens and the payment of dividends, but does not include any financial covenants. In addition, the SVB credit facility states that if we maintain a net cash balance, defined as unrestricted cash held with SVB less any borrowings on the revolving line of credit, of more than $3.0 million, then all collections will be deposited in our operating account. If the net cash balance is below $3.0 million, then all collections will be held in an SVB-controlled account and applied to reduce the loan balance. The SVB credit facility also includes customary representations and warranties, events of defaults and termination provisions. As of March 31, 2015, we have not drawn down on the SVB credit facility.

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements and do not have any holdings in variable interest entities.

Contractual Obligations

The following table summarizes our contractual obligations as of December 31, 2014:


	Payments Due by Period
(in thousands)	Less Than 1 Year		1 to 3 Years		3 to 5 Years		More Than 5 Years		Total
Long-term debt-related party, including interest	$	1,250	$	3,453	$	6,768	$	4,313	$	15,784
Operating leases		2,053		4,167		4,421		11,821		22,462

Total contractual obligations	$	3,303	$	7,620	$	11,189	$	16,134	$	38,246

The following table summarizes our contractual obligations as of March 31, 2015:


	Payments Due by Period
(in thousands)	Less Than 1 Year		1 to 3 Years		3 to 5 Years		More Than 5 Years		Total
Long-term debt-related party, including interest	$	1,405	$	5,180	$	10,149	$	6,469	$	23,203
Operating leases		1,722		4,167		4,421		11,821		22,131

Total contractual obligations	$	3,127	$	9,347	$	14,570	$	18,290	$	45,334

Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risks in the ordinary course of our business. These risks primarily relate to interest rate risks. We had cash and cash equivalents of $5.0 million, $6.0 million and $25.3 million as of December 31, 2013, December 31, 2014 and March 31, 2015, respectively, which consist of bank deposits and money market funds.

Our short-term investments primarily consisted of corporate bonds. The cash and cash equivalents are held for working capital purposes. Our investments are made for capital preservation purposes. We do not enter into investments for trading or speculative purposes. Because of the short-term nature of the instruments in our portfolio, a sudden change in market interest rates would not be expected to have a material impact on our financial statements.

We had total outstanding debt of $2.5 million as of December 31, 2013, which was subsequently repaid in February 2014. As of December 31, 2014 and March 31, 2015, we had total outstanding debt of $9.3 million and $14.4 million, respectively. This debt carries a fixed interest rate equal to 12.5%. A hypothetical 100 basis point change in interest rates during any of the periods presented would not have had a material impact on our financial statements.

Critical Accounting Policies and Estimates

Our management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with United States generally accepted accounting principles, or U.S. GAAP. The preparation of these financial statements requires our management to make judgments and estimates that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported revenue generated and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these judgments and estimates under different assumptions or conditions and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

Revenue Recognition

We earn revenue from the sale of our devices to hospitals through direct sales representatives and independent sales agents. Our revenue is recognized when the following criteria are met:

•

Persuasive evidence of an arrangement exists. We consider this criterion satisfied when we have a purchase order or contract with the customer in place.

•

Delivery has occurred and title passed to the customer, which is typically upon shipment of the device from our location or when received by the customer based on the shipping terms.

•

The price is fixed or determinable and collectability is reasonably assured. We determine the satisfaction of these criteria based on our judgment regarding the nature of the fee charged for devices, contractual agreements entered into, and the collectability of those fees under any contract or agreement.

We do not offer rights of return or price protection and have no post-delivery obligations other than our standard warranty.

Stock-based Compensation

We recognize compensation costs related to stock options granted to employees based on the estimated fair value of the awards on the date of grant, net of estimated forfeitures. We estimate the grant date fair value, and the resulting stock-based compensation expense, using the Black-Scholes option pricing model. The grant date fair value of stock-based awards is expensed on a straight-line basis over the period during which the employee is required to provide service in exchange for the award (generally the vesting period).

We estimate the fair value of our stock-based awards using the Black-Scholes option-pricing model, which requires the input of highly subjective assumptions. Our assumptions are as follows:

•

Expected term. The expected term represents the period that the stock-based awards are expected to be outstanding. We use the simplified method to determine the expected term, which is calculated as the average of the time to vesting and the contractual life of the options.

•

Expected volatility. As our common stock has never been publicly traded, the expected volatility is derived from the average historical volatilities of publicly traded companies within our industry that we consider to be comparable to our business over a period approximately equal to the expected term for employees options and the remaining contractual life for non-employees options.

•

Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield with a maturity equal to the expected term of the option in effect at the time of grant.

•

Dividend yield. The expected dividend is assumed to be zero as we have never paid dividends and have no current plans to pay any dividends on our common stock.

In addition to the assumptions used in the Black-Scholes option-pricing model, we also estimate a forfeiture rate to calculate the stock-based compensation for our equity awards. We will continue to use judgment in evaluating the expected volatility, expected term and forfeiture rates utilized for our stock-based compensation calculations on a prospective basis.

Stock-based compensation expense for options granted to non-employees as consideration for services received is measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, using the Black-Scholes option-pricing model, whichever can be more reliably measured. Stock-based compensation expense for options granted to non-employees is periodically remeasured as the underlying options vest.

The following table summarizes the assumptions we used to determine the fair value of stock options granted to employees:


	Year Ended December 31,		Three Months Ended March 31
	2013	2014	2014	2015⁽¹⁾
Expected term (in years)	6.0	6.0	6.0	—
Expected volatility	43%	35 – 38%	38%	—
Risk-free interest rate	1.08 – 1.82%	1.80 – 1.93%	1.91%	—
Dividend yield	0%	0%	0%	—

⁽¹⁾	No stock options were granted during the three months ended March 31, 2015.

We recorded total stock-based compensation expense of $0.3 million and $0.7 million in the years ended December 31, 2013 and 2014, respectively, and $0.1 million and $0.2 million in the three months ended March 31, 2014 and 2015, respectively. We expect to continue to grant stock options and other equity-based awards in the future, and to the extent that we do, our stock-based compensation expense recognized in future periods will likely increase.

Historically, for all periods prior to this offering, the fair values of the shares of common stock underlying our stock-based awards were estimated on each grant date by our board of directors. In order to determine the fair value of our common stock underlying option grants, our board of directors considered, among other things, contemporaneous valuations of our common stock prepared by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants Practice Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Given the absence of a public trading market for our common stock, our board of directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of our common stock, including our stage of development; the rights, preferences and privileges of our convertible preferred stock relative to those of our common stock; our operating results and financial condition, including our levels of available capital resources; equity market conditions affecting comparable public companies; general U.S. market conditions and the lack of marketability of our common stock.

For stock awards after the completion of this offering, our board of directors intends to determine the fair value of each share of underlying common stock based on the closing price of our common stock as reported on the date of grant.

The intrinsic value of all outstanding options as of March 31, 2015 was $ million based on an assumed initial public offering price of $ per share, the midpoint of the estimated offering price range set forth on the cover of this prospectus.

Convertible Preferred Stock Warrant Liability

We have issued freestanding warrants to purchase shares of convertible preferred stock in connection with the issuance of various debt facilities and debt instruments. We account for these warrants as a liability in our financial statements because the underlying instrument into which the warrants are exercisable contains deemed liquidation provisions that are outside our control.

The warrants outstanding at December 31, 2013 were recorded at fair value using the Black-Scholes option pricing model. The fair value of the warrants at December 31, 2014 and March 31, 2015 was determined using a hybrid method of the option-pricing model and a probability of various liquidity events required to trigger the conversion of the convertible preferred stock warrants. The scenarios included merger and acquisition events ranging in time to event of one to three years, an initial public offering occurring within six months to two years, and dissolution. The warrants are re-measured at each financial reporting period with any changes in fair value being recognized as a component of interest and other income (expense), net in the statements of operations. We will continue to adjust the liability for changes in fair value until the earlier of (i) exercise or expiration of the warrants, or (ii) the completion of an initial public offering, at which time all convertible preferred stock warrants will be converted into warrants to purchase common stock and the liability will be reclassified to additional paid-in capital.

Internal Control Over Financial Reporting

certain personnel had the ability to prepare and post journal entries without an independent review performed by someone without this ability. Upon identifying this material weakness, we performed additional procedures to evaluate the impact on the financial statements. Based on these procedures, we believe the material weakness did not result in any material misstatements to our financial statements. However, this material weakness could result in a misstatement of our accounts or disclosures that would result in a material misstatement of our financial statements that would not be prevented or detected. We are implementing measures designed to improve our internal control over financial reporting to remediate this material weakness, including the following:

•

We amended accounting system access rights so that there are finance personnel without journal entry access who can perform review activities.

•

We are formalizing our internal control documentation and strengthening supervisory reviews by our management.

•

We are in the process of adding additional accounting personnel and segregating duties amongst accounting personnel.

JOBS Act Accounting Election

We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have irrevocably elected not to avail ourselves of this exemption from new or revised accounting standards and, therefore, will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update 2014-09, Revenue from Contracts with Customers, or ASU 2014-09. Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. This guidance is effective for fiscal years and interim reporting periods beginning after December 15, 2016, at which time we may adopt the new standard update under the full retrospective method or the modified retrospective method. Early adoption is not permitted. We are currently evaluating the impact that the adoption of ASU 2014-09 will have on our financial statements and related disclosures.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, or ASU 2014-15. ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. In doing so, companies will have reduced diversity in the timing and content of footnote disclosures than under today’s guidance. ASU 2014-15 is effective in the first quarter of 2016 with early adoption permitted. We are currently evaluating the impact of adopting ASU 2014-15 on our financial statements and related disclosures.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest-Imputation of Interest, or ASU 2015-03. ASU 2015-03 requires that debt issuance costs related to a recognized debt

liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance of debt issuance costs is not affected by the amendments in this update. The standard will be effective beginning in the first quarter of 2016 and requires us to apply the new guidance on a retrospective basis on adoption. We do not expect the adoption of this guidance to have a material impact on our financial statements.

BUSINESS

Overview

Photonics is the science and technological applications of light. We have applied advanced principles of photonics to develop our Intelligent Photonics technology platform, which enables the transmission, management and manipulation of light in surgical procedures. Our initial application of this technology is integrated into our family of proprietary optical waveguides. Our waveguides are sophisticated devices that rely on the principles of optics to shape and direct light. They are coupled to a modified fiber optic cable and are designed to work with the standard xenon or LED light sources typically found and utilized in the operating room. Our optical waveguides are incorporated into surgical devices, including our customized line of illuminated surgical retractors, handheld illuminated aspiration devices and drop-in intracavity illuminators. Our handheld illuminated aspiration devices and drop-in intracavity illuminator are single-use products. Our retractors are reusable, but utilize a single-use optical waveguide with each procedure.

Advances in medical technology have resulted in growing adoption of minimally invasive and minimal access surgical procedures. Minimally invasive surgery refers to surgeries performed through one or more small incisions, which offer several benefits over traditional invasive open surgery, such as fewer surgical target complications and infections, overall reduced trauma to the anatomy, less bleeding, shorter

hospitalization time, less postoperative pain, faster recovery time and improved aesthetic outcomes. Some minimally invasive procedures, such as endoscopic, laparoscopic and arthroscopic procedures, use small tubes, tiny cameras and surgical instruments to access, visualize and perform the surgery. Other procedures also use smaller incisions than conventional open surgery, but still provide the surgeon with direct visualization of the surgical target and the ability to use traditional surgical instruments. We refer to these procedures as open minimally invasive and minimal access procedures. We estimate that approximately 40% of all surgical procedures in the United States are open minimally invasive and minimal access, and based on the benefits of these procedures over conventional open surgery, we believe this percentage will continue to grow. We have initially targeted our sales and marketing efforts to surgeons in the following specialties: orthopedics, spine, breast, oncology, plastics, and thyroid. However, our current illuminated surgical devices have a broader indication for use and can be marketed to other specialties with limited or no additional regulatory clearance. We intend to target other surgical specialties including trauma; cardiothoracic; ear, nose and throat; gynecology; general surgery; neurosurgery and craniomaxilliofacial procedures. We currently estimate the annual total addressable market for our devices in these surgical specialties in the United States to be approximately $2.0 billion, based on the estimate of our average revenue per procedure.

In the last several years, we have transitioned from a focus on research and development to the commercialization of our device portfolio. As of March 31, 2015, we market eight families of illuminated surgical devices, consisting of over 40 devices. We market and sell our devices in the United States primarily through a direct salesforce, which has grown from 16 sales representatives as of December 31, 2012, to 39 as of December 31, 2014 to 43 as of March 31, 2015. We have plans to increase sales by further expanding this commercial organization. We believe this expansion will allow us to further penetrate and grow our market by demonstrating the benefits of our devices to additional surgeons and hospitals. Our revenue increased from $7.2 million in 2013 to $13.1 million in 2014 and from $2.2 million to $4.4 million for the three months ended March 31, 2014 and 2015, respectively. In each of the year ended December 31, 2014 and the three months ended March 31, 2015, approximately 80% and 74% of our revenue, respectively, was generated by the sale of single-use devices. We had a net loss of $12.1 million and $20.7 million in the years ended December 31, 2013 and 2014, respectively, and $4.7 million and $9.0 million for the three months ended March 31, 2014 and 2015, respectively. As of December 31, 2014 and March 31, 2015, we had an accumulated deficit of $68.0 million and $77.1 million, respectively.

Our Market Opportunity

•

smaller incisions resulting in less scarring and fewer complications;

•

less trauma to the organs, muscles, nerves, and tissue;

•

less bleeding and reduced need for blood transfusions;

•

fewer surgical infections;

•

shortened hospital stays, potentially reducing hospital costs;

•

less postoperative pain and reduced need for associated narcotics;

•

faster recovery time; and

•

improved aesthetic outcomes.

Minimally invasive surgery refers to surgery performed through one or more small incisions as compared to conventional open surgery procedures. Some minimally invasive procedures, such as endoscopic,

laparoscopic and arthroscopic procedures, use small tubes, tiny cameras and surgical instruments to access, visualize and perform the surgery. Though these procedures have several of the benefits described above, surgeons are only able to view the surgical target through a tiny camera, which can cause reduced depth perception and field of vision, diminished hand-eye coordination, limited mobility of the surgical instruments, and reduced tactile feedback. These limitations can increase the cognitive and physical load on the surgeon and, consequently, increase the possibility of surgical error. Other procedures also use smaller incisions than conventional open surgery but still enable the surgeon direct visualization of the surgical target and the ability to use traditional surgical instruments. We refer to these procedures as open minimally invasive and minimal access procedures. We believe that open minimally invasive and minimal access procedures provide many of the benefits described above. However, the small incisions used in these procedures inherently reduce a surgeon’s ability to directly see the surgical target, particularly deep within the surgical cavity, which can impact surgical precision, procedural efficiency and patient safety.

We estimate that approximately 40% of all surgical procedures in the United States are open minimally invasive and minimal access. Based on the benefits of these procedures over conventional open surgery, we believe this percentage will continue to grow. We have developed illuminated surgical devices that enable and facilitate the use of open minimally invasive and minimal access techniques. We have initially targeted our sales and marketing efforts to surgeons in the following specialties: orthopedics, spine, breast oncology, plastics and thyroid. However, our current illuminated surgical devices have a broad indication for use and can be marketed to other specialties with limited or no additional regulatory clearance. We intend to target other surgical specialties including trauma; cardiothoracic; ear, nose and throat; gynecology; urology; general surgery; neurosurgery and craniomaxilliofacial procedures. We currently estimate the annual total addressable market for our devices in these surgical specialties in the United States to be approximately $2.0 billion, based on the estimate of our average revenue per procedure.

Traditional Illumination Devices and Their Limitations

Overhead Lighting Systems

The most common illumination method in the operating room setting today is overhead lighting systems. Overhead lighting systems consist of lighting fixtures that are positioned above the surgical field. When used in open minimally invasive and minimal access procedures, overhead lighting systems can present numerous challenges. In order to effectively illuminate the surgical field, the surgical field must be in a direct line of sight from the overhead lighting system. This can be difficult to maintain as changes in patient or surgeon positioning may interfere with the path of illumination at various points throughout the procedure. For example, the position of the surgeon’s head can interfere with the overhead illumination and obstruct light from reaching the surgical cavity. When this occurs, adjustments by the surgeon to the overhead lighting systems may be required to maintain the light’s direct exposure to the different parts of the surgical field. We believe these adjustments pose an inconvenience for the surgeon, disrupt surgical flow and increase operating room procedure time. We believe the adjustments can also result in contamination of the surgical field as the overhead lighting systems are not sterile and the constant repositioning can contaminate the gloves and gown of the surgeon and operating room staff. Moreover, overhead lighting systems may be inadequate for surgery in deeper cavities due to the creation of significant shadows within the surgical field and the inability of the light to reach the depths of the incision.

Surgical Headlights

Surgical headlights were developed to address some of the shortcomings of overhead lighting systems. The headlight system consists of a headband worn by the surgeon and, most commonly, coupled with a fiber optic light system that is plugged into a xenon or LED light source. Headlights have the effect of bringing the light source closer to the surgical cavity thereby improving its direct exposure. Additionally, due to the position of the headlight, the surgeon’s head no longer interferes with the light, and the light is typically directed to the area that the surgeon wants to view without having to manipulate an overhead light. Despite these benefits, we believe headlights still present limitations. For example, headlights can be heavy and uncomfortable to use and may be associated with head, neck and shoulder fatigue from the prolonged improper posture required during their use, frequent headaches, neck pain and injury to the cervical spine. These devices require the surgeon to maintain a steady head and neck position to provide constant and steady illumination of the surgical field, which can limit the surgeon’s mobility and visibility of the surgical field by other members of the operating team. When two or more surgeons are wearing these headlights opposite each other during the procedure, the headlights can collide, which we believe can dislodge particles and contaminate the sterile field. Because the source of light is still above the surgical cavity, we believe the use of headlights can create shadows and glare caused by hands, instruments and anatomy, which may limit visualization in deep surgical cavities. Headlights can also generate considerable amounts of heat during use, which can further limit comfort and can cause burns if an operator accidently mishandles the device. For these reasons, we believe surgical headlights do not provide an optimal intracavity illumination system and are not used by all surgeons.

On-field Fiber Optic Lighting Systems

While traditional on-field fiber optic lighting systems can be effective at bringing the light source closer to the surgical field, we believe they also have inherent limitations and risks. Traditional on-field fiber optic lighting systems represent a thermal hazard in the operating room, creating the risk of burns to patients, surgeons and hospital staff and operating room fires. The light generated by the xenon or LED light source is extremely powerful and can create temperatures exceeding 100°C. Thermal heat builds up whenever light is obstructed. There are two locations where significant amounts of heat are generated in these light systems. The first area is at the fiber-to-fiber coupling of the fiber optic cable to the fiber optic surgical retractor. It is virtually impossible to perfectly align each fiber in the fiber optic cable with each fiber in the fiber optic retractor. This inefficient optical coupling yields significant light loss. The location of light loss then generates substantial heat and is a known source of thermal injury to patients and operating room staff. The second area where a significant amount of heat is generated is at the point where light exits the fiber optic bundles. With traditional on-field fiber optic lighting systems, light is directed in a narrow beam, with intensity at a maximum at the center of the spot of light, and dropping off exponentially toward the edges. Since light exits these bundles from a small active area and due to this tight intensity profile, there is a significant amount of heat concentrated at the illumination spot at the exit surface of the fiber optic bundles, with temperatures significant enough to melt surgical drapes, coagulate blood, and burn patients.

We believe another limitation of traditional on-field fiber optic lighting systems is the potential for hot spots and glare. The general light output shape emanating from a fiber optic cable resembles a cone and is circular, with a common center around the mechanical axis of the fiber bundle. Because of these

properties, when the fiber is placed adjacent to the retractor, a portion of light is obstructed, reducing the light available to the surgical field and causing heat buildup on the retractor. To address this problem, the majority of current commercial fiber optic retractors locate the fiber as close as possible to the distal end of the retractor blade in order to minimize this absorption effect. However, placing the fiber on the distal end of the retractor puts it in close proximity to the patient’s tissue, which can result in a significant amount of energy and heat being transposed onto the surgical target. Additionally, it can create a very bright, narrow spot of light. Since this bright, narrow spot of light exits the fiber in a straight line in the direction and orientation of the fiber, the light may be reflected back in the same direction, and can create glare in the line of vision of the surgeon. In an attempt to minimize this glare, the surgeon may be required to constantly reposition the fiber optic retractor during the procedure.

Market Need for Advanced Intracavity Illumination and Visualization Devices

Our Solution

•

Reduced risks to patients and surgeons. Our technology is developed with design elements to help create thermally cool illumination as well as ergonomics to improve ease of use while performing a procedure. Our advanced surgical devices incorporate a solid core optical-grade polymer that facilitates efficient coupling to the surgical instrument to offer significantly improved light transfer while concurrently reducing heat transfer. We believe this is an important advancement over traditional on-field fiber optic lighting systems that do not efficiently transfer light through the fiber-to-fiber coupling, resulting in the generation of excess heat, which can increase the risk of burn to patients and surgical staff and create the potential for operating room fires. By improving visualization, our devices may also decrease risk of unintended retained foreign objects by improving the surgeon’s ability to see and

dispose of such objects that might have otherwise been left in the surgical cavity inadvertently. Finally, by being directly incorporated into a variety of illuminated surgical retractors, handheld illuminated aspiration devices, and drop-in intracavity illuminators, we believe our technology may help to decrease surgeon fatigue by reducing or eliminating the need for surgical headlights, thereby helping to reduce some of the associated head, neck and shoulder fatigue, frequent headaches, neck pain and injury to the cervical spine.

•

Enhanced operating room efficiency. We believe our technology improves operating room workflow by reducing the need for perioperative repositioning of traditional surgical lighting options. Overhead lighting systems and headlights require frequent readjustment, which may interrupt operating room workflow and extend surgical procedure time. Many open minimally invasive and minimal access procedures are time sensitive and the treatment area requires constant attention of the surgeon and operating team. Because our optical waveguides are directly connected to the surgical instrument that is used to access the deep surgical cavity, surgeons are able to clearly illuminate the surgical target and effectively focus on performing the procedure. As an example, in a survey we conducted with 12 surgeons that use our devices, each of whom is considered a leading breast surgeon, 11 of these surgeons reported that procedure time during nipple-sparing mastectomy procedures when using our devices was reduced by an average of 24%.

•

Economic value proposition to healthcare systems. We believe our devices have the potential to substantially reduce procedure costs as well as create incremental revenue opportunities. We believe the improved efficiency of the operating room workflow and the related reduced procedure and anesthesia time can translate to meaningful cost savings for the hospital. In addition, we believe the reduction in procedure times also creates additional capacity in the operating room for surgeons to perform more procedures, which we believe can create incremental revenue for the hospital. A retrospective analysis conducted by a healthcare consulting firm in 2015 demonstrated a 31-minute reduction in anesthesia time, on average, in nipple-sparing mastectomy procedures using our devices.

Our Intelligent Photonics Technology

Photonics is the science and technical application of light. We have applied advanced principles of photonics to develop our Intelligent Photonics technology platform, which enables the transmission, management and manipulation of light in surgical procedures. Our initial application of this technology is our family of proprietary optical waveguides. The fundamental attributes of our optical waveguides include a solid core optical-grade polymer, total internal reflection of light waves, light mixing and extraction by a complex geometry of refractive microstructures or microlenses.

Fundamental Attributes of Our Optical Waveguides

LOGO

Solid Core Optical-Grade Polymer

Our optical waveguides are fabricated from a proprietary solid core optical-grade polymer, specifically selected for its key optical and mechanical characteristics, which enable the efficient transmission and management of light. These optical characteristics include the ability to mold the material into various complex geometries, which is of particular importance when molding ultra-precise structures. Certain mechanical properties of the polymer, such as structural integrity, hydrophobicity and thermal stability, are critical to its use during surgical procedures. In addition, our solid core design facilitates the coupling of the waveguide to the modified fiber optic cable in order to allow the efficient transfer of light into the solid core waveguide, while remaining thermally cool. All these characteristics are critical in order for the waveguide to function as an advanced illuminated surgical device.

Total Internal Reflection of Light Waves

One of the key aspects of the optical waveguide technology is the ability to transmit light in a highly efficient manner prior to its extraction. Light travels in waves. As a wave travels through a medium it will reach a boundary where there is a different medium on the other side of the boundary. At the point where the wave meets the boundary, three phenomena can occur: reflection, refraction or some combination of both. Reflection occurs when light bounces off the boundary and refraction occurs when waves pass through a boundary and change direction. The angle at which the wave hits the boundary is referred to as the angle of incidence. That angle is usually referenced to the line that is perpendicular to the boundary. A zero incidence angle means that the wave is traveling perpendicular to the boundary. At that angle most of the light will pass most of its energy through the boundary and will not refract as long as the index of refraction is less on the other side of the boundary than in the medium the light is traveling. As the angle of incidence increases, the wave will get split into two components: one portion will pass the boundary and refract and the other portion will reflect back into the medium in which the wave was originally traveling. As the angle increases, the amount of refraction will decrease and reflection will increase. The smallest angle where the light is completely reflected and not refracted is called the critical angle. At any angle of incidence greater than the critical angle, all of the light is reflected off the boundary with no refraction. This is referred to as total internal reflection. We designed the structural and material properties of our devices to maximize locations of total internal reflection as the light propagates along the central axis of the waveguide.

Light Mixing

Our optical waveguides utilize various novel optical methods to mix light, or randomize its reflections, during the total internal reflection transmission process. The design and shape of the optical stem, or area of the waveguide that is between the input of the waveguide and the array of refractive microstructures or microlenses, enhance the mixing of light waves, while maintaining total internal reflection. Our optical waveguides utilize light mixing before extraction to significantly reduce glare and bright spots, leading to a more uniform illumination profile across the surgical target while remaining thermally cool.

Complex Geometry of Refractive Microstructures and Microlenses

We designed a proprietary complex geometry of refractive microstructures and microlenses that are placed on the surface of the optical waveguide to extract light from the device in a manner that distributes light over the surgical target. This distribution of light from the waveguide also reduces the energy density in the device, thus reducing heat. Without the microstructures to extract the light uniformly on the surgical target, the waveguide would dissipate an energy density across its surface that is in excess of the amount that the tissue could absorb without causing thermal injury. The surface of the waveguide contains a complex geometry of zones with corresponding refractive microstructures or microlenses at varying angles. These extraction zones allow the waveguide to direct the extracted light onto the surgical target and shape it into a broad, uniform and volumetric pattern. The ability to direct light is especially important when the waveguide is mounted on surgical retractors, because our device is able to push the light away from the retractor, thus maintaining its efficiency on the surgical target. We believe this is a significant advantage over traditional on-field fiber optic lighting systems, which lack the microstructures to direct light and instead direct light in a straight line in the shape of a cone from the end of the fiber. As a result, a portion of the illumination is obstructed and absorbed by the surgical retractors when the fiber is adjacent to the surgical instrument. The ability to shape light is also critical, as it reduces the focal intensity of light. With traditional fiber optic retractors, light is directed in a narrow beam, with intensity at a maximum in the center of the spot of light, and dropping off exponentially toward the edges. As a result, it typically does not illuminate the entire surgical cavity and heat builds up significantly in that focal zone. In contrast, our waveguides broaden this intensity of distribution, which allows the pattern of light to have uniform brightness across the surface of the surgical target, while minimizing the thermal profile.

Our waveguides are also designed to extract light from multiple zones, allowing the surgical target to be illuminated from various angles. As light is extracted across the waveguide at numerous different points along the surface at slightly different angles, if any of the features on the surface become blocked by an instrument, blood or tissue, there are multiple other microstructures from which light is extracted to provide illumination. This proprietary complex geometry also provides off-axis illumination on the surgical target, meaning that the light originates from a different angle than in direct orientation to the waveguide. As such, when light reflects off the tissue of the surgical target, instead of reflecting upwards towards the surgeon, the light is generally reflected onto the surface opposite the retractor. This feature of the waveguide is important because it allows the surgeon and operating staff much better visual perception of the surgical target with less shadows and glare.

Bench Testing

A bench test is a quality and function test carried out to evaluate the mechanical and technical properties of a device and to confirm that it operates according to its design specifications. We performed bench testing on certain traditional surgical instruments incorporating fiber optic lighting and on surgical instruments enabled by our waveguide technology and used the results to compare the performance aspects of the various devices. In particular, we compared light distribution and uniformity and surgical target thermal profile between a traditional 130mm Tebbetts fiber optic retractor and our 130mm Eikon retractor system. In addition, we also compared Electrosurgical Instrument’s Yankauer fiber optic aspiration device and our Saber Yankauer aspiration device. We caution the reader that our bench testing is limited in scope and

nature, with a focus on only four devices, and was conducted by us without any third-party involvement or review. As a result, we cannot assure you that a third-party evaluation of a broader number of competitive devices would yield similar results. The following table summarizes the results from this bench testing. Light distribution was calculated based on using the same minimum illuminance, or light per area, values:

Light Distribution

Thermal Profile

Illuminance

Uniformity

Traditional fiber optic retractor

6.3 cm²

3.868

50.3

°C

Eikon retractor system

30.8 cm²

0.398

33.2

°C

Traditional fiber optic aspiration device

25.4 cm²

0.731

61.5

°C

Saber Yankauer aspiration device

28.6 cm²

0.572

35.0

°C

Light Distribution. Optical ray tracing software technology is widely used to conduct various performance analyses of illumination and imaging systems. We use this software to model and understand how light propagates through various devices and how light is projected onto desired surgical targets. Using this software, we are able to build three dimensional geometrical models of a particular optical waveguide and its associated microstructures or microlenses to analyze how light transmits through the solid core of the waveguide and how light is extracted. We input and design the specific proprietary geometries of the microstructures or microlenses, and the software models device performance. We used optical ray tracing modeling to evaluate the light distribution of a traditional 130mm Tebbetts fiber optic retractor compared to our waveguide-enabled Eikon retractor system. We also modeled a traditional fiber optic aspiration device compared to our Saber Yankauer aspiration device.

Illumination. In order to analyze the size and distribution of a light pattern, we identified a target plane location and size. For this analysis, the target plane was defined to be located at the distal tip of the retractor, as that would be the working plane of the surgeon. We also defined the size of the plane, which had to be large enough to assure that we captured all the light rays hitting that plane. The light pattern was then analyzed with each light ray striking the surface of the target at certain brightness. The total light pattern was then produced by each of the light ray intensities and was used to calculate the illumination area. We chose consistent minimum illuminance for each device to determine the size and intensity of the illumination pattern.

Uniformity. To evaluate the uniformity of the illuminance pattern of each device, we used optical ray tracing modeling to measure the light spot pattern for each device. We then divided the light spot pattern into a 128x128 pixel array and exported the illuminance values for each pixel to a software program used for engineering calculations and analyses. Using this data, we calculated the mean illuminance value for the light spot pattern. Next, we compared the illuminance value for every data point in the array to the mean illuminance value. Finally, using the difference in each illuminance value from the mean we determined the standard deviation for each device. A standard deviation close to zero indicates that the illuminance values fall close to the mean, meaning that the device produces uniform illumination.

With the traditional fiber optic retractor, the conical light output is directed downward and due to its output geometry, a portion of light is obstructed and absorbed by the retractor. This has the effect of reducing the illuminated area and the uniformity of light within the spot pattern. For the traditional fiber optic retractor, the illuminated area was measured at approximately 6.3cm² area and the uniformity of light within the spot pattern had a standard deviation of 3.868. In comparison, for the same target plane, the light from our waveguide-enabled Eikon retractor system was directed away from the retractor blade, creating a much larger usable illumination area with a more uniform pattern of illuminance. The usable illumination area from the Eikon retractor system was measured at approximately 30.8cm², or approximately 5 times larger than that of the traditional fiber optic retractor. Correspondingly, the

uniformity of light within the spot pattern for the Eikon retractor systems had a standard deviation of 0.398, or approximately 9.7 times more uniform than the traditional fiber optic retractor.

Similar methods were applied in modeling the two aspiration devices. The traditional fiber optic aspiration device provided a usable illumination area that measured approximately 25.4cm², with the uniformity of light within the spot pattern demonstrating a standard deviation of 0.731. In comparison, our Saber Yankauer provided a usable illumination area that measured approximately 28.6cm², with the uniformity of light within the spot pattern demonstrating a standard deviation of 0.572. We believe the increased amount of illumination, combined with greater uniformity, provides a better quality of light.

LOGO

Light projection output of traditional fiber optic retractor device vs. our optical waveguide retractor device

Thermal Profile. To evaluate the thermal profile of each of these same devices, we measured temperature at the target plane with a FLIR thermal imager after stabilizing the xenon light source for 10 minutes. A thermal imager is used to detect radiation in the infrared range, between 7 to 14 microns, of the electromagnetic spectrum and produce visual images of that radiation. The amount of radiation emitted by an object increases with temperature, thus allowing the thermal imager to see and measure variations in temperature.

With traditional fiber optic retractors, light is directed in a narrow beam, with intensity at a maximum at the center of the spot, and dropping off exponentially toward the edges. As a result, heat builds up significantly in that focal zone. In contrast, our waveguides broaden this intensity of distribution, which allows the pattern of light to have uniform brightness across the surface of the surgical target, while minimizing the thermal profile. The peak temperature on the target plane, for the tested Tebbetts fiber

optic retractor was measured at 50.3°C. In comparison, at the same target plane, our waveguide-enabled Eikon retractor system dispersed light away from the retractor in a broader pattern, resulting in heat at the hottest spot on the target plane that measure 33.2°C, which is below the risk of thermal burn, which occurs at or above a temperature of 44°C. Similar thermal imaging testing was performed on the traditional fiber optic aspiration device and our Saber Yankauer aspiration device. The concentrated beam of the traditional fiber optic aspiration device produced heat at the hottest point on the target plane that measured almost 61.5°C, well above the temperature of thermal burn risk. In comparison, the better uniformity of light from our Saber Yankauer aspiration device resulted in heat at the hottest spot on the target plane that measured 35.0°C, which is significantly less than that of the traditional fiber optic aspiration device and is below the temperature of thermal burn risk.

LOGO

Thermal profile of traditional fiber optic retractor vs. our optical waveguide retractor

Our Strategy

Our goal is to be the global leader in providing advanced photonics systems to surgeons across a broad array of surgical specialties. while improving patient safety. The key elements of our strategy include:

•

Establish our Intelligent Photonics technology as the standard illumination technology used in open minimally invasive and minimal access procedures. We intend to continue to educate and train surgeons on the advantages of our Intelligent Photonics technology compared to traditional operating room lighting options. We believe the benefits of our Intelligent Photonics technology should also enable the broader application and adoption of open minimally invasive and minimal access procedures and help enable new advanced surgical techniques.

•

Expand our sales organization to support growth. We plan to continue to expand our direct sales organization in the United States to help facilitate further adoption among

existing hospital accounts as well as broaden awareness of our Intelligent Photonics technology to new hospitals. In 2012, we began to scale our sales organization through a combination of direct sales representatives, who are complemented by independent sales agents or agencies, whom we refer to as independent sales agents. As of March 31, 2015 we had 43 direct sales representatives.

•

Continue to deliver innovative technologies and broaden our device portfolio. We intend to continue to leverage our Intelligent Photonics technology platform to research, design and develop new devices that extend the benefits of open minimally invasive and minimal access techniques to a broader patient population. We are developing new applications of our proprietary Intelligent Photonics technology to expand utility, including in general surgery and in a number of additional surgical specialties outside our existing markets. We also plan to introduce next-generation illumination, visualization and advanced photonics technologies that further enable minimally invasive and minimal access procedures. We believe our ability to introduce new devices to surgeons will allow us to continue to expand our annual total addressable market opportunity over time.

•

Focus on key opinion leader surgeons to facilitate adoption. We place significant emphasis on collaborating with key opinion leaders. We believe adoption of our technology by these thought leaders will accelerate broader application and adoption throughout a given specialty area. We are working in collaboration with key opinion leader surgeons in various surgical fields to explore new product development and clinical applications for our technology and generate surgeon awareness of the clinical and economic value of our technology.

•

Our Products

Our Intelligent Photonics technology has allowed us to design multiple variations of our waveguides in order to target different illumination patterns for different shapes of surgical cavities. Because we can mold our solid core optical-grade polymer into different shapes, we are able to design waveguides that either direct the light narrowly for deep cavities or broad for larger blade cavities. Our waveguides also come in narrow or wide configurations to accommodate various retractor widths that are designed for varying patient anatomies. Our versatile design and manufacturing capabilities allow us to develop waveguides with a variety of extraction patterns. For example, our current retractor based waveguides utilize a complex geometry of refractive microstructures and microlenses, whereas as our handheld illuminated aspiration devices have integrated microlens arrays. Using advanced ray-trace software modeling programs, we are able to perform three-dimensional optical performance modeling of our waveguides, as well as an entire assembly including the retractor. We are capable of analyzing the entire optical performance of the assembly as we monitor various characteristics such as extracted light direction, uniformity on the target, glare to the user, as well as thermal profile. This ray-trace modeling process helps us develop illuminated surgical devices that are designed to provide optimal intracavity illumination.


Product Family	Image	Description	Surgical Specialties
*Eikon Illuminated Retractor System*		Illuminated surgical retractor with a low-profile design. Lightweight, radiolucent, anodized aluminum retractors provide electrical insulation from electrosurgical device preventing inadvertent thermal damage. Atraumatic and elevated tip for easy maneuverability, dissection and retraction. Available in multiple blade sizes for varying patient anatomies and surgeon preferences.	Breast Oncology / Oncoplastic Surgery / General Surgery / Orthopedics

*Saber Yankauer*		Handheld illuminator incorporated in a traditional Yankauer aspiration platform. Provides on-field illumination, aspiration, smoke evacuation, soft tissue retraction and blunt dissection in one device. Low-profile design enables surgeons to work efficiently in deep, dark cavities through smaller incisions. Available in multiple tip configurations (bulb, fin, taper and metal) for various surgical needs and in an optional pistol grip handle for improved ergonomics and visualization.	Orthopedic / Spine / Cardiothoracic / Breast / General Surgery

*Saber Frazier*		Handheld illuminator incorporated in a traditional Frazier aspiration platform. Provides on-field illumination, aspiration, smoke evacuation, and soft tissue retraction in one device. Low-profile design enables surgeons to work efficiently in deep, dark cavities through smaller incisions.	Spine / Orthopedic / Neurosurgery


Product Family	Image	Description	Surgical Specialties
*Eika Illuminated Retractor System*		Illuminated surgical retractor with a low-profile design. Self-retracting handle design enables either hands-free or manual retraction. Includes a handle slot for ideal cable management and placement. Available in multiple blade sizes for varying patient anatomies and surgeon preferences. Designed for anterior neck approaches, including thyroid and cervical spine surgeries.	Endocrine / Spine / Orthopedics

*Breiten Illuminated Retractor System*		Illuminated surgical retractor with a low-profile design. Radiolucent to enable visibility during fluoroscopy. Color-coded for easy identification. Provides an offset hub for blade positioning. Available in multiple blade sizes and blade tips for varying patient anatomies and surgeon preferences.	Spine

*Eipex Illuminated Retractor System*		Illuminated surgical retractor . Curved handle design enables either hands-free or manual retraction. Blade tip facilitates facet landing for added stability. Multiple cable management features for ideal cable placement.	Spine / Orthopedic

*Eivector Illuminated Retractor System*		Illuminated surgical retractor with a low-profile design. Lightweight, radiolucent, anodized aluminum retractors provide electrical insulation from electrosurgical devices preventing inadvertent thermal damage. Attachable extension for added leverage in varying patient anatomies. Available in multiple blade sizes for varying patient anatomies and surgeon preferences.	Orthopedic

*Waveguide XT System*		Drop-in intracavity illuminator with a low-profile design. Anchors to the incision wall providing a stand-alone, hands-free device. Minimal profile design is compatible with existing retractors and instrumentation and accommodates preferred surgical exposure techniques.	Spine

Selected Surgical Applications

Our commercial strategy is initially focused on targeting open minimally invasive and minimal access procedures where there is a significant need for improved illumination and direct visualization. These procedures span a broad spectrum of surgical specialties including breast, orthopedic, spine, thyroid, plastic and general surgery. We believe our technology has enabled surgeons to perform procedures that were previously difficult to perform due to visualization and illumination challenges. The selected procedures discussed below illustrate some of the benefits of our technology.

Breast: Nipple Sparing Mastectomy

Surgical management of breast cancer has evolved dramatically over the past several decades. Surgeons have continuously looked for ways to improve oncologic outcomes while combining the techniques of oncoplastic surgery to maximize both the treatment of cancer and the aesthetic outcome with the optimal goal of preserving the nipple areola complex. Skin and nipple preservation during breast cancer surgery is essential to attain ideal aesthetic results.

A nipple sparing mastectomy, or NSM, is a procedure in which the cancerous breast tissue is removed but the breast skin and nipple are left intact. We believe the relatively limited adoption to date of the NSM procedure is attributed to a number of surgical limitations. Some of these limitations include limited access and visualization through smaller and distant incision location, and difficulty in maintaining consistent breast flap thickness and viability. We believe our Intelligent Photonics technology can facilitate a surgeon’s ability to:

•

use a single infra-mammary fold incision in NSM to access and visualize deep into the surgical cavity;

•

access and visualize the lymphatic tree without a second axillary incision in most cases; and

•

assess the breast flap thickness and viability via trans-illumination.

Orthopedics: Anterior Hip Arthroplasty

The growth of minimally invasive surgery in orthopedics has been dramatic worldwide, as clinical results indicate that patients who undergo these procedures typically experience improved clinical outcomes, shorter hospital stays, faster rehabilitation and improved aesthetic outcomes. Our technology has been used in a range of procedures including, among others, hip arthroplasty, within which the use of our technology has enabled a less invasive approach.

Traditional hip replacement, also known as hip arthroplasty, techniques involve operating from the side or the back of the hip, which can involve a significant disturbance of the muscles and tendons and an incision approximately 8 to 12 inches long. In comparison, the direct frontal, or anterior, approach requires an incision that is only 3 to 4 inches long and located at the front of the hip. In this position, the surgeon does not need to detach any of the muscles or tendons, but rather can move them aside along their natural tissue planes. This approach often results in faster recovery, less pain and more normal function after hip replacement. In addition, there is a lower risk of dislocating the new prosthesis when placed via the anterior approach, as the strength and integrity of the adjacent tendons and muscles surrounding the hip are maintained.

To date, we believe the less invasive anterior approach has been underutilized due, in part, to the visualization challenges associated with the procedure. More specifically, because the acetabulum and femoral canal are difficult to visualize using this approach, component positioning, sizing, and stability are more likely to be compromised, all of which are critical factors to yielding a successful and durable clinical outcome.

We believe the visualization provided by our devices can facilitate the surgeon’s ability to:

•

expose, prepare and seat the acetabular shell and liner within the acetabulum;

•

place the acetabular screw;

•

evaluate stability and impingement of the ball against the socket;

•

prepare and mobilize the femur; and

•

internally inspect the femoral canal.

Additional Applications

Our existing portfolio of devices is also eligible for use in, and could potentially improve the viability of, a multitude of additional surgical procedures. Importantly, our devices could be marketed and sold for a broad spectrum of surgical specialties without the need for any additional regulatory clearance. We believe our technology could help address the illumination and visualization challenges associated with various general surgery procedures, including appendectomy and herniorrhaphy; hysterectomy and other erological, gynecological and colorectal procedures; thyroidectomy and parathyroidectomy and other ear, nose and throat procedures; cardiac, cardiothoracic and cardiovascular procedures; cranialmaxillofacial procedures and aesthetic plastic surgery.

We also continue to research and develop new devices as well as pursue new clinical applications.

Sales and Marketing

We began selling our first FDA-cleared waveguide-based device in March 2009. As a result, we have limited experience marketing and selling our devices. We currently sell our devices through our direct sales representatives only in the United States. Our direct salesforce works with independent sales agents who assist us in educating targeted surgeons. While we sell primarily directly to hospitals, surgeons typically drive the purchasing decision. We sold our devices to approximately 400 hospitals in the first quarter of 2015. As of March 31, 2015, we had a sales and marketing team of 64 employees. Our sales team consisted of a Vice President of Sales, a Senior Director of U.S. Sales, seven regional sales directors, a Director of National Strategic Accounts, a sales analyst, 43 direct sales representatives and 43 independent sales agents or agencies, whom we refer to as independent sales agents, all of whom had significant sales experience before joining our sales team. Additionally, we have five marketing and four customer service employees. We have significantly expanded our direct sales representatives from 16 at December 31, 2012 to 39 at December 31, 2014 to 43 at March 31, 2015. We plan to continue to expand our direct sales organization in the United States to help facilitate further adoption among existing hospital accounts as well as broaden awareness of our Intelligent Photonics technology to new hospitals. Using our expanded direct salesforce, we intend to continue to educate and train surgeons on the advantages of our Intelligent Photonics technology compared to traditional operating room lighting options. We believe the benefits of our Intelligent Photonics technology should also enable the broader application and adoption of open minimally invasive and minimal access surgical procedures by more surgeons. Our operating results are directly dependent upon the sales and marketing efforts of our employees.

Our marketing efforts are focused on developing a strong reputation with major teaching institutions and hospitals as well as surgeons that we have identified as key opinion leaders based on their knowledge of our devices, clinical expertise and reputation. We also use clinical education programs of several surgical system manufacturers, giving surgeons first-hand experience of the benefits of our devices.

We also sell and market through original equipment manufacturers of surgical systems. The majority of these sales have been through Biomet, Inc. as part of its spinal implant surgical systems. Sales to Biomet, Inc. or its predecessor in interest, Lanx, Inc., accounted for approximately 12% of our total revenue in each of 2013 and 2014. In addition, sales to Medtronic, Inc. accounted for approximately 13% of our

total revenue in 2013. There were no sales to any customer in excess of 10% of our total revenue for the three months ended March 31, 2015. We do not expect sales to these customers to increase significantly in the future.

Surgeon Survey

For FDA purposes, our devices are classified as Class I, Class II exempt or Class II devices. Class I and Class II exempt devices do not require a 510(k) premarket notification. Our Class II devices, which require a 510(k) premarket notification, are not in a category that require clinical studies to obtain clearance for marketing. As a result the FDA has not required, and we have not developed, clinical data supporting the safety and efficacy of our devices. Information relating to the benefits of our devices is limited to management’s beliefs and our direct observation of and feedback from surgeons using our devices during surgery, surgeon feedback resulting from surgeon surveys and the bench testing performed by us. We summarize the surgeon survey below and caution readers that it is limited in scope and nature, focuses on the use of our device in only one type of surgery, NSM, and involves a small number of surgeons.

We engaged an independent third party to perform a survey of breast surgeon thought leaders. The average breast surgeon in the survey had approximately 12 months experience using our Eikon retractors and performed over 150 breast cancer procedures annually. The 12 surgeons surveyed are all amongst the leadership of the American Society of Breast Surgeons, or ASBS, including three former presidents, as well as the chairperson and principal investigator of the NSM registry for ASBS. Each surgeon in the survey was asked to respond to the list of questions below, with a yes or no, or with a ranking of importance using a descending scale of most important, very important, important, not very important, and not important. The results of the survey are listed in the table below.


Customer Survey	Number of Surgeons Responding Positively
Surgical Efficiency
Improving surgical efficiency is important / very important / most important		12/12
Reducing operating room time is important / very important / most important		12/12
Eikon improved surgical efficiency for NSM		12/12
Eikon reduced procedure time for NSM		11/12
Safety and Visualization
Reducing thermal hazards with lighted retractors is very important / most important		12/12
Eikon reduced heat and associated thermal hazards in the operating room		11/12
Eikon improved patient safety		11/12
Eikon improved staff safety		10/12
Eikon improved operating room safety		10/12
Prefer not to use headlight in operating room when performing NSM		11/12
Eikon eliminated or minimized dependence on a headlight		12/12
Prior to Eikon, the surgeon used traditional fiber optic retractors		11/12
Poor lighting or excessive heat is a concern or limitation of traditional fiber optic retractors		8/11
Eikon improved visualization of tissue planes and anatomical landmarks without generating heat and without associated thermal hazards		12/12

Retrospective Analysis

In 2015, we engaged a healthcare consulting firm to perform a retrospective analysis of our Eikon retractor system in NSM procedures. The retrospective analysis, performed by an independent third party, involved the review of medical charts for NSM procedures undertaken at one of the participating breast centers in our breast surgeon survey, reviewing 43 cases from a single breast surgeon who works

exclusively with one breast reconstruction plastic surgeon. These results are based on a single surgeon performing a single type of surgical operation, and we cannot assure you that similar time savings, or any time savings, would be obtained by other surgeons performing the same procedure or other surgical procedures. The chart review focused on procedures performed from June 2011 to July 2012 and was designed to capture patient characteristics, surgical parameters, and clinical outcomes of NSM procedures. Patients were segmented into to two cohorts. Cohort A represented patients that received an NSM procedure performed without the Eikon retractor, and Cohort B represented patients that received an NSM procedure performed with the Eikon retactor. Advanced electrosurgery devices were used for dissection and coagulation with approximately three-quarters of Cohort B and none of Cohort A. The surgeon began using the advanced electrosurgery device for dissection and coagulation after operating on all Cohort A patients and approximately one-quarter of Cohort B patients. Patients in each cohort were further segmented based on whether they received a bilateral or unilateral mastectomy. There were only two patients in Cohort A and six patients in Cohort B that underwent unilateral mastectomy rather than a bilateral mastectomy. Bilateral mastectomy procedures had a 31-minute reduction in anesthesia time on average. Unilateral cases also showed a trend towards a reduction in anesthesia time in Cohort B, but there were too few cases to show statistical significance. Surgical times may vary for a multitude of reasons. Patient tissue type, ease of surgical plane identification and ease of identification of the sentinel node are factors that can create a difference in time case per case. Surgical times also increase when breast surgical oncology fellows participate in the cases as they are still being trained regarding the NSM techniques. In addition, the data from the Eikon retractor system procedure group demonstrated a statistically significant 70% relative reduction in epidermolysis, a common complication of breast surgery that involves necrosis of the developed skin flaps or skin margins. The surgeons attributed the reduction in epidermolysis to the use of the Eikon retractor system in conjunction with an advanced electrosurgery device for dissection and coagulation. Among the other complications evaluated, which included post-operative bleeding, flap necrosis, infection, seroma and hematoma, there was no statistically significant difference between procedures performed with and without the Eikon retractor system. There was one case of superficial partial skin burn that was directly attributable to using the electrosurgical device with a thin skin flap and was not attributable to the Eikon retractor.

Coverage and Reimbursement

Payment for patient care in the United States is generally made by third-party payors, including private insurers and government insurance programs. The reimbursement to the facility from third-party payors is intended to cover the overall cost of treatment, including the cost of our devices used during the procedure as well as the overhead cost associated with the facility where the procedure is performed. We do not directly bill any third-party payors and receive payment from the hospital or surgical center for our devices. Failure by physicians, hospitals, ambulatory surgery centers and other users of our devices to obtain sufficient coverage and reimbursement from healthcare payors for procedures in which our devices are used, or adverse changes in government and private third-party payors’ policies would have a material adverse effect on our business, financial condition, results of operations and future growth prospects.

In addition, there are periodic changes to reimbursement. Third-party payors regularly update reimbursement amounts and also from time to time revise the methodologies used to determine reimbursement amounts. This includes annual updates to payments to physicians, hospitals and ambulatory surgery centers for procedures during which our devices are used. Because the cost of our devices generally is recovered by the healthcare provider as part of the payment for performing a procedure and not separately reimbursed, these updates could directly impact the demand for our devices. An example of payment updates is the Medicare program’s updates to hospital and physician payments, which are done on an annual basis using a prescribed statutory formula. In the past, with respect to reimbursement for physician services under the Medicare Physician Fee Schedule, when the application of the formula resulted in lower payment, Congress has passed interim legislation to prevent the reductions. Most recently, the Protecting Access to Medicare Act of 2014, signed into law in April

2014, provided for a 0.5% update from 2013 payment rates under the Medicare Physician Fee Schedule through 2014 and a 0% update from January 1 until April 1, 2015. If Congress fails to intervene to prevent the negative update factor in future years, the resulting decrease in payment may adversely affect our revenues and results of operations.

Any changes in coverage and reimbursement that lowers reimbursement for procedures using our devices could materially affect our business.

Competition

The medical device industry is highly competitive. Our success depends, in part, upon our ability to maintain a competitive position in the development of technologies and devices for surgical illumination and visualization. We face significant competition in the United States and internationally in the surgical illumination and visualization market, and we expect the intensity of competition will increase over time. Surgeons and hospitals typically use traditional overhead lighting, headlights and fiber optic lighting products, and if we cannot convince surgeons and hospitals of the benefits of using our devices in addition to, or as an alternative to, traditional overhead lighting and headlights, or, of the benefits of using our devices instead of using competing fiber optic lighting products, our business may be harmed. Some of our main competitors are Lumitex, Inc., Scintillant (Engineered Medical Solutions Co. LLC), Stryker Corporation, TeDan Surgical Innovations, LLC, and Black & Black Surgical, Inc. and other general surgical instrument companies that supply traditional fiber optic retractors. Many of the companies developing or marketing competing products enjoy several competitive advantages, including:

•

more established sales and marketing programs and distribution networks;

•

long established relationships with surgeons and hospitals;

•

contractual relationships with customers;

•

products that have already received approval from the relevant VACs;

•

greater financial and human resources for product development, sales and marketing;

•

greater name recognition;

•

the ability to offer rebates or bundle multiple product offerings to offer greater discounts or incentives; and

•

Our competitors may develop and patent processes or devices earlier than us, obtain regulatory clearance or approvals for competing devices more rapidly than us or develop more effective or less expensive devices or technologies that render our technology or devices obsolete or less competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific and management personnel. If our competitors are more successful than us in these matters, our business may be harmed.

Any device we develop will have to compete for market acceptance and market share. We believe that the primary competitive factors in the surgical illumination and visualization market segment are clinical safety and effectiveness, price, surgeon experience and comfort with use of particular illumination systems, reliability and durability, ease of use, device support and service, salesforce experience and relationships. Our success in selling our devices to hospitals is dependent on our ability to demonstrate that the clinical, qualitative and economic value delivered by our products outweighs their increase to the cost per procedure. Our ability to compete on price depends on our ability to demonstrate to surgeons, hospitals and surgery centers that the potential benefits of improved clinical outcomes and reduced

procedure costs from the increased efficiency in the operating room workflow and related reduced procedure and anesthesia time using our medical devices outweigh the price of our devices compared to our competitors’ products.

Intellectual Property

In order to remain competitive, we must protect the proprietary technology that we believe is important to our business, including seeking and, if granted, maintaining patents intended to cover our products and inventions that are commercially important to the development of our business. We also rely on trademarks, trade secret laws and confidentiality and invention assignment agreements to protect our intellectual property rights.

It is our policy to require our employees, consultants, contractors, outside scientific collaborators and other advisors to execute non-disclosure and assignment of invention agreements on commencement of their employment or engagement. Agreements with our employees also forbid them from using the proprietary rights of third parties in their work for us. We also require confidentiality agreements from third parties that receive our confidential data or materials.

Our success will depend on our ability to obtain and maintain patent and other proprietary protection for commercially important technology, inventions and know-how related to our business, defend and enforce our patents, preserve the confidentiality of our trade secrets and operate without infringing the valid and enforceable patents and proprietary rights of third parties. For more information, please see “Risk Factors—Risks Related to Our Intellectual Property.”

As of March 31, 2015, we held 24 issued U.S. patents and had 46 U.S. utility patent applications and 6 Patent Cooperation Treaty (PCT) applications pending. As of March 31, 2015, we also had one issued patent from the Japan Patent Office, three issued patents from the Chinese patent office, and four patents from the European Patent Office which have effect in one or more of Germany, France, Great Britain and Italy. As of March 31, 2015, we had 23 pending patent applications outside of the United States, including Europe, Japan, Korea, China, Australia and Canada. As we continue to research and develop our Intelligent Photonics technology, we intend to file additional U.S. and foreign patent applications related to the design, manufacture and clinical uses of our illuminated devices and other products. Our issued patents expire between the years 2026 and 2034. Our pending patent applications and issued patents include claims directed to coupling of an illumination device with a light source or an instrument, as well as efficient and safe transmission of light through the illumination device.

As of March 31, 2015, we held three allowed United States trademarks and one U.S. registered mark as well as one international trademark registration and twenty-two foreign trademark registrations.

Manufacturing and Quality Assurance

Our manufacturing involves the combined utilization of our internal manufacturing resources and expertise, approved suppliers and contract manufacturers. Our internal manufacturing activities, located in San Francisco, California, include the inspection, assembly and packaging of the waveguides, retractor systems, aspiration devices and accessories associated with each of our device families. We outsource the manufacture of components, subassemblies and certain finished devices that are produced to our specifications and shipped to our facilities for final assembly or inspection, and certification. Finished products are stored at and distributed from our facility. Quality control, risk management, efficiency and the ability to respond quickly to changing requirements are the primary goals of our manufacturing operations.

We have arrangements with our suppliers that allow us to adjust the delivery quantities of components, subassemblies and finished products, as well as delivery schedules, to match our changing requirements.

The forecasts we use are based on historical trends, current utilization patterns and sales forecasts of future demand. Lead times for components, subassemblies and finished products may vary significantly depending on the size of the order, specific supplier requirements and current market demand for the components and subassemblies. Most of our suppliers have no contractual obligations to supply us with, and we are not contractually obligated to purchase from them, the components used in our devices.

We obtain the optical polymer used in the manufacture of our waveguides and certain accessories from single suppliers, for which we attempt to mitigate risks through inventory management and purchase order commitments. While we believe alternate sources exist for the optical polymer, we have not qualified an alternate provider. Other products and components come from single suppliers, but alternate suppliers have been qualified or, we believe, can be readily identified and qualified. In addition, we rely on a single provider for sterilization of our devices that require sterilization. While we believe replacement suppliers exist for all components, materials and services we obtain from single sources, establishing additional or replacement suppliers for any of these components, materials or services, if required, may not be accomplished quickly. Even if we are able to find a replacement supplier, the replacement supplier may need to be qualified and may require additional regulatory authority approval, which could result in further delay. While we seek to maintain adequate inventory of the single-source components and materials used in our products, in the event of disruption, those inventories may not be sufficient. To date, we have not experienced material delays in obtaining any of our components, subassemblies or finished products, nor has the ready supply of finished products to our customers been adversely affected. To date, we have not experienced any material delays by our sterilization provider and will continue to evaluate the cost and benefit of qualifying a second sterilization provider.

If our third-party suppliers fail to deliver the required commercial quantities of materials on a timely basis and at commercially reasonable prices, and we are unable to find one or more replacement suppliers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality on a timely basis, the continued commercialization of our products, the supply of our products to customers and the development of any future products would be delayed, limited or prevented, which could have an adverse impact on our business.

We have implemented a quality management system designed to comply with FDA regulations and International Standards Organization, or ISO, standards governing medical device products. These regulations govern the design, manufacture, testing and release of diagnostic products as well as raw material receipt and control. We have received ISO 13485 certification as well as an EC Certificate under Directive 93/42/EEC on Medical Devices, Annex II, excluding section 4. Our key outsourcing partners are ISO-certified.

We use small quantities of common cleaning products in our manufacturing operations, which are lawfully disposed of through a normal waste management program. We do not forecast any material costs due to compliance with environmental laws or regulations.

Government Regulation

Our products are medical devices and are therefore subject to extensive regulation by the FDA under the authority of the Federal Food, Drug and Cosmetic Act, or FDCA, and the regulations promulgated thereunder, as well as by corresponding state and international regulatory authorities. The regulations govern the following activities that we and our suppliers, licensors and partners engage in:

•

product design and development;

•

pre-clinical and clinical testing;

•

establishment registration and product listing;

•

product manufacturing;

•

labeling and storage;

•

pre-market clearance or approval; advertising and promotion;

•

product sales and distribution;

•

recalls and field safety corrective actions; and

•

servicing and post-market surveillance.

Regulatory Clearances and Approvals. Unless an exemption applies, each medical device we wish to commercially distribute in the United States will require either prior 510(k) clearance or PMA approval from the FDA. The FDA classifies medical devices into one of three classes. Devices requiring fewer controls because they are deemed to pose low or moderate risk are placed in Class I or II, which, unless subject to an exemption, requires the manufacturer to submit to FDA a 510(k) premarket notification requesting clearance for commercial distribution. Exempt Class I and II devices do not require submission of a 510(k) but are otherwise subject to general controls such as labeling, pre-market notification and adherence to the FDA’s Quality System Regulation, or QSR, which cover manufacturers’ methods and documentation of the design, testing, production, control quality assurance, labeling, packaging, sterilization, storage and shipping of products. Certain Class II devices are also subject to special controls such as performance standards, post-market surveillance, FDA guidelines, or particularized labeling. Our waveguides, retractor and aspiration devices are marketed as Class I exempt devices. The fiber optic cables and trays we supply as part of our illuminated retractor and aspiration systems are marketed as Class II exempt devices. The metal and plastic sterilization trays used by the customer to sterilize our reusable retractors and fiber optic cables are Class II 510(k) products.

To obtain 510(k) clearance, we must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a previously cleared 510(k) device or a device that was in commercial distribution before May 28, 1976 for which the FDA has not yet called for the submission of PMAs. The FDA’s 510(k) clearance pathway usually takes from three to 12 months from the date the notification is submitted, but it can take considerably longer, depending on the extent of requests for additional information from the FDA and the amount of time a sponsor takes to fulfill them. FDA requests for additional information can include clinical data that the FDA determines is necessary to make a determination regarding substantial equivalence. We obtained 510(k) clearance for the BriteField McCulloch Retractor System, in April of 2009 and for the Eigr Surgical Illumination System in February of 2012. All of our other commercial products to date have been commercialized as either Class I, Class II exempt or Class II devices.

After a device receives 510(k) clearance or is commercialized as a Class I or II exempt device, any modification that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, will require a new 510(k) clearance or could require premarket approval. The FDA requires each manufacturer to make this decision initially, but the FDA can review any such decision and can disagree with a manufacturer’s determination. If the FDA disagrees with a manufacturer’s determination, the FDA can require the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or premarket approval is obtained. We have made, and plan to continue to make, product enhancements that we believe do not require new 510(k) clearances. If the FDA requires us to seek 510(k) clearance or premarket approval for any such modifications to previously commercialized products, we may be required to cease marketing or recall the modified device until we obtain this clearance or approval, and we could be subject to significant regulatory fines or penalties.

A PMA must be submitted if a device cannot be cleared through the 510(k) clearance process. A PMA application must be supported by extensive data, including, but not limited to, technical information, preclinical data, clinical trial data, manufacturing data and labeling to demonstrate to the FDA’s satisfaction the safety and efficacy of the device for its intended use. None of our existing products are currently approved under a PMA, and we have no plans to develop products that would require a PMA.

Continuing FDA Regulation. Even after a device receives clearance or approval and is placed in commercial distribution, numerous regulatory requirements apply. These include:

•

establishment registration and device listing with FDA;

•

Quality System Regulation, or QSR, which requires manufacturers, including third-party manufacturers, to follow stringent design, testing, production, control, supplier/contractor selection, complaint handling, documentation and other quality assurance procedures during all aspects of the manufacturing process;

•

labeling regulations that prohibit the promotion of products for uncleared, unapproved or “off-label” uses, and impose other restrictions on labeling, advertising and promotional activities;

•

Medical Device Reporting, or MDR, regulations, which require that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if the malfunction were to recur;

•

voluntary and mandatory device recalls to address problems when a device is defective and could be a risk to health; and

•

corrections and removals reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health.

We and our contract manufacturers, specification developers and some suppliers of components or device accessories, also are required to manufacture our products in compliance with current Good Manufacturing Practice, or GMP, requirements set forth in the QSR. The QSR requires a quality system for the design, manufacture, packaging, labeling, storage, installation and servicing of marketed devices, and it includes extensive requirements with respect to quality management and organization, device design, buildings, equipment, purchase and handling of components or services, production and process controls, packaging and labeling controls, device evaluation, distribution, installation, complaint handling, servicing, and record keeping. The FDA and the California Food and Drug Branch evaluates compliance with the QSR through periodic unannounced inspections that may include the manufacturing facilities of our subcontractors. If the FDA or the Food and Drug Branch believes that we or any of our contract manufacturers or regulated suppliers are not in compliance with these requirements, it can shut down our manufacturing operations, require recall of our products, refuse to clear new marketing applications, institute legal proceedings to detain or seize products, enjoin future violations or assess civil and criminal penalties against us or our officers or other employees.

Failure to comply with applicable regulatory requirements can result in enforcement actions by the FDA and other regulatory agencies. These may include any of the following sanctions or consequences:

•

warning letters or untitled letters that require corrective action;

•

fines and civil penalties;

•

delays in clearing or refusal to clear future products;

•

FDA refusal to issue certificates to foreign governments needed to export products for sale in other countries;

•

suspension or withdrawal of FDA clearances;

•

product recall or seizure;

•

interruption or total shutdown of production;

•

operating restrictions;

•

injunctions; and

•

criminal prosecution.

Fraud and Abuse Laws. There are numerous U.S. federal and state laws pertaining to healthcare fraud and abuse, including anti-kickback, false claims, physician payment and privacy and security laws. Our relationships with healthcare providers and other third parties are subject to scrutiny under these laws. Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, imprisonment and exclusion from participation in federal and state healthcare programs, including the Medicare, Medicaid and Veterans Administration health programs.

Federal Anti-Kickback Laws. The Federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, receiving, offering or providing remuneration, directly or indirectly, to induce either the referral of an individual, or the furnishing, recommending, or arranging of a good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid. The definition of “remuneration” has been broadly interpreted to include anything of value, including such items as gifts, discounts, the furnishing of supplies or equipment, credit arrangements, waiver of payments and providing anything at less than its fair market value. The Department of Health and Human Services, or HHS, has issued regulations, commonly known as safe harbors, that set forth certain provisions which, if fully met, will assure healthcare providers and other parties that they will not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do not fully satisfy each applicable safe harbor may result in increased scrutiny by government enforcement authorities such as the HHS Office of Inspector General.

The penalties for violating the federal Anti-Kickback Statute include imprisonment for up to five years, fines of up to $25,000 per violation and possible exclusion from federal healthcare programs such as Medicare and Medicaid. Many states have adopted prohibitions similar to the federal Anti-Kickback Statute, some of which apply to the referral of patients for healthcare items and services reimbursed by any source, not only by the Medicare and Medicaid programs. Further, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, or PPACA, amends the intent requirement of the federal anti-kickback and criminal healthcare fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it. The PPACA also provides that the government may assert that a claim including items or services resulting from a violation of the federal anti-kickback statute constitutes a false or fraudulent claim for purposes of the false claims statutes.

Federal False Claims Act. The Federal False Claims Act provides, in part, that the federal government may bring a lawsuit against any person whom it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim approved. In addition, amendments in 1986 to the Federal False Claims Act have made it easier for private parties to bring “qui tam” whistleblower lawsuits against companies under the Federal False Claims Act. Penalties include fines ranging from $5,500 to $11,000 for each false claim, plus three times the amount of damages that the federal government sustained because of the act of that person. Qui tam actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, pay fines or be excluded from Medicare, Medicaid or other federal or state healthcare programs as a result of an investigation arising out of such action.

Civil Monetary Penalties Law. The Federal Civil Monetary Penalties Law prohibits the offering or transferring of remuneration to a Medicare or Medicaid beneficiary that the person knows or should

know is likely to influence the beneficiary’s selection of a particular supplier of Medicare or Medicaid payable items or services. Noncompliance can result in civil money penalties of up to $10,000 for each wrongful act, assessment of three times the amount claimed for each item or service and exclusion from the federal healthcare programs.

State Fraud and Abuse Provisions. Many states have also adopted some form of anti-kickback and anti-referral laws and a false claims act. A determination of liability under such laws could result in fines and penalties and restrictions on our ability to operate in these jurisdictions.

Health Insurance Portability and Accountability Act of 1996. The Health Insurance Portability and Accountability Act of 1996, or HIPAA, created two new federal crimes: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. A violation of this statute is a felony and may result in fines or imprisonment. In addition, similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it to have committed a violation.

Physician Payment Transparency Laws. There has also been a recent trend of increased federal and state regulation of payments made to physicians and other healthcare providers. PPACA, among other things, imposes new reporting requirements on device manufacturers for payments made by them to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. Failure to submit required information may result in civil monetary penalties of up to an aggregate of $150,000 per year (or up to an aggregate of $1 million per year for “knowing failures”), for all payments, transfers of value or ownership or investment interests that are not timely, accurately and completely reported in an annual submission. Device manufacturers are required to submit reports to the government by the 90th day of each calendar year. Failure to submit the required information may result in civil monetary penalties up to an aggregate of $150,000 per year (and up to an aggregate of $1 million per year for “knowing failures”) for all payments, transfers of value or ownership or investment interests not reported in an annual submission, and may result in liability under other federal laws or regulations. Certain states also mandate implementation of compliance programs, impose restrictions on drug manufacturer marketing practices and/or require the tracking and reporting of gifts, compensation and other remuneration to physicians.

Data Privacy and Security Laws. We may also be subject to data privacy and security regulation by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology and Clinical Health Act, or HITECH, and their respective implementing regulations, including the final omnibus rule published on January 25, 2013, imposes specified requirements relating to the privacy, security and transmission of individually identifiable health information. Among other things, HITECH makes HIPAA’s privacy and security standards directly applicable to “business associates,” defined as independent contractors or agents of covered entities that create, receive, maintain or transmit protected health information in connection with providing a service for or on behalf of a covered entity. HITECH also increased the civil and criminal penalties that may be imposed against covered entities, business associates and possibly other persons, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorney’s fees and costs associated with pursuing federal civil actions. In addition, state laws govern the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways, thus complicating compliance efforts.

U.S. Foreign Corrupt Practices Act. The U.S. Foreign Corrupt Practices Act, or FCPA, prohibits U.S. corporations and their representatives from offering, promising, authorizing or making corrupt payments, gifts or transfers to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business abroad. The scope of the FCPA would include interactions with certain healthcare professionals in many countries.

International Regulation

We may evaluate international expansion opportunities in the future. International sales of medical devices are subject to local government regulations, which may vary substantially from country to country. The time required to obtain approval in another country may be longer or shorter than that required for FDA approval, and the requirements may differ. There is a trend towards harmonization of quality system standards among the European Union, United States, Canada and various other industrialized countries.

The primary regulatory body in Europe is that of the European Union, which includes most of the major countries in Europe. Other countries, such as Switzerland, have voluntarily adopted laws and regulations that mirror those of the European Union with respect to medical devices. The European Union has adopted numerous directives and standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. Devices that comply with the requirements of a relevant directive will be entitled to bear the CE conformity marking, indicating that the device conforms to the essential requirements of the applicable directives and, accordingly, can be commercially distributed throughout Europe. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a “Notified Body.” This third-party assessment may consist of an audit of the manufacturer’s quality system and specific testing of the manufacturer’s product. An assessment by a Notified Body of one country within the European Union is required in order for a manufacturer to commercially distribute the product throughout the European Union. Additional local requirements may apply on a country-by-country basis. Outside of the European Union, regulatory approval would need to be sought on a country-by-country basis in order for us to market our devices.

Research and Development

We have an experienced research and development team with the scientific, engineering and process talent that we believe is necessary to grow our business. As of March 31, 2015, we had 10 employees engaged in research and development. Our research and development team has the technical and engineering knowledge that we believe is necessary to develop next-generation technology, as well as the advanced educational backgrounds in physics, optics, biomedics and mechanical engineering to support innovation in these areas.

We expect to commit significant resources to developing new technologies and devices, improving product performance and reducing costs. We continually seek to enhance and iterate our existing devices. Our research and development expenses totaled $4.4 million and $5.2 million in the years ended December 31, 2013 and 2014, respectively. For the three months ended March 31, 2014 and 2015, our research and development expenses totaled $1.2 million and $1.9 million, respectively. We also expect to expand our technology to create next generation devices and new Intelligent Photonics technology platform. In addition, we are engaged in advanced research related to inclusion of illumination in other medical devices, as well as further improvements in visualization and tissue differentiation.

Employees

As of March 31, 2015, we had 116 full-time employees, which included 64 employees engaged in sales and marketing, 10 employees engaged in research and development, 30 employees engaged in manufacturing and quality assurance and 12 general and administrative employees. None of our

employees are represented by collective bargaining agreement and we have never experienced any work stoppage. We believe we have good relations with our employees.

Facilities

We lease an aggregate of approximately 38,135 square feet of manufacturing, office and research space in San Francisco, California under a lease expiring in 2024. We currently conduct all of our internal manufacturing at this facility. We believe this facility is sufficient to support our operations and that suitable facilities would be available to us should our operations require it.

In April 2015, we entered into a lease termination agreement with our landlord to terminate the lease for our former facility in San Francisco, California, prior to its scheduled expiration in January 2016. We are no longer obligated to make any lease payments subsequent to the lease termination date of April 30, 2015.

Legal Proceedings

From time to time we may be involved in various disputes and litigation matters that arise in the ordinary course of business. We are currently not a party to any material legal proceedings.

MANAGEMENT

Executive Officers and Directors

The following table sets forth information, as of March 31, 2015, regarding our executive officers and directors.


Name	Age		Title
*Executive Officers*
Philip Sawyer⁽³⁾		50	President, Chief Executive Officer and Director
Robert Gerberich		48	Vice President of Sales and Marketing
Paul O. Davison		46	Vice President of Research and Development
Doug Heigel		54	Vice President of Operations
Alex Vayser		47	Chief Technology Officer and Co-Founder
Brett Robertson		54	Vice President of Corporate Development, General Counsel and Secretary
Michael Gandy⁽⁴⁾		54	Chief Financial Officer
*Non-Employee Directors*
Gregory B. Brown, M.D.^(1)(2)(3)		61	Director and Chairman of the Board
Randall A. Lipps⁽²⁾		57	Director
Gregory T. Lucier⁽²⁾⁽³⁾		50	Director
Eric W. Roberts⁽¹⁾⁽²⁾		51	Director
Reza Zadno, Ph.D.⁽¹⁾⁽³⁾		60	Director

⁽¹⁾	Member of our audit committee.

⁽²⁾	Member of our compensation committee.

⁽³⁾	Member of our nominating and corporate governance committee.

⁽⁴⁾	Mr. Gandy intends to resign as our Chief Financial Officer.

Executive Officers

Philip Sawyer has served as our Chief Executive Officer and a member of our board of directors since March 2010 and as our President since June 2012. In 2008, Mr. Sawyer co-founded Helix Ventures, a healthcare venture capital fund. In 1993, Mr. Sawyer co-founded Fusion Medical Technologies, a surgical sealant company, where he held the positions of President and Chief Executive Officer for nine years, guiding the company through two private financings, an initial public offering and an acquisition by Baxter International. Mr. Sawyer worked in marketing and business development at Stryker Corporation from 1991 to 1993. Mr. Sawyer received a B.A. in political science from Haverford College and an M.B.A. from Harvard Business School. We believe Mr. Sawyer is qualified to serve as a member of our board of directors because of the perspective he brings as our Chief Executive Officer and his management, operational and investment experience in the healthcare industry.

Robert Gerberich has served as our Vice President of Sales and Marketing since October 2012. From April 2012 to October 2012, Mr. Gerberich served as Senior Vice President of Global Sales and Field Development at Primcogent Solutions, a non-invasive low-level laser therapy company. From January 2006 to April 2012, Mr. Gerberich served as President of UltraShape North America. Prior to UltraShape, Mr. Gerberich served as the Vice President of Marketing and Sales and Vice President of Sales at Thermage Inc., a medical device company (now Solta Medical). Mr. Gerberich received a B.S. in marketing from Illinois State University.

Paul O. Davison has served as our Vice President of Research and Development since November 2014. From October 2011 to November 2014, Mr. Davison served as Vice President and General Manager at ConMed, a surgical and patient monitoring products company. From July 2006 to September 2011, Mr. Davison served as Vice President of Research and Development at PEAK Surgical, a surgical tools company acquired by Medtronic, Inc. in 2011. Mr. Davison received a B.S. in manufacturing engineering

from California Polytechnic University at Pomona and an M.S. in engineering management with a stem in mechanical engineering from Santa Clara University.

Doug Heigel has served as our Vice President of Operations since September 2014. From July 2003 to January 2014, Mr. Heigel served as Vice President of Operations for Solta Medical, a medical aesthetics company which was sold to Valeant Pharmaceuticals in January 2014. In May 2002, Mr. Heigel joined Solta Medical’s predecessor company, Thermage, as Senior Director of Operations. From October 1995 to February 2002, Mr. Heigel worked for Argonaut Technologies, a life sciences company, first as Director of Manufacturing and then as Vice President of Manufacturing. Prior to Argonaut, Mr. Heigel served in various operational and technical leadership roles in the semiconductor and measurement instrumentation markets. Mr. Heigel received a B.S. in mechanical engineering from Oregon State University.

Alex Vayser co-founded Invuity and has served as our Chief Technology Officer since November 2004. Prior to joining Invuity, Mr. Vayser co-founded and served as President of Medvision, a manufacturer of custom surgical endoscopes and imaging devices. While at Medvision, Mr. Vayser co-founded Parallax Devices, a company focused on single channel stereoscopic and 3-D optical systems for medical and industrial applications. Mr. Vayser received a B.S. in optical engineering from the University of Rochester’s Institute of Optics.

Brett Robertson has served as our Vice President of Corporate Development, General Counsel and Secretary since September 2010. From 2008 to September 2010, Ms. Robertson served as an advisor to executives and board members on capital markets and growth strategies for a portfolio of private companies. From 2006 to 2007, Ms. Robertson was Senior Vice President and General Counsel at StubHub, an online ticket sales marketplace. From 2003 to 2006, Ms. Robertson was Executive Vice President and General Counsel at Ask Jeeves, a search engine company. Ms. Robertson received a B.A. from the University of California, Berkeley and a J.D. from the University of Virginia.

Michael Gandy has served as our Chief Financial Officer since January 2013. From July 2010 to January 2013, Mr. Gandy was the Chief Financial Officer of Novasys Medical, a company focused on women’s health. From August 2009 to June 2010, Mr. Gandy was the Chief Financial Officer of Baxano Surgical, an orthopedic company. Mr. Gandy has informed us that he plans to resign as our Chief Financial Officer to pursue other interests but has agreed to remain as our Chief Financial Officer until an appropriate replacement is hired. Mr. Gandy received a B.S. in finance from the California State University, Long Beach and an M.B.A. from California State University, Fullerton.

Non-Employee Directors

Gregory B. Brown, M.D. has served as a member of our board of directors since February 2014 and as the Chairman of our board of directors since March 2015. Since October 2007, Dr. Brown has served as a Founding Managing Director of HealthCare Royalty Partners, a healthcare investment firm. Prior to co-founding HealthCare Royalty Partners, Dr. Brown was a partner at Paul Capital Partners, an investment firm, from 2002 to 2007. From 1997 to 2002, Dr. Brown was Co-Head of Investment Banking and Head of Healthcare at Adams, Harkness & Hill (now Canaccord Genuity) and a biotechnology research analyst and investment banker at Vector Securities International from 1992 to 1997. Prior to that, Dr. Brown practiced as a thoracic and vascular surgeon. Dr. Brown received an A.B. from Yale University, an M.D. from SUNY Upstate Medical Center and an M.B.A. from Harvard Business School. We believe Dr. Brown is qualified to serve as a member of our board of directors because of his medical background and investment experience in the healthcare industry.

Randall A. Lipps has served as a member of our board of directors since June 2013. In September 1992, Mr. Randall founded Omnicell, a publicly traded automated healthcare solutions company, and has served as its Chairman of the Board since that time and as its President and Chief Executive Officer since

October 2002. From 1989 to 1992, Mr. Lipps served as the Senior Vice President of ST Holdings, a travel and marketing company. From 1987 to 1989, he served as Assistant Vice President of Sales and Operations for a subsidiary of AMR, the parent company of American Airlines. Mr. Lipps received both a B.S. in economics and a B.B.A. from Southern Methodist University. We believe Mr. Lipps is qualified to serve on our board of directors because of his management and operational experience in the healthcare industry.

Gregory T. Lucier has served as a member of our board of directors since October 2014. From November 2008 to February 2014, Mr. Lucier was Chairman of the board of directors and Chief Executive Officer of Life Technologies, a global life sciences company acquired by Thermo Fisher Scientific in 2014. In May 2003, Mr. Lucier joined Life Technologies’ predecessor company, Invitrogen Corporation, as Chief Executive Officer. Prior to Life Technologies, Mr. Lucier was a corporate officer at General Electric Company from 1994 to 2003 where he served in a variety of leadership roles. Mr. Lucier serves on the board of directors of NuVasive and CareFusion. Mr. Lucier received a B.S. with honors in industrial engineering from Pennsylvania State University and an M.B.A. from Harvard Business School. We believe Mr. Lucier is qualified to serve as a member of our board of directors because of his management and operational experience in the healthcare industry.

Eric W. Roberts has served as a member of our board of directors since June 2012. Since January 2012, Mr. Roberts has been a founding Managing Director of Valence Life Sciences. Since June 2006, Mr. Roberts has been a founding Managing Director of Caxton Advantage Venture Partners. From 1986 to 2004, Mr. Roberts served in a variety of roles as an investment banker, including as Managing Director and Partner at Dillon, Read & Co. and Managing Director and Co-Head of the Healthcare Investment Banking Group at Lehman Brothers. Mr. Roberts received a B.S. in economics from the Wharton School of the University of Pennsylvania. We believe Mr. Roberts is qualified to serve as a member of our board of directors because of his experience as an investment banker and venture capitalist in the healthcare industry.

Reza Zadno, Ph.D. has served as a member of our board of directors since January 2013. Since January 2015, Dr. Zadno has served as an Innovation Advisor to Novartis Venture Fund and has served as an Executive in Residence at InterWest Partners, a venture capital firm, where he served as a Venture Partner from January 2012 to December 2014. From January 2011 to January 2012, Dr. Zadno served as a Venture Partner at New Leaf Venture Partners, a venture capital firm. From March 2001 to September 2009, Dr. Zadno was founder, President, and Chief Executive Officer of Visiogen, a medical device company, which was acquired by Abbott-Medical Optics, a medical supply company, in 2009, at which time Dr. Zadno served as its General Manager until January 2011. From August 2000 to March 2001, Dr. Zadno worked as Entrepreneur in Residence at Three Arch Partners, a healthcare investment firm. Dr. Zadno currently serves on the board of directors of Carbylan Therapeutics, Oraya Therapeutics and Gobiquity. Dr. Zadno received a Ph.D. (Docteur-Ingenieur) in Mechanical Properties of Materials from Ecole des Mines de Paris. We believe Dr. Zadno is qualified to serve on our board because of his medical background, venture capital experience and his leadership and management experience.

Executive Officers

Each of our executive officers serves at the discretion of our board of directors and holds office until his or her successor is duly elected and qualified or until his or her earlier resignation or removal.

Board of Directors

Our business is managed under the direction of our board of directors, which consists of six directors. Our directors hold office until the earlier of their death, resignation, removal, or disqualification, or until their successors have been elected and qualified. We are actively searching for qualified candidates to add to our board of directors. Our board of directors does not have a formal policy on whether the roles of

chief executive officer and chairman of our board of directors should be separate. Prior to this offering, the members of our board of directors were elected in compliance with the provisions of our amended and restated articles of incorporation and a voting agreement among us and certain of our stockholders. The voting agreement will terminate upon the completion of this offering and, following the completion of this offering, none of our stockholders will have any special rights regarding the election or designation of members of our board of directors.

Upon completion of this offering, our bylaws will be amended and restated to provide that the authorized number of directors may be changed only by resolution of the board of directors. Upon the completion of this offering, our board of directors will be divided into three classes with staggered three-year terms. At each annual meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election or until their earlier death, resignation or removal. Our directors will be divided among the three classes as follows:

•

The Class I directors will be Dr. Brown and Mr. Sawyer, and their terms will expire at our annual meeting of stockholders to be held in 2016;

•

The Class II directors will be Mr. Roberts and Dr. Zadno, and their terms will expire at our annual meeting of stockholders to be held in 2017; and

•

The Class III directors will be Messrs. Lipps and Lucier, and their terms will expire at our annual meeting of stockholders to be held in 2018.

This classification of the board of directors, together with the ability of the stockholders to remove our directors only for cause and the inability of stockholders to call special meetings, may have the effect of delaying or preventing a change in control or management. See “Description of Capital Stock—Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws” in this prospectus for a discussion of other anti-takeover provisions that will be included in our amended and restated certificate of incorporation that will become effective immediately prior to the completion of this offering.

Director Independence

In connection with this offering, we intend to list our common stock on the NASDAQ Global Market. Under the rules of the NASDAQ Global Market, independent directors must comprise a majority of a listed company’s board of directors within a specified period of the completion of this offering. In addition, the rules of the NASDAQ Global Market require that, subject to specified exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent. Our board of directors has reviewed the independence of each director and determined that Drs. Brown and Zadno and Messrs. Lipps, Lucier and Roberts are independent. Our board of directors will review the independence of each director at least annually. During these reviews, the board of directors will consider transactions and relationships between each director (and his or her immediate family and affiliates) and our company and its management to determine whether any such transactions or relationships are inconsistent with a determination that the director is independent. This review will be based primarily on responses of the directors to questions in a directors’ and officers’ questionnaire regarding employment, business, familial, compensation and other relationships with our company including its management.

We believe that the composition of our board of directors meets the requirements for independence under the current requirements of the NASDAQ Global Market. As required by the NASDAQ Global Market, we anticipate that our independent directors will meet in regularly scheduled executive sessions at which only independent directors are present. We intend to comply with future governance requirements to the extent they become applicable to us.

100

Corporate Governance

We believe that good corporate governance is important to ensure that, as a public company, we will be managed for the long-term benefit of our stockholders. In preparation for the offering being made by this prospectus, we and our board of directors have been reviewing the corporate governance policies and practices of other public companies, as well as those suggested by various authorities in corporate governance. We have also considered the provisions of the Sarbanes-Oxley Act and the rules of the SEC and the NASDAQ Global Market.

Based on this review, our board of directors has taken steps to implement many of these provisions and rules. In particular, we have established charters for the audit committee, compensation committee and nominating and corporate governance committee, as well as a code of business conduct and ethics applicable to all of our directors, officers and employees.

Board Committees

Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. Our board of directors has assessed the independence of the members of each of these standing committees as defined under the rules of the NASDAQ Global Market and, in the case of the audit committee, the independence requirements contemplated by Rule 10A-3 under the Exchange Act.

Under Rule 10A-3 under the Exchange Act and the applicable rules of the NASDAQ Global Market, we are permitted to phase in compliance with the independent committee requirements as follows: one independent member on each of the audit committee, compensation committee and nominating and corporate governance committee upon the listing date of our common stock, a majority of independent members on each of these committees within 90 days of the listing date and fully independent committees within one year of the listing date.

Audit Committee. Drs. Brown and Zadno and Mr. Roberts serve on our audit committee. Mr. Roberts serves as chair of the audit committee and will be the audit committee’s financial expert within the meaning of the regulations of the SEC. Our board of directors has assessed whether all members of the audit committee meet the composition requirements of the NASDAQ Global Market, including the requirements regarding financial literacy and financial sophistication. Our board of directors found that Drs. Brown and Zadno and Mr. Roberts met these requirements and are independent under SEC and the NASDAQ Global Market rules. The audit committee’s primary responsibilities include:

•

appointing, approving the compensation of, and assessing the qualifications and independence of our independent registered public accounting firm, which currently is PricewaterhouseCoopers LLP;

•

overseeing the work of our independent registered public accounting firm, including the receipt and assessment of reports from the independent registered public accounting firm;

•

reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures;

•

preparing the audit committee report required by SEC rules to be included in our annual proxy statements;

•

monitoring our internal control over financial reporting, disclosure controls and procedures;

•

reviewing our risk management status;

•

establishing policies regarding hiring employees from our independent registered public accounting firm and procedures for the receipt and retention of accounting related complaints and concerns;

101

•

meeting independently with our independent registered public accounting firm and management; and

•

monitoring compliance with the code of ethics for financial management.

All audit and non-audit services must be approved in advance by the audit committee. Our board of directors has adopted a written charter for the audit committee to be effective prior to the completion of this offering, which will be available on our website at www.invuity.com upon the completion of this offering.

Compensation Committee. Dr. Brown and Messrs. Lipps, Lucier and Roberts serve on our compensation committee. Mr. Lucier serves as the chair. Our board of directors has assessed whether all members of our compensation committee meet the composition requirements of the NASDAQ Global Market. Our board of directors found that Dr. Brown and Messrs. Lipps, Lucier and Roberts met these requirements and are independent under SEC and the NASDAQ Global Market rules. The compensation committee’s responsibilities include:

•

annually reviewing and approving corporate goals and objectives relevant to compensation of our chief executive officer and our other executive officers;

•

determining the compensation of our chief executive officer and our other executive officers;

•

reviewing and making recommendations to our board of directors with respect to director compensation;

•

overseeing an evaluation of our senior executives; and

•

overseeing and administering our cash and equity incentive plans.

From time to time, the compensation committee may use outside compensation consultants to assist it in analyzing our compensation programs and in determining appropriate levels of compensation and benefits. For example, in January 2015, we engaged Compensia to advise us on compensation philosophy as we transition towards becoming a publicly traded company, selection of a group of peer companies to use for compensation benchmarking purposes and cash and equity compensation levels for our directors, executives and other employees based on current market practices. Our board of directors has adopted a written charter for the compensation committee to be effective prior to the completion of this offering, which will be available on our website at www.invuity.com upon the completion of this offering.

Nominating and Corporate Governance Committee. Drs. Brown and Zadno and Messrs. Lucier and Sawyer serve on our nominating and corporate governance committee. Dr. Brown serves as the chair of the nominating and corporate governance committee. Our board of directors has assessed whether all members of our nominating and corporate governance committee meet the composition requirements of the NASDAQ Global Market. Our board of directors found that Drs. Brown and Zadno and Mr. Lucier met these requirements and are independent under SEC and the NASDAQ Global Market rules. Before the expiration of the phase-in period applicable to initial public offerings under SEC and the NASDAQ Global Market rules, all members of our nominating and corporate governance committee will be independent for such committee’s purposes. The nominating and corporate governance committee’s responsibilities include:

•

identifying individuals qualified to become members of our board of directors;

•

recommending to our board of directors the persons to be nominated for election as directors and to each of our board’s committees;

102

•

reviewing and making recommendations to our board of directors with respect to management succession planning;

•

developing, updating and recommending to our board of directors corporate governance principles and policies;

•

overseeing the evaluation of our board; and

•

reviewing and making recommendations to our board of directors with respect to director compensation.

Our board of directors has adopted a written charter for the nominating and corporate governance committee, to be effective prior to the completion of this offering, which will be available on our website at www.invuity.com upon the completion of this offering.

Code of Business Conduct and Ethics

Our board of directors has adopted a code of business conduct and ethics, to be effective prior to the completion of the offering, that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. Following the closing of this offering, our code of business conduct and ethics will be available on our website at www.invuity.com. We intend to disclose any amendments to the code, or any waivers of its requirements, on our website to the extent required by the applicable rules and exchange requirements. The inclusion of our website address in this prospectus does not incorporate by reference the information on or accessible through our website into this prospectus.

Limitation on Liability and Indemnification Matters

Our amended and restated certificate of incorporation, which will become effective immediately following the completion of this offering, contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for:

•

any breach of the director’s duty of loyalty to us or our stockholders;

•

any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

•

unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; and

•

any transaction from which the director derived an improper personal benefit.

Our amended and restated certificate of incorporation and amended and restated bylaws, which will become effective immediately following to the completion of this offering, provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors’ and officers’ liability insurance.

103

The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders. Further, a stockholder’s investment may be adversely affected to the extent that we pay the costs of settlement and damage.

Compensation Committee Interlocks and Insider Participation

None of our executive officers serves as a member of the board of directors or compensation committee, or other committee serving an equivalent function, of any other entity that has one or more of its executive officers serving as a member of our board of directors or its compensation committee. None of the current members of the compensation committee of our board of directors has ever been one of our employees.

Director Compensation

Prior to this offering, non-employee members of our board of directors did not receive any cash compensation for service on our board of directors, including attending board meetings. However, we did reimburse our non-employee directors for travel, lodging and other reasonable expenses incurred in attending board and committee meetings. In addition, from time to time we have granted stock options to some of our directors.

Outside Director Compensation Policy

Cash Compensation. After the completion of this offering, each non-employee director will be eligible to receive compensation for his or her service consisting of annual cash retainers and equity awards. All non-employee directors will be entitled to receive the following cash compensation for their services following the completion of this offering:

•

$45,000 per year for service as a board member;

•

$25,000 per year additionally for service as chairman of the audit committee;

•

$12,500 per year additionally for service as an audit committee member;

•

$12,500 per year additionally for service as chairman of the nominating and corporate governance committee;

•

$6,500 per year additionally for service as a nominating and corporate governance committee member;

•

$20,000 per year additionally for service as chairman of the compensation committee; and

•

$10,000 per year additionally for service as a compensation committee member.

All cash payments to non-employee directors will be paid quarterly in arrears on a prorated basis.

Equity Compensation. Following the closing of this offering, nondiscretionary, automatic grants of nonstatutory stock options will be made to our non-employee directors. On the date occurring once each calendar year on the date of each annual meeting of our stockholders, beginning with the first annual meeting following the closing of this offering, each non-employee director will be granted an option to purchase shares having a grant date fair value equal to $125,000, or the Annual Option. However, an individual who first becomes a non-employee director after December 31 in a fiscal year and who receives an Initial Option will not receive an Annual Option in the same fiscal year in which the individual first becomes an outside director.

104

The exercise price per share of each stock option granted under our outside director compensation policy, including Initial Options and Annual Options, will be the fair market value of a share of our common stock, as determined in accordance with our 2015 Equity Incentive Plan, or the 2015 Plan, on the date of the option grant. The grant date fair value is computed in accordance with the Black-Scholes option valuation methodology or such other methodology our board of directors or compensation committee may determine.

Subject to the terms of our 2015 Plan, each stock option granted under our outside director compensation policy will be scheduled to vest as to 100% of the shares subject to such option on the first annual anniversary of the date of grant of such option, provided that the optionee remains a director through such anniversary.

Any stock option granted under our outside director compensation policy will fully vest and become exercisable in the event of a change in control, as defined in our 2015 Plan, provided that the optionee remains a director through such change in control. Further, our 2015 Plan, as described below under the section titled “Employee Benefit and Stock Plans,” provides that in the event of a change in control, as defined in our 2015 Plan, each outstanding equity award granted under our 2015 Plan that is held by a non-employee director will fully vest, all restrictions on the shares subject to such award will lapse, and with respect to awards with performance-based vesting, all performance goals or other vesting criteria will be deemed achieved at 100% of target levels, and all of the shares subject to such award will become fully exercisable, if applicable, provided such optionee remains a director through such change in control.

The following table sets forth a summary of the compensation received by our non-employee directors who received compensation during our fiscal year ended December 31, 2014:

Director Compensation


Name	Option Awards ($)⁽¹⁾
Philip Sawyer⁽²⁾		—
Gregory B. Brown, M.D.		—
Randall A. Lipps		7,110
Gregory T. Lucier		131,647
Eric W. Roberts		—
Reza Zadno, Ph.D.		—

⁽¹⁾

The amounts reported in this column represent the aggregate grant date fair value of the awards as computed in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 (FASB ASC Topic 718). The assumptions used in calculating the grant date fair value of the awards reported in this column are set forth in the notes to our financial statements included elsewhere in this prospectus. As of December 31, 2014, Messrs. Sawyer, Lipps and Lucier held options to purchase 8,637,019; 38,000; and 456,000 shares of our common stock, respectively, and Mr. Roberts and Drs. Brown and Zadno held no options to purchase our common stock.

⁽²⁾	For options and stock awards held by Mr. Sawyer as of December 31, 2014, including awards received by him in his capacity as President and Chief Executive Officer, see the disclosure under “Executive Compensation—Outstanding Equity Awards at 2014 Year-End.”

105

EXECUTIVE COMPENSATION

Summary Compensation Table

This discussion contains forward looking statements that are based on our current plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs that we adopt may differ materially from currently planned programs as summarized in this discussion. As an “emerging growth company” as defined in the JOBS Act under federal securities laws, we are not required to include a Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies.

The following table provides information regarding the total compensation for services rendered in all capacities that was earned by each individual who served as our principal executive officer at any time in 2014, and our two other most highly compensated executive officers who were serving as executive officers as of December 31, 2014. These individuals were our named executive officers for 2014.


Name and Principal Position	Year		Salary ($)			Option Awards ($)⁽¹⁾			Non-Equity Incentive Plan Compensation ($)		All Other Compensation ($)		Total ($)
Philip Sawyer		2014		375,000			232,448	⁽²⁾		151,088		5,939		764,475
President and Chief Executive Officer

Doug Heigel		2014		70,923	⁽³⁾		447,313			17,486		412		536,134
Vice President of Operations

Paul O. Davison		2014		24,615	⁽⁴⁾		489,322			—		0		513,937
Vice President of Research and Development

⁽¹⁾

The amounts reported in this column represent the aggregate grant date fair value of the awards as computed in accordance with FASB ASC Topic 718. The assumptions used in calculating the grant date fair value of the awards reported in this column are set forth in the notes to our financial statements included elsewhere in this prospectus.

⁽²⁾	Includes the incremental fair value computed in accordance with FASB ASC Topic 718 in connection with an option exercise price adjustment effective as of April 2014, as described below under the section titled “Stock Option Repricing.”

⁽³⁾	Mr. Heigel’s salary reflects the prorated portion of his annual base salary of $240,000 paid in fiscal 2014.

⁽⁴⁾	Mr. Davison’s salary reflects the prorated portion of his annual base salary of $240,000 paid in fiscal 2014.

Executive Officer Employment Agreements

Philip Sawyer

We expect to enter into an employment agreement with Mr. Sawyer that will take effect as of the effectiveness of the registration statement of which this prospectus forms a part. Pursuant to the agreement, Mr. Sawyer will continue to serve as our President and Chief Executive Officer on an “at will” basis. Mr. Sawyer’s employment agreement provides for a base salary of $425,000, eligibility to receive an annual performance bonus with the target amount determined as 80% of Mr. Sawyer’s annual base salary, and eligibility to participate in employee benefit or group insurance plans maintained from time to time by us.

Pursuant to the employment agreement of Mr. Sawyer, if we terminate the employment of Mr. Sawyer other than for death, “disability,” or “cause” or Mr. Sawyer resigns for “good reason” (as such terms are defined in Mr. Sawyer’s employment agreement), and, within 60 days following his termination, Mr. Sawyer executes a waiver and release of claims in our favor and resigns from all positions he may hold as an officer or director, Mr. Sawyer is entitled to receive (i) continuing payments of his highest base salary rate in effect during the employment period for a period of 12 months, payable pursuant to our regular payroll procedures, (ii) an amount equal to Mr. Sawyer’s target annual bonus for the year of termination, payable in accordance with our regular payroll procedures, (iii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to “COBRA” for him and his respective dependents for up to 12 months and (iv) vesting acceleration of 50% with respect to any outstanding equity awards held by him on the date of his termination (with performance-based awards vesting based on achievement of target levels of performance).

106

Pursuant to the employment agreement of Mr. Sawyer, if, within the 3 month period prior to or the 12 month period following a “change of control” (as defined in Mr. Sawyer’s employment agreement), the employment of Mr. Sawyer is terminated under the circumstances described in the above paragraph and, within 60 days following his termination, Mr. Sawyer executes a waiver and release of claims in our favor, Mr. Sawyer is entitled to receive (i) a lump sum payment equal to 24 months of his highest base salary rate in effect during the employment period, payable pursuant to our regular payroll procedures, (ii) a lump sum payment equal to 200% of the greater of his target annual bonus for the year of termination or for the year of the change in control, payable pursuant to our regular payroll procedures, (iii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to “COBRA” for him and his respective dependents for up to 24 months, and (iv) vesting acceleration of 100% with respect to any outstanding equity awards held by him on the date of his termination (with performance-based awards vesting based on achievement of target levels of performance).

In the event any payment to Mr. Sawyer pursuant to his employment agreement would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code, as amended, or the Code (as a result of a payment being classified as a parachute payment under Section 280G of the Code), Mr. Sawyer will receive such payment as would entitle him to receive the greatest after-tax benefit, even if it means that we pay him a lower aggregate payment so as to minimize or eliminate the potential excise tax imposed by Section 4999 of the Code.

Doug Heigel

We expect to enter into an employment agreement with Mr. Heigel that will take effect as of the effectiveness of the registration statement of which this prospectus forms a part. Pursuant to the agreement, Mr. Heigel will continue to serve as our Vice President of Operations on an “at will” basis. Mr. Heigel’s employment agreement provides for a base salary of $250,000, eligibility to receive an annual performance bonus with the target amount determined as 40% of Mr. Heigel’s annual base salary, and eligibility to participate in employee benefit or group insurance plans maintained from time to time by us.

Pursuant to the employment agreement of Mr. Heigel, if we terminate the employment of Mr. Heigel other than for death, “disability,” or “cause” or Mr. Heigel resigns for “good reason” (as such terms are defined in Mr. Heigel’s employment agreement), and, within 60 days following his termination, Mr. Heigel executes a waiver and release of claims in our favor and resigns from all positions he may hold as an officer or director, Mr. Heigel is entitled to receive (i) continuing payments of his highest base salary rate in effect during the employment period for a period of 9 months, payable pursuant to our regular payroll procedures, and (ii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to “COBRA” for him and his respective dependents for up to 9 months.

Pursuant to the employment agreement of Mr. Heigel, if, within the 3 month period prior to or the 12 month period following a “change of control” (as defined in Mr. Heigel’s employment agreement), the employment of Mr. Heigel is terminated under the circumstances described in the above paragraph and, within 60 days following his termination, Mr. Heigel executes a waiver and release of claims in our favor, Mr. Heigel is entitled to receive (i) a lump sum payment equal to 18 months of his highest base salary rate in effect during the employment period, payable pursuant to our regular payroll procedures, (ii) a lump sum payment equal to 150% of the greater of his target annual bonus for the year of termination or for the year of the change in control, payable pursuant to our regular payroll procedures, (iii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to “COBRA” for him and his respective dependents for up to 18 months, and (iv) vesting acceleration of 100% with respect to any outstanding equity awards held by him on the date of his termination (with performance-based awards vesting based on achievement of target levels of performance).

In the event any payment to Mr. Heigel pursuant to his employment agreement would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code, as amended, or the Code (as a result

107

of a payment being classified as a parachute payment under Section 280G of the Code), Mr. Heigel will receive such payment as would entitle him to receive the greatest after-tax benefit, even if it means that we pay him a lower aggregate payment so as to minimize or eliminate the potential excise tax imposed by Section 4999 of the Code.

Paul O. Davison

We expect to enter into an employment agreement with Mr. Davison that will take effect as of the effectiveness of the registration statement of which this prospectus forms a part. Pursuant to the agreement, Mr. Davison will continue to serve as our Vice President of Research and Development on an “at will” basis. Mr. Davison’s employment agreement provides for a base salary of $250,000, eligibility to receive an annual performance bonus with the target amount determined as 40% of Mr. Davison’s annual base salary, and eligibility to participate in employee benefit or group insurance plans maintained from time to time by us.

Pursuant to the employment agreement of Mr. Davison, if we terminate the employment of Mr. Davison other than for death, “disability,” or “cause” or Mr. Davison resigns for “good reason” (as such terms are defined in Mr. Davison’s employment agreement), and, within 60 days following his termination, Mr. Davison executes a waiver and release of claims in our favor and resigns from all positions he may hold as an officer or director, Mr. Davison is entitled to receive (i) continuing payments of his highest base salary rate in effect during the employment period for a period of 9 months, payable pursuant to our regular payroll procedures, and (ii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to “COBRA” for him and his respective dependents for up to 9 months.

Pursuant to the employment agreement of Mr. Davison, if, within the 3 month period prior to or the 12 month period following a “change of control” (as defined in Mr. Davison’s employment agreement), the employment of Mr. Davison is terminated under the circumstances described in the above paragraph and, within 60 days following his termination, Mr. Davison executes a waiver and release of claims in our favor, Mr. Davison is entitled to receive (i) a lump sum payment equal to 18 months of his highest base salary rate in effect during the employment period, payable pursuant to our regular payroll procedures, (ii) a lump sum payment equal to 150% of the greater of his target annual bonus for the year of termination or for the year of the change in control, payable pursuant to our regular payroll procedures, (iii) reimbursement of premiums to maintain group health insurance continuation benefits pursuant to “COBRA” for him and his respective dependents for up to 18 months, and (iv) vesting acceleration of 100% with respect to any outstanding equity awards held by him on the date of his termination (with performance-based awards vesting based on achievement of target levels of performance).

In the event any payment to Mr. Davison pursuant to his employment agreement would be subject to the excise tax imposed by Section 4999 of the Internal Revenue Code, as amended, or the Code (as a result of a payment being classified as a parachute payment under Section 280G of the Code), Mr. Davison will receive such payment as would entitle him to receive the greatest after-tax benefit, even if it means that we pay him a lower aggregate payment so as to minimize or eliminate the potential excise tax imposed by Section 4999 of the Code.

Non-Equity Incentive Plan Compensation

We provided our named executive officers an opportunity to receive formula-based incentive payments under our 2014 Executive Bonus Plan. The payments were based on a target incentive amount for each named executive officer.

The 2014 Executive Bonus Plan provided for non-equity incentive compensation based upon our achievement of performance goals for 2014. The actual incentive payments had two components: financial goals and product goals, with financial goals being weighted more heavily.

108

The financial goals had two components: quarterly revenue and EBIDTA goals, with quarterly revenue goals being weighted more heavily. The quarterly revenue component included a minimum threshold level of achievement. If we exceeded the quarterly revenue target, our named executive officers would be eligible to receive a payment of up to 130% of the portion of the incentive payment allocated to the revenue component. If we achieved quarterly EBITDA that was equal to or greater than our quarterly EBITDA target, then our named executive officers would receive 100% of that component.

The product development component required achievement of all product goals for the quarter in order to receive the target incentive payment allocated to that component. If we failed to meet all product goals for a quarter, the named executive officers would receive no portion of that target incentive payment allocated to that component. If we achieved all of our product goals for a quarter, then our named executive officers would receive 100% of that component.

Pension Benefits and Nonqualified Deferred Compensation

We do not provide a pension plan for our employees, and none of our named executive officers participated in a nonqualified deferred compensation plan in 2014.

Outstanding Equity Awards at 2014 Year-End

The following table sets forth information regarding outstanding stock options and stock awards held by our named executive officers as of December 31, 2014:

Option Awards

Name

Grant Date⁽¹⁾

Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable

Option Exercise
Price ($)⁽²⁾

Option
Expiration
Date

Philip Sawyer

3/17/10

⁽³⁾

1,747,225

0.07

3/17/20

11/17/10

⁽³⁾

2,115,661

0.07

11/17/20

1/18/12

⁽³⁾

183,976

0.09

1/18/22

9/19/12

⁽⁴⁾

320,931

0.17

9/19/22

9/19/12

⁽⁴⁾

2,087,785

0.17

9/19/22

3/5/14

⁽⁵⁾

436,560

0.17

3/5/24

3/5/14

⁽⁶⁾

1,744,881

0.17

3/5/24

Doug Heigel

11/5/14

⁽⁷⁾

1,463,720

0.17

11/5/24

Paul O. Davison

12/2/14

⁽⁸⁾

1,463,720

0.17

12/2/24

⁽¹⁾	Each of the outstanding equity awards was granted pursuant to our 2005 Stock Incentive Plan.

⁽²⁾	This column represents the fair value of a share of our common stock on the date of grant, as determined by our board of directors.

⁽³⁾	The stock option is fully vested and immediately exercisable.

⁽⁴⁾	The stock option is fully vested and immediately exercisable. The stock option was originally granted on September 19, 2012 and was amended on April 30, 2014 as part of our option repricing.

⁽⁵⁾	The shares subject to the option are early exercisable and vest in 48 equal monthly installments with a vesting commencement date of June 11, 2012, subject to Mr. Sawyer’s continuous status as a service provider on each such vesting date.

⁽⁶⁾	The shares subject to the option are early exercisable and vest in 48 equal monthly installments with a vesting commencement date of February 28, 2014, subject to Mr. Sawyer’s continuous status as a service provider on each such vesting date.

⁽⁷⁾

The shares subject to the option are early exercisable. 25% of the shares subject to the option will vest on September 15, 2015 and the remaining shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Mr. Heigel’s continuous status as a service provider on each such vesting date.

⁽⁸⁾

The shares subject to the option are early exercisable. 25% of the shares subject to the option will vest on November 24, 2015 and the remaining shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Mr. Davison’s continuous status as a service provider on each such vesting date.

109

Stock Option Repricing

In April 2014, we amended certain of our outstanding stock options to reset their respective exercise prices to $0.17 per share, the fair market value of our common stock as of April 30, 2014, as determined by our board of directors. Options repriced included all then current employee options with an exercise price higher than $0.17 per share that remained outstanding and unexercised on April 30, 2014. Pursuant to this repricing, options to purchase 6,454,425 shares of common stock held by our then current employees were repriced, including options to purchase 2,408,716 shares held by our named executive officers.

Employee Benefit and Stock Plans

2015 Equity Incentive Plan

In April 2015, our board of directors adopted, and we expect our stockholders to approve, a 2015 Equity Incentive Plan, or the 2015 Plan. Our 2015 Plan will permit the grant of incentive stock options, within the meaning of Section 422 of the Code, to our employees and any parent and subsidiary corporations’ employees, and for the grant of nonstatutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to our employees, directors and consultants and our parent and subsidiary corporations’ employees and consultants.

Authorized shares. A total of shares of our common stock will be reserved for issuance pursuant to the 2015 Plan. In addition, the shares reserved for issuance under our 2015 Plan will also include shares reserved but not issued under the 2005 Stock Incentive Plan, as amended, or the 2005 Plan, and shares subject to stock options or similar awards granted under the 2005 Plan that expire or terminate without having been exercised in full and shares issued pursuant to awards granted under the 2005 Plan that are forfeited to or repurchased by us (provided that the maximum number of shares that may be added to the 2015 Plan pursuant to this sentence is shares). In addition, shares may become available under the 2015 Plan as described below.

The number of shares available for issuance under the 2015 Plan will also include an annual increase on the first day of each fiscal year beginning in fiscal 2016, equal to the least of:

•

shares;

•

% of the outstanding shares of common stock as of the last day of our immediately preceding fiscal year; or

•

such other amount as our board of directors may determine.

If an award expires or becomes unexercisable without having been exercised in full, is surrendered pursuant to an exchange program, or, with respect to restricted stock, restricted stock units, performance units or performance shares, is forfeited or repurchased due to failure to vest, the unpurchased shares (or for awards other than stock options or stock appreciation rights, the forfeited or repurchased shares) will become available for future grant or sale under our 2015 Plan. With respect to stock appreciation rights, the net shares issued will cease to be available under the 2015 Plan and all remaining shares will remain available for future grant or sale under the 2015 Plan. Shares used to pay the exercise price of an award or satisfy the tax withholding obligations related to an award will become available for future grant or sale under our 2015 Plan. To the extent an award is paid out in cash rather than shares, such cash payment will not result in reducing the number of shares available for issuance under our 2015 Plan.

Plan administration. Our board of directors or one or more committees appointed by our board of directors will administer our 2015 Plan. In the case of awards intended to qualify as “performance-based compensation” within the meaning of Section 162(m) of the Code, the committee will consist of two or more “outside directors” within the meaning of Section 162(m). In addition, if we determine it is desirable to qualify transactions under the 2015 Plan as exempt under Rule 16b-3 of the Securities

110

Exchange Act of 1934, as amended, or Rule 16b-3, such transactions will be structured to satisfy the requirements for exemption under Rule 16b-3. Subject to the provisions of our 2015 Plan, the administrator has the power to administer the plan, including but not limited to, the power to interpret the terms of our 2015 Plan and awards granted under it, to create, amend and revoke rules relating to our 2015 Plan, including creating sub-plans, and to determine the terms of the awards, including the exercise price, the number of shares subject to each such award, the exercisability of the awards and the form of consideration, if any, payable upon exercise. The administrator also has the authority to amend existing awards to reduce or increase their exercise price, to allow participants the opportunity to transfer outstanding awards to a financial institution or other person or entity selected by the administrator and to institute an exchange program by which outstanding awards may be surrendered in exchange for awards of the same type which may have a higher or lower exercise price or different terms, awards of a different type and/or cash.

Stock options. Stock options may be granted under our 2015 Plan. The exercise price of options granted under our 2015 Plan must at least be equal to the fair market value of our common stock on the date of grant. The term of an incentive stock option may not exceed 10 years, except that with respect to any participant who owns more than 10% of the voting power of all classes of our outstanding stock, the term must not exceed five years and the exercise price must equal at least 110% of the fair market value on the grant date. The administrator will determine the methods of payment of the exercise price of an option, which may include cash, shares or other property acceptable to the administrator, as well as other types of consideration permitted by applicable law. After the termination of service of an employee, director or consultant, he or she may exercise his or her option for the period of time stated in his or her option agreement. Generally, if termination is due to death or disability, the option will remain exercisable for 12 months. In all other cases, the option will generally remain exercisable for three months following the termination of service. However, in no event may an option be exercised later than the expiration of its term. Subject to the provisions of our 2015 Plan, the administrator determines the other terms of options.

Stock appreciation rights. Stock appreciation rights may be granted under our 2015 Plan. Stock appreciation rights allow the recipient to receive the appreciation in the fair market value of our common stock between the exercise date and the date of grant. Stock appreciation rights may not have a term exceeding 10 years. After the termination of service of an employee, director or consultant, he or she may exercise his or her stock appreciation right for the period of time stated in his or her option agreement. However, in no event may a stock appreciation right be exercised later than the expiration of its term. Subject to the provisions of our 2015 Plan, the administrator determines the other terms of stock appreciation rights, including when such rights become exercisable and whether to pay any increased appreciation in cash or with shares of our common stock, or a combination thereof, except that the per share exercise price for the shares to be issued pursuant to the exercise of a stock appreciation right will be no less than 100% of the fair market value per share on the date of grant.

Restricted stock. Restricted stock may be granted under our 2015 Plan. Restricted stock awards are grants of shares of our common stock that vest in accordance with terms and conditions established by the administrator. The administrator will determine the number of shares of restricted stock granted to any employee, director or consultant and, subject to the provisions of our 2015 Plan, will determine the terms and conditions of such awards. The administrator may impose whatever conditions for lapse of the restriction on the shares it determines to be appropriate (for example, the administrator may set restrictions based on the achievement of specific performance goals or continued service to us); provided, however, that the administrator, in its sole discretion, may accelerate the time at which any restrictions will lapse or be removed. Recipients of restricted stock awards generally will have voting and dividend rights with respect to such shares upon grant without regard to the restriction, unless the administrator provides otherwise. Shares of restricted stock as to which the restrictions have not lapsed are subject to our right of repurchase or forfeiture.

111

Restricted stock units. Restricted stock units may be granted under our 2015 Plan. Restricted stock units are bookkeeping entries representing an amount equal to the fair market value of one share of our common stock. Subject to the provisions of our 2015 Plan, the administrator will determine the terms and conditions of restricted stock units, including the vesting criteria (which may include accomplishing specified performance criteria or continued service to us) and the form and timing of payment. Notwithstanding the foregoing, the administrator, in its sole discretion, may accelerate the time at which any restricted stock units will vest.

Performance units and performance shares. Performance units and performance shares may be granted under our 2015 Plan. Performance units and performance shares are awards that will result in a payment to a participant only if performance goals established by the administrator are achieved or the awards otherwise vest. The administrator will establish organizational or individual performance goals or other vesting criteria in its discretion, which, depending on the extent to which they are met, will determine the number and/or the value of performance units and performance shares to be paid out to participants. After the grant of a performance unit or performance share, the administrator, in its sole discretion, may reduce or waive any performance criteria or other vesting provisions for such performance units or performance shares. Performance units shall have an initial dollar value established by the administrator prior to the grant date. Performance shares shall have an initial value equal to the fair market value of our common stock on the grant date. The administrator, in its sole discretion, may pay earned performance units or performance shares in the form of cash, in shares or in some combination

Outside directors. Our 2015 Plan provides that all non-employee directors are eligible to receive all types of awards (except for incentive stock options) under the 2015 Plan. Our 2015 Plan provides that in any given fiscal year, a non-employee director may not receive under the 2015 Plan awards having a grant date fair value greater than $500,000 increased to $750,000 in connection with her or her initial service, as grant fair value is determined under generally accepted accounting principles.

Non-transferability of awards. Unless the administrator provides otherwise, our 2015 Plan generally does not allow for the transfer of awards and only the recipient of an award may exercise an award during his or her lifetime.

Certain adjustments. In the event of certain changes in our capitalization, to prevent diminution or enlargement of the benefits or potential benefits available under our 2015 Plan, the administrator will adjust the number and class of shares that may be delivered under our 2015 Plan and/or the number, class and price of shares covered by each outstanding award and the numerical share limits set forth in our 2015 Plan. In the event of our proposed liquidation or dissolution, the administrator will notify participants as soon as practicable and all awards will terminate immediately prior to the consummation of such proposed transaction.

Merger or change in control. Our 2015 Plan provides that in the event of a merger or change in control, as defined under the 2015 Plan, each outstanding award will be treated as the administrator determines, except that if a successor corporation or its parent or subsidiary does not assume or substitute an equivalent award for any outstanding award, then such award will fully vest, all restrictions on the shares subject to such award will lapse, all performance goals or other vesting criteria applicable to the shares subject to such award will be deemed achieved at 100% of target levels and all of the shares subject to such award will become fully exercisable, if applicable, for a specified period prior to the transaction. The award will then terminate upon the expiration of the specified period of time.

Amendment, termination. The administrator will have the authority to amend, suspend or terminate the 2015 Plan provided such action will not impair the existing rights of any participant. Our 2015 Plan will automatically terminate in 2025, unless we terminate it sooner.

112

2005 Stock Incentive Plan, as Amended

Our board of directors adopted, and our stockholders approved, our 2005 Stock Incentive Plan, or the 2005 Plan, in May 2005. Our 2005 Plan was most recently amended in February 2014. Our 2005 Plan allows for the grant of incentive stock options, within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, to our employees and our parent and subsidiary corporations’ employees, and for the grant of nonstatutory stock options and restricted stock to our employees, directors and consultants and our parent and subsidiary corporations’ employees, directors and consultants.

Authorized Shares. Our 2005 Plan will be terminated in connection with this offering, and accordingly, no shares will be available for issuance under the 2005 Plan following the completion of this offering. Our 2005 Plan will continue to govern outstanding awards granted thereunder. As of March 31, 2015, options to purchase 25,145,974 shares of our common stock remained outstanding under our 2005 Plan. In the event that an outstanding option or other right for any reason expires or is canceled, the shares allocable to the unexercised portion of such option or other right shall be added to the number of shares then available for issuance under the 2005 Plan.

Plan Administration. Our board of directors or a committee of our board (the administrator) administers our 2005 Plan. Subject to the provisions of the 2005 Plan, the administrator has the full authority and discretion to take any actions it deems necessary or advisable for the administration of the 2005 Plan. All decisions, interpretations and other actions of the administrator are final and binding on all participants in the 2005 Plan.

Options. Stock options may be granted under our 2005 Plan. The exercise price per share of incentive stock options and nonstatutory stock options must equal at least 100% and 85%, respectively, of the fair market value per share of our common stock on the date of grant, as determined by the administrator. The term of a stock option may not exceed 10 years. With respect to any participant who owns 10% of the voting power of all classes of our outstanding stock as of the grant date, the term of an incentive stock option granted to such participant must not exceed five years and the exercise price per share of such incentive stock option must equal at least 110% of the fair market value per share of our common stock on the date of grant, as determined by the administrator. The 2005 Plan administrator determines the terms and conditions of options.

After termination of an optionee’s service as an employee, director or consultant, the optionee may exercise the vested shares subject to his or her option as of the date of such termination for the period of time as specified in the option agreement, subject to the terms of the 2005 Plan. If termination is due to death or disability, the option will remain exercisable for at least 6 months, or such longer period of time as specified in the option agreement. If termination is due to cause, the option agreement may provide that the option will terminate immediately on the effective date of the optionee’s termination. In all other cases, the option will remain exercisable for at least thirty days, or such longer period of time as specified in the option agreement. However, an option generally may not be exercised later than the expiration of its term.

Restricted Shares. Restricted shares may be granted under our 2005 Plan as a purchasable award. Restricted shares are shares of our common stock that vest in accordance with the terms and conditions established by the administrator, provided that with respect to recipients of restricted shares who are not officers, directors, or consultants, restricted shares will vest at a rate no slower than 20% per year over five years starting on the date of grant of the award or sale of the underlying shares. The administrator will determine the number of shares of restricted stock granted to any employee, director or consultant and, subject to the provisions of our 2015 Plan, will determine the terms and conditions of such awards. The purchase price per share of restricted shares must equal at least 85% of the fair market value per

113

share of our common stock on the date of grant, as determined by the administrator, provided that restricted shares granted to any participant who owns 10% of the voting power of all classes of our outstanding stock as of the grant date must have a purchase price per share equal to at least 100% of the fair market value per share of our common stock on the date of grant. Recipients of restricted stock awards generally will have voting and dividend rights with respect to such shares upon grant without regard to the restriction, unless the administrator provides otherwise. Shares of restricted stock as to which the restrictions have not lapsed are subject to our right of repurchase or forfeiture. Rights to purchase restricted shares must be exercised within 30 days after we communicate the grant of such rights to the award recipient.

Transferability of Awards. Our 2005 Plan generally does not allow for the transfer or assignment of options, except by will or by the laws of descent and distribution. However, to the extent permitted by our board of directors in its sole discretion, a nonstatutory stock option may be transferred by an optionee to family members or a trust established for the benefit of the optionee or the optionee’s family members to the extent permitted by applicable securities laws. Restricted shares and shares issued upon exercise of an option will be subject to such special forfeiture conditions, rights of repurchase, rights of first refusal, and other transfer restrictions as the administrator may determine.

Certain Adjustments. In the event of a subdivision of our outstanding stock, a declaration of a dividend payable in shares, a declaration of an extraordinary dividend payable in a form other than shares in an amount that has a material effect on the fair market value of our shares, a combination or consolidation of our outstanding stock into a lesser number of shares, a recapitalization, a spin-off, a reclassification, or a similar occurrence, our board of directors will make appropriate adjustments to the number of shares under the 2005 Plan available for future awards, the number of shares covered by each outstanding option, the exercise price under each outstanding option, or the price of shares subject to our right of repurchase.

Merger or Change in Control. Our 2005 Plan provides that, in the event of a merger or consolidation, or in the event of a transaction providing for the sale of all or substantially all of our stock or assets, all outstanding options will be subject to the agreement of merger or consolidation. Such agreement may provide for one or more of the following:

•

the continuation of the options by us (if we are the surviving corporation);

•

the assumption of the options by the surviving corporation or its parent;

•

the substitution by the surviving corporation or its parent of new options with substantially similar terms;

•

immediate exercisability of the options, followed by cancellation of the options; or

•

the cancellation of the options and payments to optionees equal to the full value of the options.

In the event of a change in control, as defined under the 2005 Plan, our repurchase rights with respect to restricted shares held by our non-employee directors will lapse, and all other restricted shares will be treated as set forth in the applicable restricted share award agreement.

Amendment; Termination. Our board of directors may amend, suspend or terminate our 2005 Plan at any time, provided that such action does not adversely affect a participant’s rights under outstanding awards granted under the 2005 Plan without such participant’s written consent. As noted above, upon completion of this offering, our 2005 Plan will be terminated and no further awards will be granted thereunder. All outstanding awards will continue to be governed by their existing terms.

114

Executive Incentive Compensation Plan

We expect our board of directors to adopt an Executive Incentive Compensation Plan, or the Bonus Plan. The Bonus Plan will become effective immediately prior to this offering and be administered by our compensation committee following the completion of this offering. The Bonus Plan allows our compensation committee to provide cash incentive awards to selected employees, including our named executive officers, based upon performance goals established by our compensation committee.

Under the Bonus Plan, our compensation committee determines the performance goals applicable to any award, which goals may include, without limitation, (i) attainment of research and development milestones, (ii) sales bookings, (iii) business divestitures and acquisitions, (iv) cash flow, (v) cash position, (vi) earnings (which may include any calculation of earnings, including but not limited to earnings before interest and taxes, earnings before taxes, earnings before interested, taxes, depreciation and amortization and net earnings), (vii) earnings per share, (viii) net income, (ix) net profit, (x) net sales, (xi) operating cash flow, (xii) operating expenses, (xiii) operating income, (xiv) operating margin, (xv) overhead or other expense reduction, (xvi) product defect measures, (xvii) product release timelines, (xviii) productivity, (xix) profit, (xx) return on assets, (xxi) return on capital, (xxii) return on equity, (xxiii) return on investment, (xxiv) return on sales, (xxv) revenue, (xxvi) revenue growth, (xxvii) sales results, (xviii) sales growth, (xxix) stock price, (xxx) time to market, (xxxi) total stockholder return, (xxxii) working capital, (xxxiii) individual objectives such as peer reviews or other subjective or objective criteria, and (xxxiv) consummation of financial transactions. Performance goals that include our financial results may be determined in accordance with GAAP or such financial results may consist of non-GAAP financial measures and any actual results may be adjusted by the compensation committee for one-time items or unbudgeted or unexpected items when performance goals that include our financial results may be determined in accordance with GAAP, or such financial results may consist of non-GAAP financial measures, and any actual results may be adjusted by the compensation committee for one-time items or unbudgeted or unexpected items when determining whether the performance goals have been met. The goals may be on the basis of any factors the compensation committee determines relevant, and may be adjusted on an individual, divisional, business unit or company-wide basis. The performance goals may differ from participant to participant and from award to award.

Our compensation committee may, in its sole discretion and at any time, increase, reduce or eliminate a participant’s actual award, and/or increase, reduce or eliminate the amount allocated to the bonus pool for a particular performance period. The actual award may be below, at or above a participant’s target award, in the compensation committee’s discretion. Our compensation committee may determine the amount of any reduction on the basis of such factors as it deems relevant, and it is not required to establish any allocation or weighting with respect to the factors it considers.

Actual awards are paid in cash only after they are earned, which usually requires continued employment through the date a bonus is paid. Our compensation committee has the authority to amend, alter, suspend or terminate the Bonus Plan provided such action does not impair the existing rights of any participant with respect to any earned bonus.

401(k) Plan

We maintain a tax-qualified retirement plan that provides eligible employees with an opportunity to save for retirement on a tax advantaged basis. We may make a discretionary matching and profit sharing contribution to the 401(k) plan, and may make a discretionary employer contribution to each eligible employee each year. To date, we have not made any matching or profits sharing contributions into the 401(k) plan. All participants’ interests in our matching and profit sharing contributions, if any, vest pursuant to a four-year graded vesting schedule from the time of contribution. Pre-tax contributions are allocated to each participant’s individual account and are then invested in selected investment

115

alternatives according to the participants’ directions. The 401(k) plan is intended to qualify under Sections 401(a) and 501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan, and all contributions are deductible by us when made.

116

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

We describe below transactions and series of similar transactions, since January 1, 2012, to which we were a party or will be a party, in which:

•

the amounts involved exceeded or will exceed $120,000; and

•

any of our directors, executive officers or beneficial holders of more than 5% of any class of our capital stock had or will have a direct or indirect material interest.

Other than as described below, there have not been, nor are there any currently proposed, transactions or series of similar transactions to which we have been or will be a party other than compensation arrangements, which are described where required under “Executive Compensation.”

Directed Share Program

At our request, the underwriters have reserved for sale at the initial public offering price up to shares of common stock, or approximately % of the shares offered by this prospectus, for our employees, directors and other persons associated with us. Any directed shares purchased by our officers and directors will be subject to the 180-day lock-up restriction described in the “Underwriting” section of this prospectus. Any other participants in the directed share program will not be subject to any lock-up arrangements with any underwriter with respect to the directed shares sold to them. The number of shares of common stock available for sale to the general public in the offering will be reduced by the number of shares sold pursuant to the directed share program. Any directed shares not so purchased will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. The directed share program will be arranged through .

Loan Agreement

In February 2014, we entered into a loan agreement with HealthCare Royalty Partners, or HCRP, a holder of more than 5% of our capital stock, for an aggregate principal amount of up to $15.0 million in two separate tranches. We drew down the first tranche of $10.0 million upon execution of the loan agreement and the second tranche of $5.0 million in March 2015. Interest is payable quarterly at a fixed rate of 12.5% per annum with interest-only payments to be made from the effective date of the loan until March 31, 2017. Thereafter, we will make principal and interest payments until the maturity of the loan on December 31, 2020. We are permitted to make a voluntary prepayment in full, but not in part, prior to December 31, 2020, which prepayment must be made together with accrued and unpaid fixed interest on the amount prepaid and any additional amounts due in respect thereof, including an additional percentage of the aggregate loan amount or outstanding principal amount, depending on the date of prepayment. The prepayment amounts are as follows:


Prepayment Date		Prepayment Amount
After December 31, 2014 and on or prior to December 31, 2015		140% of the aggregate loan amount, less any previously made payments of accrued fixed interest

After December 31, 2015 and on or prior to December 31, 2016		150% of the aggregate loan amount, less any previously made payments of accrued fixed interest

After December 31, 2016 and on or prior to December 31, 2017		112% of the outstanding principal amount

After December 31, 2017 and on or prior to December 31, 2018		108% of the outstanding principal amount

117


Prepayment Date		Prepayment Amount
After December 31, 2018 and on or prior to December 31, 2019		104% of the outstanding principal amount

After December 31, 2019 and on or prior to December 31, 2020		100% of the outstanding principal amount

In connection with the loan agreement, we issued HCRP a warrant to purchase 1,564,238 shares of Series E convertible preferred stock at $0.7192 per share. The $572,000 estimated fair value of the warrant was recorded as a reduction in the carrying value of the debt. We also paid $200,000 in debt issuance costs to HCRP in 2014, which were recorded as a debt discount. In 2014, we made interest payments to HCRP pursuant to the loan agreement in the amount of $1.1 million and no payments of principal were made. The outstanding principal balance of the loan was $10.0 million and $15.0 million as of December 31, 2014 and March 31, 2015, respectively.

Gregory B. Brown, M.D., a member of our board of directors, is a Founding Managing Director of HealthCare Royalty Management, LLC, the investment manager of HCRP.

Series F Preferred Stock Financing

In February and March 2015, we issued an aggregate of 29,530,012 shares of our Series F convertible preferred stock at a price per share of $0.7754. The shares of Series F convertible preferred stock will convert into shares of common stock on a one-for-one basis upon the completion of this offering. The table below sets forth the number of shares of Series F convertible preferred stock sold to our directors, executive officers or holders of more than 5% of any class of our capital stock:


Name	Number of Shares of Series F Convertible Preferred Stock		Aggregate Purchase Price
Entities affiliated with Wellington⁽¹⁾		25,793,139	$	19,999,999.99
Robertson Revocable Trust⁽²⁾		885,567	$	686,668.66
RiverRoad Capital Partners, LLC⁽³⁾		322,414	$	249,999.82

⁽¹⁾

Affiliates of Wellington holding our securities, whose shares are aggregated for purposes of reporting the above share ownership information, are Hadley Harbor Master Investors (Cayman) L.P. (Nominee Italianflare & Co.) and the Hartford Capital Appreciation Fund (Nominee: Cudd & Co.). As a result of the Series F preferred stock financing, the entities affiliated with Wellington became holders of more than 5% of the Company’s outstanding capital stock.

⁽²⁾	Brett Robertson, an executive officer, is related to Sanford Robertson, trustee of the Robertson Revocable Trust.

⁽³⁾	Gregory T. Lucier, a member of our board of directors, is a managing member of RiverRoad Capital Partners, LLC.

118

Series E Preferred Stock Financing

In February 2014, we issued an aggregate of 29,559,760 shares of our Series E convertible preferred stock at a price per share of $0.7192. The shares of Series E convertible preferred stock will convert into shares of common stock on a one-for-one basis upon the completion of this offering. The table below sets forth the number of shares of Series E convertible preferred stock sold to our directors, executive officers or holders of more than 5% of any class of our capital stock:


Name	Number of Shares of Series E Convertible Preferred Stock		Aggregate Purchase Price
HealthCare Royalty Partners II, L.P.⁽¹⁾		20,856,507	$	14,999,999.84
InterWest Partners X, LP⁽²⁾		1,042,825	$	749,999.74
CDK Associates, L.L.C.⁽³⁾		750,834	$	539,999.82
Helix Founders Fund, L.P.⁽⁴⁾		729,977	$	524,999.46
Valence CDK SPV, L.P.⁽⁵⁾		704,210	$	506,467.84
Entities affiliated with Legacy⁽⁶⁾		361,511	$	259,998.72
KPCB Holdings, Inc.		347,608	$	249,999.68
Robertson Revocable Trust⁽⁷⁾		275,191	$	197,917.37
Eric W. Roberts.		208,565	$	149,999.95
Lipps Family Ventures⁽⁸⁾		139,043	$	99,999.73

⁽¹⁾	As a result of the Series E preferred stock financing, HealthCare Royalty Partners II, L.P. became a holder of more than 5% of the Company’s outstanding capital stock.

⁽²⁾	Reza Zadno, a member of our board of directors, is affiliated with InterWest Partners X, LP.

⁽³⁾	Eric W. Roberts, a member of our board of directors, is affiliated with CDK Associates, L.L.C.

⁽⁴⁾	Philip Sawyer, our Chief Executive Officer and President and a member of our board of directors, is affiliated with Helix Founders Fund, L.P.

⁽⁵⁾	Mr. Roberts, a member of our board of directors is affiliated with Valence CDK SPV, L.P.

⁽⁶⁾

Affiliates of Legacy holding our securities, whose shares are aggregated for purposes of reporting the above share ownership information, are Legacy Life Sciences, LLC, Covenant Properties, LLC and Heritage Holding Co. LLC. Immediately prior to the closing of the Series E preferred stock financing, the entities affiliated with Legacy were holders of more than 5% of our outstanding capital stock.

⁽⁷⁾	Brett Robertson, an executive officer, is related to Sanford Robertson, trustee of the Robertson Revocable Trust.

⁽⁸⁾	Randall A. Lipps, a member of our board of directors, is affiliated with the Lipps Family Ventures.

Series D Preferred Stock Financing

In June 2012, we issued an aggregate of 37,313,423 shares of our Series D convertible preferred stock at a price per share of $0.67. The shares of Series D convertible preferred stock will convert into shares of common stock on a one-for-one basis upon the completion of this offering. The table below sets forth the number of shares of Series D convertible preferred stock sold to our directors, executive officers or holders of more than 5% of any class of our capital stock:


Name	Number of Shares of Series D Convertible Preferred Stock		Aggregate Purchase Price
Entities affiliated with Valence⁽¹⁾		14,925,372	$	9,999,999.24
Wex Invuity Investors LLC⁽²⁾		9,253,731	$	6,199,999.77
InterWest Partners X, LP⁽³⁾		4,852,747	$	3,251,340.49
KPCB Holdings, Inc.		3,813,535	$	2,555,068.45
Entities affiliated with Legacy⁽⁴⁾		1,539,567	$	1,031,509.89
Helix Founders Fund, L.P.⁽⁵⁾		970,549	$	650,267.83
Philip Sawyer and Grace Sawyer⁽⁶⁾		29,850	$	19,999.50

119

⁽¹⁾

Affiliates of Valence holding our securities, whose shares are aggregated for purposes of reporting the above share ownership information, are CDK Associates, L.L.C., Valence Advantage Life Sciences Fund II, L.P. and Valence Advantage Life Sciences Side Fund II, L.P. As a result of the Series D preferred stock financing, entities affiliated with Valence became holders of more than 5% of our outstanding capital stock.

⁽²⁾	As a result of the Series D preferred stock financing, Wex Invuity Investors LLC became a holder of more than 5% of our outstanding capital stock.

⁽³⁾	Reza Zadno, a member of our board of directors, is affiliated with InterWest Partners X, LP.

⁽⁴⁾

Affiliates of Legacy holding our securities, whose shares are aggregated for purposes of reporting the above share ownership information, are Legacy Life Sciences, LLC, Covenant Properties, LLC and Heritage Holding Co. LLC. Immediately prior to the closing of the Series D preferred stock financing, the entities affiliated with Legacy were holders of more than 5% of our outstanding capital stock.

⁽⁵⁾	Philip Sawyer, our Chief Executive Officer and President and a member of our board of directors, is affiliated with Helix Founders Fund, L.P.

⁽⁶⁾	Philip Sawyer, our Chief Executive Officer and President and a member of our board of directors, is related to Philip Sawyer and Grace Sawyer.

Investor Rights Agreement

In February 2015, in connection with the closing of our Series F convertible preferred stock financing, we entered into an amended and restated investor rights agreement with certain holders of our convertible preferred stock, including entities with which certain of our directors are affiliated. In March 2015, we amended this agreement to increase the dollar threshold for agreements requiring the consent of our board of directors. Pursuant to the agreement, these holders are entitled to registration under the Securities Act of the shares of common stock issuable upon the conversion of our convertible preferred stock and upon the exercise of outstanding warrants. For a more detailed description of these registration rights, see “Description of Capital Stock—Registration Rights.” The agreement also provides certain additional rights to these holders, including with respect to access to financial information, inspection of our properties and, for certain investors, a right of first offer with respect to future sales by us of our equity securities (which right of first offer does not apply to this offering). All of the rights granted under the agreement, other than the registration rights, will terminate upon the closing of this offering.

Voting Agreement

We are party to a voting agreement under which certain holders of our capital stock, including entities with which certain of our directors are affiliated, have agreed to vote their shares in a certain way on certain matters, including with respect to the election of directors, and certain holders have the right to have a designated representative present at meetings of our board of directors. Upon the closing of this offering, the voting agreement will terminate by its terms and none of our stockholders will have any special rights regarding the election or designation of members of our board of directors or the voting of capital stock of the company.

Right of First Refusal and Co-Sale Agreement

We are party to an amended and restated right of first refusal and co-sale agreement with certain holders of our capital stock, including entities with which certain of our directors are affiliated, which imposes restrictions on the transfer of our capital stock. Upon the closing of this offering, the right of first refusal and co-sale agreement will terminate and the restrictions on the transfer of our capital stock set forth in this agreement will no longer apply.

Employment Arrangements and Indemnification Agreements

We have entered into employment and consulting arrangements with certain of our current executive officers. See “Executive Compensation—Executive Officer Employment Letters.”

We have also entered into indemnification agreements with each of our directors and officers. The indemnification agreements and our certificate of incorporation and bylaws in effect upon the

120

completion of this offering require us to indemnify our directors and officers to the fullest extent permitted by Delaware law, including indemnification of expenses such as attorneys’ fees, judgments, penalties, fines and settlement amounts incurred by the director or officer in any action or proceedings, including any action or proceeding by or in right of us, arising out of the person’s service as a director or officer. See “Management—Limitation on Liability and Indemnification Matters.”

Stock Option Grants to Executive Officers and Directors

We have granted stock options to our executive officers and our non-employee directors. See “Executive Compensation” and “Management—Director Compensation.”

Stock Option Repricing

In April 2014, we amended certain of our outstanding stock options to reset their respective exercise prices to $0.17 per share, the fair market value of our common stock as of April 30, 2014, as determined by our board of directors. Options repriced included all then current employee options with an exercise price higher than $0.17 per share that remained outstanding and unexercised on April 30, 2014. Pursuant to this repricing, options to purchase 5,091,477 shares of common stock held by our directors and executive officers were repriced, as set forth below:


Name	Number of Shares Underlying Repriced Options
Philip Sawyer		2,408,716
Robert Gerberich		938,270
Michael Gandy		938,270
Brett Robertson		492,692
Alex Vayser		313,529

Policies and Procedures for Related Party Transactions

The audit committee of our board of directors has the primary responsibility for reviewing and approving transactions with related parties. Our audit committee charter will provide that the audit committee shall review and approve in advance any related party transactions.

Indemnification of Directors and Officers

Section 145 of the Delaware General Corporation Law authorizes a corporation’s board of directors to grant, and authorizes a court to award, indemnity to officers, directors, and other corporate agents.

On completion of this offering, as permitted by Section 102(b)(7) of the Delaware General Corporation Law, our amended and restated certificate of incorporation will include provisions that eliminate the personal liability of its directors and officers for monetary damages for breach of their fiduciary duty as directors and officers.

In addition, as permitted by Section 145 of the Delaware General Corporation Law, our amended and restated certificate of incorporation and amended and restated bylaws will provide that:

•

We shall indemnify our directors and officers for serving in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to our best interests and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful.

121

•

We may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.

•

We are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such director or officer shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.

•

We will not be obligated pursuant to the amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification.

•

The rights conferred in the amended and restated certificate of incorporation and amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons.

•

We may not retroactively amend the bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.

Our policy is to enter into separate indemnification agreements with each of its directors and officers that provide the maximum indemnity allowed to directors and executive officers by Section 145 of the Delaware General Corporation Law and also to provide for certain additional procedural protections. We also maintain directors and officers insurance to insure such persons against certain liabilities.

These indemnification provisions and the indemnification agreements entered into between us and our officers and directors may be sufficiently broad to permit indemnification of our officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.

The underwriting agreement filed as Exhibit 1.1 to the registration statement of which this prospectus is a part, provides for indemnification by the underwriters of us and our officers and directors for certain liabilities arising under the Securities Act and otherwise.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.

122

PRINCIPAL STOCKHOLDERS

The following table sets forth certain information with respect to the beneficial ownership of our common stock at April 30, 2015, and as adjusted to reflect the sale of common stock in this offering, for:

•

each of our directors;

•

each of our named executive officers;

•

all of our current directors and executive officers as a group; and

•

each person, or group of affiliated persons, who beneficially owned more than 5% of our common stock.

We have determined beneficial ownership in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Except as indicated by the footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting and sole investment power with respect to all shares of common stock that they beneficially owned, subject to applicable community property laws.

Applicable percentage ownership is based on 158,438,759 shares of common stock outstanding at April 30, 2015, assuming automatic conversion of our convertible preferred stock into common stock. In computing the number of shares of common stock beneficially owned by a person and the percentage ownership of such person, we deemed to be outstanding all shares of common stock subject to options, warrants or other equity awards held by the person that are currently exercisable or exercisable within 60 days of April 30, 2015. However, we did not deem such shares outstanding for the purpose of computing the percentage ownership of any other person. The table below excludes any shares of common stock that may be purchased in this offering pursuant to the directed share program or otherwise. See “Underwriting.”

123

Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Invuity, Inc., 444 De Haro St., San Francisco, CA 94107.


Name of Beneficial Owner+			Percentage of Shares Beneficially Owned
Name of Beneficial Owner+	Shares Beneficially Owned		Before Offering			After Offering
5% Stockholders:
Entities affiliated with the Wellington Entities⁽¹⁾		25,793,139		16.3	%
Entities affiliated with HealthCare Royalty Partners II, L.P.⁽²⁾		22,420,745		14.0	%
Entities affiliated with InterWest Partners X, L.P.⁽³⁾		19,913,445		12.6	%
Entities affiliated with KPCB Holdings, Inc.⁽⁴⁾		17,748,254		11.2	%
Hadley Harbor Master Investors (Cayman) L.P.⁽⁵⁾		16,765,521		10.6	%
Entities affiliated with the Wexford Entities⁽⁶⁾		9,253,731		5.8	%
The Hartford Capital Appreciation Fund⁽⁷⁾		9,027,618		5.7	%
Entities affiliated with CDK Associates, L.L.C.⁽⁸⁾		8,213,520		5.2	%
Named Executive Officers and Directors:
Philip Sawyer⁽⁹⁾		14,936,107		8.8	%
Paul O. Davison⁽¹⁰⁾		1,793,074		1.1	%
Doug Heigel⁽¹¹⁾		1,793,074		1.1	%
Gregory B. Brown, M.D.⁽¹²⁾		—		*
Randall A. Lipps⁽¹³⁾		557,043		*
Gregory T. Lucier⁽¹⁴⁾		853,414		*
Eric W. Roberts⁽¹⁵⁾		6,957,155		4.4	%
Reza Zadno, Ph.D.		—		*
All executive officers and directors as a group (12 persons)		38,789,287		21.4	%

*	Represents beneficial ownership of less than one percent (1%).

+	Options to purchase shares of our capital stock included in this table are early exercisable, and to the extent such shares are early exercised but remain unvested as of a given date, such shares will remain subject to a right of repurchase held by us.

⁽¹⁾

Consists of (i) 16,765,521 shares held of record by Hadley Harbor Master Investors (Cayman) L.P. (Nominee: Italianflare & Co.) and (ii) 9,027,618 shares held of record by The Hartford Capital Appreciation Fund (Nominee: Cudd & Co.) (collectively referred to as the “Wellington Entities”). Wellington Management Company LLP (“Wellington Management”) is the investment adviser to several entities that own shares of Invuity, Inc. (each a “Wellington Client”), as reflected in the aggregate in the table and two of which are specifically named in the footnotes to the table of Principal Stockholders. Wellington Management Company LLP is an investment adviser registered under the Investment Advisers Act of 1940, as amended, and is an indirect subsidiary of Wellington Management Group LLP. Wellington Management Company LLP and Wellington Management Group LLP may each be deemed to share beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of the shares indicated in the table, all of which are held of record by the entity named in the table or a nominee on its behalf. The business address of the entity named in the table is c/o Wellington Management Company LLP, 280 Congress Street, Boston, Massachusetts 02210. The business address of Wellington Management Company LLP and Wellington Management Group LLP is 280 Congress Street, Boston, Massachusetts 02210.

⁽²⁾

Consists of (i) 20,856,507 shares held of record by HealthCare Royalty Partners II, L.P. (HCRPII) and (ii) 1,564,238 shares issuable pursuant to outstanding warrants held by HCRPII. HealthCare Royalty Management, LLC is the investment manager of HCRPII and therefore may be deemed to beneficially own the shares beneficially owned by HCRPII. Gregory B. Brown, MD, Todd C. Davis and Clarke B. Futch comprise the investment committee that, through HealthCare Royalty Management, LLC, is responsible for the voting and investment decisions relating to the shares beneficially owned by HCRPII. The reporting persons may be deemed to be a group as defined in Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended, and each

footnotes continued on following page

124

member of such group may be deemed to beneficially own the ordinary shares beneficially owned by other members constituting such group. Each of Dr. Brown and Messrs. Davis and Futch disclaims beneficial ownership of such shares of common stock. The address for these entities is 300 Atlantic Street, Suite 600, Stamford, CT 06901.

⁽³⁾

Consists of 19,913,445 shares held of record by InterWest Partners X, L.P. (IW10). InterWest Management Partners X, LLC (IMP 10) is the General Partner of IW10 and has sole voting and investment power with respect to the shares held by IW10. The Managing Directors of IMP10 are Bruce A. Cleveland, Philip T. Gianos, W. Stephen Holmes, Nina Kjellson, Gilbert H. Kliman, Arnold L. Oronsky and Douglas A. Pepper. The Venture Members of IMP10 are Keval Desai and Khaled A. Nasr. Each of the Managing Directors and Venture Members of IMP10 share voting and investment power with respect to the shares held by IW10. Each of the Managing Directors and Venture Members disclaim beneficial ownership of the shares held by IW10 except to the extent of their pecuniary interest therein. The address for these entities is c/o InterWest Partners, 2710 Sand Hill Road, Suite 200, Menlo Park, CA 94025.

⁽⁴⁾

Consists of (i) 15,845,342 shares beneficially owned by Kleiner Perkins Caufield & Byers XII, LLC, or KPCB XII; (ii) 245,225 shares beneficially owned by KPCB XII Founders Fund, LLC, or KPCB XII FF; and (iii) 1,657,687 shares beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers. All shares are held for convenience in the name of “KPCB Holdings, Inc. as nominee,” for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Managing Member of KPCB XII and KPCB XII FF is KPCB XII Associates, LLC, or KPCB XII Associates. Brook H. Byers, L. John Doerr, Joseph Lacob, Raymond J. Lane, Theodore E. Schlein and Russ Siegelman, the Managers of KPCB XII Associates, exercise shared voting and dispositive control over the shares directly held by KPCB XII and KPCB XII FF. The principal business address for all entities and individuals affiliated with Kleiner Perkins Caufield & Byers is 2750 Sand Hill Road, Menlo Park, CA 94025.

⁽⁵⁾	The address for Hadley Harbor Master Investors (Cayman) L.P. is c/o Wellington Management Company LLP, 280 Congress Street, Boston, Massachusetts 02210.

⁽⁶⁾

Consists of (i) 7,462,686 shares held of record by Wexford Spectrum Investors LLC and (ii) 1,791,045 shares held of record by Wex SP LLC (collectively referred to as the “Wexford Entities”). Wexford Capital LP (WC) is the investment manager of the Wexford Entities and Wexford GP LLC (WGP) is the General Partner of WC. As a result, and by virtue of the relationships described in this footnote, WC and WGP may be deemed to share beneficial ownership of the shares held by the Wexford Entities. In addition, as controlling persons of WGP, each of Joseph Jacobs and Charles E. Davidson may be deemed to share beneficial ownership of the shares held by the Wexford Entities. WC, WGP and Messrs. Jacobs and Davidson disclaim beneficial ownership of the shares held by the Wexford Entities except to the extent of their pecuniary interest therein. The address for these entities is 411 West Putnam Ave., Greenwich, CT 06830.

⁽⁷⁾	The address for The Hartford Capital Appreciation Fund is c/o Wellington Management Company LLP, 280 Congress Street, Boston, Massachusetts 02210.

⁽⁸⁾

Consists of 8,213,520 shares held of record by CDK Associates, L.L.C. (CDK). Caxton Corporation is the manager of CDK. Bruce Kovner, as the controlling person of Caxton Corporation, may be deemed, by virtue of the relationships described in this footnote, to share beneficial ownership of the shares held by CDK. Mr. Kovner disclaims beneficial ownership of the shares held by CDK except to the extent of his pecuniary interest therein. The address for CDK is 731 Alexander Road, Building 2, Princeton, NJ 08540.

⁽⁹⁾

Consists of (i) 3,978,430 shares held of record by Helix Founders Fund, L.P. (HFF) and (ii) 10,957,677 shares issuable pursuant to outstanding stock options exercisable within 60 days of April 30, 2015, of which 7,519,335 shares were fully vested as of such date. HFF GP, LLC (HFFGP) is the General Partner of HFF and Helix Ventures, LLC (Helix Ventures) is the management company of HFF. Mr. Sawyer is a General Partner of Helix Ventures. As a result, and by virtue of the relationships described in this footnote, Mr. Sawyer may be deemed to share beneficial ownership of the shares held by HFF. Mr. Sawyer disclaims beneficial ownership of the shares held by HFF except to the extent of his pecuniary interest therein. The address for these entities is 1717 Embarcadero Road, Palo Alto, CA 94303.

⁽¹⁰⁾	Consists of 1,793,074 shares issuable pursuant to outstanding stock options exercisable within 60 days of April 30, 2015, of which 21,956 shares were fully vested as of such date.

⁽¹¹⁾	Consists of 1,793,074 shares issuable pursuant to outstanding stock options exercisable within 60 days of April 30, 2015, of which 21,956 shares were fully vested as of such date.

⁽¹²⁾	The address for Gregory B. Brown, M.D. is 300 Atlantic Street, Suite 600, Stamford, CT 06901.

⁽¹³⁾

Consists of (i) 380,000 shares held of record by Randall A. Lipps, 197,917 shares of which have been issued upon early exercise of stock options and remain subject to further vesting as of 60 days following April 30, 2015, (ii) 139,043 shares held of record by Lipps Family Ventures, and (iii) 38,000 shares issuable pursuant to outstanding stock options exercisable within 60 days of April 30, 2015, all of which were fully vested as of such date. Mr. Lipps shares beneficial ownership of the shares held of record by Lipps Family Ventures. The address for these entities is 39 Melanie Lane, Atherton, CA 94027.

⁽¹⁴⁾

Consists of (i) 322,414 shares held of record by RiverRoad Capital Partners, LLC and (ii) 531,000 shares issuable pursuant to outstanding stock options exercisable within 60 days of April 30, 2015, of which 151,000 shares were fully vested as of such date. Gregory T. Lucier is a Managing Member of RiverRoad Capital Partners, LLC. As a result, Mr. Lucier may be deemed to share beneficial ownership of the shares held of record by RiverRoad Capital Partners, LLC. The address for RiverRoad Capital Partners, LLC is 11988 El Camino Real, Suite 500, San Diego, CA 92130.

⁽¹⁵⁾

Consists of (i) 790,430 shares held of record by Eric W. Roberts and, (ii) 5,966,725 shares held of record by Valence CDK SPV, L.P. (Valence CDK), and (iii) 200,00 shares issuable pursuant to outstanding stock options exercisable within 60 days of April 30, 2015, of which 116,666 shares were fully vested as of such date. Valence Life Sciences GP II, LLC (Valence) is the General Partner of Valence CDK and has sole voting and investment power with respect to the shares held by Valence CDK. Mr. Roberts is a Managing Member of Valence. As a result, and by virtue of the relationships described in this footnote, Mr. Roberts may deemed to share beneficial ownership of the shares held by Valence CDK. Mr. Roberts disclaims beneficial ownership of the shares held by Valence CDK except to the extent of his pecuniary interest therein.

125

DESCRIPTION OF CAPITAL STOCK

General

The following is a summary of the rights of our common stock and convertible preferred stock and certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws as they will be in effect upon the completion of this offering. This summary does not purport to be complete and is qualified in its entirety by the provisions of our amended and restated certificate of incorporation and bylaws, copies of which have been filed as exhibits to the registration statement of which this prospectus is a part.

Immediately following the completion of this offering, our authorized capital stock will consist of shares, with a par value of $0.001 per share, of which:

•

shares are designated as common stock; and

•

shares are designated as convertible preferred stock.

As of March 31, 2015, we had outstanding 13,352,889 shares of common stock, 7,337,204 shares of Series A convertible preferred stock, each of which is convertible into one (1) share of common stock; 8,856,408 shares of Series B convertible preferred stock, each of which is convertible into 1.1877952253 shares of common stock; 28,977,649 shares of Series C convertible preferred stock, each of which is convertible into 1.0637813212 shares of common stock; 37,313,423 shares of Series D convertible preferred stock, each of which is convertible into one (1) share of common stock; 29,559,760 shares of Series E convertible preferred stock, each of which is convertible into one (1) share of common stock; and 29,530,012 shares of Series F convertible preferred stock, each of which is convertible into one (1) share of common stock. Assuming the automatic conversion of all shares of our convertible preferred stock outstanding as of March 31, 2015 into common stock upon completion of this offering, as of March 31, 2015, we would have 158,438,759 shares of common stock outstanding, held by approximately 97 stockholders, and no shares of preferred stock outstanding.

In addition, as of March 31, 2015, we had outstanding options to acquire 25,145,974 shares of our common stock and warrants to acquire 2,554,954 shares of our common stock, assuming the conversion of warrants to purchase shares of convertible preferred stock into warrants to purchase shares of common stock, upon the completion of this offering.

Common Stock

The holders of common stock are entitled to one vote per share on all matters submitted to a vote of our stockholders and do not have cumulative voting rights. Accordingly, holders of a majority of the shares of common stock entitled to vote in any election of directors may elect all of the directors standing for election. Subject to preferences that may be applicable to any preferred stock outstanding at the time, the holders of outstanding shares of common stock are entitled to receive ratably any dividends declared by our board of directors out of assets legally available. Upon our liquidation, dissolution, or winding up, holders of our common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preference of any then outstanding shares of convertible preferred stock. Holders of common stock have no preemptive or conversion rights or other subscription rights. There are no redemption or sinking fund provisions applicable to the common stock.

Preferred Stock

After the completion of this offering, no shares of preferred stock will be outstanding. Pursuant to our amended and restated certificate of incorporation, our board of directors will have the authority, without further action by the stockholders, to issue from time to time up to shares of preferred stock in

126

one or more series. Our board of directors may designate the rights, preferences, privileges and restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, redemption rights, liquidation preference, sinking fund terms and the number of shares constituting any series or the designation of any series. While providing flexibility in connection with possible acquisitions, future financings and other corporate purposes, the issuance of preferred stock could have the effect of restricting dividends on the common stock, diluting the voting power of the common stock, impairing the liquidation rights of the common stock, or delaying, deterring or preventing a change in control. Such issuance could have the effect of decreasing the market price of the common stock. We currently have no plans to issue any shares of preferred stock.

Warrants

As of March 31, 2015, a warrant to purchase 65,353 shares of our common stock at an exercise price of $0.07 per share was outstanding. Upon the completion of this offering, the warrant will expire.

As of March 31, 2015, a warrant to purchase 271,221 shares of our Series B convertible preferred stock at an exercise price of $0.9304 per share was outstanding. Upon the completion of this offering, the warrant will become exercisable for 322,155 shares of common stock. The warrant expires on September 15, 2018.

As of March 31, 2015, a warrant to purchase 370,615 shares of our Series C convertible preferred stock was outstanding at an exercise price of $0.6071 per share. Upon the completion of this offering, the warrant will become exercisable for 394,253 shares of common stock. The warrant expires on December 17, 2020.

As of March 31, 2015, a warrant to purchase 208,955 shares of our Series D convertible preferred stock at an exercise price of approximately $0.67 per share was outstanding. Upon the completion of this offering, the warrant will become exercisable for 208,955 of shares of common stock. The warrant expires on July 25, 2023.

As of March 31, 2015, a warrant to purchase 1,564,238 shares of our Series E convertible preferred stock was outstanding at an exercise price of $0.7192 per share. Upon the completion of this offering, the warrant will become exercisable for 1,564,238 shares of common stock. The warrant expires on February 28, 2024.

Each of these warrants has a net exercise provision under which its holder may, in lieu of payment of the exercise price in cash, surrender the warrant and receive a net amount of shares based on the fair market value of the underlying shares at the time of exercise of the warrant after deduction of a number of shares equal in value to the aggregate exercise price. Each warrant contains provisions for the adjustment of the exercise price and the number of shares issuable upon the exercise of the warrant in the event of certain stock dividends, stock splits, reorganizations, reclassifications and consolidations. The holders of the shares issuable upon exercise of our warrants are entitled to registration rights with respect to such shares as described in greater detail below under the heading “—Registration Rights.”

Options

As of March 31, 2015, options to purchase 25,145,974 shares of our common stock were outstanding under our 2005 Stock Incentive Plan, 15,121,624 of which were vested as of that date.

Registration Rights

Certain holders of shares of our convertible preferred stock and warrants to purchase shares of our convertible preferred stock, or their permitted transferees, are entitled to rights with respect to the

127

registration of these shares under the Securities Act. These rights are provided under the terms of an investor rights agreement between us and the holders of these shares, which was entered into in connection with our convertible preferred stock financings, and include demand registration rights, short-form registration rights and piggyback registration rights. In any registration made pursuant to such investor rights agreement, all fees, costs and expenses of underwritten registrations will be borne by us and all selling expenses, including estimated underwriting discounts and selling commissions, will be borne by the holders of the shares being registered.

The registration rights terminate seven years following the completion of this offering or, with respect to any particular stockholder, at such time after the effective date of the registration statement of which this prospectus is a part that such stockholder can sell all of its shares without restriction pursuant to Rule 144 of the Securities Act or another similar exemption under the Securities Act.

Demand Registration Rights

Following the completion of this offering, the holders of an aggregate of 145,085,870 shares of our common stock, including warrants to purchase 1,886,393 shares of our common stock, or their permitted transferees, will be entitled to demand registration rights. Subject to certain exceptions set forth in the investor rights agreement, we will be required, upon the written request of holders of at least 40% of the shares that are entitled to registration rights under the agreement, to register, as soon as practicable, all or a portion of these shares for public resale. We are required to effect only two registrations pursuant to this provision of the investor rights agreement, and each registration must have an anticipated aggregate offering price in excess of $5.0 million. We are not required to effect a demand registration earlier than 180 days after the effective date of this offering.

Short-Form Registration Rights

Following the completion of this offering, the holders of an aggregate of 145,085,870 shares of our common stock, including warrants to purchase 2,489,601 shares of our common stock, or their permitted transferees, will be entitled to short-form registration rights. If we are eligible to file a registration statement on Form S-3, these holders have the right, upon written request from holders of these shares, to have such shares registered by us if the proposed aggregate offering price of the shares to be registered by the holders requesting registration is at least $1.0 million, subject to exceptions set forth in the investor rights agreement.

Piggyback Registration Rights

The holders of an aggregate of 145,085,870 shares of our common stock, including warrants to purchase 2,489,601 shares of our common stock, or their permitted transferees, are entitled to piggyback registration rights. If we register any of our securities for our own account, after the completion of this offering, the holders of these shares are entitled to include their shares in the registration. Subject to limitations set forth in the investor rights agreement, the underwriters of any underwritten offering, including this offering have the right to limit the number of shares or, in the case of this offering, to exclude altogether the shares to be registered by these holders for marketing reasons. If the underwriters for this offering do not determine to exclude any shares belonging to these holders for this offering, we intend to obtain a waiver of the piggyback registration rights in connection with this offering.

Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws

Our amended and restated certificate of incorporation and amended and restated bylaws to be effective upon the completion of this offering will contain provisions that could have the effect of delaying, deferring, or discouraging another party from acquiring control of us. These provisions and certain provisions of Delaware law, which are summarized below, could discourage takeovers, coercive or otherwise. These provisions are also designed, in part, to encourage persons seeking to acquire control of

128

us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us.

Undesignated Preferred Stock. As discussed above under “—Preferred Stock,” our board of directors will have the ability to designate and issue preferred stock with voting or other rights or preferences that could deter hostile takeovers or delay changes in our control or management.

Limits on Ability of Stockholders to Act by Written Consent or Call a Special Meeting. Our amended and restated certificate of incorporation will provide that our stockholders may not act by written consent. This limit on the ability of stockholders to act by written consent may lengthen the amount of time required to take stockholder actions. As a result, the holders of a majority of our capital stock would not be able to amend the bylaws or remove directors without holding a meeting of stockholders called in accordance with the bylaws.

In addition, our amended and restated certificate of incorporation and amended and restated bylaws will provide that special meetings of the stockholders may be called only by the chairperson of the board, the chief executive officer, the president (in the absence of a chief executive officer), or our board of directors. A stockholder may not call a special meeting, which may delay the ability of our stockholders to force consideration of a proposal or for holders controlling a majority of our capital stock to take any action, including the removal of directors.

Requirements for Advance Notification of Stockholder Nominations and Proposals. Our amended and restated bylaws will establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of our board of directors or a committee of the board of directors. These advance notice procedures may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed and may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempt to obtain control of our company.

Board Classification. Our board of directors will be divided into three classes. The directors in each class will serve for a three-year term, one class being elected each year by our stockholders. This system of electing and removing directors may tend to discourage a third party from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors.

Delaware Anti-Takeover Statute. Upon completion of our reincorporation in the State of Delaware, we will be subject to the provisions of Section 203 of the Delaware General Corporation Law regulating corporate takeovers. In general, Section 203 prohibits a publicly held Delaware corporation from engaging, under certain circumstances, in a business combination with an interested stockholder for a period of three years following the date the person became an interested stockholder unless:

•

prior to the date of the transaction, our board of directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;

•

upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (1) shares owned by persons who are directors and also officers and (2) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

129

•

at or subsequent to the date of the transaction, the business combination is approved by our board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that is not owned by the interested stockholder.

Generally, a business combination includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation’s outstanding voting stock. We expect the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that Section 203 may discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.

The provisions of Delaware law and the provisions of our amended and restated certificate of incorporation and amended and restated bylaws could have the effect of discouraging others from attempting hostile takeovers and as a consequence, they might also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These provisions might also have the effect of preventing changes in our management. It is also possible that these provisions could make it more difficult to accomplish transactions that stockholders might otherwise deem to be in their best interests.

Transfer Agent and Registrar

Upon the completion of this offering, the transfer agent and registrar for our common stock will be Computershare Trust Company, N.A. The transfer agent’s address is 250 Royal Street, Canton MA 02021.

Exchange Listing

We have applied to list our common stock on the NASDAQ Global Market under the symbol “IVTY.”

130

SHARES ELIGIBLE FOR FUTURE SALE

Prior to this offering, there has been no public market for shares of our common stock. Future sales of substantial amounts of shares of common stock, including shares issued upon the exercise of outstanding options, in the public market after this offering, or the possibility of these sales occurring, could adversely affect the prevailing market price for our common stock or impair our ability to raise equity capital.

Upon the completion of this offering, based on our shares outstanding as of March 31, 2015, a total of shares of common stock will be outstanding, assuming the automatic conversion of all outstanding shares of convertible preferred stock into shares of common stock upon the completion of this offering. Of these shares, all of the shares of common stock sold in this offering by us, plus any shares sold upon exercise of the underwriters’ option to purchase additional shares, will be freely tradable in the public market without restriction or further registration under the Securities Act, unless these shares are purchased by our officers and directors in the directed share program or by “affiliates,” as that term is defined in Rule 144 under the Securities Act.

The remaining shares of common stock will be “restricted securities,” as that term is defined in Rule 144 under the Securities Act. These restricted securities are eligible for public sale only if they are registered under the Securities Act or if they qualify for an exemption from registration under Rules 144 or 701 under the Securities Act, which are summarized below.

Subject to the lock-up agreements described below and the provisions of Rules 144 and 701 under the Securities Act, the shares of common stock that will be deemed restricted securities after this offering will be available for sale in the public market as follows:

•

no shares will be available for sale until 180 days after the date of this prospectus, subject to certain limited exceptions provided for in the lock-up agreements; and

•

beginning 181 days after the date of this prospectus, shares of common stock will become eligible for sale in the public market, of which shares are expected to be held by affiliates and subject to the volume and other restrictions of Rule 144, as described below.

Rule 144

In general, under Rule 144 as currently in effect, once we have been subject to public company reporting requirements for at least 90 days, a person who is not deemed to have been one of our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and who has beneficially owned the shares proposed to be sold for at least six months, including the holding period of any prior owner other than our affiliates, is entitled to sell such shares without complying with the manner of sale, volume limitation or notice provisions of Rule 144, subject to compliance with the public information requirements of Rule 144. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then such person is entitled to sell such shares at any time.

In general, under Rule 144, as currently in effect, our affiliates or persons selling shares on behalf of our affiliates are entitled to sell upon expiration of the lock-up agreements described below, within any three-month period beginning 90 days after the date of this prospectus, a number of shares that does not exceed the greater of:

•

1% of the number of shares of common stock then outstanding, which will equal approximately shares immediately after this offering; or

•

the average weekly trading volume of the common stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.

131

Sales under Rule 144 by our affiliates or persons selling shares on behalf of our affiliates are also subject to certain manner of sale provisions and notice requirements and to the availability of current public information about us.

Rule 701

Rule 701 generally allows a stockholder who purchased shares of our common stock pursuant to a written compensatory plan or contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90 days to sell these shares in reliance upon Rule 144, but without being required to comply with the public information, holding period, volume limitation, or notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding period requirements of Rule 144. However, all holders of Rule 701 shares are required to wait until 90 days after the date of this prospectus before selling such shares pursuant to Rule 701.

Lock-Up Agreements

In connection with this offering, our officers and directors, and all of our stockholders, warrant holders and option holders, have each entered into a lock-up agreement with the underwriters of this offering that prohibits the sale of shares of our common stock by those parties, subject to limited exceptions, for a period of 180 days after the date of this prospectus without the prior written consent of Piper Jaffray & Co. and Leerink Partners LLC. Piper Jaffray & Co. and Leerink Partners LLC, on behalf of the underwriters, may, in their sole discretion, choose to release any or all of the shares of our common stock subject to these lock-up agreements at any time prior to the expiration of the lock-up period without notice. For more additional information, see “Underwriting—No Sales of Similar Securities.”

Registration Rights

Upon the completion of this offering, the holders of 145,085,870 shares of common stock, including warrants to purchase 2,489,601 shares of common stock, or their transferees, will be entitled to various rights with respect to the registration of these shares under the Securities Act. Registration of these shares under the Securities Act would result in these shares becoming fully tradable without restriction under the Securities Act immediately upon the effectiveness of the registration, except for shares purchased by affiliates. See “Description of Capital Stock—Registration Rights” for additional information.

Registration Statements on Form S-8

Upon the completion of this offering, we intend to file a registration statement on Form S-8 under the Securities Act to register all of the shares of common stock subject to outstanding stock options and common stock issuable in the future under our stock option plans. Shares covered by such registration statement on Form S-8 will be eligible for sale in the public market, upon the expiration or release from the terms of the lock-up agreements and subject to vesting of such shares.

132

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS

The following is a general discussion of the material U.S. federal income tax consequences to non-U.S. holders with respect to their purchase, ownership and disposition of shares of our common stock purchased in this offering. This discussion is for general information only, is not tax advice, and does not purport to be a complete analysis of all potential tax considerations. Accordingly, all prospective non-U.S. holders of our common stock should consult their own tax advisors with respect to the U.S. federal, state, local and non-U.S. tax consequences of the purchase, ownership and disposition of our common stock. This discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended, (the “Code”), existing and proposed U.S. Treasury Regulations promulgated thereunder, current administrative rulings and judicial decisions, in effect as of the date of this prospectus, all of which are subject to change, possibly with retroactive effect, or to differing interpretation. Any change could alter the tax consequences to non-U.S. holders described in this prospectus. We assume in this discussion that a non-U.S. holder holds shares of our common stock as a capital asset within the meaning of Section 1221 of the Code (generally, property held for investment).

This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular non-U.S. holder in light of that non-U.S. holder’s individual circumstances, nor does it address any aspects of state, local or non-U.S. income taxes or any non-income taxes. This discussion also does not address the potential application of the alternative minimum tax, the tax on net investment income, or any specific tax consequences that may be relevant to a non-U.S. holder in light of such holder’s particular circumstances and does not address the special tax rules applicable to particular non-U.S. holders, such as:

•

insurance companies;

•

tax-exempt organizations;

•

banks or other financial institutions;

•

brokers or dealers in securities, and traders in securities that use a mark-to-market method of accounting for their securities holdings;

•

partnerships or entities classified as partnerships for U.S. federal income tax purposes and other pass-through entities;

•

regulated investment companies or real estate investment trusts;

•

tax-qualified retirement plans;

•

persons that own or are deemed to own more than 5% of our capital stock (except to the extent specifically set forth below);

•

“controlled foreign corporations” or “passive foreign investment companies;”

•

corporations that accumulate earnings to avoid U.S. federal income tax;

•

owners that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or other integrated investment;

•

certain former citizens or long-term residents of the United States; and

•

persons deemed to sell our common stock under the constructive sale provisions of the Code.

In addition, if a partnership or entity classified as a partnership for U.S. federal tax purposes holds our common stock, the tax treatment of a partner generally will depend on the status of the partner and upon the activities of the partnership. Accordingly, partnerships that hold our common stock, and

133

partners or members in such partnerships should consult their tax advisors. There can be no assurance that the Internal Revenue Service (“IRS”) will not challenge one or more of the tax consequences described herein, and we have not obtained, and do not intend to obtain, an opinion of counsel or ruling from the IRS with respect to the U.S. federal income tax consequences to a non-U.S. holder of the purchase, ownership or disposition of our common stock. We urge prospective investors to consult with their own tax advisors regarding the U.S. federal, state, local and non-U.S. income and other tax considerations of purchasing, owning and disposing of shares of our common stock.

Non-U.S. Holder Defined

For purposes of this discussion, except as modified for estate tax purposes, a non-U.S. holder means a beneficial owner of our common stock, other than a partnership or other entity classified as a partnership for U.S. federal income tax purposes, that is not, for U.S. federal income tax purposes,:

•

an individual who is a citizen or resident of the United States;

•

a corporation, or other entity taxable as a corporation for U.S. federal tax purposes, created or organized in the United States or under the laws of the United States or of any state thereof or the District of Columbia;

•

an estate, the income of which is subject to U.S. federal income tax regardless of its source; or

•

a trust (x) whose administration is subject to the primary supervision of a U.S. court and which has one or more U.S. persons who have the authority to control all substantial decisions of the trust, or (y) which has made a valid election to be treated as a U.S. person.

Distributions on Our Common Stock

We have not made any distributions on our common stock and we do not have any plans to make any distributions on our common stock. However, if we do make distributions on our common stock, those payments generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds both our current and accumulated earnings and profits, the excess will be treated as a tax-free return of the non-U.S. holder’s capital, and will reduce such holder’s basis in our common stock, but not below zero. Any remaining excess will be treated as capital gain, subject to the tax treatment described below in “—Gain on Sale, Exchange or Other Disposition of Our Common Stock.” Dividends paid to a non-U.S. holder generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate as may be provided by an applicable income tax treaty between the United States and such holder’s country of residence.

Dividends that are treated as effectively connected with a trade or business conducted by a non-U.S. holder within the United States (and, if an applicable income tax treaty so provides, are also attributable to a permanent establishment or a fixed base maintained within the United States by such non-U.S. holder) are generally exempt from the 30% withholding tax if the non-U.S. holder satisfies applicable certification and disclosure requirements. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same graduated U.S. federal income tax rates applicable to U.S. persons. Any U.S. effectively connected income received by a non-U.S. holder that is a corporation may also, under certain circumstances, be subject to an additional branch profits tax at a 30% rate or such lower rate as may be provided by an applicable income tax treaty between the United States and such holder’s country of residence.

In order to claim the benefit of a tax treaty or to claim exemption from withholding because dividends paid on our common stock are effectively connected with the conduct of a trade or business in the United States, a non-U.S. holder must provide a properly executed IRS Form W-8BEN or IRS Form W-8BEN-E

134

for treaty benefits or IRS Form W-8ECI for effectively connected income, or such successor forms as the IRS designates, prior to the payment of dividends. These forms must be periodically updated. If a non-U.S. holder holds our common stock through a financial institution or other agent acting on such holder’s behalf, the non-U.S. holder will be required to provide appropriate documentation to the agent, which then will be required to provide certification to us or our paying agent, either directly or through other intermediaries. Non-U.S. holders may be eligible to obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS.

Gain on Sale, Exchange or Other Disposition of Our Common Stock

Subject to the discussion below regarding backup withholding and foreign accounts, a non-U.S. holder generally will not be subject to any U.S. federal income tax on any gain realized upon such holder’s sale, exchange or other disposition of shares of our common stock unless:

•

the gain is effectively connected with a U.S. trade or business (and, if an applicable income tax treaty so provides, is also attributable to a permanent establishment or a fixed base maintained within the United States by such non-U.S. holder), in which case the graduated U.S. federal income tax rates applicable to U.S. persons will apply, and, if the non-U.S. holder is a foreign corporation, the additional branch profits tax described above in “—Distributions on Our Common Stock” may also apply;

•

the non-U.S. holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case the non-U.S. holder will be subject to a 30% tax on the net gain derived from the disposition, which may be offset by U.S.-source capital losses of the non-U.S. holder, if any; or

•

we are or have been, at any time during the five-year period preceding such disposition (or the non-U.S. holder’s holding period, if shorter) a “United States real property holding corporation” (a “USRPHC”).

We believe that we have not been and are not currently, and we do not anticipate becoming in the future, a USRPHC for U.S. federal income tax purposes, and the remainder of this discussion so assumes. Because the determination of whether we are a USRPHC depends on the fair market value of our U.S. real property relative to the fair market value of our other business assets, there can be no assurance that we will not become a USRPHC in the future. Even if we are or become a USRPHC, however, as long as our common stock is regularly traded on an established securities market, as to which there can be no assurance, such common stock will be treated as U.S. real property interests only if a non-U.S. holder actually or constructively holds more than 5% of such regularly-traded common stock at any time during the shorter of the five-year period preceding such holder’s disposition of, or such holder’s holding period for, our common stock.

Federal Estate Tax

Shares of our common stock beneficially owned by an individual who is not a citizen or resident of the United States (as defined for U.S. federal estate tax purposes) at the time of death will generally be included in the decedent’s gross estate for U.S. federal estate tax purposes, unless an applicable estate tax treaty provides otherwise.

Backup Withholding and Information Reporting

Generally, we must report annually to the IRS the amount of dividends paid to each non-U.S. holder, their name and address, and the amount of tax withheld, if any. A similar report will be sent to each non-U.S. holder. Pursuant to applicable income tax treaties or other agreements, the IRS may make these reports available to tax authorities in such non-U.S. holder’s country of residence.

135

Payments of dividends on or of proceeds from the disposition of our common stock may be subject to additional information reporting and backup withholding at a current rate of 28% unless a non-U.S. holder establishes an exemption, for example, by properly certifying its non-U.S. status on an IRS Form W-8BEN or another appropriate version of IRS Form W-8. Notwithstanding the foregoing, backup withholding and information reporting may apply if either we or our paying agent has actual knowledge, or reason to know, that such holder is a U.S. person.

Backup withholding is not an additional tax; rather, the U.S. federal income tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may generally be obtained from the IRS, provided that the required information is furnished to the IRS in a timely manner.

Foreign Accounts

The Foreign Account Tax Compliance Act, or FATCA, generally imposes a U.S. federal withholding tax of 30% on dividends on and the gross proceeds from a sale or other disposition of our common stock, paid to a “foreign financial institution” (as specially defined under these rules), unless such institution enters into an agreement with the U.S. government to, among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding the U.S. account holders of such institution (which includes certain equity and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners) or otherwise establishes an exemption. FATCA also generally imposes a U.S. federal withholding tax of 30% on dividends on and the gross proceeds from a sale or other disposition of our common stock paid to a “non-financial foreign entity” (as specifically defined for purposes of these rules) unless such entity provides the withholding agent with a certification identifying certain substantial direct and indirect U.S. owners of the entity, certifies that there are none or otherwise establishes an exemption. The withholding provisions under FATCA generally apply to dividends on our common stock, and under current transitional rules are expected to apply with respect to the gross proceeds from a sale or other disposition of our common stock on or after January 1, 2017. Under certain circumstances, a non-U.S. holder might be eligible for refunds or credits of such taxes. An intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph. Prospective investors are encouraged to consult with their own tax advisors regarding the possible implications of FATCA on their investment in our common stock.

Each prospective investor should consult its own tax advisor regarding the particular U.S. federal, state and local and non-U.S. tax consequences of purchasing, holding and disposing of our common stock, including the consequences of any proposed change in applicable laws.

136

UNDERWRITING

Piper Jaffray & Co. and Leerink Partners LLC are acting as representatives of each of the underwriters named below. Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the number of shares of our common stock set forth opposite its name below.


Underwriters		Number of Shares
Piper Jaffray & Co.
Leerink Partners LLC
Stifel, Nicolaus & Company, Incorporated
William Blair & Company, L.L.C.

Total

Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have agreed, severally and not jointly, to purchase all of the shares sold under the underwriting agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the nondefaulting underwriters may be increased or the underwriting agreement may be terminated.

At our request, the underwriters have reserved for sale at the initial public offering price up to shares of common stock, or approximately % of the shares offered by this prospectus, for our employees, directors and other persons associated with us. Any directed shares purchased by our officers and directors will be subject to the 180-day lock-up restriction described in “—No Sales of Similar Securities” below. Any other participants in the directed share program will not be subject to any lock-up arrangements with any underwriter with respect to the directed shares sold to them. The number of shares of common stock available for sale to the general public in the offering will be reduced by the number of shares sold pursuant to the directed share program. Any directed shares not so purchased will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. We have agreed to indemnify the underwriters against certain liabilities and expenses, including liabilities under the Securities Act, in connection with sales of the directed shares. The directed share program will be arranged through .

We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the Securities Act relating to losses or claims resulting from material misstatements in or omissions from this prospectus, the registration statement of which this prospectus is a part, certain free writing prospectuses that may be used in the offering and in any marketing materials used in connection with this offering and to contribute to payments the underwriters may be required to make in respect of those liabilities.

Discounts and Commissions

The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of $ per share. After the initial offering, the public offering price, concession or any other term of this offering may be changed. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part.

137

The following table shows the public offering price, underwriting discount and proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the underwriters of their option to purchase additional shares.

Per Share

Without
Option

With
Option

Public Offering Price

Underwriting Discount

Proceeds, before expenses, to us

The estimated offering expenses payable by us, exclusive of the underwriting discount and commissions, are approximately $ million. We have also agreed to reimburse the underwriters for certain of their expenses in an amount not to exceed $ as set forth in the underwriting agreement.

The underwriting agreement provides that the obligations of the several underwriters to pay for and accept delivery of the shares of common stock offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters are obligated to take and pay for all of the shares of common stock offered by this prospectus if any such shares are taken. However, the underwriters are not required to take or pay for the shares covered by the underwriters’ option to purchase additional shares, described below. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the non-defaulting underwriters may be increased.

Option to Purchase Additional Shares

We have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to additional shares of common stock at the public offering price listed on the cover page of this prospectus, less the underwriting discount and commissions. The underwriters may exercise this option solely for the purpose of covering overallotments, if any, made in connection with the offering of the shares of common stock offered by this prospectus. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional shares of common stock as the number listed next to the underwriter’s name in the table above bears to the total number of shares of common stock listed next to the names of all underwriters in the preceding table.

No Sales of Similar Securities

We, our executive officers and directors and all of our other stockholders, optionholders and warrantholders have agreed not to sell or transfer any shares of our common stock or securities convertible into, exchangeable or exercisable for, or that represent the right to receive shares of our common stock, for 180 days after the date of the prospectus used to sell our common stock without first obtaining the written consent of Piper Jaffray & Co. and Leerink Partners LLC. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly:

•

offer, pledge, announce the intention to sell, sell or contract to sell any shares of our common stock;

•

sell any option or contract to purchase any shares of our common stock;

•

purchase any option or contract to sell any shares of our common stock;

•

grant any option, right or warrant to purchase any shares of our common stock;

•

make any short sale or otherwise transfer or dispose of any shares of our common stock;

138

•

enter into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of any shares of our common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise; or

•

demand that we file a registration statement related to our common stock.

The restrictions in the preceding paragraph do not apply to transfers of securities:

•

as a bona fide gift or gifts;

•

to an immediate family member or any trust for the direct or indirect benefit of the stockholder or an immediate family member of the stockholder;

•

if the stockholder is a corporation, partnership, limited liability company, investment fund, trust or other business entity (i) transfers to another corporation, partnership, limited liability company, investment fund, trust or other business entity that is a direct or indirect affiliate of the stockholder or (ii) distributions of shares of our common stock to limited partners, limited liability company members or stockholders of the stockholder, or to any investment fund or other entity that controls or manages the stockholder;

•

if the stockholder is a trust, to the beneficiary of such trust;

•

by testate succession or intestate succession; or

•

pursuant to the underwriting agreement;

provided, in the case of a transfer described in bullets one through five above, that such transfer does not involve a disposition for value, and each transferee agrees to be subject to the restrictions described in the immediately preceding paragraph and that no filing by any party under Section 16(a) of the Exchange Act, shall be required or shall be made voluntarily in connection with such transfer other than a required Form 5 filing filed within 45 days of December 31, 2015, in which case such Form 5 shall include a footnote describing the transaction being reported.

In addition, the transfer restrictions described above do not apply to:

•

the exercise of stock options granted pursuant to our equity plans or warrants described in this prospectus; provided that no filing by any party under Section 16(a) of the Exchange Act shall be required or shall be made voluntarily;

•

forfeitures to satisfy tax withholding obligations in connection with the conversion or exercise of our options or warrants; provided that if the stockholder is required to file a report under Section 16(a) reporting a reduction in beneficial ownership of shares of common stock, the stockholder will include a statement in such report to the effect that the purpose of the transfer was to cover tax withholding obligations;

•

if the stockholder is not one of our officers or directors, transactions relating to shares of common stock acquired in the directed share program instituted in connection with this offering and described in this prospectus; provided that no filing by any party under Section 16(a) of the Exchange Act shall be required or shall be made voluntarily in connection with subsequent sales of our common stock acquired in such manner;

•

transactions relating to shares of our common stock or other securities acquired in open market transactions on or after the date of this prospectus; provided that no filing by any party under Section 16(a) of the Exchange Act shall be required or shall be made voluntarily in connection with subsequent sales of our common stock acquired in such open market transactions;

139

•

transfers upon a termination of employment of shares of our common stock or any securities to us in connection with the repurchase of shares of our common stock issued pursuant to an employee benefit plan disclosed in this prospectus or pursuant to the agreements pursuant to which such shares were issued as disclosed in this prospectus;

•

transfers pursuant to a “change of control” of our company;

•

the conversion of the outstanding preferred shares into our common stock;

•

transfers of shares of our common stock or other securities by operation of law to a spouse, former spouse, domestic partner, former domestic partner, child or other dependent pursuant to a qualified domestic order or in connection with a divorce settlement; provided, that if the undersigned is required to file a report under Section 16(a) of the Exchange Act reporting a reduction in beneficial ownership of shares of our common stock, the stockholder shall include a statement in such report to the effect that the transfer occurred by operation of law, such as pursuant to a qualified domestic order or in connection with a divorce settlement, as applicable; or

•

the establishment of any 10b5-1 plan, provided that no sales of the stockholders common stock will be made under such plans for 180 days after the date of this prospectus.

Listing

We have applied to list our common stock on the NASDAQ Global Market under the symbol “IVTY.” In order to meet the requirements for listing on that exchange, the underwriters have undertaken to sell a minimum number of shares to a minimum number of beneficial owners as required by that exchange.

Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through negotiations among us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are:

•

the valuation multiples of publicly traded companies that the representatives believe to be comparable to us;

•

our financial information;

•

the history of, and the prospects for, our company and the industry in which we compete;

•

an assessment of our management, its past and present operations and the prospects for, and timing of, our future net sales;

•

the present state of our development; and

•

the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours.

An active trading market for the shares may not develop. It is also possible that after this offering the shares will not trade in the public market at or above the initial public offering price.

The underwriters do not expect to sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority.

Price Stabilization, Short Positions and Penalty Bids

Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from bidding for and purchasing shares of our common stock. However, the underwriters may engage in transactions that stabilize the price of our common stock, such as bids or purchases to peg, fix or maintain that price.

140

In connection with this offering, the underwriters may purchase and sell shares of our common stock in the open market. These transactions may include short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in this offering. “Covered” short sales are sales made in an amount not greater than the underwriters’ option to purchase additional shares described above. The underwriters may close out any covered short position by either exercising their option or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through the overallotment option. “Naked” short sales are sales in excess of the overallotment option. The underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who purchase in this offering. Stabilizing transactions consist of various bids for or purchases of shares of our common stock made by the underwriters in the open market prior to the closing of this offering.

The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions.

Similar to other purchase transactions, the underwriters’ purchases to cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The underwriters may conduct these transactions on the NASDAQ Global Market, in the over-the-counter market or otherwise.

Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice.

Electronic Offer, Sale and Distribution of Shares

In connection with this offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as e-mail. In addition, one or more of the underwriters may facilitate Internet distribution for this offering to certain of their Internet subscription customers. Any such underwriter may allocate a limited number of shares for sale to its online brokerage customers. An electronic prospectus is available on the Internet websites maintained by any such underwriter. Other than the prospectus in electronic format, the information on the websites of any such underwriter is not part of this prospectus.

Other Relationships

The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive, customary fees and commissions for these transactions.

141

In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of the issuer. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.

Selling Restrictions

European Economic Area

In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a “Relevant Member State”) an offer to the public of any shares of our common stock may not be made in that Relevant Member State, except that an offer to the public in that Relevant Member State of any shares of our common stock may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State:

(a)

to any legal entity which is a qualified investor as defined in the Prospectus Directive;

(b)

to fewer than 100 or, if the Relevant Member State has implemented the relevant provision of the 2010 PD Amending Directive, 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive), as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representatives for any such offer; or

(c)

in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of shares of our common stock shall result in a requirement for the publication by us or any underwriter of a prospectus pursuant to Article 3 of the Prospectus Directive.

For the purposes of this provision, the expression an “offer to the public” in relation to any shares of our common stock in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of our common stock to be offered so as to enable an investor to decide to purchase any shares of our common stock, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State, the expression “Prospectus Directive” means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in the Relevant Member State, and the expression “2010 PD Amending Directive” means Directive 2010/73/EU.

United Kingdom

Each underwriter has represented and agreed that:

(a)

it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the “FSMA”)) received by it in connection with the issue or sale of the shares of our common stock in circumstances in which Section 21(1) of the FSMA does not apply to us; and

(b)

it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares of our common stock in, from or otherwise involving the United Kingdom.

142

Canada

The common stock may be sold only to purchasers purchasing as principal that are both “accredited investors” as defined in National Instrument 45-106 Prospectus and Registration Exemptions and “permitted clients” as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the common shares must be made in accordance with an exemption from the prospectus requirements and in compliance with the registration requirements of applicable securities laws.

Hong Kong

The common stock may not be offered or sold in Hong Kong by means of any document other than (i) in circumstances which do not constitute an offer to the public within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong), or (ii) to “professional investors” within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder, or (iii) in other circumstances which do not result in the document being a “prospectus” within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to common shares which are or are intended to be disposed of only to persons outside Hong Kong or only to “professional investors” within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder.

Singapore

This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the common stock may not be circulated or distributed, nor may the common shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor under Section 274 of the Securities and Futures Act, Chapter 289 of Singapore (the “SFA”), (ii) to a relevant person pursuant to Section 275(1), or any person pursuant to Section 275(1A), and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA.

Where the common stock are subscribed or purchased under Section 275 of the SFA by a relevant person which is:

(a)

a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or

(b)

a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor,

shares, debentures and units of shares and debentures of that corporation or the beneficiaries’ rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the common shares pursuant to an offer made under Section 275 of the SFA except:

(a)

to an institutional investor (for corporations, under Section 274 of the SFA) or to a relevant person defined in Section 275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of

143

that corporation or such rights and interest in that trust are acquired at a consideration of not less than S$200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in accordance with the conditions specified in Section 275 of the SFA;

(b)

where no consideration is or will be given for the transfer; or

(c)

where the transfer is by operation of law.

Switzerland

The common stock may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (the “SIX”) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the common shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland.

Neither this document nor any other offering or marketing material relating to the offering, or the common stock have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of common stock will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of common shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (“CISA”). Accordingly, no public distribution, offering or advertising, as defined in CISA, its implementing ordinances and notices, and no distribution to any non-qualified investor, as defined in CISA, its implementing ordinances and notices, shall be undertaken in or from Switzerland, and the investor protection afforded to acquirers of interests in collective investment schemes under CISA does not extend to acquirers of common stock.

United Arab Emirates

This offering has not been approved or licensed by the Central Bank of the United Arab Emirates (the “UAE”), Securities and Commodities Authority of the UAE and/or any other relevant licensing authority in the UAE including any licensing authority incorporated under the laws and regulations of any of the free zones established and operating in the territory of the UAE, in particular the Dubai Financial Services Authority (“DFSA”), a regulatory authority of the Dubai International Financial Centre (“DIFC”). The offering does not constitute a public offer of securities in the UAE, DIFC and/or any other free zone in accordance with the Commercial Companies Law, Federal Law No 8 of 1984 (as amended), DFSA Offered Securities Rules and NASDAQ Dubai Listing Rules, accordingly, or otherwise. The common shares may not be offered to the public in the UAE and/or any of the free zones.

The common shares may be offered and issued only to a limited number of investors in the UAE or any of its free zones who qualify as sophisticated investors under the relevant laws and regulations of the UAE or the free zone concerned.

France

This prospectus (including any amendment, supplement or replacement thereto) is not being distributed in the context of a public offering in France within the meaning of Article L. 411-1 of the French Monetary and Financial Code (Code monétaire et financier).

This prospectus has not been and will not be submitted to the French Autorité des marchés financiers (the “AMF”) for approval in France and accordingly may not and will not be distributed to the public in France.

144

Pursuant to Article 211-3 of the AMF General Regulation, French residents are hereby informed that:

1.	the transaction does not require a prospectus to be submitted for approval to the AMF;

2.	persons or entities referred to in Point 2°, Section II of Article L.411-2 of the Monetary and Financial Code may take part in the transaction solely for their own account, as provided in Articles D. 411-1, D. 734-1, D. 744-1, D. 754-1 and D. 764-1 of the Monetary and Financial Code; and

3.	the financial instruments thus acquired cannot be distributed directly or indirectly to the public otherwise than in accordance with Articles L. 411-1, L. 411-2, L. 412-1 and L. 621-8 to L. 621-8-3 of the Monetary and Financial Code.

This prospectus is not to be further distributed or reproduced (in whole or in part) in France by the recipients of this prospectus. This prospectus has been distributed on the understanding that such recipients will only participate in the issue or sale of our common stock for their own account and undertake not to transfer, directly or indirectly, our common stock to the public in France, other than in compliance with all applicable laws and regulations and in particular with Articles L. 411-1 and L. 411-2 of the French Monetary and Financial Code.

145

LEGAL MATTERS

The validity of the shares of common stock offered hereby will be passed upon for us by Wilson Sonsini Goodrich & Rosati, Professional Corporation, Palo Alto, California. Latham & Watkins LLP, Costa Mesa, California is acting as counsel to the underwriters. An investment fund associated with Wilson Sonsini Goodrich & Rosati, Professional Corporation holds shares of our convertible preferred stock convertible into an aggregate of 37,313 shares of common stock, which represents less than 1% of our outstanding common stock.

EXPERTS

The financial statements as of December 31, 2013 and 2014 and for each of the two years in the period ended December 31, 2014 included in this prospectus have been so included in reliance on the report of PricewaterhouseCoopers LLP, an independent registered public accounting firm, given on the authority of said firm as experts in auditing and accounting.

ADDITIONAL INFORMATION

We have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the shares of common stock offered by this prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement, some of which is contained in exhibits to the registration statement as permitted by the rules and regulations of the SEC. For further information with respect to us and our common stock, we refer you to the registration statement, including the exhibits filed as a part of the registration statement. Statements contained in this prospectus concerning the contents of any contract or any other document is not necessarily complete. If a contract or document has been filed as an exhibit to the registration statement, please see the copy of the contract or document that has been filed. Each statement is this prospectus relating to a contract or document filed as an exhibit is qualified in all respects by the filed exhibit. You may obtain copies of this information by mail from the Public Reference Section of the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549, at prescribed rates. You may obtain information on the operation of the public reference rooms by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet website that contains reports, proxy statements, and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.

As a result of this offering, we will become subject to the information and reporting requirements of the Exchange Act and, in accordance with this law, will file periodic reports, proxy statements, and other information with the SEC. These periodic reports, proxy statements, and other information will be available for inspection and copying at the SEC’s public reference facilities and the website of the SEC referred to above. We also maintain a website at www.invuity.com. Upon completion of this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on our website is not a part of this prospectus and the inclusion of our website address in this prospectus is an inactive textual reference only.

146

INVUITY, INC.

INDEX TO FINANCIAL STATEMENTS


Report of Independent Registered Public Accounting Firm			F-2
Balance Sheets			F-3
Statements of Operations			F-4
Statements of Comprehensive Loss			F-5
Statements of Convertible Preferred Stock and Shareholders’ Deficit			F-6
Statements of Cash Flows			F-7
Notes to the Financial Statements			F-8

F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders of

Invuity, Inc.

In our opinion, the accompanying balance sheets and the related statements of operations, comprehensive loss, convertible preferred stock and shareholders’ deficit, and cash flows present fairly, in all material respects, the financial position of Invuity, Inc. at December 31, 2014 and 2013, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2014 in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

San Jose, California

March 13, 2015

F-2

INVUITY, INC.

Balance Sheets

(In thousands, except share data)


	December 31,						March 31,			Pro Forma as of March 31, 2015
	2013			2014			2015			Pro Forma as of March 31, 2015
Assets								(unaudited	)		(unaudited	)
Current assets:
Cash and cash equivalents	$	4,953		$	6,048		$	25,251
Short-term investments		853			—			—
Accounts receivable, net		1,501			2,798			3,625
Inventory		3,485			4,271			4,400
Prepaid expenses and other current assets		563			2,486			1,391

Total current assets		11,355			15,603			34,667
Restricted cash		35			1,125			1,125
Property and equipment, net		663			8,541			9,005
Other non-current assets		—			55			1,354

Total assets	$	12,053		$	25,324		$	46,151

Liabilities, Convertible Preferred Stock and Shareholders’ Equity (Deficit)
Current liabilities:
Accounts payable	$	954		$	1,075		$	1,278
Accrued and other current liabilities		1,455			4,162			5,159
Long-term debt, current portion		460			—			—

Total current liabilities		2,869			5,237			6,437
Accrued interest payable		38			—			—
Deferred rent		—			2,676			2,836
Convertible preferred stock warrant liability		86			136			640		$	—
Long-term debt, net of current portion		2,017			—			—
Long-term debt, net of current portion—related party		—			9,347			14,382

Total liabilities		5,010			17,396			24,295

Convertible preferred stock, no par value—84,236,116, 114,835,475 and 145,445,475 (unaudited) shares authorized at December 31, 2013 and 2014 and March 31, 2015, respectively; 82,484,684, 112,044,444 and 141,574,456 (unaudited) shares issued and outstanding at December 31, 2013 and 2014 and March 31, 2015, respectively; aggregate liquidation preference of $74,806 and $97,704 (unaudited) at December 31, 2014 and March 31, 2015, respectively; no shares authorized, issued and outstanding, pro forma (unaudited)		52,949			73,755			96,524			—
Shareholders’ (deficit) equity:
Common stock, no par value—130,000,000, 170,000,000 and 210,610,000 (unaudited) shares authorized at December 31, 2013 and 2014 and March 31, 2015, respectively; 12,139,646, 13,158,410 and 13,352,889 (unaudited) shares issued and outstanding at December 31, 2013 and 2014 and March 31, 2015, respectively; 158,438,759 shares issued and outstanding, pro forma (unaudited)		137			215			233			96,757
Additional paid-in capital		1,332			1,995			2,168			2,808
Accumulated deficit		(47,375	)		(68,037	)		(77,069	)		(77,069	)

Total shareholders’ (deficit) equity		(45,906	)		(65,827	)		(74,668	)	$	22,496

Total liabilities, convertible preferred stock and shareholders’ deficit	$	12,053		$	25,324		$	46,151

The accompanying notes are an integral part of these financial statements.

F-3

INVUITY, INC.

Statements of Operations

(In thousands, except share and per share data)


	Year Ended December 31,						Three Months Ended March 31,
	2013			2014			2014			2015
							(unaudited)
Revenue	$	7,186		$	13,103		$	2,154		$	4,442
Cost of goods sold		2,294			4,871			747			1,731

Gross profit		4,892			8,232			1,407			2,711

Operating expenses:
Selling, general and administrative		12,402			22,803			4,574			8,923
Research and development		4,445			5,181			1,203			1,900

Total operating expenses		16,847			27,984			5,777			10,823

Loss from operations		(11,955	)		(19,752	)		(4,370	)		(8,112	)
Interest expense		(284	)		(1,402	)		(370	)		(369	)
Interest and other income (expense), net		130			492			28			(551	)

Net loss	$	(12,109	)	$	(20,662	)	$	(4,712	)	$	(9,032	)

Net loss per common share, basic and diluted	$	(1.03	)	$	(1.70	)	$	(0.40	)	$	(0.69	)

Weighted-average shares used to compute net loss per common share, basic and diluted		11,713,408			12,178,182			11,915,715			13,017,592

Pro forma net loss per common share, basic and diluted (unaudited)				$	(0.17	)				$	(0.06	)

Pro forma weighted-average shares used to compute net loss per common share, basic and diluted (unaudited)					123,522,788						144,976,946

The accompanying notes are an integral part of these financial statements.

F-4

INVUITY, INC.

Statements of Comprehensive Loss

(In thousands)


	Year Ended December 31,						Three Months Ended March 31,
	2013			2014			2014			2015
							(unaudited)
Net loss	$	(12,109	)	$	(20,662	)	$	(4,712	)	$	(9,032	)
Other comprehensive loss:
Unrealized loss on investments		(4	)		—			—			—

Total comprehensive loss	$	(12,113	)		(20,662	)	$	(4,712	)	$	(9,032	)

The accompanying notes are an integral part of these financial statements.

F-5

INVUITY, INC.

Statements of Convertible Preferred Stock and Shareholders’ Deficit

(In thousands, except share and per share data)


	Convertible Preferred Stock				Common Stock				Additional Paid-In Capital		Accumulated Other Comprehensive Income (Loss)			Accumulated Deficit			Total Shareholders’ Deficit
	Shares		Amount		Shares		Amount		Additional Paid-In Capital		Accumulated Other Comprehensive Income (Loss)			Accumulated Deficit			Total Shareholders’ Deficit
Balance at December 31, 2012		82,484,684	$	52,949		11,701,209	$	72	$	1,053	$	4		$	(35,266	)	$	(34,137	)
Exercise of common stock options		—		—		438,437		65		—		—			—			65
Stock-based compensation expense		—		—		—		—		279		—			—			279
Unrealized loss on investments		—		—		—		—		—		(4	)		—			(4	)
Net loss		—		—		—		—		—		—			(12,109	)		(12,109	)

Balance at December 31, 2013		82,484,684		52,949		12,139,646		137		1,332		—			(47,375	)		(45,906	)
Issuance of Series E convertible preferred stock for cash at $0.7192 per share, net of issuance costs of $454		29,559,760		20,806		—		—		—		—			—			—
Exercise of common stock options		—		—		1,018,764		78		—		—			—			78
Stock-based compensation expense		—		—		—		—		663		—			—			663
Net loss		—		—		—		—		—		—			(20,662	)		(20,662	)

Balance at December 31, 2014		112,044,444		73,755		13,158,410		215		1,995		—			(68,037	)		(65,827	)
Issuance of Series F convertible preferred stock for cash at $0.7754 per share, net of issuance costs of $128 (unaudited)		29,530,012		22,769		—		—		—		—			—			—
Exercise of common stock options (unaudited)		—		—		194,479		17		—		—			—			17
Vesting of early exercise options (unaudited)		—		—		—		1		—		—			—			1
Stock-based compensation expense (unaudited)		—		—		—		—		173		—			—			173
Net loss (unaudited)		—		—		—		—		—		—			(9,032	)		(9,032	)

Balance at March 31, 2015 (unaudited)		141,574,456		96,524		13,352,889	$	233	$	2,168		—		$	(77,069	)	$	(74,668	)

The accompanying notes are an integral part of these financial statements.

F-6

INVUITY, INC.

Statements of Cash Flows

(In thousands)


	Year Ended December 31,						Three Months Ended March 31,
	2013			2014			2014			2015
							(unaudited)
Cash flows from operating activities
Net loss	$	(12,109	)	$	(20,662	)	$	(4,712	)	$	(9,032	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		227			344			67			398
Stock-based compensation		279			663			87			173
Changes in fair value of convertible preferred stock warrant liability		(168	)		(522	)		(10	)		504
Provision for (recovery of) doubtful accounts		(1	)		87			57			26
Noncash interest expense (credit)		68			90			(11	)		56
Accretion of premium on marketable securities		191			243			22			—
Changes in operating assets and liabilities
Accounts receivable		(677	)		(1,384	)		(55	)		(853	)
Inventory		(2,384	)		(786	)		(80	)		(129	)
Prepaid expenses and other current assets		(177	)		(1,923	)		130			1,110
Other non-current assets		—			(55	)		—			—
Accounts payable		413			143			(164	)		(249	)
Accrued and other current liabilities		441			1,034			67			924
Deferred rent		—			2,910			(6	)		131

Net cash used in operating activities		(13,897	)		(19,818	)		(4,608	)		(6,941	)

Cash flows from investing activities
Purchases of property and equipment		(468	)		(6,791	)		(66	)		(1,467	)
Purchases of marketable securities		(2,156	)		(17,510	)		(15,912	)		—
Sales of marketable securities		—			17,270			—			—
Maturities of marketable securities		18,120			850			850			—
Increase in restricted cash		—			(1,090	)		—			—

Net cash provided by (used in) investing activities		15,496			(7,271	)		(15,128	)		(1,467	)

Cash flows from financing activities
Proceeds from issuance of long-term debt, net of issuance costs		2,500			—			—			—
Proceeds from issuance of long-term debt -related party, net of issuance costs		—			9,800			9,800			5,000
Payments of long-term debt		(3,016	)		(2,500	)		(2,500	)		—
Proceeds from issuance of common stock upon exercise of stock options		65			78			26			20
Proceeds from issuance of convertible preferred stock, net of issuance costs		—			20,806			20,806			22,769
Payments of initial public offering costs		—			—			—			(178	)

Net cash (used in) provided by financing activities		(451	)		28,184			28,132			27,611

Net increase in cash and cash equivalents		1,148			1,095			8,396			19,203
Cash and cash equivalents, beginning of period		3,805			4,953			4,953			6,048

Cash and cash equivalents, end of period	$	4,953		$	6,048		$	13,349		$	25,251

Supplemental disclosures of cash flow information
Interest paid	$	165		$	275		$	275		$	—
Interest paid to related party	$	—		$	1,052		$	115		$	313
Non-cash investing and financing activities
Purchases of property and equipment in accounts payable and accrued liabilities	$	31		$	1,462		$	67		$	857
Initial public offering costs in accounts payable and accrued liabilities	$	—		$	30		$	—		$	1,176

The accompanying notes are an integral part of these financial statements.

F-7

INVUITY, INC.

Notes to Financial Statements

1.	ORGANIZATION AND DESCRIPTION OF BUSINESS

Invuity, Inc. (the “Company”), was incorporated in the state of California on November 29, 2004. The Company is a commercial-stage medical technology company which utilizes its proprietary Intelligent Photonics technology to develop single-use and reusable illuminated surgical devices, which provide surgeons with illumination and direct visualization of surgical cavities during open minimally invasive and minimal access procedures. The Company’s facilities are located in San Francisco, California.

Liquidity

The Company has incurred net losses from operations since inception and has an accumulated deficit of $68.0 million and $77.1 million (unaudited) as of December 31, 2014 and March 31, 2015, respectively. The Company expects to incur additional losses and negative cash flows and, as a result will require additional capital to fund its operations and execute its business plan. Management plans to finance its operations in the future with additional equity and debt financing arrangements. In February and March 2015, the Company issued an aggregate of 29,530,012 shares of Series F convertible preferred stock for $22.9 million in net proceeds (see Note 14). Management believes that its cash and cash equivalents of $25.3 million (unaudited) as of March 31, 2015 and borrowings available under the accounts receivable credit facility entered into in February 2015 (see Note 14), will provide sufficient funds to enable the Company to meet its operating plan through at least December 31, 2015. However, if the Company’s anticipated operating results are not achieved in future periods, management believes that planned expenditures may need to be reduced in order to extend the time period over which the then-available resources would be able to fund the Company’s operations.

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Use of Estimates

The Company’s financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, fair value of assets and liabilities, inventory, income taxes, convertible preferred stock and related warrants, common stock, and stock-based compensation. Actual results could differ from those estimates and assumptions.

Out-of-period and Other Adjustments

In the three months ended March 31, 2015, the Company recorded an out-of-period adjustment to increase the fair value of the convertible preferred stock warrant liability, which was incorrectly valued at December 31, 2014 due to an error in the expected term assumption. The correction of this error resulted in an increase to the Company’s net loss of $370,000 for the three months ended March 31, 2015 and a corresponding increase to the convertible preferred stock warrant liability. Management has assessed the impact of the adjustment and does not believe that the amount is material to any prior period financial statements, and the impact of correcting the error in the three months ended March 31, 2015 is not material to those financial statements and is not expected to be material to the financial statements for the year ending December 31, 2015. As a result, the Company has not restated any prior period amounts.

F-8

INVUITY, INC.

Notes to Financial Statements—(Continued)

During the three months ended March 31, 2015, the Company determined that expenses relating to research and development in 2014 had been incorrectly classified within selling, general and administrative expenses, due to an erroneous allocation of departmental expenses. The Company has revised the statement of operations for the year ended December 31, 2014 to correct the classification, which resulted in an increase to research and development expenses of $564,000, with a corresponding decrease to selling, general and administrative expenses. Management has assessed the impact of the correction and has concluded that it is not material to the previously issued statement of operations for the year ended December 31, 2014.

Unaudited Pro Forma Balance Sheet Information

The unaudited pro forma balance sheet information as March 31, 2015 presents the Company’s balance sheet information as though all of the Company’s outstanding convertible preferred stock had automatically converted into shares of common stock upon the completion of a qualifying initial public offering of the Company’s common stock (an “IPO”). In addition, the pro forma balance sheet information assumes the reclassification of the convertible preferred stock warrant liability to shareholders’ equity upon completion of an IPO, as the warrants to purchase convertible preferred stock will be converted into common stock warrants. The unaudited pro forma balance sheet information does not assume any proceeds from the proposed IPO.

Unaudited Interim Financial Statements

The accompanying balance sheet as of March 31, 2015, the statements of operations, comprehensive loss and cash flows for the three months ended March 31, 2014 and 2015, and the statements of convertible preferred stock and shareholders’ deficit as of March 31, 2015, are unaudited. The financial data and other information disclosed in these notes to the financial statements related to March 31, 2015, and the three months ended March 31, 2014 and 2015, are also unaudited. The unaudited interim financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the Company’s financial position as of March 31, 2015, and the results of its operations and cash flows for the three months ended March 31, 2014 and 2015. The results for the three months ended March 31, 2015 are not necessarily indicative of results to be expected for the year ending December 31, 2015, or for any other interim period or for any future year.

Cash Equivalents

Cash equivalents consist of short-term, highly liquid investments with original maturities of three months or less from the date of purchase. Cash equivalents consist primarily of amounts invested in money market funds.

Restricted Cash

Restricted cash represents a certificate of deposit held at a financial institution as collateral for the Company credit cards and a letter of credit related to the Company’s facility lease.

Short-Term Investments

All short-term investments are classified as “available-for-sale” and carried at estimated fair value as determined based upon quoted market prices or pricing models for similar securities. Management determines the appropriate classification of its investments in debt securities at the time of purchase and reevaluates such designation as of each balance sheet date. Unrealized gains and losses are excluded from earnings and are reported as a component of comprehensive loss. Realized gains and losses and declines in fair value judged to be other than temporary, if any, on available-for-sale securities are included in

F-9

INVUITY, INC.

Notes to Financial Statements—(Continued)

interest and other income, net, respectively, and are derived using the specific identification method for determining the cost of securities sold. Interest on available-for-sale securities is included in interest and other income, net. Unrealized gains and losses and realized gains and losses on sale of short-term investments were insignificant for the years ended December 31, 2013 and 2014. The Company did not hold any short-term investments as of December 31, 2014 and March 31, 2015.

Accounts Receivable

Accounts receivable are recorded at the invoiced amount and do not bear interest. The Company generally does not require collateral or other security in support of accounts receivable. Allowances are provided for individual accounts receivable when the Company becomes aware of a customer’s inability to meet its financial obligations, such as in the case of bankruptcy, deterioration in the customer’s operating results or change in financial position. If circumstances related to customers change, estimates of the recoverability of receivables would be further adjusted. The Company also considers broad factors in evaluating the sufficiency of its allowance for doubtful accounts, including the length of time receivables are past due, significant one-time events, creditworthiness of customers and historical experience. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts balance was $11,000, $98,000 and $42,000 (unaudited) as of December 31, 2013 and 2014 and March 31, 2015, respectively. The Company did not have any write-offs relating to uncollectible accounts receivable for the years ended December 31, 2013 and 2014. The Company has written off $84,000 (unaudited) as uncollectible accounts receivable to the allowance for doubtful accounts during the three months ended March 31, 2015.

Fair Value of Financial Instruments

Carrying amounts of the Company’s financial instruments, including cash equivalents, short-term investments, accounts receivable and accounts payable approximate fair value due to their relatively short maturities. As of December 31, 2014 and March 31, 2015, based on Level 2 inputs and the borrowing rates available to the Company for loans with similar terms and consideration of the Company’s credit risk, the carrying value of the Company’s long-term debt approximates its fair value.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk at December 31, 2014 and March 31, 2015 consist primarily of cash, which is held primarily by one domestic financial institution and exceeds federally insured limits, cash equivalents, and available for sale securities. The Company manages its liquidity risk by investing in a variety of money market funds and corporate debt. This diversification of investments is consistent with the Company’s policy to maintain liquidity and ensure the ability to collect principal. All investments are made pursuant to corporate investment policy guidelines which restrict investments to issuers evaluated as creditworthy.

F-10

INVUITY, INC.

Notes to Financial Statements—(Continued)

Significant customers are those which represent 10% or more of the Company’s total revenue or net accounts receivable balance at each respective balance sheet date. For each significant customer, revenue as a percentage of total revenue and accounts receivable as a percentage of net accounts receivable are as follows:


	Revenue						Revenue					Accounts Receivable, net
	Year Ended December 31,						Three Months Ended March 31,					December 31,						March 31, 2015
	2013			2014			2014			2015		2013			2014			March 31, 2015
							(unaudited)											(unaudited)
Customers:
Customer A		12	%		12	%		16	%		*		11	%		12	%			*
Customer B		—			*			*			*		—			12	%		10	%
Customer C		13	%		*			*			*		*			—			—

*	Less than 10%

Inventory

Inventories are stated at the lower of cost or market (estimated net realizable value). Cost is determined using the standard cost method, which approximates the first-in, first out basis. The Company periodically assesses the recoverability of all inventories, including raw materials and finished goods, to determine whether adjustments to the carrying value are required. Inventory that is obsolete or in excess of forecasted usage is written down to its estimated net realizable value based on assumptions about future demand and market conditions. Inventory write-downs are charged to cost of goods sold and establish a new cost basis for the inventory.

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation is provided using the straight-line method over the estimated useful lives of the respective assets. The estimated useful lives of the Company’s assets are as follows:


Laboratory equipment			3 years
Leasehold improvements			Shorter of lease term or estimated life of the assets
Furniture and fixtures			3 years
Computer equipment and software			2 to 3 years
Manufacturing equipment			5 years

Maintenance and repairs that do not extend the life or improve the asset are expensed when incurred.

Deferred Initial Public Offering Costs

Deferred initial public offering costs, primarily consisting of legal, accounting, printer and other direct fees and costs relating to the initial public offering, are capitalized. The deferred initial public offering costs will be offset against the Company’s planned initial public offering proceeds upon the closing of the offering. In the event the offering is terminated, all of the deferred initial public offering costs will be expensed. As of December 31, 2014 and March 31, 2015, the Company capitalized $40,000 and $1.4 million (unaudited), respectively, of deferred initial public offering costs within other non-current assets on the balance sheets.

F-11

INVUITY, INC.

Notes to Financial Statements—(Continued)

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset (or asset group) may not be recoverable. An impairment loss is recognized when the total of estimated undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than its carrying amount. Impairment, if any, would be assessed using discounted cash flows or other appropriate measures of fair value. The Company has not recorded impairment charges on long-lived assets for the periods presented in these financial statements.

Convertible Preferred Stock Warrant Liability

Freestanding warrants for shares that are contingently redeemable are classified as liabilities on the balance sheet at their estimated fair value because the shares underlying the warrants may obligate the Company to transfer assets to the holders at a future date under certain circumstances such as a deemed liquidation event. The warrants are subject to re-measurement at each balance sheet date and the change in fair value, if any, is recognized as interest and other income, net in the statements of operations. The Company will continue to adjust the liability for changes in fair value until the earlier of (i) exercise or expiration of the warrants, or (ii) the completion of an IPO, at which time all convertible preferred stock warrants will be converted into warrants to purchase common stock and the liability will be reclassified to additional paid-in capital.

Comprehensive Loss

Comprehensive loss represents all changes in shareholders’ deficit except those resulting from and distributions to shareholders. The Company’s unrealized gains or losses on short-term investments represent the only component of other comprehensive loss that is excluded from the reported net loss and has been presented in the statements of comprehensive loss.

Revenue Recognition

The Company’s revenue is generated from the sale of its products to hospitals and medical centers through direct sales representatives and independent sales agents. The Company recognizes revenue when all of the following criteria are met:

•

persuasive evidence of an arrangement exists;

•

the sales price is fixed or determinable;

•

collection of the relevant receivable is reasonably assured at the time of sale; and

•

delivery has occurred or services have been rendered.

The Company recognizes revenue when title to the goods and risk of loss transfers to the customer, which is upon shipment of the product under the Company’s standard terms and conditions. Shipping and handling costs billed to the customer are recorded in revenue.

Warranty Obligations

The Company does not offer rights of return or price protection and has no post-delivery obligations other than its standard warranty which entitles the customer to return defective products for a period of one year after sale. A warranty liability was not recorded for the periods presented in these financial statements as the estimated future warranty costs were insignificant based on the Company’s historical experience.

F-12

INVUITY, INC.

Notes to Financial Statements—(Continued)

Medical Device Excise Tax

In accordance with the Patient Protection and Affordable Care Act, effective January 1, 2013, the Company began to incur a 2.3% excise tax on sales of medical devices in the United States. The medical device excise tax is included in cost of goods sold in the statements of operations for the years ended December 31, 2013 and 2014 and for the three months ended March 31, 2014 and 2015.

Research and Development

The Company’s research and development costs are expensed as incurred. Research and development costs includes but are not limited to, payroll and personnel-related expenses, including stock-based compensation, laboratory supplies, consulting costs, and allocated facilities and information services costs.

Income Taxes

The Company accounts for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when, in management’s estimate, it is more likely than not that the deferred tax asset will not be realized.

The tax effects of the Company’s income tax positions are recognized only if they are more likely than not to be sustained based solely on the technical merits as of the reporting date. The Company considers many factors when evaluating and estimating its tax positions and benefits, which may require periodic adjustments and which may not accurately anticipate actual outcomes.

Stock-based Compensation

The Company measures its stock-based awards made to employees based on the estimated fair values of the awards as of the grant date using the Black-Scholes option-pricing model. Stock-based compensation expense is recognized over the requisite service period using the straight-line method and is based on the value of the portion of stock-based payment awards that is ultimately expected to vest. As such, the Company’s stock-based compensation is reduced for the estimated forfeitures at the date of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Stock-based compensation expense for options granted to non-employees as consideration for services received is measured on the date of performance at the fair value of the consideration received or the fair value of the equity instruments issued, using the Black-Scholes option-pricing model, whichever can be more reliably measured. Compensation expense for options granted to non-employees is periodically remeasured as the underlying options vest.

Segment Reporting

The Company manages its operations as a single operating segment for the purposes of assessing performance and making operating decisions. All of the Company’s assets are maintained in the United States. The Company derives its revenue from sales to customers in the United States, based upon the billing address of the customer.

Net Loss per Common Share

Basic net loss per common share is calculated by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period, without consideration of potentially dilutive

F-13

INVUITY, INC.

Notes to Financial Statements—(Continued)

securities. Diluted net loss per common share is the same as basic net loss per common share since the effect of potentially dilutive securities are anti-dilutive. Shares subject to repurchase are excluded from the weighted-average shares.

Unaudited Pro Forma Net Loss per Common Share

The unaudited pro forma basic and diluted net loss per common share has been computed to give effect to the conversion of the shares of convertible preferred stock into common stock as if such conversion had occurred at the earlier of the beginning of the period or the date of issuance, if later. Also, the numerator in the pro forma basic and diluted net loss per common share calculation has been adjusted to remove gains or losses resulting from the remeasurement of the convertible preferred stock warrant liability as it will be reclassified to additional paid-in capital upon the completion of an IPO of the Company’s common stock. The unaudited pro forma net loss per common share does not include the shares to be sold and related proceeds to be received from an IPO.

Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”). Areas of revenue recognition that will be affected include, but are not limited to, transfer of control, variable consideration, allocation of transfer pricing, licenses, time value of money, contract costs and disclosures. This guidance is effective for fiscal years and interim reporting periods beginning after December 15, 2016, at which time the Company may adopt the new standard under the full retrospective method or the modified retrospective method. Early adoption is not permitted. The Company is currently evaluating the impact that the adoption of ASU 2014-09 will have on its financial statements and related disclosures.

In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and to provide related footnote disclosures. In doing so, companies will have reduced diversity in the timing and content of footnote disclosures than under today’s guidance. ASU 2014-15 is effective for the Company in the first quarter of 2016 with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2014-15 on its financial statements and related disclosures.

In April 2015, the FASB issued Accounting Standards Update No. 2015-03, Interest-Imputation of Interest (“ASU No. 2015-03”). ASU No. 2015-03 which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The recognition and measurement guidance of debt issuance costs is not affected by the amendments in this update. The standard will be effective for the Company beginning in the first quarter of 2016 and requires the Company to apply the new guidance on a retrospective basis on adoption. The adoption of this guidance is not expected to have a material impact on the Company’s financial statements.

3.	FAIR VALUE MEASUREMENTS

The Company discloses and recognizes the fair value of its assets and liabilities using a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The hierarchy gives the highest priority to valuations based upon unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and

F-14

INVUITY, INC.

Notes to Financial Statements—(Continued)

the lowest priority to valuations based upon unobservable inputs that are significant to the valuation (Level 3 measurements). The guidance establishes three levels of the fair value hierarchy as follows:

Level 1—Inputs are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.

Level 2—Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.

Level 3—Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

The Company’s financial instruments consist of Level 1 and 2 assets and Level 3 liabilities. Where quoted prices are available in an active market, securities are classified as Level 1. Level 1 assets consist primarily of highly liquid money market funds that are included in cash, cash equivalents, and restricted cash. At December 31, 2013, the Company’s Level 2 investments include corporate bonds that are based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, and issuer spreads. Level 3 liabilities consist of the convertible preferred stock warrant liability. The determination of the fair value of the convertible preferred stock warrant liability is discussed in Note 8. Generally, increases or decreases in the fair value of the underlying convertible preferred stock would result in a directionally similar impact in the fair value measurement of the warrant liability.

F-15

INVUITY, INC.

Notes to Financial Statements—(Continued)

The following table sets forth the fair value of the Company’s financial assets and liabilities measured at fair value on a recurring basis based on the three-tier fair value hierarchy (in thousands):


	December 31, 2013
	Level 1		Level 2		Level 3		Total
Assets
Money market funds^(a)	$	4,563	$	—	$	—	$	4,563
Corporate debt		—		853		—		853

	$	4,563	$	853	$	—	$	5,416

Liabilities
Convertible preferred stock warrant liability	$	—	$	—	$	86	$	86

	$	—	$	—	$	86	$	86


	December 31, 2014
	Level 1		Level 2		Level 3		Total
Assets
Money market funds^(a)	$	5,768	$	—	$	—	$	5,768

	$	5,768	$	—	$	—	$	5,768

Liabilities
Convertible preferred stock warrant liability	$	—	$	—	$	136	$	136

	$	—	$	—	$	136	$	136


	March 31, 2015
	Level 1		Level 2		Level 3		Total
			(unaudited)
Assets
Money market funds^(a)	$	19,768	$	—	$	—	$	19,768

	$	19,768	$	—	$	—	$	19,768

Liabilities
Convertible preferred stock warrant liability	$	—	$	—	$	640	$	640

	$	—	$	—	$	640	$	640

^(a)	Balances include $35,000 classified as non-current restricted cash as of December 31, 2013 and 2014 and March 31, 2015 (unaudited).

F-16

INVUITY, INC.

Notes to Financial Statements—(Continued)

The following table sets forth a summary of the changes in the fair value of the convertible preferred stock warrant liability, the Company’s Level 3 financial liability, which is measured on a recurring basis (in thousands):


	Year ended December 31,						Three Months ended March 31,
	2013			2014			2015
							(unaudited)
Beginning balance	$	232		$	86		$	136
Issuance of convertible preferred stock warrants		22			572			—
Change in fair value recorded in interest and other income (expense), net		(168	)		(522	)		504

Ending balance	$	86		$	136		$	640

4.	BALANCE SHEET COMPONENTS

Inventory

Inventory consisted of the following (in thousands):


	December 31,				March 31,
	2013		2014		2015
					(unaudited)
Raw materials	$	1,421	$	894	$	698
Work-in-process		189		768		569
Finished goods		1,875		2,609		3,133

Total inventory	$	3,485	$	4,271	$	4,400

Prepaid expenses and other current assets

Prepaid expenses and other current assets consisted of the following (in thousands):


	December 31,				March 31,
	2013		2014		2015
					(unaudited)
Prepaid expenses	$	547	$	420	$	702
Tenant improvement allowance receivable		—		2,064		670
Other		16		2		19

Total prepaid expenses and other current assets	$	563	$	2,486	$	1,391

F-17

INVUITY, INC.

Notes to Financial Statements—(Continued)

Property and Equipment, Net

Property and equipment, net consisted of the following (in thousands):


	December 31,						March 31,
	2013			2014			2015
							(unaudited)
Computer equipment and software	$	249		$	633		$	691
Laboratory and manufacturing equipment		608			816			948
Furniture and fixtures		245			1,409			1,387
Leasehold improvements		257			6,541			6,909

Total property and equipment, gross		1,359			9,399			9,935
Less: accumulated depreciation and amortization		(696	)		(858	)		(930	)

Total property and equipment, net	$	663		$	8,541		$	9,005

Depreciation and amortization expense was $227,000 and $344,000 during the years ended December 31, 2013 and 2014, respectively, and $67,000 (unaudited) and $398,000 (unaudited) for the three months ended March 31, 2014 and 2015, respectively.

Accrued and Other Current Liabilities

Accrued and other current liabilities consisted of the following (in thousands):


	December 31,				March 31,
	2013		2014		2015
					(unaudited)
Accrued payroll-related expenses	$	941	$	1,599	$	1,874
Accrued independent sales agent commissions		153		227		329
Accrued professional fees		138		89		1,068
Accrued costs for property and equipment		—		1,453		793
Accrued sales and marketing expenses		—		95		351
Deferred rent		56		290		261
Other		167		409		483

Total accrued and other current liabilities	$	1,455	$	4,162	$	5,159

5.	COMMITMENTS AND CONTINGENCIES

Operating Leases

The Company leases laboratory and office space in San Francisco, California, under a non-cancelable operating lease entered into in 2007 and expiring on January 31, 2016. In September 2013, the Company paid a security deposit of $90,000 that will be applied against the rent due under this lease in various periods from July 2014 until the expiration of the lease. In May 2014, the Company entered into a new non-cancelable facility lease agreement to relocate its operations to a larger facility in San Francisco. The lease commencement date was November 1, 2014 and the lease expires on October 31, 2024. At the inception of the lease, the Company provided the landlord with a security deposit of $1.1 million in the form of an irrevocable letter of credit, which was recorded in restricted cash on the balance sheet at both December 31, 2014 and March 31, 2015. The balance of the security deposit related to the first leased

F-18

INVUITY, INC.

Notes to Financial Statements—(Continued)

facility was $90,000 and $67,000 at December 31, 2013 and 2014, respectively, and $45,000 (unaudited) at March 31, 2015, and was recorded in prepaid expenses and other current assets.

Rent expense is recognized on a straight-line basis over the term of the leases and accordingly, the Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability. Incentives granted under the Company’s facilities leases, including allowances to fund leasehold improvements, are deferred and are recognized as adjustments to rental expense on a straight-line basis over the term of the lease. The Company is entitled to a $2.6 million tenant allowance in connection with the lease entered into in November 2014. The Company has utilized the entire $2.6 million allowance in connection with the costs incurred in connection with qualified costs as of December 31, 2014. The Company has recorded $2.1 million and $0.7 million (unaudited) as a receivable from the landlord for the reimbursement for costs incurred and not reimbursed as of December 31, 2014 and March 31, 2015, respectively, which has been recorded in prepaid expenses and other current assets.

The following table summarizes the Company’s future minimum lease payments as of December 31, 2014 (in thousands):


Year ending December 31:
2015	$	2,053
2016		2,053
2017		2,114
2018		2,178
2019		2,243
Thereafter		11,821

Total	$	22,462

The Company’s rent expense was $315,000 and $570,000 for the years ended December 31, 2013 and 2014, respectively and $61,000 (unaudited) and $529,000 (unaudited) for the three month periods ended March 31, 2014 and 2015, respectively.

Legal Proceedings

From time to time, the Company may become involved in legal proceedings arising from the ordinary course of its business. Management is currently not aware of any matters that will have a material adverse effect on the financial position, results of operations or cash flows of the Company.

Indemnifications

In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnification will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. The Company has also entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers to the fullest extent permitted by California corporate law. The Company currently has directors’ and officers’ insurance.

F-19

INVUITY, INC.

Notes to Financial Statements—(Continued)

DEBT

In December 2010, the Company entered into a loan and security agreement with Silicon Valley Bank (“SVB”) whereby the Company may borrow funds via a series of term loans. The first term loan (“Tranche I”) in the amount of $2.8 million was issued by SVB upon the signing of the loan agreement and the second term loan (“Tranche II”) in the amount of $2.1 million was issued in September 2011. Tranches I and II were repayable in monthly installments over three years from the issuance date, with the first six payments being interest only. Interest was payable at the U.S. Treasury note to maturity for a term equal to the Treasury Note Maturity as reported in the Federal Reserve Statistical Release H.15-Select Interest Rates under the heading “U.S. Government Securities/Treasury Constant Maturities” on the funding date of the applicable loan plus a margin of 5.52% per annum. The loan and security agreement contains restrictions on the Company’s ability to pay cash dividends.

In connection with Tranche I, in December 2010, the Company granted SVB a warrant to purchase 370,615 shares of Series C convertible preferred stock at $0.6071 per share. The warrant was recorded as a liability on the balance sheet on the date of issuance at its fair value of $141,000 and recorded as a reduction in the carrying value of the debt. This debt discount was amortized to interest expense over the term of the agreement. See Note 8 for further discussion regarding the warrants.

In July 2013, the Company entered into the first amendment to the loan and security agreement with SVB. The Company repaid the outstanding balance of $1.9 million on Tranches I and II including accrued interest and drew down a new term loan (“Tranche III”) in the amount of $2.5 million. Pursuant to the Tranche III loan agreement, the Company made interest-only payments at a stated rate of 6% per annum for the first eleven months from the funding date. Thereafter, the Company was obligated to pay monthly cash payments of principal and interest for a 30-month period with a balloon payment at maturity which was accreted as interest expense over the term of the loan. The Company was subject to a prepayment penalty equal to 2% of the outstanding principal amount at the prepayment date if the loan is prepaid on or before 18 months after its funding date. At December 31, 2013, the outstanding balance of the term loan was $2.5 million. The loan was repaid in February 2014.

In connection with Tranche III, in July 2013, the Company granted SVB a warrant to purchase 208,955 shares of Series D convertible preferred stock at $0.67 per share. The warrant was recorded on the balance sheet on the date of issuance at its fair value of $23,000 and recorded as a reduction in the carrying value of the debt. This debt discount was initially amortized to interest expense over the term of the agreement, resulting in an effective interest rate of approximately 13.3% per annum, until the repayment of Tranche III in February 2014 at which time the remaining unamortized balance of the debt discount of $19,000 was recognized in interest expense, together with a prepayment penalty of $50,000 and the unamortized portion of the balloon interest payment of $143,000. See Note 8 for further discussions regarding the warrants.

7.	RELATED PARTY LOAN AGREEMENT

In February 2014, the Company entered into a loan agreement with HealthCare Royalty Partners (“HCRP”), a related party due to its equity ownership interest in the Company, for an aggregate principal amount of up to $15.0 million in two separate tranches. The Company drew down the first tranche of $10.0 million upon execution of the loan agreement and repaid the outstanding balance of the Tranche III loan payable to SVB of $2.7 million. The second tranche of $5.0 million (unaudited) was drawn down in March 2015. Interest is payable quarterly at a fixed rate of 12.5% per annum with interest-only payments to be made from the effective date of the loan until March 31, 2017. Thereafter, the Company will make principal and interest payments until the maturity of the loan on December 31,

F-20

INVUITY, INC.

Notes to Financial Statements—(Continued)

2020. The Company is permitted to make a voluntary prepayment in full, but not in part, prior to December 31, 2020, which prepayment must be made together with accrued and unpaid fixed interest on the amount prepaid and any additional amounts due in respect thereof, including an additional percentage of the aggregate loan amount or outstanding principal amount, depending on the date of prepayment. The Company’s obligations under the loan agreement are secured by a first priority security interest in all of the Company’s assets, other than bank accounts, accounts receivable and inventory. The loan agreement imposes customary affirmative and restrictive covenants, including with respect to fundamental transactions, the incurrence of additional indebtedness or liens and the payment of cash dividends, but does not include any financial covenants. The loan agreement contains a material adverse event clause which provides that an event of default will occur if, among other triggers, there occurs any circumstance that could reasonably be expected to result in a material adverse effect on the Company’s business, operations or condition, or on the Company’s ability to perform its obligations under the loan. As of December 31, 2014 and March 31, 2015, management does not believe that it is probable that the clause will be triggered within the next twelve months, and therefore the debt is classified as long-term. The loan agreement also includes customary representations and warranties, events of defaults and termination provisions. As of December 31, 2014 and March 31, 2015, the Company was in compliance with all covenants.

In connection with the loan agreement, the Company issued HCRP a warrant to purchase 1,564,238 shares of Series E convertible preferred stock at $0.7192 per share. The warrant was recorded on the balance sheet on the date of issuance at its fair value of $572,000 and recorded as a reduction in the carrying value of the debt. See Note 8 for further discussion regarding the warrants. The Company also paid $200,000 in debt issuance costs to HCRP, which were recorded as a debt discount. The total debt discount is being amortized as interest expense using the effective interest method over the term of the loan.

Future payments due under the Company’s loan agreements as of December 31, 2014 are as follows (in thousands):


Year ending December 31:
2015	$	1,250
2016		1,250
2017		2,203
2018		3,034
2019		3,734
Thereafter		4,313

		15,784
Less: Amount representing interest		(5,784	)
Less: Amount representing debt discount		(653	)

Present value of minimum payments	$	9,347

F-21

INVUITY, INC.

Notes to Financial Statements—(Continued)

Future payments due under the Company’s loan agreements as of March 31, 2015, which includes the $5.0 million (unaudited) additional borrowings in March 2015, are as follows (in thousands):


Year ending December 31 (unaudited):
2015 (remaining nine months)	$	1,405
2016		1,875
2017		3,305
2018		4,547
2019		5,602
Thereafter		6,469

		23,203
Less: Amount representing interest		(8,203	)
Less: Amount representing debt discount		(618	)

Present value of minimum payments	$	14,382

8.	WARRANTS

Common Stock Warrants

In March 2010, the Company issued a warrant to purchase 65,353 shares of common stock at an exercise price of $0.07 per share to a third party in exchange for recruiting services. The warrant is fully exercisable and expires upon the earliest to occur of: (a) the close of business on March 17, 2020, (b) a liquidation, dissolution, or winding up of the Company, or (c) the closing of a firm commitment underwritten public offering. The Company recorded the warrants in equity at their fair value of $3,000 on the date of issuance using the Black-Scholes option-pricing model with the following assumptions: no dividend yield, an estimated life equal to ten years, a risk-free interest rate of 3.73%, and volatility of 50%. The warrants remain outstanding at December 31, 2014 and March 31, 2015.

Preferred Stock Warrants

In September 2008, the Company issued a warrant to purchase a total of 271,221 shares of Series B convertible preferred stock at an exercise price of $0.9304 per share to a third party in conjunction with a loan. The warrant is fully exercisable and expires upon the earliest to occur of: (a) the close of business on September 15, 2018, or (b) a merger as defined in the loan agreement. The Company recorded the warrant as a liability on the balance sheet at its fair value of $150,000 on the date of issuance using the Black-Scholes option-pricing model with the following assumptions: no dividend yield, an estimated life equal to ten years, a risk-free interest rate of 3.61%, and volatility of 49%. The fair value of the Series B warrant was $23,000, $5,000 and $43,000 (unaudited) at December 31, 2013 and 2014 and March 31, 2015, respectively.

In December 2010, the Company issued a warrant to purchase 370,615 shares of Series C convertible preferred stock at an exercise price of $0.6071 per share to SVB in conjunction with the Tranche I loan. The warrant was immediately exercisable and expires upon the earliest to occur of: (a) the close of business on December 17, 2020, or (b) an acquisition as defined in the loan agreement. The Company recorded the warrant as a liability on the balance sheet at its fair value of $141,000 on the date of issuance using the Black Scholes option-pricing model with the following assumptions: no dividend yield, an estimated life equal to ten years, a risk-free interest rate of 3.29%, and volatility of 48%. The fair value of the Series C warrant was $41,000, $51,000 and $100,000 (unaudited) at December 31, 2013 and 2014 and March 31, 2015, respectively.

F-22

INVUITY, INC.

Notes to Financial Statements—(Continued)

In July, 2013, the Company issued a warrant to purchase 208,955 shares of Series D convertible preferred stock at an exercise price of $0.67 per share to SVB in conjunction with the Tranche III loan. The warrant was immediately exercisable and expires upon the earliest to occur of: (a) the close of business on July 25, 2023, or (b) an acquisition as defined in the loan agreement. The Company recorded the warrant as a liability on the balance sheet at its fair value of $23,000 on the date of issuance using the Black-Scholes option-pricing model with the following assumptions: no dividend yield, an estimated life equal to ten years, a risk-free interest rate of 2.90%, and volatility of 43%. The fair value of the Series D warrant was $22,000, $15,000 and $59,000 (unaudited) at December 31, 2013 and 2014 and March 31, 2015, respectively.

In February 2014, the Company issued a warrant to purchase 1,564,238 shares of Series E convertible preferred stock at an exercise price of $0.7192 per share to HCRP, a related party, in conjunction with a loan. The warrant is immediately exercisable and expires upon the earliest to occur of: (a) February 28, 2024, or (b) an acquisition as defined in the warrant agreement. The Company recorded the warrant as a liability on the balance sheet at its fair value of $572,000 on the date of issuance using the Black-Scholes option-pricing model with the following assumptions: no dividend yield, an estimated life equal to ten years, a risk-free interest rate of 2.71%, and volatility of 38%. The fair value of the Series E warrant was $65,000 at December 31, 2014 and $438,000 (unaudited) at March 31, 2015.

The key assumptions used in the Black-Scholes option-pricing model for the valuation of the convertible preferred stock warrants at December 31, 2013 were: estimated life of 4.8 to 9.6 years, volatility of 43%, risk free rate of 1.58% to 2.90%, and no dividend yield. The fair value of the convertible preferred stock warrants at December 31, 2014 and March 31, 2015 was determined using a hybrid method of the option-pricing model and a probability of various liquidity events required to trigger the conversion of the convertible preferred stock warrants. The scenarios included merger and acquisition events ranging in time to liquidity event of one to three years, an IPO occurring within six months to two years, and dissolution of the Company. The scenarios were weighted based on the Company’s estimate of each event occurring in deriving the estimated fair value of $136,000 and $640,000 (unaudited) as of December 31, 2014 and March 31, 2015, respectively.

The Company recorded a gain of $168,000 and $522,000 for the years ended December 31, 2013 and 2014, respectively, and a gain of $10,000 (unaudited) and a loss of $504,000 (unaudited) for the three months ended March 31, 2014 and 2015, representing the change in the fair value of the convertible preferred stock warrant liability during the periods.

9.	CONVERTIBLE PREFERRED STOCK AND SHAREHOLDERS’ DEFICIT

Convertible Preferred Stock

Convertible preferred stock as of December 31, 2013 consisted of the following (in thousands, except share data):


	December 31, 2013
	Shares Authorized		Shares Issued and Outstanding		Net Carrying Value		Aggregate Liquidation Preference
Series A		7,496,660		7,337,204	$	2,646	$	2,715
Series B		9,271,221		8,856,408		8,141		8,240
Series C		29,654,802		28,977,649		17,412		17,592
Series D		37,813,433		37,313,423		24,750		25,000

Total		84,236,116		82,484,684	$	52,949	$	53,547

F-23

INVUITY, INC.

Notes to Financial Statements—(Continued)

Convertible preferred stock as of December 31, 2014 consisted of the following (in thousands, except share data):


	December 31, 2014
	Shares Authorized		Shares Issued and Outstanding		Net Carrying Value		Aggregate Liquidation Preference
Series A		7,337,204		7,337,204	$	2,646	$	2,715
Series B		9,127,629		8,856,408		8,141		8,240
Series C		29,348,264		28,977,649		17,412		17,592
Series D		37,522,378		37,313,423		24,750		25,000
Series E		31,500,000		29,559,760		20,806		21,259

Total		114,835,475		112,044,444	$	73,755	$	74,806

Convertible preferred stock as of March 31, 2015 consisted of the following (in thousands, except share data):


	March 31, 2015
	(unaudited)
	Shares Authorized		Shares Issued and Outstanding		Net Carrying Value		Aggregate Liquidation Preference
Series A		7,337,204		7,337,204	$	2,646	$	2,715
Series B		9,127,629		8,856,408		8,141		8,240
Series C		29,348,264		28,977,649		17,412		17,592
Series D		37,522,378		37,313,423		24,750		25,000
Series E		31,500,000		29,559,760		20,806		21,259
Series F		30,610,000		29,530,012		22,769		22,898

Total		145,445,475		141,574,456	$	96,524	$	97,704

Significant provisions of the convertible preferred stock are as follows:

Voting—Each share is entitled to voting rights equivalent to the number of shares of common stock into which such share can be converted. Holders of the common stock voting as a separate class are entitled to elect two out of the nine members of the Board of Directors; holders of Series A, Series B, Series C, Series D and Series E convertible preferred stock voting as separate classes are each entitled to elect one out of the nine members of the Board of Directors; and holders of the majority of the outstanding shares of common stock and preferred stock, voting as a single class and on an as-converted to common stock basis, are entitled to elect two out of the nine members of the Board of Directors. Certain corporate actions require approval of holders of at least 65% of the then outstanding shares of preferred stock, voting together as a single class on an as-converted to common stock basis. In addition, certain corporate actions require the approval of at least 66 and 2/3% of the outstanding Series D convertible preferred stock or Series E convertible preferred stock, as applicable, voting as separate classes.

Conversion—Each share of Series A, Series B, Series C, Series D, Series E and Series F convertible preferred stock is convertible at the holder’s option at any time into the number of fully paid and nonassessable shares of common stock determined by dividing the original issue price of $0.37, $0.9304, $0.6071, $0.67, $0.7192 and $0.7754 respectively, by the conversion price of $0.37, $0.7833, $0.5707,

F-24

INVUITY, INC.

Notes to Financial Statements—(Continued)

$0.67, $0.7192 and $0.7754, respectively, and is subject to adjustments for stock splits, stock dividends and dilution. Each share of preferred stock automatically converts into the number of shares of common stock into which such shares are convertible at the then applicable conversion ratio (i) immediately prior to the completion of the sale of shares of common stock in a public offering with a price of not less than $0.7754 per share, resulting in at least $40.0 million of gross proceeds to the Company or (ii) upon the receipt by the Corporation of a written request for such conversion from the holders of at least 65% of the Series A, Series B, Series C, Series D and Series E convertible preferred stock then outstanding (voting as a single class and on an as-converted basis), or with respect to the Series F preferred stock, the vote of the holders of a majority of the Series F preferred stock then outstanding. The Series A, Series D, Series E and Series F convertible preferred stock are convertible into common stock on a one-for-one basis. The Series B and Series C convertible preferred stock are convertible into common stock on a one-for-1.1878 and one-for-1.0638 basis, respectively.

Dividends—Holders of Series A, Series B, Series C, Series D, Series E and Series F convertible preferred stock are entitled to noncumulative dividends of $0.0222, $0.055824, $0.036426, $0.0402, $0.043152 and $0.046524 respectively, per share per annum, if and when declared by the Board of Directors. These dividends are to be paid in advance of any distributions to common stockholders. No dividends have been declared through March 31, 2015, and the payment of cash dividends is restricted under the terms of the loan agreement with HCRP.

Liquidation Preferences—In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, holders of Series F are entitled to receive, prior and in preference to holders of Series A, Series B, Series C, Series D and Series E convertible preferred stock and common stock, an amount equal to $0.7754 per share, plus any and all declared but unpaid dividends. After this, the holders of Series E are entitled to receive, prior and in preference to holders of Series A, Series B, Series C and Series D convertible preferred stock and common stock, an amount equal to $0.7192 per share, plus any declared and unpaid dividends. If upon occurrence of such an event, the assets and funds to be distributed among the holders of Series E are insufficient to permit the payment to such holders, the entire assets and funds of the Company legally available for distribution will be distributed ratably among the holders of Series E. Upon completion of the distribution to the holders of Series E, holders of Series A, Series B, Series C and Series D convertible preferred stock are entitled to receive prior and in preference to holders of common stock, an amount equal to $0.37, $0.9304, $0.6071 and $0.67 per share for Series A, Series B, Series C and Series D convertible preferred stock, respectively, plus any declared but unpaid dividends. If upon occurrence of such an event, after payment in full of preferential amounts due to holders of Series E convertible preferred stock, the assets and funds to be distributed among the holders of Series A, Series B, Series C and Series D convertible preferred stock are insufficient to permit the payment to such holders, the entire remaining assets and funds of the Company legally available for distribution will be distributed ratably among the holders of Series A, Series B, Series C and Series D convertible preferred stock. All remaining legally available assets of the Company are to be distributed pro rata to the holders of common stock. A liquidation may be deemed to be occasioned by or to include (i) a consolidation or merger of the Company with or into any other corporation in which the Company’s stockholders of record as constituted immediately prior to such transaction will, immediately after such transaction, fail to hold at least 50% of the voting power of the result of the surviving corporation; or (ii) a sale, lease, exclusive license or other disposition of all or substantially all of the assets of the Company (an “Acquisition”). In the event of an Acquisition, each holder of convertible preferred stock shall be entitled to receive the greater of the liquidation preference described above or the amount of cash, securities or other property to which the holder would be entitled to receive with respect to their shares if the convertible preferred stock had been converted into common stock immediately prior to such Acquisition.

F-25

INVUITY, INC.

Notes to Financial Statements—(Continued)

Other Matters

The Company and certain of its preferred and common stockholders have entered into an amended and restated investor rights agreement and an amended and restated right of first refusal and co-sale agreement, respectively. Among other things, the investor rights agreement provides the holders who are party to the agreement with registration rights and, in the event the Company proposes to make certain sales of its equity securities, provides major investors (as defined therein) with a right of first offer. Among other things, the right of first refusal and co-sale agreement provides the Company and certain of its preferred and common stockholders with a right of first refusal, and stockholders with a right of co-sale in certain circumstances in which other stockholders propose to sell equity securities of the Company.

The Company has classified the convertible preferred stock as temporary equity on the balance sheets as the shares can be redeemed upon the occurrence of certain change in control events that are outside the Company’s control, including liquidation, sale or transfer of the Company. The Company has elected not to adjust the carrying values of the convertible preferred stock to the liquidation preferences of such shares because it is uncertain whether or when an event would occur that would obligate the Company to pay the liquidation preferences to holders of shares of convertible preferred stock. Subsequent adjustments to the carrying values to the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur.

Common Stock

The Company had reserved shares of common stock, on an as-converted basis, for future issuance as follows:


	December 31,				March 31,
	2013		2014		2015
					(unaudited)
Convertible preferred stock		85,996,098		115,555,858		145,085,870
Options issued and outstanding		16,862,046		25,522,745		25,145,974
Shares available for future stock option grants		9,323,089		5,843,626		12,634,964
Warrants to purchase common stock		65,353		65,353		65,353
Convertible preferred stock warrants		925,363		2,489,601		2,489,601

Total		113,171,949		149,477,183		185,421,762

10.

STOCK OPTION PLAN

Pursuant to the Company’s 2005 Stock Incentive Plan (“2005 Plan”), options and restricted stock may be granted to employees, directors and consultants of the Company. The number of shares authorized for issuance under the 2005 Plan is 35,433,780 shares at December 31, 2014 and 42,042,826 (unaudited) as of March 31, 2015, of which 5,843,626 and 12,634,964 (unaudited) shares were available for grant at December 31, 2014 and March 31, 2015, respectively. Any options under the 2005 Plan that expire or otherwise terminate will revert to the 2005 Plan and again become available for issuance.

F-26

INVUITY, INC.

Notes to Financial Statements—(Continued)

Options granted under the Company’s 2005 Plan may be either incentive stock options or nonstatutory stock options. Incentive stock options may be granted to employees with exercise prices of no less than 100% the fair value of the common stock on the grant date and nonstatutory options may be granted to employees, directors or consultants at exercise prices of no less than 85% of the fair value of the common stock on the grant date, as determined by the Board of Directors. All options granted under the 2005 Plan may be exercised before they are vested. Employee stock options generally vest 25% upon one year of continued service to the Company, with the remainder in monthly increments over three additional years. Stock options granted to consultants generally vest over the performance period of the consultancy agreement, ranging from two to four years. Options expire no more than ten years after the date of grant.

In the event of stock splits and stock dividends, the Board of Directors may increase or decrease proportionately the number of shares and the exercise (purchase) price per share deliverable to the 2005 Plan participants. In the event of a merger in which the Company is not the surviving entity or sale of substantially all the Company’s assets, all outstanding options must be either assumed or substituted by the surviving corporation, or may be required to be exercised or settled.

The following table summarizes stock option activity under the 2005 Plan and related information:


				Options Outstanding
	Options Available for Grant			Options Outstanding			Weighted- Average Exercise Price Per Share		Aggregate Intrinsic Value
									(in thousands)
Balances at December 31, 2012		12,417,962			14,205,610		$	0.13
Options granted		(3,586,540	)		3,586,540		$	0.23
Options exercised		—			(438,437	)	$	0.15
Options forfeited		491,667			(491,667	)	$	0.14

Balances at December 31, 2013		9,323,089			16,862,046		$	0.15	$	640
Options authorized		6,200,000			—
Options granted		(11,680,610	)		11,680,610		$	0.17
Options exercised		—			(1,018,764	)	$	0.08
Options forfeited		2,001,147			(2,001,147	)	$	0.19

Balances at December 31, 2014		5,843,626			25,522,745		$	0.14	$	9,483

Options authorized (unaudited)		6,609,046			—
Options exercised (unaudited)		—			(194,479	)	$	0.10
Options forfeited (unaudited)		182,292			(182,292	)	$	0.16

Balances at March 31, 2015 (unaudited)		12,634,964			25,145,974		$	0.14	$	11,603

Options exercisable—December 31, 2014					25,522,745		$	0.14	$	9,483

Options vested and expected to vest—December 31, 2014					24,041,429		$	0.14	$	8,978

Options exercisable—March 31, 2015 (unaudited)					25,145,974		$	0.14	$	11,603

Options vested and expected to vest—March 31, 2015 (unaudited)					23,899,767		$	0.14	$	11,067

F-27

INVUITY, INC.

Notes to Financial Statements—(Continued)

The aggregate intrinsic values of options outstanding, exercisable, vested and expected to vest were calculated as the difference between the exercise price of the options and the estimated fair value of the Company’s common stock, as determined by the Board of Directors, as of December 31, 2014 and March 31, 2015.

During the years ended December 31, 2013 and 2014, the Company granted options with a weighted-average grant date fair value of $0.23 and $0.29 per share, respectively. During the three months ended March 31, 2014, the Company granted options with a weighted average grant date fair value of $0.17 per share (unaudited). No options were granted during the three months ended March 31, 2015.

The aggregate intrinsic value of options exercised was $24,000 and $310,000 in the years ended December 31, 2013 and 2014, respectively, and $23,000 (unaudited) and $79,000 (unaudited) during the three months ended March 31, 2014 and 2015, respectively. The total fair value of options vested during the period was $299,000 and $335,000 for the years ended December 31, 2013 and 2014, respectively, and $161,000 (unaudited) for the three months ended March 31, 2015.

The weighted-average remaining contractual life of options outstanding was 6.9 years and 7.8 years at December 31, 2013 and 2014, respectively. The weighted-average remaining contractual life of options outstanding was 7.6 years (unaudited) at March 31, 2015. As of December 31, 2014 and March 31, 2015 the weighted-average remaining contractual life was 7.7 years and 6.5 years (unaudited), respectively, for vested and expected to vest options.

The options outstanding, vested and currently exercisable by exercise price under the 2005 Plan at December 31, 2014 are as follows:


	Options Outstanding and Exercisable				Options Vested
Exercise Price	Number of Options		Weighted- Average Remaining Contractual Life (years)		Number of Options		Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life (years)
$0.01		389,126		1.0		389,126	$	0.01		1.0
$0.07		6,470,200		5.7		6,461,865	$	0.07		5.7
$0.08-0.09		1,011,772		6.6		885,103	$	0.09		6.5
$0.12-0.15		665,000		7.7		483,852	$	0.13		7.5
$0.17		16,831,647		9.0		6,146,593	$	0.17		8.1
$0.26		155,000		8.2		136,663	$	0.26		8.2

		25,522,745		7.8		14,503,202	$	0.12		6.7

F-28

INVUITY, INC.

Notes to Financial Statements—(Continued)

The options outstanding, vested and currently exercisable by exercise price under the 2005 Plan at March 31, 2015 are as follows:


	Options Outstanding and Exercisable				Options Vested
	(unaudited)
Exercise Price	Number of Options		Weighted- Average Remaining Contractual Life (years)		Number of Options		Weighted- Average Exercise Price Per Share		Weighted- Average Remaining Contractual Life (years)
$0.01		389,126		0.7		389,126	$	0.01		0.7
$0.07		6,470,200		5.5		6,468,639	$	0.07		5.5
$0.08-0.09		832,607		6.2		757,295	$	0.09		6.1
$0.12-0.15		665,000		7.4		517,605	$	0.13		7.3
$0.17		16,634,041		8.6		6,839,377	$	0.17		7.9
$0.26		155,000		7.9		149,582	$	0.26		8.0

		25,145,974		7.6		15,121,624	$	0.14		6.6

Early Exercise of Stock Options

The 2005 Plan allows for the granting of options that may be exercised before the options have vested. Shares issued as a result of early exercise that have not vested are subject to repurchase by the Company upon termination of the purchaser’s employment or services, at the price paid by the purchaser. The Company’s right to repurchase these shares generally lapses 1/48 of the original grant date amount per month over four years. At December 31, 2013 and 2014, there were 332,500 and 325,000 shares of common stock outstanding, respectively, subject to the Company’s right of repurchase at a weighted-average price of $0.14 and $0.13 per share, respectively. As of March 31, 2015, there were 301,042 (unaudited) shares of common stock outstanding subject to the Company’s right of repurchase at a weighted-average price of $0.13 (unaudited) per share.

Employee Stock-Based Compensation

Stock-based compensation expense recognized during the years ended December 31, 2013 and 2014, includes compensation expense for stock-based awards granted to employees based on the grant date fair value of $266,000 and $606,000, respectively. Stock-based compensation expense recognized during the three months ended March 31, 2014 and 2015, includes compensation expense for stock-based awards granted to employees based on the grant date fair value of $82,000 (unaudited) and $163,000 (unaudited), respectively.

As of December 31, 2014, there were total unamortized compensation costs of $2.0 million related to unvested stock options which the Company expects to recognize over a period of approximately 3.0 years. As of March 31, 2015, there were total unamortized compensation costs of $1.7 million (unaudited) related to unvested stock options which the Company expects to recognize over a period of approximately 3.0 years.

On April 30, 2014, the Company modified the terms of 6,454,425 vested and unvested stock option awards by reducing their exercise price from $0.26 to $0.17 per share. There was no change in any of the other terms of the option awards. The modification resulted in an incremental value of $226,000 being allocated to the options, of which $158,000 was recognized to expense immediately based on options that were vested at the time of the modification. The remaining incremental value of $68,000 attributable to unvested shares is being recognized over their remaining vesting term.

F-29

INVUITY, INC.

Notes to Financial Statements—(Continued)

The Company estimates the fair value of stock options using the Black-Scholes option valuation model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the assumptions below. Each of these inputs is subjective and its determination generally requires significant judgment.


	Year Ended December 31,		Three Months Ended March 31,
	2013	2014	2014	2015^(A⁾
			(unaudited)
Expected term (in years)	6.0	6.0	6.0	—
Expected volatility	43%	35% – 38%	38%	—
Risk-free interest rate	1.08% – 1.82%	1.80% – 1.93%	1.91%	—
Dividend yield	0%	0%	0%	—

^(A)	No stock options were granted during the three months ended March 31, 2015.

Fair Value of Common Stock—The fair value of the shares of the Company’s common stock underlying the stock options has historically been determined by the Company’s Board of Directors. Because there has been no public market for the Company’s common stock, its Board of Directors has determined the fair value of the Company’s common stock at the time of grant of the option by considering a number of objective and subjective factors, including the Company’s stage of development, sales of the Company’s convertible preferred stock, the Company’s operating and financial performance, equity market conditions affecting comparable public companies, the lack of liquidity of the Company’s capital stock, and the general and industry-specific economic outlooks.

Expected Term—The expected term represents the period that the share-based awards are expected to be outstanding. The Company used the simplified method to determine the expected term, which is calculated as the average of the time to vesting and the contractual life of the options.

Expected Volatility—Because the Company is privately held and does not have any trading history for its common stock, the expected volatility was estimated based on the average volatility for comparable publicly traded companies over a period equal to the expected term of the stock option grants. When selecting comparable publicly traded companies in a similar industry on which it has based its expected stock price volatility, the Company selected companies with comparable characteristics to it, including enterprise value, risk profiles, position within the industry, and with historical share price information sufficient to meet the expected life of the stock-based awards. The historical volatility data was computed using the daily closing prices for the selected companies’ common stock during the equivalent period of the calculated expected term of the stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available.

Risk-Free Interest Rate—The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the option.

Dividend Yield—The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of zero.

Non-Employee Stock-Based Compensation

During the years ended December 31, 2013 and 2014, the Company granted options to purchase 215,000 and 171,000 shares, respectively, of common stock to consultants for research and development

F-30

INVUITY, INC.

Notes to Financial Statements—(Continued)

and general and administrative services. No options were granted during the three months ended March 31, 2015. As of December 31, 2014 and March 31, 2015, none of the consultants’ options had been exercised, and 682,000 options remained outstanding with a weighted-average exercise price of $0.16 per share.

The fair value of non-employee awards is estimated at the time the services are delivered and is remeasured at each reporting date using the Black-Scholes option pricing model with the following assumptions:


	Year Ended December 31,		Three Months Ended March 31,
	2013	2014	2014	2015
			(unaudited)
Expected term (in years)	8.0 – 9.6	8.0 – 9.3	8.0 – 10.0	8.1 – 9.1
Expected volatility	43%	35%	43%	34%
Risk-free interest rate	1.76% – 2.90%	2.21% – 2.72%	2.72%	1.79% – 1.86%
Dividend yield	0%	0%	0%	0%

Stock-based compensation expense related to non-employee awards was $13,000 and $57,000 during the years ended December 31, 2013 and 2014, respectively. Stock-based compensation expense related to non-employee awards was $5,000 (unaudited) and $10,000 (unaudited) during the three months ended March 31, 2014 and 2015, respectively.

Total Stock-Based Compensation

The following table summarizes total stock-based compensation expense for the years ended December 31, 2013 and 2014, and the three months ended March 31, 2014 and 2015, which was included in the statements of operations as follows (in thousands):


	Year Ended December 31,				Three Months Ended March 31,
	2013		2014		2014		2015
					(unaudited)
Cost of goods sold	$	4	$	23	$	1	$	17
Selling, general and administrative		233		547		76		95
Research and development		42		93		10		61

Total stock-based compensation expense	$	279	$	663	$	87	$	173

11.

INCOME TAXES

The Company has incurred net operating losses for the years ended December 31, 2013 and 2014, therefore has no provision for income taxes recorded for such years. For the years ended December 31, 2013 and 2014, the Company generated losses before taxes in the United States of $12.1 million and $20.7 million, respectively and no foreign income or losses. The Company’s deferred tax assets continue to be fully offset by a valuation allowance.

F-31

INVUITY, INC.

Notes to Financial Statements—(Continued)

The reconciliation of the statutory federal income tax rate to the Company’s effective tax rate is as follows:


	Year Ended December 31,
	2013			2014
Tax at statutory federal rate		34.0	%		34.0	%
State taxes, net of federal benefit		4.9			3.8
Tax credits		1.0			1.3
Change in valuation allowance		(40.1	)		(37.8	)
Other		0.2			(1.3	)

Provision for income taxes		0.0	%		0.0	%

The tax effects of temporary differences and carryforwards that give rise to significant portions of the deferred tax assets are as follows (in thousands):


	December 31,
	2013			2014
Deferred tax assets:
Net operating loss carryforwards	$	17,364		$	23,574
Research and development		626			782
Accrued liabilities and other		509			590
Stock-based compensation		194			259
Fixed assets		95			100
Tenant improvement allowance		—			970

Total deferred tax assets		18,788			26,275
Valuation allowance		(18,788	)		(26,275	)

Net deferred tax assets	$	—		$	—

Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, the net deferred tax assets have been fully offset by a valuation allowance. The valuation allowance increased by $4.9 million and $7.5 million for the years ended December 31, 2013 and 2014, respectively, and there were no releases of the valuation allowance in these years.

As of December 31, 2014, the Company had net operating loss (“NOL”) carryforwards (before tax effects) for federal and state income tax purposes of $60.9 million and $53.8 million, respectively. These federal and state NOL carryforwards will begin to expire in 2026 and 2016, respectively, if not utilized. In addition, the Company has federal and state research and development tax credit carryforwards of $591,000 and $684,000, respectively, to offset future income tax liabilities. The federal research and development tax credits will begin to expire in 2024, if not utilized, while the state research and development tax credit can be carried forward indefinitely.

Federal and California tax laws impose substantial restrictions on the utilization of net operating losses and credit carry-forwards in the event of an “ownership change” for tax purposes, as defined in Section 382 of the Internal Revenue Code. Due to ownership changes since inception, the Company’s net operating losses may be limited as to their usage. In the event the Company has additional changes in ownership, utilization of the carryforwards could be further restricted.

F-32

INVUITY, INC.

Notes to Financial Statements—(Continued)

A reconciliation of the Company’s unrecognized tax benefits for the years ended December 31, 2013 and 2014 is as follows (in thousands):


	Year Ended December 31,
	2013		2014
Balance at beginning of year	$	157	$	209
Additions for tax positions taken in current year		52		69
Reductions for tax positions taken in prior years		—		(17	)

Balance at end of year	$	209	$	261

The unrecognized tax benefits, if recognized, would not have an impact on the Company’s effective tax rate to the extent that the Company continues to maintain a full valuation allowance against its deferred tax assets. The Company does not expect a significant change to its unrecognized tax benefits over the next 12 months. The unrecognized tax benefits may increase or change during the year for items that arise in the ordinary course of business.

The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes. Management determined that no accrual for interest and penalties was required as of December 31, 2013 and 2014, respectively.

The Company’s tax years 2005-2014 will remain open for examination by the federal and state authorities for three and four years, respectively, from the date of utilization of any NOL or research and development credits.

12.

NET LOSS PER COMMON SHARE

The Company computes net income (loss) per share of common stock in conformity with the two-class method required for participating securities. The Company considers all series of the Company’s convertible preferred stock to be participating securities as the holders of the convertible preferred stock are entitled to receive a noncumulative dividend on a pari passu basis in the event that a dividend is paid on common stock. In accordance with the two-class method, earnings allocated to convertible preferred stock are excluded from the computation of net income per common share, basic and diluted. The holders of all series of convertible preferred stock do not have a contractual obligation to share in the losses of the Company. As such, the Company’s net losses for the years ended December 31, 2013 and 2014 and the three months ended March 31, 2014 and 2015 were not allocated to these participating securities. As the Company had net losses for the years ended December 31, 2013 and 2014, and the three months ended March 31, 2014 and 2015, all potential common shares were determined to be anti-dilutive. The following table sets forth the computation of the basic and diluted net loss per share during

F-33

INVUITY, INC.

Notes to Financial Statements—(Continued)

the years ended December 31, 2013 and 2014 and for the three months ended March 31, 2014 and 2015 (in thousands, except share and per share data):


	Year Ended December 31,						Three Months Ended March 31,
							(Unaudited)
	2013			2014			2014			2015
Numerator:
Net loss	$	(12,109	)	$	(20,662	)	$	(4,712	)	$	(9,032	)

Denominator:
Weighted-average common shares outstanding		11,727,072			12,461,360			12,234,757			13,336,499
Less: weighted-average unvested common shares subject to repurchase		(13,664	)		(283,178	)		(319,042	)		(318,907	)

Weighted-average shares used to compute net loss per common share, basic and diluted		11,713,408			12,178,182			11,915,715			13,017,592

Net loss per common share, basic and diluted	$	(1.03	)	$	(1.70	)	$	(0.40	)	$	(0.69	)

The following outstanding shares of potentially dilutive securities have been excluded from diluted net loss per common share for the years ended December 31, 2013, December 31, 2014 and three months ended March 31, 2014 and 2015 because their inclusion would be anti-dilutive:


	Year Ended December 31,				Three Months Ended March 31,
	2013		2014		2014		2015
					(unaudited)
Convertible preferred stock on an as-converted basis		85,996,098		115,555,858		115,555,858		145,085,870
Options to purchase common stock		16,862,046		25,522,745		21,032,372		25,145,974
Warrants to purchase common stock		65,353		65,353		65,353		65,353
Warrants to purchase convertible preferred stock on an as-converted basis		925,363		2,489,601		2,489,601		2,489,601

Total		103,848,860		143,633,557		139,143,184		172,786,798

13.

PRO FORMA NET LOSS PER COMMON SHARE (UNAUDITED)

The following table sets forth (in thousands, except share and per share amounts) the computation of the Company’s unaudited pro forma basic and diluted net loss per common share after giving effect to the automatic conversion of convertible preferred stock using the as-if converted method into common stock as though the conversion had occurred at the beginning of the period presented or date of issuance, if later. Also, the numerator in the pro forma basic and diluted net loss per common share calculation has been adjusted to remove gains or losses resulting from the remeasurement of the convertible preferred

F-34

INVUITY, INC.

Notes to Financial Statements—(Continued)

stock warrant liability as it will be reclassified to additional paid-in capital upon the completion of an IPO of the Company’s common stock.


	Year Ended December 31, 2014			Three Months Ended March 31, 2015
				(unaudited)
Net loss	$	(20,662	)	$	(9,032	)
Less: Change in fair value of convertible preferred stock warrant liability		(522	)		504

Net loss used in computing pro forma net loss per common share, basic and diluted	$	(21,184	)	$	(8,528	)

Weighted-average shares used to compute net loss per common share, basic		12,178,182			13,017,592
Pro forma adjustment to reflect assumed conversion of convertible preferred stock		111,344,606			131,959,354

Weighted-average shares used to compute pro forma net loss per common share, basic and diluted		123,522,788			144,976,946

Pro forma net loss per common share, basic and diluted	$	(0.17	)	$	(0.06	)

14.

SUBSEQUENT EVENTS

In February and March 2015, the Company entered into the Series F Preferred Stock Purchase Agreement with new and existing investors and issued an aggregate of 29,530,012 shares of Series F convertible preferred stock at a price of $0.7754 per share for net proceeds of $22.9 million. The holders of the Series F convertible preferred stock are entitled to receive non- cumulative dividends at a rate of $0.046524 per share when and if declared by the board of directors. In connection with the issuance of the Series F convertible preferred stock, the Company amended its articles of incorporation and revised the conditions under which all series of the Company’s convertible preferred stock would automatically convert into common stock. Based on the revised terms, the Company’s convertible preferred stock will automatically convert into common stock upon the earlier of (i) an IPO with gross proceeds of not less than $40.0 million to the Company and in which the per share price is at least $0.7754; or (ii) with respect to the Series A, Series B, Series C, Series D and Series E convertible preferred stock, the vote of the holders of at least 65% of the Series A, Series B, Series C, Series D and Series E convertible preferred stock, voting together as a single class on an as-converted to common stock basis, or (iii) with respect to the Series F convertible preferred stock, the vote of the holders of a majority of the Series F convertible preferred stock then outstanding. Shares of Series F convertible preferred stock convert into shares of common stock on a one-for-one basis.

In February 2015, the Company entered into an accounts receivable credit facility with SVB that permits the borrowing of the lesser of $7.5 million or an amount representing up to 80% of eligible accounts receivable. The credit facility matures in February 2018 and the Company’s obligations under the credit facility are secured by a first priority security interest in the Company’s bank accounts, accounts receivable, and inventory. Interest on borrowed amounts is payable monthly at the prime rate plus 0.75%. The credit facility imposes customary affirmative and restrictive covenants, including with respect to fundamental transactions, changes to the Company’s business, the incurrence of additional indebtedness or liens and the payment of dividends, but does not include any financial covenants. In addition, the credit facility states that if the Company maintains a net cash balance, defined as

F-35

INVUITY, INC.

Notes to Financial Statements—(Continued)

unrestricted cash held with SVB less any borrowings on the revolving line of credit, of more than $3.0 million, then all collections will be deposited in the Company’s operating account. If the net cash balance is below $3.0 million, then all collections will be held in an SVB-controlled account and applied to reduce the loan balance. The credit facility also includes customary representations and warranties, events of defaults and termination provisions. As of March 13, 2015, the Company has not drawn down on the credit facility.

The Company has reviewed and evaluated subsequent events through March 13, 2015, the date the financial statements were available to be issued.

15.

SUBSEQUENT EVENTS (UNAUDITED)

In April and May 2015, the Company granted options to purchase 7,114,305 shares of common stock to employees, directors and consultants, with a weighted-average exercise price of $0.61 per share.

The Company has reviewed and evaluated subsequent events through May 12, 2015, the date these unaudited interim financial statements were available to be issued.

F-36

LOGO

Enhancing direct visualization in minimally invasive and minimal access surgery

Shares INVUITY, INC. Common Stock PROSPECTUS Until and including , 2015 (the 25th day after the date of this prospectus), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers’ obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. Piper Jaffray Leerink Partners Stifel William Blair , 2015

LOGO

PART II

Information Not Required in Prospectus

Item 13.

Other Expenses of Issuance and Distribution.

The following table sets forth all expenses to be paid by the Registrant, other than underwriting discounts and commissions, upon completion of this offering. All amounts shown are estimates except for the SEC registration fee and the FINRA filing fee.


SEC registration fee	$	8,018
FINRA filing fee		10,850
Exchange listing fee		*
Printing and engraving		*
Legal fees and expenses		*
Accounting fees and expenses		*
Blue sky fees and expenses (including legal fees)		*
Transfer agent and registrar fees		*
Miscellaneous		*

Total	$	*

*	To be completed by amendment.

Item 14.

Indemnification of Directors and Officers.

On completion of this offering, as permitted by Section 102(b)(7) of the Delaware General Corporation Law, the Registrant’s amended and restated certificate of incorporation will include provisions that eliminate the personal liability of its directors and officers for monetary damages for breach of their fiduciary duty as directors and officers.

In addition, as permitted by Section 145 of the Delaware General Corporation Law, the amended and restated certificate of incorporation and amended and restated bylaws of the Registrant will provide that:

•

The Registrant shall indemnify its directors and officers for serving the Registrant in those capacities or for serving other business enterprises at the Registrant’s request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the Registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful.

•

The Registrant may, in its discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law.

•

The Registrant is required to advance expenses, as incurred, to its directors and officers in connection with defending a proceeding, except that such director or officer shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification.

•

The Registrant will not be obligated pursuant to the amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person, except with respect to proceedings authorized by the Registrant’s board of directors or brought to enforce a right to indemnification.

II-1

•

The rights conferred in the amended and restated certificate of incorporation and amended and restated bylaws are not exclusive, and the Registrant is authorized to enter into indemnification agreements with its directors, officers, employees and agents and to obtain insurance to indemnify such persons.

•

The Registrant may not retroactively amend the bylaw provisions to reduce its indemnification obligations to directors, officers, employees, and agents.

The Registrant’s policy is to enter into separate indemnification agreements with each of its directors and officers that provide the maximum indemnity allowed to directors and executive officers by Section 145 of the Delaware General Corporation Law and also to provide for certain additional procedural protections. The Registrant also maintains directors and officers insurance to insure such persons against certain liabilities.

These indemnification provisions and the indemnification agreements entered into between the Registrant and its officers and directors may be sufficiently broad to permit indemnification of the Registrant’s officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act of 1933, as amended, or the Securities Act.

The underwriting agreement filed as Exhibit 1.1 to this registration statement provides for indemnification by the underwriters of the Registrant and its officers and directors for certain liabilities arising under the Securities Act and otherwise.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to the Registrant’s directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. Please read “Item 17. Undertakings” for more information on the position of the Securities and Exchange Commission regarding such indemnification provisions.

Item 15.

Recent Sales of Unregistered Securities.

During the last three years, the Registrant issued the following unregistered securities:

Warrants

In July 2013, the Registrant issued a warrant to purchase 208,955 shares of its Series D convertible preferred stock to one accredited investor at an exercise price of $0.67 per share.

In February 2014, the Registrant issued a warrant to purchase 1,564,238 shares of its Series E convertible preferred stock to one accredited investor at an exercise price of $0.7192 per share.

Sales of Convertible Preferred Stock

In June 2012, the Registrant sold an aggregate of 37,313,423 shares of its Series D convertible preferred stock to a total of 26 accredited investors at a purchase price of $0.67 per share, for aggregate proceeds of approximately $25,000,000.

In February 2014, the Registrant sold an aggregate of 29,559,760 shares of its Series E convertible preferred stock to a total of 21 accredited investors at a purchase price of $0.7192 per share, for aggregate proceeds of approximately $21,260,000.

In February 2015, the Registrant sold an aggregate of 26,115,553 shares of its Series F convertible preferred stock to a total of three accredited investors at a purchase price of $0.7754 per share, for aggregate proceeds of approximately $20,250,000.

II-2

In March 2015, the Registrant sold an aggregate of 3,414,459 shares of its Series F convertible preferred stock to a total of eight accredited investors at a purchase price of $0.7754 per share, for aggregate proceeds of approximately $2,647,572.

Option and Common Stock Issuances

From April 30, 2012 through May 12, 2015, pursuant to the terms of its 2005 Stock Incentive Plan, the Registrant granted to its officers, directors, employees, consultants and other service providers options to purchase an aggregate of 27,074,340 shares of its common stock at exercise prices ranging from $0.12 to $0.86 per share.

From April 30, 2012 through May 12, 2015, pursuant to the terms of its 2005 Stock Incentive Plan, the Registrant issued and sold to its officers, directors, employees, consultants and other service providers an aggregate of 1,762,513 shares of its common stock upon the exercise of options at exercise prices ranging from $0.07 to $0.26 per share, for aggregate proceeds of approximately $172,072.

None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. The Registrant believes the offers, sales, and issuances of the above securities were exempt from registration under the Securities Act by virtue of Section 4(a)(2) of the Securities Act because the issuance of securities to the recipients did not involve a public offering or in reliance on Rule 701 because the transactions were pursuant to compensatory benefit plans or contracts relating to compensation as provided under such rule. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access, through their relationships with the Registrant, to information about the Registrant. The sales of these securities were made without any general solicitation or advertising.

Item 16.

Exhibits and Financial Statement Schedules.

(a) Exhibits.

We have filed the exhibits listed on the accompanying Exhibit Index of this registration statement.

(b) Financial Statement Schedules.

All financial statement schedules are omitted because the information called for is not required or is shown either in the financial statements or in the notes thereto.

Item 17.

Undertakings.

The undersigned Registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction

II-3

the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

The undersigned Registrant hereby undertakes that:

(1)

For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

(2)

For the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

II-4

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the Registrant has duly caused this registration statement on Form S-1 to be signed on its behalf by the undersigned, thereunto duly authorized, in San Francisco, California, on May 12, 2015.


Invuity, Inc.

By:		/s/ Philip Sawyer
		Philip Sawyer
		President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this registration statement on Form S-1 has been signed by the following persons in the capacities and on the dates indicated.


Signature	Title	Date

/s/ Philip Sawyer	President, Chief Executive Officer and Director (Principal Executive Officer)	May 12, 2015
Philip Sawyer		May 12, 2015

/s/ Michael Gandy	Chief Financial Officer (Principal Accounting and Financial Officer)	May 12, 2015
Michael Gandy

*	Director	May 12, 2015
Gregory B. Brown	Director

*	Director	May 12, 2015
Randall A. Lipps	Director

*	Director	May 12, 2015
Gregory T. Lucier	Director

*	Director	May 12, 2015
Eric W. Roberts	Director

*	Director	May 12, 2015
Reza Zadno	Director


By:		/s/ Michael Gandy
		Michael Gandy
		Attorney-in-fact

II-5

EXHIBIT INDEX


Exhibit Number		Exhibit Description
	1.1*	Form of Underwriting Agreement.

	3.1*	Amended and Restated Certificate of Incorporation of the Registrant as currently in effect.

	3.2*	Amended and Restated Certificate of Incorporation of the Registrant to be effective upon closing of the offering.

	3.3*	Bylaws of the Registrant as currently in effect.

	3.4*	Amended and Restated Bylaws of the Registrant to be effective upon closing of the offering.

	4.1*	Specimen Common Stock certificate of the Registrant.

	4.2**	Fourth Amended and Restated Investor Rights Agreement, dated February 6, 2015, as amended on March 4, 2015, by and among the Registrant and certain of its stockholders.

	4.3**	Warrant to purchase shares of Series B convertible preferred stock issued to Lighthouse Capital Partners VI, L.P., dated September 15, 2008.

	4.4**	Warrant to purchase shares of Series C convertible preferred stock issued to Silicon Valley Bank, dated December 17, 2010.

	4.5**	Warrant to purchase shares of Series D convertible preferred stock issued to Silicon Valley Bank, dated July 25, 2013.

	4.6**	Warrant to purchase shares of Series E convertible preferred stock issued to HealthCare Royalty Partners II, L.P., dated February 28, 2014.

	5.1*	Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.

	10.1*	Form of Indemnification Agreement for directors and executive officers.

	10.2	Invuity, Inc. 2005 Stock Incentive Plan and form of agreement thereunder, as currently in effect.

	10.3+	Executive Incentive Compensation Plan of the Registrant to be effective upon closing of the offering.

	10.4*	2015 Equity Incentive Plan and forms of agreements thereunder to be effective upon closing of the offering.

	10.5**	Lease, dated as of October 29, 2007, by and between the Registrant and Peter P. Tong, as amended on May 6, 2010, September 6, 2011 and November 10, 2012, and currently in effect. (Terminated)

	10.6**	Office Lease Agreement, dated May 9, 2014, by and between the Registrant and 444 De Haro VEF VI, LLC, as amended on November 7, 2014, and currently in effect.

	10.7**	Loan and Security Agreement, dated as of February 11, 2015, by and between the Registrant and Silicon Valley Bank.

	10.8**	Loan Agreement, dated as of February 28, 2014, by and between the Registrant and HealthCare Royalty Partners II, L.P.

	10.9*+	Executive Employment Agreement, dated , 2015, by and between the Registrant and Philip Sawyer.

	10.10*+	Executive Employment Agreement, dated , 2015, by and between the Registrant and Doug Heigel.

	10.11*+	Executive Employment Agreement, dated , 2015, by and between the Registrant and Paul O. Davison.


Exhibit Number		Exhibit Description

	23.1	Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm.

	23.2*	Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (included in Exhibit 5.1).

	24.1	Power of Attorney (included in page II-5 to the registration statement on Form S-1 filed on April 17, 2015).

*	To be filed by amendment.

**	Previously filed.

+	Indicates a management contract or compensatory plan or arrangement.

EX-10.2 2 d852944dex102.htm EX-10.2 EX-10.2

Exhibit 10.2

INVUITY, INC.

2005 STOCK INCENTIVE PLAN

Adopted by the Board on May 12, 2005

Approved by the Shareholders on May 12, 2005

As Amended August 24, 2006

As Amended August 6, 2007

As Amended June 16, 2010

As Amended June 3, 2012

As Amended February 12, 2014

As Amended February 3, 2015

As Re-Adopted by the Board on May 4, 2015

As Re-Approved by the Shareholders on May 6, 2015

TABLE OF CONTENTS


		Page
SECTION 1.	PURPOSE		1

SECTION 2.	DEFINITIONS		1

2.1	“Board”		1
2.2	“Change in Control”		1
2.3	“Code”		2
2.4	“Committee”		2
2.5	“Company”		2
2.6	“Consultant”		2
2.7	“Disability”		2
2.8	“Employee”		2
2.9	“Exchange Act”		2
2.10	“Exchange Program”		2
2.11	“Exercise Price”		2
2.12	“Fair Market Value”		2
2.13	“ISO”		2
2.14	“NSO”		2
2.15	“Option”		2
2.16	“Optionee”		2
2.17	“Outside Director”		3
2.18	“Parent”		3
2.19	“Plan”		3
2.20	“Purchase Price”		3
2.21	“Purchaser”		3
2.22	“Restricted Share Agreement”		3
2.23	“Securities Act”		3
2.24	“Service”		3
2.25	“Share”		3
2.26	“Stock”		3
2.27	“Stock Option Agreement”		3
2.28	“Subsidiary”		3
2.29	“Ten-Percent Shareholder”		4

SECTION 3.	ADMINISTRATION		4

3.1	General Rule		4
3.2	Board Authority and Responsibility		4

SECTION 4.	ELIGIBILITY		4

4.1	General Rule		4

SECTION 5.	STOCK SUBJECT TO PLAN		4

5.1	Share Limit		4
5.2	Additional Shares		4

-i-


SECTION 6.	RESTRICTED SHARES	5

6.1	Restricted Share Agreement	5
6.2	Duration of Offers and Nontransferability of Purchase Rights	5
6.3	Purchase Price	5
6.4	Repurchase Rights and Transfer Restrictions	5

SECTION 7.	STOCK OPTIONS	5

7.1	Stock Option Agreement	5
7.2	Number of Shares; Kind of Option	5
7.3	Exercise Price	5
7.4	Term	6
7.5	Exercisability	6
7.6	Repurchase Rights and Transfer Restrictions	6
7.7	Transferability of Options	7
7.8	Exercise of Options on Termination of Service	7
7.9	No Rights as a Shareholder	7
7.10	Modification, Extension and Renewal of Options	7

SECTION 8.	PAYMENT FOR SHARES	7

8.1	General	7
8.2	Surrender of Stock	8
8.3	Services Rendered	8
8.4	Promissory Notes	8
8.5	Exercise/Sale	8
8.6	Exercise/Pledge	8
8.7	Other Forms of Payment	8

SECTION 9.	ADJUSTMENT OF SHARES	8

9.1	General	8
9.2	Dissolution or Liquidation	9
9.3	Mergers and Consolidations	9
9.4	Reservation of Rights	9

SECTION 10.	REPURCHASE RIGHTS	9

10.1	Company’s Right To Repurchase Shares	9

SECTION 11.	WITHHOLDING TAXES	10

11.1	General	10
11.2	Share Withholding	10
11.3	Cashless Exercise/Pledge	10
11.4	Other Forms of Payment	10

SECTION 12.	SECURITIES LAW REQUIREMENTS	10

12.1	General	10
12.2	Voting and Dividend Rights	11
12.3	Financial Reports	11

-ii-


SECTION 13.	NO RETENTION RIGHTS	11

SECTION 14.	DURATION AND AMENDMENTS	11

14.1	Term of the Plan	11
14.2	Right to Amend or Terminate the Plan	11
14.3	Effect of Amendment or Termination	12

SECTION 15.	EXECUTION	12

-iii-

INVUITY, INC.

2005 STOCK INCENTIVE PLAN

SECTION 1. PURPOSE.

The Plan was adopted by the Board of Directors effective May 12, 2005. The Plan was re-adopted and extended by the Board of Directors effective May 4, 2015. The purpose of the Plan is to offer selected service providers the opportunity to acquire equity in the Company through awards of Options (which may constitute incentive stock options or nonstatutory stock options) and the award or sale of Shares.

The award of Options and the award or sale of Shares under the Plan is intended to be exempt from the securities qualification requirements of the California Corporations Code by satisfying the exemption under section 25102(o) of the California Corporations Code. However, awards of Options and the award or sale of Shares may be made in reliance upon other state securities law exemptions. To the extent that such other exemptions are relied upon, the terms of this Plan which are included only to comply with section 25102(o) shall be disregarded to the extent provided in the Stock Option Agreement or Restricted Share Agreement.

SECTION 2. DEFINITIONS.

2.1	“Board” shall mean the Board of Directors of the Company, as constituted from time to time.

2.2	“Change in Control” shall mean the occurrence of any of the following events:

(a)

The consummation of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, if persons who were not shareholders of the Company immediately prior to such merger, consolidation or other reorganization own immediately after such merger, consolidation or other reorganization fifty percent (50%) or more of the voting power of the outstanding securities of each of (A) the continuing or surviving entity and (B) any direct or indirect parent corporation of such continuing or surviving entity;

(b)

The consummation of the sale, transfer or other disposition of all or substantially all of the Company’s assets or the shareholders of the Company approve a plan of complete liquidation of the Company; or

(c)

Any “person” (as defined below) who, by the acquisition or aggregation of securities, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company’s then outstanding securities ordinarily (and apart from rights accruing under special circumstances) having the right to vote at elections of directors (the “Base Capital Stock”); except that any change in the relative beneficial ownership of the Company’s securities by any person resulting solely from a reduction in the aggregate number of outstanding shares of Base Capital Stock, and any decrease thereafter in such person’s ownership of securities, shall be disregarded until such person increases in any manner, directly or indirectly, such person’s beneficial ownership of any securities of the Company.

-1-

For purposes of Section 2.2(c), the term “person” shall have the same meaning as when used in sections 13(d) and 14(d) of the Exchange Act but shall exclude (1) a trustee or other fiduciary holding securities under an employee benefit plan maintained by the Company or a Parent or Subsidiary and (2) a corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of the Stock.

Notwithstanding the foregoing, the term “Change in Control” shall not include a transaction the sole purpose of which is (a) to change the state of the Company’s incorporation, (b) to form a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction; or (c) to make an initial public offering of the Company’s Stock.

2.3	“Code” shall mean the Internal Revenue Code of 1986, as amended.

2.4	“Committee” shall mean the committee designated by the Board, which is authorized to administer the Plan, as described in Section 3 hereof.

2.5	“Company” shall mean Invuity, Inc., a California corporation.

2.6	“Consultant” shall mean a consultant or advisor who is not an Employee or Outside Director and who performs bona fide services for the Company, a Parent or Subsidiary.

2.7	“Disability” shall mean a condition that renders an individual unable to engage in substantial gainful activity by reason of any medically determinable physical or mental impairment.

2.8	“Employee” shall mean any individual who is a common-law employee of the Company, a Parent or a Subsidiary and who is an “employee” within the meaning of section 3401(c) of the Code and regulations issued thereunder.

2.9	“Exchange Act” shall mean the U.S. Securities and Exchange Act of 1934, as amended.

2.10

“Exchange Program” means a program under which (i) outstanding Options or awards of Shares are surrendered or cancelled in exchange for awards of the same type (which may have higher or lower Exercise Prices and different terms), awards of a different type, and/or cash, (ii) holders of awards would have the opportunity to transfer any outstanding awards to a financial institution or other person or entity selected by the Board, and/or (iii) the Exercise Price of an outstanding Option is reduced or increased. The Board will determine the terms and conditions of any Exchange Program in its sole discretion.

2.11	“Exercise Price” shall mean the amount for which one Share may be purchased upon the exercise of an Option, as specified in a Stock Option Agreement.

2.12	“Fair Market Value” means, with respect to a Share, the market price of one Share of Stock, determined by the Board in good faith. Such determination shall be conclusive and binding on all persons.

2.13	“ISO” shall mean an incentive stock option described in section 422(b) of the Code.

2.14	“NSO” shall mean a stock option that is not an ISO.

2.15	“Option” shall mean an ISO or NSO granted under the Plan and entitling the holder to purchase Shares.

2.16	“Optionee” shall mean an individual or estate that holds an Option.

-2-

2.17	“Outside Director” shall mean a member of the Board of the Company, a Parent or a Subsidiary who is not an Employee.

2.18

“Parent” shall mean any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be considered a Parent commencing as of such date.

2.19	“Plan” shall mean the Invuity, Inc. 2005 Stock Incentive Plan.

2.20	“Purchase Price” shall mean the consideration for which one Share may be acquired under the Plan (other than upon exercise of an Option).

2.21	“Purchaser” shall mean a person to whom the Board has offered the right to acquire Shares under the Plan (other than upon exercise of an Option).

2.22	“Restricted Share Agreement” shall mean the agreement between the Company and a Purchaser who acquires Shares under the Plan that contains the terms, conditions and restrictions pertaining to the acquisition of such Shares.

2.23	“Securities Act” shall mean the U.S. Securities Act of 1933, as amended.

2.24

“Service” shall mean service as an Employee, a Consultant or an Outside Director, subject to such further limitations as may be set forth in the applicable Stock Option Agreement or Restricted Share Agreement. Service shall be deemed to continue during a bona fide leave of absence approved by the Company in writing if and to the extent that continued crediting of Service for purposes of the Plan is expressly required by the terms of such leave or by applicable law, as determined by the Company. However, for purposes of determining whether an Option is entitled to ISO status, and to the extent required under the Code, an Employee’s employment will be treated as terminating ninety (90) days after such Employee went on leave, unless such Employee’s right to return to active work is guaranteed by law or by a contract or such Employee immediately returns to active work. The Company determines which leaves count toward Service, and when Service terminates for all purposes under the Plan.

2.25	“Share” shall mean one share of Stock, as adjusted in accordance with Section 9 (if applicable).

2.26	“Stock” shall mean the common stock of the Company.

2.27	“Stock Option Agreement” shall mean the agreement between the Company and an Optionee which contains the terms, conditions and restrictions pertaining to the Optionee’s Option.

2.28

“Subsidiary” means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.

-3-

2.29

“Ten-Percent Shareholder” means an individual who owns more than ten percent (10%) of the total combined voting power of all classes of outstanding stock of the Company, its Parent or any of its Subsidiaries. In determining stock ownership for purposes of this Section 2.29, the attribution rules of section 424(d) of the Code shall be applied.

SECTION 3. ADMINISTRATION.

3.1

General Rule. The Plan shall be administered by the Board. However, the Board may delegate any or all administrative functions under the Plan otherwise exercisable by the Board to one or more Committees. Each Committee shall consist of at least two directors of the Board who have been appointed by the Board. Each Committee shall have the authority and be responsible for such functions as the Board has assigned to it. If a Committee has been appointed, any reference to the Board in the Plan shall be construed as a reference to the Committee to whom the Board has assigned a particular function.

3.2

Board Authority and Responsibility. Subject to the provisions of the Plan, the Board shall have full authority and discretion to take any actions it deems necessary or advisable for the administration of the Plan. All decisions, interpretations and any other actions of the Board with respect to the Plan shall be final and binding on all persons deriving rights under the Plan.

SECTION 4. ELIGIBILITY.

4.1	General Rule. Only Employees shall be eligible for the grant of ISOs. Only Employees, Consultants and Outside Directors shall be eligible for the grant of NSOs or the award or sale of Shares.

SECTION 5. STOCK SUBJECT TO PLAN.

5.1

Share Limit. Subject to Sections 5.2 and 9, the aggregate number of Shares which may be issued under the Plan shall not exceed 42,042,826 Shares. The number of Shares which are subject to Options or other rights outstanding at any time shall not exceed the number of Shares which then remain available for issuance under the Plan. The Company, during the term of the Plan, shall at all times reserve and keep available sufficient Shares to satisfy the requirements of the Plan. Shares offered under the Plan may be authorized but unissued Shares.

5.2

Additional Shares. In the event that any outstanding Option or other right expires or is canceled for any reason, the Shares allocable to the unexercised portion of such Option or other right shall remain available for issuance pursuant to the Plan. If a Share previously issued under the Plan is reacquired by the Company pursuant to a forfeiture provision, right of repurchase or right of first refusal, then such Share shall again become available for issuance under the Plan.

-4-

SECTION 6. RESTRICTED SHARES.

6.1

Restricted Share Agreement. Each award or sale of Shares under the Plan (other than upon exercise of an Option) shall be evidenced by a Restricted Share Agreement between the Purchaser and the Company. Such award or sale shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions imposed by the Board, as set forth in the Restricted Share Agreement, that are not inconsistent with the Plan. The provisions of the various Restricted Share Agreements entered into under the Plan need not be identical.

6.2

Duration of Offers and Nontransferability of Purchase Rights. Any right to acquire Shares (other than an Option) shall automatically expire if not exercised by the Purchaser within thirty (30) days after the Company communicates the grant of such right to the Purchaser. Such right shall be nontransferable and shall be exercisable only by the Purchaser to whom the right was granted.

6.3

Purchase Price. The Purchase Price of Shares offered under the Plan shall not be less than eighty-five percent (85%) of the Fair Market Value of such Shares; provided, however, if the Purchaser is a Ten-Percent Shareholder, the Purchase Price shall not be less than one hundred percent (100%) of the Fair Market Value of such Shares. Subject to the foregoing in this Section 6.3, the Board shall determine the amount of the Purchase Price in its sole discretion. The Purchase Price shall be payable in a form described in Section 8. The Board may also implement an Exchange Program with respect to Shares awarded or sold under the Plan.

6.4

Repurchase Rights and Transfer Restrictions. Each award or sale of Shares shall be subject to such forfeiture conditions, rights of repurchase, rights of first refusal and other transfer restrictions as the Board may determine, subject to the requirements of Section 10. Such restrictions shall be set forth in the applicable Restricted Share Agreement and shall apply in addition to any restrictions otherwise applicable to holders of Shares generally.

SECTION 7. STOCK OPTIONS.

7.1

Stock Option Agreement. Each grant of an Option under the Plan shall be evidenced by a Stock Option Agreement between the Optionee and the Company. The Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions imposed by the Board, as set forth in the Stock Option Agreement, which are not inconsistent with the Plan. The provisions of the various Stock Option Agreements entered into under the Plan need not be identical.

7.2

Number of Shares; Kind of Option. Each Stock Option Agreement shall specify the number of Shares that are subject to the Option and shall provide for the adjustment of such number in accordance with Section 9. The Stock Option Agreement shall also specify whether the Option is intended to be an ISO or an NSO.

7.3	Exercise Price. Each Stock Option Agreement shall set forth the Exercise Price, which shall be payable in a form described in Section 8. Subject to the following requirements, the Exercise Price under any Option shall be determined by the Board in its sole discretion:

-5-

(a)

Minimum Exercise Price for ISOs. The Exercise Price per Share of an ISO shall not be less than one hundred percent (100%) of the Fair Market Value of a Share on the date of grant; provided, however, that the Exercise Price per Share of an ISO granted to a Ten-Percent Shareholder shall not be less than one hundred ten percent (110%) of the Fair Market Value of a Share on the date of grant.

(b)

Minimum Exercise Price for NSOs. The Exercise Price per Share of an NSO shall not be less than eighty-five percent (85%) of the Fair Market Value of a Share on the date of grant; provided, however, that the Exercise Price per Share of an NSO granted to a Ten-Percent Shareholder shall not be less than one hundred ten percent (110%) of the Fair Market Value of a Share on the date of grant.

7.4

Term. Each Stock Option Agreement shall specify the term of the Option. The term of an Option shall in no event exceed ten (10) years from the date of grant. The term of an ISO granted to a Ten-Percent Shareholder shall not exceed five (5) years from the date of grant. Subject to the foregoing, the Board in its sole discretion shall determine when an Option shall expire.

7.5

Exercisability. Each Stock Option Agreement shall specify the date when all or any installment of the Option is to become exercisable; provided, however, that no Option shall be exercisable unless the Optionee has delivered to the Company an executed copy of the Stock Option Agreement. Subject to the following restrictions, the Board in its sole discretion shall determine when all or any installment of an Option is to become exercisable and may, in its discretion, provide for accelerated exercisability in the event of a Change in Control or other events:

(a)

Options Granted to Employees. An Option granted to an Optionee who is not a Consultant or an officer or director of the Company, a Parent or a Subsidiary shall be exercisable at the minimum rate of twenty percent (20%) per year for each of the first five (5) years starting from the date of grant, subject to reasonable conditions such as continued Service.

(b)

Options Granted to Outside Directors, Consultants or Officers. An Option granted to an Optionee who is a Consultant or an officer or director of the Company, a Parent or a Subsidiary shall be exercisable at any time or during any period established by the Board, subject to reasonable conditions such as continued Service; provided, however, that the exercisability of an Option granted to an Optionee for service as an Outside Director shall be automatically accelerated in full in the event of a Change in Control.

(c)

Early Exercise. A Stock Option Agreement may permit the Optionee to exercise the Option as to Shares that are subject to a right of repurchase by the Company in accordance with the requirements of Section 10.1.

7.6

Repurchase Rights and Transfer Restrictions. Shares purchased on exercise of Options shall be subject to such forfeiture conditions, rights of repurchase, rights of first refusal and other transfer restrictions as the Board may determine, subject to the requirements of Section 10. Such restrictions shall be set forth in the applicable Stock Option Agreement and shall apply in addition to any restrictions otherwise applicable to holders of Shares generally.

-6-

7.7

Transferability of Options. During an Optionee’s lifetime, his or her Options shall be exercisable only by the Optionee or by the Optionee’s guardian or legal representatives, and shall not be transferable other than by beneficiary designation, will or the laws of descent and distribution. Notwithstanding the foregoing, however, to the extent permitted by the Board in its sole discretion, an NSO may be transferred by the Optionee to one or more family members or a trust established for the benefit of the Optionee and/or one or more family members to the extent permitted by section 260.140.41(d) of Title 10 of the California Code of Regulations and Rule 701 of the Securities Act.

7.8

Exercise of Options on Termination of Service. Each Option shall set forth the extent to which the Optionee shall have the right to exercise the Option following termination of the Optionee’s Service. Each Stock Option Agreement shall provide the Optionee with the right to exercise the Option following the Optionee’s termination of Service during the Option term, to the extent the Option was exercisable for vested Shares upon termination of Service, for at least thirty (30) days if termination of Service is due to any reason other than cause, death or Disability, and for at least six (6) months after termination of Service if due to death or Disability (but in no event later than the expiration of the Option term). If the Optionee’s Service is terminated for cause, the Stock Option Agreement may provide that the Optionee’s right to exercise the Option terminates immediately on the effective date of the Optionee’s termination. To the extent the Option was not exercisable for vested Shares upon termination of Service, the Option shall terminate when the Optionee’s Service terminates. Subject to the foregoing, such provisions shall be determined in the sole discretion of the Board, need not be uniform among all Options issued pursuant to the Plan, and may reflect distinctions based on the reasons for termination of Service.

7.9

No Rights as a Shareholder. An Optionee, or a transferee of an Optionee, shall have no rights as a shareholder with respect to any Shares covered by the Option until such person becomes entitled to receive such Shares by filing a notice of exercise and paying the Exercise Price pursuant to the terms of the Option. No adjustments shall be made, except as provided in Section 9.

7.10

Modification, Extension and Renewal of Options. Within the limitations of the Plan, the Board may modify, extend or renew outstanding Options or may accept the cancellation of outstanding Options (to the extent not previously exercised), whether or not granted hereunder, in return for the grant of new Options for the same or a different number of Shares and at the same or a different Exercise Price, or may implement an Exchange Program with respect to Options. The foregoing notwithstanding, no modification of an Option shall, without the consent of the Optionee, impair his or her rights or increase the Optionee’s obligations under such Option.

SECTION 8. PAYMENT FOR SHARES.

8.1	General. The entire Purchase Price or Exercise Price of Shares issued under the Plan shall be payable in cash, cash equivalents or one of the other forms provided in this Section 8.

-7-

8.2

Surrender of Stock. To the extent permitted by the Board in its sole discretion, payment may be made in whole or in part by surrendering, or attesting to ownership of, Shares which have already been owned by the Optionee; provided, however, that payment may not be made in such form if such action would cause the Company to recognize any (or additional) compensation expense with respect to the Option for financial reporting purposes. Such Shares shall be surrendered to the Company in good form for transfer and shall be valued at their Fair Market Value on the date of Option exercise.

8.3	Services Rendered. As determined by the Board in its discretion, Shares may be awarded under the Plan in consideration of past services rendered to the Company, a Parent or Subsidiary.

8.4

Promissory Notes. To the extent permitted by the Board in its sole discretion, payment may be made in whole or in part with a full-recourse promissory note executed by the Optionee or Purchaser. The interest rate payable under the promissory note shall not be less than the minimum rate required to avoid the imputation of income for U.S. federal income tax purposes. Shares shall be pledged as security for payment of the principal amount of the promissory note, and interest thereon; provided that if the Optionee or Purchaser is a Consultant, such note must be collateralized with such additional security to the extent required by applicable laws. In no event shall the stock certificate(s) representing such Shares be released to the Optionee or Purchaser until such note is paid in full. Subject to the foregoing, the Board shall determine the term, interest rate and other provisions of the note.

8.5

Exercise/Sale. To the extent permitted by the Board in its sole discretion, and if a public market for the Shares exists, payment may be made in whole or in part by delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker approved by the Company to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of all or part of the Exercise Price and any withholding taxes.

8.6

Exercise/Pledge. To the extent permitted by the Board in its sole discretion, and if a public market for the Shares exists, payment may be made in whole or in part by delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker or lender approved by the Company to pledge Shares, as security for a loan, and to deliver all or part of the loan proceeds to the Company in payment of all or part of the Exercise Price and any withholding taxes.

8.7	Other Forms of Payment. To the extent permitted by the Board in its sole discretion, payment may be made in any other form that is consistent with applicable laws, regulations and rules.

SECTION 9. ADJUSTMENT OF SHARES.

9.1

General. In the event of a subdivision of the outstanding Stock, a declaration of a dividend payable in Shares, a declaration of an extraordinary dividend payable in a form other than Shares in an amount that has a material effect on the Fair Market Value of the Stock, a combination or consolidation of the outstanding Stock into a lesser number of Shares, a recapitalization, a spin-off, a reclassification, or a similar occurrence, the Board shall make appropriate adjustments to one or more of the following: (i) the number of Shares available for future awards under Section 5; (ii) the number of Shares covered by each outstanding Option; (iii) the Exercise Price under each outstanding Option; or (iv) the price of Shares subject to the Company’s right of repurchase.

-8-

9.2	Dissolution or Liquidation. To the extent not previously exercised or settled, Options shall terminate immediately prior to the dissolution or liquidation of the Company.

9.3

Mergers and Consolidations. In the event that the Company is a party to a merger or other consolidation, or in the event of a transaction providing for the sale of all or substantially all of the Company’s stock or assets, outstanding Options shall be subject to the agreement of merger, consolidation or sale. Such agreement may provide for one or more of the following: (i) the continuation of the outstanding Options by the Company, if the Company is a surviving corporation; (ii) the assumption of the Plan and outstanding Options by the surviving corporation or its parent; (iii) the substitution by the surviving corporation or its parent of options with substantially the same terms for such outstanding Options; (iv) immediate exercisability of such outstanding Options followed by the cancellation of such Options; or (v) settlement of the full value of the outstanding Options (whether or not then exercisable) in cash or cash equivalents followed by the cancellation of such Options; in each case without the Optionee’s consent.

9.4

Reservation of Rights. Except as provided in this Section 9, an Optionee or offeree shall have no rights by reason of any subdivision or consolidation of shares of stock of any class, the payment of any dividend or any other increase or decrease in the number of shares of stock of any class. Any issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or Exercise Price of Shares subject to an Option. The grant of an Option pursuant to the Plan shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure, to merge or consolidate or to dissolve, liquidate, sell or transfer all or any part of its business or assets.

SECTION 10. REPURCHASE RIGHTS.

10.1

Company’s Right To Repurchase Shares. The Company shall have the right to repurchase Shares that have been acquired through an award or sale of Shares or exercise of an Option upon termination of the Purchaser’s or Optionee’s Service if provided in the applicable Restricted Share Agreement or Stock Option Agreement. Subject to the following restrictions, the Board in its sole discretion shall determine when the right to repurchase shall lapse as to all or any portion of the Shares, and may, in its discretion, provide for accelerated vesting in the event of a Change in Control or other events; provided, however, that the right to repurchase shall lapse as to all of the Shares issued to an Outside Director for service as an Outside Director in the event of a Change in Control. The following restrictions shall apply in the case of a Purchaser or Optionee who is not a Consultant or an officer or director of the Company, a Parent or Subsidiary:

-9-

(a)

Repurchase Price. If the Company retains a right to repurchase the Shares at not less than the Fair Market Value of the Shares on the date that the Purchaser’s Service terminates, then such repurchase right shall terminate when the Company’s Stock becomes publicly traded. If the Company retains a right to repurchase the Shares at the original Purchase Price or Exercise Price, then such repurchase right shall lapse at the minimum rate of twenty percent (20%) per year over the five (5) year period starting on the date of the award or sale of Shares or grant of the Option.

(b)

Exercise of Repurchase Right. The Company’s right of repurchase under this Section 10.1 may be exercised only within ninety (90) days of the date on which the Purchaser’s or Optionee’s Service terminates or, if the Optionee acquired the Shares upon exercise of an Option after the date of termination, within ninety (90) days from the date of exercise.

(c)

Payment of Repurchase Price. The Company shall pay the repurchase price in cash, cash equivalents or for cancellation of indebtedness incurred in purchasing the Shares.

SECTION 11. WITHHOLDING TAXES.

11.1

General. An Optionee or Purchaser or his or her successor shall pay, or make arrangements satisfactory to the Board for the satisfaction of, any federal, state, local or foreign withholding tax obligations that may arise in connection with the Plan. The Company shall not be required to issue any Shares or make any cash payment under the Plan until such obligations are satisfied.

11.2

Share Withholding. The Board may permit an Optionee or Purchaser to satisfy all or part of his or her withholding or income tax obligations by having the Company withhold all or a portion of any Shares that otherwise would be issued to him or her or by surrendering all or a portion of any Shares that he or she previously acquired; provided, however, that in no event may an Optionee or Purchaser surrender Shares in excess of the legally required withholding amount. Such Shares shall be valued at their Fair Market Value on the date when taxes otherwise would be withheld in cash. Any payment of taxes by assigning Shares to the Company may be subject to restrictions, including any restrictions required by rules of any federal or state regulatory body or other authority.

11.3	Cashless Exercise/Pledge. The Board may provide that if Company Shares are publicly traded at the time of exercise, arrangements may be made to meet the Optionee’s or Purchaser’s withholding obligation by cashless exercise or pledge.

11.4 Other Forms of Payment. The Board may permit such other means of tax withholding as it deems appropriate.

SECTION 12. SECURITIES LAW REQUIREMENTS.

12.1

General. Shares shall not be issued under the Plan unless the issuance and delivery of such Shares complies with (or is exempt from) all applicable requirements of law, including (without limitation) the Securities Act, the rules and regulations promulgated thereunder, state securities laws and regulations, and the regulations of any stock exchange or other securities market on which the Company’s securities may then be listed.

-10-

12.2

Voting and Dividend Rights. The holders of Shares acquired under the Plan shall have the same voting, dividend and other rights as the Company’s other shareholders. A Restricted Share Agreement, however, may require that the holders of Shares invest any cash dividends received in additional Shares. Such additional Shares shall be subject to the same conditions and restrictions as the award with respect to which the dividends were paid.

12.3

Financial Reports. At least annually, the Company shall furnish its financial statements, including a balance sheet regarding the Company’s financial condition and results of operations, to Optionees, Purchasers and shareholders who have received Shares under the Plan, unless such persons are key employees whose duties at the Company assure them access to equivalent information. Financial statements need not be audited.

SECTION 13. NO RETENTION RIGHTS.

No provision of the Plan, or any right or Option granted under the Plan, shall be construed to give any Optionee or Purchaser any right to become an Employee, to be treated as an Employee, or to continue in Service for any period of time, or restrict in any way the rights of the Company (or Parent or subsidiary to whom the Optionee or Purchaser provides Service), which rights are expressly reserved, to terminate the Service of such person at any time and for any reason, with or without cause, without thereby incurring any liability to him or her.

SECTION 14. DURATION AND AMENDMENTS.

14.1

Term of the Plan. The Plan, as set forth herein, shall become effective on the date of its adoption by the Board, subject to the approval of the Company’s shareholders. In the event that the shareholders fail to approve the Plan within twelve (12) months after its adoption by the Board, any grants, exercises or sales that have already occurred under the Plan shall be rescinded, and no additional grants, exercises or sales shall be made under the Plan after such date. The Plan shall terminate automatically ten (10) years after its adoption by the Board. The Plan may be terminated on any earlier date pursuant to Section 14.2 below.

14.2

Right to Amend or Terminate the Plan. The Board may amend, suspend, or terminate the Plan at any time and for any reason. An amendment of the Plan shall not be subject to the approval of the Company’s shareholders unless it (i) increases the number of Shares available for issuance under the Plan (except as provided in Section 9) or (ii) materially changes the class of persons who are eligible for the grant of Options or the award or sale of Shares. At least two-thirds (2/3) of the Company’s Shares entitled to vote must affirmatively approve an increase in the number of Shares available for issuance if the total number of Shares that may be issued upon the exercise of all outstanding Options and the total number of Shares provided under any stock bonus or similar plan of the Company exceed thirty percent (30%) of all outstanding Shares of the Company.

-11-

14.3

Effect of Amendment or Termination. No Shares shall be issued or sold under the Plan after the termination thereof, except upon exercise of an Option granted prior to such termination. The termination of the Plan, or any amendment thereof, shall not adversely affect any Shares previously issued or any Option previously granted under the Plan without the holder’s consent.

SECTION 15. EXECUTION.

To record the adoption of the Plan by the Board on May 12, 2005, effective on such date, the Company has caused its authorized officer to execute the same.


INVUITY, INC.

By

Its

-12-

Early Exercise

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR FOREIGN JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF U.S. FEDERAL AND STATE AND APPLICABLE FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER U.S. FEDERAL AND STATE AND APPLICABLE FOREIGN SECURITIES LAWS IS NOT REQUIRED.

INVUITY, INC.

2005 STOCK INCENTIVE PLAN

NOTICE OF STOCK OPTION GRANT

Invuity, Inc. (the “Company”) hereby grants you the following Option to purchase shares of its common stock (“Shares”). The terms and conditions of this Option are set forth in the Stock Option Agreement and the Invuity, Inc. 2005 Stock Incentive Plan (the “Plan”), both of which are attached to and made a part of this document.


Date of Grant:		«Grant_Date»

Name of Optionee:		«Name»

Number of Option Shares:		«No_Shares»

Exercise Price per Share:		«Exer_Price»

Vesting Start Date:		«VCD»

Type of Option:		«Grant_Type»

Vesting Schedule:		«Vesting»

By signing this document, you acknowledge receipt of a copy of the Plan, and agree that (a) you have carefully read, fully understand and agree to all of the terms and conditions described in the attached Stock Option Agreement, the Plan document and “Notice of Exercise and Common Stock Purchase Agreement” (the “Exercise Notice”); (b) you hereby make the purchaser’s investment representations contained in the Exercise Notice with respect to the grant of this Option; (c) you understand and agree that this Stock Option

INVUITY, INC.

NOTICE OF STOCK OPTION GRANT

-1-

Agreement, including its cover sheet and attachments, constitutes the entire understanding between you and the Company regarding this Option, and that any prior agreements, commitments or negotiations concerning this Option are replaced and superseded; and (d) you have been given an opportunity to consult your own legal and tax counsel with respect to all matters relating to this Option prior to signing this cover sheet and that you have either consulted such counsel or voluntarily declined to consult such counsel.


«Name»				INVUITY, INC.
				By: Brett Robertson
				Its: VP Corporate Development

INVUITY, INC.

NOTICE OF STOCK OPTION GRANT

-2-

INVUITY, INC.

2005 STOCK INCENTIVE PLAN

STOCK OPTION AGREEMENT

SECTION 1. KIND OF OPTION.

This Option is intended to be either an incentive stock option intended to meet the requirements of section 422 of the Internal Revenue Code (an “ISO”) or a non-statutory option (an “NSO”), which is not intended to meet the requirements of an ISO, as indicated in the Notice of Stock Option Grant. Even if this Option is designated as an ISO, it shall be deemed to be an NSO to the extent required by the $100,000 annual limitation under Section 422(d) of the Code.

SECTION 2. VESTING.

Subject to the terms and conditions of the Plan and this Stock Option Agreement (the “Agreement”), your Option and the Shares shall vest in accordance with the schedule set forth in the Notice of Stock Option Grant. If your Option is granted in consideration of your Service as an Employee or a Consultant, after your Service as an Employee or a Consultant terminates for any reason, vesting of your Shares subject to such Option immediately stops and such Option expires immediately as to the number of Shares that are not vested as of the date your Service as an Employee or a Consultant terminates. If your Option is granted in consideration of your Service as an Outside Director, after your Service as an Outside Director terminates for any reason, vesting of your Shares subject to such Option immediately stops and such Option expires immediately as to the number of Shares that are not vested as of the date your Service as an Outside Director terminates.

SECTION 3. TERM.

Your Option will expire in any event at the close of business at Company headquarters on the date that is ten (10) years after the Date of Grant; provided, however, that if your Option is an ISO it will expire five (5) years after the Date of Grant if you are a Ten-Percent Shareholder of the Company (the “Expiration Date”). Also, your Option will expire earlier if your Service terminates, as described below.

SECTION 4. REGULAR TERMINATION.

(a)

If your Service terminates for any reason except death or Disability, the vested portion of your Option will expire at the close of business at Company headquarters on the date three (3) months after your termination of Service. During that three (3) month period, you may exercise the portion of your Option that was vested on your termination date. Notwithstanding the foregoing, the Option may not be exercised after the Expiration Date determined under Section 3 above.

(b)

If your Option is an ISO and you exercise it more than three months after termination of your Service as an Employee for any reason other than death or Disability expected to result in death or to last for a continuous period of at least twelve (12) months, your Option will cease to be eligible for ISO tax treatment.

INVUITY, INC.

STOCK OPTION AGREEMENT

-1-

(c)

Your Option will cease to be eligible for ISO tax treatment if you exercise it more than three months after the 90th day of a bona fide leave of absence approved by the Company, unless you return to employment immediately upon termination of such leave or your right to reemployment after your leave was guaranteed by statute or contract.

SECTION 5. DEATH.

If you die while in Service with the Company, the vested portion of your Option will expire at the close of business at Company headquarters on the date twelve (12) months after the date of your death. During that twelve (12) month period, your estate, legatees or heirs may exercise that portion of your Option that was vested on the date of your death. Notwithstanding the foregoing, the Option may not be exercised after the Expiration Date determined under Section 3 above.

SECTION 6. DISABILITY.

(a)

If your Service terminates because of a Disability, the vested portion of your Option will expire at the close of business at Company headquarters on the date twelve (12) months after your termination date. During that twelve (12) month period, you may exercise that portion of your Option that was vested on the date of your Disability. “Disability” means that you are unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment. Notwithstanding the foregoing, the Option may not be exercised after the Expiration Date determined under Section 3 above.

(b)

If your Option is an ISO and your Disability is not expected to result in death or to last for a continuous period of at least twelve (12) months, your Option will be eligible for ISO tax treatment only if it is exercised within three (3) months following the termination of your Service as an Employee.

SECTION 7. EXERCISING YOUR OPTION.

To exercise your Option, you must execute the Notice of Exercise and Common Stock Purchase Agreement (the “Exercise Notice”), attached as Exhibit A. You must submit this form, together with full payment, to the Company. Your exercise will be effective when it is received by the Company. If you exercise your Option prior to vesting as provided in Section 8, you must also sign an Assignment Separate from Certificate attached as Exhibit C. If someone else wants to exercise your Option after your death, that person must prove to the Company’s satisfaction that he or she is entitled to do so.

INVUITY, INC.

STOCK OPTION AGREEMENT

-2-

SECTION 8. EXERCISE OF OPTION BEFORE VESTING.

If you wish, you may exercise your Option before it is vested (“Early Exercise”). The Company may in its sole and absolute discretion prohibit you from undertaking an Early Exercise at any time prior to the expiration of six (6) months from the Date of Grant. Your Option Shares will be subject to a repurchase right which shall lapse according to the same vesting schedule applicable had you not exercised your Option. The repurchase right allows the Company to repurchase the unvested Shares for the Exercise Price. If you exercise this Option before it is vested, you should consider making an election under Section 83(b) of the Internal Revenue Code (the “83(b) Election”), a form of which can be found on page E-3 of Exhibit E. Please review the document entitled “U.S. Federal Tax Information” attached as Exhibit F. A general explanation of Early Exercise can be found on page F-3 of Exhibit F. The 83(b) Election must be filed within thirty (30) days after the date you exercise all or any portion of your Option in which you are not vested.

YOU SHOULD CONSULT A TAX AND/OR FINANCIAL ADVISOR BEFORE EXERCISING PRIOR TO VESTING.

SECTION 9. PAYMENT FORMS.

When you exercise your Option, you must include payment of the Exercise Price for the Shares you are purchasing in cash or cash equivalents. Alternatively, you may pay all or part of the Exercise Price by surrendering, or attesting to ownership of, Shares already owned by you, unless such action would cause the Company to recognize any (or additional) compensation expense with respect to the Option for financial reporting purposes. Such Shares shall be surrendered to the Company in good form for transfer and shall be valued at their Fair Market Value on the date of Option exercise. To the extent that a public market for the Shares exists and to the extent permitted by applicable law, in each case as determined by the Company, you also may exercise your Option by delivery (on a form prescribed by the Company) of an irrevocable direction to a securities broker to sell Shares and to deliver all or part of the sale proceeds to the Company in payment of the aggregate Exercise Price and, if requested, applicable withholding taxes. The Company will provide the forms necessary to make such a cashless exercise. The Board may permit such other payment forms as it deems appropriate, subject to applicable laws, regulations and rules.

SECTION 10. TAX WITHHOLDING AND REPORTING.

(a)

You will not be allowed to exercise this Option unless you pay, or make acceptable arrangements to pay, any taxes required to be withheld as a result of the Option exercise or the sale of Shares acquired upon exercise of this Option. You hereby authorize withholding from payroll or any other payment due you from the Company or your employer to satisfy any such withholding tax obligation.

(b)

If you sell or otherwise dispose of any of the Shares acquired pursuant to an ISO on or before the later of (i) two years after the grant date, or (ii) one year after the exercise date, you shall immediately notify the Company in writing of such disposition.

INVUITY, INC.

STOCK OPTION AGREEMENT

-3-

SECTION 11. RIGHT OF FIRST REFUSAL.

In the event that you propose to sell, pledge or otherwise transfer to a third party any Shares acquired under this Agreement, or any interest in such Shares, the Company shall have a “Right of First Refusal” with respect to such Shares in accordance with the provisions of the Exercise Notice.

SECTION 12. RESALE RESTRICTIONS/MARKET STAND-OFF.

In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the U.S. Securities Act of 1933, as amended, including the Company’s initial public offering, you may be prohibited from engaging in any transaction with respect to any of the Company’s common stock without the prior written consent of the Company or its underwriters in accordance with the provisions of the Exercise Notice.

SECTION 13. TRANSFER OF OPTION.

Prior to your death, only you may exercise this Option. This Option and the rights and privileges conferred hereby cannot be sold, pledged or otherwise transferred (whether by operation of law or otherwise) and shall not be subject to sale under execution, attachment, levy or similar process. For instance, you may not sell this Option or use it as security for a loan. If you attempt to do any of these things, this Option will immediately become invalid. You may, however, dispose of this Option in your will. Regardless of any marital property settlement agreement, the Company is not obligated to honor an Exercise Notice from your spouse or former spouse, nor is the Company obligated to recognize such individual’s interest in your Option in any other way. Notwithstanding the foregoing, however, to the extent permitted by the Board in its sole discretion, an NSO may be transferred by you to one or more family members or to a trust established for your benefit and/or one or more of your family members to the extent permitted by the Plan.

SECTION 14. RETENTION RIGHTS.

This Agreement does not give you the right to be retained by the Company in any capacity. The Company reserves the right to terminate your Service at any time and for any reason without thereby incurring any liability to you.

SECTION 15. SHAREHOLDER RIGHTS.

Neither you nor your estate or heirs have any rights as a shareholder of the Company until a certificate for the Shares acquired upon exercise of this Option has been issued. No adjustments are made for dividends or other rights if the applicable record date occurs before your stock certificate is issued, except as described in the Plan.

SECTION 16. ADJUSTMENTS.

In the event of a stock split, a stock dividend or a similar change in the Company’s Stock, the number of Shares covered by this Option and the Exercise Price per share shall be adjusted pursuant to the Plan. Your Option shall be subject to the terms of the agreement of merger, liquidation or reorganization in the event the Company is subject to such corporate activity as set forth in the Plan.

INVUITY, INC.

STOCK OPTION AGREEMENT

-4-

SECTION 17. LEGENDS.

All certificates representing the Shares issued upon exercise of this Option shall, where applicable, have endorsed thereon the following legends:

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF U.S. FEDERAL, STATE AND FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER U.S. FEDERAL, STATE AND FOREIGN SECURITIES LAWS IS NOT REQUIRED.

THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, TRANSFERRED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE TERMS OF A WRITTEN AGREEMENT BETWEEN THE COMPANY AND THE INITIAL HOLDER HEREOF. SUCH AGREEMENT PROVIDES FOR CERTAIN TRANSFER RESTRICTIONS, INCLUDING RIGHTS OF FIRST REFUSAL UPON AN ATTEMPTED TRANSFER OF THE SECURITIES AND CERTAIN REPURCHASE RIGHTS IN FAVOR OF THE COMPANY. THE SECRETARY OF THE COMPANY WILL UPON WRITTEN REQUEST FURNISH A COPY OF SUCH AGREEMENT TO THE HOLDER HEREOF WITHOUT CHARGE.

If the Option is an ISO, then the following legend should be included:

THE SHARES REPRESENTED BY THIS CERTIFICATE WERE ISSUED UPON EXERCISE OF AN INCENTIVE STOCK OPTION, AND THE COMPANY MUST BE NOTIFIED IF THE SHARES SHALL BE TRANSFERRED BEFORE THE LATER OF THE TWO (2) YEAR ANNIVERSARY OF THE DATE OF GRANT OF THE OPTION OR THE ONE (1) YEAR ANNIVERSARY OF THE DATE ON WHICH THE OPTION WAS EXERCISED. THE REGISTERED HOLDER MAY RECOGNIZE ORDINARY INCOME IF THE SHARES ARE TRANSFERRED BEFORE SUCH DATE.

SECTION 18. TAX DISCLAIMER.

You agree that you are responsible for consulting your own tax advisor as to the tax consequences associated with your Option. The tax rules governing options are complex, change frequently and depend on the individual taxpayer’s situation. For your information, a memorandum that briefly summarizes current U.S. federal income tax law relating to certain

INVUITY, INC.

STOCK OPTION AGREEMENT

-5-

aspects of stock options is attached hereto as Exhibit F. Please note that this memorandum does not purport to be complete. Although the Company will make available to you general tax information about stock options, you agree that the Company shall not be held liable or responsible for making such information available to you and any tax or financial consequences that you may incur in connection with your Option.

In addition, as noted in Exhibit F, options granted at a discount from fair market value may be considered “deferred compensation” subject to adverse tax consequences under Section 409A of the Internal Revenue Code, which is generally effective January 1, 2005. The Board has made a good faith determination that the exercise price per share of the Option is not less than the fair market value of the Shares underlying your Option on the Date of Grant. It is possible, however, that the Internal Revenue Service could later challenge that determination and assert that the fair market value of the Shares underlying your Option was greater on the Date of Grant than the exercise price determined by the Board, which could result in immediate income tax upon the vesting of your Option (whether or not exercised) and a 20% tax penalty, as well as the loss of incentive stock option status (if applicable). The Company gives no assurance that such adverse tax consequences will not occur and specifically assumes no responsibility therefor. By accepting this Option, you acknowledge that any tax liability or other adverse tax consequences to you resulting from the grant of the Option will be the responsibility of, and will be borne entirely by, you. YOU ARE THEREFORE ENCOURAGED TO CONSULT YOUR OWN TAX ADVISOR BEFORE ACCEPTING THE GRANT OF THIS OPTION.

SECTION 19. THE PLAN AND OTHER AGREEMENTS.

The text of the Plan is incorporated in this Agreement by reference. Certain capitalized terms used in this Agreement are defined in the Plan. The Notice of Stock Option Grant, this Agreement, including its attachments, and the Plan constitute the entire understanding between you and the Company regarding this Option. Any prior agreements, commitments or negotiations concerning this Option are superseded.

SECTION 20. MISCELLANEOUS PROVISIONS.

(a)

You understand and acknowledge that (i) the Plan is entirely discretionary, (ii) the Company and your employer have reserved the right to amend, suspend or terminate the Plan at any time, (iii) the grant of an option does not in any way create any contractual or other right to receive additional grants of options (or benefits in lieu of options) at any time or in any amount and (iv) all determinations with respect to any additional grants, including (without limitation) the times when options will be granted, the number of Shares offered, the Exercise Price and the vesting schedule, will be at the sole discretion of the Company.

(b)

The value of this Option shall be an extraordinary item of compensation outside the scope of your employment contract, if any, and shall not be considered a part of your normal or expected compensation for purposes of calculating severance, resignation, redundancy or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.

INVUITY, INC.

STOCK OPTION AGREEMENT

-6-

(c)

You understand and acknowledge that participation in the Plan ceases upon termination of your Service for any reason, except as may explicitly be provided otherwise in the Plan or this Agreement.

(d)

You hereby authorize and direct your employer to disclose to the Company or any Subsidiary any information regarding your employment, the nature and amount of the your compensation and the fact and conditions of your participation in the Plan, as your employer deems necessary or appropriate to facilitate the administration of the Plan.

(e)

You consent to the collection, use and transfer of personal data as described in this Subsection. You understand and acknowledge that the Company, your employer and the Company’s other Subsidiaries hold certain personal information regarding you for the purpose of managing and administering the Plan, including (without limitation) your name, home address, telephone number, date of birth, social insurance number, salary, nationality, job title, any Shares or directorships held in the Company and details of all options or any other entitlements to Shares awarded, canceled, exercised, vested, unvested or outstanding in the your favor (the “Data”). You further understand and acknowledge that the Company and/or its Subsidiaries will transfer Data among themselves as necessary for the purpose of implementation, administration and management of your participation in the Plan and that the Company and/or any Subsidiary may each further transfer Data to any third party assisting the Company in the implementation, administration and management of the Plan. You understand and acknowledge that the recipients of Data may be located in the United States or elsewhere. You authorize such recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purpose of administering your participation in the Plan, including a transfer to any broker or other third party with whom you elect to deposit Shares acquired under the Plan of such Data as may be required for the administration of the Plan and/or the subsequent holding of Shares on your behalf. You may, at any time, view the Data, require any necessary modifications of Data or withdraw the consents set forth in this Subsection by contacting the Human Resources Department of the Company in writing.

SECTION 20. APPLICABLE LAW.

This Agreement will be interpreted and enforced under the laws of the State of California (without regard to their choice of law provisions).

INVUITY, INC.

STOCK OPTION AGREEMENT

-7-

EXHIBIT A

INVUITY, INC. 2005 STOCK INCENTIVE PLAN

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

THIS AGREEMENT is dated as of , , between Invuity, Inc. (the “Company”), and «Name» (“Purchaser”).

W I T N E S S E T H:

WHEREAS, the Company granted Purchaser a stock option on «Grant_Date» (the “Date of Grant”) pursuant to a stock option agreement (the “Option Agreement”) under which Purchaser has the right to purchase up to «No_Shares» shares of the Company’s common stock (the “Option Shares”); and

WHEREAS, the Option is exercisable with respect to certain of the Option Shares as of the date hereof; and

WHEREAS, pursuant to the Option Agreement, Purchaser desires to purchase shares of the Company as herein described, on the terms and conditions set forth in this Agreement, the Option Agreement and the Invuity, Inc. 2005 Stock Incentive Plan (the “Plan”). Certain capitalized terms used in this Agreement are defined in the Plan.

NOW, THEREFORE, it is agreed between the parties as follows:

SECTION 1. PURCHASE OF SHARES.

(a)

Pursuant to the terms of the Option Agreement, Purchaser hereby agrees to purchase from the Company and the Company agrees to sell and issue to Purchaser shares of the Company’s common stock (the “Common Stock”) for the Exercise Price per share specified in the Notice of Stock Option Grant payable by personal check, cashier’s check, money order or otherwise as permitted by the Option Agreement. Payment shall be delivered at the Closing, as such term is defined below.

(b)

The closing (the “Closing”) under this Agreement shall occur at the offices of the Company as of the date hereof, or such other time and place as may be designated by the Company (the “Closing Date”).

SECTION 2. REPURCHASE RIGHT.

All shares of the Stock purchased by Purchaser pursuant to this Agreement that have not vested under the terms of the Option Agreement, together with any shares of Common Stock issued as a dividend or other distribution on, in exchange for or upon the conversion of such unvested Stock (collectively, the “Subject Shares”) shall be subject to the following right of repurchase by the Company (the “Repurchase Right”). The Company shall have the right, within ninety (90) days after the termination of Purchaser’s services to the Company (the “Termination

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-1

Date”), to purchase from Purchaser all Subject Shares as of the Termination Date. The repurchase price shall be the Exercise Price per share paid by Purchaser for such shares pursuant to this Agreement. For purposes of this Section 2, the date the Company exercises its Repurchase Right shall be deemed to be the Termination Date. The Repurchase Right under this Section 2 shall lapse with respect to the Subject Shares in accordance with the vesting schedule in the Option Agreement.

SECTION 3. EXERCISE OF REPURCHASE RIGHT.

The Company shall be deemed to have exercised its Repurchase Right automatically for all Subject Shares as of the Termination Date, unless within ninety (90) days thereafter, the Company notifies the holder of the Subject Shares pursuant to Section 16 that it will not exercise its Repurchase Rights as to some or all of the Subject Shares. The certificate(s) representing the shares to be repurchased shall be delivered to the Company properly endorsed for transfer. The Company shall, concurrently with the receipt of such certificate(s), pay to Purchaser the repurchase price determined according to Section 2, above. The repurchase price shall be paid by certified or cashier’s check or by cancellation of any purchase money indebtedness of Purchaser to the Company.

SECTION 4. WAIVER, ASSIGNMENT, EXPIRATION OF REPURCHASE RIGHT.

If the Company waives or fails to exercise the Repurchase Right as to all of the shares subject thereto, the Company may, in the discretion of its Board of Directors, assign the Repurchase Right to any other holder or holders of preferred or common stock of the Company in such proportions as such Board of Directors may determine. In the event of such an assignment, the Board may require that the assignee pay to the Company in cash an amount equal to the fair market value of the Repurchase Right. The Company shall promptly, prior to expiration of the ninety (90) day period referred to in Section 2 above, notify Purchaser of the number of shares subject to the Repurchase Right assigned to such shareholders and shall notify both Purchaser and the assignees of the time, place and date for settlement of such purchase, which must be made within ninety (90) days from the Termination Date. In the event that the Company and/or such assignees do not elect to exercise the Repurchase Right as to all or part of the shares subject to it, the Repurchase Right shall expire as to all shares which the Company and/or such assignees have not elected to purchase.

SECTION 5. ESCROW OF SHARES.

(a)

To ensure that Purchaser’s unvested Shares are delivered to the Company upon its exercise of its Repurchase Right, Purchaser agrees at the Closing under this Agreement, to deliver to and deposit with the escrow agent (the “Escrow Agent”) named in the Joint Escrow Instructions attached as Exhibit B, the certificate(s) evidencing the unvested Shares and an Assignment Separate from Certificate executed by Purchaser (with date and number of shares in blank) in the form attached as Exhibit C. The certificate(s) evidencing the unvested Shares and the Assignment Separate from Certificate shall be delivered to the Escrow Agent and held under the Joint Escrow Instructions, which shall be delivered to the Escrow Agent at the Closing under this Agreement.

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-2

(b)

Within thirty (30) days after the last day of each successive completed calendar quarter after the Closing Date, if Purchaser so requests, the Escrow Agent shall deliver to Purchaser certificates representing so many shares of Common Stock as are no longer subject to the Repurchase Right (less such shares as have been previously delivered). Ninety (90) days after the Termination Date, the Company shall direct the Escrow Agent to deliver to Purchaser a certificate or certificates representing the number of shares not repurchased by the Company or its assignees pursuant to exercise of the Repurchase Right (less such shares as have been previously delivered).

SECTION 6. ADJUSTMENT OF SHARES.

Subject to the provisions of the Articles of Incorporation of the Company, if (a) there is any stock dividend or liquidating dividend of cash and/or property, stock split or other change in the character or amount of any of the outstanding securities of the Company, or (b) there is any consolidation, merger or sale of all or substantially all of the assets of the Company, then, in such event, any and all new, substituted or additional securities or other property to which Purchaser is entitled by reason of Purchaser’s ownership of the shares shall be immediately subject to the Repurchase Right and the Right of First Refusal, as defined below, with the same force and effect as the shares subject to the Repurchase Right and the Right of First Refusal. While the total repurchase price shall remain the same after each such event, the repurchase price per share upon exercise of the Repurchase Right shall be appropriately and equitably adjusted as determined by the Board of Directors of the Company. Appropriate adjustments shall also be made to the number and/or class of shares subject to the Repurchase Right and the Right of First Refusal to reflect the exchange or distribution of such securities. In the event of a merger or consolidation of the Company with or into another entity or any other corporate reorganization, the Repurchase Right and Right of First Refusal may be exercised by the Company’s successor.

SECTION 7. THE COMPANY’S RIGHT OF FIRST REFUSAL.

Before any shares of Common Stock registered in the name of Purchaser may be sold or transferred, such shares shall first be offered to the Company as follows (the “Right of First Refusal”):

(a) Purchaser shall promptly deliver a notice (“Notice”) to the Company stating (i) Purchaser’s bona fide intention to sell or transfer such shares, (ii) the number of such shares to be sold or transferred, and the basic terms and conditions of such sale or transfer, (iii) the price for which Purchaser proposes to sell or transfer such shares, (iv) the name of the proposed purchaser or transferee, and (v) proof satisfactory to the Company that the proposed sale or transfer will not violate any applicable U.S. federal, state or foreign securities laws. The Notice shall be signed by both Purchaser and the proposed purchaser or transferee and must constitute a binding commitment subject to the Company’s Right of First Refusal as set forth herein.

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-3

(b) Within thirty (30) days after receipt of the Notice, the Company may elect to purchase all or any portion of the shares to which the Notice refers, at the price per share specified in the Notice. If the Company elects not to purchase all or any portion of the shares, the Company may assign its right to purchase all or any portion of the shares. An election to purchase shall be made by written notice to Purchaser. Payment for shares purchased pursuant to this Section 7 shall be made within thirty (30) days after receipt of the Notice by the Company and, at the option of the Company, may be made by cancellation of all or a portion of outstanding indebtedness or other obligation, if any, or in cash or both; provided, however, that, if the terms of payment set forth in the Notice are other than cash against delivery, the Company and/or its assignees shall pay for the shares on the same terms and conditions as set forth in the Notice. Should the purchase price specified in the Notice be payable in property other than cash, the Company shall have the right to pay the purchase price in the form of the cash equivalent of such property as determined in good faith by the Board of Directors of the Company.

(c) If all or any portion of the shares to which the Notice refers are not elected to be purchased, as provided in subparagraph 7(b), Purchaser may sell those shares to any person named in the Notice at the price specified in the Notice, provided that such sale or transfer is consummated within sixty (60) days of the date of said Notice to the Company, and provided, further, that any such sale is made in compliance with applicable U.S. federal, state and foreign securities laws and not in violation of any other contractual restrictions to which Purchaser is bound. The third-party purchaser shall be bound by, and shall acquire the shares of stock subject to, the provisions of this Agreement, including the Company’s Right of First Refusal.

(d) Any proposed transfer on terms and conditions different from those set forth in the Notice, as well as any subsequent proposed transfer shall again be subject to the Company’s Right of First Refusal and shall require compliance with the procedures described in this Section 7.

(e) In the event the Company (or its assignees) elects to purchase a portion, but not all, of the shares specified in the Notice, Purchaser shall have the option, exercisable by written notice to the Company delivered within thirty (30) days after the date of the Company’s receipt of the Notice, to effect the sale of the shares pursuant to one of the following alternatives (failure of Purchase to deliver timely notification of such election shall be deemed an election pursuant to alternative (i) below):

(i) sale or other disposition of all the shares to the third-party purchaser in compliance with the requirements of subparagraph 7(c), as if the Company and/or its assignees did not exercise the Company’s Right of First Refusal; or

(ii) sale to the Company (or its assignees) of the portion of the shares which the Company (or its assignees) has elected to purchase, such sale to be effected in compliance with the requirements of subparagraph 7(b).

(f) Purchaser agrees to cooperate affirmatively with the Company, to the extent reasonably requested by the Company, to enforce rights and obligations pursuant to this Agreement.

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-4

(g) Notwithstanding the above, neither the Company nor any assignee of the Company under this Section 7 shall have any right under this Section 7 at any time subsequent to the closing of a public offering of the common stock of the Company pursuant to a registration statement declared effective under the U.S. Securities Act of 1933, as amended (the “Securities Act”).

(h) This Section 7 shall not apply to (a) a gratuitous transfer of the shares made to Purchaser’s immediate family or to any custodian or trustee for the account of Purchaser or Purchaser’s immediate family or to any limited partnership of which Purchaser, members of such Purchaser’s immediate family or any trust for the account of Purchaser or Purchaser’s immediate family will be the general or limited partner(s) of such partnership, (b) a transfer of the shares effected pursuant to Purchaser’s will or the laws of intestate succession, (c) a transfer of the shares in a bona fide underwritten public offering pursuant to a registration statement declared effective under the Securities Act, or (d) a bona fide pledge or mortgage of the shares with a commercial lending institution, provided that any subsequent transfer of such shares by such institution shall be subject to the Company’s Right of First Refusal. For purposes of this Agreement, “immediate family” as used herein shall mean spouse, lineal descendant, father, mother, grandmother, grandfather, brother or sister of Purchaser. As a condition to any transfers pursuant to this subparagraph 7(h), each transferee must agree in writing on a form prescribed by the Company to be bound by all of the provisions of this Agreement to the same extent as they apply to Purchaser and shall execute a copy of the attached Exhibit D and file the same with the Secretary of the Company.

(i) The Company’s Right of First Refusal set forth in this Section 7 shall be in addition to, and not in lieu of, any first refusal rights with respect to the shares contained in the Company’s Bylaws, as they may be amended from time to time.

SECTION 8.

PURCHASER’S RIGHTS AFTER EXERCISE OF REPURCHASE RIGHT OR RIGHT OF FIRST REFUSAL.

If the Company makes available, at the time and place and in the amount and form provided in this Agreement, the consideration for the Common Stock to be repurchased in accordance with the provisions of Sections 2 and 7 of this Agreement, then from and after such time the person from whom such shares are to be repurchased shall no longer have any rights as a holder of such shares (other than the right to receive payment of such consideration in accordance with this Agreement). Such shares shall be deemed to have been repurchased in accordance with the applicable provisions hereof, whether or not the certificate(s) therefor have been delivered as required by this Agreement.

SECTION 9. TRANSFER BY PURCHASER TO CERTAIN PEOPLE.

(a)

Notwithstanding anything herein to the contrary, Purchaser may not transfer, assign, encumber or otherwise dispose of any Subject Shares without the Company’s written consent, except that Purchaser may transfer Subject Shares to one or more members of Purchaser’s Immediate Family (as defined below), or to a trust established by Purchaser for the benefit of Purchaser and/or one or more

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-5

members of Purchaser’s Immediate Family, provided that the transferee agrees in writing on a form prescribed by the Company to be bound by all of the provisions of this Agreement to the same extent as they apply to Purchaser. The transferee shall execute a copy of Exhibit D and file the same with the Secretary of the Company.

(b)

For purposes of this Agreement, Immediate Family means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law, and shall include adoptive relationships.

SECTION 10. LEGEND OF SHARES.

All certificates representing the Common Stock purchased under this Agreement shall, where applicable, have endorsed thereon the following legends and any other legends required by applicable securities laws:

THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR FOREIGN JURISDICTION, AND MAY BE OFFERED AND SOLD ONLY IF REGISTERED AND QUALIFIED PURSUANT TO THE RELEVANT PROVISIONS OF U.S. FEDERAL AND STATE AND APPLICABLE FOREIGN SECURITIES LAWS OR IF THE COMPANY IS PROVIDED AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT REGISTRATION AND QUALIFICATION UNDER U.S. FEDERAL AND STATE AND APPLICABLE FOREIGN SECURITIES LAWS IS NOT REQUIRED.

If the Option is an ISO, then the following legend should be included:

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-6

ANNIVERSARY OF THE DATE OF GRANT OF THE OPTION OR THE ONE (1) YEAR ANNIVERSARY OF THE DATE ON WHICH THE OPTION WAS EXERCISED. THE REGISTERED HOLDER MAY RECOGNIZE ORDINARY INCOME IF THE SHARES ARE TRANSFERRED BEFORE SUCH DATE.

SECTION 11. PURCHASER’S INVESTMENT REPRESENTATIONS.

(a)

This Agreement is made with Purchaser in reliance upon Purchaser’s representation to the Company, which by Purchaser’s acceptance hereof Purchaser confirms, that the Common Stock which Purchaser will receive will be acquired with Purchaser’s own funds for investment for an indefinite period for Purchaser’s own account, not as a nominee or agent, and not with a view to the sale or distribution of any part thereof, and that Purchaser has no present intention of selling, granting participation in, or otherwise distributing the same, but subject, nevertheless, to any requirement of law that the disposition of Purchaser’s property shall at all times be within Purchaser’s control. By executing this Agreement, Purchaser further represents that Purchaser does not have any contract, understanding or agreement with any person to sell, transfer, or grant participation to such person or to any third person, with respect to any of the Common Stock.

(b)

Purchaser understands that the Common Stock will not be registered or qualified under applicable U.S. federal, state or foreign securities laws on the ground that the sale provided for in this Agreement is exempt from registration or qualification under applicable U.S. federal, state or foreign securities laws and that the Company’s reliance on such exemption is predicated on Purchaser’s representations set forth herein.

(c)

Purchaser agrees that in no event shall Purchaser make a disposition of any of the Common Stock (including a disposition under Section 9 of this Agreement), unless and until (i) Purchaser shall have notified the Company of the proposed disposition and shall have furnished the Company with a statement of the circumstances surrounding the proposed disposition and (ii) Purchaser shall have furnished the Company with an opinion of counsel satisfactory to the Company to the effect that (A) such disposition will not require registration or qualification of such Common Stock under applicable U.S. federal, state or foreign securities laws or (B) appropriate action necessary for compliance with the U.S. federal, state or foreign securities laws has been taken or (iii) the Company shall have waived, expressly and in writing, its rights under clauses (i) and (ii) of this Section.

(d)

With respect to a transaction occurring prior to such date as the Plan and Common Stock thereunder are covered by a valid Form S-8 or similar U.S. federal registration statement, this Subsection shall apply unless the transaction is covered by the exemption in California Corporations Code section 25102(o) or a similar broad-based exemption. In connection with the investment representations made herein, Purchaser represents that Purchaser is able to fend for himself or herself in the transactions contemplated by this Agreement, has

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-7

such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of Purchaser’s investment, has the ability to bear the economic risks of Purchaser’s investment and has been furnished with and has had access to such information as would be made available in the form of a registration statement together with such additional information as is necessary to verify the accuracy of the information supplied and to have all questions answered by the Company.

(e)

Purchaser understands that if the Company does not register with the Securities and Exchange Commission pursuant to section 12 of the U.S. Securities Exchange Act of 1934, as amended, or if a registration statement covering the Common Stock (or a filing pursuant to the exemption from registration under Regulation A of the Securities Act) under the Securities Act is not in effect when Purchaser desires to sell the Common Stock, Purchaser may be required to hold the Common Stock for an indeterminate period. Purchaser also acknowledges that Purchaser understands that any sale of the Common Stock which might be made by Purchaser in reliance upon Rule 144 under the Securities Act may be made only in limited amounts in accordance with the terms and conditions of that Rule.

SECTION 12. NO DUTY TO TRANSFER IN VIOLATION OF THIS AGREEMENT.

The Company shall not be required (a) to transfer on its books any shares of Common Stock of the Company which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement or (b) to treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall have been so transferred.

SECTION 13. RIGHTS OF PURCHASER.

(a)

Except as otherwise provided herein, Purchaser shall, during the term of this Agreement, exercise all rights and privileges of a shareholder of the Company with respect to the Common Stock.

(b)

Nothing in this Agreement shall be construed as a right by Purchaser to be retained by the Company, or a parent or subsidiary of the Company in any capacity. The Company reserves the right to terminate Purchaser’s Service at any time and for any reason without thereby incurring any liability to Purchaser.

SECTION 14. RESALE RESTRICTIONS/MARKET STAND-OFF.

Purchaser hereby agrees that in connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act, including the Company’s initial public offering, Purchaser shall not, directly or indirectly, engage in any transaction prohibited by the underwriter, or sell, make any short sale of, contract to sell, transfer the economic risk of ownership in, loan, hypothecate, pledge, grant any option for the purchase of, or otherwise dispose or transfer for value or agree to engage in any of the foregoing transactions with respect to any Common Stock without the prior written

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-8

consent of the Company or its underwriters, for such period of time after the effective date of such registration statement as may be requested by the Company or such underwriters. Such period of time shall not exceed one hundred eighty (180) days; provided, however, that if either (a) during the last seventeen (17) days of such one hundred eighty (180) day period, the Company issues an earnings release or material news or a material event relating to the Company occurs or (b) prior to the expiration of such one hundred eighty (180) day period, the Company announces that it will release earnings results during the sixteen (16) day period beginning on the last day of the one hundred eighty (180) day period, then the restrictions imposed during such one hundred eighty (180) day period shall continue to apply until the expiration of the eighteen (18) day period beginning on the issuance of the earnings release or the occurrence of the material news or material event; and provided, further, that in the event the Company or the underwriter requests that the one hundred eighty (180) day period be extended or modified pursuant to then-applicable law, rules, regulations or trading policies, the restrictions imposed during the one hundred eighty (180) day period shall continue to apply to the extent requested by the Company or the underwriter to comply with such law, rules, regulations or trading policies. Purchaser hereby agrees to execute and deliver such other agreements as may be reasonably requested by the Company or the underwriter which are consistent with the foregoing or which are necessary to give further effect thereto. To enforce the provisions of this Section, the Company may impose stop-transfer instructions with respect to the Common Stock until the end of the applicable stand-off period.

SECTION 15. OTHER NECESSARY ACTIONS.

The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

SECTION 16. NOTICE.

Any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given upon the earliest of personal delivery, receipt or the third full day following deposit in the United States Post Office with postage and fees prepaid, addressed to the other party hereto at the address last known or at such other address as such party may designate by ten (10) days’ advance written notice to the other party hereto.

SECTION 17. SUCCESSORS AND ASSIGNS.

This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer herein set forth, be binding upon Purchaser and Purchaser’s heirs, executors, administrators, successors and assigns. The failure of the Company in any instance to exercise the Repurchase Right or Right of First Refusal described herein shall not constitute a waiver of any other Repurchase Right or Right of First Refusal that may subsequently arise under the provisions of this Agreement. No waiver of any breach or condition of this Agreement shall be deemed to be a waiver of any other or subsequent breach or condition, whether of a like or different nature.

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-9

SECTION 18. APPLICABLE LAW.

This Agreement shall be governed by, and construed in accordance with, the laws of the State of California, as such laws are applied to contracts entered into and performed in such state.

SECTION 19. NO STATE QUALIFICATION.

THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA, AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT.

SECTION 20. NO ORAL MODIFICATION.

No modification of this Agreement shall be valid unless made in writing and signed by the parties hereto.

SECTION 21. ENTIRE AGREEMENT.

This Agreement, the Option Agreement and the Plan constitute the entire complete and final agreement between the parties hereto with regard to the subject matter hereof.

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-10

IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first above written.


INVUITY, INC.								«NAME» (PURCHASER)

By
								Signature

Its

INVUITY, INC.

EXHIBIT A TO STOCK OPTION AGREEMENT

NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

A-11

EXHIBIT B

JOINT ESCROW INSTRUCTIONS

_________, ____

To Secretary

Invuity, Inc.

Dear Sir or Madam:

As Escrow Agent for Invuity, Inc. (the “Company”), and «Name» (the “Purchaser”), you are authorized and directed to hold the Assignment Separate from Certificate form(s) executed by Purchaser and the certificate(s) of stock representing Purchaser’s unvested shares purchased in accordance with the terms of the notice of exercise and common stock purchase agreement (the “Agreement”) and stock option agreement (the “Option Agreement”) entered into between the Company and Purchaser, in accordance with the following instructions:

1. In the event that the Company elects to exercise the Repurchase Right as described in Section 2 of the Agreement, Purchaser and the Company hereby irrevocably authorize and direct you to close the transaction contemplated, and to promptly deliver the stock certificates.

2. At the closing, you are directed (a) to date the Assignment Separate from Certificate form(s) necessary for the transfer in question, (b) to fill in the number of shares being transferred, and (c) to deliver the form(s), together with the certificate or certificates evidencing the shares to be transferred, to the Company. The Company shall simultaneously deliver to you the repurchase price for the number of shares being purchased pursuant to the exercise of the Repurchase Right.

3. Purchaser irrevocably authorizes the Company to deposit with you any certificates evidencing shares to be held by you under this letter and any additions and substitutions to the shares as defined in the Agreement. Purchaser irrevocably appoints you as his or her attorney-in-fact and agent for the term of this escrow to execute, with respect to the shares of stock, all documents necessary or appropriate to make such securities negotiable and to complete any transaction contemplated by these Joint Escrow Instructions. Subject to the provisions of this Section 3, Purchaser shall exercise all rights and privileges, including but not limited to, the right to vote and to receive dividends (if any), of a shareholder of the Company while the shares are held by you.

4. In accordance with the terms of Section 5 of the Agreement, you may, from time to time, deliver to Purchaser a certificate or certificates representing shares that are no longer subject to the Repurchase Right.

5. This escrow shall terminate upon the release of all shares held under the terms and provisions hereof.

INVUITY, INC.

EXHIBIT B TO STOCK OPTION AGREEMENT

JOINT ESCROW INSTRUCTIONS

B-1

6. If at the time of termination of this escrow you should have in your possession any documents, securities or other property belonging to Purchaser, you shall deliver them to Purchaser and shall be discharged from all further obligations under these Joint Escrow Instructions.

7. Your duties under these Joint Escrow Instructions may be altered, amended, modified or revoked only by a writing signed by all of the parties.

8. You shall be obligated to perform the duties described in these Joint Escrow Instructions and shall be protected in relying or refraining from acting on any instrument reasonably believed by you to be genuine and to have been signed or presented by the proper party or parties. You shall not be personally liable for any act or omission as Escrow Agent or as attorney-in-fact of Purchaser while acting in good faith and in the exercise of your own good judgment, and any act or omission by you pursuant to the advice of your own attorneys shall be conclusive evidence of such good faith.

9. You are expressly authorized to disregard any and all warnings given by any of the parties hereto or by any other person or corporation, excepting only orders or process of courts of law, and are expressly authorized to comply with and obey orders, judgments or decrees of any court. In case you obey or comply with any such order, judgment or decree of any court, you shall not be liable to any of the parties under these Joint Escrow Instructions or to any other person, firm or corporation by reason of such compliance, notwithstanding any such order, judgment or decree being subsequently reversed, modified, annulled, set aside, vacated or found to have been entered without jurisdiction.

10. You shall not be liable in any respect on account of the identity, authority or rights of the parties executing or delivering or purporting to execute or deliver the Agreement or any documents or papers deposited or called for under these Joint Escrow Instructions.

11. You shall not be liable for the outlawing of any rights under any statute of limitations with respect to these Joint Escrow Instructions or any documents deposited with you.

12. You shall be entitled to employ such legal counsel and other experts as you may deem necessary properly to advise you in connection with your obligations under these Joint Escrow Instructions and may rely upon the advice of such counsel.

13. Your responsibilities as Escrow Agent under these Joint Escrow Instructions shall terminate if you shall cease to be employed by the Company or if you shall resign by written notice to each party. In the event of any such termination, the Company shall appoint any officer of the Company as successor Escrow Agent.

14. If you reasonably require other or further instruments in connection with these Joint Escrow Instructions or obligations under these Joint Escrow Instructions, the parties shall furnish such instruments.

15. It is understood and agreed that should any dispute arise with respect to the delivery and/or ownership or right of possession of the securities held by you under these Joint Escrow Instructions, you are authorized and directed to retain in your possession without liability

INVUITY, INC.

EXHIBIT B TO STOCK OPTION AGREEMENT

JOINT ESCROW INSTRUCTIONS

B-2

to anyone all or any part of the securities until the dispute is settled either by mutual written agreement of the parties or by a final order, decree or judgment of a court of competent jurisdiction after the time for appeal has expired and no appeal has been perfected. You are under no duty whatsoever to institute or defend against any such proceedings.

16. Any notice required or permitted under these Joint Escrow Instructions shall be given in writing and will be deemed effectively given upon personal delivery or upon deposit in the United States Post Office, by registered or certified mail with postage and fees prepaid, addressed to each of the other parties.

17. By signing these Joint Escrow Instructions, you become a party only for the purpose of these Joint Escrow Instructions; you do not become a party to the Agreement.

18. This instrument shall be governed by and construed in accordance with the laws of the State of California.

19. This instrument shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns.


Very truly yours,

INVUITY, INC.

By

Its


ESCROW AGENT:				«NAME»
				(PURCHASER)

Signature				Signature

INSTRUCTIONS: YOU MUST SIGN THIS LETTER IF YOU ARE EXERCISING PRIOR TO VESTING (“EARLY EXERCISE”). IF YOU ARE NOT EARLY EXERCISING, DO NOT COMPLETE THIS FORM.

INVUITY, INC.

EXHIBIT B TO STOCK OPTION AGREEMENT

JOINT ESCROW INSTRUCTIONS

B-3

EXHIBIT C

ASSIGNMENT SEPARATE FROM CERTIFICATE

FOR VALUE RECEIVED, «Name» sells, assigns and transfers to Invuity, Inc. (the “Company”) or its assignee shares of the Common Stock of the Company (the “Shares”), standing in his or her name on the books of the Company represented by Certificate No. and irrevocably constitutes and appoints as Attorney to transfer the Shares on the books of the Company with full power of substitution in the premises.

Dated: ____________________, ____.

«Name»

(Signature)

Spousal Consent (if applicable)

(Purchaser’s spouse) indicates by the execution of this Assignment his or her consent to be bound by the terms herein as to his or her interests, whether as community property or otherwise, if any, in the Shares.

Printed Name

Signature

INSTRUCTIONS: YOU MUST SIGN THIS FORM IF YOU ARE EXERCISING PRIOR TO VESTING (“EARLY EXERCISE”). IF YOU ARE NOT EARLY EXERCISING, DO NOT COMPLETE THIS FORM. PLEASE DO NOT FILL IN ANY BLANKS OTHER THAN THE SIGNATURE LINE. THE PURPOSE OF THIS ASSIGNMENT IS TO ENABLE THE COMPANY TO EXERCISE ITS “REPURCHASE RIGHT” SET FORTH IN THE NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT WITHOUT REQUIRING ADDITIONAL SIGNATURES.

INVUITY, INC.

EXHIBIT C TO STOCK OPTION AGREEMENT

ASSIGNMENT SEPARATE FROM CERTIFICATE

C-1

EXHIBIT D

ACKNOWLEDGMENT OF AND AGREEMENT TO BE BOUND

BY THE NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

INVUITY, INC.

The undersigned, as transferee of shares of Invuity, Inc. hereby acknowledges that he or she has read and reviewed the terms of the Notice of Exercise and Common Stock Purchase Agreement of Invuity, Inc. and hereby agrees to be bound by the terms and conditions thereof, as if the undersigned had executed said Agreement as an original party thereto.

Dated: ____________________, ____.

(Signature of Transferee)

(Printed Name of Transferee)

INVUITY, INC.

EXHIBIT D TO STOCK OPTION AGREEMENT

ACKNOWLEDGMENT OF AND AGREEMENT TO BE BOUND BY THE NOTICE OF EXERCISE AND COMMON STOCK PURCHASE AGREEMENT

D-1

EXHIBIT E

STEP-BY-STEP INSTRUCTIONS TO

MAKE A SECTION 83(b) ELECTION

WORD OF CAUTION: IF YOU CHOOSE TO FILE A SECTION 83(b) ELECTION, YOU MUST FILE YOUR SECTION 83(b) ELECTION FORM WITH THE IRS NO LATER THAN 30 DAYS FOLLOWING THE DATE ON WHICH YOU SIGN THE NOTICE OF EXERCISE (EXHIBIT A) AND PAY THE EXERCISE PRICE. THE 30-DAY DEADLINE IS ABSOLUTE AND CANNOT BE WAIVED UNDER ANY CIRCUMSTANCES. ALSO, ONCE FILED, YOUR SECTION 83(b) ELECTION FORM MAY NOT BE REVOKED, EXCEPT WITH THE CONSENT OF THE IRS (WHICH CONSENT IS GENERALLY DENIED).

THESE INSTRUCTIONS ARE DISTRIBUTED MERELY FOR CONVENIENCE IN THE EVENT YOU CHOOSE TO FILE AN 83(b) ELECTION. THEY SHOULD NOT BE RELIED UPON BY ANY PERSON IN DECIDING WHETHER OR WHEN TO EXERCISE AN OPTION OR TO MAKE AN 83(b) ELECTION. EACH PERSON SHOULD CONSULT HIS OR HER OWN TAX ADVISOR REGARDING THESE MATTERS.

Step 1.

Complete and execute the 83(b) Form found on page E-4 of this Exhibit E (the “83(b) Form”). Contact the Company to obtain the fair market value of the property at the time of transfer and insert the per share fair market value of the shares in paragraph 6 of the 83(b) Form.

Step 2.

Make four copies of the executed and completed 83(b) Form.

Step 3.

Mail (a) the cover letter on page E-3; (b) the original executed 83(b) Form on page E-4; and (c) if you are exercising an ISO, the Special Election Form on page E-5 to the Internal Revenue Service Center where you file your U.S. federal income tax return.

PLEASE NOTE THAT IF YOU ARE EXERCISING AN ISO FOR UNVESTED SHARES, AN 83(b) ELECTION WILL NOT BE EFFECTIVE TO LIMIT THE AMOUNT OF ORDINARY INCOME THAT YOU MAY BE REQUIRED TO RECOGNIZE ON A DISQUALIFYING DISPOSITION, ACCORDING TO U.S. TREASURY REGULATIONS. PLEASE SEE SUMMARY OF U.S. FEDERAL TAX INFORMATION AT EXHIBIT F AND CONSULT YOUR TAX ADVISOR WITH RESPECT TO THE EARLY EXERCISE OF AN ISO.

Internal Revenue Service regulations generally provide that, for the purpose of avoiding federal tax penalties, a taxpayer may rely only on formal written advice meeting specific requirements. The tax discussion in this document does not meet those requirements. Accordingly, the tax discussion was not intended or written to be used, and it cannot be used, for the purpose of avoiding federal tax penalties that may be imposed on you. Further, the tax discussion in this document could be considered to support the promotion or marketing of the transaction or matter discussed herein. You and any other person reading the tax discussion should seek advice based on his, her or its particular circumstances from an independent tax advisor.

E-1

The tax, if any, arising out of your election does not have to be paid until you file your tax return for the taxable year in which you purchased your option shares (except to the extent that withholding taxes or estimated taxes are payable). The forms must be filed no later than 30 days following the date on which you sign the Notice of Exercise (Exhibit A) and pay the exercise price. The 30-day deadline is absolute and cannot be waived under any circumstances. The filing is deemed to be made on the date that the forms are mailed from the post office, i.e., the postmark date. Mail the forms by registered or certified mail, return receipt requested, so that you have proof that you filed the forms within the 30-day period. If you miss the deadline, you will be taxed on your option shares as they vest based on the value of the shares at that time. Your 83(b) filing with the Internal Revenue Service is deemed to cause a similar election with the California Franchise Tax Board for California income tax purposes. If you do not reside in California, you should seek local tax advice on whether you must make a separate filing with your state of residence.

Step 4.

Mail or submit a copy of the filing with the Company on the same day that you file the 83(b) Form, and make sure that you retain copies of the forms for your records and for filing with your tax returns (see Step 5).

Step 5.

File copies of the forms with your U.S. federal tax (and state tax, if appropriate) returns for the taxable year in which you purchased your option shares.

INVUITY, INC.

EXHIBIT E TO STOCK OPTION AGREEMENT

STEP-BY-STEP INSTRUCTIONS TO MAKE A SECTION 83(b) ELECTION

E-2

[Name of Optionee]

[Optionee’s Address]

[Date]

VIA CERTIFIED MAIL

Return Receipt Requested

Receipt [enter receipt # here]

Internal Revenue Service Center

[Appropriate IRS center address]

Re:

Election Under Section 83(b) of the Internal Revenue Code

Ladies and Gentlemen:

Enclosed please find an executed form of election under Section 83(b) of the Internal Revenue Code of 1986 relating to the issuance of shares of Invuity, Inc. Common Stock.

Also enclosed is a copy of the 83(b) election and a stamped, self-addressed envelope. Please acknowledge receipt of these materials by stamping the enclosed copy of the 83(b) election with the date of receipt and returning it to me.

Thank you for your attention to this matter.

Very truly yours,

[Name of Optionee]

Enclosures

cc: Invuity, Inc. w/ encs.

INVUITY, INC.

EXHIBIT E TO STOCK OPTION AGREEMENT

STEP-BY-STEP INSTRUCTIONS TO MAKE A SECTION 83(b) ELECTION

E-3

SECTION 83(b) ELECTION

This statement is being made under Section 83(b) of the Internal Revenue Code of 1986, pursuant to Treasury Regulation section 1.83-2.

1. The taxpayer who performed the services is:

Name of Optionee: «Name»

Optionee’s Address: _____________

Optionee’s Social Security Number: _____________

2. The property with respect to which the election is being made is shares of common stock of Invuity, Inc., a California corporation (the “Company”).

3. The property was transferred on , 20 . (Date of Exercise)

4. The taxable year in which the election is being made is the calendar year 20 .

5. If for any reason the taxpayer’s service with the issuer is terminated, the property is subject to a repurchase right pursuant to which the issuer has the right to acquire the property at the original purchase price without interest. The issuer’s repurchase right lapses in a series of installments over a year period.

6. The Fair Market Value of the property at the time of transfer (determined without regard to any restriction other than a restriction which by its terms will never lapse) is $ per share.

7. The amount paid for such property is $ .

8. A copy of this statement was furnished to the Company for whom the taxpayer rendered the service underlying the transfer of property.

9. This statement is executed as of , 20 .

Spouse (if any)

«Name»: Taxpayer

INVUITY, INC.

EXHIBIT E TO STOCK OPTION AGREEMENT

STEP-BY-STEP INSTRUCTIONS TO MAKE A SECTION 83(b) ELECTION

E-4

SPECIAL ELECTION PURSUANT TO SECTION 83(b)

OF THE INTERNAL REVENUE CODE WITH RESPECT TO PROPERTY

ACQUIRED UPON EXERCISE OF AN INCENTIVE STOCK OPTION

The property described in the above Section 83(b) election is comprised of shares of common stock acquired pursuant to the exercise of an Incentive Stock Option under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). Accordingly, it is the intent of the Taxpayer to utilize this election to have the alternative minimum taxable income attributable to the purchased shares measured by the amount by which the fair market value of such shares at the time of their transfer to the Taxpayer exceeds the purchase price paid for the shares. In the absence of this election, such alternative minimum taxable income would be measured by the spread between the fair market value of the purchased shares and the purchase price which exists on the various lapse dates in effect for the forfeiture restrictions applicable to such shares.

This election is intended to be effective to the full extent permitted under the Code.

INVUITY, INC.

EXHIBIT E TO STOCK OPTION AGREEMENT

STEP-BY-STEP INSTRUCTIONS TO MAKE A SECTION 83(b) ELECTION

E-5

EXHIBIT F

U.S. FEDERAL TAX INFORMATION

(Current as of April 2013)

The following memorandum briefly summarizes current U.S. federal income tax law. The discussion is intended to be used solely for general information purposes and does not make specific representations to any participant. A taxpayer’s particular situation may be such that some variation of the basic rules is applicable to him or her. In addition, the U.S. federal income tax laws and regulations are revised frequently and may change again in the future. Each participant is urged to consult a tax advisor, both with respect to U.S. federal income tax consequences as well as any foreign, state or local tax consequences, before exercising any option or before disposing of any shares of stock acquired under the Plan.

Initial Grant of Options

The grant of an option, whether a nonqualified or nonstatutory stock option (“NSO”) or an incentive stock option (“ISO”), is not a taxable event for the optionee, and the Company obtains no deduction for the grant of the option. Note, however, that under Section 409A of the Internal Revenue Code, which is generally effective January 1, 2005, options granted at a discount from fair market value may be considered “deferred compensation” subject to adverse tax consequences, including immediate income tax upon the vesting of the option (whether or not exercised) and a 20% tax penalty (40% for California taxpayers) as well as interest and penalties.

Nonqualified or Nonstatutory Stock Options

The exercise of an NSO is a taxable event to the optionee. The amount by which the fair market value of the shares on the date of exercise exceeds the exercise price (the “spread”) will be taxed to the optionee as ordinary income. The spread will also be considered “wages” for purposes of applicable income and employment taxes for an NSO granted to an employee. The Company will generally be entitled to a deduction in the same amount as the ordinary income recognized by the optionee from the exercise of the option that is reported to the IRS by the optionee or the Company. In general, the optionee’s tax basis in the shares acquired by exercising an NSO is equal to the fair market value of such shares on the date of exercise. Upon a subsequent sale of any such shares in a taxable transaction, the optionee will realize capital gain or loss (long-term or short-term, depending on whether the shares were held for the required holding period before the sale) in an amount equal to the difference between his or her basis in the shares and the sale price.

The capital gains holding periods are complex. If shares are held for more than one year, the maximum tax rate on the gain is currently twenty percent (20%). Because the rules are complex and can vary in individual circumstances, each participant should consider consulting his or her own tax advisor.

INVUITY, INC.

EXHIBIT F TO STOCK OPTION AGREEMENT

U.S. FEDERAL TAX INFORMATION

F-1

Incentive Stock Options

The holder of an ISO will not be subject to U.S. federal income tax upon the exercise of the ISO, and the Company will not be entitled to a tax deduction by reason of such exercise, provided that the holder is employed by the Company on the exercise date (or the holder’s employment terminated within the three (3) months preceding the exercise date). Exceptions to this exercise timing requirement apply in the event the optionee dies or becomes disabled. A subsequent sale of the shares received upon the exercise of an ISO will result in the realization of long-term capital gain or loss in the amount of the difference between the amount realized on the sale and the exercise price for such shares, provided that the sale occurs more than one (1) year after the exercise of the ISO and more than two (2) years after the grant of the ISO. In general, if a sale or disposition of the shares occurs prior to satisfaction of the foregoing holding periods (referred to as a “disqualifying disposition”), the optionee will recognize ordinary income equal to the excess of (i) the lower of the sale price of the shares and the fair market value of the shares as of the exercise date over (ii) the exercise price paid for the shares. The Company will be entitled to a corresponding deduction, generally equal to the amount of ordinary income recognized by the optionee from the disqualifying disposition that is reported to the IRS by the Company. Any additional gain recognized upon the disqualifying disposition will be capital gain (long-term or short-term, depending on whether the shares were held for the required holding period before the sale). The capital gain holding period normally starts at the time the ISO is exercised.

Favorable tax treatment is accorded to an optionee only to the extent that the value of the shares (determined at the time of grant) covered by an ISO first exercisable in any single calendar year does not exceed one hundred thousand dollars ($100,000). If ISOs for shares whose aggregate value exceeds one hundred thousand dollars ($100,000) become exercisable in the same calendar year, the excess will be treated as NSOs.

Alternative Minimum Tax

Alternative minimum tax is paid when such tax exceeds a taxpayer’s regular U.S. federal income tax. Alternative minimum tax is calculated based on alternative minimum taxable income, which is taxable income for U.S. federal income tax purposes, modified by certain adjustments and increased by tax preference items.

The “spread” under an ISO—that is, the difference between (a) the fair market value of the shares of stock at exercise and (b) the exercise price—is classified as alternative minimum taxable income for the year of exercise. Alternative minimum taxable income may be subject to the alternative minimum tax. However, a disqualifying disposition of the shares of stock subject to the ISO during the same year in which the ISO was exercised will generally negate the alternative minimum taxable income generated upon exercise of the ISO.

Withholding Taxes

Exercise of an NSO by an employee (or former employee) produces taxable income which is subject to withholding. The Company will not deliver shares to the optionee unless the optionee has agreed to satisfactory arrangements for meeting all applicable U.S. federal, state and local withholding tax requirements.

INVUITY, INC.

EXHIBIT F TO STOCK OPTION AGREEMENT

U.S. FEDERAL TAX INFORMATION

F-2

U.S. federal tax law does not require unrecognized gain on exercise of an ISO to be treated as “wages” for the purposes of income or employment taxes.

Early Exercise

If an optionee is permitted to exercise an option before the optionee’s rights in the shares subject to the option are vested, the tax aspects of such an “early exercise” will be as follows:

Incentive Stock Options

When an ISO is exercised, the spread is taken into account in computing an optionee’s alternative minimum tax. One technique which might enable an optionee to minimize the amount recognized as alternative minimum tax income is to exercise the option at or near the date of grant when the spread is nonexistent or small. If the option is not vested, the optionee would also consider filing an election under Section 83(b) of the Code (“Section 83(b) Election”) within thirty (30) days after the date of exercise. In this way the optionee would pay alternative minimum tax based on the spread on the date of exercise instead of the spread on the date the shares vest. The exercise of the option also begins the one-year holding requirement under Section 422 of the Code that applies after the exercise of an ISO.

However, an 83(b) Election will not be effective for purposes of measuring the amount of ordinary income in the event of a disqualifying disposition of the ISO Shares, and ordinary income will be recognized in an amount equal to the spread on the date the shares vest, instead of the spread on the date the ISO is exercised. For this reason, an optionee is urged to consult with a tax advisor before electing to exercise an ISO for unvested shares.

Nonstatutory Stock Options

If the option is not an ISO but instead is an NSO, exercise prior to vesting and timely filing of a Section 83(b) Election will accomplish two things: (1) it will start the capital gains holding period running, and (2) it will prevent the optionee from being taxed (at ordinary income tax rates) upon vesting, if, at that time, the fair market value of the stock has increased from the date of grant. When the shares are sold, the gain will be taxed according to how long the shares have been held from the date of exercise if a Section 83(b) Election was timely filed or the date of vesting if a Section 83(b) Election was not filed.

INVUITY, INC.

EXHIBIT F TO STOCK OPTION AGREEMENT

U.S. FEDERAL TAX INFORMATION

F-3

Forfeiture of Unvested Shares

If service with the Company terminates before the shares are vested, the Company may repurchase the shares at the original purchase price of the shares. If you had made a Section 83(b) Election, you will not be entitled to deduct as an ordinary loss any income recognized on exercise of the option if the fair market value of the stock had exceeded the exercise price at that time.

THIS TAX SUMMARY IS GENERAL IN NATURE AND SHOULD NOT BE RELIED UPON BY ANY PERSON IN DECIDING WHETHER OR WHEN TO EXERCISE AN OPTION OR TO MAKE AN ELECTION UNDER SECTION 83(b) OF THE CODE. EACH PERSON SHOULD CONSULT HIS OR HER OWN TAX ADVISOR REGARDING THESE MATTERS.

INVUITY, INC.

EXHIBIT F TO STOCK OPTION AGREEMENT

U.S. FEDERAL TAX INFORMATION

F-4

EX-10.3 3 d852944dex103.htm EX-10.3 EX-10.3

Exhibit 10.3

INVUITY, INC.

EXECUTIVE INCENTIVE COMPENSATION PLAN

Adopted by the Board of Directors on April 16, 2015

and effective immediately prior to the Company’s initial public offering

1. Purposes of the Plan. The Plan is intended to increase stockholder value and the success of the Company by motivating Employees to (a) perform to the best of their abilities, and (b) achieve the Company’s objectives.

2. Definitions.

(a) “Actual Award” means as to any Performance Period, the actual award (if any) payable to a Participant for the Performance Period, subject to the Committee’s authority under Section 3(d) to modify the award.

(b) “Affiliate” means any corporation or other entity (including, but not limited to, partnerships and joint ventures) controlled by the Company.

(d) “Bonus Pool” means the pool of funds available for distribution to Participants. Subject to the terms of the Plan, the Committee establishes the Bonus Pool for each Performance Period.

(e) “Code” means the Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation thereunder will include such section or regulation, any valid regulation promulgated thereunder, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.

(f) “Committee” means the committee appointed by the Board (pursuant to Section 5) to administer the Plan. Unless and until the Board otherwise determines, the Board’s Compensation Committee will administer the Plan.

(g) “Company” means Invuity, Inc., a Delaware corporation, or any successor thereto.

(h) “Disability” means a permanent and total disability determined in accordance with uniform and nondiscriminatory standards adopted by the Committee from time to time.

(i) “Employee” means any executive, officer, or key employee of the Company or of an Affiliate, whether such individual is so employed at the time the Plan is adopted or becomes so employed subsequent to the adoption of the Plan.

(j) “Fiscal Year” means the fiscal year of the Company.

(k) “Participant” means as to any Performance Period, an Employee who has been selected by the Committee for participation in the Plan for that Performance Period.

(l) “Performance Period” means the period of time for the measurement of the performance criteria that must be met to receive an Actual Award, as determined by the Committee in its sole discretion. A Performance Period may be divided into one or more shorter periods if, for example, but not by way of limitation, the Committee desires to measure some performance criteria over 12 months and other criteria over 3 months.

(m) “Plan” means this Executive Incentive Compensation Plan, as set forth in this instrument and as hereafter amended from time to time.

(n) “Target Award” means the target award, at 100% performance achievement, payable under the Plan to a Participant for the Performance Period, as determined by the Committee in accordance with Section 3(b).

(o) “Termination of Service” means a cessation of the employee-employer relationship between an Employee and the Company or an Affiliate for any reason, including, but not by way of limitation, a termination by resignation, discharge, death, Disability, retirement, or the disaffiliation of an Affiliate, but excluding any such termination where there is a simultaneous reemployment by the Company or an Affiliate.

3. Selection of Participants and Determination of Awards.

(a) Selection of Participants. The Committee, in its sole discretion, will select the Employees who will be Participants for any Performance Period. Participation in the Plan is in the sole discretion of the Committee, on a Performance Period by Performance Period basis. Accordingly, an Employee who is a Participant for a given Performance Period in no way is guaranteed or assured of being selected for participation in any subsequent Performance Period or Performance Periods.

(b) Determination of Target Awards. The Committee, in its sole discretion, will establish a Target Award for each Participant (which may be expressed as a percentage of a Participant’s average annual base salary for the Performance Period).

(c) Bonus Pool. Each Performance Period, the Committee, in its sole discretion, will establish a Bonus Pool, which pool may be established before, during or after the applicable Performance Period. Actual Awards will be paid from the Bonus Pool.

(d) Discretion to Modify Awards. Notwithstanding any contrary provision of the Plan, the Committee may, in its sole discretion and at any time, (i) increase, reduce or eliminate a Participant’s Actual Award, and/or (ii) increase, reduce or eliminate the amount

-2-

allocated to the Bonus Pool. The Actual Award may be below, at or above the Target Award, in the Committee’s discretion. The Committee may determine the amount of any reduction on the basis of such factors as it deems relevant, and will not be required to establish any allocation or weighting with respect to the factors it considers.

(e) Discretion to Determine Criteria. Notwithstanding any contrary provision of the Plan, the Committee will, in its sole discretion, determine the performance goals applicable to any Target Award which requirement may include, without limitation, (i) attainment of research and development milestones, (ii) sales bookings, (iii) business divestitures and acquisitions, (iv) cash flow, (v) cash position, (vi) earnings (which may include any calculation of earnings, including but not limited to earnings before interest and taxes, earnings before taxes, earnings before interested, taxes, depreciation and amortization and net earnings), (vii) earnings per share, (viii) net income, (ix) net profit, (x) net sales, (xi) operating cash flow, (xii) operating expenses, (xiii) operating income, (xiv) operating margin, (xv) overhead or other expense reduction, (xvi) product defect measures, (xvii) product release timelines, (xviii) productivity, (xix) profit, (xx) return on assets, (xxi) return on capital, (xxii) return on equity, (xxiii) return on investment, (xxiv) return on sales, (xxv) revenue, (xxvi) revenue growth, (xxvii) sales results, (xviii) sales growth, (xxix) stock price, (xxx) time to market, (xxxi) total stockholder return, (xxxii) working capital, (xxxiii) individual objectives such as peer reviews or other subjective or objective criteria, and (xxxiv) consummation of financial transactions. As determined by the Committee, the performance goals may be based on generally accepted accounting principles (“GAAP”) or non-GAAP results and any actual results may be adjusted by the Committee for one-time items or unbudgeted or unexpected items when determining whether the performance goals have been met. The goals may be on the basis of any factors the Committee determines relevant, and may be on an individual, divisional, business unit or Company-wide basis. Any criteria used may be measured on such basis as the Committee determines, including but not limited to, as applicable, (A) in absolute terms, (B) in combination with another performance goal or goals (for example, but not by way of limitation, as a ratio or matrix), (C) in relative terms (including, but not limited to, results for other periods, passage of time and/or against another company or companies or an index or indices), (D) on a per-share basis, (E) against the performance of the Company as a whole or a segment of the Company and/or (F) on a pre-tax or after-tax basis. The performance goals may differ from Participant to Participant and from award to award. Failure to meet the goals will result in a failure to earn the Target Award, except as provided in Section 3(d).

4. Payment of Awards.

(a) Right to Receive Payment. Each Actual Award will be paid solely from the general assets of the Company. Nothing in this Plan will be construed to create a trust or to establish or evidence any Participant’s claim of any right other than as an unsecured general creditor with respect to any payment to which he or she may be entitled.

(b) Timing of Payment. Payment of each Actual Award shall be made as soon as practicable after the end of the Performance Period during which the Actual Award was earned and after the Actual Award is approved by the Committee, but in no event following the later of (i) the fifteenth (15th) day of the third (3rd) month of the Fiscal Year immediately following the Fiscal Year in which the Participant’s Actual Award has been earned and no longer

-3-

is subject to a substantial risk of forfeiture, and (ii) March 15 of the calendar year immediately following the calendar year in which the Participant’s Actual Award has been earned and no longer is subject to a substantial risk of forfeiture. Unless otherwise determined by the Committee, to earn an Actual Award a Participant must be employed by the Company or any Affiliate on the date the Actual Award is paid.

It is the intent that this Plan comply with the requirements of Code Section 409A so that none of the payments to be provided hereunder will be subject to the additional tax imposed under Code Section 409A, and any ambiguities herein will be interpreted to so comply.

(d) Payment in the Event of Death or Disability. If a Participant dies or becomes Disabled prior to the payment of an Actual Award earned by him or her prior to death or Disability for a prior Performance Period, the Actual Award will be paid to his or her estate or to the Participant, as the case may be, subject to the Committee’s discretion to reduce or eliminate any Actual Award otherwise payable.

5. Plan Administration.

(a) Committee is the Administrator. The Plan will be administered by the Committee. The Committee will consist of not less than two (2) members of the Board. The members of the Committee will be appointed from time to time by, and serve at the pleasure of, the Board.

(b) Committee Authority. It will be the duty of the Committee to administer the Plan in accordance with the Plan’s provisions. The Committee will have all powers and discretion necessary or appropriate to administer the Plan and to control its operation, including, but not limited to, the power to (i) determine which Employees will be granted awards, (ii) prescribe the terms and conditions of awards, (iii) interpret the Plan and the awards, (iv) adopt such procedures and subplans as are necessary or appropriate to permit participation in the Plan by Employees who are foreign nationals or employed outside of the United States, (v) adopt rules for the administration, interpretation and application of the Plan as are consistent therewith, and (vi) interpret, amend or revoke any such rules.

(c) Decisions Binding. All determinations and decisions made by the Committee, the Board, and any delegate of the Committee pursuant to the provisions of the Plan will be final, conclusive, and binding on all persons, and will be given the maximum deference permitted by law.

(d) Delegation by Committee. The Committee, in its sole discretion and on such terms and conditions as it may provide, may delegate all or part of its authority and powers under the Plan to one or more directors and/or officers of the Company.

(e) Indemnification. Each person who is or will have been a member of the Committee will be indemnified and held harmless by the Company against and from (i) any loss,

-4-

cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action taken or failure to act under the Plan or any award, and (ii) from any and all amounts paid by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such claim, action, suit, or proceeding against him or her, provided he or she will give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company’s Certificate of Incorporation or Bylaws, by contract, as a matter of law, or otherwise, or under any power that the Company may have to indemnify them or hold them harmless.

6. General Provisions.

(a) Tax Withholding. The Company will withhold all applicable taxes from any Actual Award, including any federal, state and local taxes (including, but not limited to, the Participant’s FICA and SDI obligations).

(b) No Effect on Employment or Service. Nothing in the Plan will interfere with or limit in any way the right of the Company to terminate any Participant’s employment or service at any time, with or without cause. For purposes of the Plan, transfer of employment of a Participant between the Company and any one of its Affiliates (or between Affiliates) will not be deemed a Termination of Service. Employment with the Company and its Affiliates is on an at-will basis only. The Company expressly reserves the right, which may be exercised at any time and without regard to when during a Performance Period such exercise occurs, to terminate any individual’s employment with or without cause, and to treat him or her without regard to the effect that such treatment might have upon him or her as a Participant.

(c) Participation. No Employee will have the right to be selected to receive an award under this Plan, or, having been so selected, to be selected to receive a future award.

(d) Successors. All obligations of the Company under the Plan, with respect to awards granted hereunder, will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business or assets of the Company.

(e) Beneficiary Designations. If permitted by the Committee, a Participant under the Plan may name a beneficiary or beneficiaries to whom any vested but unpaid award will be paid in the event of the Participant’s death. Each such designation will revoke all prior designations by the Participant and will be effective only if given in a form and manner acceptable to the Committee. In the absence of any such designation, any vested benefits remaining unpaid at the Participant’s death will be paid to the Participant’s estate.

(f) Nontransferability of Awards. No award granted under the Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will, by the laws of descent and distribution, or to the limited extent provided in Section 6(e). All rights with respect to an award granted to a Participant will be available during his or her lifetime only to the Participant.

-5-

7. Amendment, Termination, and Duration.

(a) Amendment, Suspension, or Termination. The Board, in its sole discretion, may amend or terminate the Plan, or any part thereof, at any time and for any reason. The amendment, suspension or termination of the Plan will not, without the consent of the Participant, alter or impair any rights or obligations under any Actual Award theretofore earned by such Participant. No award may be granted during any period of suspension or after termination of the Plan.

(b) Duration of Plan. The Plan will commence on the date specified herein, and subject to Section 7(a) (regarding the Board’s right to amend or terminate the Plan), will remain in effect thereafter.

8. Legal Construction.

(a) Gender and Number. Except where otherwise indicated by the context, any masculine term used herein also will include the feminine; the plural will include the singular and the singular will include the plural.

(b) Severability. In the event any provision of the Plan will be held illegal or invalid for any reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provision had not been included.

(c) Requirements of Law. The granting of awards under the Plan will be subject to all applicable laws, rules and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.

(d) Governing Law. The Plan and all awards will be construed in accordance with and governed by the laws of the State of California, but without regard to its conflict of law provisions.

(e) Bonus Plan. The Plan is intended to be a “bonus program” as defined under U.S. Department of Labor regulation 2510.3-2(c) and will be construed and administered in accordance with such intention.

(f) Captions. Captions are provided herein for convenience only, and will not serve as a basis for interpretation or construction of the Plan.

-6-

EX-23.1 4 d852944dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Invuity, Inc. of our report dated March 13, 2015 relating to the financial statements of Invuity, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

San Jose, CA

May 12, 2015

GRAPHIC 5 g852944g05n61.jpg GRAPHIC begin 644 g852944g05n61.jpg M_]C_X18J17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!```` M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4 M````D(=I``0````!````I````-``"OR````G$``*_(```"<0061O8F4@4&AO M=&]S:&]P($-3-B`H5VEN9&]W`1L`!0````$```$F`2@``P````$``@`` M`@$`!`````$```$N`@(`!`````$``!3T`````````$@````!````2`````'_ MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D) M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P, M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`H`!\`P$B``(1 M`0,1`?_=``0`"/_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$` M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,! M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56 M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$# M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:F MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`\ZK:7O:QO+B`)\T[2GQC M&148F'C0=]>$MI9`/):':>#AN"(W21Z0?$A(U&8@,*U7="ZO4\M./O`CWL>P ML]PW>U[G-_=3XEC(0,5JEIB9'WB54`"O,<(633;"M-R-.59C(]Q]C1R1B?T9?XW_H#9N<(6=>))U'WJRPV MY%K::0'6.G:UQV[B!N]-G[UK_P#!5_X57NAT85O5>GXW4*&@[LAEC+QH]C*+ MG@Y;+CN9?5D[-GJJ/-D,:ZV:TW'IXMOTOE7X81XHCA.NGS?^@O,6*O8NU=B] M"_9EF9730,_!Z)CW68MK&.KNL>W&R*LUE?\`I][,G%S?\);]HI_TJFS!^JV+ MU?!8^O&OQ>O9-F7CNN#"VG$.*[[+AO8\?JN_JN3Z=;6/_P"TM2JSG?1T<>.A MN\`]!*[F[IV-T'ZMW7Y_3L-_6.GXF)8ZG);7=-C\W)KL];TGN];U<3TM_P"D M_FO31LVCZO9OUXO^K#\'#Q>F65MJIR\-E=-S'MJKZGZ_VHMM;[]M^&[;Z?Z* MQ0DLH#YZ5%7.I=0KS\FV^G%IPZ++7VTT4L:W8QP8RN@OK:S>VNNIGYG\]Z]W M^&5-!+__T//,4_K-7]I5?38P?!X= MWI9HYFYKF_KF)=ZC/T?V?)JOK2NZ7D8U5EUK:RVK^<#22X>^ZCZ&UN[]-B9# M?;^XA,Z+UF);T_*@S!;4_4#Z7T6HE?3>L2^,7(#V,:]S=K@_T[-[6V;/INI? MMM]_\W_VXG@L9;=G2.H8]9LL8WTV$-)8[=[IV^EM8-_J_0]G_"56?S=M:`UR M%;CYF(ZMV1790^UI+"^6N+6N=2]NON]EE>UU:9KU)&=,6%LNMD0=0A6.#YW^[=R7:S\90S8H.>A+(NAAI9^SP&AD:=_WD>OJ.'4 MP-=TG#N=M#7V/];<_3:][VMN]'U7_P"D;7^C?]!5'/07.4$C;8B*;KNH].%A M=7T7#:T;MC2_(=&[:)>XW[K/38UWI_S7OL]7_1H9ZE@FMAKF>'IU]_%H2Z_1?_ M`)+_``OV,\<676"LW^@"'.+[;'M8W:UUAW%F]WYNUFUG\XK+,6LAY/4L=KJW M;6R^V'-#2\V5O]/Z&[]"QFW^<5`/9Y>/*EO9S_%.8T[W.#RPV>J&$AKPYSFG M^57ZGNV._JIP]`#VGC7YI_4:.=/FC:FR'I_45/#\4;17@F+U$O0? M59XC[TQL9_J4+53-SU`E,;&>7WJ.]GE]Z"5R4Q3;V?ZE(.:>-?F@E29)))3_ M`/_2\ZQA.14#W>..>4[WN8YKFF#Z36R==',]-_TA^X[^PFQA.34!,[Q$:&9T MA*Q[PYKF.+'&IK21H8;O0:*F/#A[FO]M3'_RDS.J9;+#=6^MKP2\N%-.A<&U..WTMK/:UK?\`S.Q6 MW=>O_Z"G3U#)HK].LL# M&.+COIJLASMN[<^^JQWNV,1,;J^92T^I;?T\P=.?<$I!'CX MK0?UW,=5M8^YMI#0ZUV0^P':=V[T;@ZO_P`@J5^3D9!#LBU]Q:-H-CBX@<[? M+#8(??))9Z6]OI6>GO]-K*MW]1 M.>O6,:YE?JN+N;1D7,DB!N#27O\`HM:SZ7T/\&DI;]L5;+&"JV7DAX#,<2"? M8QT8F]OZ#V-V?0_G*DPZS0X-:ZJRQA!K:TMQB?3V[&L8[[)N]5C_`*+VIOVV MZ6GT[B00;"N6$?I1D/LT)M&7:'2TE];F[@_Z%OZ M5)2._J;['-?C5D-&L64T/&F[:YGHXU;&M]]N]G\VJV3E9&2YKL@@N8(:0QM9 MB?\`@F5[O[2N'K=XJ M=SHDNU-P\3_`-3[E9Q->H8\[7?HVDAU==C8],Z&C*LIHL]O[]M? MO_F_TB75?_D_\+]C`8+)(^V8@AQ;)L=&D>\?HOH:I'!8#'VS$,"9%CB.=FW^ M:^E^=_45^S#H;2\MKJ!:UX:X,H)['>_]>]MM=C'L;[+J_21,BO$PZ_5MQJK* MW.%;7^A4X$^VQT_9L\[OW/H5?SGYB2QS/L-9L+!G8FT`D/+W`&)]O\UNW.A, MS$K=LW9>.SU&N/N<\[2T3Z=VVL^GO^C6_P#FU8^U],]!^VMC;2S8UOV4$206 MN?ZSLM[FN_E[/I^GZ:E]LZ2(:*6EH&KCB-W3)TVMSOH[-OYV_>BIKMPV-<=N M;B$C0[G$C^SOI,W";M,.:_:P_%K74?I&._?8IUY?3&!\M#W00U MS\2L[I+G[[/UMK:[/TCJ_P!$W^:])."!]KP3N:'`AS(@ES7?X'VN9L][/I_00+\44%S3D46N9M$5/ MWSN#7>Q^W8[9N]ZNMR^D;`'5LW0&DG#!.@#=VYN]VW>FJR^F#TR\-F2 M7#[%6X-W;VOJ_I;?5K:U^^K\]GZ))3F)+2.5TJ`[8T.!(AN&V"(=7/OS/SMV M_P#TGJ)W9?2=P+:FDM+C_1&@&1L:Q[/MK]S-7?N6>IZ=J2G,E):+,KIK8``# M1LT=AUO,R]UO_:EO[W]O]%5_@U"_(P!0:\=C7N$M#GXP82'>WU3=]KN?ZM?^ M"_1_UTE-%))))3__U/.L?^D5^3@>8XU^E^:I!EEES&UUF]_I-(KV[Y#6;G>R MOW?HV-W_`,A1QH^TU3QO;/)TG^2C8QK&927CV^F-(W:FL[?:VRC\_P#X;>EU M7_Y/_"_8N,3/+_3'327_`+OH63W'$_R'I-QLUS!8WITL)+0X46$$M^FW0_FJ M^^[#VAT,#7'01<&$`%N_<[J7NM_P`!5_F._P#)JSE%C[8H])M38#=A+#)'NW[\B^SZ?[]W_%_N M(.QW[S?'^=[?]NI*8>M_P%7^8[_R:7K?\!5_F._\FI['?OL_[=_]2J0IM=JT M@_"P_P#I5)2+UO\`@*?\P_\`DU=JJP?2J?DV5X[K:S8UKL=SA],ULVN%WOJ> MUC_TNW^=_1?\*JSL>\MB`>--_P#Y.S:GMQ[',H#&B65!MFK1[M]CO]*[U/8] MGZ3]'_424NT#2Q]=#<=UCJQ;L.NS8;/3!?[W-KMKLV;_`/")\C[,T@8[\>YI M9+G%CJR':^QC76/W>W\]1=CV'&K8&CU&V6.=JWZ+FTMK]_J^[W5V^ST_T?[] MGJ?HQG&O`)+1`$GW,[?VTE(DDDDE/__5\YQR!?620!N$DZ#^TK&*US\[':76 MU_HVDOHCU0UM>_=7ZCJ6?F_Z1`QC&148F'MT^?DCXS;3G4M9M98:Q!=5ZS1^ MB)EV,&7^I[?^"]G\\EU7_P"3_P`+]C=%?4*]Q^UY]1>7.O\`T0C<&"][MPRO MIN_0_P#?U.S'ZH\.#VZI_I_GU?X3TT5B9]?40R79G4?1<170TULW%KP/3!9]K]C7.;M_ZVE9 M1U=NAR^H.A^U[O2860.X>W,=_@6/>QO\A4W8MF30&OMQP?YP-JQ+&N_ZY=3A MUNV/W>S;ZU:&>CL],V5Y-5K`[;^CJR-T$.[>]N]C/\`A%G'HVG](I,#6*LK007?G8;?W5$])VV>F^ZIC@7!^ZK)&R"6 MM]3]4W-]7;^C_P#!?224Z1Q^M"MHJR,X[GGTVFIC&[C_`#6Y_P!I-=*VL=95_A7_`+WL0/V8`UA-U32^9::L M@%L"??\`JNWZ7Z/V;_>IOZ,YC&O%M;FEVTN%.2`/Y6Y^(W\[V?OI*3NZ(W>Y ME;L&3^^YN4?WFN4;.B['2&9.PD@%]#&Q)VU;G?:'M]SOIO0F]'8 M\@,R:'3.K:LHB!^=_0DF](#BTC(I8UP/N?7>T!XAKZ-,5VZUKB[Z'[B2DG[& M#FD5>N^P;AZ?H5@[FB2T_KCGM^E7[O30\SIAQZ&Y#&W.J+W-+[:V5``$,9[6 M77OW.M]1G]A,>E`-D6UN=V:VG(X`<>78K?IN#:Z_^,_P:JFBROW/J=7&A+F% ML$_FR0DI9))))3__UO.L<3D5#Q>T:?%'Q'FO.HW^RU+JO\`\G_A M?L=!N7U!];?4.*_TSM:;,^S=$[=K=O4-NQNW]U0KMS6/9M&*_>`T-^VN@\N: M+-F=7M_/_P"N6K/&)E%X8*+-Q(:!L,2X^FP;HV>ZSV?23G`S10+SCV>BYWIA M^TD%W[HA%8Z;[9Z3*]C/=^@_S%7N.<7.- M5]&.UC)V49A+7!I_,];)N?ZGZ7V5[_\`BUG.8YCBUS2UPT+7""/BTIDE.A:S MJ;B&6YS'M)B3FL>W4.EW\\[V[=[/H_\`!_X1)IZO#7MS@TR'C]>8'!P^BZ/7 MW;FJD*+36VQM;G,JP2[.:Z"/^US M"9;[FNV^O^;M5>WIV?3:^FS&M%M<;VAA=$\:L#F_G(+JK&`.?6YC7?1+FEH/ M]7<$E-RL]3`])N:&,=$C[8T-X]0;HN_UL]B%9=GT.V.R7'<1:?2O]1NZ?IN? M38]GK?\`@BK)TE-FO+ZC?:&_;+0YY]S[+W-;J?IV6.>HY3LH$,NR?M`<`[VW M&UOM+@W=[OI-W?\`30&M<]P8T;G.(#0.23HT*Q^SL\!Q./8W:2'2(@M:ZU_/ M[M5;[$E-=))))3__U_.\43DTB)][=/FF>^QCVN:[8XU!LLT]KF>F]O\`;KUY&[:9VGND]Y>03R&M;_FC:EU7V."NO%;9?U?JMCFNLR[7["PAKG; MFS7M]-SJW36]WZ-C_>W])9^DL]ZC^T^J:?KM_MC;^D=IM_F]NO\`@_S%6216 M,K;++K'6VN+['F7./[]#2[9_A/1K5YV31;2*CUS*%=K7#(J MMKMX_2_26?\`;BC:^M[@:ZA2`#+6N$\)*8PE"E"4)*8PE"E"4)*8PE"E"4)*8PE"E"4)*8PFA3A-"2F, M)*4)H24__]G_[1\$4&AO=&]S:&]P(#,N,``X0DE-!`0``````"$<`5H``QLE M1QP"```"```<`@4`#7!R:6YT;6=R(&9I;&4`.$))300E```````0"<2=#`TR M":T*.P^V)B,ZT3A"24T$.@`````!AP```!`````!```````+<')I;G1/=71P M=70````(````"6AA#A"24T$&0``````!````!XX0DE-`_,````` M``D```````````$`.$))32<0```````*``$``````````3A"24T#]0`````` M2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!: M````!@```````0`U`````0`M````!@```````3A"24T#^```````<```____ M_________________________P/H`````/__________________________ M__\#Z`````#_____________________________`^@`````____________ M_________________P/H```X0DE-!`````````(``#A"24T$`@```````@`` M.$))300P```````!`0`X0DE-!"T```````8``0````(X0DE-!`@``````!`` M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#30`` M``8``````````````W````*H````#`!2`$4`5@!?`$,`3P!6`%\`-0!?`#$` M,@````$``````````````````````````0`````````````"J````W`````` M`````````````````0`````````````````````````0`````0```````&YU M;&P````"````!F)O=6YD'1)D%L:6=N96YU;0`` M``]%4VQI8V5(;W)Z06QI9VX````'9&5F875L=`````EV97)T06QI9VYE;G5M M````#T53;&EC959E7!E M96YU;0```!%%4VQI8V5"1T-O;&]R5'EP90````!.;VYE````"71O<$]U='-E M=&QO;F<`````````"FQE9G1/=71S971L;VYG``````````QB;W1T;VU/=71S M971L;VYG``````````MR:6=H=$]U='-E=&QO;F<``````#A"24T$*``````` M#`````(_\````````#A"24T$$0```````0$`.$))3004```````$`````CA" M24T$#``````5$`````$```!\````H````70``.B````4]``8``'_V/_M``Q! M9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1 M%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`H`!\`P$B``(1`0,1`?_= M``0`"/_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$! M`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A M$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$ MDU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:V MQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%1 M87$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G M-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`\ZK:7O:QO+B`)\T[2GQC&148F'C0 M=]>$MI9`/):':>#AN"(W21Z0?$A(U&8@,*U7="ZO4\M./O`CWL>PL]PW>U[G M-_=3XEC(0,5JEIB9'WB54` M"O,<(633;"M-R-.59C(]Q]C1R1B?T9?XW_H#9N<(6=>))U'WJRPVY%K::0'6 M.G:UQV[B!N]-G[UK_P#!5_X57NAT85O5>GXW4*&@[LAEC+QH]C*+G@Y;+CN9 M?5D[-GJJ/-D,:ZV:TW'IXMOTOE7X81XHCA.NGS?^@O,6*O8NU=B]"_9EF973 M0,_!Z)CW68MK&.KNL>W&R*LUE?\`I][,G%S?\);]HI_TJFS!^JV+U?!8^O&O MQ>O9-F7CNN#"VG$.*[[+AO8\?JN_JN3Z=;6/_P"TM2JSG?1T<>.AN\`]!*[F M[IV-T'ZMW7Y_3L-_6.GXF)8ZG);7=-C\W)KL];TGN];U<3TM_P"D_FO31LVC MZO9OUXO^K#\'#Q>F65MJIR\-E=-S'MJKZGZ_VHMM;[]M^&[;Z?Z*Q0DLH#YZ M5%7.I=0KS\FV^G%IPZ++7VTT4L:W8QP8RN@OK:S>VNNIGYG\]Z]W^&5-!+__ MT//,4_K-7]I5?38P?!X=WI9HYFYK MF_KF)=ZC/T?V?)JOK2NZ7D8U5EUK:RVK^<#22X>^ZCZ&UN[]-B9#?;^XA,Z+ MUF);T_*@S!;4_4#Z7T6HE?3>L2^,7(#V,:]S=K@_T[-[6V;/INI?MM]_\W_V MXG@L9;=G2.H8]9LL8WTV$-)8[=[IV^EM8-_J_0]G_"56?S=M:`UR%;CYF(ZM MV1790^UI+"^6N+6N=2]NON]EE>UU:9KU)&=,6%L MNMD0=0A6.#YW^[=R7:S\90S8H.>A+(NAAI9^SP&AD:=_WD>OJ.'4P-=TG#N= MM#7V/];<_3:][VMN]'U7_P"D;7^C?]!5'/07.4$C;8B*;KNH].%A=7T7#:T; MMC2_(=&[:)>XW[K/38UWI_S7OL]7_1H9ZE@FMAKF>'IU]_%H2Z_1?_`)+_``OV M,\<676"LW^@"'.+[;'M8W:UUAW%F]WYNUFUG\XK+,6LAY/4L=KJW;6R^V'-# M2\V5O]/Z&[]"QFW^<5`/9Y>/*EO9S_%.8T[W.#RPV>J&$AKPYSFG^57ZGNV. M_JIP]`#VGC7YI_4:.=/FC:FR'I_45/#\4;17@F+U$O0?59XC[TQL M9_J4+53-SU`E,;&>7WJ.]GE]Z"5R4Q3;V?ZE(.:>-?F@E29)))3_`/_2\ZQA M.14#W>..>4[WN8YKFF#Z36R==',]-_TA^X[^PFQA.34!,[Q$:&9TA*Q[PYKF M.+'&IK21H8;O0:*F/ M#A[FO]M3'_RDS.J9;+#=6^MKP2\N%-.A<&U..WTMK/:UK?\`S.Q6W=>O_Z"G3U#)HK].LL#&.+COIJL MASMN[<^^JQWNV,1,;J^92T^I;?T\P=.?<$I!'CXK0?UW,=5 MM8^YMI#0ZUV0^P':=V[T;@ZO_P`@J5^3D9!#LBU]Q:-H-CBX@<[?+#8(??))9Z6]OI6>GO]-K*MW]1.>O6,:YE M?JN+N;1D7,DB!N#27O\`HM:SZ7T/\&DI;]L5;+&"JV7DAX#,<2"?8QT8F]OZ M#V-V?0_G*DPZS0X-:ZJRQA!K:TMQB?3V[&L8[[)N]5C_`*+VIOVVZ6GT[B00 M;"N6$?I1D/LT)M&7:'2TE];F[@_Z%OZ5)2._J;[ M'-?C5D-&L64T/&F[:YGHXU;&M]]N]G\VJV3E9&2YKL@@N8(:0QM9B?\`@F5[ MO[2N'K=XJ=SHDNU-P\3_`-3[E9Q->H8\[7?HVDAU==C8],Z&C*LIHL]O[]M?O_F_TB75 M?_D_\+]C`8+)(^V8@AQ;)L=&D>\?HOH:I'!8#'VS$,"9%CB.=FW^:^E^=_45 M^S#H;2\MKJ!:UX:X,H)['>_]>]MM=C'L;[+J_21,BO$PZ_5MQJK*W.%;7^A4 MX$^VQT_9L\[OW/H5?SGYB2QS/L-9L+!G8FT`D/+W`&)]O\UNW.A,S$K=LW9> M.SU&N/N<\[2T3Z=VVL^GO^C6_P#FU8^U],]!^VMC;2S8UOV4$206N?ZSLM[F MN_E[/I^GZ:E]LZ2(:*6EH&KCB-W3)TVMSOH[-OYV_>BIKMPV-<=N;B$C0[G$ MC^SOI,W";M,.:_:P_%K74?I&._?8IUY?3&!\M#W00US\2L[I+G M[[/UMK:[/TCJ_P!$W^:])."!]KP3N:'`AS(@ES7?X'VN9L][/I_00+\44%S3D46N9M$5/WSN#7>Q^ MW8[9N]ZNMR^D;`'5LW0&DG#!.@#=VYN]VW>FJR^F#TR\-F27#[%6X-W M;VOJ_I;?5K:U^^K\]GZ))3F)+2.5TJ`[8T.!(AN&V"(=7/OS/SMV_P#TGJ)W M9?2=P+:FDM+C_1&@&1L:Q[/MK]S-7?N6>IZ=J2G,E):+,KIK8``#1LT=AUO, MR]UO_:EO[W]O]%5_@U"_(P!0:\=C7N$M#GXP82'>WU3=]KN?ZM?^"_1_UTE- M%))))3__U/.L?^D5^3@>8XU^E^:I!EEES&UUF]_I-(KV[Y#6;G>ROW?HV-W_ M`,A1QH^TU3QO;/)TG^2C8QK&927CV^F-(W:FL[?:VRC\_P#X;>EU7_Y/_"_8 MN,3/+_3'327_`+OH63W'$_R'I-QLUS!8WITL)+0X46$$M^FW0_FJ^^[#VAT, M#7'01<&$`%N_<[J7NM_P`!5_F._P#)JSE%C[8H])M38#=A+#)'NW[\B^SZ?[]W_%_N(.QW[S?' M^=[?]NI*8>M_P%7^8[_R:7K?\!5_F._\FI['?OL_[=_]2J0IM=JT@_"P_P#I M5)2+UO\`@*?\P_\`DU=JJP?2J?DV5X[K:S8UKL=SA],ULVN%WOJ>UC_TNW^= M_1?\*JSL>\MB`>--_P#Y.S:GMQ[',H#&B65!MFK1[M]CO]*[U/8]GZ3]'_42 M4NT#2Q]=#<=UCJQ;L.NS8;/3!?[W-KMKLV;_`/")\C[,T@8[\>YI9+G%CJR' M:^QC76/W>W\]1=CV'&K8&CU&V6.=JWZ+FTMK]_J^[W5V^ST_T?[]GJ?HQG&O M`)+1`$GW,[?VTE(DDDDE/__5\YQR!?620!N$DZ#^TK&*US\[':76U_HVDOHC MU0UM>_=7ZCJ6?F_Z1`QC&148F'MT^?DCXS;3G4M9M98:Q!=5ZS1^B)EV,&7^ MI[?^"]G\\EU7_P"3_P`+]C=%?4*]Q^UY]1>7.O\`T0C<&"][MPROIN_0_P#? MU.S'ZH\.#VZI M_I_GU?X3TT5B9]?40R79G4?1<170TULW%KP/3!9]K]C7.;M_ZVE91U=NAR^H M.A^U[O2860.X>W,=_@6/>QO\A4W8MF30&OMQP?YP-JQ+&N_ZY=3AUNV/W>S; MZU:&>CL],V5Y-5K`[;^CJR-T$.[>]N] MC/\`A%G'HVG](I,#6*LK007?G8;?W5$])VV>F^ZIC@7!^ZK)&R"6M]3]4W-] M7;^C_P#!?224Z1Q^M"MHJR,X[GGTVFIC&[C_`#6Y_P!I-=*VL=95_A7_`+WL0/V8`UA-U32^9::L@%L"??\` MJNWZ7Z/V;_>IOZ,YC&O%M;FEVTN%.2`/Y6Y^(W\[V?OI*3NZ(W>YE;L&3^^YN4?WFN4;.B['2&9.PD@%]#&Q)VU;G?:'M]SOIO0F]'8\@,R:'3. MK:LHB!^=_0DF](#BTC(I8UP/N?7>T!XAKZ-,5VZUKB[Z'[B2DG[&#FD5>N^P M;AZ?H5@[FB2T_KCGM^E7[O30\SIAQZ&Y#&W.J+W-+[:V5``$,9[677OW.M]1 MG]A,>E`-D6UN=V:VG(X`<>78K?IN#:Z_^,_P:JFBROW/J=7&A+F%L$_FR0DI M9))))3__UO.L<3D5#Q>T:?%'Q'FO.HW^RU+JO\`\G_A?L=!N7U! M];?4.*_TSM:;,^S=$[=K=O4-NQNW]U0KMS6/9M&*_>`T-^VN@\N:+-F=7M_/ M_P"N6K/&)E%X8*+-Q(:!L,2X^FP;HV>ZSV?23G`S10+SCV>BYWIA^TD%W[HA M%8Z;[9Z3*]C/=^@_S%7N.<7.-5]&.UC)V M49A+7!I_,];)N?ZGZ7V5[_\`BUG.8YCBUS2UPT+7""/BTIDE.A:SJ;B&6YS' MM)B3FL>W4.EW\\[V[=[/H_\`!_X1)IZO#7MS@TR'C]>8'!P^BZ/7W;FJD*+3 M6VQM;G,JP2[.:Z"/^US"9;[FNV^ MO^;M5>WIV?3:^FS&M%M<;VAA=$\:L#F_G(+JK&`.?6YC7?1+FEH/]7<$E-RL M]3`])N:&,=$C[8T-X]0;HN_UL]B%9=GT.V.R7'<1:?2O]1NZ?IN?38]GK?\` M@BK)TE-FO+ZC?:&_;+0YY]S[+W-;J?IV6.>HY3LH$,NR?M`<`[VW&UOM+@W= M[OI-W?\`30&M<]P8T;G.(#0.23HT*Q^SL\!Q./8W:2'2(@M:ZU_/[M5;[$E- M=))))3__U_.\43DTB)][=/FF>^QCVN:[8XU!LLT]KF>F]O\`;KU MY&[:9VGND]Y>03R&M;_FC:EU7V."NO%;9?U?JMCFNLR[7["PAKG;FS7M]-SJ MW36]WZ-C_>W])9^DL]ZC^T^J:?KM_MC;^D=IM_F]NO\`@_S%6216,K;++K'6 MVN+['F7./[]#2[9_A/1K5YV31;2*CUS*%=K7#(JMKMX_2_26?\`;BC:^M[@:ZA2`#+6N$\)*8PE"E"4)*8PE"E"4)*8PE"E"4)*8PE"E"4)*8PFA3A-"2F,)*4)H24_ M_]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O M`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"`` M0P!3`#8````!`#A"24T$!@``````!P`(`````0$`_^$0CVAT='`Z+R]N&%P+S$N,"\`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`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(#P_>'!A8VME="!E;F0](G'EZA8:' MB(F*E)66EYB9FJ2EIJ>HJ:JTM;:WN+FZQ,7&Q\C)RM35UM?8V=KDY>;GZ.GJ M]/7V]_CY^A$``@$#`@0$`P4$!`0&!@5M`0(#$00A$@4Q!@`B$T%1!S)A%'$( M0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.#DT9T MPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:FML;6 MYO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ: MJKK*VNKZ_]H`#`,!``(1`Q$`/P#2K%M-OS?Z_P"%OI[6CCU0<.LP^@_UA[]Y M];ZYC\_[#_B?;@Z:?B.LBFQ!_H?=AQZT.'4A?]?_`'P)_P"*^[#UZL>NHO\` MHH?\1[]UKJ4OX_UQ_O8]N#JGD>I2?7_??T][Z]Y'K+_Q'NPXCJO69/H/]C_Q M/MP=4_%U,7\C_??[[CWOJAXGJ7'_`&?]8?\`$>]CJH\^IT-_\/TV_P!CQ_Q7 MVX.JMD]3HQP.>/\`>N?=QZ=4ZF1\?[;_`(I[=7JAZDIGU3_&X_P!YO_Q'MU>J-U+3ZC_@P_XGVJ3CTE?A MU.C_`!_KC_B/:A>DI].IL7-_]8_[W[6)TB;BW3@GZO\`"XM[4Q\!TDDKJZG) M_9_Q/_&O:V/ATC?)QU/``_V)_P"1>UL.2.D,V!]IZF1\?X7/T_P`/_%?9A'T M7RF@R.IR#Z'_``_XD>UL717=?AZE0?0?GGGZ?[[GV:1=!ZG.*W' MT_Q_V)%O];V81CAT47%.(ZFQ_P"\DGG_`(C_`&/M:G'[.B>;%/MZ>J07(O\` MU_XGVK3I#(>E11KR!_K0Z12&A)IT_TH M^G']./\`8?\`&_:Y.'11,14GSZ4E,OT_WWXY]K(QP'11.:DFO2CI%Y'^^_'M M9'GHGE-,DYZ5U$GTN/\`#\?BW]/Z>U4>0.D$YID\.E=0Q\C\6^OT_/T]K4X= M$\I[LG/2LI5O;^MQ?@?U_P"*^U:#(Z+YV].->E+2Q_I%OZ?T_P!]]?:Z,<,X MZ*)6/=Z]*.F0@"X'^)_K<'^GY]K8U^?19<2D*3IQY]/$,=@/Z'D'C^G/^V/M M:@Z)I&`)JV.G&.._^\@V/^M];?GVH537I#)(*4!ZD^$'Z@G_`%@/]X]N@`5Z M8)+4KUQ:$6X'U_K_`,:Y'O7'KU"!D<>HTD?UY_/]!_A]/I;VRRYX8Z4QO44U M=-TT?Y'^/]./^*^V'6E>ET,G"AZ9JJ.X)_(_P']1^?:*04X#'1S"]>)JW2'29JD_5^0/]X)OQ]?9>XH3CHW@:HXXKTD MJU.6_`_K_L+C_;^TK^7KT80G)].DA6K<$GG]7XX^G_$>T;\:='$)-*]).K6Q M8?Z_X_']/]N/:-_,TZ,H&`(!/2;JE-B#_4_\1[0R8QT=6_D?3I.50X(']?\` MB?:"7B>CR"M!TF*L6O8?GZ_UY(]H9./1G">W\^DQ5@7('XM[12<.C./B/LZ8 MIA<7M_R.Q]HI//HV@^%">FJ?B_\`KC_>;>RZ4='-NQI^?37)]3_K$?[Q<#_; M^RR;SZ/K6I"@'RZ;IOH3?Z<^RZ3HZB/#/#INE'J_WW].?9=+Y]&K'VB?CT8H<#IKE_M?[[^OM')Y4Z61<>FZ M;]+?TM_Q'_%?:1NE:TZ;)>%^@Y-K_GCVG;[>E"8ZAN/U_M*Y\O+I2 MHZ;I/K]>+Z'CU8?Y>H4WZOQ]/I^?=&ZOY=-\GU(_IQ_O/NOD>G/PCJ*WU_V)_P![ M]T;AU8>77!OI_L?=#Y]77CU%8\G_`%[_`.W`_P"*>]'KR^?4=_Q[;/5EX=8A M^DW_`#<_[?WKK8X]8B?H/]?_`(C_`(I[J3U8\>L+?3_8^_>1Z;7CUQ]M-T_U MA;]1_P!A_O7O?X>M5S3K'[KU4\3UQ;]/^Q]U;AU91@]8O=.K=?_0TJ1[7#CT MV.'6=;_["RV_VW/OV*C[>K=LL M?(!_WC_87]W''JOG7J8I^O\`K#_>S[WTTW'J5&>!_OOI[L.M#CTX0_4_GC_D M7^]^[CJIZG)P/]:X_P!N+_[Q?W8<>J=2HR>/]8CV\O5#U+0_CVX./5.I$?T/ M^O\`\B]J%/39\^G",WT'^AO_`*U_^-GV\G'IMO7J8G'_`"4/]X]JEQ3I(YKC MJ=&?^AO\/I<>U"])VQU-B_//^J_V'/M8O2%^)Z<$_P"*>U,?ETGIP^MO]C_MC[70=()QPZFI_OO]C]/9A$<=%L_EU-4&RV_IS_MA M[70D=%EV#44ZEPCC_8@_[Q[,XLGH/W`H">G*'^G^MS_6Y'^]6]KT/1-.,4'K MTX1BQ'^Q_P!['_%?:Y#T4RBN3T]TH_3_`+#_`'NWM4O2"3B.E12#Z?[S_L/^ M1>WEZ3MQZ4=+R/K;Z<_[`^U<>*=(9.!J>E#2_P!GC^G^]#VM3@.B:![5IZ]%,Y\NE%1@ZE_IQ[6QC''/1-,348P.EC1?V?\2?]['/M5%P MZ17.%X>O2QHA]#_73_O8]K(QT434!U#I4T8Y'^-F_I^3_O5O:Q*]%DIR3Z]* M>E7])O\`T'^W)/M?%PZ*)S0D]*2G7\'@?2/K?JWM&W#HQC/>,=)RJ%@2?] MC_MB/][]H91D]'=N<9_U<.DY4_0D#Z#Z?['V@E'KT>6Y-*CRZ3%7]&_US_O# M$_\`$>T,G1G!\->DO5?5C_@?]C]?^*^T4GGT:1'A7TZ8IOH/]?\`XCVAD_%T M;P_"O33-_:_/(_WOV7S>71S:\33IJE%B>?S_`+V!Q[+)_/[.CRTJ"O4"4AP>FR4?J_V_^\$CVC?I='QZ;IOTD?X?\1?V ME;I8M.FR3D?["_\`K7/M*WGTH3@/3J$]_4?IQ_K_`.^^GM.WITI7ATWO;U?[ M'VG;RZ=7AU$?_BG_`!/MING1Y=19C_L/\?\`"U[>VF/5QPKTU.;M]+6_XI[I MU8=09OU?[?W1NK_YNH$OZC_K_P#$>Z^73AX#J(?K[;;AU;S'7!SQ_MS_`*UK MCW4]7&*GJ*W!)_UO^*>ZD]>&`3U'8_3_`%K^Z'JPX=8[^D?G@>]=;''K$WX_ MV]_^(]U/6SQZQ'C_`'W^!]^\CU1>/7#VTW3_`%A?]1_V'^]>_5[>M4ZQ^]=4 M/7![6_QO_L;>ZL?+JZ\#UP/NG5SU_]'2I'M<.(Z;7SZSK^D?[[\^]'CU;KD/ MJ/;B\!TV_64>]^G51Y]9U^H_U@?]?Z>[^G5C\/72\-:_X_WGZ_[U[]UKJ8OU M/^L?=AU7-3UG4WY_J+^[]:7CU(XX_P!]QQ[L#P/6NLL9L/I^?^*>W!Z]4K3B M.I2&_P#MK?Z_NW#JCCTZEH>+?T/_`!/OPZH./3A3\G6F]?GU M-3\_[[_??7W<<>FSQ/4Q.+'_``'^\CVZIX]4(ZDCD#BP'!/^%Q[=7JIZEH?J M/Z_C_6_/MY>'3;=38_H/^0;_`.''U]J%XCII^'4U"+V/]1_OO]@![5+Y=)6X M]3HSP3_@/]['M]./2=N-.IT7U/\`L?\`BOM4IZ2,O$]3T^O^P!_WKVKCZ228 MKU.3\?Z_M9'TBD%,^O3@IN1_OOZ>UT)H*](91JIU-C^B_P!=(!_WGV81>=>B MR>F*/:Z+HMN_P#C?M>F>BB<G!+ZA_@+_[U[7)T32FGV#I[I?[!_P!;_>_: MI?/[.D+YH>E12'D?ZW_%?;R],/QZ4=*18&WX''^W]JDXCHODP')Z4%,>5_V' M^\6]KH^`Z)IQ4O3UZ4E,1P?Z@_[S;VK3HIGZ4=&>5_PL?]X_XU[6Q\.B>7C^ M?2PH^-)_VH_[V/:J'I!=?"/SZ5]$>`!_A_O'/^\>UL9IQZ*)A4T7A3I5T9/' M^O:_^Q/_`!!]K$I7'19+6HQTIZ5N%'^(_P!XX_WGVNB/11<5)(`Z4<##2/\` M8$_X<$^UT5,9Z*KH')ICIYC:ZGCC^M_ZBWT]K8R!3HGG!*O4=.$#"W];?7_7 MM_Q'M5QZ+L=31[L"*9Z]UT3;WHD$8Z]3.>HW%>/R'28J_[7'T(/^W)/M!(W=^WHUMTH/V=).N(U`CZ M'G_;C_C?M(YPW1E$!J32<=(^O/!L;\WM]/R6/M#)Z'HYA'`@XZ2-9]7_`-C[ M2,<'HRC%7%.DW5\@_C^O^V)]H).)Z.[=:BG^KRZ3E2PY_'XX_P!?_B?:"7H\ MMC3RX])>K/\`O.K_`'DG_BOM#(>-.C2#@*\.DQ5_VN/R;?[8C_>_:&3/1G'T MQ3_3Z?X_[QS[12'CT;Q#"CSZ:9?J?]!KZ='T`&M>FV;ZG_$\?[[_6]ELO#HYBJ#3ILDX(_UKV_'^M_M_:"6E".C M*$9!\NFV;@G_`&_LNDX=&,8`;IKF'#'\\BWM&YZ7(*#Y]-TIX/\`K'_BG_$^ MT3]&$?''ITVSGTM_L/:9N/2I.!Z;7^G^L/\`BOM*WRZ4+P%>H4EK'_$7_P!O MP/:9CD]*APZ;9#P?]?VG;CTZO#/41OJ?;;=.#J)4$_7ZFPM_K6]LMU<?I_P`:]T/'J_RZ@R$$L?P?^->]>73IZB^VV\AU ML>O6*3Z'_@I_XGW3SZN.!ZP/;_8^]'SZ\.'RZB2'@V_I;_;^Z'JPX#KCQI`_ MP_Y'[T>'6QZ]86_X@?[U[J>O'K$WX_U_>CUI>/7$^VCQZ>ZPM^HW^E_]Z]^/ M`=>ZQ_ZWOW3?6-_J/];W1N/5UX=O__2TJ5^O^^_V'M;TVO65/S_ M`+#_`(GWL^75NLG]/]A_O?NR^756X'K*/=CTTO2DVOMC-[RS=%MW;E(E=EZZ M.LE@IY:V@QT/@QM#59.OJ*BORE518^CIJ3'T4LTDDTJ(B(23[9NKJ"R@>YN7 MTPJ14T)/<0``%!)))```)J>A)RMROOG.>]VG+G+EFL^[SK*R(TD4*Z88GGE= MY9WCAC2.&.21WDD55522>G+>>QMQ;!R6/QNY8<=!69'%IF*9<9G,)N"G-%)7 MY'&HS5^W\AD\<)34XR4&,2EU`&H"]O=+*_MMPCDEM68HK:3J5D-:!N#A3P89 MITOYTY$YC]OMPV_;.9H;9+VYM1<((+JVNT\(RRP@F6TEGAU:X)`5$A90!J`K M3I,(?]]_K^UPZ!IP0>I*'_BGU_I[OU7@>I"\@?ZW^]>]CAUHC/7-#^/\3_O% M_P#>_;@X#JA%>'4Q/^)'^]CW?Y]4?J5&>3_L#_MO^1^_=4Z<(CR!_7_B/;@X M]:;SZG*1?Z_7Z?[&WO?EU0\>I<9O?\`>?;Z=4;RZFQ'C_86_P!Y_P"*>WQQZ:;AU.0WL1_K_P"]C_B? M:E?+I,W#AU.C(M_KWX_V'^M^/;Z1_C_O7/\`Q'LSC--)Z()A74/3_)TY1_6WYM_L/Z_\1[,(ST37(S3S MZ56'P.5S(=Z"GC>-*BDI#-45E%00?>5ID^SI$J,A44T+U-2(7*1JQ0*DWB>XG$,K10([2LD(RR+%&))G$:%Y'(1%U,-3, M:`=+2'#5T&9K<&1#)7T%57T<^FHCC@,F,,PJFCGJ3`A0"G8K?2S\`"Y`]I+? MF';9MAV_F,M(FVW,,$J51F<+<:/##)&'-:R*&I4+DDZ06Z$.Y^U_-FW^Y7,W MM2L=K-S;M.X;A:3!;B**!I-L,_U1CGNFMT*!;:5HM91Y:*B(976,SJ,\*/8F M7J+I!6HZ4%-]%//XY_V'M7&U<=%4R,`6(-/7[>&?R/[.E)3'@?[#_>O^-^UL M9'KGHIN$(!HITYS^0K^RH_:.E)0AG9$12SLP554$LS-PJ@#DDD\>U$EQ!:PS M75S*L=M&A9F8@*JJ*LS$X``!))P`"3TAM-MO]WW"QVC:K*6YW2ZF2&&*)6>2 M661@D<<:*"SN[L%15!9F(`!)Z6M/3SPAC($M&P60+/#(\;$_1TCD=D.H6Y`L M>/97M?-NQ[I/:V]E-/XEPA:(O;W,22JH!+122Q)'(-)#`HS54AA49Z&_-_LM M[AN6]CNA+];NLDR0Z4)2L$#SOX MCX"?IH=/%F;@*!BHSY:]K>9^;^1?=/W!VEK0;!RA:V-Q?B294F*;A?P[=;_3 MPT+S'ZB=3*>V.),NX=HDD4=.]P!?_87_`,/]YX]BR-@"*GJ)9X6=7H#C)^0X M9_,TZ=J:=95#*25)91PR\@E3Z6`:VI?Z6]UVG=K+>+*/<-OD9K5F=061XS6- MVC8:)%1Q1T8`E0&%&4E2"57./)^^\D;[<\NPWR MWS5MO--MN%WMD:/:+= MN6]EYJN;*2[W78-NWB`VDWCQ_1[I;BZM"T@14+M`R.PC,B`,`)":TXR2WN`? MS_4?X>SXN#7/#J.EB90N"*Y&.(X5_:"/M!].FBKJDB":M=I94A72`;/*VE2Q MX"@'\D^PKS+S1MW+$6TR[DDQ6]W"WLX_#0O2:YD$<9YB<<`&8A3+/ MM;[3^7/U$PAK9;5;-=72P#2SS7!C4B*)5R>YVCB M5Y%::RI1'2-C9GU:.&LVGD^JVGC_`%P?:+=.;-AVK?-EY=W&^,6[;CK^F5HY M=$IC4LZB8(80X7(C:17:HTJ=0J<\J^SGN)SCR!SW[F\M;`E[R=RO].=TECN; M3Q[1+J18H)7LC.+YX'],F^VL*2S1K'(1&DM3'KET>$K.`2J%]9&=-"#TMN_:/W`VCVSY; M]X=RV);?V\W>^GL[*YDN+56NI[0J+D06IF^LDCA9@DDZVY@62J&76"`F:MQR M;D7(O8_4B_\`AS]?9BYZ!T*#C6E3TF)TDGP`']3P/8;YA MYBV3EC;IMVW_`'**TV].+N>."=*J*L[$`D(@9C0T!ZDSVR]L>?O=OFBQY*]M MN5+O>.99R-$,"UH"P37+(Q6*"$,RAIIWCB0L-;BHZ2LU+55*2O!$76(.[G6B MMI1=3Z$9@\I13;^7.7[VPL-WW(0W5RZ(@*2,NJ1BL?B.B,D M(D8%4:9D5V5@I)4T&GM][(>Z7N7L/,?,G(_*CWVT;5;S3SE9K:.1H[:,37)M M;>::.XOFMXF22XCLHKB2!)(VE1%D0LBJDEG*@%F8Z55069B?2```226/T_K[ M-IY(X8I)99`L2@EB2``!DDDX``R2>`Z`5A:W-[=6]G9VSS7DSJD<:*7=W+_H1C1Q(`2A(!(R$ MOONV^]&QWO+EAN?)OAG=K"ZO;>87E@]H;6Q&J]EFO4NFL[468H+M;J>%[9F1 M)E1G163E1A,LTM;$M#,S8^F>LK&70T4-*D#51G:<,83&],A="&/D'Z=5Q[:F MYPY9%MM=VV\1"*]G$,`.H/)*T@A\,1D"0,LIT2!E'A-7Q--#2]M[%^[;[MSA MLT7(UY)>&\%M91VC7WU+72N;9H9;13<6SQS.+N/2;7QM2@I=\- MD:K'U65ACA^QI6=)99:VAIWUHL;ND%/45$534LJS+<1(_P"H#Z^V;_F/:++= M[389YY/WI.H956&:048L`7DCC:.,$HU#(Z?"3PZMR][3\[[_`,D;Y[D;;M]I M_4_;I'CFFFO]OMG+QK&[I!:W-U%=7;(LT51:P3$&15^(TZ0=6PN?Z7_XK_O? MLQ;AT"XZ#CPZ8YC=1_C_`+[_`(CV@E_%T;P4.C/33,;&_P""P]ETWGT>6V*' MIME/-_\`'\^RN3H^M\$$]-TQYO\`ZY_WW^V]ETN*CHXAH0,]-TG)'LNE\^C. M'(Z;)?J?S]?K_OOI[02'CT8Q#/Y]-FV4?[W[1. M03T8QCRZ;9_TG_7'_%/:5SQ/2I10`=-DG.K\>TK&O3XH".HE(X#IMD/_%?]]_M_;#=.CJ)[:;IT8ZA3$\_U_'^\_\`%/;3'AU;Y=-K M'ZGZ_P#$^Z=7'D.H4GU_QM_R+W0\>K_B`Z;I.+_[;_7]U)Z]'KWD.HK_0C\$_[P.?]Z'MOJ_7 M%N+?X?\`&O?CU9?/K$QY/^O_`,3[KZ=4/#K">3;^G_&O>CY=;0=='BY]M')Z M=ZCGWL^76CP/7#WKJG6-OK_OOZ>Z-QZ<'`=O=?_3TJ1]?]@?]YX]K3TV MO'K(G^^_WGWL\!UOK+^/>UZ\W#K(#^1[OTR,'H6>D:FDI.S]K3U]?1T%&LF4 M2H.03!O15\E9\C)\=+O;%0XVCP6)BH-LTM'+@<%'LKQX"H.; MS]6^-R-9UXL6TLGDW2J6IDFIHXRJ5"0R+Y(G)3\:4& MH";]15QI`8G()&".A1]Y"XVZ7GC:[?;+*PM(;?:TC:TM5VREH_U-W(89I-H" M[?-.1()FDA1"JRI#(OBQ.2!*?3_8_P"]_P#(O8A'6/S>74A/S_L/;G53QZDK M]/\`>/>QUX\>LB_7_;?[W_Q3W<<.J'J4A/-K_P#&[C_>?=_+K1X'J6GU'^^O M[V//IGTZFQ,./Q;^O/\`M_=QUX^?3@GU%^>?^*'_`'CW?UZ;/`=2X_S[NIP. MJD=2T-[7_P!C_OO];VZ#U0CCU)C(/^O_`+'ZGBW^MS[=7&.J$5ZFQ?4_\3_L M?:A>'31X=34^@_P/^/\`K_\`$^U2G'29AU/CYM_3F_\`L;>U"''2:05I7J;% M:Y_WK_C7M4AR.DAXGIQ1N`?\?]MS[4QFAZ33<">I\9X'^^Y_WP]K8SGI#(.! M\NI\1N/]]_6_/M9&<](I!@^@ZF1'@C_$?[S?V81'(Z+YQ0-TX1D$#GCC_7_W MUO:Z,YZ*Y0-'4J*X)_UP1_K?3V91M4+T13+I9_2O3A$22/\`7_W@_P#$^S*, M@=$LRDU)Z%?8>-AJ:+.5>-EP-?74K9K!9/'5]6U92P)*J5N%JJ&GDDH[%:7*;_``02"VNH9HHQ&[%:QW*2N!+; M.51G`CE8!6TJ&(KDQ]W?W#Y,Y2L=XV#W(WO:9_;/TW%G`[V>[6ZR3QPN]S9Q,9H_%E:)7T+G;N9V&N)HFGEQ5'7TN&RE,T%3@ MI9:\Y&+=-/DX+[M>1VL5Y/MTM] M`^I+M5A\%K!X;F/P9)U(C^K*RE-!730H":KU+WMQS]]UZWY(V&YW>\V+;N:; M+EW66IZR#$"C*8-\)E\A2T^6:HH*,U>0CKTCD$A$K)XV'D(:W MLJEV?G'E?ERVG2ZO[2U@L=JMGB:Z,M;L7MK!(]L$FE\*!H#)&8P8P^M2(E*5 M`\L^>_8CWB]U=WV^?9>6][WG<.8N<]V@NXMG6TT;&=@WC<;6WW9KBPLS=[C% MN"6URERPN9(?`F5KV2.;28]/D=GLN&A5,?!3_9*)7&)K),E093^$RP//E*AV M:GRM#_%F6<(B2$J+64`HXO&U>XZ-S%U?JX5MKBU^K201VJ`"2TG M^D#0&1WC`8EM3LRR10B>(*0)D0H/U"ZAS'?N;[G\B;O]WW>^1=LYCY8EYW3G3Z MF3Z#EQ-OCO=O&U[9!%<6,O[L@^C"7MO=O,&:PN)UF%3<+X,PG'B!R(?TM<48K8+/L2S+8[]<7\\NT[G?S)MLQOK([!UC$2&4ED6R_2]A]` M(;CE#F?F'VUYEY5W7<63^VVRE6!;6-[AY M;BRMVCME#QHQCM@^B-\QYQ\-0)'JQ54_E2\<<=0LCQEPQ,WEC1`5`Y56:Y^A M_/LWW6YY]WCEVYV[:>73MO,/TDFF>26V:*.81E5%OX4LDG>6(222*+0F64$Z M>@?R;M?W<>2/=+;.:.<_=%>:O;']]VQEVZUM-VBO+JP:Z660[H+NSM;>D"(D MEQ;6MW=FXG`2*4H/%*LI*JE"?J@:98I`76!EB>0S*8@L?B6Q6.]SI'U'UM[# M%UR][@W%];_2C>(^6Y-UM6,'[P7ZJ*U6SF2\+7'UA+)+<&W:.-9W=#'(ZB,. M%,O[-[F_=GVWE[WA3EVY@B'+W]3YMPV^6\2XV>)+@V&]VEQ,L;^ M-=P1A(;6,VC>%T[4\C$H5-V4L5/U"ZD(!Y^H!/L:W'*'N.-ZVJ_VI;SZ2&^O MY;3ZRYAN9;`3[3):Q&>22YE>:,WTAD6)'N#'`,G4='4%;3[V_=KWEWERTWK]R;7>[59\QOM_.5ON]VEA:VNUV=O97"[!:K:RW=Q;[6MSN+ MU1?"03].]/Y2U.S&8A)2[@S\@&(IJ!5E](8_2Y-B?ZD>S#;.4.=YKGVZW'=K M?>Y!9[K++=13[I$[QA[%K<2QO!)"&M_'H_A&26;PWF7PPDTD+$7-?O=[`V>U M_>=Y8Y-W'D*V.] M.79?`O&W(78V^_CMZ7\2R07\E_-+9W5U(ET1<6RVKV\?AEK@QB&6,VQ#J2IW MCW#^X_:<^#<=D3E4[*W,G+ESN6KEV[EM;_EZWY=L;/>]IVFVFVD-MNZR[O#N M5T;I8]N6X-Y:7`W-'@D19<,E=#/YG,[HDU2T@-0BPO!]H!&/&\VB,&I6XXNH M/X]J;&Q]U>7^96YEW5=SN=LM]RW"68-N%NEI)9?NQ!!I@EO/#A5MP5GCK&IM MXS5M"ZE)7O\`S!]T#W(]K(O:SDZ3E7:^:]RY5Y:M+)XN6]RGWFUW[^M,HU=+QOI9K!=FWCAN!/'H#PW$!DCD:#%D5@FC@CGC+3ULT; M"KC#!I)DE@,I$^MR4N/4S`F^I3<,(,FY4]V;/ES>]HY/[FN^>Y_(7.?N?S[R MKO>U6?+/)VS[E;MRON+PO;V.TWFW;VNVQ2;-]+9+%=K:7,4=IMVWSI9F!]KW M.WE@N-JFZD2L5JIHQ4`35HE8)5*KM3M`J!(RTC)&\4B\\"Z@`&P'LZO.5?:P>R2-8[9I;B2&"6VN4!E#+$9(4C@BF:%$5 M0%L?O!]UW==F]F-FYIW[D^35KJZVZRYBM]]GNI+G=(K3;+6^ MW&SW3:YG6T:.2[6UOI[B_N[&.]FFDDBSK5%H]8EE2*6CDC8S(;+$091*MXED MF)!-])'^/MC?^5?'8KC9KE;/>+K;=CA@>.WELFW&&>(B1Y+29)`(HF08RLI4'T(Y1KBRR:XV'Y MOSH-^/S[$ONURCOG-M]M;[+8R"^L+"ZFM;D/"J1;@MQ8SVBD/*).\6LL3N(B MBK**MEM,3_YCYDVBQWC:C!?237G+4FV\P[?O$ MH>&T>U_Q=]WL[N&%KM+B66S;3$=,8E8ZAR&)^A868CD$W8DCFX6Q]@ZXY9Y] MV?FGF#>]NV">>YO=DMEFF@N+6$2WPO'N+B.,RS&58A#*T$3,L;Z$6))H2$N$ MF:P]V?NZ<[^T'MMR!S/[D;?MVU[#S_NDME97^V;O?M:/?6D>X7<<4MQ"9[A[N>QOE,^V3,\TL=W#`$+&)"0H-F0ZBHN+>NUO]C[)] MQVOW%VW9]B:;<[Z'=_W_`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`-COO+-YR7O.RP-#M&]0)MU]N5Q9;I-N M5X]W9Q2O'=W=C!MP2QMKB2&P2-I(VE21[AF&;Q35^0:6OBIZ8;-?;E-/+!7- M][6?P=*!9O'3TD\D41G0\N%8)8VOJ2:-6<1L,1EE,FH:M(5F7>X?/US>\\VUAR[%[-'E"SNI[; M-^O+\6UK=>%:V-S+#`US&YU7*1RK;F)C'XADBC0C9:CAVWD,563TF06> M-9L73)1R)6XG*_?1>6H-;)2Q+]K-01.&59)-19!I6S$"._V2^N.6VC\"'1/(@55 M;7)'XN/]O_QKV,W.>LCF%?A'GTU2FX_ MXK_O?LNF/'H[MT[5].FR4_4_TN?99*<]']NII7R'^K_)TW2DVOQ]/][_`.1^ MRV4]&T(P/6G3=*?K_@=(M_M_^)]E\IR2>C.&@%0.FR4_\:_U[\^T$G1A$*Y' M#IKF/!_K_OC[1R>?2V(4ITW2G@_7_;_X7]HI//HPA\NFV?FW^O\`\1_M_:60 MX/2M1GIND(YM_OO^->TS''3R\:=-\I]/^^Y]IWX]*5\NF^3Z6_WCZ>V">G!Q MK7J,;Z2/]C_OOS[:;CT\!GIOF8<_CZ>VVZL/+IN<\$_U/_&_=#U<<:]0)FL6 M^O(_K]/I[;ZNO&O4&3Z?[S_L;C_BOO1X]7^SK#^/;9-1U8#R'6!C^?\`8^Z] M6/D.H[>ZGK=*T'45OJO^N?\`>/=.K=>/ZAS_`(_ZWY/OW5AP/6!OJ;_6Y]TZ MH>'6(_J/O1ZLG7!OH?\`??7VV./3G6`^]GCUH\.N/O75.L;&Y_WW]/\`BOML MFO3HX#KC[UU[K__4TJ!]?:WIH<>LJ\-_KC_B+^]\1U;SZR^_+Y]>/7-?I_K' MVX.F6P>AEZ7S%)3;PPN/RNW<3N'#Q5F3W!64]5M7;>XZL?PG:FX?54QY^IQ< M5;MNB68UE=1-74L..12C>87>SF>&Y>.8JJ`B1T'=(G#0&HY^%6T ML1JH05)!F7V5WFSM>PN\NMV\"R6<0;ZFZ MMFNH$=8!(DD4\<4JJ'Y&5='5;MP`H=HY78\%/M&DB3;^9VGC-FUL,,9JZDK(Y9'A@D1)F>$3S^'RNSRVCK9W'B7B3L9CWK(T@PB`C4S MNV""`"144;2M:`_^\?=V5USCL"V')]WL5O%L\:BTN+"#;I5#7=Y*DA@MK2RA M)ECD1W:.)U60O`)[CP?%[CJIX`]24_XC MWOKQX#KG[<'GU0UKU*0@[C(ZU0<.I2?C_"P_U[$?3WOIHXKU-C MM>W_`!7Z^[#AUK%!TX(;K]#_`+8_\3[OZ=4/`]3(C>Q_K?\`XW[NO#JOEU*4 M\_ZWT]NCJAQGJ3'^KZ?4W/\`3_"W^W]NKQ'39X'J%>IT9^G^P^G]/S[41_SZ3R#-/+J?&?5 M_KVM_K_7_B?:I>'2-L&G4]#Q_K_\1[5(>D\BT!ZGQ_BWM7&:=(9!QZGQ'^G^ M\_X?U]K8SPZ1../4Z/@DV_''^P]KXCT@E'KU.C8VL/Z$?GZ^U\9R#T6R#XAU M+B-B"?I]+>S&)L`>?1'<*03Z=3HC8_X>S*(U`Z(YA\73G$3Q?_??3VNC/#/1 M1,,T/3E3OR"/ZF_^N#;_`&WM8AZ+9`0:^?2DH*F6'7XI9(S+&T,GC=D\D4A& MN*321KC>PN#<'W=X(+CPO&A1]#AUU`'2PX,*@T85-",CRZ]:[EN&VF[&WWTT M'U$+0R^&[)XD,E-<4FDC7&]!J1JJU!4&@Z4-*YXY_I_3VM0UIT3RK@]*&F>Q M7\\?["]K>U<9]>BV9`O#I0TK_0<_7VM0^AZ*9EQ3I_II/IS_`$^G^PM[5H>' M11.O'I244W(_H2.;?[[CVK4\,]%LBY-`>E523<@D_G_6MS[5HW[.BV:/)-*M M_L]*FBJ=)%B?]>Y'U/Y_//MN_P!LVS>;4V6[[=!=6996,[G MGNKF5Y+J1R[NQ)=V8U9F8U+,Q)))-2:DFO3_`$]0+`\?UM_L+G6A;$&JD M#]IZP255OS_M^?\`?#VT9">E20@&H&>FV:IN.3_K?X?\:]L,].'2M4!P>'3/ M4U%A]?\`>?\`'_>_:5WK]O2U(P`!Y=)^IG^K$\G_`(K_`,4]I7;CT81)32QZ M3=74F[>H@'Z@'A@""+_UL1[+;BTL[B:UN;BUBDN8&+1.RJS1LRE&*,02A9"5 M)4@E20<&G0CVW>]\VVRWC:]MWF[M]JW"-([J&*:2.*ZCBE6:-+B-6"3)',B2 MHL@94D174!E!"5JY^2;D'^O^P_K?\>ZR-Y=:@0@`CRZ2=9+R1_6Y/^^O]?:5 MV\^C!%X+3I.U3_7_`'W^^Y]HI&Z-H$K0D=)VI?D_GG_>/:&1L<>CNW0BM1TG M:N2U_P"@O^?]O_L?:%R.CB(4STFJM^"./]A[0R,:GHSA3M%>DU4OJ/\`KM^? M\/\`#_8^T;GCT814JM/7IJF/)-_]Y_P^G^P]E\C<>CN!16IZ:YC]?\./][%O M9;,>CRV7U'3;(>#_`(V_VX_XU[+)3GH[@6B_;TW2FY_V_P!?]8_\5]ETI^+H MWC%:=-LQ^I_-R?\`8>R^4CHQC%`/7ILD/!^GT_K_`+Q_CS[0N:'HPB&*CILE M/)_UO]C;_>/K[22''2V/!Z;96O>WT_WK_B?:-SCHPA%*=-LWUMQR+_['_BGM M(_2E!Z]-LI]/^O\`\3[3-TH48Z@3?C^GM.W'I]>F^0\B]B/\/;)Z=7SZP2&P ML.?]]_QKVT>G!Z]-DY^O]?\`D8_WKVVW'JX'`]0'^G^^_/NAZL,`]-\QM>_T M)/\`L/\`'_7]T\^G%X'J`_U(_P!]_7WKSZM2@/7`FPX^O_(O;1X=7'4=C]?] MM_O%_P#>O=?3K?GU'?Z'_6]U;K?XNH_!8\K=<6_M?T_WP'O1]>K M>76$^Z]-MUB']?=6\^G5&.N#_3_7/NB\>K=83[]Q/56\NN-^?^*?7\>_=:`J M>L)^OMH\>G.O>_'K77__U=*?VMZ9ZR#\'_6]['F.K^G6?WH<>M]W1 MTR_'HP]JXS&XND.<_C51EX=J,KAJ)-A5L>;FGR M$"^2!:.!ZV:JBC@4M%+)&Y)OP"[==RRRGP-`4KIB(+,Z!6/BC2`#@ZB%"DMQ M`(G'V":2Y]Q.4]KVS:XCOOUKW"W7C[K#,L$%G=//;1C:I! M..!2T4LD3JKY/47V6\=LPF@?'F39$528):'L?'S235&[MX2U-940]J10;MDJ MJVJ=Y99I%,<\KM(&9V=BGY6?7971\35^N16L)&(XP`#!6.@%``,@8P`!T*/O M2V1L>=>5XOH&MM6QJY5HMXB9F?<-Q9Y'7?56_+RR%I))&!25V:0,SM(Q+='^ M/^#>Q-UC/Y=2U_U[&_\`2_X^OMP=4IBG4E3R/]M_M_>_/KWEUE]W'EU4]9D^ MG^\?[#CW<=:H./GU+0\BQXM_Q/O?GTVPH>I<9^A-S:X_U_=AQZIZCIRB)(_K M]+_CGD'\_P!/;G5/.G4R,\_ZQL?=@>J^9].I@-B/]]]?;HZJ>I$9Y^O^P_UO M]C[<%<=-]3U-N/\`8_\`%?\`>/;ZUP>FR*''4N-OI_C_`+#_`%O]C[4*3TR] M,4ZG1&Q_V)'^\<>U*\>F)!4?/JBV5:'AU,!_WG_B?Z M?[;V8PGHGNUI6GGU.0_I/X/Y_P!/9C$W^'HBG3-?4=.$3?0_P"^Y_WK MV81GHGN%J*CIQAX/^]G_`%S;_B?:Q&X9Z*I%H3CI\IG_`#_K'C\?[;VJ0\!7 MI'(OG3I1TLE['_>/][]OJ<]))!J&>E%2RBR_[[\>U2'UZ+Y0*<.G^GDL0;\_ M[X?CVK1N'IT63)2OKT_4[_2W].1_MK^UD;<.BF:/C3I_IIB+?CZ?GZ?\:]JT M;Y=%4R$5STI:2U*/D=(9(ZCCGI34M1;3U2/T72Q\>GV"H(TW)M;\#\FY`O_6_M]6'D M>DDD1\QT[15?^)M_4_ZW''T'M]).%>/222+CB@_P]."5(_K_`(\?G_;^WUDX MDGI*T-:!5ZSBIN.&(_'^^M?W<2G^'IMH?+50]>-38?K/^M_R,#WHR_+KRP5Q MJ)_+J.]38$:O\>?^(]T,OSQTZ(:8TYZ;YJLCZ7-K\WX(_P`/;+R5KGI](C4` M"O33-4?VC>X%_KQ]>#[8+UKG'2Y(:4)!K_J_U?ZJ],%757N`?]?_``'^]<>V M&;S\NE:*3@#/2:JZL`V+$_T`_/U]KMJV3<-\F,5E$-`^)VPJ_:@7&M!X\@L-VY3V'EG:]JW MV]M_WC)/X\UL_@2!81%IB25:RQ:S*6+QO'(?#`#!2ZF;/NV\O[%[N7O-_P"_ M1)##MRVWA1QR`._C&?4SDJ<)X2BB@4+Y;A4^/PND13C98I8LKB&F`G:"58C'/#9%;46Y5>XWN/[G M>U7,.U20/LM]]>WWV]L^6O=FW@L[R M4A(]PB&BW+'`%S&2?!J>,R-X0)[HXD!?J-K>500KX'5?-4S*65KAE+*58$%6 M'!4J>00?K[SV>174,K`JXWY^YKO^5K7;YK&")VFD93X@8@``'&EE]?.O4J^W')VW\VW6XP;A<31I#& MK`QE026)!KJ5O3RIT9/^;]_)K^.W\O[XO[<[OZH[&[JW9N;-=R[5ZYJ,9V'E MMC5V"CQ&>VIOS/5-9!#MO8>V<@N2BJMK0)&S5#1".1P4)*LH;Y-Y[W3F7=9K M"]M;=(E@9ZH'!J&04[G84HQ\O3H6\[>WNT=...@9_DS?RG.AOYD&Q^\]T]Q;^[BQF)X5"DZ@QL0]SQS=N'+<]A#96\+K*C$ZPQ(H0 M!32R^OG7IKD#DW;N9K?<+B]N)D:)U"Z-(J""U:E98TD#FP>X=QN.Y166ZP0QQ2]JLFH4<\`VIFPW#RH2/*O0LW M[VYMMLVV6]VF>:26+N97TFJ#B5TJN1Q/&HK3-.M2:9AS_P`B_P!]]?V7[#Q^2PVP\UUU1[9IHMH= M@;CVGCWH:?<'6^XLJDE108:.2;R5<@,S,5"K91%O,/-U_M>ZW%C!;PM$H6A8 M-7*@FM&`XGTZE7E_E6QW':[:]GGF65BV%*TPQ'FI/EZ]%([6_E6_$#J'^<%U M?_+WW?VAWE2=,]I[,VRN)W\<]U]#OVA[,WMB<]4;3Q4]6_7C[:RD&\>^[A=;!-NJ01?4(QJM&TZ12I^*M0#7CY=>?9;&WWR+; M6ED\!E%#5:ZB#0?#2A..'GU;3W/_`,)8/B]B.I.S=WQCL'75NV,'G*?$]6X;)MC,QF88::5H*J&5$E+*;BQ#47.%Y M)/$+B"(0E@&(#5`KDBK'('0ADY5M4AD,,TID"F@.FE:8'PCCUHK5221.\4J/ M')&[)+&ZE)(W1B&1T8!D=&%B#8@CV-&-<]!9`0`.A&Z(Z?W-\A.[^I>B]FH7 MW1V[V)M#KS#.8S+'25F[,Y0X89*J4,FF@Q:5C5-0Y*K'!$[,55207W4RPPRS M,>U5)_9T96\32R11(,L0/V];R%3_`,)/O@/2TT]56?(+Y9TU-30R5%553[JZ M8@IZ>"!#+-/+++TR(X88HT+,S-95%R?S[!!YAO&QX,?[&_Z"Z%HV>W7_`$1_ MY?YNJ1_Y1_\`*"^''\S+L_YUT51VA\@MO]3?'[L/8N(Z.S&VLYUY3[GW9L/? M&7[@I\=FM^2YGK7*XZ;,56&V!CZA5H*6ABADJ9D99`$*KMQW"XM$MOTT,C@Z MN-`13AGY])[2TBG:;O;0"*<.!KQQU$_GD?R6_CC_`"Q^D^F.RNE>R>[=[9GL M;M*OV-F*+M'+;$R.,H\92[2R>?2JQL>T]A;1JXZ]JJA5"99I8_&2`@-F#-CN M$MV\JR(H`6N*^OS/3MQ:)`J%"34^?6LE,;FW/^^^GM:>F`.OH";>_P"$EGP* MS.W\%EJGOWY>1U&4P^,R,\<.Y^F1"DU;105,J1"3I61Q&KRD*"Q-OJ3[#QW2 M:I&A?Y_Y^C46<8IW-_+_`#=:T/P>_EE]+?)_^;EW'_+^WKO7M#"=4==;Z^3N MU\1NS:V0VI3=A5E%TEN;/X3;4^2KLMM++[;DJ\G38F-JXQ8R)'=F\2Q"P"V: MX=+99@!J('V9Z82(-*T9KIS_`"ZM^_F;_P#";3X]]P=65FUU-JU$>8IL%U3@,O+#'0YV5T$%9`PE1"25! M4HX;V665$95H?M_S]/O`B*S`FHZ7_P`&_P#A,!\)OE!\._C1\B=[=W?*;";N M[IZ8V%V1N3#[6W'U+3;>H*Q+/55$H0#4[' MGW26]D21T"K0'Y_Y^K+`K*IJ>'1HW_X2!?R_'^OR$^8]OZ#=/2G_`-H_VW]= M+_"O\_\`/U?P5I2IZQ'_`(1^_P`OHFY^0OS(/_DT])__`&CO>C>R'\*_S_S] M;\%:UJ>B2?S'O^$R7PL^'7P?^1WR>XNJ*K:^1K MAF\1C?M\S3X3J3!Y:6D,&0NS.`_OGT?55NRM[8UWQ6]]CY1QT8CFNVM MN:CJ:42,B"J@2.IC!BFC8ZDN)$8H5&/M_P`_7E12*@GK75_G7_RLJS^5?\I< M;UMMC+[LWET-V9M&CWGTMO[>(QDN?R<5`E+BM];5W%68/%83"3[FVEN1A)(* M6E@0XO(T$K*'E8!R*3Q%J>/6BND]%*_ET_"W>'\P'YB=+_%S:,E;CZ??VY4J M=][HHX%E;9'6&WXFS78&[B9HY*-:O%;_:78WRF^7NU=@]=;5S^]]Z;ER>[NDHZ#!;8VQBZK M,YO*U3+T4[F*BQU))(516=].E06(!2?42&@"C_5^?3A4=:57QJZ8Z0[Q^3N_ MF:5;Y='J_FX_P`OGI/XBIE*SJ?*;?GK=C;Y MZTV3GI3JB=S]!_L?=QP/7NL)]Z'5&X]='^H^H!]Z/ M#KPX]8?;?$].?X>O>_=>Z__6TI_:WIGKF/I_K?\`$_\`(O?AQZN.'6=?H/\` M6_WKWX\>M]&YA64W-FL+3 M6_B1"=[J"*W+^-+((T;I3?):AQV.W;M*GQ5!+C:+^X=,\5+-EX,VZL^[MX>1 MOOZ;L?M.%P\@)TC*MI^ABC/U8Y8>22TNVFD#/]0L:QU*4_3_6M_O'NPZK2AZSH>!_OOI[OUH8-.I`-Q_OOZ>]^76CQ MZR)JL,5KU*C^MOZB_/X-QS_`(>] MCCU0<1TXQ&P%C^1?_6L+_7_6]N#JC=38SS_L/\.?]M[L.JGU'4T&X'^]_P"\ M?7^G'MP4KU4]9T/T/T_K_M_I[='5".I\9O8_[#_??ZX]O(?+IMAY]2HS]?Q_ M3V^ASTRXQU-C;Z'\'_>Q[4)\^F#D'IP1KD[#!Z<(S>W/T_Y%_K>U*'ATB<57Y].$;<_\;_/M9&<=(V%.IT9 MY_I_3^MOS_O7M;$W`=(I1DCJ9&;6_H/K_P`1[,(SY=%DJFA/4]3Z0?\`8?3_ M`&WM=$W"O1;.M5J!GJ7$?P?\#[,HGX=$5Q$:,#QKTX1'\_XC_??['V81MPZ) MIUP<=.,;?ZW_`!7Z$>UJ'AT5RK4$4Z=*>2UO]<&_^]'VK1NBYQ\NE#2S?[[_ M``/UMS[?!\Z])2!D4Z45++].?Z>U*$=(Y5'&G3_3RCCG_?6^H]JD8]%LJC-, M]/E/,/Z_\BM[5QMPZ*YHP:XZ?*>;\C_B?:M&Z*IHZU/3Y35&FW)^H_P_/^P] MJD;]O19(A!/2CI:FX%^!DKI7B.E!3U/Z03QQ]?I_@?\?:A' MZ+Y8./K\^GJGK2+7-_\`8_3BU[@<\>WU8`XZ0LC4R.G:*KXOKN?ZW_']+7'M MW7D5Z9,50"3[]XF,=>^GR*GJ.]4/5ZB?Q^>?\`B?="_EU= M8!QH>H4M8HOZA?\`I?\`XIP?;9:HZ4J@''!Z::BL)OZK#_7_`,>>/;3,./2E M48FG3%55>H-8\"][?GDV'MVQM9=QO;6QA/ZLKA1\O4_8!4GY#K5Y/%M]E<-Z8-)1F[F8Y6-!Y`>@X*/,\3Q/3%)60K64=;-CL+DWQU M1]U1P9S!XC<%!%4".2'SG'9RBR%!)((Y64,T9(#&Q'U]XX>X"0^Y6VS[-S4K MR;4[:A'')+`8V%0&CE@>.9'`)&M9`Q!*DZ209_Y5VM.4_$DV*>:"ZDCT/*CL MKR+4$JQ4CM+*#I%%J`:$BO1BMB?+7=FS_LL7DL#MO([8I3XQC<-B:3;,]%`S MEY/X7'BHX,5%9Y&9.3U9#LS>6`W]MS'; MIVU6?>8O)1ED+*(ZBFGC.BHHJV#4QIZREE!5TN1<74LI5CRWYXY)YA]O.9MS MY3YHL_!W:U:AH:HZG*2Q-0:XY%HRM0'R8*P90E961BK#/59_S6ZKI=I;CQW8 M&#I5IL3O&>H@S,$*A8:;<\*&H>H4`!4_C=)JE*CZS02N?U\=)ON9>[5YS9RO MN'M]OET9=VV9$:W=C5GLF.@(?,_3/I0$_P"AR1(!V5Z$.T3>*IA?+)D?9_L? MY1U<_P#\)>'+]V?*[_Q%VP?_`'K,M[G#WB-;'9O^:S_\='62'LBNG<-\^<*? M\>/5AW_"F\Z?Y>^Q#_X%/UT.?_$;]Q^P;[6_\K'B_VA M738;P/\`AL?_`!UNMK>2..:.2&:-)8I4:.6*15>.2-U*O'(C`JZ.I(((((/N M)N&1QZF#C@]?.*_GD_RW9?@G\EI=Y==81J7XV=]5N6W/UM]I`W\.V)N595JM MW=5RNOII8,+/5"KPZL%$F(J$A5I9*.I<3ERKS`=XV[PKAZW\(`:O%A^%_P`^ M#?TA7%1U"G,W+XVC<#);Q_XC,2R_T3Q9/RXC^CCR/6V+_P`)X^?Y4?Q__P## ME[N_]_3OOW&O.6>8+S_2I_QQ>I'Y2QL-I]K_`/'VZU@_^%'.Z,]LC^:]1;SV MMDJC"[GVCU7T=NC;F8I&"5>*SN`JLME<1DJ9R"%J*'(4DA^(7R&P/RO^,71WR+VY]O'0]L]= M[?W16T-+(98<+N62F^QWCMOR%GUR[7W;15V.D-S^Y2MR?<<7MLUG=W%JW%&( M^T>1_,4/0\M+A;NV@N%X.H/V'S'Y&HZ^;7_.O^+W^RG?S'/D)LG'8_\`AVRM M_P"?7N[KI$B\%&=J=JR5.X:JBQT5@(\;MK>+9;#P@7`7'?7W(>T7?U>VV[DU M=1I/VKC^8H?SZ!6Y6WT]_.@'8QU#[#_F-1T?K_A+S\7O]+WSFW5\@\UCON=K M?%OKVKR6-J)(1+3+V?VE%D]F[3AD60>%C!M&+<=6C>,7BK8X/4I96`8VJ MW^HO(P1V+W'\N'\Z=""^E\*VAP_X5TFWQ-^+!_P#`A\S_`.^VW![2[/\`VTO^ ME_R]*+_X$^W_`"=:!,K&]_\`'V=MT7=?:FV/_P`>7M#_`,-?`?\`NII/8.;X MC]O1\.`ZT'_Y1A_[:8?E&/\`O\'\P'_>-_;S]F]S_N!']B_X.D47^Y+_`&GK M:`_G^?\`;H#YL_\`AC[&_P#?Q=<^R^U_W(C^W_)TJE_LVZTF/C[_`,*8?YA7 MQGZ-ZH^/W7NT_C)5[&ZVU138[/;W;NR6JJDJ:51& MTMX5E M+:B<4Z\[%:4ZU%/E-_PI._F!?+KX_=I_&OM+:OQIHNONWMN':VZ:O9_76]\3 MN:#'&OHLEKP^1R7:>:H:2J\]`@U24LZZ;C36^#W:&?^TZA^4V7IZOK.;(U.C'[1^0]+114&,HX-;K%3P=N8 M2CBQ$GZWFR]#B8D"B25C2ZCU+K'$?X.MQFF#Y];9O\]G^77%_,6^!V^]G;4P M\=?WWT[]WW!T%40PJV2R.Z]OXZH&?Z]@D`662G[,VQY\=%`9(X/XN,?42W%* M/:2)]#@^1Z<85'SZJ_\`^$HO\NZ7H;XU[O\`F[V3M]J#M'Y.&3;/6T.3HVI\ MKMGH?:F8=9*E4G2*KH9.SM[XYJV6-U*38[#XNHC;3,WN]P]6"C@.M(,5/0!? M\*S_`.97_<_9&U?Y;?5.?T;C[#IL-V7\E:O&U-IL5L.DK5KNN>M*N2!F\53O M#-T(S>0@;QS1T&/H+AZ?(,#N!/QGAUYS04ZT0-C;]WGUANW![]Z]W/F=G;RV MY5/5X3<6`K9:#)T$LU-/15:)-"P\M)7T%5+354$@>"JI9I(94>*1T92144/3 M*\:]+3M7O[M;N>FV_C-^[BH)]O[3ERM3MG9VU-H[+ZWV#@,CG_L?[PYK$=?] M;[>VGLJ@W!N,8NE&2R,=`M=D!20"HED$,6EHT!QT_P!`LWU^M_>_+KW6,\D^ M]=4/'K@WT_V/_%?=6/EUM?/K'^/=.K]>]^Z]U__7TI_:WIHX/7)?^(]^ZVO6 M9/I_L??CY=6ZY_CW9>M-P/0L](U-)2=H;6GKZZCH*,295*@Y!,&]%D$FP63A M_@%2=S6V]#%N8R#'&6MM30_=>23TJ?9;OBN^UW2QQEG[:4U5%&4ZQH[^SXZ+ MW'309/4H>QUS9V?NGRK/N%_#;V8:"Q,./VS2TR/'@*@YO/UCXW(UO7:0[2R> M3=*M:F2:FCC*I4)%(ODB1V:4G6_B]XTH-0$WZBKC2`Q.02,$ M="[[Q]QMTO.^UV^V6=A:16^U)&UK:C;--H_U-W(89I-H"[?/.1()FDA1"JRI M#(OBQ.Q!/&XG*9K(4V-PN-K\ODZMV6DQN+HZBOKZIHXGF=:>DI8YJB=EAC9B M%4V4$_0'V>RRQ01M+/*J1#B6(`'VDX'4&;7M.Z[Y?V^U;+MMQ>;I,2(X8(WE ME<@%B$CC5G8A06(4&@!/`'J.OY_V'Y_P]NCHN;UZD(?^*^W!UH^1ZD*>/ZD> M]CK1ZYC@^[CTZKU+0V/^N1_O?_$>[CK5,4ZE(3<'Z?G_`(FW^Q]^Z:/4^(W/ M^\FW^(]N#JK9'4Y&-@?S^/\`>?\`8>[=4'"G4Z,W4<@_\1_OK^[@]:\NI"G_ M`!%N/]OQ_O'MU3TWZCJ;$P/^^_WUO;JD]4(SGJ6AY`']/K_C?Z?['VH4]-,. M/4U#Q8_6W%K?7VI4],'^74^,W'_$>U"'`Z22`=38F))_'^^_'M4IR.F&!Z<( MV-Q].1Q_C_QN_M4IZ12#)/EU/C;_`!_WWU]JHSGI(XH.G"-OH?\`8_[?VMC; MI%**BO4R)@#8_P"P_P`;?T^GM=&WIT@E4&HZGQF_^^_P_I[7QM2G19(H[AU* M3@AOQ<7_`,?]O_M_9A$_`=%%U$,OFG4^(V(L?];Z?[#F]O9A&]>B2:.A-/MZ M<$8C_B/H1_OK^UT;=%$R$5Z<(G`(_P`?Z_3_`%OQ[6(W1;*@'D<]/--+:WTN M/I[4HV/ETBD0C@.E%2S<+S_A[?4YX])V!\^'3_!-8#G^G^^_V'M4C=%\JTJ* M8Z?()OIS_OOZ^U,;?MZ+IDXT&.GF"?Z?[ZWM6C]%DT1%2!T\P3V_U[_\3[5( MW#HMEBXD>O3U3U6DCG^GY_Q_J+^U"O4=(&0@\,=/D%9P!?\`I_MQ_C^/;RMY M])9$!QT\0U9N.1]`?J/Z?[S]?;RR8Z2O`:\.G*.K_J;?[[_>O;ROTC>`=38Z MQ;W)O8`WO]?]YM[OK/3!AS4BO6<5I_'T_P!]_L/=O$'F>M>"/?M8]>J^$17M%>L#UO^U?CCGD?[:_'NFOSITZ(3BIZ@R5@M:_\`7ZG\ M_CW0N>(Z?2!>#+TUSU?^(-O^*\?GVRTG2Q8VVWMS':;8MU M?EA#$KDB-7<$ZY--&*A%84!4EF45`Z&O)?M?![J[PG*UYNS6>WB,SRL@4R.D M94"./550Q=T-6#`*K'22!TV=9]CU79&SZ3<5=BOX14_=U=#-#&TK4=3)2L@: MLH'F'D:E?7H()8I*CKJ.F_M5M/N?=^Z&P[=NUYMZVMQ"TD3HI)C:0$$O'JJP M5D*"C$D,&%2,],\R>T=G[2/ABK9I?+ZDB"G0"1J9]0%R"#8!?\.?<@WC[@-5O`JG0" M1J+$TJ10Z1I-0"*DCRP8TY\Y@OM@L;*/;B%N)V8:Z`Z0H6H`-14ZA0D&@!H* MT(A[BH:>DIXZF$>/5*(G342#='8,NHD@C1S^.?:[W#Y7VO9[.UW/;8_"U2B- MDJ2#568,-1)!&D@@&AJ#04-4_MGS5NN]7]WM6Z2>-IA,BO0!A1E4J=(`(.H$ M$BHH14U%#G?!/C-+C-Q4E.S<05*328W(31)_6JCEI@Y_YM)[ MY&??WY=M&M.0>;HX`+T2SVAL^:=#2U70>X*JHT>7$YG;5?1:B`PJI,Q3XM_'?DO\`9Y*;Z)#'Q\Z>=.J[-7Z^-1P*M7]E?\G1Z?\` MA+>^ON[Y8?X=6[`_WG=N7]]'O=\UL=G_`.:S_P#'1UE)[+`B_P!Z]/`3_CQZ ML6_X4Y'3_+VV&3_WE1UU_P"^W[C]@_VO-.8;G_GD?_C\?0Y]U17ERVK_`,IB M?\L/\`WE]S^U_NH:WFT?\`--_^/+T@]IUTV6[_ M`/-1/^.MU9;_`#,/YC$O\O;Y(?`G([NFDDZ![HJ^_=D=VTL4#3SX6CHI>CSM M3L>B2%'JIJK8%=F*F2>!!(:C%UE9&D;5#0,@2V#8QO>W[T(_]S8O#:/Y_P!I M5/\`;4'V$#RKT,M^WMMFW#9C)_N%+XBR?+^STM_M:G\B?.G1Q?FM\3^J_P"8 M/\5-X]([HK<;5X7?>#H]S]:;_P`::?+Q[5WE3T4E?L/L+;]532F.NHX7JP)A M!,BY#$U513^01U#-[*=KW"XV?<([J,$.AHRG%5X,I_U8(!\NC?<;&#=K&2V< M@HPJK#-#^%A_JR"1Y]%I_DH=,]A?'C^7[U_TCVM@Y=N=A=9]E]_[6W/BI-3Q M)6T/=F^C#78^H*(M?ALO1215E!5(/%5T4\4R$I(I*SF:ZAO-WFNH'U0ND9!_ MVB_S'`CR..DG+MM+:;5%;3+25'<$?[=OY'B#YC/6H?\`\*9FM_,WS'/_`#0S MJ7_;>+/^QARH?]TZC_AC?Y.@QS(/]VC>GAKU MJ.UQI;[1P_:,?[7HZY8N"T$UJYRIU#[#Q_8<_GTS_P#"KSXN?WDZ>Z!^7V!Q MVO)]8[GKNFNP:J"+5,^S=^++GMEY"OEM:+';]?D[N3+]UY=YX=%;'M*I6';/6E`9;`RXRIVG@TS5,.0ISSMCT7@5(%.OM5['_X\O:'_AK[?_\`=32> MP>>)Z/!P'6@Y_**/_;3%\I/_`!,'\P*__H?;TX'LWN?]P8_L7I'%_N0_VGK: M#_G^_P#;G_YL_P#AC[&_]_%US[+K7^WC^W_)TIE_LVZ^3Y(Q_!'U(OQ]/Q[. M^D*^76_)_P`(Y?\`LG[YIC_O\G69_P!OLG->RR_^./[.ED/!ND#_`,++O^/' M_E__`/AU_(__`-U'2WNMG_HGY?Y>O2_AZT/6-K'^AO\`[P?:WIL^0ZE8G,Y; M;V7Q6X,#DJ[#9W!9&AS&&S&,JIJ')8K+8RJBK<=DL?6TSQU%'74-9`DL4L;* M\72A34=&T^8 M/R@ZM^"GQ9[9^2?8XIJ#8O3>RY\G1;?H&IL;+N'-'PXC9.P=O1^/[:GR>[-R M5='BZ,!/%"]0'?3$CD552[!1Q/7B:"O7QT/DAW_V1\J.]NU?D3V[ESFNQ>W] MYY?>>YJM3(*2FGR4UJ'"XF&625Z+`;?K_`+#WX];3KB?H?]8^VO/IWK`?>R?+K1X'KA[UU3K@_P!1_K>Z-TX. M'7#WJN*=;ZZ/T]^'7NO_T-*9>5_UN/\`>/:M3Y=48#CUR'NW51QZR+8-_A?_ M`(T/>^(ZMPZS#WX<>M]"]UQ'@LU@-W[.K]V8/8^6SU7MFMQV?W'3U_\`!JF@ MPHSXRNW*W*8J@R=?BER=1DJ.J5Q`T,C8\(Y!*>RS<3/#/9WD=H\\,8<%$(U` MMHTN%8J&TA67C4:ZCSZE?VYBV+>M@YQY-W#FVQV+=MPFLI8;N\27Z9XK;ZKQ M[.2>"*>6W$SS6\X;PC&[6@1R"4K@[0J<#_$=LX?!9VDW4VV-ITN`S&ZJ"@FH M*'/Y6/-9W)">C%7!35];2XO%Y.EQT=341I).M$&"A"@]N;2L_AW4T\!B\64N ML9-2BZ47-*@%F5G*@T&JG&O23W3N=@_>'+&S;%OL.[-M>T):7%]%$T45W.MS M=3:H_$5)94@@F@LTFE57E6V#`!"@Z-+U%N7969H<9NJ7JW8NTFPF[SB6KZ#: M'9F>K-QB3$T-=CMM;/KL9NS[)]_55/2Y(RPUNFFEAEIR(](E#A?>+:^A>6T& MZW$P>'50R0($[B&>0-'7P@2E"O<"&S6E,J/:#F7DG>;/:^:Y/:K8=G:RWCZ< MRQ;?O5U)>!H(I8;+;I8+_P`([LZ1WADCN=,+QR6Y$943!R)QD6!_%K?X_3_C M7L?=8#<>I"\6/]/;@ZIQ'4E3_MA_OA?^OO?7N(ZR_P"/^/\`O5O=P1QZJ14= M9HV'!N;_`%'^M?W<=5QGJ6AY'^(^E_\`'WOAU1@!3J;"W`'U-O\`#Z?[W[L. MJ>74^-@21^?]?^GX_`/N_'IO@>IT9%K?[$?[WS]/;BGK5*'[>KE?BS\'Z+>? M\M?O'YS[9Z+;Y;]F;!^3&W>E*SI@9#L_^%=5=3T_74>^]V]Y;DVQTSNC9'8F MY5K\WF,;AZ5DRD&-QM/'75<\=0(G:D8>8K<)"7T*5K7&37AFHZ<$?Z;2!:M6 ME/3Y]#O\=>K/C!\A/@/_`#BNS.J/BYA,=NSJ^+X,U/Q_FK8]Y[Z[1Z_S'>?8 MM!M?L?K[9U9EMY[MI\EA*?2.>T5Y<' M57@`:#!_U8Z\%1HYRJ9Q3\^J3.P.L^RNH=S3[*[8Z]WQUAO.BIZ.MK-I=A[3 MSVR]S4M'D(!44%74X'#["Z>[2V)F]^XVAS.QL-O3K[=FU\KO/#Y1TCQN5VI MC\YB*&KW%CI^725XG4@%&H<5ZVWEC^P,_CZV*JJ**NPNS*O"P[CRM'54 M^/J'BE@II$=(9"I(1K*$GA*&42J8Q@FHH/SX=,-#)JT&-M9\J&O26W9LW>'7 MNY,ILW?VU-R['W?@Y8H,UM7>&#R>V=R8>>>F@K8((_8>G"-A:WYN/:Z)L]%%PE!P\^G*-K_`)X_WW/M9&U//HNE0FHICIP@DM;G M@?[[Z^U:M^WHNDCXT..GNEF^EO\`BG^^/M]6\CTC9*'I04\][<_GVH5N'29E MU8/3Y#/8V_PY]JE;SZ0RQG(QT[P3`$'^OX'^'Y_UO:A'\NB^6*G$=/$$_`(/ M'^/!_'^]>U2OZ]%TD).1PZ=(9_H;G\?3_B?:A7Z+Y(34XZ=(JFUKGCBW^W]O MK)TAD@/$\>G.*L(_M?CVZ'!^SI.T;`\.G&.N/%SP3_L!_B?=PXSG/331$XZF MK7J."01_KWOQQ_3W<.>FO!`/K^?60UH_K_O-[?[8'WMK%4@,G;UC:N!N`;"U_]];_``]T,E.)Z>$`/`&G4.6M%CZC M_L./R.1_A[J9*FH/5UAH*'IMFK/\;_XD?\3]3]?;9;Y]/*E,*.A[^*V7V(O< M^W]M]G[?VWNG8'8,-1L7<>%W;B,=G-OU0S$M-48%LAC,M3U..FB@W3CZ!P\J M6@(\@(*`@.Y;1A/RS>W.T[M;7EKN\SV5)7]AGE6YM[$/MJ(L<+4*``* MH(X@`8%1P^SU/0CYDCNMRF&YW$SRW/XV8EF(\B2:DTX9]>J;(\G-1R^6!]+6 ML01J5E/U5E-[\C_8>Y&VO?-PV*Z^LV^?1+2AJ*JP]&!XBOY@Y!'0*W/EW;=_ ML_HMR@UP@U!!HRMZJPX'^1&"".HU36Y3/U='0Q(]55U-1#24-%31W::JJI$A MABBB6[2332NJJ.22;#VFYKYTO=RMY=PWZ^2/;K6-Y&_!'&JKJ=V^Q0268F@! MX#I[ESE'9N6(YCMT!#O\;N=3$#RK@`#T`&8OO*^P_N M_=O[:\V;'N!Y;NKA4BO)%2-$F!*QS@K)XT`J2%D*DA6(FC6-I`#CZZPN3]-* MC>&QH#PH?(^H_P!5>BO=O_(_LGN*AHL3NFMQU)A:&=:M*.L MK//4UE5531QR,$#2^--1*H";^YS]LO8/V[]I;N\W/EFSN)-WF0H9[F02R+&2 M"8X]*1HBD@:B$UM0!F(%.CVQVNWM&+Q*3(<5)K^0X=;#G_"69]7=_P`LN?IU M9U__`.]=E_;WNXU;'9_^:S_\='4_>S2Z;_>O^:*?\>/5CO\`PIW-OY>FP_\` M'Y4]B.?R@/ED/AQ_,(^/_`&AD\E_#=A[BW(O4W:';>0R>48$$X_:.9GH,\P')?%+P?TE1O5M]987$0%7`U+]JY_F*C\^F]IG^ MEO()*]I-#]AQ_+C^77TGOF=\8MK?,SXN]T?&;>%8<7B>V-G5&$I>V=N>.BD:-:M]M[MQ-%7>+7&91`4#KJU"-+6X:UN(KA!E3^T>8_,=# MZXA6XADA;@P_XK^?2WW!FNLOBI\?,MGJQ(=J]/\`QUZAJJ^2"#1X\#UYU3L] MI(Z.E1VC61J';^"$4*7!=E51R1[H!)<3`<97;^9/5SIBC]$5?Y`=?(<^1'=> MZ_D;WGVYWSOB4R;K[?["W9V!F8Q*\T-#4;GS%7DXL11.X4KC,+35$=)2H`JQ M4T*(H`4`#M(UABCA3X5`'069S(SR-Q8U_;UM5?\`"0_M;;V'[8^:'2M?600[ MF[`V'T_V/MRDED5):S&=6YS?NW]S_;AK&>2&7M;&N5%V"!FM8,00[XA*P/Y` MD?MI_FZ-=L;,J^H!_P`/^?J^?^?A_+[[+_F$?".+9O2%%29CNCJ'LC#=N;&V MQ5Y&AQ']]X*+`[CVMN;9=+EG]W4 M>(,J,5+Q;AK,=!@)J:XXF2I:%AR&(/L[:[MZ5\9?V]%PAEJ?TSU]:7:5+44. MU=LT57$T%71[?PU+4P/;7#44^-IH9HGL2-4M#QC]/\>?]]_M_:[IH9)ZP.>/]?\`XCW0 M];'F>MUC_A&97UR]H_/+&K652XV;8/1%=)0"HE%#+6T^X>RX(*R2E#^!ZJ"" MJD1)"I=4D8`V8@H[G@G3J>?5CO\`PL&K*NG_`);G1]/!55,%/7_-38$%=!#/ M+%#6PP](_(&KBAJXD94J8HJJGCE57#!9$5AR`12W^-OLZL_#KYO;>U73!].L M0_K[TQZ<4=<'/'^O[;'KU?K"??O/JK<.N/OW6AQ'6(_7VV>/3GR'77OQZ]U[ MWKK77__1THT//^O[5*:=4/#K)[OU3KF/>PRV9F,^8^[QR4:1K0:[O54<3E=$E33HS3 MQH-YGGMMMN9;:0K<=H4A=9JSJHHM#7CY*Q'$*Q&DR=[,[!L?,WN7RYM/,UC% M<\OE;F6XCDN/I(VBM[2XN6U7'B0B,*(M7=/;HU-$ES;(S3QB!WEU%0]>T^U< MKA`8L=78+$_Q*FK:F-\Q-79+(;KCQFXWII<)N>DVU4-0+0YK*!XJ0 MSN81/%'[1;%O#[@]U%/F19&H0.T`"/4E2$^OL_8^WE MMRINFQC1MT]A!XR2N#<-+-+?K#>%(9KRT2VO8[*4VHM=RO@R0&=S"L\4?0X_ M'K;F;7KK"Y?`P=OJ,SNW.#(5&T-N]=YS"1/118C'T]=09?=>7@K>O\G%2U$T M1R\,*2KZF+&*G4$DYBN8#N4\-PUGV0K02/,K9U$@K&I$JU`/ADD,^WV>SW5LIC%O$DL5Q?W"R[3.L;R(=PCC5Q5F9 MC%;J"0E?2Q7^O_%+^Y`ZY_\`4E3>Q_J/]]_O(]V'5?Q=24/`_P!M[OUKSIU( M!N/]]]?\/>QY]:IUR4\_[Q_O/MP=4(\NI:-^+_3_`'W/^'NWSZT-(DP$.>W-BJ^&O>F6GDEIM+4P22J2Q$KY$"O\`,<#]M!TZA9:,CBOG MGJWCL;YG_&K=&V?^%"O8WQ)[AV#TDWR.RWPMB^-]/C.U-O=*;][8SW3F4R]? M\C=Y=?[9R^>V?O6@H-SC-UV01FI:23/)DI((8Y:V2II(V4BD#6"RJ6TZJXJ! M7A7R_P`W3C.A%SH:E:4\JTX])'NKL7J;N;YN?R8-P9_YS].]F,WA5;DR^^]NXO=^0W'N6&FH-VYJ*HQ>.RU> MN4IJB:>A.EV(.D%\!`360D+0BH)'#A^P9\NFW(:2W;Q0**`3@YS_`*J]+E^Y M.L,9MG^1+'#\SN@55!MV%A`88/UET:Q0JS!>(\B&HU<;>1Z12K^+SZG1M_OK\>UT;TH.D3IJKZ]3(W_`,?S M[71MCHLE3)'4Q2#8CZK;_>?\/];VNB>G17#S]?Q>]O\`'V8Q M25'1)/#0D$XZ<8G_``#_`*_^WO:_X]KD>H'13+'0D4ZG*XL+<#_>C_L?IQ[5 M(^<]()4!'ITY02VMS8\?[P/Q[4AND#IZ^73Y33_3DW/UO]/];V^K>G28KJ^W MI[IZG_'D?U]J%?SZ2NE?MZ>8*G_'_6_Y'[?5Z_;TBDBH"#PZ=H:@?4'_`&'X M/)M_O'M0K^O2%XZ?9TYPU/TY_P!]_3VH5Z=(Y(0>G&*H_-_Z?GZ>WUDZ0O;4 M!(X]3DJ;6Y/^]_3V\K])7MV_/J4E5?ZW-O\`'C_6MQ[<$E//I,T!-:BO4@58 MO]2!_L/]A[OKIQZ8:&OPXZR"K'X/^\_[X^]^)UKP33ACKLUMO[1_UKC_`(GW MHN#QZV(V%.L;5E_SS<\_3_8?3GW4O\\=.+%7RSU&>J(_)L?\3]?]C^/=&EZ> M6V(H>HDE5];'\?D_['\^VS)\^E"P9-./4"2J*D.KE65@RLI(96!N"I!N"+>V M&?CTK2#"GJ\/XB?.7:?86!QO6'<^7H,-OFFI(\/0Y_.RPQ8/?='X_MH8Z^LJ MB*6DW'+#:.:.;'Y7%&NR7V[155&EG2>1)8 MWN-+!D6N]65KSGRQS#R]>,T5M?V<]K(5R52>)HF93ZA7)'SZ8EM!1H2:JRD5 M^T4/1D<_\\^LXMG5-=@<;N&?>,]!(E%@:V@BCHZ+*/"0DE?DQ4-338ZGF.J\ M0:650!H0L=/-#9_N4>X9YL@LM[W*P3E1)P9+F.1B\D(:I$<.@.LK+BCD(A). MMP!J(8N7KIIPLCJ(`3?_`'Q`_P!?WU$9@,=#A(S4 M`#SZO*_D6_/SXZ?`CLWOW='R*S6Y<-B>P=B[2P.VY=M;6R.Z9I\CA]P9#(5J M54&.]=)$M-4*5=N&/`^GN-^?]CW#F"VV^+;D4M%(Q.I@N"`//CU*?MUO>WCB_P`[S^;;\-?G)\1-J]._'_NM01\6BG'[#UKU;*WYN[K'>FU.Q=@;@R.U=[[&W!B=U;4W)B)S3Y M+!Y_!UL&1Q.3HI;,JSTM93JX#!D:UF!4D$1W*QS120RJ&B84(/F#QZ(+8O%) M'+&Q612""/(];Y70'_"FCX.9SIGKS)?(>LW[L/NR3;E)3]E[=>G%=30.S34D50()&=XF=HHN^4]PCN)1:A6M]7:2P! MI\_F.'SX]2?:\SV,D$37&I9Z=P`)%?E\CQ^76JI_.O\`F!TK\W_FWD.\^@\I MGCRRY*,XRO_`,H$,9K$TR?1[FWT]B;9;2>P ML!;W``DUL<&O&GGT0[IN,]N6DRFX]JTYV]) MN9?^SQZ)?\`SG?Y^'Q8^47PAW9\<_B/N3?N4WAVUNK:N%W]6;AV M1F-FTV,ZNQ%7+NC.1T61R#7JJ[.9S"8W'R4Z"TF/J:H.P'I=S;]JGM[D37`& ME0:4-<\.M7=_%+"8X2:DYQY=:64C?[8?7V>,>)Z+/LZ&GXU_)7MSXB]X;!^0 MG1NY&VOV1UUESDL-621&KQF2HZB":AS.W=PX[R1)E=M[CQ%3-15U,60RT\S: M'CDT2*CGC29&CD'8>E43&(JR'N'6]E\4O^%5OPB[*VUB:'Y4[7[`^-G8D%+! M'N'(XK;>6[3ZJK:M46.:NP&1V?3Y+L"CAJ95:7[.JP>K_X43?RL;_`&<6S>KJ7;F/GGL1$M77=F;GV15TE,S6U2)23R*O(C8\>[BP MG/'2/S_S=5-S&!BIZU0_Y:W\Q[H+HG^<1VG\\N[UW1LGJ3LS=/R?WE'C\7A9 M]Y;CP4O=6=SV>V]A*FDPZH:Z6B.76">>,"/4A8``CVMGA=K=8E^(`?RZ9C=1 M(7/`UZO8_FR?S_\`^7'\N?Y>?R8^.?3&].S,GV=V?MC:^*VG09SJO<>`Q516 M8KL79VY*Q:S+UG^342+B\+.RL_#.`OU(]I(+66.5'8"@^?RZ=>9&1@./6A%, MU[V_WPXX_P!?V8'ID<%'6UI_PG4_FW_#/^6[U)\E-H?*'QME;EV MI%M3869WA!48O";:R6,KWK*C%^BBF2KJ4"H_+*;CZ>T-U$\K*4'`=/Q,%!KT ME/\`A1S_`#7/A]_,HVQ\3<5\6]R;TSU7U%GNY*_>B[LV-E]G)34^],?UM3X( MT+Y3C(-++MFK\@3F,*M_U#WJWB>,MJ\Z=6=@0".M5YC;CFUK?ZW^^M[4'IOR MZC2&U[_TL/\`8CW3JP%!ULG?\)QOYFOQ3_EJ]@?*3<7RES^[\#C.UMF]8X79 M\FT]F97>,M37;6S>[Z_+I6PXOU4,<=/F("C/PY)`^A]L3QL^D+U=".CC?\*' M_P"<_P#!C^8W\.>J>E_C'NK?V=WSM/Y+[6[/S-+NOKK.;0Q\6T\5U;V]M2LJ M8,CD_P!B>L3,;QH56!?6R,S?1#[;BC=&);TZVQ!QUIO-]#_C[?Z:&3UP^G'M MMNG@*=8G^OOPP.M]8C[UU0\>N)(L?>CPZV!7K%[;ZOU[W[K777OW7AU__]+2 MB4V(_P!C_O7M2.(ZUQQUE]N=-D4-.N0]^X9ZVO69#P1_L?\`??[;WMNK="WT M=74&.[4VE69&K^QBBGR:TE4V5W!A(8LS-A,G#M_[S*;5!W#28Y\[)3+4FE_< M:G+K]&/LKWM))-JNTC342%J-*,=(9==%D["=-=.K%:'J5_8Z]L-N]U.4KS<; MOP(DDF\-S/=VRK<-;3K:>)/8_P"-QPFZ,(F,'>8BZ_"QZ%[Y0[YW'F:[:&WJ M^OV_48Q-K8[)RK@*CZ-_8FBWUDI*6DKI5$51++2Q/-( MT0U22$E?*UC;0QWES''()?%*]X1:`I$2`D3&):D#(`8T`.`.I8^]-SUS)O-_ MR?R[?W^WR;6NU0S,+1KVY#S1W>YQ1O)?;K!%NDQ2.60".:1X(VDD:(:Y)"1/ M^.N2^\VN-P9K*8K'U>8W]'@J=YZKHO:%(!MK;FSJ6ECP]+OG96:J0G48I%"BH.G7J&6%`J@ M=2C]W+ZVEO=WO,`M4+/ROM\?\`B5GMR(+>/=-MN7GE9)D\=;,0 MN&2&1FDGN'?H@S#@$?7@FW!M;^ON0NN?1%#UG1OI:_\`47]['56\NLZG_7_W MGZ_ZP]W'6CPKU)0_C_8_[U[V.O'A7K)_C_Q7^OU/NXX_+JO69&^AOR./]]_K M^[CJOG\^I<;?X_[[^G^W][X=-D4/''3@A!4?X>[CAU4]3(GM8<_T_P`/]M[N M.J<#TXHQ*@_7_?6XX]V'6J=9E//''^O]/^(]N*?+JAZF1-P/^(]O*>J-CAU- M5B1_MN1_OO\`#V^IX=,LN*=2E;CZ\_X?X?ZXY]OJ>F7%013/4Z)^!_O'^/\` M7\?CVH4])6!&#TX1-8@W_J?S[4J>F2.IR/\`0?C_`(W[4QM^WI+,GRQU.B?_ M`&_T''M6C=(G6HQQZG1L/]C?C_B1[5(W21E%>IT;?X\'_;?3_>_:R-^D4L=# M7RZFHW]."/\`&]Q_3_;^UL;G&>D,T8(+#CU-1^1^1_L;?['VNC;/'HNE04-1 MCJ6&']?\?];G\?CCVNADR.BFY@&DGY]3(W^GY'^]?\3[7QR=$T\'&G4Z*0_U M_P!]^?:U7]>BN2(GAQZG1O\`0@_TY_/^M]/K[5(_2"2.I-./3A#.01^/]]Q[ M4*WITB=#FHZ>8*FQM<`V_P!O_3V^K<.DSKQQGIY@J;CZ\_[;VZ'ITG:/4#TZ MQ5/TY'-C_O7X_P!?V^LG222#IRBJ;?ZW]?;ZR=)'@(\J#IQBJOI8_P#(_P#> M+^WA(?,])3"",#JW%DZ8>#J2M4?Z_[[_8'_#VZ)?GTG:W- M>LXJO\1Q_C[L)!YGJG@`'@.N?W:C\C_;GWO7Z=-M$AXKUT:L'\BW];GW[7UX M1J."8ZX/5?47'^M<_P#$>Z^(.K^!Z=8'J^/]A^3;_BONIDZ>$'RKU#DJ?\?Q M];_GVT9?GT^EL``2O4*6IX^O^^_XI[9:3TZ5QP`4J,]-TM4+'FQ_U_\`7^GM M.TG'I9'#Z="WLSY/=]];T<.-V7VQO/#8NF01TN);*R9/#4B*+!*3#Y<9#&TB M_P!1'$M_]@/9=-;VLI+20*6]:9_:*=+HA)0!7('09]E]K[_[:W"VZ>QMU9/= MF>^TAQ\=?DGBM34%.TCQ45%2TL5/14-(LLSOXX8T0R2.Y!9F)HB1P)HB0*G2 MM4J:DU/05SU%[A2?^-_['VV[]*40G"CILDD/U)_J/SS8_2WM+))T8P0Z:>M. MH3R?4D_XE1T:015(/GU`D M?\_[W^?];@?7V7N_1S%$!0GJ#(_^/^O^/]?V@DDX]&<2$@=-\KWO^.3;_'_' M_8>T$C>?1A%'P'3=*X-_\/I_A?\`XU[1R/Y]+HT!QY#IOF>PX//T_P"-^T;M MQZ7HND4Z;I&Y/^QO_2_M&[9/2I%IGSZP5E%74]/15E31U=/1Y))I05/2P;JCM2>C&1AZS[`EQ[;.K.Q%KXMF[C MDHFZ_H&5*_?2U2XUH#LZB=@)LGJ^RC)]4H]I6=*TUCC3\_3[>E05B:T/0=Y" M@K\9*D&1HJS'SS4U)6QPUU--22R4=?3QUE#5QQ3HCO35E',DL3@%)(V5E)4@ M^VV.,'J],@=-$C6_/X-_KS_A[;/3HZAN?J;V^I/^P^G^\^VC_/JPX@=-DK?7 M_;_Z_P!>/=3U?J$QM]/]C^3;\_Z_NIZVO$=.>0VCNS'[=PV\%N'`/MLD9`.>G!QK MY=)@FP^O^P_XGW0GJXZCL?K_`+#^OUOS[UUOB:=8&/\`C[J3U:E3PQUSH,?D M,Q74^-Q=#6Y/(U4@CI*#'TT];6U4NDMXZ>EIHY9YI+`G2JDVO[IUOCU"8F_^ ML/S_`*WO1ZL.'2IVAU_O[L2JR-!L#9&\-\UV(QLV:RU'L_;69W-58O#4\D4- M1EY=OYO;M54P M35--2YS%5V)J*BGILC7X>HJ((:^"GEEAI\OBZJE=E!5:FFEB)#QNHT3UM!P/ M3$3]3_L?;?$].\.L!)_)][/&GEUK@.N'O75.N#_CW5NKJ,5ZX>Z=6Z][]U[K MWO9XGKW7_]/2AY^IN?\`'VHZUUE6]N?Z"WT]N*:]4:F,=]\1GJ_1B/CMM'?>3WYA]R[:Q6Z8L/B!N2/);IPNU-T;@HZ+Q;3RLU M9AXYMLUV#K86,5A-:W,L1E?11&= M$)_46C=X8%5(U-5&4A2"I%1UD']W7E#GO=.?=GYFY9VK=5VBS^L$U];6%[=Q MQZ;"=I+<-92VTBW-Q$X@@\&\M;A)9X9(IHGT.'GY25>5K=Y;0FS4FY*C(MU] M0BIJ=V;3W#LO.57 MH@[W]A=[=[WDR>2K\!B*N+%K2;TJI*S;"T-/AWEER%+2B.4SQ+)+JA MC3V5\S*IO9"?#;3::B&DFBTJ'8:JQBCU+`!&:HH:"A)ZE3[L,TZ\EV,41W"W M,W-P@CEMMOVC]8)GA7KDAMQ^1_O7U_XGW[JO'J0I^G^/NXZJ,8/4E3_OO^(^OO?'K0].LX MYM;\^[CK77)&L>/\!Q_L/\?=_0]5(ZE(?Z_UO_MO=OGU5A4<,]3X7Y_H+?2W M]?\`'W8'IOC4=3$-C?W?JASTX1/:W_(_]A[L#GJO'J6#?^G^^^I]V!ZT?Y]9 MXFMP?;P/5#PZGQ-_7\^WE->/5"*Y\^I2$CZ_3Z7_`!_3_6]OJ>F".ID;6(%O M^1W^OM]3^SIAU'&G3A$]["W^M_@;_P"/M2C=)F'''4Z)O]:Y_P!?_?6]J$-# MTRRU!'GU-C:Q_P`?]]_M_:M&Z0.ND]3T;@?2_P#A_P`3[4HW2213QIU.1_\` M??XV^H]JD?AGI/(F#BIZF1N>+_7_`!]K(W^?2!D(ZFQM_7_BMO\`;>UL;^G2 M&6+J6CZ?2>?^(_V/^Q]K4?SKT72QC((QU,1B./P3P/Z?\5!]K8Y>&>BF:`J: M$8ZE(_/UX_!_'Y^O^W]KXY,=%$\!J2.I\$\`.W MIPCJ1_6WTO\`\B/MU7Z3-"":'J8E2?[/TO\`[Z_MT2>O3#0UK0'J2E6?Z_\` M&O\`>Q[N)!TT86].LZU?^Q]VUCUZH82/P]_^*^_>*>)ZV+?K`U6!^0?]]_A?VV9"?/I MU85`H!U$>K)X!MR?K>QY]T9\=/)$2<#`Z@R51]5S?^A^EO\`>?;32#I0D/'M MKTWRU7]3>P_U_P"M_;#/7ATI2*A&H=-?2D1CTITUS5!;Z M<#_??ZWMAI/V]*4B+D8[>H#R6_US>Q_/M*\E>C**WI2@SU"D?Z_@B_\`A^1P M/K[2/)\\=&4,)P*9Z@22GF_^V_ISQ_KD>T,LF,'HT@BSD5ZA.XY)/T^I_/\` MA[02/T;P1`4QGJ$[W/\`O/\`K>T,CC.>C*..M*<.F^5_J!_L2/\`??GVAD?H MQCC\NH$KV'U]HY'X]+HTI0#CTWRO]?\`?73=(_Y''UM M?VE=NED8J>F^9[?ZW^M_C[2NW2R)/EUM9=2?"OJ_Y4_&_P#E+8/Y(]G]\[BZ MEP_PW_F(=Y-L;:&5ZOP$^V$Z8[)V/7/MC8F5?K*3*IC]V+7,]2"% M*6HHX5*>PO-=/!-N)A1`YDC%37-01'#'G\Z M]#/\6OY>'\L[&=@5.^,-TQWAVWUQ\G/Y4'9/RFZPZM[,J^N=];NZVK=J[AI, M)OZEVM41[0ECJ.ULA'F\&NSLA#%*^-JDR)E\ZU4$4"6>[O"FEI%5TG"DBH!K MP\^'&OKCI^*"WU5"$JT1(!ICU_/TZ`/XW?R7?@KVE\;-J=U]L;M[TZA?Y/\` M8GR:P74+[S[`V)MK)?&S"=6[PW7M3JK:W9^RZ[9$N8[8[(SU?@(CG(<><:B4 M\Q\,-+XS._I[^X64QJ%.@+6@/=4"M,X'IUN*UB*!F)&HFGR]*^IZ-GL$_P#. M)>(_Q_X2D?)\_P#K=Q'M,W]J?^>H=/K\`_YHGH'?DK_+OZ=[7WIW#\F?D_N; MY<_*G`_%CX*_R^ZC"]*],+UI%W;N^K[IIMR8&EB6?;/6F(H*/KCKRBPTE4[K MC)LK41?=U5573-3.E3Y)W4+'&%4L[9-:8_/B>MF($EF):BCILI_Y!WP1VCWU M\TJG?^].ZZ[H?H+>7QHV'M3:E7VSUWL;=FW/]-_66S>P=Z[YW_OO+;!?'5F+ MVJ-UF#`XZ''TTM?44S4\\\K'R"IO)BD5`-;`^1\B>`K^WJP@0,]3VBG0-=*_ MR=?Y;.-BH:'N;=WR=[9;N3^9IOK^7_TON[JK>O7NT\)@\'2[9EW3L3L3[,KCMI5V7 M/2D!_+K_E; M?!OO;XD?$OM'OW:?S,WWV;\S/E)O7XS8C)_'G-;+3:/2D>$G:FQG9.Z,-EMB M9BL7;>,134Y>JJJJIA@I8Y91"%B*OZ6:17=5*T45SY]>B12H)!J33JS?9'P/ M^'N^?B;\"/Y:_P`GAQ6Z.K.RNQH:O?6\ M,5N/%[E7(468H-G0B&BIC*E-/-()#*JJWM.9'UR2J!\*D@_9T\%&D*?4]$B^ M,W\C3X>;SV=\0NJNV*[Y<;R[X^=.(^2.7VC\@.E\?M1OCE\=6Z/J]Q4N$QW8 M>)R6$RF1S59E7P2KEX9,G3/'4SK2PM3&U2;/,]7(II6F/,UZ\%%!7B>GWM#^ M7)$.\OBU_)KZTZNZ<[2ZW[(^2FX,]UINCY6;2H]DY+8E-48?O?:?7_:6X>\ M,UB]HT4^^,UN?)35-)U@D^0HA"E934=0TSR,?=1(ZM,2P('E_J_GUN@HM//J M#F/Y'GP5[6W)U=/U/3_-?H;:NWOYE4?\O?N+!_(&LV+3[G[GJ,?7TAI7DE6*$TVFHUXSBM:'%<=;TC^?0]?%7^7!\0=C M?,SX`]__``;W[\KNB*BL^;?S0^&F^9]Y[CZ>WQN^FW%T?T+W74MOW8-9F>L= MP[2HZ+<\.UZJEK*7*XG(I+1Y'3%%2RPB:2K.Q5U<`X!Z\%%01U5WW[_+J^(W M07PHZF[B[+VI\V>\/D5\O]E=R]N[9[>Z:H-KY/H#HX[4W161XK$]D8Q-M3Y7 M<572T1^ZW5XZVEEIXUF>F6`(H:X=BQ`H%'7B,=+C^9O$NE?Y6FS.A/E!\`< MCO#?>S=R[OR74.?[KWSV;L3LO`;AW-2[:PF])]K;MZFCZ_Z^W?T_V719?;U? M]SBIUKJ=*"`"=J6I;PG4;%R5;JK"E".J`/D7\FNWOE5O#!;^[JSE#N+=F`VA M1;)ILM18;'81ZS$46_+Z]>/IUA/O7'KQX=]= M>Z][]U[KWOW7NO_4TH>?\?Z^U'6NN:'FW^O;_#_?6]V4YZT]C'5P:]#!TM6;A_OQC<7@87R39*FSZR[?;+T^)CR^C;&;5HZ"?(4N1Q<6 MZ(J=Y#AY9Z6H$>4\!",>"4;REO\`122SG3I*=^DMI[UX@$-HK3Q`&%4U9ZEO MV7N^81SSMNU;%$;EKF*Z#6AN$@%Q2RN01$TJ30+>JA<[>\L,H2]\`A&."H_D M#29'&;AV?C,CM^MVN<=L.@IZ3$9O<\6Z]VQ4DFX]T5?GWGD8*6B@IMP55552 MR?:+%']M1-3HRJVI0WR\\X[;S!R?M>X\O3;6;;88DCM[F]6_OUC-Y?2:MQF5(E2[D=W?P%1/!MFM MT95;4H7/1&Y^NL'L_,XSXMQ/C=USS5?:R5];L:;'8^.G7;-+UW4) MBGR]+4OD'=LO#54KL8(VB:-I`46_6NXSWD,MK9&9(X]48`@H)03769AJTD:/ M[,JWQ&H-.AK["S7FX[B8;]FDWX2R;6T,(062;0X@-PC MF[9CN$<\#$P1M$T;2`EXW5B\/A,[5XW;^XZ7=^*IX,:\&X:&AR&-I:^2KQ=' M65B1465@ILC`M#6SR4Y\T<;L82VD7M[$UI+/-`DMQ:F&4EJH2&(HQ`J5)4U` M!P3QZQQYLVG9=DWV[VOE_F:+>-IC2$I=Q12PQRF2".20+%.J3+X4CO"?$16) MC+:16G2>/#!OZ_7_`&P]J>@WUG1N/Z_D?ZWNP/6CZ]2%/^\\_P"Q^GNW53Z] M24/X_')]['7CZ]<_H0;7_'^]_7VX#\\=5(ZS(?IR?\?Z_P"'^OQ[L.J^?4V- MCQ^+\"_^POS[WU1AGJ>K:@#[IJ-WM2C5Z88=3HV^GY_'^\_3^GM0C?MZ32*#Y=3HVL0/Z?[U[4HW#/2-T(J" M.IR-]+'_`%[_`.^M[5(_25TIU,C>Q'^MQ_@?:M'X=)76H)ZF(_Y'^'_(O]C[ M5H]"/3I$R$U!ZF(Y_P"(_P!Y_P!Z]K4?I!)'Q!'4Q&_'-O\`>1[5I)\\]()8 M0P((QU*0_P!/\.!^.?SS[61R]%DUL:G`ZE1R&UOZIT=01;GZ_[;_"_/MY7X=)GC`P>G"*J/\`7^G] M>?Z^W0_3)B)P!V]3XZLG_B.;_7W<-3JA4-@KU+2J(L+V_P!<_G_"Q]W$AQTV MT`\N/4E:F_\`:!M^;G_>N?=Q+TT;<\>LXJ3:QT_[R/\`B?>_%].J^`>!`Z[^ MZ(/X_P!O_P`:]V\04ZIX#`\.NVJQ;\?[?_C0]U,GSZMX.#5>L9J^#;_>;G_B M?>C)FM>K+`.`'6!JJW]/^-?TO[H9/GU<0Z:=O4:2L_Q_-N.?^)'MLN>G1$O4 M*2J/(_I;_7]MEO.O3X0CMICIOEJ3?C_C?MIG^?3J)D`#/4%Y23R;_P"`_P!X MY]L-+TKCMR35J]1))>>../Q_K7_J/:9I/7I>D.0`.HCR<&Y%_I8VN?:5Y?+H MQA@^6>H,DI(M];#_`'GVCDEQQZ,HH:$4'4.1^+G_`(@6Y^GU_I[022<:GHUA M@H.&>H;M_O5_]?GVCDD\J]&445:8ZA2R?T_XW[0R2<>C"./J!(_U_/\`O9]H MW?I:B9&.F^5_]]_OO\?:-WZ6QQ^O'IOE>]Q]?Z_G^G'/M*[=+46O#IOE>W/^ MV!]I7;I5&O4"1_R18_C_`!Y/U]I6;Y]+46@'KT8?`_,_Y4[0P>R-M;9[X[&P MF!ZVV-V'UGL/$X_/2P46U-@]LU5)6=E;3PL(4BDPN]*J@@>OB'$[1*3]/:"2 M&!F'8T. M,W]F(8]R;LW26.Y-SNIF88S<&=N!55E%]M43*B!G(C0*P]O;MIK"O:*#'3HF MEJU)#GCT&-/\T_E;08"/:M%WWV/3[=AZ'S?Q@BP\6>F2A3X^;DECGSW42PZ; M#9.5EB5IJ/\`2Y4<^Z-%%4G0*ZM7Y^OV]75G-%#'A3\O3HX?PZ_FK[OZ&[FW M+W)\B<7WO\D<_D^K-H]3[;RVR_ESVI\8]Y[4VOL>M:HP6WWW;UM0Y*3=.SEH MG:E.)R%/)3P>BHA9)X8V]II;<.@1"%%:\`?\/2A)"IJU2:>M.DYWQ_.)^9?8 MWS)[T^9/3W96[_B[N;O&#:N&S6T.I]X99<''M/8>V,9M'9F'SKU<<5-N_*8G M%8WRG(U5''(*VJJ9*>.ECE\*T6WC6-(V74!Z]>,KLY932O119OG9\PFJ<-6R M_(_M>IK=O=X5_P`E,+6U6ZJZLK,?WYE8*BER/;$%75--4?WTJZ:JDC>K9BY1 MB/I[V8X\]@X4_+TZMJ;^+-:]1:?YV?,.@ZX[AZAI?D?VO%UAW]N7X]CC M=5:VW>P-T[RJ4K=WYW-X]V:(Y#=51$C9)X?%]\$43!PJ@:,<=5;0*CAUX,Q[ M030\>C;;%_G%?)#I#X"=8_"'XX9O?_0&6V5V=V5OO=W=O7G:%3BLSO\`V_V& MDCQ;+.W:':E!D=K?P&L<3)D:;.RSR,OICA)O[8:%#(9&H<<*=/!R%`&.B1;2 M^:7RNV%1]2T.SN_>R]OTW0^[-X[[Z>BH-Q52?Z/=Y=A"M&]]S;;DD\DE'F-T M?Q*H-;,2S3&9BW)/O;(AKVC/6P3C/3_LG^81\W^M.L-Z=+=?_*KO'9_578-; MN'(;LV-M_L#/8S!9.LW=/45.[98(*:J23$#=4]7*V32B>G3(&5_N!)K:]2B$ M@E1JZWJ/`''26Q?S:^7&"Z&HOB_A?D5VUBOC]B]QX_=V(ZJH-X96EVKAMQ8G M=5/OK%Y+"TL,RSX>3'[WI8\S"E+)%%'EE^\5147D]Z*KJU%1JZ]4TTCI:[^_ MF6?/SM+=O4^^.Q/EUWMO'=O1F53<'4V:S^_,O7U.QMQ)3FC.Y<-'+*:9=SS4 MA\4N2E22NEC]+RL./=`B`&BBAZO4^O29VO\`/CYF;(J=L5FTODCVKM^KV5VE MOKNW:U1C-R5%/+@>VNS<1F\#O_?^.95_8W+N[#;DKZ:MJ!ZIHJN0']7OQ137 MMZV">L&W/GS\T=G=*[N^..U_DYW)A>BM]/G&W/U;1[URR[1R"[GJYLAN:GAQ MKS.N*HMR5]3+/D*>C-/!6RS2/,CM(Y:I5202HKU4F@X]-?R,^)[`W=DNF^N+&P_U_ M>B:=67CUB]M]7Z][]U[KJWOW7NN_?NO=?__5TH?:D=:Z[Y!_Q'O77NLHY`/] M?;@X#ILBAZ['O?7@:=&5^/5?U[A:G*Y[>&\Z38^7QV=VS38O+F+>LV9?:N:P M^]\3OZCVY_[+<[KO_`#?SG%L>\6U_9)!<:=R:X-C< MV^YP;K'9_N[48KAXG@"7,T3"!BIC9';N8N[LMA;'X;(4L>N=2\D85M3WULIV.*:)=P,UFT! M>XU!25;'A1`FJ56A8,:#`-10<.@[[W[MLNYW'MU;;+SE;[ZEARZ+:2ZABN85 MUKN>YRQQ,EXJ7.J*WE@35*-3J%;4]=;"STGLGKK=77^.K,_L49?MCC\]558^+5.[+,MY)("S>K[<; M6_D2"_T6QA5F[(R8UJX++KEC+,2":*KG`P;BWMV-[?PIN$VBRD6UG%GM5^EO"B2(GBSSVB5E=EF6LDD!0%M>U^#_7^M MO^*^QD.L.`?/K*#<:;_UM_MO=NO$>?2^ZRZK[0[FW71;#Z?ZWW[VOOFO227' M[,ZUV?N'?6ZZ^*%XHY):/;NU\=ER]N8JASNX>O*'X[=O5>^L#@\F\D>-S.9VE3[/DS^+Q M61DB98*B>G2&9E(1B0??M:4J7%/MZK0UH0>B[4>UMT5VY4V91;8A%JQ%X M"QL'O[\)$I76*?;UXJ:TH>@4?I?N.G[/EZ1J.INS(>YX.E!E-,:03",:M-N?;@9=(:HIU0J:TIGH:<+\%OF]G\ MEO;"X'X;_*K.9?K.K&/['Q6(^//;F1R77]>V/CRPHM[4-'M":JVI6-BY5J1' M7K`YIV$EM!!][\2,`?J+GY]>*,1P/07]>=+]R]K;ZEZOZNZE[-[)[+IVR*S= M=["V'NG>.^86P\XILLDNTMNXK(Y^-L74D1U`-./`YTO8\>[ZU459@%Z:H2=( M!Z%_"?"/YH[BQNY\UM[XA?*#/8C9%164N],KAN@>ULGC=H56/BDGKZ;<]=0[ M3GIL!44,,3/,E6T+1*I+``$C?BQBGZBY^8ZUH8U[3^SI7;2_E\_/3?6VL%O/ M8?PJ^5V_=F[GQE-E]N[OV'\?.U][;5S>.J0=%1B]Q[6VIEL-6>*17BF2.=GI MYXWBD5)$=!OQH@2#*H/S(ZKH&QF,I)JVKJ\GG]Q[1QF(HE\,)2)9)E>HG9(8E>61$:Z MW$18`2K7[1U4QR#BAI]AZ0'97Q-^5/26V,;O?N?XS_(+J39>8FIZ?$;N[.Z9 M[&V%M?*SU<2U%)!C=P;JVWBL572U,#J\:Q2LSJ05N"#[>66-S1)%)^1!Z;,; MJ*LI`^SI-[BZ0[KV3U_L_MC>74':6T^J^PI6I]@]E[FZ_P!V8'K_`'Q.D$M4 M\.S]YY3$TNW-RRI30O(5HJFC$X[XH_*;(]:2=U8WXT]_Y#IN*B.1E[9HNF^Q:OK*+'A8V- M?+OR#;DFUDH@LR'RFK"69>>1[L+B$/X9F7Q/2HK^SCU0PR4UB-M'K0TZC=B_ M'/Y#=,8#:^ZNXNANY^I]J[WU_P!R]R=E]7;XV)@-W^.EAKI/[L9C=.#Q>.S^ MBBJ8YC]I)+:*17/I8$J8KB*0LLSNW,'DL7AXX8O4[5 M$L85>38>U!N((V"R3*KG@"0"?VGICP99`2D;%1Y@$],?6W6'9O<&Y(-G=2]< M[[[0W?51^6FVKUUM'<&]MR5$0DCA,D&#VUC\GE)8Q-,BW6(C4P'U(]J6FCB7 M7+(JKZD@#^>.DHA>0Z4C);T`K_@Z5?:'1'>G1=?38ONWI;MGIS*5:J]+C.U. MN=X=>U]4C1B9&IZ/=N'Q%1.&A]8TJ05Y^G/M1;W,,P_1F1P/X2#_`(#TEF@E MB-)8F6OJ"/\`#T&:/>W^\?3C^G^/MF:](GCKQ'4U7_Q/^Q_U_\`>?:Q)/GTBDC].I22#\G_`'W^/M4C M^AZ0RQC@PSU)5_TVM;_"P_Y$/:M)/GT736YH`!U(5S<#_&UO]?\`P]K8Y?/H MKGMQ4"F>I2R<_6W^'Y_XW[5+)Z'HOD@H34=2TE_Q_P!]?G^GU]OK(?7I%);@ M\!7J4LO]./Q]?^(/U]OK)3SZ1O#P[>LZRVMSS_A]/K^1[>$G29XB.''J4E1: MW)N/R/\`8V_UN/;GB'UZ9T>3#J4E6;JE13'#J2*L?UM_ MK?\`%>1[N'^?567%"*=9A57^CGZ?U!_XI[WKZII!I0]MZ#QI_+KB:IC_:L/\`#_BGO1?Y]>$><=8S5?7U_P"\CWK7Z#KQ2N">L#U8 M`Y;CZ_[S[KKZOH/'J.U5?@7_`.*_[S]?=&L#2CGGG^I`N?]?VPTO[.EL5N!3UZCO,?ZW_`,>+?3\GVG>3 MI:D/KU%>3_'\_G_'_;7]I7EI7/2^*VKG_#U#>7D\_P"O^?\`;'VDDE]#T8Q6 M_J,]1G?@&XM]!_C]?Z>T3R=&D4`X]1))/];GVD>3I>D?RZA2RV_US_O'^V_Q M]HGDKTMCCI3UZA2/I_/)Y_Y'_A[2/)QZ71I3RSTWR2"Q)_WQ_P")]HW;I8B> M?4"23ZG_`'W^!_UO:9VZ61I3)Z@R-_C_`%_WQ]I7;C7CTJ2/IODDN>/H/]]_ ML>?:5VP17I6@ID=0)I;7_P!]:YXY]IG;I6JT`]>FV1_K_K_[;GVPQ\^G0#PZ M@RO:]N#_`*_/'_%?;#'CTZ,`#SZ@NW'^)_WWU]LL>G`!3J([$7YO]3_7\^VB M?V=/J,<.H4C$_0_ZW_$GVV3Z]6Z@S/;@7^G]!_C_`+U[H3U8#CTW.UR;?2_Y MM_M[_P"/NE>K?9U%D>P/^N/]<6_P]UZ<`H`:9ZAG\_FYO_L;6/'^Q]T)ZN.L M#-_Q%O\`8^Z<>KMC`/ MKUB6_+'CC_B3[UUOK@>02?KQ;_??ZP]Z/5C@4ZQ$^Z]-G)IUCO?G_#W5CTXH MIUP8V'NG5^L)X_V/O9X]:.!UP]ZZIUPZR(>+?G\>[*>JL,=? M92YY$W+=K3D[F?VJCWS<[Z:?P;D3;N98F-JWT\9M-KE#RV\=P@EN6B@EN1;M M-X:NR1KTX_(G:V(V?NG;&'Q.U8-HN-DT=3EL?14&^:+'5.4GW'N?76XZ7L:" MEW9DJ4T200&HJ(HU:6!TC41HMZ&(H_% ME1%+QND:B-%J(7QYWWLK:NU,CC,ON3:>W*W-;L$&Z(]W1=J9"GW!M*7'XR+' MXZBQFP[MIO1N`WV5+NP:*%888 MX=JFCMZ1N+WQGO4>-A-$K=@(Z*&#^/8RX9ZPX!\NLP/T/]./>QTX,BG1Z?Y8 M`_[&7_R[6M]?G/\`$HFUOSW[U^/][/NK_P!F_P!AZU2C#[>KH^R.WM\="?\` M"CKYU]S=;Y./%;XZLVC_`#)^R=JU%53I7XP[EZ[_`)>7R$WUM@YC$S'[3,XR MDW-MNCJ7I9PT,K0+<7`(;4!H$4^9'^'K9^(D<<]*3YC=%=-_SL/CKN?^9G\& MMK8S:'S8ZQPB97^81\.\#4U%3EMRM0T2QR]Z=1X5XY*[-_?TV/DJ)D@UMEJ9 M&C:^;I)URED8PL(W/8>!_P`G56&L:EX]$3SWR^WC\,?YH/PY^46+K\GD7ZA^ M*_\`*SK7+]=Y[^6[\7,;V;M:G,DI\7]Y]J[FR\8/*K5U9G*L][N: M`\;IZEO\)Z]7(/GC_!T=?^8;\.^O/C[_`#?=W_*+&8VBW!\.^-U=@=3?S^.P-X9ROSN\=\?RS?DSO?=>?K9W>OS6 MZMP[:['S>9SE;+JU25];ET^T_Y.O)_9S>M!U6Y_+JW3GMV?S, M?Y>&1W#D'R5;1?,#X5[8I)I(J>'P8+9W:W5VT]MX](J6&"'1C,!AJ:G#:?)) MX]F4_M$/S'0__`,X'>NZ=E?S8/Y@%1M7-5N%DW#VA MO_9F>6E9#!F=K[HV_08O.83)4TR2TU915E-*&42(S05$<51$4GABD35L`;>& MH\NO2DB1Z'SZLW_EC;QVY_-\^'>Y/Y._R*S[XSN;IW!UW:OP'[WR6,J\[/LN MDVLM.F=ZKW'4P,:X[7HL95&G@1BT?\"GEACT38O%Q.W-6UE%T@[#AAZ_/_5Y M_GU>/]9/!8Y&0>J!_DSW;C.U]T;:VIL!,IBNA.C]LIU=T)MC)!*:JI=F4&1K M3R;TL4C4E+2JAC$A4$M_:$U/V_[ M'`=)9#JH!\(P/]7SZ+G$_P"/^1_\B]J%8CIIA4'UZV(.K3_VS*_(O_QJ5A`/ M_1,]$GGVE)_W;1'_`(3_`)3TX!_B,@_X9_D'1G/BM\X_C]1?$;X-_P`MK^8% MAZ3)_#'Y,?%?>6Z:;M)9)*7>'Q\[JB^>?S7V7M?L>DW!XJR>FVW28G:&)I&= MXY8,0M*KR1R8Z7(4\U98)?'N+RU/^,HXQY,-"$C^9^W[:=>CE010V\X_19>/ MH=39Z)EVE\&.Z/Y=3?S->I=[Y$9W9^YO@SLK='4';FUIIUV9W%UIE?YA_P`$ M:"AW#AZRGEDI17?PO)O29;'>69J1ZAE#S4E13U%2OBNX[OZ&1<,)34'B#X;_ M`.H'I++`T'U*G@8\'U&M.AO^?E*_PL_E4_RRNE>@ZQ]JX?YM]5YGY*?)[?.V M7&/S?<6Z*C!=;9S;G7VZ=PX]8J[);8ZQC[#J*)L.\[4:S04\DD"SJSR;L6^J MW&^FF%3$VE`?PC-2/F:<>J72^!9VL<9H)!J8^IQ0'Y"O#JE#;GR&[+P'1?8/ MQR7.5>3ZE[!W'L[>D^UV][;*JL@V/W9M;'M6C&XG,9'$YFLH*^1( M=5933()"3#$5/!%$TT=Q2DJ@BOJ#Y']E>BAG<1/#7]-B#3T(\Q_EZ!N.2WTO M_M0O_OOQ[,%:O1>R\13JU"/TG=./4E)/][]JT>G25TXU'4V. M3@7_`*\>U*/0\>D4B<:#J6C_`-#_`,4]JDD\Z])'2M01CJ2DA%K&X]JUDKTB M>(J/EU)5P?S_`+S_`,CM;VH60CI%)`K9\^I*O;Z\_P"]_P"^'M4DOSZ0R6_& MO6=9>#^;?T_WUO:M):^?1=+;BI%.I"R'Z_[;_6_Y$?;ZR@^?2.2`^8ZSK,PY M/T_IS_7^H]O"0'SZ2/"1Q'4E9P>;?[S_`(_[?W<.1Y],M"#G1UD$G^.G_7_' M^]^W!)Z'IAH`10CK()./U?[:_N_BGIOZ9>/GUS$O^U?[S_O7`][\4]>^F`R# MGKEYB!^HC_&__&_>O%/IUXV_SZX^5C_;)M_5O^->]F7K0M:^?7C(/H3<_P!; M\_[QQ[J9"?]X]T,GJ>GE@7R7KB93?^G^Q`]MF7I]82 M/+K`TO\`KCZ?4_XGZ?3VRTOSZ?2"IX=86FOQ_M_Q_ON?;#R^=>EL=O7`&>HS MS6XO_L;@_P"M]?Q_M_:9IJUSTN2WI04ZCO*?ZW^OYO[2/+6O2^.`T`\NHSR7 MO8_[&_\`MO:5I?GTOC@`\NHLDE[_`-;?4CVD>3Y]+DB^6.H;R$_XG_?<^TKR M\:'I6D9ZB226'U!)^E_Q_P`1[2.]?/I8B4ICJ!+)]23;Z7_WG_>?:1W^?2Q$ M]!U`DDO]3_K#_86N?:9VX]*43AU#>3ZC_;G_`&`_P]I7?CTL134=0)'O<7X] MIV;I8BCAY=0)9!;Z\6]IG;CTH1?/IND>Y_WGZC_;_3VPS=/@5R>H,C\'_>/] M?GGVPS=.@5SU!=OJ3[9)].G5%,GCU#9[?7_8'BW^P_`]LL>G%%<]1)&/)O\` M4G\_\1[;/3O4)VL"3];?C\?[T?=#UX9/RZ;)7)/'^^O_`,2?=#TYY]16;GZ_ M3\_\1[J3U914U/41VU$@_I%C]?\``C^ONC>G3@SQZCL;XGY=8&/U-^/\`'W0GK?'J,USQ^..?S];?U_I[KU;KMOK; M\WY^G_(O?CUL>O6`G_'C\>Z'CUHGB>L3'\?U_P"(]^/6ER>N/MMCY=/=8G-S M8?C_`'OW[R)Z]UB/O75">NKVY_WQ]^)Z\./6+ZF_^/MKCTYUU[]UKKW/^P]^ MZWU[W[KW6!C<_P"\>_=>Z__7TH?:CK778]['IU[KP-C?^GOW`]>ZR^W!TV>/ M0O=#FK/:NUXJ,T&NJ3/T53#D7W$L%;C*_;.9H\QC8$VE'-N>HR>4Q,\U-1PT M"/5SUDL4<:EF`)3ONG]UW)?50:2*:,$.I4GQ.P*K`%BW:%!)P.I=]AS=GW5Y M7BLS!KE%U&ZS&["R0RV5Q'<0J+`->O-/`TD-O':JT\MP\4<:EF`*\^3F)I\+ MN[:%'0PT,5"^P:2JHWQM7O:NH*JGGW=O%DK:.LW_`%59GJJCK+&2&8/]I/$R MR4Y:)U=T?+,K36=V[EB_CD'4(P01''@B(!01P(^(&H:A%`.?O/[1;;+S=RA: M64,"V)V"-XS#)N4L3HU_N!$D&&:"20XRJ MGK`L!JE5XD>\2RO*DL5U?1(8SVQPRME&RVU;78[ M5?;3N_*W(VZ7:;A%_C.X;SM<'Z5[;VDCV\?C0W!F=8XVCCDB=S93RW@6`W2J M\10`?Q_2WL9]8:D$'K*&/^P/U_XK8>]CCU8>1Z-M\%.V.KN@_F#\:^_.X:S? MT&Q^B.\.I^ZJ^AZUVAMW>NZ]Q2]5]A;:WQ%M>CQFZ.P.M<101Y^/!O3-7/D) M#1EU<4TXNOOS`E6`XD=6].K)>P/FO\#NSOYD_P`P?F9G=P_+G#==_(3JOY0; M5V7MO$]!=-UV]-O[H^4/QQ[(^.66;<]+6?*BEP<^`V'B^PY:C+5$* M0O#1("[T".$5<5!'\L^G7JBI/50JYADZ":&FHT_NO@9XWJ9O-]MI(@LK2>1_U'KS-V@=!S_+ M'^?V(^"/8G=,/8G6%7W-T#\H.AM\?&_OOKS$[BAVKN.MV'ONGCI*O.[3SE5C M,K10[BP],]1'%!4Q"GJH*N:-GA3OSXR9[Y8=K]J[4IWM\[LWCU[WCVW MF.VZWKV7)?Q3'4U)A=FQ566H:9YR*AM M^`?S:^*WQN^#/\Q7XU]K5WR"F[#^L-H8?(]>=1=<[HV7UX_560[(R%#D M,GEMR?('8>;W"NYCOF))HXL92G'BG9E:JU!1J2-VEB=::5)\_P#8ZH&55<&N M>B3_``;[5ZGZ%^8'QX[X[;K^PUV'T5W9UAW++2=<[-VWNS=^YI>K^P=N;TI= MMQXK\_DGT;4=H1[2[JWE4[X;!=K[(VGLO<>V:RNQ^,AJ,.HVAV9V M9C,U2PU<$VBJ\]([1A"806(7T"M'&J/2H'E_Q0ZU(0SL1P/1D?Y+GS<^.W\O M3Y;TWR<[\@[HS]-@MC;TVCAMG]0["V-N>?*3[OH:.@%?D\UO/MOKN/$18^-) M6\45+6-*0GJ0$Z=7,3S1^&A&3Y_\4>MQ.L;!C7HE_0>%Z;K?E9UIA\IU_P!Q M_)'HW_2+AWS?76U<$NS.Y>S=BT"-F2 MLI6;S0JF9O":C!7IQX@'I@*NH8)%>E]_,/V7\:NN/FK\A-C?#_+5.9^.NV=Z MPXWKNKJ,]'NF.F$>`PLF[,-C=T1Y+,KN;`;=WQ)D\?C=) M8T\*4WB7`TZ`FGB:^>>'SX5_/K99!;M'FI:O^#Y]%B^4O9/QDW[U-\1MI=*; MH[WRFZ?C_P!$9'I[=\7:75/7^R\!G*[-=]=W]^Y'<6V\QM+N[L/(K209CO"J MQD-)58^-S38Z*=IM.Q<.;=[=Q7A0^F0:?9C'7#9GS_ZA[C^%.P?@G\XMD=BYG;?1.XLKG?C M/\C.F?[L9?M?I_'[A=WSFQ,YL+>>4VO@.S]BUDDQ9:9\_A*J.."EA2H5*6G, M3QMI([E[NU=0SCN4UHU/.HJ0?R/\^D_C(\"V]PIHI[2.(^5#Q'YCHM.\L]\) M]G=1[DV;T]%WSW!V?N[=FSYY^U>W^ONL^EL?LOK[!-DZ_<.U]F["VOV7\AZG M^]&Z\NU!YLY)G83%14K4Z4HCFJ4J5T;73R*TFA8P#@$M4G@22%P,XIQZ22+` ML9"!F^#?2_8/1'3,?7>S,7D]E]D;IEW M9G*CL.@I:I=VYZEKI]Q[MG@Q%=KIX8E>OD:HEIY*LQ4GW/V<#]B+N.+3>3*\ MNHT(%!3R\A_JQGB4UX+=WK;1E8Z#!/GY]%(1[-?\`6^GM2DF./25XP:=2DD_-Q;_;'VJ6 M0=)'BXXSU*20?7^HM_OO]M[4K)\^DS18)`QU(5_Z&U[?F_\`MO:E9>%3TC>$ M'X<=25D_!//X_'^^X]J%D'D>DKP\01UG#@VL?]M_ON?;ZRTZ2O;XK7K,LG]3 MP/Z<#Z^U"S4Z1M;$DFG6=9>?KP/QQ];_`.\?[?V\LH_/I(UN34'K*LG^Q_/U M_P`?Z7]O+*1P/25K6II3/642D?2_^W_XW[<$WKTTUL1PZR"6_'!_WC_BI]V$ MH]>FVM_5<]_>*/7K7TQ\@/V= M>,H']"3_`+`_[V3[KXO'/5OIC08ZXF4#\W_V/_&O>O%KU?Z8CRZZ,W]?];Z\ M?[87]MF7''IY;=JX&.L1GY_4/]@0/;;2_/I0EL:V6EP> ME$=OZ_Y^L+3&_P!?I[3-*.EJ0-UA:3F_U_KR#^/]Z]IVE^=.ED<%"*BO6!I1 M_P`:O_Q/M.\OSZ5QPT\L]1GD_K_MOI_3GVF>4=*TB)\NHKR7X_WK_BGM(TGS MZ6)'7%*=1))`+@<_F_\`7GVF=_GTH2,C%.H3R?XBW^P_'M,STZ5)'4TKGJ%* MXO8?7_7-O]C[3,_SZ6+&,4&>H3R6N+_ZYOP?\/:9WX]*HTX=0I)+CCC_`&/^ M]_U]IV;I2BFF.F^63ZV(M^>?]Y/M,S=*53IND>]P#Q_6_/MAFZ>`].H;O^+G MZV'MAVIPZ>`./3J$[_4$W/U/-[>V2>GE'F>H;O\`CCZ`_7\_G_>_;1/5P*]1 M'>_UL/Q[;/3P`'4-W)O?Z?TN?K[H>O<<=-\TOU''/'!^HX]T)IU<"G3>QL;< M;^ZG`/3@%,#J.S<6!X'^W_K[;/3GI MU'8\_P"O_ON/=?GUL^G4=C_O/T]ZZWY4\^H[GZG^G'X_K_Q7W0\>MC'7$<`G M\_7G^O\`3_6O[UUL=8F(_P!C];?[?WJM/MZV?3K$3_O'NO5":XZX7OS_`+;W MHGIQ10=<2;#\?ZQ_/ML=7ZP'_D7^O[\>M$TZX>_=4ZX,?Q_3W1CY=.`4ZX?\ M3[UY=>^77O>NM]>]^Z]UP]^Z]US M0_4?['W=3Y=58>?2ZZYVW1[OWGAMMUU1D*6++&O@@EQ>/RF4K#D4QE;/B85H ML+B<[EG@J>3QA#(T"B.V@NIRKSK&DC16 M\SQQL\@C;33IQ[*VKB=IYC%T>#W-D-U8VOP--DJ7(Y/!3;[[79['S-<;KML]@DR336K6;A?%FB4"!YIF6-UB$T.IE M<12HLL44JO&IE^KNC\O#@/MM]=!=C9BNDSU)G,?E,+CJ-USV#?%34J;1KJS* M9W&T^U\955LZU3Y.FAJ:M>``JIZ@YNF]PFXU6._6Z($*E6)[6U5\0!5)<@#3 MH)"_MZR2]K_8[=X=A^FY[]@>8[R_:_CN8I[:&,BZMC`R#;Y9)[J%+*%Y&$S7 ML,^FP:8ZS*;@KCKDPO MR";CC^GO?6CUD1[_`/$_UN?>\]>X]9U-C_K>[#/5.(IUG5OI_3W;KP].LX-Q M]?\`?6]['6CUR5K'F]O\/^*_['VX#U4CJ5$XU#FP)L?Z^[<1U7B/GU.1_P#7 M/'^\`V_/YO[V,=4..I2M]"#S_OK>[UZJ1^SJ">,LI4Z)X9&1Q]&5B#<&WNPQUHCK.C6_U MOP?;H/5"/EU)1_Q?G_>_;@ZIU,22_!_V_/\`Q3^OMU6X=-E<=2E<<<\\>WE; MIHBG4N-_SR/]Z_XW[>5J4Z;9=0I3/4V.2]N>?^*_\5]OJUIJ27MS M;CZ>WE?IIDKD=2TDM_Q3_;?U]J%?I(\?$'J4DG/'U_WW^M[4+)Z\.D[)3J6D MH_/_`",_U]J$?I.\=>'4M9!QR>/]]]/:A7^?29DZE++P+_[?_8>WUDZ3M%CJ M4L@^E^/]]_L#[4++0\>D[1@CAUG60?0GZ?G^A_U_:A9?/I,T?D>LZO\`T/\` MA_K_`.O_`(\^WUFX#IAX!D@=9EEMQ_QK_D?MY90?/I,]N?+K*LH_J1?_`'W^ M`]NB3SZ8:#YTZS!Q:XMS^;^W!-Y5STR;<`5"]N M>F&MR/PT'7/S'CZ?XV/^\<^[B7Y]--!44TXZY>7\\_ZU_P#C7NWC'UZK],./ M7O-]!8_[O'ZM]+7_4>N)E/]1_KW'_`!7W4SYQ MU;Z4@9`)ZX>2][G_`'D_\:]MF8>O3ZVQX>77`R#\'_>/K_O?MLS=/+:^>>N! ME'/-_I_46Y_J>?;+2?/I](*<1UB,H_J?Z6_`_P![]LM+TI2(>61U@:7Z_P"' M^P_XV/;#2CUZ4+$:>G4=I1_C_M_]X_Q]IWEZ4I%U&>7Z_P#$?\B]IFDZ4K'3 M/45Y1_2P_P!C]?Z^V&D/KT^L?45Y>+WM[3N_2J..O'J')+<<&U_Z_P"Q_P![ M]IF?I6L?4)Y1_OO]]]/:=G^?2A$ZA22_7ZT[/TH5>&,]0I).#_3\ MGVG9NE2ICY=-TDE^!?3S:_\`7VRS=.@?LZB-)_C_`%_''^]^V&:@Z=5?+J'( M_P"?H3]`/Q]>3[9)Z>`IQZ@R/_0W/^\_X>VF/5P"?LZB,WUY_K?_`'W^'MLG MIY1U$D<'C\?U_P!\/;;'RZV?EU"EDM<'_8<\^Z$TZL!3CQZ;'<'_`'G_`(W[ MJ3U;[.HSN!:Y-O\`?6M_K>ZU_9TXHP!U&8V)/]?H>;`7/^WX]T)K]G5P.H[- M_3_;^Z5ZM2G'J.S?\;]Z-.O#U/6!F'T_WP]U/5AZ]80=1)_H;?[T?^(]UZ]U MTQ%_\!_O?O75Q@=8B3_O%O=3D]5)_;UB8_@?['WX]:49ZX^VR?+I[AUA9@;6 M]^X=>ZQGZ^]=4)SUT2!]??CUX"O6+ZF_^-_;73G77OW6NO>_=>Z][]UOK"YN M?];C_??['W[KW7'W[KW7_]'2A]J.M=>]^Z]U[W[KW7@;>]\.O=#ET;35E3O# M%U&V\!V%F]U8:JK,[(-AU>&%9'M*AP673/1PT&7VYGJ:IR,\TT$<:3++3UL< MCT7@>:IB(*=Z=%LY5N)[=+5P%_5#4\0LNFI5U(`%22*%2`^H!3U-'L?:WD_. M.V3\M[!S#?`\US$0\ M?(VIR%3NK:DE?M3>.RPNQ:&&AP.]:/;>*R--01;DW0D#4."VK@-K8O`XEG#B M.G_AU+*TBR3,'\PED:Y>6-;6Z$=U#-^N26C+L"="5JSL[,WJ=;"E!BE`;_>, MN=PN>:N5)+_E3>-E`V*)8K77;3T51AEWK5)D(I=YYC:M7D:]L9M"+%X.NGQFU,]/42Y2 MNI:&#&:9UTTJY:-HTBD:KIB3F>+;7NE%SJ$W@BGZ:N`-4FI@"Z@:06+X^+PB M"2`C3K]UK=?&39AO;B56W&XL9)I3#MZP6TK0V-T[M/+';165)! MI@&[1M&D4C7=L1`>QV/3K`KKD#^/]M[?RZT.'68'Z_6W_ M`!)M[MU?C]O7@-)O_9_-_P#7_P!A]/>^J]9U:Y^O^Q^O^'NPZT?7K.K?B_'^ M]>]_/JISD=9U;_;>[=>XCY]9?K8^[?X>J]1]?Z^[=4(!X=3$;Z#_8V]V'5,\.I4;CZ@_[[_C7NWV=:IZ]34>_-S_K_P!? MZ_7W:N.JG[>I<F2".I:27M]/K MS_QKVZK?/JA%1U,20WN#S_0_GVH5@?/I.10]3$EO]3S_`*X/]/\`7]NJU#TR MZ!N''J4DA_K^?H>?S[?5^DS+DU'4M9+_`.^M[>5Z>?3#IZ#'4A92#];_`.Q_ MWW]?:A9.`Z3O$#6HZEI*#;G_`'C_`'O_`&WMY7^?2=X\YX=25D_UK?7V\)/G MGIEHCQICJ0LM_P#?<_ZU_P"GMY92.D[1+QIGK.LA_K8_[;V^LO3)B.:'K,). M!>W'Y_U_]AQ[>64?GTRT?D1UD$H_-_\`8?CVX)?3ILQ>AZRB4?35_O/MT3=, MM"*Y'602'^H_U_Z_[W[L)>J&'UZY>4_G_B?]XY]W\4=-^!6M>N_)_KV_P(_X MV?=O%^?6OIUS2O7O)_OKC_>K#W[Q?GU7Z8?.G7?E/^'^\?\`%??C-UOP0,4/ M7C,?ZB_]0?I_L+'VWXO3HB7C3^77`R_XW_WL?[S;W4S?LZN(2,`=8S)_3VV9 M?GU<0G\NN!D_QM_K?C_>/;+3<:'IU;?SZPM+_OO]]]/;+2D]/K%U@>7_`!_W MUO;+29Z4"(`#J.\OU_'^/X^G^'MEI.GEC].H[2?F_'];_P#&Q[89^/3ZQ5IZ M=16F_P`;_P"W]L-)6O2A8@,TKU#DE_J;_P"M_7VPS^G2E4->H;R_7G_>O]\/ M:=WZ?5.HKR_7FW^/_%/Z>V6?I0B5ZA22V')L/\/R/:=FZ4*E.F^66_\`@/K; MVR6Z>"_LZBR2`7O_`+`#_?'\^V6;IP+Z=1))/Z_ZX_WWT]LD_/IX``<.H4DG MU'Y(Y_K?VTQZN!7[.HC-;\\_G_`^VR>G0!U&D;C@_P"^_P`?=">K?X.H4DMN M0;_[[Z_7Z^Z$]6`]>FV60L>2/J?Q^?\`7^GNI/5OGU%<_4_T_I;CZ?[V?=>/ MGTXH`X\>HS$$"_('T^O/U_KS[H37AU8#J,S?B_\`QK_#^ONA].K`>O6!F_XU M[UUOB?EU@8C_`'OW4GK?$]1V/-OR?Z6_V/U]TZMUT3;C\_\`&_?NM@=8V/U% M^/\`>?\`8G^ONI./GUX]8B?>NF^)ZQ_\3[J3T\!0=<6-A_B?]]?W0<<]6ZP' MWLY/52:"@ZX^]=5ZQLU^/Q[HQZ<`IUT?Z6YY_P!\?=>M]=>_=>ZZ]^/7NNF- M@3[]U[K#[]U[KW^/XY'^\>_=>Z__TM*`&_\`OOI[4=:Z[]^Z]U[W[KW7O?OG MU[H>?CW592L[%VOMG%0XM:ROR>3K:"MJ-I4VY:L9*#:6XZ2DQ]=HPV9RK[3K MGK+9.&.*2..!34Z0\"NI+OHB3;KFXE9M"J`0)"@H9$)([E76*=A)!)[:T:AG M/[O]QNEY[B\L%75\^36%WMA=W[67?AVF(#6H61Z M:V7G;9N;^5EY\.T_OB;9$=?W?8R[?"(A>WR*KP3VUG(9M2,S.UO'JC:(#6H6 M1_=1]&X_M;:61S$>XLIMVNP&X):?/ULNT]T[DP<6WYZ+&24-33MMO`UL=/D* M:H-8]6:JKAB2G6)[*@DD&]UWR3:KN.$VZR))'51K1&U`M4'6PJ"-(72I-:C) MH.O>TGL;M_NOREN.\1\PW6W7VW[@R74C6-]>6RVC1PF)U-G:R!)4?ZAIS//& MBPB)Z*@DD!>%-^/Z`?['V(2//K'3KG_O?NP/SSUHBHZYJ?\`C?N_'IGX3UE# M<6_WU_\`D7NU:]7!\^LHY&D_\CYX'X/OW7C\NO*=-@>+]]:ZD M*>!SS^1_A_R+W8'JI%.'#K.C?C_?'_#W:O[.M?,=9E/^M;_>O^1^]@]>-#UD M_IP+_P!?S[L#3[.J]98WL;`V/UO_`,:]W'\NM=3(Y/ISS<_ZWU/U]WZ:;^74 MM'^G];_0?\1_7WL'K7RZF1,#_3\_7_>/]8^[5IUHCJ6K6M_O'^/'_$>[?/JG MV]2TD_!_Q_WWT]W4_MZT>I*O_L1^/;@/5"*=24?_`(J#_A[5^F&C'#K.)"+$?C_'^O^'MY7Z99".I"3'_`'G^O_%? M;P?IADIU)68'_#_?6_!_'MU7IPZ9:,-CJ0LI_P"-?[X^W1)TR8:4(/6=9?Z_ M3VZ'Z::,]9A-?_?,/7K?@-Z`]=^ M0_U_WO\`XK[]XPZ]X/RZZ\O];_[S_P`5]Z,H]>M^`.NO+P?Z?['_`(J/=3+^ MWK8A/7'R.KK%UC,P'Y_WOC_8_3W0R]7$8&//K$TW]+\? M[[_'CVV9.G!'PQUA:7Z_[#_B?]Y]M&3Y].*G6%I/Z'_7_K_Q3VTTG3RQ5]*= M1WF`O^3_`+S]/;1DZ?6(5'GU%>6_U-O\/]Y_V_MEI.GEC)\NHKS#\7_/^\7] MLL^.GUCSU%>3_BO^^_I[89^GPGKU&>0?Z_\`0?[[Z^V6?]O3ZIU"EFM]>?\` MD7MAGXTZ?"HKN!_CQ]/\`6_XI[99NG`I-.HCO M]2?K_OK&W^%O;1;IT"G4*20_3GVV3Z=7`KU&=[?Z_P"3?_BOT]MD^G3H&.HC MO]?]]>_NA/5NHCR`7_UN/\/]?D^Z'JP%,GIOEEOQS_QKW6O5J]0V;\6_UQQ] M/Z_7Z>Z]648KU&8DL1:P`Y/^MP?=2:8ZN!7[.L#M]2?SP+?B_/TO]?=">K@? M+J,S?4_7G_;GZ^Z];XX'#K`Q^I_WUO=3UNGD.L#-?^@XXO[KUO`ZX?07/!Y_ MVY_Y%[UUL`]<";$_U_WK_D7O1\^K$^76(^Z_/ILGRZQDD_ZWO1/5T7SZXDV! M/]/;?$].=8BU_58?@6/^M[V<8ZU\SUC]ZZH<]<2;#WHFG5@//RZQ>Z<>K]>] MZZUUU_OO]]_L?>^M]=^]=>ZPLU^!]/\`>_?NO=_+KW7O>NM=";T]-AZ?L3!29UZ<8XT^X(O'5Y> MMP%)65\^VLQ!B,;59R@S^UYL-3Y3+R04SU3U]-!`LI>=C"LBL7;LLIL)A`#X ME5X*&(`=2Q"E7#%5J::232BYIU)GL_-L\'N'L.GCJ$I5XI]3)^7U(M[MB9 M2'G)#.@C+#0BZA&%30N*`4J2"WXNA9]X.[BGYBY1M47:XIK78HXI;>PNY-PC MM)&O+ZTZ2;;NP\'N[&/O'( MR[5R=?@ZG/YC;6^(,;MTU]?@:/&9*"<5@I&Q;*:ZEJJ-I$0(I;RJ=[C;;=XW+?*=I-R[R'8[OMAWB9 MK&:6V>ZN+/M-J9W?._\`?.=QVV-H;/VSCJC+9[<6?RU2E+C\ M7B\?2I)/4U53/(``!91=F(4$BX8`5/#JC+7[>CV;A_EQ[BV5V:.A-]_*OX<; M,^1T69I=JY7HO+]D=AUN8V[O6IJ!0OL?<_;VW.H\[\8-O;IQ^3O25L%7OV*. M@JU:*HDB<6]ZUU%0II_J_/JH%,5'1'^Q-A;IZJ["WWU;OG'QXG>W6N\MT;!W MABXJVBR46-W3LW.5VWMP8^+(8V>JQ]?'1Y;'31K/!+)#*%U(S*02XI!`(X=; MKY=(_P#4.01;_;_[U[MUX]=HW'/U!'^VM_Q/OW6NLZM_ON>/=@>J\/LZSJWT M_P!]?CW?K7#/EUG5A;D_[W[]UXBO#KG_`(^[`]5ZD(_(!^G]?\3^/];VX#U2 ME./1L>I?BAO/LSI_=WR'SN].O.E^A=F=@;TMT8;*;FQO M7^UL%UGL7LK?NY]Q0[7P]1DZT46'FIL=0JDE5-#YH1)4R!6"4)8BN/3K13&J MM!T&W=/5&9Z-[-W%UCG<_M3==;@8=OUU-NK8N0R&6V9NC!;KVUAMX;:W)M?) MY7$X+(5V#SNW,_255-+-1T[O%,#H'NZN&`(X=484-.@X22]A_P`4_P!C]?IQ M[C[]._!_)]N_!OY<_-O']L[-QV+^ M)&8ZI/X+NJLWSFY.Y^Q-O;`VYE6RTN.QVS\5@WDRM9/$\%;DJQWQJ$`^74F.0C@_3_'_>_;@8=-E37ACJ2K$W0U.JG/$9ZEK+?@'_;_P"P]NJ_KTRR#R/4E)#_`(@7_P")]O!J^?31!%:] M2TG^E_\`;_0_U_WCVX&ITVRUJ:=2%DO:Q!_V//\`K>W5?Y],&.G6=90?KQ_3 MVZ)/GTT8QUG63_'_`)%;_;>W1)TR8@:UZR+(1^2/]ZO[=#]--%Y=2%G(MQ?_ M`%O^1^[A^F2ASYCJ0LP/UN/]?Z?CW<2'UZJ8Z^7602\<&_NXD/39B&:#/7(2 M?[&_^Q]W\7Y]4\$$\<]$+C@ M.N_,1_A_K^]^*.M&%JU)ZZ\Q_K_O!/\`MO>O&%>O"&O'KQE)_-_];C_B@]Z, MG5A"?+K&9?\`$_ZW^^O[H9.G!%Y=8S,+7O\`U_U[^ZF2N*]6$7GUC,X_-[?7 MFP_WC_#VV7ZN(QCK$TY_'^M_3^OMMI/GT\L9IU@:;_'_`&'XO;VTTG3RQ<*] M1VF'^M[;:3UZ=6,5X=1GE)O<_7_7]M%^G1'\NH[2V_P_WWY_I[89^GU3J-)+ M;B]A_A_A_C[9+GCT\(Z=0I)_PO/X_P!?Z_[W[;9J_9TZJT&!U$9^3<_Z_`// M/'MHMU<+G'49Y+?3_??X^VF;IP+U%:2U[&_Y_P`/]Y/]/;1/3H'IQZB.Y)(' MUY^O]/\`;^VRW5@OKU%=K6O]?S_Q7Z^VR>G:=16>YO\`C^G]?]A[J3U;[>HD MDA']/I_MA_3ZV]MD]7`IQZ;Y)238?\;_`-C[J3UOJ&[?7Z_7_B?]?W7K8!)S MUA+`_P"^M[J33IP#CU&=^>?\;?\`%?\`7]T)I]O5Z5ZC,W]3[KUL^@ZP,W_( MO>B>M\.L+-^/Q[IUO@,]8KCUY17KK\6]MD]/=8F-SI'^^/]/?@*"IZUYGK$?> MNM$^777OQQUH9ZQ,;G_>/^-^VR:]7'#KH_X?3\?ZWOW6^NO>NM=>]^ZWUP/?NM=^J=?_]329]J.M=9E((_Q`%_?NO=< MO?NO=>]^Z]T/GQ_QLR[JAW;B]X;8VMG-GY7#5<(W9)BX,3_=_(0YBGW1GYI* M[<&#R%3_`'=H8D"4N,6?)335<;PF`Q&92/?9`;4VDMI++#*K#LJ6U`J47"L! MK/F]$`4@ZJTZGGV!VZ9>:8N;-LYOVS:]\V>ZMY%^O,*P?2RK<)>W3&2[MI7^ MDC50L-F)+R22>-H3"8S,N#OS(8K([HVY6;?-#%MU]EXV/`8^#$5.%R6+Q,&8 MST$%-N"EK]S;PRDN5JWC>LCFJLA-/)CZJF.F)=,27V))8K>X6?5]1XQU$L&! M8JI)4A(UTCX2%4`,&XFI+'OY?[5N7,_+MWL!@7EX[+"+6);=[>:&!;BZ54NT MEO=PF:=R&N$DGNI)'M9K8E8ETQ(;;H_9>>V#A6HJ7/2U$.0[$.1HCATQ).&-ZO8+^ M;6T`!6WH5E@=BC,Q)9&6-PY`%`"ZQ&H97;)7*WV0Y+W[D#9FLK;?GDBN.8O& MCGVK?[.U6^MX(4B2WO+:XW.T:SAEEFULZ6EUNL30O!/9PZ8DGK<'N1>N;JGK MFK6_/'_&O>^(^?6^'6PC_P`)AMU=7[7_`)N?39[(J\9CLAN38/;.T^J\GE33 M1Q4?:.=VE/!B(J.IK%:GI\OF=N)E<=1@^JHJ:Q*=`TDRHS4E=)'6QU2CW7UY MVEUUWAV?UAVUB\[#W#M;LC=.UM^8[+P54F?J=\TF?K*/,O-'(AJ:VIRF5U2Q MR`-]R)5="P=25"D$"G#IIQ0XZMM[.^+VQOBM\$>IOF5\C>KX_D[\G/DK\NOD M+UCV5MWM[L/M*GVWU*>B=T9;;^^\5N'(]0=C;(W7N;NSL'>])5U\V7R6>KJ` M8TZHZ&:9VK&H&)8JIHH`ZV.`)X]6(57\ICX!;*^0GS5Q&4V_V_O[K39G\G#* M_P`SWI_9$?<=+M;=O5&?GVO55<_4&\LY3=?Y.7.9FAKIX,AA\A6T[145"U,F M1QV7,DCM42.0G"NJG5J>7RZB[/\`B7_*_P`^_P#)'[/JOA)NA,+_`#1]R]E= M([ZZRC^5';*[0ZXSO7'\62%%_&L;@Z6.B,' MV,IG\T6]3_JC7\/RZ]08QQZ+IMSX)?"7K'I;^>3V%V+U9V;V_G/Y9WRYZ_Z@ MZG@_TTS[`QVZ-C;H^6.4Z6HZ3<<&"V17SQY,8C:LIRM5Y9S74F0DBH5Q57%% MD5MKVU_,7_ET[ M/^6^W\Y%\E>QW7NSK3M+=5/BNO,154B9/?34-7U9*\]1NO+9>EJ),@H MCHJ>.G*3U\201LVOX6IPX]>HNH+3!'5/N>^.GQH^(WP8_ER_*;LKIZA^5&Y/ MG+O?O;,;_P`9F][=F[3V]U=UAT7OG:FQWV)US_HJWGL.6;M;=B9^JK)LGG*K M*45!44T=.N+=$EEG?#,[R(#333^?5"`H4\:]6.]Q_P`JGX'?$YOYU-5NO:79 MG?\`!_+\J/A/N?J''GO"#9$R[=^5>8H:BKV)OJ7:VQJ^VYMF_9STM76EIADL M36)X*?&U@2N%%ED;P:$#57R].K%0-7RZK!_F^_&CX]=`;M^$^^?C9UWD^H-E M?+;X`_'OY7YKJRLW[N/LK';&WAVJNYI.)T@B=A=B'U&M&(Z;=1VTX$=#U_+:^6_Q_V5\>(/Y>G\Q_X^;FWY\*OEAW M#!WCU9VUL+*U&-["Z?[@B$71E?V)M]J&H#YC&8A]KK!5T:N*VBIQ4.V/RE-D MEI9=R*Q;Q86_4`I]HXTZT"`-+CM)Z/7M?XZP^6>8^& MM9\-]M;#WGV1D^Q<-7;@ZW^1/8F'W*NRLY6=5=@[(K]LY/;']WL:JL1 MD:[(P5-+-.M`QHO=/$>5K4ABH:O\OMZ]H""4$5I3HC>_/C)\4_BOMK^5TF]^ MB:'Y"5/SXV%MGN[MO=59O_MS;\NP=K=E[XH=NX?JOH6GV!OG;N(HMT]<8&L; M^(5FZ*?=DE9F?%JAAI]5/(ZLCL9J-0*:#AY>9_U#JA55\.HJ#T*_RF_E:=1_ M!+;?SM[ZI,;#\N]A?%[YK=7?%S9W7^[<_NS#;?P6S]]]5X'M_/[Y[QR_3V>Z M\WA79'!S[VP>QZ-L5E,!2-N22KGFBD40T0W'.TAB6NDLM?YTQ7]O7GB"AS2M M#3_BZ=&>_EY=-;%^:?PK_G+],_'+9^)^(VP._P#MG^5E@>NMK=R=GUFZ,/UO M09SORDEJ&JNP]T46"RV[H\Q70U,^"I6C-?DY:RCQU.]34RQR2TF>(J*3=-.G\7Q?\#BHZ%K_`./^]7O_`+'VI#>73)7S`ZDK)Q_6W^P]WKU2GKQZ MD+(1^>/]Y_WCZ^[AJ?9U0K^WK.LE[7/^\?[XCVZ&X4Z;(]>I"R'@GD?C_C?M MP-U0KU)64<$'C^A]N!STV5KU)22_-P.?Z_[X'Z^W5DZHT?6=)2#;_;VO[=#_ M`#Z9*T\NI"S_`->/\/\`??3WI"R`BX/-O];_8?GVX'Z;*#K,LIL+_ M`-/S_L?I[<$G52G682_7GZ?["_\`L+@^[B3TZ::(\1UE$H!'U'^W'^]CW<2' MUZ;,9].LBR_D'_#_`'Q'N_B>O39CIFG7,3$?VKG_`&'O?B=5*5\NN7GO]#_O MO]CR?=O$Z\8SZ==B8CZG_>?^(!][\2OGUHQGCIZ\9N/^*@G_`'OW[Q!Z]5T' MR0]_%_GUL(WIUXS'_6_P!O_M_I[KXGSZL(SZ=<#*?K?_B3]?=3 M+\^K"&HJ>N/E_J?I_K#W0R=6$6>/];W0R$>?3WA`_AZQ-,. M?S_O%K?7F_'MLOTX(^L#2W_K_OO\?=&L#3#^O^V//^^(]LE^/3RQ^O#J(\_'UYN?=&:O3BB@H.HCR$_GZ_[Z_]?;9; MIP+^WJ.SV/'/^O[:9Z<.G%!\^H[R'GGCZ\7X'^M_L/;3-U<+Z]17EX_XWR>/ M]Z]MD_/JPS0#AU$9RW'X_P!M[H3C/3@4#K`\@`(!Y_V%S8_[>WMLGJ].HKR< M<_F_^^_UO=2>K4SU#DD_%^;_`.]7O]>?=*UZO?X M>HK.!^>3_C]/^-^ZGJP'GU%+$WYX%^3_`,5^OO50.K#/#K"S``J];X?;UA+?T/\`O'X]T)ZV!3/G MUAMJ-[\?TY'^Q^H_K[UUOKS'FUR`!S_MO]Z]^ZL,9ZPDW]U/RZJ3UC)M_OO^ M1^_=4X]`H.'6-C;C\_[U_QOWH#JW6(GWKK1-.N'OW5. MN+FPL/SR?=6/5QPZQ_[W[IU;KWOW7NNO]Z][ZUUW[UUOK`QN?S;\>_=>ZZ]^ MZ]UQ)][ZH3UU[]UKK__5TF?:CK77)38_X?GW[KW6;W[KW7O?NO=+WK#;N'W9 MOW;>W<_%N:;#Y2LF@K8]GXZHRVXV1**IGC_A]#28S-54H6:)3,T5'5214X=U MAD*A&0[E<36MC<7$!C$R@$>(0J<1Q)*C[*LH)H"16O0[]L>7MGYKY[YW^ M+=TBUNL,A4(7ON#KJ#K'/X;`1OG M)*BJVQ0Y;(OFL#G<`C9"?(96CJ/X+3[EP6VV>_;-L$$`LLMK$6D$JJ'1%DLL/9WFCFO MW!Y0EWS>8-FO-SL-TD(N'Y?V>\-M,8[623=-ZNIY[2:&*<)&CWT*27.X M>W-O;Q[+V72XZDVGW5O[H[X_=@_(';RX>F6CQ%1BOD)O;JS/]VTF1Q-.@%+5 MKGQ54[*&CD5@#[J%7A3KQZ";9GS6^2VR-L[OV12=C4^[-C[]W\_:VZ=B]N;% MZX[SV/D.TIA5I4]F4VSNZ-H;]VSA^PJZ"NEBJ,U14M/DZB"0Q2S/'Z/;FE33 M&>F3J4_+I9;'_F)?,?K_`'EWCV%A.Y:C*;W^2FTTLQV+UW MEZ.+&Y3KO-5G9NS=W20]>Y#%TT%)-@J7[?%/24E-`:?Q4T"1^T+@$8'6PW[> MG/%_S(?F)AL1\:,%C>RML4^*^'.7R&?^,E)_H0Z%F_T.9W+RQUF7S&U)ZCK" M6I&3S&8IH,G5SU+U$E5F::GR4I>OIX*B.VAK`UIZ]<X]>8I* MFF>GEI,Y/-DX2F0GFJ9-Z%[33APX]:J<]+:@_FO_`#SQG:O57>.-[FP6-[9Z M.ZM/274.^J8J?$[?QF/K:JEHHHXP:"DKZR" MG,45;5I-KPTH13!^WKU3^?02;$^;_P`E>NMMU.RML[WVY)L63L6I[,K$*C:]'B'2"..%;111HKFA3D\? MMZK4C!Z<<#\\OEA@=D_(CKZ/MJ?.;;^6F7I,_P#)([XV?U_V+N/N3,XVJGR& M'R>]=[;^VIN7>N1J]OY>KFK\8XR"'&9&>6LI?#52R2MO0A*FF1PZU4BOH>DY M\@/EWW]\I*/J_']Y;PPV[Z3I;8F)ZNZMCH.N.L-CMLSK?`1+!M_86+FZ_P!F M;6G;9^WHPPQV.F:6DH/)(:=(S+(6VJA*Z?,]>8U`/3UU5\U?DATQLW!;`V+O M7;_]U-I;HK-[[%QV].J>H>TJCK;>>0>CEKMV=69CM'8>\JU(X=/73GS[^8?1&8[RW!UCWWO7#9[Y*4;4W M>V;S#8C>N5[,E;)Y',IF=QY#?6*W)5R[JILMF*NI@S$3Q9:GFJIFCJ%,KEK& M.-@M5%!PZK4BI!X]9-A_.CY1]>[/V7L3`=F4^3VUUEN+*;MZJIM^[!ZS[4R/ M4>Y\W5T^3R^=Z>W%V=LW=^X^ILGD/NYP)K32A_-%&X&I10?ZO M+K2LRU(;[>ILZR$?[Q]/=P:]4 M*]2%?Z6-N+?[>W^'Y]W!]>J$#K.LA'NP;JA4]9UDO_A_L?Z?[;VX&ZKUG63_ M`!_VQ]N!NJZ>I"S?@D'C_BOT^GNX?]O3;)UG60$\'_7O_OK^W`_39C_;UF60 MK;_B#_O/MP-U0IYTZSK4'Z'Z#Z\?[W?Z>[ANFBF3UG$X/Y7G\G_B;'W8-U70 M>'602?G5;_#\?Z_U!]WUGRZKIZY>2WT-_P#8?X_U/N^L]5T#SZY^6]OH?I_K M7_KS;WOQ,=:\,'@O7(36^MO]O[]XGSZUX:C\/7?G_P`1_M_I_MO>_$^WKWA_ M/KWG_P`1_OO]A[]XGV]:\,^O7O/Q^./\?K_O'OVOKVCKWF^OT_V]_P#;<^]: M^K:!Y]<#*3_:O^?I^?\`;#W4R4/6Q&/(=8S(?ZVY_-A_Q/NNOUX=7">5,]<# M)_M0_P"1^Z&3CU8(?3K$9@/][^O_`"+^OMLR=.+%\NL+3_\`&_Z?\:]T+'UZ M<"*.(ZBO/?\`XI_Q']?="W5P*\!U':5K_P!!?_6_V%_="WSZL%]1U@9Q]2;_ M`(^O]/;1?TZ<"^O6!I?K8VX_UN/]M[H6ZN!3AU',GUO]?S]./K;^EO;;-U8` MTZC/*>1^/I?_`!]T+<>K!>L#-]=1X_%B.?Z?U]MD].`=1GE)N!]?S_Q)_`Y] MT/V]7`ZB-)]?I]>?]Z]U)IU<#J*\IM]?]Z'^\_7W0]6P.H,DI)X/^Q/'^\\\ M>]$];ZAM)8?CZ\_U'NO5@*"IX]8"U_J;#WJN.M_+K$6-N>!_MO\`B+$>VR>K M@>G49F^O]/\`D7NO5OLX]8"U_>B>MX'V]86;^G^^_P!;W4GK8'F>/6'EOSQ< M6^MS_7\^Z]>KUXG\#BW^]6]^ZL`*5/6-F_'XXYYYX]UKUX_RZQ$_[;WKJA)) MZX'\G_;?\B^ONI/3BK3[>N)(')]TXGJ_6$F_/^]>]G&`>O=NJ'/7$FPO[ MT3CK8%>L?)/^)]T)KU?KKW[KW7O>NO=>]^Z]UC=OP/\`8^_=>ZQ^_=>Z\>/? MNM5IUQ][ZIUU[]U[K__6TF?:CJO7O?NM]9$;\_=>ZR>_=>Z,;\>-S M;,PV>K*3<>*V109.7%;I?&;XW?N#L;#Q4D==M7(XB?;'CV57K2K%FTJGC^YD M@$U/'-,T;33?;0,']_MKR:!'MY9FC#)6.-8FK1PP?]05[:5H#0D"M!J;K(K[ MO7,O)NS;[=VG,6U[)!N3VMZ8=RO[O=[=8Q+8S0-94VZ4(%N0[)XSQ"2)))C& MTTWTT#,O?>2VWD-Q[:CVS7[;KZ;&[.IZ&O.T\SOC<&$I7LQ1+C=3]5*?#EC=C18U9RB M+56)D]3=/83LO"U=9)O*GPN6H-R4M!D\?5)3Q+C]K3XNIJ6W)2"6?[[<^2.3 MB6GBQ%!"U5*`S:A=`:;INTVW3*@M"\31D@BN7#`:#BB"F2['2/3CTJ]J/:#9 M?B*=;ZY>[`]:(KUR M4W_U_=^F2*=9`?>ZTZV#7K,#;D`V/U_XU[W7JW'[>O,#<,HO]3_O'O?6J=9$ M8'_`<_7_`%O>Z]>XBG68$?U]V!ZKPX]9E:_^O[MUKAGRZS*UO?N'6^.1UD_W MWU_XCWOJG697(T\_[$?7_6(^@/MP&N.JD=2D>]_K_C<_4_X<_3W;ILCTZS!B M/I^+\?7WO[.M>>./4J.7_7`X^O\`OOI[L#UKCQZDB3D$<#CZ'_>^![L#U4KY MCJ4DOX^O]/R/]YM[W4]5ZE*YM<'C^E_=PU>O?GCK.K_T-C[N&ZT5ZS+)^#?_ M`&X^OUN3[N#U0CK.'_H;CZ\'_8>[`_/JA6O'K,K_`-#_`$_V_P#3^ONP;UZH M5(\NLPDM:XM_C[N&].JTIY=95D_Q!_V//NX;KU!YCK,LQ7@7'^\V_P!Y_P`/ M=P_5"@/6<3`\<'_8^[AZ>?5"G'TZR!U_K8C\?\B]W$GKTWI'IUD$G^I(_P") M]V#CK17TZR"5Q^?]O;_B1[MK'KU3PZ^G7,3G\VO?Z#_B??O$Z]X0\^N?F_UO M]@??A(1Y'K?ABE.N_,/]\1[WXORZ]X0Z[\R_[X_\;]^\7K1B^77$SC^G^]_[ MX^_%Z^O7A%C/71G_`-?_`'W^V]ZUCK?A^AZXFH;_`&WY^GNI?T/5@OKUA:H/ M^\?CG_8>Z:O4]6`'IUC:<\_7C_D?X]ZU#JU#UA,I/Y_WWU_K?W4MUL*2>L9< MGZD#_&_^'^O[H6ZL$SU@:8#_`'G\W_V/^'/NI8]7"CK"TM[_`(/^\`>VRWSZ MMPZPEN;WO[H6^?6P#Z=8'EY/UO\`CZ_Z_P#6]_="W5PN>L!>_-Q_7D_[ZWML MMU<+Z]8&E`!L?\?K^?Z>ZD]7`\NHI0`&W'^%_Q^/= M246^I_P^I]UZM^741GO?G@?0?X^ZD]>%2>HSR?C_8\?\3[UQSU M>E/LZCD_D_[R?=20.O`5ZQL1^3_L/IQ];BX^ONA/5P.HSO?_`&'^]7]UZM\N ML#-_QKWHGK?#K$S6_P!B!_L/]\/="<];'KY]1[ZOP;?[WS]/];WKK?7=[<*/ M]?\`I[]UL#K&QM=?]:_NIZ\37K$3[UU0Y/7"]_\`B/>B>G%6GV]=>VR:]7ZP ML;G_`%O>^`^?7NL9/O75":]=?\1[]UKCUC)U'_8?GVV37IP<*=NM]>]^Z MT>NO]]_QKWZO6^NF-A_O7OW7NL)-S?W[KW7O?NO=<3[WU0G/77OW6NO>_=>Z M_]?27'M3TV,'KE[UU?KWOW7NLRMJ_P`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`3WOJM.N2OR1S?Z6_XG\^]]>^7696''/^]>]@]5X?9TKLKLK> MF`V[MC=^>VANC"[4WLV739FZ,MM_*XW;N[6V])0Q9]=L9JLI(<9GVPP(J0#UJGF.DXK?T/O?7L'!X]900?S_M_=@<]:(/61'(_( M_I_7_&WNP/KU4CS\^I2R`CZV_P`/^->[BAZH5_;UF#7X_P!X]^KU2A'V=9TD M*GGG_8>[`]:ZE))J`Y_/T_/'X_J/>Z]:('4A92".2`+?[[CW:O5:$<.I:R@F MU_\`8_\`%/=@3Z]>KUG60D?U_P!M_K^[`^7EUJG657YX/T_VWNVKJM/7K*LA M_/X'UO\`\1^?=PW6M/SQUF67C]7^W_X@?Z_O8;JA7Y=9A)M.J ME1Y=90_X!_V'_(_>P_6BIZYB3Z?]XO[WK]> MM:/EUS\Y^G'^O8W/OP<=>*>@Z]YF_)M_L/\`BMO=M?SZKH;KWE/]?]X'OVOY M]>T-UUY3_4V_US_QOWK6/7JP0TRN>N)D/U)_XG_8>_:QU[1\NNO(/Z_[Q_OC M[KK'7M'7`RB_U'^/^(_Q'NNOJP0#SZQF;^A_VP_Y%[J6/KUO2.L9F)X'NI8> MO5OLZQM*3Q?_`&WNI;KU">L!E']?]MS_`,:O[J6^?6PI\^L1D)^G^^/^]>ZE MOGU8+0<.L)]5ZL`.H[2*";FY_(_P!Y^OT]U+>G5J''4>26X/X'^O\`X?\`$^ZU]>K< M/MZB/+R>>?\`>?QQ[K7KW^'J&\A/^^'T]U)K@=7"^O49W+$6/OU?3KW`=8BW M('U-['\^ZDTZV!7K$TE@1_7_`&/^M;VV3TX!3[.L#/?C_>/>CU[[.HY:WY_W MGCW4GK>!PZQ.XM]?]<_['W4GJP%///6'E_KP#_K&YO\`[?WKK?79-N!_Q'T_ MV/OW6P/7K$6^H_'^\^ZU^77B>L9/O75":X'7`F_T^EO]O[T3U95]1UT3[;)K MT[UB9K\#Z#_6^O\`A[\,=>ZQD^_=5)].N/OW5>L;-]0/I[H3Y=.`4X=NM M]>]ZZUUU;WNOIUOKU[?7WKKW6%CZZ]^Z]UT?>^JD]]^Z]UW M].?>B>K#&2.O_]#26]J>FNN0/OW5@?+KOWKJW78)'T]^Z]T9'XSYROQW96!H M,%3)3YFMES4\V9CSN4PTM1@J':.X:S(;:KI8=W[1Q4.(KZFG@J7JGG6HI)J2 M.6+RE?MY2#F.&.3;IWG:L*A>W2K48NH#C]-V+`$C2!1@Q!I74,A_NU;W?[=[ MD[%8;';"/>9WN6:X%S/;L]M%875TBF:9I!+!)!'+'XI7Z>69 M\K,EN"N[26BW.FWQF,!M^CPE3)MK>F=WSCIA#E,S7)(V2W)5568Q]4HK]$E' M+H,6@/H4R'W3EB.!-LUVQD\&20L-<:QD=JC@@"D8J&''A7'2S[U.Y;_>^Z`L M^9DV\;Q8;?';.;/<;GXB<>+I:W?24TAM"F0]8NJ.M]@[GV: MNBJI-\S8B.7#8W*9]\QA<=@:2JR&#VSB-O8S(U,.\6R.:HVCJ'16J$J]03@4JW[5>W'(7,W M)R[YS=)N<-TV^-`&MX9[HW%M%:QO+;6=O:0RNNX&6XMRDUZ8K+0RH"[^($+= M[$7'K'"N*4Z[#6_UOZ>_`T/6B*]'W_EA=[=)?&?YY_&KO;Y&;2R&].FNNM[5 MN6WCC,3BZ;-93$&KVKN'#[>WWC<55JT=?D.L=UY*AW)#&H,S28H>(&70/=F[ ME(''JM*&O1Z/YV_4W<'7%?\`%7=%=\CYOEO\2>X.LUW[\1.^LUEMQ9;>NX,5 M2=7]"[,[-PV]H=VR39W:^X?XEM?$[@K,-K:"EK]RU-0VFNJZZ*/24-12AZ]6 MGV=44J;'_??3VY6N#QZMUF!!^G^V_/O61U[KNY_'NX/564'KF#?W?IH@CJ[7 MI#^4_P!3=H;._ETYW=WS'RG66;_F8_Z7=L='T-3\=XMQ[5VWVUU3V50]0)L+ ML'=$?>6%RV/QF\^P:L4.-RU!A<@W[U,TE&OED%.T9""_;4+U<#X<\>F#:O\` M*+R.(AV13_)3Y0=+_&3*]G[S^4.Q=D5N_=R==4&Q\?E?BYNS';^T,EM[&56WMO[MJHGI&GJZ6G5X(YK>)_"M>'\^K4!X\>@M^ M6?P)ZA^*?2O2&_LW\K*K<';GR(^,?1ORJZMZ0'0V:[8Q^\E]F]C&CJ<=MJK M@DW%ELGD:293BX:<15$K[RZ`33`_U8ZH%#>>>F[U=F9C:.4WSA-^U.,V[CMRYO<3BFRM M51(L,4<3O3GRRBE\')=D"\*>?KUZF`2>GSY+_P`M;&?%S8W>R=@?*/J*#Y!? M'BJZ'-;RR'9\>.CW3@^I!C>W!ITV17K,K, M.#_Q-O\`>3^+>W%;K1%/LZSJQL.1_OC^/\?>_EU4J/+CUE62WYM?BQ_Y'[WU M3[>I"RGB]C_L;6_V%O>P>M=2%?Z6/^P_XCW8'Y]:I7J0LMC_`+'Z_P!/]M_3 MWZM.!ZUI/EU(28'\_G_?6Y%O=@W6O7'4@2O4KQZRJX/^'^M^ M?>Z]5(ZR*Y'T/%^?=@?GU4@4X=9!*0?K]?\`??CWO5U71ZGK(LW^(_U_^-?7 MW:O6J$8\NN8E_P!YY_V_NU>J_:HZY^0'_B@_WQ][#'UZ\0/3KGY./J1_A<_\ M4'O>HUS3K5!Z]O>8_ZK_>/^*>_:OEUNIZZ\OYU'_??X>_:OEUZIZ]Y3]+_[;_C7 MO1;Y=>R?+KCY"?K?_B/>M5/,=;H?/K@9!^"/>BWKUX`]<&E_QO\`[Q_O/U]U MU=6TCK@92?I;_;W_`-]?W753SZMI^76,L2;$_P#&N/==7GUL+UP+V_I_L?\` M?#W4DGSZN%^76%Y@0;?7\?T_/^OS[U7JVGK`9&(Y(_V'^^M[T3UL#TZQ&0"Y M)_U[K<.'45I3_4?X\_[Z_NM>M]1GDN M#S87-_Z^]$]>"D]8&E'(O<<_3WK[>K4^?48M?D_\:]ZZ]QZQL;_3Z?[R>?=2 MP'5POGUA9Q]!Q_Q7\W]T)KGJU`./6!F_WP_'O76Z$\>L):U_=2>M_(=87>P/ M^]7^O/NO6Q@4ZX"YY)L/\#Q^>#_C[UUOKHM?Z?3_`'WYX]ZZM2F3UC)XXN/Z M^]'K5:]<"?>NJ$UZQDW_`-;_`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`Y(/0M](=P9?HSL*EW]B=M;0WJG]W-];-S^RM_468K]F[OV?V5L?<77>\MN MY^#;N=VQN*"GR>U]T5:0U>-R6/R6/JO%5T=33U4$,R>'IU[H?OF!\UMZ_+.C MZ*V=4;3VQU;T]\;^K<1UOT]T]LBJW=D-J;,-1B\&=_YFBRF_]U;XWMDZS>&X ML/')KR.6K9H!YI;J`*^IZH?3HEH/O?7@>N8-C?WNM<'J_693<7_ M`-X]ZX'KW7?^(^ONX/52*];&'9ORZP7QX_EA_P`F+)=4#XL=C_)/HF/YC9R/ M-5?:--OWNCXF;VW_`/(O*=C]3[LH>J=@=U4&%QN?S6W9H\M&-[;5S])C:Z@H MU>"DJKQ34"ZGDK6AI^?5350N.JZ=F?S+NX,%\=5^-N_>IOC5\A=OX+=O8&^. MK-_?(CJB3L_L[I7<_:=;2YG?U?UYFJS@R^6/S/WK\P*'X\T6^.N.J-C-\9OC]L?XR=?5?6M/ MV1255=U/UQ69ZNV?C-T+OKLK?E)DX=&HZ._G$=\_' MZ+X')LGI7XV5=9_+LI.[*;H/)[@P_=M?5U\WR&GSE9VMD.Q(J+O3&XW<59G\ MCN&HJ8EI*?&T]#)I6GCBB7QFIC4ZZL>[K6JE/EUP^.?\X/O[XO83X[87J_I[ MXRQGXJ]N=K]M])9C.['[`R6:VY4=VQ5&.['V;EJVG[4H(]X;9S.W:C^$PUN7 MCKMT8_&QQQTF7A9%D&S&K:JDY'7JTI2F.B]]\_./=W?WQV^/GQDR_3_26PNO M?C'N#N;<'4M;UW1]K4FY,5_I[W5C-Y]BX?(5&[^V=Y8/)8:MSV&IGI$:@6>B MCB$<4JH65KJH#,U34_Y.JDU&DCI7_)[^8OV9\N=CX3`]L],?&`=F4N"V;MS> M/R9VYU#_``_Y&=JXO8>+Q&(V]_?W?&1W#E\&F52CP-''4Y'"8C"Y*L@A^VGJ M)*226GDVL80X)IZ5QUXL3Z=$"#6]N=:P>LRO_L?\";>]CJM/7K*C#Z_3Z?4_ M['ZG^ONX)''JI'68-\CK17C M3K,KVMS_`(_X_P"P][KU2A\^I"S?@^]UZ]3K.KC\$<_ZU_\`B?>Z]:ZRK*R_ M0\?X7'O?6BH]>I"S+Q?C\&Q'^]>[:NM$'K.LG]&'^WL?>]0ZK]G619+7N?\` M;^[5Z]3KF)%/Y-_Z6/OU>'6J'UZYAA;ZV_PYYO[WJZ]I]>N8=A^?>Z]5TCKO M6?Z7_P`?>]7[.M:#UV)"/ZCW[5U[0>N7D/\`C_MA[WJ'7M!_+KPD-S?G_;?\ M1[WJ'KUK03FG7O(?\/K_`(?[;G@>]:NO:#YCKVL_X_[Q_P`1]??M77M-.NC( M?]5_O8_WH>_:NO:?GUQ+GZ_4_P"Q/^]^]:NMZ?GU[6!_K_T^G_%?>J_/K87/ M#'6/R#GG\?2U_P#>_I[U7K>GY=8VE7\?[;_?7]UKU;3\^L1E)O\`C_??ZWOQ M/SZV!UC+WXN/]:_NM>M@?MZPF51>W/\`OOZ?T]Z)ZM0>O6!YSP+VMR`?^(_' MNM>MX\AU&:7F]_K_`(?\1[U7KW'J.[C5S]3_`%_WC_#WHGTZW3K`T@!_Q'T^ MM_I_QOWKTZL!3CU'9R3?ZL9/]>/?NJY/6,\GGZ?T]U)ZNJTX]>O^/Q[H37ISK&QY MM]/Z\V'O0Z]UB)]^ZJ2*'KC[]U7KB6MQ_OOK[J6ZN!Z]8_=.K=>]^ZUU[W[K M>.O>_=>ZQNQ'`_U[^_=>ZQ^_=>Z]].3_`+#_`!_P]^ZT<=<2;^]]4)KUU[]U M[KOW[KW7O=2>M\,==>Z]:Z__TM)?VIZ:ZZ]^Z]UV/?NM@TZY>]=6X]#MT)L[ M<^6WOM_<=-MSL.KVC09.LQ^>W#LC95?NV.C%1B9XJC&5L"[O2& MNIYZ*M#T%0]Z:<,(W)-\N[:*SGMVN+<73*"JR2!*T848'6C`@@E2&7N`[AQ$ MY^Q'*',NZ\Z[!S#;X M#6TKUMI@PC=W^26/S&)W?M>AS0:J4%` M[``#@:@&7WD-NWC:N;N6++>II#GB66&1;^R/O:W>_>CW"]N[_FGEWF78+&;9+F8A+K;N7TMI%@AV\@1ULS M>Q7#-(/$N"##*S6\2RPN*]5^>QWU@#U[W[KW7O?NO=LJMR+FQ'Y^OY][KU8&G635_7\_0_UY^ONW7J5\^N%B MG(Y!M_K^_=:ZR(]_]XX/_$>]]:H.LP/'^^_I[V#UJA'ECK(&_P!C[L#UJ@/# MK*K?TO\`\3[WU[A@]9%8?[[Z^]U/7N/#K.KV_P`1;CZ#_B?K[V#UJG60&_T/ M]/=PWKU6GIUD#6^MS_K\_P#$^]U!IUH_9UE606_(_P`>?\/>^JE0>'60/^>? M]]_M_?OGU723\^LZRD<'Z_[#Z>[`]:^WK*LH-O\`D1][J.O?.O642_\`%+VY M_P!OS[W^?7J?(=9EG8`H?/K*LG]";_`.W_`.*'WZOSZU0CRZY"5A_C_M_^)][K\^M4 MZ[$Q_-O]@/\`C?OU?GUJGIUR$W'/U]^U=>IU[S?\;X_XW[W7K>GKWF_WUO?J M]>IUQ\Q_WW_(O?J_/KU!Z==>8_[X>]5^?7J?+KKR-_C[UJ^?6Z=<"_\`5C_L M?K_3_7]^)'7@*^6.N!D7_5?7CZ_[W[UJZWI^76/SJ#P"?\;?\5^OOU3UN@]> ML)J"3]?][]UKUO[!UA>;GZ_6_P";>_5Z]U@,M[_7_7_''_(_>B>O?8.L32?C MG_87_P![]ZZW3UZP/*.1]?\`6_I_M_>NK4IU@9_]A[\3GKWV=8]5_I]?\3_O M7]?=2>MT/GUC+6YO_M_P?\.?=2>K`>G6)G!^G]>?]?\`V'NI..K4`ZPL_P!? M]?ZD^Z];I7[.L1;_`!_V)_XW[T3UOY#K$7_I_O/NI/6Z?.O6(G5<`\GBY_/' M_%![UU[KU@OTN2?];\?\1[]UNE>N)('UO_K?T_WGWHGJU:<.L98\\FQ_'NO5 M2:=<"?S[]U4Y/7`DGZ_\:]U)Z<"T^WKKW0FOV=7ZQ,U^!_M_Z^_4IQZ]UC)] M^X]:)IUQ]^ZIUT6T_P"O_P`1[T3U<"G6+W3B>K=>]^^SKW77O77NN_?NO=<6 M;3_Q`]^Z]UB)N;^_=>ZZ]^Z]UQ)][ZH37KKW[K77O?NO==_3GWHGK8QGKH\^ MZGKQSU[WKK77_]/27^OM0#TWQZZ][ZUU[W[KW78]^ZV#3HRO2%9UC'CY(-X[ MNIMK9"GW#59BOAR\G9<6*W%@*#;5;'CL%3OUY7T[P5-1F:F26:>94J81#`M- M]QY)J5P[O*;D9`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`1Q^?>P>K"AX\>NR+D%3S^?]M[WUH@]>#$?4$6 M'U%_K_MOI[]UKK*'X^M_\1[W7K1%?MZR!O\`'_;'W:O6N'$=9`__`"/_`(U[ MW7K5/0]9`_\`C_O-O]X][KU[[1UD#_UY''^^O[]4]>P>'699/J+WX_WWXY]V M!ZJ1US#7'UT_['C_`&`]VU>O52OIUS#?T-_]8^[`UZ]4CCUD$MO]]_QKWO\` M/K0IQ/'K()![]GK16O#AUD63^A/^'^^^GOW6B*]76L>G7,2\?4#_7_XU[W7KV.N8D_(/(_H;>_5'7OSZY^=OR2? M]M_QKWZOSZ]3[.N8J#<<_0?3^O\`C^?>^O4I^'KOSG^O^]^_5Z]3Y=>%0?Z_ M\1_O)O[]7KU/EUV:D#\@<6Y/Y_K?_#WZI]>O4^77$5!_!!_WGWZO7J?+KWW# M<\@#_?#CGWJO6N'EUP,Y/]HW'/U_XW[]7K?6,R\_7_??[Q[U4=>_/K$9;'Z_ MT_WW]/?JGKWY=<3)^;_7^I`_XJ?>J];H<=<#)_C_`+;_`(KS;W[/7J?/K"TH M`_I_C]?]A]/?OMZWUB:3GD$G_;?\1[T#Z=;QUB+D?5C_`+?WJOKU[)^SKAJ/ MX''^/_(_>J]6H.N))X)_U_\`C=OI[J6ZW3K&S@7M]1_7@7_/T]UKU:E*=8&D MO_K_`.QM[UUNE?LZQ,Q_K?\`WKW4GKV!PZQLUO\`7_WCWJO5J5&3UB+&X')_ MP_H/Z_T]UZ]UQM?Z\C_8C^OXO]??NM]>+<6'^W_H/][]ZKUNE./6,M_3G^I/ M^\>]$]>K^SK@3Q_C_7WKJI/7`G_;_CW[AUH`L>N/^Q/^M^/=2>G0H'#KB2!] M?=,GJW6)FO\`ZWUM[W@=:ZX$^]_WW_(O>^&.O=>]ZZ]U[W[KW71-OR!_2_OW7NL+$D\F]OZ?3W[K MW77OW7NO$V_U_P`_D?[#W[JI-/MZX>]]5Z][]U[KOWXFG7J==$^Z$];)Z][U MUKKWOW7NO__4TEA[>'38Z[^ONP/7CG/77O?6NO>_=>Z%SI#`[1W1O^EP.]Z: M:;!5N!W=)+4Q[@&W(\1+C=KY?+#-U-<,'N"6:/%0T+S1P)3NTE0L=TF0-33E M6\SW5M8M/9L!.'3&G7JJZKI`U+\50"2<"N0:,LM>R>QVU1];UU- ME=OU>T8*^7*T^XJSY:*JGJZRJVQM".FJ8HJ&.'P04,<*QQ(]V=W/ MNFS7%]RL`CJL:1^'';)&$1'JSNYZ,3\7IZC';.S,<5 M72Q5Z[L2IJ:?+':,=1M:A?%X*IHMT;O=X93>65RX#HV.Q<])4214D/( M>:"5"#F15DNX25)3PJ`KKHYJP*.R2QK&J_QN&`+'R#`Y"?=CGGV_E#>(XKN) M;\;L'=)_H`]E$8+9X[VTMKW:K^?<)YZ,IM+*2"5T@BR'F@E0BBMJ_P!A:_L; M=8+=^VE_P"<>^__`+"O:_\`==C_`--)9?[S=_\` M;+T4?O\`W7_IB=T_YR;=_P!M_7O[N8?_`)[[:7_G'OO_`.PKW[]UV/\`TTEE M_O-W_P!LO6_W_NO_`$Q.Z?\`.3;O^V_KL;=PX_YC_:5OZ?9[[_\`L*][&V6( M_P"=DLO]YN_^V7K1W[=3_P`Z3NG_`#DV[_MOZR#;N'(O_?W:?_G'OK_["_;@ MVNQ/_.R67^\W?_;+U0[]NH_YTG<_^[3_\X]]?_87[ M]^Z['_II++_>;O\`[9>O#?\`=1_SI.Y_\Y-N_P"V_KD-NX?_`)[W:?\`YQ[Z M_P#L+]^_==CP/,EE3_2W?_;+U;]_[J?^=)W3_G)MW_;?UD&W\1^=^;3_`/./ M?/\`Q.S/?CM-C_TTEE_O-W_VR];_`'_NO_3$[G_SDV[_`+;^N?\`=W$?\]YM M3_SCWQ_]AGOPVRQ\^9++_>;O_MEZ]^_MU_Z8G<_^;O_`+9>J'?-T/\`SI6Y_P#.3;O^V_KD-OX@_P#, M=[4_\X]\?_8:/=OW78_]-'9?[S=_]LO3?[^W4?\`.E;G_P`Y-N_[;^N0V_B/ M^>[VI_YQ[W_^PWW[]UV0_P"=CLO]YN_^V7JPW_=/^F*W/_G)MW_;?UD&`Q%_ M^/[VH#_A1[W_`.)V=;W[]VV/_31V?^\W?_;+U;]_[K_TQ6Y_\Y-N_P"V_KG_ M`'?Q'T.^MJV-^?M-[\BW_AG>]_NRR_Z:*S_WF[_[9>O?OW=/^F*W/_G)MW_; M?UU_=S$B^G?FU?\`6^SWM;_WCC[W^[++_IHK/_>;O_MEZU^_MU_Z8K<_^ MW?\`;?UE&!Q'_/=;5_UQ2;V_^PZWO?[MLO\`IHK/_>;O_MEZU^_=T\N2MS'_ M`#O_`-A_O?[MLO\`IH;/_>;K_MFZ]^_=T/\` MSI6Y_P#.3;O^V_KF,%B?^>XVM_YR;U_^Q#WO]V67_30V?^\W?_;-U[]_;L/^ M=*W/_>]N_P"V_K(,%BO^>XVO8V_Y1-Z?[Q_OT/?OW99?]-#9_P"\W?\`VS=> M_?VZ'_G2MSK_`,U-N_[;^LG\#Q'XWMM>_P#U![S/^][0)][&VV7_`$T5G_O- MW_VS=:_?NZ>7)6Y_\Y-N_P"V_K+_``/$VYWMMC^EQ2;R^O\`Z"/'NW[NLN`Y MAL_]YNO^V;K1WS=/^F*W/_G)MW_;?UV<'B>/]_KMA?\`6I=YF_\`L/[I7]V& MW67#^L-G7_2W7_;-U4[YNOER5N?_`#DV_P#[;^O#!XNW&]ML\?\`3+O+_P"Q M+WO]VV7_`$T-G_O-U_VS=:_?VZC_`)TO<_\`>]O_`.V_KF,)BQ_S&NV3_P!4 MN\O_`+$O?OW;9?\`306?^\W7_;-UO]_[I_TQ>Y_[WM__`&W]<_X/B_\`GM=L M_P"QI-Y7_P!O_=+W[]VV7_30V?\`O-U_VS=:_?VY_P#3%;G_`+WM_P#VW]_?NRS_`.FAL_\`>;K_`+9NO?OWY_\Y-O M_P"V_KG_``;%#@;SVT#:_P#P%WC]1_Y*?T]^_=MG_P!-!9_[S=?]LW5?WYN= M/^5+W/\`WO;_`/MOZY##XO\`.]-M?^]O\`^V_KO^#8O\[SVT?]>DWA?_WE/?AMUG_TT-G_`+S=?]LW M6_WYNO\`TQFY_P#.3;_^V_KK^#8K_GL]L_\`G)O#_P"Q3W[]VV?_`$T%G_O- MU_VS=:_?FZ_],9N?_.3;_P#MOZ]_!L7_`,]EMG_SDWA_]BGOW[ML_P#IH+3_ M`'FZ_P"V;KW[\W7_`*8S<_\`G)M__;?UW_!L5_SV6V?_`#DWA_\`8H>/?OW; M9_\`306G^\W7_;-U[]^;K_TQFY_[WM__`&W]\+_[SM3W M[]VV?_30VG^\W7_;-U[]^;I_TQ>Y_P#.3;_^V_KLX?%_C>FVO]C2[P''_H)^ M_?NVS_Z:"S_WFZ_[9NO?OS<^']2]S_YR;?\`]M_7#^#8H?7>FV?]8TN\?][_ M`+I^_?NZS_Z:&S_WFZ_[9NM_OS=/^F,W/_>]O_[;^NOX/BO^>TVQ_P"Y_[WM_\`VW]<#AL9_P`] MKMG_`,YMY6_V`_NC[]^[;/\`Z:"S_P!YNO\`MFZV-]W3_IB]S_WO;_\`MOZX M?P3%\_[_`%VQ_K_:[R^O]?\`CTO?OW;9_P#30V?^\W7_`&S=:_?NZ?\`3%[G M_O>W_P#;?UP.$Q7YWOMG_6^TWE_]B7OW[MLO^FAL_P#>;K_MFZV-]W7_`*8O M<_\`>]O_`.V_KC_`\4?IO7;`_P"J7>?_`-B/O7[MLO\`IH+/_>;K_MFZW^_= MT_Z8O<_][V__`+;^N)P6+/UWOMC_`,Y-Y_\`V(^]?NVR_P"FAL_]YNO^V;K? M[]W3_IBMS_YR;?\`]M_7'^!8G_GM]KG_`%J7>?\`M_\`CT21[U^[K+_IH;.O M^EN_^V;K?[]W7_IBMS_YR;?_`-M_7$X3$#_F.-KC_JDWI_\`8A[J=NL_^FBL M_P#>;O\`[9NM_OW=/^F*W/\`WO;O^V_K"V#Q1-_[\[7O];FEWM]?_0/^GO7[ MMLO^FAL_]YNO^V;K?[]W7_IBMS_WO;O^V_K&<%B3_P`QSM7_`,Y-Z\?^N?[K M^[;+_IH;/_>;O_MFZ]^_MT'#DK<_^;K_MFZ]^_=U\^2MSI_P`U-N_[;^N#8#$D?\?UM7_6^TWOS]/^ MS./O7[LLO^FBL_\`>;O_`+9>K#?MT'_.E;G_`+WMW_;?UP.WL2W_`#'6U5'] M/L][G_8W.SK^_?NRR_Z:*S_WF[_[9>O?O[=?^F*W/_>]N_[;^O?W>PX^F^MJ M7_ZA-[6_UO\`CSO>OW99?]-%9_[S=_\`;+UO]^[KY\E;G_SDV[_MOZZ.W\1_ M:WWM4?X"CWM_]AWO7[ML?^FCLO\`>;O_`+9>M_O_`'0?\Z5N?_.3;O\`MOZQ MG;^(/_,=[4`_ZA-[_P#V&^_?NRR_Z:.R_P!YN_\`MEZT=_W7_IBMS_YR;=_V MW]<#M_$?\]WM7_SCWQ_]AOO7[KL?^FCLO]YN_P#MEZK^_P#=3C^I6Y_\Y-N_ M[;^N/]W\1_SW>T_]C1[X_P#L,]^_=EC_`--'9?[S=_\`;+UL;YNOGR5N?_.3 M;O\`MOZX_P!W;O_MEZ]^_] MU_Z8G<_^Q!-SOW:?_`)Q[Y_\`L,]V_==B!3^LEE_O-W_VR]:_ M?VZUK_4G=/\`G)MW_;?UP.W;O_ME MZT=_W4_\Z3N?_.3;O^V_KW]W,/\`\][M/_SCWU_]A?OW[KL?^FDLO]YN_P#M MEZK^_MU_Z8G<_P#G)MW_`&W]<3M[#C_F/=I7_P`:/?7_`!&RO=3MEC_TTEE_ MO-W_`-LO5AOVZ\?ZD[G_`,Y-N_[;^L?]W,/_`,]]M+_SCWW_`/85[I^Z[$_\ M[)9?[S=_]LO5OW_NO_3$[I_SDV[_`+;^O?W']9++_>;O\`[9>O?O\`W7_IB=T_YR;=_P!M_7O[N8?_`)[[:7_G'OO_`.PK MWK]UV/\`TTEE_O-W_P!LO7OW_NO_`$Q.Z?\`.3;O^V_KW]W,/_SWVTO_`#CW MW_\`85[]^Z['_II++_>;O_MEZ]^_]U_Z8G=/^^ M_P#["O?OW78_]-)9?[S=_P#;+U[]_P"Z_P#3$[I_SDV[_MOZQ-MW#'_F/]HV M_'^1;\O_`.\3[]^Z['_II++_`'F[_P"V7K?[_P!U_P"F)W3_`)R;=_VW])JO MIH:.KEIZ?(4F4ACT:*^@2OCI)]<:.WB3)T..KAXF8HVN%/4ITW6S$KN(HX)G MBBN4F04HZ!PIJ`<"1$?'`U49!I44)/;*XENK:.>>QEMI6K6.0QEUH2!4Q22Q MY`U#3(V"*T:H$,FW^O[9Z4$TZX^]]5Z][]U[KOW[KPX]>/\`3W4GJQ].NO=> MJ]>]^Z]U[W[KW7__U=);V[TUUX>]@TZWUW[N.O'KKW[K70S_`!ZG>E[DV16K M%42ICZS(Y*I:FW!!M=J6AQV#RE=D,C/G*K*82"DH,70T\E35*U92B>FB>+RI MY-0*-^`;:+U*@%@`*J7J2P``4!B2Q(`[30D&AIU,GW?IWM?>'DF]6*1TMYII MGT72V12*&VFDEE:Y>:V6.*&)7FF!N(1+"CQ>*FO4%E\HJQZW>>TI'WA+OPIU M[BX3N>7<&#S_`/$9(MQ;I6I*/M_/;IQ^+CBJ_(OVG\2K&0@R%T$BQ1H^6D"6 MET!:"#_&&[-++3L2GQ*A.*=VA?2AI4C#[SMX][SCRG(_-[;Z1R_"OUK75M=> M*1=WH>AM;J]BA"R:AX'U=PRFKET$BQ1CW\=MRU^6V9A7HD["R^Y8M_95]]YS M%]OYS:6'Q6VL+MW:D>VMP=BRQTM;*=H4E%%+CTB26)DI:&N9+[=>3=F>R3F"[YD7?I MSN=S#O\`1] M#[<'5"*=>]^ZUUR!]^X=6!]>L@8C_'_>_>Z`\.K=9`;B_O7`]>Z[_P`?=@:] M:(!ZY`_U_P!X]WKTT4IUR!]^IUJI'616M_B/Z>_5/5@>N8/%P;?X7'_$^[5Z MW6O'KD#^&'O=>MT'EUT$(Y##^GT'_%??NJ]=J]OKZ3[]U[K*'_P_V(X][ZU0 M=?7,/_OA[MUZGIUD$MK\VO_7_ M`'UO?NO<,TZYAS8?U_US[W4]:P>N?D!`'TM_Q/OP-.O$=/I[V&^?5=(ZY7-KV_WO_BGO>H=:T]>UVYY]^KU[ M2>N]?YO;WNO7J'KVO^I/^V/_`!3WZO7N[KVO\7/^M8_\4]^KU[/7O(?IJ/\` MK<^_5Z]W==ZR?R3_`+`G_B/?J]>SUUJ_U_\`7M;_`'GCWZO7L]>,A^GU_P!M M;WZO7@.O:R>-(_V!'O77J?/K@6/]+?[[^GOU>O`#KHEOR?\`8?3WZOSZM0=< M2?S_`+O=>U#ZW%A_K>]$];IUC:6X^EC?ZG_#_`&P]ZJ>MT'EQ MZQF4GZG5_K_\5]ZKUL`]8RY_XU]?>J]>H.!ZX%B?KQ_OO\?=:TZ\*^0ZQE_] M]^/>J];IZ]8R_P"+\_T'OW6Z`=<>3_M/_%+#Z_X^]=>Z[X'-O]L/\??NMTZX MDGFYL/\`8'\\?3WJOKU;`^WK@6_U/'^)^ONI/6JUZQD^_=5)].N)('^O_OC[ M]7K0!.>N'U^OO1/3@4#KWNA;TZOUP9B/I^?S[T!U[K&23]?>R?+KW7`^]=4) MKUU[]UKK@S?@?['_`(GW4GRZ<``^WKA[IQZWU[WOK77O?J>O7NO>]=;Z][]U M[K"S7_UO?NO=O;_7_`.((]^ZT<#KA[WU3KWOW7NN_?NO=>^GNI/6^ M'V]=>]=>Z][UUKKWOW7NO>_=>Z__UM);V[TUU[W[KW7K^]@YZW7UX==^[]:/ M0W?'&2JC[HV2E'4BCJ*R;-8Q*U#-4<56TM"$ MI*B62L2)(T,C+[)^8`IV>\+K50%-*:@=+J:$:EJII1NX`+4DTKU-?W=9+F/W MFY*2SN/!N)GN81()E@>/Q[.XA,D,K07.FXC$A>V"P2NUPL:1H9&7I4_*2?+S M[RV@.2-V2\M"(6EWX(A\/Z@_V2E8S1$%5JSUX<0Q%<8((Z%'WGY]VGYPY2.]OO M1W`*>_0/>7TBI/X=K9M"0KC3#+;I(%(>KQO&[&1Z=V[T!N,Q9+"[ M%J-\4#9^@HMQ_P`5V304U'LO'X/#[:@J\_DZJL[DI_X)M?.^>>I:LJX*_75P M5A%.J)'"X>W:??;>L*ZU3Q7A%NJ M(D+UL^Y"ZYQ]>!MR/?NO=9E:X'//OW7NN7OW7NO>]\>M4Z][UUOKWOW7J^77 MOI[]PZ]UE!!%[@?X7]N`UZH5Z[][ZKUV#[]UL'UZY@V-_>ZUP>/5OGUD#@_7 MCWJAZWUS][!IU[KOZ?3W8'JA4'KL,/\`6/NW39!'7._OW7@WKUS#$?T/^!]^ MJ1U:OIUR!''-C_3_`(W;WNO6Z]<@1^;'_'@_[?WOKU`>'7B`3<'G\#CZ_CWO MK5#UWJ;^T.!_C_Q%_?NO=IZ=< MPW^/^W][KUK(ZY:O]A[W7K5?4=<@]OS_`+?WNO7L>O7+7_O@?^(][KUZA\CU MR$G^)'OW7J'KD)?]J_WW^Q]^Z]7.>N7D)%P?]M?WZIZ]BG78DM;^OYY_XI[W M7K1'7+R#ZD\G\7Y_VW]/>ZGK5!Z]=:U(O?\`XW?CCW[4>O4^?7>M?ZB_]+\_ M[;W[5\NO4^?7O(HMR+G\<7_V(]^U?+KU/GU[R"WY_P!]^+>]5Z]09]>N)D:_ M]5_US?\`WJWOU10^O7J4ZZ,OXN+^_:NMT^>>NFE'X_WCWHDGK=/EUC\C7X_W MD^_=>H>NC(3];<>]?GUZ@'GUP+D_G_B/>J]>J.N!;_$?\3[]7K>3CKHM_C<_ M[Q[U7KU/4]8R]OJ;?[W[U7K8%.N&LM]!?_7/_&_>NM]>L2/42/\`;>_=>H>N MKJ/H`?\`??UM^??NM@==:CSR+<\N!/]3[UU7)ZXDD_X?[W[U7IP)Z]=>Z%NK@4ZZ)`^OO63UOK$ MS:O\/]C_`*WO>!3K7'K@3[UQZT33KKW[JI->NB;>_=;IUB+$_P"M_3VV37[. MK@4ZZ]^Z]U[WKKW7O?OGU[KWOU2>O==$@?7W[K?6)FU?X#^GOW7NN/OW7NO> M_=:ZXGWOJAX]=>_=>Z][]U[KOW4GK?`?/KKW7K77O?NO=>]^Z]U[W[KW71-A M?WOCU[K_U]);V[TUU[W[KW7O?NO=>]V!IUOH8>B*7'9#LK$XC*[=VUN6DS6. MW%BWH-TC=$E%']Q@,DS5..IMG^3/UVX?%$T6/IZ:&HJ9JN5$IU2J,$\17O;2 M)MTLL5Q)&R,AJFBN&&"9.T)YN20`H):JZE,N^QEMMU_[D;5M&ZV] MW"8KWZTQC7:S$O$FWUNI;O2I2TBACEFDG=%MU2Y,$\2I^2VV,;M3>&V:'#XS M;.,Q=7L>BR-"-K4>[(**O@FW)NB`92?(;UJ:G/[AFKFIBT.0<^">B\`@+P)' M*Z;EVYDNK2Y>:21I1,0=90D'0AH!&`JTKE>(;5JHQ(`G^\CRSMO*W-_+5EM& MV[;;;7+LD7J^,TNXN]U=M*4+1W3'PY;?P!`7@2.5QGZ#GS&V M]L-!A-];%3`9#>RT./R.0V!VENBNR.2KL!L>NWA@Z.DVU34U11XQT>AQ]:]7 M!3_=".1*>H^WFFUE&^"&XN09K*?QUAJ0)84``:01L2Y()^)ETDTJ"RZ@*3)[ M#3;QRYRRT.R\\;&NPW&]"**:7:][O999I+7;9=PMHX[-$>.$@VUK<-/'%XX2 M1+>X^GFEUD0!]C:G6#`/KUW[UU;KL&Q_XCW[KW60.#Q]/?NO=<_?NO=>]^Z] MU[W[KW7O>^O=>Y'OW#KW7,.?S_M[<^]@]:('62WN_5*$=>]^ZT#3KL'WZI'V M=7!KUS#$?[[_`'KWO!ZWUD#`_GG^GO5".O=NPW^P_V/O=>FRI'7._OU.O!O7KD&(^A_P!A[]U:HZY:@?Q;_>O]M;WL M'UX];KUS!/\`4$6_WWX][KU[!Z]<$6/'^M[W7KVGKVFP])/^W%O?NM=>O(/K M]/Z?C_;#W[KW78D_V'^QO_Q'OW7NN8DO^5_V/'^]6/O?6J#TZY:K?\5!/_$\ M^_5ZU3TZ[U_XG_8_[X^]UZ]0^O7+7_B/]]_MO?J]>->N6H^]UZ]GTZ]J/^^/ MOU>O?[7KO4?\?]@?^-^]UIUZGJ.NM7^+?[?W[5UK'IUWJ_Q;_;^_5Z]CKK5_ MB?\`;G_BOOVKKV/3KVH_Z_\`L?>J_+K>?3KUS[]7K6?3KK5_K>_5ZWGTZXEQ M_7_;>]5^?6R#Z]=%N/\`'^G/O5>M4/KUPUV_(_V)_P"*GWZO6Z=<3(/Z_P"V M_P"(_'OW6^N.IC]!_M_S[UU[KP#$W)('^!`_WCW[KW7@%'-_^)_WKW[KU"?+ MKNY/T`_V_OW6Z`=<"?ZM>WXY/_&O>J_+K=?EUQ+?TX_V)]UKU4GKA?W[K6KY M==$^]]5R>N-R;@6'^-_^-CW6O5PGKUQ_U^3_`%]U)ZN%`Z\3_OOI[K4GJW6, MO^!_M^?^->]T'GU[KA?^I/OU?3K7V]<+^]=5)ZZ]^ZUUT6`_Q/\`O'NI;JX7 MUZQ?7W3CUOKWOW6^O>_<>M=>]^ZWU[W[KW71-A?W[KW6$L3_`*W]/?NO==>_ M=>Z][W3]G6NN-_>^J$UZZ]ZZ]U[W[KW7?T_XI[T3UNE./77NO7NO>]=:Z][] MU[KWOW7NNOI[WU[K'<\\\7]V].K`>O7_T-);V[TUU[W[KW7O?NO=>]^Z]T+7 M24N"'8%#3;BPVT\WCLCA]SX[[?>F3GPV'CJZG;N3^RDCRD>;V_38_*U%2BTU M)/45,<4,\ZR!X95BJ(2W>/&^A=H)I4D5T-8P&:@<5[=+$J!E@`20*4()4RQ[ M+2[&.?K*VYAV?:;W;[BSO(=&XS-;VX=[2;PR)QCH*#<^"I<30;`H,1#M.DCQ@ZZRFYLWAZF"'-Y^">IK,SNY1FLK7FO MBF2*H)>GEQ\=,U.[P&-C79'>2VF:62=I3*:^*$5@=*F@6/M44H2.(8MJ`:HZ M,O?2SL;#F;8[7:;'8(-I3:HQ#^Z9KRYMW5;FZ5GDN+\?43R^*LBI*2T4EJML MT#/`8V)@?BOON;K[!3M49K'8&G.]:;)9>CJ\)W-FLUDL;#C,+40+0XWKVII- MM*K4\DC0_P`7$D54TNE@(022'F:R%_.H6%G;P2%(:W50:L#4R@OQI710K3UZ MGW[KG/4O(&R3M<;S;V%O^^DFGCDM^8;BXFA6&W=1%#M3QV8!4L8_KPZ3E]+` M1`DD3D5DD='0Q.CLKQL&5HV4D,C*_K4H18@\C\^QL,@$&HZP:D5DD='0JX)! M!J"".((.13AG/KUU?W[KP(Z.C_+S^'TGSW^8G2GQ,C[3VQTN>W\YE\6W8V[* M,96@PD>&VQF]SO3X[`'+X!MS;GSBX7[#$XQ:ZC-?DJF&$SQ*YD6I-`3U;IO^ M??Q*J?@I\P>\_B95]E[8[?GZ7W/0;?/8FT*!J`>O=6;?*G^7'UMO&EZ:[-Z8RGQJ^'O5 MH^+7\MO.]M_WUW1\M]W1UO>?SHZ,W)VGCG='QZVSM_HKM[Y+]$]VUM5D M>ZYNO/DOT7U;NW-_&3M7);R^?/9GP4RNR,QNWY`XC8$W;_ M`$J_6V1W#AM^;FV=U]L_?^.Z[WU@^TL1-CLQMN6>O@@JB:I*&>&:*/6H4/V= M>Z0>]_Y761P^\]A=;]??*OH;M#LC?OQBZ8^36+ZXQ6S_`)-8S>M;ANX]F=?[ M]QVV-NT;="9+!;DRE#L_?RYL-'D893@\=63U=/0U<1H/>]0I6G7NJY^S=E0] M;=B;WZ_IMY[.[%BV5NG.;67??7M1GJS8N[6P>0GQTF>VC6;HV]M3<%;M[(R4 MYDI)JK&TG7W9F[=@9'H2'H#XC["VG_`"Y_Y?OR MD[NK=Y[F^4NZ<+D-W_+FGZIVSF,SAJ>+'?)K?,L,':G;V-I(L=1Q0K38QU9( MZF6.:1JUX_;U[HAO?_P'[(^+,>]R^O=Q14/]XLWM^MKJ'!U-5#3M%)2&IL&Z M]]O0>?#[IRN[W[AK]B8G"];[FRM)TQ\CNP*+;':>=[(VWMK,CJOH#LGLG(34 M67ZN1-P)NW:N(VM49W#4U54T6'R.3Q4-'D)6I*B6":^H4ZIIZ67RR^"7<7P^ MW7USLS?V3VAO'-]HT$M=M-^MH>PPZ_;(0Q&GFGJ6P2.-,=;%:\>ATI_A"_R1^(#=F];]Y?R[,;N[MKN/Y+UG M>/:65ZHK?C[U=@>A?BQ3_#?9O7NZ.G<[N+XO[*QW0V&A[%[5C3QMK4/>/;N\-C?(KLBNR/QYRU5LC;78/076V:\6TRP-<&M.O=!IBOY7?:V[-HXC>6)[B^->-S^^NBN__`)*; M`Z;_`(YW7'O#1Z]T'WRU_E\;]^'6Q\=NKL;M_I;_.XOCAG>L=DGN!=\ M[7[%Z&H=I5/9YKGWWU#L7:6=VSMNMWOBZ/\`B^%RF4QN0GK8CCYZR):F2FLL ME<4Z]3H@9O\`B_\`M_;@/SZH5KY9ZY`\<_[[_;>[5ZH5(SURO_C[]UK(ZY:O M]@?\+_\`%??NMU'5XG\KO^79G=^=O_`GY)]H8WJCLKXW=J_*CKSKWNHZSM.?KNLPG84V+V-4=2;?R-=D7IT5W#_P`M#M+G-J;4[>Z,WAM;O;J*7N?KWM?:4G>&XMK9 MC;5!W!ENA=QX?';!Q?1]1\B-R[OVCVE@JRBR=!A-CY4P4%+/EE>3#4]1D(K> M(*$T-0?]7RZWG'0G87^3G\ALID,IM[(=Q_%W:&],?WW\H/CU3;*WGV/O'!Y; M,;G^&>3VI_LRV[,?F).M)]D4W7756R=S2;LK\G79:C8[=Q-:\4+UPI:&JUXH MXT-*#^?6Q_/I/=@?RHNW]C]0=B]YX/O_`.(W=O776N(.8SF:^./;&Y>^H(HH ML93Y*JI-PUG6O7>?Q/4E9$:E::G_`+_56THLK6?LXZ2L8K?8D!(%#7K6GYXZ MJWM&3??NO=2_P!-7^^_V/OW7J#KWD_X-_OO]C[]U['76L?T/O76^KB? MAA_*3K/F!_+]^9_SO3Y-=9=6T_Q&CW#HZGW+C!79G?$^V-CXS?U!5[:K\/C=F]DYOLK![4H[Y>O5L5I3JM/)_RV.T=K[8WYMG^+_&?>]?6] MQ?`#:>S^Y4[$[:VS24^TOG!UUV#V%TAO;:,F\=M]>['I.I>SL%!'/N.NWCCZ M;<.V9,'$JT5%%-5R37\08X\#_+K6D]!YL#X0;]VY_,;ZN^#NZ\?U7O?L3)]L M]8;&R&W>Q6^0G7?5FFP]#7456 MLDD3-3JM2^RXT%A6E.O:37H..\?A-VGT%T5T?\@=VYW968V5WWB,!F=GQ;2& M_LJ:*'<>V%W;2X[([PK=A8OJC+;CQ&.=86@HJK]KWL." M6`\NMZ<#/0]=>_RG?D1V/N;:FP\7OGI+$]CYFH^)DF\^O,_G^P:?\.S9,=UEE-OKA-R9;MK:<=?3X&NSN8PIW'2"NHH&6K6FJ9`*FAIG M^77J#'3%UU_+'[7[+VYUGNK$]P]`8?#=BX_YJ9&MK=S9OM'%4O7$7P-V/M#L M?N^+?M2G4U9"DDVS]Z4M9B)<.8^86U-J9SH/LO_05URW&P#?)7ISIO_3ATJ=N[5PE7NF,U M>^:..&AW=CZ59-OYZ>K&*DR5+##3Z+87CG[/3KV<]&BC_E2]J=9]GUNW,EO7 MXI]]OALS_,*Z;W%@J3=?R4PFV-M]Z?!KHG+=C]L;+S&4CZKZNW'4[PVIMG*T MNZ=KS4$]3M/-U=!'0Y&N6-ZBBDT)*CS'#T\^M4Z3>_/Y=2=1;7[1K<'V]\G0V=*?RV-Q]"Y+.;P[_P`? MU%VKL_M7X+_S6,SUNN,HNP M0VYNW:M3NK9^29C58K*SS4RRPZ+@X%:@C_#UX*?/H@7QB^$>=^36P=Z]FKWW M\?.C-E;"[2ZEZ>SV:[PRW;-!3Q[T[QQV_P"NZTC/^C'J#M(T.$SLO666IY,C M7?:45#-"&JI(8"9EVST(%#U8)Z]#'O/^5OW[T[MK?N]M_P"X>E$RG3W4._>_ M-W=55N:[#K=R5FW.E_FED/@SVQLV:?$[&I-JR;AVEW=B3'61Q9^"GK<-5Q5. M.K:B3S)3U\0'A7JP4#JUS*?RW^L,?_.>Q^Y-LTWQJ[3^)-%_-;VU\9>R_CEM M3'[XI)NCVWYNG>.0Z^Z][+ZZWCU]L/;N0VON;;NP\N:"HVW7;EVY))C)*2KG M#$TTC6LZ..:=6ZJ2S_P*W96=2?'KN;<6Y?CG\?\`IO>G275^=R7=F>SOR)RN MW MWW-ZBI'G7K71:NF/BUN;N7;':_87^D3K#K3JGIG.]=;5WKVKV17[WBV?!NGM MK+[CQ?7.`H:;8VQ-];PJ*K=$&S,S7).^*BH:2AQ51)5ST[>));%@*8SU[J[; MXD?RU=F83&]`]%_([,=.;:[0[E_FX;B^$WR7Z_W5LK<>\>QYMB?'T_'K>E=L M'ICM'&=5;AH>K\[G\CNS(1Y#<.W=T82GS6#W/C(WK*^"*NI<>V6)J?*G7NB9 MY/\`EI]U_(W[(ZZV'T9LK;>Y*+X[97MO;^[^WHOBWL MSN+JGXPT_377&]:/J?-=F;>JH:FHCVG09F1**OS%3C?`M35FVH#R..JT)\^D MUUU_+.WMVBE5U+UOV'\3.P]SYKYK_&KXK8CO##;Q^1T%/ANPNZ^F^Z]]8_9- M)35_5^)VOD>O9,EL6IH-Q9.3`U&Y,'3Q4+28FJJ:F7Q8#)KPZ]I)Z3U+_ M`"J>T*C%;?WN_?GQV7ICA-]8GNBB'R$RVVJZC^1?;O;G1VP<)3;)Q_Q^ ME[G_`(W'V)T5NBBK99ML08:(T$!CR$@R6,^\H7^6>K@`"G038;^7]V'N7YB] ML_#+;O:?3N>W?TUN?=&U-V]BX-^V]P[`R&4V=N[%;"W$FQMO[:ZES7>79,F. MW?EUI6AV]LW*5+4M-591(WPU+/D4U7%>O=#!3?RC>^Y<=VS]WVM\?,5O/JCM MCYK='OUE69[M>IWCOSL[X"=>0]L_(';6QZ_#]/93K]6INN)3EL/4YO.86DRD M2&$2QU16G;VH8Z]TJTL=U;5_("C[B_ES;IPV+H\?NZK[ MAZ8ZR^2'3?R4[2P6'W?FLOM?';(QE'V[LB#;>;CQV!RN4KJ<4_BS2453%!3+ MJN1Z=>Z!O:7\MCL?>/3>U.WL;W?\?*:JW_\`&#O/Y;[#ZKKJ_N@=D;LZI^-V M2[5QGZ1G?_\` M+^[G^.NT^R-S[KW!UMN6KZ,[,V'TU\AMG[(S&Z*_=G0G:'9.V-T[GV?M+L"# M/[.VWA,BV2CV)G:%LCMRNS^'@R>)FII*M7DI?N/5KU[I<[8_EH=D[MZ-VGW5 MB>\_C@M9OKX\=E_*?:/3U9GNVJ;M;/\`2O26\=_[/[KW%C@>FWZSGRO51ZMS M^3R>'&Y?XO48K&RS8^FKG'B]^KU[HYGQ<_E@9_HK^83\-]K?(^HZ'[MV!EOY MF&[_`(1=H]=X>3?6XL-+OKH_(=8Y#>E)N+'[OV)LC&[@V5N7;O:F)R&+>&6L MBJH)&@R--!(L]'[T6P:>G7N@_P"J?@SB^OOCQ\O\YN^IZ#[QHNQ/B!\7N[?C M%WKMD]C9?9V.H=W?S*.AOCQOB?&C/[-V-V=L_.XO)T.YMJ;E@.`ILW##!4Q4 M324U4KU7B_=4O:.[OC[TEE<;V'WD>L>A<+GN]]T5F^M MH=8?(_?7Q[RT_2NX<[USN2.LV)B-][!SU%AI]^;BPNX\IB=OS5DT4CRP-5;& M:=:)IU7/[MU0FO77OW7NO>_=>Z[^GO1/6^'EUU[KU[KWO76NO>_=>Z][]U[K MWOW7NL;&_']+^[#K=/GGKKWOJ_7_T=)4<@'V]TUUW[UU[KWOW7NO>_=>Z$+J MK;6"W?OW![GI? M/4JTT.YW$UK937%N`95T\59@`6`8E4[CI4EJ#)IU(/M9RWL?-W/> MRP3R3R(Q672"L1+C<-OW*3Q3=W<5?J=L`M=)CACI&`'0U+_`!#H0]@+V97=>9K>^-^0 M&1Z[U;AJ,96IG=^9#;\>X9=M;>VU#C*7&U&*S59NW+Y:FQ>32!8!C#10TM/$ M/N1I$<:*^.W)?PVI(90BJ6%:Z]18GM\S('(2^Y-[[?;U MSKMWOY<"YDOYYT@F6)8OHC;QPQ1#Z@:1'&`> M]VW(^YLA+NW*IG-P31XVHK1J MCR%A/:<2`'MG].+:,6L6B`5`725I1C4:2!0`UI04I\/;3J!N=6YC?F7<)>;- MT%]O[K"TEP)X[KQ@T$;12-<1NXE=X3&79F,NLL)Z3"0!)^U/05ZS0S2T\L4\ M$LD,\,B2PS1.T.2-P"K`@@BX]^ZL#CKIW>1VDD9G=V9W=V+ M.[L2S,S,269B;DGDGWKJW1^]W?S/?F;OO;L6TMT[ZZRR.VH:7X\4,>&A^,'Q M7Q="N/\`BA%G*7X\X[Q8CI:@U8WK#%[FR%!14Y)AFQ=9-0U*STCM"=4'7N@= M[$^8_P`DNUXN_P"DWQV=65V-^4W:V`[P[]PN&V]L_9^W^Q^UMLS[MJ\3O/); M>V;M[`83&Y`9#?.4JZF+'T])35U;4+4U,4T\%/)%Z@QU[HP6;_FP?.[W4G=66^1FQMR4OQX^-.,R-'WIG]LX':.X.TLZ^+Z?HH]Z[OW!A M]K8UZ^JS:Y$UU?0P5\XDKHUJ1[2.O=0-I?.[?E?O>F[L[6W=FQW5TG\>JCIS MXL9GJ#J[IKJL8NN.UZ;J/::=G;MZ]PVPL]DML=2]29.M&"$U+GJR23&8S#L: M?#^8)ZGEY=>Z`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`L7]O0PC&4'V^RH/$=:J>N.)_F,_+7`MU>V$WGUWAUZ6[W?Y+]50XOX MX_&J@I=C=U'%[7P=-N[!4E+U%%2T]+BL+L7!4F/Q#(V$QM+@L;%2T<*4%(L. MM(SUL-U)@_F1?+NF&W5@WOUW%'M/J?NWHW;T*_&_XSB#&]4_(W,;FSW=6SDI M_P#1!X)Z+?>4WKF9)YI5DJJ9C4_P`RO^8WUI\U M\#D*/";1_CVYLAW+1=@;2["WI\O= M>X_QO_6__&O=@PZT17KE3JE\!F%7N2@CW'0UE935&0Q.5U M34,],7<-[0O6M3#I_P!R?S0OF[NK=>TM]9+MK;U%O+8_/Q\$&Y,77FJQ&:AB6.KI95%O?O#7A3 MRZ]K/28R?\PKY3Y';NZ-J4^Z.LMKX'=V([&V]7T77OQK^,W6+X?;G;^U\5LO MM;;FQ:[KOJ#:^0ZTVYV1MG#QTNKY]%P M[7[7WQW=V'NCM7LC)8[,;XWG70Y'<63Q&V-J[,QU95P45+CHY*;;.R,+MW:N M)7[2BC#)1T5.C,"[`NS,UQ1<"O6ZGH/;@_0'_B/?@>O5/7M0_K_O)X_WOWNO M6ZCTZY!C_JA_OO\`7'O?7JCKUS_4'_#_`)%[U7KV#UWJ/]+_`.L#[]7KU!Z] M>U?X'WZO6J?/KVK_``/O=>O4^?7KW^JW_P!]_K>]5'KUN@]>N]7^T_[W?_B/ M?JCK5!Z]=:C^![]7K=!Z]94JJB*.>".HDCAJ51*F%))$CJ%BD66-9XU(658Y M4#*&!`8`CD>]]:H.N5)5RT5535D/VSRTE1#4Q)5TE)7TKR02+*BU-#705-%6 MT[,H#Q31R12+=75E)!U7Y=;J!TM MU[C7HKH*EQF;Z?RW7,?4.0VA5;*HNKZ?8B_<=6PIM_\`B"8Q,HF(1:5:D1*% M%=*@!:8K7KU1Z=/&2_F3_,/+8RBQ%9V'LL8_'Y'XRY6DAH>@/CMBGCJ_AQBZ MG!_&E6J<7U3154U#U5@JV>@I*5W:EJZ&HFIZV.IAED1M:%_P^?KQZ]J/7#>' M>OS6Z=[^^/OS.WCDAM#NG.=>]>]N_'3>5;L+J=\%3=9;`;-]&]79G9W54.V* MKK3;6U-J+U-58O"8YL#2P4T6+BJ:>G"-3U#^HA!7RZU4]!;VE\O^_.X^O,?U M1O?PZOJ_KO+;HJ>K]A;.R&\*_8_7V M0J<3BIZ(PNZ.Q8]IKOS?FU.ILMA,?-@L-G@ MQWR4VGA=C=]46-VMA^BJ';F-I^V-J[?I*3-+!2QBK6,NW[DDKOK0OI_,]>U$ MGHN?2'R<[D^.?^D<=1Y_;F`';6U*#8_8"YKK3K#?R9W:6,WEMOL*DP,:=A;- MW4F%H!O39V*R$BT`I3//CJ?REUB11L@&E>M=V>C%O_-/^;[YC,[@/9FPSF=P M]B=_=LYK(?[+=\8ON,CV/\IMBCK/Y![NG(ZI76'R8^>??C;DZDZMJ:#>=7\3? MCIMW#=@K@]P]D5/7F-W=54_6VW.HL544F9J,LVX8X\#CZ:"K=H*2$:.D9/K\ M^/6Z=9=P_P`V+YU[KJ,K6;B[0Z_RM;G&[TDS-;4_&7XL?>Y2?Y-['PW7'R#J MZZKCZ5CJ:FN[AV;M^CI,_.[&;(O`)Y&-26F-=*^0_P`/5NN7Q@^8VTOCA\/? ME-UAAWR9[^[A[E^+G8G7%7G>AND^WNK\!BN@*/NZFR=7D[$ZDV]N>J[#ZUQO M5_8%)VI693H;J?M+=6(Z>[)[RV_VIOQ][]N;BZPW-V9B-AYCY#Y['YAIZW-1 M45+N;*(\#15-:"OW!09.>@FR%7-3M%-55#R M>HH%*8Z]U.P_\S_YIX';5)LK%]C[%BV31=8X[IZ#9-1\=/C3D-E_W`P>]=X= MC;9QL^TLAT_5;=J\OLW?'86>R6"S$M,^:P53FJXX^KIA5SB3VD>G6BWITAO[ M[?*GX4Y_P]@;KAZ5[[QM=6X#=&5R6VCVKU[NB#L_! M[-[@V-NJAKC)CMP4./WCMV>>HCJ(*45H&ZK4]*':W\R7YF[/R.P\UB.V M<75;BZU^1&^/EGM/=FY^I>E=[;RA^1?9-)246^.U\]O+>G76?W1O+<>X8,;1 MF49FKR%*DF.HI(XDDHJ1H?:5SCKV:CIOV/\`S$?EIUK3=84NS=][*QL?2G8% M7V7U#)5]"_'S.U766XZOL%NVFQNQJ[<'5F4K=L]?TW:;#2^0.V_E-(T?0_Q^RT M5#WQL[&[GQ&T]^X*ESW5N4I=M2;;QN],M%18[')2XBF&0G,=*K2,?=2*];KT M@IHOXJ]335*]>Z+EVQW5\ MB_BI\G_D#O+9'66`^)\?REP$N]VZ"K=G]:]E[)P?Q^[WW)M;Y$=5[-@VOOK; M.Z]K0X_!4U)MW(8F88ZAR6*GH(&ACH)$,*;X@#TZ]UAJOYJ/SAK,[D]RS=F[ M"&O= M2-J_S!/E3LO;O7^U-N[SV)28+JWHWMKXV['HZOH'X]9B7$=*]ZU6?K>V]DU- M?FNJ\AD<['OBJW9EWJZ_(35>4!R]?XJF,5M5Y?4'7ND'V_\`,/Y&=Z[7EV;V MEV*VY<)D-P[;W?N;P;4V1MO,[_WCL[:U9LO:>\^T]S[5VU@]S=L[QVYM;*5M M'19;SV?A[2^0_9W>%9M[KOO'&YW>O=$_6U;C>RFPV3Q+U&W:"O2C MEDEHY$R-3`G@,D]>Z2>[?YJ'SHWONKK??&?[?V\=X]3=X5?R4V/N?"=%_'O: MFJL+5;SW3N/&[.Q9RLV:;(+E:JBBJJQ9JH&8^TCK MW0?8GY^?*7!#><&*WKLREQ6_-D;)ZUSFU_\`07T'-LBCV!UWVC#W=M'9^S]B M5'6,VS.N]OX[M^$;EEIMOT.,CKLTSU=4)YG=F]I!ZT33[>G;N3^8Y\Q?D!LO M=NP.W>T<'N[;>]=][W[(R^KI[I#![AH=T]F;GGWKV0=H;SVWUOA]Y=?;<["W ME65.6SF#P-?C<'E\G655554DL]54/+O2!U2I/1'O>^O=>]^Z]UW]+>]$];&* M$]=$W]U/7B:]>]ZZUU[W[KW7O?NO=>]^Z]UP8\@`_P!?=@./6QQZX^]]6Z][ M]UOK_]+21!(^GM12O'JA'IUD'T'^M[KU7KOWKKW7O?NO=#9T3#'1[\V[N'^+ M[?II,?DLE33463GR]-7XZ@DVEN.KK=YP55%M#=M%CZ?:L%&U0M9)3U`HJQ8) MI8#3K+)&3[T2UE/!X4A#*#4!2"=:`1D%T)+DTT@C4M0#J(!FKV,ACM.>N7N8 M/WMM\4Q,[,< MZ^*T\MS2\O8_$N+AK';A/,/#\/4EJJ)$D4`>0Q,[&#^ M(F)P^0V3JK-UX39U?_I&KFA/^C[;.^=P[PIH*38%'_!VDS6"S-=A\?B*[-PB MG:FT,\N3G?Z0LRD?-,LL=Y1;5YD^G'^BO&L9)E.KM90Q8*:UKA%'GUD!]TG: MMHO^2PUYS59;/??UBD*_[JK/3/PA9 MEKO]C_KGL13KKW[K77O?NO==W]^ZV#UR]ZZOU[W[KW78-C<>_=>ZS`W'^^_X MJ??NO==^_=>Z][]7KW7O?NO=>]^ZUU[W[K?V]=@D?3WOAU[KF'_J/]M[L&ZT M0#]O7+Z^[5ZH01U[W[K77=_?NK:CUV#[]4CK8(/7,,1^?]A[W@_;UOKF''Y' M^V]^T]>ZY`@_0^]9'7NN_>ZGKW7C8_U'^Q_XT/>P1UHBO7=S_P`C]VKU4H/+ MKNY_-O?J]5T?/KVH?ZWO?5:=P>O9'7=_>NO:CUZ_^%_>QU[5U MW?\`U_>Z_/K=?EUZ_O53Z]>J.O7]^J?7KU1UZ_OU3Z]>J.O7]^J>O5'7K^_5 M/7JCKU_?JGUZ]4=>O[W7Y]>J.CR_R[-A]'=D?)2/;7R+I^L*CJP=,?([-S_Z M6^X(ND-K_P"D#;O0O8F;Z4I8=[2]B=9#^*YGNNAV]CXZ+^(NM7%5RJ\)B#RQ M4M@@GJUBB^/W\MSM+JO8-17[9^%'1N]-Z?'+XM=K;DR&T_G=N?$ M5>S.X-P?/:CZG[MZK:F[%^1/R*JMJX:#X6U7]\\K2UFUMR[FP^0#U-'$RPMA M7;JP)XD5]/E_GZW48X?ZCTIMZ_'7^6'L"GW!V10[6^'?9\NSO@SO#==9T]3_ M`#DI=L;=W3\M>O/F-@]G4.!PF.V?\ZNV>Q*Z;L+XK559G%I,9O'(TF4:!:C' MTV,JY&Q5/X,_"IX^GE3[/7KV./RZ2O8>T?A'VS\1_P"5_6;^[4^/D^Y=G[!^ M/75/RM*=YT,7OR$ZRW=O;#?*[8E1N/>W6O>.W>V^FL5MCM'+_'J>JRD>TX M-U5>XYWP@HA1Q1Y++[=KM5;MJQX^E/+K>D9H!T1;X\=7_':N^(6Z^WZY/C!V M)W7MKL;L?"=F=9?);OC>O3>X-H=2#K?:%3U#V'\>=F[`[2ZUW#W=N.NWYD-R MKFZ&F3JJ;%CJIFG6@@IU:A2?#G^5Z.^LU@,IG/AE!T=D MOYJ/32[`W#1_/S;%3EZS^6OO'9O?-7ON/=-8GR>JY=LXS;.?5](Z*WMG9_\M_/=1]+;@[;Z9^//2N2[9^>4'1G< M5?UC\O\`>7:V_P#XY_ ]#\8Z;)]S;5V!#\@][U>X:7L#/4'9*39[(X?-XB M"GK&JL;2R0QX:-]ZFJ:$\.MT'1D^N>EOY6N9[#K8M_\`0'PSZRPD7R5^#O3V M>Q>PMC=T]-QRTNR-DT6QQTW=`M\6>OV^$-1LR'X2;#S6`^*W\UGK_OGNZ+Y*[# MP?:N9[2JNN/G;TGU-M;?V(W+\B)=O5N-[1VWNK8V1PV77;0BR=3E8XL+DEQ, M$F/I=4)U^*.'<&X\?@\]WW45W4N!Z M'\U.C^/U9#VGFJC$ M5GR5ZI[=^.M)G-C[UZLVALVFJ<]0X'=$=1BL28,5C,DF2S-54';V6J6>K9-/ MLZ]CK!WS\>_Y?6W\)\JDZ+S7QER?45'\'YNT?BYVC'\P)8_D?O[N>L^2'2F1 MJ^N.X.E,E\@#BL=V!LOK.MW30T>UJ;:1BR&-P]'DTEKM5'ET MOOE1UO\`RX.M?C-\M\)\<=D_"/>W8$6WOC-F]C/F?DI7[M[AV-BLEO7YC[5[ M9S.Q=WT7ROK=F=N]@;9H]O\`7N0@H=HPE,OB,U1Y#/['QLQEQ.(T-516M/\` MBNM&F>B.?-KJ[XA=:_,7XWX/XQ3=(9OJ/+X[8=7O?:U'W''V3M3'YN+O+?.$ MR6+[A[=C[BWIL"MASFR,9C)Y\IBMQM+92:&O'KU,C MTZL8[]VU_+G[O^:O=_9.\8_B=DMN=A_S+ODCC?DSNW&?+/<.WALCX@YW*;8W M%UM\K/C0])WYN?$=V]F=ET>Y-W;DSM#BH-UT=)N7&X_"4NTL133BFJ:!B`!\ MNK4&:]52_,;;'Q8Z^^-GPSPW1VR.I\[V/V1T_C^R^YN[-N=\Y'?':&+WK0]G M]^;>EZLWYTQA^W=X[.ZEJLWU=5;%SM7!58:CR$-9"*>FEC(R<4FJDDYZWU8% MANE/Y3N,[PGQ&]EZ"/QDHOD+\*\)T3VC@ODWO7-=G]Y=/;U[5Z^POR,K/DWL M7!]U5V8Z7H\7T5E-Q[BR==#M[8,NW-SXVFQ\+3PS&!M=WY]>Z;,=\7/@/M[L M3H#&;OC^'^XOL?@I\Z]T]M[5P?SRVBVP]U?)_J?>GR$Q_P`6<9GNSL#\DZ_' M[?WGV9@Z7KXC'XO,TN)ROWL]12T8IHJKP>J?Y]>Z*]\$.O/A-WIG_E3E._MN M=*]/8O+;OVHG3-/OGOO)8'8_16WMWR=PYK-08O;6X?D-U5V]VWMC9])@L+C? MX]0Y3L'<&%`IFEVKN>HRH-/XU%*=>Z/C\@>NOA7W_L[X]-O[?/Q1PO8/6>VO MY)G2&4[)V[\S-M46=WIUGG/BW3]5_+/:W85!ANP>X]N;8POQWWOLK`PU6XMO M['%;@DKJJHR`R--'>'617CY]>Z9-V_'C^6IL',[K[(I-I?#KM+!;8_ESP]AI MU%#\WJ7:.`S_`,W-E_,=MB;CV+A\\Q3Y(Z:O M%_:R5$>/@]D^O'KW0:8CI_\`E?5$WPKV[3=?]9Y?;.\MG;>WCVOWK6_/O:F' MWCN_=-7\4=][J[/ZP[+^,6Y]U]=-;)ZQ[(WIG^K.R.B=[]2[I[R^0>V>L,5TWV)6[OJ<#L M?K;?_P#!]N9/*[?W-D\SV#MS9FZ<+E:>3:U=G*NKJL[04LU0M35>-ZB38_GU M[HH_O?7NO>_=>ZZO[WU4GKHDDW/OW52:]=>_=>Z][]U[KE].?>B>K8`KUQ]U MZUU[WKK77O?NO=>]^Z]U[W[KW7![\?Z_^\_CW8>?6_,=<2;^]]6IU[W[K?7O M?NO=?__3TD?:CK778-O]C[T<]:(_;US!!^GO7#JG7?O77NAJ^/F7K\+VEAJF MBS.?P<38S&OKZ?$Y^H@PB2XZ.6MDBH*ZIAIXFE MIX)*F.%?91OL23;;,KQ(YU)0.H85+JN`64%LD*"R@DT9@I/4T>P&[W^S>Z&S MW-EO%_91&VO/&>TG:WGSY) M;IP6\MW[:W#M_.Y_<%'7;(H6DJ]R9C-YS(4\R[@W,$H&KLSA\'&KTM%X140T M4+T,%89D2:H=9)I&>7[::TM+B">%$=9CA%50>U,T5FXFM"QU%:$A10`[^\=S M/L?./-W+?,&P;Y?[A9S[)$3)>7%SV`*1^&)8[:-K:.X,R)- M.ZR3/-Z:V)N+-86FS6.[@J^M:;([RFP.,HL32=AY+(UF;H,/0P5.3EI]DXRK MIL:B8O>?VL-1530^5)ZF,,L8DO3=KV"&9H9-J%PRQ:B6,0`4L:#]0@G,>H@` MTHIXTZ6>SO(O,.\[+;;UMWN[+RW;W&\-:PQP)NTTTES%;QJ\S+ML,B0@0;AX M$M9;B,,J"2I;;^Q"#UCC7UZ];W>O7B/,<.NO?NM=>]^Z]UV/?NM@TZ[ MO[UU8&O7?OW6^O>_=>ZR!Q8`_P"]<>_=>ZR>_=>Z][]U[KWOW7NO>_=>Z]S[ MW7'6L]=\ZGK8SUR#$?GW[!^WK?7( M/_7_`'C_`)'[]I].O=<@P/Y_V_O5.O=<[D?D_P"W]^J>O==>_:CU[KQL?Q[W MJZU2O7N/>]76M(].N_\`8_[#GWNOSZ]I'IUZ[?UO[W7JI3KUS_A_O/OU>M:. MO7/^'^\^_5Z]HZ]<_P"'^\^_5Z]HZ[NWTMS_`$L??J]>T=>NW]!_O/OU>O:/ MGUU<_P"'^\^_5Z]HZ]<_X?[S[]7KVCKUR3];?[?WZO6PG7C_`*]_]O\`\:]Z MU?/JVD>G77'O6KK=!U[WK5U[KWO6H];ZZ)L+GWKCU[K@7_I]/=M/KUJM>NM9 M_P`/]]_L??J#K?7"_P#C_M_?B?3K7#KJ_OU3UJHZ$'LKM7?7;N9P^=W]F*?+ M5VWMF;.Z]P$5!@]O;8Q&$V;L+`46V=KX/$[?VKBL)@,=3T>,H%:=X:9)J^ME MGK:IYZRIJ)Y=4ZT3T'GOW6NN['^GOW6Z'KB6`O\`[[\_[?WK5U;3Z\.N!8G_ M`%OZ>Z5)ZMCRZX^_?,]>Z][]CR'7NO>]=>Z][]U[KWOW7NO>_=>ZXLUN/S;W M[KW6(FYO[]U[KKW[KW7O?NO=<2?>^J$UZZ]^ZUU[W[KW7?OW7@.NSQ[T3U;@ M.N/NO6NO>]=:Z][]U[KWOW7NNO?NO=<=0/T_WGZ>[4ZV,]^K4Z][]UOKW MOW7NO>_=>Z__U-)'VHZUU[W[KW7AP;VO[]QZK2GEUD]UZKT.7QS>./MG!.M# MN:NR4>.W/-@QM#,1X?.TN9I=M9:KI:VA+X;.G*5%/'!)XJ%8'^ZG,:-'41ZZ M6T5-5-&6;ON[O''[K;&ZV.YS[BMO M>M;?07`M[E+A+.=TDCK;W/C,H5M%L(F\>4HC1W":[6=_^3^0SU=OG`Q;AI=R MPUF+V=38M*K=N]=M[\SF12GW-NF2KFK,QM2&GPM-+C\K/4X]Z2-%>GDHV$@# MEA[9Y<2!+*8P-&4:4FB1O&HJB4HKU8U6C:CQ#8QT??>:O]]O>=]BBY@M=R2\ MMMG2$/?[C9[G$^!::DJTCD:R M)*Z;=K);AHQ=7]DLH0C]6)&/>QT:0S]O#37-64D<2`)O9WGF?ENUW&3E7V\Y MYN-IFNXI-.U;Q=V\5;.UB-X9VM;`B=@7-PT9\,0P3I'(U$25RD>Q1UB;UZY] M[J>MU/7=N+^[#RZ]3%:]=>]]:Z][]U[KOW[KW78/OW5@?7KOWKJW7O?NO==@ MD?3W[KW64,#]>/\`8^_=>ZY>_=>Z][]U[KKGW[K7Y]=^_=>Z][]UOKWO?6NO M>]=;^?7(.>/>]1ZT0#Q&>N>H'^H]W!KUK3\^N_K]/>^JTZ][]UKKOW[KU>O7 M]^IU;5CY]=W][J1UZHZ[N/Z\_P"M[]7UZW4>O7+6?Z_[U[UCTZWUWK/^'O=! MZ]:ZY:Q_3_B?^*>]4]#UOKVL?X^]Z3UJO#KO4O\`7_>#[U0];Z]J']??L]>Z M[N/ZC_;^_9^?7NO7']1_M_?L_/KW7KC^H_V_OV?GU[KUQ_4?[?W[/SZ]U[4/ MZC_;^_9^?7NNM0_K_P`3_O7OU#U[KHN!_4^_:3UHFG76L?T][IZGKP->NB_] M!;WZ@]>M]=:S_7_>O?L>G7NNB;_4^_5'D.M?GUU?WZIZ]4==7]ZZUJZZN??N MM5/77OW6NO>_=>ZZN/Z_[;WXFG5@M>NBX_`/^\?\;]TU>G5J#TZX%B?J?=3G MK=3Y==>_=>Z][]U[KWOW6NO>_=;Z][]]G7NO>_=>ZZN!]3;W[KW6-G-^#Q_L M/?NO=]^Z]UU?W[K1-.NO>^J$UZZ]^Z]U[W[KW7=O?NM@5Z]?^GNI/ M6Z^G77NO5>O>_=>Z][]U[KWOW7NO>_=>ZX%A]/K_`+U[L!UL9ZX>]]6`\^N_ M?NM]>]^Z]U[W[KW7O?NO=?_5TD?:CK77O?NO=>]^Z]UX&QO_`(>_'(ZJ1G'0 MV]&9'%/OK;N"SJ[.7MDWU-N3:7NI9_%N+7;IF\>*QNUMH"^Y>';F">=XT>">X@A> M3PG\:WE2.XC'#Y4;'H*#!;)W=35.,KIH\1@<$V6VKBMHX+9.0I\MD>P\K1XG M%X?9\=7B:7/[5QN)IADGAR61AE&1@\;)$L;SDW+5X[S7EJRLHULVEV=I`5$0 M+%I*,59;2UMC/8P6%MMTJSS;M/' M!#;[>'@2ZL88(1>-'>7<9(=EY5O=FGYDWC:[]=\ANG M2';6O?'M?`C<0V82PN2M[-<16DFB\FBL)4AMVDCE*AD)C[%O6&_7O?NO='0_ MEY_#Z3Y[_,7I3XEQ]J;8Z6/;^YWI\=@#E\`VY]S MYQ<+]AB<8M=1FOR53#"9XETNZGZ1 MW;B\)+OG;$-1C\!NF#([=P.ZXZ2OQE+F*ZKV]GL93YQ<;F\;'D)Y<7EJ:JI5 MJ9&A\ILIJ.O$9^?6P9U!\/?@7W;\?,K\@M@?R_\`;V[*7YNJ?EK\2LW!_LS]/GO-E]_5VV^Q]OO!*<]#L=Z_P``R(6- M4J2:TU>?6Z?+JM?LC^7'1=S;FW?G>I-U_"3XB]8]+9;%?%7+9KNWY09CKO;O M?_RSZ/8D%;2T>_-UPQ4]2N1PNV8\/D<,\>EYJN;W:OV M]:IT2/XJ?!+N_P"86W.YMT]4OM:EQ/2.RMR[SW')N>IW+"V7&UNNNP>U*_`X M9MM;6W/!C*Z79G6&7DCR.=DPVW$R'V.-FR<62RV)I*W9(%.M=#?F_P"5GV7@ M]H9C=+_(/XSY"NVSU=\5.\MU;,QM?WY+N;;G2OS#S73VW^I^S*VKJ?C_`$FS M*[$TN4[RP"9?&T&7K-Q4B2S20XZICBU-K4/3K8QT+_8?\J3>6UJKY0]5]9=A M?'3O23XX_+N?I+L+O3%/\D]C;JZRH>MNH/EOVAVG#N;9N[]BXGKV38VV=D_' M'-9?=-1BDW1E:7+82AHMN5V8IJ^1JG5>'5_7H->FOY=>Y>^=LXS9W3G8WQ4[ M-R&_OF-\7OC9M3O*@W%\G<#+B-X]]=/=V[YPFTC@MT]3[9Q'^CZJJ=AU$&XJ MZLVY)N3%9[#4D=$'Q=74SR[)IU[IUZQ_D]=^]R=F]8]>]9]P?'7>>$[LV1L/ M?/3_`&MMK+=U;@V)V!1=@[U[$ZQH*&CP6#Z.R7<>U_[J]G]4YW;VZ,KN':F' MVWM+(4U.V8R5%29'&5-9[5U[J?M_^4AO;=O7/1>^,!\H/C+BJ_L_IWM/O7L? M"]G9GL/J[!=`]:]5=[[G^..:W7OKLO<6P'Z]RN(F[CPM'M=$Q]=)DYMP9:G2 MEHJK%?[F&UJ^77N@_=E;HW)WK MT5G=M]0=(9/NVJ?:VYNF-L;PS.^2PZ4U?%]A5YBDCPM7NN`: M=>Z,]\K/@QB,K\5/C!WGT;F>C=76?P0Z_P!^]W;2VE1=FX;L#M3^^W\P7Y%? M''"_(7&_WBZWQV`W'C]P9_)[5PK0Y3,8[=$5,L(7#0T-&PI]`Y(^?7NF.O\` MY-7:>PW[%'?'R"Z.Z5@V-\1\W\M:+*97#=[;KQ.7P&VOD7B_C%N#:U6-J]/U MV=IY,3V9D%@CS6,H,W@\U2U>/R.#J,MA:N3*TOM7RZ]T7+XJ?$+;G<'2_:OR M9W/W3UCM'"]`=U?'7K[(=0[VVWVWDLKVS6=TR]AY3"[=Q>Z.G\S/Y5N]=P?.'NND^.VZ?CDO2^_ M/FA_,%V!AFP6>W+UYUW\5,7\4,K7]L=E[/[HJ-Z=?;-P>Q@<"O7NB6=:_#S,K\N=^_&REW3\6^_LULCIWOC?M#F] MN=O[QW?T'V!3[$^,6]>ZI0[6^/F_P##5V:^(0W3M':^2[LESFQ] MO?-GK#,]R?'WJ#U M[HV]?_*>K\/N[L?,S39[`0[VW'M\9:FQ.(BKJS*U.0S&+H-:O\G7ND;\*?Y>]/GC\,NA=V];UD6_\ZM12?(C+-NK!XS<-?/LO#=1 M[SIS^G>E-F_'7#Y[M'?>?[5D[+CP6#ZV'<>TNI1D,3BNI^L>U-TY./";E[%P\ M<]/38UI$II]<:OH91;72E>M$`^71FX_Y-GR&3M+H;JW(]N_&^AF^27?-3\?^ MIMZ0;H[0SVQ-R9^LZ=Z*[YV!O*ES.V^HLO53]>]M]9_(O;%;@:^*FDFAFJ)Z M?+P8J:FE5=^(/3K6GY]#;F?@?M'N38'\OK=G4^8^.>W-Z8[^7LOR+[=^/N9D M[*VUVAW[MKK'Y7?*UNX.T<;EJ38M3UON?)XKJ?9:&NHZW>>*W#/BL%+'C*)X M*2!%]JRU?7KVGAU@^8G\O'(;@[-^9F^.I]N_'KJOHKJO^8;_`#']K;E[#_B' M<>/K.D^L.@^RNGMMXC8^ZNNMJ[4W%M6AZQVW4]U;7IMM/L[!YG-U-=NAZ:N: M*CH8TI?!L#C6@ZT1QZK1Z^^)^X>T>Q^Z-F;([1ZCS.R^@^O]T]L=C=[QUW8$ M74=!UEM;+[:VT^],=%+UTO:V4H>'Q5!1Q;6_BLM=DH5DI(HQ+)%8F@& M.J]6,[*^"6+Z&^&'RD[ZW[VY\8:C.[GP7Q.QG1'8&YMB]B]J[$W/T/\`*R+Y M.[/8GQPZHH]U[HP/QXWOVCF>B M]NGLCR8\'C\K86H- M3ULU]>B\Q_RQ-[[$H>U<)F.S?B!V5O\`QGQ?ZT[QS&S(][_(V+>W0^Q^WMX? M$"LV5V?-2X3JW:^T,GNNOP'R7Q5"F(KZ[,4?V%3EZD44M518V27>KY'KV>FK M>?\`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`#K+LKOG MK+%4^]L;VOO>I[`^??R$^/&,[L>=MF5FPMT-6[DR^UMOU,?3='OS._%WN+Y3[+VM'6]L M5>9[#P/0N5[!Q79W6FP:&EZBEJ-S=F8W_1;FZW&R0K_=3>WBN/[(V?N#;6/@J(L?5YW-;?K(<7#6(]%+6>#@D M"AZ]3H`NLO@IW=VO\6.Z?E[MM]K4_5W1U+4U^XZ3*U.Y4W'FL=C-T]8[/S]9 M@GQNULGM"@;#Y?M_"F.FSF7PU;FH?X@^&AR7\'RXH=E@"!Y]>`)%>C1Q_P`F M[Y!9#=_4>Q=M=Q_&G=^Y>T>T/C/U%FL=@-T=KK/TONSYA=*Q]^_'*7MRGS?3 M6&JZ3;W9/7\=88,CM^/<-+1Y#'5-)5M3S"%9JZQZ'K>GH2>E/@KMO8WQW^7' M:&ZMY?&CY!];[[^#V^MW=)]\;"/:&:QW5';W4/S&^$W7W9V(J\-V!UIU_P!@ M;5WCM+9O?-,]?-#MJM%9B,U`V*JZF*>='T7R./'JP4#I.[W_`)0'R,W3VU\@ M,3@ZKXB=+9+:WR8[6^.G4W2-=\A\GMJ?O#M7K:MVDNXNJ/B2O>-5+OON"HP1 M[%V_14C9BNI\ADJW*TU*AEK7:G36OK=/0=!_\EOCWUOT]_+FZ'RN+S'2W8?: M\/SK^6W5W8':75&*[(BKY*#8_3_Q:RV.ZVW5G>SMB["R&9J-F9S=62J*=L-3 M5.WC!DDDIZF:IDJR-5)/Y=>ZP=M_RM$HNM,C\O\`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`JMS93[/["DEPB1Y.26EGEEGJG;0-2>O=9 MMO\`\H3Y";I[2S_1F%[1^/D_Z*I\B/B+N/XX9C MI*/BQF`[8WWTIOFDW#C-Y=6;+[+H\IU_ MV!UMEZ;(Q4^WJM:B&!9L<]='+&6V#7KW5PV(_E1;1QVW_G=$\/W5\8-]?(K MKOYO?!/H;K+OO.;5[WVHL'87:]+\QMJY3XZ/6U?5.X*[;&X=Z;RZ^P<)J*.G MJ=H254D#U6XF@B#4FM7`^77NJJ]P_`'M/9GQGI_DOOSLWXX[`BR^'R&ZMH=# M;V[JV[MSY*]@;&Q7:F8Z9R.^MB=45\4N/E MCC^FNNOC'O;_`$%[_P#[W[XR6VNO.ZMRU7>=1'LO*86+`8?+348Q%=%]]645 M:OB2#\NM5Z,'TA\._C-G?YD5'M_OWHG871_QEZH^,?P^W9W[U7N?NK-]&XC% M]H_*#H#H6FW1%-V#\I^Y6R&$WSUOV/WEF]ZT^UJK/Q5%?B]A5&+BI99?,LOB M33!SU4<<]('I+^7]L2@K?D)\7:O8?3/>'\P_I'Y0]I]9Y3XZ=V]E=N].9;MO MI78^`PN-P^2^'.=V+OG8FQ=T]W9#=,.?KY<3N*MS)J\8,-/C<=6K]Y!6>)X' MRZ]3]O2ZQWQO^'6Z^W_Y2/QAJ_BIMW;X_F%_%3H[)]A]T=>=@_(>J[>V/W+V MYWQWET?1=G[5Q&\.Y=X]1MMK!S;#PV6S>&J]KRTT]&F12EFQWE@FI/5/<:\# MUZ@P.@V^)'\NCK_M'XJ_.*#IOAMG*3MK9N$W9D,M$FP?:' M=<6Q>E,MO;$[Y[EP??W7>3R&,Q&3PF&R\6$K-L5@J)(1*U_%J$>G6P./0'YC MJSXX_$O8WP&R'BH>_=:Z][]U[KWOW7NNB;]^Z]U[W[KW7O?NO=>]^Z]U_];21]J.M=>] M^Z]U[W[KW7O?NO="UT7FJ?;W:VTLS49S&;;^RFRAI*-!LQO'M8$2XN@(9)MP_QV:X_P!%>2X) M;1+%&A\)(^C3],=@;(V_M6GGW9V1NG'SQ[RQXJ-ZT>^.XQO)[EEM=OB9?"-(S'`S1C6_ M<"9!0R'O!"MG!%0PZRB]F^?N2=@Y6MY^:O<;=+>==XBU;C'N6_VL&XNMG9%; M:5(=KF,B;;"%LWB>>W`C"NCK#+;R"N[V/.N>O7O?NO=6*>"62&>&1) M89HG:.6*6-@\_=>ZZ=WD=I)&9W=F=W=BSN[$LS,S$E MF8FY)Y)]^Z]T:3IKYM?*OX]X7K_;G3'=N[^OL%U;W-7_`"%V'B<&V,^QP/?5@>ARZ'S_\P[:/ M2/8FV.JMF9_(](Y"CV7\@\S2]B=)]8]@XBBJNQ^R\3\9]C=Y=-UW=NQ]R97; MF]]U=H55/M>CW/L26FSDM;CW05-L7,]+;MZU0]*OX\]E?S)OC]O3L[X5]&T- M'0[VZ9W7\H-V]B=89KJSX\]HUW7>XMI]2Y_J_P"5N0I-U]E[0WG!@\?6]1;& MK,+N&+%Y-,?G*&BC@T5;FG#>-#D]>SPZ!?.?S$OEKN+%;UPN3WYLH4'872_3 MOQZW7_#.A/CU@JVMZ?\`C_7[=RG36T2ID^RI?%Z@ZU4]&$V_P#/7^9S5;2[=^6&TMUX/$[3A^2W6W87<7;&U_C_ M`/&#:<60^2VZ=B]L[=VIFMP'#=5XBLS^?WWL'+;TI=P0I!44.?H\SDUSL=3_ M`!6;[KU%X=;J>G#X;_S2^Q^J_D]U+OSY"Y_^*_'["_*GJ+Y3]J;%ZA^/OQWQ M>=K]X=)8S.XW9/\`HSPV-P?56*Z^IZ3&[@R%`F.PF5P.&AAS.0J&I9Y:B>.H MT5QCCUL-Z]`QM_\`F7_+OJ_>FX,SU1V_BJ/"_P`>ZPK-GTF1^._QTQ>V]M1= M!;QWEO/H[<.Q.FSL7=G6/1NY=G;DW]G,S$NTTIVI\KG\G(U75/65,\_J#S'5 MNF;`_P`RCYB[9CVQ3X?L+9$%%M+%]N;;QF,JOCY\N_^^G=P=C;BK,W#LW.0Y':N*R4WGQ^/I75"OJ#KW0.[+^5G>'7G=. M5[_V=N';&&['SF`W;M#+JO5?4U;UWD=D[YV/D.M-T[!JNELEL>LZ8EZ\RG7^ M3FP_\`.`_@T&/*PPTT:QQA?4\NO=&%V!_,Q^=NWSL?:76O8&W:&OP&TNM^H> MO:#:OQT^/3[DH=M]>]\0?(OJ_:FVJK']12;@:NV]\@O%N7&O#(U?_&=++(W" M>_4'7NA0^2GRH_F;]";_`,OU'\GMO4'4NZX>J>V>E*KKC>WQ$^-NTML9KIKL MKNV??W8&/P&UH.E*/86[MD9/O_8%1G,/GL9#64U!N*BJ:W"UL$[SROX`'AU[ MHDO4GR<[EZ/V?V!U_P!=YS;%-LWL_/\`6>Z]Y[?W9U?U7V70UVZ>G1_F=_-G*;G MH-Y3=L;>I-RT'>?;WR2.4PO2'0.WGRO&Y]STV!ZNQM'N_'=M; M,A7%[APF5CK,#EJ$>&IHI$)!]0>G7N@7V1\M>].N.YL]W_LG/[0P':.XMJ;P MV-69.FZ@Z-@@U>&NQ]3)35RU4#F,ZH.O=#SL'YS_S*^S8 M>]^UME9_;6\8NN\EW?\`)WN;>-7\>/BWDFV%5_*W%8#X]=_;QQE7N'JEI-IT M/>5'NN@QF>P^`%/2Y>ID%?)1O40/5Q>H.O=*WH7Y3_S;>W-D2YSH'`YSMK:G MQ)_V7/M.NW5MSXD="]CY3KS)_%NDAZU^..\,QNZNZ6SFZ-S;SZJVYNYJ+'S5 M55D/929#*]E?)GXS;HZFV M#34/072/:_6O^D/=?>W4'=-?F^P=@]E9C!]?X?:D3]4M1TT-#MW,B@GR25=+ M20OCX(Y?$5I3KW3!L'^9]\V^M*V#*;6[:P#9;&]M4G>6V,QNKI+H+L#,]?\` M9]#MC9FQZ/<'5>7W]U=N;)=34=/L;KG`8-<7MJ7%8@87"T5!]K]I310K[2.O M5Z1?^S\?*1,/LK!P;VV=0TO7.UJO86R:S&]'=#8O<&W>O,AOO.=DY+K6BW5C M^LZ;<[=9Y/=^Z,G-5;A6H_YM'SUH,KN/,4 MG;^TH*C>G9'PM]?(*@V[CNZ,CV+M=NGSMOL#%=BQ;/Q$N M1Q.9I*[#R5F)HJI:5:FE@ECU0>G7NBQ;4^4/>&R>R]\]M[:W?18_>/9F$W3M M;L&.39FQ.T=Y+"NX-EY_J_*;9K>LA/XX M.I,'MG'/UCX-E[-V:=U9AHL#AA082I;.Y1JFDF;)UYJ/=HR.O4'0N]\_+S^8 M#'B,[E._,UAAB_G/C:CY3++N'I3X\,^[FW55[FZ7RG>/6T&.ZZ-7TAO'>S]9 MY'$Y#,[87;6:S=+0B6IDJ*>6&67P"XIY=:(/2`F_F/\`RYJ-Z[[[#EWSU\=W M]F]1]<]$[[RH^.GQMC3<74_4M5L6KZ\V?58R/J),/!2[;DZQVXB5$%/%6SP8 M*@AGFEBI($3=!UZAX]&G^/'\V7MG$]B;YWE\ANP*L9;)9OOKO#K/L#K7XP?% M_<^5V%\N_D/!LS:O:?=VZ.LJW%=0[7[GNUMO;ZZM.TI/C3\:]D8R?J M#=_8>-[$K<=!U_MG8N9VIUSNG>-WEA.O,-M[;>W,U7[!ZXI>R)ML[/Q]5B=G;9W7W! MB]HT/;/8&VMFXNL>FP^/S^;R='BJ?3'21PHB!=@`<.O5Z+A[]UKKWOW7NO>_ M=>ZS1U%1%%/!%/-'#5*B5,,A=R;$^6<>"[]V3\>OAI@MI;XZMW'LC:^]=E=8[DI=R_'KJ*DS.[MK[?P% M!3[=S]$U=13_`'=-/(KUDM34/#/6-)2J#/6]+'HFW;/R5[[[!V-L[H[M7<.( MS&"Z:I,;L?;_`)NONLZ'L#'X+8T-;@]M[)W#VYA-I47:.^-H;%IIYJ;"XG,Y MO)8S#Q'30PPJ%M;`J1UZA\^C59[YM_S&/B)EMI=,Y[=&*ZHW/UGTO\?]J[5P MM7TC\&U/FWT%2'="];Y3<<==C]_;GQ>^*:HJ:YLU3Y><-5R+4 M++$M>T_ZORZM3Y]-,WRT_F'[WQW7_P`T<1N*#!8?X5]@0[0Z_P"V>M>I^B>H M\5U1OCOG-;][,7:M%A^N-B[-H\[2[QS5!N3*24$U!D,=3/65I>.$9&1:GW;D M>O6J=!;6=Y_-';7Q2V;LO<6*SK?%O=66[*PG4F^]_P#0>R=PTE/DLQ7O4=Q; M6Z)^16]NN,GOG:,.6R61E;31(K4<>K?:.E,OR?^ M>?4_Q9V5UCDZ7,[7^+W:?5_:?4G6F#W+%]Q3FEK%U#6":^?7NK+^MOY@.+[N_FK?`3* M]08OO+>_2&P=[_"$TO3&VNC>B-B]R=C]R_'CHO9'1-#+D#A>U*3%=K5F3K]L MU7\`S>]-X^7:>$W%6TE,M/20/'5UTG2:\>O=5B;B^=WRW%2=6= M-8S/8'N[(XG#8+-]J=69C&=>T>1Z1WSNC"[=H*7,Y#9DF!J,S!21)7-4*@'O M5!Z=>Z1G?GSL^2OR9V0G77;^Y.NLIM%>V-P=YOC]G?'OX[]2U=3VWN_;F+VK MO+?5=G>HNJMBY_(9G>N(P=#_`!LSU4D68JZ*GK*Q)ZN&*=?4`Z]U/E_F!?*J MIPM!MK([VV5FMN4?4_5W2-9M[&I*:MCII)(F]0=>ZP]B]F?,;X\?+[&=W]F9W<>RO MEUM3(=4]V8S<>X:+:>6S6WZC<^P=G]C]1Y:+;\E%EMGXZ@INN\_A9,=A6HEI M<10^"A-)3"G^VBW12*#AU[[>I&%_F"_*[;\>ZZ#&[\VA_=G>6V-I;0RO7E?T M=T+F.I<=A=@Y_=N[-C-LWI[,=8U_5O7F;V;NOL#/Y7%Y7`8C&92@R>>R55!4 M)45]7)-J@Z]U%Z2[$^6/2'2'=?;_`%3!0T/1_8F]>JNC.Y-W;GZ]ZG[#Q&=W MM'E\I\@NL]EE>SML[JRL%-"?GU[H3JC^: M_P#/)]VU>_Z3N3;VW]]Y/?-#V+F=Z[/Z(^.^R-V[AW1CN\JSY,4QW-N/9_4^ M$S&YMO-WU72;IEPM?-4X6HRI626D<(BK[2.O=!?6_/[Y456V<%M&DWUM/;F' MV?ON7L;KV?8_2G1G7^X>J-QU&\J3L2JI.F=W['ZVV]NWIG9E7OVBBS,VV]K5 MN(VY-DU^Y>A:4ECZ@Z]TU?('YP_(WY0;5Q6RNY,]USEMN87L/=G:^.H]G?'S MX\]1U4/8N_L5A,/O_=DF8ZAZLV+FJO)[_IMLXV7/&:HDCS5;CJ6KK5GJJ>&9 M/``=>Z-#MOY0_P`TF.#J'Y";2GSV8R'8._OP2V]M M+?F7W1V'44/6^6WSW12_'S%9?$[BGR&\8\OCZ2LHAE6D>LQH.'7NB0= MR?)?N3O["=:[<[2W#@EDAK-Y[7R.YLE6FM=#+7Y M#(5-76&HJ9Y96]I'6B?V]`AN_P"9?R(W[U..DMW;OVYFNNZ?.;NSF'HI^J.H M8=R[3_O[O:J[(WGMO8G8=)L.G[$Z_P"O-R;\KI\M5[7PF5Q^VY:Z>60T.J1] M6Z#JE3TALK\@>T^]:/"8_= M.>J^U,%L[&]J;@FS5#M?%0RQ9+-5=/XL1CU6-5H:00[IFO7NC*]O]^?.CLKH M',=H]UU\.\NG?DQW1MASTI,U_,^^>_<&^L7EJO?NRL]VM MEMPC^Z.\-O?&3XOX+M7#;PW%MC:W6L62ZXWYM;IC$[XV+NW(X#:N(HXZ[!5U M!7^>CAG245*B;WZ@'6ZGJ/VS\VOGCU=N0=!]B;CV=U_V+\6-M;G^(N/J]M]$ M?&;;';W3NVMCY[=NW-V=8[4[UZ\ZRHNRM5/0Z_&+^8 M;3['W?U)A_E9T]L[Y(]']5=@[KWSU[@TPF'VCO?X[9KL+,_WAW-N3X\0X.'$ M=9QXW%;N\>?HNO\`=>$SO6LN1@=!AZ0UE34GU.O5Z)+WUN/;F\>Z>T=X[3WY MV?VA@MX;WW#NVG[$[JP.'VSVSO*KW-D)LYEMP=AX?`;W['P\.Z\CF*^=ZR:# M-5RU^M]<";G@\?GWL=;`ZXCWOK8%.N_? MNM]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_]?21]J.M=>]^Z]U[W[KW7O?NO=" M;TY@\?N/LG;&(R^V:G>&*J)LC/DMOTN7I<#)5T&/P^1R-74/E:W+[?I:2EQ< M%(U7/KKZ)7A@9//%J\BEV[326^WW,L5P(I0!1BI:A+``:0K$EB=([6H2#I/# MJ2O:#9-OYB]QN6MIW7EN3=]KD>5IK5)TMC)%%;RRR.9Y)[5$2%4,\FJZMPT< M;)X\6K6KYWGL;"[`W'M[#8*CJJ>GJ-H4&0J:RJRVWLF](RW&NK0!F MF:5)U[W\C[-R'S%L&S['9RQV\FT12O(\]K-]1+X]S$\ZK9WNXPVZL8@@@^LF M8&,R-H\01H9WXBYI\+M:&;(8S;M3A).R9WDK]V;RV%@*.C-%AMNUN5.#Q&Z- MH;DW!F*V+'1I-7#%S4DY@CA"L9`I4-\U0B:Y(CDD$WTXPD'V7EF*:_VS;I-D;F-B9;[<-KM8X_#M[22_=>ZV3JS9_\`))JOA-4_)ZDQ/3.(^0\%/\?.SJ?X;5/9?RR=U]W?RZOBC+OS:,_RNZ\^^E[_P/\W[;?9NZ=M';79O M=F&.@ZV1V)UECOY]GS.[/K M.PND6[ M#PV/BEI\]1S0R9'2T]++'(\-J]H'V=>Q7H9$ZN_E$/TS@^QJ'H'H/>W?LV%P M=+\H_CK2?S/Y.ANN/CNPVW7RT^_?BEO[?N?[CROR/AW-!50Y#-8&DSG8N:VY MF*5,;34->LDL8]W>N/LZUCTZ*!_+>W1U!1?$?Y<[$[6VQ\;>T8=[_*'X`YI^ MF_D+\BT^/,.Y^O=D8GY?8KL_>6UL[B.[>E-Y2Y38,78V),RMR_&O/;7V1U=W9UENSYK87&;Y[G^0_S!CV!O M7JOJJF^=V2V91;1["^%<-+CLIOGK;(?"N/$;JFW?/446#7*5=:QTGNG]J_RH.Q:_M#'?)/K7XM?'C?\`LGY!;UZ2&/ZM[][KWMUMO/;O MR1H*';?0?>>QMTX3Y6]F;1DV9\/]Z;=S&X-Z5N+R64P%=M_(T=(\+320,OCJ M\CUL4Z#.797\KVOZ,^0.[ML]3=5;PW?M?L7L?J$-_L[6=Z)W)UWU]U_TYL## M]8?*WHSJCM/-[WW#\IJ[O;MP;ISN3VU2/4MB/!08A,=CZ*H&6'NZO'K=1T// M:72G\K#:Z_)INLNEOBEG\)T[T#O'?/QEWSNG^:$^_)?ECE,?W'T#1=>U^\NF M]I]A]+[[ZO[+W!T[D-ZUV9V6N0QV8AK(VI:?&4\E+25E;KNQG^76^B%]KXS8 M/QP_FE=,[J^&FZ?C5L?";6RGQ`[NZRR,G=>.[:^-^PNY%ZIZH["W[M+<_9S= MB]DUV/V1M;Y$09S#U'\9W%/6XR@A5ZBN\2I6MOB,]>Z6'\]S'=(4WST[#RG3 MV]*S,YG<>Y^[L[W)U_'V5B>W-J=1]JY+Y/\`>E9F<+L7>.WXXL'BL!V/CJBE MWU-M6!JJ;:&4W558NKJIJZ"I2+R\.O=4R!B./Q[MU[K(&!X!_P![]^Z]T:SX M5=?]7]H?(S9VS>X&Y-FX3/[RGS& MTJ2GAS^[\30T<5!/N/:,69GG3''<6!-4,M2:/#KW5_>"^*W\I.D[MKJ3(Q?# M/.=0[_\`E)\!=LT-;F_G(V!;J[X[=R?$;<6?^8>Z=NXW;GS5S.4Q%9T]\DJ2 MDI*/^\F8W<^"J)5IJN?,T7KFK5OGU[H!]A]=?&_I?XD?*S']9[Y^(&2J.X/Y M5F#I,OV1DOEKL:+Y&9[Y0XKY$_&GL'O?XXP=,Y3OVCP9P6V'V'F9ML5&)V3- M4;NQV$H9\1F]5WC\"<=FM]X7:&6RD^;[#Z_SM%LC;67QM/CL#DY M\GG=G28&AKJ&OR_AJ_-Q%!GKW6M=[MU[KWOW7NO>_=>ZOM^)O0/PNB^'/Q7[ MI^2G3'3N4V?VQWS\PNK_`)&=U;N^2F\.K^Y>NNM^L]G?'S+;%WE\=.I:;O+: MN-[9[&VA6]D9>;^'4FR]W4E9(*&CR--":RGJ#4DU/KU[HQM3T!_*:_TV;0V% MMGJ7XU9'I&AVIW7N?:?R(W5_-:VZ*_Y`8+;/Q7[0S75AV?!58NOR&W)H*C)5E#2XS*4*39#%ZJ?]0Z]U6E_+^V?\/.\OE]VBGR3 MVMU#U+TED-N;DW%LG:F[>[,]M/JCK'+9#MOKS&XG&-N+4CFHZ/>K[JDQL$V8I(=P5F.7!9:S5`QU[JQJ/KWX6?(/XP?$K9/;N^OB?%O M#J;X2?&3$83M&K^8V$ZUW[@MP9_^:9V1'W!T]N/`'?FZ\5M_$8KXI=N97>E9 M]UUIEMX8EA#/'',:=\1/7()^WKW2=W1\7_Y:V+[VZ>FQO^RHYW:#_!+YD[F[ M.Z^H?F?MO:?764^6W3DG<.-Z#Q!W9%\U.YLOM7)=K3Q['EHZ6+?E3CL]'6SU M=-0T,<61Q^-WW9X\>O=`!\C>EO@UV9UE\>L'\5MA_&KIG>G=TG7V[+`[;WAN&NI),W0XF@G M7(YJJRE0(=AF''_!U[JCGW;4>M=>][U'KW7KV]ZJ>M]=ZC[]7UZ]UZ_OU>O5 M/75_?JGKW7O>]1ZUU[W[4>O='\_E<=T=._'GY[_'+N'OF1:'K39VY=QO7[E? M!R;FCZ]W1G-@[MVUUMVQ+@((JBKRT/4'969Q&Z'AIXIZIUQ!\$4LNB-JL201 MUOJQS^7KT_UST3WEL+MWY`?+WJ7"]D8+^8-\&LW32[7^;_QJWIU3W;U+1?(/ M%=J=L=L]F)0;CS6XMKT?3M'UPF9:IW+7X>NR53N2GA6GIJVAJZ:NT22.&*=> MZ"/.]2_`>LZGWIN3-;EZGRVXNRJ+H3J/K3 MIG"=B2[9[!Z,WWM7';.,FX:';FXJ:JH=PY;(G-8\T*TU%K/7NCA=\[<_E_\` MR5[5ZQJNP,_\9L;OG*;8^%>W-F]J8OY81T>![7V/L#^5Q'A^V=K_`"4HX>U< MOM'I:OZF^275&T]K8.(MUE4[JDRU3CJG*4,1EW5BM"H'^KUZ]T#_`,QMH?$S MJ;XG_.':GQEW]T)1;0[7W;_*5[3VMUCLCY#]=[^SB;KV_P!(?)ZC^2N+VKM! MN_\`OCLB/&]<]M]C0T]90S;CW2^+BKHRF4KZ)%K6V*U%?GU[IK^)NX_C[DOY M:U7\+/E'W!U/LCK7Y![E^27RIV#ONBWYU7O7L7X[_)/I#8W5R=3Q^*H'7NC%[@IOB]\H>OOY M>>[^]=^?$N3;G3?PS[KQ?^@'/?*SJVAK-C4N-^;V7JNGNK-SX/8_?72&ZMR; MKQ/Q5WU3U:8FOWKU[EZR3'R5DE;792CJ-O9'V<_;U[KW4W6?\OSXQ_)3H_=. MQO\`91\[DL!_/&S&#V7W=D/G;M;-UO3_`,$>HN\/CMVGTMW1-@\'\ATV-7XC M.;*Q6\,3-E]PXRH#Q):5!DS1,VLD'[.O=!#+T-_+AJN_,Q7K_LLW=G7D'QZW MQN_J+'9WYLX[XZ;A^2?RAHNU-A8_M'8WRGWQE.Z-W;)^..0V5MW([LK]@_P& MGPNQM[4%#C5I]T9F662JFWF@X]>Z*'_,/_V5&3XZ?$&J^,?2GQCZYJJB3OZB M[3K^N?D/4]T][[>W-@/DEW=B]H]?]B22]B4%9N_:$W4(VSE^= M--M7>VT.V=R]J?$[:G\Q'$UNU)/D]CMX[$CP6SMR=BY2II=U8R*6D%`)L&PI M(`IU4^7SZ]T&.(^.'\O_`'[UYLG=?\-^%?6O=>-I_G7M3;_3 MW5.X/C[COC#/W9N[=WRQS^7ZKH.PMKYCL_(4F>I-S;+VIN"OV[BH(Y::"O@> MMW4U\^O=&B^1NVOY=F_=X=D=Y;]V7\8?DKV#E=I?$?;62Z[V_P#S0.O?CY@> MDNENO?Y?GQMZXJ\_U#FZ+<7;3]S;QVUWIM7>>#RFWI*K=F[*.GVQB:B+$9.F MS"557H5&.O=4V_S#\1\7>J>V>HMA?'+JKHVJVKM+JWI'>N]=^==_(C=/>^+[ MIWEO+H[I;-=I;/WQ6;>[FWAA]B1[#[EQV[<9]C@JC!Y/QU\S-*8%QDD%A6F> MO=7K;G_X;YS/8_R$Z,GV;_+RQGQ+[-_FU_#&CPNV=E?,[#;1VS2_%5^N?E+M M/>?R]PE5MKY:"NP>\=A;2[2QC5./22EVSC,C41P5NV4J(JNE%,XXUIU[JFSN M'JSX/=>_`O&U.P-M["[2^161RVZL=O#O`_,[;6-["ZQ[$VK\DMS;7INN<)\/ M\#0[@A[9ZKW=\>,9BLWC]]8^L3#S5>3J9CDH9J2'"U5A6ORZ]T:7X_;%^!W: M'6'\N;'=B]4?!VEQO^RT?-[,_)/=V=^5_P#H0[P'Y][;Z[[EZ^P&S>R_D+!N#-ML M[X;9/(YW`;=K>OMZ9K<@QT67H=Y5E142;=IO=U:=>Z,/N+K;XI[@Z\^-71>\ MLO\``_9_6O4^[_YRLU7A^K/Y@NQLW0T;]C?%/J/+_#GM#^]%3\MMT[LK\YVQ MV1U93X>?'SRPXEGBDH,GA*&6I\;ZSDT].M5'23H_A[_+:[.W_M/KK![6Z!QF M)P/?7\K6&KSG0/S&;?\`VKVIU%W)\=LIGOYB*Y;;VX/D/VGA:+;'Q^[8QL=3 M6Y3#X/$3;9H!6/65IH(FGI=U/^'K7'HJ7S'^+O2/6_>G\N>@INDOCKL_X]]F M9C#;%[<[KZ&^6M+N[HCY"[OVWW3B:/NBHV_W-D_D5\G<=TGMCK_JO>FV:&MJ M\>O,+G.XJO<&W)/[P8O>.? M-#-/2^*KQE573X2@]GK>.G+;O5W\OK'_`!1V[O1.F_@[OKO*#X2]2=TI@]X_ M-G?^U\ONGY-9GYT9_KO>_36[-HXSYJ[-EV[2T7P_R5#N2LQ,,.)S%-4T<=0E M5!_EE)-ZIKYTKUK'1F& M/;O3WQ8WMT+\6<9UCW=\?X]@]\8JO[FW3$-BY"DQ5'D<#OFFS%9AFH*FCCK* M@3>]9X^=.MBG\^B(9/J7X"X7K+'Y_8FY>IJ7-8_:7P,S_179O^G@?Z9NQ._= MX9GKO_9N]B_(#I_.]BU6W>GNNNM*G(;P>BRTNW=OX^C@V[AR,WE$R3SU6JGK M9X=!+_-QH>H\G\C.XNT^M5?V+U=\F=H=V3;_`-BY?OF/ M]^Z]U[W[KW7$FPO[V!7KW7$D&WO8J.MBAZZ][ZOU[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7_T-)'VHZUU[W[KW7O?NO=>]^Z]T8'H?LO![*R M==C=T#;N.P=?09^5-QU756U.P]P4.4J]OU>+I:!)LTU+7Q;>KVE`JZ:.5TF7 M5"!`M1-4QD6][=->1I);>(TRLO8)GB4@,"3VU&H?A)&./=I"F?/8SW(V7DS< M[W;N9AM]OLL\%TPNWV2QW6ZCFDM7A2(-<%)5M)=0$\2NRR+JB`A%Q-<1L?=N MZMJ;JW#@)=H3TM5C\1M2GQ%75X_8&"ZSQU3DOX]N#+324&U,!65]+30I396) M&EDE::69')].CV_L]M17)[='1@OB_ MALQD]H-D,7-MZ>KVYOO)Y?%/NK;U=D(-@I!M7'U>X>R=JF#+44>ZMSXIL?BP M<2E+720I#%.1'K0N10>%9UL5@N7C6..< MB/6AQD1U@]GKG[KU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z[O_4>[ M5ZM4>8Z[(]VZ\1YCKC[]U7KWOW7NO>_=>Z[]^Z]PZ[O[]3JVKUZ[]ZZMU[W[ MKW7O?NO=>^G(]^Z]UD#_`-1_MO?NO=<@P/Y_V!]^Z]UR]^Z]UU8'ZCW[KW7O M?NO==^_=>Z&?P.O*#.X'=?9, M6&I]]9%NPL=M6D['S$.YH-MXQ*FEK\M5493&42K$HI*81>H./7N@8]^Z]U[W M[KW7O?NO=>]^Z]U[W[K5!Z=>''O=2.O4Z][]7K?7O>ORZ]U[WO\`+KW7O?J_ M+KW7O>NO=>][Z]U[WZO7NAY^,O2E%\B>[=G=/5_8^S.J*?=E/NV8;VW]G=K; M:VY2U6V-D[CW?0X'^-[YW5L795%G][5V`CPF&_B^;P^,ES&1I8ZJMI87>>/5 M:#KW1TNO_P"7;L+=>UNW<]E?DW0R576'\N?:W\P2ECZLV9L'M[!9B+.;QVGL M3/=&;ERN-[]V]F^L^P=B;JW]C*#*QYG$Q9&&IILFXQIHXL569K53C'GU[I69 MC^6WTW@.Q.@JW)?*/>X^*?=GPHSOS,K/DF?CIC5DV13;6;>.W]Q]3Y?8.*[Y MW#!4[KP_;>V*78U3/!FY)(MQYJB$=%/32Q3S:KQQFO7NHV[OA3\#]D]`="?) M/-?,WY/+U_\`(S@?X,];PY_$YKXY1;`_C7]YEH?G3FH(H=S2]FXQ M,0*99EJ:E)(JV3%P'[Z/U34BG7NDE\IOY>FROBSC-_;VW!\@\INSJ+Z##H3XK_'_`+7^,O<_=/8'S`P'2O:?6_\`I!_N3T?N#86' MS)[6_NGUG%OK;G\*W<.V,)G<1_>W]^Z]U[W[KW71XY]^Z]UP\G^'^\^_=>ZX%B?\` M;WX]^Z]UU[]U[KWOW7NO>_=>ZZO[]U4FG77O?52:]=>_=>Z$GJ/MWL'HO?V( M[-ZOSD.WMY86AW+B:6NK,'M[=&+J\)O/:V:V1O';V>VON[$Y[:NY]M;MV;N. MOQ63QN2HJN@R&/K)J>>*2*1E/N/7NIW:'=G8G<+X%=ZY#`1XO:U/7T^VMJ[( MV'L'JO8>WVRT\-3FJ[#=>]6[8V;L;&YC/34T)R%=#CTK*_[:`5$L@@A">IU[ MILQ/:F^\%UIO+J'#YBGQ^P>P=Q[1W5O/%T^"V\N3W!E=B09^':L%;NLXH[O& M`Q;[EJJ@XE*],545OAJIJ:2II:66'7GUNAZ#P\>]$]>P.NO>NO=>]ZZUU[W[ MKW7O?NO=>]^Z]U[W[KW7$L`;6/O=.O=<#R;^[#'5@/7KWOW6^'7O?NM]>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]'21]J.M=>]^Z]U[W[KW7O? MNO=&:^/:AI-C8^MK MA0NY0GS2LLLXLQ4+I)MR[()+:[8/J_7(KXQG_P!#C_T0@5^P8'#C7I+]Y+;I M=LYHY/@EL#;%MA1A&=EBV`@&_P!P&=MBDD\,FA/B.0\OQ%0NDG+T^W?D.V(S MU;6Q087*;^HL+24BTNVZ^MR&\Q04>>BI(XT;>^\/+49]L+U4V: MZWZ.W2,):2R2[AX4=RJ!9HI95A*VUN\ID\.R=X[<3$NB:2U^Q#UCEUV"`;FY M/]?]A_K^]&OY=5(SUS_Q]ZZUUW[UUKKWOW7NO>_=>Z][]U[KWOW7NO7/O=>M MU/7?O8/KU['Y]>]VJ.O4ZZ]^ZUU[W[KW7O?NO=>]^Z]UW?W[K8/KUW[UU8$' MKOW[K?7O?NO=>]^Z]UW<_P!3_M_?NO=<@Y_(O_O'OW7NN0_=>Z]>_T]^Z]UW[]U[KWOW7NO>_=>Z][]U[KKFWUY_K[]U[KW/^'^V_XW M[]U['7?OW6NO>_=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z.C\1_E-L[ MXT[1^7VW=R=5[E[(K_E)\8-P?&>@RF$[0Q?7M)U[C=R[[V'V)7[LK,57]6=A M3;TKHL]UGB(X:5*O#QK2&L1I'DGAFI=$5IU[IR_V>??+_`F#X)U.V,158C'] MO9K?6$[6GK9FWCA>L-T_W5W'N_X_4%+]IX$ZYW+V_L'`[TG7SZAG,5&X3U,Q M]3->O=-?;7RFVCV1\,?BC\4\;U9N/;F=^,N^N_\`>]1V97=G8S<.(WW+\A)> MNIMQ8Z'KZGZOV]6;4CPYL[E*;:-%U5LJHV M3]EN_>5=%20-E\QHQJP1222SQR5,W@,D]>Z+AVSN#KG=/8FZ=P=2==9+J7KG M)UT,^UNNLOOJJ[+R.UJ):&EAFH:G?-;@=L56XFEKHI9UE>@IV191'9M&MM]> MZ#JX'U(]^Z]UQUK_`*_^^_Q]^Z]U[6/\?]X_XK[]U[K&6)_/OW7NNO?NO=>] M^Z]U[W[KW7O?J=:J.NK^]TZUJ'77OW5:D]=>_=>Z][]U[KWOW7NN_?J]>IU[ MBWNI/6Z"G75_>J]>KU[WKK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UQU"U_>Z' MK8%>N'^)^ONW5APZ][]UOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[K__2TD?:CK77O?NO=>]^Z]U[W[KW0V?'4G_3%M-52C+30[GI MUER$.&J:"A:IVAGZ=X[W*BA(2SI>H&E6W>*,O872">2. M[GM;>5+FS34Y3;N8J:OKVEJ)ZS;>W=J[7I M"XWAO."-*C%[-W%NC"-5+30Q_O)62-)'I#!61E5%RO(KV=WIBD11.0`[.Y_L MXS@R*C4K7!44-?7H;?>JV^>PYRY/-SN>WW=Q+R^CM):6EE9)7Z_<%`>';[N] MMM815_46X8LND,%92JK/XVXV@;9-?/-@>PSM=-NOYK9;H3VT4 MO@S0P[C:%S:Q)!(2?V,.L,.O>_=>Z\#;_BG]??NJD= MZD=:/7+WKK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UX&WO?6P:==W] M[!Z]CTZ][M4>O6NNO?NO=>]^Z]U[W[KW7O?NO==W/OW6ZGKN_OU.MAO7KOWK MK=1Z]>]^ZWU[W[KW7O?NO=>]^Z]UV&(^A]^Z]URUG_#W[KW7?D_P_P!Y]^Z] MUV''^M[]U[KO4O\`4?[[_>O?NO==W']1_MQ[]U[KUQ_4?[<>_=>Z]>_T]^Z] MUW[]U[KWOW7NO>_=>Z][]U[KWOW7NNK@?4CW[KW7KC^H_P!N/?NO=>U#^H]^ MZ]UT6`_(]^Z]UQ\G^'^\_P#&O?NO==:S_A_OO]C[]U[KCJ8_D_[U_O7OW7NN MKW^OOW7NO>_=>Z][]U[KWOW7NO>_=:ZZO[]UHGKJ_O=.M:NO>_=:ZZ]^Z]U[ MW[KW7O?NO=>]^Z]UW]/>B>MTID]>O_3CW6O7J^G77O76NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KHFPO[V.M]8]3?UM_MO=J#KP!Z][]U?KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]/21]J.M=>] M^Z]U[W[KW7O?NO=")U11Y^OW[A*;:^'P&X,Z8J-%#(:6!8)99*H1B-3)I'M!N;P)8S-]EMN6=HL+_`'LIQ>&ASN>:J MHJ.EV5)+AZ>IAW3)DA5QLQJ$K?*LEK`!C9_H3;2/82R.C259I"Y8L56A)D[B M-&C2>!6E.CSWH_K]'S+M=G[@[7MMC?6^WB*WM]O2PCM(;=;FZ+QQIMQ:W1UO M3>"=2?%6X\59*4`!O^C\-MC8NU\13;?WKMC<4_8.ZI\=G&GV=04^TJ?"8"JK:"KRM6*EJO[F&62KCB8?M.OL*;S-<]LW"??]T:*YF:PYL>* MXMQ'9*NWQ+8K;6KR123SB9I_&C=IXXB/TG7JMWW(/7.GKWOW7NO>_=>Z][]U MK\NN6KG_`'W^W]ZIUJG7*X_K[UUKKOWKK77O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[WOK?7K^]@]>X]=V]VKU[3U[W[K5#UU[]U[KWOW7NO>_=>Z][]U[KOW[K MU3Z]>O[]UNIZ[O[UU8'KOW[KU1Z]>]^ZWU[W[KW7O?NO=>]^Z]U[W[KW2CVO ML_=V^,F<)LK:VX]WYD4TM8<1M?"9/<&3%'`T:SU1H,32U=5]M"TJAWT:5+"Y MY'OW7NA%_P!EO^1'_/A>Z/\`T5N^/_K%[]4>O7NO?[+A\B1].ANZ?_17;Y_^ ML?OU1Z]>Z]_LN'R)_P"?#=T_^BNWS_\`6/WZH]>O==_[+A\B?^?#=T_^BNWS M_P#6/WZH]>O=>_V7#Y$_\^&[I_\`17;Y_P#K'[]4>O7NO?[+A\B?^?#=T_\` MHKM\_P#UC]^J/7KW77^RX?(@_7H7N@_^4NWS_P#6/WZH]>O=>_V6_P"1'_/A M>Z/_`$5N^/\`ZQ>_5'KU[KW^RW_(C_GPO='_`**W?'_UB]^J/7KW7O\`9;_D M1_SX7NC_`-%;OC_ZQ>_5'KU[KW^RW_(C_GPO='_HK=\?_6+WZH]>O=>_V6_Y M$?\`/A>Z/_16[X_^L7OU1Z]>Z"G,8;+[>RE=A,_BLE@\UC*AZ3)8C,4-5C,I MCZN(VDI:Z@K8H*NDJ(S^I)$5A^1[]U[IM]^Z]U[W[K5>O>]]>J/7KJ_OU.M: MOEUU?W[K5>O>_=:ZZ]^Z]U[W[KW7O?NO==^_=>Z];W[KU#U[WHGK=*==>Z]> MZ][]U[KWO76NO>_=>Z][]U[KWOW7NO>_=>ZZN!]3[WU[KB3<<&UC^#]1[V.M MT/7'G^I_V_O?5J=>]^ZWU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__4TD?:CK77O?NO=>]^Z]U[W[KW0M=/ M8W*+O';6X:7:^U]Y4M+N*'$_W;W/N+:N'HLID*W$9:KIH9XMRUJ4\:1P4,LL M-344\U"*N***02-(D,A7NTD?TEQ`US)"QCU:T5V(`90?@%>)`(!#:22*4)$K M>T>V[FO-_+?,%KRSMF\6L6X+!])>7=C;QS2R03R(K"\D"`!8W>.:6*2V$Z11 M2"1I$AD>>_,?-BMQ;6Q[[;HMKTU)L;&TV/H*;>NW]^U=114V:W!3+7YC.[4A MI=MKDYYX9%\%'##''3I$67RM(S,[)();>Y<7!E8S$DF-H@"54T57J]`*98DD MUH:4Z.???;YMKYAY7L'Y%;Q MQJD2Q%E\5G9EAUQ2]B2=25>8P7?-5UA@<9N3<5!'@LGO>LVMAGP69J=Q9;+U:Y2[P?PDT4:+K^Y#R2*$NX-8#=%BFV07,[1H=0C#LHJX!8L MH15%..O4>&F@'0M]N[;W!D]J+K=]C]])>6=BMMQNXA;3;E)96\[B&SD=;=+: MX>[GG<35:/Z$VZ*-?U`>2107+.86LV]DY\37O0RU$$=)/Y<;D:'+4,U/7T=/ MD*.:"NQU14TLHFHZJ-BNKR1,3'(J2*Z*?PS)/&LJ!@IKQ!4U!(-00#Q!^1XB MHH>L>-[V:\V#_=>Z][]UHBO788#\DG\W_'O5*]5.#US!!^GO5*=:Z[ M]ZZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>O[W7K=>O7]^KUZO7=Q_K>[`];Q M3KWO=1U6G77OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KOW[KU>O7]^ZWJZ[O M[]3K>KY=>O[]3KVKKUQ[]3K=1TH]K[QW;L?)G-[*W3N/:&9--+1G+[7S>3V_ MDS1SM&T]*:_$U-)5?;3-$I=->EBHN.![U3KU1T(W^S(?(C_G_7='_HTM\?\` MU]]^H/3K?7O]F0^1'_/^NZ/_`$:6^/\`Z^^_4'IU[KW^S(?(C_G_`%W1_P"C M2WQ_]???J#TZ]U[_`&9#Y$?\_P"NZ/\`T:6^/_K[[]0>G7NO?[,A\B/^?]=T M?^C2WQ_]???J#TZ]U[_9D/D1_P`_Z[H_]&EOC_Z^^_4'IU[KW^S(?(C_`)_U MW1_Z-+?'_P!???J#TZ]U[_9D/D1_S_KNC_T:6^/_`*^^_4^77NO?[,A\B/\` MG_7='_HTM\?_`%]]^H/3KW77^S(_(?\`Y_UW1_Z-'?'_`-?/?J?+K51Z]>_V M9'Y#_P#/^NZ/_1I;X_\`KY[]3Y=>J.O?[,C\B/\`G_7='_HTM\?_`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``'/\`0```?ZWL M:]8,DU))ZZ]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>!(O_`(^_=:I7KD&% MN3_O?O5/3JI%.N?NO6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[WUOKWOP-.O>G7?']?=J]>H/7KUO>Z]>T]=>_=:Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NN_?NO5Z][]UZI]>O>_=>J?7KWOW7NO>_=>K MU[W[KU3Z]>]^Z]7KWOW7JGUZ][]UZO77OW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z[]^Z]3KW'O51UN@ZZO[UJZ]P/7KGWJO7JGKWO77NO>_= M:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NNB0/K[WQZ]UUJ7^O\`O!]^H>O=<`Q- M_P#'_>/];W:@QUL"O7O?NK`4Z][]UOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_];2 M1]J.M=>]^Z]U[W[KW7O?NO="[T2SQ=I;=JTK,?CCC*3<^9;)93;^+W518V+" M;2SN7FR3X#-9?!8[(38^&B::$/51M',B/&'D5(V*MZH=MN%*,VHHM`S(3J=5 MIJ56(K6A[345!H"2)9]CB\?N?R]=I=V]N;:*]N#--:PWL<*VUC'-]<9&*2>JHI>LJ5\?DY-EXCKZFRU)+ MOC?4PKL7M/%9#*?PO'>:1XAYIC)43Q2U"@131DH^78?`AW",@!QAK]Y/?/ZP;U[>;A%(\MFW+2&*8[=!M23HVY;DWBPV,$L MW@Q:BR?J2%I94EG4"*6,D5>N-X][;\V_#E\/O38.V5AW+)@MDX<=.;UWC@JZ#3D*^IIU:4)>55B:2,LW"TV6RG,4UG/(3'JD; MQW%$)8"H:9=>0W:H.*XR`91]N^;_`'QYZV&+=MHYRV+;53<3;;=;_N"TE,EZ MB6SL$FMMFN19$+);4NKJ:(%PE9`L321D6]C3K"#KWOW7NA9ZDR71F+R&ZZCO M;9W:N^,4^TC#LC$=3]C;3ZOR4.^FW7M5Q7[FW+N_J_MVE?:T.R8\VAI:;$?= M2Y.6B;S1PI,']GRZ]UL#[A_EO?`C;WSK_F%_!'9NQODEN3?/QG^-/RFWGU'O MGM+Y'=7+L[/;ZZU^-^9["V?N'=5)M[I+IN/;,>%WO-C_`/)ZO-3XBI@9Y:ZH M@@I9(*ZM30'KW59.YOY:?R2V7M3*;)W'\>.T6^1J?+_I?XOXE-O]C]+;IZVK M-Q=V=.9;M78.PJ3#[8S.$FQN;PFY\?DY-G-@EG629IY(G3=1Z]> MZ![X^_%+=>_?F3UM\5MW]?[KW_N7=.YZ+#5NP>D>TNF*7=>ZX,CM:3=>.@Z] M[5W'E=R=*R5&3Q$D-335DM55T4\3:(RTKHOOU<5Z]THJK^6M\S*'IS;W?]?U M=MV@ZBW-M+J+L#'[PK^Z^AJ*.BV#WKV#5=4]8;[W-AJKLZ+<6S-E9WL6BDP] M3ELQ24./P]:`F2FI-2D^J.O=+$_RD_YA'^DO-]/1?'R2L[(VQNC>>T-T[8QW M:/2V2GVIE^OXNNY-U5&ZJ_']C5.)VSMNCF[:VW34^9KJBGP^0KLQ3TM)53U) M:)?:AZ]>ZX]:_P`J7YK=B=K=,]/UO7&!ZQW1WGVS7].;0C[7[&Z^V55TVYL' MN?L_9^YJ_,[3K=RR=@T^W@ZA8K^5=_,!S%;W9CZ/XU; MK6I^.VY]\;,[=:NS^Q,52[:W-UK@(=U[^Q6/K\KNRCH=Y2;2VK509.NDPZ M.F\GMW;W9FTL)AMU[PVQOVKV/OO=U?L[<&WMGY^ERHQ-93)FQLITG\>^_>V,E_H0[Y>EVK6U>5RV.C<8N;R>L>Z]T-V9_E%_P`P M+;V?ZYVQF>D]O4.9[7[5V+TALBGD[\^.#T]=VQVEUI%V_P!8[&S&2A[=DQFT M,UV3UY,M?M\9F:@CS3G[:C>:K!@&JCKU#TD,3_+'^;&:EQ4-%U-@HOXWN;$[ M'Q-1E>ZNAL%0U_8&X-][_P"M-N=;09'-]G8Z@;LW<^].K=P4N+VV91G,E'C) M:FEI9:4QSONHZ]0]&3W)_+7W5NWX+_&GLWISJ7,0?(7'Y3^9/N+YW9>U M-H9;%]>_#6OZ$DJJK#=?]B9O9M32UG66%WQE1E\5BHZM[XGN+([SZZJS%455;1XG'T&-JX MZR)9IJ:7WJHZ]3H0:O\`ETUE;\`<#V-A-G;=H?DC@?E_W9UUVIN[<'R%ZGQO M4]!TMUY\>.A>V]NY;';ZS&^<'TI24N8K^[J6"GG3-9"JS-?-14M!*\]5'1MZ MN>MTQ\^JZNU?CEW)TEM7JG>?:6T(]I83NS;$.].MTJMR[1K\]F=IUN"VKNG$ M[@R6T<1GLANS:6+W#MC>^*R.*ES-%CURM!6I44?GB#NN^M4Z.O\``CX2[$^4 M/5G>_9>3Q/;'<^[>BMT]65V>^-'QZWOUYLSOC*=`YVEWS6=O=Z[%Q?8&T=]S M]I-U=/M[$T3;?0;8'^5O\_]T;*ZP[#V_P#& M+?>4VEW%68&DV#DJ>LVK]QD8]T[(W'V7MW+YG#2;ACSFS-L9GKW:.1S=/E\W M38[%R8JE:J%1X61VWJZ]3Y=,FV_B$.J_E]MSXU?/C/U'Q+Q"8]L_O?=6>2IW M!0XO$Y3K6O[!Z[-+G>N,%VLKX/LRN;%XJ//8O%[CAQ`RAK'HJS[26D?>JO#K MP`R.CQ?$G^7]\3?DCO7O396P\]WQ\H,OUC_+>VK\N]L83X];KH=F[MSGR$_O M1U1MCL'XYYC;.]/C1ONM-5A,[VN,;32X/!; M:,WQYKDRV3SVX$HL)34]6U4E&8&G/BV1Z=>IQ]>@J_EP?#WJ/Y/=O_)CK#O! M]WRR]*_%+Y)=[;;J.K>].G>NMNY3>G0.V*G/TV`S_:V]]D=I=91[`W350""3 M<,=53XRAI2:_[J6E%_>R:4IUH#K)V?\`RY^T=S;VGQ'QDZ8W?_#=N=046_-V M8C>GR4^-_:YS^>HNH,3\C]WT70G96S4ZJV_\BH]M_'C>^V]S9+%;2P^3S6(C MKIA+'44J4];4>KZ]>ITB.B?Y87RR[^W!L/`;;PG6&TZCL''OFL7%V/WMTOLK M<.)V\_3NZ?D!B]R[JZYRV^D[2VKMS^\AUIB3MC#;:Q6_A\WNV-8*/?GVQV?54\\%7%DGHZFGJ)-U'6J'I9]I_P`KWYO] M*4W855VAU%@=IP]48G^+=BBI[LZ#KYMI,V/[&RU/M_*4V([0R%2N^'7J'K#WYL3^7WM[XP],[AZ$[6[RW5\KLS_H M]_TT[(W=3[6J.J-O_>[!S62[+_NEDL;M+;NX$_A.]&P:8O[J>K\M/7U])+>; M%?=UOA6IKPZWBGSZ-C\AOY7V]]U].?$'MSX7=*Y3=V+W-_+[ZP[_`/D%MG&= MN;+WSV_4[^W'WUW7UKN#?^&Z8J=QXWMO([$>#;^"I34;>VQ-@\82$GG-1]S- M)H-QJ?/KQ'"G0*C^3)_,N3*[5Q-;\8[^I&[WV9MG:+UG:M/!V#5;VZE3^-827`/DZ;, MP$1T4D\Y$1]J'KUZAZ:ML_RZN\NX>J.C]W])]19^?)[LZ9[)[NW]O#?W?'QN MVUUEF.O=G]V2=3_Z0-C-N#>&T,ALO:&S`K$GJB MIKUZG6.A_E-_/JKSG96W*WI#%[3RW4=9W52;YB[%[IZ"ZOI*5/CEA]N;A[VR MFW\KV+VEM?%;YVYU5@MW8RLS65P4^2QE'3UL4C3Z6O[]J'KUNAZ+WT/\0_D+ M\EZ6LR'3FQ*7/XJCWKLKK09K<&]^O>N,#D>S.R&RB[`ZUP&>[,W7L_#[E[%W MD,)5MC<%CYZK+5:4TCQT[*I/O9('6J="OE/Y:?S9P?2V>^068Z4;&=8[8VEN MC?>?JJ[L3J>FWGBMI;%[0'2N_,W5=42[[7MA:787;!_@&>`PADPN2O%6K`0? M>M0K2O7J'IMZ#_EW?+GY/;+V[V!TGUUMC=>V=X[[W+U;LV7)=V=$;&S6\^S] MH[=QF[<[UOL[:?8'9FUMV;KW_!MG-4=?#AL?0U.2K:6ICDIH95=2?$@<>O4/ M7&E_ES_-BMV_UAN.D^/V[:BG[B[5VCTEL/"Q5^UWWO5=G]@;7DWQL+;&X^N1 MG_[_`.P6WSLB"7-8:LS^,QE!E,1!+6TT\M-#+*GM0ZWI/0JX;^4%_,+W/EMB M8;9_16'WU5]E]>8#M;9DW7_>?QWW]B;J<5DEH8JC^&U_VWM0Z]I/0??R[OC'UI\I_G!T7\6>]MS=F M];X'M/LW`]FH*J* M-3B:I7?Q:9J#'6Z>1X]*+X;?&/K'Y#]4?*_.;HV9\CLAN3H[H7M3N*@[)ZM? M;]?U=UY7;*VE_%>O<%V7LAM@[KWIOBC[7WA%+B*JJQN6VZFT*"-LU4FOQ\&0 M-!HMU['IU7G?WNO7J]=>]=:Z][UUKKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NNB;"_O?'KW7%FM_K_[Q[V!7KW71-_\`6_WF_OP%.K`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`CM_P#F1=WX3^8#A?YD%7M+JCN"W?B=\ MTN`W!AMZ'K>KW'@MF4NR<3DYW5A^J M>DN_NOB#OOJWN#:&=S'7&^NK.K3M#);1RNXZ;;6[ M]J;N_P!(])O;9%#N5\_1YBCK6S@=U*TS"E7VD=>Z>>I_YOOR3Z2Q_36)ZXV+ MT7@\1TAWQM7Y$[4P3[8W[D-J_P!_=JT6\L=X,7LK(=EU&R^KL#NNCWK,NX8M MAX_:55N!Z.DEKZB>:`2-[2,]>Z[Q_P#-E[,Q/4$?1F,^-?Q7H>O:?XY]X?%> MAQU-C_D2E5C^G^_/D/B_D[NS%4M9_LQI?^+8;L[#P'%5L@DFBQZF"I^Z+&3W MK3\^O=3^]_YOOZ/CK\0]\TW9G?3/=W0F9V#N&F[0FV3L_KKOS;U;M#>5!L?\`@7:6`WA3Y#'[ M4R,]!C:G*YC+20QR&6;SU(6==TKQX]5R,]&/^0O\V/O7Y$[.W%M3)=7]%]9U M>X>Z/C?WU%O3JND[GQF\MN[_`/BGT+3_`!OZ@J-N5F[^Z][8:BH<9UO3VJEE MH9YZC(.:H2HZQA*TH>O5KUFRW\W7Y.[P[![5W_VCMOIWMD]I_)+K7Y;C9V\] MM[RH=E=?=]]0XW+[?Z]WGU[CMA]@;*RE%3X3:FKURPO\WSY58++?'_=U+C.JJOLKX_=V?*+OFD[.RNW]WY7 MC-I]']H=4?'GO8]>;GW]N3K;MGNCK[,[R[=V)!VMO2O[#[.VQC#ZJW!6[BVQ1;]W7N;LK/]Q[YJC4US4TV0R&Z MILH,=%!1P5,--2TT47J=>KY]#=N3^:[VUNB7N*>NZ)^.=)-W9\VJ?Y^[GJ<1 M%\@\7D,)W[#MW>NWGJ=DY:E^0B9;:N!+]CYW(T[03G,8O*Y!:K'9"C>CQWV> MJ=>KT,M?_/8^4V?Z][GZHWET]\7=]==_(KL/=O8_>6U=U[1[=K*'L[+;LZGZ MVZD\&XYZ+N['Y`5FWL?T_MO-X_/TLU-N\;GQS9.IR]3/6Y'[OU.O5Z+'N+^9 M-VIN_I/8G0.[>G_CGO#K[K'I?L'IGKQ-\;&W9O[.[#3L;;'6NV,GV-L+-[X[ M`W%5=>]@X1>LH8R^1_A3U>0EE&Z=>KT%'Q?^96_OB3D:7=7 M5^R.LJGM#;.>RVZ^K.X-QT&]7["Z3SFQI]M;ZVQMC*-48RLBE^ MRW-B]PXM:NDAD%*+S+-XBO7J]&:PO\W/O;#;JZB["?I3XH9SLSK;J:EZ#WKV M-N/J++9G='R1Z/I.IZOHV/J[Y"I4[X_N_N7`S=45*82IK,)0;>S5;24M.*FN ME:"-EU3KU>J[^U>P8.S]\9C>-%U]UUU7CLBT28WK_JK"9+!['VS0P1A('JXG>_8FX/CC\3,IO3Y.8+X]X[OK-Q[7[N MP([)W+\=.S]I]OX+LG*XC:O?F!P&,W[V!OC8N*J=U38VDHJ#)FF=H:2DEJ:N M6?5.O5Z$O9G\^_YB;(J.RZFCZ^^.^X9.WMK=(]?]C/OS;_<&_P"LWOUOT=#V MC0XS8>_\QN_NS,9WM'%;ZPOB M)_&_YIYSXO[^[\WQL+I#H_,4?R"Z?[@Z%W!L/=X[IK-G;/ZK[PQE9@=[[9V+ M+@.Z-M[UIV.WJPT-'69;,Y>NIH463S-4:IFMQI4]:%,UZ$GX@_S*NS?A;A,G MB.L^E?CMN:MRF[]W[EDW7O\`VUV55;Q&"WYU1F>F=T=7U>?V9VQLB?<76%5L MO/U1I,=EUR,V(R4KUV.J*2JEFED\<];J!TM;]'?%S-=S]* M]=/U'D>SCNOK6+H7<_QHQ.T^Y&Q7:>*Q==#A>G-TRXJ.NV]3;G22S?\S[O7.[+J]HUFQ^G8*[+?'G:?Q`S^^L= MB.PL=O3/_$C9&_,)OO;?QTKYZ3LN/;M+LBA.U\7AVRE%C:3=T^!QT-'+F7'D M>3V!UX]+G=O\WGY`[H[1^5O<%-UAT/M+>OS(QN\<7W$=LT'=+10U`RV'I-W4&Y:';V?C7(8N"CG,C/Z@%!UX\>JI[>[U MZU3JTGKG^;I\HNG8.HLOU)ANJ^NNVNC?COBOBMUWWUM[#[ZE[.Q72&-[%K^T MI]J2T&<[$S'5-359K=F8KVK,D=L#)/25TM-'/'#XTCK09ZW_`).CY?#S^<7@ M]CY[Y+=GY7JOX']$=F=GY_I/<&/V7D>A_D74]'[PW-@MY[NW=OOO*:?JO>N^ MNS-J_(;8F9;%5>R305&'P&$J,ADJ[&-BJV,)7Z(J!QZV/7HJVX?YM-3LE-^= M2_'KXX=*T?QQHJS^8;L?I6E[2_TYYGM3"=(?S`:Z@PF^L-O#-X/Y!T.%R>[\ M3UKMC#8R@JE@E^RDI7ED>LJ))*F3U*Y)SU[I3XS^>W\CR:3X\_$H;B MP?>W0/R(QBR8/Y$OCJ??_P`:/C+5?$[JB(TO^S)B2;`8SJVME>JIGD:2MRK_ M`'$LI0"`>('#KU:=`5M;^:KV;M/HC%_'>A^/7QHJ]AXCXT=R?$VEJLA2_(1] MQ-U)WC\@,7\F-XP39"C^0U'1ON&F[2P\$U!6BF4P48-/(DJDGWZF:UZU4>G5 MO&*_GC=7=E=8P-\ANMOA_NC$=];O[ZWW\V>IJ;KGY=;0[YBJ.T\AC\!NG97Q M'[9VKOC<.UMK;<[;ZSZWVP^3DW!NB*&JSDTM'74:8C'TCR5IZ=;J.J$?CI\X M^SOCEL6JZPQNS^LNS^O!WAU?\E=O[1[4QN\ZS&;/[YZ?H\[BME=E;>FV'OG8 M&3DR4.#W+64%909&HK\+D*611444CQ1.ECDUZK7HR>>_G#?(K=_6>YNN]Z=9 M]"[OK]Z]"_([X_;P[,S>+[@7L3E_T3\V^M?CI_+6ZBVULJOZ=W7\O^I/YC>^_ ME9L#;._ML?(&JW%U522=.=$;1ZZ[3V;E-K':?2.>W'A]^=:U%<^*W'7YRB\5 M)3/)CY2[PGQJ2?3KU:#'0C_$S^O.W:C<.3^0O1_5O=6$ZJ[)[*H=D]DST^2J.Q]W]F+3;_P`KB=O3Y&J@GES4 M%%49J)GJM$=>KZ]*GY4_SC,1O#:]/MO;WQZ^$._,UV1M*IV9\AML["Z[^2&- M^)&4VQUCGZ3*?$6IZIZM[0WSLG>O6G8O1&1SF^:USBHZ+:^2I]XB*JH:UONH MT]3Y]>KU3_\`%3Y.;K^)'R,ZW^3NRMF=>;UW[U3NNEWQM##=A4&ZO[E4NZ6P>4W#24>1D9_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NNO>^O==%K#\\CCWX#K?6.U_=^O M`5Z]8>]=6H.N_?NO=>]^ZWU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U__0TD?:CK77O?NO=>]^Z]U[W[KW2MV'@L3N;=V#P61JFBJM MSUL*3TV*T4\TT,CQRUN-@#3U$20HTM33PH\@:26.,,X2WL\MM:S3PVQFD480 M8+9^PG`S@$FE`"<="OD;8]JYDYLV38]ZYFBV;;+B4J]Y(H9(**S*2#)"M6=5 MC4O-%&K.&DEC0,X<^Q=LOM/)X?$3;NQ>[:A=N4$]3_",O0YREVY+)4UR_P!V M?XEB4?1^-!-<6[&,`2?H3/& M!,`=,@D139?&7*UU)UXE-C<]A-LU-5VE48ELCNO9N^=R8S)1YW![8G;:^`GV ME%#2/E,[3[;F&1IIZF.HDH(TCB:.*>I+A?F*)&ORTD#R*+8-1)(T(TL_>VO. ME2XT$`@,234A:95?=LW2]M?;]+;;M\LMMN9>9V@\6^V__=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=:H.N]7_`!O@<\>] M4ZK3CUR#`_U_V/T]ZIU[KNX_J/\`;^_4/IUKKWU]^Z]UW[UU[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZZ^GO?7NNB M;?@^_`5Z]UT6X!']>1^;>]TZWGTZZ)^MN+^]TZW3AUU[]U;KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO__1TD?: MCK77O?NO=>]^Z]U[W[KW0I]*5&.INS]K-E\I@<-BYYER6 M$R>.F%2*'-[;JJ>:=*KQT]0N0H?M:EXYC/$L9=2S>%D;;;GPHW>04("$!B0P M.*JX-*5(TMJ%1I-:=2A[,7&W6WN9RPV[;G8V>V.TT4LUXLCVZ)-;31-K\.XL MW1F#Z(I1=6W@S-',9XE0N%!WZM.-T;>>.'8--63[.H9\O2]<4^`@V]0Y&3-9 M\_P[7M6:LV_5U6,H?!3B6GJJQC3Q1+//)4K.?;.QZOIIP3.4$I"F4L6(TKGO MHP!-30A*:X8Q)$L\\ERLQZ//L'!83!46,J=D8VHIL=N;?&5R$TVSN[>F9<`D3PX"B MI,UMG'[\PE1NK:=$])/.E+%1O3;LH_WH*R=F2C8`N^GFF>1;R0&2.$#]2WN- M7XB5R[)9;;<V,91I5A2W:'?+?]:"\G9DM&%4ON3>N6G7O?NO='T_EKXGXX;U M^6G7?4/REV%M3=O6?>EZB[([!QE9MWJ?M0UG6V_MA256 M'VKV778J3,T^4DJ\=)@S5ZHXY!'/%HUICKW5U/R4^(7Q#Z`Z'ZB[]W+_`"\= MJ[-IDZ>^0F9^1FT]W=B_+:&CV-\D>CJ?;'Q6P71NVLE%\HFR.0I>Q/E?O['= M@_;S+'DH>NC!-25=72)72)4$GSZ]U1S\P/@MV'\*I]K8?L[M?XW[OWQELEN+ M;N]^K^G^Y\#V%V;T?O':M-@9\SLONO9M)3T62V;GJ>?.&E5XA6X^2MH*RG6I M,M.RFP->O=&"JOY/WR7I]S?$/:T6].EJRI^9?=&?^/\`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`'OCG MT_WCCENN\/4[ER6]ZRMQN0P^XJ M2MDBVQ+5Y2DI5K%Q3S^KU[K'V!_)U[VZ[R6]8LEW=\:\SMKJV;Y:T';N^MO9 M7O.JV]UEG/A3OOJ3KKO+`YC$Y#H3%[_W978S>U_LY]K87<%!/25\M3+40 M0T&1>D]JX=>IT#6\OY='8^W_`)BX?X6[7[:Z5[)WYE>O,?VA4;UVQ6=G8?8& MW=J5?1]5\C:Q-PG??6&T=[CQOC7NW,S8[)_(.#);@SWRXZ;WGW?T+U=M M3`93X\T&=J^R=^;4V5)#!15M/004U=7T<%9/2NU4*3VKY=:I^SK!C/Y37=&2 M[(/5W^G#XQX[/[:^4&T?AMW975^[NSA@/CC\A^P8=ZTVQ=F=P92DZ?J_)BMT M[OZYSFW(-P;6CW-MRGS>-D2JKZ>F>&JDU4>?5=)Z&3$?R./D'BNP?BSLKO#N M;I+H"E^6:]1CK:OWY@_D0NWD_C-GNXMI[O[+RW8?6W2G4&Q=X]>]=;E[<[<;L([-H= M_P#:=-O');'VC'1]6=>]H[VK,EE<%UYGLOY1'R%[8[`P?4.V>RN@X.XZ["_&_>&Y^J77'7?RNW'U;MCIOL7 M>J4W4M;@FV]D:_O+94F5IVJOY'8_<^>J_A5LO;_8WR4V7BEWM\;]H;<3< M_7NQ-ST>36:KR5+@\O'+X,;D:RK!I_?J_+KU.IV:_E$][4Z9'%;.[E^,_9_9 M.V\;\7-R;[Z>VAO'LG#;]Z^V)\P*+J^?IOL3L@CI;U(W7KU.LVY/Y1?<.PLSV)0]H]]_''JO"]:9SXKX3.;J MWO#\F*:EG;YE=:[D[0Z,K(=F87XUYSMK$?Q;#[2R%%DZ',;S M^T\OB/X+N:AW1+3^.LAMM[)8BCJ_O,E0UV3KO"OGUXT\NA8ZY_E&_([L[K/I M'M3`;XZ3I-O=Y[]VSUWA$S&<['I1M_/[UZ4[)[]VE3Y#<=+U;6[!WOELUL7J MG+TQP6RIT6EOA?VY_LS6\OBRD^!7>?76-W MON7L#<^4H=_;5VCL?8O6/7N2[5[*WWN[';RV-MWLS;F%V)L'"5M=D:*LVY#G MEDIFHXL?+7/%2R;KBO7J9IU:#W!_+*QG<>QOAQG>D^UOA=U)UUMSX%]29SN' MY$]D]@[EZ!Z>[+[F[2^6OSAVCL^5]P=O[(VYOG*]A[QV[TS5P&7*XG'TD-#M MB4I)!C:>DOJO6Z<.FS>WPVVW@?A#U-3;'RGQ&W;ELQ\!ZKYM=VU6[<%VO0=W M]?[@J_GKF/C.O:NQNV=H=9_PK=&S,%M+,X;9Z[-DW=D]L557BLYN-<#)5G"Y M*N]Y]>\N@>S/\EGY$4.[-\;)PG=GQKUJG0T M_`O^6MC-I_/[X?TOR%[,^'W;'0F^/E;L[JS:;X+>6[N\NK/E7D<9A^M]W;^V MCUO5=6[$W-C*S^X]!VSMZDS";R?;.*@R]>*&K,JT^1BA\3CKP&>JS_C7\?LM MW9UI\I<[BL=U9/\`Z*MB=.9:LS^_\YVKB=Q;(B[(^3_2W3%)NOKRAV%09':F MY,@N4["I\?F*+`R%768Z&7)4M.%WU[I8?+WX!=C?#K&KF-T=H=,]JX MZA^07R`^+.\*KJ"O[-J5V#WO\:JC9:]E;$W*O9O5O5\E;(M!O_&5E!D,,,MB MZNGE=34QSQ20KX&O7J4ZL5V9_+AZMNTI\735^V,;G,O+13R05 M])A_N*BD?5>'6Z=%.[6_E&=_]%;,[2W1W5W+\0.I\]UO7=Y08?JGL#Y%;9VM MVSW+B_C]OG<_6V]MP])[0RM%3C>F-RN]MD9K&X&GEJ*'*9NLQO\`Y@V'UP?DE5_*W^7K\>/C_P!Q[^W7W/AL9L.O M^76\>X]F9:GS>(Z_W#7;7K\7-E^OL5'#55FULQ44*UM6Y5P833>/7@*UZ"'8 M'\L;M'L+:'7V]Z+NGH'!8'?6#^<&=KJG<-9W.G]P8OY?^P=H=G=YT&\DPG2V M5/6X-L.N7HZ[QO#+44U3HA;=>O4Z$W(_P`G'N]-[[:Z^VSW]\7- M^;BS_>'Q,Z*KX]MYOO;'4FT,Q\Z.NZ[L_P"*F\=S5.^>@-G`[*[:VM0.8OX< M,CFL15,D.5QU"[#WJO7J=2\-_)A[^W?US6]P=;]X?&?M3K"AH=UQR[IZ[R7? MN?R*[RZ]JFI^RNOZOKA_C[1]N87)=:0U..JMP9_([?H]CXJBSF,J)LZL5;"Q M]7KU.LF/_DZ=G[\[VZ2^/W1_R!Z3[9WGV_\`'OH?O_)ST^W^^]MT'6F-^1&" MZLRG6N&W/%5].9#)YN'<]7VYC135^$I\E'B\5#69;)Z]3H.OAE\1^N^[_E9O MGJ_+]A8'N;KCIWI/Y"]^U5;U#4;XVLO?M+T%TQNCM6AZYZT/:VP>O^PL?5;[ MS6"AQE1)78#'Y"EQ_P![4PQ7ABD;=>O#CT93X]_"[K?^9'T*,OTCLKJCXG_( MS;/R]^/7QGH:$[O[SJNB.VL3\I,+V=4;.FJW[!W#W_V%A.Q]B;BZIK&K6Q%1 M)CI\!6+)+CXIJ=JFHUPZ]2O0$]9?RONQ^S-F;&[(3Y!?&78O7>\OBUE/ES6; MV["SO<6'PFRNL]N?)G_92]W8W=<.'Z4W!G/[U[2[?DB@JXL=1Y"AGHY5GHJN MK7Z[KUZG2[_E2]+?'/N7)?.*E^0^RNH=T8;ISX;;@[UV-OSMW/?)S"[)Z_W= MM/O3H[KW^,YVA^-&Z-O[_P`_M#*[<[3KFK*08O)5WGIZ1Z<4X6I6;1\NO#SZ M%SNS^3QN;,?*W9.S^A]X]?=<]#?+3Y7[VZ1^'E=W#NC>^>R5?M>JV%U!W3T] MN?<>=ZYZWWO05NSNT^K>_=M5&!R5'-D98Y)9J?,C'U--.??JXZ]3H(.L?Y7? MR[S^/_=_;6P=I[FSGR'Q^VZR#9WQ7[([XFI)>R.N^O[6VS/EVP.+W96PXSITR[D_E%?(G'S;=PFQ> MPNC.YNP,WV?\/.J,EUCUKF.U(=W;.SOSOZGJ.Y/C9E=SUO8O477VQSMS=NTJ M&H6NJ,;FITP9K^5OVK14G?.8VG\@OB'W'M;X\=)XCO M3?&\.@>X`KT7WY9?#WL/X8=K;5ZE[@SFU\WG-Q[,P&_WJ.MTW;E< M9#M[/[AW#@Z(X?+;OVELC%[VCR5/MQ\AC,O@) MV>POCQUY0=6?(C9?\/[0W#TM\D.K:GN?$ON>/';=PM#D*K<]/+C<-)BH9JZ@ MJ#3UKUN@Z)CUK_*,^2':FS?CAO7;&].FEQOR9[XZ:^.VTQD,AVI%0;9W]WWL M#2&'U?EU[H)=J?RR^P-R8#;F\,EW_ M`/''8^RZB]R?RO^_NCNL?D!VYN[=G464V9\?-X[ M`VEE:_9&=WIO./?5-VOMGJ#?G6&]-GY#!;`J<%@=E=C]==W8;/8"JWA6;5GS M=%!DH:&"?(8NOHH/5Z]T8;^45\'>K?ER_>N.[?AV5'4=B;6KOC)\9,CO7N+8 MO4TV#^5_96S=X[SZPW_M3#;UWKLVJ[JFVKN7K_$;6R6U\,N3R7_&1:&K%(?$ MCKIC2G7N@!^/O\M?>';V_?C9U]V;WGT]\9=S?*?>.V]N=1[.[8Q7Q-J]58WK;IC8V=['[0[%R MT.^-@[<['QN#V3M3;.0>KISM^2OJJNE-/CH*]YJ0U/J]>ZL%^-_P9I>H>LOD MW\G-]]F_&7<6'V=\)MH?(KXI=C;OV)OON/HG?-=N_P"877OQJW569+KW<_16 MZ*NMW!MZKH=U[$_@VZMH0G&[LS>,RQ^UQ](,W2Z)K0?/KW16_A-A_C+NS8_R M'P_R$Z-ID&(BQ-=5U.SY=>Z,]O;X8="X/X]]J[9I]J0T?9 MO4_\M'XE_P`PJ#Y!-N7>DE7N;=_R$[%Z%QN=Z2SFWYMP3]:TFU:?:/R/@QV( M%'A:;.'/[8,LV1E@J)Z8:J:_GU[H*/D9U?\`&[IO='\NW='4_P`9MS=C8KY! M?"C;W;.4Z3WWVQOK=U=V3W9N;Y,?)OJW##=>=ZOQ?66[,UB:K&;"PU$,+LV/ M9M35K31+#415Z++\_-L=![+^77<6U?C-0TN(ZAP==M.AQV` MQFZZ_?F`VOO5-@[4?M_:&T=\93*9W);RV-M'N%\]C,#E9Z_(2Y'#4E-4-55) MD,\FQ6F>O=+?K7^75W-VC\9=P?*K!;NZRI-@;6FV'+GL772]F5N:Q6#[![UP MGQUQ.:R>X-L=9;BZKQ62H.QMPTCU>UZOKFG7NAE[ M'_E!][=<2[WK9NY/CKNW973V^_DUUK\A.R-HY/NV?:'Q]WC\3=P=4[7[5QG8 ME-G^B]O;SS<JQ^7VK45G7G4NX=\=N_&?J'*YWL1LQV=2[6S6`V_O M/=.X9LO4Y'_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z__TM)'VHZUU[W[KW7O?NO=>]^Z]T:+XNMM5=X-,])N8;_Q^-W; M7;=R-!O_`&-LO#143[0RM%41Q-N_!5C_`-ZHGJ7:@EBJ0D!UK25,&':BQ\5/M',9;=M--EMGT%+5T&U35U5#ID)!`TO0=M.#'I+[3^Y?(7)_*V\;- MS1L4\]Y-=M*XCL=LNUO[]^Z]UR1WC=9(V9'1E='1BKHZD,K*RD%64BX(Y!]^Z]T:;N+YN?*[Y`X3L M3;?P,%VQVSMCO/L'%9Q\8:/.I10U6'Z_J_X3 M%3TO@HS20TZM"QIJEQ>\-X;)ZAVWN_MK=&SMM;0W)W%OG/;HS>&Q,>7STV>W'+#RT_V ML$[Q^P.O=";EOYL7SQSF]NONR,IVYM"HWUU?W77_`".V9N=?CO\`&BFR='WK MEMIXO96:[2S$M)T]`F[=WY[`X''?Q"JRZUYKZW&T5=4"2NHZ:HB]0=>Z1G?/ M;/S)ZVV%BOBMWM1X/:6U:_!X;M[:>R\AU)T=0[FVCLKOB+&=U4%%U[O3;^RA MOKJGKC?SYZFS=5L_"Y3$X-JF>]3C$F#J/8X]>Z:=D_S!/E;U]TW1]`[JW1@=EXJ&KI/.,?(]!#+X!,OD]^``Z] MT7_KC*[ZP78>P\WU?6YS&]F8;>>U\KUWD=LR31;DH-]8_.4-7M&MV_+3_P"4 M19RES\-.](R>M9U0KS;WOKW1W^T_F=\X^J>W_DEL'L?(]=;+[-S.6'2GR*V9 MC_CK\5J#"3;AZ5[CBWS78FIV]M'JG^X5)N+'=V;1BR^3S.'ACJ\[EJ&*IK*N ML*1O[U08Z]UD'\U_YW"NW/7_`.EG9S#?/9/3;?8^^OD#1[; MH>Z*[LK:C]/-MCL7#=CILS#RY/#9NDK\+-5XFBJ12+44L$L?J#KW2L^.'\PW ML2F[5Z,Q'>DE+N/I[K+NS=O?6R=J=0]`_'[`[GV9\A\_UW2;+ZU[#VEBMM[9 MZODW#A=B[KVELR=MC-G<3MS*X/:]+@U%'2+`T'B/3KW1C/G+_,/^0FP-X[LZ M!3`;(V[WEM_(;DZ\^7W:F[OA3\+^H^QNZJW:_9W778.P>N.P>NNK,9VQUC'1 M]"[XZJI*S&9K&Y5LAEIZ@I6$P4=*OO0'GU[I!_'O^;EW7BNTMQ]B_('M#,4N MZ:23Y&]G=.]G]7?&7XR;DSG67R:^4E;L7%]Y]I[@ZRJL=TYM;MC!]N]9X#*X M+,8+,9<86.MR%)E_L:J;&QTTWB/3KW2.VI_,"Z_PO\S6F^<5'L1NNMOP;=W! MB6'6_5G6*5K]@Y3XQYCI"7ON?H:JRF*ZIBG7NF+Y>?S(=U]V[/:FZ=J=X[LVQU5MS/T?5>[]M8/M6?;T*;;W`5KZ:EFKJF3S9.IIHM@ M=>Z*_P!O_-+Y,=[XFKPW9_9;9NFR^]<'V7NJLQ.T-A;+SW8/96V<)D=N[>[' M[2W1L?:VV]R]K=@X7$9K(1TV;W)5Y3*0ODZZ59Q-6UZ,EC_F9_,[^ M:?;?55=0]R=F]R]G?&K=79WRXZMI&79\&-ZVW3L_*93Y%=D=KTV"J,;BMEF; M"Y#;]1E=%93S1+'$M#2PF)XZ1_4`Z]T'N+_F8_,+!-A/X%O+JS!P[9S'R"SN MVJ+"_%OXJ8G&;=R/RIV?3=?_`"!;`XK'=*4V-P]'V7LFBAQ=72T\4=+!11)% M2QP*J@>H.M=`WT'\M^_?C)C.R<%T[O'%8;;?;V*PN(['VINOKWK3M/:&Z(]L MU5=7;6RE5M+M?9^]MMT>Z=I5>4JY,1FJ6E@R^*:KG-)4P^:75Z@/7O+HPNW? MY@G\PKK'%=5=KX[?F;Q5'CJO:>U>N>X]S=)]7Y[*;W;XR9[96]=G[%RW;F\. MM,KF^Y:HL#4TN!F^VA-'BC#[2.'6L]*/?WS`_F%?&HX' MJ7?]1L[KF6KV3VKV'A=H9#XZ?%R27^X_\P7KC!5_:M.WKEZ63['INFV4VOMS*83IZ@ MV7L+KQL1MF+)5>8[(WAG=U5)PF+-;E9\?VKN/![>W]B\CF]BY[,8/)XS#;TPN(W!E=IY;+[3RE;2P4.X\7B]TX&NQE1 M44;S109"BGIW99H9$7W6NCN4G\T'YITNR\?U]4=A]>9W:>.VWL#:8QV[_C3\ M7][U.3P?5O4.\N@=@0;ES.\.FLYG-VUFV^E>PFEE>-8P MGJ#K=>@AH/FA\FL7\C*;Y98SM&LQ_?5'1X_$T^\:+;>S*7&)MK%[!I.J:'9+ M;`@VXG7$O7D/6%##MT[X_G)_,=INB]F=H9 MU^LL9\==Z3;MZ`V)'3_$WX;8?J[)U?6VX?\`3!7[9P/7&+Z4I,!1UW5.[.YZ MK-;*BEVODMR9)L)54D]7D%?5!U[H!Z7^8I\M*395!UZ-Z[`J]J8[H6'X MPQ4>5^/'QPS61J^AX>S:7N<==9C<68ZEKMR9_%S=KTB[@FJ*ZKJ*Z?*-)/). M[2RZ]TZ]7I;I_-=^=\6Z]^;YINW]L46[>T.YJ7Y`]@9W']`_'''5N[.V:?86 MZNKJC<>6-#U)3Q38_-]=[\S^&RV'"KA,S0;@RD5?25*Y*M\_J#KU3TL\E\VO MYC7P[W;CMO9G*;,ZOSV6SG4WRTV/L_+?'#XIYS;_`%WN3='7NS,UU?VQTKLN MNZFSVT.@,YFNN:+!AQM&DV]/+14\%/6Q$Q>)=4'7JGHI76GRU[QZ?D[E/7>: MV1M^E[__`("G:F'?I?I3,[;S=)M;L?#]M[&VOG^O M@P%+BZ*)\?31"+P4\42;Z]T,/=G??S7^4/0.\.S^VY\3N?HBG^7>=WUO'>>( MZGZ.Z]IZKY=?)+9>8W#N?+5F3V!LG:.ZA2W!WI_,GPW3^#J=P[5HX^R]J;^IM\;@WMN;(Y+-=$_'T;IV[ENRYVJ^R/]&.]:+JR MDWATYB^PZV:>HSU!M*NPE!F*FLJIJN&:2KJ6EW3KU>E+U3\U,3\;/BW/UM\< MH^R=K=^[^[T^-7?'9/8VY*K9^3VSLS>/Q"W1WEN7J')=-TM+BDR(;-5O:V(J M\A!FH9_X?6[:D\SL1L#O^CQ>V]N]&XO`XJ'MC:6"I:3,?;4\1J?%Y>)G>1O4' M7J]##\VY MO_,R^]ZG:O86R=G[=Z_SNW>F^ MW/L=]5AKL[MFLCS,\Q@$V3JOL:&2'=.O5Z:=F?S3?G!U]!M:':G:6S*!]E[? M^/>W-O5U9\>/C7G,Q3T_Q0AJJ3XVYJNSF>ZAR>8SF]^EL96RT.`W'73U.?H< M:YHTK/M?V??J#KU3T@,?\_OE9A_]$#8/L';>WZCH/OK>/R:Z@K]N].=([?RN MQNZ>P,]A-R;RW3B\OA>N:')SXO/Y/;.,$V"J9I]OBDQE'2+0K2TE/#'ZG7N@ M5PO?':FU>YJ/Y`[&W+3]:=L8S<[;PPNXNJ-M;3ZHQ^WLV^M9#MC9_7&#VOLG M;.'F@E>"3&8_'4V-DII9(&IS#(Z-[KW0KO\`.KY.4^Z^L]X[[@_F:_,/&CVI@JOMH)GX5Q?VO7L]!W\9 M?D#\G/C]M[O_`#/Q[QF,GVIN[K#'[,^163SGQ]ZI[RVY2=29O?&VJ2BQ&\ZO MM7K3L/%[*VAN3L:;"0,P:@@R683&Q.TM1'1JOJ>O6Z$<.ACVY_-B^>NU\IBL MWC.Y-NU.6VUV+@NUMC9']Z1UX5\^F;`?S//F?M.EI*#:W8/7FVZ"DPY MP;X_!?&KXP8C'Y.A7I33U.MTZ;L[_,L^:&X/XG+4=K8/$Y'+[G^-.]:O<&S^FNB]A;LBW9\ M.\"-K?&7<&-WALCK3;VZ,+E.GMN`T6+EHZR!OMF:.?S*S`^H.M],DG\P;Y6_ MQ3M3,X_?.S-MY'N;;=5M3?,^S.B/C_L9!ALCMWM':>:795-L[J[!TO5F4W+M MWNS=M+E\AM9,-D,O'N&N-;/.T[M[]0=>Z37;_?ORJ^3=70=\=C5^=W50])38 M/:E)O7:/6FV-C=?=893?F]>PNU,'CIJ3K#9^UNOMK[E["W]4[GSJR34\60SN M16OJ6:HDBF9/4`QU[I?UW\R?YA9!=UTL^_=A1;?WUM+LG9>\=B8_X[?&W%=7 M[DQO;VX=@[L[(S&7ZIQ?4='UM6;]W3N7JG;%=-NAL4=RQ5.WL<\-?&:*G\?J M#KW2KVE_-?\`G=LBDZ^I-O=L[.C?JW)=&9O8^5RWQV^,^Y=QXG/_`!HV5F^M M^B-QU6Z=S=/9?H.O=`]L+YR_)K MJ[#[9P77N^-M[0Q^R/D4ORNV&V$ZBZ9I,CU_WN8-ITE7NWK[-+U\A MV)AJ;([=Q%11[:R5+C*:"JQ\T42H/4'7NCF](_S0L[%AODI6_(^OP^?W;N3X M3;D^*7QHP6QOAM\1*[JC9_\`>3Y.==?)N?&[XZ\_A'6O7\'7E#NK9N3-!3?W M=W%_"Z[<4U914L#4RQS^IPIU[HEN<^SE_N M1UU3;AW!#4U/5=7+M>DWM2;1@WKMCKI9NC]H!-K8G(4.VXH]N4$:4*I3HH]0 M=>Z5NY^T_EC\8<5\:NL\]5=<;.;I+=Y^5?2F'QVS?C3N_?&Q.P=Y9;%+69GL M_+X';^Y=^4V]Y*WK+%QU^S^P:ELCCJ;#XR.IQ4%-#0*/8->O=+/(_P`UGYWY M2HP==4]R;?AR>U>YY/D!LW,XSHOX]87.[%[1J]^T?:67RFP,[A^J:#,;#VWN M7L>C_CF8VYAYZ+;>:RD]345U!425=4TWJ#KW0:=3;S^6>X^T.X/E_P!*4=/C M=Z=0[OMA]6;&V+M+9>_\E0=2[E3)=7X7;N`ZK?9F]YNQ%PE?MNE MPXR-Q=BT>WZ?LC=6P-I[HW#59#% MX#)Y:KPV-K#%+34T3T].8O4%:]>Z%_#_`,QSY8X+='2>\J#Z:K,G\6/BIFZ?9G6^O\`,-[;[5ZF^0'7';.V^L-W9+O+']+XBBSNW^F/CYU+A>L: M/IO>V:WO09;8NU>I.EMERX'=^5FS^0QLM9CLECJ"IQ>;RJY*@R=544-7C/4Z M]TG-D?S$?EMU[U+B.C=N;_VA+UC@MER==8S`[IZ*Z`W[7P[#;N:D^0U/M&7= MF^^KMR;QK=OXGNRACW)CZ:?(218W):GI!"KNK>H.O=+]/YL7SO2NW57#MG9C MKO[L/NCM/L3$S?'/XR3[8[*WG\BL9M[$]WU79FT9NG)-K=C8/LRFVCB7RF&S M='7X6:JQ5'4BD6II8)8_4'7N@3W?\V?DKO?O+ISY)9C?>%Q_='0&)ZCPG4>\ M=F=8=3=BF:6D@A MA3U!2G7NAF'\U?YP12[3JJ/L/K+%5_7ZXH=>Y7!_%GXGX'-==RX#_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]/21]J.M=>]^Z]U[W[K MW7O?NO=&-Z9ZPVQOG`9?(YO;NY\Q4T&8CHHJC`]N]0;"@B@DHHYQ#5XCL*FD MRTLWD#-'4PL:>92R`*\+Z@_N^Y7-E/%'#<1HK)6C03R&M:8:(Z?M!R./`BF0 M_L[[:P3R3RJ["6@*QO&*:4--,G=Q)R<'RX=!KWIY,V/ MDC?N7]LV':KFS@FVI9I$N-QL=SE,AN[N/4;C;0+4`QQ1J(D`90NI^YB28OXL MX;8E7M)*W?NV=E9*@?L.JIV;J_&R;KKZ;%;6J(L#1YO=N:QV[*2GVW55 M$%544M#!54N17(""52K.K$/,LMZMT4L;B97\`$Z/&.@%G&HJBE"7`(!8@KIU M#RID+]V#9^1KOE1+WGOEO9KFQ/,#I%]3VO2RTF'JH\:8DFPV*VZ\];%B:&#,5XV_@ MJFLPN"BRF9BJ*E*.DD:GIDE$<=D4`"JQBGAM8X[EJRBOXF?&HE1J8!FHM`68 M5-*G/6(W/>Y[!O/-6Y;ERS;-%L\JPT#6\%H6D6");B7Z6V>2WMEFN%EF6W@< MQ0JXCCHJ@!'^U?01ZL(_EM[#^-?8'=.]L9\HL;LS)['H.I,CD-MQ[Z[:VUU5 MA*+?-7V'UKMR@S!AW1WQ\7Z3LN3"[=S^4JI=N4_86UJR2CAGR,4]7_#6QE=H MUICKW5K6`^)'\J+,35<^XNT?BWA.F7^-\>$W-VQLOY59/_2UA?D%US_-`GV# MV%O;J_I+L7MM.PLW2[K^`64CSV*H\ELNIH,]!14]1AJ;[_\`B"2ZJ?\`5]G7 MNF?9M%T%T/MG^8?L1MC?RW<]2YSXW]4[=V;UEL#YW;@W-UI\F$H_G[T5OO`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`/E9U__*NWUW)VWOS?N5ZNWS'\@?YB7?6<[T^6 M/77SKV0V_NA]C[W^>^>K-L5'57Q:VW!O:/O;K;=WQ-KJ3/-N?'4F0IL9D,O6 MI55=+5XJ+'5517'V=>Z+)MC8'Q/V!)\W-@[ZZ;_EA[B['PWQ5V[6='0;*^7^ M_.Q^L-UYC'_*[K.MW5O#9G:V>^8>WMO1=UGH2KRE=0[;Q>\,1G<@FWHZ"3%1 M1Y/*XK+;],GKW2[[?^/W\L>/?_8VU^B]C?&43]>]2=A[N^+F=W]_,JQ>Z^J/ MFRF/[$Z0H-LY+Y!BDW7TWG/BEVG'TKEMXYREV=6;HV=5Y+<].F,-,L5'$,MJ MI_U#KW08=K[D^,>Z/^%%6Y]X]R[BZ)[3^)N^/Y@,&ZMU;MKM_P"V=]=![@ZI MWSO&DS-'N7-;VV-NFJVAD=L4&+S,%7D(JFODQ]-)!+29F`Q15U'[WG3\Z=>Z MBYKIOX`R[.ILGNS;?Q7Z_ILE\<_D_F>\S8+8$*9CR[XILI'NG.5,NX\0N.6+%>SU[HI_0/4WQWR_P MTWKVQ4U'QEWMWE@-_P#9^W>R>O\`Y'=\;KZ3K':,W3G:'QMV3LWLK M8.4[SW7-V!DMR_QG'I3;KJ*>;$8J`X,4M345%5OSZ]U8KM+XX_RF,A\BNKML M9O/]`TW1U3\S?CIM'KO=DWRFRD%3WI\,<_USO?+?(;LCY7FH[JQC_&K>^S\G MB]M2T?B?8M2MCIM=+JII\^O=!]O[J#^7_D/CSF<]0=9_#38G9-' M_+]VWW_/)L#YL[DW)NNF^7VROF?'UWN7X[X#:6YOESV)3Y?&]B_%&CEW)6XY M,97YHULWW.&K:.(Q4/OV:\>O='NSO2GP3^)WS2[KV'MW;?QQ^+W873F]_P"8 MOU!UGD:#YB46Z*?LGX[;P^!7RPZXP%3WW3=L_(/L?%=8=ST/=.Z-DX';^,BF MVOE,U%GLA]SA=6,EJ8]9('Y=>ZHB^22?%FC^+'Q^W?UIT[L39O<_?5'#N#,3L+M?=VV]TXOY);[H)\]]P]-4_P*;"5&.HWI MT\L8L*U/7NCU_%S87\HGMOXU=9Y#NB3J+H_O3=&RMV]*[F;/=@]]RS;8[=Z0 MR-?W7/\`*/<.,A[H./IME?(+IB>@Z\IL+#CEH:C?SS2XF*A2"6,:->O=*7XT M8/\`E\;GVSU5VGDNH_AUA\MV?)_."QV*^/'=7RLW)3;/V=E#\>>OZ[X%;;[% MI][_`"?VUG^MH\KONAW%MW'[SR60VW)5R&"L;*4^4I\#DZ;QK_@Z]T[?-NB^ M*7=_4';68FQWP_Q/;/27\M7^6-E^E-]];?+FCS>]SXVGP-1O*FJ<#235&3J15PI7>% MA/BKO3?>ZOCG6[6[)WC@]I?,S>V\N]]W;9^7'QMRTGR7&'RU1TI\<]L]@T%% MOKKZH^-E+CJ^ESE3M#=M'_$\GE&K*O&M24U/3[SGKW1CMS==?RX]N;I^7N\! M\8/BI`G1OQSZ]S_4G1W_``Z>>X]C]U]BU7REVWC/;'PM)38K)5D-%[UG&?Y=:IT8?972?\K7MGY*;%S&_MI_ M`'K[XWTW5W\NJ@EDVW\OC^SL M15T]9429'&[AQT*?Q7)['W]/E*G*TNLTQQZ]3HO^(^/_`,"]F]146Z=Q8GX? M=L=B['^#W:FX(-A;L^=\4N$W/\F=F?S&JW9.Q=MU=#UI\LMHYA*SL'X=96?< M53C<%D,=CIY$_B%)%3S2R+)OCZTKUJG16,3T)\*J/^=6.@:O=_5.9_E_K\Q, MAA#N_(_(#!TG53?&F;<=5EZ>H;Y!XW?^,H3C22N9H MV]3M^=.O4S\NC>;'ZX_E-[NZHZWW#O\`Z-Z4V$^^MQYS8WR=W;LS^91/B]^? M"S,8+?-/UYB=U]-=`[NJ^U]U_+K9^X-AX2DWN:S!#.K:SP5 M&J'T/7L=`!WI\9_@'M7J^H["Z8F^!F]>RZ?JKI#(]Q]/[I^;&YH=M]:+G?AQ MUIE=[[V^.%?M3Y%'M)EMJRY'>F1QO\'Q,<>&^RKVEFW0]>QT MQ8GH?^6!G,+\4-G8BAZ@H*W=G4-+O>O^06]_G7CL:W;7?S?$;?6ZZWX\_)/X M^T[8FO\`AYL#&_,NEQ.V*C==3GL-!+MA4DHQT6_P#F25.Q M=[_,?XM1X>JZ6W!M2O\`B1_+PV1GMK]'=P8+M[KS:.6V9T)UAU?V#U/%O39? M9W9.8HIMD;HVMD<.896DZ<^6WQJP_P`<]T[\[-[:^2O^_-]])9+M?%;CV/G,_#,L.WJ.J&*PN6EITK-"N#Y=;-.GCN]H?!CMOJ?*_KG^6AVGL;J+KC>/? MO66.^,O5_P`8.[^^IOCIMGY>="]5;SD^,?5 MG15=V3MW!]K=F_#/OW=7R7P\W2.:[6CH:_M/*Y[.=E]X8W#;]Q?6LT\Z8:DF MI*E/M(WK,/2S2A)=YH3UKHP.XND/B3@NU>Y]H;BVY\%4WGLKH? M1AHIYHZ#)>SU[HY>`^.G\HX2KB<7C/B3N[';NW_\N\-4;EWY\WN\%N#.8G(0[IVQ!33K4S334N7DU1OGU MO'21Z[^,/PEWKLG.=Z;?^/?P[WIEL-_+QZ$[VWGT@_S?WMM3I#K+O[,?S",+ MT?V'@=Y]@U/R[GWWU579[XQ;KP^1BQ6Z-US2C<.05*"E>H_W%#?VUX]>'22K M/B]_*YKOCY\I=Q]4[XZ(WAG#_IIW5\3LKV=\HL1L'N*O;K;YH46T=A;%WMM+ M=7??3D.U:/L3XIO)DX\95]=YFHS$2_Q>EW?B=U?%+>'6/1GRN[*[8W)V_P#$C?"PT571/4$B?5#0_9UZ@QT0;,=+_$W$?S M;NG_`(K9G&]2XOXS]5][=-_'7Y)[WK.U-Z]=]=[\BV#G,-M;Y6]PY+LCLSM) M)]J8^NS5-N*?%38O)X;'S8^BH/LJ)9YRD]O*OGUZF>ARI=J_RWGZ6^0_8[_& M_H7/]D[<[;[/Z]J.K*/^8KENJX.F^N-B]3;!I>H^X^C:7<>Z>VMP?,;_`$Q] MGC.S?CK1;1^6.[]];:[XV'@^D>]LQUKM_P":>5KN]>U:KXPK M3_(3"]O4'#HM6!ZK_ES;9V)VEVE MN/K?XQ[[[>V!\+.L>P=P_%[_`&<_.XWJ&+Y,U'S!BVEG=I=.=D8+Y$TF]^VJ MK._#K'-NO-X'#[CW2<)EZJ2CIZV.L>"AI?9ZWT(O:?6GP.[!J>YZ_96R/@MU MYMFC^%7\NG.=&9'8_P`OIMFYWLGL[,[T^&>/^3N`[(V7N/Y;STM#O/:F"H>Q MZ/+8O)8+#9OPX],[6+49F6'-UGL_/CU[H8\[\,?Y:/8?:&[L#U%@?B+B$PV^ M_P"9SLGKZOI_F9NS='Q[QVR>G]S]'9KX1]\?+G=E#\F]V[^V'UIV7L?+;VP$ M&YA/BI2?SHNEOC]V=TGU1\9OBBFX_ MC?0]NX/(=\Y3$=4[AV+N3JS9N_.QNX:/O+._(;?U#C-B=EIGJO,;6FQ6\(T7 M`3XNF"ME#4^?>=)SGKW0R;*ZU_E.;PZEZYS^_>C^ENOI-^;ASVQ/DYO+9/\` M,HDQ>_\`X4YG![X@Z[Q&[NE^@-Y5/;>Y_EUM+/;$PM)OC[S"+N?&9'-[@R6- M%7@L71TZ%7%_'_`/E2 M1;NZTV[7]<_`ZNV[4_(K^6SUOOO=4GS^WE25:]&=^?%>'-_.OMN22#YMIB:/ M.?'GY`4#0XQH*<4.+J*J2GR%%E:4P1Q:S\_/KW3#U=\;OY2..W/\1^N-S[)^ M._877N[]P]#XWNWY:;L_FD[5V/N7#[IDW+0GY,[)WS\9L)F-N9/`;*VWCQFZ M+;^Z*"MPV`KZ#'XW*4N>R%35KBZ"JFV!\$=O=1=D[AP?4/P"SO<78 MO\LO9>\<9U-N?Y<9;)['V9\I=F?/!]L]K8?9FZZ_YBT^Z-I]GUWQ1Q.*W72X MI]VBMS]3%/2X:GGQ==E,!5^S\^/7NBF?S$^GOB!UWV!T`WQ+BZ+JL?N#VL!F\'\A.K=XXGY.[>V_O/?_8.X,KG1N6##Y'+4FVYL3CH M:7;%&*F:"30KCCPZ]U77_,%V/\%>K^COC]B?B/MOK#>^5["S'O==%LW9WR-[^VGTYMOL?I7$]H9+:O5>8[+^.TFP]R9.+([6QF1@R"M!"*5 M_OZ8;%?/KW5BFW=W_$[:=-VSG.N^K/Y>^*V3OS^2K\:=OU6Q*?Y3Q[/C^0/R M(W%VC\#M\=P=4=JX@_+O$]A[.WWLW<_7.\@T-$VT]R2TN/DK,G/DC-35L^L^ MIX]>Z#[;WQ4_EGXKM3Y9;0J]Z]%;RZHV/_,:3;_3M4/FMUWA\CNWXG1_&?Y= M;FQ-=@WRGR-ZWV3VIMG`=J2=<00U[9/`Y#(5L\V$DW5A?OLC64.ZG'V=>Z)E M\6/CW\=>T?YI/E^3=9O'O M_`=:X7']4;JBBJLON[&4FY5I> MAZ_KS`_(S,8_XU5.Q?F73/E?DO\`%>GZ![]W6-Y_)2KWWW7MW`])=DXC>.U> MO9:?$U-?U)-N+<.XLCMF./&I;+8;W=U[H5Z?XH?RU-I[)H>Q=T]<_&_?'067 M^7_>O1W:G?F#^4786R]P===38+XL?%+N'%Y_XV;)JOE7NO&=K]R]4[W[CS^. MFPE!'VUB,AD,>E#]_D:2:CR]1JI_/KW05;5^.W\KSE_@5@]KUG\RCMS M8/S%S^VOD_VL-Z=:](9^7XX4_7HV1FI/D]CM^[]Z)K(I=UT;;M%!NC`X./"M M5PY2@GK\AD,Q[.F(^ MW1_%^KMG]_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO_]321]J.M=>]^Z]U[W[KW7O?NO="GTIN*DVEV?M;<=;F M:/`0XJ7*3QY7(TE?68^GK&PF3AQT=CJZ^6*&6II(7JJ1)#/"!)& MI!9O%N]UMMS;I$7+4&D$`D:A6FHA20*D!B%:FDX)ZE#V8YAM.5/^\QMO-;IP4VT M?VWM;:U#G(1L&FPV7WK%*,'OCMCK?&Y#;PPF)VS1Y[,30;MV#D\U4'-5R M-5+#B5IJA*41QZWD2!V#>_P7%S[WI6^FW+?-HAEM?IH+..YN&6_VN:X?ZB4&81V M(AE6$1IK=U@=JZ_8]ZY[=>]^Z]TM^NNLNR.X-W8KK_J7K[>_:._,[(T.#V3U MUM3/;VW=F9476\6*VWMJ@R>9R,B(+E887('/OW7NA1@^(7RRJML[ZWK3?%_Y M$5&S>KIMX4_9F[8.E.RIML]=U'7LL4&_X-]9Z/;+8K:,VQYYT3,+D):=L8[J M*D1DCWJH]>O=#ETU\(MS[X^'GS%^66^MI=R[2VIT9U5U5O3IO=IV'D,=U-V; MN'>_RDZEZ)W#B:C?N8QO\-RS83`[VR=13T>*D,\E;1L\LT<=)+!4>KD#KW2T MP/Q![HS7\N[:O>\/6WRH[4VSV3W;WGA^H<3UI#G\GTCU-4=%['ZLWAVUVQV3 MMFCV+O&FSHDBCJZ9I?5'KU[I"9/XG?*;"YG:VW,S\:^_,3N+?._=U=5 M[*V]DNG^PJ'/;N[.V+6TF,WKUUMG#5.WHLEG=\[1R5?#39/$TL4M?0U$JQS1 M(YT^]U'KU[J/O/XL?)WKG`;DW9V%\<>^-A[6V;5;?H=W[EWGU!V#M?`;5K=V M8S`9O:U'N3,YO;U#CL'5;EPVZ\75X^.JDB>LIZ.5TG_+ MZR^_/B_TWWYN3J[Y6;JH/DQ\E-T_'[K7=GQ[ZNJNU,;UO#UI_HFR&X=R;AZT MI,$,AW+GNU*??N?Q>TL!0[JV;5KDMCY2;RY*-7@I]$YIU[I,]J?![%[9Z;Z) M['Z];O??&8[-^%76WR0SM)MWJ"3?6T\5V1V)\U.U/BW1;(W%N7;65HWZJVA7 M8O9%,V"R-=!FJG/[G>/&I%3-DH%I/5X]>Z+SF_A?\Q-L[FV]LK6[T<5N;/E& MBO7NL/97PX^7'35%NO)]M_%[Y"=9XK8M+@:[>N8WUTWV'M;#;3H= MU9"CQ.V*[<68S6WJ/&X:AW)E]^Z]TX8G)U.%RN,S%''CYJO$Y"CR=+#EL3BL]BI:F@J8ZJ"/ M)X+.T>1PF:Q[RQ`34E93STM3&3'+&\;,I]U[H2^]N\^SODMVYOOO;N?.X_=' M:?9F6IDIZ*%JFH9YI M=W_F*?+5VW=F;-Z\P$6/P6WML8C";-V#M^BVS MM;!8G;VU,5A,!CJ>CQE`KSO#3)-7ULL];5//65-1/+[KW0>>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=:Z][]UOKWOW6NGO;.XL MKM#>HLE@\S1I5TR&6D MK::HI*A`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`THWWLZIZ^WOA-W;#V!V?LW>.S*K<&W- MW';^Z=A]G[8WCLK<%#2[MV=B*1?=>Z2>_\`L#>' M:.[Q=+C M<5BZ"GIL=BL;204E)##30Q1)[KW2.]^Z]T,V7^0':F=Z'V9\9\CFL&W3'7_8 M>[.U]K;9I-A=?8S+4G8.^L1AXJC,X/;6-HWAR65JZ9*; M&T<<<:)2P"/WSZ]T#/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NAHZ$^0?:OQEW\_9_3.:P.W][2;2WOL4Y7<'7_7G8]*FUNQ] MK939&^,9#@NS-J[PV]`VY-GYRMQE14)2K5?8UL\*R*DT@;Q%>O=`R[%W9V"@ MNS,0B)&@+$DA8XU5$6YX"@`#@#W[KW7'W[KW0U9/Y"]K9CH':OQAK\SM]^EM ME=C[G[;VWMN#KWKFBSE%V'O/#8;;NZ-QU'8E#M.F[*RTF:P6V\;234U9EZBC M-/C:-!$%I:<1^IFO7N@5]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__5TD?:CK77O?NO=>]^Z]U[W[KW M0L=*8+:VYM_T>"WAC*W)8;(8;CW%3;97#O1[=R>1;<=9D:K%9=&H]O4M M'+5F,1$EXE8I4*K4LY7O$US;V+SVD@6973BI?55P-``9XL[RICNTL_IS':32F[DE>"<&.U2-YR@0DLBL4G56M9 MY?=FV=H;5W'A:'8L!?;53MBGK:'.G<_]ZANMVS6=I:G.K6#`;76B2.HI&H!3 MB@IP!0^2S&4NU=GN+NYMYGO6_P`8$A!71HT=JD+34]<'574?BIY4Z5^]'+7* M7*_,6S6/(\!/+,3V#DH*CSX>?#97#[GQ>1W=X^H]NYZMS.VY-C[479F!VLAVG5XC:FX'QT35 M1K*UZ.ED:IIZB=IB*@.%M^EL8RNF4/$\9"?KNH5_$?Q&?O#.M>W2NIA1E%.V MF6'W?=JY^W&&Y,^T/9[I:;G#+?TV*TNI+BT.VV(V^ULA]"\%C=&)3,;BX:WA M8S07$QF(G#UR>Q_USPZ][]U[HW/P[^2FT_C+O#LO/;UZIK.WL'V+U!F.L?[O M4N],/M.'$9.KWKL+?6%W5D<3O'KCN#K+L;'X?*["A#8#=.ULUB)7F2LBCI\G M18^NI=$5Z]U:!NO^=3UYNKL+=78$_P`2-[T]1O/OKY^=\YK$?[-!@ZB@7*_/ M_P")6'^*V]]LX\O\9$>#![$IL.N=Q9E%1)43N::H)%I_>J?/KW1<]W?S'NG= M\=+]P;.S'Q7W;B.W>\OAQT'\0M][_P!F_(;"X3JU*'XO;@Z*SW3?8.UNE,M\ M>]R9;:V2D7X]X*FW/BJ;=XQF922KFHTQ-5.)TW0^O7NF?XY_S&]D]$];?%/8 M.2^/^Z=YU/QWW+\[ZK=&:H>\,3M2#L79WSW^/N-^.V_\%@,34='[JDZ]W+LK M:^W\?78?+5%7N*E:O2H-3CI89XXZ;Q'7NG+O?^9#UGW1T_W+TS2?'#>^S]O= MA]4?R]]A;,K1\A,'G\ALO_P#9?8,DV0Q% M,,!64F4I(YHLH\#/2^_`<,]>Z,IN;^=3UOF^_P#I/O\`Q_Q!WCB\SUG_`#"N MS/YB>[\#4?)_#Y/'[X[([6V)U-MO<>Q\'4K\::"?8^SJ/=DR*:I@BOEU[HG_8_\R'.[_\`B%@/BNE+\BL(FS:/?&S,%F8?EMN= MNNM[=7;U[DR/="8[Y"=,XSKS"8KNKL_;.;R/V6/W(V>^!GRL[<^3XR47=N)VUANU*CM2/J5 MCLW^!2]);EK=C+M^MZ/P$B9'^(YAIU:O7[>-JBF>B\16O7NE_1?S/>GZ+I_% M]1+\6^Q9*+%_$?J7XDPYQODSM<5[[=ZF^=TWSLH=V&$?&#PIELUNJ48&HI@? M`M`@G4^8:??J?/KW1VNH/YFO3GR8W]WQCMY]'87:FS]ZYK^8SWYO[ICM;YB= M=]>[>^4%%\\=_?&G*YSXUXCNO>?5?5>!Z=SW46[>H<)O[`;GJ,DU15P;-FQB M4-55UE-!)JE*=>Z`+Y??S%>BY_\`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`206;Q'-+MMS'`A9R!@*K$KJ&L!7[2=-:` MXK3J4?9?<-FVGW-Y7W'?;Y+6QA:9EE>XNK2..X^FF%HTMQ9?XU%"+HP^,T%' M\+6*@$D++Y*[AH=T[XPV;I,6;VDY>@>VLY86BE1!*=(=(T--*>47;357/$FM>AA M]X_F"QYHYUV?>K7=MLO;N7:D^HEL+W<;^'QA=78"F;=`MTKK`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`&E<2(N"Y0Q-JHK#L-:J5:H;MX84@ MU`B]]N1N5.1]]DM=IV^3;KZ=EEBM$OH=UMA;>)=6\I^MC6)HIX;FT*-:L+N@ MD8/=))"T;NO4G8'<.QMM4-%LK8E/N#$[AW1D!BZ^KV_G\G+79"2/;-)N#;U# M+B\G11/1YJ*BQ]-5*$,\L;-!'*JRSH[6Z6.TWMP[WEZ8Y8XQ4!E%!WE6.H'* MU8C-`:,14*0:>U'/ON[R1RW96?)G(\=_M6X;G+X,LEK=3-)*19QW5I&T,T:F M.X6.UAF`7Q'4M!'*JRSHY:?8BZQOZ][]U[H??C_NGK+:N>SM5V>:,8RIQ$=/ MC?O>F,3W2GWPK8I'T8;+]I]518=OMU;_`"I*JJ9AZ/$`=8]U[HUG^F#XD?ZO M!?\`I!>RO_NQ??L]>Z]_I@^)'^KP7_I!>RO_`+L7W[/7NO?Z8/B1_J\%_P"D M%[*_^[%]^SU[KW^F#XD?ZO!?^D%[*_\`NQ??L]>Z]_I@^)'^KP7_`*07LK_[ ML7W[/7NO?Z8/B1_J\%_Z07LK_P"[%]^SU[KW^F#XD?ZO!?\`I!>RO_NQ??L] M>Z]_I@^)'^KP7_I!>RO_`+L7W[/7NO?Z8/B1_J\%_P"D%[*_^[%]^SU[KW^F M#XD?ZO!?^D%[*_\`NQ??L]>Z]_I@^)'^KP7_`*07LK_[L7W[/7NO?Z8/B1_J M\%_Z07LK_P"[%]^SU[KW^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_I@^)'^KP7_I! M>RO_`+L7W[/7NO?Z8/B1_J\%_P"D%[*_^[%]^SU[KW^F#XD?ZO!?^D%[*_\` MNQ??L]>Z]_I@^)'^KP7_`*07LK_[L7W[/7NO?Z8/B1_J\%_Z07LK_P"[%]^S MU[KW^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_I@^)'^KP7_I!>RO_`+L7W[/7NO?Z M8/B1_J\%_P"D%[*_^[%]^SU[KW^F#XD?ZO!?^D%[*_\`NQ??L]>Z]_I@^)'^ MKP7_`*07LK_[L7W[/7NO?Z8/B1_J\%_Z07LK_P"[%]^SU[KW^F#XD?ZO!?\` MI!>RO_NQ??L]>Z]_I@^)'^KP7_I!>RO_`+L7W[/7NO?Z8/B1_J\%_P"D%[*_ M^[%]^SU[KW^F#XD?ZO!?^D%[*_\`NQ??L]>Z]_I@^)'^KP7_`*07LK_[L7W[ M/7NO?Z8/B1_J\%_Z07LK_P"[%]^SU[KW^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_ MI@^)'^KP7_I!>RO_`+L7W[/7NO?Z8/B1_J\%_P"D%[*_^[%]^SU[KW^F#XD? MZO!?^D%[*_\`NQ??L]>Z]_I@^)'^KP7_`*07LK_[L7W[/7NO?Z8/B1_J\%_Z M07LK_P"[%]^SU[KW^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_I@^)'^KP7_I!>RO_ M`+L7W[/7NO?Z8/B1_J\%_P"D%[*_^[%]^SU[KW^F#XD?ZO!?^D%[*_\`NQ?? ML]>Z]_I@^)'^KP7_`*07LK_[L7W[/7NO?Z8/B1_J\%_Z07LK_P"[%]^SU[KW M^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_I@^)'^KP7_I!>RO_`+L7W[/7NO?Z8/B1 M_J\%_P"D%[*_^[%]^SU[KW^F#XD?ZO!?^D%[*_\`NQ??L]>Z]_I@^)'^KP7_ M`*07LK_[L7W[/7NO?Z8/B1_J\%_Z07LK_P"[%]^SU[KW^F#XD?ZO!?\`I!>R MO_NQ??L]>Z]_I@^)'^KP7_I!>RO_`+L7W[/7NO?Z8/B1_J\%_P"D%[*_^[%] M^SU[KW^F#XD?ZO!?^D%[*_\`NQ??L]>Z]_I@^)'^KP7_`*07LK_[L7W[/7NO M?Z8/B1_J\%_Z07LK_P"[%]^SU[KW^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_I@^) M'^KP7_I!>RO_`+L7W[/7NO?Z8/B1_J\%_P"D%[*_^[%]^SU[KW^F#XD?ZO!? M^D%[*_\`NQ??L]>Z]_I@^)'^KP7_`*07LK_[L7W[/7NO?Z8/B1_J\%_Z07LK M_P"[%]^SU[KW^F#XD?ZO!?\`I!>RO_NQ??L]>Z]_I@^)'^KP7_I!>RO_`+L7 MW[/7NO?Z8/B1_J\%_P"D%[*_^[%]^SU[KW^F#XD?ZO!?^D%[*_\`NQ??L]>Z M]_I@^)'^KP7_`*07LK_[L7W[/7NO?Z8/B1_J\%_Z07LK_P"[%]^SU[HD';^8 MVCG^Q=PY;8A@.U:O^$_PHTVPJ+K&#]C!XRFKM&Q\=O'?]'A/]R4,U]&7J_N3 M>H/B:4PQ^Z]T&OOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z__ MT-)'VHZUU[W[KW7O?NO=>]^Z]T+?1>.HLGVEMJ+(92NPE+0P[BSSY7'9^?:U M512;9VOFMQ4\HW%2X[+UV(@-1BT6::FI*FJ6$MX(I)="DKWJ1X]MN#'$KLQ1 M=)76#K=4/:2H8T;`+`5I4@5/4K^R&W6>Y>Y_+D=_ND]E:P)=W1GBNFLGC-G9 M7%VK?5I%/)`NN%1))#!-,(RW@Q/+H4J?Y%2X:;<>S'P&;&>Q:=>XVDI:F/?> M>["I:6'';DW5C8,=1YK<6U=FUM-2T=-2(JTB4$<,1)96TVP"86]V)X=$ MOCDD>&L1-40DE5>0$DD]VHD_*G0F^\))L\O,/)S[#O0OML'+\*(XW.ZW5$6* M[O85ACN+NRV^1$C2-0(%MEC0U96L,[AL/+O=\92[JKX/;/?-GVB7>FVV+=)5F$` MWO2T,L-NQ@VR7;;RUM(+_4)'E;<*P*);=F_3DG#UX^QYUS\Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NAC^/_07:_P`H MNX=C]"=';;H]X=L=DY27"[)VO6[KV=LJ/.Y>*AJ\C_#HMQ;]W!M?:U)63TU% M)X$J*V%JB73%%KE=$;Q-,]>ZX]X]"=K_`!OWQ'UUW%MB';&YZK:NS]]8H8[< M>U=Z;=W'LGL#;N/W9LK>.T=[;$SFYME;QVMN?;V4@J:/(8O(5E),KE1)K1U7 MW'KW67ICX_\`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`CPI#%!/)4O((5C=G"E!NCVL>WW3WL!EM0O[YF?:HG03EOJ(;9YKAHX9XY(XY89!(97\.9`^B1'%8W0E3=4 M[IWA@]LT:474F`['P5'V!'48*MW+0;BJ8/0D]K>: M.;MDY:LTLO:BPYBV2'?P]M)>17;K%N$L$;26]K]/_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NCR_P`M/Y'=;_$/YU_&KY,]N4>]\EU[TMV'!OC<.,ZXP>!W%O+) MQ8[%9..CQV&Q>YMV['PDDE9D*B*.62?)0B"$O(JRLHB?1%01U[JPCI7^91\1 M,PFU9/F-U3E.R:SK_P"072M/2OAOB5\7>TZ/?_P.Z3VUUGLG8'Q=H9N\-YU^ M]?C;'L#"]=U53&^T<_7S[M_O)746?R52(H:UM$'RZ]T"7Q<_F";`Z,^8?>_R M)7)Y[K[9G8LT>SZ?K/KOXB?&S<737;?0[;@QL.55J7JFJX_$8`Z]T?_>_\T3^4GW%@.N-K]@?%KM?;>V.L M<'M'!]6X7#_&[XQ=G9SHK#4'8GSOWOF=F;4[%[`[6QN=[7Z\Q$/R.Z^CQ^W] MTTG]W*VMV-4U=1BX9*Z03:TGUZ]TC-S_`,R[^5+-O+;>9VU\*<.-M;C[O3>/ M;F"D^#/PPP+X/9#_`!$ZAZ\QD_49JMX[\I::LV%\P]D9WL:#9LZ8_:.Z<3GY M,+FFDH3)2GU#Z]>ZHA^1^]=F]B=U[ZWCU]))4;0S-9BSB*V7IGJ7X[R9+['` M8G&5^7;H_HF>KZCZP_C&3HIJH8G!U%524PFL:BHE,DSW'7N@1]^Z]U[W[KW7 MO?NO=3L9'C9HC6NJ\?BJK)X2ER==34 MI9XJ>2MI(YI%"--$"77W7NKT]Z_S!?@KV#_,A^:GRSWCT_OO>W6OR,K-O[EZ MEK^S^@>C^V-V]2[A@[$ZOW7O?&YGH+?W:F9Z=W;3[XV+M3-[23,R9[[[#09@ M9*DIQ4IX!6AH!7KW1J-I?S3?Y1&2W#TMN'L?X8Y[%;/ZEP-5LC&_'G'?#WXA M]R;)QW7N=^27R%[`WGM8=N=B=C;5[$W3-G>HNV-N1XW)U-!097;N[MJ35E+4 MR+GLU/6:TMZ]>ZI7^>7R&ZR^1V_.BL[U5#ON+!=5_#;XF_'/,R]@[=V_MC+9 M'=WQ]Z9VWU=N/,XS&[P%*]>Z(][WU M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_ MTM)'VHZUU[W[KW7O?NO=>]^Z]T:_XW;"P&_<'V!0YI\=)+3YG8*T6.FV)G]\ MY?*"KI]\+5T^'@VA68G=6*,20I++40UM/1#0GW5U"-&&.8+Z>RFL7A#4*2U/ MB+&HH8Z%C(&1O0`J6XZ>MDY]LMY:W:1+S:Q'"VV76Y3S:TW( M.ENMA)!>P:0JN\L=Q%;C2GU55",@>_(/9.VM@=EY3;NU#DCB(:>">-LON/;N MXZ]II):E)3,^WY)&PX_:`6AK[9&%0&FN'0E?L5Y<7VW1W%UI\4DCM1D'E_%\ M7^F7M/EP/0!]_N3.7.0O%90YOM/=^RMOUU1@-KXRKR4]+#5O5C'T=34B(PT\[ MQ^)IU[H%TQ\[Y)<4LE"*IZY<>)7R>-CQHG:<4PD;,R5:XA*'R&YJFG%,(_69 M-'J]^Z]T(*=/[WD[,W5U&!M!-Z;+J.QZ;<'G[+ZUI]H12=48C<>E=W_)#O#J/X_=?5.W M:3?7=78NT.K]G5&[,S%M_;B;GWOG*+;V#7+9>2*H:EI9HD9A'#% M+,R1MXX%>O=!OGL-5[=SF9V_D#":_!9;(X:M-.[24YJ\9634528)&2-I(3-` MVEBJDK8V'T]^Z]TU>_=>Z,-OSXR=D]=O\9XL]-M.6;Y7]6;>[>ZN3';CIIH: M;:NZ.V>QNF\3#N_(5$5)B]O9AMU]89"2HA\\T=)1R0M/)'-YH(=5X]>ZC_(/ MXV=C_&G?6^]@]B3[,JLGU_W?W;\?LO4[2WMMW<(FW_\`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`=N9'IK8^'P]=OG!]<[4W%V?NRGS6'HH<-1[V[-HL901L*J MOJ\GF8J''4U575L%--HT''KW6+?GS2_F*=:;YWGUQO'YA?)>@W=U_NO<6R=U M4./^2.\=R4%%N/:F7K,%G*2AW%MG>^8VWGJ.FR=!*D5;CZNJH:I%$L$TL3([ M>QZ=>Z2G_#A'SQ_[S-^4?_H]^S?_`+)?>Z#TZ]U[_APCYX_]YF_*/_T>_9O_ M`-DOOU!Z=>Z]_P`.$?/'_O,WY1_^CW[-_P#LE]^H/3KW0*]J]\=V]Z5F'R'= M7;O97;5?M^FJJ/!5G9&]MQ[TJL-25TL4]938N?<61R$M!3UV^=N9G=-#0218? M"?+K+;KW#MK/R];=5=HYW8W86S\%V%5[SZVWKM';_`Z]T4#_`(<(^>/_`'F;\H__`$>_9O\`]DOO=!Z=>Z]_PX1\\?\` MO,WY1_\`H]^S?_LE]^H/3KW7O^'"/GC_`-YF_*/_`-'OV;_]DOOU!Z=>Z]_P MX1\\?^\S?E'_`.CW[-_^R7WZ@].O=>_X<(^>/_>9ORC_`/1[]F__`&2^_4'I MU[KW_#A'SQ_[S-^4?_H]^S?_`+)??J#TZ]U[_APCYX_]YF_*/_T>_9O_`-DO MOU!Z=>Z+AO\`[$W]VMNS*;\[/WKNKL/>^;%"N8W=O7/Y3<^Y9JJS(U@H,50P4T/DD;QP0HBV50![KW2-]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7_T])'VHZUU[W[KW7O?NO=>]^Z]T+6P\5W?D-M[CHN ML\%V3D=KY^MH*3=#;)P6X:_'Y&KPM/52T>-RM=A**8.*6GSKR-2O)H83([H2 M(R"N]EV:.XMWW&:W6Y0$IXC*"`Q%2H8^96FJGD0#QZE;D;:_>K<.7.8;/VWV M/F.XY9OYHH[T[=;7?N0=S]OKGEVPWB.ZBW* M]VN*[DAN+2XLY;=WEGB:!H[E$=]#0&DRKX<@-4)`J1)Z@HN\8\309;K":GCI M)=]QX+#QM2[=R=;+O.JP+UAAI*3*T&1J:.F?'TM/++/((<>*N"CE=_N*:F>( MOW5]F,KQ;B#J$&ILL!X8:F2I`)J2`!5M)<`:68&1_:2S][(]JL-V]LYHUM7W MT6UN"EI-(VX/;&33''/%*\:&)(G>1Q':^/%9RN_U%M;O$7?V?=8^=>]^Z]U9 M)_*;[7Z>Z.^:.W.U.]>T\!U%U[@.F?E-MVHW+N#;G96Z8JO71N%V M;M3='Q-I-[;+R'\K+-[2R^Q/B)N+8>?J-R;:Z0W?LG^8M+O'>%'\7]N9CL'9 M^3[3FPF=;$[AJ]?Y7W76T/Y?&9I.V^C=G]H_'C MYF_RVOD5V!O"#XY]M8+L.BZWZ_VMG\I\P=F97<>TOC-N;>F[MT4G;%)AJ]H< MEV'O+`YAX%JMN1;;I2^#CV:YZ]T4'^7W3=?;BW__`#0=U5E7\;P.ZPK?D-L7L?Y/E=\/G278>XNK_C/U!TYMW+TW1N_ M:#N#I?O_`&7_`##.Q^XMQ=LTW=F3Z2Q.Z:[XYY'XO;\R=-4[9HLKEIZ_-9&! MEP%-60RUB>H:UZ]T/7<'>_\`*Q[9[*[DWM5]W]!Q=F=C?*#^:MVCUEW1N/XG M]J[YPNTA\A^V_CSO_P"*6[/D!M32G]0]>ZJPZ3[-^-M'\E/E'N;MW)]+5[[LZB[3POQV[._V7*&E^-N MTN_:W+;3DVWV%7?&K#=?YJFQO763VGCMPX_$T)V;5C%9#+4%?-AX&IGCIMFM M!3KW1^-Z_,+XFT7PK[NZ=ZA["^*^U^YNR,C_`"^V[#=OA_4-UMVWV/U'4_)6 M#O'N386V,I\5\OMOKS:V$VOV?L2B6E./V]D*JLP>Z:G&8F)O="K M\TOG'\"NY?Q_CKO3K/:-)T)-\ M:\_UQL'J!>KN^^M]]-N.3=&4WX,;79S)55%D)L[EH*8T3Z`../7N@V[&^0G\ MN[^?Y9W?6YOD-D<)6? M#[`X#8?9_P#,4W%LWNG97P=GQ6VOB;\,>P<_\<:3X7=O]F]+5?QFV9M?Y$9# M!]M35W7R8O*4FXMVX=.Q8JFD#&CIFI=9QU[HLH-R=B_"O!0;5ZCZOZZH^C^UNLM_\`4_5^YH=[;DV%0]1]6XNJW%W'C]W2 M;ASE#F-MTU;BPNL.C:S:WS;ZKEZ-S/QQR6,P/9O:W6&Z9RN([W/?V\-L-D>M^U=@;][I)RVVZ+:%+EZFFHJNBB88.' M'U%-7^%:GKW53T>UMC-U+5[V?M#&Q]E0]BX_:U-TL=J[K?+UFQJG;63RU=V@ MN]UH/[CP8W&Y^DI\2<4]5_%99:L5"1?;QNXMU[H1<7U;T;6=F=2;2R'R@VWB M.O\`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`2[NWOD-FYJ"/&R9#!T]5C:Z299Z>5H5=E]^77N@ZCVML9N MI:O>S]H8V/LJ'L7'[6INECM7=;Y>LV-4[:R>6KNT%WNM!_<>#&XW/TE/B3BG MJOXK++5BH2+[>-W'NO="+B^K>C:SLSJ3:60^4&V\1U_O;9&T]P]E]L2]5]K5 MF-Z6W;F=OU63W+U]E]H4>`EW=O?(;-S4$>-DR&#IZK&UTDRST\K0J[+[\NO= M!U'M;8S=2U>]G[0QL?94/8N/VM3=+':NZWR]9L:IVUD\M7=H+O=:#^X\&-QN M?I*?$G%/5?Q666K%0D7V\;N/=>Z$7%]6]&UG9G4FTLA\H-MXCK_>VR-I[A[+ M[8EZK[6K,;TMNW,[?JLGN7K[+[0H\!+N[>^0V;FH(\;)D,'3U6-KI)EGIY6A M5V7WY=>Z#J/:VQFZEJ][/VAC8^RH>QZT M']QX,;C<_24^).*>J_BLLM6*A(OMXW<>Z]T(N+ZMZ-K.S.I-I9#Y0;;Q'7^] MMD;3W#V7VQ+U7VM68WI;=N9V_59/UMC-U+5[V?M#&Q]E0]BX_:U-TL=J[K?+UFQJG;63R MU=V@N]UH/[CP8W&Y^DI\2<4]5_%99:L5"1?;QNX]U[H1<7U;T;6=F=2;2R'R M@VWB.O\`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`2[NWOD-FYJ"/&R9#!T]5C:Z299Z>5H5=E]^77N@ZCV MML9NI:O>S]H8V/LJ'L7'[6INECM7=;Y>LV-4[:R>6KNT%WNM!_<>#&XW/TE/ MB3BGJOXK++5BH2+[>-W'NO="+B^K>C:SLSJ3:60^4&V\1U_O;9&T]P]E]L2] M5]K5F-Z6W;F=OU63W+U]E]H4>`EW=O?(;-S4$>-DR&#IZK&UTDRST\K0J[+[ M\NO=!U'M;8S=2U>]G[0QL?94/8N/VM3=+':NZWR]9L:IVUD\M7=H+O=:#^X\ M&-QN?I*?$G%/5?Q666K%0D7V\;N/=>Z$7%]6]&UG9G4FTLA\H-MXCK_>VR-I M[A[+[8EZK[6K,;TMNW,[?JLGN7K[+[0H\!+N[>^0V;FH(\;)D,'3U6-KI)EG MIY6A5V7WY=>Z#J/:VQFZEJ][/VAC8^RH>QZT']QX,;C<_24^).*>J_BLLM6*A(OMXW<>Z]T(N+ZMZ-K.S.I-I9#Y0;;Q M'7^]MD;3W#V7VQ+U7VM68WI;=N9V_59/UMC-U+5[V?M#&Q]E0]BX_:U-TL=J[K?+UFQJG M;63RU=V@N]UH/[CP8W&Y^DI\2<4]5_%99:L5"1?;QNX]U[H.O?NO=>]^Z]U; M3_)A[TV]\?OFIUQO3=?R&ZZZ'VA7;YZ9P/8F/[CV)E-Y]6=K=7MWGUOGM[;3 MSN1Q^U]X4G7^Y=K)@*7=.W-Q5U-14>&S>!@JFRF,DBCJ!5N'#KW1"/DY7]'Y M7Y&]ZY/XSXO.8/X\9#MOL"MZ2P^Y&J&S>+ZNJ=T9.;9-#7BLEJ*^.2FV^\"* ME3-/51H%6>664/(UAPSQZ]T!OOW7NO>_=>Z][]U[KWOW7NG3!_9_QK$?Q'(5 MF(Q_\4Q_W^5Q\!JJ_&4?W<7W60H:83TIJ*RB@U211B6/6Z@:EO<>Z]U=M_.J M[_\`C-\B-S=%;UV1V9LSY"?*K_1YUO2_(GY,=9X'>^U,!W3@Z3XQ_&K&[3S' M9V`WC08;&TG>V,[$QV\X,A38#'4%%A]O_P`)QF0$F9I*Z*CJM17&.O=4:^[= M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z__]321]J.M=>]^Z]U[W[KW7O?NO=##TCG MZO';^V]C9]XP;2V[D:C*T>:GS$M?)MIZ++X*OQ.2I\G14>;V];^,8^RV_7 M>W\^FU9YA=S#3,D=4: M,QH,_0^)VG_H*WWF=T]B93K]:G-;GQ-`=M;AQVU\UN&KI\'LR=,76/4;KQLV M[<6L60D/\.DQ\T,,;5#QSI-,$8HWN6Z_?5E%;6"ST1&.M2ZJ"T@J*(=!P.\, M"3I!4@5ZF/V,VKE7_6/YXWCF?W"NM@62]O((OH[J&RN+N1;;;V$,A:^A:^A" MRL?I'M9(XU-P\KL7VI6;AQOQ_V)D>Q-Q;37%97M/JF'%5V;P.)GCHJHU=1& M*OQI+&D;-,FB:=>ZY87X;;D[!^-/2OZ%'X/_RY.Y/DA\X^LOBEVMTY\D.OL0W;NPMA?(>IQ'46ZJ7>_2&#WA,) MER.]>&ISE.D,5.&J?#4)&8W\305Z]T4W;WQ=^3&[ML[6W MIM3X[=Z;GV=OG-4.V]D[LV]U'O\`S6V=X;ARF2JL/C,#M;/8W;]3B]P9K(Y> MAGI8*6DEFGFJ87B12Z,H]4>O7NA_VM\;OYGO3M)NC:.RNA/GGU90]S[2S>!W MIMC:W5OR#V/2=L;$V]M^BWIN3"[HPN)P6+AWUM+![6SE-EJZFJXJJCIL?61U M4JK#*KMZH/F.O=!%C/A?\Q,UC7S.&^)_R6RV(CV9BNQY,KC.B>T:_&Q]>9W$ MYS/X3?CUU+M:6E79F9P6V,E6TN4+?8U%)CZF:.5HX)63U1Z]>Z'X_P`M;Y)5 M6[5S>%Z'^7N6^-"_):J^.=7W##\4MU/V9C\MB-RX;"9],C\>L?NS)YC&[_HH M,PJTVW:G.P15N91\2F26KBJ/!ZH]<]>Z+/GOBW\CL%USD>[:OX^=^4/1%%-1 ME>Y\]TUOO!]AAC_`(E*CY!'IHY))$(] M[J.%<]>ZC]D?%[Y*]-[-VYV)V[\?.[.K=@[PR4F&VIO7L3JS?&R]J[CR\5&^ M0?%87/[CP>-Q>2R7\/B:H$$4KRM`ID"E`6]^J/7KW1U>B/Y;V[>R_B_GN\]] M[%^4FS\Q6_)CXD=1=84VU^@L_O&F[+ZU[_Q7=.7WQO3J?:E1_=_-=X;QV9CN MLZ2IH\1B,C04TR5T*2U?^6QR4VJYIU[HC*?'_NS(XC$[LV]TUW'F=B[IW_\` MZ,-E;P3J[=JXC=F_IYO=*6I^(7RRHJ[=N,K/B_P#(BDR6P,;09G?>/J>E.RH*[96(RFW9-WXS*[MI M)=LK4;;QN1VG$V4@GK%ABFQRFI1C""_O51Z]>Z4G5O7?S?ZK'^F+I;9'RHZU M#;&VKGE[1ZQVYVSLPR];=Q;VJ^J]DY>+>NUJ/&F?97:78N)J-NXN9:EJ'-YB MDEH8#-40O$OL=>Z&;KWXG?S4:/Y'[/R.P^C/FWLGY5[O;M+L?8>Z7VGW#UEW M+N.LV#2U\O;>[=K[USD&VMSY/-85ZV6CRE135CU7>6*H M_P"\&Y8LHL[9`>::J6<2&;UZO?JCR/7NI&%^+'R=W'@^NMS[>^./?&>VUV_N M&3:/4NX<+U!V#E,'VCNR&CJVX8J"CFG:BQDE34K#$[E-* ML1NH]>O=/5'\0_E!'V;B>I\Y\9_DE0[\KL!AM]5'7]'T9V%4]FMUOF*N*"FW MSB=A5>%Q^9R.`KDD(HJQA%054NE!4"^H:J/7KW0E_+?XAY7I_P">/R)^&_0^ M&['[CJ.I^Y^Q.M=DT&-V[4[L[&W7BMCY#(1FOGP6S<1KKL@F+QTE34_:4:QQ MQQN^E44D>!P">O=`D/C'\DS4]BT8^/?>!K.GZJMH>VZ0=3[]^YZNK<;0UF4R M-'V+!_`/+LFJQ^,Q]143QY,4KQ0022,`B,1ZH]>O="+B?@'\[<_C\=E\%\*O MEKFL5EZC;])BN$R6YMF_$SY,;MVWALMN3`Y?<&V>B.TL]A, M5G-FY;'X'=^&R65Q6U:J@HO7NGFG^ M&O?L./[`P>>Z(^46'[GV=V?USU91=4I\:NP*J27 MP]_TVWL!05V%V\V$KZ[<&/K:FJ0TL%`6J/5'KU[I"0_&/Y#1R[IDRO0?>]!B M^O-V8#9?9M=#T_OBIEZ]W)N3+X/!X;;>Z:>IQ>.I\'NS,Y/R.SU.6@HZ(SU$V-!JD0P>OWZH]>O=&Z^/W\O_`&[NW`XNG[Z_TR]:=CYR ME_F3T\6R/[O4.V*W:^X_@A\+-D_*3#8;>E#N_$OF<5-O7([U:"OA,"UM'1X^ M!%@`RT>0H=$^G7NB5]]=38'K&'H_,;:R64K,1W%T#L/MDX_.O329K;^>K:_< MFQMYXVJDI*'&1'%U^]]AY+*896@$L>`R%"DDM5(K5=1L>?7N@!][Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U8]_*Z^!])_,&^2M)U!F-W[BVMM3;U#M'=V]J?8&W:7>':N?V= MENXNK^K=P0==;9KLAC:"6JVO0=CMN'-Y2J>:EV[M?#Y+*R4U;]FM%4Z)H.O= M$0["PNV-N;^WQM[9&Y\AO;9F!W?N7"[1WGEMKU&R,KN[;&+S5;0X#<^3V75Y M/-56T,AGL5!%5S8N6LJY,?)*8&FE,9=M]>Z2'OW7NO>_=>Z][]U[KWOW7NLU M/":FH@IQ)#$9YHH1+42I!3Q&5U023SR$)#"A:[,QLJ@D^_=>ZLX_FH?`WK;^ M7?WIC_C_`+7[CWEVGO["[=V94]CQYSK*':VR5GSW2O2^_*??73_9%%NG+4G: MG6V]]X;XW%14(EQ>&R."&`-+5BM=UK9=*:BO7NJP?>^O=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=?_U=)'VHZUU[W[KW7O?NO=>]^Z]T,_Q]GEINV=N3H^+BBCQ^\# MD*C-55-1XZEPQV3N-F1[58EM[_Q6N'2.%+? M]W78N9&,EI?QDQV_BNDNP,KMW8>V=G5E)6)%A\/E MZ:DVRM--L;#O%G.RX-T5>+K%Q6TI!G=UY;(TTE?%!@L=2*F/@T741Q0DW+5G M?1SWMQ=H02[*2]1(W;"4##4_:B@A29';N-Z&006)^IOIY87N4BVRT@"VL.BJB.*'/U=L_X^]C0TM1 M0[`RM(,9FS3;JBW%W(V/GI,`D&)EI,WC<;1;$>MW/6Y:62OC&*Q\@JT:C0+) M_E"M'7XX[35_P!LN4?8/W#AMKBQ MY"NHA;7NB]6[Y@,31VH6!H[F&&/;#)>R3DW2?16K"=3;H%D_QA3&1[V,NL)^ MO>_=>Z-1\//D]5_$_MK)[^DV50]E;.WMU5V[T5VMUY79JKVPV].I.\NOL]UK MV#A,7NNAHLG5;4W"<%GY*C&9(4E;'1Y""&26EJH1)3RZ(KU[HT?57\P;K#I2 M,;"Z^^/O8:=#8_J3YQ[)P6S]S?(3;>8[3INPOGCT;M+X]]F=DYCMG%_'7;NW M]>8!<1@J;:&.1*W'M/+6.:F93ZGSSU[HV6!_G3=5T/8O378.:^&>Z MZZI^/?<7QB[ZZKAP'R=P6W,@V_\`X]?&?HOXLY+#]A9.I^,6X*7>76F]]C?' M[#5])BZ:CQ&3V[F*O(R092HIZQJ9=:>.>O=)G;G\YF@VYN/XK9VBZN^4E+A/ MC'DOC!C3T]B/GMGL-\>>S.O_`(>[PV7NOIBFW5TM3=!/M>#M&J?K3!#4S M8/+Y!*W*TNW<;E*J"JHO:>/7N@O^+?\`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`!9IJKY)UT^;QV\-Q[9Z MFPN5VU\C MQ%^/V+ZDWU\:=S9W>\7QWV;\9VWM@;3R'7_7/SO3YX[,R6'ZPJ/CY MO%]N;IBWE/5X+(2)G:C&U.+FB>FHJ&2$B7U,\>O="77?SB^O:[LS+;_?XJ[Y M%)NSY;_S'/D[O#$/\F<#/DGQG\R+XY2?'?L3KG9N=E^-#4VV)NO,>D&4PF6K M*#,0RU$;156.E1U:/5/GU[HH'R>^=.TOD%\=>J.AL7TGF-OY/JS_`$1T&-[6 MWWV/M'L3?2;1ZEZ?J.J:'8%!F]L=']2[FR6S,K/4+E(*3=65W:=M"E@QNWGQ M&+^XI:G8%#7KW1U>H/YS?6'56`^.F._V3?/Y3,]"]S_";ORJS=!\B]MXRIW[ MV%\-.E-]='T,.9SV;^,N[NSJG9F^=O;V,]-B'I3Y`_(W MOWKW>N,W7+\9\S@J/#9*O^3N?QFZ,!58:OCS<5)CJNFK,964BRMNF:UZ]TF< M_P#S'^N=W_-KYL_)K=WQBRF=Z@^=>U.P-H=H='/WA%0[[VG1=B[JV#V3E,EU MUWO0]00T6%SF)[*Z^I:FAFJMG5L)PDTV+JXJOR25 MU/2R_P"RQ1-(W4%+MZ*HPTT@+UI=HYP@LP]3Y]>ZD;1_G,["V71YJ+`_&3M7 M$Y/,=9_#+K;^\.)^4VS8\K2P_#3XA=S_`!#V]E9Z;,?$O.[>W##V%MKN:IR& M=Q.7HL6VE2?%R@W#7[%PN.Z)QPVAV#O^B^-\Z9*?;DVWMC3IN-8 M9]H5%+M_;E-C/`<,]>Z5';_\XBA[,[`WEVQBOC=5;8W]4T/\P+;?6GWWSL/\0L4E;B?E1L\3[5;XB_"WM+X7 MX27'TF;^)F>V_G>Q66H*[#Y`1/C*NEJ\=55,,GM/SZ]T0'N#Y M]=P[G[EW-V9\?\UO+XG;=R>2JLIMG8_3>_*W:DFSZW<75O7?57957B-P[`Q' M7-/AE[>Q'66,J-Q8O!8W`[9G:GIZ6EQ-)CZ&@HZ7=,4/7N@`VCVI@ M?R)VIGN]]C[4PNV-I9;8%)ON;K/(YO9.Q]FTVR]F;6QF]<9MW<4NV*7`XS%T M(66+'5$DRTS:[R3/-[WU[I,1[@ZY7J6KVK)USDI.W)>Q/W;N" M2'(1X>#'Y1,;'$U,E3*K^1??GU[H.H]P=&[=ZRB[TRF/R7;F^<5M^JH-V;WQ'8";#J:SK M/'[MW!)#D(\/!C\HF-CB:F2IE5_(OOSZ]T'4>X.N5ZEJ]JR=Z M$7%]@?'*F[,ZDW)E/CIN3*=8[5V1M/#=N]91=Z93'Y+MS?.*V_54&[-[XCL! M-AU-9UGC]V[@DAR$>'@Q^43&QQ-3)4RJ_D7WY]>Z#J/<'7*]2U>U9.NI:O:LG M7.2D[.R'7+=9C`FBJF4Q^2[^([`38=36=9X_=NX)(Q/W;N"2'(1X>#'Y1,;'$U,E3*K^1? M?GU[H.H]P=&[=ZRB[TRF/R7;F^<5M^JH-V;WQ'8";#J:SK/'[MW!)#D(\/!C\HF-CB:F2 MIE5_(OOSZ]T'4>X.N5ZEJ]JR=Z$7%]@?'*F[,ZDW)E/CIN3*= M8[5V1M/#=N]91=Z93'Y+MS?.*V_54&[-[XCL!-AU-9UGC]V[@DAR$>'@Q^43 M&QQ-3)4RJ_D7WY]>Z#J/<'7*]2U>U9.NLHN],IC\EVYOG%;?JJ#=F]\1V`FPZFLZSQ^[=P20Y"/ M#P8_*)C8XFIDJ95?R+[\^O=!U'N#KE>I:O:LG7.2D[.R'7+=9C`FBJF4Q^2[^([`38=36=9X_=N MX)(_= M>Z][]U[H[O\`+[^274?Q0^375'>7;76.^^P:/K/M/J/L?;^2ZQ['BZ[WQM#( M=>=D[^'W+M?'UV*K\%6C&BOBJE$>3H&4RG1!(QU[H$/D MOW=D?DM\A^\?D-F-L[?V9E>[^U]^]JY':FUH3!M_;U;OOG MHILB4\\@\U0P,LEW=C[V,#KW0(^_=>Z][]U[KWOW7NO>_=>Z<,35TV/RN,KZ MW'4^8HZ+(4=75XBKEJ(:7*4U-4QS3XZIFI)(:N*GKHD,3M$Z2*K$J0;'W[KW M5G?\Q'^87M/YA;,^.?3O5O5>Z^MNG/C?M#;>+V)CNS.PT[4WGMNH?H/X^=2[ MEZ]V?N%,!M^';W3F%RW1YR6/H5B>IRV:R^2SE:8*C)?P^@T!2I/7NJM/>^O= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=?_6TD?:CK77O?NO=>]^Z]U[W[KW0U?':KR6 M/[EV5D,1CILGDL?/F*^E@BJZ>C6G>CV[EZELK5O5[CVA1U&-P<<35M73393' MPUE-3R023QI(6!/OZQOM%XDL@6-@H)H36KJ-(HCD%OA4A&*DA@I(IU,WW?+K M<;#WAY,O]IV][G<8'N)4576,*8[2=S.Y>[L(WAM@IN)X9+VUCGABD@>>-)"P M$+Y=Y2OS.^MFU^2ADIZN;KC'F2F?<-)NI*75N[>--)H#34Q!)'_WL]TO] MXYXY/OMRA:.[?EV*J&[2]"5O]P/AK0Q6S]A[QDW-14SUN)C MIX:F2ECO55&DZ1*ZE?,XC%X7\$,_TX!+0QRA164K1I)(]!-')(!.%^0,K_=5 MFW.3DN*R&^26MDO,DDD,4&];AMDMQ(8]KAN!+!8;9?F\C0R6*Q1S/"M9KC2= M(E=:^?8ZZP#Z][]U[JUW^2EMW:&]?Y@NP]C]@;6ZFW=LO='2_P`NFS>.[IZM MVAVYL;'5.S/B9W5V7M7=%7MG=VRM_"GJMH[VV1C,FM5CL=+DO'2R01K+%/-3 MSZ;AU[H9>_.D?AK\E.F\W\K>O^TL?T_4=/X?X_\`Q9WQ%UK\9\1M3K'Y0_-3 M?_6/R,[*B[#VKMF/L'JS;_QXZHW&.J,=MZMJCMV@@IQ%/G/X-3/*V,?61CKW M4K(?R6ZVFPORYW-C>]]Q;APO\O\`[)W?U5\ML?A^A96WQ#N+:<<="^9^-NSZ M[MBB;O394VXHJD5%?E:O9,]!@XH\K-3"&=(A[5PQQZ]T`5!_+RZJJN@^S?D! MF/E?6;#P:]A]T]9?&79^_/C9V5#O3O7=?1_5O7W;>X<3V.-BYG?^T?B]69K; M/9N,./?W*)/E])V*WPZ MVQOGH,92[9Q]3D:](8JK%0Y/6KY=>Z%?^9[\):'>7>/\VWY78#?,=%4=&_-'MW; MD?2.V=EX>IJDVI1]F].;P&Z(<7D:>EIL MV<,F:PL];X'X1\NO=%WZ"_EP=1][_%OH7M2+O'LW:OVM MO'8E+U5\%NFNLN[=_C;5;%V[MG?>;[1KMF;KJ7P>,IL360;BRE5'0SM@*3&S M9G([)H>O=$_[^Z%IOC2_QC[7V'ONC[,V'W[U91]_=7UF^NM?SG9NUY:>FW_`-49(0+)69O`[AP[Q2:G$E320>!K7KW5]7S8 M_E;=$=W?S#]\8/!=KT?QIQ?=_P#,,[2^!_1_4O2WQ%ZY_P!&NQ-Y=:]==![K MVY7;@7;'N-A4M+O<[A6.G7(8G,XNE>BHJNM5$V32N.O=9NN_Y>V#VMF^LLH.Z/ M-@^X_P"7M\^ODCN&?=GQ@V-O^LVDGQC@^3O7^_=I;9VEN_ME<749?.4_1=;7 M[/WI3U^+RV(KZV@K8Z2EEA+1[KQ^WKW2F[0_EA_%O'?+GY=?'#K3Y1]Z+C?A M[N[+3]JY7>GQOZXKZC;_`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`WO2]O8-8=B;1S%/G]L9;,4F#S;T#''PT<=964,^1IT][K7RZ]T*N[/ MY,G66V^QJ_9Z_,^JI]N[>[5^;'16X=S;VZ/V/UI+6=N?"_MSX^]397!;0J]X M?**BZK3;O9E=\B<9/B,OO#>&R8A4T%3CQ%-75&*AR.M7RZ]TGMM_R=MA4&-V MQCN^OFOB/C_VKO#_`$W[FPG56X_C=VSN"2GZOZ"[E[6Z,WYG]Y=I8ZNHNE^K M-[XG>W4&27(X7=FX,'B]NQ34S9K-8[RV'M7H.O=5F_*#XR;R^-7:>_=B5^/W M;E]K;,S6TL12]@9;:^,Q.(RYWWL'#]F[.(R6T-W]E=>S3;FV3FHLICGQ&YFV'O.HW-N_%XW-[3V[!M?.39W M=&%S-&^1Q&7V[B(Z%LAF\7E^O=,J[;W"VWI=W+@ M")Y`I121[ MKW3U!UQV'59W;NUZ;8>\ZC5Q\;3TU131RQ3PJ71F47]^Z]TRKMO<+;>EWB MW#54-1DZ;`RYH0?PV/-5&-I):A*4RB=X(GD"E%)'NO=/4'7'8=5G=N[7IMA[ MSJ-S;OQ>-S>T]NP;7SDV=W1A0*44D>Z]T]0=<=AU6=V[M>FV'O.HW-N_%XW-[3V[!M?.3 M9W=&%S-&^1Q&7V[B(Z%LAF\7E")Y`I12 M1[KW3U!UQV'59W;NUZ;8>\ZC5Q\;3TU131RQ3PJ71F47]^Z]TRKMO<+;>EWBW#54-1DZ;`RYH0?PV/-5&-I):A*4RB=X(GD"E%)'NO=/4'7'8=5G=N[7IM MA[SJ-S;OQ>-S>T]NP;7SDV=W1A0*44D>Z]T]0=<=AU6=V[M>FV'O.HW-N_%XW-[3V[!M? M.39W=&%S-&^1Q&7V[B(Z%LAF\7E")Y`I M121[KW3U!UQV'59W;NUZ;8>\ZC5Q\;3TU131RQ3PJ71F47]^Z]TRKMO<+;>EWBW#54-1DZ;`RYH0?PV/-5&-I):A*4RB=X(GD"E%)'NO=/4'7'8=5G=N[7 MIMA[SJ-S;OQ>-S>T]NP;7SDV=W1A0*44D>Z]T]0=<=AU6=V[M>FV'O.HW-N_%XW-[3V[! MM?.39W=&%S-&^1Q&7V[B(Z%LAF\7E")Y M`I121[KW3U!UQV'59W;NUZ;8>\ZC5Q\;3TU131RQ3PJ71F47]^Z]TRKMO<+;>EWBW#54-1DZ;`RYH0?PV/-5&-I):A*4RB=X(GD"E%)'NO=/4'7'8=5G=N M[7IMA[SJ-S;OQ>-S>T]NP;7SDV=W1A0*44D>Z]TS>_=>Z][]U[JY;^176]1XWYY]82=O= M>Y3'PV6V M3#FY?/5[8JMRQYC'T\V0H:735N'7NJ^?F+UYO3J7Y9_)CK/L7%]=83?FQN^. MU]M;OP_4&+H,#U1B]PXK?&;ILI0=:;?QE/1T6W-A4M4C)B,:D%.]^Z]U[W[KW3EAJ*HR>7Q6.I,=59BJR&2H:*F MQ-#K^]RE15544$..H_''-)]U6R2"*/2CMK86!/'OW7NM@O\`GW[.V_7[@^/W M>W3NPNI.LOC;V%MC96W^M^K\5U'ANL/D;T3F<+\-OA1N&L^/_P`@L_1X#&5_ M;-/LC8>Z=N9;;V1;);B&%.XLABY:R&6'[2.J^8\^O=:\7NW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO_U])'VHZUU[W[KW7O?NO=>]^Z]T.O2/9]/L?+C%Y7';*& M%RO\96?<&X-D8#<&4Q-5D-N9#$T<39>LVWN/-4^U:JNE@7*4]/3U+O0F<01> M61M9+O&VM>1>)%)-XRZ:*LC*K`.&/:'12X%=!)'=IJ:#$X^RWN7;\D[L-LW3 M;]E_<]U]0&NKK;;6ZF@>6TE@C!GDM+NX2R>5HA>Q113,UL9Q#%XLC:\'>N>V M_G,]M:/`Y#:&5?"[+I,3G:[86TDV9L^;.MN+.2ID MI8GGG20@:-/NVRP3PP7)GCE4/,642OXDFG0BC4VILDJ2`":"GG7I/[X;[L&] M[[RNFQ;AM%T]GLR07,NUV(V^P:Y-W>3L+:#P+9F58IXE>9X4:257(&D+TJ>E M=FU&=RL%56M&( M\?04U3JDS][FY7>'<&1HEE,3>*8%BMKC%[;$(\=S>QS7!71:VL-QJDL;^O>_=>Z&CHS?7R(ZXW97[H^-.\>Z-A[Y.`R&#R>XNC-P[XVONS^ZV9>GC MRN(K\OL&LH_<>O=*?&0?+O"];;AZ:PT/R/Q/ M4&[L]0[IW7U3C(^S:#K;<^Y\9##38W<>X=C4HBVQFL]CZ>GCC@K*FEEJ(D15 M5P``/=>Z$/&=K?S$\+F]B[FPW9/S2Q.X^KZ6MH>M-P8S>/>5!F^NZ+)8FDP& M1I-BY6ER,5?M*EK\%CX**>/'R4Z2TD$<+`QHJC5!Z=>Z2\>?^;\.#[-VQ%F_ ME7%MKNO+?Q[N7;T>2[<3!]MYS[F>M_C79N)684&_G7NF_?'8?\`,![-Q>]\'V3O MGYB=@X7LS<&-W9V1A]\;F[JW9B^P=TX;';X,5B-G8BE MIJRO2HJ8*;%4<2.J4T*IN@].O=,VSL_\W^N]K46Q^O\`-_*O8VRL;OFC[/QV MS]G9+MS;.UL?V7CJ2"@Q_8=%M_"S46)I=\T-#31PPY:.%:^**-464*H`]3KW M3'N"#Y=[LWWCNTMTP_(_D:)#$4*BWNO=#77_(W^:-E,UBMR9/OCY]9'<6"W;/O_"9 M^O[0^0]7FL-ONIVZNSZG>N*RM1G)*['[MJ-I(N+?)0R)6/C@*8R&$:/>J#TZ M]T!B8WY8QU&)JXZ#Y#I58#?N3[5P52E+V2M1A>T,T^"DS'9&)F""3&[]RTFU M\8U3F(2F1G;'4I>9C3Q:-]>Z&',=Z?S+]Q;CIMX;@[C^=&=W;1;?)P;ZG M93LCY-[PVCW#4=I[#^2_<'?G;6)V'U\W?O9VYNTMYY[;'2NU:@Y/.]Z8^WNQOF1W/F>A-P;F MVIW)1YOXS]1;`Z7Z3;DS.[<#O_+[@ M;LKY!MF\KOO:V)&!VQO7)94YHU]=NW;F#'V5!DI9&K*.D_9BD2/T^_4'IU[I MD3MS^8Q'2;$Q\?9WS62@ZNW%FMW]942;T[T6DZZW9N1YMT8:D?<6[*O<>Y)Y*?+18>DE@QV,@HL9 M145'3Z`IU[K'N#LC^8-NW>6TNQ=U;]^9&YNP=@YB7<.Q=];@W3W9F=Y;*S\\ M=!%-G-I;GR5=4YO;F8FBQ5*K5-'/#,RTT0+6C2VZ#TZ]UDS/9W\PO<<&)I=P M]A?,S/4N`[#J.W<%39G=G=^4@PO;%6[2579^)AKLA/'C>PZF1BTF:A"9)R23 M,3[U0>G7NHO^D#Y_&NW[DSO?YA')=J[6H]B]H9#^\G=/WW9&R<(^2>[.MNM5K$ZY MZ]W,.T,]L?8"9&1YL@NRMIY3[K`[56OED9IA0T\`E9B6N2?>^O="3M7N3^8_ ML3&=?X79':GSQG6?\8BJ8,O_H_H,1E*.EV9_%(: MR9*G^')3>=97#Z@S7U0>G7NC,=`_,[YJ].=0_(+K7/XSYO;SSW9/1>W^CNC- M]8?N;MC9M7\8<1B>X=C=RY:38F/K=C[TK!@=W9CKR@QV3Q.'R&VHJK%U%;$\ MS//')3^(KU[HG.%W+\Y-M;&7K';N?^5^`ZU3>N-[*3KW"Y7M[%;&3L;#UM/D ML1O]=IT,\&`7>N*R-+%/3944_P!]!-&CI*K*"-TZ]T)47R*_FB0U5570]Z_/ MB*MKLIG\Y75<79WR&CJJS-;KK<+DMTY>JJ%S8EJ,IN7([;QU1D*AR9:R:@IG MF9V@B*ZH/3KW27VOVG_,0V/BX\'LKL?YH;/PL6Z]P;\BQ&U]W]X[?Q<>^=V8 MZOP^Z=YQX_$Y&DI$W7N7$96JIPV_:CY-[WP^ZMZTO96Z,5N^7M32^:6.W?L;L+'U_P`H:'?W6&W,+L[K7?%' M5=KTN[^O-H[;Q=1A-N[5V-N6!TS6TMN8#"U2^:6.W?L;L+'U_RAH=_=8;\YMIBG&`EW728" MOGH8LBU.:R.CFDA601NRGW7NE91Y+YI8[=^QNPL?7_*&AW]UAMS"[.ZUWQ1U M7:]+N_KS:.V\7483;NU=C;E@=,UM+;F`PM7+1T5#03T]+2TLCQ1(L;%3[KW2 M37:GR938TW6";;[U3K6IW73;\J.O%P_8"[&GWS18BKV]1[SFVF*<8"7==)@* M^>ABR+4YK(Z.:2%9!&[*?=>Z5E'DOFECMW[&["Q]?\H:'?W6&W,+L[K7?%'5 M=KTN[^O-H[;Q=1A-N[5V-N6!TS6TMN8#"U2^:6.W?L;L+'U_P`H:'?W6&W,+L[K7?%' M5=KTN[^O-H[;Q=1A-N[5V-N6!TS6TMN8#"U2^:6.W?L;L+'U_RAH=_=8;\YMIBG&`EW728" MOGH8LBU.:R.CFDA601NRGW7NE91Y+YI8[=^QNPL?7_*&AW]UAMS"[.ZUWQ1U M7:]+N_KS:.V\7483;NU=C;E@=,UM+;F`PM7+1T5#03T]+2TLCQ1(L;%3[KW2 M37:GR938TW6";;[U3K6IW73;\J.O%P_8"[&GWS18BKV]1[SFVF*<8"7==)@* M^>ABR+4YK(Z.:2%9!&[*?=>Z5E'DOFECMW[&["Q]?\H:'?W6&W,+L[K7?%'5 M=KTN[^O-H[;Q=1A-N[5V-N6!TS6TMN8#"U2^:6.W?L;L+'U_P`H:'?W6&W,+L[K7?%' M5=KTN[^O-H[;Q=1A-N[5V-N6!TS6TMN8#"U2^:6.W?L;L+'U_RAH=_=8;\YMIBG&`EW728" MOGH8LBU.:R.CFDA601NRGW7NE91Y+YI8[=^QNPL?7_*&AW]UAMS"[.ZUWQ1U M7:]+N_KS:.V\7483;NU=C;E@=,UM+;F`PM7+1T5#03T]+2TLCQ1(L;%3[KW2 M37:GR938TW6";;[U3K6IW73;\J.O%P_8"[&GWS18BKV]1[SFVF*<8"7==)@* M^>ABR+4YK(Z.:2%9!&[*?=>Z2G^ACN'_`)]1V5_Z`NZ/_K7[]U[KW^ACN'_G MU'97_H"[H_\`K7[]U[H9>B]P_-3XR;]QO9WQ^_V8/J+?6+JL54QY[8^%WMA9 M,A'AZ=N_QS"TM1-B\G!5XZJ:!1/!(HT^]$`\>O=!1D M^K.\\WDLAF5RN3VAO"OR63R5?4255=D,A756.EJJVNK:J M5I)99&:221BS$DD^]]>Z@_Z&.X?^?4=E?^@+NC_ZU^_=>Z]_H8[A_P"?4=E? M^@+NC_ZU^_=>Z]_H8[A_Y]1V5_Z`NZ/_`*U^_=>Z]_H8[A_Y]1V5_P"@+NC_ M`.M?OW7NLD/3W>Z_F]\FMPX3=?R"J?D7W%N+;>UMN[*P&6[`Q>^]QU6(VSM;!8O M;N)QU!]_0R1T[/C\/#)6SJHJZ]_H8[A_Y]1V5_Z`NZ/_K7[]U[KW^ACN'_`)]1V5_Z`NZ/ M_K7[]U[KW^ACN'_GU'97_H"[H_\`K7[]U[KW^ACN'_GU'97_`*`NZ/\`ZU^_ M=>Z]_H8[A_Y]1V5_Z`NZ/_K7[]U[KW^ACN'_`)]1V5_Z`NZ/_K7[]U[I#YC" MYC;V1J,/G\3DL'EJ/P_=XO,4%5C,C2_<0154'W%%6Q05,'GIITD34HU1NK"X M(/OW7NFWW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?__0TD?: MCK77O?NO=>]^Z]U[W[KW0F=.X2@W'V7M3"Y/:F1WOCJZMJ5K=LXJN7&UF0IX M<=6U,LOWKY/"QT]+C5A^[J"U;1(:>!PU1`I,J%V[3/;[==31W2PR*!1V%0#4 M#A1JD_".ULD=IX&2/:'9;'F'W(Y6V;MOGF<26<$@ADE189'9O$,UN% M2$+X\I:XMU\*-PT$)E5R[JVG@]E;JQ^W\%B&)AQ,@1:8)!E*Q144LMV1BT4;>T74UY;///*C$R&@75V"@HK: MDC;5YY1<$8/$F?O-RKLO)G-%AL.Q[5>6\,6W1&22X:`B[F+RA[FW^FO+^!8# M00A8[VX`EAEJR,6BC,;T-1YK$8""@Q^\=FS;?R&_,7D-F5>?ZT[4W/&N_P`; M;QE%6YO;%-@<=14]3DMO-F_XTF$ZP,)`LT* M?I:R0KEB2`VG7V$-3B:B@R']B[/>=IV&"QL.;]G?8+C?89=NDNMGWN\`W3Z2 M&.2YLTMHHU>:U-S](1?(]LTJUC4I)J]^Z]T+W3_;+=29?+99=H M8S>'\5QR8[[3)[P[7V=%2:*F.I^YCJ^INPNN\K5R-X]/CJJBHIP#J$8Y=T0;(Z@^).0[6WI54M574VT.MNP?GAOG=%1142JU9608#;'R, MRF6FI:174RR+$4C!&HB_O7Y]>Z2&3^8.7PF2R&&S/0&`Q&8Q%=5XS*XK)]S? M-:@R6,R5!424M=C\A0U7R9BJJ*NHJJ)HY8I%62.12K`$$>_?GU[I2[0^1O9' M839!=@_%2??#8G[/^*+M#LCYU[E;&_Q&2:+'_P`0&%^1]::/[Z6GD6'R:?*R M,%N0;>_/KW0BYK=ORBVVFY9-Q?`/LS`1[,Z^P/;6$,UDOYB&*3:G56ZJ@4F MV.S=RM7=^0+@NOMQU1$5!FJKQ8VLD.F*9SQ[]^?7N@HVG\I=X[^W)AMF[%^- M-)O3=^XZZ+&;>VIM/M;YP[CW)GLE/?PX_#8+#_)2LRF4KIM)TQ01/(UN![]^ M?7ND]_LZDO\`SY':7_H\?F?_`/=.^]_GU[KW^SJ2_P#/D=I?^CQ^9_\`]T[[ M]^?7NGFI^6&YJ+`8C=59\&P.Y*GMWYNP8#-Y?;4&&J=QXK$9B M7Y+)CLEDL!3;CQTE;!#(\M*E?3M*JB>(MK\^O=>W'\L-S;/S^8VKNWXY8S:V MZ-NY*LPVX-M[C[=^;N$S^"R^/G>FK\5F,/D_DM2Y'&9*AJ8VCF@GC26)U*LH M((]^_/KW2RZZ[L[G[?&X6ZE^'&>[17:6/7+;K;KK>WSWWL-LXIXZN5,GN$[: M^1&3&%Q[Q4$[":I\496"0WLC6]^?7NDW@/D[OC=>.W5F-K?&*'Z3'^SJ2_\^1VE_Z/'YG_`/W3OO?Y]>ZS4_S,K*NH@I*3HK;%5554T5/3 M4U/W9\TIJBHJ)G6.&""&/Y-M)+-+(P554%F8@`7]^_/KW2[F[Z[:I\KOC!U' MQ$RD&;ZR4OV3AYM_?/*+*]?*,Q1[>+;XQ[_(M:O::C/Y&GH2:]*3QP_YQ MU4Z_/KW3;6?)+L/'5>^\?D/BR]#7]6R30]FT59V7\Z::KZZEIMS4.RJB+?=- M-\D$FVC)3[RR=-B77(+3E,G414IM/(B'WY]>Z2'^SJ2_\^1VE_Z/'YG_`/W3 MOO?Y]>Z4>VOE'O/>DV7IMG?&>FW94;?VWGMXYZGVUVK\XL[-A-H[6H)OSZ]U%J?EAN:BP&(W56?'+&4 MFU\_DLWAL#N2I[=^;L&`S>7VU!AJG<>*Q&8E^2R8[)9+`4VX\=)6P0R/+2I7 MT[2JHGB+>_/KW4R3Y0;VBV?3=A2_&2"/8-9N*JVA1[XD[3^<:;/J]V4..ILO M6[8IMRM\DQA9]Q4>)K(:J6B6_V=27_`)\CM+_T>/S/_P#NG??OSZ]T\TWRPW-6X#+[JH_C MEC*O:^`R6$PV>W)3=N_-V?`83+[E@S-3MS%9?,1?)9\=C/S/_P#NG?>_SZ]U[_9U)?\`GR.T MO_1X_,__`.Z=]^_/KW7O]G4E_P"?([2_]'C\S_\`[IWW[\^O=>_V=27_`)\C MM+_T>/S/_P#NG??OSZ]TN]P_(+M+:..GS&[/B77;8Q%-)M*&IRFX>POG?A<= M3R[^P&0W9L6*>NR7R-IJ:*3>NUL359+$JS`Y+'TTM13^2&-W&OSZ]TA/]G4E M_P"?([2_]'C\S_\`[IWWO\^O=>_V=27_`)\CM+_T>/S/_P#NG??OSZ]TH=L_ M*;>&]QM3F,_FIZ+%?)2KJ8<3 M@\11S5594LHAIJ:)Y9&5%9AK\^O=)[_9U)?^?([2_P#1X_,__P"Z=][_`#Z] MU[_9U)?^?([2_P#1X_,__P"Z=]^_/KW3[6_*O=>-H]LY#(_&Z@H*#>M#49/9 MM=6]L_-^EH]VXVESF3VQ59#;-3/\E4ASU#3;EPM9CI):5I8TKJ2:`D2Q.BZ_ M/KW4?/?+;<.UZ:O]G4E_Y\CM+_T>/S/_`/NG M?>_SZ]U[_9U)?^?([2_]'C\S_P#[IWW[\^O=>_V=27_GR.TO_1X_,_\`^Z=] M^_/KW7O]G4E_Y\CM+_T>/S/_`/NG??OSZ]U[_9U)?^?([2_]'C\S_P#[IWW[ M\^O=.N!^6VX=U9S"[8VQ\=\1N/8SF>SF8K(ZQ_[.I+_`,^1VE_Z/'YG M_P#W3OO?Y]>Z]_LZDO\`SY':7_H\?F?_`/=.^_?GU[KW^SJ2_P#/D=I?^CQ^ M9_\`]T[[]^?7NO?[.I+_`,^1VE_Z/'YG_P#W3OOWY]>Z]_LZDO\`SY':7_H\ M?F?_`/=.^_?GU[KW^SJ2_P#/D=I?^CQ^9_\`]T[[]^?7NO?[.I+_`,^1VE_Z M/'YG_P#W3OOWY]>Z]_LZDO\`SY':7_H\?F?_`/=.^_?GU[KW^SJ2_P#/D=I? M^CQ^9_\`]T[[]^?7NO?[.I+_`,^1VE_Z/'YG_P#W3OOWY]>Z]_LZDO\`SY': M7_H\?F?_`/=.^_?GU[KW^SJ2_P#/D=I?^CQ^9_\`]T[[]^?7NO?[.I+_`,^1 MVE_Z/'YG_P#W3OOWY]>Z]_LZDO\`SY':7_H\?F?_`/=.^_?GU[KW^SJ2_P#/ MD=I?^CQ^9_\`]T[[]^?7NO?[.I+_`,^1VE_Z/'YG_P#W3OOWY]>Z]_LZDO\` MSY':7_H\?F?_`/=.^_?GU[KW^SJ2_P#/D=I?^CQ^9_\`]T[[]^?7NO?[.I+_ M`,^1VE_Z/'YG_P#W3OOWY]>Z]_LZDO\`SY':7_H\?F?_`/=.^_?GU[KW^SJ2 M_P#/D=I?^CQ^9_\`]T[[]^?7NO?[.I+_`,^1VE_Z/'YG_P#W3OOWY]>Z]_LZ MDO\`SY':7_H\?F?_`/=.^_?GU[KW^SJ2_P#/D=I?^CQ^9_\`]T[[]^?7NO?[ M.I+_`,^1VE_Z/'YG_P#W3OOWY]>Z*QV/O4]B;SS.\3@Z3;AS'\.OA:'.;TW) M2T?\/Q5#B_VLUV%N?>6\*W[C['RM]YDJGQM(8XO'`L<2>Z]TA_?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__T=)'VHZUU[W[KW7O?NO=>]^Z M]T/'2>[MWTF379>SMO\`6=?E&IAR.]=D8'<&0:$[8K%R>$AS&1Q>0K:? M'9;%44M.*;BF=ZAQ(5265O9)O%K:O']9=SW"Q)I%(Y&4?&*-I!`)5B#7C0"F M0.IS]E^;.;;3"-XO!Q" MS2N)"J22-TS=SQ]D1;EI*7LC9])LJOPV-7"8S#XC;&.VOM^"@CK*S,N,12X2 M"+"5,<];FYIY)J8NLDDY8L2?;VT';S;LVWW9F1VU%F`'1 M/[QQ^XL7,=K:^XO*,6S7UG;"VAM[>SALK58A))<'P$ME6V<-)>9_WB\OH)-Z2`[==;CN5C!"@M;1!);HF[1FX>_E M,CS1B"X*S+*VDK<1PK7E['G7/WKWOW7NC1?&KN;:_3>/[SJLY#N/^/;MZ\ZX MQ6PZS:=;%A<]3;DV;\J?CKW%714&ZI:3)'9%9/M'K+)M2YF&CK*BDKXJ=!$\ M4TRG1%>O=6H[%^?7Q][.[2[-W)V%'U=L3KKO9N_ZGO3ISY$;=[>W]L_='47> MWS+PGR"H?C?LKM3XW[&I>S=K[FZ5S6#&^MK;HAP^.HY-P9"K@G6G1%@JM4/7 MNE+N+/?R1\W6;BS6UZG9F0BS77F8R^P\I\G,/_,+W1W7-W<-Y4$N]JOY_'4V'V[D:3<4.,VUV%LG'?Q"@W'CMQPPLNRNUMR8J M14D;RX_.5E-(\L4SAMT!X]>ZN&ZZ^4GP3WCOW8NY>_>R,-5=1]R?"S^6U\#N M_NI*S;7?M+O/86V_C#W+\&L[WSV%E\YU]L=,;D=HYOKKXH9=\`=L9VNW`V2S M5%'-011PU#^]4/7NAC^+_:/\F#X__*3XR?(S;F_^KMG[JZPRWQRWIO3'T^V? MY@FX>I=MY3:'ZZ*AC6_E`X39N:RQ_T*;US&U_A=C9]C;-W12_S$L)OGL+YE4>9Z-3 M>U'VOO/:>5HNMWP^8&([&?9W]W,7M/!0X+*8$9R5'_">O M.[8^(.?K>KJ[9F_MS[UZ[P?S`Z]W%)\SJKKWK79N2@Z,D[AWKM/>NU>W=U[N MW"VVJ;:>^4VG18^CK:FNRN[H#DHTH<13FH]W9Z]T&VV-U_R@8.J>X97VI\;< M1W/G]D?+[96P\9N.E_F);KZTQN6QN_OB+3_%O?>-R?CK-X8C*;JV)A>VLC3S MAH9J7(UN-ILS34M&[TP]G'7NAQVYUS_(9[)WOG^J-EYW:KU._?E)OW`].9X9 M[YJ[-WK)U;EOD_\`$+&=!;4CW3V-@VZ6VIBMR=#;B[>ILWEMU4'W>-J<=A:B M:KII!+)5>[NO=%^_F-;HQO\`+K^0&,Z\^`LNR.BL'O7I&GH^T*')I18O=M)5U$=7B'H?#/ M'KW06?!CM#X&8CX<]K=,?+?([,?-]B_,+HO?L&(K,#\AY=X8_9/5W1/R5P>% MWC_>/J6BI=N#9F.[;[4PN.S^->OGSD^SX_XRLWQ8Q>R,[\B=R]MXZCW`/XA\P::LZZV+3],="Y'<.6ZGA[%@QG7.O=#5C]I_R58NENE9Z;M;;% M9W[2]4[LJMXT>_MH?-NBZWR':^9V)TME]K87Y`'8%'69IL7M#?478V+_`(EU M?-1P54Z.?W-\J_Y66Z^P_YCO:VS^[-C9?+,5%?28_>=-O6F M:&EJ!B98ZF3U#CY=>Z`7N/)_R'CZYR.\/D]CN[=V='1X^"?L' M^]V"ZJ;J;(4T.\DJ*4[U7-I34M7A!%"WN[KW3/UEN[^4]T)U-L_*]6?('"GO M[XL/' MD=OIB\9_=B?%U%:DU2E;4I[)\NO=%Y^(Y_E1TWQRVOD/D@G660^2%)C>^JC+ M8/L,_.--M9/+4WFH<7'0Y#J";N59CA:RG=9(L9]Y)'5&G+[ M-:_+KW1LNYNROY-&X:SH_JK;>:ZRW9U=TALKY7X7K3/YC`_.;"8>:3<_\P[< M6_\`JG"_(&KP>%VOV/G8:WX5;@JI\)7;7H)*VGW]5+39V<8>FIJ:"O=U[I#K M-_(RH#C:?;-%UEF\3!\>]TY_&9+NBM_F)1[VK>_YOF%@DV=L;MS'=/4V%V;! M0T?PH,\E=5[1F&,EWA]VL=2(DH6EWGKW0A4.T/\`A/!6_(K$;ES';6+PW0F( MQ^\-JYCK7!;5^>U=2;NQE;\J>V]K;)[.AW7E<))O_`=KX'XBILS<=9CU=MJ5 M^YYL@@I*=:=,/6>[J=>Z#S(U_P#),W)@]A5.ZJKJS!YG`=:?"7;DT'4FWOG' MB:_<'86(^/W=N(^5V:[BI]R8:/;=;M"I^3/]Q:NKJ]K/2[AK=B1U3XPMG7J% M?W=U[IOVO'_(_P`AUYO*AWG/UY@NT\GM!<5/F-N'^8'4;(V]OE/CA\IJH;E^ M.<>1I[L=>Z`'XQ57\K7&]%? M'&F^0>,ZXSO=FY.R_DO!W=E]RU'S6OUQMRDZTI?]E#KMZX/J&IVUM+G&,"5[S-!LU\NO='NV?\+_Y:>8^%/7/=W8]=U5U91[W M[=SN]M^]_2?[.YD*+;/3.`^1/:?76'Z_Z5VS@J_L3K+/9;L&E@VK2S[)W!FJ MSNK9^S:#-;LEHLS!5TO\*K4UIU[H+M_I_(:CRN$BV/-M"7`[S[KF_C=="/GY M-G.H.MI?BATEN+;_`(<7G8L;C=P]>0_,_&[WP&XM-7F=YQ;$R%-48O[FNCAJ MH=]W7NA+[%[4_DY=T[JP6Y.X]\=0;ESNT^F?B[U%MS^`X3^87AM@X;%=)_RQ M^XNKMV'B_FKLCK2+'5F3:HW+5;9JJB6JJ&4UO@]GKW3AV%\ M3?Y86Z?A%\K_`)+_`!KV_P!.;KS4./RU!U_5Y_>_SAV_L_J3=VV_CY\/]Y=@ M4VPLOGJ2'%[?R&([7W'V5A=C[:[BFDJNR:K)8G^"Y>M?"5V.R7JFH'7NBQ_' M:+^2?D^LOBM6]]U&!V]OP;E^,^.^3>(J%^:<^>."P_9ORXH?E%GFEV'!G-C? M9;KZJS'4-9@TV]5"MCR6*R*K3T:O405GN[/7NASZ3[+_`)0/278&2[8ZU[*Z MVV/OG._'O?VR]PXZLVM\[<]LW8NZ^\/Y;6X.H=Z8CXXRY';VY<_7+3?+C>V> MI,TW8R9>GI]E5-)486KGK4D\7N[KW0$;^KOY.U#@/D3N#KO%=#[@?']!XRJ^ M)O7^;I_YDN`[#RW9F3WMUS+D,?\`(?=KUE/MW.[*[0W9DMY9GJG%8O-]5T!AP=77;AJ\O/FZEJ:*@H*^K]W=> MZ`3:VZ?Y0V.Z_P!UM6;6^.X[/WU\6]SX:NPV8I?Y@NY.K-C]ZXWYY19#%S;` MW`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`]D5NP]G; M0PE!@-LU%/NOLB"AQ]0Y<3"%5-N`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`2I.F@8"H.13CU)7M%S+L_*7N!LV][^ MX7:%BNX9&:W6[5!=65Q:B1[1GC2YCC:8/);NVB9%:-PRL59Z[OW-M;<^>VW/ MM+(8K)4&.VE%C*J?#=<8WJVB3(#X!E/0X_&V3K`[)KX=^Y'8=-50;X M;(8REW!6X7%5]1D1A,?B<%2[B:MJHLCN/KNLGR]7+6TB/14M&**662>266GA M)-S`-R^L0V,V9Y+OH>>]QV M*.Z3>S+"EU);P2O*+:*"V2[,CK+=[3(T\[W,"M;PP"WEEDFDEE@A))_8PZPP MZ][]U[H?/BOU)L_OWY(=']&[][&KNHMK]P]F[1ZSKNS*#9M/V`^RJO>^7IMM MX7/5FTJG>&PTRN%H\YD:8Y`KE:>6FH#-/$E1)$E/+HX'7NK8I/`9:OP][]?YK9F$[+Q6W9Z$5];MJNJ6R.WW7NC8_-3X:9'XVT?4>:VKL7NN79U?T3\:LGW1V-O#!U61ZWP/R8[QZ9Q M7?.4ZGVUOC%[)VUMO'5F'Z_W5C7&!JJK(9BEFIZWR5$Z1ZDT#7KW0#[D^)'R MMV;0565W?\9/D)M7%T.SJ'L2MR6Y.E^R,'04?7^3SV/VMC=]559E-MTM/3[. MR&Y\M2XV#)NPHI:^IBIUE,LB(?5'KU[IAS'QQ^0VWML;[WOG^ANY\'LSJW== M=L/LW=V8ZNWQC-L==;YQ>=I-KY/9F^\_6X.#%;1W7CMS5\&.GQV0EIZR&OFC MIWC$KJAW4>O7NIFQ/C!\ENT=GY'L+K+X\=Y]B[!Q$>7ERV^-B=2[^W=L_%Q; M?6B;/2Y'$7)4QJVEG44PJ(_)IUK?U1Z]>Z=J?XA?+*K[#H.HJ M7XO_`"(J>U\KA1V]MO=>=V)N+/4&RX]M-N2LPN!WQM?) MX:MJHZ9H*7*XZJI)66HIY8TU4>O7NO4?Q"^660@IJF@^+_R(KJ:MQN$S-'44 M?2G953!5XC_'SLNMZ![1J=O\`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`T]=@JZ%ZS'0U-.DM'.A M<-#(%W4>O7NC)?,;X69+I_Y+]]=*_'K9?=O:FU_C-M+9U=W5N.;;-1O"MZ]W M'3];8#<7=R_ M%+Y1;,VWF-Y;P^-O?FU-H;>Q-)GL_NO"VW@\'7_P!R/LZQP?%CY.U61R.(IOCCWQ49;$ M5V^L9EL7!U!V#-D<7DNKL+@MR=F8_(T4>WFJ:*NZZV[NG&5^=BE59,119&EG MJQ%%41,_JCUZ]T8S:O\`+/\`EWOCK_ONHZK%X1*[;N_>5WE1[DPU=@%Q-#4XFMV^Z^6JU5@QWJCU MZ]T6W&_&#Y+9FBVKD\/\>.\\MC=][4W1OS9&0QO4N_JZBWEL;8])0Y#>N\]J MU=+M^6#<.U-H4&3II\ID:1IJ/'PU$3SR1K(I/JCUZ]TT=B=`][=0XC$9_MCI M3MOJ_!;@S^[MIX'-]B=<;QV5B,WNGK_))AM^[:Q&2W+AL91Y+/[(R\BTF7HX M7>IQM2PBJ$C^O=/^ROBK\H.R=L;O7ND!O M;JWLWK2+:T_8_76^^OX=\[?&[-E3;VVCN#:D6\-K')Y#"#4AFIONJ66+7KC=5]U[H6=M?#GY3[I[AZHZ#H^@>U<1VYWAGL1MWJS M9F\MF9O85=NZLS66APE-6T53O:DP&.I]NTE?-_EN5J)HL9CH4DFJIX88I'75 M1Z]>Z$FB_EO_`#DJN^,'=6W<+\:^O,3VCVK5[JZSWOMP8O9V>W-B-M M83(XR/*8"GDS7\5CRPML;(J^U6W7\;-^;'RG6^],WUA@>Q]W[9W%AX)MV/C<)MVFRDT^ M,RN0FQTV;V_%!F&H:&*I%/%ZH]>O=!M7_'/Y!XK957V5E.B>Y<;US0;*V?V5 M7;_K^L-[4>RJ/KGL+=-;L;8._P"KW548./!4^RM\;VQE3A\/E7G%#D\K3R4E M-+)/&T8W4>O7NE]COA?\G.DQ?W,!:*7,!J&(R5,4\<6JBM.O=`UNOJKM#8F\: M?KO?'6^_=F]@5;8E*78VZ]G[AV[O&I?/"$X-:?;.7QU'FIFS0J(S2!8":G6O MCU7%]]>Z'KMGX%?,_H_><^P.S/C%W;@-T4^UMR;W-)%UUNG,T51M+8^VZ+=G M8>Y,;FL)C,AAM<)7+)N2MI*B>DP3)(M;)"8WMJH]>O=!Q3?&/Y)UF&R^ MXZ3X]]X56WMOX''[IS^>INI]^SX;![8RW661[KQ6X\OE(L`U#C<#D^F\/5[M MIZR:1*>;;-+-E$O=&<^(?PBS_97;=?6 M>WLCATW%C\]V#MV/;;9?9F%KMOR+70U61AIH):-A,K&,AO>ZCUZ]TWX+XO?) MC=%!UQE=L_';O3<6+[C7<[=19+!=2;_R]!VHNR?#_?-NN*S'[?J*??"[1^YC M_B9QC57V'D7S^/4+^J/7KW20QW3_`&UE]W;PZ_Q/5W8N4WYU[0[UR>_MDX[9 M.Y:W=VQ\;UK3U]7V-D-X;;IL9+F=LT.P*3%U4N;EK88(\5'32M5&(1N1ZO7N MAVV5\!?FEV-U_O+L[8_Q@[LW-M+8YZW-K2]M[&S_9VPLWBMJP M8U]T9_:V9ZXVY/G7R]#1U&+H\3/15-34119&@:IU4>O7NDET!\2OD'\H,=W! MF>D.LMS[[PG0O6F:[8[6S>&Q&2K<5M+:>&I:NJC6OK:*CJHAG,Z*"H7&4`_R MFN^VJ'C4Q4U1)%XD#KW0;;KZ?[:V'MK:V]-\=7=B[,V=OF$5&RMV;KV3N7;N MVMX4[4=-D5GVMG_=>Z][]U[KWO MW7NO>_=>Z%'K;H_NKN:/=4W3_4':/:T6Q<*^Y-[2];;`W9OJ/9VWHHJJ>3/; MJ?:^)RB[>PL<-#.[55688`L+DM9&M[KW0]8/XH;CQWP_[%^4G9NPNX=IX?); M]Z;ZR^-6XZK:^2P?7W;>[-\2]C9O>RX?*9G:\L6_*':>S^M*H3/A:Z,8_(UM M&M4S?L>L\EA]F_'WS_P"7?\GNALAO7:O>/2'?VS=^X78'06[MJX+"]'[IW7@\EN#Y M%Y/:W^C_`&)O[=(JL*O7&?R>%R.9I:>%:3,5L^\=OU.W#2Q5:54U%ZH/#KW1 M=JGXY_(.BW3N+8U9T3W+2;VVAL;+]G[LV?4]8;V@W3M?K3`8QLWGNP]Q;?EP M:9;";&PF&0U=7EJF&*@IJ4&6254]7O=1Z]>Z4%/\2/E;6;HWWL>D^,GR$JMZ M]6[>Q6[NS=GT_2_9$^Z.NMIYW;\&[,)N??>WXMMMEMH[>S&UJJ+)TM;D(:>F MJ,?(M1&[0L'.JCUZ]TM?EG\?]K=";GZ'V'M2LW7EM[;U^+OQZ[?[2PF=EQU= M4X#LCOG9M-VIBMK[>H\5B,96T>+_`-&N\-M3QT=8M17QU=7,K2NIC`\,UZ]T M8/8G\N#MRO\`CO\`(W<.^/C]\IJ'Y0[*[C^._3_2O1.)ZZW-1[SSF0[,V)VG MW-V+F=W]/UW7&1[*R>#VST_U_0Y"FJZ.;&0T_P#'J*HE^XIYD!]7(SCKW1&- MO=$]W[MV-4]G;4Z;[5W-UK1[EQ>RZOL/;W7F[LUL:EWCFZW'8W"[3J=V8W$5 M.`@W+E\CEZ2GI:!J@551-50I&C-(@;=>O=*G+?%#Y2X"KW909WXU=_86NV%M M3+;\WS1Y;ISL3'5>R]C8#,[FVYG=Y[LIZS;D,VW-J87<.RLS05>1K!#1TU;B M*V"219:6=8]5'KU[I!;]ZE[5ZK3:4G:'678/6\>_]JT6^MB2;]V9N/9Z;UV3 MDJBJI,=O':3;AQN.7BR.%I*V78FQ,:E M3DLUDXU-)C\?13S32(D3L-5'&O7NF+L_HV?.?)G<_P`?_C+TW\B,_G\%N6LZ M[Q?6>Z<)6;Z[UW#O#:+R8/=59-L39G7>U,QMZJS&=QU151;;..KJ[`0R"AJ* M[(30/62^KC/7N@ZK/CYWYCMK4N^,ATAV_0;*KMP#:=#O"LZUWG2[6K-TG,UN MW!MJEW!/A4Q-1N`[AQE30?9I,:G[VGD@T>5&4;J/7KW2MKOA[\M\8]?%DOBW M\C,?)BF[-3*1UW2/9E(^-?I6GIJON1:]*C;$;4;=2TM;#+N82:3@8Y4:N\`9 M2?5'KU[IMH?BK\H,IA*/$KMH]J;QJNNN ML-U4>5I]NR4-3MSL?L&BFP6!KDD:ES&9A>BI'FJ5:(>J/7KW31D/CM\@<3C. MPLUE>B^X\9ANI-QYK9W:V6R'6.]:/&=9;NVUD(<1N+:O85?4X2.EV7N/`96H MCI:VAR3TU52U$BQRHKL%/J]>Z[WC\=/D'UWMRNWCV!T3W+L7:.,KMH8S);IW MCUAO;;.W,?DNPML-O;8./KLYF\'0XRDKM\;,4Y?#Q22K)D\8#54PD@_<]^KU M[H3_`(W?!3Y=_+;.;#Q707Q[[9W]B.Q.RO=!;NSX]=\[$V]E]X;R MZ5[9VMLW`[JRVQ\QO'O7NC<_%#^7[V?W)F>PU[-Z=^1&`PN,^(G;'R,ZG MI]N[`SN)S_;N9Q=;A.N.FJ785-G]G98]@;6WOWOO7!8"H;#0SSRBKD6FE$Z! M3HGTZ]T0#_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_U-)'VHZUU[W[KW7O?NO=>]^Z M]T8GX_;HJDW%1;%CV#L/>%-G9=Q5<]5N#9.Q,_N#&!=JUK-E:/+;XEQ^.CQN MUEQPRC4=16TE+-]O*CRQB9G!#OMLIMWO3?3Q,@446215/>.TK'4U>NC4%9A4 M$`TIUD'[!\S72\PV7(\?(>Q;O;7SW"TJH[>M= M(&:#ATL^\W9P[?S;RC90;?9PI'L$8+VL&V6T$[&^OV:9+;:;F[M(.XF+1]1) M*?"\20@N`,/3W76PMY[;JJO<\.^H-I`1(6&]UO[ZTN%2V:$QF,4#.B$.S44OK8 M'PR`0`@+%JTX=,^T?M[R)SCRY=7?,L.^)N,.XNS/:V5[=QS6$%KXEQ#9BTM9 MD7<(Y)(I7>\EBM8H&C9Q1RP+?[$'6.W7O?NO=3,?D*[$U]#E<95U%!DL964V M0Q]=22O!545=13)4TE7331E9(:BFJ(U=&4@JR@CW[KW5OWS)_G$]E?+[JSN3 MJFKZ9Z\ZPPW:W?VXNYJ"MVE425%=L?;W8T>TMS]V];8B:?$TE174?>7>>P\1 MO[<>2EE2>;-TK00104,IIUJ%IU[H"?GE\]:;YM=G;/W.G5N4ZNZNVG62Y*BZ M9H]_8#*[?PL^3QFR]MYC$[)GVCU3UAA-O[?I-F=>X7!XB?(8?-;GI\1BZ*ER M6:R\5#1+3;`IU[HUF\/YS$W8W?$7;6__`(]U6?VGF.Z=X=T;VZW@[E_AZOD] MN;'[BZZ^&VW^KLT>K*S"]687X7X3MV?+8)1@\L,]NY:K,9!0]8M/2ZT_/KW2 M=SO\V39U;M'?NR]N?%'^Z^WLKT;\3.F>N]L+WYN7/;+VW%\;-Z[O[BW75=C; M>S6QZBI[5VOW?\@]UIOG+8F&MV]51YK'Q>?(Y!*K*?Q#U/GU[H,/EC_,]W1\ MH^C]E=75&S=S[2W1!UQU[U]V]NT]@;0R&![5?9&=J=_9O=$V%VMTMU]V//E. MT>YLA6[[W%2;PWIOK$ON_)5>2H*2@J&IWIM@4Z]T<[;WS?\`B1T]\'/C9L+; M78^<[`[1Z?VYTQ1;UV=MU]_[1W?W/U]D/EQA/E_W7\3]TU>Y.B!LCX][$V?V M1)7ST&^=J;VWSE-VU6*Q4U9A:*GJ9L=B=4-3U[H&.M/YR-5B-X;V[J[P^/U9 MWS\DMU_([M7Y(4/;5;WIN+9.-P>XMQ]7Y7:G1.#CV=C=F9BL?#_%'L?.Y#=6 MR8J3,T%)CY,I5T\5-!4"AR-#[3Y>77NH^VOYP@INH>H^D-_]!;@[-Z_ZEQGQ M*V=18/-_(?<]#C\YUOT;VE-W;WMM7+T=+L>6+(9#Y&]FICYJ2OK?OH]DX;`X MO&04N2AII7J/:8ZRK^X-Q9:/"P;C:*KVIOG8>$J?[[YREK<)58RJ7' MIZF1U[I(_.'^8EUO\K^MLAUWU]\7).CUS7R:WI\CV(#25)QVWS3T0!J8JO(9#8%//KW62N_F M/;+R&VMO=?GXVU&%V-'\!ME?!;>E5MGN6IH>SZ2&S_Y@\.$^>^Q? MFMN'I>CR^*ZKVIMK9/6?46W=]3;4FVE@^I?CO3_'SX\UW=OYN?(38HMFBNO>FZ?K_&=:=0=M M]6[`CQ?9NX:W9N`R'R1WQW-7_(S?U7MBIPR;HW/NC>73/:Z==;>GRFY*NIVE MMVGKI8:BKKLHU12ZIFO7N@N_F&?/.I^=/8^/W3B]@Y;J38N)R6Y,]@NKI]X; M3W-M_:F7W72[9Q%;0[4I]@=1](;8HMM8+:FQ\'@L3)78;);I_@N'HJ7*YW++ M1T;4^P*=>ZL2W3_/L-;NK!;LV)\3:?8F4V?\EMM_(K:^0;OW<6X<[52]1_%B M'XX_'79W86?DZ^Q5?V%B^J)Q/5U451]MA\YM^KJ,3_"Z*NJZ[/U>M/7N@=_X M=PZWW?B<;B.\OB3N3N)$ZX^+6Q]WY3(_)W*XC/=H+TCVCOKNWN?:_864JNH- MQ-5=&_)SMW?LVX'6/R?V MEM?IO)=7[\^2_P`F.\._\_V/L_M:FEK9\;WS@=I[;W/M'>M;F^L,EVGN#+87 M&8?-#'UNW]X[/P4J[OS--D,#7X^I%"GM/#/7NA8P?\[K/2]O=[]@=J=`UGW5VUI]JPY"AHMJP8M$Q-; M2PH^'2"KW3KW2Q[:_FQ83M7H7=/262^,TE0^6^+OQ6^,.W]S[I[_`-];D7#8 M+H+,YO?G86=R^'QV`VK4[@_TR]SU>.WJ*2'(8UL5G,5&E;49RA*4D/J?/KW2 MD[7_`)TF_P#=';'W<2^&^/V:[RS>Q,;V)N M[9&-ZUZ>Z;V_D:?$]*;3GV5M7SXZ/=6(I7QM9D-Q9F7"T41UIX=>Z)A\Q/F/ MB_E-M?X^[:H.L\MM*KZ/V$FRF_-KI,?6;BR5#2XNGQ^P*=>Z/M6_P`YS9NU]Z[` MWAT#\/I.DO[@_(J?Y%4N*I/D7N+<='D:W8WQ^J>EOC'U55TT'6^V,0>G/CGD M1RM?K3ZGKW1/.WOYA68[,^3_P`4ODU2]90G M+?%O&]%S0[8[/W]G^W:+L_>'5.[XNS=ZY[>=9DL?MVGIL#V]VG79C,UV&H:. M""A3-3TL[J;>/4NQND^NOGMWMUKA\SV M7G=\]N][?,;Y<[0V9UI]O6=N[2^/]5M[;%5@\+MW"YO`ME]JQ8"FRVTA/DZJ M>2LCB&B.O=(C%_S7=I1[$P'6&X?BI#F]B;([)^&4^P,70=X9[;&2V[\>OAYD MNR-PT73E;F\/L5:G.[Q[.WQV]N3=.5W3(D6-BW1EGJUV[)3TV.HJ+VGY]>Z= M^QOYQ-;V;WAU?\F]P]"U1[QZ`W[W5V;T=4CN&6LZNQ_8';'9^X^U\9V!VQU_ ME.MJ[/=F;UV?N+<%/#Y*'<6VL17XW;V#QW\-I\9COL9_:?+RZ]TB.[/YLN\> MZOCIW3\<,SUUFDVAOS:OQ"ZQZICR?;F4RV+Z8ZE^*&!W'"=N'"4.T=OMV)NW MMK?V=CW7GL]7U=,\^8HH?+2U$4-.E/NF:]>Z1G4?\QG!=1=:?%'KS$?'NEJJ MSX\[>^7V!W7O=>T,E1;CWK5_,':F_.N=V;RZ]IO[H5>WNH]^[:Z^W%@*>BRM M71[LE&3V5BJJ-:>G:NH*OQ%:]>Z;>MODSU%VI\R_@/D.WO)T'\3_`(N5'2O5 M\TAJ]Q=A;NPW1>Q^U]R=O]B5>YMP;%V7C\YO3>^^MS[]W)+]QCMO4D-.,G!3 M1TJT]+<^(P?7KW1HZ[^<\:7-+\FLQ6;9W!W9DZI\QW+\M M>U>N=V]X=P=BY7$]7[/A[%QNXNKNM*/8&+V[_"L%38O:[D-)-6/635>M/SZ] MU`[E_G7;O[/[!W7N3"]'P[1Z^[*^IXMI[=ABZNP6&PF=CR@A@7&Y>#+T,2XFD7"TYJ/:>O=`QM+^9/MOKWMW MY.=F[)Z?[5@E^3VSI.MMS[DW3\F/[U]X878^^^_MG=V=_2XOM.3I;&;3HNP> MS,7M:3;>)S^.V?BVVS1UC5IILCD!)/-NG#KW0RYO^<3M3/[`W9CZ_P"'>#C[ M;W%\>?D!\?<3V3C^[=SX[;FR\=W%3X'J[:FZ=N]>4>SHJR;-]'Z\SW6FVOA[FL505G775/7.W M]_Y3N/I3>'<>+VCTYD:/(;%ZEW%OC=GPJRV*WQT/M9MM;<7$TE;AU[&H%VOB MHCOB>EQV.IJ/VGY]>Z(=\8/G76=";\^5G9.^.NJ[N[='REZJWUUUG'W!VENS M$T-'DNS>P]K[PW[N;=\E?2[MW!VDNZ-N8O+8&LILGD8ZBJIL_4SSUDLNH2;( MX=>ZM(^1_P#.-ZVW%C^N/D;U!M.JI/D[NKOCY#?(VDZY;L/=N4V-\.]VMU_L M;XU?&G$5N,W%T?MK`]L3=2]5;.K=U;*.V<]CL-B,UG63*8^2&F7%&NGR\NO= M4Z=$_)[;_2_Q^^5_3-9U#0[[W!\F,;U%@:'?.3WEE,+C=B;>ZTW7FM\Y+%9# M9V)Q0J-]P[AWFFV\Q3QR9?'4E)D=K4IJZ?)4DT]&UJ<.O="W\NOGY_LS6"[: MPF`ZH;K9?D'\G*7Y9=SSY3?4._ONNQL#M'>FS-B;0ZOC@V-L<]<]/;`PO9NX MH,=A:E\[7&"KI(ILC*M!$7\!2G7NJZ?>^O=>]^Z]U[W[KW7O?NO=6E]2?S#N ML^H?BM_H)PGQ0HZWM%^B?D/TY/W7+W1N#%XN3.?(W?-&V\^U_P#1G@=G8RH_ MOG7?'V)^L:\ON&1:[;L=/XVI(OXA29+5,\>O=&:W#_.-Z:R78&S]W8'X.9#; M>,P/R5[F^1]?31_)F2LW7C,EV+\>L3T/U=MWJ?/0]$8W9W64?Q57#4F1ZXJ9 M]LYV/!Q8K&T[4TT\%97Y'6D^O7N@_P!T?S7>KJ_H_,]![-^&C;/V9FN@_CO\ M<*V27Y)[YR];E>N>IN]=X_(;M1-P)0[-VY09#-=Z]G[K;-U-330T!QN8FKWE M7)8^M7&4OM/SZ]TO,A_.TC3=?7RU[0^2.[*9.]MT92?&;=W M]\>M]?'O;.T-JFIV;#@L'O\`ZCQ7:&=RFVMRKC7PV/KGQVC;:G%4KCVGY]>Z M"'J#^:_/TGD\!C]E=+YS'==[4^/O7WQ,P&WZ'NB;$[W3X]?[,3E_D5\CL/D> MQL9UM3A^S^_\ONW<&$I=U4&)QLFR\+G:E,?1RSD3'VGKW2Y[+_G!;5['VCW) M+/\`$J'%]V]O]=?*38M1VY%WWN6?&[WY21YK?V,V!#L6@63=.(^,])% MU/)%_%HL7-M>CHX*&DQ>.2JQ-;[3PSCKW17^P/G5LWL+^8?2_.&7H[U=T;0ZKZS[PK,%OG9%;UKL_&[;ZCRNUNZ-Q]=[QQ=!N?K/*;;PV1H)6V= M)A7.)AIGQ7VS2(VZ8IU[HS%;_.2K\1CIJ+J;X\XWJ!L;W#V9\D=IIL_?^*Q& M'IOD9N#9'2G6?4?:FZ]L;7ZIVGM[*TO26VNJ*S.T6U\#3[7VE5;^S,>7AQM! MC,;2[?.M/7NDQ6?S2.L4Z[^,77&V/B"VSL7TIVS\4>P.SZW`?(+<5'5]Q[3^ M+W6=)M%>L\+%2]?TM%U=B>P^PMU]B;SKJPQYZ:/-=AU[R)52P)4R^T\<]>Z; M#Q^)W7DZ')8C,4DS0MZG7N@D[W_`)@W M^E?YJ]*?,?;_`$YB\9ENE]R=6[OFV]V9G\#V+F>Z]U]:]C5/8]1NSO[<6R>N M.EMH;WW7O>HFBQ>;R&-VM@YLOCZ.*HR/WN8FR&5K]TQ3KW0U[`_F%;`HESM= M18#.=:P]/;$^F4W?U!OSI/EQA-UYV+M?+;E?_:>O=%[W3_-(R^Y<-5Y@=1R4'<\/4/RT MZ-V[OO\`TCO7;*Q6S_F9VGVWO_N#>65Z\J=C_P`?W'W?5;;[LS6VX-S2;HA@ M^S@QU5)CI*RA$LOM/[.O=8_FS_-$SGS,ZB7JO+]9[@VTU)VGM?._C^3R^[*KS5NY,MNFOGEI:8B`1[ M`H>O=+WIW^:=U9T]UITAU_2_$?);RJNE>HNY-@X#<^[.^,8N8VSNKNCJ'L[K MG=.=ZJSFVNA]N[[V;U]D]Y=Q;AWM4;5SN=W<<=N6N>?;62VV9JUJS1%:YZ]T MEMN?S2,7MRJVGG4^,FT\UG(>K/AY\?>R-N[CWK)F>G-W_'WXB]F]5]J0=<;7 MZWJMEG+[-K.Y]S=*8"?=F4R&?W&]352Y6H@@ADR1^WW3Y]>Z6/5/\V/9O3N_ M_DQN?!?%[+=@[?\`E5GMJP=H4??'?2]K[WS76S[L[([$[5VOD=US=.;?V;5; MMWEV+NC;N5PV9@VK1XW"MM*!,CAL^:VKD;6FM,]>ZJ>[6WE!V+V9O_?\$V^Z MD;WW?N#=T]9VAOJ'L_L?(5VXLI4Y?(Y+?78L&U]DQ[WW7DJ^KEGK\I_"<>:V MID>5H49B/=NO=(#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7_U=)'VHZUU[W[KW7O?NO=>]^Z]T*?2NXL#M/L[:^?W-X#@J*3 M*)D(:R(38RLCK<'D\?'CLVG\#W-*-OY.HJDI\BT6/K:A*&65H87E"*2W>+>> MZVZY@MJ^,=-*<11@:KW)W`"JU91J`J0*]2?[,\P['RK[E\L;[S*4_<<+3"59 M%U0R"2VFB$-P/IKP_2S,ZQ7;):W$JVSRM%$\H12K/D1N;8NZ=T;6KNOEQ,.$ MI]D4=--18C$XW#1X^NEW)NC)_9U])A]H;)Q7\73'Y&G:J^WHY(8YG,2U-2(_ M,R78;>]MK:Y2_+&8S$U9BU1H05!9Y&TU!TU8$C.E:T`J^\'S)R/S/S-RQ>\@ M+:ILL>R1HT<$$-N(I6N[V;PY8[>PVZ#QQ%+$9O"@:-9&,:W%P$\5A]^)^*W+ MF=C9:#`5N]\9'0=AT.1R=5A]GQ;BQE?C*;$T59-AMO5;;9RE/!NZ;,4&.J)X MLE608?PT]*U1&YTLI'S/+;PWL33I"Q:`@!I-)!+$:F&L'1I+@%%,E2P4CSGG M[J^U\R;QR1NL.PWN]6T<',$4TSV]@MW#+"D$]^Z]T<'X"_'G:7RH^7G2?2?8>]\7UUUKN+<=;N#M/ M>&5CW)(F&ZEZYP&7[)[7J<>=K[>W+7P9Q>N-I90T$LT$6/BJQ&]94TM*):B/ M1P.O='C^3'\NCM7=^>3O*+M?X*;T-O]=?$C:V[=W] M2[;[:W-L/:_0^W=U';LVYMIX7`1Y.MQE?O+=N?W3C7E3(Y%\[+C=`^77NFGJ MO^2!\L^V\G#18+?WQQPM#DNV_C+U+MC-[K[#W3B*7>$_RZZF7NSI3>>W<-#U MY7;QDVQF.O:JCK*VBJL92[GQJUFJ?$)%29*2B]J'7NB+?)3XE;Z^+N1Z;P^] M]Z=4;HRO=76%)VMA:7KO>,VX:?:^#KM^[VZ\I<9O/-5^'PFWJ',5&6V'5U<; MT59D,;)BYJ:J2K:.86V#7KW1SJ[^2S\NJ'=M#L]\YTQ45F8[?V'T9MROHMU; MOJZ'>/8VZ?CKEODWO3`[$IH>OVSN_Z(9'\<]WY'NO?W2VV<[M;=3]:5V]7WEV50+N_!=;X/:'7DM2-V] MC9:??&T=I;WP.TL73TC.(HYI6KZ'(1T4^'S\4F-S#8VI%+#7:K4C'7NAU^"W\NWKK[.U=C= MCY_Y/]V[Z[:WY\9VV7NO)5E)\1OCEDLMF=X[DRYWYUY0=;;B7/UW1_8.$R=) M+D:BA:."A-)]_&V4..T3\77N@NG_`)5GR#[R[2R6ZML;N^+NW^O-_=<8SY.[ MC[)VSF]X8/XY]&;=[<[6[8V7MKK_`'17X?J>'^Y/V.>[^K^T=I/OG?GPN[&VK@J/Y?=G[UQN6[F[2CZSJ.J?@CO2+:7:F7WG MNCKO:NW-[46U.T,]%-B]MG;]7_'S5PSTV0CPM=3R0IK5U[J+V5_*\K>M:GLG M974V^NDOE-OS;/0_QBA[`QDE;W9L'<75O??R;W+M??&W\7U3C\WMSK+"[DKM MO=14=54Y:MW=(=N83;LF;JZ]LOX48[XP=-?)'O?MONVMP_R]8M^].Q;:Q&^,VN#WM\D/D+@_C;UCF:F@[2H9YZ2JI99_5K0?/KW0-_$3^6GG/ESU!3;XP??/5'7'8._>^ ML)T#T/UMORGWS-3]G;FI]@;U[$[&DS&[MC[3WG2=:_W/Q&&P@@DS5-3XJ6+- MFJR&0Q5+3P25VR:=>ZGX#^49\H-P[5V;O6@S/5%3MS>?7GQHWU1U6/W1G,D] M+F_EOWFG1W2'3IFI=JG#93N?=#+/NML50UM50TVSZ62NFKHY3%2R>KU[JQKL M3X:]6[(_F$]F_*?&X/XQ[U^$VQ\E_,/SF"ZHV1B&RVUJ.'X&=*4E!A=H[RV; MG]A;:Z[W(W8W86\]E4TN4VO5[@VO49_,U<*93[J`J:UQ3SZ]U6WW9_+OW[U; M0[9;LO=7Q?Z.P.T.I]@INGLD[\[EW+A-_=N]E]=9CY+;7ZVR-)0;3["RL_?$ M/3V[S9.PJJ'??:JX?#[CS>T-IX+JOKSL[=E9-M';FY,779>MJ,?3 M8RACRM#$U2:FKIX)/5Z]UA?CWW_`-I_'W9/=?R8^4WR$V?\ MF<;NG8N]NP-_]*?$?X1Y[<&/[EK>K]X/T9O':&R=X9+??2F^:>JW+@,O2R30 M46)IHLJN-DW0M!JIX@8Z]T!^_P#^5O\`(_Y'=J=-[HPF<^(G5E)\N.T=A=;_ M`!?V!A\/NGI#%[CZIWEB]\OU%VWMW:L'1.U*KQ MW=/:%?\`P&A^/G22=C?(."7^#;7GV3E.JMHUO8=!0YW,4N(S.5_CNV7EPLT^ MW6J,E6^U>>>O=,&T_P"37\A]U[OV;LR/N/XOXO(;PPOQMFDKZC?N_L[B-H[W M^5NW>SM_=1=6[SJMC]5[MGP^YJWJ?J/,;RKLS'%4;(H=K?;5SYXBIA1O:AZ= M>Z`7XN_"+&?(JD^4FY\G\A^LNN.LOC'LZES59V9D,!VGN+"[[S^[^QL!U+U7 M1[V\=T43F=MLOF:>B<_P"XMYUFBI]D\,=>Z&+#_P`H+Y"5 M]7W309CMOXM[,KND?E@GPLR]'NOMO(4\^\^^ZZDWJ^W=L]>C$[-S*YQ=TY;8 M\^/I%J30UD,U1'45E/2XZ.LK:7VH8Z]T&W8WP@WUE]][NKL$W1O73]B=S[\Z M_P#BUTELC/\`=F[9/D7DMO\`>$'2#X/XN-N3;6^]YYO9%+O>M:@Q.;["RV`. M8&-KHHZJIR%!7TT'J]>Z!'Y:_$_?'PX[(P_5/8V[^N-T[PR&S,?O#+T/7>8W M#DVV5/79[ MZL"ZP^&&:[N^!GQ>ZRZIZQVEF?D-\B>Z?D[\G=R=L5FV\C49_K7XB?&_;NT. MFL1'E#-0XBFR%5E,QC:"DAHZBL%+&=5H3Z=>Z+OO; M^61W3LO";'S:=E]`[OI^U_E%G/BGT_5;,WON;*[1[0WAM[L;<'5F2WG@>W:W M8N+Z-V[L2+=.`$QCW)N?![E3!9''YM\.F&KJ>O?=>O=,^R_@!N+.?S!-E_`' MQ,!N7-;_`,#L?=W94FTN\L'M?95358"' M@J8\IMS'4$.3A9JBK@QBR9)/5Q7KW1[=]_`G:=?\`=E+TQOKX^YZ'S>QNX_B]\3=I;:V5M#9>P,I5]3P=FP29C);(WS7U&+W'%M[ M;G]X6QM&)UR%;0QSZKGKW5;ORH^"GJ2IQM7%'L&O# MKW1LZ;^2;\KY.Q=J=<5V^?CS@ZK?'R"Z:^,.T-T9S?VZZ#:.YNW^W.FAW7DM MO[KQ^&WA)04=2U+N7+4>/QRY-Y)'BUJ'7N@?W%_+%[AVAN M+`8G/3.R-A[L_T>=8[NW;N[ MLW?&]=DUAP^$V3B=VU-?BPAIZZ>EWJ'7NCF_//\`EN;NW5W7W[VGU10_ M'_H[X^=<=H[<^*_5%#6?>]<8KO/?G3.X^KOBYVON3JJ/";-R&VMQ9++=RUF6 MW#7#(Y&CR>3HZ3-SXR"LCP]7!2Z!P.O=%CWY_*(^0VS=X=\==87M#XV]K]B_ M'G>?6W5V\]A=2=C;BW=NK+]P]J]_9CH':?4&TL=+L/%KD]__`'N(_O'705#T M='C]OS&.>I3-TN0PU'[4,=>ZKZ>F>LW%+M[+TN M.I*C(04U%6;U?+KW0G[C_E4';O5&]ZCM'N#XU]7=H]/]'_&.;`[9V/G.^=[; MA[G^0/S3WGN7LKH_K'M;/U^RLYU5L+?K?'[&9.)8MOU%%@X8\9AJBNE$=3F\ MU3ZU?+KW3QN?^2IWUN7=V]*;$]B?!SK';73/;I^)_9&Y\6.I8UPV:KF?&8:+;4:5L'M0Z]T2WL M?^7CV?U/\8F^4&^.T.DL5AFQOQUR-)UC'E^R*[L[*-\H]E9OM'JC%XF>CZOF MZIR6:EZEP$VY\Q2Q;I:7`XZ2""O$&3J(:!]US3KW1I/@_P##I=N=<_(3N_N6 MAZ8S6:K_`(79O,=(]$]C87-;CWO+N+Y,=B;&^-WQT[ODBK]E5_4FR:>EW_V$ MF;P<&Z2'=?\K+O'#9CNA-LIT#-/\`'KM? MJGX;9';'1&=^0':A[C^5#[;ZSVUN':^TJK);'W7)MWL/=N\]UR352;HJME;8 MRVX*?,X[:"UD6*DHZ?=1CKW0"O\``;<4&.W=N&K^1'QMAV7UID-I[0[8WW1Y M;N7<>T^M^X-\[IWQMG:G1U=6[2Z3W!6;\[#S,'6V%9/5Z]T,6>_DZ?+G:>*W3E-UUO4&WO]'N+^9&<[/I:S?5;6#K'!_"C+4>T MM^97>N9PVV\IM:BI^S.RJZ/:FQXZ?(551G,]JCFCHZ:-ZI=:AU[I4;A_DP_( M+:.X>I=N;C[M^+J5W<_;?Q(Z@V;!MK?'86^LA49?YF]?9;L;JK/28;9O5>:R MAVW18O"3TN2D6,U!J6AFH8:[&U,&0D]J&>O=`QW?\!Z'9VV/E7WKTYWSUYVG M\5^@N^JSI#K_`+,7#=MIG^X\J]1MNJQU%1XG&=3U>$Z^SE-MW=D%1))O"NVS MA<[-CLM'MBOW`N,J778/#UZ]TF^I_P"7KVMVCU1N/MFN[#Z8ZEQ^#V_UQN^A MVQV_G][;9W)N?:';79^.ZBZ_W'BJW$]?;CV-A:?=&[JV::@H\]FL-E*_!8VM MS5+2SX>F>N]^KU[H8^[_`.4%\C>@]U_W2WCV3\=_R*VKV!F-I[_P!T M9C`=2[=^,%-U[6]E]H]EY"?8&/?";(EINT,/'BJ2GCK-TY#)U*XE<.N9D@Q\ MVM0Z]TZ?-;XWTV3^1/Q.^%_QPVKUQN;L7:?Q%Z`HM];JZ\V]4=>8?M#LGL;8 M5;\C]U=J;US'9.WNN]U8FCVYU=O[&19:NW;182;!XS`RR9&FH9(:RW@<$GKW M1?X_@MD)-OT>_5^2GQO?J3-;YVYU/M/MV&3Y`5>T=Z]P9;:^!WCN7J[:V#H^ M@*CLVMW#U=@=TXR3Q5?\(,Q3;>[:P]=68O;.6VC#_$<[)-14 M&5_BG]WL;5TQAW#D<'+44257M0Z]T\;0_D5_*S>^_MT=?8+MOXJO7;2^07Q_ M^,^2R]9V7O6CQ=1VA\B>LCV=MS'XR@EZN&[*Z/9E(K8S<=.N,&4HUNQ93MB@ M[*[.W5\8^KZ'$3;#Q&$.>[JINV*2/,X"@2KR&SZZFAI);=>O=8= M[_RE^_>N7[J3>'8O3>+/QXZ7VIW%W"8:?OG+)M)M^'>8V-LB.3#=$Y!-S-NX M[)E^QWWB#7].R#)X@MO)?XQC?N?5'7NA'[)_E&=[X3=_1?4V0S/Q;V'V'ORJ MZ\Z+V92X+?\`W7N*L[V^2'8N%Q/;\/7V0FJ=E[LP&TNU=E[([LV1A-Q5"G;G M7V,-=BR:]JJ3*U2ZU#/7N@7WK_*Z[PZ_^,M-\J=S=G_'6GV+7="X7Y!8[:]! MV1ELQV+D-MYCORC^.OEK\3-_?#7L7#=3]H[BV=F-^5VRL)O+/8?9T._I*;:!SU1D$H<'6Y M[>.P]F[=WHU30T*5]'G=H5>Y=GYC&UE-5XO,UT$H<>!KU[H]G6GQ"AK/A%T? M_HUW-T+N?Y(?./=?>.Y<[A=\[*SF6W/TO\//C/C,GD=T=E8W>.^>HZ_:'6-' MB]W]9;NK]TY[;>7&X)\-BJ#'XJ6N$VX,=3ZKG/#KW09;,_E3=P[UQ.X=ZQ=Y M?%_:_4&W^A^O_DO_`*:]][Y[`V=L#+=,[^[VKOCE'NO'8_-=54_9,$VW>T<+ MDZ.JQ]=M^BR60&.=!J>P:R+9< M=5`(ZX2"812>:H&.O=#ITQ\.>B)?CGM!NQMMPYWLCNGX&?-_YTR]F-N;Z`R7:77/QPVCMS#X7=.+V763=L]T])9''[CGSV.S\E31[DQE'C8\374E M34U&JYZ]T`?\NGX79+Y&]P=2[RWON'8&PNB<;W'3T6X\OV51[LRM'V32]3;< M/>7=/7^R=O;2V5OB3/YS;W2.`J\ED9,M%C-LT,=710Y/)T9R-&)]DTZ]TI]E M_P`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`SIX@]+ M/>3E#;^2]]Y?VS;>6=WVR*7:8I6&Y0_2W-Q(9[B-[GZ,W%U)9QN8O#2&69G/ MA&8:8YD4&6V)V=U)4;0V5+N&'HO:$F%W9E,G4[6K]C=T9[)4,L=-M.GFW#C) ML#N:JQ$N8S4.)5_\H$%.?!#%?T3,`[>[=NBW5X(#>RAX@`XDMU!RYTG4@;2N MKRJ!K MBX6`-^J(XCX<45>R5@0GV-^L$^O>_=>Z'[H/O67H;_33D<7MO^,;I[0Z![&Z M*VSN#^--BO[@1=M_P;:W86Y/LX\972;B_CO3E1N3;'V0GQX7^\'W332)3-1U M6B*TZ]T-NZ>T_FEUQ@^I?D7N_/XU=I_(#H->@.N),QCNE=[;0WS\?OCO5;2Z MJBV#G^EI\?N';])MK:6X^ML7)$<_M^GFR6XL4IE& MOV!CKW0\;M_FU_/WL"MEK.PNZ\#V'!/V3O\`[>J,!V!T3\=M\;,J>Q.SL-A< M%O#<53L3=74V7V74M4T6WJ.2AI7H&HL/71?>8^&EK'DG;VD=>Z+WUU\QODGU M7V1W)V]M#LZL_P!)7R#PFZ\!W-N_=>WMG]AY3?\`1[WWYMWM'.'+4F3HXZBGJ8I`6/J#KW0H[Q^9'SF^9-1N?I/U*_P"1_P`@*_N3=.U,5M+8F%RW8G=6],;L;;%365F1VSMC!9&/;KT/7.`$ M&!6I@VOC'Q$%5#14\D/F'J`=>ZC[W^8?S)V#+B>E,WW-B31=&=/=D_$K;U%L M&IZ4WGM+%=2;]CW1ANQ-K[?[!ZQH\_M3?<.YZ^Y/BYOAURW=7>FZ>EP=D]B[AQT>UMH5V0?L/JK&[XP6PLY-6;DVWE, MO0Y+9$?868DH8HY8HZ7(SQUBH*VEI9X-TZ]TM=N?S#?F)M#J_&],[7[DJ,#U MOAND-T_'/$[>Q>R>MJ27&]0;U[5I^[MT;;HL[%LY=QTV4RW:5+'EVS:58SR2 MH(HZU(/VO>J#KW0GT?\`-Q_F%4/8'8/9T/R"\N[.UN[HZG`P8V+"5E5GJFMGI)*TI4)Z@].O=! MYV?_`#'_`)L=S;.WML'LKOK/[FVIV-LCH[K;>F-DV_LC%S9S8WQQH=RX_J'; MT>QZ0[#S^ZNT,I\C:K;F#W15[5SU1U?CNRNF:.NZ?V;B M=G9ZDQFZ*R'G7N@JI/G9\K,97;NKL)VO-ML;UZ2SWQSR>+VKL[K[:FV\-TONK>&%W_N? M8^P-J;6=OO:SS^H.O=+#L[^9-\T. MYL+O[`]G]O4.\*'L?>.4W_FY\EU7TU'FL#NO/[0P&P-S9+J[O2FW<=M3K[=6#I,#@=] MS]H[5HMS=;]8]B/L;LJIQ>&PU5V!UW6]B[-W7D.N]YU>/VWBUER>#EQ]9+)B M,?*TAEH*-X?4!Z]T8++?/_/Y+*Y+.C9.0?-TWP2K/A7L/,9;L&MS65VG5=C5 M,E9\CNV\ED*G;D57NC(=XU?8G9LLV++T34,F_"TU=D&H93DO4_P]>Z#BI^?? MROJELA\=\:-Y;JP^PJ' MZ]J]+9.7;^`W%N2IRVXMN48C;%UU)-##*GJ#KW2>QGS3^3>&ZMVCTMBNT:K' M=9;$ZZ[>ZHVKMFDVSLF!<7L3OK+Y?-=M8HY=-M#/5]=O&;<&0II,E4U4V4IL M77U..IJB&@J):9_4'7NK`.IOYR&\<)M[O_\`V83J*E^1^_?DSNFGR/=N= MZVV+L/MG8&`VG28'8/3V].MZ#H7<,NS-C;`S,N8R5#-U=F>L\S.^Y,A'55LY M7'RT.M/"G7NBC?'7YT;O^+GQW[FZDZDVQ0X;L[N+MWHOL:H[MR$6Q]U3[5P' M1%#V14;:VMMK9>]^MMU)@]Q'?&_X-PTVY\9E,;EL9D<'0M3:7C\GO9%3U[H) M-@_+KY%=8/U1)LGLNNQ,G27?F5^477,E1@]JYR3%]^YBGV)3579>:?<&"RC[ MWS4$76V(^TBSIR5'CVBJ&I886KZ\U/J#KW0AXO\`F'?,+#4W4R8SMY:7*]'; MNI]Z=9;S7KWJQ^S,#D:/M?(]Z4F$KNU9=D2=D[JZ^I>XX=K]=9;)_).'K'$;DS%'UQUKLS;_`%YM MCJK=]+OO;^-Z0Z^Z[V1M#:_3M=59^E:&K;`K1XRIQ=;6T[X]I:HU2>IPZ]TZ M;/\`YA'RYV-M79&P\'VAC:G877?36\N@-J;"W5U=T_OW8M)U/O\`[/I>Z=U; M(^?_`,J< M)C-C86CWQLZHP^PC,$4[J?4'7ND;M[YB?(O:OR&;Y58+?]/2=Z?PO M/8*GW9-LCKW(XG';>W#UEDNF:K;.&Z^R6U*SK?![8QG5>4DP6(QM'B(*'!8Z M.GCQL5)]K3&'=.O=..[/FY\IM\[3KME[K[>S&8PV2V?M'8%=4RX;:D&Z)]E[ M)[%WIV_A]MG?-'@*?>R8NN[6[`R>Y,Q&N0']X] M_DYW/\ENQI>V.X]Q8'<.^:G)5NM.O<7E]RY;*/G-Q;OSFU.N-H;2 MVEG=Z[OS4AJ\[FJRAGRN=J;2Y"HJ7`8;`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`,-VM\NNI.K>I<+\=Z/K#'=-Y#"T76&2K M=[;9W95=7=5X/:=7MNEZ+V!4[3Z>ZFSN8Z\:JFIJQLCV!D>P-[.V*HU?/NQK MY,AX"A.>O=)/:?\`-;^>FQ-M;=VEL_NS%[>PVV<7\?L)3?PWICH6',9O$?%A MJ=.@<=OOG7NDQB_YE7S M7P=?4YO"=T_P7=-=V?A>WZ3-#\]/D_B]PYW<6-W=L;'KN M#+;)W!+L^BZ&^/\`2]48+<76]=NO)["W+L;I>'J].HNN-S;1R._<]44&1V_A M,96TTV>R3I*&R%69O4'7NE1-_,P^ MH/3KW4O#?S//G)M[R=.O%KNP(>O,28J019Z7)196EI*2+)+61T=(L/ MJ#KW43!?S)OFAM_;L.T8.WJ',;67:7:6R,AMW>?5?378&%W-@NY^V8.]>PI- M\8W?77NXZ3?VXLCVY2PYVAS.;6OS&$K8(OX954:11HOJ#KW2=SWS^^7.ZOD^ MOS*W1V_4;F^18Q^6P\N^=Q;,Z[SF*K<#N'9V:V!N3;>3ZYRFT:KJ_+;7W1L_ MF$N-WOM@Q4>^QV;M M?'Y+ISI3.87K3?J8/!;:I]S=,8'-]=Y'"]'Y"AP.U,/2TW]SZ?"1TL6$Q@B5 M/X=0^#U!U[J!5_-SY25^`J-L9#MO*9#"5G6%'TS7T>0P.T*Y\GUG3=WR_)&K MVMEJVJV]-7Y6GW-WC,VX\]45,LM7N*N:V4EK(OV_?J#KW2]W)_,I^;>[=YYG ML/.]Y5U1O3<&^>]>S,MN"DV1UGB:RI[`^2/5&)Z.[9W?&F'V704U'GLAU7A8 M,3AJB!(WVE'Y9L#_``RIGGFD]0>G7NN5'_,K^;..P=!MF@[LDH]OXO;'QQV7 M08BFZ]ZJAH:?:GQ-?(R=%8(0)L95?'[:;+5'\21M7]Z1*1GCDP`!Z@Z]UWN/ M^9-\P-T;8R^SLAOKKZ@VYE,=FL%1T&U?CE\:=COLG:VZ,>N+WGLCJ:OV7U#@ M,CTQU]V!0M.FY-O;2FPF$W&:ZN;)TM6U?6M/Z@Z]U(W3_,X^<6]MW;LW]NKO M&;-[VW=O+>/8B=Q;NV[@J"#(U M>RFP$U6:"EED9IJ>&1/4'IU[I+;:_F!?+K:&(.`VYVU_#CH5V' MUE4Q4VW_`(JRYFIZ2P%$U9LRHDH<'@ZS<60J,O1PM'3[MJJZHFSZ926:1V]0 M=>ZA^N.LMA;)VGTY793?61KY\G/@XZ2BR-/F&HMB[&VB-]92H7`8-,=A:S( M3I6U=+/64]-/#Z@Z]TU]6_)SN;I7`S8'J_<&W=INU=NC)4&[:7K7K"M[0VU7 M[SVU0[0W)5[([@RVS:_M;8,V0V]CHH%.$S-!]NVN6'QS2RR/NG7NL8^3?>*] M.)T&N^YEZM3"S[67"K@=K+FALJJ[`C[:J.O#OI<&-_'K*7M:)=SG;)RG\`_O M%?)?:?>DSGU!QZ]T*O1/\P;Y=_&C84/6O2?:]/LO:E'E.U(EKZ2GJHM$` M]>Z6T_\`,2[J[/VUUEU)\J\WN;O7XY=556(SNWNFMK9+8G14];NW8O1FU.A> MJLMN#L;9/5E?O#.T.S]F=<[:HZJ*I>2OR%!BY%BKJ*OJY,FOJ#RZ]TE=[?S$ M/EMV!N?Y%;SW)V1BZK=7RFS&[,KV[ND]<]:3[TGI=\X+(;1W=M?8O860VC6] MA]5;(W-L?)RX#)8;;.5Q..RF!(Q];%44H$7OU!CKW3?T/_,"^77QDZ\FZLZ, M[;_N%LR;/]G;H2EI=A]99G-T&;[FZPQO3?9U7A]Y;EV9F=YX./=W7F$H**>" MCR$%/'/CZ2MB2.NI:>IC]0'KW2H['_F$=Y9SLOY-;LZERM1TQL?Y,;0V-U'N M#8%#_=W>&0PW1/4-#M#`]-]946_\QM*CSU#)L/:W7N#H3E<+%@9ZT4-O'#3R M&F7U!CKW2?W?_,)^6^^.R&[?S796#HNS:C#]D8K*;TVAU%TKU]F]R5?;?7^X M^K^P=Z;PJ-A==[:7>?:^?V3NW(TPWGEEK-VT<]6]92Y&&M"U"^H.O=$N][Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]?21]J. MM=>]^Z]U[W[KW7O?NO=#[T+MG>8W-C>PMM[>VMN?'[8R<]'D,1N'?FQMJ?=& MOQ513O`]+NG-T51)%)25K-%(])4T2PN)Y8WD4$,L< MCTHP/%%(XC(U!@#4$5!ZGCV*Y;YQ',FW<_\`+FP;7N=AMERTVV.OQ8 M'0J4O;F-BI20E':":W=T9'255EB,?O\`H*C'[JV_%4;K:16M234DTQ3I/[]V,]AS1L,5QR]#MS'9XJ*NXVNZS3!9[F/Q[ MN[LE2U:X3;:;JVM#)^Y.;)M=V\(F-L)1*+:6 MZ9%>3P%#4&&4BI-_=>ZLY_E393IG:'>G;G:?=%+\;\I2=0?%ON M;?G6V"^3^Y-R8/8>9[DE3;NRNN$Q6(VENC;FX]^[BP>7WBG8'4&!BVMUI\'_`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`[5Z M[P6(["P4,3;3J>N]L+19:IQ\E%]Q)4464K3CZF;&9+S5J*5Z]T:;=FYOY9_R M0^2^\/D3VYA^KH=QYK:7SA^;F\TS_P`K-W;:S66V1UM%09W;VSVI,=4197*8>O>?612G7NJOOG+T_\`'#J#9?Q- MV)TH_4VZ^S9]I91N^,UU7W+2=Y[JW9O,0[+H4R[[VZY[C[2Z1BV%O#._Q>JV M;BJ;;.Q]]X.A=\?NG#U4U/0YC+6%>O=7'=\=+_RJ^N/E1L3X\?(3K+X^[.Q7 M1/8?7&P-T'JCO_,T6X,KTS\;/C1O;>GS17Y!YS;?;61VLW:_9OR-5MO==86F M@VQV)EZ_Z4WK#O?,? M+NFW?\G]WUO=_P`==O=?U^1V)@]H=#]=GMK9^]NU^V>R=E[8HM\#*R[3W+MJ MNWCO(8ZEH<1A,-6T,.\]>Z-A\;?C5$MLT.P=^[>Z^^+O;6\NB_@5WEW_P!O MT78/R0VSN;:U5WU5X?I[JCHNJ[>WW1_(*J^-F+Z\WSW[V_!+M?;E53=<[\VY M34M?C]QXZKJZ3$YS(Z)/\^O=%UWSUA_*IQ'4_P`I.[]FT^P-\9["ZND-@].8 MWO//[4V]MGL?$?%_:--N'Y$=0;=WCW0WR6WUUIN_Y7;NKZO9<=5C-_XZ+`[2 MFH]RG&19>GRF/WG'7NA?ZK/@)MG(]4;<^:.,VWDJ[ ML/O+L*N[J^3N_:?L;L;=E7L#:V\.M^G<8.JXZ/*P1;/VAEJDY3<'^6&GFD]4 M]>ZJS^=/3G36V^RNU=[_`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`,MFJ6=P[720A(RQ%!8^5]+LG&S;6I$HNP:OLFN MPF-RF6W3O1(`E3[U%MR7MTW+%JEGO\ON M-/90S3WNXB6)IK?ZK=4(FCNMKVFZENB1;J+F2U6,VT$4*5,;RS,W0?>>S.K- MLY+%9_';GJ\E6[@GK89\13XZL@H*2OH<3C6S>*FR.:H9\%NO!4E-6FDFH4IY M:B6KB\]3XJ98)'M[V6[W*YCE@DC$8C`HQ()(+'2U%(9&)74&J`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` M[S;HDERM'E-[R/N.'_;WDCY+KO!4N0,SIDZ`F8-/-*0AI8W))OUU$NXA/WBDL'.O>_=>Z-9\,?B1O#YO]ZX;X[]== MA=3=>]@[HV[O/.;0E[DSVYMJ[5W/7;'VKEMZY/:U+NC`[/W;C,%GJ[;N!K9J M27,MC,5(]/X7K8YI(8Y=$TSU[KV]?B)V!UCUUW7N_L_<>TNNM^=`=V[3Z#[' M^/N[<=V=1=S8_>^\\?OW*X:HIDINN*SJV7`F@ZQSLKS2[HAGT4(9(7%32&H] M7KW0/8?K.IS^P5WCA]V;0R6Y*KLO;_6>'Z:H:C/UW<6X:G<6%RN4I-V8';%' MMZHQ>1VA3U^.BQ4L@R(KSE*^FBBI)4=Y8]]>Z'+N?XBY[I7XQ_&7Y&9W>&/K M:KY%;_\`D[UY6]9KM[/8C<756=^,N:ZPP>=Q^[:[-0T5/79C.U'9*2BGHX7A MHHJ=5>H>>26"FU7)'7NBA>]]>Z?L#M;LDQN"RE.)JB>FH7: M9G7[=`@+:!KU[H*.BNE>P/D=W+UAT+U3BZ?-=D=O;WV[U]LO&5E?38JBJ=P; MFR4&,Q_W^3K7CI,=CX99_)//(=,4*,QO:WO9QGKW4CN7JB@ZBSN#PN/[9ZP[ M>CS.`JSFV\=3YS`YW;G:&VX-@==;[W?NCK+ M^\F=V[UI4]E4L3XS878F5R6W,'3[>W_ALG(V-KZ0&>E_B$4D=+4U2*9/?NO= M,/:&QJ7K7?\`NC8M%OW87:%+MK)''P;_`.K\GE\SL#="""&<9+:^4SV"VQF* MS&DS:-=104LGD1AHL`3[KW2"]^Z]U[W[KW1L/A5\7)?F/WWCNBJ7?^-ZXKLE MU]W)O^ESN3P.1W&E5%TSU)O3N',8.DQV/J:!?XEE=N[%K$@>HJJ:F60#5)J* M(^B:=>Z>_CG\,,[\BNFODAWM!W9TEU+L/XKXWK?-=IR=ICNJ;+)ANU=^XGK+ M:.3V[CNJ.F.U#F(9]Z9RFI)XR\-1`',QC\*M(/$TICKW1?>WNN5ZE[&W+UXF M^-E=D+MR:@B&\^O)-TMM/,??XF@RQ6A@WSM78V],978PU_V=?09;#XS)8[(T M\]+4T\4T+J-]>Z&7X.?%NK^:_P`L.D?BO0;_`,'U?7]T[O7:-%O?<.'S.X,9 MAJI\;7Y&$-AL#&U=D*RO:@^VIHVDIJ>HIX=O=%1][Z]U[W[K MW7O?NO=#=\>?CUV=\G^SL=U1U1BJ.NS]3A]R;IS66S61@P>T=D[&V5@Z[<^] M]_[ZW+66H-L[,V?MS&SUE?6SFRI&(XUDGDBB?Q-.O=/'9_0F)V%LN#?NTOD! MT9WCM_\`O>NR,J.JY^VL?FMO9FHQ5;F<949?;G<74G4N>;!YJBQM3]ID*2GJ MJ.26FEB,BR(RC5?EU[HO/O?7NO>_=>Z7O5^QJ7LK?^U]BUN_=A=7TNYZ]T@O?NO=+W< MNQJ7;NS>M]W0[]V%N6H["QNY,A5[.VUD\O6;RZX?;NZ,AMJ'&]D8^NP6-QF) MR6Y(*`93&I0UF1CFQ=1%)(\,I:!/=>Z07OW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NGW,;6W+MZAVQD\]M_-87';UP,NZ=G5^5QE904>ZMM0;AS^T9M MP;>J:J&*',86+=6UV\CNG"8K,20K09#+;]97X[9>T8<[E:3%R[GW=D,5C,WE*';&`2J-7D)J:BJZB*DBD:.&5P$;W7NA M*P'1.8RV\L5MW-[RV-L#:&XINS8=J]U[]GW7ANFMW'J[&9FLR0V4R-+#5?:AY7B]U[H#O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]TO9=C4L?5]#V4-^["EK:W?N5V,W6$63RY[0H:7&;>PV?CW[789L$F!CV%E9 M>]-H[/J=S[8V13[KW/@-MS[SW MO65^.V7M&'.Y6DQTM@?W%K9,['35>8S&!J^L)6JJR.G@I7FG,=/YH8TJ9]`UKU[H MJ/O?7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HV'P9^+P,3U=5 M]U;QCVA2;YS6"RNY:'"5,N.KZ^%OX%AY*>KR556/0_;P1M/2P>:53-401!Y% MT30$]>Z*?[WU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_TM)'VHZUU[W[KW7O?NO= M>]^Z]TN^L]RT6T-[8?<.0_B,=/0IEHQ68K:R.NBA%;2B=Z<1M+&K%@BW&W>ZLY8$TZFTX:FE@&!*FJM0,`5)TM2M:'H< M^VW,EGRESGM&_P!_]0MO`LX\2W+>/`\MO+#'=0A)[9GDM))$N4C^H@$C1"-I M8U8L%'W1O/#[XW1CLKBLWNO=,])MR@Q>;W;O*.*CS&Y\Q35F2G?)IB*;)96E MPF/@Q]53T<%-'._HI?*_[DKDI]HM);*VDBEABC!D)5(\JBD#&HA2Q)!8DCSH M,`="'WDYQVGG;F;;MTVO>MUW2>+;HH;F^W`+'<7EPDDS&80)-.EM$L3Q6\<* M2-VP^*_ZDCDJOK#J#"=D;0HZNOWK7;-K!O\`FVS%+D]N;HSFW,C)E<-BZS'4 M.`&`P=73MNR44-6]3#-5Q,]-#3E4`U.$NY;K-M]VZ)9K,G@:\.BN-+,"6U,# MHRM"%-"6SY="GVS]I-E]Q>4K.[ON,P.&DW\^2J:J&MJZ MD_9+!'3$S&:'1Z]U:SU%_.2V!E,-\9LA\P>A:CNKN3I/N?8-;O\`[PQ$>V9M MZ=R](=9]'=^=5=,UV]J;=2U&W]Q]_?&C<'=7\6VSF MLT5XTZ]T-5;_`#E^B8HND:ROWE\KNV-V]"?S&/AK\I\'O3=/0OQ?Z3'LE+%CE?[=)5]I/RZ]UAJ/YU?QUD[ M1R&\MK5_R M_P#?/3VP-Q[)Q^?HJG/92CK*>3&4T46)%2\V1/M)Z]U6)\%?G_4_'O??SEWO MVOV'\@,;NGY@_&/M7K8]F=)5U#'O[%=X;W[5ZY[2QG9666KWKU[`(9ZG:N6H MJNLI:P5U)%G)F@AE5Y87V16G7NK-S_.:^(G^B7IWK;=VR._.]=J]*XG^4:^V MNENTNL>K*3J:7
O=5@?)+YD;'[N^;W77?![;^4&:V+UY0[:PNW^X*O8/0_3GR@VO2[:S6 MY<_M'5[2RW8-=VIF>JNR>H:2BBPF%?;R9B&MQ.`Q MDE/4X*L>2:G\%(X]>ZK+^87S7Z2^2GSBZ-^2F/VKOVAV3M)>I9NXJ*IVOLR* MKW1F-L=EYK>6_LAU?U)V7NSY#]>[+VMD<+EDIL/M#-Y7^>S]9\H*W+39#"=-QP[9\YK:O*8?3]O1RS42H!K2?Y]>Z%0_P`Z M/X#CY$]I=O[6V]\P>GMO[^[V^9._]WX7KCK'J$_[,7L;Y;_&2CZ@V_0=_8)/ MD?MFB;.?&CL5:K-[9H$KLYB:_P"]JZL?PO(UDTH]I/7NJG?Y?WS.ZH^+GQ]^ M='6F>[1^3G3W:/RDL]2 MS;LQ6(GPC4U#-(HIZV1Y)9(]5/)8BM.O=';ZN_FH?''KOH7Y%?'3(?(+^81N M?#]YU&\.TME=LT73_1>R=\?&CY)[GPJ+O#>_2VV,'\D:BDQ&Q.^\COO>.+WC MA:7-XIJ7`2TYH)7KJZMJ(-4.,#KW3=\:?YJGQ8Z6WO\`R^=XR5/R_P!E[*^- M:]*/WK\8^O,!UCG.B=S[]Z-VSOG$?[,%U^N=[7VU6Y'LGN;([H>KS^/JZ#!" M@K\G659RV5CIZ:A?Q!->O=#CTK_.<^&^Q^X/CGW7VA%\N^SMZ]4?%_XY]"]H M9:3JGHRBJ^Z:KK?LGO\`J.TJ7>.6G[LJMYYS96Y^G.X\=A*/'3YM,)DSMZ&G MSF%K4AP]7A-:3GKW2=^*/\QGXS;@^/O0O\O+*;B^0F?HMV_'_?'Q+K\?OKK7 MI7$]+Y[NGM3Y\;([MZ.[8WQ7[O\`D7D,3B=K==]9PS[6JZ[)4E2=OTT[M`D] M$KH?$&I/7NK)_E]_,;^+G7*0[OK*_P">_56R=N]H_*/KO8W3W>G1/7E/W'UA MV%\H!4]C9'Y:?$W:?8O:D_76[NJOCW#L.GZ^P.VU.S:F"DR"O5R* M^@#U[K6E^/W\P?%]2?-3Y&?(#?\`M3/]M=7?+/8GR/Z2[YQ$%%UUUAV'NGJ_ MY+8?(X7>>Z,)1[!VKCNL-F]AK65$&9%)08Q,6U2DE)Y`DS58O3`'7NG3XS=_ M?!;XD=D5^]-G/\DNV\UN?9'>/7=#VENWJ3K#K/>'QV3LCJ'=&Q-C]N=/;*PW MR`[*Q>\.W]@;PW'%F(:BNS^WHX8Z!$HY::IE^ZBT03U[JT#HW^>%\=NL^_D M7L/?N/VC)&E;GQD<)M6@&7R%0\DGBUI/7NF*L_G,?'&#;>0JMM[S^8&"[>A^ M&'R:^,6U>TJ#I[J;&YK;FX=\?-K&?(CXV;FH*FA^3"U=!A>E>F(:G9M)'"PG MP2RF/&AZ6211[2>O="=O'^=]\*MU?*/HSO.KPORHR.UNF/YD7=/ROP&`R/2W M2L65VK\=>WNBME[5R'2.SXX?D748Z"NJNXMM9'+9"E\E+BZQ,]49%Y&K4:FJ M/:33\NO=%BZ^_FK_`!1V-@OBKBJK`=X[CS'QSP.W=EIGUZOP^U-L5>PL?T!N M#IKO=0 M\S_-0^(\Z]8?P'9WR(QN;P'QW^?71Z=DY/;?7F5[0Z!W+\HODANWN7ION7I_ MI?'5%,/MX8O:3U[HU/2G\][XL;`RNQ M*C-X'Y,8BGP?R(^,N^NWJ[:76/5&7R_RDZ[Z7^&F]/CEW!N/N6/)]\;T M?DYOG]>\=K M9KN;XO[EZ8Z2WGU1M#;.1S^T.R:OM7K+>^U^S<]19CMG9<>V:K![?V-7T4ZM7[)_G4?#O+][[N[4Z]ZF[IPVPZWY"?++NC>/2 M]=U]UIB=E_-S;?R8ZFQG<.4H<+C>J-VX;(1TD]-2[QCJ<;E9J MVFI\;E"SO72>O=5;?S&_G/B_EIC/B]L?KO??=>7ZOZ*^-O1_766VGVUMG;&U MX'[NV!U3M/K?LWM/!0[;['[(;+2=HU.U8JZHJJVHIZXM82H[ZI&L!2O7NK9] MI?SE_@[L_)=(''+\S:O'])]C_*'=6UZ[,=4](566P&R?DM\,ZGI=.M=M83"_ M(';77VU]L=9?(2DH=VT.)VSB-J[3GC'W-)@\16TZ1S5TG/#KW3[TG_,VVGVE MOGY)]EO2=\;_`.BML_RS?BCE/DIN'?[X3K;,YCYR?"*HZSFZ([7RV1VOVEO* MIW#2]T]W[3H=OM5&ICS]13[E=9(4BHFF/B/VUZ]U3S_+\^;G7_QT[F[S[>^1 M=+V3V57=U;.SFW=V3[6H:&MWMNJ?=&[:'?VYJ^F['G["Z^W+UONW+[QV_C*B M3-QMN/%UU"=V[7R^1[>VQV!MZC[4Z9\>S\CFL#5; M9R^(I<11T-53;FP,M5B&]0Y].O="C7?SHOB94;LZ\ITP/RK7J#8OS#_F-]T8 MGK>BVOU30;?VAL/YLT<^5Z;W[L[8F7[3W=U?/W9\-M[Y.OJ]K8;*8BKV])+7 M5%9#78^>=X1K2>O=5JXSY[;8I_YDVW_F7N?/;[[/P&VL7D\/)O#??1W2^%[" MWO\`:]+9_J[:^=W/U-TWNWJ7:.'S"-5T,&EJ(MTQ M3KW1T-U?SS>A-][6^/_8_7WS#ZKWA\J\# M\C&&SG;NTNW<-@MOTVUG;`4-:*G&45*HRT>FJ-7K2>O=*':?\VS MXVX#>GR-P&?[:_F(;]Z6[7QG2F9ZNRNZ\1U55]A].9KI;YH[/^6^V>L,'ME. M[EPO]S,0N'R6%H]RKGS64XR`>FP5'`AICO3\NO=+OM;^=+\>\CVQ\>Z3FW?YQ7QNBS'Q)IMS[K^:-;U M[\>L9_,8VSN_K]-I;#R^S]\4ORGR'R8JN@=]P;.R'R-H<)_?/JJC[SQE-4P5 M3.N*@P03'5LZM%XO:3GAU[KCNC^A^T>O-\]1_)'/;6S6S\]6+A/VDT^?7NJT_CA\L_CUUS\N_E#V[OC;/=.V^N>]]L]_[W1V#MG#8^3`Y+Q9;;OW>/S->]-4TTA MC7W8@T'7NCI[<_FT='XS:.*I=RX+O??^9PF+^<6'[4VGO/"=?9/8OSYSWREP M>4Q_7?V'.!WWTYE^1GQOW_5;2J^G>F:A,CT9UW\$S\9/D%U`]+4_) MV6A?&_(CM2CH-Q9:@D9\;54E!`U9YZB*.-=:3U[HGO2G\WCI#J#X8[&^-.([ M%^7F%W/LOX<=Y=*T.=P'576],7+5_)*ERL==U/UK05 M.V:.L\,>2PSS`T%X.!NAK7KW0F]E_P`XKX2YO?\`O+?_`%YMKO\`PV0R/SI^ M2?RCVAC-W_'SJ[([>QO7OR*^.W7W3V:V%D:;9ORUV7O'";@HL[0;KR%/DMK[ MAV_DL;D=P)FZ+(PU\<]-4ZTGKW071?S:/B`,U\=S'U]\D,?MGIC^9=B_F3+3 MK%M3);@J^I?]/'>G9>]]H;YG/:^)VKW_`-@[[V;V+CL3#79;$;>R6)BJLICZ MS.9W$08JD@]I.?LZ]TFM[?S7?C9DME[XVQLW:O=>'V_N'XV]W?'RGZ;FV3LB M@ZFS'9_97R-W-V_L[YZYR2B[CK:[%_)K8&&W%1U%-24^/JYXLWMVAAI]R0XV M62*+VD]>Z3/\V7^9]\?OGIUMFML=>-\@)\W0_-_M7OKJVD[K_O'U/GJC9V)GS.U,C%6B:5;7;M+L'I7+?)A>].O:+;79V/^74W9O6 M._=IX$4F(HJU-PY?;^*@Q+8^7"9C!927%4.M)SU[JN/^5M\W.@?A)VON?M;L M2E[\Q]9C^T>A]]]?8?J#';"SCY_:'7^_,WD>S.JNRMXY'=/4N_*7;V^M@9DX M]X<=D9MLYF=2-P;=RL<>/;'6()Z]U;C\@_EW!TA_+N^*=3L.A^16=V9\OOCS M_,(ZMZEZ;S/6^-P/6-56=@_.WMN7X_\`;6Z*O&=C9R+`=Y=%['3'5>S<=A,5 MF)*,142T&7IZ(D2U`R>O=&4^8?\`-`ZW^#?\TCMKKOO"3Y.=J==[$^<^Q/D) M@=MY_JG9(I/CWLK:76._]L;JV3\3Z3MD?:N+@Q^$= MTQU=55U.D]I]-=0;-^7ZUG9BR[7I^I,)LN&D@IH*/?-/38^OF>B>'(1?>U% MM/7NN73'\Z;"[=VY\%,#W1USOGL.MZ$H6ZN^1NY%SN.S-1VETIU;)VMD/B%4 M[8VWNFKJ-JY#L'XY;M[XR^X:>/-TS460R^T=K.\R_;2LGBO'KW1@/C=_.C^- M'4G=M+V]O7,_+W+[SV=\HNO^UI^YME=3?'78O87ROZ(V9T3BNE\;T/\`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`^ M2U&#T>_>0FBEYXVF*V2W@M8=JC1+2`;9HL0+FZ)MO$VA4L)F+LUR\D2@JUP8 M9.^)@#I[!P6$P5%C*G9&-J*;';FWQE@K)V9*-@$+Z>:9Y%O)`9(X0/U+>XU?B)5S&P1S4 M"I:L+89%%7'697(>Q[+LEEMMQR7MTD>W;EO<\K-M_,?+S6H4K:QQW%G%N=LU M[8QE&E6%+=H=\M_UH+R=F2T852^Y-ZY:=>]^Z]T)_4O3W87=NZ*G:G7.WX\[ MD<5@,SN_<%17[@VWL[;NV=G[;IUJ]P;IW;O;>>4P>S=F;.2HD[`W3V#O/L3+5F4QNY*.>GV3%BH:J%%CO2B&H.,GK MW5=>._E^?+7,8+M7<^(ZPQN5P'3.VMW[RWIE,9VAU#7TU;M3KS:6U]_=A;AZ MX-)OV9^YL3L#8^]<1F,[-LX9Y,/CNL'OT[=[9R?;G4FS,]A]V=<9/MO;F\ ML-\C?C'D^N,OUY@-Y;>Z]W3N.D[.H^Y)NO&CV5OC=N*Q>?ICDQ68"MR=)'D8 MJ8U$.OU1U[H,H_Y>_P`NGVK'O-^K*&DP+;=VWO>I;(]F]1XO+XCK7=^^AUMM MON'<>VZ$T_RD_YA'^D MO-]/1?'R2L[(VQNC>>T-T[8QW:/2V2GVIE^OXNNY-U5&ZJ_']C5.)VSMNCF[ M:VW34^9KJBGP^0KLQ3TM)53U):)?:AZ]>Z&WXX_RY<_1]0_/_>GRLZ@R6T,Y MTA\0^V^Q^F\=N+LO;^T-YT?:?5?R+V%T)N;,R=-TNX:?LK>.QL#N/(;BQ$N> M^Q;:M-N'"R4$T\U41`NB;#U.^\9U7A:_* M;PV%L>#>':>:PU;N#$]7=??W^W1M=^QNR\CAJ%JB+;^!&1R[I)!:GO44XEW4 M#KW1J?G#\3]J?%'XW?`RB79.U&[4^1?1D?R)[%[)J>V:.N[&Q>9W!V3VOLM. MG*_IG'[\KJ+9FQ-H;:VCA)DS5;@J6NJ=SMFZ&3(224-1C,5X&M>O='$V;_)0 M[2/1GRNZVRNS^NM\_-[9N[?Y=@Z:I-H?*GI:3:D&W_F3M/L3>M1LG+05.^V^-AX?LO M:WQD[!RNS=P]@X3J_!Y%3@*2NRN\=Q=G?Z%L13T.WJ_-4NXZC!5/;5]N-FEI M#A8O=<<%_+.^<.ZL#VCNK:71.0W?M?IS'Y/)[ZW)L_>W6 M>Z\!%383K;#]OYZ/:F9V]O3)8[L?(;?ZWW!0Y7(TFVY,M54$-5$E1''*XC]^ MJ.O=!%UK\1OD/V_UU)VMUWUU-N'8[;URG6N)R/\`>79N(RF\.Q,'MG';RS6P M^NMJYW<6,W;V9O'$;5S%)7U.,V]0Y.M@IJN%WC42QZO5'7NAHWU_+`^=/6&9 MVUA^R>B:C8$>Z\!N;=..W1O/L+J?;/7&/P&S=X[9Z\W/D=V]JYG?='UIL./" M[[WKA,1,F.@"F2OI%F]4=>ZZ[)_EC_-/J/![RW/V!UCM+"[=Z_Z M^ZW[6W;G*;OOX[[@Q6+ZY[:[PS?QOV+O!*[;?:^7I\GAZ%//_P`J_P"3?5^V.SMN=Q=';BP/M+!O?-YG;^XMY9W9QBPA?(8B+&0X^LJ\DIHY:> M9?:@?/KW4WL3^53\BME5&2Z74?;73?870^Z9.O?A)\H>U>N:3M787559G= MH9;#]E[AVNIW-LG%[NW]@.FJ&')=L9SK#KC-;EQW8O:6'ZZH96DS%3MW%92& M@$%0)64TU0(O5'7NH_>'PR^1?QRVMU?O/M_96#VY@NZ,/A-Q=9-BNS^J-\9? M=.W=S;9P6\MM;A@VSL'?&Z-RX[`;DVSN6BJ\=6UE)3TM]^B=S[0PO:>U-Y9?$[+ZIZ&Z][1JMN; MVVCMW=%5@.DMW[)J=PY>7<^,W0:'/86FQ@J*]:*FD"G5S8/"O65F1^^=Z""KBQ>ZCUZ]TSY_^4O\`/[:='OW([JZ- MQNV,=UEM+;6^]Z9'"Q^+VGO*AWY7;1S-+6Y3M*DI<]#N9NKMQTE!'C MWJYJO)X2MH(T:NIY*=?:AZ]>Z5/_``S'_,B;(XS$1?'_``]5ELQF,9MS%XJA M[[^-U?DZ[=&>ZKI.[=K;2@H*+M^>K;=^]NJZP9G`8G1_$<_3PSKCH:J:FJ(X MO:AZ]>ZBTW\L/Y(=JX?J?*="=([EAIL]\:^C^Z]\9CM?OKXS[=P&73O;N;>_ M36PM][(K\OO38]-MSKK=N\\#38*FQF8FGSN.RT$[Y!H:>II`/5'7ND%A?Y6G M\P3<6`[,W+@_BUV/E,;U!N/LG:6_(:,8"7-T&?Z>W/'LSM"BPNV!F_[R[TCV M-NEGH W M>S_G%M'O&MQ?<&TNUL96CI#<'0>+V1A5IM@9_/[3V'F-IC>V5I,CBFE.8CK2 MYKB+000>!J3Z=>Z'W"_R\MC[`^)_RG^3>^NIZJHRG5?QO^(%9M'8'='R0ZEQ M=+E]V?+WKGL_.57R/V%6=5;XVCD\UMW!S[*HXMLXGOC9>P^V=P; MJH]GT6XJ^+#[6_B$V_*_&X&3<^%J,C38NF_BS8RJ:I!HZ(_Q*/Q-*^O7NBTT M'\O3O+9#]LX_N3I?>N2RF"^'<'RJZ^EZF[>Z%SN)BV5N'L'`;'VIVYGJW'[B MWG2;_P"JDS/\2P>1QNVYQGZ;<,U)32F"19*>7=1U[H%]R_"?Y+[1^0NQ?BIN M#K['T7R`[(W!CMH[2ZXC[$ZOR&0JMXY7>F9ZYHMF9;+XW>E9MO:V\VWWM^JQ M,F(RM;19*"N18I84:6+7ZHI7RZ]T.U/_`"DOGW75.+BQ?36V,W19;;_;.Y(= MR;>^0/QLW#LBAHNB#1GN3';@W_A.WJ_9.UMU]:P5T<^7P>3R%)FJ.E#SO2B& M.21/5'7N@TR_\NWYC83;&Z=V5?3DE1CMG;F4WYO7J#"]B44V-DW=AL;7[:=X9)8ZYZ=&E'JCKW2_I?Y4GS MGJ,SNS`5'6.P,'D]A;@V=M'?:[M^3'Q;V91;)W?V!NG?.Q]F;.W?E=V]T87% M;9W?N#>76N=Q<&*K9X,A]_C98&A632K>J.O=,62_E=?S`\1M/?\`O7)?%7M& MCP?6.]O=/.)_E>?*K(;%[P[#KST+MW;W076F&[/WI+F/E1\;&+XS M-=PTW2,.W::IQ/:>4QF+WG3;T6MAFQF6J,=4+-0"B`;)U^(HU=O;AJ,#V+DJ/; M./V-U97Q;@K\OD9*7"QXEC4BK:-68>U#KW0:?'GXS9[L7Y-Y;X^[HV'N_?&> MVCC^\$W9LGJ#LGJ'#[LERO46P]\9G*U>U][[OK\UUMN+![1RVV#E,JU!+7?Q M#;E!6R4$MS'4IZN*]>Z"_MCX[]P]&T?7]9VMM*/:"]G[8PV\MH4=5N3:=?F) MMO;BVSM7>F!K-P8+#YW(YK9-1F-G;XP^5IJ7-T^.JYL;DZ>I6(PRJYW6O7NC MG=D?RAOFSUOE.Q\?4;:Z@W/2=.]<=/=E]K9S:OR6^.U9B.OL;W=U56=N[)P. MY7R/9^+K:3=>0VYALFE)0K`\F:?'FHQ!R%!5XZLK-:AU[J=LK^3C\\]W]L;1 MZBJ^N]A;0S&ZN].IOCQ)GMP][=(5NV\!V'W7T@WR4Z\CRD^TNP=SY2NPNX.B M8)MP4M7C*3(1UG@;&TWFS!3'M[4.O="QO[^61N'-_P`OSX\]Z]%]>XO=/;.V MLW\_LO\`+S/X;Y$=0;UP%7US\9Z[HFIPN[>L*'&;SAP.\-J;)VUO++5.3FV? M)N:0PK+7U-5]H(%I]5R1U[I?_,;^4CVKM_M#8G1GQ6Z:ZXW:FP,V)ZNDSG9"[DPFT8J/'X>@R&WZ3' M5O=$^^37QDV'TU\%OA%VC#M?,8#O;LON[YZ]7][U=?NH9[ M&5U5\>-R]!8?9V/P>,H@<%@Z?;\6_,E!.]-)5M7U#/.U2\1IX8-@Y/IU[I'1 M_P`M'YMRY':F&3I&8YW=W8/6/4]/MX]@=5)N/:W9G=6%3<'4.Q.T]O/OEO7N@FW7\1?D%LWO:@^-&6V-1UO=>1 MCH)H-G;3WSUYOV&&*NQ$NX))%PE/-5Y9JO(PC"P4\SY#[8 M02E/5''KW0QP?RR?FM74]#4X7JC;^YX<]C\]DMDMLWNSH3>C=JQ;4ZZQG;6[ M*7I.+:G9^8E[QS&T^OZ4.T/Y3_`,\M M];(V-V/MOIW;51LOL;:W5V^=JYO)]^?'+;J3;,[HW=E^ONL=UYRAW'VWBGS)AH:AH:JIIHI?5'7NFV/^5E\[Y=I[AWB.C8TI-L5 MGR$QV2VW-VETQ3]G5&1^*.;I=O\`R-QVW^G9^Q8^V=VY#J#(UL)S,&*PM;+! M2RK5*K4S";WZH]>O=&X^0?\`*7[EW]N'H^L^"?QN[!WAL;V%P^2W7D]MING<4-)62/%A\#2&:.E6F"TBR5,7GT#QJ M>O=`&G\G?YZ9C.=:[9Z^ZQVIVUG>S>F.L.\\?0=9]P]1[D.VMG]S)BZCK"DW MM4?WVI*;:V?WY19NEFP=-5.@S\?W+8IZY*"O>FWJ'7NJR:ZAK<96UF-R5'58 M_(X^JJ*&OH*ZGEI*VAK:25X*JCK*6=(YZ:JIIXV22-U5T=2"`1[WU[JYSY0_ MRMQTG_+6^(WRZQ.&[7P_9>^.QZ'8OR$@[(P53M3KF2G[WZQVOWK\9]U]5YW. M8S"XH[$I>N\E/A]QY:IK9Z:+=D=12O)3"G1)*@Y(Z]T"N9_DV_S&=OYZ/:^8 MZ%PE%N!Y.W*1\4_?OQMDJJ3,]$[,Q'8W:VU^T^OLY39UL#4F+, MUF(,E92TT]/#-)'O4/7KW18-J_#CY$[Y^0>R?BOL_9.'W)WOV+C]K9+9FQ\1 MV3U;6QYJ+>FR:+L3;=*N[(MZMLFAS&0VCD(:AJ"IR4-=3RO]M-#'5`PCU?/K MW1@<#_*/_F';KH4V3NOKC?-/G=Q97LW&=,4#[,&T-YYN7?FW*GM3+P8(9O"+D,*,CKC-6/#,4 M]4>O7NDUB_Y:'S@S\?J^"'RAI>LMZ]SG8FVZOJGK[,8' M%;GW_B>X.ELWMB*BW-V/4]/X7>^%R>'[#KH=V]257:E%-MUMZXG[[:,&9B>D MER23*R#U1U[HTW<_\ISY(='XS+]:Y?JC.=C?(.#Y8]6?&C&9/I7N/I7M'K)= MX]C=9;SWA3=-YC9&U6Q,_7&X^W*;>])WW\=I.KJSKG9G8%#U5O?=%%VV>V M%ZQK:/8G8>5H\3GHXLN]1@ZJNI171TZU,#2>J.O=)+KOX#?)'?\`\W,+_+XJ M=M8+8/R4R/:,W4F6V[O_`'AMO#8':VY\>9YLS)E=TT>2R>&R=#C<=2RU47\( MDR51E45(\;%6SST\,OJBE?+KW7'-_P`OKY:X+9&XNQ9^M,/E=I[8V)N#M>NJ M]H]K]-[ZR>1Z@VKO5NN]Q=T;2VULKL'/[GWWTKB-Y1R4,V\<)1Y#;*M#+)]\ M8HI)$]4<.O=$R][Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U__4TD?:CK77O?NO=>]^Z]U[W[KW0A]4[UAZ\W[@]VU$>4DI\..Y1;BVF MMC+;R2QRQI/")O%A9D8+(BG!`(4'=?8]%V;N'!9BAK=\Y!<5M>#!35?8.8Q& MW!E?3D,-B<+2O01PY=%C4TZR*P8$L+'VQL^WOMT$T3I"I:0M2)65? MA5>#,QKVYS3H^]YO<2R]RM_V/=[*\WNX6UVQ;9I-UG@N;IF6YNI_[6W@MT,0 M6=0@,092&!)%#TJ.H^SNOMF[4S.%W5@:ZNK*S+RY"I6BVGL/<4&\,.U%CXJ? M:.8RV[::;+;/H*6KHYI5K<2)*K56,X4/!$2FW3;K^[NHIK6=50)05>1/#:IJ MZJATR$@@:7H.VG!CT)_:?W+Y"Y/Y6WC9N:-BGGO)KMI7$=CMEVM_;F.)4L+B M>^1I["))(Y'%Q8AIJW!<*'@B)+I[/^L>NO>_=>Z,Y\6?E5O?XH;I[$SFU-J= M?=A;=[@Z>WET+VUUKVEC-QY'8_875F^:O!97,;2-]$5Z]T?ONO^;)\EMT45/C.S/BUT#LNLW=V/\`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`#!.YOC%LC:_7^U]L]8;YV]UQ\BMN?+?J"/LC![GR-1U%\D-K8*A MV[B^U=GR;3WELZ+*9!\=A,7]QB]PIG-OU,N(HWDH&:-B_B*]>Z2/RP^9G8?S M%BZ+F[.VCU]A]P=#]1)TSB]W;/7L!-Q;\VVN]]W]CME^Q'WCV#O+$U^Z9MZ] M@YRNDJL728B.1\D\;1&**FC@\!3KW1UL)_.Q^0>%W76[Z/0WQ7R>\LOO'X&= MA[@W#7[=[R@J]P;Z_ES4#XCX\[FR=)AN_L3B4JGPOCI,]34U/3T&1BA0Q4]+ M)KD?6D>O7N@@WE_-%[1["QW7E/O7H3XO[ASG4V[=X9KK??M5L[LNF[)V9LK> M/9VZ^XI.G]O[\QW;E%N3&;&VOV'O7(9#`Y**==ZX1YBM)GHT9U?=/GU[I_[N M_FX]]?(_86ZM@]X=0?&/LR'*9Z/=6P]W;QZXW3N+L+IK=53U?L#J;=6Z-D[U MS/8==F=X;B[#V[UEAJO<-9OU]YSY7-4BY"5ON@LB^"@<.O=!I\2/YEGR)^$F MQ-P[,Z#I]E83([@W-6;L;>^9AWSG,Q09J5-CG"UZ;*GWY%TIG,KL:OV)#7;; MR>9VID\OMVOKJRHQ]73RRHT7B*]>Z7M1_-.WS+V)VSO.G^*7PJQ6TOD%L3.[ M&^0/26%ZL["Q/5'H[,38'> MFUY7V7UO\@J[Y:=?]746Z=G]R[>V;0S;$WIF*R6CHJ&EI:R7$S(M::H1))[U M3/'KW20[*_FV]X=F[@^5FZ\AT[\=]O[D^8'=GQ^^07967VYB.Y5EP?97QMR> MY,MU_D-BT>X.[=P8O&XVLK-W9$Y.DR$&3AJ%J;1"#QQ:-Z>'7NC1Y_\`F6?S M"ML5?8F^LE\%>M-EX.K[G[1^<7=\.7^/_P`DGV%GL7\^^LL7T/V*O:./WQVI MF,+3=`_)'`K'%CY)#2-4Y.IOA\E#>*)-:1Z]>Z(-DOYA_9C=(=X?'K:'5/1G M675_?+&4V\J["U M^_!B*FII9,W(LQ(W3->O=9NJ?YDWR!Z>ZPZOZZVSC.NJS+]#;5^0FQ_C[VSF M,-N9NS^C]H?*3%9O$]TX'8]3B-X8?9&1AW''NK,3TM1N#!YNMP]5EZJ;'S4S MM&8_4'7N@W^0OS)W_P#(7??1O8]7LSKCJW='Q\Z@Z4Z6V%5=7T^^TA;:_P`? M-O8C;'6&2S4/8V_NQC5[DP^(P=,DT\#4T%4Z:Y868DGP%*]>Z/57_P`\?Y%5 M.8DS>/\`CW\0,%59[O3N+Y!]H45!L'MK(;=[KWM\C^F1T7\D<=VAM+&X- MJU^TN]]FPPS9ZAQE%BC!DX!48N3'&2=)M:1Z]>Z`WKO^:;W7T]097$]0=3?' M/K#%I\F.E_ECUSCMH[&W?!2],]M=&8K<6WMJU&PTR78F3;.X;,[9W=D\=F(= MX'=-174M:Y$\O=)G>G\P_/[JZK^2O3.$^+OQ-ZMV'\H=S]0;OWEB MNJ]I]O;63:N:Z3KM_979LVQ(9N[,I04L;Y7M#.350RT&8+QUD=+$8:*CH*:E M]3@:]>Z-AC?Y[WR-Q._\-V31?';XCIN/`]Z]!?(?'!\'\C),?'V!\:?C/6?$ M_JA9*5ODJ7EP.+ZKKY#54Q?76Y,BHED*CQ>]:1Z]>Z#+$_SA>X,/UY@>LJ?X MZ?%F7;>WNC?CW\>*1ZB@^1C9*HZX^-/R3JOE=U]3UE5%\D(8FS%9V]623Y.J MCCB:IH6^VB6!`"/:?GU[K-O'^8WS\=-^=L=PU_?N^L1U+4;F['SN"GV=DNW\ MOD+4;9R7<7W$6_\`N/L;%MA]XY_9V-R`I8Z:-<9/2B''FDHWDI7V!3KW0@=L M?S2^UNX.@MX?'C/='?'7#[4WKU1\/NG\EN+;E#WE#O&DV[\'-J[KV9T3D\;4 MYGO;-[;CW!1X#>==%E))L9/2Y%W5VIT9`??J9K7KW4'X?_S1.YOAEL[JS9>Q M^J>@^PJ/I?Y09;Y<=;97M;`=EU^CJ(99!54H99A%)-#)XBO7NE1C/YLG:N)QV/P\'QW^+=1A\;\(*3^7]#B< MGA.][N]^Q\IB<945&/Q,%5DZ+YM+^9W\@-H[!VGL MV#;'4F;W!LKXXYWX>X/M7UN@.D]_P",^8NYUWQL?H'>7R=WMN:OW#W!A-^[@[$S6?VW+W308S!0[M[# M3'P8BG%!!314=-&K:ID4Z]T3G>O\WWY8]E0[,SO8F.ZR5?=G4&YMP]L4_>&9VOL.KCST/7=/L2I[/A;)P4=?MW(5.-,\T-#4TU/ M(T1]I'7NDMNG^9;OC<2?*C'XWXV_$_8NV/F)L*DVAW+L_8^R.SL5@JK<5!VA M@^Y:+M3`3U_<&6W%B]\T78NW*2OIZ.2OJ-ITPC:"'"QT\DD3;IPSU[H?.R?Y MW_R)[/R^W]U9;I#XV[:BJ,(^*J<;G\;!+0R4M+Y:.36D=>Z*5UQ_,`[8ZZ^:.^O MG2FQ.G-U=L]@UG>];FMKYS;&Y,'U;22_(C9>]NOM^KA]K];;SV%E*".GVIV# MDJ>@'\23ZTZ8W51^7NJLV70;@@V?E9*;)(N%.-K2J.*2)Q<^I3KW0_4?\]SY-T,G M769INCOBM#OOKCN/XS][TO8,.TNWH=P;M['^+/1V0^..Q,SO:B3NT;;R,>9Z MVMN]TXB"IH_D-1B3^$[3VAC\7MZ>59*BAIH/-4 MO6ULDE4_M/SZ]T)6WOYW/R`VYW/OCNNG^/WQ2J\KV!G/@_N[,[4R&W.\JS:5 M#OS^7O3PXKXY[]P*U'?LNYL?N/%;:IUQF2C?)3XK(4X\QHDK;U1]I'KU[HG7 MR/\`F_O/Y*]4[`Z>W#U7U!L?;/67=?R1[PVGDMA1=HKN.#.?*+=&"W1V%MG( M5>].TMYXFOVIC9MIXBEQ0-"F2IZ;&Q^:LJ)IJN:HV!3KW1E*;^RJ'M MZ?971U=V%E>]/C7\D.Y\_/@.R*9_DEV[\2*.KCZ+W%W)18KM3'8^"EVQF*^; M+55!M*+:M#E\L_W%=%4$!1K2.O=%*ZU^9'9O3WRY_P!G*ZWV_P!?;<[";>.^ M]V3[,EPN:W'U=6T7:.(W)MOL78^1P6[=R9_<.0V5O':N\,IBZN";+/6"CKI! M%512".1-TQ3KW1D-L?S7NZ]@-L1NM.GOCSUP.D-Y]K[^^+J;6PO;KK\5MR]V M[&P&Q^R:OI_^\7Z4.WOYOO:[AKII]_P">ZVVKA<;G:7*?Q+:> M73#4CS87R"9YO:U\7,G;/56&R-92T57C7Q^'K:>NJ8\AC*Q9G!] MI^?7NB-=A=V4_9&X>IL[D^FNC]N4O5VPMB;`R&V>O=F9+KW;W;5/LFNK:RKW M7VS'M'<>)S&8W[OR.N:GSV7Q=9B*FH@2/[8TKQHXW3Y]>Z-PW\S;L:HP'SKV MADNA/CCE]E_S`MW[-WSVSM"OH>]!@]A;BZ^W-D]X;-JNE$HN^*.OV5'M[/9B MH-,E7/E1%12''K;'?Y)[]3AU[HZ?6W\Z#L'M/Y/]:]G]W4'0_P`>=O;,^:>[ M?YA.[]X=7;%[XW!N'>'8U9U#M7KW??3&+PF8[7[%QD6VN_\`9G6M!MD1U5+! M28ZKR4E3/7TE":@#6G'7NJS>DOF]VAT9\U,+\[,+MCKS>/;NW^S]P]MXO`[Y MQNYWZ\BW9GILK/&&P>R=V['S"8?!294_844&1@IH4ABB9'A7QG9%13KW0^]) M_P`PNO3"_'OH+L[JGXQP=4=1=TS9SK+MG=W7G9.ZNP_B]UMV)VM'V#V7M3KG M,X[=NY\EF=E4N2R>1R-(N;PF[]PX^KJ)*G'5*5[)+[]3B>O=&K^0?\WS*=9_ M-[Y&[Z^)VS?C;O3H3=OR>^5W>FVQ_`/E%3;<[@S_`,D]E=C]//V]V-C>P>S= ME]D8SLO']*]JYW'#'8P8#:V-RF;R,U)BV44M< M[T9\9]Y5GQCS5*W37:.Z]A[PK^V=K]=TO:5?W!'TH^Z:7L6@I,EUM%O#,UYI MIJBB?<^-ILA4QT.8I3(7&Z<<]>Z$/MK^;7\@>^=G=K;%[HZQ^._:&$[*SVUM MYX6HWOL;=^X=Q=3=C[:ZBVIT?6=H[$W9DNQ)]S[E[%WOU_LC&1;ARF^*O>$V M7K:.*MF'W4<W-T;=^0GQN^2=!6X MO;W>55"^^/BS\>'^+G6>'J:+<'?V-^*O:WP\V[T'\9=I=2=PX_.XO=<^U]J]GXG>#4E=W3M7O7 M:;_QZ/MZ2'.Y3K#=NS:&BP60S=-ELB<%$N.R,^0IXJ=8=TR#7KW1@=T_SR?E M5GMX9CLG`]8?&_KCM#._+#J_YHY'L/8FUNUH,Y-WCU;U]N+K"DR+XC<_.9IF0V/5[.Q>Q^GMJ9)?CGV!\/-M=@[?Q78K;XV/\`$WL?>^=W MOG/C]MJ3/]FYW:D^SJ0[JRF(H\CE<5D]T0X/(34C95QXWC]0=>ZKA][Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__5TD?:CK77 MO?NO=>]^Z]U[W[KW0I]4Y;:FW-RX?<&XX<<=NYK;V;Q MN2RKOC-W;5RHK:.>HBCCCIIH*B/S?Z,3D-C38NHH%VW!!DGQ&P*+K M>C3++FL[+]M'MV@R&4IVCH\3-20Q5!GEFD@CC69Y9DDE=K9H+RWMI8[T,)/$ M)&J4RG3I7.L@'+:B10`$F@`(`,O>S?N2^8N9MIO^2)K:2P&W*LQ@VN/:(Q.+ MBY;0+2*69:1P-!&DID>1XE19GDF225S6_$+$X?(;)#UF[,'LVO\`](]%-!1]?T?\',F:P.9K\-C\179N$4[4Q1GERD[_2%F4,\U2RI>=EJ\ MR?3C_17C6,DRG5VLH8L%-:UP@'GUE-]TK:MHO^2]5YS59;/??UBD*_[JK/3/PA9EKL]CWKGOU[W[KW5F'\J_X\],_ M)?O7N#8G.EFJJ7(T4-3BZW1-!U[J^+Y6_RZ.M?F+MCXS=F= MC;C[RZ*W]M'X^?R+>GM^=O=EY+#9WIU>MOE#U#EMB;MW#EUKMB;?S:;[ZNW' MLF$9/-5FXDQ55D,I'3U5-0:ON/=0:5_/KW5('RK^$/4/4?S(Z"^,>+F^07QH MH.Q-R;'V/VWD/FG#TS%E^J:[O=&TS_`/*IZLVSFOD+B,YTU\R*#L?X]XW8$>(^*\/: M74>9[W^2^)WIWQG^O\G\@NEJW#=$UE11]%[1Z\H,9D9]6UQDM3CI7A7[-]:C_@Z] MTGM\_P`L#X3X[X]93Y#R]+?-.GV/U7_+=^"_RXSN6ZL[>V#N.B[6W1\C]R;) MP?;5/2S[C^/.7I=MS=1MN?,5.0D2K:C--M^F%ZB[Q;"5_7=;%C-M=@?$_KSY+[![5ZXK<)LG>F MUMO;6BJMT9K$,TN7WA296FVW4SO5X?)19+!XKVKCU[HF%1\4/Y?F=^'G?/R: MVY1_+'8F[OC=V?D>F^T>E^U^ZNG:3?5%O#L#KH1_'ZMQV"I/CAB,A/'6=U[= MW52;EQZ77\OWX3XOY2?![[W?^^/DA@^IJC^8 M=MO9^\MM]8;:7=.Q!2XOX7_(SL.C[&EQ>%ZRWUOJ'=.W]Q;8Q^`KLCCXK-NT>?GI*39HW;W*B8S;V#RWVHQD^3S-+5"E,+_;G5>VO7NA MFWW_`"Y^@^N/B)W3\D-^_'#^85L/?&P/D!U3\;\7TMFNP^J,GF]K;U[*Z*W9 MNW^+]DU]%\;J*MI\30=P;^4>Q>U-VX=N MA=&X8^TLR:C:E-2X^NQT%340H]/5&5'A;6K[.O=%CW#_`"LL%L?IKM#%]:UO MS+P_3W;]5_)9[(RW5.7?:64RV=PGS*I.P*W<&WMTY>@Z6Q4.:WK\?=RQY+'8 MS)T=%CZ5:[/1PUV/:2#35>U9_;U[I][%_D7_`!]PO;^P>R6T_A9W_T[UMC^T-K[X;J7$Q;:VQO;KOLS)9<)1;1WW6O M5[?9UIX<1+DLG@_:NO=%H^>GQTW/\9OY:>Y^AVBW[FMD_'S^>)\X>IMF;MW; MA,A0?Q78FW>DNBL%LK'Z&["S.X>T]Z4V9Z%^,'R9C[-Q>3VG5]`=K]N]A_(K9/7V]/Y? M6VMN)UMG\Y#WM@L'N"JIJB9LYE:F*KP>0J:G`IC625/%NO=6M_*KXM[(^2$O M,S6`VSUAU[V/M/;]#_>;J+8^W:W MKSO;?.)FQ/56(R&7I\5MW<68@J9LIFEBE+UK3/RZ]T0[I'^3)\3^Q^PMX[;W M7U[_`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`!C[]6D46^<^;ARM9[&V;)M MS7TOCK)O"[?):F%%@%U+'XL;MJBNYXU,:O+X+NBAOJ!&Q_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NAAK^Y\S5=&X'H2BVKL;`[; MQO8.0[+W%NG"X6M@W_V-N%L1+@=J0;]W!69:MILCA>ML5D\M%@*2CI:&.E.> MR+S?<23J\?NO=`][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]?21]J.M=>]^Z]U[W[K MW7O?NO=#Q\:ZO'4?;>(FKI-RP5/\!WLF"J=I93^&;@BW$^S,\,/%B[8?-RY' M)9*I_P`CI*5(29JRHAU+-&'IIR3F%9'VN4((RNN/4'%5T>(NK5W+0`=S&N%! MR#1EG/[N-UM]G[K[1->R;BES]#N(MGL9O!NENSM]UX"P_P"+W+2S3/\`XO!" ML9\2XEBU+,@>VG=_DX^8FWEM:ISU/O6CRE7L'%U%11]B[G_O'O>E5\]N401[ MA@CQ6%HMM5+TZK)%CJ>GC04KQ5+@3U,P#7+@B%I[7GU>Y(#=7FD7:B"WCLW*@ M,EI%$JB%HKAP)[B4`9_B]71T.P)HLCG1AJ?+=AY"BP%-C\CV4AS6:CPNU8ZZ MCW[@-B;9S5!N79D<-?2+3TF0JJ".5IJU/(%9F4HYD0O?`QPZV6`%B1%VKJ>A MB:1U*28:K*&(HAI6G4Q?=EO4LN0YHMPWSZ.WNN8)8[5(I=W'U%P+>R$D>Z6N MV6=Q%>;>%E@$4%U-:HYDO$\0*S,I"?8WZP4Z][]U[H=OC]\<.S_DYNS,;(ZG M&P'W'AZGZ5Q%929'>^S>O,?08S=?]]]B=E0]*8.C^-?\7I>U]L[<^1O1 MW;6]MN[@V]W)TOT7N+:&3VWTGOOLFHVWNO`;[[VPR5='FFQ;100U9N984AEU M48Z]U7G[WU[KWOW7NO>_=>Z&S=?06^=F]"]-?(S,3;=;8'>F^>Z>O]D4]#E_ MO-R19KHBDZJJ][3;@Q4=-X<-0SKV_BUH-<[5%1XYW:&*(023^KFG7N@3]^Z] MU[W[KW2KQ^RL[D]F;GW]2G!C;FT,YM/;N:-9NO:N.SS97>U-NBKP$>%V?D+H:RDQ>F$5LE.:ND$_NO=)3W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=#=T1T!OKY$Y[?NW=@S[;IZ[KCI#NOO_<;[ES28 M:%]B]"];[A[1WK!B%$%75Y?ZX]$]! M;Y^0^?WWMS84VW8*[KOI+NSOW<+[DR_\(@;8W0G6FX^U-[0XO135E3E-Q5.W M=L3QT%'%$?-4LOE>&!9IXO$TZ]T'V]=E9WK_`#HVWN0X,Y,X/:FXE;;NZ]J[ MUQ3XK>NU<+O3;\D>X-EYK<&`DK),!N"F:KI%J35XVK,E'61P5D$\$7NO=)3W M[KW7O?NO=#E\@?CYOOXV;PVSLGL&JVQ6Y?=O4G3W=.(J-H9Q-QX>39O>'7&W M.TME'^+0T\%)49#^[&Z*7[H4YGIDGU"*::,+(WAGKW0&^_=>Z'+;?Q\WWNGX M]=J?)C%U6V/]'?3W8_5'5V[J.?.(N[_[R=RXGL;,[.J,?MV&GGE?!M2=7919 MZN>2G3RJJ0B9EG\/O.G7N@-]^Z]U[W[KW7O?NO=+7K7KO>/;_8VP.INN\+-N M3L#M#>NU>N]B[=IYJ6FJ,_O'>V=H-M;8PL%173TU%!-E,WDX(%>:2.)6D!=E M4$CW7NN78^T,5L/>>9VIA.Q-D=KXO%?P[[7?_7"[T39F?^^Q5#DIOX,O86S= M@;P'\+J*QZ*H^\Q%)_E=-+XO+!XYI/=>Z1'OW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NALZ)Z"WS\A\_OO;FPIMNP5W7?27=G?NX7W)E_X1`VQNA.M- MQ]J;VAQ>BFK*G*;BJ=N[8GCH*.*(^:I9?*\,"S3Q>)IU[H$_?NO=>]^Z]TJ\ M?LK.Y/9FY]_4IP8VYM#.;3V[FC6;KVKCL\V5WM3;HJ\!'A=GY'-4N[]T49I] MG5[5M7BZ&LI,7IA%;)3FKI!/[KW24]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=#9UOT%OGM/K'Y#]M[:FV[%M3XR;&V5V!V-'EV#TI@8=K8F.FJ9\S7+N[L6ADJ=1@IZ:BCE=YO*8(9_5X=>Z!/W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1F.HOA[\B M>]^O=_=H=5;"I=T[2ZVPN[=Q;BOOCKS!;JR&%Z_P-+NKL+(;#Z^W+NS#]@=J M0]>;8KJ?([@&V,9F&P=#4PSUPIXIHF?5>O=->0^*O?>*Z83Y`5^PFAZO.-P& M>GR8W-LZ;NMR[NQ$V+Q^XZW$08*MR)BIH M:MYIX$D]45IU[IRW?\.ODWU]V%T?U-OWIS=FR>S/D?@]K[CZV*VNQ67KZ.JV=_%]\[-R-)''G%QLJPP+5NJT]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U__]#21]J.M=>]^Z]U[W[KW7O?NO="KTE`D_:& MUO-B]J9BEI7RV2R%%O>ICH]JKB\3@LIE,K7YBIFQV8BCAQ.-HY:M-5'6*TL" M`T\]_$Y9O!(VVYI)*C'2`8Q5ZLP"A15?B)"GN7!/+MFUW MEK$T\TL>Y.([(0P6TTT\MP[17"A8(8WG6MO<`O&H,$U?"=Z[RQU!%G\16[=P MN/I]K-MK&Q8W<>(S$NXZ;=O^Y7V:W MCY8.VPK#=P7#7:7WZ]Y&;N:X-G8#QY);>X@*&SMFTV9.ARK2NL^C:;)#;U=5 M8OY'2=-&;<0IJK!P9M<3+D:R*GQ46W\E/$-V8%ZO%U,V3JUJYI(FI:*GH7:1 MI))((&2;RT?CHLG+_P!72.H8KJH*MJ`[&H11=(!JQ8`4`+`8>R-ON(Y?O;G; M/O$-R<7W'0]LMP(#+($@%K,R_76I>!VFG$\C(8;>*V9I&DDDA@ M]^Z]T,?QWR^W=O=_=(;AW?N+'[1VIM_MOKK.[EW3E:+/Y'&[?P.&W=B,EELO M6X_:N%W%N6MIZ"AI9)&BH*"LJI`NF.)V(4^/#KW5T4GR_P#CUM_Y-?SP>S=F M]Y]&9FB^6N[ZO='Q?RG;70O9':/5_9,>[OGQU?\`)2>FW7U?O_X^;PH(/[J] M:[=KTK*?=6WX:7^-PQ+1?=J(ZD5H:*.O=<>\N\_Y9&`V1\]\!\9-J_$C.5W8 MWR,^2N0ZVRG<7QZ^1>X]W57QW[$V/L^3XX1?#'-X[%;#Q_Q_WCTYO_\`O$,Q M1[RCQ](8ZFBGA?,4E*,/)[.*]>Z#CX$]I_`7#?'+`X'Y(;D^/>T>R]M;M^?^ M+W+3=F_&O=796\=_=?\`>GPJVGL[XPG`;ZV7T1V4E'-U7\I]M565BJZ[*XW+ M[=^_,N.+TU77*GC6O7NC!2=\_P`KC+XS<6RNRLG\6\]U)1_&O^6I7)BNH/B) MG^O.Z=R_(7KW?OQR;YZ8W9GNVLS+34FZ,UC]Q97"5B'-4--+5 MTNJ'Y]>Z*`?F_P#$_IWK/IC>W7G2O\OOM7L&M^;/R$[`^1_2>0^&%3FXZWX[ M93>O1NX>K=C]9;D^0/66^*79G7&4AV1O"DI*&+==9GL%AMP4L(2G=ZJ"EW0G MS/7NG[Y.?)C^615;,VSU[\8=K];/EL-VCMSXZY7L[L/XF]>XEMU_%[;>^MN] MOR_*K,U>!ZH&Y<)V[G=PU]5LJ:*AQ]1N.;8V(=:I9JBM"-X`USU[HS'7OS@_ MEN;6^7G9G;>7_P!DVPO6?67\S#XN;V^*2=0?"#);2SL/PNVSV1\F,_V?GJV- M/C=M^LFW)A]N=L;-^[@R]0F:>IVE$V)ADDQ>)DFU0T_+KW12=V_(+X9Y#XV[ M5V,\W\NO^,.0Z[ZNVSBAJNQ_E%%\0Y?B;2XXQUFXMTUV* MR68AW7UMNG;;8Z66IFW5B(<-B%U0XX]>Z)9\7^WOA_M'X.=C['W+M[XF)\D] MR[][4Q^],M\J.C>^.V-WYSJ+=?6&S,%U'6?%;?O3%/'B^H-^]:;^@W'7Y5BV]CJ/<'2DV]OCGM?"]28G:)RM;C.P,1546SEW M]EZ>3,PQR4XHL<-4(KQZ]T"/7'RR_EVX[JAL-OO`?RS=W_-S:M*:;!?(/>?P M<[KQ_P`&-[=31[J?(Q=9Y[ICI?HOK;?$'R`I$@66#?4O7!6KP\@QE96-*7K1 MNA^=.O=,^V_EA_+TZR^6WPJ[\ZPW1\:]K_'G$=\?'KL/MGX\X3X,Y.J[N[]V=/9C<^2R>XMK8O'[YW7FL9328BE3&TE9AZ>HC]0 MT(\^O=$Y^*GR=V-U=V3_`#&3OWM+XCC.=V?%/=&PNH^S(_A[@-Q]KXON M3HWS4=>Z'KX<=Y?"CK3H M/!45'WUTCTENS?'PF^>'QX^1FU.U?C?V)O7NC<7R![VZV[\V1U#VCL7OSK_X MY]P9'!]&/MW>&S\-D,)C=P;;K,:V*KIY,9E?OJJ:?QKZ=>Z%K=?RS_E]1]T; MK'3V4^'W271V2^%7S^ZIZDS75OQS^4FR^Y\?/\A/BIE^G.H^J/EQN&3:FYL1 MV5V?C-YYA7J-P8+'Y?$)&:^MDS8^ZBQT?J'KW09[G^67\O'9^Y_DC2[?V-\< M^Q<31]'?#ON'XOY_;7Q#V?'CUUG@D7)9><2^H>O=*GK_Y(?RRSO3^790Y_:OP>P?06T-W_ M`!GW;\D8-Q_%#OO/_*3!9O9G7533_*/%=Z;RQ>T\WTYW;U9VIV.U=58"AP>) MS1%/6XN`XW;\=!42-ZASQZ]T3;X<_*KKK9?SA[6[5[7R/Q=V!B-Y_&GY-]); M0WGB?BWB,U\9ML;_`-R_&+=?473V]GZ&INC-WY&GVAG]V4^,DW#(NQJS)Y>F MR61.7H*J/(9."?9&.O=6';R^7O\`+L[?K_X?\C]\_&_M+KW9WQ7_`)4F(P=- ML3XH[LV)V_E>U^@\]\;-J?,7KO9':6%^,VP=V8+;V1Z-V!OK#XG$UVGW]E?C7\=/D M7U/T#N3K:D[>JMP5TO;?4^\_X!V?NC+H)*VC@6DH:O)3QI7 MR;`-#U[JU;K;YA?RQ]GYW=5"G9/QKI.L>ZOD!_+=W'WMU#N7XE9G?'6?^BWJ M+:;')GLI6AZ M]T2?;VZOY:]#\%^V^J*/M'X\T_?V=VV*WK/<&[_CIVA5YS;/9FQ_G!C,W19+ M(]C-\7NS>R.4VM2;QV/COAU5=D?"CMU.BMQ?%\9GN?/=G;)@ZZZ=V-U# MV3AOE965N]ML)B]U;F%-2/08"3&)F<3`E/63:H<<>O=5L_+W?_PXW1T+\#\5 MTU#LP]C;'V0F.^2FW>L.MI=CSU]>_770\%;E-T=E;GZIV?NW/]AYC>.'W1#5 MTLV4[!P5'71SY;$Y+'T.83;N-L*YZ]U:+TM\O_Y:/5'S#ZJ[9Q6Y.BMM=?[+ M_F#=3]R?'O<6Q?BUO+9>[?C1\,L)M?LY^RNK/D7/B^FZ_.=W=DU*9'9F,PM9 M1R[ZR5/N7#9#,IN&CCJ/)5ZH:'[.O=54?%G>_P`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`^?K< M4W9-=\8]][DBZN^8^W^_,;U1\3GZWW+WGW_NB@W;2?$+MOXL;LQ7QRZLQ70? M5VR)ZG9SY#$RILB.+^[^;EJ=NY23+&.LUGKW07_RT^P_@[LO9ZQ?+O-]#TU? M1?//X+]@18SL_H7>/:>?JOC%LBM[<@^7N&_C>UNENP8JC;6\=M;CV[%%MZIR M`%=78XSQTL4D23R;-?+TZ]T/,OR1_EXU?;?QIDW_`$OQUS>P^U/C#\F?C/\` M,G=?3GPYV]MNJZ>SNX>W^]X?CA\B^N-@Y;H7KK:R]K[!ZSSNQ:R3.;9H?X]D MJ;$U=+7S"M?R2:H<]>Z$WKWYJ_R\-T[-V+N;.=(?RU=@97>';._*CY*]9=\_ M#/OO<^_,3M_/=R5$O56:^.FYOBMCMG=MVUE:C)XG,9( MT6?JLL]-5>H?4]>Z5E1\R_Y;N(VOWAL['93H:JZ][,WS\`^P>S^L<9\4]N-+ MO;8FP=Z_)+&?+?I?X]]E8?X4],MA]\S];[HV7/MW<^5VYU?4XZIER$=%EGKH M*G+9O5#U[H)=B=Z?RVZ3NCK3+]B9?XB[CJ]NU'\PS)9S?V.^(&\,!T)7=>[\ MZ0CP'P4ZSW1TIB/CG%5;G[7Z_P"_'JLY6YU=L+3X[`S14]1F,K-%'%3[S3KW M1./D%W1\5.S/@1L2EQ5#TEMGYC9#Y`9S??8.#Z8^/^.V"E7M?/;Q^260KH,K MGO\`0]M'';%VUMS#;@VE!@\)M/=F0VY78EZ&FFVSAZ&&@[ MC_EWGIG:V%DH.H*<'X\_%;:^W]G5O0F7;NOKWYA;7[=ZWR7R-[R[3[DAZMRT M'8G0NZMDXS>DB[=_CFZFJ\?GL3CJ?`TO=,/\S3MKX4=N;+R59\<\ MM\ZN+X*[YAZRR_QJQV]9:;H;J#!;PRVT5ZB7`86DZBQ5/D]C?!3"] M5;6J>B<_!W+TIW/LK)]>I\SNR^_.X\9U=/+W)U=OZ#'[TJ*?'4N:W,]3%G\. ME)@,=_#334WLUZ]TA^Y.T/A?W9_-5K<_F,A\=]@_`[:W;/8TO7>3Z?\`CCO+ MK+K/<73.(W;V1VCTYM3M'KWKWKO8W;M77;NJLSB]G[GST6$K<[B<2^NCBKZ; M&45/)L5`^?7NCF2_++X,;%[<^7^3Z$[&^,NS\%WU\(OA)M7;M+O[XN[HWQ\? M,E\ANJNX_C'O?Y$;=W_TO1_$3;^RLC'NA>H-Q9.*JQO76%V[6UF2I*BDAP]6 M[18_5#0?;U[H)-U]_P#\JS,8??5;L'K?8>Q^K,MC_P"8,N:Z*W1TYD<[\B]S M;V[&W)V36_!#N>P_CIW3C-P_&W%R8?Y<_RMN]-Q[*P/Q!W'0]B]7;$ZJ^ M(.8Z.^:F`R^1B^.M+LRNK*KON'';[&/V_G\MCZVK4YS&N=PAD;U#G\^O=:Y/ M>&:EW%VUOS,3[GZJWI)69Z?_`']G1_6=%TWU+N%*>*&EBRNP^L]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M1DOCQ\?*7OS']^5,O9>`ZYJ^D^@=]]YT$6YMO;OR.)WU)L)\9/5;"&Y]O8C( MX'8>H M/C;WSNO:F_.CMD83>74GRJW_`)_8G6_:VS\=EUN\]T]<; MFR6V\#329ZF^RCRE;6SO35,-"XT:^G7NACW_`/,WH#)?'WLK=&#W7'6=J=P? MRS_B5_+T_P!`O]U=V1U.R=S]!]A]&Y#?'<>Y,]6[;I>MZ_;>.Q_D-\@>X<5BZQJ?X_9#(Y3%Y[;O;5#2T];B\=G:)J^"HIZ MV**D*U,GO6HZ]T6'YE;G^-_?GKMU[^1?9G7U)B\-!M?J/:%5V?@,CNJBPN97&3C&[B@I*:GCEI9J>/8J*# MKW1`_>^O=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U__T=)'VHZUU[W[KW7O?NO=>]^Z]T,'0L];2]K[7JL>"M131;BG>K&X M3M1L310[6SU1MLN5D^$E!3 M1KU'6M%TU6NHT7XEI6M12O4N>Q4][:^Z?+-S8"D\:W;%_J_H3!&ME<,8@AAD#%"*?RB[)W5N;(X+!3;@_B&S*S&4FZ,=2X[=.WVUM'-,(-- MV&*$E%1P"J,58)VY-&%"U`0"Q()ZE#[SGN-S1S)N&Q;'-O\`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`M M0XJK#4M4I1LN.U>T]Q&.I;]BMMDW?W7Y1VZ&>]AGE><)-:/HGMI!:SLEV&\: MWI':.%N9ZSQ*8(I`SA2>GGY$8JMQ>^Z4Y3?.Y>Q,MD-OTU=DMS;DI:.F:>H& M5S-#%2X:3&9_=&(K<)2T5#$J2TE?/`)_+'Z'1XT9V&5)+)O#LH[>)9"`B$F@ MHIJU51@Q).&4&E#D$$G'W@]KO=LYXM3N?.^YXC5+
"-4@(FG8L$X(.99K62[DMVN(EE6 M`?'+,E-1:FE(Q20TR03G"^?60WW8-CYIL.3]MYBM.7=UNMKGWV1E^CVG9;U9 M%@6U5EN;[_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO_T])'VHZUU[W[KW7O?NO=>]^Z]T(W4L&ZJG?V%AV5 M2XZOW$]/GOM,=E\8F;QV4I%V[EGS.)JL*]'D/XRF5PBU%.*18)9*EI1&BEV7 MV7[HULMC,;QF6WJM2ITD'6NE@U1ITM0ZJ@"E2:#J1/:F'FBXY\V:'DVVMY^8 M3'\.1$K,JR%R MR#9[;;B\E_8W-Q)JJI\1I#4D(:TDH:E52C>:TR12D@^]'-'N1#9[9[?<^/CR&\>RZ>/$5E+6]910;:I::1'J: M;RNT\;"2-G`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`5"T2DEG4!^]6-%&K5@KIU8J`1D+[#> MW]SSOO6WB]]MKSZMET&VML[@VGCDZ\I"<3N7`[LVUD4F7=^\XA*,5O3/[FS MD-(::*-(B:QXF5/0J#TBO+DL\UM>/<7$/3_ M`-Y;:-@V3FCDVPY7X_T+RUOK.8,+_<%U>!N-U>7*IH5%0F=D(7L M"#M`G_&O#XG+;$K(,ELC(YVEEWGDY,]48C:?5>XZOR[F&66*]0QWBHPA&D,\R!'+/1],2,KU M`[@]5"H=0TFO4E_=RVC:MUY&NX=QY*N+ZU;>)C6XOHQ`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`4E!48+%+4SI4U$VFF0/ M)&T4ZQ3Q%&]10/9F6:Y,(1E.L(';XEHNDJQ(9J"@&<`U6H,Q>R&[;]:VMVALIKR6R@8"TF+W#3I_4W!' MN7;D6?VKMW9_BV?3)B,5MO>!WW3OBO[Q;E8UE?N5]R;KDK$WUCY\JS)D,S3_:$U%,B M2.JU$8*=]5Y-Q145"5@!SX(4:F<'Q3*A+1D+\,9U88D"JGJ8/8"YL=L]M]PN M+V>\CBNM^966$;Q-/,;:"TDC7:H]INX8[;]^Z]U[W[KW3IDL)FL-'BILOB,IBH<[BX\WA)JBB7(8N6NQ]1"M1"7B:6"1`VI&`]U[IK]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO="'UIU%VQW3N"7:73G6'8?;.ZJ?%U^;GVSUILK M?)Y>7#;6QN5R,>+QT/KGJ#&(H5Y=@/?N'7NN6#Z?[:W/L#=W;&VNKNQ=P]6= M?U5!0[\[*P>R=RY;8&R:W*STE+BZ/=V\J#&5&W=MU62J:^".GCK*F%YGFC5` M2Z@^Z]T'7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NG3"X3 M-;DRM!@=NXC*9_.92H2DQF&PN/J\KEQLD:,Q_I[]U M[IK]^Z]TZX+`YS=&8QVWMLX;+;BS^7JHZ'$X/!8ZLR^8RE;,;0T>.QF/AJ*V MMJI3^F.)&=OP/?NO=9-R;;W#L[<.>VCN[`YK:N[-JYK*;;W/MCJI:B*.>GGC:.15=2![KW3-[]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z=,KA,U@I*.'-XC*8:;(XO M&YO'Q97'U>/DKL+F*6.NQ&7HTJXH6J<7E:&9)J:H0-%/$P=&92#[]U[I8[JZ M?[:V)M+8^_M[]7=B[-V)V=2UM=UKO7=6R=R[>VEV%18T4AR-9L?<>7QE'A]V M4N/%?!YY*":H2+S1ZB-:W]U[ICV7L7>W9.Y,9LWKO9VZM_;OS4PI\/M39>WL MONGJZ2JH*JIH:ZFJ**MHJB:DK*. MKADIJJDJJ:1H:BFJ:>94F@J()D*.C@,K`@@$>_=>ZC^_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[K_UM)'VHZUU[W[KW7O?NO=>]^Z]T)W5^6P M&W-Q87<62W+-@ZRCS/V51#-L6BWOB&VYE,+EZ++U5?C*W.XN'*PNTL=)-0,@ M\E-522K)KB$3EVY13W%O-!';AT*5'ZAC;6&4J`0IT^;!O(@`BAJ)+]LMUV'E MWF'9^8-QYD>RNX;SPW5MLCW*`VDUO/'.\L,ES"LZDLL$EL5&N&9Y5DU1")WC MNW"/:^'KLC0ZQ2Y"% MVJ5F8S%[&Q6P9V>WN;>"=;J-E=I:C5*9C32@KK8`\0<4Q^?1O[T\Q\L\R[]R M_<.BPT7$%-=34.9>[21IIX95AW$$&G4S?=V] MQ>3^3>4;S;MV]P1L-[<[VKW3&3?/%-FL,(B>QCVEOI_J8W^J9SN$<]O(1;1R M0O'K'14MW8C"X+/U>+V]N>DWCB((,9)3;CH*#(XRDKY*O%T5;6)#0Y:"ER4` MH*ZHDICYHXW9H2VE;V]B:UEFF@22>V,4I)JA()%&(&5)!J`#@GCUBUS9M.S; M'OUWMG+_`#+%O&TQI"4NXHI84E,D$$^(BL3&6TBM.DW[4=! MSJPK^4ONG<^T_P"9[_+YJMK;CSVVJK+_`#/^,.ULM4[?R^0PT^4VQN?N[8V& MW+MS(S8ZHII*W`[AP]7+25U'*6IZNFE>*5'1BITW`]>ZVZZ_L+T.B-P97)4?6>VZ[?&T]O4V`S,V9-,AH:FGJ]PU-1 M0O21_=-%'''#8$9-.O=!YN_^3!\G<#LGY>[JV=V;\8^Z=Q?!3YW,83&5VW0UU3!+)%*U)%)4IXD#KW0B]=?R M5OE=O/K'!]O[T[#^*?Q\V)E?DIE/B;E,K\@/D+M?8W]R^Z\'3[JDS6U=[)C: M7HC&*S'S3THGHZN$KY(RDBVN/>^O=;-'\ MY3M?M+<'\G_^0=2Y[LK?^;INP^G/DUD-_P!/E]Y;BR4&^ZK'Q7\H#Y5Y/K#Y&[UFS?2F' M[,^)W6"]V=\_%?+]A54'R8V#U$NVX=WUV^\OLVFVW5[/I*?![;JX*G)XJ;<$ M6X,6\\=/5X^&J)@%M0Z]U9ET=UY@^E/^$^^V_DEU!\M-C?%GOK>7\S*GJL[W MCCZCY-[>W=D:38GQA[8I-J_&BFS_`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`@=>ZL M,^%/P0^0?\O;^9U_*$[%R?;?56_^L?EUW#M')=5]Q?&/LW<.Y=B;[VI0[KVS M@.SMCU^4KMO;&S338V'=5)1YF@FHGH9EJS`7F*3)'JH(;KW13/GC\9)NR/F[ M_-8[IW1W7TQT3L78WS]^5V!Q%3W'+VO#D^U]W57?6_ZJIV=U%B>L^J.S*S=^ M?P-'44T^7U+2T>&IZZEEKIZ>.IA9_`X'V=>ZJ1VQNG<^R-PXC=NS-QY[:.Z] MOUT.3P&YML9?(8#<.$R5,=5/D,1FL544F2QM=`W*2PR)(I^A'NW7NOHF?);L M[O\`H?\`A2/'LS<6[]QS_P`OBB^/.%J/EKM7M3*3UWP^PNP9.DMY9-\KV;B- MZ33=38#*/O'^%-0U&HGCE:'P5\^O=:@.+_EUY/Y;?)O<$_QU MW1U!T!\;_DE\IN]>M?@GN+Y'[QS6Q<5W+28#L!Z;9O7O7U+A=K;SW7F,Q2XO M=&`Q!K9L=!B!FJ^&@>M6K9HEZ174'\I7Y:]R=F_,3J/%'I[9V]?@M MA>SL]\@:'L;MW:FU(<)C>I),M3[LK\--+/5OE<$E7BO%%F62#!+]S!)/6PPN MTB>J,?/KW1H/C#_)HVYVMV!\OMJ=D?-KXPKA/BM\'MZ?+BNW=TANG?OZFI(VIL1BJUJA:RGT6X8\ M^O=%RVM_*?[=WE\=\K\N,'\AOAX/C)B^_$^/?^F7.=RY?:.$JMS-0S99L]_= M;=VP\%V3A\2F%-+7C$Y3!T&\9:#(4]3'A'A,CQ;KY>?7NH7=7\H[Y>=+?+79 M?PZ>@V!VCOOL;JC%=][&W[U!NJLW;U!N3HC(T&X'XUY?:N0ZRW?L[Y4=RU'Q MYZTWU4Y#L+J#`4O=BF-\7UQNK'?(_K;I7>>*SNZJ:3R85H,55TF7*O#2S2U, M,3V5\5^T/D!O[Y(;G^,<72G5?>V*W3V1M' M=^U,5_'\EO#?VWYL1BWVKUM_=Y6K6R,SFHI$C>&LI::J4T_O6H4KY=>Z(=W7 MT32]/T&R\SA^Z.GN[,!O9MV4D&9ZDJ.RHAMW-[+RM-C,WMS=V![8ZSZKW?@< MT(LA2UD"OCF@J*&KBECE;4578->O=`'[WU[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NNR+>_=>(IUU[]U[CU[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=;@?\Q_HOY:;=VW/\L/Y6>[)N\_Y/N>^*]!U$G371F\H M\MM7I_:6?Z#/6_;N.[^Z.VGF(*C*=BS9?)9+=N5W5-C:VOQ&9GAFR,]+-04[ M&@IP/Q=>ZI[[4_EC]?\`6'\M3XJ?.*K^6O5$N]?E1N?MT;-ZWR>%[GQ-!F,/ MU?GL;L6IV/M/-KTS68.G[#PV\X\G_'K/BAFNZ\SL7 M8/3C9SJ;8%9@\GN7>E/A MFJ&DI]R9>7$87$T>-ZUHMWPY*6*""B:Z,9_)'^&WR2^#/\Y?\` MEPU6]\TK]6?+7K;Y)[CV7NW8M5V-MW:7:6UMJ?'?N&LS>UMS[2[%VCUGOVDR M6Q]ZXO%U=3B\_@*4152T-;3B533S^],05/7NM7[M?_F:797_`(?^\?\`WHLC M[OU[I`>_=>Z][]U[KWOW7NO>_=>Z][]U[[.O>_=>Z][]U[KWOW7NO__7TD?: MCK77O?NO=>]^Z]UZWOW7J'H7^AJ2DK^V-J4-;B*;-P5ISE)]G6X+&[FH:>>I MVYF(:3-5V!S%;C\3DJ+;E4Z9&9*F>.`1TK,YT@^RK>V=-KN724HPTFH8H2`Z MU4,H+`N.T4!-3CJ6_8NUM+WW4Y6LKW:8[V";ZF/PY+:&\C1GM+A4N)+:XDB@ MFCM'*WNWL=3KA2U'LRFCJ*C;NQ=M;!PU7.^YM MTS>>BQ>T,UN';N15894B>MIJN4221M&^F2)E"7EUVDLYY&UYF-`\CRL!H3!+ MJK#UTE10&HP>A9]Y2PM]KYSY?VZ!;/5#LR!VM-ML]KMY&-Y>MJCAL+B[M)0% M94:XAG<,Z-&VEXF4"?T!M(U-!7X`["Z9W]E(-P8V^3W%V#LFFG7'[LQ6VZF? M$44=1A\_/D:J.FI&IX)H'D.+K*BL5(&JPKQ%N^76EXY_KKN",QG"Q2$51G`8 MT90!4U(--:A*MHJ#)GL+RH;BQO\`83R)R=OVYI?P_K7>Z[_-R0P;;ZL[+VOOC,8_'X3K?:&]]SY#.93'X.6& MBC6A$!J&4330I=QH\".MTP#T+W\W/L[I;O[^8A\E>^^A>XML=L=6=V=EUN]] MM;BQ&U^UMISXC'9*AQ,1H]R83LSKO8^;I\A2SI*KBC@K8B(B5KI)I9)2+F)%]7O7`-7KW'H(ODE\C>EOY=WS3_G MC;]ZZ^1&"[V[K^855\Q?BYMCJ79W7W;NV5Z5RW>'R%;,=R[A[GS_`&1LK:.R MJK.]0PX"OQ>V#M*OW?1YZJF%5428^G9HCX9"]>Z![N'N7^5Y_,$^&GPJK^]? MDUV'\.?EQ\)_CCLWXI;GV9B/C=N3O+;O?/5?6>0R0V3E.O2OR%3`051*Z?>03C'6ND#V=\COB-N#^1_B_AWL;ORC@[LP MW\R3=/ROQ/5^^=K=Q5^\?]#<_2V_MA8+&[A[!PO3<'5&0[/JLIFJ-:J*GR46 M-+R/(*A$!M[\5?EUL=4A[.V-O;L7-KMKK[9VZ=];C>AR633`;.V]EMSYM\;A MZ*;)9?(+BL)25UJ_E:?\ M)YMI564UY/"]`?)C<.Y<3CS%)FL=M?=&]^E\9B\>P6K:JG3"TE=M*D@D$2RXZ. MGB>I]1C2OKUKJO//=]?%O-?R)-A_":A^2NR*;Y$X+^895?*:KV+F.O\`Y`4Q MAZQJ^C-X=>PT=1N;%].YO8PWG%GL]!YJ*#+5%&L8D:.LE"J7W^*ORZWT:WO/ MYC?"K>/RA_X3_=H;<^5^P,CM#X`]*?`?K7Y+UO\`HS^3E'4[5S?QMWCM[=_8 MM;@Z"OZ#I:K=V'DI<%)2XY\>LT]55RQZH8H-M=5N_+KM3XG=P_S M?^P^^\KVGFM^_#_MKY=MVMNO>W4.%W_M7?F/ZAW#V4IU95O[Y>?RSMI?#7^<+\..DN^*.BVI\F M=U]![[^)E/M/XO\`8>V=NQ;%Z;[NQV_L7U/N#=^XP>S]Z]MKM?$K!7YW>:T6 M-FJW\T.4D$TE-35H:J>O=%WZ7^;NTJ?^1SVAU#V#C>UXG%#4T\B[:V9B-X90%IZ62DS.?P]1&Y,`BDV1W=> MZU_/=NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KPZ][]U[KWOW7NO>_=>IU[W[KW M7O?NO=9(4626*-Y8Z=))$1YYA*8H59@K32B"*:W:KK++4E5 MM?/83XG;A3,4NV9=A34]=JAA>1ZB-J83('(H*@G'7NFKX<]U_P`LKH3;?R\_ ME^=Q=^Y#='QV^:WQEZ1V_O[YJ]7=3]M9;#;+^2_4O9^\^U]JYW#]5;]V;LON M"KZTVE+NO&8^KCAQ,$^8K-LQSBGB2N,M)LU-#3(Z]T&?P$^2OP`^"'S'W[LO M/=B=I_(SXB]^?%GO;XC=_P#=]+UF^P*B/"]\18=*_>/474>7K,WO7&X?$4.U MZ#'UM7D:E,S70U-7)%CHE@AIZOQ!(^?7NA=_EO\`8O\`+'_EW?S6?CKW)@_G M5N;MKH[JRN[SSN]N\,]\=^X>N-HSX?>'0_9W5W7>T]I=5XC:_8_:NY]\C.[W M6HRN2R%)@<30TA,=,M6S/(NC4@XZ]T`O\HWY$?&OXE?SC^NOD_W;WWM+;_07 M6^X>_<_6]CXS97=^XJ;<,'9G2_:>R]NT>W-JX;J>KW\:Z+/;\I8ZG^(8G'PQ M)!.ZR.JQ&7;5((IU[H0>E_D=\4]F?RROYP_QDS_R;V!3=M_+?M[X\;HZ*Q$. MP/D94XS=6"ZA[WH.Q]Q5U;G(>CWQVVOXCMZ%A019%Z::2H&B9(!9_?CQ4];I MT:W87S=^#V(V=_PG2Q^3^6&Q*/(?RX^Q^Y]V_**C?K#Y.SR;;QF_^V>L]_8. M/;,U)T)44F\:R/$;2JX:A**1UCJBBJSQL91JA[L<>M=*3YG_`#[_`);G\R+J M#Y=_'OO#LCK'IKLCIKY+?(;OO^7%\NMD]%=R46R>TMA]T]M;FW]7=4=U[3VA MT_)V/@-U[JH,K3C-YBHV^D57D8*?)3S55;1U/\8\`10CK=/EUJH[:PF*S>Z< M5@,MO#;^SL/7Y2.@K=[Y^DW76;[_ M`.6AT!U%\#.Z\[V9N/;7RVZ*^9NW>UODSM?<71V?[ES&Z>HME=JXK=>Q-O?' M3*9>HAZFZPQ$>)QD57GIFIGJ8Z2CH:OQJ:^E.O=&\V-\XO@GBO MF!_/L[6F^56WJ/8OSX^*?ROZG^/.9R_4?R&@;EJ\;@^I=QY;` M;>Q;SI2UU=EJ?'2K4K)XJ:6`)/)JAHN.O=5_?R>OD]\9OC;GOYAG5?R3[;FZ MRV7\M/@1\@OBIL_N7"]?;Y[$VYAMX;_AI,7A,Y7[2V]AXM]SX6LH_-40!J"G MD+(D=3]KK9X]M4TIZ]>Z6<7?'Q&PW\CWM#X.8'Y/;>RO=V9_F31_)+:^WL]U M7WCMZJRG45'TSL[K!JLU@:BJ3'#.U3C'E&=UJ&:F7V=5: M>77NK*-W?S4_Y?&!^9OQ4W5G.Q6[W^,6[/Y*>W_Y57RRJ>N]@=HX3?76>1R< M^[*O>NZ-KXGMKK+94&Y,2LM9CZ-:G'/4U#4%36N*>1HXZ6JU0Y]:UZWU51UI MA_Y:/Q(^>7Q`W]T[\\=Y=]=<];?,?H'N[>/:.X?CEVAU'U]L+IWJKL##;VS. M*R.V6Q.]>V.R^V:V"G-+3-C]OXK$4K4LI\LZUZ_8[R0:CK726^17R,ZOS'\Y M3M'Y:=&_*VHV+U_O;Y'=@=R=;_)3K_9O9D&3ZSDW%D=R56S\MN#8N]>ML1N[ M*T^.KWI&SV+I\/D(JW$5,U,AG=WC7WX:4Z]3K%_-E^6G0'RV@^*^[=HXGIW< M/RSQ'7F^(_FQ\@>@.L=V=/\`5?>N^NT.O-P5^\]M[(H&.X M\W-@L_=>Z[L?Z'W[K777OW6^O6] M^ZW3KW^P]^Z]^77K>_=>H>N_]A]/?NO>G7B/S_7W[KQ'IUX<]=>I3CU MZWY][Z]3SZ\/\??NO`<:]>^HX^OOW7L4Z];W[KU.O"WTMS_7WKKPH>O6][Z\ M!GKW%_I[UU['3_M2KP./W5MJOW5BI,[M>BW!AJO7,X"FR---F,5% M44=;C*N"3(8Y)(5>*IIY%+W62-@&&^O4/IUL(?`CY7?%G^5)WGWA\DNGOFE# M\B>J-W=9=E;.V'\/\1U9WUM7?':-;N7'UE-UKC?E#0]B=^WCT#OO\F#^7Y\8JSO7,;%^ M2GPWW_\`)Y\[U;4=0[TW#0[QQ_>_;>X=\[T M64&H-/CZAX8HJG8J">O$>@Z-=\H_F9\+NR_YC_\`)3^06S_E'LC)=4?##H7^ M7]L'O_7W_V+3XO!U_1M/GMST]=@LL@Q4N/IITJ9XG2 M;[<:&?5#1L=>X<>E!AOG?_+LW/\`+[^X.F]U]?=L;C['ZJK-R=>;]Z^VIOVHH*7(YE:_*P8W'UVNHH*.&,R>2 M2HHO4-%QD=>IT`G\L[L[^7!_+[_FJ_&'N&F^;&X^R^DNE_\`9@\KV1WON3X^ M]L[`V?FGW_T?OWJW86W^JNH-O8+M/M>KR9R>X8:O+Y3.1X:!H)D@BIE-%YZW MQJ0<=>X<>J(NVY,-4=H]AU>W-Q8O=V!KMY[CR.(W+A:7<%#B\SCLCEJJNI*V MCH]U83;>XJ:-X:@`I5T--,K`W2UB;]>IC'0>?Z_OW7@/4=>_!M[UUOB#3KP] M^ZT.NO>^O#/V]>]^ZU0^G7O?NO8Z][]UZAZ[-O?NMGTZ_]#22M_L?;_7J=>' MO?7AQZ];G^OO76P/GUZY]^ZU4UZ'KX^XZBR6^L4D"U2YVADR^4E:3=6QMO8O M([5IMKYV/.;>2GWUA./&]=N+CJ"BPR)LBC$^WL M?F]AYNDV],^Y=TRIC(CUKCL9M#&AZ22*I^WIXV<_<>:5VEE<^V^7-?T=P9'+ MGQC1BLBENQ,_JDN7-@.<^75V^QALT798]5K%<[9M=B;SI=N9I-H=@U%51 M?*39VPI\AF]][7V;6UU+E-MQ4Z[BS&+QT%+##!#41HTW[K11`3`N$[R1+F6^ MGW"]A,Z:X@#9R2@+&\@!#UTJ34DD'&*G&,N^3-MON6-JY!V/VXY&WB+EZ\6P MW5WCYTV_:VEN=SLMODE2:S5!=W$,*I''''*JF3]5HH@)@6JLN?I[DOKET33K MWU]^ZW2H!Z[O8"W^W_K[]U[APZZ^H]^Z]Q&>C"?%3Y&[F^(WR"ZL^2.R-H[& MWKO?IW=N(WSLW#]C0;NJ]I1[GP-9#7X?(Y*BV5O#8V:KEH:J$,(?X@D$G(D1 MQP/'..O_:?R#W-LC8>P=X]R;[WAV9OG$=<+O>+:M9O??NZ M,SO#=6:H:/?N]M_YG'?Q/,YN4BFBKQ201JBQ1)8EO4IUH9QT!(XYO_L/?NMC M'75_?NO`U/0]_&GY/=\?#WMW;_>WQN[&R?5_:FV:?)T6*W/C:#!9F,X_-44F M/RV*RNW]T8K.[8W#A\C22E9J/(4552R$*Q0LJD>.1PZ\!\^DOV_W7V?WSNN# M>7:FZ)-RYB@PF,VM@J6FQ6#VSMC:.TL+Y_X-LW8FQ]I8S!;+V!LS$/53/2X? M"X^@QM/)/*\<"O+(6]3K0.:=!81_R+W[K=.O7_WCW[KQ.?EUXC_'W[KQ'7C_ M`+;W[K1-,#KNW`-[>_=:)].C5]W_`"^[$[RZ6^.'0.7VIU5L7K?XS;=SN*VK MCNK-D1;+J]];DW.N$I]Q=H]MU<&0K/[]=HYG%[:QU%-E9%@_R6C4+$KR3O+H M>?7@QR.BJ#D'\?X_\1[WUXG]O71'']??NO8I\^O#GCWX]:)Z[`'^O_K>_5Z] MJ(\NNAR?>^M_/KEIY^M_\/>J]:KD=O6L/ZW]^Z]PZ\.1;_?#W[KW$'KUK<@^_=>7S)ZZ]^Z\"3CKL M#_>/?NO<".NKW/OW7@<_+KNPO]??J]>.,]=$\\>_=:)KQZ[(Y_I[]UO!!(/7 MCQ]/?AGK08D=>M<`W`_V/OW6C7KQXX_WG^OO?5O+KP%Q_2WY]ZZT3PZ]:P]^ MK7KP;CUY1>X_P^O]/?NMDFG78'Y^H]^ZI4GKH<\>_=7K@UZ\%_QO;WZO5*_+ MKU[G_#WZG6P`./7>GGZ^_5Z]7/#KB2;V_I[]U:I].NR!_6U_?J]5J?3KQXM; MCWX=;!QUZP(O>W^O[]UHG/#KQX_/OW6ZX%./7@+C^G^/OW#KQ/#KWT'^OQ[] MUO@/GUX<\?[;WXXZT3CKUK_=>I\^NKG MW[KP.>O6Y^OOW7J"O7K_`.V_I[]UJO79%S]?K_O'OW6Z=='CC^GOW6B>%.NR M/S]/]\??NMG/GUU]![]UXX`IUW]1[]U[B.NOH/?NO_WG_B/ M?NO<.'7A_C[]UH&O'KP'OW6P*>?7K^_4ZT&Z];_'W[KU!Z]>O_L+?T][Z]7/ MRZ\1[UULCY]?_]'22'M_KP_EUWQ^/?NMBG70][ZT*UX==W'XO?\`U_\`C7O7 M6ZBO0R?'ZBER';^T*6&EH*UF?.2M%D<<"J*`2'][%2O._)YDM##<'E MZ(R+]#/MRZS?[B6\.TN+#;98X@>V+5;NQC"Z[FYD#S.!5-_>_LS=&$QU)]KD M-QR8[$8'$!/X#MM31;7PT-!B89:P_P`'QRS4&'Q4<8GGD$T@B4,[/:YRWTFW M6TTC56WU,S?$^7:K8[CEF)H!05X`=0A;CFWW)YFV;;[7PKCF)K>"U@I]+:#P M[*W6*!6D_P`7BU16\"H)96\1@BAG9J517'Y]K.@6?*O'KH_X>_=>/`4Z]_K^ M_=>\L]>XMQ?_`!]^ZUY8Z\/IS_MO?NMC`SU[C\#W[K5<&G7A^;_3_;>_=:!I M]AZ[%C]./]?W[K=0*]=`&_T/OW5:TX==W6_Y_P!>_OW7ACKH@_T/^]_[U[WU MZHZY$K?D<^]#AUK-.N)!O^??AU:M>/7?']H'GUW MP`+\W^GOW7C4GCUXV*\#Z>_>?6N!Z\/H;_["_OW^'KQ->'75@1=;_P"/^M[] MUO[>NT_/]/>^&>O'AUX6YT@WL?>NO4/72@ZA^+>_=>^77?IO]"#S]3[]Y=>H M>'75C?Z'#KIAS_7_`'WX]^Z]PX]!^?]YX]ZZ]Z8ZM%^.WP`ZJ[\ M^"/R-^8M-\ANP:/=_P`3]T]=4_=O0.U?CWMS>6:QG6796Z1M[$]M;5W=D/D3 MLM]R8'%10U+Y&GEP]"U'44Y2244S"M]Z)R!3KWE3HSGRQ_DX=8_&3MKXW=28 MKY;;W[=K?EUN/KEOC[N7:_QIVGB=M[ZZE[!VUUOFHNZ7GR/RGJ*O`[4HLMV! M-C8TK8H?N'P=?4-+!3Q"0Z#5J:=>\^/12?CM\2?B+WGWWTOTYCOEYO?)UG;_ M`,]-A_%?![9H?CM7;?WGE.C=_P!1C,!M_P"2ZY;)=A9OKW;W\1WYEH,3)M:7 M(U^6H:1VR/\`E*Q_9R;)/&G7JTZ&/Y6_RZ.G>A_B)\E_D1L[L'LO/;KZ5_FZ M]C_R[L3MGO=C;#[4WG2;OR&0Q=.>6@VKB1)/%'AJ&G:2KB M6BE!AG7UNMR]3_WN M^_VUA\GFO]^!N^JK=PX#^`;AK:O%_P"42M]U]E]S':*9`-YID=>!SCH(N-5K M&_OWEU[C7UZZL=5OS_OC_3WOKPZL3_E_?![9OS9A^7K;B[HW-U%5_$_X<=S_ M`#,JXL-U#B^T*??.SND$P!W-M*GJ:[M[K*3;VY/3>V,ON.6AGW%E-N]8]G;HV3A,CGI M\90XO&S9JNQN$BEJFIZ:G@:=V,<4:V0;&0#UXY/'I'-LWJC_`$!CL(=S_P#& M_=>'\^O#A22+W_XCW[K MW7N"IM_L?>^M?;UY1^?Q^?\`C?O1Z\>NU-P;"Q]^Z]\J]<5!O_0CWOK8ZY`K M?_B?>NM=/+KSX"C5S[]YGKW71^G'T_I[\./7AY]>`XN?I_ON??O M/KWGCKO@@Z;_`.W]^\^M<#UT!];C@>_=;KZ=>%OP/]N??NK`CKH#_>/K_K>_ M=:!IGKOT_P!#?_B??NMCCUU8W]^ZT:C/79T_XG_>/>^MU'71^OO77FQGKOC\ M@_[?_C7OW7O2O7C^/Z?C_#W[KQR:=>XMS?W[K?EGKWU^GOW6B1@==?CF_OW7 M@10]=\$<`_[W[]Y]:KY`8ZZ''UO;WOK:G]G78TGZ7!_V_P#Q'O1ZT33@.NA[ MWUL8/7?']#?WKK=17KKF_O?6A6O79(_I_OK>]=;QY]='W[K1!KU__]+23!)X M)]O]>'GUZP_J/]Y]^Z]@$==7/^P][Z\#GKO3_C_L/S[U7JM5Z%[H:2I7M7;4 M=(V--15T^Y<FR>&FQ<^XXZHT$%0*J$0SU*.20 M""5;V%_=EP6U:04-5`8K1U.K20U0E-1%#4`CJ7?8R2Y7W1Y6.\B$< M\S6\4_C6-S$;4SI-;M"UV'-K'*)H_#DE1B2`07COZ#+0[BVK#EML83:$J;+A M^UQ."W]4]CTII&W5NQ_NYMP56X-T-'4S532@TRULJQHJM9"Y16MC:(V]R8KE MY1XV6:(1&NA,:0J8I3.D5SQI7HV]^H]T@YAY7BW;EFRVF5=F71!;;H^[IH-[ M?'6UT]U>D.SEP8A<.$4*U$+E%&/HB#:%'T]F<]NF@V1KQV_FQL%"[6=ZQ7;2A3O37;[K#!;/-1 MH`&$:LY4,[=XJ5C0]E`Y]C(>4K7VAW??>:;#9?$M]^GF@?<;FWM( M;F6VLK<+9R&-;K<[^$B[:1["&SCMF-&>\5SI0DUKB][?[[_>O8PZPO)KUX\6 ML?\`8CW[KVKR'7K7%R;?Z_OW7B>'IUX\#Z_7_??GW[KU?3AUV/4#^+?[;WZF M>M'S;KP%@2#?_>O?N/7N/7E]5P3_`,:]^Z]Z=>"VYO\`3_>??NO<<=>#&_\` MK^_=>/7>CGD_\5]^ZWD9ZXZC?_#_`'W^\^_=:\NNRHN.;7_!^O/OW6^-3UXL M0;#BW^\^_#K7EUXB]C]+\?\`&_?NO9X=>-UL!_MQ^?>^O"N>O6U"YX(_WD>] M=;Z\?2.#R?S^/?NO4\^NQZ@;GW[K7IUX#3S>Y_PY]^Z]UTI)X_WW^O?W[K?7 ME`%S>]A>W(][ZWPQUX,2;$\'WKK0Z\%%_J+7^GY][ZWPSU[4;G_;6]^ZKUV5 M!/UM?FW^^X]ZZWY==%B#8?0?U_WGZ\^]]>Z[90>;_7_B?]Z]ZZWUYCIL!_2Y M-OK_`,C]^'6NO6U@&]K7_P!8_P"M[WUKKQ]`L/J3R?\`B![UUORZMG_DP?*C M87QM^9V)VQWQ78^'XJ_*W9&[OB7\I*7.UL5!MI.INZ*)<"VYF&/GUX=6._(SYN?"G=?\`+YGP&Q]P+6?);^7I MO'?WP7^%.XZS)F/=7 MQ*TU1`]32Q-JAK\CU[KC_+B[%ZIQOP6_ER87?'=GQUVIO;J__A0)TC\@,_A- M]]\=&['WQL?XI['V?LL[@WWN'$;IWMA=S8;8F+W\^=GBCJXDDFFFEGIXGBF2 M1_&M3]G7NO?-#L#9&7^"?S!VUUKWY\>%VW\DNA=4?-[XA;5V#'\X?A!-'CNH^XNFL%V/N;XW;7Z(W+U=M&@.:W74PQSY"2FH*6BDG]0T`^76_/HJU M!WUA>B-E_P#"AIOCU\F?C;LW>6]_GAT/O[X+R[,^0'QY@_CN`K/E%O[?N[]Q M=+)D-WB@J,!A^J?\`"@3K/:/R+^*^[^I=P[E^"7:/PDV5M;O/X[5-%N7>V.W?LC=7RMW=TUA\ M+NY5=329-\S+2I-7Y)FFIX1.Y,1\!\..M]5)?R-=Y;0ZYR?\SG-[O[- MZ+ZYJ=_?RFOEUT?U=!W?VETKL7';[[L[%J.N*OKS8.-V_P!R[EQ&(W>VX9-M M50FBGIJG%".,QUI5)523;>7V]:Z-7LWMWI^LZP_DZX_Y!]S?'F+Y<](?S)-E M[LB@ZN[5Z2Q'2O3OP-PN8V+N[<%=VK)U'N&A^-6PM]R[WVX*RFCA:FW#6T,< MBUJRUCA#JA[O3KW0H]9;VZ?V'\ZOFY\K,7\T?C1LB@?^0QY=>Z#WYY;BZI@^&7R_V=TGWK\7LAO\`JO\`A0IO3O\`Z'Q/6_R1Z!J, MI2?&7<6P^T*'K+?6S8<9O^-\5UY@M];\IUDEC$5)B))9:JH\-+%)4)X<1]G7 MNBM?\*#?E9DNYOG1W'U?UCW9UIVE\.,!O#9_8O0>/Z>W%U/O7KC$Y'*]+=>; M+WI6X+_=>'783GZ_3\<^_=>X4SUT&.K_#G\?\`%/?L MT^?7ORZ[*>K@V_P_WOW[KW718@\<6X^@][Z]UV5N0;@7M]?>NO9].NB=-@+\ M<\^_=>Z[MJ`-[?CGZ&WOW7J5Z\;J!8_7ZD<_ZP]^Z]3KKEAS^/S_`,1[WUOC MUW^@$@@W('O77J==`EO23]0;?Z_U_P!?WOKPIUX"W-_ISQ_OA[UUHCKRGGG\ M\>_=>X]>"V/UO;\?GW[KQX"O7M7/]1_O7^M[]UXYZ]I%_K]?]O[]UZF,==$D M'_6_K[]3KU*8Z[*WYO\`7^OOW6B:8Z\WIL!_K^_4SUX8SU[Z@$FWOWKUZN3U MX^D<'D^_<>O<:=>_4.?Q[]PZ]7/75K"_OW6Z^0X==@EK@GWX^76CC/70%N;W MM?WZO6N-.NK_`(]^ZOJ-.N](_K_L/?J]5##SZZ!N1_C;WX]6U'KO3_B/];\^ M_5ZK7B3UXGGWX#K8QU__T]),$&XL`;>WSY=4/J>N@.??CPZV>'7(%?\`4_ZW MOW6LTZXV)/O?#JW1D?CUMRGFW)C-XT^ZMCT.1V[4[F-9@=U[IPFS:Z&@CVI4 M-09_`9?<45;CYLNE953-1N*2ICQU51)45(6$@D/;[<,MO):-:S-'($HR(T@) MUBJLJT.F@&KN!96*KGK(C[O_`"W!+S'MO.%OS3LD&X;?)>&2UOKVWV^18A8N M8KJUGNUDB:<2/(8&$$R6D]NEQKWSAJYLECLVM;M*FFBSE-O+; MN_LKF$3<.Y*7[S<^Y=J8S%8*KSJR4[0B.",^"ABIHV=G5O=N70%LI4\-D(E/ M:8VB"]J&B(Y9@N:U)RQ8@4Z9^\A*]WSKL]\=QM[U9MI1A) M>WEC#!:R7(*%-,:'PK9+>-G9E;H9^FL)UQE=K;9W/F\5U$F1W;V!-M*#;FX- ME]G[AK%FVM@=IB3%[5I\#G)8\EFL]#DDK72ME^WGKJQ8(K:S'$4;M-N$5S<6 MT,MUX<4&LNLD*CO9^YRRX5::>T5"KJ/"IF+V=LY27<-VW] MK%;2ZV_>;N3596MB##8I:W+":XNEF6X9;A_"EN9U@CIK,<9$6'Y_'L:]8-`> MG7+@`:A?Z_T]^ZW3KIN0-(L/Z?T_U_?NO=>%@I#"]S_K_P!/\??NO?;UWPRG M2/S]/^)]^Z\?+KI>.3]/I[]]G7J>HZ[%B"%%C;\_G_>3^/?NO==+<'_`?7_6 M_P!A[]UOKNZWX%CS_OOS>_OW6APZX@'5_L?]]]??O+KU.N5UU?3F_P!??NO= M=,#<_P"OQ_Q'O?7N/7)BM^1<^]=>ZZ8$GT\KQ;Z?\:]^Z\>/7C8!=0N?]Z]^ MZ]UVP+`:1Q_O(]^Z]G\NO6TIZAP2#;_6_P"1^_=>_+KWU4Z1;^H%_P#;_4_U M]^ZUUTH(!)'%OI^??NO==K8W"BQ]^ZW]O72`\WX%KFX-K#\<^_=>Z[4J38"Q ML0"/R?H/S;W[KP-*=<5#:OH1SR;?[ZX][Z]URU+?Z?GZ_P#$^_=:ZXL#J_K] M#<`VY^EO?O7'6^N3:0;,+D6!/^]^]=>'73!B;CZ?C_#W[KW7(Z0JZA^O==BP7U"][6'^V_K_K>]>77CUX^I?3P+ M\C^O^^'OW7CBG72W`)(!'TM_4_3CWOKU>NP058*+&W^W'^%A>_O77NND!!O] M!]#?C_;^_=>Z[4J38#23P#_C^/\`;^_=;`ZXJ#J'X-_K_3^IO]+>]]>X]<@R M7_3^;WXMQS]+>_=:ZZ96U'^O]?\`8^]=>\^NR5'U%VM]0?\`C7OU.O==.#>X M_3_9]^Z]7KLV4*'%S_O0^G^W]^ZWPZZ;D*5!L!;\GFY_I_A[WUZO78X3U"]_ MH/I8?D_['WKK7IUXC4OI_'U'U)M8?[;W[KW'KR\*2W`_I]+DV_XCW[K?7EL0 MVD6-K_\`(O?L4Z]4]<5!!)/``N;_`.^_J?>^O=]?EU[KD"NK]/-_K_C_7_;^_?/KW7$JQ/_$^_=;KUR8J M#ZAJ/YO_`%_VX][ZUGKIP2>/H?I_K>]=>Z[)`"AA<\_GFWOW6Z_+KIA<`@<6 M_P"('OW7LGKL&R>KD?@7_P!;_8VM[]U[KQ]2V4?GZ?[`>_=>ZZ7@$D>!^?];WOKWSZ[!6YTBQ_K_O7O M77O/KH*U_P"G/OW7AZ]=@IJ^GY^O_$_7W[K?V]=%6OP+\_C_`'W^/O?6NN3% M0>1W!`_V'^'OW7J>G7(E;#4+G_>O]Y]^Z]@>77%OH M+?3^G]/?NO4SUW]%]0OS8#_8>_=>ZZ/(X_V/^\>_=:\^O`6!)''X]^Z\1Y=> MX(.D6]^Z]YCKI1^?Q8_['WOKQI^?78LW`4`V]Z/6J?+KB`;_`$^G/OW6ZU'7 M*XO]+?X^_>75:>?7$_4C_'_>_>_+JU<=W^ M/5.N@;FQ^A^OOW6Z==A1_6]OQ_K>_5Z]@XZZU'Z?X_3WZG6J=#CT-5XW;O8& MV=UY'=N'VY#3Y:NP%0U3D,CB\QC:;<>U=PXY]SX^OAVMN6@H5Q$DJB*=HY)( M:Z2!C&L>N:(GWM)+BQN+6.U>0E`PH`5)1U.@@NA.KS%150V:T!FWV*O=MY>Y M]Y;YHW#FNTVZ&.ZEM6+RRPW$*7=C=PF]BE6RO(HQ`6`24H[1W+P,8Q'KFC4G MRASV$SF\=I5&"W_7]CQTNPZ6CKL]DL\FY*NGKUW=O&I_A;Y5=K;->58*&I@E M57H(F036#.NERFY<@FAM+I9K$6Y,Y(4+H!&B,5TZY.)!'Q&M/+AT(_O-;WLF M^\W\J7&R<^S\Q1Q[$DQ]USRZ]8-8_3\'WOKQZ\3H``^I^I M_P!\?Q[]U[RZ]^L<_4'WKKV//KWZ1QR3_MOK[WULTZ\IUW!_INO8ZZ5BQL1>_^^_WGWOKW7()8_P"JM_2Q_P!X'O7Y M]>ZXAS>WX)M].?\`C7O?7L]WO76L^O7K:U#7`_')`_V/ M)O[]PZ]^?79/C``MR+W'(((X_P`"?>^M]="SCG@@_6X`M_L;>]=:SU[]"FUB M21SP;?[$>_?GUO[>O*==P;?ZYX`/_(O>_P`^O>O7@NBYX:PXL;C_`&/TX]^Z M]UY7)]+?0\?ZWXN/]8'W[KW7(1@$FX.D7L#_=>SUQ$C%@";B_T`'T M_P`"`#[U\^O5QUS\2EK:K<\C\_U/'OU>M=<3*P-AP!P!8>_=;Z[9`Q#7"ZA< M@\$?ZWU]^Z]Y=>9RC:5_']5!N?ZB_P#7W[RZ]UXCR68D`VL;V%[?D6(]^_/K M7Y]=->,*%_(OJ'T^OT')_I[WUOKP_<4D_52.2?J#>X_'OWY]>Z[/[2W!!+&U MQ^`!]!_C[UU[KRDR`@V_)''`L/\`7%KW]^Z]UX)H!>ZD@?CFW^/)_'OW#KW7 M2NSG2QX/^`^OX]^X=>Z[6,#U7!L+@7N20+V(L/?NO?GUUY6U6/(/%K?@_P"\ M^_?/KW7+Q#5;4/J;C\_[;_8^_=>SUP,K@\'@?U`/TX]^Z]UR:,$W#*MP#8_7 MD7_K[]UX^773L5.@<`?U'U^IOS_6_O=.O=3QS?BP]^Z]UX7D6YL"O!)'!!^EOIS[WUOKQ_:6X(+$_4"X`MS M>]^>??OSZU^?7E8R`JQ_QO8"UN.??NO=>5=`+BQ(X%B#];BY]ZZW^?72N6.E MOH?Z`#FW!XM[]U[KP10;E@?\!>_^Q_I[]UKKH2$GFW].`/R+?CWOK?7+QC5P MRV)/%^;'_"W_`!3WKKW7`N;_`.%_I;_6_P`?\/>^O=;T``6/%[_ M`%_VW^'OW7OLZ["ZUN2`1]+FPY_U_P#6]^Z]]O71&A;@@DG_`'KW[K9^77E] M88&W`O?\>_=:Z["Z`6X)_%C>UB/K^/?NM]=*Q8Z6M8_X`6_!^@][ZUUV$`-[ M@V%P`;GCGD?CW[\^MYX]<0Y)%^;G^G/^'^O[]U[KEXQ>VH?4?GZW^@'O77NN M)^/K_C[]U[[>'7%F(-@``!_OOS[]U[\^NRN MH`_0F_U/]/\`8>]=>^WAUTUTL!_2_P#KW][Z]UWPZW)"V_//^-OZ^]?+KW71 M](%OZ_7\>]]>]>O`ZP0?]>_]/?NO==VT@GZD>_=>X^77$,3P?I_OOK[UUJG7 M86W-_P`'@>]TZ\:<.N@WXM_O?O5.O4IPX]>TV/U_Q_QX_P![]^^77NNBQO\` MZWOU.O4Z[*?G^OOWIZ]:\NO_U=)11:]QQ_C[4=:Z[%N;?TX_K_O9]Z_+KWIU MQ`-Q_K\G_>^?>^O=<@4O_0_U_'^]GW[KWYYZ$OIW!4&XNR]LXC+[9J=X8J>; M(SY+`4N7I<$]908_#Y'(U=0^6K6Y-WVN M1Y6FM4G2V,D45O++(QGDGM41(5C,\FJZMPT<3)X\6K6K_P!Y['PFP-R;?P^$ MHJJGIZC:%!D*FLJ(A2#)U,BF$R-H\ MHC1G9;R:^MYY9G!82D`!6&D:5(7O2,L>]W).S#MK'$]=)*B-"REWDHQ]&*@:G)I3*3VFYB MNO3;_??D>Q[CKGJ:]>8$A2!Q_R+W[KW7?`4:A?^@_/XO\`T-O? MNM=>877TCC\@7/\`O=_?NM]>464EK@?C\>_=>KUR&DH0O!`O_B1_K?X'W[KU M*]<4!%RW"VYN/K<$`#_8^]]>ZY+I-PHLUN"3P3_K7-O>NO=<$!UCZCF]S_M^ M;\>]]>^SKD#'JX!N2;$D$7_!M_K^]=>].N!5M5OS_6UO>^O#K(QCU>H7/%R# MP?Q>WO77NN$@):_UN!:PN+6]^Z]US.D6#@L0/ZV_U@>?Z>_=>ZX.+Z2H-K<# MZV_J/S^?>^O=_'K?78TE&""Q^I!-R1^;?ZWOWGUKKJ($$EN%`YO^;V MM_L;^]]>Z[&FY""S$&Q_5_L!SQ?W[KQ_GT<3X^_`GY,?)^?9]'TE@NK]SYS? M>.WEF=J;1S?R/^-W76_,UA>OJ/"71HD#CU[J9V5\#.]>I?C@/E/N^?J.?JR;MW:72]!5;![OZN[=R M&2W7O/:796\,774]TZUT8CK3XT=@=L=)_)?O[;-3M&/8_P`4]O=9;E[.I\ON M*.AW364/:_:6W>HML#:&W(Z>IK,ZT.Z=S0/72O\`;TE)2@EIC,\$,VB0"!UN MOJ>B]&.1W(16D.EG&A2W[<:&1VLH_3'&I+'Z``D\>]]:/#KLE%TAQJ86N1Q; M^@_QX]^\NO>74N@QF1S>2QN(PU#59/*9>LH\9BL;0P25-97Y"NJ$I:.AI*>) M6EJ*NJJI52-%!9V8`[;SW1V]=V[`WCV!LRHJ,%O['] M<9;-YVEV#V%B,ID=O[RZLW!6YC;FWDGWOL3,/0UU93O'. MV@0<]>ZY=L_&GL7ISJ7XY=R;MGVI+M#Y1;1WGOGK&/;^XJ?/Y,;>V-OG)]/0=]F]9;QZ9W[NGK'L2@ MQN,WCLW)'$;@QV(W-M?>.-I:\4\-25HMT;+S.X=JYF'PU*'S45;40DFVJX(& M\4Z]TA"%*-XK@@W()N2H')!'X_XI[]U['7"($:B>%"G4#Q?_``'Y]^Z\.N:Z M"&$8(;2;$D\_DCZ<<>_=;^SK'&KZP?I;D_ZP%S_K\>_=:ZR`PZN%.JYLVK@& MQ]5OZ7]^QUO'#KA)%+',T1<^]XZWUQE%PA7E2O%A_3@WM]#[]UKSZY#2$42`FY)`N00O^^!]^_+K M?EUTXN@*#T@\C\B_TOP"??NM8Z\E@C%_TWM;\WX^G^P]^ZV!^SKLZ61A$"MN M6%PQ*_CD?3GW[KWK3KC$+:BWZ0IU`_G^GU_)/OW6NN:A""$%FT\$\D\WM]6` M-K^]=;X\.C7Y?X*_++`=&[0^2-?TYFI>H=[[MVQL7"9S#9K:6X]Q0[IWQC)< MSL3$[FZWV]N#*=F;);L##QBIV_-FL/CZ?.T\T,E`]0D\)D]45IUKJ;N_X%?+ M?96]M@]=UW26?SV].SMR;TV7LC!];Y?:G;L^7WQUM64U!V/L66?JK/[RHL-O MOKF>M@;<&$KI*;*82&>*:M@@BD1V]J!!/6\===??`KY2]F=U=R_'W;>Q-L8[ MM3X^YC=6WNX,3O\`[DZ1ZGVYLS<&S-W2[%W#@:CL7M/L;9O6^5SE-N:FGA@H MZ#+5=170TM14TR34U//-'ZHH#UJF*>?12ZRG%%65-'.:>2:DJ)J662DJZ6NI M'EIY#%(]-74-144593EU.B6&22*5;,C,I!.SU[AU#D#:O]5?D$#@C\?[Q[]U M[.>LC%``'%V"\\_[8?4D?4?7GD`_['WOK77E%D)<>DD6'T)/\`7\'B M_O76^NS8JV@6_KS/RZZC!&HG]-C<'B_]/K]"3[]U[KM=!#!>&*F MU^;_`.`_U[^_=>/IUPC!#?D"W)_PXO\`[Q[]Z=>ZYJ4U<"Q_!)%K_@_7Z>_= M>IUC"MJ`L;WM_L?^1^_=>ZYDH"?R1Q>XM_MKW]^Z]UQ=6U7L?P00/Q_MO?NO M=_?NO?;UQ<'@CD$"W'T]^Z]CKO@*NL7/-AS<#Z_6X^OO?7N MO,+J"OTO]!_K?['WKK770X7U?3^G^^M[]U[KO@J=`MQR.;V_WGW[K?72C@EN M!^1:WY]^Z]UX%3?2+&Q_WW)/U]^Z]7KI`0;V(_U_]]_3WX]>SUVNF_\`0_U/ M_$<^]]>'7'2U_P`WO]?^-^_=>ZY$K?Z?Z_\`R*_O77NN+7U'_>/>^O=?_];2 M54EK@_T_P_XI[4=:Z["VN?J?Q_K^]=>^WKB&)-C]/Z?[[^GO?7NN7CL?\+_3 M\_ZWOW7NC8_'^IRL.R-_5N#;I^@S>*W+M.AH\IVO2]>T=*,=N_!;VIL[0TN= MWAC'K9VJ:3;T<7V$56D;Q3SOH(\H<+[XL9O+%)OJVA:-R1"92:QM&5)6,T%" MQ.HJ34`5X4RK]@Y]SAY)Y[O=C?E&#>[7<;&..??$VJ-/"O[;<4N8TN;^$R,7 MCM%3Z9)U1DDG>]\.^P[YRPV^R>3-?PV#';:V_ELE%+09.FP;8;*L:+9NX%6*A-36U%3% MY?N:N,4T5/$/+)/&SN=_N5M*!91P-!HK5V49!;4,R+QHH!I13J+'`4G/M9R! M[9\R[3+)SSN>_6V^B\\)8K.UGF#13);&WG_3V^Z`6/7<2S)K\:=!;1V\8\1Y MXR]%-8#752?J";?3\C_7]GU<]8_4ZZ8F.P!_'U'T/_%1[]U[A6G7>DR*"2`; MVNW`L>>#[]U[B>O&\:\'DGDCZ6M_O/O?7NNU)D4AK'38@G@"_'/T^OO1KY=> MZ\%\8+7!/TNIN!?F_P#O'O>>/7NND9GNK&]QQ_K_`/(O?NO==K'I]5P;"]A_ M7\7M^![]UK[>NED8D`\@D"W%[?3\#WKK?V]=K%ZAZE(_H#R?];_'WOKU.NO* M^K_#_4V'_%+_`(]ZQU[KLQ]CKV>/73DQA4'U`OJ'T)/]#_3W[KW#'7> MGRJ"2`PXN>`?S^?J??OGU[C4]>8&)`%-RQ-V'(XXM_3F_OW7OLZZ35*K!C]+ M,&)L/Z6-N/\`;^_=>XXZY!3$K,"&/T!!N!_6_P#C[]U[KBC-)=&-[CZV^A%^ M20/I^/?LUZ]7UX==K'HN^H-I!-@?S^/]<7]^Z]\^K/?Y/GE.A$Z-^6W970FXMF[A_F.] M>=B]G[)[/Z"[8[EP&>^-6TOC=WUUQNG?FT:>/HO=U-@]T9+=6_<5#@IH_P"' M;IH5>>?10Z?(?$'R].O4Z*'\LNUOA+7_``K^//7'QPQ?Q^/85!MSK"G[9$71 M'<&+^4>*[AV3B=XXWMS>N0^0V;R.!Z\W=T=W%G,\,IAL,:3(Y6@IUH*66BQ3 M8[7)X5))KUORZ-WA/D%_+YPW\N[NCH;8'<_6G6V;[]^('P_VGN[KK-_';L.M M[M3Y/=-?)O8/;OR+S6Z>YMJ]2RTV\-A=B87;574;+QS;X&.IO\DHJJ'"O$]6 MWJ&M>M=#Q4?+#^5EU;W?L_/=%[_^,F'2I^$O\QWXS9_?]'\+=YML"@W_`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`5\]U9T%O?;>\UP5;NKI"BH.IE/Y8_Q&[+^0'6_P`:L[B^UO\`AT?K M#>N%S?Q\QNX_D9W+NC#[6Z?3XW93K[O3$]79?-];R='=L[TIZS)9.KW5A9X] MMUU1345)F&44<7C6IZ]U$[Q^4/\`+JW-VWW]M[JR@^&6W\8GQ?Z0I?AWW=C_ M`(9Y2CZIV3WO)0?'=?E)0=Z=99?XWU&Y-_YGX4Q(K\//29+, MK!+)!H:C3K?1'*KY"?`6@V=M;L'KV7XK;,WP.^-_YGY&=*93X.5^_8.Q,?5? M(K`]@=;[T^)V8[2V_P!JP=.=.8GJS%QX&MVEF=W8VH@HUK4.)R0KQ!%O2>'6 MNCT[%^8W\J;L;Y?]\;^^0V_OB=F-FUO\US%?)79F\=R?`BJR5+VI\,]X]==[ M[:W%U%D*7&?&0[@J\MBMP;WVK7[A3=]+3"OS>*GS<%3DZI? M^;^[?AMN/X^_#;:OQZJ^OCW#UMM3*[6[UGZMZVS>W=L[OJX]A=/00]B9_?/8 M'5'5O:.=WAN;>N-SYFQ5?4;KQU%(D]=CZS%4N3BP5%8`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`!OS0^/>POGM_,,[CKN[ND^]/A9\K_DIWAO; ML[X\Y_H_M3-;H^0G4F]-P=H]@]95/6V4[`Z+Q3=4]J;,RV_?MH,A59C:DN*S M)$Z3Y"A4L=4-!Z]>KU23N_975^(ZQZAW5M3N`;P[)WE_?X]K]4-L'<&W3TQ_ M`-PTN.V(/[\Y&IEP/8A[#P,TF2_W'1Q?PGQ?;U&J1@?=_/KW02O(P8JI*@<6 MX^@_J;7Y]^ZW7TZYF/R:7!52PN0QY_IP+?0GWKK7V=<7)CLJ\`"Y^I#:KD$? M3BWO?#KW7>GRJ#=5-[$L;`\7X_%_?OGU[_#UYKQ*`#?5R67ZN MA>56N;%;6)/]?J#_`*_OV>'7N/7M)C4D'438#3R!?\G_`!O[]U[Y]=*2X*&] MK$W_`*$?0\`<<>_4Z]6O7)8RGK)!T_A;GG\$_3CW[KWV]=+(S'21<-Z;?GGW MJGSZ]UX16;EE(!O8$W-N;`6][Z]UT)7U?X`_3G_>O>NO==F*YX90#]`3ZO\` M;#WOKU.NF<@E1PH%@.;V'%S?^I'OW7NNRFNS7`N+G4;<_P"'OW7OLZ\Y9+*" M1^;_`-2?K];^]?+KW7B/(H-PI%[D\`_T^@M<>]]>_P`/71O&H`/U-R1].+\` MV]ZZ]UX#R+R;%?R38$-SR;#\CW[KU.N[&-2P()-ENO('%_\`;^_=>IUTI+@J M3];V)^@L+^_=>Z\$T78E6L.`#^?I<_X>_=:ZXJQ8A3R#P?I^?S]/P?>^M].;>]9Z]UPUF_]1^!_K^]]>ZR>*[7U``G@$B_]?IS[UUZG[.L9 M8@D?@<6_Y&/?NO'K_]?26!4A@HL;?D_7\<6_U_:CK772`ZKG@#ZW_I^?>NO= M=J4U6`-S>Q)X'^O^?>^O=<0&U`VYO]?Q_K^]=>Z>(LY74^*R&`BFMBE"&E@$JPR:BI96C6>95*L.V61:H;"]C;WQ@W3FJ9ZZ3$ MT,.,QHK'BK4>KBHL93QTZ1R%HQ!$B:=**`7R[5MDX7QMOA:@(%44TU&IIC%2 M221FI)\^I"VGW:]T=@-PVR^XF]VKS/$\ABO;A#(T$2PP^(1("ZQPHD2HY*"- M$2FE%`#F4$E2.5(XM?C_``_/LPZC[KOTJBZQ<\D#\V-_K^1R/?NM=>D%T4J/ M3QQ];$W^OU_`]ZZWUY3I3UBX)]*_0_Z_X-O?NO=>-C&=`TV;D7N3P+?DFW/O MW7L4ZXH+!BWZ;6L1];^]]>^?7-2I5@@LQ']?K]"0+F][>_<>O=<(U;5>W`N6 M)_I^1_C?W[TZ]UD5HRUE72QO9B>.1]?J??NO>E.L2JQ<"QOJ_/%N?R>/?NO= M9=4.O]/Y'J_'U^MKCCW['7OGUC=6#FX)-[WMP?Z$$?BWOW7L]96,8(#KJ90` M2#;G\@\@'W[KQ].LZ\MEC/D!*EN%^AN+W(/X'/OPZ]\NO-I M:,B,%;$,RWN3?@6_V)]^_+KWKUZ'TARP]!&EA]"Q/Z0/\;^_>OIUZO7)2A5U MC72VF_UU$J+W"W_/OWK3KU:BG7"$-JO]`.6)O^D`W_V/X]^\_EUZGRZR*T3- M9$TL00K,UQ>QM>]O^*>_"G7ORZQ(DFL6!!U<$_X'Z\VX]^]/7K768O!Y"=%R M&_5>W((]5M5K?X>_5%>'6_/K#(C^1KBYN>1]"+D@C_"WOQXGKW#K,YB!"NI9 MPJAF!_M?2WYO8>_8'7OM'7"96+:E!*LH*$7MIL;"WXM]/?CQZ]ZGKF3&J(LR M%FM=1>Q5#8J#:_U!O_A[]Y"O'KWRZX2^I4:,$(`5T\W5OS?_`(-[\:$#TZ]U MVEEB/E!.IKJO^(_4Q/)L;C_7]^\LC'7NNWL\5H5L`X+K]6)/"GZ#T@_\1[]B MF.O="1DNY.W]P=:;8Z;W'VKV3G.G-B93(YS9'5&9WSNG)=;[/S^9EJ9,MF-I M[&KUR2R M@W(7@G7:NX]Q[.W%A-W;3SV:VKN?:^4H<_M_^NQ-\ M=K[RSW879N]=X=C=A;KJ_O\`M^ MUITC$M1/*X1%6]E%MBGD*=>Z1*+)Y+`$-?\`-[`VO<@_BP]U'$>O7OLZSZZ? MR7T$G7^JY(/^U6'-O]C[MCTZ]^76"19-9O>Y8DVOR2Q((O\`@W]U\SZ]>ZS2 M-$&`D37(``Q5K`FW/TN+@^[&GF,]>^WKA.&9@P!9&4>.P-M'/I_I<6Y]Z/\` M+KQZYDHL<8E4L0+@_'X]^\L#KW74)L)&<'01I(-QJ)Y4`_@@CZ_P!/?AC[.O?ECKD"CHZQ+I:P M)!-]2#E@+@&XL/\`7'OWD:#/7NN$`96N>%`)>_`*V((O^23]/S[\./RZ\.LJ M-$3^VI1V4Z2S7`8BW^'U_P!C[\/D.O=1U5Q)8`@ZOJ>+?DW^GX]ZI7[>O4ZS MZX/)?1R&_5BU@!]5/U8'\/]M=(!NRDW)XL#?W[KW'KT9TJY<>D@ M"Q!!+`W%C_7W[KW7(%&5Q$"#P3?DD7]0'/Y]^\L#K7J.L40(:YX4`EK_`)'Y M'^N??NMCK*KQDD(FAB#I))(!_P!@;@GW[KW^'K"BMK'%B"+D\6_Q-_Z>]=>' MRZS!HO)^GG4/5<6O_6WX%_>\>G7JU^SK"ROK/Y-SR/>NO=97*!O4MVL`3>PN M./ZCZ>]]>^T]8Y`2UQ_P#3^GX^OO?6NN:E&OI4*Q!`-_I?_7)M?WKKWRIUC56U M?0BQY)_`_-_>^M]9`T>L'3_:^M^/]>U_>NO<.'6,JY8\$F_U_P!YO[WU[K(Q MC!LR$L``2#87`Y_(_/O77O\`#U__T-)=5T:FU*UAP`;\DV!/^M[4=:Z\LA9M M+_=>SUXQ@ MM^H6_P!YM:_^]>_8&.M]>:1@UA<`6`!^HM[]GKWV==L@`/K_6_/OW6NO%?(JM<*>0;_VK?GW[K?7;7C0`'DBY(^A`(`M_ MK7]^X=>R.O`>9"20K*?U-]+'\/7NN2H(P[W5RHXMS8GBY_P]^'KU[Y]<8Y& M=M+DE6]-OZ7!L>/Z>_<<=>X]=I$`]RZOI]14'EK`FP^GUM[]3KW7$3R%AG4-7UM]./>Z?/K?7%IG5[(2JBP4$#Z?X\? M[?WJO7NN;PAR'#HFM0Q61M)YO>P(YN1Q_7WLYS7KW74KM&51#8+8G_:B0"6_ MQ!]^X8Z]UVR>9%E+*CH?7BWOW'/7OGUYF,"(L;#4P+,X%P?I8*3 M?@6_I[]P^WKW7B3/'ZBH9&-GN-1UX]>2,1*\NM)"HL MHC.H!B19FX_2/][][X9KU['744SR-XW)97&FUA<&W!X'X/\`O'OW'!Z]UVD" MJVHRQ.$NVE&U,VD$_2W^'O=*&M>O?X.N*U,I>S$NA)!2PY']!_C;Z>]:CCKW MSZY_:KY=(EB`U6"EO58GZ6/YMQ_K^_:?*O7NN+U,JN0I*(ILJ6`L%-A>]S?C MWZI\NO==R0AFUAXX]8633(^DW;ZVX^A8<>_4KY]:KUW+,\+>*,E0BJI/'J-K ML_(/!)X_P]Z-0:#AUO'7G3SJDI>.-F]+>1B@OB M\^O==V^WB+(ZL[MIUH0RJHL2M[?J)M[]\/7APZ\C-4J\?>Z4SU[B.NHI7F)BD)97!' MXX/U4\`$`$7/^'O5:FAX=:IY]=QPA&UEXI!&"^A'NQT#CBPMS[WIIFM>O=<5 MJI2X#$LI)NH_((L0+"_T^GO08^N.O>G7,TJ^33Y8@-=M)?\`<`O]--OU6_Q^ MOO>GYCKU>&.N#U,BN0OH0&P0J.`#:S<$WXY]ZK^SKW7*2!682+)%&'`?1(^E MQJ`)&FW]?>RMO$TX]>EE>$B*,E1&`IX%V/U+'Z\&_'O1)!IZ=;X]>=/. MJ2ETC8@JWD;0&9;#4O!!XX/]+>]TK0USUHXZZ=VIU2-&%V!=I%LP:Y(`4FX( M%O>CC`/7J^?7*S5$6IV"M&=.M[*C*][`L/[0(]^`U>?6SUUS31ED96>1@H=& MU*H4`D7M^HG_`'CWNA'GU[KR.U0KI(W(&M7:P":;$ZB`.&'O0S4$]>/I3/7D M3PJ\H=)&`"KXVUA68VNW`M8#C_$^_4H":]:ZZBE>9C%(=:N+"XY5K$AAI`X! M^OOPJ<'KW7<<`5BQ>.0(-11&U,;N*U,I>S-J4FS(`+% M3^H#B_O5>MXZY?;+Y+>6.VLC3K]=K_32`>2/>]/E4=:QUQ:ID#FQLH/I2PL` M#P"+?[#WJI\NM\>O20AFU"2.,,`P5VTL-7/TL>/\?S[W3Y]:]<==R3/"1$A* MB,`?CU$\EN0>"3_MO?LC'6_LZ\Z>94DUQHS#2WD;3J*>G4/K>X^O^/OU*YKU MHXZ\[-3JD<;#GULZ\ABPL+$BQ`'OV1CK>.O6-1%J9@KHUB[^E6!!L";$:@?] M[]^X_;UX]>(\$6I&#.[%0Z690%M<7L>3?W[AUZN.O(34(Z2-RHUAS90+<$$@ M`6-^/\?>LGK?V]>6/Q*\FM)"M@OC;5I+$\D_3Z?[S[WP%?/K77&)VE)C!]![]7UZ]]O7DB"G471@HU:5:[&PN`1Q;GWZG7NN*S.7LQ+*W!6U^ M&^H7Z?U]ZKPZ]7KD:?UD:TM<\7-[?TM;Z^]T^?7J=<6GD#\$@#C3_K?@@_UM M[U7TX=>Z[>-6;4'5-0U:6/(O_<>MY_/KQO$GI-RQL6'T`'XO_`%/OWV=:_P`/70)E M5@Q%QZ@QL`!P"#Q[]^?7NNPOC5GN&8<"WXOP2?\``>_<.O9ZZ1V?I M;_'_`%A[]U[[>O(BJQ8D,%YL/K?\?[8_7W[KW7EE8FQY!-K?X'Z_['W[KWY] M="+U@:E//(!-_P#6_P!?W[RZ]UXRMK^M@#:UAP/\>/?NO?/KS(";Z@+B]B>; MVO[]UKK_T=)>-2I)8672=5Q]1_A_C?V_UKKDFF[!`0Y_3?\`K_AS[]U[[.L: M*VL6N.?K;@?XG^@][SZ=>'7,&+6.#];7-K#\?U^GOV./7L=<2CZR+$M?\`_U M_%O]?W[K77-C$)#J#$BURIL">/\`>/?L=;ZZE1RU[74V*D#C2?IP/IQ[]PZ] MUR;0H02`L]KFWX4_0'GZV]^^WK774BZ@ACN4TFPMRI'U!M^>?K_C[\?6G6^N MQ98P)03R2H%M07B][GZ%O?L8KU[RZ[8:HQX@=(;U"US_`($GW[RKY=>ZZ1=, M;E[A>!I_)>_!6_Y`_/OP\Z\.O#S].NP59&$8(-AJ'Y*C^G)MR1_MO?O(TX]> M]<]=0JREF<$(%.N_%P;V`/\`4GWX?RZ\.N<1B8NL899"A"%CJN;O8X=8XHY!(M@5L;DD&PMR;W'T]Z`)/#/7J_+K(&IC*+*RG5PQL5!_!(^ MND'_`!][[:]:ZQ&*7RE=+:]7UTGECZK_`)X-_>J'A3/7L=99#`'(=69A8,RD M!=0^I`_U_>SIZWZ]<9TD\I(Y#`,A4&VBWI`X^@^GOS#/#KWRZYOXE$:S!FD" MB^DZ=*G]`8'ZL%]^Q05K7K77&9"PC:,$QZ+*!=BI'+!K`\WYO^;^_'Y<.M_+ MKD`B0H)PQN2R*#9E'^-_H#_K>_>61UK\^O2!7A4PAM"L=:D@MJ;]+'_"P]^\ ML<.O>6>O1#3&[3!@A*J%^C,U^"M[<*+_`.P/O0``)(QUOKD`DD,@@5@05+*Q M!9D%_P!-O]23<\>]XH=/7J]<*9&#.\@*Q*A\FH?J!^B@$@EB?I_3WX#C7AU[ MK)%]NQ=8ED61HV"%[-SIY"@&^IOI?WL:&<2E=#ZM9!X-K MWX-[?G^ONE#Z9ZW7K-*U,)3Y%=G%A(R$:&<"S,!P>3[L=-<]>^SK%.DGF9K% ME:Q1E!(*$>@"P_`_'O1!/EUKCQX]9I/"@19U=Y510VDA=/'I1K\ZE4\GWLT% M`1GK?$]<*A&;QO$"8B@$87DK8#6K"Y]6J]S^?>F%:'\/6OEURLJ01BI5S=G, M:@A61?[5P?PS?3CWN@`&H=>^774JK)`AIU;0KL'4W+ZCR&-B>-(L/QQ[T<@: M1CKW7HAXX)#.&\;,H2/@.7'U9;\BR_7BQ][`H.[X>M_9UV`DD$@IU8,"&=6L MS21C^EOPAYM_7W[!!"\>M?9UPIXV76\BL(EC/DN"-5^%47MZBUO]:WO0'$GA M3K9X=9(C"_D6G5TE9&"%R#?_`%0'JN"4O_M_>Q0U`&>O<*=8Z:*43*;,@4W9 MF4@*BCU:M2C@CCWH`U].O=9(VI3,NA'5BY",UB@;^R2.&`#?X^[`I7K5/GU' M,,_D*E'+%[7L>6O];\BU^;^ZZ6K2F>O>74B1J42D.KLP90[+949@07:UR;:K M_P"O[V=-G74BZX$,`;QJS!D M/+*Y^C-8G@@\?@<^_$5`(&.O=>B7QPRM.I\;,H5/[;2`DZEN00`M[G\_[#WX M8%2,=;Z[`CDAE%.&4@JSJUG9T'UTVMPK$&UO?L$'3QZUUQIE9?*T@(B$9$@8 MABI(QUOK)%X7$BP*R3-&0A>QU["AJ%&>M? MX.L-/'*)EX9--V9F4Z551ZB;V%K>Z@&HQUOK+$U+YAI5U)8@,Q!12;V)%_H" M?>ZI6HZ]Y=8!#/Y=(5M?DM?G]6KZZOI_C?W6AKPSU[C]O4B1J7S'4CLVH:G4 M@(QN-1L>;$W_`-?W8E:\.M=8:B*;RL2&>]F#*"5*D76UK_CWH@U..O?;UEE, M*>-9P[RK&H;00+#[V:8!XTZ]GK'4(6T-$K&(HH0`$E0+AE;Z^H- M_O?O1'`@8Z]]O7.R1PQB=69B69`I`9%(MZB?ZL/Z>]XH`W7NNI5UPH80="LP M=+`NKG^TQ'U5A]#[T:4&GAU[%.N,:Z(7,X;QLP"KR&+CZD?T`!Y_K[\.&1CK MW#AURLKQ/X%8,&5G5O466Q`*D#D*WU]^H"#I'7@>N,"L@D:0$1A2'N/U%KV" MWXU`BX]^`^6.M]=Q^-M:PADE*-I+MJO]"0O]&*@^]BF0./6L^O6.%)!(#8J% MN6+#TA?[5[V'T]U''K=>LL;4_D]*LK$^DL;J&/"FWXL3_L/>QIKU[K`(I?); M2VK5:]C];_6_'^W^GO5#PIGK76>1H/(;JS->S,K``L+:B%^MC;WXZ:];QUAG MC?R$V+`@$$`D%2/3;_D&WOQK4]>ZYR>-=*2*QD"J&TFP_J`;WN0#;_8>]X\^ MO>AZXS(Q*,H+(5&BPO:U[J;7Y!/O7IZ=>_/KD0J1H)@2WJTJI`(6X^I_U_\` M;>_>E1U[R%>N+C7&IC!T@D$&Y8,1>['_`!'T]^/RZ\>'7E`6,^0$J6LH'!!' MU/(YM[\/GU['7C9XF\8("D%@1+GWZF,=>^SKJ)2NLN"$T^H'BY)LH M4_UO[]ZGRZ]UR7QLKA`RL5-M1'(_M`6_-O?OD./7OF./6.)6#@G@+X]9$,1?T!E))*EC<"_`_V(O[]U[CUA"2:OH;AO\`>;_7_#W[KWRZ MRLT6HW!)!_5QI_U[`_7W['7J"O6.1'U&X)_QM^+7_P!8\>_?EUKAU__2TF$9 MI"48W#`_CZ$<@FPO;VHZUUR6+02Y96T`M922;CZ?T%O]C[WU[KBLSLP#&X)L M0`!P>.+`?3WKKW604UGL72U_H'!?_6TCDM[W3K?#SSUP,[JYTW5;\*>;#Z6N M>3Q[U4\!PZUY]QM;^O/]?>Z=>QUYY7C;QJ2JI91<"_'U M/^Q_U_?N&!U[/79C,P634B%AZ@Y"W91RR\?0^_4KGSZ]CKIV:!5C0_4:F86( M:_\`3^JC_>_?LCKW7((:B,.6564Z2SG2K"UP`;&Y%_I[]D_;U[TZ\P--&-)! M>0GUKR`!QI%Q]3>Y]^R.!Z]UVFJI1E8BZ6<.;*!/>M1-,]>ZYBC&OF1&`8DJK>L@7)4#38$CW[2:TJ*=:ZQF MLEUW^B`@A+#](-]-[7^G%_?M1]>MT\^LC499[J\:A]+!':SC5;TE1>^D\?XV M][*_,=:QUPEGDAD`CZV)NW(OZKWM[\21@'`Z]Y]H M2'3=E])8"Q)!T_[#WZA;->M_EUU*\E*$BC:WIU.P%P[..;%@04`%A_B/?B2O M:.M<>N7C-7$)2RH\9\;,[:4D!]2D6!LR_0C^GOV6%:YZ]PIUY@U'$-#!GE/Z MP`Z!4/Z02MKDFY_I[]E*4.3U[KI/)6QNLC#5&1(LC>E0K$*RL5`'YN#[]EZB MN1U[A]O7(1-21O*&21V(C5HF#JE^26XX)`L/Q[]0J"U<]>)ZZAEDJBT$IU"1 M258(`8V7Z-PH]/\`7WX$L=->O4IUR2E,.J8O%((AK"1-K)92MK@C]`8W/^M[ MV$IW$@TZWZ=8HJJ6618Y"720^-E4*"=?I_`%R+\>]!B2`3CK5!UE2@O)8R1L MBDDJC_NL%N;6_#6'NWAYIJ'^7K?Y=8OOJCR<&R:OT64^G_4ZB-7T]UUGCY=> MZS/0ZI`5DCC5U5A'(Q#H&&K05//%_P"OO?AYP1U[K'+5302-%$Q1(OV@"H)) M2ZECJ6X+&Y]Z+$=H.!UJ@/7-Z4U&FG51@0* M]>^5.NII):313Q$J%`=GTW\C.`;C4#95`L+>_$E.T'KW'/7?C:MC61F5)(V\ M;-(=*27!<:3;AA?D6]^H7&JN>O=>?70Q*(W4O*=32)9TTIZ0@)%B;DD_T/'O MV4`HNNB=9&`>$AUD8:4TN;%&*@6-Q8,C MR,?$C1MJ1-0)+,2/U$+8?CGGWZA0%JU/RZV?/KC%++5ZH)6N'4E6TA1&R`N& M8J!92!8_X'WH%G[2>M<.N4=,:;74,\4GB4LJQ.6.HD*I(L/0I:YY_'O>G34U M!IU[\CUPAJI99!%*6DCEO&P"@-Z_3<%0#=2;^]!F)`)K7KU.L@Q]I?5)&ZAB M2B->5@HOI"VX8V_KQ[L(\T+"G\^O5K3'6'[^?RZ@;('N$L"`H-PA)&JP]UUM MZXZ]3SZRM0:I`5EA16(8([Z9%5SJTE;M5^77&:26CT01,190[-I!#M(`;KJ!]*@6'^L?>B2E%!\N MO<>N_$U;$DS.B2*3$3(2BR`#6I4@$:AJL?\`8>_4+C545Z]PZ\^NAC4(P+RW M9I%LR:4-E12;@D$W/Y_'OQU)2AR>O4KGKT>NNC=9&&N*SI*_H32QTE&(`47L M+?G@^_9D%"$+4<3SAD=R1$AC(8('OJ9N!_:"M6)!(ZW^76.&JEE<12DR)):,J``?5P&!4`W4 M^_!F)`)P>M'K(E!:0ZI8V5"251B96"W-@MA9C;Z>_>'GB#UXG'#K%]_4>2^K MT:M7CL`-(^BWMJ_%OK?WK6:UKUOK(^/_`'+++&JL197:TBAK$`J`06%_Z\^] M^&:_$.M>N.LDM1JC/7AUPFDDI"L,36``9GTAO(S>JZEE/H4&P MM[T25[1UOKGX35QK*62-P61FD.A9+>I6!"VN+V(^GOU"XK45Z]UQ?71QH$92 M\GK,B>I-*%E"K?@VO MZEU<@`1L@)NU@!H/T-_?JEL'K>!UW'3^`/,6CE,:Z@L3ECJ_LLU@+*IY_P!A M[]I(J:C'7O/AUCBJ)97$ZGWX$DT)QU[[.N:T>E[M)&Z MH265&+2-HYL!:UV/^/OVCRJ.M>76,5W^/O>CYBG6CUCDJ)4JD8KPZ]QZY/!Y;2AD3R*&(=BI#?0D#3^EB+C_7]^I6AJ,]>_+KJ622` MK$C$!1=C;]3-R2+C])MQ_K>_5TX!ZWUWXVJ8UD+*K"Z,7)`8WN"+7Y`X]^I4 M`UZ]^773ZJ9%",-3W+.O*D+P%4V^MS<^_]KGZ<6]^I05KU[UZZC=IPT;GZC4&M M;05_)X_2;^_<<=>Z\(3$#+J1BHN`IOR38$W`^E_?N&>MT].N*2/(WC'KUKKDM/9KET8+SI5KLUN;6-OK^??J?/K=.N`J)-5_[-S= M;<6_I_MO>J]:'\NN9I[OPZ`$_I+>H`@<'_$7_K[W3YXZW0>O6-Y6#%0;*I(T MV^EN.;WY]ZZUU__3TFU*,KB)2CZ?J3JNH_4!_0V]J<>7'KW'KC`&$H(M91=B M1QXQ:]Q_B![T.M"@ZYQM#KLL>EB6"L6U`&W'IL/S_MO?L>G7NL(67R``-KU< M'_&_]?\`7]^_P]>^WK.ST_E-XRQ#.O<.L,JOY6!'JN+: M1P0;:2.?I8CWHUZ]GSZSR-""HDC+R!%#LKD"]N`1^2!]>?>\>F>O>76.HN2C M+RA3T6'T`X(/)Y!]^/\`+K7^#KF618HA.AM] M>FLT,31K:/U+I^I5P03<_G4#<'^GOQ\J<.O==H0D#&9=:%QXT!TFX'K8-^%% MP/I]??A0#/7O3KLZ6IW\"E`K@RJ?4Q4BRF][Z0P/%OK[]@@TZ]UPI_2LI<7B M"6=?RS&V@#DZRQF-TE6G0QRE#]26+(.7"\V!M_KW'OV"# M09IU[K'2AA,#>R*"9202HBM9[_@W!M_K^]+Q^77O3K-`]-Y!HC:.0W".S^10 MY7T^GCBXXYX]V!4G`Z]U$C27SH%N)!(+$_A@W))XX'U_UO=IF)N"`>0?TV^O!7Z?T]U( M-37CUL=2IW@5D6>,R3*B"1E?3ZK?0@7!918$_DCW8Z0>X9IGK7Y]8*L:G1U_ MS31H8;`V6,<:3R2&5@;^ZMQ^5.O#Y]9F:)(8%J8S*^@LH#%&6,DZ0Q'UN>1_ M0>[54!=0J>O=<:FSP0-"-,`#+H^I2742VIB;DLMK'^GO39"E1V_Y>O==Q%$I M6-2C/&TH\2`E6U@'4X-_TZ3;_7]^&%[ABN.O<.!Z\[1R4K?;(T864&9"Q9BI M%D-_]2&_'X)][-"ITCSSU[[>N-)Z(YVE'[&@*Z6(,CEKH%/'J47-_P`#WI<: MB1V]>/6:)HGCF2E0QSF,V#.6+Q@_N(A)X8K_`$^OO8H0P44/7CY9ZCT0<3ZO MHB*S2L1Z?$%(8,/SJ!M;^I'O2<:^7GUXXIU(@DI3+IAA:*5@RQ2/)J57((6X ML`+FUN#]?>U*DBBT/V]>..H<*3?<*J!EEUW'!X(-R3?\`?7_``]U`:H`^+K? M4UIZ'[DMX"W[G^<#^@G5RXC_`"">;?T]WJFKX?/JN:<>H=2DPJ7#W9RUPR@D M,#RI7D^DCZ?X>Z-74:\:];\NID[THDTU$+2S!4$KI)I!?3S:P(8@\$_U_'NQ M*\"I+4Z]0U)!ZCUH#_C[T_&OE3'7AY]9Y&AC@ MITJHVEDTEE`8HT<3$:%D/U)(%P/P/=NT!0PJW7OLX=8ZJST\#PC3`-:^/ZLD MM[MJ_/J%K'WILA2OP_Y>O>>O#CUQI/ M1%4/,/\`)RH5D(L9)204"?2Q47-_P/?DP&)^'KQZYH\#PU"4T1CF,7]IB[21 M`WE1";6;2+V%R0/]ML%2&"K1NO$&O''6&@#+.7:ZQ)'(9KC@QV(92#]2QX'^ M/NJ?%7RIGKQ_GU(IGIC*5@B,,S*RP.\GD42%3I%K"VJ]@?ZGW92E:*I#=:(P M/3J%`DQJ55+B7R<$C])!NQ8G\+;G_#W10U13CUOJ89J'[@L8&)$O,FLZ+ZN9 M/']-'N^J/5\.*]>S3Y]0YXYA4R*US)Y#R`?46:Z$"YL"""/\/=&!U$'C7KPX M=3:F2F$H2>(S3*B+,\;E%:15]7`!N038_3Z>[L4KW+4]>`/'J/7*S2JXYA:. M,P:00!':P6UR`5/U_P`?>GXU\O+KPZRR&)(:=:J-I9"K%0&\;)$3^T&Y.J_- MOI8<>]U`50Z]U/Y=>'VXZQU7KA@>$::>S*([ZBDH8E]1_+,+'_6]U:A"E1V] M>\_GUS0I'1C[E3(CRW@C!TL-(M(X/]E"2!_B;^]J0%[ABN.O4SURDT24;?:J M8U26]0E];FXLC%O]2I4\?UM[\:%.T>?_`!77O//6*D]$=0\HO!I"O&>#)(3> M-4/]EEY)/X%_?EP&+?#UX_+CUEC,4D-0E+&8Y-&I@9"Y>%3>55/&DV%[DXU\J9Z\?EU(II* M8R$00M#,RN(G>0NJR%3IX*@`M^"?H?=E*UP*-Y=>H:#..H4*3?<*J`K+Y`+D M'TD'DM?^R+<_X>Z*#4#SZWU,$M#]R#X6'[OZS)=`2U]9CMPG-[7_`.*>[ZH] M6%\^M9SGJ%,DXJ'62YEU@%A]&8D$%2.+->X_P]T(.HUX];'4RHDIA+IGB:65 M5199(WTAG``;@`7(/!^G/NY*5R*GK6?7K#6@F56`U1,BF'2#816L%M^-)!!_ MQ]U?CQQ3'7EZRR-"D4"U,;22A21I;04C)O&I_)_)_P``?>\!5#"IIUX=<*LZ MXZ=H@1`5950"Y26Y+JQ'U+"W/Y'O3Y"D?#UX==H42D`J4+JT@,$8.AQI#+(] M^2$O86_)O[V*!>[()QU[SZZD*/2'[9"BI(#-'N--9(IVF4F$A5*'TEY+W723:Q47)/X'O2F@8GX>M]L5$&$A8FT:QL9=0-M'-UM<7+&UO\ M?>EXU\O/KQZS0O3LY$41BE*L(W:34`[`A18@6)^@_P`?>P5)[10]>].HM.LG MG33Z6#@ZB.%YN21^5'U/^'NHK44X];ZE"6C,X(A8?N7$FHZ1=OJ8Q]%_WKWN MJ5X8Z]Y=1)4E\[*WJDUGDM?/K!5!C+J%M#*IBT_0);TJ/\`@OT_U_>CQ^76 MQUFD:)$A6=#)($OPVDJA/H5OK?T_[;WLT`4'C3K5.L=3ZDB,8/AL0`.=+@DN M"?R3<&_]/>C3!'#K8_EUY=*4ZF9"RLY\:WLP`N':_P!0I-O]C[]Y9Z]UTY5X M/V5*HK?N*26-S;0Q/Y'U`'OQX"G7NO0V6*5I+F+A=)NI:2X("M?C2M[_`.P] M^'G7AUKKD#&TZCC\NM]9(WB+$11E)"K!&+W]1^@L;]#-.O#K,)*;RW$9_7PY)*_4V8I?Z?FU_>\5X8Z]U'=7$ MC`@EPYN1^31H0_J0LPX9E.D%@+&PYN;_GWXD>G7J]?_]32 M=6,0AI=<25O%*2ZR>DC2.&/T;_74 MCWH$D@'KV.N24H5]321NJ79D1KL=/.FQ`-_]Z]["^IZUUP%7+KY/IOVKCWK4?RZW]O64T8,G$L:JS`A&8B0!B+`BWZA?Z7][TYI4=>/KY=8WJI$< MK&?'&OI50`?2.!>X)YM[\6/EPZT.'662F\I699(H_*NLK(Q0ZR;,1>]T)'!] M^TUH:BAZ\/D.NI9GIF$,3%1&!JX7U.?43=E;CGC_``]^)(P.O?GU[Q_=(DFJ M.-[LCF0Z0Y`!4K9;%M/UL/?J%@#7/6Z^7GUW(S4:)'&ZZW];N@NK61O&KQ'4B*+,US8#6>/]A[]30M:Y/7NNHY)*P/#*UVL7C=K`(R_ZO2`- M)4GG\'_7]^!+U4GKW#[>N20"D62H,DX]Z5F8Z6.#U[AUDCH0CZY)(I%0-(8T?4 M[!!>VFPOS]>?>PE#4L"!Z=>KZ#K"N0G,@UMJCU^J/2A!2_*@A`>!].?=?$:M M2<=>I\^LYQO[Y`GA5-8&EG_=L;'3IM^L7]V\+--0_P`O6J_+K#+73+(5A8I$ MA")'H7A4](!U(6N0/Z^]&1JX-`.O4KUFEI!4,L\RFKN#`5Z]6GEUQGJ):-EIX&*K$JAFTI^X[>IG!=&LK:N+?CWYBR'0I MP!UL9ZY-!][''4>1(I"3')YFTK(R`>I+#DE;7L`![]IU@-45ZT#3RZZE=\?% M'#$_[DH\LLJV9&%RJ*A(92H"W^GUY]^-8Z*I%3UOCD]>4/D8#Y)$6:!U(EE. MA&22_I)`(#`CC_#WX?J`U.1U[AUXHV/A,DDE/,WJ"F6*4@*L;("#Y"H5=#*Q%S]+_P"M[\"9*JQS MU[`SUSCIC1))5&2&9XU`B$+Z]+N=(=_II4`GWL)H!>H)'IGK1-:#KA3U=FDBG!BMI6Z,?T,-*J3I-O]A[TKECI8U!Z]P`ZY18\0N)I)Z>5(E>4QPR: MY'\:E@`+`6)'//T][$=#4L#3KQ/RZQ)DJ@R#R'7$6.N+2G*&X*@A0Q-CQ<_7 MW42M4$G'6Z=2#BOW](J*<(9+>,R?OJNJY0H177J=9IL>*AA41S4\`G M5)?'-*4=&?EN+&ZD\@^]F/51]0`.<]>KY`=<*BKEHW%+3OH2!1&3I4EWY9GM M(C<%F-K?C_7]Z9V4Z%-`.M@5SY]3&QPPPN#)(#-+,H#(^HE45"RD%5TGD?7WHE MH@%0Y.:]>P:GKM4?)TY:26..:"15\LQ6.-XY%9@I*J`&1EX_P/OP!E&IF&H> M9Z]P]>NV1L93ZTD1YYWT"6(B2-(XPK:064CR.3]+?07_`![\1X2D@@L3Q'#K MU=1Z]!+)D4FIYW!<()HIF`1(S&6#"72-.AM?U/TO_7WY29`R,<\0>O'!&>NX MZ0T$4E/))P-(`X`YN?Q>WO830&?4"?*G7J@XH>N%+53 M5LGVE2YDCF1D'H0%'`UI(`B"VDIS^+>]*[.=#&H/7L#/62''+3N9Y9J>=($: M8PP2%Y',0N`05&E;_4^]K%0ZBP(&<=:U5Q0]8$RE291Y2)(68K)#XX[%'N"H M-M?Z3_7W42M6I.#UNGSZD'#WJ2HJ:<(9=(C:3]\*SVTE"O$@4_3^ONW@=U-8 MI7USU[5C@:]1Y,E4I,RQ-XXE;2D>A#9$.D!BREKV7GG@^ZF5P30T7TZ]2N>L M\^.$TBSQ34\*5"1RK%/)ID4R+<@`*05U@V_VWNS15[@P`.<]>#4\NN%35RT3 MBDI6:*.!0A)16,CD!FDM(#8.3<6_'^O[TS,AT*:`=;`KUV].->O<:GKD%;*4Q>21(YX'"F64Z(I(WN0I-M(9 M&_UOK_C[\!XHJ2`P\^O'!ZXE&QE.9$D22:=S<)$D4<:%2R@L+&1FMP1^/\ M/?B/"6H(+'KW'KN"67(I+33O=@/-%*ZA5C:.RMY"H`",K'D_0CWI2T@*,%O((GEU)Y)+@?0`@#F][>]Z/##/4$_+KQ-:#K M'3U4M9)]K4,98YE,:V1%9'^J/=0OI5AS_A[\K,YT,:@]>X>?7.+'"%FFDFIY MT@5I3%!)KD;0+KZ=(XO:_O8CH:E@:"N.O$U%*=8DR=290)6UPEK/&(TY1K@J MIL&OI^G/U^ON@E.;>ZLQ0Z$-`.O`5ZY24YK4BJ3-#%(X*2"9A&':(Z=<=EYU`B M]K`>_:?$`>H!^?7JTQ3KJ>5Z!(J>!P&(\LLBV979_P!(0LI!15][),8`4YZ\ M,YZ\$;(P:WD1)H6"F24Z$='U$"^FP96'^\^]"L@R>X=>X==LK8Z'7&Z/+,Y3 MRQ%9(TCCL2H)%B[D@FX_'^'OU#&M0>XGKW'KA$[U\X==I!]E'+4>2.5P/''XFUJC/J!=^.++>U^#[]30" M]03\NM\?LZXT]3+4N:>=F=)E*7"J"C?59`40'TL/];WY69CI8X/6J4X=XL"!GK=:]88Z^9I%25C)$Q"O&% M0:E;TD`*@:]C]+^]!V)%3CKU/GUE&-_>L9X2@?\`2'O-I!OITVX>W]/=O"S2 MHIUZO6)\A.)3XVTQJP58[*1I6P`-P6N0/Z^ZF1JU!H.O4ZR240E;SI)#$DBK M)XY'T.I<:B/I:Q)X][*5-00*]:KUPFJ9:9A3PLRI"-'Z5];6N['4#8%C]/>B MQ4Z1P'6QZ],E2Z<&X/Y_`/O>G4`U0.O==2R/1*D4 M369AY'D2Q#EN!INI!10`+_GWHU2BCCUK_#UU8UL09W1)(FTF1SI5U?4P'"GU M*1_0<>_9<9.1UOAUT0U'$-#*TLI/[D9#`(MKJ"5(.HGGCBWOQJ@%#D]>P?+K MT;-6*Z2,-:#6DC6`4"RL'*J!;Z6X]Z%6!!Z]PZ\L/VJ23:TD<#0AC)8(7!]3 M>D?@&W^/O=-(+5SUZO7".>2H8PRL660$7*KZ&'J5_0@-E(Y_P]Z!KVGKWV\. MN24XA)E:2*4(I8+&Q8L1?22+`Z;\W]^I3)(-.O5ZX)5RLP60ZD8Z672!PW!` MMSQ_3\^]!C45..O'KE]F/);RQ$!OT!CY"`>%TZ;:O>]'EJ'7@/V=8S5RAO0; M(&]*:1PHX"_U`('O537K?Y])`]G".UF`&8<#WL::D#CU[J-3I,9T"ZE(<$L00JZ>23>PL!^/S[TH-13CU[J4'HC." ML;`Z^&OZ`=7!T7!TW_J./>P4KP/7O+J(\M^5>IDKT8E(EC9Y!82.ATJ7`&HVU#\_7_`!]W.D'(SUHCK!51R>9B`61K M&)E4E3&190+`_0#Z>ZL,];X]9W$$<<"U2N\H2]D]+(C&ZA[E;FQX'U'NYT@* M&%6ZUFN.'6.J76L#P`F$QV55!)1@3J#\&[DF]_=6`-"!VTZ]Z]]+0!B MP[>O'T'7+]F2GG6D1U<:&=6]3/$I_L68\!C8 M%(%C83:P1J5@0J@&VIB]K?T]Z09)/P@9ZV>&.I$#4KZTI4DCG:)Q&TC*>;W`8]6%->M9Z@&"I\Y73 M)Y3);4%;E]5@P:W^QO[;(;52G=7K?$=3YGQZSD31/),I42NG$;N`-9TZP/U? M7_?'VXQC#48$GY=:[ORZC5T4WW#-RZ.%:%D4E/"03&%M<`*HM_O/NC@ZCC'E MUO''J1+]M%'`E;$\E0(06\;6*(WJCC;UKZPI_P!<>[G0H4."6IUK)R.'6*MC M9A3R4X9J5H@L0`)\;+S(C'U>O622?S[JX^$@=M.O`^O69!!#1Q??*[ZY&:"- M3IE2/3I=SRIT.P%A_7GZ>[#2L8\0<3CKV:XZZJ52:B1J)&$*3,LT7+2"1A>- MY.6U*4!`_H?>F`*`I\-<]>\^N%*J14]0]8CFG9D1(R"K/->X:.Y!70@-[6N# M[\@`5BX[6.CBDBJ7@D6%I3K!-KLB>HZ9)$N`?H/=ET&H0$.1BO7LCCPZ@T4,YJX M2%9`K!V+JP01JI,A:]@!HN.?ZV]MQ@ZUQ3KQI3IP@EQ)JT$44J/K;Q2N08A( M;Z&*%SQJM;^G'MT&'6**:UX]:HW36]-6+4-&RR&;RZ=0U7,A;A@W'U/(/].? M;)5]1%#JKUNHI6G3I4R8Q:DK4Q2S3*$6HEB($;2JH$C",.O]KZ_X^WF,0:C` MEO/[?/K0U$5!QU`R$4YJY6TM(CD21,JDH87`:+20"+*EA_KCVW(IUG%1_D\N MMBE/GU.G:BB6GCKHI9JI8$\IC8(8P=1CCD%UO(D9%[W/TY]N'PP%$@)>GEUJ MI-:<.H^2C=S3RTZ,U(T"BG5%)$07B6)[%AK$AN3^2?\`#W605*E?@ICK8X&O M'K*GA@HH!D4>37)(]-$IT211^D.S&ZVCDD`(!_Q/O8TK&!*":G'6LU[>'7"K M59:.%Z%)%ITE=98C=G69@"CN;L6U1BRGZ+8C\V]Z<`HIC!T`Y'G7KPX]W'KN MC5(:*H>O1S3/)&D<0],C3@`EXP2I4+&?4?[7T_'O:`!&,GP>0^?6R34:>/60 MBGGHJA<+'Q M30U;T[B(RL&)TZ6EC0ZV`E>(,`1[NOAL&$8(>G6LBA/#J'CH:G[R%E#1A&\D MDCBR+"@)D+ZK`J4XM?F_MN-6+K04]?L\^ML10]3Z>7$FJ"Q0R12&1A%-(0T* M.VH1R%-?Z0Q!'TL;>W5,&L44@UXGA^SJO>!Q'34U-5BI*%)#-Y2NH7_SFHB^ MOZ6U?GZ6Y]LZ7U4H=5>KU%.G2>7$K5,)H9994=5FEC($+R*-,CZ-8NI<$G^O MMYC#J(923Y^GSZH-9&*4Z@9""J%9*7#2ZB'21$)22-A>,H1QI"\6'TM[;E4Z MV\Z]6%*`]3YS1P)319".26K2!?(8VTM&K$M''(=:WD2,B_%_I[NWAJ%64$O3 MR_R]5&H_"<5ZBY*-I#2RTRLU(T"BG55/[6@VDC?ZWD$ERQYO?W605*E1V4QU M8'C7CUE3[:&AIUR,F6.$V5B3J6R/*IL#?GGWL:%0>(I)KBG6C7 M4=)ZZJU2:BIWH484R22++#;5(D['4DDIU,6U1BRGZ*./S[\X#(ICKHKP\Z]> M'&AX]=4:K%1U+UZN:1Y(ECA_2[U`()>(MITZ(R=1!Y!M^/?D`5',@[/3Y]>) MR`.N9^UFH:ED-'H;6\CJ0BQ)W5,.O"FOEZ=:[NFM:>L-2(PDHF\VD-I-_)Y"-6L MC\-S?Z#Z^V=#ZJ4.JO6S2E?+ISFEQ8JG$D4DKAQY98R%B9P0)&"!AZ==^`.? M;K&'6:J:_P`NM=WY=0*^&I^[E+!I=1#HZ*2K1,!XM)`L`$L`/Q[;D4AS7SZV M*4ZFSFCB$$5?&\U2D*^1HVTE022DAZD`4\-'3KD$> M1V9WA13IDCA)L-;%QZ6<$@<_\4MVK&OB`D^5/3KV:XZQU2+)20O1*WVZ.ZR1 M<.ZS-R'DTZB=:#TF]@!;\V]U<:D4H.S_`"]>'F#UU3(L5+*]:K&G:2-4BL5= MI@+ED)9194^I_/OR@!&+CMK_`#ZV>../7;B":EF%`CH4='G5C=WCY"D'4Q*H MQY`_//O9TE&T`_/[.M>8KUCH49//).K+3+"PF5EMY-0_;1;VN^JQ!_'^Q]U0 M4U$CLIGK9^7'K/`:219HZ-'BJ6A;07.HL`5+K'ZVM(R7%^#:_/NPT-J"`AZ= M:J<5X=0J.*-?#I%PJJ+,AM<74_7W M5QD$?#3'6QZ'K(!%%30K6*SL2[0HILZ1GB[79?2S?3_D?NW:%&L=>ZX5"J]/ M"U,&$2LRLEB7$A]5V-S<,OT_H![TU"JE1V]>^1X]=0A(Z:0U2DQM(HC3D.7` M.ME)M86(O[TM`I+#%>O&OEUV_CEII/LU90CHTR$$NRVLK7!-T5C]/=C0J=(^ MWKP^?7"E0KYGF#"!8R)`5L')_0JWT^LD96L55;N[,#I$8'JU7XL1Q[JH[AZ M=>IU(B:D,MHD>-S<1NY)CUD>BZZB;$_3^GNPT'`!KUX\.H:QSF8*%O=1)TE M$S@ZC=B00#8J>5*V_!7Z>ZD9-1U[K__6TH899*DM!*Y974Z3860CUAB5`X]/ M-_:H$MVD]5H!GKE#3&(M*SQ2>%3)HC<.VI?H3;Z*";D^]A:$FO#TZ]UQBK)W MD"2,721M#(JJ"0_I(``U$\_2_/O0=JY-1U[KFN//F"F:$@/8J)!Y--[$!?KJ MM[WX>:$CKU<=<&KJA9?2VE%8:8V"BRJ;!6XU?0<^]:VKQQUZG62:AO+>-XHT M>S!))`)$#@-I*_7B]O>RF>(`/J>O5X^O7514S4\G@A8QQPV071;DCZR$.K6+ MGG_6]^+LI*J:`=>I7->N4U.:I8JD/'$TJG6LK:+NITLR7^JM;WXKJHU0*^O7 MJC-.NI9):%(H(7L63RR2"S*[-Z0%)NI5`OX^OO9)C`53\^M4K7KLQO70),SH MDD;>)WD*HCCEUTG@:EU6M_3WZAO#!Z[;7CJ=3&RM+.YO*EGC"1\!5 M)%BUR;_T]^S&HHP`B>,%PQT*OH-K->_!][5FDJC&M>O8&>NZ:D\#/4M) M!,*=#,(X91(Y92-.I5MI4,02?\/?@A4EJ@T'EUZM>N$&0J9)EAF8RQ2'Q/$% M2Y63TG390=0OQS[TLCD@$U!Z]0<>N:8HBH"-/3LHD-T256F94))41<-K*CZ? MB_/O8B[J%A3[<]>U8X=8SEJL3%E:T>LL(=*<(6_03I+))-+I'--XYHQ(`P5HRI(*DV`O_L?=C$2V&`!]3GKVKY=<:FMJ M:29J6G=X8H-,0#(NI]-[R'6&_6QN/H+6]^>1D.A311U[2"*^?62HI#6K#6"6 MG@,\8,BSR^$F2,F-Y$!!NCZ;_P"'O10O1Z@$^O6JTJ,GKJHJ)\:L-)`^BR>6 M610'69Y0.8V9;-&BC2"`+F_O;,T8"*?S]:];`#9/7)H9,I2QU#21131.:=Y) MSXHIEMY8RK6TB1-1!`_'/O>DRJ&+`,,9QUK@:`=><2XJD5HG1IJJ4WGBTRQ+ M'""OB5B"I=F>YXX`]ZHT*`@]S>8X4Z]\1/IUU$9LM3S1SR+Y:=DECGD(C0+( M0CQR,`%%R`5O^0??AJE5@S9&:G_!UXT4X'7*.G?&4\U6)(9IF*P1/3R>9(== MR\DG`LVD67_$^_!3$K25!;@*9I]O7B:D"F.NJ2JJ,D9:&I?R":(F-]"KX)(K MNKL8U6T9M9KW^OO:L\M8V-:_RZ\0%[@,]6FJ!21-4+%3S"9S(E MO&7TA=$:N;D_T'ORQZ:N6!IG'7BQX4ZQTN2JZBH6GJ)'F@J&,$L:I'J*R@QZ METJ&NA8-_L/>DED9@K-53CKQ50*@=9(<*WW(22II)45R72*8/4.J7)18@+ZV M`MQR+W_'O8@[PI<4_G^SKVNH)H>L39JN$^I9"(O("L&A`OC!`\;$J6OHX//U M]U^HDU5![:\.ME!3AGK+481JZ2=Z2FE>&&EM`BZ(]1,8LTC:D8WD:[?6UC[\TCH M2B&BC'[/\_7@JL-1''K+4XXUGAK4EIX/NHQ+)'4S"%O*#HD>,,O,4C+J'^O[ M\T9DI("!J'F:9ZV&IBG#KC5U%1BA#14SZ-,:SS2@*PGEG16U1,RLIA4+92`+ MD&_OS,T-(T:F,_/_`&.O`!JL>NWADRU+#4M+#%/$[4TDM1(L,*'T)$C MD,C-J9BW%QP/?CJA4!6RWF/EU[#DU'#KN/S9BCF6>11/2.DB5,I6.+QS%$>& M1K!5)905XN3?WM=4ZD,WGD$T<&L M&221C8#60EE%N";^_!3"K2`@MP%,TZU74:>77&DJJG*>:BJ7UB6(O'(55!#+ M!JD5Y&15TQ,+JU_I<'_7TKO+JC=JU'[*=>(5*-3KNFH6H?)7-+2U/VL3RQQT MTZSL939(V=54$11L^IC]./?EC,9,A(-!BAZV6K1:'/7&DRE74U"TM7(]13U) M-.Z!$U`3'2)$T*"&C)O^>/?DED=@KFJMCK14`5&".N<.#?[K1)4TLJ1N_DCA MF#U+I&&+(L(&H2$+:U^/]A[\+?O`+@BOD]_>C/)6H.*\.ME%IUFFPC&I(2HI(HY&5HXIIPE0B2@. MB-$03K`:PYYX/O9@[J!U`/JLM5CVK1!7)+34WW<0D>*HE$+>5"4=XPPN\ M4EM0Y_/O;1^)20,`2,U-/V=5#:<4)IUPJYZG$BGHJ64QD1B>:551DGEF`.J- MF#!XD50H(M>QOS[\S/#IC1O*I/J3_DZV`'J2,]=M3R96EAK&EBBG5WII9*AU MACG"#R(R&UBX5])`%N+_`-??BK3()"PU#!KCKU0AT@8Z[E,V&I(E@E5IZQVD MDJ8BLL(C@)18HG8:6.IB6-N";>_'5`@TGN;S'IZ=>^,Y\NNHC-F*69*B11-2 MNDD=3(5BA$FD6=(#*0SR2,!8$K'91;ZG_6]^"F)&D!!;@*9IUXG40OEUQI*BIRW MFHJF0R%XGEAD*HH@EA4LKR,B+:)@2I)N`2./?E9YM4;FN*CY$=>("48#KE2T M#41FK6FIJDTL;21Q4LPF)E_0CR*`I6*.^HG_``][6/1JD)!TCR-<]>)U4%#G MK'29.JJ)TIJEVF@J;P2(JH&"R>@.NA`UXR;_`.P]U261V".25.*?;ULHHR!G MKG%A#]T$DJ:62-'8ND,ZM4,L7)58``^M@+6!)'^/O:P=U"ZD#T.>M:\<#U@_ MC=;]QJUDP^0G[?2@'BU$^.^G7<+Q>_O7CR:@:]M>'^3K>A:<,]9IL(WW)2.I MI4C=P4CFG5:A$D(*HT1&HNH:P'U)_I[V8.^@8`5\SG]G7M6*T/7"JR553U#T MU,[004W[,:%4+6C])9RZL27()/\`@?>GE=245J*,=>"J** M8,U/,\\@ACF*`,CH3<%K-8@"W'^W\5,JJ]0&X&N*];!TDKY==2F7$TL21.AF MJF:1YXR)(Q'%:-(HV(*L;N2QMQ>WO1U0JH4Y;S'#[.O88FO`==(TN5II%F=! M-3,DB3RE8HO'+9&B=U`56+*"+C\'WX$S*0S9'F?GU[X2*#KRPRXRGEJ$EBEE MD9:>.2G<2I"'N[EC8*'(2P!'/OP4PJ7#`L<8Z]AS2AZ]33SY)9J2=R^I#+%* M555ADAN0SE0-,3@V8F]O?E9I:HYS2OV=>H%R/7KU-0FE\E8TD%1]M&TB1T\O MF/DN%1I0H4B)"=1//`]^5-%7U`T].O5K0=8Z;(5-1,L%0[2Q3WA9`JAOW!I# M+I`)92;_`.M?WI9&9@K&JGK94#/7*'%E9P9)Z:18R6:*"8/.ZQAB42(+?4VF MUK\>_"*ARP('SSUK5@=81EJLS:B]XS)],S1T132G\^O4KUYXGKX8ZEGCCD4F&1Y76-)-(+*ZL1;4`;,! M^??B#(`U0#PSU[X>NI#)CX(UC=3)4,9&F0B2,I'=5C1C=6.HDDVN/I[\:Q@: M3D^G7L-UTHDKZ=V=P)(&6TDEDC*2<&-F'I!4BX]^S(.XY!XGKV!6G72QO0T[ MSJR22.XB5XV$D<8L&8D_0.?H!;_'WZA0%@02<8Z]@]>AEDK%D@F?5^V9(W(4 M"-H[GUD`61A<$_B_OP8R55CUO`Z]%3&G$E09(I/"FI5C8.=;'2K,`.$0F_\` MC[\%TU:H-/3/7OE3KC3U4U1*()G+I-=#90""W"N"H%M+<_T]Z#,QTDU!ZU0# MKN*A*R`R21.J7=HXGU2-XP3I5!SKUC%?/Y020R:P3'I7E;\I M?3JO8V!^M_?O$>O''IUZG7-L>?+99(E5F!5&D`D4&Q`9#ICK_]?2E1H)$F2DC9)C M$P]1OJ0$-(J5F%E$0'KO]">/Z4"&)HI3J$4CM=%_MNAU`?BKUNO3B\N/$Y,D+,X;UR*;1E@;,X74 M+J6!X_/MRL>JI4UKUK/4"J2;[F3R79V>X9;E6#1B&>%4.ETA8BVLW M!LS@E1^![L-(51("3Y?9UK-<'K'6VDIJ:2G4K2@,FCZM'-J9FUVON=.8XJ%OO%+P23KX(UXD+J#Y9%:ZZ4`L/]?\`WG:T"=X[ M2<#KQR>N4AAEH)10(\:)*KU,;'5(8R-*/JNUXPYY_H?>SI,9\,>>>O<&R>L5 M`!''4R5"EJ01!)4_U5>M$-3)KTU0PU/W<:('$WG`%[\2!^2_P#@ MK`ZO]C[:"MK``[Z]6)%#Z=.S5.&%:7:FD8^:[3:SX2VKF41%C=">;6Y'^V]O M:H-=2IX_EU2C4XXZ;*^*I%;,)@6E:2]TN5<-S&8OZJ4(M[:<-K8-DUZLIQTZ MUMCAB2H>%]"B2QLCVED@B^TTJP"PJ-!CL2?4D@8-S]>?=)LL"/@(QU9`:'UZF%Z*&BHH MLG#)/,(W>)8F*214[N#&)3J6Y:Q*C\+_`+S>J*D8E4EO\G6NXDT..L.1M-24 M7!8$]W7*E,4.-8 MY"-Y*:6H3[6%25D,J(PEE0DKIC`(!_J??DTB,^(*J3@>?SZ\:EAI/#KTS4\V M.D&-BDB2.H1ZN-V+2.K#1`]PS$QJ]P1^&(]^?2T1$2T`.?7Y=>%0W=^77'%V MB@KI:I2:`Q+%+'8WFF+ZH%BN5_<1@3>_"_[#WZ$@"0N/TZ9^WRZ\W%:?%U*A MDHIJ>LAQ4$D%6].3:5M;2PI9IXX6U-ID,=^!RP'NP\,JZQ*0]//S'F!UHA@0 M6/;TW8A9EK!(/3%"DDE4SJ=`I@A\RN#:Y=38#_5$>Z0@^)4?"./V=6>@4?/I MRHY\6U1HH::6GK'$BTDLTFN-)VCD6*X+M8EB`#8V/MQ&A)`C0AR,$^O52'`J M6P.F>D@K#7Q)"KI5":ZEKC0ZL;LY((TI8D_X>V45]:@?'7JQ(TG..GMJO`?? MEVI96(J`SS!OV"=8+S",/S&3S;^G^V]OE[?Q*E#QX^7_`!75*2:>/3-D(:O[ M^=909)GEN&C!9)`]C$8R+C0R$:1^![8E#>(^K)K_`,5U=2-(H<=.U9-BXY53 M(4TU371Q1)52PR:5:8(`RM=UU2(.&-OJ/;SF$&DB$R`"M/7JBACD''4',I+) M5)*HUTTL$+T7C!T+2A`J1@`MH:-E(87^O/T(]MS5UAOP$8^SJR>8\_/J>\E% M!14$66@DGJ1&\D:Q,8Y8:60GPQS-K%R;$JOU5;`V]N514C6927I^P>5>JT8L MV@T7J-E2DU)CY*)"M`BRQ"'ZR0U>LM+Y[%[M)&5*F_(]UEHRQF,?IBOY'K:8 M9J_%_DZY4K4T&,ME(998)JK720H3'*&C3142AM2Z8B2J_P"+`\<<;30L7ZHJ MI.!Y_,]>-2W8<^?7.I,%1BF_A43PT\-4'KH7)>;]Q=%-*6U,6AN&%A]&_P!A M[\Y5HCX2T4'(_P`!^SKRU5N\YICK%B0(:>OEK8V;'&)8I8B"KS5#,&ITAY7] MU-):_P#9')_J-0X61G'Z5,_;\NO/D@#XNI,/II::NEBFC MI)JB77&*AT81K^M@C.?2K6-B;?GV]&T):D2D2$8)]>FV#T&IJCIBHZ>L:OAC MA5TJEG&DL&'CD0WTZ+)K4**/7_57_+TZ2-)KPZ?C6;>^_,C4DSG M[K69UD/V[,)-32B/6;Q:N;6Y7\<^WR]MXE=!X\?+[:=-Z9-/Q>73'6P5:Y"H M296>H:=KL@)#N[:D:,K?TR*05L?H1[8D#ZV##NKTXM*"G#I[R%1B5J%2OII: MFMBCCCK9J9Q'$TR(JN`-:AW0BQ;BY'M0YAU`2*3(`*D'SZ;`%EB2+EGBJ0^N83$:KR2*ZLIOROT^A]UEHRH8Q^GP^P^ M?5DP2&^+K/2M3P8H?Q6*26GGJ==%#&2DUXD9*F4/J33#J91;\L#Q^?>T*K%^ MJ*J6P//Y_EUIJENTT/GUZJ:GJ,4XQ4+PPPU*/70NQ:BGI*^+$4\M/.8`\@F?R/ M+3(UZA(2':S`6)'Y6_NP*,DBPJ0U/Y>?6J,&4N<5ZAX59$JGE?T4L4$CUID5 MM)IK>N/20`SR&P47Y:WMN&H?5^`#/V=6>E/Z7E]O3C138IJAHZ"FEIJV2.6. MDEJ)-<:SNA5$Y=M+,393;@_Z_MV-H2P\-2'(P3Z]58/3)J.F.D@K#71)"KI4 MK-<:KKXVC:[F0V-E2QU?X7]L(K^(H`[Z]7)&FIX4Z>UJ\#_$`XI90_W!(G+_ M`+`D\A(E,9D-HM1O:WT_'X]OZ[?Q*A#6O'R^VG3=)-)JW3+5T]8*^:.56>I, MWJ*@G4TC!D*6%]+!@5_PM[3NK^(P8'77IQ::6&)J M,Q@Z136*H@`'#(ZL"/PU_;4]2^K\)&/LZNG#Y^?4IY*.&FHH\G3RSU`BUIXV MTM'32,6@20ZEN2O*C\*1[O6-4C$RDO3RQCRKU45);2<=8,I^]#0RTJD4"Q-% M%&.6AF5@9DEM?]U[J;G]0Y_K[K+0JC(/TZ?L/GUM<$@_%UDIVA@QH&2B>6&6 MU*K$/%%5)P//YGK1!U'3Q'752T,V-(QT M;0PQ5"O5Q.2TI+H!!)JN=40(8'^C6X]^]14`J+@E#3V]:$6LS.;`#^O^'ND50]?P@9^SJS\*>?4ZEFQK3,E'!+!5 MR1R)3R32%T$S(0B\R&S,38'^ONZ&*M(U(<@T)ZJ0WXCCIIHHZC[R$1#3()EL MS@Z4T79C)]/2%4ZA_3VR@;6H7#5ZL:4Z=14X7[S4M/*#YRRRLW[.O5=7,?D/ M[8;FWX]O:H-==!X\?+JM'IQZ:JJ&J%8Z2ZGJ#*;E;DNSM<&.P!LU^+?CVRRM MJ8,.ZO5P13'#IRJY<>LH2LA>:J1(EJ)(G(1I0BAQ;4H++:Q/]1[=8Q!J.I+^ M9'KU6C&I4XZ@Y,.:G6.898T:G91Z13Z0$51_9*6L1_4>VY0=5?PTQ]G5E/SS MU,E>FCAI(Z^%YIQ""`C:&CB8WA24ZN3H-P/P#[N2@5!**O3^7E7JN:FG6#(6 MDBI9:8$485HXTYO%*')D27U-ZVX/^(Y_UZR4*KH'Z?\`EZV/GQZ[A,<5"/OD M>2*64M3(K%7NJD2O>X_;U$`#\GGWM=(0:Q4$X_R]>S7!ZXU!CEHP:-&CACF_ M?C8WDUNH$3EKDF/2"!_0_P"O[TU"G8.T'/7L@T/7&CM'3U#U(O2MICT?VI)[ MAE$?(L56Y)_I_7WY*!6+?!_EZ\>..LJM3R4]5'0QO%+I#2*[%V>!21($-VMI MN"?ZCWOM96$:D'_)U[[>HE`'65G(M"L4AGU`@-$5(*?B[.W`_P`?=4P23\-, M]6)_;U*@>E=F6DB:*I:-Q"TC7745-PI+7#$`@'^ONP*5(0$-Y=5^WAU"I4F^ MYCT#2X8&[BP4+RY>]O2H!O\`X>VU!U"G'K=1U.$^.^Y#")E/EN)#?QWU'UZ- M7"W_`!;VY6+5\)ZU0^9Z;I8YA4.C@F3R$&W]IR?JI''(^G^O[;8-J/\`%UO' M4Z>6C$O[T323*%661&LC2JH#^D$?1A;_`%_=V*5H5-?/KPX8X=?_T-*B*G^S M\E5YH9S"GH6%B^EW(17DX`51JX_J?:T+HJ]02/3JE>O4]9/52?;3DR13#QV6 M-`R,UK.-*C])'^V]^5RQTMD'K9^77.'&JD@=ZF"58M4C10N6E<1@MI"\&YMS M^?>UBSE@0/(<>M5^76-#[KXSUJ>'IUZ@IUE M;%*TUEJZ:-&<:8GEM4(CL"J&,_5PK<"_/NQA%:!Q_EZ]7Y=8YO6>>@2I9:I*BGIQ4J)C#4RB-PS$ MZRH(]4;,"0WY][:/51@P%?7'7@?D:]=5-7-CBE'3-I$**9'9%8S22`.774#Z M.;#_``]^9VCHB&E/Y]:`!R1UV\'\3ABJVG@IY0&AE-0_B25H])$D=@0?2UFL M!8CWXCQ0'+`'AG'7AVD@`TZ[EFDQ,,4%-(C23`SRU"VDB==11$A+`@A;7)%N M3[V280JJO#N.>N2ALS3,T\L4,]*X'W$Q$4+PRMPCD#2KJPX-O>Q69.Y@ M&4\>`SUKX#C(/783^#TSU$4T-1/._P!O'-`WEA@`"R/J-@ID<`6!'TY_K[U0 MPH6#`L<"GEUOXC0CAUU!439>.:CJI%NJ>>*9@L:0M%<,92H4"-DM$!#J`ZYPT:XQ)Z_STU6\"!8DII#*L+:J+0CKC2Y*HKY315;&:&K4P`)'&KQN>8Y1H5+Z&%S?@ M#GWI)7D(C?(;'7BH`J!GK)3X9(Y_+)64M0D&N9Z>FF$E1*(5+Z%C%B+D6/UL M/>UA%:F12!G!SCKQ8TH%/[.L"9ZN:<"4J].TEGIQ$@+1,2#&K:-=[&PYN3]? M>A`K#%`\4994B`CLY9-88E>1?CZ? MCWXW#AB$PH\J>G7M"TSQZD5.)CK'2MCJZ.B6LC6I^WJY3#(K27+LNI3KB=P2 MK?F_]/>WB#D.'50PK0G/7@Y';I)IZ=<*ROJL2Z8ZCD\:4\:>5S%&QGEE'F>5 M=:LPC;7Q_@/?GD:$B)#@#^?7E4.-3#CUSEH_XQ!!D6J::CFD#03FK?PI/+#H M42PD*004-F```(_U_?BGC!92X5C@UQ6GIU[5H.C23]G7JB:7`004U'*CS5(- M3-5Q@2P2+=HTC@9TTNJA>3];_P"!M[\2UNJHA&HY)\ORZT`'))&*\.NT#Y^C M8U$\,%31RJ#5SV@IY(I[VC-\!2-4P5-/55%5**>.>E<3T\$:!99`6L5,TEQZ2.!S^?>J&W0LK`NV*C('7 ML2&A!`'KY]=TM5/GX:FAK94$D:?=4]6R)%#`8KK(*@QJ@$3I)^H_3_7M[VKM MO$+&0RC'7*GQ\>)CGR9JJ2O>F0+"E%/Y1'-.3$DM05MHB6Y_ MK?Z<>_+'X(:;6&(X4]3BIZ\6U$)I(!]>N%'F*S)S?PZM?[B"N7[?T11J\4CV M\]),\C>'(:JV.O%%4:E&1USIL&E-,*J6OH*Q*19*EJ:C MJ/+43?;HT@14`!L647/X'O:0!6#&12%S0'.,]>+F@&DBORZP0[EKWJ5%05EI M9'99:9(HP6BDU*41PGDU!3QSS^?>ENI-0U97TZ\8ETU`H>I;;70UOA&4H$0S MA1`\_P#EJH[`B-H"!>8*?IQ?Z^]FU&O2)5I7US^SUZUXO;70>'Y=1JG<5=!4 MM#1D4]+3%88:>2&-G5(+1@2,ZF74^GD$W%[?X^]-DJ;QM(24/Y!^G'O;PASK$BJ&%:$^ MO55)D7%T#^*&B18G,D,3FHF),DL_[J,5CD9[K;@KS[\\S MQ,(HS15%.'$^O7E0,-3"I/66>@&:AIFI:&6-IZE?O*BL M14F@E4EHXHH&92K(N@DFPY/^P]^9FME5$;N.2?+\NM`"1BS#`\NO!)-QT7GJ M:FGIJJAE$+5-2P@IYX)U+I'J52BS0O&;`*+JW//)T`;E-3,`ZFE3@$'_`"]; M_LVHHJI].NRC;91&0RC'IUW3XX8:&IRHK*.NEI8_'3I M12_<+!/4GPK/4^D*JH&.D$;6K,!BFO%@Y"$$#Y]<*'*UN M:F.+R$GF@KD:)#'!$K03*/+#.!$B%DC>/U"X&FY/`]Z29YF\&0U5OY'CUME" M=ZX(ZYT6"BI9C62U^/KHJ**2K:EHJ@33R&!"Z#1I],8DMJ)^@_V_O:0!&UM( MK!H`K50MZ8C`0+SVXM<"_NQM M!XFGQ%I7A7/_`!?6A+VUT'_)U'GW-D8JEXZ8B"DA<1Q4SPQEEAC`C5)&93(& M95]7-U)L/H/=6NI`Q"X0&E*#R]>MB)2*L,GK/68&*IG6KAKJ"BCKT2J2EKIQ M!/$9T\I!0@GQE@=)_H?\+FSVX9M:R*H;-"Q MABHD6.1I8(S)43O^Y+46D5M*.7](_P!3S]"/>GE>$^%'@*/VGUSUY45QK85K MURGHESL%-E&JJ2@GE5H*D5DO@CGGIM">>G]+:E9&4,``%(M_C[VT?CA92ZJ3 M@UQ6GF.O`Z"5H3]GSZXU%74;=@IJ*BFB>:8-65%9&J30S!V,44=.TB$&-!%< ML`+M_L?>F9K=4CC(J1$U`:5FB9;6`^A!/)XW0W*:F8!U/$X!K_EZ]_9M@5!\AQZZ,;;H@JJRME\$=53%9Z6FB@$_4-LA96!=L5&0!_GZ]_ M:-1@0!Y=<::LJ-P0U-!73()(T-935C*L4-.8;+**@QA5$3I)8,1P3^>![TKM M&8V][5/`#2ZU9A@4SQ\SUIF+E4TD#Y]=4&5J\Q*V+KV\T5;&T2-%#& MKT\J_N1S6C5"Z(R7:YX'/^OJ.9YF\*0U5OY'UZVR*@UJ*$==TF"BI9352U]# M71TD;U34U#,9IY3"NI5T`"R:K:C_`$_V_O:0!6UM(K!+MR?=1=2:N[*'RZV8EIC!ZD#;,? MWGB.4H#'YV!@$Q-?XPWJB\.GBHT"VG\'WOZ4:POBK2O"N?V>O6O$)4G0>HTV MY<@E2RTY6"EC?1%2O%&2L4=E$;N4+@E1ZK'C\$>ZM=2!CIPGD*>75A&I& M%&:*O\SZ]>55<:F%:]=S4'\9BI\DU71T4LZF*=:R40K++3D1^6`\ZD9;7`'I M(_/OS)XP676%)%#4\2/,=>!T$II)`].NJJIFP,-/04*F M,4Y<.&A1$_4+7/\`3D>_,S6X5$.3DGC6OIUX`2$L1CKP1L_1^:>>&FJJ-_$] M34$0T\T,VIT2ZBRS1L/H!8@\^_?[D)J8@.II4\#_`+/7O@8``T/IUTT;8"B, M]//#4U-9*85J(+3TT,,(1W34RZ6EE+C@C@#WZG@)J5@78TJ,@4_R]>_M#0J0 M!Z]<8)ZC/0U%+5S1I)`%JH:MU6*&(*RQRI.R*JA)`XL?P1[TI-P&1VR,U_S] M>-(R"H^77.&B&'@J,BM335LL8$,'VDGFC@DG#+Y:@E1I"K>P(()//X]^">"K M2Z@S#`IFE>O%M1TT('SZQT.2JH\BW^O[VL(4ZC(I"YH/EUXL2*:34]1X\0Z:Z3U'ES]:DY6!A%3(P6.G:-"1'%955V M*F0%E7U<\7]Z-Q(&.G"^F.M^&*9X]9:K$I42_JG$<\?F&MA MI(Y4L3I/''O;0ZCJ5U`;-"MJH;N8<>NI50\_,Q@"HA%>)/']G7E&NI(ZZTMF*9999H8 M)Z>01O//:*&9)`[(NI182QZ?I;E3?WK^V6K$!@:5/`];^`@`&AZ\P?$4UX98 M9IZER!/"1-`D<(4E%8C296:3GC@>_9A7M8%F/$?+KV&.1PZXQ229:&6&HD19 M8`)XZAP$B1;A&25@H55:_!_U_?@3,&5B*C(/EUXT4BG7<=,,;%-6">GJ9$`B MA\#B5(9);J9)6L`/2+"XL3[\$\,-(&!/#!_P]>J20*&G7"GK9Z]C1U+ZEG1E M5PJJ8G2\JR$(%U*I3U#^GO2NTA\-S@]>(`R!UW!0+3.U2]12U(ID:;Q4\VMV M9-)6XTBR!CK7%#UBARD\DHCF/DAE.AXU10Q5QI.D@:BPO M]+\^]"5R0&R#UO3Y]9!B!Y]!JZ8KK-X@Y:H*J>5$=N9+?X_7WOP4A"$B#66(QI<(I`5&8J3]![J96!Q\/7J`C/'KG+C@\GD6IIX5E MTR"*9RDJ"0!K%3^`3Q[V8\U#`5SGKU3Y]?_1TI,=&1+(\H*TZPR?<:@;&,K8 M*!;ERY&G_$>UD8R2?AIGJI^7'J71_92/)'1K-'5O`ZP-.R$%]-R$*GTR,@(! M_P`?=DT$D("'(-*]:)/F<=0*&"I:LB$8:-Q)KU%`>G.K?%K5.DZ3RS*46> M2`JD32A5\A5#8_J!O_C[>?P=9U@EO.G"OGU4!J"E*=1,K%**QFMKBD"24S(I MT-3D6BT_6R@"UOZ_Z_MN93K/H1C[.O(77@22VGAU'R<8>*BDI%9J,PLD2Z26CD M5_WEDTEKR,Y!O^?=)0"(R@/AT_XNO7EK4@_%UG04T.,IADDF?=AH$2B6N2:4XTZUDL=/Y]=5:138R%L<)!315#BIB?U3> M9E_;DD*W#+H%EL+#Z?7WYZ&)3$.T'/K7K:UU$'B>N./C6.AK9*Y7%$S0HL8` M$LE4K*P-.6("LL=]1_(_UO>HP!'(9/[/_+UYOB`''K*HHYZ"M3&1SI.HBDF6 M=D>22E1SK$6CZ*KE2W]0/=J(8Y!$#J\Z^GRIUK(8%N'6'#1.LE3+."E#'2R_ M>:UXDC?TI$E]/[KR6T_D$>ZPC+LW]F!GK;^0\^IM"<;+)418U*F&ODIIEI7J M6C9=9%V2/0;I*\>H*Q^E_=X_")(B!$A!I7_5QZJ=5*L<=-6+IZQ\C3K"KQR+ M+J9W1@D<<8)E9P=-T$8((N+_`$^I'MJ)7\1-.&K_`,7U9B-)KTZP2[?.0C\< M-6CFI/BD=HS2*YD/CT M3)*U6:G1J4-=IS(+.'M^6]0/^Q^GM@K)XFFA\2O\^KU4J#^'I\KI,&M?(M9' M5S5*-&*J6E:)*:2H55$[*C,&_P`X#JM;F_/Y]OR&W#G6"6\Z<*]-KXA7MH!\ M^F[.05`R+N09(95CDHWB5O$:1D'@6.PL`B"W^N#[;G5O$8\0>'V>75TII'\^ MI]3_``Z"*AAS$59+7I21AQ3-''XXG9WIXIO)_NU(2!_@+?7VX_A*L:S`F0+Y M>GE7YTZJNHU*TTU\^HN8B9TQ\U(KMCI*0+1K8EHBC$5*3$7#3F:Y9OS_`+#W M29:B-D'Z6G'^7\^MH:%@WQ5ZE1BDI\-2#,I._EJ)Y*&*`JE1'3Z565F:0V$4 MLMB%L.1>Y'TN`JPIXX.3BG&G^;K7<7.BGSZXUT<$^'IVQ"S"DBJY!602E7J! M4.J^&:0H2&C\8(!``!X^OO4@4PJ80=`.1YU\J];4$.=5-5.L>,CAAQM?+E$E M-!)+3QQ1H-$TE8I+:ZJ]P===*>7V_P"KAU&P$,DJMK`4O337/31A*:J.5HR@,6B M7R222(RQK3HI:H+WT@H8`01<7O;VQ`K^*E!2A_EY]7DII-1Y=/5#-MDY2+[> M*MCE:H/V\LYB>B24EO"[1@B7Q![$`GCB]O;\9M?%72I!KBO#Y8ZHPET<12GY M])Z2BR2Y%X&CF:N-24UC7=IVDXD62P!#.=0;Z6Y]IRDOBE:'Q-7\^G`5T5'P MTZ462DV\F2D6NCK9ZM#$E9-1F%*22H2-%G98B0]C(#J`^IO;VHD-L)#X@8MY MTX5\^FU\32"I`7R^SIFST%1_%*IB/+'*5EII(D8Q-22(K4WCMJ&E80%_UP?; M-PK>*Q.0>'I3RZO'32`./G]O3Q7G$P)0PYB.LFR4=#"M0U&T4>A2NJGBJ/(? M5410,H8VYX]OR>"H19U)E"YI_('Y]4&LZBE-%<5Z@[@A:08ZHHU9\5)11I0J MJG]EHQ:HAE`+#[@2W+G\D_FWMN=2?"9/[(KCY>OY^O6XS@AOBKU(1:.GPM", MY'4R"6>HEQ\-.42HAIM*"5I#(WIBFF%U6U_R#8\6`C6"/Z@$DDT`XT_S5ZT= M1=M%.`KUAR4<$^)HY,1%.*&*JG6JAD]=0M8ZQF*:;QDAT:`:4(%EL1>Y]ZD" MM#&80?##&H\Z_/\`+K:U#D-353^77/%I%!AJ^3+K*2G M,A"1A(.&-K,#:]P`?1!5AD,P/A$B@\Z^H_+KSDZUT?%3K/IH:G#Y),%'4Q2H M]/+715)5ZF6B0M?PF,D>**4AG%OQS^/=OTV@E%N""*5!XD?+Y=5.H.I>E/+[ M>H&`A>-J^>J5EQL-#,,@K*1YEE&F"&(DJ!4//I*&XM;_`&[<"D&1G!$*:_/ MT'VUX=7D-=('Q$XZ<:#^$SBLI\'%6PY.6@G2F:L>)Q(!H:>*#QFZU$M.&"M8 M`7/T]N1^"VM8%82E32O\Z?.G5&UC27(T5_U?SZ:0J$->GJ@FVP-?&I9F@AJ2Y.J>*$J";7(M]?;\G@J(UG!,H7-*?D#\Z=-KK)8H1IKY]-N?B M\HQD]$KOC'HE2B14.J$Q,14Q3E;JU2)V)=OR6^I`O[;N!7PF0?I%=?G_DZ\M1(0WQ4Q]G76*CB@Q&0FRR MR?PV6>"."!`%J)*Z,EC)3-(P$>B$D.2+,#;\6/H@%AD,P/A$B@\Z^H_+KSU+ MJ$'?3^7SZS6Q]1ALG'@DJ8ID:GFK8JO0]1-11M8^$QD@1QS%2X_H.?Q[W^FT M,H@!!Q6O$C_B^O9$B^)3Y4]>H>`B,?\`$9JQ73&Q4$BURE"#*LI`IXHB;`5# M3@%#^-/UY]TMQ0RLX_2TY^?H/MKPZM)^'3\=<=.%!_":A*^#"QU<.3EHIEIS M6/%)Y%!#SQ4^@^FHDA5@"1P/R/;L?@L)%@#"4KBM/SI\^JMK&DO337IGP-/6 M'*TQB!@\3>2>65"(HZ=%/W'EU:1H:(E;7%R;7'MBW5S*A44IQ^SS_EU:0@(? MY=/%%/MDY2+[>&MAF-0RT\M28VHXYF8BG=H]8E\:R$:02+?GZ>WD-KXHTAJU MQ7A7RQU4B71W$<,_ZN'2>2CR7\46$+**[[TJ)+-Q4":_D\GZ0`_JO_3GVGT2 M^+I`/B:OY].:ET$GX:=*&NFVVN4D\\-;+*M0HJ):D$1&LX8RA16E/R!KY@=574=10C37_`(O^?3;G(O(: M">C1FQTE%$*,*A)B$999XI;7'G6H+%S^2WMJ<5\,H/TBN/\`*/MKU9/Q`_$# MGJ:11T^(QT>:2HDE=YYJ..G*QU$-(VFWF:7ZQ2R`L@M?^G%Q[O2-88Q."2:T MIQ`ZUW%SHX>?V]8 M2!GX14A-G-N1Q]1[U&%$3F4'PR13UK\NML26&D]W7-UHY\56KAHZE&CF@DK8 MJ@K)/)3+K5#&8_3XXYB"PM?Z'Z#WLZ&AD$(-016O$CK60ZZR*'A3UZPX2)HU MKYZM63')2.M6K*1YBY`IXH2U@M09K%3^+6XO[U`*>(S_`-E3/^3\^MR<5`^* MO4R@_ALZU<&(CJXZR3`KD)?-%522+,!/)"T:TSS+99F"$E]!>][7O^ M/:AS;^(=0)-(?YIE9#8Q))R1;@\^]D*8F\('!S7C3KP)U#6>L&+C*+62U*LM$E. MRS@@@R,Y`B2/5;]T.+@_C_8^ZQ"FLM_9TS_DZVV2!Y]9Z?[&9*N/'I41U;TS MB/SE'UH"'FCBTD6D>,'_`!_I]/=E\,JXC!UT\_Y_RZV=5032E>H6+CE^]C<_ MMQHKO.SJ="TX0B4,#8$,IL/\>?=(@=8]!Q^SSZ\QQU-I7Q9J@($GCG.M:>2= MD:!)61_&64>JVKZ?X^[IX.H!`=1X5X5ZT=5/*G34E/5?=B,+()_-:Y#7$@;E MF8@VTGDG_8^V@KZJ4[J]6Q2OETXSR8O[MO+'.SB4>1XR@A:0$>0A+EM!:Y/) M/MTF$.:@UK^751J(Z@5T4ZUDVL%RSEE902KHXO&4X/I*$6_I[;D#:VKQKU89 M'7__TM*VFJZK),]#4/K6>-_&RQQH8I4'D1SXT74EUL0?P?:]7>0^&QJ#TV0% M%0.LL&+>B9JR5X)EI4\ZQP2EW9T(":K*MHT8ZF(_`_Q][6(I61B"%SCKQ:M` M//K#!EJR698JAC-#,QBDB6.,,RR>@A&C57UKJXYY/Y]U69R0&-5/'KQ4`5'' MJ2NWY/N=+3P&$2-J"2?Y08U))`320)"H_P!8'W86S:J%AIK^?6O$QPZCOG*] M9CXWT0*]DIVCC;3$C6",S(7OI')O?W7ZB0'!HOICK>@$'UZE38*265JZ&9J* MCD:&"D`@4/%$[NR7US,98V-Y'-Q:PTV]Z>5XV\-#15QUY4##4>)ZRRXZ3+1P M9&.2""2H4B=*F1HE>:+]MI(?2UT<+R!^D^]F)I@L@8`GC7U^77@P4E:=<:FH MJ\&L%%2R:':/[FHF"I(DSR\*(3*A'CC2,"X`U&]_\-,SVX6-30\3]O6P!(2Q M'63[6?/4D=8TD4=5`YI9I9V$,,ZG]V,J530)4U$$#Z@W][TM<*'KW@TS@'K5 M=#4ICKT@J-O4D?AD5JNMD9FJ(M,U.L,%U$2&12KR$O=CIX^@_K[\==L@H1K8 M\>(H/+KPI(QJ,#KE3R56XJ>HI:F4&HIE6JIZAPL4*J76*6&X9!X?MZV0(R"!@]=K05.!IY\CY8):@&.FIVIW$Z0M,2SRRAE M5;A(R%!!&H\CWOPVMU:2H+952CJ.LM+A)<:9U@:.LKD$**T'KUHOJHHK4]1Z7<.1J M*B.GK)#4TM2WV\T$<$*.R3`QGQM&@D\BZO3SR?=$N)&8!S5#BGV];:-0*K@C MJ3'M29:L+)54CP),Q:.*=FJWAC+,56+Q_P">95M:_!]N"S;5EET5_.G6O&QA M37J*=U985!D214IQ+J%-X82HBU\1&4Q&8W7@F]_;9NY=5=7;7ACK?A)3(SZ] M3:C:LL]0)::HI(::IT31PU4SI4PK.HD\@W:,O8<\V]N-:,S$HP"G.3G/5 M1**4*GK#7YROQE0^-Q\K4U+0VI522&&225HKB2=VGCD;]V0D@"P"D6'NLDTD M3&.,T5<A[M!)4"0&A)P#UK4(2 M5IVGAUU,M7M6AC^WG1J[(RNSU,.F>FCIZ8A5AC,L?C>5WENQT^D]CQ&10>77@1,U2O:.NJ=ZW=-+4TM5.AJJ(QU5/4RJL$`CD(BF@G,*!!<69 M#I+$J1]/?E,EVC*[#6N0>`]"#UL@1$$#!QUECH*C;-'4Y(RP3UDC1T5(]+(9 MX:?RZGFFG5T5"VA+(""+FY!]^\-K5&E)!/7#'9.NW" M\N(R$IF6LB?P2K##%]M44X,\>.WA,@"Q::>.0AW-S8+]+7] M[2V:'5,Y!TBM`:FOE7Y=>,H>.MM&BJ649'4N#9DRU8^XK*.6E MCD=Y8Z>5VK)8H@SF-(/&+2R*NFVKBYY-O=ULF#@,ZE!Z')`_+CUHSC3A2#U" M;>.8^Z,B2JE.)M24AAIV41!N(6E,1F-U%BVJ_P"1;VV;R?42#1:\*#AZ>O5A M"E/GU.JMHRU%7YJ2II*>EJS%-%!6SNE9"*A5D:)XA&Q9T9R%]5S87-[^W&LF M=M2,`IS0G(K\J=4$P44()(ZC9'<&3QE7+C9VF MB=[RNI8`6`6UA[K)<2Q.8HFHBX&!Y=66-'`=AD]2JK;\^;%-F*>:EI?XA`LU M1#6S/"14H[1S/`/'*33RE=2W^@;^E@+M;-0R-=MH4V'Q\OB,4"U%74&*.9:JIJD5W>'SQR#[:$`*I4"Y!O<@^ZRR M26NF")J4%2>-2?2OEY#K:JLM78=G6&F)BBIX3/$8Y'U2%I&T@BZCD<^],)+-%56&MS4D9& M/+/V];73,26&!Y?;UW3M5[MHJB&KEC%;CI!/3UDRK!3>&I*1RTU088Q&C7C# M(=)9K$<"_O:^)>QLKM^HF03@4/D?\G7FI"P*CM/7-,?4[6HJC)^:GGK9GCH* M26E8SP4JR@S2S3!D56D*Q@*I!`)!L?>_">SC>6H,A-!3('J3UHLLS!:'2,Y_ MU?MZQ4&5R.X_/ALA-YQ5P2/32^*.%::JI5,\;RF");T[A2KZ@UK@CW6.66ZU M6\C5J*@X%",^7EY=>9$BI(HX'K)2X&?!>?,5$M)6?P^!I((*.=Y6:J=E@A>4 M".,BGB:4L_-R%M]"?=DMWM]4[,ITBHH:YX"OR'GUXRB2B`$5]>L&/W)DZ^KC MH,C,U71Y`FBFB2&"*0+5CQ>2.2&%'UQM(#^01?CW2*ZED81S-JC;!``\_2@Z MVT2A25P1GJ33[*G2N'W-91S4T,KO)%332-6S1PZF$:P>,:990EB-1TW_`#;E MQ;!P_>ZE!QHO6C.-.`0W4$[TS)JS(DP6F\^I:,PTY`AUW$#3>'S'T"Q M:^K\^VOKKC5J#=M>%!P].%>K>"A`%.[UZG5.S9Y:PO3U='#2SR1R10U4SI60 MQSA91%)%XVO(FL@>J[6YY/MQK%V?L=0ASDY%>JK.`,@U'IU&R&Y,G05DF/QT MK4='CV6C@BD@@EE(I5\!DE>>%W+R,I/]`.+>Z2W,T;F.(TC7`%!7&,UZVL2, MNIA5CU)JL!-G5IV> MX"SH0-0R":9X5'R/6A($K&0<>GI\_GUAR&0K]L"EQ&/G,)C@6IK)_%'*E74U M0#EJ=JB.0&FA50BE0MR&N+^]2/):4@C:AI4G!J3Z5\NMJ%EJ[#_8IUD./JMU M4%-DWJ((JVGDEH*B2K;[>&I1/WX9(O'&R+(@F*LH`!M?C\^\*2\C274!(#0U MP#Y@CK6H0L5IVG/7J@UFT:"&&EF3[[(NTU161!9Z80TUTBIH#-&4=KRZG;2" M.!R+'WYM=DBJC?J/DD9%!Y#K8TS$DKVCKC3/6;MHJBGJY4^\Q[K4T]9*%@IA M#,4BFIJ@P1+&A;2'C.DL2#R!?WY/$O4=&;]1,@\!G!!_R=:.B!@0,'KDF-J= MKT53E#/!-6R/'0TCTDGG@I/->2:>?7&JEM$6E000"WT-^/>$]G&\U07.!3(' MK7KVL3,%ICK'C\A7;E^XQ&0F,WFA:>EF$,42TM52JTB/,8(T'V\JG0Q-R"1; MGWJ.26ZU02-6HJ.&"/7Y=;94BHZCS_E_GZRTF!GP0J&BF>8 MFI=A'%)./'&5@B+%FL1<#W9;=K?5.Y!TBH`-<\,_(<3UHR+)2,`BOKU%Q^X\ ME7U<=!D)6JJ2O)HIHHX8(I`M7^T)(WAB1]49<&W((!'^M2.YFD=8Y6U(V"*# MS^STZLT2*"RBA&>I,&S)DK1]Q5T]^?;7ULVNNKLKPH.'IPKU;P4T\,]3:C9LSUA^WK*2*EE=&CCJIF2M MBCF"N(Y(#&294U6L6&JWX)]N-8L7[74(3BIS3JHG`&02W4:OW)DJ"JEH,=,U M+1T)%'%#)!3R2$4W[)EE>:*1]5%DJ[#CUD>@J-S45/D_-3P5D32 M4-5)4N8(*KQVDBFAT1NBN%D(=0`+B_'O9C>Z19:@.,&N`:>G^7KVH1,4`QQZ MXU!J]JT5/#2RI]Y7O)43U<06>G\,!\<4$!EC,;L#(2YTAA<#Z6/O3>)9HJJ? MU&R3Y4'D*]>%)221@=<(7K-U4<\%5-']W02)/!5S!*>G\,["*6">9Y-<81I'\0"@C@7/\`3W[0]JC2:@7.!3-/,];JLI"TQQZXT-?6;C^X MQ5?+Y6EA:>FG$44:TT].K%6F,"1CP2*Q5M0-B1;GWI'>YU0R&N*@^A'K3RZ\ MRK'1U&.N=+@Y<.)\K/+25?V,1E@AI)FE8U+,L<,DP"(13PL^IK'D#^E_>U@: M$-,Q!TC%,Y_S=>+AZ(`17UZCT6X,E7U*4-=,:BEK2:.6-(8(Y?\`*?V@\;11 M(Q>-F!L38V^GNL=Q([B.1JHV/+SZVT:J"RC(ZRT^UY8*H25-123P4[/+)#33 MLU5,L"M(8HXM"DM)HL1J!%_K[LMHRL"S`H/0YQUKQ01@&IZBC=>6^XUM*C4_ ME+&F\,*J8]9_9$HC,WZ#:^K5[;%U+J!)[:\*#AZ=;\%*?#GJ7/M29ZNT%32Q M4\KH\<=3,R5<22V<(\)1F:5+Z;7Y(YM[NUHQ8Z6&@^IS3K0FQD'5U%K,Y7T5 M3)14,C4U+2$4T44D,,DEH/VR\C2QNVIRI/UL+V]UDGD1F1&HJX_9UM8T(U,* MD]9:C"S9,0Y**:FI_O85FEAJ96A99[LDAB5E8&"1UU+S]&_I[L8'FI*I`U"N M?7SZT'"52A-.N%;7UF$:+&44OB%/$C3R&..7[B>9?*\D9E1@(%U`):U[$\^Z MN[P4B0T`&?F3UL*K]Q'7)J*;/TD%?Y(8*J)FI*EZEO##4:/W(I(BJLNL*]G` M`%^>+^]Z&N$634`XP:X!Z]41DK3'7"H^ZVY301P2K]S6L\TU1$$F@\J MJ)!31RT[>:"!%T2R%RRA#*^FR@@_2_OQ1K="]1K.!3RZ]7Q#2F!UCI:NKS(F MH*N3R%HVE@FT1QB&:%;CRF)%'A=38D@V-K<^_*[SAHW-?,?*G6R`G<.O18R; M&+/7R2T\[4L1,24\OEM++:)'E`"GQ)K)//)%O?A$T0,I()'"GKUXL&HN>L=) ME*RNF6BJY'F@J@8&6..)'5G_`$2*8HT;T-R;W&F]_>DE>1A&YJIQP'7BH05` MR.LL.!DAF\LTL$D4`>5XJ>0O/*(0SZ$0+PSE>>>![\MNP-6(*CT.>O:ZC`R> MHG\>R!F#O(#%K&J'QQ6T7_0)-`?@&P:]_P#7]Z%Q)6M>VO"@ZWH`'#/4B3`2 MFH/CFITBD<,B22$3I%)8A6C*@F15;Z?FWO9MF+=K`+_/K6O&1U'J,K60S/!! M(88(#X8XFCC=@L5H_69$9BY"\_T/NK3.I*J:*,?LZV%!!KY]?__3TM8WH98: MN/&4\L-8:9B&DD+EX496GCBNYL[1@_CD`CV8`QE7$2D/3_B^FCJJ"QQU!Q`E M^]5E(6-$=JIG!,:TJK>;7^"K<`?[41[;@KX@(X>?V>?6VI3ISHY\.:I124TD M%2WE%++.Y>%)V4B+6K2-:[$`?T/MY&A+`*A#>1/"OEU4AP,FHZ9(XZTUJQH) M/O?N+<_K%0'Y+$G\.+DGVG`?6!GQ*_SZN:!3Z4Z?IJC!+7-YJ6229:@>>>.0 MBF:4./+(L;2W,7D!-KW`8UCC\923FE/3Y]:.K4V@_;]O6'+, MLE#CYL>C18M?+$D1)9X:P.S2_<$,X:26,AE-_P!-_I[I-1DC,8_2SCT/S_R= M>3#'5\76?'O3P8>1LO$T]%)5)]A`A*3&=%;[B6)KJ5B"6#?@D_U]VC*K"?&% M8RV!YU\S]G7G)+#0:&F>N=2]'/AZC^#1/31QU,3Y&&1M<\D)L*>0.&-/+\J]>`8.-9KZ=0\(4CBR,U:C/BUI@M7%8J9IFD M'VB0D:2)PX)!_LJ#>W'ND%`)2X_1IGYGR_/KHO4B46((=;`?7U$'\>V+8'Q01A0,_9Y]7DI MI^?E]O3WCJK;TE:B4%%-2UT@E2BJ*J0RP1U3QNM.7C,K_60@+P;,1_K^WXGM MBX$<960\"3BOEY]4824JS57SITEZ6*O;)Q1Q"1:[[P!=0.I*A)?4S_7_`#;` MEB>+`W]I4#^*H4'Q*_SZ=8KI-3V]*J2MVG_$]34,Q;[L,]4KG[0OY+O/X/,; MP,UVM;D?CVK,EGXM3&2=7'R^WCPZ9"S:?BICI-9E*Y-A`@(#XBB6Y,ZDQENT>=? M,CY>O6GU%QH-&`SUZMEH*G!S_P`!IY*6"*MA;*0R,[SR(R%:.1G,DFJF$P(T MWX<@V%[G;F-K=O`4A0PU`\?D?LKUY=2R#Q#4TQUAVZR0TV6FR"^3#_;1QU4! M7UU%4SWI(Z1;PC'*EZI9E'ZED0:0+'UD? MTX8M0WC`CX0.[TT^?^KUZO+333S\OMZ?\=5;;DJQ'B:"HH\I)'41X^HJI6E@ M2K>"58"R/42`%G8!25(#$U+@0QE9B#I).*TQY]-L)0.]AH'''ETE, M=%DFR]/%3>5,B*HA6>X:.96;RM,6N=**&,E[W6][^T<2R&9`G]KJ_G\_\O3S M:1&2?AITKY:_9HR[&3'S,XK/W*M9&^S:026:<0>=@U/K]5M)NOXMQ[6M)8^/ M4Q$]W$<./&E>'3(6?3A\4X>?25S460&9K%J]4E6U02'C4E9`X!IS"`6;QF(K MH%R0+`\^TEP)/'D#Y>O_`!5/E3AT['I\-2HQ3I3Y&JV]%4)%FJ"IK,M'34B9 M"HIIC'&U4M.BNK6J(TDEC6RLP%B0?:N5K96"W$3-,`-1!H*_M_;TTHDI6-AX M9..F/=`F;(QR@AJ&:DI7Q?C6T2X_QVBCC0EBC1M<.#SKN>`1[3W@/BAO]#*C M3_I?(?ETY#332G<#G[?]GIZ>;%4V+Q$6Y:6>MK33/)3+`[1S4^/=A]JE2_GB M#:K'0.="\6!O=]FA2&!;I"TE,4P0OE7_``CINCEW,1HOG]O3?N%H9\?B)L2A MBPH6HB6G-S+3Y`2%IUJFU.6EDA9&0EN1>W'U;NBK16YB%(*''HUX3$ML?J5)C+]H''AD_9P_/K3ZFD_2(#4S_D_/KGD9*.IV_(VWH9:6CAKP M'L;?GWN4QO:GZ9"(PW<#D_(_97^?7E#++^ MJ>ZF/\OY]1]MLD-)EY\BGDPGVZ15,!!U5-:S@TT=*0T9%0H4L2#95L6_!%;2 MBQW#2C_%J9'J2<4^8_EUZ7B@3^T\OL\Z].$=1AJC&YJ+;]+-15QHM@21&K8J=S/+I/B%V7ZLO^M=75:W:&=;6,K+I\_,>=/]7#JM)`Z&1@4K_/RK MTS;4\B9)IG*I0Q4E5)DS(A:)L?XR)HW0'U^20H%`!]1'!`M[3V>)JFGA!3J] M--/\OE\^G)OAH/BKC[>E!BJO;DE4\>&H9Z'+24]2F.J:V4RQ)5O"PB%GJ)4C MD<\*2+7-N?H54#VK/I@C*SD'22:BM/\`#Z'UZ:=90*NP*>=!TD<9#DVS%-%2 M^6/(BK*@R`ADE5CYC/?U%4`8R@WNMP1[0PK*;B,)_;:OV'Y_Y>GWTA"2.VG2 MNDR&ROXL[/CYG?[V[U?D)HFD$WKJ/#]P5-,7NUM)!7^SS;VN,FW^/F(_%QKC MCQIZ?Y.F-,X2FLM-6P+(&O([.#"T/);0RE3&!]% MM;VAF603R!\RZO\`BJ?Y.GTTZ%I\-.E?E:O;D=6L68H9Z[+1P4Z9*HHY3%`] M4D*B5;)/`CNC6!(4#@C@BWM=.]JKA9XBTX`U$&@K3/Y^O3""4CL8!/*OITP[ MK\KY&*9"KX^>CIFQ!C0K$M"(P(XD7^PT4@(<&Q#G9IL738S$1[EI*BLJVIWEI%A=HIJ?&NX^UCJ6\\1?658Q MCG0G%@;^WB84AMUND+24-*8(6N*_SI\NFZ.9',+`+7-?7SZ;MPM'-18F;%QO M#A1'-%#`;LT%<)G:H6H;5(3+(A5D);U)>P^OMJYHT<#1"EO0T'HWG7Y\/RZO M$""X?^T_R>74K'2T=-MX'/P255%-7WQ--&Q2I5HXV%;/&_EBM2ZV52+V\E^+ M\^W(C&MK_C*DQENT#C\S]G^7JKAS+^F0&`S_`)/SZ[R$M'4[?F.WH)*6DAKD M;+T\K%ZEA(J"BG:0R2WI?*I&G5P]C8?4^D,;VI^F0A`W<#D_(_9_EZ\H82TE M-21CT^?Y\.HFW"L5)EY\BK/A?MXXJN&Q!J*IIE-''3G4A%0INUP?2HY_!#=K MVI.T@K;::$>I\J?/JTM24"FCUQ_EKTXQSXJIQV8BVY23TE:*1)*@5$ADEGQZ M2C[N.F;SR:2NI2XXUJ+"YM[=!A:&=;6,K)IJ:\2HX@?Y?EU2CAXS*P*U_GY5 MZ9]JB9U4!SCRZ2.,AR39BGBI?(F16K`! M<,6CF5CYFFN"VA`&+WO=0;^T42RF9`G]M7^?G7_+T^VD(=0[:=*Z.OV?_&+C M'SB7[[TUAE;[(2^?BI\)J0!!Y?58BP'X`X]K?$L?'_LC75QKBM>-*\//IC3/ MH^(4IP\^DADHT4JR"=P_\` M:ZOY_P"KAT^A70"/@ITKLI5;"&OP+V]I[ROBZO]#(&FGI_JX].14TTID$UZ'PNTS,8VH*_SZA;B9)J7$S8Y3'AO`\5/`-6JGJED8U25)+27G?@AK^H?2 M_)-+JC)"T8_0I@>A\Z_/JT507U_'_DZDX^2CIL"ASL#U-)-6,V+IXRR5(T*P MJYT?RQ:*;6P%K\N2;?GWN,HML/J%)0MV@HV!:&&BRLV21Y<48X(G@'IDFKC*#3+3MJ33+'&'8D$67Z^Z MV^E4F,H_1H,>I\J?/K;@EET_%_DZ<$FQE1C,K%M^FFI*L0(]2)W,DT^/1O\` M*8Z=C+(%T7!<<:E_!-K.`Q-%,+9"KTS7B1YTR?SZUWAE,C`K_EZ:-LB5:]I2 MP2BBIIVR9E4M":'01+&Z@C6TC:0HY.KFQ`/MFUKXI;\`!U?9U>7X:?BJ*?;T M\XZIP$E0T>)HIZ3)2P5*4,]5*9(EJ6B81J+SL%DDO920;$^WHGMBU(8RLI!T MDGSI]O3;"0"KL"H]!TF<3'6G*T:4VJ.J%2H#,I&C23YFE'I)C6,,7'Y4$>TL M(?QD"_'7_B^G6*A37ATIDKMI?Q0,M!,K?=DI5-)_D@?R'3.8?.-,&NS6MPOX M_'M4)+/Q01&?BX^7[*\.FM,VFFKRZ3&1BKURE3'4ZWK34D,8[WDD=E,31<#T M.K*8P!^FUO:219!*X?\`M*_\5T\I73CATI,C4X.*I\>5HIZO)1P4Z5T]--XX MGJ%B0.MEG74Z6TL0!Z@?I[52-`'I,A:6@J1PKTRHDH=!`7R^SICW`)#D/("# M2R0POC]`*QBA*#P)&.-/C-U8<6<'VQ<5,E:=E!I^SIQ,+GXO/[>G:>7&4]%C M(LW32U5<*74G@?QO!1NVJEBG(D4%_&;@6NJD?[%YFC5(A<*6DIY>0\J]4`-LQ!)44TU6YQT4;&.5?'&162HVI`L#2%5(_+@F MWY][0JL(\924)[0./S_+_+UXU+G1@@9ZQUS4\V*1\3#)!1Q5;BMAD;7+Y9$0 M4TLC!GO"P5@OT`?_`%Q[](4:$&$$1ALCS^7Y=>6HH69_)++1J3YUA8.^C2;%AP2O\`7W:L;1R"!2&IFOF/.G^7 MK5&#+K-1_EZ:$'%1+(_%'%33M7ZENAIBA4H02+O)(0%_.JQ_'MJ'#DGX*&O MV=7?A0<>G.CFQ8R3R)3J7TB((I M]5AJYX][6V*M5V!49('''RZ]X@(``-3U&CW-D?NA([JU.927I1%`08F;U1AS M%Y+B,V!O>_NOU4NH,3VUX=;,:Z<<>IDFUWDK/V:NC2EED1HXY)RM6D,I5@AA M,=_*JO8`_4CW M50]68<>LDE#+N2EI.=X=#QS0Z4*DF.4!@``#]/>RC7* M+)J`<8-<5IU[4(R5H:=>JJBIVS24M#131_=5&JLJJN)%FA=68Q0Q0--&59%$ M9+&WZOI[\S-;*D:'O.2>(^5.O`+*2Q&.N<:S[KQS>>:&+(8R9?\`*I[04\U- M4WLDC1Q^-)$=/3P+C^I)/OP#74? MGFKZV44E/44Q$]/30IIFF+-(GC:60@`*0;6N/H??M)M(V>H,C&@(R`//\^O5 M\5@M"%&>N%#6UFY(:O%5TR/+XOO*.H>..&."6F-G$IAC0"*2.1@68'2?H"3[ M]&[W(>&1L\0?0CUIY4ZVP6(AEX<#UFI<2^W8:O+SST=9-2Q>.DCHY&G6.IJ= M4*35!T($1`QL#PUR+@VO9(3;AYV920,4-/6+&9VNRE2,5E M9#4TN14TA"01*\4TEC!.OAB4DQR`$WN!];<>ZQ3O*_@RFJ,*:-4%4' M<.LU'M1J6J^YK:NAJ:6B$M5-!23-+52+3J9`@B,:7U,@U<_2_NT=F4;5(ZE% MR0#4FGRZT9JC2JD$^O4.'>&5:L1IY%DHWG/EI%@AL:>1K-$CB-9B50V4EKDC MF_T]T%[-K!8U2N10<.K>"FD4%#_EZG-LJ0Y#QKD*!:4U`"HT[?>K3LX(7Q-& M5,XC-A<\GG_#VZ;!O%TB1=%?7-/L]>J?4#3$K3\NHE;NS)P5LD./D%-0TSK M!34SP1.1%`!&!(TL1G#/IN06NM[?CVV]Y*LA$1I�"GD/Y]76)2M6RQZFU^ MVVRTL>5HJFAI(LG`E8U-73R121S2W,WC'A9FB:2Y#<`W-A:WMR2T,Q$T;JH< M5H30U/'\NJ+,$&A@20:8ZPY3+UVWI8L+C)S%%0P1K/(T$+FHJIQ]S-*OFC)J!1G`R3DG/EU9$60:V&3_`(.'66?%2[GI*+,1STE+ M5NCTE>:QS3QU$]*%5)X2L;*Q>,C4%`4$6`^ONY@:[1)PP#\#4TJ1YC\NJZQ" MQCH2O$4SQZZK*FJVC146/H98_O:H&OK:Q8TFAD5BT,$-.TR:3&@C))M>_(^I M'O4C/91QPQM^HW<3Q'H`.O*%F+,P[1@#KN(3[QQC"HF@BR>+G4_=S@4]/-2U M>K]J1HD*+*DD/IL!Q^+W/O:AKZ(ZF`F0\3@$'R]*XZV=,#X!TG_)_P`7UX4U M1M#&RU45135&1R$ZTD-12'[BGIJ>$">:[21B-IIFTC2R\*+@W'OQ5[&(N&!D MN\=6U6ZZ>MQ.1F5ZE8EKZ"K:)(HZ>6G.B5*@T M\:#Q21S6U$'3S]38>]1.]ZLL$K=X&I3@`4]:>1Z\RK"0ZC'`_P"QUDHL*^V8 M:S.U%11ULU)"(J*.BE>=$J:HM`LU23$@1$#'@_JN?S:]TMFM%>Y=E8J,`&N3 MBI^76C()2L8!`/&N,=1\5N/(9>J&(RTIJJ3)HU$=-/`DD,TI`@J%\$49;QR@ M7OP`;_CW2&ZEG?Z>=JQR8X#!/`X'5GB6,!T%&7/^?K/C]IR8ZJ_B-;5X^JI< M:LE?+3T50TU3)]HC3(JQF)./(HU7-K7O[M'8F)_%ED0HE6(!J305X=5:<.-* MJ0QQGY]0Z;>N6:N1JQUFH))F6HHUIX+?;R75XXW6(3MXT;TW:Y(%S]?=$W"? MQ`9&K&3D4'`]7-O'I[10^O4^384QR?B3(T"TC5(*QO.W\0%,SAM/@:'2TZQF MPY`)YX'MT[83+I$J>'J]G5E@0@ M%P"QX]2\AM:3+5"Y:CJ\?1P92&'("FKZEX)HY*A%DF4`0MK0RL2K7%P>!87- MY;-IV\>.1%20:J$T(KQ_*O#JJS!!X;*21C'6++9ZOP-1'A,3*::GQD,=/*ST MT+/4U+7FGJ"*F*1D21Y?2!Z2.0;$6U/U2MD*ZL2..>&0.6AIX:5IXV5HT6)BQT\MR+7(]UE=]O2*&)AXC=S,,@UP` M*]>55G9G<=HP!_//7<<-7O3%B2>IIHLEBJGQ/55-J:EJ*2K&M$9HH=`J(I8S M8*H&D\\F_ORK)N,.MG431FE3@$'_`"BG[.MG3;O0*=##RSP_XOKMXI]EXIIH M9J>?*Y2H:"*KI;5%+34E-H=T#RQ!&GED>Q4K]!NL=75>[Z2NP^2F0U447\1Q]88DAC@>GM'+'4FG M1$6"1)K:BITW)Y-A[K%))?I+;S,-8&I3@`4XUH.!'6W58"KH,<"/M].N5+@Y M=L4V0SDU515E324XAH%H)&J5AJJQOMA45!:-$5(DZ07,MT_TMPY*.*)(AXL:T*_\` M%'J1C=I-C*ELGD*R@JZ;%Q29!Z:@J'FJ)FI%\D:Z3$@2/78L2;?@\&XO%8F% MC/+(C1Q@M134FF1Y>O'K33AP$12&-!4C`KQZ;Z7>^7>OC-=(D]!+,RU%$E-` M+P371HX76(3EHU?TW:[$`,3<^VTW*X,@\5M41.10<#_/JQMHPO8*/3''CU/; M8,O\3\:Y''I1-566-JAA7K3,X(7PM#;[@)^+VO\`[;VZ=J8S:!.GAZO7NI7T M]?\`+U472Z0=#:J>F/V]0:S>F7BKY5HI%IZ"";QTU(]-!Z:>G81HDC21-4*S MHGJ&JX)L+>V9-PN!(PB;3$#0"@X#`XBO#CU9;>,KWK5R,GJ=D]I-DZMGBP6'F^WIL7#'!*\E-$[U-5(HGGJ+5"2,D;O(= M('!^H)!%JW%U):O]+;M1(Q0U`R>).?+TZW'&LH\1QDG]@\NLE5BI=VTU#FHI MZ*BJWB>CR'WLK4T=144>A%JJN%=6UVT*.AQ./GB%5.CY*OK(TBGIY?,_@IXJ M8SHRM&B0'4;7+?2W(]UDDDL$B@B8:SW,1D&N`!4&12`%4"QYN6XV%;<8=3,HGC M-*G`(.?VUZ]5;=Z`'0?+YC_)UYH)]EXJ2IBGIZC*Y.?[:&JI+3TE+2T^B24! MI(A&\\LAL5(^G(_2?>RC;="75U,TAH",@`<>/F<=>J+AP"IT#UQ4_P":G7'' MY"KW;2UV'R4T;5"1#(8^L>.."."2F81S)4M`B(L$D4I&HKZ;GZG3[K%))?I) M;S,-8&I2<`$<:T\B.MNJP,'08X$?YNN5)AY=JT]=FYJBAK:F&%:;'K0RO4K! M4UA>+[FI(B41I'&#:_I8FW!M[VL#6*27+,K.!1=)K0GS/#RKUHN)RL8!"\34 M>0ZQ8?.UV?GDP>8F-1392%Z>-XZ>%)*:I3]ZGJ`*>&,NJ/%Z@WI_)X!O6"YD MNG-M<-5'%.`P>(..MO&D0\1!0CK-CMIMC:DY.OJZ"IIL9'+7O34$[SU$KTJ^ M5%TM'$%0.H)/^%CP;BT5@86\::1&C0%J*:DT_+]O6GG#@*@(8FF1Z]0:7>V6 M:O0UKK-02S%9Z-*>"WV\VI&CCD6%9F9%?TW8EKT4;_+U-78DHR6AJ^@-%]T;Q+.YKC2B34(_#X?^!!BX(OP?;HVP^+0S M)X>KU[J>E*<>J_4C0.TZJ>F.H55O7++7.:-T@H(Y0L%&]-3\00L$$;LT9F5F M5+MZKJ20.`/;3[A.)#X9I$#@4\AU98$*]WQ'C]O4W);3;)50R5!64%)3Y**& MN6FKYV@J(GJ@9)%TB)E9-9NI''-A]+ER2R\5O%B=51P&HQH17/[.JK,$&AU) M(Q@=8,MG*[`U"87$S-3TV-B2"5GIH7>IJ6O-/4?Y1%(R!WEX`X/U'!'NL]Q) M;.+:!J(@IP&3Q)SUM(UE!DD%2>LE5B)MST]#FHZBBI*B>%Z>N%9(T"35%&1# M]Q`5B=662,#4!Z4(M[VT#7BI]2N]BL<$3#73 M4QXUKPI7R^?7D59RTC#'`#_/US6&?>&+6::>&')XR;P2551_D]+44U3Y'16: M*(QI-$Z$``6M]>6X\%:_A#%@)D-*G`(/^7KU1`U-/8WD/7K@\%1L_&-/#44\ MV3R51X8ZFF(J::GI*72\@5I(@AGED8`@CZ"XY'OQ1[&$L&!F+U!K@#DD`'W6&> M2=OIYFJKXX#!\CCK;HL8\1!0C_!UEH-KR8ZE4 MR1KI\2602*-1_'^Q][CLS$QED=2J"M`:DTZ\TVL:54@G&>H5'NS)SUD45=** MBAJ)##4TR4$U05%XG6/QQ"8E`_I`:Y(L?;<=Y*S@2FL;&A%!P/\^K&%`ITB MC#AU,79,@R(C-?0M2+4&\:SDUQIU>Y40B+3YS&+6!(!]N?0-XFDR+HKZYI]G MKU7QQIKH-?Y5ZA5.[LFE8WVDBP4,4@2"D-/#<4$5521GC:8%U3U>KTWX^@] MM/>S:SH-(P<"GE_A_GU985TY'=U*KMM'(3C(4570TM/D(XZU*>MG:&>)JA?) M(-`B8-'Y"2I!L0>./;DEJ96\5'4*V:$Y%>JK+H&@@U&.'6')YNNQ%2,1C)C! M38Z..G):"%WGGX>>H/F24@2RR&P!TD6/T/NDL\D+>#&U%44X#)\SGJRHKC6P MR>LU7B7W##1YB&HHZ2:IB,=6M7(\"RU--IA::GM&X=)%47`X7Z?4GW9H3<*D MZL`2,UQD>8ZJ'\,E*$TZQUM75;9IJ/&4$JK/*AK:RI5(Y8Y6G/CB2G:9'5HD M2+]0'/'T-Q[U(S6JI$A[R*D\:U].MJ!*2SC'#KH1S[IH$EEFIX:^@F\,M14V M@@J*>I5Y(1KC01B>)XR-(4>GGZ^]`-=Q@E@)%/$X!!_R];-(F``.D]=2"HVK M0#P3025V1F(^Y@TU$$5/2A28U:1-+2O),-7'`_V'OS!K6/#`R.>(R`!U[$K9 M&!_EZZIJBHW-255%6RQBKI@*VDJW1(842Z13PS&%`JJP8%38F_\`L/?D+72- M&Y[QD'^6>M,%B8,HP<'KE#CGV]3U64DGI:JI55IJ/[1S/'#+4A@TTY**J:(@ M=(/#$V/OPB-LKRD@MP%,\?,]>+^(=-"!YUZP8_*UF9>3%5\OECK89$B<111F MGJ$`FBF/AC0L@:+U`W%O];W6.5YB89&J&'[",CAUMD5`&4<.N=)@VQDK9&JJ M**JCH8I*E8*2=II&ECL(=2"-2L:RD%C^+>[+!X9,CLI"BN#7[.O%RU%"D5]> MHM-N*OEJDBK7%123L89Z=8(5)CJ`T;:#%$)+H'X`//T]MI<.6`D-4."/MZV8 MU`JN#U)7:DHK2C5E&T"S-J192U4T2DL5$*IQ,4%K7X/NXM"'H7717US3K7BB MG`UIU#FW'7I5-]O((J6.6T,#10V6&,@(C,8_)ZD47]5Q?VVUS)J)4]GD*>76 M_#4#/'J158`SSFIIZFCA@J5CJ(X:J5HYT$ZK)H:/0QL"_!OR+>[M;ECJ1E"M ,FA-#GK0DI@@XZ__9 ` end GRAPHIC 6 g852944g12n39.jpg GRAPHIC begin 644 g852944g12n39.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1#N4&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!\<`5H``QLE1QP!6@`#&R5''`%:``,;)4<<`@```ESG,3A"24T$)0`` M````$#PD_<^XM2()RHK8&Q`5\?/P`````````IV96-T;W)$871A8F]O;`$````` M4&=0.$))30/S```` M```)```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4````` M`$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$` M6@````8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/__ M__________________________\#Z`````#_________________________ M____`^@`````_____________________________P/H`````/__________ M__________________\#Z```.$))300(```````0`````0```D````)````` M`#A"24T$'@``````!``````X0DE-!!H``````S4````&``````````````!6 M````1``````````!``````````````````````````$``````````````$0` M``!6``````````````````````$`````````````````````````$`````$` M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$ M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<` M``!6`````%)G:'1L;VYG````1`````9S;&EC97-6;$QS`````4]B:F,````! M```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`` M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`` M````````3&5F=&QO;F<``````````$)T;VUL;VYG````5@````!29VAT;&]N M9P```$0````#=7)L5$585`````$```````!N=6QL5$585`````$```````!- M'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO7U M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1 M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,' M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6 MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`._^L?U@Q>A8)R+C+SHQ MGHN^VOW-<0S$8P/=.]X9.UK=K:?H>M^?1_A/T/Z:W(Z-E9/27OPLBO8 MS?\`0=YE^W9/TO9ML0M+Z5TGJN/U.E]E!);6XLWF!NCV^I`^COVJ\N(P[*!8 MZ[I5YP+B`7UC6MT3`])\L?O"6M8\$D#GVSN5E)2DDDDE*22224__0]/R<:K)K M].R1&K7#1S3^\TK!MZ`^QG[-?4#C':VFUC6#[/76&PVMSOTK_M#]_J?\997_ M`*-=(DDIXGJ?U0S,/]/TUQR*A_@C_.#]V(_G/[/^8L_%ZOD4$4V@D-]FUW(U M]\;OSUZ,L[JG0\#J;9N9MN'T;FZ._M_Z1O\`60I-O&6],Z/UH66._57URRJL M-]\C_#,L]KF/]1WZ)4^IG4JNGY&0[J^'94V_9D#;:UKG/9M9D2Y_\` M@_\`"^HNA;]6>I=/RA=CQD,K@UZ\Q[8>QWO]W]M9WUQ^K-OUHQFY>%4QNY^W])O=[-_Z-(*>M^K_`-9.E_6'#^T]/LDM@74/TLK)[6,_ MZE[?8M5>0?5SH^5T7-UWXW7*2`:B20]KH]FVL^G?39/YCEZ?T?JU?4Z"[8:; MZSMNI=RUT=OWFHH=!))))3__T?54DDDE*22224I0L8'C^4-6F)@J:22GGOK- MT2WK&/4S#-=&958`W+?NWU,_PGI;/;SM_\@LCZTY-&-T#, MNL@D5.;6WONVF&-_L)*;?[?Z=^POV]O_`%+T?6G\Z(_FX_TN_P#1?\8DO-/M M%G_C4_3/],]';K]&/1V_^CDDE/\`_]+U5))))2DDDDE*220[KJZ*W6V$-8T2 M2=/RI*6R/FN2^M55^9@L+F.,2Y]@T:WD@:[OZCO^H_2?\`&KZH?5VZ M]PZWU<;[7^[%I=PUOTFV1_TF?]OH%+T'3L5]SFYN2TMT'V>EW+6_FOL;_I/W M/W/_`#WII)(H4DDDDI__U/54E\JI)*?JI0L]/;^EC;(^EQ,C9S_+7RPDDI]Y MZA1]4_\`G"RW.R1ZTZ4.:_9,_GN#/3W>M]/?9_H_^#78KY5224_522^54DE/ MU4DOE5))3__9.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%`` M:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`FMC.60B/SX\>#IX;7!M971A('AM;&YS.G@](F%D M;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U+C,M8S`Q M,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@("`@("`@("(^"B`@ M(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UP.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&UP.DUO M9&EF>41A=&4^,C`Q-2TP-"TR.%0Q-#HP,SHQ-BLP-3HS,#PO>&UP.DUO9&EF M>41A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$871E/C(P,34M,#0M,CA4 M,30Z,#,Z,38K,#4Z,S`\+WAM<#I-971A9&%T841A=&4^"B`@("`@(#PO7!E+U)E7!E+U)E7!E/2)297-O=7)C92(^"B`@("`@ M("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@ M(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B`@("`@ M("`@("`@("`@("`@(#QS=$5V=#IP87)A;65T97)S/F9R;VT@:6UA9V4O97!S M9B!T;R!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P/"]S=$5V=#IP M87)A;65T97)S/@H@("`@("`@("`@("`@("`\+W)D9CIL:3X*("`@("`@("`@ M("`@("`@/')D9CIL:2!R9&8Z<&%R7!E/2)297-O=7)C92(^"B`@("`@ M("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@ M(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B`@("`@ M("`@("`@("`@("`@(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I M;VXO=FYD+F%D;V)E+G!H;W1O7!E/2)297-O=7)C92(^"B`@("`@ M("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO&UP34TZ1&5R:79E9$9R;VT@&UP+F1I9#HR M,#4T-D8P0S%&0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO>&UP34TZ1&]C=6UE M;G1)1#X*("`@("`@("`@/'AM<$U-.DEN&UP+FEI9#HX1$4S M,D(X1#=%141%-#$Q.#`X,D-#0C4R-#4U13DW-#PO>&UP34TZ26YS=&%N8V5) M1#X*("`@("`@("`@/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YX;7`N9&ED M.C(P-30V1C!#,49#-T4T,3%"048P1C#IX;7!M M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP86-K M970@96YD/2)W(C\^_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_]L`0P$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!_\``$0@`5P!%`P$1``(1`0,1`?_$`!P``0`"`@,! M```````````````)"@8(`P4'!/_$`"T0``$$`@(!!`$$`@(#``````,!`@0% M!@<`"!$)$A,4%A4A(C$D00H7(T)1_\0`&0$!``,!`0````````````````$# M!`(%_\0`,!$``@$#`04'`@$!D:21S165NZ'+I\=OWQ*Z]141.7UA7OA;^1 M9IT=]N<+U>Z?TE]5 M-/=?TQ"M:R;69QMSF=N"T1U4[8:[[0TV42=?V-I>1,*N34!,GL(D6O%E;(I2 M1OUZ%7A9&DUX)4@)F)$G5U>9BL][`J)S'K:IV]>_OX<,:OC'75S;/DDC@#@# M@#@#@%/'U8NDF\.S6_\`)%WKD)24))=9BVC,?QROS+(37DK-\TAT$`U;45E1 M-A0\+%$)CEAEUE'/+R37MG#?`R$Z8>9F:Y9Y=>CVFJNJKNMS4X:=,6Q$N8B( M3X;C337IJE*4OI4Y]82X^]TB.OIWL;/^F60Y?HW8F')14`LP6*2FR",TX'#+ M89%#KI-!+F^`SX\BK#77T9:V1(86O-%G-=]4HS+%.EKJJFJJATTTM55.:823 MEX>Q9N^4$]^FI=U/O5562::EM0E+49A2XXNQ,9I[(,%#E$K,^J>RY'6;8$R` M.1D-+%8DO6^1/BO.\:%Q6X?,JXQ!Q)DRO\#_G-E45W=L:150=3&8GL87:M!V_$S^VO^(_+:ZN]-^=/ MWGKPF17`.R6@=I"IW8!N/7&32;_]JFIK\OHW7TLJ#0A(S*`DT=RDL+?/SQ70 M4.)6N1[$5J^+TU4I3E%;IJIRFCVSDG(X`X`X!YSLO6&-;1HV5-Z(D>;`,Z=C MV00?8*ZQJV^)XAV53*ZS'J@1$9KT/FW] M>O7*^U[6V&$63*''M8;$QO&<:^QHG&,/J:LTJU_(KA#9'>S-B6[+H=E%E2)$ MVFAW-C3098X4*IEOYJ7>IJIV--2^*:V8SO\`ABFJ*Z:H_2TX\&L;\9W.^33# ML;Z2>Y=#C7-^O-],VEBM:U7R\6.)8V9P(PGC)'=$#%:L>Z>V0BO(^`RO.T:L M8D24Y"$Y@K[)W;T_4MN]+C>_)>1OI[4G^I14O+E:W@_4U&UUVQS_``$T?"\U MK)$YE-(D5+Z3)H[W2HLPYU2>=XIXT]LN)[B"#'DJQS#-:CVM:BKRMZ$2XPIS MNY];BUZ\IJ<^GDK?.3+KC0O5CNC97\@4\&FI&#L)!@Q#1)@LCOI ML:V7`-7NKY;AOJ71V/']YRF]CA,:QW>AVB'>+^W%QLW)OF4M)Q;P?^2N-_Z- M8-L>I'WT]#G/-&8-FVYK+N=HW;=!=9!5X/N:L/'SK$\;Q:?5UI8V/[#;-+;/ M(D>P(L5LYLFK&^.Q35Y/<-'>G350UB5>&K7^8*JU2VYIO&RSX8R^;GA@M&^G M+ZJG5;U,=?FR?2&2OJ,ZH@"?G.GLJ-&BYWB1'^UJRVQF.:.^Q]YW?#'OZMKH M_N4;)\>N.<`"09B2G@#@#@#@#@&F?9[HOHKM#5O=E..1*+-([5=5YU0Q0P[L M)6)Y$&Q<)HQV\#W_`+OB3FF8U7/(+V&5'IS4N]353B:6O"5`VSX==>I"U-], MWL/HC8L>_P`2CMV)C5`@K2KE1'A)'GE@R?LDBVL"2])\,4EBI'%%&2=[O;Y] MS&>$YX:[)VK2K=*H[]*=JUMOF&Y3X7Y[-5.K1MJB9LY?'C-M_+<>)^K/T-M? M5IT+0/UKBDS6/:[K9`MYF&:_RL4BK%G^-6!P?E=(&9(&(@PR[."AJIPT?$<8 M4%7F:%7.3U-!:M,32U.4X?&7.W9'^'+KI2AU3&'/#$XV'#@Y5@U#+L24C+.IDJ1[!#?32Y5)D]7/#&D1K2L#)GL^'Y`3 MHP_:C-=M0[>?K[%_7IEW&K^RM!,QO+*&9@6[L)B1A9]A=@`L<1BHY\1]_ MCZF:TI*B=*`9S8TA@Y,-RJ'_`"!BJ,_M9HFXHM>XA MBEOV(PV?5'U+E^36,BA=@>0R)$5D^^?:P`NLGPH5;*DV`:#R2NM?A>(I/D0B M)/5IW<>LG"A6>7GFW91;RC>5E==]&/4KZ:=U<^V[?[2L$755,.22]PV!,6!'RF)+K`.`.`.`.`.`8'F6/6$M8V08\1HL@J&$1([U1L:\K7^'2Z M6:O]-^=K?,*4OE\*5[2L_BXC7L$-2OG;U[G@V];C!8NELXS7.1PX%+18=<6K M0VJ#;,I;8L9\^`-)/A5;;R[E6Q(@%\`/)(@&*I%]J3;TOLO?^D<3IRQW(C0_O8MG<$C@#@#@#@#@'575Q"H:R9:V!$'&A@(9_] M*Y_QL5WL8U53W.=X_9//_P!551$5>`07>HUD]_N#JON*X@6#J34\>')Q^G^` MGT[+8^?7C8]7$LQ&_8DC#<#EV;2TLV,Q13YIERQ?=&Q4@K$&]? M%GZIZ'_2I.G?4&7-MZ4]#F_8K/K7>.1U,^-]6VHJ6YKJRFP#&[0/A'!F5F'U M-?.E1"(A(,ZXF0S-:<)4X77]G1,EP!P!P!P!P#XK&PB54&38SS-CPX87GD&= M_3!L3W.=X_M?")_2?NO^N0VEE@CXS+9/_?M].J8LI];HG&))?SC(B2!QFY3) MBN+'=A%`9JHAX\T3B'RV[`0,\P_5&-[RGXAF>6XR$ M>ML!^NW76(2`-%46TZL(-L6Y?6HJ#?C%86,CJB',"JWDI@["8W].CC!9"(^[ M?&9]Y-V."1P!P!P!P#A/(!%"21),,``M5Y3&>T8AL3^W/>Y4:UJ?[551.)B[ MLA$V5V1,=X>X>M<0QVP_+R*G M\I$>*V05T#YE$QIW@<[S]7M*=:2NDX:6^=\W5NI---#HI=KM9V8QO6['H97U MXQ6K[)UN-Y140I%5UGIXD21BE6E>>E9L22QSW(&1%A_LB+ M1-5Y16!87H7Y;/O\NO<#,&95#S"\*1)=J]D<[1E;%DG*6[-XO>-Q97J)4V:;>Z&K[U M,KR+>]145=!5UU)25\2JIZF''KJRL@`'%A0(,0301HD6.)K1A``3&C&-C4:U MK41.>X93L>`.`.`.`.`='D6-TN5U9J:_@LGUQWB(X+GE"]A0O1XR@D1WBD1R MM5%;\H"C(HGD$KOC(]K@(0.U_HX8[V;[.8#LN]RB=5ZTH9`6R<;H6QF6#(/\ M5F!C3I\T"XZT8FK!@`QFN(`<0II+6Q;`CWOS_@0[-)3/&/+_`'D1"5E:9Z]? M;<3981A6+ZXQ''L%PNF@X_BN+5<:GI*BNCABQ8<.*SPU&B`P8U,8BDDRCJWY 8)4LQY)G/,8CW7I*E)+"),IY('`'`/__9 ` end GRAPHIC 7 g852944g20r03.jpg GRAPHIC begin 644 g852944g20r03.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[0^F4&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!<<`5H``QLE1QP!6@`#&R5''`(```)'1E96Y":71B;V]L``````MP#A"24T$&0`````` M!````!XX0DE-`_,```````D```````````$`.$))32<0```````*``$````` M`````CA"24T#]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H` M!@```````0`R`````0!:````!@```````0`U`````0`M````!@```````3A" M24T#^```````<```_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@`````_____________________________P/H```X0DE-!`@``````!`` M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#-0`` M``8``````````````%8```!&``````````$````````````````````````` M`0``````````````1@```%8``````````````````````0`````````````` M```````````0`````0```````&YU;&P````"````!F)O=6YD'1)D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F M875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP M90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L M;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H=$]U='-E M=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$$0`````` M`0$`.$))3004```````$`````SA"24T$#``````%4`````$```!&````5@`` M`-0``$/S1B>4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($ M!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\` M]57*]9^L>=]ILQ>G.;46>WU7:P?WOH65^YH]N]=+1D59-#;\=P?6\2UP_)_6 M:[Z2Y87,<0TX8>1`+H$DI'10=KH^5U'*8Q]SJW,:V+7`:N?`+?3C:WOO?[5J M*ITL,^Q5EE?I!TDLB(,D?P5M)2DDDDE*22224I))))3_`/_0Z:S'ZQ]5,FV[ M!J=U#HMSC8_'$FVEQ^DYNCG;/Y?_`&[_`*947==Z-=EMR,3,=27NDX]LMC\[ M:[<',^E]'99_UM=ZJ>1T?I.2\OR,.BYYY<^MKB?[3FJ0SA/YXGB_?B:DMJ0^ M65#LX&5]54(< MS^2YP]F1_;2B<9%2!']?^Q1X^FKW22\QZ;]=^L=!R1@=8`R\=IVLN!)):/SF MV:_]+_MM=[TGKW3>K5!^):"[O62`X?V5&N=%))))2DDDDE/_T?54DDDE*4+: M:KF;+6[F_P"O=3224\E]9/J3B]3H=$ML_-N8/F490G:&V3(,:$C]X)*)]8+NCY-C[<8D-I<_6`TQ5#OY53F^H@I](22214_P#_TO54DDDE M*22224I))))2+)K992YKQ(`D>1&H*R,?I..%[GOUO\`W]1Z)4^OIM1LGU+)L?/BX[O^I5'(R;K.J654 MM=NEM?!T'[[OW6;_`,];C6AK0T:`"!\DE+I)))*?_]3U5)?*J22GZJ27RJDD MI^JDE\JI)*?J2L4_:+2T@V$C>.X]K/\`ONQ&7RJDDI^JDE\JI)*?_]DX0DE- M!"$``````%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O M`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``0P!3`#8` M```!`#A"24T$(@`````!+DU-`"H````(``````<@$R``(````4````D(=I``0````!````I````-````/``````0`` M`\`````!061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W`1L`!0````$` M``$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$````````````` M`\`````!```#P`````'_X4^D:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP M+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](EG)E4WI. M5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B M('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@ M,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@("`@("`@(CX*("`@/')D9CI21$8@>&UL M;G,Z&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA M<"\Q+C`O(CX*("`@("`@("`@/'AM<#I#&UP M.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O&UP.DUE=&%D871A1&%T93X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^ M"B`@("`@(#QR9&8Z1&5S8W)I<'1I;VX@&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N M,"]M;2\B"B`@("`@("`@("`@('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O M8F4N8V]M+WAA<"\Q+C`O7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@ M("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#I#0S`V0D$P M0S(Q0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@ M("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#HX,C`T,#4P M,S)$0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS M=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B`@("`@("`@ M("`@("`@("`@(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO M<&1F('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W`\+W-T179T M.G!A7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V M=#IA8W1I;VX^&UP+FEI9#I"0T4V1D%%13)$0S=%-#$Q M0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V M=#IA8W1I;VX^&UP+FEI9#I"144V1D%%13)$0S=%-#$Q M0D%&,$8W-38T0S,Y1D-$.3PO&UP34TZ2&ES M=&]R>3X*("`@("`@("`@/'AM<$U-.D1E&UP+FEI9#I"1$4V1D%%13)$0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO&UP+F1I9#I"0T4V1D%%13)$0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO&UP M34TZ1&5R:79E9$9R;VT^"B`@("`@("`@(#QX;7!-33I$;V-U;65N=$E$/GAM M<"YD:60Z0D-%-D9!144R1$,W130Q,4)!1C!&-S4V-$,S.49#1#D\+WAM<$U- M.D1O8W5M96YT240^"B`@("`@("`@(#QX;7!-33I);G-T86YC94E$/GAM<"YI M:60Z0D5%-D9!144R1$,W130Q,4)!1C!&-S4V-$,S.49#1#D\+WAM<$U-.DEN M&UP+F1I9#I#0C`V0D$P0S(Q0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO>&UP M34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@("`@("`\+W)D9CI$97-C&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YTI&>6(K)MD\U3^/BQWA#$CF,8BQ:L96(8 M1,(F$3")A$PBP_3=YUGD?3*?>]$N8>Q:WL=8MC26D$B$%(;_`"")',Q>Q(L^ M#-">OM*Z4P4VLLHLNNG@CS(IP#YR1NC>Z-XLYCBT\;YKC$")(II"8-<3Y&#Y[[NO[.=,^&.7 MJ'2)I"^Q>2^FN1E[CJ(&T;FL&LAP;>/5OUE]*>]\MD:_-K2K)+9-KK.)8Q9-:Z("U+*CUDRLNHLZ-&)#B&JBM&Z5GR?K M7L9[X[*AEE[?I(JF1^H/:R:FK8Y8GM)<^_5)F21/+=1?"Z%N@6TO<39N]=[4 M*BH#&10ES#^FYA@86/!`(#FP/9+&+AK96R'60;M;@F9F]^KE0]'HX0^:>'-_ MNM.O)K1TN\<9PQ7FISX[(#"_-638VK)==;/-F"0RMH:9KRXN&.1-`-H]!J5!0T@ZI:T&I#KHRZL>*(/MAC!KG#<&L, MY$]M9T1K2]G^1/-&(F:*IZEUD MG.D$?;S5#_._IH\150*?0=AT:_P!(V^(\BZ5REHT$\/8=6*QS MWQ&W=A!#\;:H#D3SC,D21$:/Q:08G(J)[[M+VF5_;D,4G7ZB*6%KB'2%@CP! M8V+&O=<^#@6N&""%JJKL=TC73T[Q-&ZX(L7M)!_:]_Z2",$`.&[2HC<$>L[U M3^G1R;^GCJ]KR\O<855F6GU7?/R!3V,FA"1S84F+9.60!CXT5&(>!)6(H3>8 MO;-XHY?`U=0RKJZFJC_T551-4,L+#1-(Z1MK`#9PP`/(!>EBC]U'''S'&QAS M?+&AN/3AUAZU$O.)=ZJI-B<0WGU>?-BQ[T#B(Q4:**\C" M2V]WHU%$-"*YKU]E&-\UZ%V*96$3")A$PB81,(L9VO3]>W6J-3;%7CG0RJCD M7NHY`"-[^!HTAG8H#,\G>+V.14[KDHQZ-''74IIMW\9TFJN&C-)I-QJ@M^?2G5W8(K2M$U6VXT[HKYY&+(7_`#W1 MW[DNPL!@8`'`_I1V5.\V-`5C45JXPET MD@Y%_GSMZV^*O\<_6WX5R='L-'LL$5G06D*V@&8P@I4(S3">,B*X;T5OWX$1 M%5CNW9Z(OBJ]E[9(<'9!NHOLY43")A$PB81,(HL\\])W&'.%/-!:Z]3?E2E' M.8LROCRZV98Q7M+$-.AF8]B%&1B(R6!&'$BJJ>2X3\>N5!K<>+)^H4.WZ7O% M'#D54NEEU-+4VL,5A47,5D9OO1A>^`L,K3>:`KI:(*?$(S^'P>+R3"<"'9%K MDG(X)_@9V&ZOAGUGUGQ5`O1/UW]0_29ZE/Z3]MGW=CT^;9\JNTRIO72)[M(H MK=A]DUUHK`BD+._XW:-N]+#%E%60^J;'D/_D77^68IK>[ M-'\#S*^LN]K%#5\=C%]Z,.;:173FN\Q)$"3W/(3,X:6FQL/(C8Y&-L;7!^W" MYR/5L8^W'`L5=(UK6-:QJ=FL:C6IW5>S6IV1.Z]U7LB?VJJO_>Y$3^\ M(M"<0I\K8:2J$\CAZM23+2:1W=%6?9!!7B"3Q_:A"/F6TQ[.R-C&L:[5-*AG:&9 MM>RQ57_+GLB48R73S>*]U4:RH46.]43Z]]._]Y#_`-?5-EK+HSJ-A;K?)VU; M1+FRK+8>5]MK8?RF^(&T6GSS:_5D@(JKXQSJ&2KD1&M<4;G_`&YSEP/OSYHI ME943")A$PB81,(F$5:/4;SC%H.=H%762'EGZG1Q:EC58)P`6FV2UC2(R$1BG MCF5K:ISI+518["M(Q6=G+A%8#HE0ZCU"AKRQVQ)?PDG64=HA@0=O;%);7'\( MOXQN=:39CWL'V8CG+XHB=DPBRW")A$PB81,(F$3"+6;N,=?-R4?DB56UQ[=: K.!31)9(XBS(X8Z7+)8D4D=W@*8RU8I2#.A'K%&-[5&JX3U\ULS")A%__V3\_ ` end GRAPHIC 8 g852944g26n56.jpg GRAPHIC begin 644 g852944g26n56.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1E@4&AO=&]S:&]P(#,N,``X0DE-!`0` M``````\<`5H``QLE1QP"```"````.$))300E```````0S<_Z?:C'O@D%<':N MKP7#3CA"24T$.@``````\0```!`````!```````+<')I;G1/=71P=70````% M`````%!S=%-B;V]L`0````!);G1E96YU;0````!);G1E`````$-L```````$`````#A"24T$&@`` M```#-0````8`````````````!5\```5?``````````$````````````````` M`````````0`````````````%7P``!5\``````````````````````0`````` M```````````````````0`````0```````&YU;&P````"````!F)O=6YD'1)D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX` M```'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E7!E96YU;0```!%%4VQI8V5"1T-O M;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/ M=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H M=$]U='-E=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$ M$0```````0$`.$))3004```````$`````3A"24T$#``````/N`````$```"@ M````H````>```2P````/G``8``'_V/_M``Q!9&]B95]#30`!_^X`#D%D;V)E M`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P, M#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X. M#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,_\``$0@`H`"@`P$B``(1`0,1`?_=``0`"O_$`3\```$%`0$!`0$! M``````````,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<( M"0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C M)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3 M=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1 M``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S M)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`" M$0,1`#\`\KLL?8]UECB][R7/>XR23JYSG'Z3G)DDDE*22224I))))2DDENT? M5/(LS&XCLAC2\U["`27-MHLSJ[*FG9O8YM7H_P#&I*<));#/JZ/09=;FT-%N M/?>QE9]1X=CL9=Z%S6EOI.N]3]"I=/\`J[5F58+W]1Q\=^<;2:[##JV5"T^M M:26UL98^CT_TCZOIU_SGZ7TDIQ4EL6?5JYF+5D"]CFOJON?`<`T4"?I.#?YU M[F4?19Z>5^K6?I59L^J#JLYV(_,:&LSF8!MV&`7^G^L/UVUTN]=GV;W_`*U5 M7E6_]ITE//)+9H^K;KL5^4,IC6-958`02=MSWU-]3:?T;]M?T/\`"6?H:U0Z MIT]W3`Y@`)'=W?^TLM)2DDDDE/_ MT?*DDDDE*6U95UQN)C/RLDOPM]`KH]8&)8QU.W&W?Z+9^9_YZ6*M$8W2ZV46 M49KKLDOKW4>DYH$@.LFUSO\`!V?H_P#I_P#%I2!ARY=NL)]KOSP>W]91G(]- MTO,[F_GCP=_*35LJ!=%@/M=^:?!1#6>D[WCZ3=8/@])2G>ML;+CR?SAY>:D1 M:'"">!W\E`ANUON[GL?)%(:'-=,D!L:'P"2DU'VD.)XF>2%:H+V[MW)&JJ5/ M)L(L/,QSIRKS65MK))[%K,L#A)T24M-K M^-!XI`O;H=2IN=`D:IP=)*2F!ETNC14JYT[0UMGZ)WL_2V?I/Y"KW8&11B49=@`IR=WI$.!)VF'>U:1 MNZ]=T[%?>P_LOU*V5V"M@:75_H6_I6-]3IKI(XGO\`[%7==`(UCL)1,NZP.((\=859GJF7%NGP24Z'3*VV6$G0@:!: MH8&MA9_3:W!^^-(@K6JJ-I(F`-24E(-IVS^"1:0V?P5EV-8/H^\>7/W)-QK2 M?<-C?$I*:YK:X:K)SA37=$3HMNVOTW[9GNLGJ8JS^QM_Z:#3AL;C8^4,RISGVM!PP7>JV'.;O>W9Z?\KZ?YZM=3>3] M6NB-W%P!RM"Z=I]1IVAD^S=NW_Z_I:.,[I_ITMV6_;?59[]S?2V[CN]FWU-_ MT/S_`/U(E(V5N!=^D:?:[\[R4=A])WO;])O?R>GK%$NASS[7?F@=OZZB!5Z3 MH_P1`2PM+'`N]O?R0R&;&ZGD]AY?RE9H+7.#8[ M-U@>`\TE)"18"+GAKI,:_%&QJ0?;(<3P@9&-L)<9[]OBI8&]UK6,,.YDI*=_ M!PR&03#0=2KX()%=8D\!C>4+&&VDN)F3^0+7Q]U.-4P`->6R\@:ZZ_2_JI*: MPZ9GG_!@=Y+@H.PLUH)=2Z&\D:_YJT&UVN&DP4G,M:>3IPDIR#L?+71J-3&J MS.J8;W4EHU_.:1I,+H\V;,9[B`7UD.W1K$^Y9.8TNJ:08Y'W]TE/)/:_UFP0 MT`C2?@J:V\K'8+`7$S(X'P6(DI22222G_]3RI))))3K]5R\2WHO2<6F\778K M;?6&UP+?5++=A=8UK=K/=5^C?9_-^I_A4*F^\X>-2<*IM0M:1FBHBQWO<=CL MB=COSF?];6:M2AO4?V=CN.4TX/KM#<07-+@[=],XF[?7N_J>])32KL82[]$P M>UW=_A_740]OI._1M'N;I+O!W\I&9]MEVXO^B[OY*'ZSZ;I+IW-[_P!=)2,O M;L;[&\G37R_E(]%K66`P.&^/@/-"/K;&R7['=OT)C[UML>+*J;0 M(<]HD>8]JQ,)\M+3R0'#Y+9P3NPIGW4.+?D=0DIM^LZMH!"8W.>W0(+["_E) MEA:"$E(\AVS$N>!+C#([`._.6-F[A6S;V!CXK;SRVG"V_2?D0/@!JL+.?^:. M6-U^*2G*>9>"\#D>/]ZYY=*&.<09,:2%S22E))))*?_5\J22224I7J*NGBBB MT7O.:;6AV/L]@;N^GZV[_H[/_4=%7J,C"-./CMQ`,L6M+LOU'$D;OH>A_-)* M:]==8+OTC3[7=G>']5,&,])WO'TFZP?!_P#)4JC1+H8\>UW+AX?\6H@U>DZ& MNC#_P"0DIB6MV-]PY/8^7DG+`2(Q\/@M'!Z+9F5M>98PR6B9)G^ MRK=WU:=6-P6TV MT/N`=(&FD_#R6*DI22222G__UO*DDDDE*6EBW]4LP64C7IU%]>^&,TL>7.KF MS;ZWYMGYRS4I,1V24V6.NEVZL#VN_P`&T=OZJBUS]A+V@-WMGV#CW?R4'U'G MEQ^];'U;?C8]]G4\IGVG['M]+'<*DW^EMWEFWVAT_ON;[O;]%:.;@N9A#+VH-:_VM8Q6W_77+=DUW5:].KVBS%< MP!KB]HNR-U1EKG?:'>K6Y)3S?5\FIM^RIS7Z'=$&%0Q[9):6CXPNC^LO7,3Z MQ-)LQW568E3W46L#6D0-WIV@#WTNV_\`6_\`!KD:["TS*2G?PW^B]KCH"5TV M!DUUV.+G11>WW'L'>+EPCLLEFV58_:V34*S386MV-``)B6B/&\?P5>[_&7>*:W853`2&BS[14T=G[JZ64V% MGIU_HMMOT[/]$H8O^,O*>\G.J9Z(!+3BU-+P?!S+[&UNK?\`1?[O8DI74,MM MEAMW314-M78$Q&YJY3*RV.M>[D`0-)X*%?U;*R,M]]S]U?N+JR99M<"WT@/^ M@Q96]WB4E-NV]SLAI:."W\T>2II2?%))2DDDDE/_U_*DDDDE),5A?DU,`:2Y M[1#S#3)_/=^:Q:K\>IM)R#T^MS"-^\9$")+O;7+7_P"#PGVES#_FM9*%CF:7AX]S; M&Q]SE6J<1C.\R1_T0DIT?6I;T[-L_P`(YC:J_B][=W_@3'K$1K;7>@VN='.W MGY#:W\KD%)2I4ZR-KAX0?X%04Z_SOA_$)*=3"RJL:F\W5BT;6-K:>SK/>7#^ MS4HY&73=CU^A3Z1E[+.\R:[&?]%KU2U%;AV+F_DVZ?PA)3![OT<=W M'\G_`)TKM?U=ZS;CUY56,ZRFUN]KVD'V^Z7.U]NQK'/?_HV*B_Z+?FI#+R@P M5BZP,:"T-W&`"',[[MH0SM;546N$D$N$Z@AQ4 M0^"/#N)^])3!YET>&BBIW[/7LV?0W';'A.B@DI2G5R[X?Q"@IU$`F3&B2G6Z M;]7>L]6HNR<#'%U-#@VVPV5UM:8&GZ=]?[Z#G='ZAT^L/RZVL:7[&O997:TG MW;H?COL9^:NI^J^9TW!Z&UKLRNNW/]1V16^ZMI80YU;/T;O>S=54S^<0?K)5 MT>SIIJQL^NUV*P7UM%M1````<@$R``(````4````D(=I``0````!```` MI````-````/``````0```\`````!061O8F4@4&AO=&]S:&]P($-3-B`H5VEN M9&]W`1L`!0````$```$F`2@``P````$``@```@$`!`````$```$N`@(` M!`````$``````````````\`````!```#P`````'_X4D]:'1T<#HO+VYS+F%D M;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB M861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR M9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(*("`@('AM;&YS M.G-T4F5F/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O M8F4N8V]M+W!H;W1O&UL;G,Z<&1F/2)H='1P.B\O M;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@("!X;7`Z0W)E871O&UP.D-R96%T941A M=&4](C(P,34M,#,M,3)4,3$Z,C&UP+F1I9#HU M-F%D86$Q-BUB-V%B+30W,38M.&(P-RUA83(X8C)B-#@Q9&0B"B`@('!H;W1O M&UP+FEI9#HU-F%D86$Q-BUB-V%B+30W,38M.&(P M-RUA83(X8C)B-#@Q9&0B"B`@("`@('-T179T.G=H96X](C(P,34M,#,M,3)4 M,3$Z,C&UP+FEI9#HY.3%E83$T,"TV,6,W+30Q9&8M.65C.2TY,F8S86,R M,30P,&,B"B`@("`@('-T179T.G=H96X](C(P,34M,#,M,3)4,3$Z-#DZ-34M M,#4Z,#`B"B`@("`@('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O M&UP+FEI9#HW,S)$-C-# M13,P0SE%-#$Q.48Q1D%#-T5#13-&,S(T,B(*("`@("`@&UP+FEI9#HW-#)$-C-#13,P0SE%-#$Q.48Q1D%#-T5#13-& M,S(T,B(*("`@('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z-S,R1#8S0T4S M,$,Y130Q,3E&,49!0S=%0T4S1C,R-#(B"B`@("!S=%)E9CIO#IX;7!M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP M86-K970@96YD/2)W(C\^_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_]L`0P$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!_\``$0@!N`&X`P$1``(1`0,1`?_$`!\``0`" M`@,!`0$!```````````&!P4(`P0)`@$*"__$`',0``$"!0(#!`4&!@D*#1$& M!P$"`P`$!081!R$2,4$($U%A%")Q@9$)%18RH;$C0L'1X?`D-39R=G>RMO$7 M)3,T.%)UM+73&"9#1$935%5B@H:5TD5'5F1F9W2$A9.4HJ6FPL/%"F-EDJ3& M]47#5Y9VU9.N6%VBAI#8JJ# M*RU*8FZ+(+I+TN[7E3D+PH5$L>UYCL\(DKAN*E5#2Y? MTYU)=K5,G:-0KCE6ZI<$M6I(+F[%OR)=`[5=`^2#U'D)*NS6F':SN'520[7M M4.N>BUD7%0*;9O:+N_3.CKTBLV]:G3+VJ4P;,H$M,3R;=MC41QZM*=4VRRMU MJG)#4GY+WL\=B/M"WOVE=*^TII9KM==PZ2Z&=IWM'6M=FE^NUM:;4YRV>SII MC5[Y_J?5>W:SHSJ`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`0"`0"`0"`0"`0"`0"`0"`0 M"`0"`0"`0"`0"`0"`0"`0"`0"`0"`0"`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`ZMZ=IJ^[Y[-.AG99JM*M>6L#L_P!]ZQZ@V=5Z?)U5J[*C6=;A8PNJ M7N&>F*Q,TJ:I\A]`*-\Q-4ZBTN8EO2*AZ=-5'O9?T8-QM7/E;]>M8-/-5J!4 M],-`[7UB[0^G5GZ2=I?M66A:=W2/:"[0&G%F+MIZ6MN^JG4K[JVGU*-SS%F6 MC,:B5FP=/;.KE_NVY3Q=9G MTUEB0JTF&E>IE^U?534C4'5"X)>GR=>U'O>Z[]KP)VA]9/ZA_T+IEISJNT&-97=/I9B[)"MU1,MH59MOWY?+MRT&TD7)< M%MSB[>N:DS-NV]4J6W=5?$W*/2-!5(U2BSE3#'ZI=AG7C2#3NMZEW?(VXBC6 M]/N"K4B2J\Q]+I&U%:G7OHO3=2)VUZC3:;5:=8E;U6TYO"Q*=/U-F2K#5MV6#F`_,'P@/W!\#\(#\@$!]AMQ7U4+5[$J/W"`Y/19G MGZ._CQ[IS_HP'P67AS:<'M;5^:`=R\=@TX3^\5^:`[+=-J+N[4A.N`_[7*OK M_DMF`YOF6L_[TU/_`-`FO\U`?OS)6CRI%4_]`F_\U`/F2M?[T53_`)OF_P#- M0'Z*%6SRH]5/LI\V?_DP'U]'Z]S^9*O@_Z$!\>B3?\` MN68_\RY_T8!Z'-GE*S'_`)AW_HP'&XTZR>%UMQI1&0EQ"D$C)&<*`.,@C/B# M`<<`@$`@$`@$`@$`@$`@$`@$`@-R[8[:EV6MIEISI,SHYV>ZQ:FFU3OVJR2K MBT]J-9J]QS.J5J4:S=1#<]1F;HXG'+JHELVHF9GZ`U;]6IJ-&F/G M!<^&7UX^4.[2O:2M*X[4U7KEK5=5V5'CN&YJ99U%H%U5.U9;4.\=6:)IF]4: M0S*RS>G%LZDW]=5X4&W9>09=EZG/2+,U4)RF6];Q;SNVQ]#;SJEG7) M6K7J4SJI8E/F)ZA5&:IDT_(N6E?\PN4=>E'&EKEU/RS#Q:42@N,MKQQ(!`1- M6O\`K>OZ^K.H"OWUU5@_?-0$UL#635BJ3]R-U'4:\YY$M8-\U!A$U<-3>2S/ M2%MS\U)3;87,$(F)68;0^PZ,+:=0E:"%`&`KI6M.KJ\\6I5[*SSS<=4.?_U, M!W:)JUJ?-5NCL3%_W<^R_5:]T,RTO7JO+R[#=:GTM,L,U"8;:9;0'@$-MH2E"$I`"4I` M`P("-*U-U#7]>]KH5GGFM3Y_^?`22Z[YO.7%MEBZ:\R9FU:3-S'=U2<3WTR\ MN:[V8=PZ.-YSA3QK5E2N$9)Q`0]5^7JKZUUW`KVU6=/WO0&:7=MT*M9$TJX* MPJ9-P.L%\U"9+I8%.9<#1<[SB[L+45\&>'B).,P$?%W7.H#BN&L$[\ZC-?YW M^F`S%+N&OS+5:+U9J;Q9H[KS1:=GI1MQ"IE]3:TK?;2I"@5 MX4E05@@[$'?8P$VM=BY)J>`,]4"CO5'^V'B``K9/ULGF,@9VQL#`;".T^:3+ M*S-S85P#MG,!9R9-E6R6@3X8!Q[3T_H/6`Y4TT#?N#@^&VQ]F3R_+TS`!3 M@3@,GR'#[N0'MV/+!SC$!-*!;J'"E;C0&_4`8W\QM]YP/.`G9H$F48+2>'&^ M`,Y\]N>WYR8#J?1J2R3W:>O(`?<1CQ\CR@.RFWI-./P*>.N>G*`Z52HDN^TH!L9QX#/@2,^?M\^L!5=2H:Y9TGN MB021D>7AMG8'Q.!Y;D,49''^I*WYE(W\_`^!\#`?"I5*?K-D#KDGR&_GOG.< M\\=8#@=EFN$D#8`YP<#&.9]F^.OAX0%"7>N=DIPF6GYQE.<@-3+J0-]Q@+QY MC&V,0$0>N"X"UPIK-42H).PG9@>6?[(.6JTW<*:_4FF*Q56)=$TM# M334[,(;0D8]1"4+"4@;[#EX7PW1<+2.-Q94I7"VVA*)H$?.4BH;;[3+6X/7EC) MZ_&`ORBT23I^2IML*!5@D8SN=_'/%OC!.?/,!WYI]A:@TGA]AW^WS]G7F8#% MUF@F82AQ+1X?1)/?AYXEFAT2=]L]>GO"!MT)U$TG"-PL=.?+VXV\_?`;4V-+ MN,TUI*TX.YW&.B?;MT\M\P%L4UD.84H')(YDV\/COT^_S]T`*@.9@/CC&VWW#X0'T%`[`[^>,[=<9@"@%<]Q[CC^GEC?/E M`8"HR"'4$\&3UY^1Y#<9Y>'#CP@(DY(`$CKCPP![R,_=G?K`8FP_' MD=^7B<9@(E-(*`XG&",[9\CX>?2`U]N]*E3;G$.I(.^WAN>1Y;D[8V\8"$R] M/=?6`E)5D>'7;D?'`.=SCX0$^JTH&:U4'5H(2J:4I.W/EN-CDTH\F8JUB.(Y&S7A[Q=ERY_7X[P&MD`@$`@ M$`@$`@$`@$`@$`@$`@/0[2/Y06NZ&:>Z,VKIOI%8[%VZ/7CJ;=DM?MXS,U?Y MN%O6>S;&T_U.H,W:-TRD];M'IM?L[3NWJ')3%#:DZI1)29N)N2GBU7'FF0[O M:&^4DU'[1=@7I9UPZ<:=6M5K^6[0KBNNT&JU35NZ8L=H'4[M-T33J3M@U%=K MR#%*U8U4J\^[EZ5;M76_JM M8DH9:YJ!3+BD&TKM*_WB^S)U27F&&9L%D-IF4)#J67'F@>!Q8(0Y>K=37_L+ MTI3^\TSM)/W4Z`FVG^H\_/3]R(7:^GDL&;!OJ;"I&P[;DUN*E+;GWTL/*8D4 MEV4>4@-S4LLEJ984MEU*FUJ20KE6I=05_L5TY'[VP+93]TA`=^AW_//URC-& MW+#;#E6IS96Q9-O,NI"YQE)4VXB2"FUISE"T$*0H!22"!`?5V7O.-7/>7)J<==4!Q..K45N+)6HE1)@(V;VG#_U!LP> MRT:$/NDX"277=$RS]&R*3;*^_M6D3![VW*2YP*<5-9;9XI8]TPG'X-E'"VWO MPI&3D(@;KFCSI%K^ZVJ0/NE1`9_Y_?5:B'S3J"%&X76N[%#IH8`%.97W@9[C MNPZ2>$NA/&4`()X1B`P(N)_.33*!X;4*F#WC]C_$^R`F-MW"X6JR3(TALM4= MUP=U2I)H*Q.R"0ET)9'>-^OQ*;7E/$$*/K)3@.TS<#CKK9,A1A@CE29'`&$R:<"TI.,\LX^X8/O]L!(:OY=\?I@,X7`A(QT\?CCIGV[? MD@.FY.M-YRX,#'E]G7RQR@,).W`Q+C(6,Y\'P&T!S/*!&2 M,>/Y3TZ''Z8")3/#WA(\?=XG[3C8X$#'S+?&VKU1Q8S\-_A^3R@(-46>!S; MD??OYG'Z?"`I^\63+I+Z)>57C<]Y*M.G/M<2?<#L/8<0$9MJM22GN"8EZ<@C M`!3)2R#SY#@0.NXSF`S%W7'*4];@;9ISK@6>+OY.6F%@\\DN(43D8YXY;P%8 M.WF^\2EN0H2MMLT6G*P!Y%C!.PY\C]@4-V@)IR=G[%F'6V&E+L]W\'+,-2K" M0FZ+B3ZC#*4MH)QE?"/665+.2J`U^@$`@$`@$`@$`@$`@$`@$`@$!(*1:5U7 M`]29>@VU7ZU,5Z>G*70V*31ZA47JU4ZF)9BF:<'O3&&E)<=92@@P%CT_^Y^NS^."P?YFZC0%-P%DZ8_ME=7\ M6VHG\U*E`5M`9FW/W0T+_#-+_P`=8@.U>/[KKI_A'6_\IS4!'("97ARM7^!M M%_E3?]/VP$02G.Y]P_*?+[X";H:2+)0I72Y7CCE_U+E]@?<.6("(H(W'+/+\ MV8"243/=5[A/_4-[?S^<*?@XYCICEF`[,BAY01A*LCGCPY\_MSF`L2V6)_YU MI005A/SA)'D>DRT,G`._S@.PXA&V!F`ZK-(FYW"EA>#Y';ER_.-OA`=I5OS#&%!*MM M_+&_L\.A'F>26P>+;S^W?W0$)JJ@K`!S@ MD^>YZ_KSSX;A6%X,AV0>!Y$(]X/+SYC^D0&J<\J<9FG/1UK3ZR@>'(Z^6#X M]>7P@.>ZF:B[6ZDE3CG"F;5PI))]7P]G3WG.8#`L]Y*G\)Q#&.>V-^7V[>X0 M$"UN?3,.6$M.-K1F4G'B+KN//MYCK`49`(!`(!`(!`(!`(!`(!`(!`(#UCT] M[:>BE"T=[)UC71=7:I-U=GFX=:9Q^:MMFP6;/DK4UHM2P*55;`HE'7SK6J5/-I=K(3/MK?*9Z<=J;3K52B6]IC?%HW M%J?,Q<-LINJ37JM8C+4@NL3]%#$RJTK_`%IF M_2:<._<*&FW6>X60T>^[PCC;1`0U5W::'ZND3*?^75S'[Q`3?3ZY+$?G[E$G MILU(*18%].NK%W5Z9[^59MN?HBK-0Y]'4ADUYU` ME_G6=(#AIK"B]WA/>'*"$=W]08XAN28"&-/4%3BD_1Q(WZU6>///4CQQC&^\ M!8MK4NDSR*MW5$;82FD.*M&=D,MDK'J964KXT^L.`)&RC`322H=#E MY?B^9VN+;_JA,$C'D1GPZ;#8^82&@.T=FJ4]`I"6CZ=*<*Q-OKX%%]L)7A0P MKA40L).`2.$\S`9]FH41Q3B4TM(5Q*'%Z4]DD';RWSRWW]4DDP',TN34\E3< M@D`>$R\=LK!X3*M*"?^*.%//)()/F'Q M;U6:9G.%2>`%75Q2@,G<8/Z-_L"YY>>8<;0>-.".8(QG]?=[H"<6P4.3`Y*' M$D9Y@;_'.WP@+@82G@!VQX>'GOORVZ>,!TIQE3J2D=?SWJ.O6`Z4O;@2_WBQE(WYY]N-ML]!CQ&^8"7R\HVTD)2D`#KCR' MD.F/+;.8#F6RE2<$`YZ8_7[8".3=*XEY:&/8=P?>/OZP'VS2@$#BV^\\O%/M M\#C/AL'"JDJ#@*1G?GG[/?X]0?#(@,\S+I0@`)&VY&-SX;CJ/B8"-7`$M,$@ M8//.!@G.-\^(ZGW9@*GF'^-Q14H\ M6C;!'-.XZ=.72`IT)I:W5.+HZ%9YDSTR,^X8_/R@)%8@.U>/[KKI_A'7/\IS4!'("97AC_2I_ M`ZB9_P#S3?Y(#`22`MT)/3!'N,!::"E-E(3SSQSS]X8=FZ)EQ]" M.+U%$#<[>T!+*K35M--XQ@2< MD#MC;T5K?I@`=?#EX`*KGWG)5U:FU84E63P^7GY[$>V`[\G=D\VTS^&V#K@. M^Q`0UCKYGGX8\X#8;3BZ/22VEU62"G))WW/M\#L/9RWR&T4E-(>:2L'ZP&<' M)_-GKX>S.X=XA*L]3U'C]A^R`^N!/A`.!/A]L!^*6$_T@>[V^4!\AY!VW_7E M^OWP'UA*]_=T\OT0'[PI'GU\>7A\?N@'"D]/AR/Z^4!\+4E"3C;QQX<_?F`K M:\:HAII2>(#'GX#^CD.[IM6Q#O7.>%MU0ZXZ#8?9M`5]-S3U0< M/&HX)SC)Y>_Q\=^NXWR'&95M#*E<0!`.3X<\;_T0&)OY]"*Q5VPOG-N_D\^7 MGCEYP&M5PL%V84X,G).Y'F=LCX8\.?.`BE_MEN1LA)&,V[/$#R^D]>`^.,]> M?.`K>`0"`0"`0"`0"`0"`0"`0"`0'M5H5J-V2)73?L8,WCVA>SYI+>&F5=[0 M[^JDS3.RG?\`J5=LE;>IFG^FLM93M9U>MO4&X=/;/KDSI5N5BF?U5;$,LJUI6ES4^J>^B6H'`E]%6G).73 M)]QZ05J;6I[ONY`1P%9`1)36@WXD_JZ?#BI%FC[JV?T^4!-=/V](!/W)\V3F MI*G/H#?(F/3J9;"$"1-MS_IRF?1ZLX3-IEN\,HE?"RI\(#RT-E2@%=*:T;_$ MG=3<_P#"IEK#[JN8#NT1O2H5NC&5F]02_P#.M.[D3%/MQ+/>^EL]WWJFZFI8 M;XL<92DJ"`C\N;&0Z"F8NL[CG*T?K[)SSSXX'G M`68PU:KUIM\+UP^BBX'B#Z/3/2._^;6,C`F2T62WPX(5Q\9(^K@P&(5]#V$8 M#MP\6^Y8IF2>0!_9/+//PW\1`=65%$F&JWZ,_6\&CO![O69%*DM>FR15W00\ MUTXY$LR0&VW1[&1C'/.("V;%J%&:JU/;2 M]5%.">DBT'FY4-\??HP%E+I5PE?#Q%.58R<0%[49N@S+H<0J?42L_P"IRQ'% MQ;C^R9QX'&=L>P++DVJ0TD$&<\\I8Z;[X7TQ^?S#AN*>IB$!*B^/V+*XX4M? M5]';X.:@2?RP&!:>ENZ;P7RCOW2"0 MV%9X6LY`5C'][OG.8"Z=/7"EY):+H&Q&<#EGJ%>/W8]H;34.M.MA#2R=N$9S MC/AUP<;;;>68"?R]4"QE6W,9R<8Z;?=Y9V@,HU-H'N]X=T*! M^S,!@ZFXMMLE'/8G',G!Z^[]3`8F0FWEN87G'+KX_?YT!+6N7/H.9ZF`^ ME+2G;P^'Z^S\F(#H/3S;9.5`^(SU'OVZ>>-Q`1JI5ONVU!/][CF3OGET^SXP M%.7-/JF6G%K*P,'ZG/&XY9P?;T`SMM`4\PNG*J*J0]C4GD?%SRY_I@,74*K;C;2TJF*QR(PEJ1)]@R^ M,G'B-\@=<0$0O:=H3U?J:)ARO=_Z4YW@EF9!37%GDT7)A*RGE]<#!'K#K`0I M4I:"DE3SMR=3O+TL[D^)F?'GD^'7D%6ZOID$KLM-,,TJ2%M37=*G$-(F"3>`I5DHX2H!61`4Y`(!`(!`(!`(!`(!`(!`(!`(!`("Y*?_<_7 M7X_U8+"_F;J+^B`IN`LG3']LKJ_BVU$_FI4H"MH#,VY^Z&A?X9I?^/,0':O' M]UUT_P`(ZW_E.:@(Y`3*\.5J?P-HO\N<@(FVHC'B/NZ=/=X]8"SI";)LYK_@ MW*]M_P"2Y?Q_+RWYZ3O0WMSX M_.%.YYSN>N.I\\P'00SUR#X0%Q6O<#K"L+0X`'%$9!S];.0#SSX'?V[F`N27NB76SP MJ(2H(P0<@C&/$XR#C//Q(@(A=5Q\4PE*%;&2DB-_&49.=S@YSC;;GDP%8SL^ MIW)).ZMR>?+&WCOX[>(@.:GI5,)ET(RHF9=!&W]ZQUP3MXYS[(#:.Q:.9660 MZM."4CIN,CV'E]F>?2`NND2JG%`@P^.?$/H*=95DD@C!PK;8]/N.3U\.@9F7G@4^L<*``WV&V,[@^\0'4G9H.# M`QC;/GMT!\=QL?/,!CY=26EA6.O+._CG;!_H\-H"1MSK90".$8R#SZ>W&!C; M;IY0&.FIXD$(.,;$]3R]QW_3`8E?&YG/$1Y>[H/';.W7$!A:E+%3:L(V"<8] MQR>ISCWP%>5*34XVXV4]#C?H>7B/9\8"B:Q)S-/JJ5!)X2F9((QM^QG\=1C? M'/\`(8"F9BKS8*D@'(.^Q!'+GMY'Q^$!AG)V9>/KA9SDG)QO@XZ]?9Y'J("< MU>F^EW)5%')/IKV=B#@G/+!\>>_,@5*]I#4%':=H]W]HQBC5NZM&*I3=(9^S[JU0IS5^T MNL6_(V^[3M7&9"R+5:MF8F12J52*NU,U6]96>K08#M"6AV+[3[*4W3+.J6C] M5U=DF*2).JV+=XNC428UJ<[0VM)O&GSKM+K-1H$UH0SV75:13-!JE.EU4A5\ M"CRM*J2KG&I6VXX^'7V&I8(EUH+W>K:0L(DJP+"3GAUQLA?/ZMLZHC/A]:QD M\X";:?V;:$K/W(J5U:M*I*<,Y:$NE3$DTI4R M\TTIR:<;;4B68>>*&U!72K*LU(/#J]:*ST`H&H8S[U6>F`[M$M.U&:Y1EM:H M6Q,K15:-IR,A%!0:$D;7K1E>RF7/OX8S0Q`6%2:+23;#+/TII9:^D+ MK@F1(U[NRX::RDRP0:4'^,(`<*RWW7"H#C*P4@+/H%ETB892I%RTMQ1`((D: MZ`20#GUJ4DXY[G;/7I`6+1+%:2S5^"L2#X1QX\]PBDQ4)9N9(159<#<;,3XS\94=.><9]NX#DJ,U+*<9<< MJ+&3)20"2U-DJ`E6N%0X6"`E:0%!.Q&1Q`*V@,:IV3)SY`8Z>W\P=GNW.'.X'0^.^V-L'W?I@.NK(.YSX;[)\MH"H+TM5A"5.>J.%+PR4E6RD+3T0>0.<'?;/7<-4IBA4I M$PZARL2;6YV5+U$D'P]635RP>1^`@,<]0J)PE7TCIJ2,[F2JYQMCI3=QR!QG M,!,)B2IB[CJ)"ND`K$K2TLJX M;IIHPC']I5[8@>":4-I(*DDH*D%*B%)P"`0"`0"`0"`0"`0"`0"`0"`0"`N.G M_P!S_=8_[[]A?S-U%_/`4Y`63IC^V5U?Q;:B?S4J4!6T!F;<_=#0O\,TO_'F M(#M7C^ZZZ?X1UO\`RG-0$<@)C>'*U?X'47^5-P$53R`ZX$!9=+XDV@P>>;F= MQYGYK8'3Q'EGD#G:`N"S9]Q`0#OR&^_3'GC/AMM[(#9^T5I>E*OEM.](='+/ M.0_)G!(^./"`A!=9;JU/24@'T^3W_\`&6?A M^C$!45?G?P[P;_OU;GPXB-MN@QGKOXP%?SCR1DJ40KEY\\G'D3CGU]\!T:K. M.J<82VK?T"G#F2=I)@=,C)QGF//<0'=IB)IQ"5*'GD9ST/CC&,<^1Y0&TVC" MV1.2Z'@,EUW&>>>%C/Z,=<^.X>@M)0T)9HH"<%"?M@/ MQ>>$XZ8_H^./#\X1.H)=6^$]"?#8[[]>?/G^0P&8D9;A;22/6/E@X'Y#T]O3 ME`?L^U^!)QN`-_+W$'QSTZCQ@(_3V^]F""`,';GD@;_;MS\]X"5>CI*-T[=> M6_F=AGQ/M]\!&*G+K2HEL8R1M@C('/<;<_'/@8#)4@.=UZXP<#/F<>S\I$!( M>8_7[H#B<(2.0_H^[G\/L"G=0)]IN7=&VZ'2-AG9"^74_5Z8Y;>0>>5Q5-ST MY\MD@%:CMDX).WAT]^YQ`1I%2=>XDD^.^<'<'IRZ^,9(Q_3`=MPF;;25`GBYY^&_/IY]=L8$!1^ND-9KKTUTWTXO#0JR=&*A+6;<;K@2H9'ML?)^]FSL^Z,ZA7WI9?=YW?+6S<\Q(VEJA4KKMBNV M+=MV)[2FM^DE9[.$M+VY:DE(3VJ&GVD^G]F:QW%,A3INWY-YC5:Q)M;EQW3;=IR:FDVEJ`R4,S]SU6DR4Q M,E;R"F38?2R6F75H"%KTAN9&D)^Y5NU6P70]8%]2:1):GZ=5!:7)NVI]AMQY$E=#ZV)5"UI5,SCP1*RC(4_ M-/-,H6XD*Y5IE<">=7T^/[W5/39?\BZE0'?HFGM;EZY1GEU.QUI:JU.<4EC4 M>P9AQ01.,J(;:8N-QQU9`PEMM"UK5A*$J40"'W==C5AZY[DF$U"STH>KU8>2 MEV_;)9>2ERH3"TI=8=KZ'V70%`.,NMH=;7E#B$K2I("-JL>KIYU"T#^]ORRE M?R:\?U\X"377:M2>%M\,Y;B>XM2DRZ^]NVUV>);:IKB4SWM71W[)XAP3#/>, M.8/=N*P%J'[!6#MY?9`6O3K-J9M279](HA6+@=>XD MW%0"R4&FL(`](34BQWH4,J8[SO0C"RC@4%$)U;=M5*64CC?HNQ&3](J$K(P/ M[VHY//S/,C&8#92SI9YF6J:''J8>\I:D`MU>E.I!,U)J!66YQ7=HPDCO'.%` M44I)XE(20_:FPM+2L3%,XL'']=Z7L.O^N\>&Z=^N>4!3M2:?35Y!STBGE*)Z M44K@JM/6HA,RTH\#:)HK<60G"4)!62>%(*B!`5/4I=]+KBE/TTY6HX-4IO$/ M6)/^N<[8&WQ)P#`0F?E%NN@=_(C)P.&IT\\R!CU9G?P_+R,!E#;KKBV'`Y+$ M&4DN<])YRF4922GB>!*3@E*MTK!"P2D@D)!(R2V$%!,K[IJ5/+&`MK3?OFJK**0I&S[A]1UM7,,C?/G`"AG'LS[_ M``/GF`^D-)1L`,>P?;^OG`-M MCC!.VY))./#W>Z`LNU)J80Q6=]OF=T9\_3I#.-SC\T!&ZY6GF$J"E*P`25$] M!U&_COCGD'V0%6N7`7:K3LJR?G*1&2?&9:SCPWY^&_C`5?4:HZMUX!9/X18( MSCDK;IX8/GS.>4!C&7GG5`E)(ZGGOSZ^_P!_.`FB9F8[YA.5X]!IXP=]O0F! MRST\O*`L2BR9FFPI>=_$;XV&_/KX>/EL%Q6/(*DZA**"-N_'+S MQY0&_MJN!4DSM^(GIR&!Y]>0]X\8"8CD/9Y?D_7W0'=D9&8GWDLL)*E*.-NG MZ>G,>.V\!.&=.*LXUQ\"LXR=SY'8>S'7?;G`1BIV[4:8I0<87C??!`&/,\\# M;;PV@,$$9.2>0!._+X[G?P@("M"VEJ;<&%I)!!V.WZ\_9 M`<3GU??XX@*GO)Y:.(A)X1Q9`W.VY.=L\6X[D[DX/4=<=-^O7&.O.`REPUU,I<=7"N$XGG,YP3C8^SEM MSQDY&8"04>[DEL_5V`'7<8&,C)\C^8Y$!6.NL\*A-6/,#_L3F4;=>&ZKB/B? M[[$!0\`@$`@$`@$`@$`@$`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`2>Z[/NU M[Z-=Q:]PNF7M6D2S_=T6HN=S,M*FN\8=X)97=O-\2>\:7AQ&1Q)&1`8.2L^[ MFW>)5JW&D`;E5#J8V]\L,>T;XSB`M!B6N:6M%F4^8JVE\7"Z\6/FR>2\&/FU MA"72T6`YW9<"DAPIX2I)`5G,!DK9D[F=>X7Z'6T@GFJF3P`VYY+')7//P@-B M;4H=2$O5N]IE105TEQ#8IQUQPG,!KZNC5R7J\BM^EU)I#=0E%K6Y)S*&T) M3,MJ4I2E-@)2`DJ*E$``9)`!@(ZB@5=YY9-,J!'>+(S)S&#N2#_8QL?NQTW@ M)A2[.J*V^)VGS:=MLRKP5G'FWT'3EY=("2KMF;3,,\$G,83)R25%+#A'&B5: M2L'U=E)4DA2>A!&`08"<4&DSB'$-^C/^L0,EI?7G^*,[G[\\X#:BP[*<>0P\ M\TH86IS?8^LEOD".6V?L&X$!M#29#T-A+8&.%(\NG+S\.>&1Y9@+.>JKZ7EB7[M+*5<*$= MT@\24;<168V('/>`_'%TRI(+<_+);4007,!2"3MS'K#SXMNO$-H"*5 M#3:GSJE.2SB"E62.!04,')V(!YD8]4CX\PCJM*%!1PH!/09QGXG[-H#(R&ES M#+B5S"AP@@DYZ1^\AJ95:-<".\2FBUEP`J'J4V<4,8(VP MR>>V^=QCV0&)NFC7#.W#5W9>A5F897.NJ;=9IDZZVXD\/"I#B&2E:>N02#`< ME+H5TI4$&W*^,XS_`%HJ&,XVW]'W\=NO/;$!A-6Y6:DC94M.2\Q*S+=LS1<8 MFFG&'V^\N>O.(XVG4H<3Q-K2M.4C*5!0]4B`I^`0"`0"`0"`0"`0"`0"`OCL MLUV@6OVG.SGITW-2$X)6;:$U)3,Q*OA;#SC:@SE=UJUCNBRT:<7+JQJ3<.GC5U5&^FK M#KE\7-5;,;O>KJG%U:\D6O/5-^B(NNIKJ%054+B3(BL3JI^=,S..&:?[P,W2 MGGF-`+L<8==96=7K"05M.+;44&SM1"4E2"DE)*4DC.,I!Z"`J/YQJ!YS\X?_ M`!I__IP%CZ9SLXNHW2%SFL`@CBWR-L0'9O":F1=MTA M,R^$BXZV$@/.8`%3F0`,*Q@#88VQR@(WZ5,_[I?_`//.?]*`F-W/OCZ*8>=' M%9]%4<.+&5%9V\("+IF9A/)][_P`XO'V*_7[@EK/I;UI-*2\Z M%&YGDE7&K/#\UL$#.8V`W/B M.N>@Q`5E5:8M-8IJT\?`:E)%7/!S-,C&_3;?\I!P%=,I=3,+2%.`]XH;%0Y* MR=\[^>WET@+6H3+CR6TJ*B21C).PZ_=XC8\H"T4T`*6TH)/]IR1VS_N5G.Y. M1'+KUSS,!S)G)A/JIF7QY!QS\\! M\+=<=SWCJW">?$M2MP,#()Z#;Q@./'QP/U.P/W0&7EBQ-R#E/?=#:N(D<1"0 MM*MQ@DCUN)2LIYXQPYQL&`%D4)I2B\XPI3IVXE)&2<@8P3`58L<22?=\<<_/R@-<];97^LTP6QZ_=G&`KR%17,O>LX$\2C]9?QY[8V]AYYZ!R76PF4N&KJ=6I*1/.X" M5$#;!QSZY\!Y;9@*WF:LMIX%#[H''D#O%[8.22>+GR!P?*`^KUFU3E/LQU:R MM0H4\@J)))`N2MD9)WVS[H"`P"`0"`0"`0"`0"`0"`0&RG8UK%-N&^4JL6WJA;X2BH4VMWM MBT:;4FI.8N$FEIF4J#T8^5DI>F#DQ2*UIE;/95D6ZMJ=?]3?K'9O^4,O'MK5 M"J4B84J:E9VXK5NFXJL_I]1WO2$34G6G:119JH3+JJ;,L,*8,LT'BG`;#=EW MLT:A]K?5ZF:*Z7+IJ;OJMNWI<\JU4).ZZR]-4ZP[4J]Y5N5HML6#;-ZW_=]P M/4>BSHI%KV19URW'59H)3+4LRS`IN`LG3']LKJ_BVU$_FI4H"MH#, MV[^Z"A?X9IG^.L0':O']UUT_PCKG^4YJ`CD!,KO_`-BF_P#L.HGN]>;_`*8" M-L(0M8"B!N.9Y7M@(U5Y M_B:PV/JI"1@=<8&_3["4K3I6I3M*"DIXC.R1.X)&)AO&1MY['IX#:`@ MDS:\(&`G!WSCEN,$[C`@)7/ MSGI+J$M[,LIX&P1@*.W$OASL3N`!@A(2",Y@.@5`'`.#L3L,#X>6P^'/>`Z/ MI$Q,3'HM.8,U,,@RH'?@X5\6 M#C(XCD9\\9VR1O`<\E:5W51PH;E4RJ=^39><(`Y;HX1[D;`=(#\J=IW;1"5/ MRWI:,94@MEMU(W/J^K@^0*=]AD#F&"$S.J5W;=+G5NY(X>Z0D`YZJ!5L.N,G MIC>`_7)F;E"GYQI[THVH[O+`4V,_WY2D<'/=2O5&,J4!DP'>;<2XD+20I*@" M",8/$,\\D'(WSX8!4WN=ATYY.,#?<$DXY^TAK??]OKJ ME.F&N[XG$H5L1N"`>GOY>T8SO`>;]_RS]`FYAEV60D`J]?NP,>!)P/<3MO\` M$*IU`FO2[AK(&$_LYW8>Q/AC'AQ'/YPJ1Z34IPX/-9YDG8_''E\?"`R=U,]S M2;+3G.:'4#_[RUH>`\-QT^X(5`(!`(!`(!`(!`(!`(!`7CV;[EUTM[6BPI/L MW5&X)76*]K@I>F]FTFW42J$I1*A:]S M250MRN-S29.KR,S*+6B`WR[;?^CHTSL&?M35.H=G&AZ07)<]JVO=#_8YL[LJ M6#I_?]QU+2W3C7JTF;[J/99LZS4Z@4NHV;?UK79:E1NDUJS*U6*36*A9TU4) MZU)V=E`\G("U='M:+_T*NB>NW3R?I,I4JM;-=LVM2E?MFW+OH5;M:YI9,K6Z M)5J!=5+J]'G92<;;96E;DGZ3*3+$O-R3\O-,-/)"Z-9NW;VH>T%:]K"YZG4265(TI,@$,L:\KHLC0V\JI:=;GJ#4)C56Q9!^;D'$MNNR;EI7_, M+EU\25@MEZ69<.V>)M.#SR$27KWK$OZ^H5PJ]LPU_F8":V!K!J;5)^Y&ZA>E M:FD2]A7S/LI=?;(;G)&VY^:DYA.&A^$EYAM#K><@*2,@C:`KE6LNJ*OK7M6S M[7V_\U`=ZB:JZBS5;H[$Q=U8=:?JM.:=;4\CA6VY-LH6E6&QLI)(.,'!@/VZ MM2K\E[FN.59NBJ-R\O7:O+L-)=1PMLLU"8;:;3E!/"A"4I3N=@(".*U)OM7U MKHJA]KJ/^A`2.Z[WNU@6WW->J#?I-JTF;?X71^%F'ES7>NJRD^LOA3G&!ZHV M@(L+\O!0WN"HG?\`VT8Z>*?U&W,[A-)6Z[L>M=N9-9GB^:^[+]Z7/7+(IK+@ M0,)QP]XKBV!))Y](#B=K5VO(27*K/*!'/O`0?'\4`^`Y^76`E]L/UIUBL+G) M^97W%'=>:*U#U'A.2*`M.P]8(6XD9SGB.!OF`[HNNJ4R64ZU49DN)_X0Y`9_ MO?LVY[8&#`8VC:GW.JL2+;M3FE-+GY1M:%.92IM;91+O\`=J5@JE&'1G.Q2IY7J#8G\9)&V,=0W$TST"H]L,-SUS]R ME:>%8DN-*^(X"CWSN=U9SQ)QPCGD[F`V&8E]/W@B3^:Z7W:0$@!IO(QRP002 M1OO^3,!(I.D6-2FR]*TZ1;R,C#+>1S.^^>GWC;.(#!5B2L.XN*6G9&07D$`I M2A"D]-B@@YS[>73>`A']273.3=](4R%C.0A;QX0-S^*L9YGKMUV@(S=VD-B7 M+(NLTE3>E>(J3W M"#,R_"$0%8S=&NFEJ5Z;3N-",\1;#K;H`_\`NEG`//&>'P)Y MP'6E9I,TCC05)6E12M"APK;4G'JJ2<85UV)VP02#DA(Y1U,^DT^<`="T*[I: MLE6R5>HHG.2$@X62#T4?J&CU-;OFA+GM4Y!B7P^].Z>RH=NV M5:8_#./TAM#?KE,![%_*ZUS46LZ,:5*U8U(T=I%RLZZZBR=DZ#:+5_L0W-2+ M@T,H%BV3:FC':"N^J=B.@T"WGKM^@]"I>DR)V_92515*/;$HO3"W+0M:3JE$ M;#P%@)MI[I]<.I]TR%FVM,6G+5NI)?5)KO74"P],Z&XIALN&77=>I%R6G:S$ MX_@-2,C,5EJ\M-':W\SVE=U8@.U>/[KKI_A'7/\IS4!'("97ARM7^!M%_E3_+(_7W_D] MD!;5$<83:O=RCA'S&[@`=?3Z?C.V?'EC?V[A6L](/J04D'KGPW]N.N M?LQRQ`1V1D5L5:G$C?YRDN6Q_MEO'V]/$;YS`8]"U(?7S^NK'3\8]3CQ'YLP M$\HM16V4^MCD#D[;=>G7;EL,0&P5I7.J1J,EOMZ-(DCI@RS!\<_H@/0"SZJ* MG2V'0[]7U$A(2!G`("1R`R?=S@*[J%?GZ@3WKR\';` M)`Q[-ON]\!B$ONH5QI<4%>/$?SP'=55)]Q'=E]PH`Q@+5D M1NZ?E0$.$/MC&4N#B.!C<$A1R>1Y[=(#.3\A;UZ4.HHFI!A$XW*NK:=2A`<; M6A"BD@\.<'&_CNDY2<0'F57)=N1NNH2[*0$J:*EH&%@KU6+6O6D#O]2YNUI:^7-2>#4*WE?0%% MDSM8MZ3O!=X8^CR;6FZ_0Y:X%5$4E^KTUJ;7.,A[8_+?TO4V6LO1ZJWI6-=9 MBWZQJ+>,Q:]$U>I'R-`MNXN^U5L24]"NBF& MK2#/':=_O>E,2XF);@FT]SW27N-6&77D2DSP=S-L[=\PI M;?$G/$`KI6I(5_L`TT3^]M=8_P#J)@.[1+^#]<],3QO.8XW5X'$LE6!G$!&U7J%?[$K)'/ZM"(Y_P#CG3I`22Z[H#7T;_TN MVN[WUJTE_P##4DK#7>*FOP+`])`1+MX_!M[\)*LDY@(H+H!&?HY:HS_>TA0_ M_N3G[ND!,9*XE_1AM]-&H">*X76NX33E=P.&G,+[T-]^3WQ/JE>3E"0G&V8" M346X'YA;:?F6WQGEBFK\3XS',^.?'>`ONU&W)V7J9-+I">&DN+PU)E(7^RY) M'=N#OCQMDJR4@I)4$\^'<..>I'X-2OF>DC;)(DE?Y[&=N7V;P%9S[(%2DD?- MM-:S/RK?$W*E+B2J9;3QH)<(#@YI.#A0!P<'`53,S?`\YB1IVSB@/V, M\ZG!/@/#80'?D*F>).)*2`)&P8.V<;[K)YY\_B8#:32RU';BG99UQADM)8DU M!7=[[L-'`];9*92.\6G"2-MW,)"B>1X?K$#/(`#$!CIQ_T=A;A!4OU4I`."I2E)"4CQRH MX.-^L!N)V;+?70;>G:]-)*0MDM,K(QQJ`*ED$X&2M7(Y)_H]W4P'`AM2]@,C\G7EGP/.`RK%.4[C"=SY'/ET_4]8#.RUO.K`(; M5C8[CJ#MMOCV#V[0'<=MIWA^ITSR]^.7G]HP>L!@)FC.-'=*MM^70^W'ECQ] MN(##KE'49!&X\ML?KX(#K%)3L1CP]GZ_9`2>V)KNYIFU?-M,=27%*"WY4K<5G(RL]X` M2?''D0=X"C[@K3,J',T2@*`R3Q4XJ&P/_P!]X@X/OY0&J.MTXB?G;/F42\K* M!=M3(]'DVNYET<%RUU.4-\2N$KP5K]8Y6HG8'`"D(!`(!`(!`(!`(!`(!`(# M;?L%T^A3_;,[,RK@UXD>S+*4G6G3NXI/7*?M.NWPC3VN6W=-+KMOUN4MBWZ/ M79JJ55%:D)%JD-S]/^C[=3J5YURS[ITG[&':%[.5F:AV9IO:5(TMMVI574GM`6E93>HM9TOI4C):36U M0-,*1,42W+0H"D!)+0LV[]0;CI=G6%:MQWM=U;=<8HMK6 ME1*E<=Q5=]F7>FWF:91:/+3E2GW6I67?F7&Y66=6B78>>4`VVM20D-?T@U9M M2W'KQNC3#4*V[1E[MJ5@S%TUZS+CH]N,7U1C-IK%EO5NHTV6IK5VTHR$\*E; MBYE-8D524VF:DVE2SX;#/T_/^A^NOP_JP6%\?H;J+^>`IN`LG3']LKJ_BVU$ M_FI4H"MH#,V[^Z"A?X9IG^.L0':O']UUT_PCKG^4YJ`CD!,KQY6I_`VB_P`J M<@(FCD/UZF`GDB/]*#/A])WO?_6IC[LY_/`36U6TJ=;!\L9'L/(8V'Z^8;A: MS:`HFOV[+LU2 M3(6A.*A)$Y3TY\6#G>` MQ\P._GJ9+DY2[-95ML0V,@O+V&`]'*5*HI5@4"5ETA"7I9"UE(QQ%2" M,X)SN>4!@!ZRAYG]?L@)12)(/%.=\^&-\_;@'/Y\P%J4JWVBE*BD#&, MGAWY?F_7ED)E+TIAL#U0<,!!:I0$-A1X0.>P'@,Y_3[8"MJC+!I9'3.^.GL!WQ^>`X* M4Z6IUA6<86D^'49]GZ^(>JKC94D@XV.#N.>_(\ MX#6VEH,XN621ZCB4+7TPD`*7D]#P@@J-QL3U&.?M/P@ M->*A,MI97QD?5Y>S=//EYXY8Z0&OEXS32WW@#GBXMN9WY#?P.<#P@->Z])IF M5+XOJ;;#!Z'GL>>_B#\8#5O7:43)3MEM)Y*M:9%D/52CRTG2:I<%7=%:2SZ'0UR4XF5D9Z9JU,#UC^7 M1J]XV3;^DFB%WVWJEIWFN4&[+/TYU`[*MZ:#6];>E^G.CUI:*:?T?3>\;O[4 M_:47?M%HB+?N&I7+-BHKN>I7Q>=PU>];HJLPFB4RD!_.1`;2=D/M%279EU4J MM\U:SI2^*%,G*V.1(771 MZG8=!TNH/:3UA[3ENMT&TI6R*%,4W4I5VZOS]M5V[)"L25N/6K2YJ2HMET9% MQS,O30TJLN?MRGZ%WD]E&K:GUS4JE)MUCNES3`6PB9RLRZEAT-.E'`0KI5>TX M/U=/*LG_`)=O*_\`VX(#O4.M6&NN49+%C5-AU56IP;=5>3KP;69MD(66S04! M80HA105)X@.$J&.U:2M MGAN!31:EU*FN[85BEJ[U3>%9>(05Y'J)QN$5%1M8@8MB<&.6;B6?A_6L?EWZ M;;A-9.=H'T5;<%"F4L?2%Q(9-:45!T4QE2GN^]`!"2@I1W?!@8XN+)Q`2RW* MO;R%IQ0YA&,`@UM:N1'A(#&PSG;W[0&SMBW'24-U$M4YYH(I:UN)-14[WC8F MY(=V,RJ`@Y*%<8R1P\./6X@%F(NVE.RI;3(N`J2<`U!1Z=3)`?)P#+LD)P6\$A..)1()(XB!G`#>S3:^G:RRVV\"%>J,$D^`]^>73P M\8#?'2F?6XVIE1)2!L-SR'+&W3;VCG`2>JGT.?EYE.>"4J"LC88;4ON\YQ@< M)QX8'6`])]+9N4O/3^7E>-)FZ:V&2G(SW?!EE:=R<%!'$2!ZV1T@([/2BY&: M<97L6UD'KMQ$9Y?K[8#/T>;[I8R=MCX9W\=]^A\\^V`M>FUQ"$)!*>G7])'N M_,(#(.7*RA)W3_\`F_H]V?AX!UA=+1..).?;_P#]9@.?Z1,J23Q)Y;>L,Y\/ MS0>0\NOYN85=4IGO'#C!SCS.`D-IVVY4GQ M,N>JRUA1)Y;>>V/%1@-;.T]= M.?CU@-9+JN1N("MJU/2JYZ9;=DG'BA:DE29U38 M/3(2EA8!/0$GW[P$>>32%)4I=&>5YFJ*'C_VF=\G[X#3SM.I837[),M+JE65 M6:X4L+=+Y2?I3<84>]*&RKC(*OJ#`/#OC,!K+`(!`(!`(!`(!`(!`(!`;R=@ MGM*:4]F?4;52KZT6=JI>%A:L=G[4;0NJHT3ON@::ZG4)C4&;MHS]9MB\+EM6 M\Z5353%%H]6MJKLO6_."I4*X:I37`)>:?2H+.[57:C[)=Y=EK2WLN=E32_M+ MV9;5A:XWWK3,U+M':R6!JN_)S5]61:=GU2@V.Q8NENF/[KKI_A'6_\IS4!'("97AO]%!_W M'40?^M-\_P!>4!%4#ZH]GCU_7\\!-V74(L]I/+-SO;>(^:F//E[>6W/$!V*; M.!I0/%PI.^3CRSY#8=<M2X%L-UK"R,4-TXSGE/4X>8VR?'IOL(#+R] MZ*;(RZ>6^3\?;[<9'OS`962O5#M0IJ5'B!J$D,'!_P!>68#X7--OMA(0GD/Q!MP@['`R/LVZP$OMV MGF2`VQ_K5GD,=??\8#=_3&U523+3RA@G&=CXMMI3ZL@<)Y^&WCRYYQT^\)94`B:])*P.!Y3I"1X*4I6WGRQCR!!Q`;6]E M&N3?>S4LX26TR*DN]0"TLA)Y],*W\.O*`N"XGDS54F5HV'>J&PQL"1G'Z[X@ M.U2Y%3I3PISG'+/+?PS[?S8$!+%R3S+6=Q@`@[[#IX8QGKS(@(I/SCC14.)1 MQRSR`WW\]O//Y`Q":@Z5?6QGPSY9W]WZ]0D,BX^\``S?V;8YGVX@(5-LK;<.1U/3R&?Z//R@+4LR=*Z3/RS7#W_H^TI!ST4,J&_GPD>>>6("A=2*:):I.*'#ZYY1^..7 M,-3[XH@7QN@'QVZ;<]QO]_*`K*I2BOG"<7P_ZJK/7;`Y#GX8QMUVQ`1Z>F1+ MMJS@8!QM@\M]_P`F,#!.W4--NTE,"9K-D+')-H/)^%U7'S^,!K?`(!`(!`(! M`(!`(!`(!`(!`(#;SL-ZV6WV>NT+0]4KFFI&0EJ3:.I%&IM0J=JW1>%.IU;N M^PK@M.F3TY2[(U(THO&6:EGJT5IKEL7E*UR@/=U6*=(528DT23H;W=L_MJ=D M?5[1/4&P-$Z'J3*,7#<+LU:EF:@T&5==HE[_`.B4ULU6KW:0J5^*O6YZQ5[X MOS1V_K*T5GJ/6'*Y711Z#Z'<%VUN3LJT*C4@\W;'8M!_0V\DWI4KCIE,&JEB MJEW[8HU-K<\Y/BTK_#;3\M5*Y06&I0RYF%*?;FG70\EI`84A:W&PB2I#0K\2 MZM5S^^L.TD_=J(J`FVG\GI&F?N4TRXM1'W#8-\IF$S]GVY+(1(*MR?$\ZRN7 MO::4Y-M2Q<7*L+0VR^^$MO/L-J+J0KI4EH]^+A]MMT1/W72J`DMTR]EGZ-]_4[G3_I6I(ENYHE*7QRH5-=RM[CK[?= MOJ];O&D%Q"=N%U6=@BXE[**O4J=TX'+-"I(/EL+B/YO;`3>6I]KJM9HF>KWH MOT@=(<-)I_?B8^;6,I[OYY+89[OA4'`[WG>$I[L`!1#&OLVDPGU*C<&P&YI% M.'3RK1@)';;]O%JKI9G:RM*J.Z'B[3Y)"D-&=D,J:[NJ.<3H6$`(4I"2DK)< MRD)4'=5+6\II*DSE9R=P/FV3!)ZC/SGD9&<[^68#FHS-&-5IZ6IJJ%[T^3+2 M'I*50V7!,MEL.+34%J2GBP%*"%J2D%02K`R$GE*+1G`I1?GR>,[*E)4\\_\` M;I/3GSP#L-H#ON4NDM(V?F\G89EY<;XP<@31QD9Y;''/E`3NS$R+=7E$AQXG MN9/ARVV$\/H[002>]R"I."H8("LI!(PJ`]!;12U\W-%&,<*>6/`#EOOC?8\_ M#:`V\TSG&7I!E3EU,U)Y# MJ2"'5;D8*@5$Y]I]OCYP$WMX-`)*@G/AD>0QN._4>`\?T"`Q"=E#V_?M`3F@N("D9QT\#D9\QC/G[/9 M`3UY,NN7/+/`23D`=<]<]#TQS@*MK*$]XKAP.>,;>/+H/<.G2`FNG$DXM]Q9 M0>[*<;\CNH9Y>!'D`2,&`TD[3%(EZ5=,8VSYXW"@+_J2ININI)R$K*1OM@`[` M9QXY\,#;$!K_`'>ZT&5!PX'U20`5#)SL"I(]^<>>\!4U3>I2)B9$P_/)=[P\ M09E9=:!D`G"G)QHJ`VYI!W/N"!5!-OS!6@SE9&=O4ITBK[ZJGX]!MUQ`:;=I M65EI2NV6W)KF7)8V@XMI/Y/+?$!8\O46A9;:58!^DSVY(VQ2I;(P? M=SY;>$!%IAQ,RA26E[[^!V\.>3D(P.OSA3?9\?+ MW0$GDZ!4D)2'"LI'0H(QCF!^7(&/M@.RW(.2-4I:N$I_KC)>.W[):.1Y'Q@/0C2RN.U"G,I6"=@,]<$#/ M/W'P\N86Y4V2U-.$CU7R74G)W2O)5 MODG9601DC;ID0$MT5K3E`OAL(5AKTIEU3?(%F8*4OH&2=CE9Y\P,8@/26[+9 M1-R;=6EDCUVDNY&/701Q[8YGA)QUQL28"LY6HKE%%)."DX.>I'M]_P`(#[G* MPIU."HG;;<=<@D[[>SE[N01AUPN+*B<_K^H@.+]?UYP&1DYQ3"AC8)Y8\S]W M/V>,!)!6UEH)XO;O]F<#<>&_7,!VJ/1W[@F1PY*`I/$3OS(Y8P,X/EOS/,0% MY2].D[0HY_I3=SJ4+"T+G%33N M"2$MMK/=@XY95W:?$<7Q",R.960G)IWU4+0$IXA@J[L*R1D\LDA..92>HV#5 MBZIA+]2FEMX([QP@YSS.!^78'D>?*`UNO*==4\II1P-\X]NVP.XSN3@=(",5 M:E=_/3>!G+R\>S(ZAZD;>/+`@-,^U4SW%Q6*CE M_I)<./\`E; MU)KQ6JI>=6JCEL.TV5T%J'97J>D5K6G8DMJ#-RU,NF5H> M-BT&F7#H;>4I5;OM^RV&M5;$F45*XV+DF).9>3:=_M"291;%`N&<$RM#JWTJ M?E698-2[H,P'2VVX$27IM:">6N>F*_WM-U5_^+38?;`36P+&MJ4G[D6QJW8- M2+MA7S++;DY#41*Y=F9MN?9=GG?3+$E4F6DFU&9F4LJ=FE,MK$M+S#Q0TH*Z M78=L)Y:P:?K_`'M/U(S_`.M8(@.[1+,MYFMT9QO5*R)E;=5IZTL,R-_)<=4B M;94&FR_9330<<("4%QQ#?$1QK0G)@/JZ[3H3MSW&\O4>SV'':[5W7)9V3O4O M2ZW*A,*4PZIJT7&5.LJ);<++SK16DEMQ:,*(1LVG0QRU%L]7LE+T_P#BM),! M)+IMZE.?1LKO2W&.ZM:DLH[R6N@^D-MKFN&:9[JW',,.Y]1+W=3`X3QLHVR$ M5-O4D6.9S`7OIV[(2K%8 M2FX*0^%T=U*BAJK?@D&TILEL%(0>["W.-:3P%'$I(3F03(SB^%->I M"NGJM5;<=1@TQ.>O(@\H#)3MIR[\Y3W4U*0=4FW=U';UE`Y_8&,CVX]W(.G+4)I" MP/G&2)_>3YP*D<3C_`?5"U`8Y8SUZ'RY'[#`=$E2O$\OT0'S`(#]P>8!^$!]<2QS*@# MS_1`7GI8\SGA5PE7>#8X/A@'GOSQS_)`8CM*70Y1;95+,KX#-)/%PD?V-"5* M5Y;\B?Z(#RIIX74YYV=>)4[/37`D]$LASA0?).Y43MSY^J(#IZB5TTZ33),> MH.`)`2,`)`P-L]/+IYP&MDRYWA<<<.2O*B6( M/UG@\1T."&673L/`8@.$KEG9^;"ZQ3FE%Y66G$5'C1G&RBW(.(ST/"HCS(S` M=Y^0DNYXE5ZDIR#S:J^`<9_%I9Y9Y>S&T!YY]KE+2+MLMMF98G&V[+4D3$L' MPRX?I5/[KKJSS^D=<_RG-0$<@)E>!VM3'2S:+_`"ILP$2XE'DG]?L@ M),0#9[>0,_25W_);'N\=M^77$!'E!(2,'VY_+O\`8?'WP$JMBH.2K5=X%*"3 M0WQL2#O4*9SG?\NP^V`S3=&<*`HI/( MD[=/M&VV3["<`QR$%2N'SP8"2R=*4Z-DDY\MS M@=-L`?J<0'%.TI;.24\@3C&`2/'V\_*`R-J5PT2=25J(;40".@.>9YOM+5=UG)J,FKO5R3:B^E&ZNY<0H+7C'XA/&K.`$@YW&(#S0IBG*?,KE'DE M+M/F`"G8%307Q((Y$`C*"-OJ^!@.GJ+143\D*@RH$=WQ)SD9!&=_/RZN4]^:4 M^D/1?MN=D7L6Z.:2:I7#H??=`NQ-NWW7J?IYJ#2=9[?U$G;MNF6[4>NFG$WH MHJWZ-,2#,U1;8[.-H:6ZS-ZBREK2HGZC<0?RK6J]W:&7C M3J*:3Z4QJK8DZX*Q<=NVTP9=NTM0&%%J#C[>)9A]R94CC=2T6FG M5H"'*T8OI'UOH7_Q=4M+E?R;Q,!-M/\`2Z[:=/W*Y-&U0E^P+ZDF_1]0M/YQ M1F)RVY^78"T2=SS"VF>]<3WLRZE$M+-\3TR\TRE2P%=*TJO!//Z)_P#%U%T\ M5_)NDP'?H>FUTRUU*3+.\=S6TU^% M:5-XX7V>\97OW;BL'`1--GUM.Q^9AU_=/;!!^%7Y^7E`2(6W4O MHJW+'YK[[Z0NO8^?J$4OP!)!@,$_9U:0CBX:7P MD=*]0N?_`#EC]>4!WZ+;-32S6@1(_AJ.XTCAJ](<'&9V06.+NYU0;3PH5^$< M*&P<`J"E(!#)4&V*XB;;X52*1Q#'#5J2H#<';$[[,YV/A`;8VZY4J>S26YA< MJ2B;E%+X:C(+)2EUDJPA,RI2U8!"4I!43LE*B0(#(4]R:F'5%1E=U+.?G"1. M"5'_`+:/F>6>F^"8#O/2KJ]B);?E^S9)6">8/[(\_DRX.4RS05@=X-L@X(V4/622""0GU(H\R7VB`C9:?JNM*Y8!!X5GR]@&T! MO'H[W;$Q*H?'KC&^0<%7,$92%D+(3S/AO@DXVQY'?[X".RT@X71ZIQG;;]'YCB`M2@4WC0G*>8' M/S]I^/\`20'-7J4E+1V'U3CV#KX>_8YQ`4Y4&BRZ<=#SQCQ&WGOG>`G]ON"9 MMJL2\U^$9]#F$D*W`!;)Y?WO,>/WP'F/<:4"[YWN1A`ESQ8(X3^%2$$YYG8^ M&!S\PX;N?;D;<[EU0XRRHX)P>-621ON0,XYDX$!Y_:C24U.!U3`1N23QO,M# MJ=RZM`]F^,YY0%`-T.H*:]"X') MA13QU.FM*P>7$AV:0M)\04I(Z@/*`T5[2KKKE>LU+Q:+K5I.H5W,Q+S3>]T7"XGA?E77F5^JL<02XHI5E*@ ME0*0&ML`@$`@$`@$`@$`@$`@$`@$`@$`@+DI_P#<_77_`!P6%_,W46`IN`LG M3']LKJ_BVU$_FI4H"MH#,VY^Z&A?X9I?^/,0':O']UUT_P`(ZW_E.:@(Y`3* M\.5J_P`#:+_*FX"&CF("7)(^B#)/_9*Z?_9;'ARW&_G[-@ZZ9IEQH-G<\L>. M-_/F/M@);;?=MRU>X=P*$]L<;9GZ;SSRZ>_IS`#(4)U*'D**<;Y)`\^G(>SE M@\^D!<=)>,Q4*2D*V$](C88P?26N7CCSSGD1XMO9\, MP$CEGEO.``\SMR`'+&X/(\P3UY\]@MZELX,MD9S)277KZ&S[/=G89SDP%T6= M3T3"DN$9PL'Q'/'+PY=>>PP8#9.S&W&ZG*I9RG"D#;.>>_QZ\]\B`V@JF!+2 M(8&WV@>7L."$.G;:[]9/"0.9]7ES\!Y_#V&`ZC5II0H>H M,\^1)V/CC??[?L"6TZCAA`"49W(@/ M->XF5R5Y5)E])"TI((4-R67^$^S/&/:.HV,!B-19!R>IB9AA7$CNRK;<8()\ MQG,!J'K MRUW,_9:.7^E>:/\`[TW",[^.,^^`H6`0"`0"`0"`0"`0"`0"`0"`0&R'9/T8 MIVONMEO::52CZI5^4JM,N:H+I.CM`H-HE7KTXSJS8VBU(??+0$KNNV[B?^C"6:#6GBW:5'9<#= M+GG"V\A4UQM+"6#P.(R.)"L*3D9`R,AAI73R]9S'=6Q7-^152YY(.>6Y8&,^ M>("=G2N]TVFVQ]'ZEW_S^Z^6_0YCC[HTYE`7PEOBX"M)2#C&1@',!%5Z?W;) MJ`F;?JZ0,YQ3IL]?_P""<>/LWZP$QMFV:N&ZTAVE5!HN45UIL.2,T@K<,_3S MP("FAQ+X4J5PIRHA)5C`40$EI-GU5"TDTJH)!Z&1F=O_`.ERVR!Y^EY^F+=I\TA")Z2*U+EG$A*4OME2E<2,)``*B21Y!):12YU!07).:!&#ZTN]]7..J/+;)@+60^J6[O\` M8SA`DI(;-+V4)5I)!*1L4J3A23@I(P<8P`M"P*VVIWN%H6A15CUD*'WCSR#] MN8#;G3SNUU9CBP1QH4,@=,CJ>NWEGGR@-@Z\L(4A9R$HDPH''+UG`<=/;G\I MR&RG9BI`>I-7F,`S*Y8+XLCB5QH()V_X0]WD,0%\4F6*I[@6D<07PGF.1&?9 MX>6"3CJ&PU&;1*2B%\/()P#U)P<'`Y[#R]G0))+SSP<0EY"2VZ0D%(R$Y(&- M]^@\"?#P#/S,M)LH[QSA`"0>$YWST&VY/+;PQ`8]N9D%N)1P!(Y#B!`)Y#<] M/S9@,C-(9E98O)2E6W3!VQZN,YYGD<`\MSX\ MX"H[QD$!*EA`VSG8\]SD>T;XV'MZA!;7:=55.[0"4GC"@-O5X3D'IC8<_;R@ M-'=:Y1-/U%FE-#@#LV^TL#;'&CO2GET4@>7(Y@(G,)#MO3"5[ALNI3G?8A"\ M#_C+5@;?'F&H]>(;=G!S`4OIG&"2=N>W+E[8#5.\1/+GG%,2,ZM*5$Y;E)AS MQY%#92>O+<=("`WS.U<=6=S@\O,>."&O/:.E)B2K%DL33+LN^+1>6ME] MMQEU''=5QJ3Q-N)2M/$G"DY`RD@C8P&N4`@$`@$`@$`@$`@$`@$`@$`@)/:- M[7GI_6FKDL.[;FLFXF&)B68K]HUZJVW6F9:;;[J:EVJI1IN2GFV9EHEN8:0^ M$/(]1Q*D[0'?N#4O4:[*>_2;JOZ]+EI=@,I;];K2Z_1$KJ]46E57IB5)74)M25),ZP"E04Z001L000 M1S@.Q=]7JR+LN=":I44(1<-:0A"9V92E"4U*9"4I2'0$I2````````(#IT5N MY*_/LR$C/51]Y]:4`)FYE1R?_P"9Y_"`](;`[/)GV+?GZ[-3[LPQ0J7+.2PF M'>%3S*7%N+Y!Z>M[P<8S`=N7:>9GZ>%.O$>G2@*5.+W'I#>0H%1!'/.1@#8C&8 M"*3%5#+SG&ZO"5JWXU#\;GSVSN<;>WQ#ML72PWDEU0.PW<4-QOCZV.F#CS'E M`=FIW3QN-):>4`9.2/JK4,DR;2BKGUSDXW.(ZCV0%PTB?EYB60A2A@A.2#NDC;B M2.OW^V`DTNF6*VU.3'$E*L@$8Y8()P,^/P\H#*5-WTI+184%);2"1Q\4J>F7P01 M]3B6VC)R0$X*3D]-SYA!KSJL<9SC.<;<@!B`\_=3 M+R^;6)KNG.%U96?55XY.V-\GF-_AS@-%+CO2J/3+RO2)M/$I1`#SJ1R_O4J\ M?<=_9`=>Z*U.NW%6&_2IE*$SKHX0\XD#E@!/&`!T`QT\"(#,VW-S'$D&>F-C M@YF'`0"`0"`0"`0"`0"`0"`0"`0%T=G;16I]HS6_3'0VC7;9MBU;5&\*+9M-NJ_ MZC.4RU*3/5N<;DI1VI/TV0JM6F%//NMRTC3*-2JG6:O4'I6F4JGS<]-L,J"] M;]["NHNG^A+NN%2NVS9YN4H%*OZH6'(HN475(:57#K7J-V>K>U%?G)J@R]JK MD*EJIIE6:*NA2U??N.4D*Q;%9K MLJZ5,O-(N.?E@MQ;F)?C1G\48YCSSG'Z0]>M.M/O2O1P&"M:PV$H`Y9`Q@>6 M?#X]0W=M'1="I=IV:9&.%*B"`D#//IO_`,5..>^8"QSH_2^Z*2PUG?;"L]1S MW'/RV]N("LKOT90AAQV69!V)`QQ))!^KQ<(]8\@%)W'N@-)=0K!,KZ0I+'`X MWQ<2<8W"CTP/?D?'E`:17];R)4N32&PE25+X\#'B21MC?PY8YP%`SKK2:E(X M(_M^3&0-P1,M4!,/FR;+TOQJ6K$C3]__$F`G/@,;^/OS`36C-JE7&SC MU@H'.,';!(.P!SCXD^,!MAI]G+$NU-2E5EN5D%NS\AJ+0Y>KTYYL3S;0]):3NM#HX24*2"=LJ(2K!XDX.Z M3DAU5U*.VV/`>`9:6O%X8!=).VV?';D3X>^`SC%Z M@8XE`Y\R#M[_`+L_`0'>5?*>'''TQ]96/@3C'Z[]0PLU>:CD)5C.=@<'&2#U M..9Y^_G`1R;NU]W*>\.#G\96WD3X]?=[@&=MJ@KN!?I$R5*:XAA.2`K&":2BMD**TGN>3:3C!W#5_4:\%OO3#BW#PH#@ M`)VPE*E:):8"%JX M>$C&Y(/N)VW`\?+;>`C.ME6367[(FT'(%K337/."FZ;A5C_UH"CX!`(!`(!` M(!`(!`(!`(!`(!`6'I1JI>NB>H-KZIZ=3E&IE\V74V:W:]6KEH6??$K1JU*' MO*?69:@7W0;EMQ56I,R&ZA1:D_27IVBU67E*O27Y.IR=,F;)?JR:NJ@4#3_3>R)9!:KMR75+427>L>T+2[WK%.;K`3+MW)5)5I'S;2%<++ M=1F&FT<:J>5JPA(3Q*45J.Y)422'L-H935OTJA^DE+CBV&EN*#;3>26TDGA: M;0@>.R1]P@/6K0NV9=XB<>;24,A)&00``A77&1CA'Z@0&U5)E)VX9\4^FY98 M00C+8QL#@JV^KGP&P&>L!9B])YQ,OWB9I[ON#..,_6WSRYY^[R@*NGFYNC3R MJ94_PK2O5XE@$X5D#=F'`9I.$N*`RQ+G.YVSW1/QY=>N]QOU774$^!98WV`Z-#?/A@\QS`,!:Z+C#JV@@MCBE)%>S;7UG)5I2E#* M=@25$<@/Q<`X`9>7FIAYQ"@L*W'#ZC?^;^!\,\X"U:!-NLIE5%8&7U)/JI`Q MPM'&`D\3_>D*/%D'/3;80%]]ER[IB1KS5+F7REMUQ=/>"CE*L9[HX. MV2H#!VV7U)$!MMJ/*!N9;?;1CC3N0G`.,G.`/'GGXP%6!3@VW^W\GWY_2'WW M[P_&(^(@'I+O+C5CH"HGW^>8#\+SJ_QB?9`<8XB1D*YCQ_7W\_?`7?3ZJNW+ M)GZHH\"I63><1G;*\$I&^,DG!VZ0'E]?ERU&[KAG433ZE2S;Y7-Y407EJ42& M]N2,;*P00D<(W4H@,'%M7='U!ZOULJX2!X!6,="#`>?.IE=,OEA M+H2IT3!P<$[,O*3G(/XR<^X9S`:K4JY*L4K4J<2!N0#+29SRQOW&WGOT@.A5 M[OK;3:^&=2G`/^M9(],DG$N2!G[=\Y@*MU-O.N2M:K4O+SP2VU..H;09227@ M``8XG)=:B>>Y43G?.V8#7UR^[E;F,IJ*=E#_`%E3\\\;_L3\OL\8#KWU5)JL M2MHSTZ[WTPY1)U*W.!MO(;N&L(0.[92AM/"D`;('%C)RK)@*]@$`@$`@$`@$ M`@$`@$`@$`@$`@-C*IV5=9:-H72NT//T2E-Z?5>FTJXF&6[AI#UV2]E5Z]KN MTSH&H%0M-J:569&R:UJ-8=V61(UV8ET-_2"EL,3+4O+5RW9JKA%Z?_<_79_' M!8/\S=1H"FX"R=,?VRNK^+;43^:E2@*V@,S;G[H:%_AFE_X\Q`9NM/"7U`KK MQY(NJL'_`-JS,![?=GJN2\[1J$^A84/1V49R,;-I!&-QMXC&.0Z0'O5V)-%= M3^T%.5FU]+K9=N"U!I3(SMSU*TZ'<$G*L.34Y(VK<4G6*RQ+,(+SS MS=.6W*O3Y;;2HEFF&=F%$?@F5C$!A-*Z+6]:+I9LW3^0%5K3DH_/S7>NI8DJ M7399;34U4JI-*!$K),.S$NR5\#CJYA]F78:>F'6VU!&NU+V/=:-(Y.1OFX)* MB5FT7YIB0G*W:LY/3S%%FGUJ3+-5IF?IE,FI1N;<_!2TXEEZ36\6Y=NX>0>OMPRU/I=;F5N`<+$R`)==];)XU= M=AA7+PVXNF,NW3/0==QRQ`6(I)EI-EQ)^J^ZKU2>B&3XC M/NYP%U::WJTVZRTMU*%ME(`)P-MMAL3G;'GG!S`>A-EW))U^EHDWW4E90G!V M)2KFE0SG?](.Q@)#0ZC.6/<;=2)4)-YYM2)IL'NVIA!3P<1_$*@@'UN9"TY5 MD$AO]1]9K+NFDR[=<=1*S:&4(4X25-.*0,%Q"CQ<.>9"CD'(&0=PX5WSI9*K M#2J@E962.)*5*&YV/$$XW.XR1MT@,Q+2]I5]`=H]9E3Q;AOO6\@GH,X)4200 M-_O$!VA9["=UU&7#8W)[QO&![\>!/3V"`QL_4]/;?3W52K$NMX#UD-O)6I)` MP04HR<^(^'(0'')W1I>^0\FKL)X3NE2P%''@DI"M^6W+IT@*]UBUDH'T>
J,YV#3.D4]Q)F*I4P&@^\J:+;@PL[_@^ M,$D@!*4J*3@J)X<8),!2.K%^2K:'F4S"0VSQ9&0,D9.^_G[AF`\N=2=143]S M,2K+P4@">/J$8]62FCS&1M@>'Y8"AZ?=P:842[R3G?ILG',Y'MV\H"(UN]U+ M*T)6>1!WSC8YZ[<\C._7)@(GJ'7ES%T5P%PD>GO;3B`SE?)51[/)_WHJ(_]XZQ^7,!%8!`(!`(!`(!`(!`(!`(!`(! M`(#:*M=KS5RO=GNB=F^?^C'T0HE&I%GIN9BCOM7[4]-KV=+ZM7/G M%5/FK(M[4Z_;JOFGR[=%8KCM9GY*7J==J%%M^VJ51PJ2TM29JU:!5K8>M:T; MJHM7J],KCTG=,E5YI,O4Z3)U*0E)F472JW1U(4)6K3K3B72\E0!258(#$JU#IZO^MCIJG][3KFV^-UF`^6M0Y:7> M9F9?3S3UE^7=;>9<13[AXFW6E!;:T\5S*3E*TA0R#N!G;:`]"_D\>Q/J-\I) MJQ>-J6I*:1:>42S:']+;[U&NNBW?4:?(OU:H^BTFE2-+I5P)?J=?KLWZ=,RT MIW\A*MR-,JDT]-MJ88EY@/Z!;&^0YUNTZ0F3IW:%[/U8ITNK+#C='U(M9S`: M24H7*N25VH1D@IXA/+"485PD^J`]-=';^=^2_P!'ZW;-3NBV+QU@U.K,M6)Q M^T79]RDT^@TB25)4601/522I<]-%#K]4GYIYVG2[:79Y$LR%AI,K,VW.SC$^3.RKKJVUR-184\K MT;TVEU!F5J,IQI[M4Q*MI5ZI4DAH"/DIK9O*JF> MF912^\9]#GZG=,Y+-*=EU(/?*ITR&RH\++B4^L%#]J+Y#3LM7;IE>,MI]K;J MS2=1W+?J"[,F;YG[1J=E+N=MA;U-:N:GT2T:/6/F2<>0B3G7*;5$3DDR^J>: M1.JEA)/A_!I?U&N[2Z^;EL*][18MF];)KT[1*]2)V6FVYJG5>E3*FGD'BG"A MUOO&P]*S+7>2\W+K9F9=;K#R'%A!%5=*U%1I=+)5DG#!_(0TE+:4_P!G_%2D M)'7"=SGW&P\\`P$KF[G;]&+?=2X2,D#A6`E2 M@,G^RCGA/LVZY@*_7?3]&G!,2X:1PJ!/`7`-E;)ED!Y(ZB]LVVT%U MNGTFI(ERK<*K4HM?!E0.Z*:G&0$A1V"<#AXLP&O6J%X3-R:0U/5BU7%*10)J M3:NNWZPHS#LM(U*;8I\K6:;/R:Y)+[*)^;E)>;D7Y9MYA$VQ,-OOH#R&@\VY MW4F9?G/3D4FC^D`KPZ69]2DAQ*D+&%5`_60I23MC!.,;0'5:OAI+:@*#0>75 MBHG/O%3`'B>N=^9,!B)B[&G"?]+EO$'F)E]?>/.+EZCQN+.,J5PU1('%@9P!Y=(#K"Y)?.]L6T!_X/5/\`_;?D M@.A6:TY5_04F3D9!BGRRY66EJ>V^VREMR:?FW"1,3$RXI:WIAQ1/>8P0`D8@ M,+`(!`(!`(!`(!`(!`(!`(!`(!`(!`(!`(#+4&@UFZ:Y1K9MVFS=9K]PU20H ME$I%/95,3U4JU4FFI*G4^381ZSTS.3;[4NPVG=;CB4]8#^P'LDV9;GR9F@#% MF3M=IM1UFU$GI*[M69V3FFGI2G55$CZ-2K1ILTP4>ETRU)5;[!F>-Q$]6)ZL MSTNL28^406EL`55DJ.^[A`2H[8RI9)&2H\_`#```#S3UL[5ER:IZI MURMSE'F>(<)'"H<0P1P@'ZQ@/=?M;]HZJ4CL54"Y;8KN4U&; M3453?SDE\NN)5Q\9=R%A6003MOTV5G)@/?+LV_*#4V;THL=V\:_W55;HLM+S M"EO%2GERP[E'$.,**U(0@J*E84[]'/GUR%ETVY"T MVG\)MG'/I@9Z^&YS]T!EGKJ*D?V7/J^(.V#CE^4YVYG,!#:G7%.YPL8WQSQC M/%X[_8/`\H#9NE:BNR>C5E4MIX.-R4K6)=[AQE#LS#=4TS;NEA/:2N'M`L:]BWIBU*#3M.+M9LRET^=?NNY*=15SB5V8S M3:XN:O:7^5B[2MDZ^ZG6S8=>L^EV91:C1VZ M-3*E;DC57Y9F;MRBU.80F==?EWU-^DSDQW*'%+6E"FVBI;GU@UYGOEG^U^VV M?],&F[J0X4D_0EMHA*4%1XOZY'A*\'(2>#=*@2.+`932WY8SM3UC5&RJ17SI M_<5%JE>EZ7-T9JB35$$X*@EV5E0J?9GIA;*&YEV7>=PA04RA25!OB+C8>N'9 MXU8U,[:.@5HZ^27:%?T&FZA-7;:=9TVL&9LUZD(G+3NFJTUBHI;O23K==EIJ MI2'H*GVC,IE>!+3TNRGCXE!_,O\`*7=IQG4/7J_[6H4^Y5I33>I)L.IWF]/- MSM0O.=H4I+T>IU:??E2*=O6Z;.MRJ:(C.VVT!<=MZA34CI1J11)G*Z?5;;G)*8"T<3:9B:4PW3SPD< M)4B?$HMM>Q:6E#B3E"J%;J#RB^LX<6HA">)1`&20`. M(`)'3E`:ORM2O*9/`)Z86`DGHH\.YSG&W/W;[=8"Y-/FJA-234W.E:W'YA2' M5JR27?JDY/4D;XSCD.60'1UCI?HM$K0^L12YE94-MNZ7[BG*%-U2VFIB3<<=+2V6)B77+)4DJ.<+:;.PQM[8"^+ND9B7M MU]YQ&$M,H25$$`92,?6`&22/#8]>K4'7`GA;)*B3G`&$D[[`[<@P./+I^O3]0`&:9J>`,JP<\M\=//Q]GLY0'. MJJ)5OWFXV.=O'R'GS^\8@.D[4"<`9/Y/CX>S?S$!:>GE[TE%)J%EW*E#,I47 MW9NB57PZA"A+S`*WD%IU;K`0BII6Q./M$GB: M6I!!VQPJ(QC8[$X'V](#DITZ4.!MQ;@:6ILJ[LX<;6V<.5HXT.&5>?<:4HH=60X`""5);)/$( M"Q[]U8KEW5^LW1427:A67&''W&F5(0$R`YW/"0I M:=O6HEPCB>2D**L'/"!QE0`"B=@3R^S\4!E:!?57I03Q<2FEX4@#B.PZ#8.S5C,TF1,XL.-M3*T*4OTN8EUF:F"V$?@ M65<*UN.G.5%"LI!4<<)2%3W/4I238%-D.\/>.B8J$RZ!E]]M+B$-RX*E*;E& MBXXM'&I3CJW7'7/KI2D(1)2QGII"$C=Q82,Y/UE8S@;\L_&`[MYW:Q+TARQZ M.PIMEN<"Z_/.8*YR;DW3W2%K6K*IB8:;4WPM-@O!4L`R>6=O"` M0"`0"`0"`0"`0"`0"`0"`0"`0"`0%S:!:/+UZU0MO2F3O2V[(KEX3DK1[9GK MJE+EFJ75+AGYZ3D:?1..V*'7IJ2?FS,NOIG9^6EJ6RU*/"8G6G5R[;P9*;[. MVH;S=*K%JRLI=MBW-/UR2M#41J9;M:U;F1:\I/SES3\L]?2K9GJ33;>;I=1% M:G[ADZ3*TWT=I2EYNW15+@J5.E9 M1B?LK3RLZF3U'I+;,U,3ES3TW;5(;FY=RV9:KR,M*U>CU:IS-7*11*Q=?T/J4[:-(N*?MU5PL(0RU-+D+ MI79*JRQ29U9KO%3P'TE)RX9FGWC,R%0#S33:9=R8#,=FJY6+.[0VA]SS;H9DJ M+JO84Y475?513$W-345(JV5ZID%S`4"D@I)!!!(@/Z(NU1HXRFL3,S+L?@G" M0KB'K(%*3)NVQ,+/(@M3$L>>`=LG(&Q' MGL0W*O&=IE2TYK+P<9#K4@1PD!M).,>9*CO[H#*R])5-.Y"`1L,8^X8Y[9QY^$!N]IK92[9T#UGU)> M_`HM;3VYJHV_DIQ--TV81)(2H))"W)Q;#30R"I2D)&ZH#P2,!^@XVZ>&WY08 M#E2H'RQT@/H*/F.O+V<\?=^F`_>(GK^2`_.+J3\3Y?'W?9`<97X>>3^8?G@+ M*G&S,TFB56#C?\GZC:`V2TDJ)IMUUF7=*4)5(R3J^)PIRA,H^E*!A2DA(<=;45`%0&R5 M8X@0]$M%>SG1K^T'3J)-/LN.S-6J[#;:\!7!*S;K:`E7=A6.$`\_6)V0#O`4 M;6>SVVB9>[EI/"5)X5)*_P`=1R@Y2,%/JJ(.V`OI`=Z\NSLS;&B5X:A):X7Z M$ND<7'Q''I=3EY503D;JX'SZP(ZCB!2)*D\`(`P.%>,;G(:T5U]3D\_Q$^JXH8.1N">6-O'&-O$F`R=IEMN?7 M./'A8D)9^?>)!(2U*LK?<.VYPEL[`@D`A.5$`A4;[SDP^],.GB=?=<><5_?. M.K*UGF>:E$\S[8#B@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@+L[/%6U-M/5RR M]1-);%J>H5X::5VEWQ(T&0MRX+GEE+HL_+N,.UBGVT6ZF*4J:6PQ,.M34F>) MY#29EMQQ&0L:S=:-6]+C8;[FF;+\II)8^I5NR)KE$OBCS$M0]0+MKE(K]PS% M>HE9H%JIJS:GJ+H])Z(WQ/VYW5ZM-33]PV?3::Z]]*V[E;DZQ M)-S]/1*EQUM81&1[3]]S[/S"FS+2KDS/57LV3M":1)W0NH4^X^S9:3.GMASE M)8IMQ,>GSEQ6X[/TRYJ?4)>IRD],5=^:HDG1IUFGN2@2J^>TSK/0J;6M.[WT MVHEGW@Y*SE`J54K]N7E0;[I]@5K5Q6OR]/G*16*XS3):@NZBS/S[+U.8MSZ6 M+IKJ:2+BKSNNM?=33Y._:?-TTZI7-1]2K MZJ=OUZUKMI-TT!-L.6TVE%1I%SYBNTNY)JHTNI3JB%.:PZ_W=K4JHKN M>EV[3UU/5K5362950Y:I,?Z9M74VB+DDVQ/52H!%&E%6;3ETB7/%.,*F9X34 M].I7+IE@HU"UMK0XVI2%MJ2M"TDA25I(4E22-PI)`((W!&8#^K*^]5F-0]`- M)M4%N!R;OS3VWZ_4U`J4A-?=DTMW$RE6=RQ6$3;"B3DJ;.<\68#1J@ZE>B5D M`D>J58!P,YR3DYR4CP\L9,!K[=L8&58V(W@ M-$\@NC6W4FW"K*2%A'UEI@/Y]X!`(#]R1 MR.(!D^)^)@/R`0%D4*8,Y9\[(K()I561-,G?B#51ERAQ&<;-I4W,SU&D[D8;(."BOI7-!:TG`45*2HX.1 M@#R`#6Q7;$F`7&U2I="ED]XIG<]"<$C.%5[2U(U'[,.I=FH*55 MB;;ILWW6"EQ#4I.L3;P*!D>HEDKRKBW22-P,AYX5VXG:Z_:LHM7>-RCO>9&> M).&P`E6!PGA&23@X&0-@,A5]067IQY6<<3JR#TP5''B.1`Y9]T!DDS?S?;-; M?P>\G&FJ4R=B`J<4>_).-LRC4PG(/-0\1`5C`,'P@$`@&,\H!C'.`0"`0"`0 M"`0"`0"`0"`0"`0"`V@[.>LUL:/T'7P7!;]/NN>OO3"BVK;-N5I5V2]"JM7E M=5].[JF45:H63J$K*2UO-:RNS5BV9IE;]M56NWE?$_3*-6+ M):JUR2,K6-96[LLBIT2[Y;NE42GVMI4B6L29IKE>F6!,2=1E&;5JDM=,]7Z< M$&D-?M-Z5VW[AULI]%EK?TE5?.I,I9LK8=GT>V'[/LBO4>Z+/L*Y*#:<@*1( MLW'9M,JE$NIIMQ^6J,[7J29B:J2:H^N>`;`61JWH5-47Y@JE[6=69S1+LU4F MTZ%JQJCIK3+M17KOJG:SMJ^)N7LRP+TE*Q6:Q+6_I_=->MZ3[^DFN,TM-SU) M%,E*++(4@*YKW:#T-JU(E:;1:?+6[:-OU3MP2UI6$[85+54J/1];+%NB5T8F M#<4C(NKG$T*L52E4><9G:L_-45V0DI^7#\C2I"8EPI#M$WUI->%%T_9TP%'I M\I3:32&?HM(:6T6T:K:#5/N:O(J%5;JA:8J" M:DFL,3E9J%"I8:K0'LCV>-27;B[$+%NS$QQSNE>H5;K;2/JIPRE(!XG+L[FIJ4',*"E`')SR/@<=?'.Y\(#EDILS]DW6 MK/$35'W?/*B2#GVD>[GD;D*?ELO6_<94!D2:QG;;"/?DC?PZP$&57%N6_(21 M0U0:&I0P"%-=S<(&?Q7LC8X@/ M.F`0"`0"`0"`E-K.GOJC*RKC4PE9_>MI>2,9/KD=8#)2:@B;; M4M7=I#FZCDX"3G)&_M^&8"4WC4Y"IKI,S).*/-ES3^^IQ25#B"G*?;50FI=7#Q#^QN MH2L'&Q`(P0("M+;7+FH>D3;Q:;E*?.3"3PJ45.H:*6D(2G?B)(`XL#.,J&V` MCTPI+K[BTY*5J)`/FN_R=C2'.QC\M&M;2%EGL/Z3K;6I"5*:6>V[V:$%3:B"4**%+05 M)()2I22<$B`]!^U9V8OD_P#0_P#T0E?E.R=3Y6U^Q/VG_DQ?I4F3U3UFGJMK MEI1VI-#*MJ7KKIW=R*A?[DE0Y'TRW5)L.K6&U:EU44SK789M.V&>T#JE2NPSV].T)I;4+0N6\ZM<]]:C7!0;PU![!EI6A; MEKUQKZ377(:"6[IMJK*V?3Z54)VYJ_JK6Z'<,CM6@5E#$W0*/1JI1*3,R`;%=HOLC]F[M=_*1]H#LVW%HMI[V67]3 M.QQV3];.Q[KK1*CJE0+!N6TM+-/M)[TUQO*G.7;?%RV9>]OU/L_LZT4-FOV] M)/4I%8T`I3+/>7\]?E5N8/Y6M8:]85T:LZF7'I79J-.],:[?MW5;3JPFZC5Z MP+-L:?K\_-6G;"ZM7ZC5ZU5'J)079"G/U"J5.>GIUZ7I+8J;R2O&'%`'/F,9'+?F"2>0//,!L M=H_3&J[8MV%1!4@K=_OB=DCQVSN?:1R@*MF:$/MY!SR"@N;4*H%;O>L4"3D+:E!G(;12F>&<0GR557J@[@;`ND#80%/P"`0" M`0"`0$EM(GYZ:2#@+E*DA7@4FGS)P>>W$$GR(!YB`R*E9<(\"<^)SO[O'GO` M?LP0"WX<(Y;^)QRY==O'I`3W4&H/ST[12XKB3*VG;$BG)*B&Y:F-!*<'`"05 M'`&WK9!.8"!>.?U'G]L!/=/:JY29^MNHQB8LZ[9#!))Q.42;ECA(QDX6=CMO MR/0(93_5=6G*4ER3?2>($\D\6,C&/JD`DG[\!CL85@'<''NY?#;ID[GE`<%P M!(E*60?7*ISB&_(>C8VY#GCEO[H"+0'VEUQ"7$(<6A#J0AU*5J2EQ(4%A+B0 M0%I"TI4`H$!20H#(!@/M4S,+#@6^\L.EM3H4ZM0<+*2EHN`J/&6DDI;*LE"2 M0G`@`F9@.IF`^\'T<`0\'5AU(;0EML)\NY(W%4&.19FG4 M'BV/JJX2,;;Y2>G+;/,0&T'9^J(8M"YD')[V66,=G'4[C MC:E4%]2.1!X@@I'M@*DFYEZ=FIF` M0"`0"`0"`D5J_MRU_P""U'_$)G]?T;P&6",N'SS[L8'C[/OZ0')/ME#K*#L2 MVV1@;[D`?ROLQCK`3*^FRQ5)674`%-4FE(*4C'"$R30PH$9&=CT&`DC8B`A, M!E:,\6GIH#ZQI]11P$@8XI5T$9/K'(/+."3`=*4.)AL)SCN7@-DG/J*'+8<^ M>)7D1G'LY''3?KS/E`<-P`>@4H]>]G@?_`-,?;MT\O&`BD`@$ M`@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@/I*E(4E:3A25!22.BDG M(/N(@-B[XFDUIZ1N%*1_7VFR-55RX4/SDHTY--CA./P,WWS2L'`4DB`N/1=P MM6W6D#;O)5TGZW,`C)'Z!L(#`2S9FJ9="!ZQ2V^>>^`#@'(WP/ZN8\!PM\!WY+&QSF`K^ M`0"`0"`0"`0$BM89K3`_[6J!'M%/F?NYX/A`9UD9?*1O@JP/=^;?/GY0'8J2 MDHFI-9"5I0VPM61@*X59*=SME(X>+;;:`S-Z5!53N"["$*0QP(1R0TEEL M(3DX)".()!(SP\.`BH.1OOTV!\/'^C'(X,!VY+B2\Z<')E)@^L.8+"B,\ MOK#A]Q@.NPX0Z@YQA"T@#.,*"MMN6?/SQSS`==2O65]N_,Y/Y,8S^>`X*^1Z M#3.OX6=\/"5\/;`16`0"`0"`0"`0"`0"`0"`0"`0"`0"`0"`0"`0"`0"`0"` M0"`MZE3RY^S:&,[0'/;&WA@;=(#:/5HLIGK:X`!Q2,OG&V_`D_F MV/4\N4!KS<@Q/-'F2R>>^3QKQC;//',_E@(?7W_P?0.*OC$A2O-R=/^+0$4@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@$`@$ M`@$`@$`@$`@)I:4UANK2*E'A>EVYMM/0NRJE(4/>R^XH[\FQ`6[;=45(TY(" MB..5*?`8*U^\\CRZ'R)@.6WJL6U5@<6SLLZG'4CA.X&W\KEUQ`4]+*X:HRK; M:>;.!@8_##^@;_`;@-A-39\3$];Y!)*).7&1L<\"1GI]\!3=PJXYZ7Y^LP-A MOD%Q8&#Y;X]^,F`KFIO=_.O*'U4J#:/WC8"4G&!S`!WR?.`Z$`@$`@$`@$`@ M)#:ZN&LLD=)>?Z9_UC,9S[.?N@)"RVT_,I0]WA05$DMJ`7MN0DJXDC)&0<'! M@+_T$T.N'M):R4?2ZS5*:JE;MSVM-#?H4M;"Y.O3I3;< MHMUV7H++SAF&*4RM]Z8?6U)LNH9;4\\\YP`%:BK.`K(XXB`>7+KOC&>?+?P& M_78P'7KJBJ2IF?Q7)P8\,^CYZ`\QMGS@(Q`(!`(!`(!`(!`(!`(!`(!`(!`( M!`(!`(!`(!`(!`(!`(!`9.C+6FI2H;XBIU98`2"2KOT*9X`$@D\?'PX`/.`L M-4V[+2S#1"VU"7`*5A22/PB\I(VQMR'GS@."0J*V53)!_LK3B3OSSN1[`,=" M.9Q`1Y"B'TN@*PAX+X@,@$*SO[?UVQ`6#<5?349BG+XC^`9:1N>H2!S.3SSX M[>^`X32)^XJG2)6ERC\],/,DE#".-*0AU:G%'.`$M->NO)V2#MM`4T[GO7,\ M^-6?#ZQY9Z>'E`<<`@$`@$`@$`@)%:HXJU+IQG+$^"-^7H$SD[`\N?0>)$!( M$@I?)QMD_#&3X[]?"`WI^3-KZK<[<6B57[Y3'=$FTE:N/A+@26PI1"U84,EV+8:;4I4G,ELI;2<^JT04%!(W)"D<(5@J*0`"1`9Z[C+2/9RL M6;3@.!$@5%)R4`%'&$Y];*58YE.^!Q#&P?RU]J>=-1[0.J,ZHD^D7--K!(/U M>[:`)R.>!GS)VP-H#7_A"FDRCRF@DE1X M`A2@$A2RI12-MR3X;YS`5JVOAXO/B'AGF/M\=]_*`YEN(]`;2,<0<(SC/%A6 M<_#`ZX'.`ZCCJN))SG`Z[\L`#',=,].6T!L?V?YJCS%R,R%8EF9A*EH[KO0, MI"E!"RA6RDD`E64D'/7;<-39Y/!.SB,'PX7EC'NQB`ZL`@$`@$`@$ M`@)-:`S7I8NAFE.TMB4MV0?FFYNB5`2\A5FZB_6UHRV M]-3@$N`TW*]RXIT/?ND7+2:10JK8*J5<4ZY.K13)&?1)U!:C-NS::;3&7&Y& M5=8<74ZJEU$HI"A^P6_3G.[ER%J"L*?V1-)-8;EK8JU_:CR$[,2,Z&I"F6D^ M9N9J511T]V^\!P*G9;BV= MZ8SW:^?C]7J?;`6#IU=%%H%QR%2J,_Z++L/H6M?<3+G"@*R^R'6M-M8M6FK5O2>U/K%PLVW]&]0:PI5-G&*3* MRU2>73;-K]O<+0EG'TR;>$_:=G&;JU);EFU M.+OI]J;:EPT53300K7;Y53L2W->U2J5B:KROT>EF?F^V)9G3B_I/NZ#;S/S9 M0D5!%4H3Y%?NZDKJD[>DSW3LLY<=1E9]"U<#I8#07Y2?MF=F77[LM:=6;IOJ MTU>FH%#U"36JC0T6]?=)5)TY5.GI:9GRNKVA0:"/2)ATS`EY:D]/J.>)QS3S]_+K`=:ISK4S+RC+2N(-+F%JV4,%SN@-E`#< ;(.X\/#A@,-`(!`(!`(!`(!`(!`(!`(!`?__9 ` end GRAPHIC 9 g852944g28b95.jpg GRAPHIC begin 644 g852944g28b95.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1JB4&AO=&]S:&]P(#,N,``X0DE-!`0` M``````\<`5H``QLE1QP"```"````.$))300E```````0S<_Z?:C'O@D%<':N MKP7#3CA"24T$.@``````\0```!`````!```````+<')I;G1/=71P=70````% M`````%!S=%-B;V]L`0````!);G1E96YU;0````!);G1E`````$-L```````$`````#A"24T$&@`` M```#-0````8``````````````OT```=L``````````$````````````````` M`````````0`````````````';````OT``````````````````````0`````` M```````````````````0`````0```````&YU;&P````"````!F)O=6YD'1)D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX` M```'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E7!E96YU;0```!%%4VQI8V5"1T-O M;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/ M=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H M=$]U='-E=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$ M$0```````0$`.$))3004```````$`````CA"24T$#``````0^0````$```"@ M````0````>```'@````0W0`8``'_V/_M``Q!9&]B95]#30`!_^X`#D%D;V)E M`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P, M#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X. M#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,_\``$0@`0`"@`P$B``(1`0,1`?_=``0`"O_$`3\```$%`0$!`0$! M``````````,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<( M"0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C M)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3 M=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1 M``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S M)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`" M$0,1`#\`S_K3FYN+]8^I8V/EY&-C8]C*Z::;[:JZV"F@AE=5-C*ZV-G\UJSK MNHY^,]M>9UJ_%M=!-5F7E.L;/^FKH-OH._X.YU=BO_68VCZX]:LI#3=58PT% MVC6VV-PL.BUVCOYA^1]H_P",J8O3>G?5SI/2L!G2<.EGIN:?M+[&MLLN)_G+ MM9:YWY_L_,K_1?HTE/DEN=UFK4Y^<:G:UWMRKW5/;/IBQE]=[ZO<_V M^F]_K?\`!J'[3ZK_`.6.;_[%7_\`I9=/]_<+PT`-UUIS_JFKHOK1U4X'USZM%%=\W5NVV5&S_`T=VN: MDIQZ>J];R'FO'S\^^QHES*[J77:!.1F]1H'C;=DUC_`,%> MQ;G0\ZGZQ];P>GYYLIQAO>S'J:6^J\,=^JB_"]#*HKJK:Z[?:^W^874YOU4P M<=OZK?GX1[%N5;']IF99;6]O]A)3YP.K]7(!'4LP@\'[5?\`^E5&WK'66UN( MZEFR/^[5_P#Z56WU;H(8Y[WNJ!`W#-K#*X,_]Z>+C?H'4._\M,1E=E7_`&LH M?7_-\SELLJ%M5K37;6=EC'\[FM9D7-:-/H[6V;6[5+KC M2[_&AU%S9W4L%[8$F:,;&RO:T?G_`*'V+I.N547^O58T&J0+&_N@B:;F_P!C MV_V$E/F?[>ZY_P"66;_[$W?^E4OV_P!<_P#++,_]B;O_`$JI];Z39@7&-:S. MURR=Z2G0M^L'716XCJ>9,:?K-W_I5=C];,^UOUVZGCY/5,[`PV>GZ7V:UX:V MPX^,^MCF>K73338]]GJW?^K%YW:[]&Y=C_C!(_YZ=6:=0742/_0;&24V'8?6 MP*VOZOU#$MOTH^V6WLIM)^@VG/QLG*Q/4=^YZBR\C.^L&+>_&R<[.JNK^DPY M5W!^B]KA=M?6_P#,>U`KZYU"G8ZJTD[2V^JR'47`_F9.-_-W,>SVOW,W_P"B M_?6Q?TAF9CNS;\@T,MQ#F=*I!;82US=XQ'_&JF+00".")4,A_Z"S^J M?R)*?__0P_KADTT_7;J[,@$XU[Q3D!OT@QU6.[U:_P#A<>ZNK(K_`.*70U?X MPNN8V-39DX-6;<*ALSVY#,>J]AU9DOHR&,LQW_S?JM]G_6%QW^,-Y;]=.JC_ M`(5G_GJI5^E_65E%-.'GTLOHI,57$!SZFN.NCP_>QO\`824D^L?73U2XM9:2 MYUANR'M+G[K2(V4;6U_H*MVW^7_Q:8?M#I?1[,:QN/97UNIE@>'%UK&MX]OT M/_4OY_Z);.;CT7/;996USZOYMT?1UGVPJ(Z5=E.>,>O=MC>>PW3MG_I)*KO_P""]%:'UZ,?7#JW_',_\\T)*<6IS*"=@<'. M&QCV$M+#.[?O9[_S-BL,ZCU)GT,[*9'$9%H_]&(%5D-N&X#?7MAQ#9]S';07 M[6[M$/!ZM3B-NZUT?IZ'?1MW?I%4^LN*RJFK( MK`8'@5;1Q#1-6UW_``+6OH;_`,!Z%?\`@%E;EJ5.^W_5W,Q7>Z[#9ZM1.NE; MF6-V_N_J_P!JJ_ZVDIZ.ZEN1_CDR\=VK;J[*R/)V`UJU\^QSJJ+W^TEC&N($ M;"YK):6_Z#U/=[OH>I_;6;3_`/EQ?_:_]L6J]UT#%>ZMWL89J=/NK,?HV;P? MYMW^"?\`0_MI*<'/].QKL:YLM/T/E^Z?WF+C>HX;L:TQJP_1*Z/,R'066`[1 MINY`(^C[OI-_>K65E.<]I;:);^]_WY)3AV.EA77_`.,9^WZ[]5'G1_[;8ZY+ M*J-1(/!X*Z;_`!FNCZ]=4_ZQ_P"V^.DIP_578]`QV68_3+KI=1BT;75&2TMR M#;O]5OT;&;W;/2=^8N"]2-5ZOTOH6<_H?3+<>HO-.%4;'-A[-SGWD^E8USV_ M:*ZMGJ;?YO\`?24\#UG`/2^H/QAK2?=CN.OL/YN[_@UGW634\>(7?_6'ZI=7 MZC0UE;:[0_%R^IXU&148LJLM:US3&[W-GU2_\N,/_MYG_DDE/G+O MJ]]:7?\`>3D?/T__`$LNB^I?0>I8[,\=2PK<3^N/U4ZK;]4Z<'!QCE M9+.J6Y6RKD4VV9MU>[U/3^@S*J99M_PG\A8OUQ^JGUES?K1U'+P^G77X]UC7 M5VMV0X"JIFF^QOYS%Z-_ST^J7_EQA_\`;S/_`"27_/3ZI?\`EQA_]O,_\DDI M\@_YD_6__P`JQB?]NM_O24^0_P#,GZW_`/E3D??7_P"E5I=`^J7UHQ\RUN3TRZNC M(I=2\NV0-P=6QWML/\WZOJ+TS_GM]43_`-[&)_VZW^]/_P`]/JE_Y<8?_;S/ M_))*>#Z]]7?K%_XXUO7<;"RW8E5U-E=^**RYVRFECVM]:RMNQVU]5F[Z:W[[ M?M-UEV1]6NJ/-\FYDT;0Z(WU?K/^O\Y_7W?^>GU2_P#+C#_[>9_Y)+_GI]4O M_+C#_P"WF?\`DDE//-;CLES/JGGDEL.K(HV%P[_TG=7O;]/9[/\`@GJ+L?#) MEOU3Z@TCO%'N!^G78TY.UVW\RW^>_P#1G1_\]/JE_P"7&'_V\S_R27_/3ZI? M^7&'_P!O,_\`))*>*ZC]7>FYU-C/^:_5,_(?^=_@?H+(^O_ M`-3OK/U/ZW]0S<'I]M^-;Z/IVMVP=M--;HW.;]%[-J],_P">GU2_\N,/_MYG M_DDO^>GU2_\`+C#_`.WF?^224^)_^-]]<_\`RIN^]G_DU?Z5]7?\9O1W[^F8 MV7B^+&.;L/\`6I<]U3O\Q>N_\]/JE_Y<8?\`V\S_`,DE_P`]/JE_Y<8?_;S/ M_))*>1PNO_XS*6?K?U;9DWCB]NVIVO=[6O>QRY;ZR=#_`,8GUBR_M6;TJT!@ M(KK;LAH//NW[G+H\W_&FSI/UPRZ3:WJ70+A4:W4%KC2[TZ_4=CO;[;6.?N]: MBQ_\Y_-^G^DKM]%Z?U#"ZGAU9V!!_.8]OT;*W_I*W_SB2G_ MTN._QC_^+;JO_&,_\]UJO]7A_3 M%4^L.3@TXAQ:\?I=EF0YVW(P"YUE8KL=_.N>/2_6&_S?HMJ_1?X.O^;7L7_C M=_4K_P`JJOO?_P"32_\`&[^I7_E55][_`/R:2GP;I1Z*&Y?[6%Y/V=_V+[.6 MC]8T]+U]_P#@?WU7P7T5YN/9D.L;0RUCK74QZH8'`V.H]3V>MM_FM_YZ^@?_ M`!N_J5_Y55?>_P#\FE_XW?U*_P#*JK[W_P#DTE/G&-U')S',NPK>M75@,=:[ MTL>PNJ>?2>UE6WWWW;,]E=WZ3V4^GZ=E?\VL9W4J668U8ZM55B.&2YM+<8-K M-NYTVT,8W[+OR?VA^BW;/T=%7_%>D_\`,#ZH[0S]G@,`+0P6W!H:X[GL#1;M MV/=]-B@/\77U+:06],8"."'V`_?ZB2GS]^5UBL9%N6_K3,"F?3)Q\4[&5U65 MYGJN_4YID=.:"1M/Z2W5O[COTON9_)3?^-W]2O\`RJJ^ M]_\`Y-)3X5C_`&+]N.?@BLXE=EEN-7U`MVO96'6TT94&NO=]3U/_QN_J5_Y55? M>_\`\FE_XW?U*_\`*JK[W_\`DTE/EQ?TIM]E#W]#-;P]C8I?M]GM]3[0Q[K: M7Y#<9GH?SW]*_2>G?ZB%ZG3V6#>[HCB[;8QHJGFM:WW/?5=7 M=3;_`(*VW_M-ZM_XW?U*_P#*JK[W_P#DTO\`QN_J5_Y55?>__P`FDI\2^M#< M9U]%^._`AS75NIZ>US6M+';M]['^WU;?5_P-V15^B_GE5R#T3]BXPH%O[7WN M^U%W\ULE_I^GK]+;Z7YJ]W_\;OZE?^557WO_`/)I?^-W]2O_`"JJ^]__`)-) M3X7T_P#YM?9?\I_;?M>]T?9O2],LV_H_Y[](VSU?I_\`!HY_YF$$`]2:8T)% M#M=S_=MEG^!]'\[^<]3^NO;?_&[^I7_E55][_P#R:7_C=_4K_P`JJOO?_P"3 M24^%]1/U9^RC]F#-&5O;/VGTC7ZIZ6S^0M_P#Q8W?6YO6#7]7P M+,80[.JO)&+M=[6NNG;6O2^F=*Z=TC#9@].H;C8U?#& M=S^^]Q]]ECO])9[TE/\`_]D`.$))300A``````!5`````0$````/`$$`9`!O M`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@` M;P!T`&\`FMC.60B/SX\>#IX;7!M971A('AM M;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835`@0V]R92`U+C$N M,B(^"B`\"UN7!E+U)E&UP.D-R96%T;W)4 M;V]L/2)!9&]B92!0:&]T;W-H;W`@0T,@*$UA8VEN=&]S:"DB"B`@('AM<#I# M&UP+FEI9#HW.3)$-C-#13,P0SE%-#$Q.48Q1D%#-T5#13-& M,S(T,B(*("`@("`@&UP34TZ M1&5R:79E9$9R;VT*("`@('-T4F5F.FEN&UP+F1I9#HR9#`R,S0X9"TW,&(P+30W8F4M8C`W M,2TX8V)E,S9F8CEB8C<\+W)D9CIL:3X*("`@("`\&UP M;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"CP_>'!A8VME="!E;F0](G1````4"!`,#!08.!PX.$0,%`0(#!`4&!P`($2$)$C$305$*%!IA M<14B@9&A\!87(S)25E=8E)>QP=76&$)9F-'4X1DD)R@S-S@Y4V)RM-CQ)2DT M-4-':'5W>(*2N,@F-D9(5&9GDFY*DM%0%8RGG,L_2.Z=BI-U#)*I"J/U%`Z3D:<4#[HEL?Q/T?_%\`](TXH'W1+8^ MWZ3]'_Q?3`/2-.*!]T2V/XGZ/_B^`>D:<4#[HEL?Q/T?_%\`](TXH'W1+8_B M?H_^+X!Z1IQ0/NB6Q_$_1_\`%\`](TXH'W1+8_B?H_\`B_Y,`](TXH'W1+8_ MB?H_^+X!Z1IQ0/NB6Q_$_1_\7P#TC3B@?=$MC^)^C_XO@'I&G%`^Z);'\3]' M_P`7P#TC3B@?=$MC^)^C_P"+X!Z1IQ0/NB6Q_$_1_P`7^I\`](TXH'W1+8_B M?H_^+X!Z1IQ0/NB6Q_$_2'\7P&R]P'L_F8_/O;7,%4^8R?IR>E;>5S1T#3*M M.4I$TJBWCIF`DY!\FY0BDTRNU#N6J)DU5M3)D`2%V,.`B[XT?&CSW9*<]M96 M%L+65"PENH2A;;SK!C.VXINI9$LC4M.)2DK<53[I%K?Q,T7_%L`])6XJGW2+6?B9HS; MUZ^;8!Z2MQ5-/ZY%K?Q,T9K_`(MI@'I*W%4V_HDVM_$Q1?R_SM^3\N`>DK<5 M3[I-K?Q,T7_%O@_EP#TE;BJ?=)M;^)FB_C_U-\^\,`])6XJGW2;6_B9HO^+> MK7X?B!Z2MQ5/NDVM_$S1?7\&Z_)@'I*W%4^Z3:WV?28HS?XVWP=?#VX!Z2MQ M5/NDVM]GTF:,_BO3Y?'`/25N*IT^F3:W\3%%]_C_`#MZN[X0P#TE;BJ?=)M; M[/I,T7_%<`])6XJGW2;6_B8HO\[;`/25N*I]TBUH_P#J9HO^+!U^>F`>DJ\5 M3[I5K?Q,T7_%<`])7XJGW2+6>SZ3-&;C^#==L!L>>3Z<3'-;Q#7V:IOF8J6E M:A3M.TLVM1WT-47"TD9J>M5KFDG?/1ATTP?@J6EXGS<%P'S<2+"F/U M4"<:;/9P\\[5&6-RTU;0$'0$WERH6Y+YG5%NH&K)$]4SU?W5IZ173DY,/.$F M9XVDX8B;,OU))5)=4OOG!]`@X]*3XN&VEQ;.CKL(?22I#8?:)0]H_P`&`E2R M6\>[/O=>O%I*\EQ+7IVTI&S-"7EJR/BK60S20'AQ0LWV96A;O3US*@A&E0ENQ53JUD$K; MR`AE&=DUGJM,4>\,Z8%*WJQ5M7%*W&IJ1J$B+3SQ]31S^YK1FYCUGH:]U6>4 MA\6^G@U+<.U1?>@<.VLI1HAH8-0`!*B4!UU#H(CIX#@+2N/*B>+@B<2A<:SP MZ=WTDJ1UU#J73DUU[^NW37H(AZ?I2?%P[[BV=[_]I.C^[_D_#[/@P`?*D^+A MIK],6SN@==;)TAX?X/R],!0/*D^+?WW&LYW?[2=(;>.NH=/CW[^_`/2D^+AK MH%QK.?#9.D.NO3ZWV>KK@'I2?%P[[BVX=O5KO@*^E)\6_ M;^B+9S??7Z2=(;:_\GV^KKO@*#Y4GQ<-=KBV<'?H%DZ0';01'?E^`.OYL!4/ M*D^+@/\`MC6=\0_H)4AX]/K?#7@#W]-L`]*3XMX#I],:S8]-?Z"=(Z!\/*'RZ8#8I\G6XNF<_B07IS'T1F@J: MAYZ!MI:^D*JI9*E*"A:/<(2\S5;N(>J.W,6`'>H&9(D*FBK[Q-34Y=3=`]+C MV<7;.ID"S96SM'EPJRBH&BZGR^T[<.6:U';^!JMZK4TG<.Y=..ETI"52470: MC&4O$D(T3T3(L1=;DN<5?3^N1:ONZ68HP>N_7S?Y^&N`KZ2YQ5ONCVJZ]/I,4;K_B_SUV]0/27. M*M]TFU7=O])BC?XM\/STP#TESBK?=(M7^)BC/#`IZ2YQ5_ND6K]OTF*,_B_P`]?9@)W^`3Q9LY?$"S'7DM MKF2JJC)^EJ,LF>N8%O3=!0-)NT9\M=4I``LN\B4R*N6XQ\P\(+534G:BFKL9 M/<($./)_;9,V_P#OA9S_`*/-I,!$/@&`?GP#`,`P#`,`P#`,`P#`,`P#`,!N MQ>2G_P!93-S_`,*5N/\`Z3G,!!?Y2OI_-5+D:]UK+,^&W_88V^?R]P8"`S80 MUV'Y?;IWZ_/3`/F/J]O7Q#U?(`A4/Y/Y?5_FU]04T#;;;P^#Y^/AZ\`\->[? MN]0"._A\6_C@&GM]GJZ?%I\]<`Z;`.FWL]6WQ]/@TP#K\_GTZ;AW;X!Z]/6' M3O\`X<`Z]_ST^7Q^3`5W\?Y/G[K+E@$W5,W*R MJQM:TK7]&%3AD']3TK5$0UNW5%`R[@6M0T\HE*0L@S!9A)-TU"IJ$()TCE525337;.$%TU6K MQFZ11>L7B*[-X@@\061`(DJVIE:,>KI&2$HE.8!+H(:@`CZNX=]>FN@ZZ#N% MIERB0P@(>^`=!#IKMMH(CH&VFG378`P'JBH&H]-N[IH/3?7H'@&NNNNW4X=O5\8;`.F^W=T"@J`.G<(;]0WVUZ=/DV`.FXX"G:=!W#7<--]-/A` M1UW$`TU'OVU#`5[4-]==-]/@]0#J.@[]>O<&V`=J`]^XZ_'H`:]_7;OZ``], M!3M@U$-?'3I\'7;Y=/'`5[740U'37P[@ZB`B'LWZ]=1TP`%=--]NFH::".FN M@]=-1T#X-]AP#M.X!\.@``Z]V^H#H.FH:=X^K`.TT#Z[00T$`TWZAUTTVUZZ MA@-R+R-PW-F7SG]-K%V[Z!_X_P`AZ@#XOR"&`_'E7_\`9_V4#I_2B4;O_P"N M"]NWC^7?3;`:OX`(B4@:"83`4`V#<1T`-]M1'0-=?4.`D^@.#SGYJ>TM(7D8 M6$KAE2=:0[6H($SAI2\U*2T)((E=14NE2],UK*5U$QDJQ.F_CG,O2":[R/7; M/2LD4%TQ.&+U5*G-4VHF$NDQI:M7\2R0703.1P]J4:6:T M]&E!P99B<)60CP\Z:JD0.X+R&,'5H/+[6044H8![)F\>JK..8-?ZL M:/;O$$@T`?K5E3A]:=,@ZZ!UVH++W&ITJBJU/K2;1,.8SV#,652Y0W,<6[?_ M`$023*&YCN&2)2AU$`UP%K3%$@F(<#%.4PE,4P"42F`=!*8!W`P"`@)1`-!Z MZ;X#\X!@&`>H/S?+_!KI@&`KT_*._7KK^<._OP%,`^>G=\0>T?#`5]0_/X]/ M``WZ!W8"GS[ORX"NG3U]_P#!KI\^_3`;5?DF6V9^:>Z:GF1`YNCLJ-JPD$IN@KQTU<=4C- MPY;1S1Y`S+@$@:O72H-FM.2$N=Y)(L6HD4,U1>-&KI=1--57L6SU<+/9J;(W M:IRVJ[VS=E("X=7KKJM%%8M0"RL4W+'>AE5#U6D:M8+4=<..<+Q\C`2:"\?V\@T5,BZ;M$7W*Z; M/D5"&(XAGP%D$#@SV?%\^N`K\_G\>` M:Z_F[_GH/7`4U_DUVP#<0_)\7P_GV\)];,-=!_886K'V:7%] MWZ[HB$<2D=+J*/KAT)'H]JXDU^Q[-2M:09@3F&L$D4D"340F8B=9Q[^*;F*H M4BA3E`(]*B@U6BAQ`!-RZ\Q2@/,`[["703.O70.NVVVH^&P=VO4,`[8NNNI=-AZ]X[ M[CKW^S?IXX!VQ1T'F+OJ'<`>(:"&X"(>O370.[`4[8H_M@'N#?ITV`0T]G>` MB.H::`&`=N4-!YB[:Z[Z=W7J'=TTU#U"'0/T*Q1WY@ZAKOU#XM^X?$=0[]("&`IVQ1W`0$3#ON77I\'M``[PZZ#J`5[V=I[C)1C=G3EF:YB*8%&H7"2)E%TWU,RZ=)7`BI` MHF0BR/:.JZ:AVW9*.$Z:>E(FZ=A&3F#SU\3RRT]$IWIIJ8HJE$9-TJ:]5$-W M5<6I7;E:&,BN\G M8/U7L.JB'733<1CE-400[O M3Y^/RX!V:F_O3#X^WQ_+U[O#``24']H;X`P#LE/L#?%\G\/PX`*1N@%-ZP'\ MF`IV:GV(CU^?7X=>F`=F?[$?Y>[`5[-3KRF\==-/9[-\`!-0?VH_)\Q]08!V M9_L1]OSUW#;H.WAK@-JKR3,ABYR\R`F`0_I95>H?^5*@-=^OA@,../*(?S63 M-N&H!_HA9SO_`-SS:3K\F`B'Y@\0^,/G^7XL`U#Q#XPP&>EL;/6CL3:(9-3ELXQ5JZM_;P"+#4=S990IW$.V9QR;F/=R)I,4#.(B$:O6)GK1(\[-R45 M2;*0>F"+;-CQD\R%[Y)>G;)OW66VT+!)6.@Z>H5RW95J\CP\X10H8M8BG8.T M'\),QS@@\R9^R6*U?,UR"',0W*FH4=RB`X"2W+)Q3K[6?D&$)=*5D[W6X$Z" M#UC5DBN]K:(9`0K=56FZP=*C)F5!J1)L=E,.G:2L>B,9'/H`KA1Z0)L:ZR_9 M<.*9;6'K&CYZG*9O,_B&?TOKX%,G".JBJ9L5@P0MK>5F4P(+.7KE1XW:R@1Z M$_3LDU9D:O7U/.WBYP\=-<&7.U;7*_75VKNU%1$[5M`@RD6=M*96?5%63^DD MQ<$GEI.I$01@GU408$;K-X*%]WU)M`':#2H)*<*UC781O@8/ M$/C#Y_,-,!NQ>2GB`V4SG_H8V^7 M`0:QU$UI+)(KQ5(51)(."@H@NPI^6>(+IF`!*=%5NS435(;80,0QRF#I@.RM M+*W>>Z>:VRKI7F'80I>8(`B/]\HS(&VG7N#K@/3J.T]R:0+''JJBY^G4I91= M&.6FF1HUNZ5;ID5633Q_ M43`4-@=CU,(!Z^8.XGC:JIR M>IJ03,8AV4_#R$.[`Q1$#`+>1;MU1T$#;\F@[Z:[X#@?\X_/X/DP#IMXZZ:] M=/5UUT'Y^(5P%/@]?SW]OCXX`'Y/7KW!K\&HCH`_P8!O^3I\N_R^.V`=?Y?9 M\^@_#@-S'R13:5SY_P"]^6__`!F]^`BG\KX6[/B?VT#EUUR7VJ[@Z?3=O\`Z M=^H[AH(B'70-=\!JO^=@;0=`$=>O*78`'ZT===>OK'77?3H&PAPKYE.+SM\, M>66IQX\15M'7E-2N&BX8ZMI=&Y5,R2K^("GZJ@))U2MP:/6=$> MNJ2K*/;-7$A$G=%31%]&NV3Z.J&EID6S0E1T?-4_4B#1NVED42!!_G'RU.J< M>SU9TI$.9&GI=RXD:SI./:J.'*;QGFH:U(F128B M$#U6#EI580475MV5HQ;Y%)XQ?LE"N&CEHY+VR#E!9,3)+H+)G*HDJ MF8Q3%,'B41#$B;CE6QSF`O-R:[B7IH(ZZ@&H%``U[M`]6FX=+57$!$----1$ M`*3I]=X!KJ.@Z==-!U#`>'SH-1U`!ZC]87;J(["`:>&H:#N(Z#@*^=!S"/*& MNH_M2Z^.NNNP!T]H^`"&`>=:_M0$3:#L4!`?`1#0==-=M>_OUWP%?._$@;!T MY2[[AX>(]`$>H[!@/SYV(]VO<("4.[<=A'?00`=N_00[L`\Y[M`T$=1U*734 M-`UU#\^^H:#IM@`NM=!T#V\I!'7?;;Z[NZAKIL`Z:!@'G0=Y0'UTS,YT@WT+8FW/<``&MP) M$1TT^3^'7`>SY6!I^S_LGJ;3^E%H[;;[L%[-]_GM@-7T!#4![300'J'*`@/= MIX:;;ZAUVP'5Y^DX*?63?R30KR0;_5"/G'(M)G.F`F23+,J%--M4$S?U-"/D MF:9?K>42ZE$-@#)EFPN+=C+A0P7#FR5!3BT$[%&(6CFQE6;2GY648),6JTJB(JI*G/L$S-P,I/`YSIS+*XU!K.^''F@F8=&JEJJH]F MVMO1S]_(K"F=]4+:$=I6O0\[D.T?&<0M0VSJJ947-L`\@+:YRZEEINW)GC&%M-G42!=Y75LEE3),8*DLRQ6#0 MJU74,HHHG'(7%3CW=1P`*-`46DHLK>DD`DFK29I&^)9"V&8+W(^BPL18(.CKF:KP\@<`,_@7Q$55(MVJ4CI`R:\5)HM MI1DX1P&'H#_?_D`-?GWZX`.GV8;?X/K\/7\GA@*ZA]G\&H;^KI\/P8"FH:_7 M_'R_P8!J'V>WP?DT]7L^#`5Y@^R\>\/Y/7W=^`:AI]=^3Y/'^7OZ@#4/L_#H M(=-MMP[M/C\<`U#IS_#[W73\GSZX#:L\DQ'7.7F0`!UTRR*#W?=3H#P`/'3\ MGC@,+./2L!.+/FZ+R[^Z-G!UYM-OV/%I.GQB'4-M?5J$0?;$^Q#_`)PA\_F' MKP&<&3&R%(UY+U;>>\2R,98*P$*]N! MR+%)%923CVSB'2[-U)-E`"'#-SF2O=Q,LU41'453U75$A4%3L[<9;;'P;\G$,IJG,RV8V1:-9=M-R=4!(4 M+VYU6L'33PK)M4\B&TXXI^E:#@6=+T/3L#1E,Q# M/B(ANS8,FY`#E(DV03(4``"E``V#`?-+E\R]YHZ3>4'F3LK;6^E(+I*HDBKB MTXTF'L6"I3E,ZI:J$A;5?14J0BBGF\W1L_!2[83&%!\0#'*8-*?B.^2L5!`Q M507PX9]7O;AT@S6,O4666Z,Y'M[F4>XM/U-4"R*#H-??)E>FX>2#,H_M5?"!JNW,#-S2%)7:H.NH.1I^5HZ?3 M*LVA:@F*Y8:3L1%BG)3':O)]Q5+=ZY+ M')XH>OWWA MW:Z_#W?)@`+%\`_YP]>[O^7^#<';E\`#;[(>GQ]/4/AX8#=M\E'/SV3S>#H& MUT[;AUUU_P"Q*<[]1P$&7E+VW%-N>(&%,WTIK.Z'#82"%$H"!@$P"4!*.X"( M"&H>T,!CS0.5"EY!!LF&;JXD4S(4$&;>`D!101;E,#5NV0.F+YD=5,AD4_J2 M2)=S:I%`#)E#.FWO#\MG+II&>9Y,TQ2'U[08>L&\<0!Y1.('66H=PD@0!,"I MQ56,3E+S]J0P`)@NK3O16/5@Z36HF`%O(J7'1MVHY5/)(J)%`J+I(N@(*ARLQQC/)^7B:H'L)4[Q M04SDYX[+;1J*8J'Y0,4IGE4M5"I'^J"FH3L%$!5!4&XJ)%``C\XIMXLN=;57 ME^:62MI4=OW=4TU*3C$TS]#B!BVBBH)HE3<6=G2]858P([F9:70G5BB<'C0[ M4S-99)(@("&"4#::]-4P9:JI&S-YZUI,7+MD-5T?:VOJKID'S42`^9JU#3\& M_A1?,A,EYZS!\*K<%$BKD`!(94.K25/5O"J).+?YGKI0I`4*J1JA<"449J', M3D7%>-?2#AL8JPB8!#0AA,=1<%$3]HL(9F0W%\S#3S)*G,P]"V.S544<@`_A M[M6P@Y&441`Y@<@C5#`K.:2<*`8Q2K)N@,!A;B8Q3:&P'B?VUX4N<0.QI1[5 MO#PO,_1*+1I-/'-RLN$K(]D?9PLH0E4472I5K*VZJ0Y1HB]%`R"=86EK9NL4RC8\+6$:06S9\LD4Q_<2: M2BYHH$4.#`Z!07,&&&O7J(^L/;Z@^3X-QW!ZOBT]GR?)@&O@'Q[?F$?D^'NP M`1#3KZN_K\&_Q8"FO?W=_CZ@]H[?PCJ&`W,O)%/]=,^7^]^6_P#QF]_CO@(F M_*_E3$XH=LP`HB`Y+;5:"'_"[?\`U]OC\],!JM><&V'LS;B'J#7KU[]AT'J& MH^W4)X[*PN8R`K2!;2T2[8S,+.1K64B)6/<(O8^3BY)JF\CI&/=H&40 M=,WC19%PT M`'!Q`1`G378>_0=.G?XZ#N(#ITP'Z[OC@/T9# MIW!H.O>.WP=V@]W7?``7/N'(.G0V@&]6@^(]=M]N_J`X#5DJ&)Q`K)`&F@Y0J.\-=?IPWM[QTT[^GC@ M-74'"G][\G3PWT\=-=]\!^BKB)@`PEY==^[;UZ]?:'Y!P&5>6"]U(6*LW&4E M7-0IP04?*2K%C*BUDG31]$SU2/)&*?K*L6;KS`R*TR5A(E=%2;M1;@Z\X.T, M*I`S]J&[LE(,?,G$@8_("A$VR8\YQ$J:XD_;>^$R>AM`,8QA[,A2!VFA@QDM M5Q',T&72KT*HLK*C&.0<-P.U]U&)( MZI&*"ZIH:;C'1RNBA.[9;,;E`XJ-&3E.UI0$+:[,06$Z$JI.`S:"ZH2=DRMB/89YSB5S'N7B2)7"T?(&48F,JLJ M\`7#1)^R4[5F9JD$5\NS>0TH^BG07V>'P[`'L$/EVP%07./V/38>HAT#QUWUVZ#XX!VZO?R>S;V[;C MW;=1[AZ8!VZF@[E]0]-=?7W;=_37IL&`=NI_>;^/L\`$=@T]GPX!VYQ^Q#?Q M#Q$1'Y_!@`KG[A+IOKWC[>H#TZ`&O0`]@/.%->I1`/6`:[#UW_-@-K;R2A0Q M\YN9/FY=LL:@[:=]U*`[PVZ?GU#I@,(./FKR\6_-Z77I(V:\/O=;0CW],!#Y MYP'7FV]H::=?'I\.`S$S[5Z\R]\-;+[EWI\5(RIH%'J(A^3`8Z5O+B05@,(@._CH/7YAOZ\!TF&M%)UW&*3;V93IZ,5 M,H+4ZK/SM5RU3`>U>"!G;0B#?8P)'4./:`0ZO*5'LCJ!S%+V%IVGG*DV:M). M4CIB,>Q+3I',W9PMPY&FSJQ]/U\QGB4U=2EDDG!CF1A:S@8R)FR1BR@G74IQTZ ME*:=JJ>=.H19TF@NB&LSGAR^05C#YG,M,#[JU-3L#;)LZHIS+(*+SZ@TTWCJ M]H,'[Z4(\>N7D8SD&C2=FFSI-[4,XYF.Q6<'5D6+P-3JO+24[6Z@S,6J--U: MDJ9E M$C$5*!@`#:D,7F!3F,%SO.`$>N_?];\?4?5\>`><:]_Y/C$?'7\W3`/..F_B M(=/'N`?E]?C@';^O\GK_`">.`W?O).E.TLCF_P#5=2V_RTE.CXC@(-/*:#F_ MFI5TTP-R@:T5H`U#82ZT.CJ(#W:==>[`0T6VN_>:CHZ+AX1"E7+>*:(L&0/X MZ9656(W2(@B+D6]3M".%#%*0QRI()]LD/*4A4S$*0,Q*-SI9CJ;*@"=+4*^[ M`QA344^B9H041*!3`RZXM'BIJ(CSN#(*`3SA,CI:=`H%>-R)LSHJHI) MBT6`C5,K8R:J01QM;+7MS7YB[?TC9VGHVJZIB[55+&L8R1F#QB"#*.>0;V1D M0_72N[RZJ&!0IHU2W%ED5="4D2KD>^YC=F)E M"A;/*QG]NQEY4J"W;LC*Y5FZB%S3]U,L]Y8\LW0L^R1/YHYC75/S:2IH&88* M-^S2?1X-G<6NW`@@FH0!('=U5Y[<5'FJX=JTU-4=3K):;O;E5G7(RUV M;&II/L]7?MMIKW8!VI_$/#30-_SX#Q<,@Q4Y"J@H0-Q_ M+_/1=Q&56TND_P"TI/,E:.'S2VO59H)NVZ$+?2D4OIG15.H\Y"2[B)N4^+;4%<6;7TU&N)6?A(]1> MCGJSI_.1+1!192G';A4SAY44*W(4YAC%U3JNZBA6Z8BDN9:=C4A<*2C=^$4% MQ*'4C5U5$RD5;*E!9%='E51<(JASI*HJI\Q%$U""4Y#IG$BA1`Q3"`@(AC;* MLCMS&Y>8`#7?<--=>O3774!]O7ZW`=:5,)3#HFX:ZB.F@!\O<.`\ M`N-=0YC]?K=PU`=P$=]^[U>O7`.W'KS&'IIIJ(=->\=``=!UZ#J(]PZ8!V_> M)CA\/<(AL!N??IIJ'UV^O78';B/*(&,;4---]`#IIIJ(:B(?`'0OUV`_7;CN M/,<>HCX;:[ZZ[!L(;Z:@(Z`.H8"G;&U'0PZ:"(!S:CN&@#U#EZ;Z:B`@/@&` MH#@?LSB(B41#7N#?4=!#01[MP\1AGYLS6=<-1'2Q5N.O_"!(]W=UVZ_ M!WA^_*T5>SX@ED`YBEUR@4=UT'_;BO;UU[N[XL!JV>=;?U0G333;X=A#O\== M^O3H%/.A[U""`[#\H[;#IU\-/7K@.CW+,N\H*J&J',L<\=S@BF`F,(-UT'*@ ME*777D(B8X\NX`7<-,!)#'3YZ\H2GZEMS<.C4*7<1#(9JIFKQ1Q)T[(M6;,L MA"SC.79,THJ49=LDHJF5(62R!TEFLTNFLI@,-ZH"'CYM\QIZ94G(EL9!)O*+ MID1,\4!NCYTJ1(A2E!$'8KD1,0I0.D4AR\Y1`Y@_=&UW5-OJI@*XHFH7U,5= M2TFUF:?GXE<&\A%R3-0%$'#-U5F;U!PT7604#8=J^ZU M)\1')-4=8*(Q]/7;H5O'1E9I1IC-ST-6K1XSEX.O($#NQ>DIKSM@6LZ?3?R" M`(EBJKI-W)22<7)2$B$)T&>MZZKQ2)8L$"5@SU85XT;NVZ49!R@:BY?*N4QY M31,HZ1+-0CQH8ZDC-FZ*'9$*&#?G>O50GAT`>X-]=.\?GM@'G6W]4('736[3.=F5#F*(AEA,(Z=W]%6WX==`\.GPX#!#C_+@3B[YPRB.FDE M9';0!\?;@(?&O:OG+=DWW7>+I-4`#345G"A4D]-M-SG+U$-.\0#`9 M)\73`$3E*9JHJQF(\YD%"E/R M]D8$T"G*@F'TF^"K:>-LOPGL@-%1C--B#S++;6X_YC@,<95-M4-0QD0JIR)2, M@@V6,7Z_L3J!VO((:"!Q3`P$'H!M!'8,!>V28-Y5ZTI8.;7`:PO%EK)G)W8J^I6HK'D<[N%62[!)-99,SADH MN4BBR3=/1!)V=8YCK+)D(0B1C&[1,Q2G*<#8"_\`E1NH]M9?N@YPR:@`N^=4 MO(LEA4:"NTJM@Y@027-VC=9%-%V^9O>8%"G(9L0_(IR]F<,HZ'S'RV67,'?2 M"C:*J"O:0N6VJ!H[MG#GB8IX_5JY@E4+))BA5#MA$QZD>J^4:>],=0B!#DC& MCUT5BD(061"5:0MR7U1,XU9.`F5F/NB@X?1B3A(2LVW.Y%K[H&$'4:\!;7D% M0%$BN")"=`/?\OJ'P#^ M'3Y<`%T70?7J/J$0T]74=ATVP&\CY)4IVEC\X8^%UK:=^O6D)[`0@>4VF`G% M(NLH(:B2T%H#!OI];0R0]=_@]?CI@-;5A?ET@DD0680PI`8P>](*0?N,OE4E35%"H`5NFM"@\J!DJD!W"B;]%L:`(02/.V3 M,@9G/O=4BE#^>`:*IJ$$BY5`N&M=JX*_:$/+.T1/V9@[)K%`8Z@?5#*YMZ?1;.DV!2D< MSAX=,#H>:-V0E742;+IB*JX)E!=140.X!(I@WH\IF=BV^;:AOHT9<06,R[5$ M]J>=A4K&H3&4YI.MTXOSL:^$T^FOY[SJ2!X\1`Q6""9"*'5#.9 M>S]UI9@1_$YY;RSC!4!,D]CJ&RE/6:I=.J;EGE]424*)>\B@AIH.`LS4MF+N ME%3FS?7K4$-A$]!Y7R=Y?[G8`F_3;IKX@.X8YU1:&Z93G`V:R\*OOATYZ*RV ME$0UT'7L[%E`-Q$>[7Y,3O/K?7;,6,E[37-`3ZYH+MGZ]:-R\`.WK)9,`Z[A MMMMMBC$6J;(7:^UE0YW\J=,1U)5?3#4\SG`RX0!6 MJ*%%/%W0$>7NMA!MRIJ?2PEW3A)2IXAFD8*2?K*28-VD(JN+4(;N4NG3Y@'S M[]_;@*'L[\!N<^2&@`2F?7UL,MW^,7OT^+ M`1'>6&F$.*1;``V`@#MT MU'700T_:]X;G.5J*AS^3NU?6\O&&D5;6H1M;L7:"1UI"`;+9AKJ4-6E01*9# M$$9-A:^M:[1;@)TR&(Z53,LB0XK)A,!D"/+KY>J!&(,HY@(A,S5U, M2=P,I%=SMP*9<1[*.BTWCQ]%P-1T^_2I*GXY,SVJG66JG((IT?=I50`\CB>@ M8F\'N[3$O"R]M\S$"VJ:`GH61;2$1*W2H^GVR!W<;(M%%VDFI7UH8N*>1_F: MIFZZBL_.HH'3+I4[#5A!3-,U$R*_AIIJLR?M156;*&3..I%VKMJJB\ M8/V:Q$GD=),7#=_&OT6S]BX;/&Z*Q`Q`IVHI49)$#7Z&%E#'7E&")1]QEE5)-H0L:=ZBQ","X-%+Q+A;5(>S'WR:B?OB& M(8.8ABHE,`@8#%'E$!`2B(;X#'R19F0,?WPZ`8>H;@(CH.HAUT]8ZB.NH M@.`ZV8Q@'01*&FNNP[B(]1'7P#0=NX`W#?`?GM#^(Z^`@`#X>K4P";V[^(Z8 M"H*'$=`$O<.X"/ON[3<.\=.GUH!Z]0_(JFZ:Z#UV#7;IKKKH&G=IIJ&V^H8" MO.81[@#V:ZEVT#81'['?Q\==P=J;8-0VVUTW'7KIOM\6NGJ^M`"G0==PU]]K MS:^`;;"&P!TUT$0TUP&Z1Y%T(CF:SL@/=8FV_J_VP)'7;NP'B\K?4%/B#V,T M#77)_1_=KK_1CO=ZAZ?/K@-6#SD==.7?_`[_`(O';7XL`\X'78O>&_)Z]A#; MQ[]O;K@'G`ZZ:>`@/)^<-PT$-QW[],!^D7:K=JJR0U09K.?/EFB.J355Z)`1 M%VJ@0"I'="D4$A<&(*W9E*GS\H``!^?.#"&@AIOH/O`VU[AVT[M_9N.`IYP; M3ZW_`-T/7XE]7Y?5@)(N%BK5,UFLI.V["3BXNB[VB6RU?$G0?>Y4BE7_`&[& MEV;8K%H\5&IB5&@V?0W*5D9=BSGXUS+Q4/(R[L@33YAW&951J6V52"\)S/ ME(]5TYJBCTW!CB=M%@*X-S_P"B?U0$U0,7`:^/G(]Y=/\`D:Z_)[?# MI@'G!M-RZ>OD^'?WH!T_ETZX"O;F#]KMO^U#P$=O>^&@Z"/LVP%`<&TW#3_D MAWA[`#U^/CL.X4\X-MM_[OKT[B^K78=!]F`J+@W>73337WNO7X/#IX;=VV`I MYP;N`1]I/A^Q\/R],!MF^2(JB?.AF:Y@$/Z6`>H:?[:U`:!T#U_%@,`/*#'8 M)\8+.,37ZV2LIW]--4 MVZ2>"RR MRVRM]*JI"7E+4=I8-&U=3HF*41`AT:AHV23,0=#%Y=P#I@,Q;E3;ICVI"B8" M$*(`(AML`Z?P[CX[;X#&FDZK6=70HUHEC-NP2&$D"O6`O#2`$!L=N$&]3U0D M%)39%2&!68 M75,2<@`%U*+J]9X(Q3U0ZJI$>U:KK'**HD)H4Z"@[F.8I1!4ACZF$O:[BF1( M1"XGGP:AH.G?KKT[A#I[=-_7@-ZCR19<%K%YR1^QNQ;(/CH^>]0#W#@(3O*< M3&#BC78+I[P;.VAUZ=!H9+4=P[M,!JYL9FB$1*1PV@C`F4`$ID8TPARAN4>8 M!%34!T$1#4!]Z43:ZX#M[2I[6"F`.XZFQ-R"!C"WCB(SJ#@`-]34;O$UBFW((&Z!PI[79.5B%3MY=*L89H4-6S&V>CLW.8JFV!4U!3:H M5%9.X+4XFYC`=:0O%9JY8#"8PA:YU1M_&22I:>S'4S4I$P M4+YS+T]CMJ!2#VV_53;`8O543,-1U3N:UIVR](+IS3T' M5Q*'H>\:4U&U88PI(+U13Z=;6^ME?\`N%3\U&T5.O8^BXIVBS;PS]E1UR)NK*=K M"U-2+.J/9(QC9&LZ2BV=)NIPT;+32Y7`1L4[/U_D"S`0-R;6R%2RM!MY%)E` M/Z_HVVDNO`5%3L*W?*3<3&3C-G-1T6*#_`*:7:\.8P?TE%J>@;:?3@S`ZZB([=`Z: M:!OKML&J-S`(?7J:!]B!0UUUTWYM]QZ`7QY0ZZ!O\<)*E$JUX"MZ:?5BT9M1 MWEWOPYCXET@5VA)3$-4^8.9@F*S83%!PFXF&#%,R(G(*I3!@T2156?`F8.1S+V'JTC6>J_+T[A86MDZHC[B_0!42JK.WM65W"2C M:9)/M'+-%=Y0-85$#=W`59.P:0Q5=4U4%30]912\I+Q]:TN'0J1O)0U[Z2;U ME0[YT9NLFV"7@)IDO#572DBZ9HO@AJJI]V!'D/)E;.$EB`H4[.0:G1DHAW(1 M;EJ^7"Q-W:6?3Z#*9IIRVC:[I)PO*4A)/#+IQZJZR)4Y*FY\6H*++4K530@1 MX*=IU^J&$!`.G0`#]L&A]!#N# MWH"(Z:Z=X5Y@U`0.IITTT$?>]`#43&+W"&PAW;Z@.`<_7ZHH'?T'81U$0V-I MX>S3UZ"'YYBZ?U10>@AZ]>H[FT#?X`#K[[0,!NJ>19&`V9O.YH8Q@^D5;;37 M73_M_D=OKA#;\F@=V`]'RNQP5+B%6)#G`!')[1XZ#K]V2]N_J#`:J?GI.@*E MZ>`Z>([:]W0=OC$`U#\^>EZ=J4`]AM=!#^3X`V#737`5\]+_`'0OAW[;AT$! M[AZ=WAZ@>>E_NA=.O0=.FOCO\]`UT``"\+_=2]-]A\/F&O<'MTP%//2?W0H= M_?U#Y-NG=OW:X#.SAQYC*]R^YK;;2M"5,6#4K>6"WK]!PQC)&/D7=7-G<#2A MG#>7:/6C9>,JZ3AW[2432(NR!-P@=88U])-78;N[097LQ2#I-K5IF M,S2M0RA6R#\J:$A&)/:DBUTU6KM!PU9UPQH=PCYXD5$?-W!`,B958Q`@8;YH M:VI^[-'5LA4CRGQA\^GA@'GA?LR]![A\>NGY] M.[3`4\\)_=0#3U#X]^^_3Y/4.`KYX4?]D`/7H/YQZ]^WY.@!>EV^J%Z:?M@T M^'7NT]6FFO3`//"ZZ]H4--N_0.OK`/'?I@'GI1#3M"[>H=/'7<=M?#IW8#;: M\D$7!7.GF=`#@?3*_OIW?T5Z!^4>\`Z=_?@([_*&G79<8O.63FTTDK(CUZ:Y M:K-C\OP8"&=C-J1[UD_1,';,7C=XCJ(A]5:K$72W#0WUZ91'E';?00$,!+5G M6J"E*8"S%V120T>(S$<)&2$F=/F.+>')4<9*G2!50RC3 MZ-J?:*K/';KSUP$R?DHG$QIRW;ZK^&G>FIFL.G5=52]R,L,O,O009NIZ5;H' MKRTK95T9--!Y)*L1KBE69`UD)!>M43&!ZJP;N`W)KS.G3([@P%.!!`3%$.G+ MN(#X:"'R=<)&%M*UM'Q]V*)4`I2*H^[4\F MWGI%-LIJHX!E'-SPT?'FHU+(HI%;I2#H6Y5`4!LX. M5RWU(02``%5U.0I"\Y0(DJ4J?OQ`@:C@.PL*K3,`@X3['D`#BLF8%$=A`I1T MYBJD,/-H4O*H/+KH;;0`E>X-])25Q\Y4/-H(F4B+84/6E7R3DAM6_:RD6:AH MUJ8Q?>><+.:L,[22$2B=)@Y4`!*@?`;559%C:?@Y^=F2HDAH6)DI:7.X`@MR M1<:R7>R!U^U^I]@1HBJ9;M`Y`3`>?WNNH:`R[H7"ZJZ*";8JBAU2M&_*1!J' M.)R-6Z>H\I&^O9I$`0T*!3:D*7FP'J=N8H``";E+S!J(_M!`$P$2@4NFF_,( M\P:F*3LR@/(H'.4Y(*-YR,4(4Q1.\;)F]\`B4BZB:*W,)="@4I##N!1*?M5- M.0`#E#(3S\!Z'^7X?#P\/Y,!OA>2!+@O8G.<(#KRW:M@'PC1T^.VP?/IM@(7 M?*<"BMQ4;I-0$"BXM#9U$#"'-RBM1"28&TU#FT$=1+MJ&H:ZZ8#670L%-"B@ MHE7%(`8Z9![-RI-(K)")1]ZII$+Z'+IRFY3F#40T$P"`X"A[&5.F74M84$H' MOMAFI1(XB&HZCVT`F`"80T#WW*.NHB!0Y@#C2VVFX*1:O9A-K5C`$UD%6E%5 M0Q1DD3J8G*9(4A54$VJ9@!%42AVM*)I0-EZ&NLGJ&_9SE% M/-^4`Z^;L]1$0-KTV$NI@$#"<+TV-@:>7N"@$'3]Q6;WW%E-3U$6G3QP@!FH M]F!X=ZLX\X-RD%N8R9"%.4VO,<4Q*'=+ILG$55R[=PGR'.P8.`````$BR0\@ MAR@!.4"@!2\GO="@`B)N8V`MOVH_`/=MX[]P[CZQ'3?4!U`<`[0!`=2!IMW` M/Y0T]@:#\FN`]IA(O(IP1W&.5XUVD8#IN6"ZK-PFH4=CIK-C)J$,`CL8IP,& MXE'`9%T)G-S5VU6(I2-_KG-$D3E51C9>IWU6P"*Z8ZIK)TU5XSM/E6((!HL, M6*FP!SI:42\QJ,R@"51:2DH23D21D MO).C\R?9Q$U1D)'H&**$*X.F!#A-/:/-?9O,9!$G;=5;'R`\R#=W'BJHB\92 M#AN*Y8]VT?-V,DR>&%)ZFS:RT=&/)9.-D'\2U?13?W0.%F;W6\>C.-KN6Y*J MWN+2QW$D]@FSA!G%W6B$8Q>/=T;4`KE.V:R$ M9L6@8O24M;6_*[(SUD>=H"[%NY*D*RIF5$L;-,)Z">-UI`,6+5T^SME5]P\B.8.=.]L+F+8M@HBX+I, MB3:"JA%9RVM+>9JV54<)PU04I47-25RH=!XX31;N9UNFM.Q#N"EY`(<;H6]J MZSUQ*TM;74::)J^@JBE*9J!B8>8B;Z,<';F5;JZ:+L7B8)O&+HNJ;MDX;N4C MF26*(AT3MAU^/P[]=-/'Y=/RANC>2!FYI+/N(]S'+:'_`,1?#?\`*&O?I\&` MB%\L:4Y.*=:W@@&HA MMJ!A'?700#O#I@/I6>3;0D?5'#%I*#E4@6C)V+JF(D43;D5825U[VLW:8Z#N M51NLH3KJ)1TP'7.$%3D22$S44*)HM"N[@Q=F,V$Y%3`J(MV-]9R.E:NJ.3.F MDV7<,$X%:.L=(24A%$7EXZ0?E?,#C,"U<+!D="7(3KI&:92D.M25>TJ\3BZ^ MH9ZY*Z=T[*JI&4:/&#\J+9*H:0J!!)61I"K&;9!M.1G.FY:1-01T_3\,$>54 M6Y:LKKUE`Q$JXHVKW"D4+D/5*SFX M26H,JHILXE]UHP8ES#3TT%BKC0P4\_3; MM[J1R!!,!6#-$C5A<5LW23.=>3I9H1)E4O*)5I*B$"K<[MU1\#%.@\DHY35) MVA3$534*50BA#E.FH0X`8BA#E$2F(8H\Q3%U*8!`0'3?`6"KN#:2[9=,Z1#@ M4.".I8`4O<4,!:TI5W%K*D,B8X%$0`2@)]--=!T$`-TTWUTW MT$1'?`66>$!,PEY`+R^]'4HZ^&_P^K;;3NT#B_..4>;0@:#W"(#L'7J`@`"& MWJTZCO@/R#G334"[=!UZAMJ&@].@AKW;!H&`J+COT*`==>H!W[AS`&XZ@(@& MH``:;CI@*><`'4"[=X]1WY>FO-ON&_AOJ(!@'G&FX\N^NNNPCL.N@:!L&^@@ M&VG74=@W6/(K%.TS-9W=-/ZQ-M>@Z[_3`D@ZZB'=ZMM.[01#A_*^%^RXAEB` MYA+KD[I#H;3;ZO MIKOU[L!3SL>]4V@Z@.X?)[T-^GQ!TP%?.^[M1^,-/#73D^'`!=#_`'4>@=!# M7IL/UFVG^;;`4\[UW[4?'J'MW]YZ_5N(;Z8#F("J'%,3L+4K58WG=/2\;.-1 M`0`W;Q+U&01$HB30!!5L737H.X]V`V\+\R<^&5J2IH&4V:"I!_69Z-29QX>< MS2SZ2:O7#MG(.8N6<-6S`8%?FDHUBY5%T5PR;K%?%`A0UZK12=ZZNNY1LM;3 MSZC)4T]%M&E9<[I-2)=2CM*-9(L%N105G3MZX;L&D5$,W,E*G4,1).755*BL M&QK5V6.CLP^5RJ7%SJA5KF_1:/I&"=U*Z94Q#$9Q,4\;!3:T!$48QBZ<2B%C M->S6?M&;I=Y*)2BQIRH(]S&STJ&HG=_P#]4?9J'_X?GP#SH1_V41_Y0=_7]J'CU$=-=]^X`NQ'3ZJ. MFW?_``E_@]FG4'G8Z_U0?6&NGY"Z[>WUX#;H\CW6%7.IF@]]S`&5XNVO3^BO M0>W0/;WX"-ORBMUV7&5SFD`1_P!<+'".PCM^QILUX![=M?9@(3_/@\1W]7KW MUV#4?'7IW],!*7PXK]T2)ZXRB7N<(_2=OV@Y28N7C@6K>GJ^5:M6K9VB]4<( MM8M:8:Q[-)C*KHNPCJAB8)5-$I5G1Q#$S-;EGN5E@NH:-.O-1CV'DDZAMO<. M$,ZBBS32->)/8>IJ;E6*VK.6BW16PO`C9%9:%ET/YV>+H@R?N0GDR5^5:W)M MS1L-9WB'6WG;SQL`T;Q,3?FW246WN6NQ;D!NA]'5,23V&@*C=HIAJYJ")?1; MUR0A"JPSIUVKM<)"JCX^/"5K&)]W$,S$_33U9,%S4U,6.O7G\U.>(H M.0@%%RF]YVC>=.U$X>]<]G[_``%J[G^4J9/ZRI(:6H:Y[J/G&)&S/Z/+@V\K MM)5^JT`IFM01-/PE/SY"R2"J2;E-Q,R+4A'Z17*L,Z16,W1".F&XB&7Z[=5M MHAY>%.[U=5/(BBU?15+5V%75"Y4*;4)&'=4HP;.U"-B&%RZCE(YJDS2$2QC1 MLB(E>-@EG0LHT"NV4D=U&!JNU:^N#6M22U2S494\C)S#QP[=.G;"2>.E5'"ZB MYS+KG0$ZRJJRAW#@X@4JKE514"$Y],!PZ=.UH<1[.E:F'7N3@90==>GUK4=] MO;MU$0`0#U3+NTQ+'"DN+Y55K-]2B,?73>GY M=`6,M%M'=.O86G3^Z<6HM%N7@[.D[0",-9(Y3#S@8`YM`$? MVO*`B!0+R[B7E`-]-]`#E`0$`](PG$I@!,P:"`G.`:Z�-0$.8WO"B&HK^^T]NOB/A@*`/J#XQ# MO\=>FOK]?KP#4`_:E^#F^#0>;N_SZX!J'V(?&;_\N[3Y[8"Y5J*X:6^JY&H7 M9$Q2"/?,0YR\X=HY(42#H)M`-]2'0>8@E^N`Y1`#8#PW1K5K7U7.*@:E)V*C M-BS`"G4,`&:(@0>7F,)@`=0$"B8X@`[FYM0`+=\P`.H%#U?7?_EK\HX!S?WH M>OJ/>'B;KW^`Z;B/>%=0U^L``W^S[NO[;KI^7?`4Y@TV*`=^PF_A^$/;UZZ@ M$P#I[TH:]VIM/;IS>K73OTZ8#M]#U_6-M:A:U70L^_IJ?9E.DD^8F3.1=JJ) M!`;A@7G1BE;TV-[D4DZ2R^YC&3YHLRE4ZFI5NLC0-4S317E<-Y)]!,G%)3YG)$U&\Q3K M1FL4JZAB8"+X!#?4/7U'7Q\=_BZCU#`;I'D@.\EGY'0`_G'+9TU_N]\/$1^? M7`1!^6.J@3BFVO`=-\DUJ!W+KKI>#,'ZAV#4>H:;C@-3T'1-=`T``U^M#4=! M[M/:._0`$-=>FH?35\F.2!QPTJ`.73ZV=TV$H?UW[U:AH/3;KKKW^K4+2V,: MN[`<1I"6CE5&%*U)@042!449`U793J1BXI9 MDFJ];Q=2RT@U;F7.?0,D+\6\?SLDVK6AW[*G+KTDV=MJ=FWJ:QH:?B'"B;J0 MH*MT6I#NW]%3JZ"*JAVY#RE-2J;2I8(!?,U6EV]SXZ*EH2N;$ MU$I)5[0;CL5ZEB(DT;YMM'[102K,W29AYA#%&5JJ>MR8D1]3CFB#F6HLA`*4*:;2$$FBW2I5LK(@F'A1$Y1WUUT]?\'Y> M_?7`8_UW%-)9NNDLF10JB:A#@8H&*8!`2Z&`=0,`@(E$!#00$==0#`187=MJ M-*K*D33$:;54`C)`@8!#?K@+8NS%((ARZ"`]P:`&@;;Z;[``:%\ M==-0#`>@+@`T#WO?MRC]EZ]!Z!KKMMN&@]`_(NBCT`.NFG*`S`4!T70!$":!KU)UT'73;<.GRCMT$`J#LFH#RE_YH]P=P:@`[]X;>`8#= M:\BG4`^9K.]H`!I8FVP[`(=;@R>GCI\GK#4-(>WI@-3;S@=.OAH'.77<>G7\XCL'?@`KFWUT_P">7<=O$>X/R]-\ M`\X-MOM_AE#3N$.NNVO]#2" MNK6EO)*Y\Q,SLTT>U152RKIX\=N9,T::&44%SV*AGSHR2)5/,DB&2;(E2.W3 M$JIVG8!UJ*I1Q1SZE)3S2,!@9LYJ=::JY6-0C"ME$GB--Q<1#L2-6JR4D_21 M5>24B16+6,Q<.EVT#0<(9^V"<*)I<(^B2/(V53FJD;(M6[R5;>Z\BU>R3P:= MJY9/-&[EL]923!PYC)>*=,9F'>/H>18 MOG(:_0K'*(E,``8!$!`3$`0ZAH(:]WSVVP'Y[&``N8/#40^R+\6@&`-P'73?7;OP&WSY',H*F=;-+S=V5Q+0>8 MH_[;%"!T`?;OWX",SRCYT*7&?SH$U_\`UUC-/ART6;UW[NFGY_`(0//QZ:]W MC[?F'^?0.7@JG7@)B.F6Q$5EHYTFX*BX+SHK`&H*I*@&@@55,QR"X6JM6,C59E^N/2%S*+DF?GL25_*H M,YM3WR9%6+>6CFJ]*S*R(KMA!WYY!"N=F48*1BU3.I>/FC'.7LDG:BS^&1(C$4RH]3 M,NE`0I6LY((-U&$_(1*0LY":"/.X=W*FN14KZZ-:5<9Y(/5@?EE^W.V:QCV,O7[&&0 M2`=5NRIJGU#&V$$VQ6#!F[5-H/UY/>%TT,J!^4HA.;PM\H]G;AT:;,4YDGMR M;R,:@DHJ>"H_-U6="31!!TP>PS$#KB_=R\*NRD6=5/5W!@%9PTC$(YY'R`J! MG9FGRFV[KNW\W4-?JL*/<4E$.Y!G<(XI-EX%)`IE"(/CF$@2D4X=&*F,0H8R MR[A8"10H2*Z9S!K4O8\P%U,3E'0>8=1+IJ!2\HE'FWU*`F`#`8-1`P%-[TQ1T+J7`<.LP$O4#^]U`!'0!V MTTUY2#JF@U%-TU/]8(+)CO[WWP'YBB`E`I1]\70A"^ M]`0YC#R@8`#NP/M1V'O[]?5W=-=_7@-_OR-=;M[!9VA^QO!:P.NO_<74`]>O MQ[X"(CRFM7DXKMR`U*']"BRP[@&O_::CWCOT^+?OP&OWYQXF+X=WR"/00]7R M"&`IYP(:^^(&NPAH7O\`5\]L!7S@>FI/'ZTHAIZ@Z>/MW^`'G([>^3V]1?GW M_#@.B7$?+MZ?*H@03J#(-0Y4M`-IV;C4>H#W>._?X@'GH%ZLO3J*Z^I%#NG0 MF!303!R*]F74!$0`!(4H:`.FF_UPCJ'<_.!UUYBZ]_3?NW\?X?6&P5\X'7ZX MGK^MW'3IW=?`-.[PP#S@?$GR;AMN&_Y-.O@.`"X$=0U)KZ@+Z_EWW_EP%/.! M^R+N(^`:Z=?Y?RX"OG`]XEUTZ[!I\]P]>HX#W(Z9DH>182\1(NHJ6BGK62BY M2-=*L9"-D62Y'+&0CWK51)RR>LW*:3AH[;*IKMW"::R*A%"%,`3061O@AFPL MW4MI:FDF$%FI^IUX@KN+F6[<5'$)(J'(C4E)S MD>=5L69@R3+!Q$5%3SA=--1S'$?Q3Z+GXV$GXT+)UJ\C#O+EP%Q(65]W*>JYU535K-5,W: M`$"RJADU#IG,F(D.8@]!#4@\IN41T'E$0'UZ#XZ:!NE^1_*=I)9^1U`?YRRV M]```W<7Q\-L!#UY9'K_-4K6Z:Z?L([5:Z;?[<.8'OZAKXAX@'B&`U,S?7=3: MCKT$VH`&X[:[:==/'IMO@/I\^2])@IPRZ`'3I[N!WC_MO7IVV#X]0W'<$5D6QY2EI%T1!6;I*2@9\B14)1$PAB+>NBI%_*-Z^H1=A%7 M)@F)X](\@8Z,#6].`JLZ5H.M#M6SQR$0HZ67?0$\T:N9>BYY09:/0DX=_5-+ M52&%ME:YC9&`J2W2+9]#/[2S1*;)3$VH@6?IRE)%L$G1L'+MT7+TI%*:C3KT M.V?E>OFE2MZ0+5D3)2\#/Q,L^#DJE52717;N$TUD%R*(K(K$*=)9)4#$4243 M.!B*)*$$2'(8!(8IA`2B`C@,)J[I1Y34.^B(9"3GKL=JTC:+3<0ZZ!KS;Z@`[:CJ.NFF@Z@&FH M`'1ETC%$=QV'0H^^VW'3NY@`>H>`Z:#T'`>IJ;7]MJ7VB("/<(CL(=.NH>S4 M-0_0B(^S7?4!#0>[341'X!`!T'?P`*`)M0TU`--=M=N\!'333\@ZB&PZ#@-V M7R)\='K_`%B;:=1UZ5_):^KP]GY0Z=Y8NKV?$2R_A[W0V3>DNNOW9[V^ ML`^?AT#4G!R'B0==.[7?3KKKZ@[MM_#`4\Y*/0Q`VU$=.OJW,.HCJ/Q>O`5\ MZ+WB4/$-/D^N[NFFG3PZX"GG.NP"3U#IKKOIM[[X?#4/#`5\Y#?=/3?3;3?K M]EI^;X\!0'7K+Z@T'QTV]]H/S`>FP9(9/EBK9I;!-3"0Q7ETJ18&+IN8K^5; MLC%V']L580T_OMNNF`V#ZJB8`]QJ!"6.L@]>I/8F,215[)+L5Y*'/(MQ3*`] MLXE&Q$V#%J/9MEE>=)XD^0."*07\GIV.J4/IAQ%%1196FXZN:@:Q$C#O:ABZ M?IFW;.-3HFDU8("M$'=+T*^BZ;GJM@TA;N*HK4(N@`6=)OI`@!=NUE>SK9"* M6KYT5TA4$%%0-=*NGBL[&L:J1>2]^FNVIO7IW;>.^`_7G(=>8O_-[N\.NX M!\8]^V`_/G0>)--]M!V[^G-W#WZ^.@>`;A7D:ZO:9V,U7UNV5I`0$``-0&[- M";CN.NHAX>'4-\!%WY2B[!'C4YT""8`_GJQ0Z".G7+39OU^`#_+@(+_=#K[[ MX-0U[OEW'U:Z=0P`9$.G.`!KON'7OTW[^H[Z[^.`[E;FN2T+<6@*X[,BXT37 M%)U>5`P`H"QJ:GX^:!(2"4W,53S+LS%$!YBCIIH(@(;EDY1]!5LHWJ=-D)7C MMK'OV=44=*3E(R+F.532>LG"\S3,C#FFV2"9DGC!"57>L%#JIID9B452G")2 M^]29X[>UQ55.T#-7=FZ$8/"MZ3DV%$QE2HJ1+U!-VW9&E$:6D%#2+`[A5NN[ M653?JR$;VCQTHY("C,,2;@43FYN^R33GC9D91I,D2>/H"6"6@H,DD4A4W!UD M5HB%CQ'MTA7:R"IBKN&X(KJ*E52.D@%EVW#3O'+K*KR-$,J>[0.T,\JRN6RR MJ@ZJ%#G2A92:D.T,HB=N*:C0%2*%,50J8%,8H MS=/&::[E=NDLH8RJI":G(!@*"2*B:8%(42!R<@Z``B.IA'`9:V2LY;JJ:>=U M(\@FKJ3CIQ9@=-PNY4:%329,73=8K0IO-2[*K"?S@#E5[%10!**:ANHQB59S3%6T\Q=N8^+-,TV_*=%-)R[0 M(X@)&99$[!V[35;![N<3-[7F9^6-&%:&HRUL:Z!S!4(U<@X!TNAVQVLS5[T$ MD33,P=-3E2;)))147H1M'-#O//Y:0".^0C0,(B;E'E(4P!S\X`4"EY!*)S@8 M2@4P)ZAL05!(4IN8H@'37D7RCS"02&$0$@F*!3:[?6@]YM2\H#J8Q#"',!"!PJJ`M_JAS M`0$P$3&-J&@I%%3;70`Y.7<-#CW%!3?0.O>Z`?9?!J'=Z]0]OQ],!]!CR+]? MM\O>=\_72\MK`ZZ[_01/B/C_`)M-=\!$KY3@+!OJ'VZ^K7I@.]VXMTUNM4A*56Y2 ME\Q>R6I1$IC&9%*!2`8.;01[<1$P%-H7FZ`&I0\5P*!;6PJ-6DTU"*$0:-'A M!,J"@\L@EYP`#HFD!-C`($$IC``@8QQ,8=`Z4*B?@3?41Z]=N\1]@;!X=.\* M=JF(ZZ)AX[#U`-/$0'X`#33`5!9(--B>T0#V]==<`%1,>XF_40]?7O`0^8A@ M`*I>"?@&VNFW>`]!\=0]0#U#``42\$^X-]]QT]>WMV\<`%1(1#WJ??Z@#Y0^ M>NNN`[51%<35O*JAJSIAPW:S4&Y.NV%=$7+%V@X0692$7)M!.0CZ'F8QR[B9 MF.4.5&0BGKQDL/8N#ZA.+EONK2LRDS4B9+ECKER-25$2,?.BN92.J1[,.I)5 M%95(J:2B;!N\);^5>>90;=25I6D)U&#CD;KTZ$B%^*_CX^9J&V5*2:R;5I7= M4SU'>>*I=JDS=FMY6-8PL@N!"&(ZB*+MD\;K-G*75)PDH MD.@ETP&YQY'N8II#/UR\NGF66SZW3^[WQZZ".`A\\LG,(<5*UN@Z?TDEJ/C^ MG#F"[]0_+I@-2\3"77<==]PZ#UTW\-=_'<-^HX#ZB?DM27:\,6@S"`C[ZG3IOIW!KWX"]68 MD0,!BF'F$>@]=M^G?T'Y1]F`L964=79!8PN>S.Z#'&78J-EC)G(8N@CIKU$NN@Z>/33?74.H`&`ZT?7H&O@'O MAZ[#RCMH'7X,!X!,;7EU'770=QVZ^O4>[IT[]`Z``P^(`&X;B.GCH(:^.GJZ MZZ8#=J\B<'7,YGB]5B;9^L-[@2?3^70>_3?40MWY90L*7$6R^!MH.32DQZZ: M_P!&B]VVF@B(8#46%YL(Z^P.8>[U#KIH&@Z_&'@%?.Q'X]!W]>G700_-[1TP M%//.@ZAI_A#O\8"(=>OK[]\`\\'Q';4=!-U\?A[]]`\1Z8!YX(:]^W4#>`== M=``"@.O=[-=Q`/R+O3<>HAK]>;X=]MO#Q[@#`90Y(U//,Y652/#K)9B;.18> M^UU-*5_3\>!1#J25/%)4B6H*W1C$T`*O/ M'I6(>U`UBU'HKE.T92LM$1<4[29MS2;QF]=D8/HM\@T=`'N5%F!:6?48TK$M MV[,E.H0C--IYJQ.\J-W0L`PN9.,911PL`/DJBS(2\E.U.Z ML$8>JIMH8@0%OT;U569)O4^7^J#1H7I!ZYFJ1/&SA'YI*`:J1RX5/%HVR!JAI1J8')YV*:QE>4M<.D&:H/$9>D,P%N((K4EM[*K8"(/.1:-K5$+. MPCI,_9G4>2$:Z<.$WKJ+ED^S7="\?(@5NHN/GC127=M`!C.LY&$N"Q!-G4LL M9D&O#.,7U/RK^'DD3(O&#A5LND<3%$#$,)1$-0Z"(!UTV';PP'#^=[Z[@'3Z MX=/R::==-]-?>],!478^([#TYC=_CJ&G7IL`=X>&`>=CW=-=@YA`=RZ=P:[= M1TTTUUP#SP=?;ML<=-=>_8--@TUW'3UX#<<\C%6[7.SFO]65EL/770!NU0P; M;>K3X]\!%;Y3&Y%+C9YTR@80T<6''U;Y:+-[ZB`]VVG^;`00>?&^R'<>H[;A M\`=-/Y.N`>>FU^N'7X-=`'3PW^+XN@@\]'[(=M^[80`>NWP?$(;8#8HX9><^ M"KBA8;+Y<.6087!HAD,903Q\)"A5]%MD1391#-1142+U)2S8JHJ&+VASE$!!7F*0"G10.0Q2"=5( M4S$#4.E/S]L"Y"B!2%4*8>118YR@4Y"N/J@J))%%1!0@E(4@I*B42JK&9"J* M@=)D7>J("4HI.%B%,H0!3,)E#-P%($P!4Q$BI`FDW`A`4*4>U."8&`IA$2\I>T24.8$Q.`"*NYA4!5(QPZ$ M]B^H&#ZPI!*`B!E.4B8EYS$.7M!`Y2$4,8I$P,N34HZ$,D4.K/(PVIRB42@) MU`$ABB`E,.J>A@'742B!MA`1U*?LR_7"8.K5%1]9OZ>5D:;HRJIR/,\4CEY: M%IV7E8MH=NFBZ6;NI%DR6:)/BI+M#G;+JD7!%RFX(3L5$CB&/'GA^G,/=L/L MUTT`.[V?'UP'T-_(JE16RZYXS".NEZK6%UUU_P"X6<'P#QP$4'E.W)_-8[D< MPF`?I265W`0T`!HY+N'?4=.[XM^KV]=>\! M[]=]_+[+I0EPB/3`8X#"2J&@@40#M`0'<1WY3IE43*6"C4`()2^\[%=\)`*.IA$@D4()1-H/*8`*0A>4@!8O5/Q/ MJ&N_O1#NTV#PZ]P#W],!75/4!U/\@^WU!Z].NNH8!]3W'4VNFHZM#)(35)W4B>Q4AY2E9$$UG\?.3[ M)F6+BVD.F9Q4=:Q]O(J2*Y@B2;%V$L=.596+"L\L:]TT6"CRG\R[>B75>PJ2 M+:DYF>EK)W9@V[67:*+F4I2H)PE44W/TXU,!H>IX:H8B1AUHR47>T?!A@SQ: MK+I6WS*-[A1Z2Q(*^M+M*T54T^H)5S$"G`5VT(J<3+.GC]5"#K:57W0S]\O-_J++9U#0-U[X>`!@(AO+)!$.*E:T.XN@%\1`@=1V#?IWB.Q?@WP'U*O)64P6X85"Z_MCS8 M:!II_7=O2(=.FH]!\-?;@,U,]-(.V.;G*Q<".%^"\92=S:5\Y=+/A)%1L>22DY-1-BT<\X1K9DGG(WDH6-J-[3TU*4?6U3V592\@:GZF@C`C)*3MIY M%S*5NVAY1(S&?I9]1LA7\A.TM/050/:>IAH_%NV#I=0SE"W:I"6"&F86LJ1J M)C*P$H,6_3=-UD7;=:/EXAV9N<%F3])-55J^9KBWD(]<%$5T4'*9BE#"!4]2 M>:K55%K)/+F4FN:B;EQ!E$V#*XH4X"0M'SE,YDVD34LK!NHZK:1E%1!%JQJ% M"GIE<(I8KN)#TAK.+J:*3EXEPH=NL99%1%P@JT>L'K14S9_&R+%R5-TQDX]T MBLT?LG)$W#5TDHBJ0IBB`A;"9D!#FT4$1W[]>OQZ?R"&^`Q0N!%M8R9^B9%P MO%MWBVKZ7CS))O:;E5@20)4"8K%4;K0TF5%HQJJ+>H.8I;L(V;<-$!92;\0X M4U8/$'2<-5":+*85$Q63QIVA8:H.0IE-8PRYU%6KXJ1#K.8-VJJ\0(1=1JO* M,6ZK\`XB3D-0,'-KIJ`@&^@COKW]^V^FH]PAKH%HJJ9M9)NNBX(15-9,Q3IG MT.0Y3`("`E[RB'-KS#UU[\!B15U."Q6,FX?@`=A'7774`TZ:!NU^1-CKF9S MP!MJ%A[9]/\`T_DOB[]OAZX"U/EFRQ4N(QEY`QC%UR8TH(@AUZCZ\`\Y3#;M#Z`'>(>/CX!Z^_?3?`989"52K9Z\E"('.(K9NBBM2[!J(#KH.FNNX;ZC@-X_B=V9J!![;P(4[!G4):4EGT$Q7[0AIB M5-5=.Q\=`)I+)D8$;R[EZ2/MW\G#H.%KFL#1=%^8O92+9-Y;-_65M754 MT'/I4:N8/6JVYBM0)M9J@9HUR*\%>2.G?>L60JT+#?1+&1TO4U3L62].$D:Q MC)=KC*^IEO M%0-P';%5J5ZM7+ME$F4IU[Y],U!(4A<&KS4=%25*?1.Z81-8W^M#%51`S\VG M>JJ&*X8]WOAFDFS,BS49.VKIFV?4^[@43GBW+)=FYF(EU2;90ZISQ+R+=/JC MH9LFM(HC`.ZQM:[,HO`1B34->'-E;4&K]6K8Q`I3H"5.4(T/VB8IF`#(.D5= M!!RS5(*:C-UL8[4Q"+?5T5,!@CYT3O44UZ#[X.H=0#4._0?5K\0A7SLG7M5. M\/K@TTTUVV'J'A_F`#HG]T4`0#3NTW'V#\GM[M<`%T0=??J>OWP;^/P^/=X: MX#[5$?"&_CU'`13^4X*"7C=9TP`?]FL+J M&FH?V,]G-AT^$.NOP@&`@5[81[]]->H]_?U\,`%<=>O70?S=?GZ^F`KVPB'< M/AZM?E#7IW>'JP'F;/W31P@[9N%FKMJLDY:NFRJB#ALX0.55%=!=(Q5$5D5" ME4243.4Z1P*\^BH+]J0#8"7++MF_MUF4B'7T.%=0M:1+4'R.V**A%$DUBB(@Z3225`XE456$#+)+!U1ZN*@\QCE[,JQ4VH$( MF!0.;E'S8ARG,D0%3$/YLBD83@+@3J$%9!1,0MU)HD]Z4$RG(3SE,Q$PU+H< M5DS-T^W^K*J&(Z[)-P/U?MC>;�H+)A;J3:FU4*8@*:=H8?>I`LL5,.S<^^ M05;IJH`NJ`K@)6PKMVZX`3E64*0+=2+`!(!S%T4!,"AVW.)@<%`IU#H>]*8C MCG,'*FJ9PX46,X1^I@0P)A;22C4B`=$Q?>J3E*4ZI1#D*50-$TE><2+)B MW5*(J:$23('9\V`Z1+1I![85RE$^RH*',*CCM3D.D;4"GY@6.8%2#VI2=L4X M&(HF7LW*0=%=0RSE9FJK7FJA&I).86U4*LVU13:Q[ M1JT;!\BZXR(1UPJ[CR$!)-A6=4,2)$*!"$(TG'R`)E*``4I2`GR%```H``AI MX!]!GR)LXGRX9Y=>@7LM8`?_`."3GS'`12^4]GTXLMQPU_VI+)^/VGI?!U\/ M'?`:]?:>O_/^;X=@Z[;8`*GKZ[^'S[_R#W8"H*#M[[33V^/4-`]8:;;Z!UZ8 M"G:?WP^'=X:[^&_=XAIW8"YMI%N6K2B.@ZQC[0!+SZCJC^U#43"``(@0"'$^ MG*!%-1(8/S-F+(ZC%L9#W0%`S'3`4%40#773V[>/J'P\-@ M^4*]IZQU[Q'<-].\._;0==NH^.``IOU#774.O4?#X_'3;`.T]8Z[>P===-@W MU]FP@.X8"@*:ZZF$._;PT_/H(_+IM@':#H(Z]VFFO\OP^T-0UV'`.T$=??#M MX=^F_=U\/F`X#VV$H^B7[*5BWSJ.DXUXV?QT@R74;O6#]FL1RT>M'"0E5;N6 MKA)-=NND8IT52$.0P&+K@)X*@N''W#M7E2N6,53XTI4^8*Q"%?TG)`@M`R,> M]GIVCEV;1@Z279H0-+S4E6P/_\`=>_X_7@(C/+)!'^:IVN]]H`9 M(;4CIXC].+,$&XZ#M[>NX;]!#4B,(\PZG$0YA$P>]T'UZB&X!J.N_4.[0R%.9)['RC9=,*[L'1!S-5XV307431(M$RI-8]R$0+V M^<+.U*:A*SA9>U5TE4WAV]!5H9D52HD(\H&>REO:GCEW--7#A4TC%>*J4[(* M3L,S6;#5].TL_5/&IAA/==S]+^ZC"K$>9.F+H>8475Y$TR^;1]<,BJDM]5+I M0HD!$)]H9S;N3=*`JX?RAK8Q212(-3G(&,5UK?4I4,NXJ9GY_2=:BB5L2N:- M=EA:E,DD!O-T94_8.HBJF+41$[>&K.*J.#34^J^YAE"D.`8*U=4%?6OK8DO5 M:2==4Q62+*FEY>C(D[*I"SL0C)2,3,3U)*.562ZBD(G*1DG)4Q(+/)QVTIR/ MB:,8&2;,U@MS-S<7).Y"OK:/F\TZ!4K6M:8;J$:N9H6:":92N8]Z9FM`7`B& MB:;=F$TDQ._9$3@9TJ""<-*4^'$&J*.G8]&5B'WG+%R!S)J&(HBH11)0Z*[9 MPU5*1RU>M'"*K5ZSJX.?MQE8-0$P;.A.#M9D1F^*NL^;/W*8=,=SDA3G,G*.%9*#*`@WFUM# M/HPF@\B4YV92BY:IA[TDV0O:$2$IIA,#)KRS@/"Z?IK%YQ,0Z9R\Q#%'F*8I MMRF#0VAM0$!Y@$0$!#377<+?3[)H_15(H3M"G`P&*.@E,&^NPZ^O0`'8!U$0 M,'-@,R5$0`!4T#8XZ=H4NI@$^NH6J>IBF80 M'777KKH.VO?IU,``'=IX[Z"'%\V@Z`;!WB&XCL(>&P;M_D2X_TS MF>,!$1'Z1%LQT'N_H@2>P]^H=->_?7?`6@\M!,(<1O+KI]YA2H]WW:[W8#3] MYS!\P^/\_P`],!7G-ZMO`0ZZ!OUZ_+ZNF`ISF^?^?7J/=^0`T!SFU#?\FGK` M=_$![@V^$<`YS;=!'41W'KJ'YO`-!Z]1VP%`,;Y/$-OE#?N\?D'`9A\/^/EG M.>')S(1[-5R6*S4Y>I-0Q""Q2H\9ZL)99. M";U/1M`W#L%4]+UC+N4:3NDMEZ?6@NM%NYIO3M8R`6JC8:JI6#T:*#5J M>B$:I).2,!??+A423=GEGO-%^XOT-%@Z^D08H!X6ML;O3R2<'"4-YY2/G2<1 M`$8&E(-V]J=ZZD9^4AZ'3J\6,_!MZR;QPWJM!2->1L`HVD'%2TC1-;OR1A*4 M?A&_?JV$E,1[Z=C&Z4O&.3`@^<,FBA&IE9$ZX(KJ,'*1', M0U1I2U.N@%9,J(!!]],9NH8 M?JJ13$,8SE!T5,+;`H M=0^(.]6SN34-J:\IFX%+N!1EZ:DT7J:0F4(@_:;IR$2\Y-#&8RK%1Q'O`((' M\W9',) M3RFQX*^5VH8^@`'OXNX%0,3>]```-T.F@``;:==0WZ_(DS\^6[/./A>^UH=/ M_$.;'V=_=@(I_*?C%+Q9[CZZ:_2DLF(Z@`ZA]!R?37^#X>[`:]7:%UZ%]FW7 M`.T)H(^]`--P'37KKMH.^GSWWP#M"=P$[M!VT#IW=_\`!@'.7P+[-OR_R8"Y M=HJAI^GJ\B7M4"FG`*D>,I)<4E%@:I.6JI4G'9)!SJI+>H`#OP#M"Z:>]U^#UZ?`'LW[QVP#M"Z?M/B*'>'@/4?$/BTZ!3M"_WFO7N MZB(=?7^7OWZ@$Y!^Q'U:%T[]._V=/R8!V@?W@>W3\OAMW]-1WP%>T+_>[==- M-_#`.T+X$_)\6HZ_&'R]`S:L?6+::L-4]M9)LF_2I>\UJ[@(1ZHE<)2,,[G& M))I%\V,',6&BW=,LF`#SIMO/K@K)&`RS[40V(%()2^TJVRLU,JZ=5*VRDYE: M)<3#\6YY"0;5?/62H^U%R0*3E(Y=16D%#LV;%Q75)52R:-0C&;6OF(* MI:X3!J/["*U&G7K].+,%IJ`"&NFFO7IU$>F`U'3E3YC@!-^@:CH(`(AT]\`A M^78=1,`ZX#ZI'DHQ`-POZ&``Y0[:;TVZ?T6[SZ!ZP_)I\&`FHSLTVG*VKI>< M%-FH^HB]-GYV/\^6=MTBJU!6D?;.1[(T>W7D'#EQ3UP)IFWCF/F[J75FIE!M>2C MT@("C%Q0UPI59LSK)U!NTVSZ#+<)ZPK%G(MPEW%SIMVBQC`#&BB[O)W$I7M7 MZY&]:4\LK3U>0CA@^@I.+J.-4.U6=N::ETF\U!QU1(II5'3[:4;)+&@Y-@83 M*&`YL!:.Y[92HZ>DXE)T9F\5*BZB9$I1,,9-QKE&2@Y,$]^U]S99HS>=B?5- M8$105*9(YBB&-4G&P-PXV+JEQ&N86I19G;#*13E6+J:"?M5EFLM"J2S$4U7* M<9+-W3-Y&O`>0[I=J8'#)TB.A@L+,0]QZ*FE)N.(WK:#?J$^B9LT0;PU2O"E M(1`D][F()HP$K4+5NDD1V[BC4Z$NQ228>X#ATVCW;<$35,!6S91W3DJA)ID_ MU2@4%V[]F)C&`J;^-=)(R#!03%,'9O&R)AY!T`=!#`=2JBFU)5FH@(G;."*` MY9/2>^68O$>847:0'+RB8@B)%4C?4G+=11JN!DE5"&"W[4%Y!!9%T@5"4CU/ M-91H!C&(FY`A3]LW$W*91H\2,1RS4$`$4%"I*%(X3702"W\A`2,`=1 MXF,9Q3Q%.S%(3"8QUX4ZAB)MU#"(F/'+*$8*F$#H&9JBJ9T'@1,TDFWG#015 M)S&3.4>=-9!8GO%&KANIR*MW*!M2JH+I$72.'((+)JH:E$H MAKJ;4N@?7`/[40][H8`^NWUTU#`8YU'3ZC-8R:A!/J/U)Q[X`4``$1`P`(AS M@`[Z`&O+OKH(E"V[AJ"9A`2"`AKKN;780_OM=-`#4!$1#37;33`;M7D2I2ES M-YXA+WV(MGKN;37Z8$F'[8>[3NTV'?`6;\M&,)>(YETT^\OI7O`.M[+V^._P M_GP&GN(GVV'3_"`1]N@ZA[0]8=VN`SD]>XAW]X]W0`'U`YSZ=_JZ=P MAT'IW#W>&FV`S<`\>[KUT#OTZ[8#]I< MQE2%'?F,`"/,74`$0#4=N[00[AT'U8#:OX'^5ZT]<552M4STHV93\3*QLO&O M"KIHNF$E'NF[Q@\;*B',DY;.DDG"!RZ=FJ0A_K@$,!ME\4#+9F@OG='A])91 MV2;J/(XO0C>6=\\29TY$T\H>U"T>WFG1>=WYNNHI/F91CB)BH23*)'K^B(@YU@.T*X($:M59$ZQLS2 M;5%>NJJ;A&;RW$56=5NW;N;@*POC8E&X5GZ)N">77H*3K&C4+8W%IUW-EH^L M)P+OPF6BDIRD6E#T]$R!8,SI2G:(K=NQC&MRGM34I!,G,?.V^@ZG:_0O!7Z< MVB>*P5_]]D94MW!FJ^C*2F).J+C4K1#>K9`L_=JE8*&JMEFEMC9&5EXC-;8"G:V=US:\("]EA`D9`M.R*"<E M!('3)=$ZB#5<5FJ`0Z5!34Y3+U9A+L5FBZ!SIF*H7EW+J`Z"8/$-NFN^H==0 MZZ)S[=_?H(EUT'O[^O?U$/';0`W//(I!,.=W-SS?>K,O#[KE$>&@^K<.[XPB ME\IZ$0XW^=7_`,Y80?;_`$M%G0Z=?7\&`@,YC!W[]?B^+J&^WJTW$FFF`KSF\?5W?E[]MMQP#F'O\`';XQ'IIMH.H?!OI@`&-UW MT^0!WZ[;[=W@.V@X!S#X^W3YZ=_AX=^`V8LM4D=;+_9@ZZPZ?2XH]H4Z0I)K M=DSB6C0IDQ3(*P@@4IDC!S?5#I!S@',8I`O(+T@EYU^9-70ZG,84#&[0@`HJ M8A4N4H`!NW!RUYVYB-ST(N1(G.903]J9(J*9TN43'7717(D5(5N15! MT4IRB15LJ8N@)D"_G#BI-&X?$$1A7R:2Z-#Y8:^K>+CU$?JD;/3]PJ&I!RN4 MRYU3INDH-RY9"<5!<@B_>)J&Y7"@J!L9N+*(GYP]SS?7:@)0`WP^]$?R=0Z" M`8#KCBRI"B009J:=!`R(]-=OVNFOCTU]6`@LX;5'`''LS<4H\3%%-WEZFWA4 MR@&HK=OEW?"80,40W,+HQ@ZZZ[[#@-ME6R[,Q/>FT`0`0`S<--=>_0P>T/E# M`?+`D,&@#XX#>:\B-'7+;GH_ MX<+6^S_M"FL!%'Y4(80XM-QM-/ZT-D^O_H>3IZ_S?!@->3G-M]:/>/4/@#\O M7Y.@.B$?'@H9?W/8=N8XG.KYHB*@F$=1,)Q3U$P[" M8==3#N.^X![H'-_>B&FWS^+IM[>H@YS?WHZ:[;[#KKIKK^0._7`4YSZ!N733 M41#K\H:?/KUP%1.?U!^3^7?O_@TP`#GT_:ZCW;[?"`=--0'O'N\<`YS_`-[I MIUW\/7IT'0=M`TP#M#:?M>FW7<=.NG33Y]^P.<_74-?Y-]_AUUTWZ:=<`YS> MKQZ".G=IW?`(^/3`7BLI.N(JHJ@9$3<.$)RA:I(]:,$C*RJN/9 MD4?)R-"7;N9<4]0OV3=L)W!I:DT;915;,%6*+]_)1<+,4W%L'#ZHT5FP9X>3 M;4.TMQG$XQM(1B1$(./NQ:=[3"*8E$B=(5!4M_*CH\I#$]X9/Z%Y:(%,Q=C$ M$IM1YM62&$.*K:X`Z_L(;4!WZ!K>',('0#%'P'O#;?NP&HT8V@B)M>H MA]<(AKKKL`[!H._0W7IIL`?0A\DFXBU&#;DF2BK`C8.5A%%HR`="=?SB0D)F MKZLJVFY=RLH(I$8U(]K.8H1R4Q4VT-5,-0+$'3N1NE'L&`;L]U*$AKE6[K&A M:@%V2(J6!?1[E=@N+:0:"9,5FSY@Y*!O-W[!TD@]9+@4W8ND$E-!Y=!#4XCK MKU!.2/G:,!)KF(RGZ?=/ M7TI0E4@ZIV0>2L8K3545.%EZXAGSX5@3(H/,)A#E(._7]L.F_A\7JP$9][LO MB1[C4U7R[.5AS5.+"WS^KZ>6+%3],S[UVJG04T$F5,Y5X^3EGIZ+DH62;2\/ M/R4W1B$Q$O(^)$$PX"4MG=>A2_T0:<=U;2A3"4+AT9"NW#^,0(F8PN*WH6/( M^D$"```#B>HY.7C3'%9_(P5(Q*1C)!QU*V)5?5?V-/.&Y.0>4C'2E;,:/E9J/35,]J6)I\CYM5C$#%TT7DI1R(B<+?/=,X M")%`(JF?F(H0BA3%*%F*QR-U6DLM,0+!Q&3:9.7F4;G5BY9-(INS93+4A044 M2'401?-S)2#$^ATU%FHN&#L+%?2*E'CMY!2,*\@JJCD>W?4\\3$'0M!.*)): M*6*4J4O`N%@`J$JU+R)JF\RD4H^538KF(8"NA*43BWUT`"N"%*8P) M:F%5+F53`2E6*B&X'Y%3$.HC-%GC2=)F3,-B;:@`&`0^MN!):B',`#U]HCU' M`8_^6FGY>(]ER#40`OR#J' M7``4_OQW#0==>[3U>`=VFXX!VG]\;O\`LOGTZ_,,`[38/?CW[;^.P:AKL'>` M@/B&O40"H/3GUW#;WP]WJ'??0.X=,!0%.7004,`E,.G7U[CIKKKH&N@AKKKK MX!F-EISE7(RYS;-_34NZ1;H+)G%,BAP'0IBCH&@EU#0.@Z!ZP'01#;RR'>4; M-8]M$P%Q9,Q3I%225.Y.(&Z$*(B!SAX`.O0=`\-`#:)L%Q8,N][&\(J-30YG MC=P5ZQ[=PASM7:S-TP451U4,)5#LG[QJ8P:"*#E8GUIQU#/1%W96[[N0E'XP M%2QU3TQ$4O44)(I,9*(FXR`E9.4A&S]BZ*L@Y;H?1'5#!TW4(9%_'SSQDZ(J M@?DP&-%Q;2FMW(D9E.RJ"AZG0@:.IV,'4W2].5#*TU"7PN M3/MU*2N?2#BDWQ$Z!N-<=&DI.))2N8#+35S^/E6]]*)=#;>Z]AI6J)&N7TU3 ML+0TI*AV:W-DV46,C$?065[*2DE53>X%--?U*BU@I2Y-#G91]SZ88MFM,NZ@9N)2&C&3IPYEI,,%\[ MU&6HJRE'<`K$Q(I)LQ:(I%11!-%!,@D102``T311*`$13*`$33`"$`"AI@/G MV<53+%0-"KRTW!%:M%>U65`J/*&@\QS=`#NTV]6VG>`:Y*Q@(JH7G$.4PAJ( MF#I[1'KOX:A[1P&Y]Y$^;FSO9NMQ'3*JQ_\`NY1'C^;`15^4]_V\#.K_`._=@'=[0'X`Z[#\>NXZ!UTWP%-_;W:_D MV'Y`$/@VP#?UZB/<&H^W?PUUZX"GR?/_`#C@*COO_F#P#^7Y-MPV(,N+X"6' MM,`J)@5.@*>$2K"040`C1,@JG,FV*N3LC:&5,*QC(HIE%(H&`ZI@O.I)``', M<$RG3(4H@IV":Y3`4KI=7+7D(4J0ICRJ=CRB3E25.BD5T8P`0?J+@#'3#A'CPYSJ8G*9;9$XMR:&% M#0B@"9PX1T6,+D!36$#KN4E5UU2=D`9Y<%R*),\46HF`%!0B^26MBA]+X=`#S?K_`(/CX>'RB/3UAK.Y,*6/">4[WPIPA$T?HBR_U\D!#ZE((145 M19=`#D'JI2AAZ#H)3#MMAUO`W,5+?.BE]ZDD?0/VBA-_@/R?D$?R8#Y&G%PB M5(+B?9]XU4G9G2S57H7Y-MBOZVEGY!VU#WQ'13`/?J`[AI@-T_R(T?Z6S/0' MA?"UORT%-8741,>5%]L'%LN-R!J7Z4%DM^T`N_T'DUV$0Z;"(^OX&`_/,YU^M'_^Z4/SA\&P?)I@*\R_V(^`:JE#XM-NX`Z[_&.`"9P' M[4=@#8%"Z^P0W]FO74-O4#F<`/UH^WM"B&_ST]7?L&`"9QJ(:#N.FO:%Z".W MCW:ZB`:;:[],`U`#J/74/'3;X0"@"YZ[P'8`WU[PTWT#?`-7`!]:(=1T[0-=M=0V[^ MNG77;4.F`[M;6J"T3<6@*R?I&484G6M*5.]3*H`]JS@)YA*N4C%WYRJI-#IJ MIB`E5(8R9RG*8P"&VCPD5I2=KG,PVE2HJN+1*D].^.Q)2E.72GW=/ MJG6%1P!J5=UB-+D47=/%9`D,245='5?J)I!+%Y/O#QC3-7Q)*EIQMYG15P*5 MRC53;AN4YU&Q;9L6]\:(MXK'F4U.$:XI"CXA=@F(2DB)*&!C($CWCF*T]/LHJHHLR4M$L'*0?6)RAW^=7[L^HC5*Z1KJ4.T;4]7Y4V012 ML:6<.FR4U#+J" MS>P\\SA)^(#V+#Y=U+J-J@IRKZ=)1MW[J;;5PT:N9B@*T08M$Y9DD^AY>/@*VINL*3IP+_5)PV:3KJE)^CJDC3JQ% M2Q+V(D`:*G9OD4'R!T!=QKY,!7CY1H8Y749)-A([CGR+=ZT.FX03."Q<.1P& M73*FUK2D92"KA&-5NM:>IG]K;M),6@,VJU7P+*.D6-4L6)BF]SX6Y5%S5*71 MIV/!5P>+@:TCXEVN,G'OTD@MSF3X342SIZ;O?ERCEJ2O_;QX\NO3D!#-3/J' MN[54'3TQ&NZ8KJW?NA$1$Y+5M3$G-4@A5,-*457(.9.,1=5XC!-G#%8.3M]% M6T%C0I+YT[#VL+<>-I>0MK=F.E5*ARW7?0K)FW?4L:@[KNH^&^AZ&H.K)>0=BPHE"O&34TVL&:Y.#KRMZ+80;!N[?2:95%3R-V+:Q#9 M1S430CRX%!L%KAMZCIJ[`79J+AS9;[\4K3TK*4]3=,YN%5?,%DG$=4=)3K!TLS7*JU?B@J`F?;^R,!JUR%U]DMJ MN&<4BU)F$R[W9N"X9S$/<:H(JEKDVCN)6*S1"G(RDZZ;0+2C)ZF;GU*8]/QC M:YJ-,NE[O5%"K55=I>1N'*SC<+X47EYRY77J(;>BG(V[O"E&*2TA9&ZL*:AK MIM8]N8$7\I&0,@=1C75-1[H09N*ZMI+UK;]9V`HLJJ=FTP'`7>X.%N;CQI$' M#5U&2L>JH]IZIX-4C&I*9DQ1.D23A'ZC=RBFN"9S)NF+YH_A)=J96,GHJ5B' M+N/7",NO.&O+414C"WUY(V-C7M12*8-R7=1\2$-/EJ']L= MRY?\2ZE?_O9>[U_F^+`:=X^T/CZ]--=1_,&G7H&P4\-_G\?C_#ZL`U\/7IL& MN_Y?5M_!@'?TV[_'^#^7`.H;_+T^8;;>O;OP#QZ]/'XO@^>N`I\_R?%@/.W< MN&QRG;K*)'+H)3$,)3`(;["&FF_AU\,!?JW&9F[ML7;=S3=6RC8&YBF(F#I8 M2!RCJ`;GU#H&^_LP$S66'CS7]M,YCFT_,/GK)`4BG,=8QP$I>4#:ZG`=].NW MJP&S!E;\HPM==JV>,GC=91 M!TU<)*(KHJ'25(6RZ=,$AO=^`D(F2B1AGD9)N&\BW?1*[4S- M2.D2/E'`OVRS151LNF\%?SA)10JXJ"HH)PO72%_;*TE$-DXVI&LFJUCXB-"3 MD9`CZ4D6E-)*LJ9=R[U8YEY*>C88Z,.ZGW)U).8;MDCR:ZYB)II!8J]&>FDH M]BZ28SK(A0(?WQ7"8;:#T#G^??N&`UX9=0!'F$"F+S&V*'-OU]H>.X!@(W MS")C"81#41U$?$==^GC\_#`;HGD3O]F]F[_XJK'V?UW*)_AU[L!%=Y3W_;P, MZO\`YRPH?_+/9[Y_(.PX"`S4.F_?U\/4'=KW]?$,!3J&G@&OS\.FGK';V`^? MS]?S#`4'VZX"NN^WQ!N&O<'?K^4=>_7<*8">O+])@C9&UX$'MCDHJ''L^82J MG[-F@DHD"G*`$3,`$`IC]J0O(*:[==!8A,!=0'WOB@)A$@&[<_:"@8QDRG$Y MBMTQ4$I3*(@;ZJKVI!,*PBD/,`N@\*KPXDT!0Q3>^2.0XE1*NHL0W)H!4@.F MKS\HII$<)+=D^3:*!X%5E.RT4`Z@)E*)``HDYC$`J1$2"9-OVR)R``@ M35NBX3*JL`]MR'3#U1<)@("55/FYD^HB8_:\@;M;HM*"J8'4@W8&-I[V52>0PAKKN;W8:LA#\FG?@.:84 MQ$R!"FCG;=\GIISL'3=ZGMW@9NJJ7P[_`.'$PCQ`@`M;P[FD'7N0X;249$/80K(KI1W M)-7+;S92C9U.R.E_5"&2$NH`4Y3E'7O^O`.GQ]=M,!\@;CDL0CN+?GU;@7D[ M2_4X^$-.II2+AY,3>OM!><^O?S:[X#<%\B-_L;<]/_#A:S_Z"FL!$EY4>80X MM]Q@YM`^D_9$>@]?H0+ZP\`ZX#7:[0==SE#J.FF^@CKJ/OM!ZAK]:&WJP%`4 M'O.'Q"&H]/$!Z]=M-P`!TTP%1./V?3IH`[^&N^V_KV^3`4YS:;F#;U#W:^L! MVU$-!`-0TU$-M0KV@[:78VHZ!X:[`'34--=M1U``$*]';U:[>O3J M(ZZ#UP`#B'[?<>[E'777VZZ:_#IW:B.H4$X@`Z'#Q#4I@V[^@[Z[^(^O38`= MH/V8!J(_M!V[]`]\'AO\?7H%>T'H)NFWUH_%L/LU`>H;#OT"G:#T$^FO4=!' MU=-0WT^#N]H.T-]GKN.OO1Z:?![--M!'7NP#M1U^N+J.PZEZAH'3QTVZ^L-L M!0QA.`E,8HE.42&#E'Y>:@6*@`.':M/W*",H:9.Q;`2."Z;V>>*`T;G41# M;HX0]H6]D[SW2M\R1!-E1.1G(7;E(Q3@3UY#.(7P\Y=>6MDTW+XT*H9K?8QVE04I5I&%3T=+JMW* M3$CFKX(Z*3>LG[]J&5*/EB/"?0`H%M#G1#0-OZ%EH]-/Q[]^FO7U^`X#'>^_ ME77#,JF2IJ[UF+=9O*0S#VR;O$*1EYFU]K6])7"I%\LFZJ"R]UC1U['\@XMY M5;ANW>LYA@Q?3ENZQ90UJ`R8:>68<+,[5N=W:#.&D; M:YQ48.K*!5M]>*GWEM[6(#+!2[UY/VJK2$32O8Z;JSM,O)FLZ5F&RRL:$S3] M9L7KF25/0T/%NPOL/EF'"MWUM1G5[Q$/I86D#8=?_+OW]>[X,!CQ:;RL?A74 M51URK1U99?--4UH7]=UFXMS3+NT=HI9JA:ROB-:IDZ"JN#D[T!"^YM.5K4%< M4Q2T*Q(\A6]L&5%Q1R$YK:]535]9IU!T;X.F3:E:]>N'KJMK M?NAC(F,JE4:VI5PT=3=5Q4P%ZZQ\L`X1%P*4J.AJUL9G&J2D:NA).G*E@)2U M-HW$=,PDPS6CY..>)?3X+S(.VBZJ)^0Q%"@.J9R'*4Q0Q\A?*J>%)6MJ`M!F M?LEFJOC&4A4#AI0=95%:FT\C6$Q2\61!2AZSJ"0^G-%O*5O+!-5SPTS5]&R* M+F5FH4:_AWM-N:E-3%.AU=OY6IE"LR\0"S*.<>]EN!>H]K:;,S15O%:PIF)$ M"I';T!F0A;OU#6K_*[^$#<.F9 MBD*VL'FYJ:F:DC'$54--3]G;,R\-+1SU(4W/TED"-:+=H>WE,SM6*W4HZC:89.8J5J5S'L4HI:F+A5HLZ=D>(J'72RY!_N+J5_P#O9>[^'`:=WAMIX>OU]_S[L!3`5Z?G_@]6GB`^ MS3`/;\>X[=.G?I_GVP#QVW^?A\8?!U#``U^$/4.W\'YM?;@*>WV;_/NP#V?R M^'J_S#@*_F\/9_)KON.OQ!3Y_/\`AP'(L921CEB.&+M=LJ0=2G14.0P"`Z_M M1#O$.FV_MP&1%`YM+UV\41&$K&5(1+ET*9VMI[T`TZ'WZ?PAM@,R:9XL^8>( M:IMG-22"Y0*!?]5*".G3J)NNG3\O=@/1JWBDWIJ1NJ@K+O0[0O+J9O+D.%5IZ9=+$4,(BF*IN40,(]=QU'?U>O?;`67,8QQU, M8QO6(Z]?7KN(Z>`:^O`4UZ]^OR=WAW>'LP&Z)Y$[_9OYN_\`BJL?C^FW1/YO MGX!-]Q,_)6*?XCN=F\^F+1.KOFH0REOFN7ME6Z$!]!%MJ/MX0"5.M>> ME%)/W2)2198W-`,?-#/S,@!P#8':X8'>@[TGK_;)JA_>H1O^4/\`FP#T'>D_ MW2:HO7_2H1N^_P#QA_GL.`>@[TI^Z35#I_Q4(W;_`.8?PV_S8!Z#Q2G[I/4. M_7^E0CM_7_9$?R>K`4]!WI3]TGJ']ZA&_P"4/@'H.]*?ND]0_O4(W_*(^?MW MP&6="^26FHBFX6F4>(*\?LX./0CFZQLK:#9=9%L)NP[^;3JU[J>5?$E'<"M-#S MQ#0S8\B9F(N1;^=N`E4X*G!MC.#G;B^%O8S,&^S`DO16U+UDK*OK8H6R/3IZ M:@7D(6/39H5[7@2A7@/!3BQ/$IS9U#FE=YO) M"SB\_1]$TF:B6]C$*\3:EHZ(]RBO@J(]W:.,L,@'U<6PPB?FIO>`X<;'`(\@ M\C-@0Z<1"7_>LM1]@?V0VN@>W7UZB.`!Y&;`A_\`N'RW[UAI_E#>H/R=,`]# M-@=/[8?+:^/[%EKKUU^^&^/QP#T,V!UU_FA\M^]89_Y0O3U8!Z&;`_NA\M^] M9:;[:;_TPV_P[^`A@'H9L#OIQ#Y;?QRLM1VUU$/[(;O_`,VVV`>AFP(__N'R MX]/^]::_Y0P=>_OTVUP#T,V!_=#Y;]ZRTZ==/[(;\FG?@'H9T%^Z'RW[UEKI MJ/\`[0^OKTUP%/0S(';_`$P^6VZ?TK+0?^L-N/3_37_OA@\-O`-@P`?(S8(=OYH?+:>'[%AI_E#=/@\.N@8!Z&;`_NB$O^]9 M:?Y0V`>AF0'[H?+Z?\5IK\(?V0W?[.N^`>AFP(]>(?+#_P"RRT_RAM?;XX`' MD9L"&W\T/EM/^*RTW]H_LAM?@UW[^HZAG13?DT[2GK-NK-)9U)4D5.UE3%0U ME,QM@8YE(51"P$19=LK`KH/KN3+-NZ&>LE3]0P41(-T*9&GVK8U!3MQ)_W3;B>H9U84Y-S<-X MD2/54,:/38)F%\].Z.*(0@\8WR;^%XN&:6ELS,CF]E;#KTS92E+.%HUC8]I< MA%XE3%85_5@5":><77H@[=1Z:NSL!C2Q"H-RQA7(/UA=B@V")[T'>E!UUXD] M0:CW_L3XT!V_]HCVZ^([[8"OH.]*?NDU0_O4(T/^L1T^8:8"GH.]*:`'\TGJ M'II_8GQN_K'^F(^?QX!Z#O2G7^:3U#KIIOE0C1_+F(_A'U[X!Z#O2FX_S2>H M=1ZB.4^-UU^#,0'R:>W8,`]!WI/]TFJ$?_90C?7_`+HCIH.F@?!I@'H.]*?N MD]0_O4(T?^L1@*^@[TI^Z35"'LRH1OKV_LA]=-_'?H.H=`IZ#O2?[I/4/77^ MQ0C=>[O',..O3OUU[PZZ@#R'>DPT_P!,FJ']ZA&_!_WQ'L#V;:Z8"OH.]*;_ M`.F35!O_`+D^-\?^,1\'Q8!Z#O2F@!_-)ZAVW_L3XWKXA_3#[?/?`4]!WI37 M7^:3U#TTWRH1OAH'_?$!N'SZ!@'H.U*?ND]0B/C^Q0C=>_\`W1'KP#T'>E-0 M'^:3U%H'=^Q0CM/#[XC7IZ_9@*^@[TI^Z3U%I_Q4(SXO[(?I\]<`#R'>E--/ MYI/46G<'[%&-#OU^^(W'Q'O[]>F`FMX*O`&A^#IYE=C)B[%P+8S0S1@"($!;SA77L@#IO&:\G7A>+ MYF+MWF!DLVDI8-:W]FHNT2=*L;*-+E)RB496E:U@$^>9<73H8S-18]8F8#&A M%NBIECRN?/CBZ%N@$0GH/%*?ND]0_O4([QU^^(P#T'>E/W2>H?WI\:/_`%A_ MG\.`>@[TGO\`Z9-4/J_I4(W;_P"8C?`/0=Z4_=)JA[O^]/C?\HCKZ\`]!WI3 M?_3)ZBW#3^Q0C?\`*'_@P%/0=Z4_=)ZA_>H1O^41@'H.]*?ND]0A_P"RA&_Y M1'Y=E/W2>H?WJ$;_E$?/4?@"GH.]*?ND]0_O3XW_*(P#T'>D_W2:H? MWJ$;_E$?)@'H.])[_P"F35#^]0C?\HC`/0=Z3[N)-4/[U"-'_K$?/U8"OH.] M*?NDU0Z^/[%"-]7^Z(^?P8"GH.]*?ND]0]?O4(WIX?V1'\N`>@[TI^Z3U#^] M/C1_ZP^`>@[TG^Z35#^]0C?\HCY_)@'H.]*?ND]0_O3XW_*(P$RO!<\GOA^# MW>R[5Y(S-;)W^4NI:U&V2M//K,-;:$A$T:LA:J"93E&]T*Z-(',:'!CY@9@S M*!7`N//!%($5`V.L`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#` M,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#` M,`P#`,`P'B663;HJN%C$O7Z3&F'; MB[&5^IYE-[JH%7S9E5U)20-XRX5L:F5;E<+TE<.EB MNG2\%--PYQ;KI+OH.;;$]TJN0_P`46P'P&\!E M]DDSUYF^'I?"#O\`Y6[C/Z$K2,[)G-QB@&D:-K^F_.D7+VC;@4PHJFQJ6F9( MR).U;+"@_CG!496!DH><9L)1J'U6N#7QZFVYX?O0LJ? MX?=W]=\`]-MSP_>A94_P^[OZ[X!Z;;GA^]"RI_A]W?UWP#TVW/#]Z%E3_#[N M_KO@'IMN>'[T+*G^'W=_7?`/3;<\/WH65/\`#[N_KO@'IMN>'[T+*G^'W=_7 M?`/3;<\/WH65/\/N[^N^`>FVYX?O0LJ?X?=W]=\`]-MSP_>A94_P^[OZ[X!Z M;;GA^]"RI_A]W?UWP#TVW/#]Z%E3_#[N_KO@'IMN>'[T+*G^'W=_7?`/3;<\ M/WH65/\`#[N_KO@'IMN>'[T+*G^'W=_7?`/3;<\/WH65/\/N[^N^`>FVYX?O M0LJ?X?=W]=\`]-MSP_>A94_P^[OZ[X!Z;;GA^]"RI_A]W?UWP#TVS/#]Z#E3 M_#KN_KO@+DRWEA'%`@(UW,SO#LLY"P\>CYP_E9:EB:ME,AV7^-I2?4!&"J=_%WU9T]-+ M"!Q!*)FG%5IQLBH()J"";-RL803..GO3:!SDQY83Q/Z>C7DU/\.VS<'#QZ8+ M/Y:8I7,)&1K%(3D2!5X_>U&@U;)BJH1,#K*D*)SD(`\Q@`0ZJ\\M$X@\ULM4$;*+';QDA!I+5>0\LQD5TU$&+M@5PW=JD.FW M44.4P`''27EK6?*&D'L3,9,LL$5*QKE9E(QDDI>1C(,'C90R3AH]9.JS25:@NG&WS.BM2L> MH*+^IDE2U6)%*?8JE,D\F2&&-;*%$BSDA@$,![$)Y91Q(:E3CU:_$JG)A#F0)+#'G852N5Z$6=TU)(^;"IYD9R@5SV0K)@8.T",OEA'%`/+*P).'99PTXA'HRRT*6E,PII9&+<.%FC>25C@J,7B M<>NZ;N&R+PZ(-U7""R)%#*)'*4.L*^6>\0Y!2H$5\C.75%:DR$4JI)5G?!-2 MFDU'";1-2H"'JT#0Q#NE4FQ#2(-BF<*IHE$5#E*(>F[\M.S_`#!&'A94_P`/N[^N^`>FVYX?O0LJ M?X?=W]=\`]-MSP_>A94_P^[OZ[X!Z;;GA^]"RI_A]W?UWP#TVW/#]Z%E3_#[ MN_KO@'IMN>'[T+*G^'W=_7?`/3;<\/WH65/\/N[^N^`>FVYX?O0LJ?X?=W]= M\`]-MSP_>A94_P`/N[^N^`>FVYX?O0LJ?X?=W]=\`]-MSP_>A94_P^[OZ[X! MZ;;GA^]"RI_A]W?UWP#TVW/#]Z%E3_#[N_KO@'IMN>'[T+*G^'W=_7?`/3;< M\/WH65/\/N[^N^`>FVYX?O0LJ?X?=W]=\`]-MSP_>A94_P`/N[^N^`>FVYX? MO0LJ?X?=W]=\`]-MSP_>A94_P^[OZ[X!Z;;GA^]"RI_A]W?UWP#TVW/#]Z%E M3_#[N_KO@'IMN>'[T+*G^'W=_7?`/3;<\/WH65/\/N[^N^`>FVYX?O0LJ?X? M=W]=\`]-MSP_>A94_P`/N[^N^`>FVYX?O0LJ?X?=W]=\`]-MSP_>A94_P^[O MZ[X!Z;;GA^]"RI_A]W?UWP#TVW/#]Z%E3_#[N_KO@'IMN>'[T+*G^'W=_7?` M/3;<\/WH65/\/N[^N^`>FVYX?O0LJ?X?=W]=\`]-MSP_>A94_P`/N[^N^`]= MWY;)G>>-'30^4/*J4CINLW.8K^[G,4JZ9DC&+K6PAS`!A$-0$->N`TM\`P'; M:#KVMK6UG3-Q;;U94-"5Y1DRQJ&DZQI.7?0-24Y.1JQ7#&5AY>-6;OF#UJL0 MITEVZQ#AN41$IC%$/I`\"_RI>B,@I<-TD!`0`0'4!`!`0Z M"`[@(>W`5P#`?("\J$_MXN=;_#L'_P!&>SN`@$P#`,!V>BJ,JNX]94E;RA(" M3JNN*\J:!HVC:7A6QWLQ4E55/*-82GH&)9IZJ.I*7EGS2/8MB>_7=.$DR[F# M`9^7ZX2>?#+I6%H[?5U:2"J"MKXUY(6HMU2MHKM6BO=/REV859@VJ.V$A$6G MKBKY"`K:F',I'MZABIMLP)%JNDP6<\H*&(')9E>#]G\RFT9#7#N_:&!"B9&N MHBUDS4MN[MVCN[%6^NC-JE086[NBYMA6U6%MS5*KA1-L#:K/Y[?L@S7#^@CLA2.4 MPR?T0^Y@"/+YWS;8#)JT'!(XC]^;50UXK465I6JJ6J>I;D4?2$8:^UAH"NZU MJ:T=325(7!AJ*MY4]R86M*MD("E&6-O# M<.\<-EZHNVM95!?"?K8;;Q=JV<$^)6RU=$DE8AQ2Z\$Y20>L)9A(H.&THWD$ MVON2+5VI)F:(M'*B09WWJX-7$+L3.6DIBJ+,0=65'>VY![,4'`V=N]9Z])LR/)2=KYR,M;755/::JZ#CTSOIQO.(L8Z*9IK.GJK=7>M%=JFJ6O%/.2M&%K[ASELZVJF/M[6)G!@2 M,PJY>);&.54C=XN=!^Q=T M@M_7E>SS>EZ0@[DL+<7&J>5MZ$[43MM"M).KV$/$%E'#:/7?HO'+=%4+>YN. M%#G*R.T?*5IF+@;.4RR@ZO94)-P-,9F?\D=*VZMS0"+2+6*FC(+-E5T2'"-_`,`P#`,`P#`5`1*(&`1`0$!`0V$!#1EC3$G$JT`A4S*C&4TD@DX167+%*[+Q?:$R+67HB_%K*]8U35M0J)+Y-*>R]6#I>76K*T%?64*WA4JSJ9U3 M5,I4_(0TE*RSR?*DI-QX885CFCS/<03(OP71$[,T$TJPJ"#_`-ST&45D&KFNJ*I2V=&1#:X$L+J\ M)+(UO17G\G6E/I,R1U.W#F).8A(6.9HN700J<=/)K=FWV/> M*-(Q\HWD'C9LJ$W^4/-O;O+Q3N3F\C"J+.594-DO)J?4]45RH M&_CZK82SE7P_NHFX6E*S:L2,EJ,,"<]*Q#U86;)0IRFP&-&=O-18O+ME;X3M MR>$YF.JBT%(UOF`S@5P[H6F:^2A;M9<*=O;4-@).N\O5P%HR96FB4_2]21$U M"0/BU0%0YGJEK>W%"Y/\T="92& MD-FKHBS;2%?5C666AZA2>7F^%<2;FWMLJAJ-[`)N(JHTQ=Q\:\B`EG+99"+6 MY`M[;[,2_P`OEZ>)W?++UG=S?P$"EF?\TD6 M%H[N4E4M/T(]?EGEJHE'=O#K,)R!HZ4GI99LY)*L5G@75N+GLLE9;,3Q%+N5 M.C:K-E9NG>%#D7M9!557USJ'JJJN([::TZRID4+WU'0E=5E3 MDK"+0`U'1$A1,/-3$K+>HQR,U4\;2U7KDAVB M*_FZ8=\HVK\KU_.+?PZ.)-:?-5:BZH7JLUF7RX9K+E3<-'Y:%I#,_:G*! MX%$4_;F@L1=I.LY>2CYNH[B3];4I0YF-L&K."D&%71,,ZKJCIR3GUI M.(B'%-5)%R<$[F3KF:D#NB7`]S81]],U=GKAW&RQV8I')A/TG25^LS%XKM/: M#RVP%8UY#QZL\SB*=D:LE;UTL]K"WBUOKE4S1U304R MWF(=BL"S674I^:CW^L<]B47:+E-`.(AN"3G&^G/F0M1R_6"I7*>C0SF]F M8^]MX(VD\M<"WNK%1T]:0T-%F[RFRN65O(L(0EY8"ZL%#3 M#^;IIS4,FQI]*/84HK5",DN!WT"TC"FD0#GK$\$6[N8F[]S;'VXSH\-^0KNV MY?=-JW)FD-,Q]RJ-1MNUNM*7#MB[I*@ZD/4-%TY2#A9>J7S]O#2%-/XR783, M6S6CEQ`/-;_@@W8N-2E?7#BL[7#=B+745?Z-RSP]V:HS,RD);&Z=VI6V%(76 M9P-JZU6MJI#5.48.KTXI87*\4Z0J&GZH9*,P:1/N@X#%/,;PT\SF5*UE:73O M;&TC2[6W^;^K;,O>F[[V@!GVKHT/%40HI'D166DU&;5Q&.)`/?LGP.+ MSWWK6_%O:2SE<.%E5.7KZ*IFLV4CFF)*-Y:V-&4+2]Q*AO?24A1=#U8QE;/Q M=/54U)*56\7BUH27BY^&GXN*?P[E$`Q7O)PX[KV>H:W=SD[IY?;KVYNMF5K; M*W0=90%#WA%-U4-U+"L-4&C)C+`!E) M.XMK(M(#",<8'U;THP`4:94G8IC&4>B'TI[97.MW>>@:4NG::M::N+;BN8=K M4%(5K1\NRGJ;J*&>E$S=_%RD>JNU*U86UOY9.XLI6M=6WCZ`NQ;VM7=PK M7Q$-/W(H=&E:LB9TU6T%"5%*0D!+5C3WF`2M.,)N7CXIU+M6B4@Z3:F5'`;7 MUP.,7PZK39D\D>;6G4X;-]FAMEF&N-5]_,Q]JLGK+)-6-3Y=KH6AJNVDS`W` MI(M;/J0N9F8BI^M'%P(^OX%C3=,JNH%"%3EXXDD]DG(8(DS,<-[(YE=S4V0R MF9F+Z9QJHSSU[EX&HWMQ;%R%EZ3R_6ILK>"/N\J]J1"9J:H'MT+W/G;,E/)S M%*L&-,(-%Y*69ND%^RC7X9,W&S6<*6'XRE`\6&@,\]QJ^:S>=&F;O5Y8]YD\ MN'1ZE!VY7B)%*>F6EQ'M8R05<_@W;&);HPK.AXY[+%EU%D>P)&J@N'2:5S>\ M+FZ>7/(:A?W-=?JTM>9%\UN;?,*M;*SN76:K&L+KQ-V\QS*[5#0U)7.EZPHV MC[W%'.V*U84Q0EZJ8K2@7SBF)-TI$QTA<*E*=K$9]N_66AF<_5,>J91S#( M21G#0+V9<+Y\+KAA9Q7.C;FTZKEW+8IY;BQEV;45G;2 M1E(2I*NK]V\J7,-22M7)33%>%C(^A9\&#E`*@IQ7S95R'9*;S3<-_(9EOO'E M^RKYE[V9PY+-]F&RF5O<"J:ZL1+62HRP-H,MMY65W`$(&7J>HY:X-[IAVV3A M)"7IYDSI@T$9Z9BZ2' M>1SP,:N.)G1R/YT8VX5?9>LP%EZMJ6I,PBMS8*@J7X:RN7J\B\!.)U.V>?3) MS7+54YDKEGB6TRDXF&TQ33)6KIPC&:.DTH:KJ1^C&0D0C(3;Z,AV2CY\X10*YDY!DR2$X' M<.44P,<`W(;3^3#7;7X-68R?N;DGJA'BQM+U1[:PL2-[XI(SFT9JCLF5\N$5 M#W:&R"X!`.+O?5:G$)T.Q$R8>=)0`B&H7F4RTWOR@7HK'+SF-H1U;2\=`>X7 MT744]EZ>G7,-]$M.1-6PG:2E*R\[!.?/J>G8J1+YC*.>Q([*@X[%TFL@F%BL M`P%^,K5AY?-+F6R_Y::?GHVEIW,!>:VEF8>IIALZ>1-/R=RZPAZ/8S4FT9:/ M'+",-55W MS,/#(<#NE7^:6Q63^VF?FVMQKR7EOG4MD)"+/EOS/VZC*#>4A2U:3U0U0ZJ* MY=`4O3-7Q,?*4BE3HMJ,G)9VY7G6$JS!Q$)KN@#JA.#50-87/;6FL7G_`+57 MHJM"T&8^\E3-VU@,R-LBTS`9=;?*5[(-5#W9H>CD9QQ5P-W<'%+4^O(I1CYN M#B5!)JX;G4#%WAW\.@,^,5F4JN7O]2N7N@\L%"T37E=574EN+FW26=Q]=UNV MH&(:Q%)6E@ZDK)^Y).OF)7'N?!R'8MG)G:Y$6;5VY1"]]'\(VF*KJS,?4[G/ M)9>C,FV5EO;-C<[.+7UK+^4?"/:_NM'@[IBU-"V/G*"9WJJNOA4(^4>1J=,L M6B,+'+SY'RC)Q&E?!WO+9P<[%YH+\W$R_P!N>*KE9F:HI>%?5M0\C3]KC;V+94S)4-3[>485924P]/+LIZ)?0K`TG)HG:%"T0<(^ MK;CT(QN#E,OY;_-=`U=GTMUD$M2YHZE*YH).Y-?W#LLPN^E6C0MR8ZGY"F:1 MIU9Q(TC.GJ:.CUFSF%D*A[3W!!)R<.VWPX.K2A[3YBJ[R^9Y\LN<*O,FC(LK MFULY:"/NE"5-;.GVU0M:1J.L:(G*\HZ`IV\E#T;4SM&.JNI:.=IHQ2"B3\S9 M5)3D*%WK[^3O9J,OE]:EM+6=P:&=4F'AZC=437,18:WR%=U[: M=-$R2;RG[E1Q7#5DK'R*BS9)A*P-0"HHPEBIMPBOR-90JQST9F+?Y<*-J2`H M0U5)5-/U;)&P&?=B.!CF3$9<"BJT-,6,6R%NYEG=*-N#"1[9RU&8FS>;_*G=:M*AM?`WQLPE6L&C3MUZ6BT)Z7 MMG<6@[D4W2U8T55:M/.4ZDA6[MB[:3-/C[IMW:9#)IG"-W`7DR_9?[OYI[QT M-8"PE&.;A7>N5).XBB*-9R<'#.9V18Q,A..FR4G4LG#0;0R,5%/W8GD)-HD8 MK<4R',L=),X;@_:2]`5;2K=*$CZ@G:9AG*Y)"> M:++D?3LKXR+G)"I%Z4IEO.(,>P>3 M;@+]YA.+QD'SL7&XAEJ,RE!9J:5RC9LLT-KLWMEKAVDBK8GS`VINS;JS<59I M\QKBWM1UNI0%54?55,)2;4S1E79GD&X!O)M2NG3P1APM9EMXKV2/(G:;-K9W M+5EMK*^EO+LYB\IUQ+=T)GFH:S-VH*J+<6<@*CC[ODN:2'5:0U%5U6,E/.7% MOE:/I>KR4J`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`5>5XYC$I%@[(HS#"?*SG(R890,S^=2K;04AF15RYWHR,YG M-O5]ZK61=(0M4W.4@']&T=%P*]5H2DS+MJ7///:'\.3NT&53/K2^:UC^QAS=5%FNM!5F5MC:V<^CMM64#0T; M55J[@L+F5)30TZ1Q(T%&NXJKX!:451:O7+=:.05:D5?AG507E$]I(0EVJHN! ME(I&[<[?+BY2F=ZM[877MW;ZY]`P&7.7MC$4&6G:`JNJ7_NE`9B:=/!QYH*K MT*(:P9DTWBSA^DSE7D%@.[V1X[&66A:!S9T14&8+B%4]4]\.(/<;-M3M\:;R MT9*KHW`JJV]86RHZBX>B;FTM>.N).WM-5-#OH-4KA:W,,C%!'PD*6#7AHJ1= MTO&AJJWEEZ0J"[UTIZWTI5\Y0DW<2M)>C)JX,/3E/5W+TM)5'(O8&3K.`H]T M^I.$JI_&+-G4_$TP]=T_'2JKIG#N5H]%NH8+;8!@)L>%%E*X2N9*C[Q2G$DS MV5CE`J>EJDI5A:V%I=M'.$JV@9*+E7%1RCOSZW%(JQR8"HH4105#64P#`9Y\.S)I$Y]+XU9EW3N,Z MH"YTG8B]==V$CD:<1J%K=6\UKZ(D*^IVS\BLI,1"E-MZXAH"HD$*F;)S3B/D M&3-NE`R)GH%3"4Z@/)Y*^JVEN%M6LO>UM3]-Y[V=7S]^WHTBV=&RB4I"VO?9 MB:9F*B(:J$/=U2L,N$:^N,R:S7T&F0=MPBP,X:N&\FH&-%&\(1W<+AM7GS]T MM>`Q9^DYJY5?V7R]S5+(,:ZO+E`LK75#VWN_F-160G'18-I0E5W`CFDK#@TD M6@)4Y5BB,LL#)`5`N/4?!>I.GKG7+J)3,;+N,DE'\-V"XD%)YE26U8DG:VHZ MM(:,@:#M*2B#5L,-#W.J2^CN1M0$4ZK-0S(89Y+.DDUQ"+*%Q\S'!'M-ELR8 MTAF8D[G9WJRJ*M,HMELRD?(4CD/D9C*[#5'>RBZ?J""MU5>9=I=E2(I_W/GZ M@9TU(RSBEU'B"KN,5&&%>11:`'$7CX(UMK)V]OS0,KF!S#7-ST9:+.4Y=&^% MH+!Y)+D7AR]VMJRK:50KF#LG7>8:F:D.%-5.-'*K3TM7DM1K*@8M".F6P/'C MF)7(<+74QP=H"H<\V6')X>_EMVR6>4K(5%E;J_,8>WC>G MAK%-&79M'-+DI0M2*S$FEQA4U$`CU0N-9W@N68J)6N4%DKCMI4&,/"HQ%=2D=5(R3-Y!KJIK%2$(T.)#D[MUDKNC0UMZ& ME,UCE[45"?1E.QF;;*I(Y3:WCTG4]*PT0[IZCI6MZV=U)3$C[C229*C!PP;A M)Q\A&IH+*,UE"A'7@&`8";K@]\<_-'PEJ^2CJ<PLTU M*$I3DO,Q"S>05#Y;7E0G]O%SK?X=@_\`HSV=P$`F`8!@&`N+9^E8RNKM6NHB M:,Z)#5E<6B:5ECL52(/B1E0U+&1#\[-=5)PDB[*U>*F;JJ(+IIK`0YT52@)# M!N'YK?)Q\LS2K'-KK.Q^:3*5689ZK(Y4+3UOFMKRV=>V]S:41=*5D6=87'LA M3M.45;JMB2%LX*.<5HX:NEI"#F(ML>&1DO=%\+N'"-RMYC[=V9K>)HFZ82-+4Q1M+2EH*V7<2J;(OD"R[\8)WD;O55]X*.ROU905EJ>A;P?1;3 MJ]4VDNE?7+[;:N:;N+6:BM')0U2VVIRY=8J-JH@B,:?=-*)S$51Q#LI]EYEO8ZL8->VT'E)S2U_.4[;"KCJJ4W,J?3(NG05+/;K0'^ MCRS>F*;JFE4)6`>J'\ZD0YV]_!GR.T=GLRQ908BTM\:)I6[6>P)HZ8J%;,+;4+? M4C1=0P=,1$XRB*:E4JABW3)1S4<7#KFTM=4E.Z M<&YSJM$*M@Q5A:7N8T]RH^FW;,XU&")G($EGJC8-8"\][;NYBKD5%>&^MQJN MNS=*K?5#5,[[BP["GXGW3EWZBKIW[G0D7'133M3F[%BR;-R:$2 M*`!:[`,!DIDTOTRRL9NVRLEG&RO9P6U#\06XLQE]S#5E>0;9YB\ZE-W;ME&T MY7=%UM`3=(6DILEF*=/;MPE*3M,^YC\\A,M6U+TZ>"58N%EVT@T##3+-QK[W M06;=MF#ST55?/.51;&R.8ZQ411DW=5.-J>EZ3S&4DK251DI2J9Z"J1G#G1:> M:.%-89R1PX8,SBGHERB%Y,I/%=R+Y':LS'-\LF77/#::W&8^R%NK_]&UK0UU'M?.JNH6[+"R#9I`Q4]!IPU)O88:5>.CLQJ#GD11ETTF@=02X MLF6NJYW-O:&_EB56KZ"L8G M8RZ]F::LO*7HOE-XJM4Y.\K%JK/6NH0BUVK/\`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`AM%2GE(]TE^#5 M3F6=CF6S@(<2AC>M>J9G,-[M&20=VS/6D])I4Y]-`E:&JYQRTN\BH[W)5IHC M(#M?-@<"D@FN<-6ZZ-T[CWMN!55UKNUK4=QKE5Q)FFJPKBKI1S-5+4DL=%%N M:1F)1X=1R]=F0;HI"LL6NS,AP7KHYN7=)J*7_`*;X MCML;`0U;_1#4J:+6U-19=ZXKV8ID:63ERTBX4=53#1\D$VY@EJ@0*W%DWE$F M"JS90)/?7N!?"E,GRS6HJ#M M9;R#F)20IBGZHFHQJXITKJEX2+D7<:\DI1RJ[E63-RD%WK,Y!\F><^L^&)>V MC\D-AK'99+Z9U([+3>VBK29\[WWQKN13JJBJDK*D[=7:I&HF<74]G[B1,+1D MU+U#,0%P(YW)LY6G5DJ>9)2':H!9&\W#DR=Y&LBM:9KZ_)E;S[5#2O$VI*TR M<'EXS27E?TO&6(FK/78G75C+CSM.$HYS259IU+3T#/N)9C&2E6MVS!-HG4_F M+YZU5#&_C:T%D6L'.6&LUE5R21%@*GKW+UEFS25#=1OF#OQ="120 ML7DGE;XW?R`EOI4#R]V?7-):G,E4=RY5[<"!:U!9K+W2SF7MG6K9%S`1J]-1 M;UW`PT]5+&6I]_&H1Z)EW(=:D\A.29+A`I\6AOE/N0E4SZQK6P09;PJRYIK: MQF8!:Y#JA#<0N^&5B.JA'-IFCG4+?5!;>U-#5%$WHCX";K-S350S* M\Y6*L@M14Q#!2X!'HM#BLT741*$HG%@X2>03++8;/Y5\=E&H[*U1EB(^T\-E M(S)4EG:K6]%>7QOS5\?1D\_LC<#+A55A%I->%BJ[RWTQ]*6N[C+D@F+M)C4%5^<2L@,:HPB0QLXDEK^'1P^* MXNWP[X[A_P!=7CO':RS5`R2>>N2S%W2IBIJKNG6%#4C7KFY<5:>(8R-IU+#L M_HD7IQA`)1I91\U9"LM63>8YI(H=[S)45PQ@R)<.R]=L>&;3EK;C\0>O;S4> MXG6F;7--6"=F4+(W^HVWIWL!$U77#V'K!6LZ?D))!\E/,&A88[SMXXYW3=NX M3"\.9[(IP\N'^3B*YJ*KRE3F:2W]H>)&ID4L/ED<7MNK0]M[1T\C:>+NL^N9 M=.OJ9EGUUJC<2A'HTA1$=(U0A'J2?GCJ2<2:Y6:#0+NT#PE>%?.7+NK<&[T9 M<[+]ECO;PG;&YX[>Q-2UG5-15QD3K^_5[X>S:,E(O6[^'<77MS1K]R6J(]>X M<9).IN@'KMP\CC2S1H_$(EN,!PUX/ANVAX>M'3-)QD/F`N';[,G(7]K"GZPJ M"JJ7NB[HS,/4%.6GKZE"2E)B`^AV*I\LG$R;.0G(X)Q1X)0@ MUP#`36<*7B89/LA-(7AI[,YPS;.Y^)6XM24K-4G4-T'U"M'5NH^!C)5C)PT2 M6KK07-6.WGG+]L^="R=120*,$@5;N3B11(,N<[_&SX=69[*O=^P]FN"1ERRO MW,N'#PL=2E^:+E+6KU/;MW&U9`3[R1B4H'+M1TN=:2BXE]`+`RJ6*.#667$Z MRJ(*-EPUFL`P%^\K.8>M\I68^R&9FVXHFK6QES:0N7!,W:BJ4?,+4M,M9)U3 MTJ9#ZL,-4C!)W`32:6BBL5)/$B"!C@(!+S5OE!.9JJ/YINU3M_1L1"\1R"IJ MF&L(TE'HL\M,'3E`.++%9VK`D<@"IY.Q+MQ:^16`D&*C+L)0A"&358+ASMN_ M*+,UEIW]E+7#D+/,ZEJ&X5+9?)MU[FM$Y6BJ8NI4\I<1F^573.:7*P;-XMBU:"" MP7RS!\8.W.97+C2-F;CY(FBUPZ#RJ6MRO4I>*)S>YFX&+8-K/T+'4?15?/K$ M4]4L/9B>FV#R-0J1:-G::D&D@^(@VDW#U!J@8@7@4\H0K%W!71N!(9/[4.,[ M5[K`O,O%XLV;.[%\8*(NE3CNW+BTP5[7V6J`JV-LY4MWFM#.563*N'K3L6,@ M873"#:L=(K`6_I?CF2]-VSM_(FR<64E,[=I)U6-R4ZII:Q1*+F+ M;12Q[-I2WTLIFYT%0$])T[&7#D6YW0D7`[^,?,S.(YP'%V?XUZ]`KT#%W"RF M4'>.WE+\,8_#`JNWTO52H,FM(1[T]17YJ:J)R`;QA'3MNA# M0CIO%*G=.'JJ`NU3J&#"S`,`P$BG#>X7>;#BCWI;VCRUT9VD3%JLG%RKNU,1 M['6NM/`NE#%"5J^?0:N3*/W14U@@Z5AF\C4U0+(K>Y\:9DSDG[`/K`\*#@]9 M7.$K:%Q1EF6+FL+LUDRC@O)?RJ&R2=9W'D&(G619-F:2SAI2%$1CE98T!1L0 MLJ@U*)'DU(U!/&=3;D/FR^5"?V\7.M_AV#_Z,]G,(P(&*E'XG5DV#PBADQ#UJH8:CF4KBY8$EVUH$4)5Z\[=*E(%BL6,5IHA09+1C5DP1,V;-$ M4RAEI6G&ZS35E=VWU_4[.Y*:)O9;J^[',:QNM;C*G;NB+@U+<@_C;;5+-JC4;RB%RO(M*H2DE MFGF[D.80PWP#`,`P#`,`P#`,`P$T5[LK--NN#SPUKW6JLDYE;P7)OAG=@;LU MY1E*S$U4E1P%"U1;QG03"IW$6@\`&<"W?RR$,"J2`%*LZ*4R@E-RA+?:7(1E M,=LUGD_U'9X8S*U%GGX]EFBS&JWGK&B)"L[AQU*R#2JZTBJ M4@%FE1U32M-.6&VG#YL%?/,=E&O)=RRN0&WUD,SN1' M/M**L5$TK$3=JI*J(QHU2MLUE&L])T=.3 M#5].IR$(DU#"F[]G:R%+3\Q:JO!G[3%E9>-IU\Y.G$$6D'RI6TF@J3D#!KCXR%G*,X@-Z M\K5C71=SE95'$R\E!*HNDX M16GH:F&[=&4D"N6KLZJ1T0V>Z1X>7`PD>(-EABZLI*FXBX<+0^7'+S5>1%O' MZ4S?2]&8FP]'WEH?,TLV&9,Y^@"FZ$J*Y;*X+<$VS56XM#T.*A&J\NU1JT(? M:#RVV*IEEP(G5,Y(Z"S'S6;*\/$`M3?BUY8HJ,[>"C83-`>W$#($J!1\R^AF MH[.T(NZGJ/K`)*$94PE3HKS\FC3831CADY(5R.LC=.?HZT>6RG*,R\N'E14)7 M%SH2,:34!6K^GY>:*K.('!)>FF0N(4-9'/I863RO9S\S>7Z88T-%R-JKRUO2 MR\/;)W5K^WD(5O,+N&\'1;ZOG#RMGE-0C9RC%1#JK'CVH7#)HDK+/7;TZSA0 M,2<`P#`,`P#`9]Y3^*!GCR/T#55KLL=ZT[=T!6M7(5Y4U,O+:6CK]A)5[MW[[VAFZ3B*2HF2H.ZM^ZQ&OKMU1"NJ/IZ#4*6LJH,=Z\@G0N:;9,E5H.) MB&$"LK&'"]UQ>-7Q-[J5E9^O*RS13#B?L-<-&[EKD8.WMHJ0IN"NDA'OXE.X M:.$H.>EF`1+"4:P!B/#+'BC. M$D%DPXN^F8B\F96I*6JZ]M:.*YJ*B[:T%:"F9)S$P,.>+MS;"#1IJA:;(A3T M5$-7",#"-T6*3]V@XE7A2`K(OGC@3*B&9E.<8KB*TK86"RR0]_6(63IBVKVT M%/TA)V9L+/.(BW,@RD8]U3+&JYVV$E6:"!FTM(@D]+4/NHV6=*.FSY)T!%BA M;=3B99WE9A_+GOB],E)99$T:5M`H_Z7S6GVYR^? MMW36FD9M"8.K-I2I)=95Z<,>9;,+>&YJQSFZ/;E?,5'U#0UM)>F;EO;1DA4K;RDA2#VC5J5AYFD4J?B4HN M:IJ&A94$FZB3AXNF[>%&H):+I66A MZ]HBY-/)TI65)S5#2,`ZH+Z'Y6GT&L:E%-*9:LXE)DP4ADH]=BT51"YK[B]\ M1V4RVK92I+-%5TA8UQ;[Z4B\$]I^@W=6KVI%$&HVS6NLO2BEUU:!%D`1PTF> MMC0HQ(>Y`L_2HVVE2T;F()>)840E3:,:A')1[$J$<=9HH%L[Q9J,P.8&A[%V MXO+D)4\- M&-&[=Q_=ZP^2B/DC!,79[B<9D M\T]@*6M!(6FN<:U0TJ\JB[,334XL%(V6MW0\P+V%T%^C,`]$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[ M07Z,P#T0[C)?:58#\>T%^C,`]$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[07Z,P M#T0[C)?:58#\>T%^C,`]$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[07Z,P#T0[C M)?:58#\>T%^C,`]$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[07Z,P#T0[C)?:58 M#\>T%^C,`]$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[07Z,P#T0[C)?:58#\>T% M^C,`]$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[07Z,P#T0[C)?:58#\>T%^C,`] M$.XR7VE6`_'M!?HS`/1#N,E]I5@/Q[07Z,P#T0[C)?:58#\>T%^C,!G'8[@? M>5*Y9[J-B[=V/JZ%S7#%5#:R@ MX5>6J+9MZUG2P\=F]UP:JNO=WZ4= MQKE5Q)FFJPKBKLQ47-5+4DL=%%N:0F)1W'J.7KLR#=%(5ECF.*:1"ZZ%#`7% M/Y-[Y1.K?"F\RRE=T4>_]')TNE2MX#9GV@U_`)433;*CZ1)%U'YE[H-"T[2T M\I$MQ M"6OIRA+HTQ2L%9(]PS6@C(?-.@U:VT"[47(0MSD:)(5F(TXVKV+E9)I532,% MNUF2/7)GJ*JBICX#A8GR;SRBF!J.QU7PE?T?$53EGAT:>R_5!&9I46,M9^!0 MEI6<)#4`^;-4UZ=BQEIR9>JL6)TVRZLH_*LFHF[6(<+@V-X"?E.>6=6OU.%G+E=0ZJRIU#&,(<-Z(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV M@OT9@'HAW&2^TJP'X]H+]&8!Z(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@ M'HAW&2^TJP'X]H+]&8!Z(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@'HAW& M2^TJP'X]H+]&8!Z(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@'HAW&2^TJP M'X]H+]&8!Z(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+ M]&8!Z(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+]&8!Z M(=QDOM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+]&8!Z(=QDO MM*L!^/:"_1F`>B'<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+]&8!Z(=QDOM*L!^ M/:"_1F`>B'<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+]&8!Z(=QDOM*L!^/:"_1 MF`>B'<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+]&8!Z(=QDOM*L!^/:"_1F`>B' M<9+[2K`?CV@OT9@'HAW&2^TJP'X]H+]&8!Z(=QDOM*L!^/:"_1F`\+CR17C' M-6Z[I:BK`@DV1575$M]8(P@FB0RAQ`H1FHB!2CH`=1VP&L1@&`\J""[I9%LV M15<.'"A$4$$$SJK++*F`B:2*28&.HHHTB86%B(UNFTCXN M)BV"2#&.CF+5))LS9-$$6S9!,B**9$R%*`N0_P`46P'P&\!=BQ]B M[OYE;ITA9.PUO*GNG=6O),D32E$TC'FD)B4="4RJRHAS)M6$;'MDUG\O,R;E ME#PL:W=2QUKK3P+HYP++5C4*#1V87C MHB2X0=+P[:1J>H%D5@C(M5HTD7K$/J\<*'@U94.$S:WZ'K0PX5O>JIXQNVNS MF*JN-:IUY7:Y3IN58F+1(H[2HB@FSM--2+HF%=JMP\W:O)^2J.=24FE@EPP# M`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P# M`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P#`,`P' M@=-R.VKEHH)@3=(+-U!((`<"+)F3.)1$#`!@*81*(E$`'34!#;`8Z93\HF7C M)!96F,OV6.VD';"V5+)"9"+BB*+R4W++D2+(U-5D\].O,535$N=(BDG.S;QX 7_<`1%N55)DU:-D`R2P#`,`P#`,!__]D_ ` end GRAPHIC 10 g852944g29k48.jpg GRAPHIC begin 644 g852944g29k48.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[0XD4&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!<<`5H``QLE1QP!6@`#&R5''`(```)'1E96Y":71B;V]L``````MP\`````````*=F5C=&]R1&%T86)O;VP!`````%!G4'-E;G5M M`````%!G4',`````4&=00P````!,969T56YT1B-2;'0```````````````!4 M;W`@56YT1B-2;'0```````````````!38VP@56YT1B-0#A"24T$&0`````` M!````!XX0DE-`_,```````D```````````$`.$))32<0```````*``$````` M`````CA"24T#]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H` M!@```````0`R`````0!:````!@```````0`U`````0`M````!@```````3A" M24T#^```````<```_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@`````_____________________________P/H```X0DE-!`@``````!`` M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#-0`` M``8``````````````#L````[``````````$````````````````````````` M`0``````````````.P```#L``````````````````````0`````````````` M```````````0`````0```````&YU;&P````"````!F)O=6YD'1)D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F M875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP M90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L M;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H=$]U='-E M=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$$0`````` M`0$`.$))3004```````$`````SA"24T$#``````#S@````$````[````.P`` M`+0``"E\```#L@`8``'_V/_M``Q!9&]B95]#30`"_^X`#D%D;V)E`&2````` M`?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X. M#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M_\``$0@`.P`[`P$B``(1`0,1`?_=``0`!/_$`3\```$%`0$!`0$!```````` M``,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+$``! M!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S M-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($ M!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\` M]*L/5'6N;2VJNIOT7OEQ=Y[&;%SF1UKZY]$+K.J8%74\(:NR<$N:]C?&RE^] MWM_J;/\`AEUR22G.Z-UW!ZQBLR<7>P6"0RUNUW]GEEG_`%I[UHK.ZATAN14? MLC_LMVX/W-D-)!GW-86_YZHU=;S>GVMQNL5&3]&YL&0--T#:VW;_`,'^E_?I M25;OI(6/DT9-8MH>+&'N.WDX?2:[^2Y%24I))))3_]#U5))))2D+(QJ,JIU. M0P65NY:[\K?W7?RFHJ22G(9TQ_2ZB_`>Y[02Y['PYQ$S&YH:ZQM;?W_TO_"K M1Q,JO*H%K.^CAS!'(1EE,_R?U(L^CC9?T?!KYT_Z3MG_`&RG_,#^\M/I/@ZJ M2228N?_1]522224I))))2E4ZEB?:L5S6_P`XSWUQH9':5;21!(((Z((L46IT MS+^U8K7.,V,]EG;W#\Z/Y?TE;6=50_%ZFYS!^AR!)'\K4K13O3Q7^CNCU<-? MI;/_TO54DDDE*22224I))))2+(J=96=AVV-]U;O!PX_L_O(7V[2?2='I[^/S MYV>A_P`9N5I-V[FMC.60B/SX\>#IX;7!M971A('AM;&YS M.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R92`U M+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@("`@("`@ M("(^"B`@(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UP.D-R96%T;W)4;V]L/@H@("`@("`@("`\ M>&UP.DUO9&EF>41A=&4^,C`Q-2TP,RTQ,%0Q.3HS,SHU-BLP-3HS,#PO>&UP M.DUO9&EF>41A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$871E/C(P,34M M,#,M,3!4,3DZ,S,Z-38K,#4Z,S`\+WAM<#I-971A9&%T841A=&4^"B`@("`@ M(#PO&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N M,"]M;2\B"B`@("`@("`@("`@('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O M8F4N8V]M+WAA<"\Q+C`O&UP+FEI9#I#-$4V1D%%13)$0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO M>&UP34TZ26YS=&%N8V5)1#X*("`@("`@("`@/'AM<$U-.D1O8W5M96YT240^ M>&UP+F1I9#I#,D4V1D%%13)$0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO>&UP M34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.D]R:6=I;F%L1&]C=6UE M;G1)1#YX;7`N9&ED.C%$-30V1C!#,49#-T4T,3%"048P1C7!E/2)297-O=7)C92(^"B`@("`@("`@("`@ M("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#HQ1#4T M-D8P0S%&0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA M8W1I;VX^9&5R:79E9#PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@ M(#QS=$5V=#IA8W1I;VX^&UP+FEI9#I#,44V1D%%13)$ M0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V M=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B`@("`@("`@("`@ M("`@("`@(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD M+F%D;V)E+G!H;W1O7!E/2)297-O=7)C92(^"B`@("`@("`@("`@ M("`@("`@(#QS=$5V=#IA8W1I;VX^9&5R:79E9#PO&UP34TZ1&5R:79E9$9R;VT@#IX;7!M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\ M/WAP86-K970@96YD/2)W(C\^_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_]L` M0P$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!_\``$0@`.P`[`P$1``(1`0,1`?_$`!P` M`0$``@(#```````````````(!@D!!P,$"O_$`"80``$%``,``@(!!0`````` M``0!`@,%!@`'"!$3%!4A"1(7,4'_Q``:`0$``P$!`0```````````````P4& M`0<$_\0`,!$``@(!`P($!0$)`````````0(``Q$$!1(3(08B,4$4(U%A\+$5 M)#)Q@9&AT>'_V@`,`P$``A$#$0`_`/MTTA7IVVU%Z#C*WJ/'9&OFB'I-#L9M M%K;>^^8(YG67Z#/DT,(8+9GO#FK2[<(]'0K..=)%*US7]/[_`(?T^GWB:9]_ M[)_K,>#BK+1^K/*'3_M/SV#/.;:]Q>.S--E=OB:)9%GFL-1UKHFZ&V-@J0FR M2D(%G`,\!#&Y]OV(K6H0]^?GTB;5O'?N7I'VUU?FNT>K%UV>#U`WY%?FNR,[ M)E-',K(I)BFU3T(/SNLA!9&Y3S\5?Z.O`58V'E"S2QQ+%7:M@[`J1ZJV,_X) M!_7Z@3K#B2,@_?\`W])8W)9R.(CB(XB.(CB(XB1OZ!\DU_96:+_Q+H7=+[MV MBJ-4VZSZ6H=):VE,6TZ!;6GH[6H@&.D+CC+9>!Q2RLL61GVU9H6Q_A/XJJ&Y M8QGN<>_I[9`[X'?U]_YQV*S+A2`?OZ'V[]C_`-]#]1*.;]J=V>:M)5]7^SL2 M42IOVK1]D9V2O)GO*P53@'TP/"2ZMN*^5(K"DN1HB(?SJ6 MW%"M0)'I$:'!*BL3X):S-N(CB(XB.(CB(XB83V'UOA.V,K98GL;+4^OS%K#+ M$55W`R3-BDE'G%:?7%,6,ZGN!(B9G5MW4DA7%40Y"ZTX0ID2, MO8WOG;0:;15XMJ;?:3+:R&MT6CMJAU&RT6:W:B]BTCJWZ5V8]2M.1=NP;J!4)/3"AP.;5.'(66+U3 MV90]M8NMV%"^-C2'2!VMLG`R`<,C84LC*Q522H[&Y62RCB(XB.(CB(XB.(D"@2 MIYH]'RU#WQU_4G>,R2A,>^1`,_KW'0P`)`LTK1PXR[JZFH"1@X6P0B6>$&1T MGU3(+Z#\/J/%FP7:M3UMSV*GE:"X-UVGK3E;85+\G9M-4;W=E9WLT]W'`Y"8 M@W:?PQNU5!Q1MV[7<5/$].JVQB*P&`PBI?:M6,A*ZK$+>Q%]<\^FWCB(XB.( MCB(XB.(G0GH_JA.VNL[.I"BD73T;TT>2F&(<$7^[K8I71A#G1OBD$EL872C" M$_:Q@-HM=:K\R5T2II_"6_/X?W>O4D!]-J$;2ZRI\%&JMQQ=@P9<56!6?*-R MHZU..-K`T7B+:5W?;K*`/GU,+].P[-S3^)`1@_,3(4K4L&U>V*M:6N0&9$`1E<\0SGEV4NJ*$M+%`B$5U.44>8RP>9*:&.(CB(XB.(CB(XB8 M3O\`-&:;.D0TQ3*[45DC+G(VKW/9'7:2O1TM^L-;3VDB"6-18Q. GRAPHIC 11 g852944g49c05.jpg GRAPHIC begin 644 g852944g49c05.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[0ZT4&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!<<`5H``QLE1QP!6@`#&R5''`(```)'1E96Y":71B;V]L``````MP#A"24T$&0`````` M!````!XX0DE-`_,```````D```````````$`.$))32<0```````*``$````` M`````CA"24T#]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H` M!@```````0`R`````0!:````!@```````0`U`````0`M````!@```````3A" M24T#^```````<```_____________________________P/H`````/______ M______________________\#Z`````#_____________________________ M`^@`````_____________________________P/H```X0DE-!`@``````!`` M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#-0`` M``8``````````````#H````S``````````$````````````````````````` M`0``````````````,P```#H``````````````````````0`````````````` M```````````0`````0```````&YU;&P````"````!F)O=6YD'1)D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F M875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP M90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L M;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H=$]U='-E M=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$$0`````` M`0$`.$))3004```````$`````CA"24T$#``````$7@````$````S````.@`` M`)P``"-8```$0@`8``'_V/_M``Q!9&]B95]#30`"_^X`#D%D;V)E`&2````` M`?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X. M#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M_\``$0@`.@`S`P$B``(1`0,1`?_=``0`!/_$`3\```$%`0$!`0$!```````` M``,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+$``! M!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S M-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4 MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($ M!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\` MW^B?XR^FYFVOJ##C6G_"-UK_`/2C/_!5V&/D8^34+L>QMM9X>TR%XIU3ZJ]1 MZ:\V5#U*9]K@MWZI59--(RAD6U7?Z-CH&WW_`,Y7_A/H($A5/JB2PL/K9W$Y M+BZN``0S@_OO6OCY=&2USJ7;FL=M)\T@;4F22214I))))3__T.]ZIT:W,]C]W]NK^;6-D?4G*QZ3=TW+-F6-?3L`96?Y%?I_S?_7?7782E M*'"%6^2?6/J/6^F4/HM>[#OL#2ZHQ[F[?TFRS_"?I%1Z!U*K#L;D^K=7FG=L MRP[>P#]ST/YNQ>N=3Z3T_JV,<7J%+CO_X'_2_Z'_BD:M%T^@ZI+']'ZP<[JYCU(G\[Z/V;CZ/Y_K))GU7/Z=66D`D:;OBM1)-T4I))).4__9.$))300A``````!5`````0$````/ M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4` M(`!0`&@`;P!T`&\`FMC.60B/SX\>#IX;7!M M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!8 M35`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z M,C<@("`@("`@("(^"B`@(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W M=RYW,RYO&UP.D-R96%T;W)4;V]L/@H@ M("`@("`@("`\>&UP.DUO9&EF>41A=&4^,C`Q-2TP,RTQ,%0Q.3HS.#HT,RLP M-3HS,#PO>&UP.DUO9&EF>41A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$ M871E/C(P,34M,#,M,3!4,3DZ,S@Z-#,K,#4Z,S`\+WAM<#I-971A9&%T841A M=&4^"B`@("`@(#PO7!E+U)E7!E+U)E7!E/2)2 M97-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^9&5R M:79E9#PO7!E/2)297-O=7)C92(^"B`@ M("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V M=#IA8W1I;VX^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IP87)A;65T97)S M/F9R;VT@:6UA9V4O97!S9B!T;R!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO M=&]S:&]P/"]S=$5V=#IP87)A;65T97)S/@H@("`@("`@("`@("`@("`\+W)D M9CIL:3X*("`@("`@("`@("`@("`@/')D9CIL:2!R9&8Z<&%R7!E/2)2 M97-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^9&5R M:79E9#PO7!E/2)297-O=7)C92(^"B`@ M("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V M=#IA8W1I;VX^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IP87)A;65T97)S M/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O7!E/2)297-O=7)C92(^"B`@("`@ M("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI M9#I"0D8T,D5$.3)%0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS M=$5V=#IA8W1I;VX^9&5R:79E9#PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@ M("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#I"148T M,D5$.3)%0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@ M("`@("`@("`@(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z0D5&-#)%1#DR M14,W130Q,4)!1C!&-S4V-$,S.49#1#D\+W-T4F5F.FEN&UP+F1I9#I$ M,C`V0D$P0S(Q0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO&UP34TZ1&]C=6UE;G1)1#YX;7`N9&ED.D)$1C0R140Y,D5# M-T4T,3%"048P1C&UP34TZ26YS=&%N8V5)1#YX;7`N:6ED.D)&1C0R140Y,D5#-T4T M,3%"048P1C&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/GAM<"YD:60Z1#(P-D)!,$,R M,4,W130Q,4)!1C!&-S4V-$,S.49#1#D\+WAM<$U-.D]R:6=I;F%L1&]C=6UE M;G1)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S M8W)I<'1I;VX@&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O M8F4N8V]M+W!H;W1O'!A8VME="!E;F0](G;A0 MDZ`A^U;*:SI32E-*4TI7E8;HO"PW$;6+O57^*TBRF"?*'%MNM MM5"<7ZU'LBJO/IV5%]/7F MI9_"8CN3(/$J7+5-E_)\+G"$B)"8A(ODBQK8?VM^?*HJ?\6*I1;TZJ/JJHO/ M(JM3<]KD$L=VACK)_3QH0=!H:>Y2"Q&\DDCP8'8NXQGM5IK#^]AXJJKJ,G7* M\72.?$+%:[=<;7"3_5EU-4\V_28P)LF1"2)PG'+6KJ+NP#- M#0"W*';R=I?2,2#!!QW\'9],9^U2#X^RM",H4-VN4*O#=YH+)?'HY75;0\-I M=*=6D=;#ZNPHKS?!*@+P2<@*\)KK+)YT)W8D^3D^E:Y><1+Y=O\`O&MCZV5[ M32E-*5'5NAV10/G#[$>1TZMI/A=@#MIXL)";X^(1N[:8Q&'+.VU1IY&\ M$[)F-H9737:_N"NDFS90&MQ&'S^T6.'XPN_"=BCD4IXBT)Q-I5Z(#TX7)39< M(I&*(JI@?8LOZA)R&SJ53CJ)`G;T`JOGXBNXW>QM:A4 M@Q]*Y;?=O^0I306&YWC'E'VFCY1P!DYQB2B*E*V_:]2+MP2KPO'KZK[P? M!J0L./B&#@8GJ5]<'M65XI*'!!\Y."\9+=VU.],7D.&RT.$)3$C44+G@45/3L.#9((,B4LQ8@)` M+B0<;$D1(:JN])/EX^6TD",3K%6X=C?C88ZR/.+3@3=!,<4V3)%Q:((;EJ#2 MALL:9`;!$4&[_9GR0\82MXE<[T5?4N,>88HCU,T!MFO)!?EF1F2,:F6AF42, M--8VH(=P&(Q'F,`SE+.7>*L)D/;C^6JNY8YRX.?3UVBI8+/X5A^G]W^FMP*F ME+GQ%:NO3_S6;N/W_G_S6WD5M]/O3WG;U_U7SN/W_G_S[O\`WOTY#M]/OO\` M]I3WG;U_U7+VY[:9M^WDXXJ\3[C,91;*<*JFWC9I;Y:P6]6.[$RK07R+R)OR M*J,2!M20FWJ1QEPW``#(&?,`@`&1NT]MLD?W`[F<5)6GE>#/<,SA@TN!#*!8 M@LS53FWD?!PLX[7JZ[9.V+O5FXS#J7`KO=L`2ZO\K)]G`5)UQ8PX`#3RL6FR M`6W&?*R`@#PVCW#I)M"N00[[!VE]2)9C(!&QVA79)TT@N1J[#R;75FS!-N@P M+<89';5N#QXLG>Q_6R#V+R!%I7;%L^4<"94$2,L;93`?G,FV**N.)R2#^D04 M13$34@7.QU*8]NPEF#XF6&_E2Z&P\NS3C/D-?L]6A_`,\8*4Y1Q++-H67*28 M97SCBRQ)<,#G0N?*%YG\$!YN/M0*JD@]VO.QV\H.I-J@CYQVX1&*A"#^,V:> M%2L)4%BV$E)N%99`03*@2>L@B`623\1/,#57N)7;)`!)4%!`Y>97-RI9/*T) M((=NIA(8I(G\8P?O/D3#-[N^Y&.P&YW-INKK89:L=6Z5V^-U#@)WM=-(GZ^V MN7<*=4X*L6AIA-Q3%L%;$"*6>/\`P^@\J?9B[B1`7[VYU;GJ4E6=P#7$<1[` M_.N_?NW;'YQV>"LK63:X6S^6_P"%;ENPC"4)N<3Q-^^N`ZEW+JU*428!"1(G MKEZ^J4TI32E-*57Q\6_9WB61UC644A]\M]'FZA;P7N7>CUM$81)H'+B>9C&4 MI2+?569A@J;L1.<#-76T=IL>4L\[.F"$VUL*SR\I.(`.0&#]FR`,ID/%>$P1 ML#]/E_/I58WP??#;W8XF\2S&D_E%HK(+#MO^39(S-98_6H+-RM4;*2Q.31]I M15?,\WRW6'Q=#HC;OHBJB*D&Y?0%"8?.&#R1&N`\L79W`KKJT].0ZDNV4GF2 M2I+/U,#D%]GSZ0&I565-*4TI32E-*5I;<13T=5@S*5-#;Z&VD`W2NN*1FM2E"GX5$5PWO*`N/K$OZ M$U4FT6(QJ8&C'F+%CA^X&1%>\VG@,SN1\I_B!6B-O<7F-WV^0NKMU3::6KKK M GRAPHIC 12 g852944g50q30.jpg GRAPHIC begin 644 g852944g50q30.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[2`T4&AO=&]S:&]P(#,N,``X0DE-!`0` M``````\<`5H``QLE1QP"```"````.$))300E```````0S<_Z?:C'O@D%<':N MKP7#3CA"24T$.@``````Y0```!`````!```````+<')I;G1/=71P=70````% M`````%!S=%-B;V]L`0````!);G1E96YU;0````!);G1E`````$-L.$))30/S```````)```````````! M`#A"24TG$```````"@`!``````````$X0DE-`_0``````!(`-0````$`+0`` M``8```````$X0DE-`_<``````!P``/____________________________\# MZ```.$))300(```````0`````0```D````)``````#A"24T$'@``````!``` M```X0DE-!!H``````S4````&``````````````3S```%7P`````````!```` M``````````````````````$`````````````!5\```3S```````````````` M``````$`````````````````````````$`````$```````!N=6QL`````@`` M``9B;W5N9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG```` M``````!,969T;&]N9P``````````0G1O;6QO;F<```3S`````%)G:'1L;VYG M```%7P````9S;&EC97-6;$QS`````4]B:F,````!```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P`` M``$```````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<` M`````````$)T;VUL;VYG```$\P````!29VAT;&]N9P``!5\````#=7)L5$58 M5`````$```````!N=6QL5$585`````$```````!-'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI M8V5697)T06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````1 M15-L:6-E0D=#;VQO7U5F9VAI:FML;6YO8W1U=G M=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1 M%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1E MXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>G MM\?_V@`,`P$``A$#$0`_`.#+WV$O>XO>_P!SG.,DD\N<2FE1!T'P3RDI=*4T MI2DI>4I32FE)2ZM_LS+^Q.S@:CCLQQE/(>9%;K7836.;L_GW9-=E?I?]-4Y4 MVWWM:6-ML:QS?3-)V_3<[Z.]^W^NIORLI[S M8_(N>]QESW6/+B?;[G.+O<[]%5_VU5_HTE-T_5_JH?Z>RLVBRZI]0L]S7X[Z ML>_?[?\`2Y%/I_Z2O](H6]#ZC3C?:K6UMI^R,S]Q?KZ-CF5U^S;N]5[[6>W^ M;_X;V6*H,G):X/;?:'@.`<+'AT/'IV>[=N_25C99_I&)FY&0UI8VZP-RJRK9Z@V^HT/;J#+27,[?NV5V5O_`);$F7WUOKLKM?791I38 MQQ:Y@)<^*[&;7L]UEG_;BBY[G;=SB[8T,;/9K?H,'\E)2TI)DDE*232DDI4I M))I24__0\_'`1,9V,V]ARV/LQ_=ZC*CM>9:X5EKB6_0MV/00=`BXS\9F0Q^7 M4^_'&[U*JW;'&6N#-MGYFRS8])3>QJ.EY_4\+!QZ[\<9>=50;'/#B*+7-JX< M7M9DMW[O\+7_`,+^_#K&%C].ZIG8;"^RK$R;<=CW.:'%M<0ZS:S;O]W\A'Z3 M=TYWU@Z3]DQ[*'?M3&;.CY#+,':ZLT9C:S6]K M,3$L^Q[:W6XN/Z'3_48S?9Z63D^MZMG\VDIY1XV/-3JWML:[8:W`AP?,>GL+ M-WJ?\']-1EI`(D@B>?\`8NHRVPXC,+[6+F-J MI9F?9K&7U/II^S?X*NI<]U%F17G7#+JLIO+B]]=K][QO][?4MVCUGN:[WV_Z M1)2"1YI$A1D>'XIR0DI6B6B:0D2)24K1*6^?W_[$@1*:1/'XI*9-VD@0=?/_ M`&)I9X'[Q_Y%)A;O&AY\?]BB"R/HG[__`#%)3(EFUQ`((:YPU!$M!=^[Y+;Z MMTKI'1LSIS,G[1DX^?TRG->&N:'LNN+A[-OH;J&>G_-[_P#KBPY9M?#2#L?K MNG\UW\E=5];;<"OJ'0G=0H?DTGH&(`RI_IN#B;=C]_\`)_<24\UDOP7-K^R5 M65.!?ZGJ.W@MEOH;-?I;=WJ_R_\`H`1LFS">VO[+0^AP<_U"YY>'-);]GCQ^13]II;.^C>:MT@AOZ5@<]FU_O24Z?3+^GV?6#I?V7$=BSU M3'I])U;O\+^>C=>JLROK-U&BFKUK[^I9#:F!VV7$ MM]LF&_YZ2G'=Z+OI5S\7?^8I.91M9^C'?OY_!7F=$ZO8XM9TZS<`#M+P'0YW MIM]KG[OIJG8/3BM]9:]A>US23(*2E2/#\4B1*L-Z=U%SJ&MQ+B^O=]-)35D)R1*)3A9MYK%.- M=8;H%6VM\.W;MFUVW;[_`$W_`.8DW#S'UMN9C7/J>898UCB"3N<-NUONW-8_ M_,24BD2-$B1/'XIW5V,#765O8'DAI>US02TP_;N#=VS\]1)$\?BDIDPMWMT[ M^/\`L3`L@>T_YW^Q)A&\:=_$JXSHO57LIL;A/->0&&E^]H:X6;?2]Q?^=ZC/ MI?S?^$24TY9M?#8/IOUW3^:[R74_6V["JZCT%^=C.S*1T+#!I9::3,V>[U&M M?]'_`$?_`$USN7A96$37EXSL=]E5CF;G3+0'L+AM+F_2:M[ZT9&'7U#HMF;B M_;:F]$Q6^CZKJ=??M=ZE0<[V_N)*>>R;<.P,^S8QQG-<_>38ZS-&?38"QSB?3WLVXSG/][MOTO6W M*UU_+Z?^UL_?TUEA.9>'..1>),M.[:UVWW*E1FT7=1P_3PZ<8_;J[6NJ$$,W M-#<=WM&YK/I[_9_Q:;K+VGJ6D_P#E35_[$7_^ M20+'5D`LJ#&DNVL#G$-&[1FYQW.VJ&]G^C'WO_\`)IW.;L9[!^=W=X_UDE+2 MW]W\2D[:0`6Z$:ZE-N'[H^\_^22)&GM''G_>DIV\#/R;OL>1E=:.*_'RA30R M&^K56ZL[LMEGL:W$W-KQ7X[_`-`GO+6EV6[ZPUY64S&-=+?3-ALJ:-]6(_UR M=NY_\SZM-MM=WIV?36%(\/RI$Z_=^1)3TMF9E8>&TXWUFKL^RUNKQL2NL:M8 M&NJKUWM_2;?T?J;[/4]'_"?S,AD7T5LQL?ZTT^E0!32T5M#6L'T6;G%SO3W. M]_\`.?X&S_`7_9.8E(G5)3H=6S\RZP8EV?\`M3'H(-%Y`[QZGI_2MJ][??N? M^E_G%GDB3I^)2!U&GY4I$\?E24R86[VZ=_$H]61TQM;0_IE=CPT!UAON:7'N M_:UVUN[^2J["-[?:.?$_WI@YL?0'WN_\DDINMR^E@.CI58&UQ,9%_9I_E+6^ MLF5A-ZATNV[!;D4_LC':,9UM@`)W[7>JW]*[9]%FVWXU>8QO3:&>E:7``^[](W9^>S\WU&65_\&DIRLJ_'M;6*<5F*6.> M7%A)W!Q;Z37;A_@&MV;O\)]-`1\G)JO;6*\:K&+'6%SJA&X/+36QX_X#;L8@ M)*?_T^+^K$'ZPX'MW_I3#1,SL?MUSM_P!/^<5WZL?^*'`,Q%A()CG8_;S'Y^W^7_H_TBI5Y/H9CLDT MT6;;+":7M'H>XO9M])IV^FW?^C8UR2FPS.KR,S'#<7'QS]K9<'4-#2&DM;]G M_E5-=^D_UKV1ZD]IS,HEH=.5:=2X=F?N.8D>H_:\FL#'QJ)R1?\`>E(_='X_ M^22<1IH.//\`O24M/D/Q_O2)\DI'@/Q2/P24M/DD>>$ODG/*2E@=1I^5*1/` M_'^].!J-!^*7R'X_WI*781O'M'/G_>H@B![1_P!+_P`DIL^DWVCGS_\`)*(< M(^BW_I?^224N"(=[`/8_7W?NN\7+4SLQF/EX5UF/3EAN#4STL@.+-9]XV.9^ MD9_@]_J,_P""66T@[AM:/8_4;I^B[Q>5?MSAAY6+D&BC)#<5C/2R6[ZS/=S- M/;,6Y]%A:6%];BUVUT;V;F_O;4L?)= MBY#QKO\]#R7@/M.UKIOL^E. MFE?[KF*=O5;\TLKL](-]?UP*F-9!/LV-;7[6T_N5[?8AVNC>=K73<_Z0G\VO MC5J2D6\?N,^YW_DTY=[&>UOYW8^/]9-O_D,']D_^24I+FL`8WOV/C\4E(]W\ MEOX_^23D\:#CS_O5W'PC9RT??()$H]^.ZLG1`//'@DI;Y* M0Y4?DIM^DDID!PGV^2DUJUND7]!9A9]/4_LQNL`&,+*[K,AMH-7H&I^-^C;B MN_3,RJO4IR/\)^L?HZ$E..![AH)GS_O0I_DM_'_R2ZVO*^IO[?IS7W].;A>B MQF7B'&RGT&X-:*'/.2^I[3:][YV%N5]HKQ75T8&^NKV,_6/UI)3FM=.X;6CV/U$S]%W\I7!G MNP.ZW[7`VUP# MZC\C>YM?H[?YSWUJH_+LZ9G;JG8^0:JS1ZA;ZU#Q,>I4VX5^JQVW]'ZM:2FM MDYS\QM;7,J:*B\@U-VD^IM]KX/N;7Z>RK^1^^@H^3U"W,;6VSTXI=8YOIM#3 M^E+2YKMOYC-FVG_1U^Q`24__U?.1PBXV5;AWLRJ2T65[MI>`YON:ZIVYCOY# MU`<(N+DWXF0S)QG;+ZMQ8[:'Q+7,?['!S7>QSTE)+^JY><0R][7--_KPUL0Y MP]/:W_@MOT:__,T-[H:[VM=-K_I"?S6(N1U+/S(;EV%[#<;M6[0+'#80W1NU MFUO\S_YFA.=##HTS:[Z30?S:_%)2/?\`R&?YJNX='J;!M:.>!YJGOU^BS_-" MU>EO9O9,)*>AZ5T@V0&MU\5K9'U?M95N(*U?JJS&=%W_UD]%CWAL=UPV8YI>824U$1@]RA*G6?=KZX`8YIW-`@':"YF[7W;7*Q3U"_I^37E4%F_TMA]1N]NUWTO; M\E78Z2X;6CVNU#0#]%R/CYV7@9#,G#=LN%6R=@?[7:/]C@Y)2/)ZADYK:VWO M#Q4ZQS"!!_2EKWC^4SVM]+_1UH"L96=F9;:QE6&P5FPUES=NMA:^WLWV_0V- M_P`$JZ2G_];SL<(N/D7XM[Z_=:Z\[@T?I'#:][=K6[=W^C;^C5JI=8VZC(99CFQN@)>S_&'N;NW$^&YD?]4JN%F,#+V.:-SZ[&^8<;';/^ MJ24])UK)^JG4:&X>*YN-E/VI]K:[3M8^2YP MY`;N)1O3PFUOM9=ZA:6RSR=(*2FSUR_IU.?97T^K]`UP#9M]:-!N:VX;FV-9 M^_O?_75*P@/<&`;`?;+1,>>BK5DNN$_FB?N".[VMWN!#"=H>0=N[Z1;O^COV MN24K>Z"`&B1$AHG7Y(V'GYN!D#)P[?1O:TM;9M:X@&/H[P[]U`;[P2P%S6_2 M+02!W]T?1^BER)''BDI+E9V9F!@RK3:*R]S)`$&PA]OT0/I.;]'_``?^#0%) M,4E/_]?ST<))#A))2Q`((/!T*M_M/.U_2-)<227,:=2(_."K)DE-AG4,RNH5 M->-@$"6@D#W2-W\K>A_:+?M+YM]Y),;A'^=*6X-LL)_.KC_7_`#5'V^ID$>+8_P`X)*7Q;[`+ M6@Z/86'X.^E_T5-"QQHX^)A%24M"9P]KO@?R*29WT3\#^1)36K>X`CML>/\` M.Y46F&V?RFQ_TFN_[ZD##>8EI&OQ3-AT@'6"8^&J2DM.MKCY'\JT\+K'4L"E M]&'<*J["XN]@<9>*V/\`<[_B*EEX^MA^'\0K"2G5;]:>M-FQ9EUME]UE]L&RU[K'D"!N>2]VUH^BW51224M" M:$Z22G__T//1PG66DDIU$EEI)*=1,LQ))3=OY[_1[?'NH-YLY_-_+W55))3H M4_0^;ORJ:S$DE.FF=]$_`_D6:DDI[7_%CO\`V\_;MG[.?I;?WOS/5_/6M];O M4_9N3N]:/2;'VO9Q#_Z)L_P'^C7FB22FUC?3_LG^"L+-224Z22S4DE.DDLU) M)3__V3A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T M`&\` M````<@$R``(````4````D(=I``0````!````I````-``+<;````G$``MQL`` M`"<0061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W`1L`!0````$```$F M`2@``P````$``@```@$`!`````$```$N`@(`!`````$``````````````$@` M```!````2`````$X0DE-`_T```````@``````````/_A`3!-30`J````"``' M`1(``P````$``````1H`!0````$```!B`1L`!0````$```!J`2@``P````$` M`@```3$``@```!X```!R`3(``@```!0```"0AVD`!`````$```"D````T``` M`\`````!```#P`````%!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*0`R M,#$U.C`S.C$R(#(P.C(V.C4X```#H`$``P````'__P``H`(`!`````$```5? MH`,`!`````$```3S``````````8!`P`#`````0`&```!&@`%`````0```1X! M&P`%`````0```28!*``#`````0`"```"`0`$`````0```2X"`@`$`````0`` M```````````#P`````$```/``````?_A2*AH='1P.B\O;G,N861O8F4N8V]M M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H M:4AZDY48WIK8SED(C\^/'@Z>&UP;65T82!X;6QN#IX;7!T:STB6$U0($-O&UL;G,Z&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(@H@ M("`@>&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M M;2\B"B`@("!X;6QN7!E+U)E&UP.D-R96%T;W)4;V]L/2)!9&]B M92!0:&]T;W-H;W`@0T,@,C`Q-"`H36%C:6YT;W-H*2(*("`@>&UP34TZ26YS M=&%N8V5)1#TB>&UP+FEI9#HW,3)$-C-#13,P0SE%-#$Q.48Q1D%#-T5#13-& M,S(T,B(*("`@>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X;7`N9&ED.F1D M.64Q83!B+38W,V$M-#)A8BTX9F1D+65D831A-#AF-S`W,"(*("`@>&UP34TZ M1&]C=6UE;G1)1#TB>&UP+F1I9#I!-#9%,SE#13$U0SE%-#$Q.48Q1D%#-T5# M13-&,S(T,B(*("`@>&UP34TZ4F5N9&ET:6]N0VQA&UP+F1I9#I! M-#9%,SE#13$U0SE%-#$Q.48Q1D%#-T5#13-&,S(T,B(*("`@('-T4F5F.F]R M:6=I;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#ID9#EE,6$P8BTV-S-A+30R86(M M.&9D9"UE9&$T830X9C&UP+FEI9#I!,S9%,SE#13$U0SE%-#$Q.48Q1D%#-T5# M13-&,S(T,B(*("`@("`@&UP+FEI9#I!-39%,SE#13$U0SE% M-#$Q.48Q1D%#-T5#13-&,S(T,B(*("`@("`@&UP34TZ2&ES=&]R>3X*("`\ M+W)D9CI$97-C$*%R4S-%+Q)B5\`N8D!;V%@$V&YU[^0V7`#POH3L%0=MM4V M[G0%S=;]3JB=[?X>.`2BY'BOY7IJA^``P!Y_(:%;7%^B=-_FN`"D^!U4H4UO MVMY^&`/-LE_!=+;IIMHMDOH`+8^'S.NMQ^=\`WGMU.OGTZVW^>N`*CJN_5.A MLOVMET(7L#>;2Y[VVO\`E1V.HP`YBA'Y_)\_!;X!%NM M_OP`[?G\W.`6``*X!*FMM?P^>MNV^`:&@4O<6NM]E'C\47`-)U6Q70Z!=[:I MX;K>Z@N8WT\4^>WW8!I-^W=-/N&`;SZ@D):ZZ]NEDMTZ8`*==0=-+>6I(`^6 M`:6T)N-DZ:*=/Q.`:1N&KFZ&WB1IO_#`4U!'500A2Y4(A6R;;E,`T-6*)J5* M`$(+`Z%?DM@IP#38WN=U.^N_;11W"VP`)1;]R4O;OKM;[ML`Q0>JZCX);;0J MAZZ8!-'50NFXL!IW/\47`,#1OH`FJZ;:]`>MP/C@&D[?-5U^7\<`TG5!Y(@M M;0*MNB]%7`-)!W`(W!&P5.GEWS7.W37``D]3:Y.Z7**>O774*,`THGQ'<@6W0E"M[C0IO@&$A/K!""F@(46*CH M/X#`,YM#<@E0.F^P\00!WT&`;S*"="H/:R'2Z`%%V'?`,5%3H!_=V)5`0NB@ M?@$((E45;C="I!52`"-=3;=40X!BJ$*&ZA2ONHFIW-O'3`;(7IO^?S\L`50$ M;?NO@!I@$O[OO4=.ML`5LF`"GX:8`DKK^3U/4X!*1O8?G3`!5[X!8!+^[K@% M@$OY_/7`-YAU_(\,`N8:K;HAU_(P"+8'YM^/3`,+1.A0=^W6W[\`B2H!*]4( MO\/QOX8!I/0D]>Y_AIV37?`3>E\LLR*W@XB8T9E[7%6RZ%BC!14=2]*3Z?P< M+&>J=/S"1$5*H"+%GD>,EH&RC+;,>H)M.)!(0KQS.)=!0#Z,ECUW$NGL.V[C7+AIA^[;B(I*'IRSPXBW_KI"[@VYJZ+F$/ MM+T-PC/JW!#]M'9YB&, M`C9N[<-R^$C'[+UTTYAG\0[?O0\=EAVT&V20RXRXS%:IG].&*"K1JC`Y;B#5 MS-+3PTO[.[BFH)X_^G_8?HKU3$8P8-MX(OE9BF6G!:#T%C`4Z5R[S`KEW&OJ M)H2LJO=2YMP[F#VE:8G50L0#R)9;;AW<:W*8&+9A6W[#I\TY8?-.VGK+IX6` M0PUR@V49=YB3^PQ;N:RJ!@7\=+ MFX6./L<2S&.')<1:0[T,OCR8".S:4360S*,DT^EDQDLWESYJ&F,JFT'$RV90 M,2Q=N'C8&+=.(F%?L6+3I\Z8>,V+3.BA=1],5++8Z62J94[/9?,YU"2V-DLN MCI3'PD=-X*4G*6XIU!,32I:/J&12YJ,?,/'CF%8C9I+H2%,4]=N'S;MP'I?/&73U MMAGE=M$!@']*U3"O8AQ$TW/X=]"22&J:+.HAMB(1+/LS(+3XL`$X#&TO1E9UQ%Q$O MHNDJGJZ/A(;VR*@Z7D$TJ"+A83UK#D1<1#2J%BWSF&]<]=.?7O6&'/K7C#', M6F@S@,;/I#/J7FL7(JFDLVIR=P/JA'2:>RV-E,V@S$.'44X$7+Y@YAXR':?P MKYQ$.?7.6/60[YT^85V\8:(6#F!C8EQ&Q4-!Q41"RUR[B)A$N(=Z]<0$.^B7 M$$YB(U\[8:8A7+V,B8>$=/7[3MAY%1#EPR2]>NV6@JS&5324/X>&FLMF$LB( MN#@IC"P\Q@8J#?Q4OF+AB*ET?#NHAV[;?0/';3 M+1"ZF=,U1(YP[IZ=4[/)//WA@P[D.'[EIMV]"NBG9"OC;R!G,=;7/S MU_/@NJX!--*EU/52GP/CWL-L`Q=P04U^'ALJVZ:X!O/OJ$\^B+H/W`GHH`D* MFEM1^Y//8G7HH,)5=@I5-P=.EPA3SWT`*I[J?X^(^/A@&\P[);I8*-1LFQ^> MV`I\P*GW4"%+=T4CJ>NMAO@`6FE1+&Q)M]4:G8'0F^U]\`QKQ"LWU72R;>!0 M=M!@&ENRF^`:%(ZDE"1LFR=+&POIT0@U2"M[7`)0L6-U%]=D M47'7`,54`L-$UYM!8ZHJCS&ET!I:7H1S*/#OV`[%>^`V."65/5`EKV4>0'3\ M,`>==?`$;+XGPW&`7.0>W15VZW\?E@#SW*_QU_=X7P`)-[KJEQT(T^8L/F,` M>>]@H^?Y_/;`(M*.GGY=OET4V.`1;/;PN?S]_P`Q@&\Q\$U3\/R<`@TA*GX) MK]U]/GK@$6E!&EUM^/W_``P`4Z^6R=+[#3?QP!+1-NNWY&^`:OY-^GW8!!H; M&_EX=>Z>*[X`$I^?+;``M=>X-QM]^B#3RP")Z>:E.Z7Z_P"-L`WF`0(RB+KM MH;("=--5ZX#VK]#IGCG-0#KCZIBA,X,SZ(IJ7>C?XS\SI;3M)9@5534B@,SI M!0$@21S"PKJ3U;#P[%02UW#N&(*8.&73MED.@?0SS/.# M-#+GTI\ZDL7Q=YC9PUA07#]/XZ:<+N9473G%354ZC^(2'F=23J09C3F!J:8/ M8^,=M3"8UO'3"&F$9.*>,_X,\P,]N'#TE7%-FE6PSED>>N4 M'#7QM9@P+OB%G\54N=\OF=+\.U9U+E\YS0J.+0/#A/H"<92QM5<'?&0Y8E[UDN95-N-+. MG,+,>B*7'(5?BC.&^3Y`R!M\261,'A_D6:%1^CWXU9=E%).-6H*J'%'PKQ3R`X"LQ MG.5^=[,G=Y><0#$;$QU1OI#43+Z@W3][!L3Z6?1[+43-'M/OO:7?LI8>!JST M;E6U1D[-O3%5)Q`UWQ0945W2/#WZO-:M\NZA+GBNIRN6N,;)B650]%2U#4-- MOW]?1=1Q,5+ZWCYI4,%%QSJ,J%I^]?Q+\N'P7O'W0`XP/2+\!V2,MGU6U#EQ M6O#1PJ2:2\4F9T_<5#F3GADE/(&<9C5CQ#YI3>'@(9XZJ*@*E[K.B.)?)?(?CJR*STH+-&:9(YY9C\,4XJ;)FF MV8.1'HQ*K9#5F9%85+)JGS%=9U M\0,C=U[4;0J&GVZ;JC.R6TAPNT-.,GY2&)HU,(K,R0U%0 M]7.:@HIB",_D4%3\RFDU@X26N?:6@W-Z,;,^CJ4X:/1%4-/^(GBHR1J#,+C" MXGG%%4YD=7$JHK*+-JJ9+5^4473V7O$/%3&=.VFJ9K2HGLFH*6OV:0K*&A8> MLIX8Z`<0SQMIX',/HH(G,.OLYO3`S"D>SF"RCX/JG8R[SWHB M:S+C&RKFLUH/*:HWLFCV9`^H]P\CY-'LM21LM4G*YO`>S0Y?C&I>94XY=,3*ON-^OY1FW,(-AQ,8^#C'Y8?/I$Y:A@[JX/\` MCA;XL?2F<).9W$E"94T4W2$IS(I:B)E.(R=/:"@A(^4Y:Y=.F)/*Z4IBG:>E;4.0YQ](A"B:*D>8-5/ZMXMJ9HN-G=-1[,;FI/6GLTCH?*Z=5,U-HW)"#G5 M2Q<>R7%;3*12^`I:-E$5'AI+TCT+#N^)QY/'L-#P-85_D7PIYJ9M0#ARQ#>S M9VYK<,.4>8>LNWL,V[8#A%4!' MR)4IL-$M8[(=K)@&%KJFNJ(FN]D';%^J(5%KW&HZWP#"T@*H5ONO<70:&RH<`TMZJ$OA`730`PMM,JH":=;738DHFW;`;'#7^'3KH"MKW3IL<`@=A M=#N;[W-O`(F``:*A2R5^0\3YGKYH@.YK$[!?BH3XZX!O,=>H!`LM[)>]]3:W M;<'Z_?KL-U7=00;S(UK:UU)%]]4\MO'`(D!"&@2="AN@4[-=D('E@&\R`[ M;>-[=-;]/A?`%=2J`W`L2"-SS+UN4VT7`,+5K7[K>U_)4[&Y08!-%FQ/0(.R MD]0=?'Y8!G,=[]+!50+<;#78_/`#F*'O\+_=\^R8!$J-];Z)\@+VP`YC<$V/ M4_GH/X74&J$_/P\>F`"[;W*6VV73M_'`(M,_=\[_`)[IXX"GS*I(W&BKUMUT MVW)1%P`MU0W7JEA;XZ?$Z8`X:4]++J/W?<#&FPB+I8HMK'KY)H-;:X"7R[ M,*KY31=4Y=0$Y?.J)K.:TW/*DIQ\XA(N71L\I`35BF9XY9BX9^]ED[E$-/I] M+X>;2EY`Q[4JGRN:1T(_"&$J$74@ZZ6\AN=+#SP%:$BWL#&0T8X9< M-/H2(<13EF+A8680K;V'>,OG;,3`QKF)@HV'+;`#Z%C8=_"1#LM.8AR]9+[GS":_N^ZQ3`-Y[ZA+V\=DZ=L`UHE#KXC:RWN-M"H[)90#305$.PWZ M(%U MU[J/-=MB<`U0%061"A.A/?>WW7"`8!%"+V1I%[V72Y%D`0FU]J$:[8`!KQYDLNB_/\`\(3P(P#"TEOK'=+* M-[[IUL`/D#"U=;$6(\%L.5%*6"V7S7`-::YBH!9%R=BBE"ITZJ+7Z7P#3M;0 MCF0=3IOS*N^FR)@-B*@.Z6)T6VUOW7[C`"P96^P1;HA[]MKWVP!YMB;6%@E[ M]-=-SXG``JH\EU[^(V[KHHW!RI@$HL=PAMMK=01X>:E M,`"0FZ$A=M4-_+7\G`+GU3374WWT*G0H-K6P#02`%TVT774*NEQ\N^`//U)V MTLB?>?A=;C7``&_8;@=4'AX*GX8!%O\`)ZVO8#O_``TP#5U1;_/S\?/YX`6FNF M`:2`1N-0BJ@NB$:G=;:^&`:6^UM%\+E-`2;I?3P"@E-RS?SL/CI\-UV0@.8` M,W-M?@ORMOV[8!C1*V4Z>Z39;(/-1K<^-\`"UU12@%[!`#;=#H05-TZJ%,M[ MVLA`2Q(V/4I9;#PUP`)(-_@2NJWZ:*,`PE$NA.AZ=RE_QTP"YAL`=[7%MO/` M,:*7TM<=+Z[VV7>V`:3S(%&UKZC3J>B>&Q3`-5`@U[E!S;'7I9/OP"YD*;D6 M52@3;;`,+6B=>X\=EMJ=/O&`8T6DVW464!%773;SWUP`YFE`)N"I&BVT6WP0 M=^P!0.8DD`*E^H95$-T475?*V`9S!D!FR&_4H>_1``B+W3``$:%2;$#<@A;G MNMUV'Q!A:/O;*-4L4\]NM]O(&EI!8KI8:C;HH3`-5GJ"-2"5&R_,6%K8!I:T M!*G4(SQ/3MM_C:V`2A5'DB);]WY M.``:Z&^I0_/[_P`G`%4T/S^.`2_NUMX>6I^/7`(M#GE@$6]`#>^^I MNIW3IXKWP"6W3?7M=?`V[7ZX`+O\_P`5P"#2JA\^_38GPP"YAI&`/,.JGM^?G@!SC95[I?QOI_#6^``:"ZHMN5-#VU7>UEWP`Y[E-. M^W8]]/SH"+5U(3J=RJ#^(7MY@.8C>VH_AOVMWP`YK7(*+J=TT_.G3J`[6U[E M;'R^_P">`2DG]]]]>H4J=[+8&P!I)501TW706MV[:=B<`%V)WN?`(!VMOLA0 MZH`1@Z-:%?[VJ(G7\0=18@&-/-0#H2-63IH1H?FN`+30)Y5`!L62$3=/SX!3 M@*1;O8D'?5"OS\#]XO@`6E9"Z]UNBWMM=!:Z?`!SFR$`(=DU4(1?9$713@&[ M%>P79F_Y_=@`=R"MK=51=-?F=/B#2TK5M-U)\+DFZ6`ZZ[K@&!K1;B^IOHZ=3M@&JU?5!:^A[#`)554(W4^5_`?B,`W8`HJJ+IT M0H=]5UT`ZX!I;%Q_LH%OX?!23=<`WFY0>9-QJ5/D0-D`W%_#`,538H=?#46& MM]-0$TU7`-4A39DJEQUW!LJ_!$TUP#0MA];1>74Z^\/]KH4^^X-:[*-4OH1: M]NPMX;6P`7NG86LEB=K'4KW[X!G,/'^&YM:Z7"_'`-504"`@'2VRD;:(GQ4; M@1J-5.@-@4U*[W!:\0>V`8TT/.]_*X&Z(-\!2::`'G\D)7NH%AJ=NN`!;0HA M:3H!?0E04"!"%VM@&^\O-8A%4*20$31$_*7O@*9(5&;G52I&@-B4*(>Y!4;X M!O3OJ025LJ^:][X`&ZKNOV38]]@;#4[HAO@)^MT-T4>7CN//X+@!S;#7J#MW MONOYM@"JV7IV'3XIN4WP!YMK*;]U._F%T3`>B7H_>$/+3BUG-84S7%8U!3=4 MO*HRKR[REDDI?1\G@:VS$S4B:Q@9!38YFY<0--OZ\JN4Y3RC,/U>6$OKJ>TE4SVNY>]B:/IR21,_R[HA[#S"85U"SZ6!1]'YZ-[B*])9F#7. M67#B\R]=5)E[1KJN9\UF'5$92\N,C?3N`D#`@(J$DD];B8WV^8PZN&W+A@.. M=YZTE@,-!#N.O@4SQ]'?GE@>_CM:X431T"PJ5]0S2 MVM%5'H2G_9H>7AWP%(TE!#2N*,:':)G]^P6GNF`>]HQVZAH>-;JRDV82*>Q+ MB&?B)G7(^>P;,.U$L,K(^97+,5#EHM,LAKUHY2TC7*%BU3D+M5M*M)T?SE2/ M.2!3IV3=5P%%J0PK/_M13+2)H^F^I"_]3*G0^%A@*+4B<72I*?[!A]-2B;?Z M)&M^^F`IF40XUJ"1M-)9'DQ5!XRRP.UM\`69&'C#UXZF\G;=P[MAX_:9>Q_Z MMAX\9<,-DM2\:O'C#%@6E:'V;X"U^C7+`4SB4DE``'L:=MQ[#]VY*W-@8W`N MMIK+5O\`5;C">^L$-"%73;=/&';N-@VFVFPRR`8@$M$_\`ZN!T`OM@&>SL M#2+@D7^\_P!3T5QY?#K@*9<,Z^UPY76[]?-7`W\;ZX!IVGS5.@$PCO>/@D-R.:(%ET_LW MD;I>VPP#C+P&&7ICX$,-M/&&&BW$D%IT&2V`/9B58#;()('UMRN``@'=EF5"^H;C1>VWL)[H.ODH.^BW!"&=R<6(5I['= M;D!F7G2]BA_$#]$."I,^D@7^\]F(*J"BB6J!OHIOUN%T[IL1#J(?.J@D+;F$ M98?1+7KID`X=MO7<.P\(^C%1I\]=NARLM$%L$V!:P%,2"&_[34V&MR7TWL41 M?]#M`W^/1<`X4W"GW35M+"V[^#K-[CUXB*0 MX8\BVZ3=YDUM+ZJFDF:K>>1%/4Z(6CZ9FE5S?VV:0TLF[]P\,JE$6(1VQ`OO M7Q/JG3;3IAIIXR&^_2*^BLXI/1?S/*B3\2S_`"R>16<FY/'3&)EN3$FSHRXRHJFN*1IF,H&$I_,R=2A_7;IW"TFY MSNH>=SRH(R6RF22Z8LRVH7D$&O>(7A[X6,G:JFU/NLU7N=K^J*FDSC)7--_1?T]3;N>O)!)*.W$@G+IN=15*LTK7[N-8@:S9D4C#@0D?((IM?H""J; MFR>\O8&EL%"B[="1K?L=QK@`4:!4[+<[VU]P%GK8V&O3`,*`:*22FWGM?O=` MER38)\&V2>R$J4V-_P`]L`1RDN``:!:T7;L%T7H5N.M]4` MP!!%@2%"VZ!4`'>PN;V-AL$_H/-G-#*M[/7^5^95?YU'3D81[7(9Z\I^92YJ;R2)(!B95'M1$"^0>MAVDP$@K?B!SZS-HZF,N\Q\[ M\W\P,OZ)$O9HVAJVS*K.JZ.I%F4RMJ1RH4O3,^G4?))`)9)&VY-`"50,((*5 M--2Z&]5"--.IL<$`KS=M"NU]1XE"=EP$KF#0%'4ON/IN MK%#2$_V>F?J]A^&`B;3WH=]]$4=-=-EL3@!SIH0%U\.P3I>R#X+@&EXEM4*A M#OWUT_.M@!/-:P)3WEUNET4^15/+`9F7$B73_2T!")TO-H!!U-E`3S78,(I* MFZA2M_AK;X?!"<``3';7^-L`EU*BUR.WW?PV2^` MNY<4CH3<"(=I>Y/-<6M^\(MUP%BI%SU1-P-FCJ#KYD8`--DFWNCIY:];[=.N M`1:54-B-#MJ/SXCO@&%H@("4[;F^GQLJ7[K@$2JK_^`O'[0,O@KG^U1JZJG)!A#9=;=!;?`6 M',`J*;]5MW0]]! M:_\`#4KM@*:J@%]?$'=+]4&AO<(N`!)0@,ILNVH(**3;ROLF`:I52`1RD*#: MYZKKHOBETP$]RL(_G(HI?^T4M10@"1#.IV-O,KM@/;G^3)O2Y],3P[-&Q%'9 M]^\;#_>1KH;H3KMOV.`]9OY9;$>NKK@"`:YBS2/$9NHO.K)I.)C#2IS&S&81CF7NHEB#=Q4? M&1##EE]$/FVPL*OS5S.K^44?3U=YCUY6M/Y=2?\`1W+Z15=5]05))Z%I_P#5 M'Z!HZ63F81D'3,F`AW*RN2N("!_4NOU*L,($!:.]P1JEQW4D*//XVL`[A4LB M(!<_$)JFFW7`,)4HNBE5N3=+H;IJAU.AP"2WO71>IW6VUQ;7H+8"<NUB2?.R?=I@/K1_D MB[X.N+KBC:77APEX0E%_SFTKTLMM_N3`<[_RJ-Z'GI/)8WJO#'E0RB]*ES'- MRJZG`>'LTRPS&SDSKD^7.5%$U)F#751TWES#2:EJ3E,7.9Q'-,Y;TJ\?/F86 M#=MM.H2#<,O(F/CXCU4#+H1T^C(Z(AX5T]>L!T)Q(\`5:<)674/-\X)M+VLQ MYB\A/7TC(G[$?*Z58?O&0W"S"=NC[/.)PRR2ZB1+093"O0V(6-FS!=Q3(>>9 M.X":[7&@OX)Y*-5(P'V<>@4X5N&^<^C%XB.)+-?A\X(<[,UW_$O!470+_C;F M]&T?EW3E*2^498R^,>3C,>H*,K^:4C*XJ,JBK(F`A9334QB:CJ"4PC0I7/OTV^2&3?%'Z/KAFX7,H,N>%>M\ZW-`<,,CX->'CA=S1X!\ZJ]@LE*BR`HB6T%$1V75&/Z=F+$!73,GAI> MXJ::5!2+$]E<\$3#NY4)LZDTZDLKE$1!M.7H?)=PG9H9)Y,\0&7F9O$-D.SQ M,Y4TA,HF:5!DJ^K=Y0,NK2(9E\6YDSJ53A[!3J/D+4\\?T9-J:B>):I*3D4EAI;-I;2L?4;.9KF8N11CN7Q=.QT+*)14$3+C!A\O M>7\QX$6.#.J(2MH.GV^(\T_F"[=F-A,]7F<3W,Q[4DA;RAC\M9C((IWPWPF2 M6;O#32?%E MG!QAQ^:M72*09G5WFO1V7.5&2&5==Q65#IF7RW*"M:`GT\S)KRM9'6$W^:F8TTX6F*N@,DZ@DE'5)2U+UTV]B MJGR_CY_+Z8FU6Y;1TY?,L-53#Y?5=%SRDY/5W(&ZGDLJET[?_M4:_)#FGG[: M'4:WT33X(NZ[8!I:.[*#S%_$=?QZ8` MFV`O)>08Z$.@]>[T4VYKFW3M\L!9*;:DD@#?[_)3\=<`%"Z+KJ=]`#\DM?;` M!0GC?OHMMQIV^>`',$UL`+#Q'@3JE_#`4RTH!W"BZ;J-D)![[)?0X"XBFD?( M="[AB-]8=V!;34ZC2^NX6H)NRSX;)91LIT!TN?/`,)&H*)JA*\I74=2-@IL/ M$`FBFI3MHH!*E=1LFW?J`)/U>IN55=-EL`0MR3J;FV`O'S0^CH(CW6A$1W@1 MRP?XA2I\\!CRV"B);5.ZA;)J+WT12,`TM(2R-;)Y^?Y)UZ`%.B*!;QU5>GB2 MO3L`*E;V`OT75+(%ZE/CK@,]*&OZ(JD[F5P*CEV^GI5]VI-U^.`CG-VWU!VZ M^'W)WP"+?V;*MT0V15%E%U\;V5&[6H M_/D+LG\R=SV12.$?5%%2<3J7M!.\Z.(7A8 MHW)KA]GV4DDX9D/)>YEDVXA#4])U?E'FG"4KST'E1)<@GTFI)W+GN:3B MEX`T]6M/1F5\UJ&KY-5;8>OG\DI?ESQ;\3Y9:1>'.`%UO_G,I;3;8;G`:A_E M,#ND9EZ6.A87,&L)[2DA@*IJ>3TT]K"OV)U,J?IN:S^E9=/ MIQ!R]J(B)=*8ZI9#"1T4PZAW\U@G;QI^P'UW>CRR,]&QESPLL5QP&/Z7S">U M)2E(R[,K-J-BH.-SNG$;#4A(6I7),SQ$PSN=4'%B2N)1,F,OG4KIV10Q?,3B M"DSUN.;FD:'RN^G*F5%.#&B:4M.X_P#I5S[T+5CB7C^U:HW3,WH7YKPWU=D%QV<,.>E%YD/ZF= M3NE.*GA\J*$JW,&(D+$PAIJ:9G\IJV;RJF9,W"M.8B3.(J54-/(6;R..89BW M4HG4L8G4P#T[K[^4EY32OTB?"[GID[D1F:>%GADR8J7ARAI%4\_I^#S4K++N MOF:6_2VHVY2[>SJ3PTXE$50="1],R:.K9\)R:4;:G,[D;RIHIW)0@7$SZ5OT M<&4O`/Q2<+GH\LN>)6:1?'MG#5]?9I3_`#M:I&F9?ES+9]&TS,:II6DWDECZ MCCIC".9?"0],4]+(R`B_9)?.IS-9A6DUC82"A(D.,5=F.FU(QL+4,Z@Y;, M)K04DG/KW4GF4([,4W3=13J74M`O(2?QKV+B(&*G%=1 M4/(9?#Q(?+*U'4P2HD,T!_\`Q`Y/;_J,+\[6P'IOE_GOP6Y\\,63?#IQ@3_/ MC)F?<+D]S">9,YJ9/9?TEG5"U/E7FC4+% MLH*`9<59.)5/)0Z<0$OB'X%B M&@YS,7)0/]%QNM_Z68(MW$M6QMTP##%2AI4EL8$O_I%GX?Z.!-D\=DP%(Q$K M`M+XHW_ZP8:\_P"P@7U`**J6&@,,1+_^A1/0'VYAJ_E!A?O3;`7,(\@S%PP= MPSUEKUS*-M18:#)5`UR>SLJ%U',%T6ZX#'^OA%*0SX!%"Q3)T"&_LU[IMWV. M`!>P1UNA5_J&S;>('S/J=[[\WM$,.; MA_R@#U+OE9`]2T%9&Y.MPF@"V#Z%VAWW4GVH`$F^GJ+[6!"A,`O6P:@^S/B$ MT,2RNR_ZN?\`$DVO@%ZZ"3^QOBH4CVQGY'V6WDNJG7`+UT`=8*)__GF0O_\` M:KNBDIUW.`OGC^`$!"%N#B6F?7QG(R(UAEIEKEA.8M-"$(:#0+'*SRL\I9*E MKF1D+01$I&LNBBBD'Z29!/A^P'HFM].V`/M4F-A+(PZ7^E78`2__`%D`A&OTMAV%U-R:7(^&XNNF`J";T$$6CY^U M=2/TSAQJC6OZ)E2%(LF`G.6TSH=[7E).H&DY]!1[<\@!!Q<15[B,L+S`/6[^37O"QZ7?A[>`HE(Y[#<:Y+5NS8!"% M'X(HP'JQ_+!GY>UQP&DD'EI3B%NILLWR>W*]-,!Y-\%&>/`M3_"53^7_`!60 M^4K=/RK.JAZEKZ2R"BG$^XF:_D\%Q!Y15!4%*0\?'&"996Y^ M9H969(.:$RK=YB3+.#,>?4U6F3%*0U#Y20%-UK3.2\3E92TRJ:`H&50[RH)/ M%-/WX0WLJ_N&^M[(%/=$V^LB*5124)!\T)\0@.) M!!1-PJ#N#[NAN-4V[X"8`JNVWP_((O\`P`J-1\_F/REE&`&IZKTU7_'_``.` M.^J?A]VF`&`*H?CI]Q*634*NR=<`KK%WQ9<3AT)X= MH"ZI_P`I5+;7Z:7U^(<_?RH9OUGI+9:TH/\`ZM>58)4&PJ/,0ZI;7SP'E+0_ M%?Q`<(.?+O,SA[S*G^7U2"C\M8.;N)>_$13U5R@9=THV\D=8TU&!]):GD[PG MF9@IO!Q`A'_JXZ7MP!XU,N7,555+N:(S1A'T&U/)=*WK^ M+I6=ML/G?KIG3K^(:;CI>R]:+;QY))FW$O8-@LLN)K-&0\;=AY4]S8)?\Z=E MWU*8#U\X>_1S9-YPT5P\SFI<]Z\I*I\[9?DK,X^6R?+2F*@DE-N,[>,C-+@] MDS#F8Q^9%.Q\:^I^:4/*LPYN'TMAF'\FBHZ1PK;$2^A9M#A(:8]%32?36J9)*7LT;FM/4QF#)VLLXH-JP?HPLL:HD_#M155UU6F3<_JVNH#* M2(AFLOX6=U6YK[,GB=XQLG8&<9I2J<9M,R:5QU'2?AEIPU#!T(^E\GBH2*#Z->EYUE].LSZ(S3JV=4M*\FH[.:,8CZ'E942V8"*+B8,31B8P;IY.(=J0M!F\[_1MY.9;4KG MK,:6SZKNH:DR;>\24Y^R M]Y3+QU)HU_\`2%'S-['NG4).8=U*0RF2GHZ\E,^\LN'"KG>9M;Y9-5AP_P`_ MKC,F<0&7M59P-S>NH'BKS`RAFCRG*8H2$F,U@)+E9EU`4G6F8SEXZ*@YN&NN)_T M?<5P^Y42NNZ0G>85:/IM(95.:EE,]R[8D3+BCHC+;AXS,BLTJ7C93/I^U-\L M9/4^=8RIFU3S*%E$%"UC3[J&,2U,)K%R20AYP7R%M]M508`*=T- MNQ\$*'Y?O(!R]K;[[[=M[X"XBS^M/_P"BA][' M]G=!/PP%KS"VRJ""#9+=O\;)K@`6CY>6BB_FI'3X$X!A(-_BBWZ6N!:VN^`; MS>ZFJ)XA2$U-ME5/`;A?/FDET$65_M,?[I%R.6!L5TZ*NBX#'DG4$!%L;*E] MP1:_,=%4W%\`PDA>8H"=4(W31="FP0+TU`-M6YKZX M"?Y5%RG\F]>%GTN'#^04(I//-;IKDQ6_7 M:_3HB#`>J'\KV?%Y6_`FNU*\0175%G&4&AUT[X#XURUX>]\4(`Z6TT'1-+D& M@D`>\ITW7<^?S.`6B->-D/;\I8]L`U"5Z[`::=2AUTOYK@!H;JHNFIWZ6T": MH3@`NX`06N2$!O=5N?@ME2^``+(2R$W*A0K5RJ$`@IKHO?`2\-\P2VA-K#?4 M*#>XN3?``%H;*$YM40IS)8;;A!U1;8!P;)(6VJ]!TOOIV3I?`-.Y.@[J2-5' M:_32Z'`;.RHR>S2SRJ6/I'*:BIU7-02BE*IKF;R^3.G+0E-'T3)XB>U/4,SC M(M]#0,!+)5+85MIY$QD2Y9B(M]!RR#$3-)A`042&UHG@NXG8229<5%%961T) M),V/H9JC)C%U%1T*X+FHJ(?YFT]%55Z^HG;S+J"GV6T+%YAR..S#8I>#G%!P ML36$N?1%.0SZ8NPP,;PJ\0\NRMJ/.>/RKJ*"RXI*:S.45%/XMY*W$3+7LCJJ M`H.=S)NG7L>S4[^F9-74UE=#SBL(62OZ4EE9S&"I2.G4//XIQ+VP^A_^2BO> M7BPXF2J+P\P.JA/\Y-,>?F4WP&@?Y3T]YO242TW*<-^5MU*?[HLPT!ZW'R^( M>$^ZKN--@ETQ+1HNEE_Z[JT+ MH"/9Z7**5`7NI(OTP$15KF(3_:[LJ=]]@I"8`7)V2VJGQM_$8!J)Z_DM/0#Z<3 MV914VF3V`D34AD,EA&XZ,>OHAN'E&`9H3?1%VT_ MBH4A3X8"^E[1]OA2G_#L`V*D*I4IL.B;;X"P)-NP0_E+7[E-?`&EM5ORCN?" MZ%5^.`;S';MJFO0!>Q*7Z8!%K7:ZD)8`D:@WWV/78!0',`EA?JIOUWU4C3LI MTP%>++0?-!1_50]B!K[.ZWO]VW7`6I:W)[%3H!9/)+WOUZ@WF%]=UVL-NJZ6 MU4A.P!0"JE%O:R[V7X:C778!SW"A+HHN#J476Z+]QP%X^;_HZ#0G^T1YN`@] MV"L;F]]NI*%+ACU*-7][NTN@%A]]]3X@X!M@I9.QU-@4&@U!`O\`@,`TDD%= M6MNQ1$3I\[[X`'F+0*E>JIWUN@WMY!$4)%*&@9/5A(N97+T.Y_I^5!=--D4_ MO"-;I8(H)^M<+M9.RD;:$X`+;0J-M_F=/#4KUL"YAH2O2R!4UN=-;ZI;=<`T MM>ZK)`ON#8WL0>AU[==PGV5)_P`Y%$75:CEA\#Z]E5ZZ!/CXA[%?RI7\KF>ENM^!A""E*\0`6Y*F;91]_E MN0.F`^5++KAUSRS;I2=5OEKEA5E9TM3U94%EW,IS(Y<8MPS7>:$Y8I^@*/@' M1;9B9O4533EZX@9?*I1#QT8R]BH-J*=0[F,AGCT)E6/!MQ*4#,I]*JIRS?P; M^FLMXG-N81Q,("'_`$5J$RT(OFQPS9\9'TY1=69KY;SJC*?S`/PZG;`-)(:Z`(3N2RI0`(%74!2MQ9#@&J2@94V!!*(H6WR47/4K M@$MD`787N-;`D&QMKN2N`E7-JG330H/-4T%M^BK@%S%"@UZ]--]5O9=5%]P< MNZ'ZJC;?QZ(5V\\`WG/2P3^)Z?(+VP'8DFKV3QD MIJF35U3T-'1<4X;I&MJ8ED/`5!ZMY'RZ4N(NLWDYG4B=L/9;4K^42EW,'3$1 M`2Z.@`V9Q#^DEJC//A^R+R/E>7$-EO&Y'QV6\TD%>R6M)I'S>21.665[O*R6 M0.6C(E$JGF7M/S^"AX6J:FD\;5E:-/:N@(*8T_'4[",Q,OB@TI..*:053PUT MIDG6&2\GJ+,++FEY[ESEQG8]K>K)?$TKEQ4N;\?G=-Y7$9?RQ[#2"I*L-9S^ MKX*!JR>1\5!0],59,)?$TM'3J64Y4YOVT#0G\IM>!YZ2*6D%5X<R!GI MA7-4"DJ;BA,P(B(G%4.GK?L4N/.[AG%.M.6>4PG(SR&(?789!:YT;+7*R@10 MUU5+1!,T!M_T*6[ZK^R@>")MN+!2:K2I2T29DNX_8Y?XBPA?Q6Z]L!1:J^H& M@ACB3O\`LL"JBVGLP[_O.X4S5,\*?MR@?_"P8UM9(??5>N`R,#4$U>2^>MO( MKF:<0<*\=GU$,.5IN:0+MH\K+ID%7;;3*-`BZA"R"`PGZ03K=!0 M2%N&;:I8^"#`6)F$21=Y=="P[3>Q'(I0)\/B##'Q%U>`?_NW8OT7D\?QV0&> MW1*@^L`51]1BY\0RE][%"G?`+VV)0H\^##'CKRW35;!.@P%/VR)!L\)0;NV. MFOU0==[)MI@*\5&/V7I`>%"[K:X]6Z1;``>ZH.A"]>F`7TC%BQ>DK<([=[Z#ZE]]0 M#VTP!^E(X*`]`96Q#MU:R*3ZLJ.NNET7`7[R:1S$!!O`_',U$1C#7ZIS]AF$ M+(N[0%6FBH%U()L,!9F=3$%1$H`%/ZF'MV91RAL;6^6`/T]-`;1039'$.;E2 MO]2J$#L@UN,`]FHYQJ(S33]GA%*]3[.3K9;Z&Z8!PJ:>#2-3?^S09(Z*3#]3 MYVP$BE52SMN55*\:C@7CB70+QPU[+!CD;:G4L-A&@T`6N8`-!D M@,(S6E2.Q[LR7P@X"ZK8K"E+GO;;`5&*YJAD$B9D6N/8)=;R]CVW7JB=0JC, M"K6`")N@U),OE8&BZM01\$O?7`56=R]ER1P'J%_*V'H;K3@<(/,!2^?JA!?^E\ MI$7S3QO8X#PCX54\I.2TD]FXCY=/)+39I3F/=U)G'F!+: MVJVH3F96+NE:=I9Y,)32N*=R^D#X2")J!Y(I;#3F.%03^;!S43FG'$CIV M4!QXR/LFW0"R#2R:J2JD&RX!J@%%!3Q)`"7N6E4-+LR`A/+9`(:99#)OS*:AG071^P'W#4KOVP'U!?R6F-$)Q3<2#1*%KA M_@6?>-_]\6F2ES?MJE_#$MXQ;H:&_E+,4(OTC,M>J"G#MEBR4*BU09@$77OO M^(Q1XC9QD"N&R=J2RU[@?YMJ3MNHTU_Q#5W,H3M?J03NEK+XI@"2.GD.J*BW M/YMK@&!K8CS_`!-_C<[X`@Z?O&VVY)&]E)[:!+IDV115*D#_`(]J[7[7[/2V MB'3QUZ)@(@&M]K:D?U]SN M3?X]+`$"EB3J/#]QTTP`50$1-?';Q%]L`PM"_O(@4$>*77N"018B_?`7LN:( MC(1;_M#I=]TU`1#OJBG2V`LN8(G-H;[@JH0W"H#KHGBF`9S(4*$]$%@-T[Z; M(4!P")*!$OKU46)V(6X*J0<`%0D+X'<#8*%6P125ZX`<_+W7YC8`:&Q`\-,! M6B6D?%0"/5N"!J5+AV#T.B]R4'8!:EI>YL-M-$-@H)WT-QT(!"X+.K74_>NJ M@6379.@,+27OEE\`J8`%JUFD(M>PMK\D5-3?I@+U\3]'0)N?VF.Z MM;0+5Q;0GSU(M@+!;7'5;D`7MM`4`22@!1J_*BW(ZV%D*!;ZWWP#6MB6N4(;V`&B@H=0E MTN0@[8`:!?>MS*&B@2QN`B&VA`3H+'``'ZP/VK&VU[,Z*;(MN@.`DA;35!JE MEONN_P!X.AMJ"Y@!X=4/4Z)=!]Y.`0;5#L0E]2+E+IKU1;+@#ULB?$&W8'5! MWN;*4#T6]'CZ/',7CZJC,J$IES6,+265]#U!.YU-Z)H>95_.HVMHBD*PG>6U M$N)-+'KD0+NL)K2$?#1U136)@Y5*8&$?0KAN853-J5IV>AM'.7T=V5V0N7O# MG7F86?4U=R_,&'RBB,]9K):?H2HZ>R&J39O.LS\T*CKVNJ1K7 M-[+F24]DD\F&6+[)^B^(>,X=GD1F/7D+6<1.EI4X?LMF5'43ZO"-SHNPWUP'E#F;EW44\J=Q-H&)I-B$BZ0RZ+EF85Y M1$HC`'67E+.&O7RV:U!!Q\*2VZ;+#,1"NB\3H",PZ#:*ZZBI$*W3Q-]5"W.7 M51,_ZS2=D7EKRB&CNIYF:@.X1.HWUP%`T!/V;F(ICK:MJ.:`(33EGI1>PVNF M`D<5.];+554R'19?N:<9=AW$&;>I?M@P[P/73EXV\<@ MNR^9=A\Z+81)JCIV#_7T^3NE64N3K:[,W/;Y!=L!1:I2<,K^MD2`"XJ>FS\. M6:$'Q470=\!2-,306];)B-"14<@/;[,R-Q?I\\!2:IR8LI^LE!Z)4$C:"ZW( MF"E01U"ZX#)P$FC76-/YZ8"DU*8MF[3;D[@1)51TO@*9E[X$^]"$V(2/@2;D)?VCXH3JO M3`7$%"/V8V&;::AR&7S!:#,7"MM$(1\EFH8G1/:X3 M4#8^NNJ!+KJF^`'LKX'ZSG4C^TPQ0Z@V>D^11$4*,`WV=\I]YRTO2)AP0;[% M[=+KKU7`,,,^*>\Y12G[5#6U%T>Z[6'8II@&^S/@"K3DWT]HAS;L0^_(/C@+ MB(#4BQ1"J@E0H6XA7QN"XTVB89$"[![Y'K;1 M<`?8WZ@AJ'&R>UPR$%5U?>750@.AP!,$^)^M#IT]LA`5)`Y2/7C2X1!;;`(0 M#^PYH6VYCH-".MW_`%`/E@+][`1+2U=DG4F9%NI:C5*'KL%3`.%/S$ADAN5=0?IR2J/L MH>:/!LAUU!%\!(93()@S*ZD=M/)43$2V"=NVF9W)6F`TQ.I8]_6MB/:8<,EE MVT&7CUIVP6RPZ9:+UMEEH,,*4FQMZZ2@# MR`=S55,LW)!3_2X1407.HU"X"NS0T];-G].(57FJ^E&;K_M3D(M]2G77`/%` M3\HD131)(!)K:CV2MP@YIV`>VAVTP$\RVH:>0%>TA'/WU./(>$GD!$/68:L: M2C(DNW;X-'U$)"3I_%Q+Q`>5Q#N7KUX49=NVFO=P'I/Z`=^8?TH.2#X-2=2,!Y:<) M'HCLXN*CAS@<_P""BJCI25UUGEDWDYEA,&Z$FTUR^BI9F%G53.2579@5Y73E MZYEE+R2C:HJV%9A9,S-R-JF.H^@:AAYEUQ7%+5`ZH/.)_4> M3YH_+&&K=]0=(5XR8*C)4EI!8GL3<^-@OE=0!;Y2#HC*$`E&4%S=&=2B$@(OVB%!I+1!T0 MV(6R&PVW!N$VUN"`:;W.Q"%2=0.6ZKU1KKN47`2+UB@;$[6N1HFI/^"8!W,S MH#S(H.Z[@]$UO]Z8!!H&XZH`#?1`#="+[Z'K@%SA`5OT%K[C?\BV`D%+UA4] M$3F'J.CJBG=*5##PLU@(>=T[-(V336&@I[*8Z0SJ$=3"7OH>*=PTVDDSF,GF M3EAZ'4;+8^,@8AEY#1+UVV$NJG.W..N*'HS+*M,ULQZLRYRY9>,Y?T%4E;5% M/*-HEEZZ+AXQ2E-3*8Q,FI\-."8<"5P4-RN"7(1T2P04-G=G#`Y6S#(Z$S8S M&ALSR.HEW,6:S^3:Q@A>)3B`;!3FR.@V5-O_`&]IT[^&`TG_`"A6*]HX^(![ MJ1D-ET`1<6GE<7*:?63`>0>2UQ-*-JF6454D1$PE/5?,*?F\%2\_BX%[$.(R&DL_B(1U*II$0KZ"BW,2X@ M8J(>N'L+$.WK#+3EZ&0BO.=/"WQ-R4V10._A@)W$98YG04DE-2Q67-=0E-5! M+YC-Z?J&)I&H',CG4JD\&\F,WF`BD3*II!0,MFD9+9C#2R+]G;?"&??J7W(\/+@,_,6P:)I70_T]6`2VT/2M]QU.X0]+8"'EHE#S*` M;:?6(._07OX:;@WFL0B-#[U2_A?0>=\`BT1O<#8CL4&IUZZ&Y!P`YKCHHWZ[ M%%'B%"6TP&;EC1,LJ/K]'0=MKSB7;:77L@ZZX#!EI"4LOD$)4[=="AMWN0!: M3E4HG?A1>R>86);552VJ=;A%\@!\<`BI%NFA!Z!=['\VP"Z>>IN1?IKYK M;6^`6WCL+)V%[#S^],`"!V37Y:D@F^OAU7`7$64?+JCJ&4@JBP[JQ3XW54\# M@+;F1=.Z`A-+=]M4VN+8!*%%EZ$D"]C\EZ+LES@&\Q!O=+#50>8A5UT3<)UM M<&EHGQL0?B-?'QN-,!?/FDET#U]ICPMC]B")YE1$VWYP-&53&4-)HYU*IO6D+3TWB*3E4 MT?\`LOL\LF52.81J3P,P>^VP1=P<5&NXAX(N%Y';7M#H-!%;WL1H+D6ZVN%( M0`BP4J+7"?27*O-"I)+`U)3N6]?3ZG)G4,'24OG\EH^HIK))A5 M9PTDB9ZS+XOZ&<3B,A8J.@Y4]F8="#=S2*@H&.C8:`:?B*?0L'%1#ITTYAWC M;(2W*G_?*HD$CF%1RT'J1[2RA6V@/1=U2X#T_P#01Q`A_269*O"@Y*9S>`4_ MWLJZN"77SMYX#T4_E-T:S%59P>DGZE.YUCW;IS3++(@GE"B[.R?(8#YD)%7- M94M+IU**:JRHJ?EM2/),]G\!))W,)7!SI]34S=3RG7LTAX*(AW,L)_6 MU1.Y-`/'[<%*WP\(P_$,Z?1,2]8=AX^>MMA7KO._.3- M20412F96;.8^85-9:R<4_EU3]:UM4E3R2@Y(S#P,&S**0E<[F4=!TW+&8.5R MV$9@Y0XA'`@Y?`0C+L0\%#.W0:O!`'+=4#)0CW@0;]U6Y53JI(&`04):W-S) MK;E"`C8(0;J+[X!$BY5"IMRKS;7Y2-`=QJJ%4.`/U@`B)U(T)W_BI.`S2[_: M-RB6`%Q>ZFWSP!+6NRIWML4)NJ]2`FE\`+;$:GP5?ET!U1=$P`#0&B6ZZE?S M8HH[*A!P:Y2%)4J2%!1?*Z#;3;=<`.95`"`WLMNNJKY)@&E20O;6UD7P0[6) MP'T-?R=B,]EXBL^&B47)6$9`N#_NYI\J==1U[WP&FO3Z10B>.J!>*2/YC,OV M!Y3NM#VT70)JM\!Y/9RM?Y=/;+_DCED1;IEG2`4D:'L/C@.]J5](M24LX:LJ M>&ZJ>'Z,JF4T!1E6T//)_#YETM(WM0053R?C!E4).Y+#-9'S><2.HZ>><6<3 M,90_JJI\QI#+(^@H2-D5.R2/J6.CI>%;,KTE!9 MD,#4$BB(2G82KI)Q6N()PZ>.LLY>]F`IZKN(:@:VAG@^CW\3,>'ZB(D^B))0&6N7$[R*IRH9#EK+LM8*"::F=&,OYZ_P`N\EZSRGAX^IF* M@REJN"J5ZYC:PBJLI2!J:$G9=EFQ$UE**S@JO:S*G5>5J'D++WL//*?GL^GM/P;Z?T]4\YC(ZLYK#\ MLMF$1634MFL=,IA"R67RQV'$,Q/^0]**4'T[5Z7N$<4K\==.V`AY*$NW9,`Y=-[GH?'6X\QWP#23]WW^`&FUT&YTP&X%TM@+^42N9U!-97(9+` M1$SG$ZF,#*I3+8-VT^BYA,IE$NX2`@H9RRI>1,7%/G+APZ9',\>ML,LW-P^R M*JN#[A]J";\#>6DTEG#3G73G!/QW<+7"WF7(\F,T,L*DJFI\H,]9?EEE96-9 M<1DJIB$J6-A&);QE4W5DUBZ9KN6,OYY3.83_`"Z9FDG=AY'RT/`*G.'W)'-; MTDE>915P^E'"!D/(\RLP)Q4-,YPYFT[1D?):3HHQTU.6TIKNM)'E_3TLJG,- M_!N:=HF)FDBE4LIYBHX*/B86/EDC?MQH>R7%=PN9-5;QC\+^:V8E9\`F7-)T M]Z._)?-.0Y%RS/W*NA\I,T\TZ>]9!T?EW!SQN>0$&^RAG,UJ2539[6;Z/BYI MF)E90M50DAF$=/8EW,H8.5_2"9FTMP'>F,XC:^C\M,I,W*>JZEJ3BI;1F7U2 MY;0KNA6IO)LOXF)<\C[+W,RD:$J6:/J'FLFJBE)G0+Z93/*?,6:LRU[3[^KY M-4D`%[PEN*',>KJ7@ MXJI6H*`?9;95UM.9P\&O+K-V#JFK']590-Q]2Q>5E15Q%0D/(XJB:% MFM60T)`,S]FEXF#F4KF`87*C@@R7R$X:<4W(IW/ M)U"TI0_#)Q!Q$YGE.P-0RN:F-S5J+)7*-B7-/6)I7;EIQ,XF5ATA7O`WDIF= MPFY'2RH,N\W:>J_*KT*>0Q$FD60DJJ+AZXE^)"-@**S5DQH".?U# M5.:#AW`TJQ.&LR)7.:=>S++V"E5/SMS&/VF`H5]Z*G@NR_S"@Z+K&6\2.55* M4!QB96\%DZSCS.JVGW=&<2C[/C+?,*(IGB$REAH;+R1.*3IK+O,"2TK5,YI^ M"G^9$GF64DZ@(J.J>7S>+]>\#%9%^B5X7W$CJ2$XA#G+.LR\ZJ!R MLC4!"D+@+%$L/+=>Y7P38)@*8*%/[G0;[!!I90-M,`B2;*G:ZJ-['07T M5+;X!+H-04"A"+V%NA`T"HN`D4F_T/5G-M*I>%-B5J"4V0H-;PF;DU/S&$F52<-U1Q5)SV3/LJ:BJU_` M-/N':%A7XD>8].R2D,MIK3#NC^&"4"C*:@ M\O)7^C=15S2T\F=0RNBHC@J@YHQ5,^9R6EL+.)A6E(\*=>4K/(D4["P3,)Q' MUT\TM3=52NJ)N(F=2*53"JV(#B M)R(SUC*8CYE,,NZICX:D)Y+\EWE&SB0.XM]!1D74$MJIL)3433M2AG,T?22T M5F%DW6>4LNX7)'3\57%"T32TRS"BLQOI:J9)/Z(@J[A'%54;+I7E[3-(THY8#O8Q+)4=# MXJ2-";#`>D?H08CV?TCF3KTE`S3N;032YROJL(->J].A06#T%_E(\;[75G"0 M@YN2G\Y5)(L&ICEN5N#KRZH4MOH'S*>K+*!2FFA0BZA?L_B1ML#;=%MH6E:: M4W-@`T!JNQ"!+G``-(#:Y`"@A18%$+(1.I4E4T%@3+=B`@0,H0/>%S]H(2&B M#GEH+8`@]@?S MV/YWP!4+\!:Q:['K8E>]EP'IUZ,2,X%Y=F/F)&<9T_=2IN.RZK>F/VVFRV&F&&0&B&Z_3!2KT6T MSXM86)SJS4X^9-60RGHUVQ!Y89$R\0KR-=EUZIS'-OW+AZ_D]4D)_P"K/PKZ[FW%?OKVP`_1GT+) MUSK])[8?_DS<*P(3K_ZUW^/5,!K;-F0^BWA:$FS_`"+S3X^)[F6R]EOT%+,V M,B.'REJ&?N&IC"LS);AH=X]B70 M-]U7`-+NE+=50];&]\!=RJ9.)!-9;/9%.ZGDL[DLPA) MM)IQ*BS+II*9K+HAW&2^:2V8P4RUBU"-5<\E$]F,L:JIN7SR$J>`;J-J#G3HSQN!J6 M!@:B@S-#$F&GD%"39R68^&14U?9-3233RI8:LG-',Y?QD3)G5$R6<0D\G4K9IRGG[N*A M95!T]&/9%"N2T98R'#Q6@U55-5SFN9_,:KK:JZLK&IYNVZ>3:HZJF<74,_FC MR'AG$'#O)C.)K,(R81KQQ"0T/"N6XF(>M.X:'<.&"'3IAD!GJ/S8S%RYE]22 M?+S,_,JA)164%]&U?*Z.JV>TQ+ZKE?(]8$!4L%))Q`PL\@0P^>L>R3-S%0X9 M?/6?5(VVH6-#9CUKE;.GU1Y9Y@5[EU4#^71DG?3ZAJDF](3A]*8\.Q'RI[-* M?FL!&O)='AT[$7!-OVH:)9=L>N=-<@0,\]SRS??QLLF;_./-M],9+4=-UE)H M][7=3O8V45=1LF@:=I"JI7%MSUI_`5)2M/2R6R*FIY"-NII(Y-+X*5RR*AH* M%AW+L`XSQS>A*3BJ$A=SQB41# M52NWC;$_+Z#;,Y8;;8F/M(:(("D,YLUPLQIR;3"$D,YE\/&S.1QT/#1\HCXAV\BI9&N'43!/7+YT[>@&Q M.=N;,;2V;].U%6 M-74_G3G%(:MS#9CF-MM$,34^9=15G2V7-%5%44]0L.FH602ZHZ MLG=:SQF'=-QC09?3*H)]'1,4]9#);89A')`8AG>`B#P2LP,(><&/:(TLEF M'<--EHB"Y^98GE`LQZLAHW+0(90%H+1D21DA7\TN;\L)"'4`"QC0BVU2X.EL M`\?0"A8F;:A!['!V*W_UX$L@A+V0H9L M!9%+LJ&HR?*3;EETN:ZIK-%-QW0WP$AE+%,&55*'<7/RZ^C8(11:@)<'S#KZ M;EO(7#(F1#;1?ATRTR\;=!ART\:#1;#+#0=29'R3T:<=1;3[B2S-XXJE`4FW-PR M\*;7+S74+Q8'30=+@!;X!?HOZ%7_`.^STH2W*_\`HR\*F_V3_P"MA=-$:/9; MX";9;TUZ&)FOJ0:E>=/I-7LQ^G9>8-W'<-7"W#P;;\/F?5LQ3Z'XJG[YVY+2 M3^B@EO&WEI$Y0YL>D)FU>.Y+F(S*H#,?(#ASIRDG MKAY050L3)J/FM-\252SAP]=2XQ+R!9AY/$,/XQERY?MN'#;;]V&<_E*;[+5[ M5?"+_-[-:XF3`I_.<34UI))#)FW3?TEEH(02_P"@Z@GS,0R\9,08DQ+4-ZMI MEQZME]S-^K#SNX MS@X.*7S.BWG"-0.468&6V:'![EC03V&F>4CFDXC)NO7EC<#WNH!P"W501X'0Z@;)8=[V3`(K MJH9NH&EM4&JH+W*IO@"=&FD5``"+;(5:4V!L=/AJ&6UO]DH%'B4L>NA[CI@. MY.!++&FZWJS.NNJWE>7DPH;A]R#J7.>IXG,BGJ\KJ32AW`UG0-"4[&R_+;+Z M?TM,LPIU%UE7E.21Q):CJ*54!*H*:S"K:Y^DI%3S^2S,-L\1\UAZSX0\F\^9 MEEOPS1[K-NIZ]RWA*ERFR&=<,M1\BC:;;-4!YAGH#TOKWUWTZZ;WN"-AMT_P`!=>PW MP"OHH6YL19>PON-EWL4P"NA!%C8AOT"=?'`:H]-F_,1QFP3Q?\`D.N`P8:ZE`+C1=-"=#X$?#`#FT3:V@ M5.BW7Y!;IT#M?T=E8Y59?\9625:YT5VWEG0%-3:HIE&5JU(8"HH22U`[HNI' M5%F;02*7SRI9;0%45#24KBHJIZ9E[NH91+8V$#L3TL7$?DI MQ#9J<)%?9>U_068574MDR:.SVK"A(3,9J7QM:4SGMF;$RN(B)_FC25'5U6;D M4!&TR]E%3SZ20\QCY(U`.WD%*Q#NY1`AZZ9B^D?X.*HXCJO.)R@,XZ:K/ MCPS'S0R@F4@R6K*33#A0X=*\R*SORSJ.19COXW+*F9C,XNK\SJ^H.JIW):1? MYA.Y@XHZ.S#BIF^J"8-%SZG99PU>C*=\/-.0N7\-+HP9[9=T)E)3' M$I-I?/V*0@IPU5TLEL)6%+5)/I_.`ZF]/RN$DLGC)A*8"3N&`A^3G$MD1*_1 MZT3E)"<1U,Y&.I/3^?-/\3^0O\P,+F=F3Q+U]F%5KN(RCS"IJ=5#1,XH+Z(H MVBWDGDKV=U#7=)U+EE%43%3&BY'-YI4,%$O@]7\PO2%\"L5661L5&<0>4.9T M/D[Q29@U-1%2O:,S%GD)%+:QEE09$96TC((J99A1>7T%6.4. M5E$LY7TS-8^3N9.W-(:%F<9+`\"^,KB9H'B%;]']F;6TWEV:N9%,9!P5/<5W MT7((6EIW.Y[3?$=G!&RFFI]$2R34[*8V:-Y)Q%#RR73*5^T.(63/95`MQKN( M@'KB&#V9K_C[X'7^=&7L_KS/'*S.F0GBLS,S1X8IU(.'.=0$KX$.':J,@7&<-191UC&Y;T=#9C2.7N,J8VK(*9QT[G3F5Q@:TH[C M;R>ED-6DMF/I",L('B(@*SR)GN?'%FWPD_I)*N)7(ZB:/K6!S!R'RRDL7E"[ MF&:$P@I_.9`&8C/>E(?@UB^'$5HWGW1D!F M*^]%5(N#N'R-BJ`KMQ6\)F[1W%Q)LSYI.YE.(:BVAVX9_2\=**ICX MV8LNIU"1T')&96Y=1X<'^E,S@IKB@XI>(GB"H_.7+>K,OW/$!6^7&267\@D- M04Q4@R7;F]25Q(*? M31D/,(M$`C0%40+XH;\Q12EML!>OB1+8$JA]JCD`)"GD@O=*+?JOU22.V`QR ME00S8Z@FZI940ZV0@`:F^`1!9.@`4%5`-SRH=E%]">O8@X`JAY5]U2I!1511 ML03YDD60X!GNDZV):!#14`&S26!!)(4DJJ]+A)I,0)+5MR@E,O*!+)4$IZ&Z ME=2AT)"+@(T&E!#+(T"J;E3?E[%1HFBG`!>IL#LO-H`?#4LJNZKJH-*DJIN= M2++\"ME'F0;WP"^H1=0=5062Q"=UZ'J=%#8&4Q/\YE#W*"I)8EBMXAD:G8$A M2`$"8#OCT/;XN./?*MZNDAS-071#ES4JW)/B;(2;((DEF]R@L/M`V"=%-@=M-!@""25UN6V3OJK0.W3F"7N3 MK<`#IML$)'0CO=/EL<`A<&VY#0:O[J:J=KZ'JMM@2BZ:E+BZ@7.EP51D:;W1 M%`%H!&T`4+9=@UM<@I8J2ECK@$6K%DVN66M$(0LE#?=02@(VP&6YBI"Z$C^- M@=D.UMEO@.[/1[Q\7(,[9Q6DIXO8[@PJ:BLOYS.J;S+E[N6O'D]BXJ;T_()G M1\="3BL*-E\VIY[3\YF]35/3KMY5D\J604S'R*ELNZWJ*82Z2/0TQQ#\6'$9 MQ8SZ1U+Q#YMU5F?,:8ECZ34O#SI[!05T!)0=D(O;KMO\`DAL++3*C,K.6HHJE,JZ* MJ*O*D@*;J>L(^4TY+WLPB8&E:,DL94555!&^K`=P!M&-X0.)V6R++.J9GDI74KIK.!AT\RZJ&:RMF622?N8BEA7,/% M/)I'OX>#DD'%4(U^GD)&U$_E4+%4-S5DX>O*9#4U`82*X8>(:!RNJ+.J,RC8>3R.P%*S1Q,"]89B(:%E-53654I-)FW#B52ZJ M)K+*;C8UQ.IA"0+X/3ST'T7[-GAG"T6DYLJ8=E2=?\KI*1\$\[]\!J[TR\3[ M3Q?03WF"?S144P>Z3:JS\UWTZWP'GCG*?\O&M;TAEBG8?S9T@4OL?+X+@-5@ MZB]D`[7W"IX+\L`23LB'[U`+1Z)J-3^``M'3=;?$CX>*^-L`E.MDZ]#NAU51 MM86VP$PF1!HBE"ND^K'4$J##THORP$.)T*6%K_GHGPP"WLG1-;VO^[;Y8`:H M-PJD[7T3KO;7QU`+[I*V&PUN4TZJFO[L!G97:5U&"-)?!IU/]-2X*>Q(-];> M!P&"6Z=0JKKV[K^'8H"Y@!WU5;`!-//``-7W.I(4"Z*2=2%&O8CO@`&@K0&P M^79;"ZC^&`O) MU4]%"E=NH1"B+=1@`2RFH1K8`%!X:H2JH+\OE@!S`KKS!2G=?,#F\`+J1H,! M?O2S]'00(YC[3'DFQ0\L#X(+KUV-\!CVM62-$O?NJ(21YD6N"J)@&D$VN03< MJMCIW2X4"X`/C@&M)<%;V9NI*7-NZ!`?%`;@&&S):L0F]E0HI0&^O>Y1,!)9 M,")/5A`M]$R_2Z_T_*#HO<@$[A#NH1M"MC8*H^J.JS\9`N4_ MY/JC&Z?WB`>G8V#M/T[47[747#6C2\DES29LT+UGE]EG6E:TO353T/1<\G5.2&/F\'!5AF3-7LCH&E.:$=/6XJH:OF[AN M7R&2P;N(F4PB48<.#S,%H)I6_"+Q+9;SJHJ>%C'E/U%3M1.Y M;'L0DS>T]4,BGK$(U*IQ+HN*#2S2D#?0,J$+2JI)`07L`?[I1<`"`B-+<;); M=;72_O!`HV9N<`E(N$*][6.G]TA-K[A!@'%4'5E18%%#*H&DZ:DIT1;X#)\W M87L@U"#KOTZ#RL&X2/J-FM-YD4Y4T9-86`AY5/,L:LI:M"7KZ2PLU;EDYFDLF(=/<5LSG.74L MC,L8OT>='\%T;.)E$RFHIC/I-GM4V8TVF%-1$BF\TIF55%Q"UQ6KFBFI)$Q< MB?SIQE]**9J]F#FCJ353/IA(YR]E<6'`'/S!3T2R:][7\TVVT#O#@7XZYUP1 M5'6\T@,G9CPD\G*QRBF\[S7R[HNILK*"SDALWJADE.RW+NK< M\(S/Z="ILII7(7/Z<5VS6$]JV5P-2SW,!JD&:SU)2:5/953?]YP') MV:&8$3)ZJ/ M"^(?-L(7P8M*/898B,K^P.!< M]`&?=ZZ)8VUP%,3%NY,'+`?>"LP+@%1VOL%1=ME3`+VYHJ3"0!U']D=LK;H` MIT_'J,!7@8IIN.A`7$(SS/6%]7#NF6F26D'*T`"&B4Y2JZ8"Q:B=_40FN@AG M9"W)U``^_O>P+VFY1Q#70$>SLJH74H0`$V\L`UJ+*#]3#&VHIZEP07;C5RR2I<.CT5&5T3W4Y4(`P%O[818N'"%?^`81="4(YE%][(I5<`[ MVU!_4P@MJ8=@W&Z$!1KIRX`"-:!!]FA.8`!5M_'`K"N6F&.5F#0A@@LCF#:--! M5``"^Z`%H)JTR@,%+2`OUH&'`N+$J+(`+`DJNNF`J?2[00>PRLJ1_P`6PYT0 MA!RJEUNA'E@'"=-@+[!)S=3S2N'YC877E'O>&I(4W"A49G[;(_T9(EV!E$+[ MQO<-RJIGAEDE8+F6P;T,B5PH8>@\OT+39)^LLB@FA8$J&2QL@4DWV`P%056^9_XC MI,'_`&Z=@&D"6)]SLF@15.`>*O?,_P#$%'V4$M4U+C8+0\2[=LOG+]GZS#QV06&AS"XP'2_HM8DPW&GEL_-@Q)LPELI'/ M0E0,A6]-S8@=8K M&?26EI71%*UP^H>)C*(@973\;$2VKH.0PTC>AJ[BAXK)7G!5LGB4,%DM*O8>D9;):; MEX<5E"`C-VB0+%$78W7FY@NM@`%`7`$,WU1LAEFR)<[&VO+N"A32Z@[D0LLK MS"W+N%.IL/+WBI[DX`,@L@ZGE)(9)*E"-+C1.@M=;X"^YF0MU(4H2A5JR`J+ M[HAW0I@.F^"FHOT4XN^&2I6JYIW+)B19ZY7S5[F'5\'!S"E*+<0=8RE]$5+4 MT),*KH2%?2"3N67D9.&36U(OA`.HAJ&J22Q3+J8.`]`O2MYBM3N2Y14/3#7! M5+5E`2>DY M,]A)3[:^E$^FL[,XJ-_,(]D/&`'ZP4$"PW";JA2]MKGXX!Q:U%Q?7PW/4(E^ M8E0;(,`E`!O8JK1.Q\%"GL-/-`):"J-&0$&A!)3?I8(AO9,!ZQ>B0C?8\W,T M&V2G/EQ#L[K:II4=R+'70;'J,!KSTID7[7Q.0SUHDD99THS>[*,S"HS>^MTW MVM@.,LZ2/T];7ZQH[+)0I)4Y94@G^RG?J;7.`U:>4=K7]X)9"+'>QNF]QT`! MIE#8;W775%34*"#]GRP"+3-BJ:*B6'; MQ`NMB40H3=20G3`+G5F]U4+T'0;A&D70C7`)597J``0;J/M`?:)%AK?P&`S< ML)^C*CL@,O@D2Z$SF6@C0`COM\1@,&3N#]77J47WBNQ)*7OW&`))1F^S+*`H M-`IZ#1`O36YP`4_5T7FN$%_]GW4[K="MTP`4JBZ)OJ515-]`#Y$I;`7TN(,P M@B#K$,*+HO,NNESH=$.E\!8CF5I=.92FH`-@"E[:_+]BB!GI>V`0)(`(W0-:A3>_12H"FPN0=P86M2 M395N!M8&Z!/X;@#`9!\?Z-@2#_K$>SREDW(9@40E3IHO9""5`%FK= M!]4;66UDP`4`-7NBHH5!8Z\NR@-#1G4JF``;"A`T>C)NO5606E*[Z``;%2"7 M4"VJBX1FR#11<[]!V0)#)FOZ&JX:)*9>>Q`G\H53<`;(`#>Z*N`CG,2I!]U2 M$4G_`,P5=+DIL3UP".UQJ5%U)L`A"W6Q"DI?4X`JM_LM(R&;G[5R>H") MN`2C0N]`0/>HJ>!5T*@Z+UWP'5OI@H[VV>9#-$EHNI3F&`= M4+<91X`2ZJ64M?L=@\9`K*(5T]T:@M!$N"=&@"!>Z]#@'Z(RC>3^$K1K,ZCIU`S2E*HI"CZKD M;B3U)*XB*GM+SNN&(BG'%02H%F.E3,9+)U^U.6'ADTR=.GT.0],_3$59F5.L MD.%Z19I.\[XB=2;,O/.+EDVXF,YLB*XSCC91-:FX)EL/G_6S/^T3:Y`%T53L%*$H0B:V#T'] M']Z.[-CC]JC,F`HB&JZ!I'*VAJ@J.I*HI'+6ILSXQY5K5)U;/4CEO5-=\24R MIAR*KR`I#B,;F>3C[Z'REFG$UP[S+B4RM>9>S.`S!F$=FU`N:.E453-<1TTD M>6CFFJO:AGDO9J&E8AW4F`U)67";EO1?#E):@'+`V4"HI82NMQRW"6ZX"">DJBC$\1<.] M!5AV_;;((:RTKMG5>:E9 MT#H;E8'52HU4B_<*1RCS28_Y.JU8W/-3$X9!^TEX.ZFQ%TM?J%!O*K,IF[=` MU@-00:/77J"T[8?M0S\.FFN4-^I> MAA>1H@(>:#K8)S4C4C)9362S`7L=?47_`#>V`HM436`:"TM/V?K7:E,:`+IN MYL=^AWZ@*9H^JP#S4W//[H!ED:$'4CU2^*J3@*?Z+5,S9J03D$%2?HV+.Z6_ M5VW3MW*8#*2Z03QS+Y\R]DTS=MQ$!",.V6X*(9;>/&9K`/6V6&6G:M-!T[;> M%EF_*PVT0@)`84R"?,DK)YE;58*)"JAU+OS4&RD'4(%/Z$G3!O*I@-1_8XA` M025`]6`.Q14W2^`9]$S5E.:6QH*D`&%?,]AJR#LI_P#+W`-$LF0:YFH"-9Z? ML[S6]B`SLNG3YA=0,#&NXV&:>0L2P[8?,EMMIRV``H*J6;)IP`0L4&C^S/B%(N[:4WYD7EMI9-[VT`+V.+4`0SX$ M`W]4V2$4$I:R!5(*"PP%:(AHEX\LX?-#U;D%IATU[I#AVR0J%?>YE"%.4@BU M@MS!1:%GV:)())!]2\"\VJ^[\$TN<`[V*,4@0D2T";@N6K`H$2UU15)(UWP! M]AF!_P!3BBU9&0X>)X'W1\3VW3`(2Z8DHS`11(W$,]NUL;L%5%_KKNMB/ M97,6Y?!NV8&,+QB(C&^4.'I:98;$'REMD,^Z&FF6^6R'E-T%@M&I+."U[LLC M]U2#?J65/*0>1#]6U[@^9`F0SP@#Z)F))N4@8C5-00[((%R.H*V7`.%.3]H^ M[)9JA4!(*))(MT82X!(W*VM@*HIBHS9W(9L;`WET4UY?U=P.O5+D*0$CE-,5 M$[EE3N&Y%-F7D1+8%W#NS+HIEJ(>,SR6/6V'3/JE>-,N';QX6662T';#;0!# M'NAA11M7-$\M,3T\VJ2J-)_[R!SX`;`ZF^`J"A:S:",TG4;19L.641Z>((AR M;FY/FNF`K?S?5VT2!1M2M`W]V2S$HJ*A]GN$ZVO<64A59RUS!6U$U4\YT*"1 M3,HOV0/9M0--$5,!L#+++JNY=7](S&.HZJ(.`A)_+XF+BXF1S%S#0L.Z?LM/ M'[YZ]AF7;IV[9!:;>-M(`"T3T#.,9.*_A_EV?.3V2F5+^-RVJN:414[68^A*LJV6PYY M7<]F4[?RFK73R$DT/(F(N8AJ'-WA.R"RW@9=5TOXG9]$Y>9D\.,^SQR!C*SR M/B*/KG,*IZ:S@S!R4F66544;(LQ:[EE!Q,7566531TIJ1BKZF@W]/19LTM0?!/1W M"0ZI5^*%RFI^84C5DPDE/R>8YBSR"S3I[-*H)$TZ>-2BG*)J60P,=!2ZJ'DZ M@W`>/3(L04-]=+H`>IVM;1%&`FE!9C5[E;/W559=U9/*-J%U!S>7.YK(H]]` MQ;,#/I),ZHI@YHZ-F;49+ MYDV\B)2R^9<-PC^;2>3SJ*EI'T9%3V42F=Q$(\FLK@(R'#K+T;T4(7,BOF@H MYZ'D%?\`M&?;AXJI0E/,KI]6-G1ZDZM"WPW0.=,Y MGSUFNFF6'SUAD4?EB$8;;`97+*D"2/>3=;,ZE3=^V@9LF_@"JG<65`'KWI-WK[E5/ZQM"MDLT#YIM;` M$O'J!7SPJJJ\;\D(_>!MI@);-&V_T&I0\[Q?IVL+%XVJ>STJ@)7[*D`'OU*A M$"\>&X>-&PLIN-]55!;N`NRX!I:>AK^L>76X;)-P>I!U2_70:X!H:>W!;;MI M[Q^K8E0@">9/12N`1;>)]9HDC[1:OKI=2NU@.Z8#-2YHF5U(2VBRV#^TI"SB M77%]>4D;=#@,#S-DJ'K8Y6NYUT^L2$"E!M\L`X-\RL\[7]T'RLI)L3L!YC3` M-]8\2S5PA4M$M=`A)Z&ZVZE;X!O.US`LEH:J0TJZ;H?)$&X"JH7DN+0CX0J2 MK]UO_M]OQ6P[8"SYRO-S%;#5H$$H-"2!8C4D*JX`--M*""2+!!9`%-UYNJZ' M;HF`!;(M[P!*ZM:[J''+S%"?4.3S=2R+W2ZEE-L!;M&P0M79YD M4`'[35PI5%"W&R'8&<[1:/,H56C8^;2%.;>P.JVT&`<2T`O,TC/UD4)8(ATN M2`BLZV7`#G:'NK;9"4M8W4@`=$307"8#(1!:$M@2SS?VB8HTME#$$$/77YB0"T5]\AI#HI_%`JC3``MM^Z MC32H5*D!0H0$:@74:I:XE,O+/OD-7G\G*[E2;!"ANHVP$;YVT3G;[>\0TH10JE;C5!;8;@WUKRY]8 MT6F6BB-M`D*;W)50;K8[WN`/KGI9`#;P+?Z[0T"`%$%T`)!52!IJ#FGSU?ZQ MX-Q^L:)+5SK:P07*H"5UL&P%C](Y6QR\S7*6?:&3I_=T&J7 M"BY&`WMP*OS#\2U%/=&6)95PUN.:EIL`HV/46O8X#HCTF,6(J;Y/M*3ZN75K MH0IYHFF;=-`J6TU2^`\_J3S:S.H62SJGZ+KRJZ5DM11%.QDY@)#.8^6N8N,I M"?.*HIF-YX1Z[?0T7(JBAH>=RV*A'CB(A9FZ=Q3MX'C#)`7V<&=V;N?U8FO< MZLQ:KS-K#Z,@9*Q/ZOFT1-8R%D\O;?O825P)>M^J@):YB8N,C1!P3N'AWDPC MYA,7CMJ.F$;$/PRF97$3GMG'35`T=FMFS768%+Y6RIB39?R*JJBCYQ+:6EKJ M7RR3L.9;#Q3UXPP^8DLCD4B=13[UT8ZD$AD4C8B&93)I9!PH:<#1!9*JMV5) M0$D^Z6C_`'43E*^6`/,H(:Y2H:!Y3H2/J[%=D"%5&BX!O.SRA2E@+BR%JY%S M921H+#0LI@&\Y))-CH;D@:W74V/@IV08"\YM43S")I;1?>4E2"5L-`0&^^%6 M.I66\3.0,PKG,.J\HZ-@\X,O(JJ#E,TB(-W`1`>J7IC)G"1<)DZ[FW%54F=U8150 M5/44ORO/&U5?&]165^7U0Y7Y(Q\/&0E95#455.*6J:/S0;S3I6(AW<]>S6K* M5H^F*BF,ED$/]&B:!X9`Z`MB?$;; M8!UD0@652+JB@A/*_3N<`C8L[$]S9;H=]-%N+!,!WIP"1;4+F!6[3)`9:HYT MR/\`^M0!WUTUUZX"(\XP& MZJ#EZG14`*K8[@A!TL#@`645%30:%&$^[77ZRWW M.`O9>R1'P8L![0P5NJAH$%-T.UMSHIP%@JLL6!5%:2S+276X0J-K(0AP#;DL ME"K-R?OT^L=RJ7WWP!"$D[J4-AN`20=3UNG4A<`".5`W8V47(-M4#1]T7NC2 M[I@`A`MIJH*@J%0@*`J*%74%%7`748$?$,J?U<."1?5P[0>*`':^IT&`H!DW M7WB?)"H4%E3VT0(BC3`$C95V][;<#WD\44Z6M@$4)T`(L38E00!W!"'3IT.` M:C**`0>H`7F5#[Q4KW!WU`U"_?\`^C(+?]JCPNB'E@AWUTT^XJ%@GNBVI4DE M4((L$/4D+^)P`*$W(6RA5%DN1T^/NC`(`&S*V',J%%1539D*SJESI@"`;ZE0 MMENR0;IL2E]KZDJH223%HR>K0U8LRF``LJ)4,J9M>ZZ[`#M@(TIU`4$V31>A MW`_VEZVM@$0#J+D$6*(4#*DE-&O[Q54O@&\IV)/D0B:D=4.PV)-B<`4T.[-F M?K!=T0Z!-3?4("40-A93D?SF4/JOZ2RP$VU$0[4$*?%572VIP&X>#-][-Q!4 MH\9Y06("J1S%KF:5JFIHRMT&AU0ZZI@-\>D*B_:YIE7S$$L0%7HNP,13RG0B MWSZ6P'G)SHMV@4N`A%N;FM??:QNH))P%/FM=DJ&MP"H)T+'4C8H=[J3@"201 MH"623N"@+)L4L%4`6L3LN`844`-*NFP'VNI"H5)T.A2^`+27"=`0`050W(U] MX7!14/54!HYK#0D+RFP*DZ[E5(UTV!P`7D/+S`@="%-E+)(.IUU)75RWB*R>CY1EA"P=/Q\5F!,8*O)'$ MPE(N8>JWCFFR\GC]TQ`!_/HB&E,)Z[VN/BX:&AWD0[#UX]+5F%EQ4N067=*9 MC9AY[9XYSR?,#,FHLKT]%/)#*#6<^J.-ECMN7N(R50`?.L61[I4`[@!+C)&`]3/1 M:2?ANG695;PO%&\X"D[UF<.YB]R_$XJ:GI8^ES# M34%$UHU0$//>(MRS#4VSDK*'P?UDP\#HWB.C^`S+#A;X.Z\RRIGA^K_-6GHC M)K^<"C::GE'3VJ*T@H[AR:&;-03[U#ZIYY)HB79Y%N:S&F>)O+"8LPE6_1,' M0LCJ3)X5%2;X.=*E9X>9OP*PU24-)>$J25;,Y96<=F?**JJ:JG/%%3F>$7Q& M![1,DR.D;F9S&=S#*R`X-YKPE"LMAH7@FBO9* MWJ]L'ZU*NV-PH^EX,JFBV^%L!%N,:(]JS==/#_V1DK(WTBYF3\$"::G`87-* MFZ.CJIDV'8;BX&">PCTOG++M^/4O& M@PR]##:-L-L@-;&E*$!49IRMM`0OZ)U8%30H9>FG@I3HF`H-4O13/NLYF2]I M;H*7JD;W/O0(`ZW2W8V"BW3E'#W1F+`M:$']&JD!-SHL"-#;13:VV`H-4]2@ ML*^@6@=S3U0L^Z""`/V-%5=PMM-"$EF$FIW]#Z9=FL(<.'<[JIIW$F33H,Q+ M;R'IL/7(=B&]8[]G#MT6FWK++#P/@'9)8>`!$6I+3B'EK&$)1!_0D[4=A^RA M"@Z+MM<*+4GI_E3]+85I$%Y1-Q90OO&&6YNJE-00F`I-2J2$?[J'!%Q:4S5F MVF[@*I`4[V2R8!AEG3I[N^H1?C@!ZEP@/M;!2X1V]!UN3[M['90-!;`7,0[\47L"%5;:X`AQ#"QC6+M*OJ(D(BJ/=9"=2+>`&`=[/")_I M%D(!_J\254V^RO*5%M\!D7KB%,!!@S!AED1$80U[-$>]S,08+(#+!(Y`&2K0 M0\UM"@6;,)+U7Z5=@79_LL6>8*J_U9"@(=2.]K`[V&6E1],N6$9^M['&&QU9 M!]6%LI`0@=!@*C,!*KK/73+1ZP,P:2RJ/U0*-:)V54O@*@E\HU:G[IDW*_1\ MQ*ZC9R?SMH2$CD\OE3,JJ9D3]RVRW+8$/7@E\Q!AV69W*VP\:#;@-/.=XRRZ M#+"M,-/.8^XR6L!@Q*I%RD-57"L+H!*9N0@TL(=0-0I!5DGJI!WT13I-ZOAF M0=!]"SII?)F&ON2$)-^H("L)+3.];0K`9W:D4]*$ZEKEA$7R"#X`*GT%2A7F MKR!9:50?T?J%5.K1#,(GV=0=;=,!/\LY%2[G,"CW\)7,)'13F?2]XX@!))ZX M;B7K#\-,N6'T1"L.'+3QH!@/7S3##*Z\H.`S7"8^]FSQI=Z-&("H]VOM4_,1 MN!8V`ZZX(J9X+IWPLQ MYXEXWA0E9OY,P\ACZFJ.>2[-;U+_B9RCALR680(0GEMR@%%"D\3S%+\J7`!(5KX*J.0T;QE<*=6 M53`36;4[3G$/D].YQ+)`:W^GH^`EM?2*+?0>43)X^5Y(2B;.*QS*@9A`Y3T(\CVV8XN'4[@7L6'CZ"`01?3 MZH2Q4%4Z#?0IJ,`0@/:Z=[$K91K8&^B[X!&Z($0%K12%LSJ`H53X!#@"--T[ MA$-[=M;*G7Q#K3A"?^IJ^J6@"#^C;#*J@7Z3@R1W0[=$0X"/<53WUN:#IX5* M4Q*0BV01,QNJ7`4K??K@(!G1_N];Z?H=EB4"W_S8T>$``/4Z[8#5"A$`]XG? ML.ITU%U31+8`DKJRNWW*4WML/!,`X-`H-;LZA/`?.RV51VP!*H;"ZD*4O=%5 M1?2P-DZ#`3&9D_H/28U/T]6-E*$F&I11L@Z$]DP$-!&JH>FJ#_"UK],`5`MH M#T5H@"^@4=;*+;'<$"+I<]%4J+#JJ`*22=D3`(@%5[\WB;$@&X2W\4"AG)6# M]&5&MS]'0>Z+_3,N(MN=CJNG7`8(H4`W)73HFZ62R=@#@$1H@2XVLAV3L#9$ MN!8X`#FVVLH4E#\;K=>RD&Z`#JT`RB^ZI9!-PI-KV-R>R#ZR$+R6@,Q\&4!) M?NP5(0!E"%O9-4-]";`H%F#9I0G8!"0EN@`/0777L#39"=-22-3MH![UBJHE MBI5<`6FQRE;*-S<@G78#54)(L;JIP#`B?6!*(;,]/>*6L"J=;-)J,`@?J^*` M:@LZ(2H!0+8@FP";X"ZB_P"N-K!RY0`$D->H=(A.NA50;,LJ"POXD6WNE@40!?'`/+@6)(/VF@2T%0H$'2^B#X`(` M#I+;V!1E!`;ZH$_577R4;;Z]"$"W!5`08()(2_4DHFFJ[6U.WC@#R'5%/= M/=O8`A.^FBJO2P3GAE:#C.&G6U* MB#GX9"D(#)(X6)WN+^.Z'`;8XRG_`*^.H`Z\D'4=B5)5])NB#N;BP/;`<4YDYQYAYJTAFAEOE/7G"'EM3W%)0D]SGJ"5TGE!-:HI#/ M[)&BH:G84SIBDN$7B=GW$[.'M:2W+7)_*E[4^84_JNJ:GG=- M2][E[E?E_3E*2J&;@82.?2*?S69/9Y/XF8S1H/&=&051"$`NBV.A[;KTV0#` M;=RJR`SPSU:JEWDOE%F1FNW0\C;J.KG>7M'3^KFZ;DC/KB)C.&9'`QS4$Y>^ MRQ'LY?!EY%>S1(<.WOJ'WJPSS7"MQ*NI!EE5;_(?-F'I;.5I\[RGJ2*H.HX6 M09@"'@(B:OWE+S>)ESJ7S5P[E$'&3EJ(AW[QP)+!Q4Y9;,LA7\4[#%ON'+/V M&RQJ'.N)R7S1A\HJ3JA_1-49EOZ%J1W15.U=#1D++(JGIS4;_?3`%"%ZAE0`I-B@N-[:H%\;X!&P!\1;]WGW ML<`+DDIXA=$-S<$]E[W0I@)A,O\`EA_HRH]2LO@[\J(DYEJ!2JH.AMVO@,&MC]I!8'0J40:(! M]V@70#S%5T'0GLBJMM^C27M:U@@3LO7`7,21[0BCW74,JBQ6'=Z$G[*W-B`+WL`:P&B/> M`6XL+D%/$H3UUM93<+AEE0$)"]0M]/SKUUP%?U9Z*21L3V/A]:Z7*K@'AT5Y M4"[V[*JCH=;J?A@+YZZ!@H);'U\=M?WF81-E*(B^:X"R+CQLB^%O='4=Q;;7 M`-]40AONEKW\[=-E'QP`]58H++91=?`@7O;8^&@,#I$/4G30$(AT4`GNB8#, MRUVDJJA3I*X+_P#W]EC,RB9O.9-)W+CVGF:F\WE,J7Z0F< M'#OPR]<<*?$SEM/ZEI3,'(+-JB:CHZBVX?.:>=Q$OF3E_,RS[-#/I5.6'SQVW)YF(0(WF'D!G?E'3M!5?FIE#F/EU2V M:HJTHZ?4U)ZYDK4)+I@)E2TPFT%"0LYA6I=.)1,V'L`\?!N5SF3S) MD&`F;LR^8,Q$'])RJ6QWJ?:X&%?.@PRA&CJ0/>0Z606L`G9"2.V`:UV*MG%1R= MU'37,)W2$5+(NFYU,Z.C*HHN4S5\&K.&5Z'=35$0T%,B8!973^D(:UE^=]-C M@,)Q%O/69@L'_P"02V^FC^/))7QZ_?@,_FA5E'2^J(>"F.5]/SZ.<4;EJ(B< MQM0UM!Q<:TUEQ2;QVT]A974<#+W1=NVV(=D0\*Z9:8=,MMAM\T\>$-:O*UH9 MM0,G:89V(%49@E`?^]5)O;4WTV`P%!JKJ+3W MYT"BW5='-?5RND#)NB5!6K0!(`2]0D#H3U\$P%LU4]*-?\FTC9VM/:Q)3H5G MQ(-C=$1$"I@)-,J@IX4?3+W]!92TY>3JJ6'<*9O4WJX=ZZAZ:+U^P\$X#]MJ M(#QTR\8?/'C#OV=@NF6"V]YPA[504Z=*#E#*Z$3BJ"@LA]Z<$$%50?O&`H-3 MR1$J*+E3*E5$UJ.RGJ9J=0=40FVAP%,SB1(@I"6W"#^DI^;%-3])E`@`'0&U ML!2:F\HU9I:`',`J3&=M("B*LQ('V0-=P+X#*P,REK4MJ!IB0P3##N"A'C;M MB,FK0?,F:P#(=-M/(UMID,M%EZ/5-,M--,,LM-%VTTRT&!^DI:-*?@QM:,FQ M1`3;FC$*A$5=ALN`:8^7D$B20@`"K[7,B.7NL64_(W(P%/VR#("2F&9`*']I MF!TT5DQ1O\3XK@*?M<*0&1*G`)0D>T1I%R0"5B"5NO@+JF`NH!_#^VN`S`.6 M&B_=HVR]BB6?>"MX:!`@G7NG9_$$HJ,@DO&EN2US7W0G8&"(<-*#".^;?];$J@%A=Z536W M1";X!%^X13!.24/_``D1<%059+T(5!!2VIM=07K'!T@W7D\?`JI4DAZ=`FW2 MV^`N8AMTR])]F=-GU<.5:>/KAIR[1!SD-`!H#F[74W(%T\=:^R.PO1Y$6MNK MQ1=>AN+KH&1=MN2A,([4@D_K7]MR/ZR^H^]4"8"^=M0Y#*0;LV%O6OU*^#WO MWZW!N%8-0XT@79T3];$^/_.J@L%4:(ET9"^:,/[)#$P3DCUT4R&2]BN5EI(< MEHX47P"];!AK_1+BP4+ M$1Z675(AD#K;[S@*C+Z!_P"IX8A3?VF8_&T3L%3#>1P;2H!^US,7 MU"@1@\?-`EL!D8&,ES,MGY^@(,.WT\$6AY2 MT@:N9M4WO$$FR3<)JNJ"YT0X"HS4--K[U!28G4K.JJ`-E(M.PNJBW9;K@*XJ M6EF;'+F2-!403VKV2MTN)X!L4Z[*IP$^RSJ.F8FOZ0AX;+Z2R^)>SV7.G$>Y MG=5OG\(\:>LAB(=N(J=/H5Z\='E:#$0Y>.6C9MAIDY15A"U/4E54::&;<9/<166O$33\#%2]G*:(SA<2^,G.7+FG M:@R_E.>$LR:J9J80==U'EK,J\IB4SAH-3<7G&FSGY7T-5.3])3_(:4QN4[>5 M>8,-(YW1$DG.<$OB:TJRL7SW,R'R.RNR(R[GL#!050R:AY9+1ERZ]JIFB*;? M5#%SJ9NWD2[#'<7_`!5T/Q./H6J)'EI6U!Y@U54+FN,WHR<9P158Y?S6LW=# M4A0SQG*_+B'I2EY90%//13,7-F'"%2T$6 MX(ORD$)HH/@A)15WP"#)`5ME0"$`",D$*>X34=@`4M@&\BW6P4^]_M?6)*#E ML=5&VN`9RC1!9;W4%0HZ%+LW":H38X#((3;=`O1HDE.G+N5^6`=V` MZ&X=V_55'/D)O)6=221^WPY13\4%ET.`PV?;1;KMVT"/]!2]G4J/UT=<`*#K M]UE(P&'SI9_R\::YD2CLL;(J#^;&CPNNO0?$Z#`:K%['0A5`(!NA0(NEU.J8 M`$-:7-TTNA%FK'91I:Q2P3`(,D;VV(WL1IL#<)TT1"H`%!S(5`T"_513=-3L MA*=C@)E,5-#TF;*9Y612ZG]GI71`=P%[C1=`AI+1"D#ZQ"#0"Y4E"+(@\$.@ M4"C)%QN>5IFY!776UMR5Z],`+(C6OCKX#;2]\!?2T)'P MAT5^[L;W4=#_`(WOH@6-R1?\$4%2%5!;1=?+`#7ZO9+LCE4E2=E(0H5'>Y`` M(02T5NTER+`'6P*W%D2Q[#`'E/O#IH4*D7*]4(U1;6)L1@&M!H*3OT4C4[!` M`;E;W38H`NHG^O\`J@?JW"(J?V=V`;!+$AH$(B"X.`J.SL`=.8'<*5&RZ+;0 M66RX#,N604.A*>.Z6MK\44$8#(NF/=%KE+7*E?\`:N3M8=?(+D.M">@^Y"!L M+],!=M.R82'!`"/8G7:T.03M\ML!2]4H``46T%U(U`^\IIM@'^H4\NNNVJ@7 MN.NVA!3``N$1`G3W0I`*;);7P71&`Q99`0,ZGJ-T12A"6N- M1JJ+@$A&@5`HLJ#F0D]=;)J-T%PID("T#JT"NXT"#3?8ZZ;D$-@Y3$_SF4,- M/\I96MR-8ADHB#4K\;%,!FLCFR[S(DP6PAIM<:`B5Q3*7UTOT(3`;"XDGI;C M*0.I$/.=_P#WLL\-M_@>H!`7W M00A0A#875%*E+*EL!?J>FC5Q92A0%/-=KH1J<`KLW/\`XMRNU@B+\$W&`04$ M"^B!"-UN0@4=[KJ0,`D7W2+%0.OEY`7*$A,!V?P2<)4JXQLQIQE7_.L[RZK1 MY)6HJAI:**B*N_2B;\L1ZPS-XS4E,,R:FI674(ZG$3(#6^8L2_FTL6>U=QF3]'<3U>513,<_G&6]0/8;*^F(2@*'S(R M[J2;S^*J&N)8V[JR&HP-3UCPG430W M#]),W)UG_*6ZVKV159F)E)EQ`9;U?%R;,+*6C\[IMD''5*455,J>H^=!IC(AOU4^G1764L@GO[;#E-04"I MY*3H@8K.QYSUDP;D_0\$AZ(]B_)-KK8G;4#G)`QC^N"\=PD2]=M4=EGR-NW# MQMEM,LZ19:(:9!9/*V""A0$%G48#5@@(_0P,8RC)0F&?+M?^K'RU%\`WZ.C5 M:'L<4#;_`%9\NJH"6!8V&^]^@`P44$YH2*L"I]G>W3J.3R0#1-L`/8XH"\+$ M%6A_P#T;!=6;6&BGIJ,!+YE"Q'Z$4H/4/N9F>5@6F"Y;)`,-2O+S,\J@$AI" M44LVT*!#C"Q`0F'?W`(5TU8C1!RKWN=KWL0'LK\A2Y?*T1;U3:G8J@&HO?JO M1`N',LBWI*.'J:78;)\K+LJH5%STP&7<4S&/"R3#O+ZM%EHE.P0)O9$U\@E$ MOI.*$!.&2Z;'K8.'8^JU[W+,8-YT.@9Z]=$P&'>4I%L,G]2W?162J#2R=?R2 M76^W1>NBV%\!AFW#QT"'CEOOSH51'('6YY3X[FQP$RR[RSS#SU(_>0T@HN@Z:G%6U1. MG[ER\B7SJ62&104?-(XN(5R_B8CV>%>>HA7+Z)>\CET\;9#;&>W!_P`4_"^9 M,UQ%\/&<>2;FHVWSJGHS,O+NJ*1EL\B(9V'L3#2B:3B6PLNF,9"NFF7L5"0D M2_B89T\8>OW3##QEHA-8?T?/'/%Y5,YX0G!]Q)1&4+4C_2=C,1QDS7SREFZ7 M9A/I`U0[F;$A+EY3/T>LP-0L.&D7D:5%/N%="`6D'5 M;].]L!V+2?HZ^/6L/&0X&8E$UF$0U!R^63".BN5^ MV(6#@HB)B`[A7;;Z(;]2Y=-O>6'=.GCZ(;#*.7;#;QHLLL--`,&Z@XQZ]8=N M82)>/7CQEV[=.X=ZT\>MDAD,,.V62TTTTTT&66&`I7E`)(&`O(Z23N51;V`F M4IFDNCH=ID1$''0$5"13EIH!XPR^AHATZ?.BT[:#QD/':EEH-!0A`61AHLC^ MRQ!50R/9V[!>O*I1--!;K8-A94PD2QF71+QIP_988J25EHMNG@992(8+1+19 M]T6()*`)J`"6'F?SET3L"`MT*+KXG`3CB">>MB:70J68> M;HH!17DNMH;$AD`KKL=0&Z\B^!B8\1/#GF-FQE57$?5>;=`U#0TG&0TDR]CY MK'SXYC9J4'E!2,GEU3N:@=S>(KBH*HS`E,=*Y1+X(%"+`+<="OV@"";==QK MUP#4UY@T5"%2A',I*^(/8H/@!#(4DEDAFP2VJ$A$V2UP2OD0O5MO>Z;#5%.^ MB(55+$64%M8?X\UR0`0O9`1X)@`-1T/VD7WEN/[U[ZH2`!?`$:#0W*KJB:@D M]$L5M9#5U._24R_1FM)!]&U93GTG,OH.)K/N79(3'AO@LSJCALE)K'/(^84&[,#[$^8?SF5U)%RIB9 MF#:GKBF8ZJ)#)*HCZ1AYLYI>/JF52ZIHN3OY[!N)@P&-R9>>JG4V(]U96Q:X MM[4Y-]+VZ^-PN`QF;KSGJMDJ3_14&A^MH^B^O9>FF`F^:F9&85PE&Y:LPLLEE43N`E\,R\RVI2(>LPT%"1SEPX#Q\]>O7@=,,AIZ\>/&E;; M::(:U;S5S1:3FS(KXV(4UC4+5U&I,R)%S?4#:]\!2:S.S(;*M9AUPT&K`&K) M^5&Y3V\]RO@388"DU><3,@VU*Q*%+'74`D8#84IA9[$!J_ MOS",;T\7IUNI/;R#9DKIV9O0P6HR/:L+F(B6C>VI;\T[IX!/(*DHLP\1S/8E MIHNV.57KTD->N=*63S%"B@G5"0B'`6472$6&"?6Q(14_6O=O!K7XG=,!KJ=T MW'.F6R(B*"+?US\_+F`Z6M8^6`U!.I5,7?,/:XUE%TB'XZJAYQIJ1\-$P&N8 MMN:0S33+<;&M,"P+45$%%T%G@4J5V\=3@*]KX"Q,9&DWBXDWU#YZOO=+I9/J^83`'VR+"?M,0NJM/WBKM M?F'E9!\,`/:XIH@>TQ*:G]9^_+2)S>M;2X0?:U M\1;0`:8`&*B>7^T1!%P3ZUYH18W;%]=%'BN`NG[]^'Z,OW[(]6X5'C:*7+LM M:-6*G4!2H.N`K.7T02GKGW=7K9(`\R=T(79$T0)%#-OB!^M>IU]8TG??R)1= M2,!F71?_`/.O#;3UC5[A/M:):V_DO] M4[:#YXI:>@_K'BH`[Y5:!'?4E%-EO@.T^!KBCXRN$[-6;YA\%DUGDNS-G%)1 MM'3A_(\KJ)W^3ZY;YA<+6=E><3]`\/O$73TRSQS5XK6IM4'$3&UFS5 MC4I@I7)G-VH\DZOIOA_X>,Q:'_FNX4YOES34'(JKE69L]HV@Z*IV5 M?SB1%20]32:(JB52J'C'V7TMF\LAFHV(8E\*Y#XD\[LLLW,,`/MIX`.+#CQE=.TUZ6_TLG%!#<-O!=0>3\YHK);AZIV5NZ$A^)*) MJ2&C(REZCALDI,7,JG$6\@WS#S+F/AI<*HG,'(Y3'2EQ)J`$)G-3%/4GF935/5 M3]#R-I[+8"F:\IZ!ILP%3R!Y$PDLB:UTR3RUI5K)!4_P"44X9!T]VT8=5VT1=+8#Z*.!?T?S/'%EM1)3@8X@(+*[B3RQG=`3Q]#SF+INN;@G_`+;+7ST0,Y@Y;,F'T&[#16=[PO8FG"I/*XF@4E0"6X(J MA)"H-UWTW"ZI[BLXB:0RBCLB:9S8JB0Y5S"-0E-Q%6RR#J6)E3R>.&(\!`LR\WLSLXYC3TVS2 MK>H:[FM*TE(*#I^85)'-S",EM(4Q#-0DDDCE^VR'CR%@'#3P!X^:>Q42]>/8 MB+B7[]ZV\(3#-;B5EG1 M%`0[[DW/77;55T(7PT.AM8TN$\UU73`(,[K]4@C?1+$G MS(4_@,`+$BZ)HED7=#T"J!KOHF`(&I("E%'6X54MUT\++@$@")V3>Y1"$%EL MFV^N`2H1>QN"NYU\0B)8KH=`7LC3_XAWIU'W7P%CF8UZRH MV6B?^+X4$7V>1!T5/RF`R.=`)KQYIR_H=EB"`H)_S94>%-P4\M>Z#`:K0:;? MGX=;)?``,J!]H!I0>@&G;J`=3U.`"`A"/_J(N#UUWMU7`%-`1HR4W"D:?O&P MP$QF+HMT12;+.IGE865$_9Z4N==R@N+;W.`;)Y*7I9YF3KN!^(Z>2W[X#<]/ M4P7A=^YL/J3O=$\-!T1+AVXV3`80:,W0!04&K-@FG,$50MU%\`5L M`A[J;[$B^N@T&]DP#4!5IDD$+:_Q`TOVMOA MK>R7'5,!?^RDNG2CZK;W8W/ZI!?KI@.V^`KCSXAO1SYV?SX,/TU'$GQ59*R'ANI/+#(#A*R*D]9P.8D9E[PLT+'9<0-1UI+9N* MBELWG+\3N/8=B`J5ES5#F'DL-*/:JDAH2=S9],XZ`EKV##J:"_E,'&Y#R:$G M<7DKP@37B1E^7;>5\%Q<3#)J(>9Z.J5>-F*;=-3!U4CF0M--30MSQN3.Y.YH M5_/$C8BC7S!>N'@>>\C]+#Q,2'@CS3X#9K3F4==Y29SYKM9R9BU76\AKB9YI M5%5L5F%1F9TL]FD3+IE.7;J:0\;$PL=!!Z M(SC^55<>T^DK4NGW#AZ/Z=RRF(&&9D,LF^2&:4SEDK=>T0,O9<0$#%Y]OX>" M@$+( MIZAB2`&7<`3<6'ZLDD[`:V0:';`==>F1]-UP!1&5D[X(Z/RPR[XWHGHN:(X<*WS(K>6\3L!D$]RY,GED/-IOG-F/`9?S M602Z+9G3N,F-'O)MG1E$PW`LOF8%[5U04/+'O)OARX3*\J7)#A4KFMXB?4I.I_+\AN)^CZSJB/R^F.3Q8C)%G]('&;6 M9U42S-V>YB,MYE1;$3DG*,N,K'\.XRPFSZIWQ='Q3TQ2U/MAY_Y:^Y,IA=$@0!UL_=E-MU\,!8YA^_4# M)W$!#V.JAX__`'C?0[)@-LYGY??3%3N)H:WR^E7M5'9;-?1TWJ-N"F4.7>7- M*N.2*A/8'OJBUZLO77ZQH-N7CIM1SI@-<-997"6_3O+B^G+4S1!`\)>R2=M3W*8"BWE^&?JUME\T!KRU&T=TN?81L%M MU.@P%NU0@"`5E0K1M9FH&FEU3_4MPNRV.`F[%'%JEZ=A#/*=?&&FU2/O6NIB MTVX>^UN:?!8`ZIHW+WUGJOU2V!7E)%O)$\=TU" M*'1TDH5RZ8=CU/.00=/=\$WTZ^28#9$+1;WD]R&1=.5C7<"P73L7 M*`/$Z%4'0&>S5JQ:]9:RH`K-P#[N_2QO@# M[*@/Z^%*D@GUUTT4#E``%EZ=@,!=O84>N*OG((=N!=X0?=*:@_9"7P&28A=/>8Y2`3XAH`A$LH)0F]D6^`RSN$#3MAGF=V;;U M*"_(`I[`*0=R-1?`>P-9YD^C9G4OK*32?+.DI##1TRSMEM,S^34CFI]/P%.0 MLDR(F>1DSAW415DOAGLXCJS=9Z.Y^S%OH!\^E$1!R291L3*24-$.Z4BT;5,X:KQB@*TJ.J@K5MG=P"32:YKS\4+3U?5%./T_J* MC:CK^2YMSV>1U5,YH^BM@:DDDYAI-*8ZD8"N8R5Q-(S6F\W7LQCJ.E?$-Q/5#!3N;31 MVTY;>R^?9%U1PZ4NY=0D\%6&*I*<.IG!R:80)F4\#D7B.J[A!K/(E_!Y4451 M-&YQ.(KAGCHF.IN4UQ)X>/9B\C(MUQ-N9B9Y-9E(&)>YSZ@:;-,P$!#04+#P MCV,>TNZ$HC9B\?!T1FKFYZ-',>.S7K2>4OE[.*UK7,*GYI+XF`;S`H%B0T"[ MHK("7TU**8I"3991\@>SFBY_)+K&CI?4<),X`R./S%,1)']-AENZU@FX]T'F1Q0TIP_3VX5X[-]]7^6D)E<]KW/Z3Y M65Q4=1S'B&RJD-04K7\=,L^9!5%%TC%94Q]6P[4\@,D7.3LGHN8U-F96&?-, M5K1DJD("'<;#[AUR;S)BJ3D>17#K5,]J7AE@J:GU4\.&?,CKW(Z79W1%:UDV M7KS+;+Z.>3[B+H3]*ZOEV7M7? MIM%5)Z^#G\+EQ63FI(NJJ=A:&>4)3]*QL('F(J+_`'K@HFBZD`VZD*`NHM@& M@!-1K8FVFHU]Y52ZVN-\`0%%T0JB)RJFUE0$IU2^I&``*+<&UP0AV`!T^J+` MDG8(J=UTM>YP"1G>_70V31`G[]L```0EPB!3K:XV7IYD^0(#95WU_ M'0_<>E\!L3+LI,H\G_H0&V[]V;[_`)O:^`LJ^*SUE/\`H,.>FC;X:HHN0J=+ M=GYOU#5A"(=--$W(Z=;#`+HTBVT\]-;D;:7 MM@`FJ,@DC4]>J;6_.X"[@H9I^^9`94`W/\3KK>XT%KX#?2"0N@S_5S& M=M:?\XZDW?\`V!U^6`W]1=.>L:=([U(^SOL!OUT\=,!V=E_18>&')=V*+[J" M_74A%6Z:(@O@.TJ,H=I_ZEW#N"63RLJ&2I.A1!;K\C@.MZ+R>;BF7;;<.2$! M7E:+1V3ZJ!21VUO?`;UE^2)+KF$)95NQLG@=+^6`CT_R7Y&'C/L98Y0T5+!+ M)0$DEKYZ6O8;!S#7.5CV"#QXPY1D+9"+*>R*EA=/@F`Y!KFB66V'H#GD:9#2 MLED@G9;#6WO"^`X>K^D"Y;?_`*O=I;=T7KU[?/`H0,[WO8:FV`>Q"DV2P91"1Y)T"E%5`4%]2%
!-8-PED_XR M@S>^VOB$Z8#3T:+M%=3N%1`"0B@@JHU!!O@,*OVN4@$H3RI E@21H#@&D!D(-"`%MJ@V2RC MQUMS*%`!2AW)W)LH^JE@O5;VM?`!H$!"=-C;^Z0@!&R7T3KI@,ZJ;)Y*?GK^ M=L`3=2@52J;7(\.4@+\R=,`@-CU`\%U51V*:(=+X!,@W)9L%*;$7`T0`CI8C MY8#9.763&<&<#=3L92949E9IM433L76%9L9(P_P"1LI@,2UDCG.[R[G.;[>4>9[O* M:FZJ_06HOWX#5K0T!N>VEM!\1_`X`HH^T$"#M%AIGW514V(L22B=B;7P'ICECDM[0XA2\@BPR]+*GU;1 M]YI+^Z-#W)0D7UP'84JX=W;,(PW[(&O<9#1#HD!I=K,A`$LH10O7`:VKW(#U M4(];<0/ZT-'[#0!LB^\!RIRD*-2>8VP'`6:V4+Z$8B&(F$+#/+[JNR`H%FF5 M%['HG=!@/,O,ZA#!/XEL._=9:;(1G0%25%[GPTT4X#@'-"EV2'SUETBK]FRW M!"Z#J!@."*TDWJXAOW$1LC3H3T7KUMIUP')U3P`#3WW;$G150"X")O?HA.`T M]&.0[?-,@$`M'R(07Z^6_BN`M.50!>X53J$U)ON$/Q)2PP"Y;7-^FZ`W9'GW MTT.`0L+@!4!2VV_EO\^@7S[^T'0*ZA[J3;U#NUC:YN2HN==,!G(!D$LJ;%$[ M)Y="FXVP$_ESLD"Z@`*B`H4"IU`O?52$O8)G".B&0"5`0Z64[E!>R]"J8#,N MW9#+)5$4G7NV03=24.@*`J.EC<(MRJ'0$$,@RY'(!R#1,!@9 MB[1@Z(!8J%L`ENZHNMMMPUG,@&8.=I_T1P2B_P#6$&O_`(NVJ;:X#3,:1ZP@ MCW0NP^8%KE=-=L!A2+E%35-UOJ-AIH$0ZJHP%.X5K1#<@&X1+)<]?N*"X$$M M@E=AH@`_N@VU77H%"7P&PPTG&5S"RE]3$)4T=[=!,PDA?S M1U-(GVV&]3"MF(<\X9FJN&[B'H6H*PI&N,A\Z*-JW+ZEG%Q)V2^`",\J[ZJB!-QU"J4UMHML`D"@'07.NXO6)_04 M%"S0.-J*:Y8V+NO[*+$W_K63JITN/S8+2L#S3<%1_9'"Z^\0T]+*)JEUT[X# MLM.V6PZ=AK=N.RE7W*4S!`:_O5]3K5[D*!EPRJ)XWW%L!1;C M,K2A9I>NP-037-/FP6_^]\SH!IHB+]6DB:12NU"@M=_ MJGYX"6RAY1Y:8]FD]1.O>``?5#+7R7"+ZNFG"_XG`=#4NS*S!2[U4+&,N_:H M[U;+<8X>-@AF"YRTVS`NPT&AR!@!@%DAI2US#E#M#*J$<-O8?E=M_69)#;;+ M:W!0\K#/@B6O@/2_*&0,QL7"*PR06F0$&P[_`)%]L![.\/F7?MSR`;+I@.V2 MPT264!"`,A2B($"^=L![&964'*Q#0[IJ&8;:8:9/*'8:!`#*E#]8*S>Q"*-% M)#JES34-#N7088`_'`>*6= ME'NW3,:P7?*1SM#W>4J"ALFI/4(%.V`\K\T)0PY8BW)&S13XK;70Z>6EL!YP M9B0;EB)>GE*EHJA0*%-PG^/SP'&E6NG#+;Q7;S4V]8Q;XNBOY[#`:(F[,(R] M*N(C5%#]V%%UN8;Y=>BX##%J$3^IB?K:^O8)(0;>S!=P2I5$3`#FA5LYB%^T M2_=G947V?J1M@!S0R_U41;5'SM.W^KK:UNB[8"]>M0S+\,EA\3ZN'(_7NP!^ MH=C0N"52R@W^L@5`&9E[4/S!';X(0GZY@WV4!P$"@_C@-B2LLDL(RVJHI;9) MZ?W$/@/!5M@)O".K@ADJB7-AV)#.Z`;;@(;X#-.G#2(=$5>UTNA"DA"B[>07 M3,.V&D9]W5"N]TLE@A157J`B8"[8=/`%5%)5GZR-,]%L%U\44X"Z8=$!;$V6 MZBP&Q&YO8=%WP#FPBAH!0>:Q1`I0)OK(>-,-%LAX M"P&F>4%H-L!JY_$TOS'UDLGS8&O)/(!C51]JGVSHOGUP%H(BC`1S26IK%1RU M)*PMP%O2S1W'=+>(5A%4*GOR2K"=`&:IE3-]"G^2+2KU:!`%[$X!XBLO?M2" ML"R0I#-6R=DDA4N:+(U1"NR)@)[EG$T&U7U(,0$AJUQ&F?P#,(_BZJE$5"NW M_KQZMN(A'5'0CU^Y9;^LZ=1<.VVR.5E\[*'`:VHT\L_@VK_U<64)T_97O3I> MVEAO@,[F&TKR5K9'49?5/>A]O&_A\P]&>"WTAM`<'^5?L+C*FL,RLVH7,+)^ MI9>ZJFJ:48RP<27*;B5RKXD8:60+]Q1G\Y,DD=03/+!W3M5Y9.:EF5`U5.)M M#YDS1RQ4--2B68#1?$GQ@.ZW%`47D#$9M4-EA0.0\YR&B8G,&MH"H,QLRZ;J MK.#-+.RI!7\TIV5R64/8)F>YJS6F);+86'?!NFY;S1T2T\G\V@&0N.-#BNR_ MXF7DLJ*DZ;S>I6L*IJ!S7^:TEJO,YW4.4DJK%SE[1F7[4%E!0$ODTLAI#)VX M>D3%.IU/GT?4<+(']/4$Z;>2JCW4VG@<%$L&RD`%$1H:_P!TJ23MV)`MK@&M MV9(9!L=451=0O,.5"AL=5P"3F!)!0H5!4Z+M?F:"IU)"C?`-0\J M)S%;C6VZ)H5P$BY2-NME"E3LH0+\^RX!(1=`JVU14U1GJ@%TZ=,`"%")J02" M@Y;*5&X^`&RZ$#RJM[W"*1LG;MV2XMH#@RA.EKBPUZ=0!J/A?7`-(ZBQ-T/E M94O;FYM=R@P!Y#L4"[WU"=++T':^`E5*'U<7%%/]6#(-K_K&"MC^4P%O5!]9 M,@UI^SN@A-_K/+CJE[$Z:;X"89RL_P"7;?\`^$,M+"RG^;6D5[)I]P)TP&K& MF4"BXT(:W&G15\=MQ@!R("$0C3DV'8$A"H7=.U\`2""#J;==0FUU[GZJ:G8! M.9'$(6;JA9)'NZV3X7VP'35*Q3+,KE+9-C&3,+:Z.Y=T_P"\`FRW[AVUE+,G M3+UPT6@$`W7IY?BAO@/5S(*80SZ+@P6@$[HI]VRZ'R6_3`>^?#4]A.2$91VV MO(>4&S0*6(!6Z(@&J6-\![`Y;NH/V-T\#MVY;Y!]4`N7KL,\S(`L0$)+0LRI(/*-K`Z?`,=,7T+"P[3+;;!MRL@E$V0'7K:PZ6"8 M#@OB#CH)N&C0[=NVVBP>4LEDM,M@$M!&=`%/6Y.]L!X29]/X8/(]XU[H1Z0+ M:D&X-]39-RN`\:,X)JZ$3&,AIBX;T:VO`N0Z#(`Y430B^BB]K'OXG<#`.:9Y2N]]+:%5/BG+KNNZ8"PB`&66D.O5-> MEK=%47V5X)UN";*B$HGQ*_'``L ME/'WA;;IY[H+WU6X;`RH7^:H M#J-C?0X!($L2@-FE12I*,D64Z"P0>"8!QT&@^T=-CN;V):T6Q[6(-WT"W+6H M()]U?L[Z>2W.`D2'P0>5B.FVEM4/C@"FG;3;M^=L`D\OSJBJ4_C;`!/EIV78 M'\-K:6P'6O"+PNRWBLKE_ES_`#S4;E55DQ?04MHR!JNGZTG,/4,QBX&?36/F M\ZFE,R282JA2V92QS.(N4!T57GHRZART MRGX9,YZVSJH224/Q%/:'=?3,5*9M`R*E7F8&4#O.64P+JKYW$2>BYK-I7)HF M"I&JH2H*AH6#IZO8^$A(R9&CF8^MX$-"5GPGR>@\C91FY4.?F6[FHJVE-4UI ME3EJXE5;/H_,_+2D MQ47`3%N2R&;ARY3YY(A^O_,_%&V3W5-#YVP%"?-*DV MLO7^F`]T>&+.QEJ9266PK]A_&3"*@8&$<,O`6GL3%OG,.X=LLL@M*V M\>,,,H">9OI@/?"DX^II&7#N8QLC+3++(:8AXY\>9&0!_6P3HJ2G10FXP&P) MGFRU3+,,9J'+AB,?(X>LOBT[)8Y6FF&FFV6`"RP0T`"020F^`QU05'4$[N@VPP_B'P:',PK'/ZJ'>$-,AI&@RT65L%1DN7KF*_4FW7?`-M-$H6@B&P M0Z(%0]="%[X"@6&M%T3JI3H-SH4L=.F`"I0X`J`KYHEC]^`VI*XMVC-]``HU30DCMH>EM[8"7.7[IH,DA0-]5W M&V_;=4P&09>N0RP3_>:M?;E*FX^'7M@*GM+@IMJOS2ZI\M/#`4VHARA[WZ]+ MW)TMHF`PD=%.V66BJ*NA-M2J)TV/5-Q@-4SV.9:YPR;7)3MLG7;"*3KX_QZWP&P,J4_G)HBR_Y12PVNG[0QN"5V MU5;DW3`1FG/]W3:J!N>MUT`3`9.KFN=N!NG*P_U5+M.;Z@>"J# MK@.PN'G@@<\2.6,TK"E<_LL:=K*25!0AR2 M05(Y2#JH4["XYE_O#X$@W)`(L@JS9/\`:U4$E`E@@'8FZV&`IEE0-DT104LH M4[%$*D(J;G`+F`0$$[C0G8`&VM[Z*J"]\!)"#U`!-T^*:I;Y+KN`0"ZE$36V MMTV[X!)9%N4L;>!Z7">))NBX`H>K*"Y%]^]QX;W48#I#(/BSSPX9I;F%)LHY MO0L#)\U9?)Y17TKKG)/)/.275%*Y#&/YA*Y:]@LY0H+-#BXX@LY\MZ7RDS%KJ$G5"4D]I2*@)=!T1E[34UG M4;0E)/Z#HB9UY5U+4K)*PS-FU'47$Q5+TQ.,QI[54TD,CBHJ6RN+A8:)?NW@ M6,#Q3Y]2[(J/X;(.OFW63LIGE_+JJA*(F=6R^&J>/I^)GC'T@0T&Y>OG!)=/"[::'*2R!>RZD$ M:A=$UOM@&/WSU\USO&B\;`#/,0+!GF0%$%[Z>9-\!LUG./,'U,,Y>3&21#,) M"0,`X>QE%4/'10A8"%QD93C^+B/9X1PY<,-Q#]X]+MVP&FVDP%)K-R MNFRIBJ<-PB4)0;-]+4DZK3,*NJ.H"F73F/J6MJFD5)R*#AY5`%Y$3:?S*&E<"Z##F##1 M9,3%.^=H,HPR&FRC(+0#[JJ,]&EP,4I2$@IZ8TK/9_4\LE<%#SBMVZXJ>736 M=39PX=B.F?T?+YDXD,$Q%Q(;>N8*$E3MQ#.FF'(#SE:>-AL2G>'/A?X>XQWF M=(GU9O(BC&6IK*Y?/JKA)C)?I.'YO88I\X^B86-?O81]RQ$.Z:CO4%^Z=M/G M3YD-,$--U7QF5%[6\J5F<`00?>M8A6'[OE#@/$NK0/U/K-`H@/+>^`ZNAP\KR2 MRQ>P[8)>O)S2TLJ2+>$A/UDPJ1S-H]X`#8-Q10W`9.`\$_3(<$4JKJGX+.WA M7H242RL:6@GL)F#EO1$I@H!W5U.PSMMY"U!3M.RR'8AWU327E+F.@)=#,14[ ME3QVVZ=Q$?+6'48'QXSZKIAZY\Z>JZ?N6WCIZ[>P[MV],-.>=AX MPV&@VP0&F6F4("$8#7\1-(N(::+33`!*I[/#H-![WZA04NNP*J,!1$7$HC33 MH[?V:&2PNB.@-;`FUMUP%/VV(#0)]5:Q/J7"`+T]5MU%M.Q(-,8_6Q=C9?4. M/&P]6GBH-S;L!]H>E4+HV!'ZF'4W'_N]OXX#*R.!FE1SF72.7EPU&32+=0CA MI\[S8/?5%H^YZQ@--,$-$,D%G`3J0492$9%.'!K&;N@ M_:98=M&EY8VA:LA+$[0JT%'U;$!5!0/H#X$_0X9/9\93N,R,W^(&JH=NH(J/ MFM*P&44FD\7#PM#01]@=S2KXF?R:8-2B?1$YAIK!Q,I88]CES$`X+$SF34Q= M>H#M^D/0.\'=75::;DO$#GQ$.2Y#;B(;.7#B.C7PA&XQ\TX@6Z,+#N!A';IZ MS%QL1%N@P];A7;MT]:B`R[#;CS^3H<*K##+8X@L\'+/UFF8N:9.L/$1?==_H M_P"Z3IS-%-+;B>]W\U@PC7\GNX2W;99;XC,L MO"ZYQ=D%EOG#+0#`5M^E5"U`_D45&2B,9#EQ%P$>XIZ2!S'R^,9YX6)88>RS MG=M$!MS$.6BWZB+H;+FO(7-"@7SO)+(R.KRCLQ8&J)96, M+6E-YN37+:.S9D]1.)Y)94&9E`UJXB#)("'I=MIJEV!)\!JO/#B'S:XBIU3L M^S9GTFFKVCZ;_0^DI13%"Y?Y8T=2U,_30P\=4E1SZH) MHW*J>A'\UG4XF,UF3V+CXM\_:#,YP\5>?F?M*T-1V;=?/*JI[+URZ8IZ&%-T MA((N*BW$@D=)N)]6,YIJGY-.LQJN=4M35/TVZK/,.8U15;N02B7RAFPP$E(Z:*"4UTTT1!T0K?M@%RWNA(" MCN$L6NOC@#RKM=$W/Y\1KYX`!FPZ672_X?O\$P`2]QN""-++Y^2GM;`'E&W@ M?A<>*';]XP"15MV)1/,:]@/QM@$0H`4CL>_7S-R=.MUP"]T:V!0)=?,=?RM\ M`$-M4'4]]_+1-#\<`@R=[]B3IN+63L/X8!5)^.EK@%JH.BDK<(GB/RAP"*A"!9="JKHI'7POO@/HM]$!D1E5E5043QPYL MS"7Q]2/(ZI*LL-"(8`1AJW*SS$%4`U)V-Q@-%9W\<[ M68E),4O3DXB@_F$TA/;62]3F@V6'C38"$*R6PP"#JH`*A"'.T]K^I7LC:89C M'Q=>I+)]]NP++7-:WN[G<`E>P=+>C)XEX*ELR,[:?K>IX.7YMO*SS^XC']-3T3.F'N9GTI M`OH9\6X1J+>TQ3[F,]2AY/=?0[;ML@,JUV08"0<+_$?&Y29U36(FTR>PTBC9 M#$MQG.\:,.Q$.WSHNWC7/[@!7E!:'-BS1+*6350@3`<:3?TEDJCZA=%S'P[#HQ`^M$,--H6RBLLA`1J`# MK@/*KTN3&4U<1F3^=M`2212.JJSFQ_'`-1$U!0>``U4K:W2P[X"7T-&F M4U/`3!EL,F%$LE? M>(!]YF_]X;7T4K@*4IS!>PC;IXS$-*Z(:8*H66P"`63KS`=;$D@BYP'TF>C6 MS=SRS/RGI&CLGLZI/EVU13Z8TI/97.*4IF>AY%/IB_G+$5[1.G\(^]5$NIFR M_##3;YA2VP[99+!)#J[B(](-FGD1$\0>1T8U3%39LY(T=EQ,G6;4,X@F8:IH MNL)Q3,7%0<=2K@/9/+X>&E\\>P;;J%?Q+TMPSMMKD>/6RR'G@]]+UQ1L`>M= MY9--D,L7I1V&+,`-%EIB,LT#S`J"3]8$`J0BTQ]+OQ*/"T6H'+9EIEJQ=T^\ M=-`$DJ&6(DJR+@*RT2&0240X#H;AU])MFEF%.LNJ`J.FJ7<5!F5FD,N8*OG, M0W!L4HW4TN@V);,H*2EEF`BW\OB6FXMIB8/7CJ((9O&A4>=>0^3 M-=SW.;/IUFC3KZ5"F(>EY=3%&TZZF,WGT2S+8%V_C90]C8T.V67CV)>NG3#I ML,.SS-,L.V@0^4W,&N8N:Q<7%,MM.G;QIXW#N0T?U,.]:+UPS8!/5LMLL,H1 MHMK#`:=E$[BH>:NXOUC2AZP026D0-AKJ#=H!4U%B@)P'0U>5&W4S-,1;YGEB MH61LPKUH@\SQR(Z,B'#1;!`:`:B'S#(16>4,J1@-?Z;;KTT!4_>-CKI@&_!= M447M9?SL+X`-!-;6334:A-4W`-^HP#0S8E-!N=U'8`:)H+KU7`(C1K=3O9?W M(JW(34K@&D:C7IW70VNNXO\`A@$!8J?,Z'2PU0]$^%\`+'0]#MIW54%OA=01 M@`0@ZH@Z`CR]A;[C@`E_']W?M_#`)/&WQMU\-\`DU733[^WW]-C@%?R^]>OX7P M!0I9-]Q:_3>_37``,V-B4*W-@?AM\L``-]NO4W4+VV!TP!Z!;]/XJO2Z8!=. MJ?(:].GQP'T8<,=$O*X]'AE<^AWC3UB4Q.84"^<.>9D.XG]/*KBGOK.1M"\+ MB(A&_?"^K;=[H5%P'4'"11,69?F9"!MM]$0F84Q-/'#R(98ES1NR$B7[M0SRI;F"7[F^`T#-Y4_;=-`O7C2?7 M(::5?JDE3J5LFBM!,`**I5[%3Z7NRRTVT\BF&2R4*AHIRV`:50%(!L?@&R?2 M.03JE:-R$I%MRPZBXAS5%2/N6S3$.T[DDOAK"X9?O!$-7`);'AL.IT.``"7OL!X;J=!;S'D,`@%N>B`65#]^MT0 MVZX!J;;WZ_=K^=L!<0L0W!Q+B*=!GGAWS+P,M'W6BR02PT!?UD*_84M.GO,@7D;!9+!+MMDA$3D9#3H?ML$ M`-M!-$)_Q^&`VI157SZ3/VXF3U#/)*T^;K:;/*>4I@.A8.L9[*8&J6H^-BYE%5S`2Z"F$;-(V*F<<_=RV:0D MT8:>1D6]>OGKQU[&Y<,EZ7A9=V9(8`P&O9K5S]A`SSL(@",M*$!'+S:6.MEY ME("BX1K]+8EMK]8VV06@2221T4C[0ZA$[(J!+X6H9G'P-N8AW,1#NX9W$NW[HLO7+;#AU[C;MIEH%H-AKF!.`Q%0U'.)P'LOJ.HJDB MX2#;9BGL)'SZ938%^67K$-ZF'BXI[#.GS3#39](&`TT`[=LE&';ID=\!)>4E23IJNJ>%P@(VLF^J`>50#8E+:639"40Z!/G?```E""GA8I?IV/ M46M?`)%4FVZE5U'9-%L%OV1`2`(5VYMCV"'H+)UP"0A`U8!;%+>*7"G6XTUT MP"#/O7/,%UV/Q\UL4^X%RDW!!NJ!>BD_O0K^`;2F^2]?2.BJ?S!C86F7U,54 M&S('LJS"R\G\YF#<-"0\;,7+-*2&J9E529P_F#H+*HLNZRI.+F\MJ*2O)5-9!5<9 M1$WD\1%R\SJ#J:!9::B)>U)G46\FCQVSREAF8N(1[*W[SD=.(QZ];=L-!'OH M:<$Q@$IF7-+FGCN8`0$2L"VY8>O'S,8SZK]F:=NW+YX\9?A@L,.7K;8998:( M#+TS0]55C.Z6IZG)+%S":UK4$MI2EW;0=P,+.*AF\1\JG)9U!>A\U] MHAD)/7V5DBEM41#I'/K68AOZY0%D-$G5H!4)L`.G/4=O*N@8WF5D$,Q$%!%YJ4*I8W*C4BV`U[Q<3B#G>;,)$2YVT(2,G\GA M`RWJ22Z+2HT?K-!IL712@&V`@<=+G;4:]AN=@CG9YM0SRM``]0JG0=623?`= M.<.>6,+4F8-.P;Q@M,/(MVTT@#0+`())!!`4$@[$;+?`28'3=`3HED46 MZ?`Z8!R`%4^.]NNO;7`,(-M[_DF^FJ!;:77`'M8`=+6'@FZC8>.X`6(Z!2NI MNHU\^8]CVN`*`$:E=^X\$6]]SK@+6.@&9C`1D&2K33AM\Y93_AG"O00-RT[9 M>,`@-?7N@NR&AWKLNWC3LV+#2%=^H3O;L=^QJ0 MHWMIXX#KND8-U6$=ES(06`W.9G#P@)Y"?4O(4-,K;F::]7R@M$D*;Z+@-TYC M\/T+)(DP[EADM`$M%AI`$84#[6I`'7ITP&J)=DFU$QSMPT[:##QM@$@*G-U] MSJ=%^5\`R>T4Q0V9$33;P`,LT]+)BRNK1BF#J#=5='R#1V3`U]#W!O*;H>8;%"$L4L MFVY3J.AP`Y>9;(;Z$)ML;Z*-+GXX`%2$&I)6P&H-B!92OQO@&M,#4$]2M]KK MT.ED"ZH,!3+(0`A$`UZW[7&NH\L`X`HAZJ3/[^^`01"E[6W(5;K:YM8;DZ8`@!;`[Z^2>. MB]0=K+@$0-4(*)8$`V7HJZ&R_`8`$$JO30#S!T77;6P)M@"AWUU&OS4(-/`6 MLJ8!(REBB*>I4`$$!+B^_D=,!TQE_G]"T++\IG$/*9FS,LLOY]W[$P@XR'FY-%0',P6H=NGXV'9F$26R6G[L,L0_(V%P&PY#Q72*1Y0T]0+5(5 M%.IQ)W]'S*,,^J9W-J3FDZI+-UC,A[,#+8V#?3"`-1R]_'2*90L'%L0;AZ]B M8WV:-?S:.?.P?F!Q6RBIX:=N)3+J^?1$=E=.Z#E\ZK*JX2>U$YF4UX@I%G7# MS2+FD-!P+;4)+H:5/:?@G#AT[?0Z03UV^]6Z:&`O(_BXD3S,:I*YAZ7JIXYJ M;/"K3![%5(YB)]5U+Y=92U1EE$0];3!W M#PKJF*8R6D`I"KWXRRS#R) MKV8.(JIX682Q_$911D\>SEW3CF-@O;)4W5SJ;^TLN6XPRV4OP\@H:"+IEJ,B M@X+;:YFVVA8-M--)=4::5=2A!TL%V5AAS2_17.O,_+:*BF74)F3EG%1 M\NAVVSRQ53T3%L1\([89`N^^@YA43[FLT67!"DH"'0V?N!&KL,/(%^Z]U%124/ M<[E,!QMFS4SR'KV>PC#TLL/HX(SS*&@WRE5!`*Z7M\,!K&FZ@$ES@G[;QX`( MNEH`!6@S=F(::0$]+[+8]L!NS(ZLPZJK-R-9?%EEY$P;Y@\P`5W!P[*VN40; M_A@%FK634?#R2HR^9>MN:PE[3;TD$HX!)O?^[O9?C@,4&BLKTVP'DCQT9G M,9P\6^>]=.'WKX"+KJ8R.4O@WZQA])J0=N*1E#YT0RR`Q$RZ1P\2RRRH'KFE M;>$EXT')M[]#;HOW?'X[J"35-OB!X=M_*PO@%9._FB7'Q^7G@`EOP0*;W0;K M]^UC@$`3J$N@7;Q.WE@&\NJ+H+"W[D!/ST*'`5H=YZF(YP\?UY1+Q2?T;@XZ=/02H9 M=2I!9&UA8$]@Z,S5XC97!3YZ[8>,Q(9(YU]YHM$FR@H`-QMIK8!"Z9XF9$\G M4%Z]T[AW;;YV&WC;/*``02I^K?95^.@8GB'KN#F&;8#J\Y1^)(9P'',9$M1$%-HPV:C)R^>$DG2YU:5JP(`6YNO8(LZ" MO&5U+0[75.HUN.W310WY",AU+)9#@)ZJ%#;1"*6W_P"L*D7/N>K%SMS``%2# MR&2>MKZ:C5;Z'32V`EE79?5U035-?IS1U548:SI&25[2+-42":R#]*:%J4/V MZ>K*GA-(6%^F:5GS$+$MR:?RX/Y5,F7#]N$BWX=/$"'BZ@A$.S)T7N%N+KN< M`2R=@HU`4,@$[6Z:]_'`3.=9:9B4VS3[50T)6,B8JNBG69%+-S>F9U+6:DR[ MB'TR<.*\D1C()R)M1[Y_)INY=U-`A_)6WLJF+#,9S0<2'80@[CWNFQ[?)-AO MI@&\K2(J]O\`S7TN0NI[W0`X!A!OHHZVV5=ET[JO7`!$3IS$E"3VLMAV[8`) M?3E^*(EK#IHM_NP#2R"!U46'V4T!LB>]95ZG3`-V0]=5((0$V1;V4D:JF`!% MCH.EMNHL5-EWW0:8!UO'J$TP$G4):^@"VVZ;7W_`(X``"ZGE&XZ ME?#4#IH2N`19[D#KH+!0BZJE]OQ!!%_=MJNW3_'`(D$`ZV!`WZ=0BB]PIT6R M8`@#HB[DHH%T/;J!8GXX!MCHI.A73H;==M-QHB`"TB'3OX!+=S95'4^.`]#, MSLQUH\ M?RJ82R;S^>Q,PJ9\\@G#J'BC[(`S]0TOPO514>54PJB:45(X::QE!RF:1E'U MY+YH]J232S(2`^EVZVDCNIY9+J`>PV;$KE5(A_%QU!-36"F<\F\7-V'<+^E; ML-,9P4[P\4W),UV\OW5DV* M*SO-TC_.1/J^BY;/!E*_I&#F;LUK',.'SVBF:?C:3;9DTAF3`-A26@^'6@9WP^32I)-EU"1TRB\AYE-H"?9A14X<5#)LP<@H*J:V MGN8U.150-NZ'EDBS!FL@BI"_BG4@E,P@YG%^N=3.203?L8:YI.FLDYW#4;#U M(WEW&SZ5923AX*0G6;#NDZ,=56WQ&U5+YK!3&MX&=OWT/$R+*Z*;J2FH-F;1 MT34#AS+9G"PU4B)AY5.PX5C7<.[C(IB%;#R%8BHAB&>!X\?<\.R^:#AKUKR% M@7CWG=!AH-MP4$TWJW"0S2NF0WAPOYD_S0<064V83Q\TX@9#64L8G#YG5W() MQZV0U$T600&^62S./;Y%1LHR4!P'1/%!73V6YDU5!,Q!+#B3]5[2\: M=GL>0A0>Z7P&@9'F`]CJ@I-GU[38AYNY>`!KFLTRTR2RIZ$CMW3`4O2R0'\0X*E5ORD'0GOX]\!H[,*I#*,QV8L-$>MDSEPT02"H/,+]5L>R[Z! M-\E:N?M.\PG[#QHM13(]X-6(9<,"YYB2/=%QNJ'`-JFK8A]0,.P7A5F>A[S% MII`6.;7IO?[],!KEQ6CYJ(9);TNH;*@JFM][@@]"0ML!Z(<,6;K>7L'/ZZ$0 M/:*7IV;SR`8>$-,/IE+Y>^B)8X+)Y@D1'L0T.TO_`#I0$A"'GD]>O7[UM\^> M-/7SUXV]>O&VFFFWCUZTTTT\;;)+39:)+31)YBJE7G@$4(4!--+]`=P?P%SX`U-.NZVN==^^_X8#4U=.6F)P7B6B'+AXI M4J0P&&VM-/6,-#2_?4A<4C&P4([C'<9$,.O:X6(AW8:#1YWC;EIAEDHR;%IH M7*(=:$RSK?DYRK++1A'09+)-B5/NG]X0-/3R.?3&8/X MM\2TT\TYCS#E`2]SHA'C8C`8AAIH-,*`BC3:]K@V_/3`;GK\LFC\KIGS->T3 M"5U"[?-DMM-%B"FC$.Z%T9]QEEH!%``V510== MT#E#E37W&5PN98Q;J/FC^1S#-R1U]FM+Y%E/!QD2)9FA1=.R42IS&2XPK`8/ MA$RBX3&C/"N/_0WI9S3$L]*,.(^D*PK/*>AZHCJ[J;*6?5%PI4[*\KI MY-H&K:F@Y)-HH1V5T;*)'&TY2S5//H!W-9?-G$O@(L)]PI5MDQ069^5-/9=. MN$^+K/-ST%M:T<[A,WICE.ZHF=<4LTG.;;V$HBMJAS#GLIHBF:LK23P4ND52 MRJLYW(F)O(8F#E4W>N8.8./6APWFU(^&=WZ,O*7B4IRA\OI5GKF5)Y?P05'2 MJ$,*JK')^;\/V64[J>&+4;,8^J50EU%T[#4"QV3M^`-(0)R]54(GGU2Z;]UP#2-!UU.HMT6RW^6 M`801H5%PR@U'54M\;]C@$`A/NV.WR]W;?=%ONN`E(`V*]S2[63_$X!%D*=R;HO@%Z[:X!!E-"G5$0GYZ(!V%NN`![:ZA$(/4Z&_4?!=P M%D0D(@70$$%40*.N@[=\`[6XN>^R%4(";C7[\`U+JH4FZKVM?L$0(HUUN%S$ MQ47&ML/(R*B(M\Q#PT&P\B7[U^\8A8&&N85LG@UUW*C`4I_,R\HPN04Y8Y^V@UT:1;]]ET-S@-10T8]9;!YCJ-">UCMV_(&` MZ1I:>Q4-0LS@F'S0^F8F!@G@4C]DAFV)B^3?E+^%A';;.A9?-,E0TA##\K2` MDA$4HNFER;`+S6OT!-L`[E(&R=5T32Z[BY`L=K8`$@@+T*6NJ%5"_,G14.J@ MT$"UQL5%EZJIV^_SP!#(Y@0+:I?0+;KTUV&NV`&I\1X$*-S>Z>8'S`-WV"6" MA-4UW/\`AWP#?+4[@`^"::)J+'`:UK\#VB`/_P`(0;_99?Q``U7JE^Z7P$#< M`DM'<,MFPLH.`FE`3!J7O:K>L`EJ(HN>0:"Q/M/LS!`:LBA50JA1#@(2]::; M;:+10BR7T4=4[W&YV7`-"AMEH?66UTW_`,3MT.`V#54R,=2F7L$5262^?,)S M*GM,Z>OB1=&`B!`-0O0`(5$GF@H!I?JL/6+7(1O<615M?9>^`IRYDM1<.QJK MUW\VDWTZ$'1#X8#H%Y]=MH^][S07LIN=%ZD^?@%)`-EUWT':Z$I?M@!W"6_^ ME>JZIKV*K@$B#OUT0&VFMO`:C`,(L%[H4TMJRNBKMYX!$%``FW<$:6(.O;Y: M(&Q:US>S3S(I_+RE*_S!K"L:8RCIM]1^6%.U%4$RFDEH"F(F.>S2*D-)2N*B M'D'(9=$S!\W%Q+B7N7#,0^]6V^YRZ=<@:W-EL-4N;(;J0EE.ODB;@$4+`'+;WE/DFQ.@ M_<3K@&M`*BCG M*20-D`V%[G`2C\K]P^>`7Y3\K]V`7RP"_/[NGPZVP"O_``_C^'S.`%[V_C^[ MYX!7_)/G_#\,`<`OR-L`-=1T^5]>WWX`X`(.FNOGK]YWP!_/YM@%@`B`!3;O M^?#PP"OJNUE&G7IKO@+ZKGKV/R\@&2"VU)IE%P++:*68>+#,>Y9-DN_>1AVV M1+X#4=!O2XJN4-7(9BV&D_\`&"O;3[NN`ZTS:F[3Z;2=I23ZJ%8&A)"`6!%U M\K]$P').:Y::J0-D:P["6VV[8"\RT::8@ZB;"I[(62B[LC\]?OP&,CW[3R21 M#M2@?/BB]!OY6'QLN`@D,5;9W\^A[?E/'`;ZDBF50CLFSOUC196P>/N1IJ]E M_5L.;W]W0K@,FBFQ]U3]R:E=3IN+8!(5:"H`%W0A?+NFM\`4)"67F`:1]D!$%OAWUO MOH+J$T``$F^OGWUW^"_'`#PT^[X:^07M@!R\IU7=1L%N.ZZ]^NB``.:R794` MFQM==.G5#MI?`-*C3E5-=RJZ#S6VIL,`$T4ZW('4!;V&AL0AUO8G`--RHN-M MU(LF@38$$;KL,`"`J652HLH0GNMREKG=+X!B6L@'BGB"#]Z;)WP$D^-]+:GY MC\]\`NEM-NM_R,`D/3X_'\_+``^"?G7SP!V7EV(6_P`?%?CHF`0"[_P`3\CO M;`'E*+\._P`N_C@!X==_RF`0LI%]EN/S?M?`#[NN`7Y.Z%%[?/;9<`;ZG3O^ M=->FENP)+*J*NET\B=OQ&NP+\C\_F^`2#<[I?X=A]WAM@$1=!\]_\38?/`71 M9#^13^!:*!N%\I2XT<1#\G7ZO;`:BI1CDJ:#)MR/F24U^N+]M4 MZ$:;X#HS,IMMJ92-K4"X#H"7.@X@W#`9Y3ZMEMI=26F05:/4`AGP93;`7G*$[V MTL+%?ELODF`!9'PNGQ-R5MJFG1<`BJ]40@=EZ=>_?;`#:_90=0=B5*7LHVW. MN`:@UL2`5`*#4+HMB=+"P\R"Y4"ZD$:C?H+Z?-.QP`UV!M;=.BHBJJ'?\0'1 M"IM9-!<_?;YZV(:QKX$14$/_`(5GN/ZY_P#'Y>.`B\O91R])3E+A\JZE40`* MIT&B?#4,G34P=0G86T3L4P%NTWS M0KIAHV9:;0::I^-UTN%[!4EY_;(9+_KG:'31H6`3;7S`[X#H5\/UC9V]8W?_ M`,1'?[E\U^YUZ"]K=;I MJ,`VR=/Q_)^";G0$64NA3OX!?`+^3@`%&^R:`]%/5=1\^V`8;A;A"T4.NZ7V M3[[=,`B.JA+JB*E@@[CJ`MML`S4@^6WCJ`$075-DTP`Y0AL22=54&X`3XVML M`>@"0H3<:C7Q\]][8!(T3=>OYZ*B7P`0ZIHG\!T-B-NFF`/*>EEVO^.W7YX` MHT1\M>G3;K]VN`!!Z>/2WR77?6V`2'KT1-.U^P3O?K@#=+!`$7RZ[V*F_53@ M%=#XGX[W7HNMDP#>6Z;C\4'X^-\`=4"+?5?)-/@N`==`$12AUWOIO;5>XP#4 M3;E_#H@_Y2WY^XIUTP"M^]?R/.VUC@"0%[(OYNH\]^@T!["$M,%> M5ZY?N54BSYRVZV4DCF!`%RT`RHM@-32=IJ&J0%JS3HMD[A6'C"W2XZ@6'?`; MFK6>L1$1*"H)=!P5^MHFPM>^G3I;`:XSHB6(N8R=ZPEY>P"FBBWX8"5Y)O6& M*5K8-(OJF47?]6%^^QV\W;`'MK\\`L`/W] M#^=?(X`)=>U[W[)^1IKJH(`_)-_P*?->A")@$@5$V%]K+;\ZC`-Y0=3J"H'0 M]!W.R:%-=0UC7P'M,&!M"#;4E^^("IN;]R;=@AKA^Z=N'@+:D.GC)3[):(#* MM714T%]EP%S)H9ZU#S-MMTV'+R#8Y6BR4:!BG5P1B8!R9%!Q@C7?MK$8^ MAQ*_9XCVAJ$Y"\:C_:0P8,.@^_9_4%Z(H--!X'9=GFP$?)1VR-&@2"H((-M0 MGGOIH";!C]8\OJ\:`&GVB@NB(H^.NJ`W:] MCJ#JI0[@6V0?/?`-T%D2]^YU'5$75.O3`(A01V-B#;O;?:YZ=L`$Z%?E_#OK MI\,`VRK\%(7\4Z%-;IUP!\ON\/X]=L`PK_$"Y0>:^9%E%\`;H0.G7MHFH\U4 M:]2#$`&Q%U'FAV&_7?J0N`7*J]OC:U]DMY;8!J==+K?X#0ZW0W'E@&$`ZV1# MY*NZZ$+^3@$63[UR02H%K!538;_G3`,(*ED7"ZE4!Y?]D!;ZJ>XP$A`)3ZM_ MK`&WAVTULOP4"&2/P&_QT)UU\T7`!+$]=VNECV^-]+'`+E.I/X[V'2^Y4*3? MN"0G0H-1[Q5$^&NO0X!`;7._8FQ^L/EWWP"2P#12Y3>R?AUT'G@%RZ#8][$= M!?QVT4[7!S(LB_)-=S_'N"HP#4LJW[`;%2=^G4(;8!%DVOKKU\45+:*,`Y-] M1RC07.^X6_3GBF`U3&,B'J:.0@!EA^T MSRZ?69YD.O*6M"5*>>`JSF;%\W#>^?U9=]-`0!\.FZ6WP&+KF-]M>2T\R^KA M&61?;PP$RRNC_9:>JQUS!GUKEG<*?<31/S\L!#7;PMRZ-'5B+:/_`)&BJG_$ MGP"!LCGT00/V=PT6;?;>HZ#(UT9+;0W!`3?`;;0$$_`A0$'EV074DWP M`V38[:73[D/W^.`&O30>6VJ]_)3Y`=CU_@5^X>&`'E^>VO4?F^`7\?S^=?C@ M%@%^>_YTV_@`0)=3\5^5_+\,!JS,!H>VP8W$(R=]W[\_+`16$=0KJ6S!\V\? ME\\<@N'3#IWZIEMA\[`:>O&V^;DY6V@C#):5-L!Z'<+GHS>*OBKD3\F@ MHAS/7SQP'46S'NH%MPX+!=\TUAH&/A!$Q#UZ[9=0+)]:&D:;Y43`=MSK^3K> MD+E,^E5,Q$@HJ#G,V<.GP8F]3OYS7]!CQTY/S.&E=62[+J)?QKQTU#MR&K'T>R^9>DHSZEY)X>+#;2HPR(<-- M%!U)#C3-GA$S.R)I*KV,TJ0C&)_+GLH>2.;P,=&,2R1P(BGWTNZFD(_E\.'[ M4P8>P[$*]>O6&G#QT2R#SH0XE566@;$%5">";=$W)T7`7$"V6(J';N>5ZP0G M4-`^1[G7RN'1CT$/&U"\KQK1;@DA;$W(OJO?`4BS96;7^JM@H0HNO377`(]B MAZ`>?4CKOI9,`D^T@0LKJ3<"ZWW*KX;8!O*?FA/FFP4J5V73M@`43RZ]_P`H MFU\`@$'7Y]K_`)0X!=ELO6WS4I<^"]+8!J62PO\`G;P7L=\`"%(_#S^'<]^R M@`1HI"C=$T(O]_QP#190>B@G^"[I;37S!$74HI^&BB_B4_'`,1$[?!>H'`D"=/#K^?.UA;`(A0=B=2F`!9!"?D?PTM@#NB:@_(C]^ M`"!430?%5MX?C@$;#XZ6V)_#`'0H-U/P3`)!X?P\;>>N`'*/S]P.P[>/7`(A M!\!:VI'2QO?3`);!;^Z3T.RZ>/RP"4\JCH"/@%Z:I^4P")0KT-DM]E<`-SV+ M/S3HFGGWP!^U^=P?'8`;8!("!:R"RGMWP"#()(/]U=.Q^]-0$VN5.^`A$0_;:>!2;(=5\-=$P#IF_;?&'YRO*Z"'?`9: MGYD_@829.G2`V!0T"S#2DQH;Y MFHQ\V"SRH'8V`1%E[,G?PZ]O\`#``" MQ:Z;(.W[]UZ>`-`U[#IW3KWP!%R!Y8#5F8#`]J@VMVH0?)]$)?R^>N`@A>$P M33.@5"E@;LD*/+[NF`^UKT`M9SN`X5J7E\-&13APYS!JQMT8>*>0[UTT'DNY M2[>NN5M@L$\S)9:4$#E0A-GV>)=QK#YRK04^K;8):]Y5O@/$O+ZJ*UG.==+"2^,>E[.*JGLT M>-F#YKG890,MAH$!EE`.48#D;TCTTC_`.;3.AS$1L9&>M;I]AI[ M%Q3Z(>$?33MF[;YIXT0@%N8#`?-T-_#\1^5373I@+F#"Q3ID[OF%/_C`/Q7P M['`=*18`B8AA`C+]X-.C36G372Z)9+(%LU]0'9%2_6UUV_A@$BDW-CL=;`W5 M<`F0"0-FAI>RH.O?\W4&DK8W54/2Z?AU['`(A6F@5N1?NA/\/QP":"$7U!TM MH/W6_#`,(^1(^'^.`'Y!%MU_A@'$6\>4Z=5/X?D@8!C)YBFB-#H>UU\,`FD" JV_O#IL3;II@&D(URZCO?1>_Y^6`;J!W(9[]3\^WG@!H5\+=F@J?A@/_9 ` end GRAPHIC 13 g852944g60l42.jpg GRAPHIC begin 644 g852944g60l42.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1%`4&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!\<`5H``QLE1QP!6@`#&R5''`%:``,;)4<<`@```ESG`#A"24T$)0`` M````$#PD_<^XM2()RHK8&Q`5\94P`````````IV96-T;W)$871A8F]O;`$````` M4&=0.$))30/S```` M```)```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4````` M`$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$` M6@````8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/__ M__________________________\#Z`````#_________________________ M____`^@`````_____________________________P/H`````/__________ M__________________\#Z```.$))300(```````0`````0```D````)````` M`#A"24T$'@``````!``````X0DE-!!H``````S4````&``````````````!> M````1``````````!``````````````````````````$``````````````$0` M``!>``````````````````````$`````````````````````````$`````$` M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$ M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<` M``!>`````%)G:'1L;VYG````1`````9S;&EC97-6;$QS`````4]B:F,````! M```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`` M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`` M````````3&5F=&QO;F<``````````$)T;VUL;VYG````7@````!29VAT;&]N M9P```$0````#=7)L5$585`````$```````!N=6QL5$585`````$```````!- M'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO7U M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1 M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,' M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6 MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`-WZ^?6W.PW.Z9TA_IW- M'ZS>/I-D?S=/[OM^G8N`QNO]2;=ZIR;S=/NL]1^Z?Z^[W98SZ#M-)T/N"Z/"_Q@]3JVC(:S(;YZ.C^Q_WY M!#Z*DN0P/\971LC*;C9%=E#G&/5`+ZQYO?M9L;_GKK:[*[&-LK<'L>`YKFD$ M$'AS7!)3)))))2DDDDE/_]#,^OWU:R>E=;ORV,)PLU[KJK0/:'/]]E#OW7-? MNV?\&LC"948#G$+WO(QZ,FEU&16VZEXA];P'-(\VN673]4/JU1=ZU?3Z@Z9` M,N;/_%/QLLN`<&G3;KIL9]-9^0NM MQJ^TA^,/YMQ9^E;Y;FG:Y4,W_%QG,I;M)W[1].QOM=N;Z>^[TG?I?T?\[_@EU72/K%TCK.]N!>'V M5B7U$%K@)V[MKPWL4=5OKJ.,U^W)?4[38[8S46>C9_A?3_F4J4^I))MS=NZ1MB9[0D@I__1 M]522224I))))2D#-R68F'?EO^C16ZPCR8"_^".N8_P`8O4OL'U6RFM,69<8[ M(\'_`,Y_X$U[$E/)_P"+RF[K/5>HYV18X$ECC'!P- MMEGJ,W,B-SG.]1G_`('18I?XJZ!C]$LOLS_`!C7 MNSNIX/3*=3=;,>/T*:ORW)RGO/MC_P#FU]M@[_L?JQWGT]Z2N_9*OL7V/_!> MEZ,?R=OI_P#4I)JG_]+U5))))2DDDDE*7F?^-_-+K>G]/:>&ON MO3%XI_C)S3E?6W):';FXK64L\H:+'C_MY]B(4]?]5>M?5_$Z%BXEMIINIKBP MQIO=^DL_\$>LKIXP^L_XQL=^):IZA!$E@+_P!W_3/7!MR7ANT$A>A_ MXH<$.?U#J3A]';16>WN_37?^B432GTI)))-4_P#_T_54DDDE*22224LYP:"Y MQ@`22?`+YVZMEG-ZIEYA_P"U%UE@_M.+_P"*]V^L^9]A^KW4%]@Z-A81 M&UU%%;'C^4&CU/\`P3@\!QUAOJ#VLMK_<^FQ<1 MF=-_Q>DG9U@L\`:+''_.JKK_`.H14\C]6\+[?U_I^(1N;;D5[Q_(#@ZS_P`# M#E]"+SKZEX/U,HZY79@]2^V9Y:\8]7HVU`':[U'[KAM<[T=Z]%04I))))3__ MV3A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\` M```` M<@$R``(````4````D(=I``0````!````I````-``#H+-```G$``.@LT``"<0 M061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W`1L`!0````$```$F`2@` M`P````$``@```@$`!`````$```$N`@(`!`````$``````````````$@````! M````2`````$X0DE-`_T```````@``````````/_A`3!-30`J````"``'`1(` M`P````$``````1H`!0````$```!B`1L`!0````$```!J`2@``P````$``@`` M`3$``@```!X```!R`3(``@```!0```"0AVD`!`````$```"D````T````\`` M```!```#P`````%!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*0`R,#$U M.C`S.C$P(#$Y.C0P.C`U```#H`$``P````'__P``H`(`!`````$```!$H`,` M!`````$```!>``````````8!`P`#`````0`&```!&@`%`````0```1X!&P`% M`````0```28!*``#`````0`"```"`0`$`````0```2X"`@`$`````0`````` M```````#P`````$```/``````?_A/LEH='1P.B\O;G,N861O8F4N8V]M+WAA M<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ MDY48WIK8SED(C\^/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&%P+S$N,"\B/@H@("`@("`@("`\>&UP.D-R96%T941A=&4^,C`Q-2TP M,RTQ,%0Q-SHR-#HS-"LP-3HS,#PO>&UP.D-R96%T941A=&4^"B`@("`@("`@ M(#QX;7`Z0W)E871O&UP.DUE=&%D871A1&%T93XR,#$U+3`S+3$P5#$Y.C0P.C`U M*S`U.C,P/"]X;7`Z365T861A=&%$871E/@H@("`@("`\+W)D9CI$97-C&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q M+C,O(CX*("`@("`@("`@/'!D9CI07!E+U)E7!E+U)E&UP+F1I9#HX M,3-!-S,U13%%0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO>&UP34TZ3W)I9VEN M86Q$;V-U;65N=$E$/@H@("`@("`@("`\>&UP34TZ2&ES=&]R>3X*("`@("`@ M("`@("`@/')D9CI397$^"B`@("`@("`@("`@("`@(#QR9&8Z;&D@7!E/2)297-O=7)C M92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#I#-$8T,D5$.3)%0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO M7!E M/2)297-O=7)C92(^"B`@("`@("`@("`@(#QS=%)E9CII;G-T86YC94E$/GAM M<"YI:60Z0S1&-#)%1#DR14,W130Q,4)!1C!&-S4V-$,S.49#1#D\+W-T4F5F M.FEN&UP+F1I9#HX,3-!-S,U13%%0S=%-#$Q0D%&,$8W-38T0S,Y1D-$ M.3PO&UL M;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O'!A8VME="!E;F0](G$R!1-RLC-"\?_:``P#`0`"$0,1`#\` MEBZ[75GS=@I[(;7MF=C95F_1\>B;,N3&*2;NV5@D[&D=,ZK0UW*2C"&E6D2\ M;RE@M*";N5BG#^.CH1Q"S$;)KE^M%$;Q#Z!G]..O:6:Z0&)+$X!TY:FP?L7# M5`\>[]MRC6W?NJ5SGGB1OHO1&1MALW# M]B]DW7+X-?906,CJ&;SC``-H,62=%*:(FB)HB:(FB+CP;BLOY)R'NU]Q^/(<&[A#VY M-^M@(\<^P:,=9N7+VS$@CC^EH#WO>"VH$7CCK-F4F>#]TEYQ)/5^U8^MQX.Q MUYX9W`2*+2-1<1;H4SME#MI!DHFY3!=%15!PF)O3614.DJ0Q3&`>0OB>'FOF MB^;![QRMSMU936X;^H"W,TY)DWR)#5+*4<`I(G,]:-XN6]`A@!04%H9Y^I+. MCASVN9$LEY'N.B;VUJ9U\\=;_8N^I:V?6.^Q..LH4J_4&3E7C./"P5UH^O=: MCG#HY4S.)UPG"P*\6Q;&-_Z3LPFETBE.841[1`,?R?9D:P=B9FW>>Q96&ZG; MZM?*[$6VEV"(M%9GF2N]TW\A;/][V6,D1E6?*X%W"7FPY5QS<6$>H%>C9*YOW M-CM6.WZZ*7VD3+5J?>2R4/'+*%_4*L2,D&@G,2009>EL]K34!6?YVJL7JR69 M@[&J,%I(5MO/5WR7A]+W[B2%'SAFOUYX+1M(RZ[(>X!\A[#X^?\`H%'WY\!_ MKX^IV@)];#\>_75:Q#!Y,Z!XOKY%UNY,[(,[Q]!A\HU:IV"RT">:G4BKI%Q$ M^G!.00:K%5!T$7&%27?>D9P9YVJ*)B)1-QH=I3;[7O;]6XRD@L7C1GUW&J)F.*DLDQUU@7$^=FA+R$2 M@P*TEV,T\5!N\`0$#!X`!XY^>=S?J-Y@Q=DFV,+;8`X:X5@S;GU_,K62W4^@ M/L4-[FD_CW\DLVB9%VC-S3."!1;[>H.WL9+*(E>*II0*K*QMEG#ITLD6-DH0 M"ED'7.::G,9.D*"&/?/XT4]>U;J8[.=XL^-*PSE=@^R(2-JT?(K)=Y#D(HFH!0.0Y"F M*("&@)%D!(D0HXJ?T3NFS2+B2Z0VW*OJNTGAWR4#+/'LO3DESF,JU5;Q9H["^MHZ*3IG4ZQ'P+>KLJ]#-:VU9A'M MH)"-:)Q2#$J8(E:),2I`W(@"0`F"94P+V@`<:E\Y4K07+X M>L2DBSJU/6?=:_P`> MBABC/IPUZM.NZE#Y.K$[B=P]4VBIP1<@AH#,>HMJ'=L+5_-GTZ^>Z[+.'&-;)$W M6`!-PJ*[55%M.OW':8Z!5(]YZ`H=IA[#*?JJ@'-R;L(!O%"NAN+R3H?P\R)F M0'3?B9>_+SEZ+1_:MMURGAK?C6<5SS1C4\CXM1BIBP,;`HW".C(6#DR7J505 M6;N'2'W\W$,DGI4@<*"9-V03^1$-=U&R%5-)#&`Q=VCA\:M&--46Q#D.<AY*VW;X-K6\-3=3CO$52<43$N;GED9SU/GDUE6V)F\O:I9W(6)%U^W5DX M^,@ZZQEK''M49%!2/2?-#.'+4QS*O[#W#BQ?(/PX\9UF]C&>N!>!A'-%G:O)A\!R1$P("T`54E*P, MBACNO$7./!2J-X*130`_CR@'MV^/4V=9IV8J8_;LZ3&?M=O146!(;K.`P.+W MXNIL.LS$W';SLXS'-1%\9HEE8&<>6+EM]NX>U]^S"D1L<"ICF[3N[E>8=B?L MX]8JX$,7L4$!JC:"L&H9)$\N#"00;0ZG/GGSHI.NDED];,/3GVJWU=HLR4D< M>KQ?VR_/L*$$@G_9*J.)V5K]%@7_`'.(M& M4U*V1(5#[\E#%4$!.`&#TJ*35L:!3<"@E]!NU1S'NCO&GM/[7 MN_U0^^$KKBQWBP_C["!+3$X^3,`@(:_P#G)62>G3B+^A&Q/:;BHZ)V[RKX+Q^,P@J4 M2*(V"=@FUDL:2A1`!`Z<[,2)!`WY?C^7GG7G;0-M-I_G7_L4JN>$=H^%NAJ% MB:(FB)HB:(JCOU:V;%JWMFP7@R/>'0=9,R!(6&4:IGX^\AJK&J`FFJ0/)DRR MKIFIY_$1*`<#\]?TU((VA(!)8!P"-1`=>GM/H=N**31 M3OO2]7WFD@,"&(U=FYINGSB.#WU+"_32[J%#CG>IU7]@VW?&F6XG,-;E&?F-%1'/OI#Z0>^+JQC]+EAI7,W46MF8YL#.8[`&*;!2.C.V/\`5*8JL8?U!4(@WJ)6]>*@@83& M`B)7$6Y5*4A@)W*F,''<;7=00P8$``8G>9\0/WJRJJ[78#V?0*-LIA,8IA'@ M3?D/GY'@?'_/C2NQ)^,J5?\`?I%<)KUK;?N_,L6X(S!D607*V:4W'%OGE'!N!*D9C"/%$3B`B`#POZ?N(! MH%HDA<9*Y61]"^`` M`'MH)8\_A"7).I=O-%CJ8\J``>?X\>WMSY#V``'P`_(?'^-4;%_'A8NKAT&L M+$PCTLMKT4LP/'S5[KLOE6P%4#M,Z=WF2%Y'VU]]@`:R:J152*:H+7(A@2' ME52')Y%N>.'=4R@"A3E`.`Y$G(^P^X_W"/R/R/OS[:^^\!P[<-'PRE93 MCJM/KO?J=3HQ!5V_M-J@H1F@0!,JLI(2;=F5(I0\F,H*W'8`>>>-C<1WJXSM.90U@2L; M%S&Q[.:B7CU-,J14K!!.'$:XDVZ(%!9D#*=AUVKOA<5UBAZ0Z*C3(/O\$*A4 MW7SC[*MIDSZ4-=TNN&/S`"W&/.#M"S#8G],78<`[JL2Y\S)D6@2M2Q+;F%\9 MU6K24S/2]CL-<B 2T%B^99G%Q<6MB%<1T4IHB__9 ` end GRAPHIC 14 g852944g70u47.jpg GRAPHIC begin 644 g852944g70u47.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1#04&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!\<`5H``QLE1QP!6@`#&R5''`%:``,;)4<<`@```ESG`#A"24T$)0`` M````$#PD_<^XM2()RHK8&Q`5_LA@`````````IV96-T;W)$871A8F]O;`$````` M4&=0.$))30/S```` M```)```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4````` M`$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$` M6@````8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/__ M__________________________\#Z`````#_________________________ M____`^@`````_____________________________P/H`````/__________ M__________________\#Z```.$))300(```````0`````0```D````)````` M`#A"24T$'@``````!``````X0DE-!!H``````S4````&``````````````!T M````1@`````````!``````````````````````````$``````````````$8` M``!T``````````````````````$`````````````````````````$`````$` M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$ M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<` M``!T`````%)G:'1L;VYG````1@````9S;&EC97-6;$QS`````4]B:F,````! M```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`` M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`` M````````3&5F=&QO;F<``````````$)T;VUL;VYG````=`````!29VAT;&]N M9P```$8````#=7)L5$585`````$```````!N=6QL5$585`````$```````!- M'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO7U M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1 M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,' M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6 MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/0,?]1ZS;C3%&>#?2#P M+6Z9#&_UV_IEJK.ZY38[#&50)R,)PR*P.2&?SM?_`%RK>W:KE633;C-RFN`I M>T/#W:`-(GW?NI*2I*+'LL:'L<'L=J'-,@CR(4DE*22224I))))2DDDDE/\` M_]#U0@$0=0>0N&^MGJ]/Z?\`LYTG&JR69%+)+?4H>;/4Q][?]%:__J+%W2R? MK+T>OJW2KJ2V;ZVE^.X<[P)V?U+?H/24X'U&ZC2[JF?@X9L'3WM%^+5<9=7& MQEC![G_G6_O?X-=JO+_JOG5X?7\0D.:VX"LN_-.]L;3_`%-N_P#ZS:O4$E*2 M2224I))))2DDDDE/_]'U5))))3YU]9>DOZ?U1SZ1#+7.OQB!R"?5OJ'[UF/> MW[2S_@K+O](NTZ%U6KJ?3V7-<#:WV7-[AP_UW-?_`(3^<4^K]*Q^K8;L:XEC M@=]-K?I5O'T+&+A7V=8^K/49>&UW'\[7[/DLD';_`,!9_H_]"^RS_`I*?2$E MD]#^LO3^LM-=9-&96)NP[=+&_P`IO^EJ_P"%K]BUDE*22224I))))3__TO54 MDDDE*5?.P,3J&.[&RZQ94[L>0?WV.^DQ_P#*5A))3YKUSZL9O1K!D5;K\&IV MZG(K);=3_;9_,?V/U7_@*UK=#^NUHVT=4<+V=LI@VV`?]VL?_P!&X_\`VVNS M(#@6N$@Z$'@A2WZ8;^]M5U>*X+<_H'7K,BVN+@7EK7G8^M[A_.>G_`(3_`-&+ MIJO\9&32ZMN9LW5@N>P,_GFZ?1/W(_TN[]'L_P!(DDI__]/U5))))2DDDDE*22224@R<+#RQ&517<.!Z MC0Z/AN"X3)^JW3+OKJ_$%0&&S']5U8@AA@\:E<)E?6+"Z=F9W M6;V/L&5I2U@;/IU@4UN][_SV^_\`Z\DIG@NPK/J]U+ICB78-&;52R1PU^175 ML:W_`(UKG_\`7$EG].<\=`ZLW:=[A1='_"-NWG_I/8DDI__4]522224I)))) M2DDDDE.9]8\HXW1[RTP^Z*6QS^E/INV'L#HTU$KJOKDXC"Q M(X.3)^560YC5Z7H[!Z6W9LCV[8V[-O[NU)3224__6 M]527RJDDI^JDE\JI)*?JI)?*J22GZJ6/T+_F_P#:,W]CQZF\?:MN_;,OV^GZ MGZ/T]_K?S'Z-?-J22GZJ27RJDDI__]D`.$))300A``````!5`````0$````/ M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4` M(`!0`&@`;P!T`&\`FMC.60B/SX\>#IX;7!M M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!8 M35`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z M,C<@("`@("`@("(^"B`@(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W M=RYW,RYO&UP.D-R96%T;W)4;V]L/@H@ M("`@("`@("`\>&UP.DUO9&EF>41A=&4^,C`Q-2TP,RTQ,%0Q.3HT,3HU-BLP M-3HS,#PO>&UP.DUO9&EF>41A=&4^"B`@("`@("`@(#QX;7`Z365T861A=&%$ M871E/C(P,34M,#,M,3!4,3DZ-#$Z-38K,#4Z,S`\+WAM<#I-971A9&%T841A M=&4^"B`@("`@(#PO&UL;G,Z>&UP34T](FAT='`Z+R]N&%P+S$N,"]M;2\B"B`@("`@("`@("`@('AM;&YS.G-T179T/2)H='1P M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O&UP+FEI9#I$,34T13,R0S)&0S=%-#$Q0D%&,$8W-38T M0S,Y1D-$.3PO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@("`@/'AM<$U-.D1O M8W5M96YT240^>&UP+F1I9#I#13`V0D$P0S(Q0S=%-#$Q0D%&,$8W-38T0S,Y M1D-$.3PO>&UP34TZ1&]C=6UE;G1)1#X*("`@("`@("`@/'AM<$U-.D]R:6=I M;F%L1&]C=6UE;G1)1#YX;7`N9&ED.D-%,#9"03!#,C%#-T4T,3%"048P1C7!E/2)297-O=7)C92(^"B`@ M("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP M+FEI9#I#13`V0D$P0S(Q0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@ M("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP M+FEI9#I$,34T13,R0S)&0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO&UP34TZ2&ES=&]R>3X*("`@("`@("`@/'AM<$U-.D1E M&UP+FEI9#I$,#4T13,R0S)&0S=%-#$Q M0D%&,$8W-38T0S,Y1D-$.3PO&UP+F1I9#I#13`V0D$P0S(Q0S=%-#$Q M0D%&,$8W-38T0S,Y1D-$.3PO&UP34TZ1&5R:79E9$9R;VT^"B`@("`@(#PO M&UP;65T83X* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`*/#]X<&%C:V5T(&5N M9#TB=R(_/O_;`$,``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`?_``!$(`'0`1@,!$0`"$0$#$0'_Q``=``$``P$``@,````` M````````"`D*!P,%`00&_\0`+Q```00"`@$#`P(%!0``````!`(#!08!!P`( M$0D2(1,4,146"AS> MN%IB-Y4P<1QT,6*P]A$@V4\C[$ MAMY@C*'&EXP'ZF'F8BPQ@4U`2L=-PTDP@J.EH@X:2C#QG//L("/#=>%*87XS M['F'5MJ\?TJSP/9LTBY*26IJ-V2HV[]?U_,S+ MP#&SM!W`^^,7'4!MDC'!B'Y'7]]GV&`HULPV78C)6KV_#4=B#A58DMGC>E[8 M9DD[.@>AIV$J$GV=[::#TR?L5CK-.PL;NO1-%VI*IE;%K8:,[B=5MB4MR)43L>JUZ=N&HI0%MK$LS=(F,>-&K&'U)RIR MOWS[1FL6..7]1AU@L2699Q-0<*8$&4OTNMW5_2G?70KQ8=IC8[80@%%/DWUH M&KQO[WI;X`T4>X]E#8@U:Q$+LI+K_L0,K6UV4XIO.,J2DW.LX;M.`X#@.`X# M@.`S\_&?QG@8S?4HZG3'7'M'*3=.CW`(&Y3D]N#3+\9'O+R<"=(-WO9=$!;\ MY1,6W4VTXQC<57C492D"AVV_A,K63;Y'#,TTY^[W_*ZY>Y;#;PTT=%NT=:[5 MZ#J]VCY80BW1#6*SL*%P_ED]678@R"D1S&;+KV_PR&\V M76M_C!RF8*XP"EK:2Z\(DPH&4C''FAIR"/DX8EUIH[+S091):P=O?2J[!MER MH<-6;F4IU&9ES!G^F[M=34G@GF1!#["QV]8V[ZC4H_43I-2.5A3,C#2C33S0<_7)^QF(L@3TT-R=&+)&[&JSULV'U\I4XQ8M>[DI4@?5=QZ#7DO)#Z<6>NX& M)UR4)E+*(Z1@LM:1D24-*7K:LR1PD*I?";6PYK8MC][W^J+#.C?K36,3]&UW MVREHK8\#AL<<#?EB]O6/;CK5N:7CH'5^YJ18=G&(8&)DE9=F":SAU=@#B% M$LCMRAL.RP23(!`K(*&$$,+<9P*&2ZT$B^`X#@.`X#@?4/`!E03(R4"%D8V0 M&>#/`.':+"-$);4R0*4,^AQD@=]I:FWF74+;<0I2%IRG.<<#/UW:]$*DVMBR M;,Z<(B]%(SK&5,4I:!8]I)5%6Z@(%J*JPZ MS)?`9'M`XWQZ=G>BV["M=/2U=0";V]`0]FFBZ/;=3WN<@WL?NA5.-1[;:$6( M0MA/M8D(*RPAJW$K-BS?!.<>]5GX7EUG^)%OM)DJH#NI MJH_JM8AY:7LM:$I9*?YV0:_T]`A,#/0TNLS5=EBT"2)`CDA4[#!2[A[C<]#U M-L<;Z%I)WR1K+T-N_779/3>M]\:FFDS^NMJ52+M]6DLI;;(^QDFO+H$D.T\0 MD*:AS4%1$Y'9>=7&S`)P#JU.C+SRCK?`&8<\Y6V(3*`DD"8SE2L^1G6E8SG.<9QG/G@9-+MZ5_6:]>L MQ>]1?LP"D>-'#88GOIOQAZS-MZVE9JMX]%FU5H37O9O05!/,DM8]>^R=^JNN,D@.1X M\-7BK#8(J1KL:.I7TVPV;;4K)9%H0G"OOK2:ZM:L/-I11=1P'`>=<5A"&VFDY6XM:E9PE*4I3E2LYSC&,8\YSP,F^S?43TKU M@VKVG[J;#K-RMK.ZB,-:\BJ5648S9K8SA`D]%X;L?M;%:P MA=]<\#(4KV)GO;6U/B_?42%]`F5+%E.QT.8)(C%7".HNP)EL_P#P7!RQ[!+M MGLQCX]Q3ERB\+_[Q@%.,>?GE))PTD%=RP<+_,J9"JLY+1[Z5MJ9.KU7D)VQ#.I5[FW(K"\8S[?'`RZWZ*J M<['X%G:]"SF0O[9_<8W$S^/'G'QGQG\>,8\Y^,>//GXPDKH+8/1&@'R;9V'N M/V[B1@(NFU')64^&73").PS+P[:OPIQAD=AQY/\`R0DAC*L8^HG@:$^`X#@. M`X#@4_\`K&R!(>INO;;2G4,.]AG2"O8I26W\1FB=VR(P[WCXSC[P8<8 M<%2K&/]4(^YS#!`\MNJP&;"98+84P4/6,C#0U9PM*DX^H-*,1YEHC'TJ6EV*L82L9 M3GRV@+2N`X#@.`X#@59>K[2B['U.9M@0KAKVJMFTZY/,-(RX[B-FFY765, M+AJ?#&C-E0X!V8ZQ`1&6U.EA-DR%@2"6'!'-\2?P;6X>(BZ_$Q<#! MQXD3"PD<%$1$7'L-B@1L7&C-!@`!#,I0T.(&*RT.,PTE+;++:&T)PE.,<#V/ M`P:YWJ34E#/6=N[U=5F?RW[)!,837G_V^*_A? MAU##)`TYEM&4XQ]93_NRI6,82/WZRGPO)X#@.`X#@.`X'PI*5I4E6,*2K&4J M2K&,X4G./&<9QGXSC.,^,XS\9QP(Z:(ZFZ`ZSRVS)K2&OQZ(9MR=%L-W:"FK M'(1I1P+\R8&/#1$S+R,75H@4ZQSYHT)60XF*8>EB4-"(&:#8%7ZSGY$C.!__ !V3\_ ` end GRAPHIC 15 g852944g78f56.jpg GRAPHIC begin 644 g852944g78f56.jpg M_]C_X0I417AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!```` M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4 M````D(=I``0````!````I````-``"OR````G$``*_(```"<0061O8F4@4&AO M=&]S:&]P($-3-B`H5VEN9&]W`1L`!0````$```$F`2@``P````$``@`` M`@$`!`````$```$N`@(`!`````$```D>`````````$@````!````2`````'_ MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D) M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P, M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`H`!\`P$B``(1 M`0,1`?_=``0`"/_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$` M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,! M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56 M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$# M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:F MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`\Y"F$,*83@A,U%8@,*,P MI\5I;#%9IY51A1ZW058QEJYHNKCD*^PB%D56Q"M-R-%:C)H9($ELW$0LV\C5 M&LR)"IW62FSDNQ0(:UBKV(SRJ[RJF0NCB&B)Z"41Y0BH"V`Q*BI%134O_]#S M@*0*@I`HJ2-**TH`*FUR<"@MICD9KE4:Y%:]21G3'.%MMEA"/1DL9:Q]C/58 MTRZLF-P_=W*'VOIOI-:,,FP5AKG[R`;-A_2;=SO^U.QWM^GB^M3Z7K>C3#B9V&RM_I[FV?29C?:*-_[_I6J49=&`X=4MN9TY^XLP[&%VXB+ M]&S]`-9Z7T*U0<\]T>K*Z8QKA=C/O+G[@0[TRUFT?H6N#K&_SGMWOK]]3_4_ M17;%3R+:B\FH$,/8C;&OAOM_-_EH'(NCB6>Y`>Y)ST)SE#*5L\8TLXH93DJ) M3%RQ3))()?_1\W3A13HJ9`J0*A*>4E)0Y3#T`%.'(VBG0Q[<`,#=MGW?I*9C^3^C64')]Z M-HITZLCHX]$W49)/4K]7W?X147O;)VSMD[=W,3[=T?G;4 M(O42Y*U4S<]0)3$II0M*B4Q2E,@E29)))3__TO-DDDD5+I)DDE,I3RHI)*92 ME*BDDIE*:4R22EY3))DE+IDDDE*22224_P#_T_-DDDD5*22224I)6<7':^IU MSVDCU&45DG94++`Y[?M%[O8SV5N_1_X3_K:W;E##]7> MZC)Q6CTWFQAWV8[]WJ4^I_.(2TX?Z]U7ATDLXQQ<.M_RD\RDN_N^I70C1F9N M(76UX/2'7Y6,;"'4YOH4YN)\4DNZPOJKT.[K?4<.V MA_I8W6*,.IGJ/!%%@R"ZN=V]^_TV?I7?I/\`A%0?C_5EGU0=U=O2K'9;US_^TO\`X.DIY1)=7USIOU7Z=TVGJF(Q^4SK-E=W3\5U MKFG'QZMAZA5D6M_G+GY3K<&O=ZOIU?I?6]6MI9>`ZS[.6.KN`;?1"[&=A.,@_JSAL=B^X']%M59)+]B*%W6K>_ M;O6-]]GVNS?E8XP\@Z>^@-%+:'MV[?YMNW=_.*Y3D867TG$Z?U'K.15BXSG/ M;@-QC8RLN=9N-5S7LW6/8[]'ZG\UZMBQ4DDO697UBRGLQV_\Z\B\XKF6XS78 MA.UX]M?VJ]WNLLJ8]_JN=]H6>\=)^QNZ>WKUSL+USD^D["?!NV>B_(TMW;WM M]M7_``7_``BPTDE.AU.ZEV/B8M&?9GTX@>RAKZO1;2QSO4GG`%SOV@USJMHV["U MI!D2[]*'-=[/S%;:?J_M.]MA=PTAU0'YWNC:?Y#=G_7-_P#@EEI)*=`GI'ID M;0'[7PYI;&[W^B=KOW?T/J>[_2+.'"=))2DDDDE*22224I))))3_`/_6\V3$ MP)3I(J=*[ZN=8ILJ&DM-E3FN9+=+!ZCBS^;<-EG[EGZ-1JZ!U2ZDWUU` MU"MMH>70'!S&7[*]WTK&5VM]3]Q9Y+BP5DDL:26LDP"Z-Y#?Y>QF])Y-CMSR M7N,`N<23`&UO/[K4E)LG#RL1S&951I=8W>UKHDM\?:7;4%*3`$Z`0/(3N_ZI MR22FXWH_4W@.KQW6,(#=KV,R![K-GT:[:_4_<1C]7>K,-7K5"AMSK&M MLM.U@])GVFQUCX=Z;/1:]_N_T?YBI8F)9F9#,:HL%ED[?4>&-]H=9M]1_L;N MV^U67=!ZFRH7"@/K-?K%S'M,-]Q]VYS/?[/YM)2_[`ZW#C]CL]@W.$MD`C=N M+-^[;M57)Q,G$L]+)K-5A$AI@Z2ZOEAQ'R>BY^+2[(MK::6!KG6L>U MP&\[6=]V_#A"24T$&0``````!````!XX0DE-`_,```````D` M``````````$`.$))32<0```````*``$``````````3A"24T#]0``````2``O M9F8``0!L9F8`!@```````0`O9F8``0"AF9H`!@```````0`R`````0!:```` M!@```````0`U`````0`M````!@```````3A"24T#^```````<```________ M_____________________P/H`````/____________________________\# MZ`````#_____________________________`^@`````________________ M_____________P/H```X0DE-!`@``````!`````!```"0````D``````.$)) M300>```````$`````#A"24T$&@`````#4P````8``````````````W````*H M````#P!#`$\`5@!%`%(`4P!2`$4`5@!)`%,`10!$`"T`,@````$````````` M`````````````````0`````````````"J````W`````````````````````` M`0`````````````````````````0`````0```````&YU;&P````"````!F)O M=6YD'1)D%L:6=N96YU;0````]%4VQI8V5(;W)Z M06QI9VX````'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E M7!E96YU;0```!%%4VQI M8V5"1T-O;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<````````` M"FQE9G1/=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG```````` M``MR:6=H=$]U='-E=&QO;F<``````#A"24T$*```````#`````(_\``````` M`#A"24T$$0```````0$`.$))3004```````$`````CA"24T$#``````).@`` M``$```!\````H````70``.B````)'@`8``'_V/_M``Q!9&]B95]#30`!_^X` M#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3 M&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0 M#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,_\``$0@`H`!\`P$B``(1`0,1`?_=``0`"/_$`3\```$% M`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$``````````0`" M`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(& M%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B M9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>G MM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%" M(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__: M``P#`0`"$0,1`#\`\Y"F$,*83@A,U%8@,*,PI\5I;#%9IY51A1ZW058QEJYH MNKCD*^PB%D56Q"M-R-%:C)H9($ELW$0LV\C5&LR)"IW62FSDNQ0(:UBKV(SR MJ[RJF0NCB&B)Z"41Y0BH"V`Q*BI%134O_]#S@*0*@I`HJ2-**TH`*FUR<"@M MICD9KE4:Y%:]21G3'.%MMEA"/1DL9:Q]C/58TRZLF-P_=W*'VOIOI-:,,FP5 MAKG[R`;-A_2;=SO^U.QWM^GB^M3Z7K>C3#B9V&RM_I[FV?2 M9C?:*-_[_I6J49=&`X=4MN9TY^XLP[&%VXB+]&S]`-9Z7T*U0<\]T>K*Z8QK MA=C/O+G[@0[TRUFT?H6N#K&_SGMWOK]]3_4_17;%3R+:B\FH$,/8C;&OAOM_ M-_EH'(NCB6>Y`>Y)ST)SE#*5L\8TLXH93DJ)3%RQ3))()?_1\W3A13HJ9`J0 M*A*>4E)0Y3#T`%.'(VBG0Q[<`,#=MGW?I*9C^3^C64')]Z-HITZLCHX]$W49)/4K]7W?X147O;)VSMD[=W,3[=T?G;4(O42Y*U4S<]0)3$II0M*B4Q2 ME,@E29)))3__TO-DDDD5+I)DDE,I3RHI)*92E*BDDIE*:4R22EY3))DE+IDD MDE*22224_P#_T_-DDDD5*22224I)6<7':^IUSVDCU&45DG94++`Y[?M%[O8S MV5N_1_X3_K:W;E##]7>ZC)Q6CTWFQAWV8[]WJ4^I_.( M2TX?Z]U7ATDLXQQ<.M_RD\RDN_N^I70C1F9N(76UX/2'7Y6,;"'4YOH4YN)< MXE[;K,;,I?=]#]#ZU-O_`!=57*^JW1J3E=4#'CI.;7@CHE;['@FS.+?5;Z[? MIV8#*\4DNZPOJKT.[K?4<.VA_I8W6*,.IGJ/!%%@R"ZN=V] M^_TV?I7?I/\`A%0?C_5EGU0=U=O2K'9;US_^TO\` MX.DIY1)=7USIOU7Z=TVGJF(Q^4SK-E=W3\5UKFG'QZMAZA5D6M_G+GY3K<&O M=ZOIU?I?6]6MI9>`ZS[.6.KN`;?1"[&=A.,@_JSAL=B^X']%M59)+]B*%W6K>_;O6-]]GVNS?E8XP\@Z>^@-%+ M:'MV[?YMNW=_.*Y3D867TG$Z?U'K.15BXSG/;@-QC8RLN=9N-5S7LW6/8[]' MZG\UZMBQ4DDO697UBRGLQV_\Z\B\XKF6XS78A.UX]M?VJ]WNLLJ8]_JN=]H6 M>\=)^QNZ>WKUSL+USD^D["?!NV>B_(TMW;WM]M7_``7_``BPTDE.AU.ZEV/B M8M&?9GTX@>RAKZO1;2QSO4GG`%SOV@USJMHV["UI!D2[]*'-=[/S%;:?J_M.]MA M=PTAU0'YWNC:?Y#=G_7-_P#@EEI)*=`GI'ID;0'[7PYI;&[W^B=KOW?T/J>[ M_2+.'"=))2DDDDE*22224I))))3_`/_6\V3$P)3I(J=*[ZN=8ILJ&DM- ME3FN9+=+!ZCBS^;<-EG[EGZ-1JZ!U2ZDWUU`U"MMH>70'!S&7[*]WTK&5VM] M3]Q9Y+BP5DDL:26LDP"Z-Y#?Y>QF])Y-CMSR7N,`N<23`&UO/[K4E)LG#RL1 MS&951I=8W>UKHDM\?:7;4%*3`$Z`0/(3N_ZIR22FXWH_4W@.KQW6,(# M=KV,R![K-GT:[:_4_<1C]7>K,-7K5"AMSK&MLM.U@])GVFQUCX=Z;/1:]_N_ MT?YBI8F)9F9#,:HL%ED[?4>&-]H=9M]1_L;NV^U67=!ZFRH7"@/K-?K%S'M, M-]Q]VYS/?[/YM)2_[`ZW#C]CL]@W.$MD`C=N+-^[;M57)Q,G$L]+)K-5A$AI M@Z2ZOEAQ'R>BY^+2[(MK::6!KG6L>UP&\[6=]V_FMC.60B/SX@ M/'@Z>&UP;65T82!X;6QN#IX;7!T:STB M061O8F4@6$U0($-O&UL;G,Z<&1F/2)H='1P.B\O;G,N861O M8F4N8V]M+W!D9B\Q+C,O(B!X;6QN&UL;G,Z&%P+S$N,"]S5'EP92]297-O=7)C945V96YT(R(@>&UL;G,Z&UP.DUO9&EF M>41A=&4](C(P,34M,#4M,#%4,3`Z-#$Z-#DM,#&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#I#.$-!03E#13(T M1C!%-#$Q0C=&-D(Y-D4P1C1",#1#."(@>&UP34TZ3W)I9VEN86Q$;V-U;65N M=$E$/2)U=6ED.F,W93!B-F9F+3DW9#`M-#AC92UA-F-C+3@Q,&4V,34P.3$X M8R(@<&AO=&]S:&]P.D-O;&]R36]D93TB,R(^(#QD8SIT:71L93X@/')D9CI! M;'0^(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^<')I;G1M9W(@9FEL M93PO&UP+FEI9#I#.$-!03E#13(T1C!%-#$Q0C=&-D(Y M-D4P1C1",#1#."(@7J% MAH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76U]C9VN3EYN?H MZ>KT]?;W^/GZ$0`"`0,"!`0#!00$!`8&!6T!`@,1!"$2!3$&`"(305$',F$4 M<0A"@2.1%5*A8A8S";$DP=%#$A:.SP]/C\RD:E*2TQ-3D])6EM<75Y?4H1U=F.':&EJ:V MQM;F]F=WAY>GM\?7Y_=(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZ MBIJJNLK:ZOK_V@`,`P$``A$#$0`_`-*H>UPZKU(]Z''KW7(?G_7_`.('MT<. MF7^+K,AY'YOQ_O/O8X]>'#K*/TG^HO[MU9O/KE%_9_V/^\W]^ZKU*0_\4_VY M]N#AU7RZDI_Q'_%/>^O'@.LG]/\`??CW<<>JGRZD1_C_`&'MP<#U4<3U+4\' M_7_XI[]TVW$]2E_5;^H_WK_D?NPZT.'4^&_-R#<?=QQZHWGU.C^@ M_P!?_B?=QFO5.ID?`(_UOK_3VZ.J'AU(3\#^M_\`?'_;>W5XCJAZEQ'Z6_K; M_;_\:]J%Z:/'J?'^I?Z6-_\`8?3_`'OV\G3;>=1U,C_'_!CS_L/^(O[5)QZ2 MR#'4^/ZB_P#L?]L?Z\_CVH3RSTF/4R#_`'HC_>[^U8]>D1X]3H_U7_K;_;7( M]JDX=)'XGIQC_4O^O_A_3VMCX=(VX'Y]2QP1_KG_`'D>UT/ETBEP#U.3@#_7 M!_VXO[71]%LI*BG4T?0'_"__`!'M?%T579S7J9%^E>?K_4#@'V9Q<:=!^;)K M7IQB^G^/'/\`K_\`(O:^(>?11<9'SSU.C'('X/Y_V/M;'YGHGEX@=/=*.1_K M_P"]^UB^72*7C3I44@^GYM?G_>/;P^SI,W#CGI24HLHM[4IY=(9?,]*&F'(_ MP`^O]1]?]A[6(,`=%$Q'<1THZ9;6^G_(O:V/HIG/GTI*->1_3_??\5]JTZ*) M./\`B?:N,5Z+YR!FGKTKJ%+D?T%N;B_^^/M8G`=$\N7- M#TK*10VD$?GG^MR?I[6(N>BV=M5`>%?V=*:F0UL8S\NBN4X8 M5[@>E'3)I53_`*W^\C_>/:V,5-.BRX?\+CVI1:](9'\AU)$7%P/^(_XGVY@8'31K2I/731 M?6L\0>HLL8Y-O\?QS_`('_``/MHK3CT\K@D=-TZ<7_`#^/ MH3:__$^TSKQQT80N05HW3-5("#_Q%K?47]HY!Y^71S`X^&N>DY4J.1^/I_Q7 MVAD&":<>C.%JLH!.D?ZO\/28JDMJ%_\`>.>;C_8V]H9!0_/HVMVP!7SZ2=DS5CEO];_;_`(]HI.'1K&14`=)^ M464_UY_XI[0R>?1I!A5]>FN?@'_7%_\`;#_>_9?-T=6U?+CTUR_J_P!@WLLG M''H]M373TW2`$?[W_MC[+I?GT=Q'`IY=-TP]5_\`??[[CV72>?1FGETVR?7_ M`&(_WH^R^3SZ,8LDUZ;IN;?ZW'^MR/:)^EZ=-4MN?Z<_[:P]I).&.EL?`]0) M?H?];^MO:-N)Z5K2GSZ:Y!Z2?SR+?X?GVG;CTH3A7J$WU/\`OOZ?7^GM,_#I M4O3=*+D$?@&_^\>V&Z=3CU#?Z_[#_BOMANG5ZC37(`'-O;1X=.#IKD^O^N2? M=#UL<3U#F_U_=&ZOY=-TAY(O_P`C/O7ETX/AZB'ZF_\`7VV>!ZN,TZX-]#_L M/=#U8<>H[_T_Q/\`O'_(_>NMCB>HS_\`$^Z'K8'$]85_M?\`!C[KU;K@W_11 M_P!]_O/NN>MGRZPG\^]=4/'K@?H/]<_\1[HW#I_K"_U'^V]Z7AUKK$?>NJMQ MZZ)L#_K>_'K:\3UA]M=7Z__0TJA[7#B>J>0ZS@6O_B2?]O[]7(ZWUS7\_P"P M]N#IE^/65/J/]?\`XGWL<>O#AUE7^U[MY]7;A^77)/HO^O\`\3[]U7J2GX_U M_;@ZKY'J4G^]W'^\>]^?6APZR_T_WW^'NX_R=4/EUF3Z#_8_[V?;@ZU3/4Q? MS_K_`/%/>^FFXGJ4AY6_]/\`BGO8Z\//J?#]+?FW^^/NXZHU2>IR?I_WCC_7 M]W'5.IW5Z;/4M/]]_L?;@.1UKJ1'>Q_U_\`D7/M2IZ:(Z<(_J/]B/\` M;^WDX]-/Y]38[W_Y"_WBWM4G29LGJ='Q;B_)X_PMQ_O?M0GETF;B?MZF07Y_ MV-O]?_D?M6OEZ=(&\^I\7'^]7]JH^DS^?KTX17NO^OS_`+;VKCZ1,,?GU-%K M_P"PN/\`7]KX?+I%/Y=34/-O\%_WA?:^/AT639/4ZU_^2?\`B;^UT1X=%5TM M?V=3(OHI/^'_`!/LSB_GT17``SY=.,0YM^!_A]?IQ[7H>'SZ*)AQ^73C']0# M;CZ?[?VNC\NB>7C7[?\`#T]TPY'^P/\`L3[5IP'2"3XCTIZ0?0 M7I,P(\NE)2VM_L1_Q`_XGVJ3RZ0R^=>'2@IOJ/\`??@>URB:4TDZ5U$.5O<_7_>_:J/ MY=%\]34'TZ6%`/H?R0O^]_3^GM6@\OGT52'2:_(=*JC`+7M];$_X?GVK2N!7 MHME^(FF>E12KPI_Q`_V_/M?%T4W`(J0>E)3@<7Y%Q_O1Y]KH_+HIN6-2/P]/ M$2@#GFU[6X']?\?:Y/*@Z)I116+'A7IQB`M_A>QM^?:@5"_/I#4%_EU+]N#` MZKUT1<6]Z;AUL&G$8ZB3``$_X'Z?[$^Z$:@">/6ZE2:<.FV4$W']?ZE\?&GSKTRU/`/^V_WW^M;VBD&.C>W?-2,TITG*D#G_??VO:*7@.CB$D5I MQQTEZOZL?\;?CZ7(]H)!FGET:6[$J2>..DC7"[@#@7_W@"_M(XH&]>C&/N9/ M3I*5HXX(%V/'YN#P?\?:&3SQT=0UHO=QZ1]<+EA_KC_;7`_W@>T9.#T8H.[I M-U8%F_Y'^3[0R='D%*5/#I-U(X;_`%O^-?7V@EZ/+?@/L'29JQ^H?UO_`+R3 M_P`5]H).'1G#PZ2]2.3_`(7!]HWX'HTAX@],,WT_V)]H9?/HWAPJ_P"KRZ:9 MO[7^P_WH>RV;H[M>)_+_`"=-4H`)M^+C_8D>RV;H[MA0@=-\P'(_Q_X@^RV6 MO'H]@_GTWR_@_P!;_P"QX/LNEX&G1C%2HZ;)N&/^PM_MC;V@DX&O2^(]P].F MV;Z`?Z__`!(]HG\^C!.'39(!^?\`?</:.0_MZ7Q>0Z;I38'_`%O:1NE: M<".FQ_I?_@WM,_GTICX?GU!;ZD_UX_VWM._ITI4>?3?(;7_K[3MPITX@XGJ$ MWU_WW^O[9;AT\OSZC2GC_8>VFZN/+IKE)U<_B_\`MO=#UL>?4*;ZVN/]\/K[ MHW3GETW2?4_GWH\.G!\(ZB?D?ZQ_WL>VSP/5NN+?3Z_G_B/^*^Z'JXZC/^/] MC_Q'O77EZC/^/\?;9ZL.'6)38,?\3[UUL<>L9/%O\;^ZGAQZL>L1-KGWKIKS MZX$_[W?_`&_NC<.E'6%_J/\`6'^]GWH8!ZUUB/O753QZXL;`^],:#K:\>L7M MOJ_7_]'2I'M<./5!PZD#Z#_6'O7G^?6^N0^O^O[<'33CSZRCW88/6APZS+]3 M_L?][]['5SPZ[C-C8CD&_P#O7O?5>I2\7]W'5!Y]25X/NW6AP/68<6]V'$=: M/GUE0\?['_>_;@X]5KPZFH;_`.MP?^*_['WL=4?B/3J0G('^''^V][''J@X] M.,!L;?FW^Q_V/NXZT?(_/J;&?J/]]S[N./3?4R/BWX_%O]O_`,3[=4UJ>J^? M4I>>"?KQ_L!S_MO;@ZH>I*?0^U*_SZ;;CU/C_!^O^'^O;V^E*],O7J9&3JM_ MK$?Z_M2OETF/Q''4^,\,?K:UO\+"U_S^?:A<$=)3Q/4V+Z?ZX/M4AZ2,,'J> MEN0/IQ^?\+?\1[5QUZ22$:N'4]/JO^N/:R/I)(`#CSZG#EO]A_QOVNA..D$H MJ3U,C-[?X`7/^PM[,(CCHLFXUZ<%_P"(^O\`L1^/QQ[71>719<\3CRZE1?I' M^NO^]_\`%#[,XN/Y=!^X!TYX].<7!_PX_P"1^U\=#2O'HHG)4<.IZ7+*?\/] MYN/^*^UT9QT3R@U^73W3?53_`%('^]^U2?Y.D4GKTJ*4^H6_U-Q_MO;R=)W_ M`,_2DI6%A_O-_:I,XZ+I?,CI_IOJI_WWT'_%/:Y.`Z)IA\72DIR+C^O-_P#8 M6/\`O7M9'PZ*;@<:<:=*2BM=;_ZW'U_'M:G#HHE`K7I649Y%C]+G_#D\>U47 MSZ+KCSIQITL:$CTC^@7Z?U!_XU[6)7^?13*,T^72IHFY'X!M_MOI_A]?:Q.B MR4FH%.E32GZHFNE^;<7_P!Y!M_L/:R,T/1/,*HV>G"%@!:_T_X@?\4]J@:@U'2` MC2:>?4P$6][!I4'K5"<@=>)%O?J@X'7J'TZA2L+$7Y-_S_OOZ^ZEJ5ZV%U>> M3TVS-:Y)M;@V_P!YL/:1O,=&"#AZ],M2UE-_S?\`//\`@;_ZWM)(:C'1Q;C3 M34*BG2W^L./:&0XXXZ-H/(`9QTEZMKZA]/H?\?J3?V@D)U5Z-8`-) M'GTDZUO4/ZGG_8\>T,E>'1U" M`0IID4Z2%;R6_P`+_P"QN3]?:-L*>C*,$R"G2;JR+'_??X_\3[12<>CJW`TG MT_XKI-U)%C_B/]Z]H)?3HZM^`Z3%41S_`*YM_P`E&_\`C]/:"3HV@X?ZO7I, MU9/JY_WPO_Q/M$_&G1I'@'IAG-@?\/\`C1]H9//HVBX#IIE/U_UA[+IN'1W: M9Z;)N&/^/_&Q_O(]EDIQT?0"CKCIMF//T_(_WHCV72G'1Q",D]-LEA;CFQY] METOGT9PCATVSFV4CD'Z@7'^\GVC?HP08ITV2_0_['_B M?^*>T4G1A$`*=-TOZ6_X*?:5_P"?2E.FQ_\`B/:9R,]*%X=0I+#_`&QX/_%? M:5CD]*EX#IND-K_Z_MAO+IU.'4)K7XX_K_K\_3VTQZ=&:#J-/?\`V/X_']?; M3=7'36]]1O\`[ZU_;?5APZ@2\M?_```M_C_OC[H>/5Z=0)#S_K7_`-A;ZV]Z M/3GD!U%_/NAX=6'$]<'_`.*^V^KC@3U'?\_X#WH]>'45S_O`/_%?=#U8<.L* M_I)_Q_XI[UU8#/7%SS_KC_;\G_>_=2?+K76%OI[UU4>77#VVW3_6%N#_`*UK M?[W[]^'K76,^]=5/7!_H/]?W5N'6UX]8_=.K]?_2TJ1[7`TZ;7AUG7Z#_8_[ MW[T>/5NN=^1_MO=QU1^'60>['JB]9P>1_B/^(]W].K_AZ[_M_P"P_P")]^ZK MYGJ0AN.?=QU7S/4E?^(][ZT.)'4@6M_OOZ"W^\^[CJO62,_[[_??ZWMP'JOI MU+C_`-]_O'NQZHXZDH;?[<'_`'GG_>/?AQZJ./3A#^H?G@?\5]N#JIIZ>?4] M39O]?G_B?=APKU0X/4J,WX^EK>W5%.J=3%M^?Z?\0?\`B/;@^75#U)CY_P!8 MV_WW^M[?0]-MU.B/`/Y_XI[?7B.FWX=35^H-_P"HM_OOZ'VJ7RZ2MY=3D/'] M`?J0?]X]J$Z32"E?GU.A/X_WW^^O[5+QSTD/#'4]`/3_`,%Y_P`?I[5QGI)( MH[?7J>G]DC^OT_I[61GI%*,XZGI_M_\`'_>/:R(^72*2O'J7'<"_^L/]M^/] MY]F,1S3HMGPM:=."?0<_X?[S., MT*]!^;*FO3E'_3_B?]C[,(SPZ*;E:5ZE'2-<+_OO^*_GVJ3R/ M2"4$FGD>E#3D>C_'ZG_>_P#>_:R,XZ*IUIQ\^E'3$77_`'P^@'M;&?SZ*)UR M?V=*.C;D7/T_'^^^G'M6AQCHHE'<-7`=*NB<$BWT_//]/H!_2]O:Q#T6RCNK MY?ZJ=*ZBDY4CBXY/^/\`A[6(<<>BF8=V!BG2KI9+:;<ED_3_C8_P"^']>/:V,BH/19,IIIK6O2BII+@`&_%O\`;CZC^OM=&U#G MHKGCU+\^GB&6W!L+_P"OQQ;_`!Y/M8C<".B>:.A*G!].G!'`-[V_V/UX_P"( M_K[4*^./2&2$5K\^I0E%A_7_`%S?_>O;@?`Z8,;9H#3KHR_X^_&3!ZVL3$U/ M45I`=7/')'^!N+?CCVVS#->GHXJ>>.FZ60&_^QN?]C[3LWGTOA0.:'IFJY+` MB_\`O-KVM_L/:)V!-?+HYB2BZ:\.DY4RBQ//_%>>+_CVCD/'TZ,(5IH(K7_9 MZ3-7(#]5^I^O]>3_`+U[0.>)KT;0J*"JT)Z2=8_+?TY%K_X<>TDA_;T9VX.J M@^'I(ULEKV_K]1_2WU_U_:.3UZ-H,8^?24JFNS?XW_WK_BOM')PZ,X*UK3/2 M;JVX;^O/_$?X6]H7]>CNWX'U_P"*Z3M218\_\5'LOE.3T=P)A:>G27JVY-OQ M_M^?:&3AT:0_$*=)BK;]5N;G_D?M&YST91CATQ3&X-Q_A]?^(]H932M.C:WR M%KTU3DV%OH2/]]_A]/9=-_/H\MN`(&,=-DW))_Q-O]A[+)32HZ/;<5"FO3?, M>2?\;?[8?\:]EDO1U!P&,]-LGUY_P_VUN?9?*>/1G"#TVR?7_"_LOD/1A&,] M-3^73=.1I;\7X'M*_KTK``IZ]-D MGY_UO^(]I6)('3ZBF!U!D/!^MOI_7VG;B>E"\.F^3Z&_XY]L-T\N*#J$>3?Z M?[X_[W[9;IT8ZB3$Z6_V/(_V/MH^75CY]-CDCZ_@#_>0/=.KC-.H4IY^O%O] MC_7^G^'NAX]6\^FZ0_J_/XO_`%N?J?=3T[Y]1[_X_3_B/=#QZL.L;_7_`&`] MTZOY=1G^I_V'O1ZUY=19#^K_`&W_`!'MOJPP.N)_1_L!_P`1[\>K*,]8G-S_ M`*PM_MO=#QZUZ]86_'^O[\>'6DX]GNL!N;G^EO>S@4ZUUC]ZZIUQ?\ M?[[Z^ZMU=1BO6/W3JW7_T]*D>UO3:^?69?H/\+W_`-B?^->_'K?7/^G^O[NO M6FX=91[L>FAQ/693P.?]A_L3[V,YZOY=[=:ZSI]/]C;W8=:/E MU)0^[]5_%U(7D?ZWU_WK_B?>QUH\3US7Z_[[^GNZ\!U0^?4N,CG_`&'^]^[] M:.5/4I/K_L+>]]-=3H6Y'/U-O^(_WOW<>77FX=3U)N#_`(V_WFW^]>[?+IL^ M1ZFH?]Z_WO\`Y%[W1Y=-GSZEQ'^GX_U_I_OB/; MRGRZ;88ZFQ\$_3ZDV/\`2_'^PX]OJ>'39%1CJ:IO8_[S[5*>DS"H(ZG1\V_I M;Z?C_C7M2G2:05(^SJ=$?K^+$?[#_D1]J5/20X)Z<$/`_P`#8_[S;VJC-#TF MD%0<>?4Y#_3_``/M9'T@DXCJ=&>/]8V_VQ_/M9&<]))`:'J;&W!%_P`\?[V? M]N?9A$<@]%TV5('3@G(%OIP3_K>UT?'HKE%5J/7J5%P3:UN"/]N?I[,XF!`Z M(9TTLX`[>G&,_3_>_P##Z^S",GAT3S"H^?3C&386YYY_WC_>_:^,_/HFG''M MZ=J8GZ?FW^]<^U<9Z+W7!6G2DI6!`!/(_K_OOQ;VH4\.DCTI2N>E)2N./:A. M'2*4"ORITH:9AQ_0'_'Z]@?ZW'Y_WGVJ0T()Z+YA4% M1D]*RDE(``(N"+#_`&/(_P!A[61D>?#HJN%85`.>E723?IY!(XYO:_\`QKVK M0X(Z+Y14@D?+I2TLW"CZ'@_G\^U4;?/HLE2F`N?\_2@IIK6/^'_$>UJM7AQZ M+V0BM>'3W%,#;G^G'^)'%[>U22"G1;/`2<_ZL=3TGMQ<\?[#^G^]^U"OY^72 M"2`@D=9_/?DFW^V_XI[=UCUZ3F-@1J'71F7^O^^_U_>M>./6A%4UIU'DFN#8 MV']!_O?XN./;3/3CTI2'4,<>FZ68`7O^#P?J?Z?3\<^V'D]./1A#`#2HHO3+ M4S7N;V')'^W^G^\>TCM3'GT8QK6E.'2?JI;^FX'U_P![YMS];>T4K]&4$1X< M.DS6RV!'!/X_'T)_U_:1F]>C*-#Y#[.DI62\D"USR1_C;\W^GM([>?ET90)Y M#CTDZV47;Z7^@^O^L>/:1R37/1I$`,@9Z2U4_P"HW^@_QM]/:.0X/1G`M:'I M.U37^GXO_OK?XGVAT4AZ,8U\O/IEG/U!/`_XC_B/: M*4^?1Q``*#IKF-P;?[#V62GC7H\MP="@#IMD-[VO^2/KS[+)CGH^MUJIIZ=- MDI/^O_7_`&/LNE/1O$.!Z;Y3R?\```?['CV72GHSA!ITV2'Z^T,AZ,(L_MZ; M9SPPN.;\^T3_AQ_ MO7M(Y\^E:\>FV5AS^/\`C7_&O:9L=/KQZ@R'C_"Y/_&_:=NGQP'3=(>#S]>/ MK;\>V":]/"M:]1#]#_K'VTW3@X]09V%C_K>VSU8^G3:YOS_4_P"\>Z=.+Y=0 M9CS?BW']?]?_`'OW2N>K`$FO3>YL/]?_`'H>ZGCTX//K%_OO][]MD\>K=86- MS[K\^K'``ZCL?^*_\4_VWNIZ\<=1).;C^I)_V`Y/NG5^NB#91_0<_P"V'OW5 MAUB?ZG_??GW3TZJ>!ZQ-]1_A>_OQZ\G'K@U[7'XY_P!M^/;7GT[U@)X/^/O9 M\NM'@>N'O75.L;'FW]/=&.>G!P'7'W7K?7__U-*@?7VMZ:''K*GU/^/O9R`> MK>9ZR^]KUX]9`?S[OTSP/6922/K]"#S_`+'_`(GW88'5QQZY-]$/^(O[WUH\ M>LR?G_8'WL=:;AU)3\^W!U5O+J0O_$^]CKS= M[^76A3/4I>2/]!?VXIQUHY'4M#_O8_P!B/^1^W`>J'J5'P1S_`%_U_IQ?VZISTV>' M4Q&-Q^/Z_P"O]?\`8\#VH7ATWU-C/U']/I_L?^-^U*G'2<\3U.B/TM_OK_[S M[4(>'2:09/4Z-N;?UL?];\?\1[5)Y=(WP>G"-N!;\?[86L;?X_7VJ0])Y%Q3 MJ?';C_>O:N-ND,@XTZGQ'_#^AY_Q_K[6(ID9M_KFW_(O][]KXFZ02 MKZCJ?%]`!_K'_;_\4]KXVST5R(.X=3(S;G_6'_$_[W[,82<#HGN5R<8ZG1FW M^Q/Y_!%_9E&?V]$4H^+TZBUQYTSTH:1^;7_WQ_XU[4CUZ1.#73TI*5_IS]?]]?\`VWM]#Y=)95`!KTHJ M9QZ;?D?\4]JT.:]%DZ@8Z?Z5^0+_`.O_`*_XM[6(V.BF9*XITH*>3Z?[[C_C M7M8A^?13.GGTH:.8@@#\V]JT(.>BR12N`.E723VL2;\_3_??Z_M4C?LZ+IHQ M6GXNE11SA;I%ASR.?]XM_B![5H_P`^BZ2,'RR/+_+T[PU)!N/QS;C_`'GV MI#C'2-HS4XP.G*.JN.;?XGZ_C_;7]OB0^?25H0:@#/6<50L+D?X<#Z>[^*?( M=,FV4_&V?LZ\:D6X/^\#_D7OWBGS&>M_3**:6_EU&DJOZ?X\@\6/^'MLN?RZ M>6)0>'=TW2U/'UO_`+$IJ0+_U_WGZ\6Y]IG?B*]+4C MJ1C/^K/3#4S_`%)YL?R+$<_4^TK-@]&,<8%"5J?]7\NDS65%S>YX_P!;GZCV MF9J=+HHRQ!Z2M9/:_//T_P`0+6]I'-?LZ,X4(`]>DO5S?@V_J?\`C?\`B/:1 MVZ,8UX`C'2C:"/S*])^I?ZV_K_L./:"5J<>CNV0 MBM!TG*N2P/X'^^^GM"YK7HVB&#Z=)JKD^H^I^O\`OO\`8>T4A-3T9PH-('GT MFZE[GC_5?C_"_M&_F>C&.A(`'GTTS$"?Z\#_8_C_;>RV4^O1W`M!]O3=*0#_O'^P^M_\` M8>RZ4\>C:("@QTVRL.?ZWO[+I#7HSB%!3ILD/!/]/^*6]H9#TNB&./3;+_3_ M`'W^^Y]I9#CI;&*9Z;9FO?\`WG_>A[1.:5Z,(@!3IMFOQ_K_`/$?G_'VDD/S MZ5H,`^?3=*0`?]C:W]/]A[3L>GUX'IOF/`'_`"+VF8\>GP.`].F^2]P/\?\` MB3_4GZ^V2:].CJ,_T_WW^^Y]M-QZ<''INJ#_`+UR;_GG@^VVX];'ETWO^!_O MO]]Q[H>G!P/4&4@7-_S]..?\?Z\^Z<>KICIOZ=6 MZZ;ZWMP/]]_Q/O1ZMP'6`^Z]4;K&?J?]]_3WH]73AUP;Z'_??7CVV./5SUA( ML!_C?_>/>R:GJI%`.N/O751UA;ZG_7]MMT[UU[UU[CU__]72G]K>F>LJ_4>] M^5.G.LWOR\>O'AUR7Z?['VX.F&%#UG4\_P"N#?\`VQ]['$=6'EUSX*V/XY_W MOW8=;;KG&>!?F_'^\_\`&O>^JG(/4I/Z_P!/K[N.J^74A#S_`+Q[WY]>XKUE M_P!]_OO];W<4ZJ1UG4^D?U_/_$>W%ZUC'KU+3Z_7Z_\`&_>QQZ;84(ZEQM]/ MZ_3_`&/O8ZIY$#IRC-[?[#Z_X_\`$`^W!U3SZF1'Z#_&W^^_V'NZTSU4<2.I M:GG_``_WUO;@H>JGJ5&1<7/U(%OZ?7_;\#VZ./3?4U?K_O/^]>WU\NFSQIU+ MB)N/\?\`?#_8^WTZ9DX]3XCS_3\?CVI7I-(*BO4U#8@_T/(_WW^-O:I#@=(G MXGJ?$3Q_2X/^\'_>_:I#GIA^`-.G"(V`N;?[[_C7M7&<](I05H>IT1YM_7_> MO:Q#PKTB=>)IU/1O]OP?]C_3G@>UL9X=(I5-/GU-C-C^?][_`![,(S4`]%LJ MT/4Q?^)!_P!O[7PMPZ*+I/B`ZGH?H?\`6_U_^->S*)N'1#<+34?+J?$W`/\` MMO\`8GG_`&_LPC/1/<+BOETXPFQ'X'^O[5HV1T5R)Q:F.GRF8VO^+C^G]/I_ M7VJ0](I!Y]**EDO8\W'X/^W_`-Y]OJ:=(Y`&STHZ:7@?U_Q]JT/G7I!(!Y<> MG^GD'%OK_7\_X^U:-T6S)@CSZ?J>3Z&_X]K$;HIFCJ21PZ?*>4_D_P!#_OO] M;VK1NBF9.))Z4M'/P+GG_>^1_C[4*QKTBDC!49Z4M+46T\\<1_@+\? MU]O+(/SZ3M%7(..LXJ;VY/\`K:O]]?W<2'IIH4.*&O71J;?U_P!N??O%/GU8 M0#``)/4>2J'(U?[U_O?^P]T:0<:YZL(2*BG[>FZ6KO>W/]/]\/;+R?/I1'"* MD`8Z:IJD@7)O^/Q_4?F_^'M.SCUZ7I$0!C'3#5U5[@-]+W/^!/\`7CZ>V6;S M/2E5K@9Z3=347)N3;\?[S_MO:5WX]&$,0!6O#I-U51R>>+\?UM_A]/:5VST9 MQ)0`#I.5,OU_V/\`M[?3Z^TSOTOA08Z8*F7ZV(Y_XWS[0NWKTCB!*`#Y=)RKE_`/TO_P`:_P!;VB=O/HSA7RZ3=5):_P#C MQ>_T_J#_`+?VBD;Y]&D2'!`Z89F-R2?R0/\`??[#VCE;C3HQMD.&/'IJE-P> M?\?]B;_[S[+Y6Z/+=:@>O39,W'!Y'`_I^/9;,>/1W:KZ^73;*?\`;?7_`(C_ M`'H>RV5N/1W"O#INE;Z_@\_[&_U]ETIZ-(EZ;9F_%_9?(>/1@@I2AZ;93Q^/ MKS[1.<]+44TZ;I2/\0;'_B?Q[1N>/2]!P%,]-G1@@''INE/U_ MWPN?\/\`8^TKGI2%ITW2_6W^^/M.QX]/J.`'4"8WM;\7X]IB>GU&.FYC=O\` M??T]M'IP=1W(]MGIRE!TVS$$\_T_WK^O^W]M'JRC)].H#GZ_Z_NAZOY#IOF_ MV)^G^P_Y'[KTX,+U";ZG_7/NAX'JWIUP<_[S[H>KCCU'8\?['WKKPR>HS_[V M3[;/5AYGK"+%F/Y!_P!XM;WKK?7$G@\_4\?[<>ZGY=;/EUA)]ZZH>/6+\>ZM MY].KPZX.>!_6]_=5ZMUA)_'O7F>JMUQ]^ZKUA_U_;6>G>O>_=>Z__];2G]K> MF>N8/T]^'$]7'`=9Q^#[]P/6^N0^O^O[='33CSZS+]1_O/\`M_>QQ/6AP'64 M#DCZW'_%/=O3JYR.O+P2O].1[]U7J4I^ONXZKP)'4E3_`$_U_=NM#S'68?3_ M`'GW8>76CUEC///^!_PX^ONXZH1YGJ7&?]N![MUIABO4N,_4?X`_3_'D>[#I ML<>G")OH!_4?[W_Q7W<=-M4'J=&>;WM_OOI_KW][!IUX^1ZF`\#_`%K_`.QM M[='F.J,/3J0A^G^/^^_V-A[='5#U.1AQ_7_C0_Q_Q]OITVW\^I49XO\`D6_X MK[?0\>F7`ICCU.C;Z?7G\?C\?X_T]J%/3!&#U/4_[R/\/P1_7^MO:I#\^D3X MK3J="0;7X_']1[4H>D[BH/3A$?S_`$X^O]+B_M4IR.DCBJ\,]3XFY_WWU^H_ MV'M:AZ1./V=38S_Q4>UD3<.D4@R0>IL;?0_[#_;V_P"*^S"(^71;,M>/4]3< M`_X<\^UT34Z+9E)'4J)B;@\$:UOZ_T/^\_X^UB']G1;*G$T\^GNGE_Q_WU_:M'Z*IX<5IGI[IJ M@BUC]#_K?GVI1O7HKEC.:=*.EJA87/UL?Q_MQ[4(QXCI+(@((/3_`$]7;2+_ M`.]7M_Q3VH5Z\.D,D-.GF"L(_M"Q_KR?I;\WMQ[?#\#Y](#&16G`].\5:+?J M_I]?K;Z?[S[=#YZ9*"GGU-6LO]7`O^`>?I[<#^AZ8>$'CUF%6;<,QM]1];\# M^@X]V#^O5##PH>'[>O&K-N68#_6/^]W]Z+_//6Q%@UK3K`]5];-_K7-_]Y^G MNID\B>KB`<0HZ@S5J@?JY_P^G/\`6WNA>O#AT\J!>(STTSUAY)/''T/U]LE\ M<<]*4A:N1CICJ:O5?D6!_K;DG\^V&?I9'$3Y?ZJ])^JJC<^H?C^GYO[3.W'I M?&E,TSTGYY[ZN?S_`%^G^^'M.[^72Z&,L*TZ8YY@;WM_OA[22/Y5QT:01#TS MTQ3S?4WY^H_WW/M'(^#T;6\?"@Z8:J?@G_;?[[_'VA=OGT;1J.-.DY4RGGVC MD;HRA3'#I/5,IN?I;BW^W]HY#T8Q*:TICIHF?_6_Q_V'^]>T,C"O1O#&0!CI MKE>][?Z_^O\`[ZWLOE;HYMT).*5Z;96O?_??['V62MQZ/K>.@4>?3=*U[_[[ M^G_%/9?*W1M$HQZ]-TA^G/\`4G_B?9=*V3T9PKBM.FR1C/2V-EZ@T%.FV0\?U_/^V_Y'[2NH,A_-[_7_'_6X_V/ MM.QZ?4=-LIN2?]?_`&__`"/VG8]/#J$W)/\`K_\`$^VVX=.#J+(QY//^M^>! M]/\`>/;1X=7^737*UR3_`+#_`!_WP]MGJXK45ZA.?I_KG_;6M_Q/NA/5N)Z@ M2L3>WX']/]A[KD=.#&/+J&">;_U/X_'^'NC=6ZX.>?\`6'^\^Z>?5Q@'J,Y^ MO^V'O1Z]Y=1W/^\#_??[U[H>K`4'6("R$_DCZ_Z_O75AQZX-^/\`6_XGWKUZ M\>/6%OH?>CU09/7#VTWIT\.'6)K"P'^^_P!]?W[R)ZWUB/O75#D]<6-@?\?> MCPZVO'K%[H>/5^O>]=>Z_]?2G]K>F>N0]^\QU9?/K.OZ??CQZMUR_H?=P>J, M*]95_P![]WZ;'$CK,I_2>/Q?_87'^\CWL9Z<'79%F!O]3:WO?5>'4A#_`%_' M'^\>[#K1\CU(4\?ZWN_53@UZD*>/>QUH\>N8^O\`L1[N#U4^?4I."/\`??X_ M[W[OY=:IBG4M#R#]/^-_[$<>]CIGSZGQG\7_`-]^/][]W'6GZFH3Q^/H>+?U M]VZIQ%.IT9N+_7_7_P!Y]N#RZUY?/J0AY_V(_P!O_@;_`-3[<&.J4KCJ;$;B MW^'^W_K_`(_7VZIZ;/4Q#R/\3?\`UK_\4]J%/33#'4Q&XM]?I]/]?_>?:E3T MPV./3A&P*@\_XW_J#;Z^U"G@>DD@XTZFQ,;_`/(O]BV0`:A3/4 MI38@_B]C_P`3_K>S&%O+HHNHL%J=3XFL1S_B/^(/^W]F$;5X]$<\=*BGV=3X MVM^?]]^?Z>UT;<.BF9/B/ETX1-8@B]OS_P`5_)/M8C5Z+98Z&HK3IYIY>`+^ MU*MTBD3RKCI0TD_"\_[S^?\`>/Q[>4BO''29AY>73]!+8<'_`)$?Q[5(W2"6 M,@4ICI\@F^G/X_WP_P!A[5(W[>BZ6,BOIT\T]1_C>_U_VX]JD;HNEC.:=/$, M]K$$?C\^U2/7%>BR:'S`Z>*>JTVY_/M0K]%[H17&.GN"L'IY^MN;\?[[GV\K M=)9$4XZ>8JS\ZO\`>?\`?<^WE>E.DSPGNQCIQ2LO]2/I^/Q^/]>U_;JR4X'/ M21X2W#AU.CK0/SS;\_[U_6WN_B'IKP*9`ZRBN/\`JU'^L1_0?7Z^[:QZ=-&) MJG/71K6`X=3+?D_U_Q_I[H7Z=CA`\JC]O39-6?XC_`%A]/];_`!]M%_3CTL6+%",= M,T]7_C8WO8'\_C\'\^V&>I.>E21@*.F6>H+.&>F"JGO<\'Z^TKM3HQB0DU\ND]437OS^3S_OOQ[1NW1C" MIQ3ICE?DG_B?KR3?VCD;HQMX_/IME87/]?\`??\`%?:"1NCF&,>G3;*WUO:Y M^G^QL+>RZ5^/1S;1_#4=-\A^M_S^+_[?V72-Z='D,9J*C/3=*PL;_P!;WO\` MT_WKV72-T9QIQ-,=-DSEL8(6OF>FV M1AR?]A[1R-Y=+HUS7INF;ZV^@X_W@^TCFGV]+HP*T(QTVS/?\_TX]I'..EB4 MZ;Y#^3_2_P#4?3Z?;)/GTZ!P'45C8?GVT>KCJ%*P%S?\`U[_[:P_US[;8]7'3=*>;WO\`\B_H M/;9Z<'4"1C8_Z]O]AS[UY#KPZ;Y#8VOS;G_8W_WKW0G]G3H%>L7X]MGJWIU@ M/NO#JS>74=C_`,5]U/6Z9`ZBN3^/J3[IU;KS?0?[[\?\1[\>MK@=86/U]Z/5 M3Y]8B>1_M_=3PZ\G'KB?;1X]/=8&^I_US[V>`'6O7K'[UU3KB]N!^?=3YCJX MX=8_=.M]>]^'7CU__]#2G!!]K!GIMN/78][ZT./65#^/Z_3_`&'U][.0#U?K M+[\O6CUS!^GMSRZ9X'/69?J/]O\`[[_;>[#A3SZN.N9]2WO]+^]]>(ZRH?Z< MW^G^O[V.M4KCJ0A^G^V]W'EU3B.I"G_BG_%/>_/KW$=9?]\?=P>J'K-&?IQR M!_R+_>O=QU6E#U+3_>Q_O/T][ZJPH>IL3<6'^`Y_P'NX/5>(ZGQ-_M^/^-_[ MW[OTUP/3A$PL%_VQ^OU%R/=@>M<#U('!^OYX'^^X]N+UH@@]2HC^/]\/I_MO M;JGATV1Z<.IJ$_6_^N/\/Z_[?VH4X&.FC4U'4U#]/S^/]]^?;Z'IEA6O4V%_ MQ].?IS_6_M2AZ2L!D4ZGH1Q;Z_G_`!_I;VH4\.D[#B#U/C:]N>/^)_/]![5( M?+I+(IXUZFQ,#_A?_D?M6C=(I%QU/C:X'YM]!_A_R/VK1NDCKY=34/T(/^O_ M`(^UL;#SZ02*02>G"-A_3FWM=&V.B^9,UIGJ MZ:8<<_3_`'UK>U"MTB9*#!STH*:HN!S[?1O3I.RZL'I[@F^G/^/^'M4K=(98 MCD=/$$_TYO\`UM[4))Y'HODA(ST[0U`L#?\`WW^W]J5?I!)"#4^73K#.+7O? MZ6%SQS]/SQ[4*X/GT7R0')''ISBJ;6-_][MS_A[?5Z=(G@;CTY0U=K>H@_X< M7_XI[=#^AZ3&,@\,]."5VGZGFXOSP+_ZWMP-4\>F&0`4/4M*X?U_IS?_`(G\ M^[^(?7JG@CTZR??#_5?7_7_XH?=]?3)B:N*4Z]]\/]5_T-_O/'O1?'5EA8L* MT(ZQ-6WOSQ_4'Z_\3[J9*#/5Q`#Y=1)*Q2+6(4``Z;9 MJN][&W_(_P#8>Z%_GTZ$]!TVR5(Y-_Z_7_;^V'?RKTLBAH`3TV2U`M]?]A^0 M+_U]IW>O2V.&E/3IJFJ/]]<_T/\`O'M,\E*UZ,H8<+0=,\\_U-^?ZC_B/:1V M/1G''D8STQU$_!%_]YX]I7;CTOC2N!TPU,][B_Y/U_XGVD=N/1A&E1D=,<\H M)^OT_P!?_>Q]/:1V_9TOABJ<>739*_XYXM[12/T;01\!3ILE?GZW(_VQM[02 M/QZ-X(\C.>H$C7)MS:Y'X_V_LME?CT>01@4!X]-\C?4G\_[U[02MT:Q(>/GT MW2L+?7_C?^O[+Y&R>C&)*@`]-DK`G_6_WW^\^T,A\^EZ+TW3/_QO_;^T3MQZ M7HHHHZ;I&Y(-_P#?6Y_UO:1V'2R-:5]>FZ5_K^;#_??['VD=NEZ#Y=-E"C&>H4C6%OZ_@_\`%/:=B.GHQ\\=-TS6O_M@?\?]A[3M MQZ4KPZ@,UO\`7O\`U_XI[:8].`'CU$D/X'^]_P!?\?Z^VCTX,4Z@3$`6_P!8 M_P"V^O\`MO;9/5QQJ>FZ1A]>/^*GW0]6]!U!D/%O\#_6W'/O5>K+\^H+\M_>NMC))ZCN?\`>?=#U89J>L'Z MF^MM-O\`;_[:_P"/=>M]=-;D_P"P'O7IUL\*=8#[UU1O3K%>Y)_VWNI/3B#K MBQL#_CQ[;''J_6`^]DU/6CPZZ]ZZH.L3&Y)]MGITXZX^_=>ZZ]ZZ]U__T=*1 M/R/]C[5J?+JC#SZR>[=4ZYK]0?\`$>]C@>K^AZSCWH8/6^N0/X_VWMT=-.,U MZRJ;$'W[KP-1UF'-U_P`_P"(]WZV>O*;$@?CF_\`MO>^M#J2I_WJ_NPZKYD> M74A3]/\`;^[>76AQ(ZD`W%_=AP^?52.N2FQ'^/NX/6B.I2,?I_3_`'Q'NWSZ MJ M4\.FB//J6C$6!_V'^O[?4Y/33=2XVY!^G_$\_P#%/:E3TE<4(-,=.4;$_3D6 M`_UQ^/\`8>U"-Y>73#C\5.IT+6`Y^G_$?7_;'VI0YZ8=00:=38VM;^GT_P!C M_OC[5HV>D$@J.I\;<@C_`'GB_-O]Y]JD;I*Z_MZG(XX`^AY'^^_J#[5QMZ]( MY5KD<>IT;#_6M]?]X]K8WI3TZ0N@-1Y]38VM^?\`C7^O[71OT6RQT-*=3$-[ M$?4?\1;\_P!?:Z-Z>?19/"&S3J5&P'^W_P!OSU:/T72QU&1TX0S6('Y_K M[4*U>D,D?&O3Y3U'TN1^+G\_['Z^WE/ITF9?(\>GNGJ/IS_MCQ;_``/M0K\* M=)G354'CT\0U'^^_K[4*]?MZ1214!%.G6&HX'/\`Q3\?7VI5_/I#)%0?+ITB MJ+6YM?\`Q_WQ]O*_222(5Z<8JD<&_/'Y_P!Z_P!8^WUD]>D3V_'3U-CJ+V]7 M-N;?[Q^.3[=#])7MZ_;U+2J_Q^G]3[=$GSZ3&W/&F>L_W5R/QQ]>/=Q*?7IE M[?7ONR/R?]X'^\A?>C+7'7A;D&O6,U MG%CQ<_4VO_Q7W4R>73RPG'4=ZD?UX_U_^*>Z-(1Y].K;C\NH;?7_B/] M[]MM+THCM_EU!EJ0>?J?\#_OA]/;#2<>ED<'P^O3=+4CGG_>?]?VF>3-.E\4 M`P>FJ:H^O/\`C_OOQ[3N_P`^E\<1K7RZ9YZG\7_K_O7M,[TSTLCBJ0!TR5$_ MZK'_`&-^/S_C]?:9WZ71Q>G3+437N!S_`(_4<\\_U]I7>G2U(RYH.FN1[?D7 M/U_'Y]HI'K7HU@ATT\VZ;I'_`-<'Z?X_7Z_X>T4KC/1K#"20*=-\C_7G_`^R M^63TZ.K>&A&H=09&L"/Q]/\`6']/9?*_'HWACI0]-\LG_&N?]OS[02/Y5Z,8 MEH*]-LKBQ_Q/^\?\:'M!(W1A$M,^?3?(WY^I'^]^T4C=+HD\Z=-LK?K_P`4]IF(STL5 M3CIOD:Y/^'^]^TK=/#)Z@RO;GG\@7_USS^?;#'UZ?4`+TVR&]P?]ASQ[8/F> MGEK3/41SS_K#_>O;3?RZ<4>1ZB2-R?H/H?\`'Z?\5]MD].4\NFZ9OQ_OOSS[ M;/5Q_/INX(X^G^QX^G^\^ZGIRG#J'[H>G!UB8\GW M3JXP.H['G_86]Z-.M>74=S;_`&`O_L?=.K#AUB6P4F_U'^\B_O76QQZX-]!_ MOOP/=:\>MGCUA;Z$^]=4I4]M]83]?>NJ'CUT3;W[ MKP%3UA]MGCTYU[WKKW75N;_[#WZOEUH=?__2THU-CS_3VJ7JI%>LGN_3?7(> M_>?5QPZSI]/]:_OQX];ZY?D'VX.J,*CK*/>^FQQIUE4_G\CZ_P"M;_C7NPZ< M'IUS8VLW_&KW'O?5>LRGCZ\C_>N/>QUIO(]2$/\`Q7W?JI\CU(4\6OP/I_M_ M>QUX^O7,7!!'NZ^?5#U(1KD6X/\`Q3\/V8ZS*;'^@_P!]Q[<4 M]4/4R-OI8\?U_P!]^/;RGJA'[.IT;7`)/Y%_]A[>5NF6`K3J2K7'^O\`7_7] MJ%-*>O3++4$=3HG^G^\?X^U"MTF8$&AZ<(WL1_M_K];_`/%?:I3YCI@^G4Z- MQ_Q3_"W_`!(]J$;]O265,D^74Z)^`+\_[>_M4C4/2*1:CAU.C8?[$_2_^(_V MUO:M&Z2,!U.C:UOZ?3VKC;I'(E&QU-1O]@1_K?[?VNC;A4](98P02!GJ;&X% MOZ?[Q;VM1_V]%TB#CU+5A_O/%OZ?FW^/M=%(1Y]%-S`"!09ZEH_^/!X_UK^U M\4G1//"*'S'4Z*0CZ'_#_7_P]K4?]G17)%3`^+J?&P(%C8\6XXN?Q[5(_GT7 MR1UQY]3X9B"+FQ'^^Y_V_M0K>G2-X^-1GIW@J2"!?Z?3_>_;ZMTD=3PZ>8:J MXX(Y_P!\?;JO3IETJ./3M#4CB[?\C_H;^WUDZ2O$/RZHZH8S7AUT: MO_?$>]:Q\NO",^AZX-5`_G_;7]U\3Y]6\`'RZCO5?3D6_P!?_BGNIDQQZ>6" MG#J+)4_X_P!?]X_V/MII.E*6^,]0I*GCZ_Z_^P_XU[9:3Y]*4AI2@STVS57^ M/^M^?;#2=*TA^6>FN:I)^IM_L?Z>T[R<>E<<1('ITT35-P;&R^T[-FIZ6I&- M-/+IGGJ"Q('''^P/X_I;GVG:3'2E(RQT@4Z;9);?D?X6]I7>G1G#%3AU!DE^ MI/\`7_??[#VAD?B.C2".E#Y]-\DAYYY_-OQR1_O'M#*_1M;Q9%./4"1OK<_\ M;_XW[+Y)..>CB*(BE>H,CWO<_P"O^?Q_Q/M!))QIT90I7CCJ!(]_]8?3_&W_ M`!3VAD?CGHQBCX#RZ;I'!_WO_8WM8>T4CD9Z6QH#CR'3=*]OI_K`_DW/U'^P M]HW:N>EZ+2@Z;I&M>]OS_M_:1VJ3TJC44R.FZ5]1/)M]3_Q'/M([5/1A&H5? MMZ;99/KS_K?\4]IW/[>GUQPZ@2-86_WP_P!];VG8^?3JBI'ITWS/?C_7Y]IV M/2@"IIU!=K7^G-_Z'VRQZ=I6G421OQ]?]]^?;9..G>H4C6YX_/\`7G_6]MD] M6`K3INF8\\_XC_B/;9_GU?\`P]06-_S8_P"!M]?K_MO>CUM>/4"4DD_[&_\` ML+`?Z_U]T8XZ<&3UA)L/;9ZN,]8&/^^_Q]ZZWQ-/+J.Q_P!X!]T/5N)ZBN;L M!_4@G_;_`$]UZWUVQY`/T%S[T>MC@3UA8WY]Z^752>L37O;_`&/O1ZVHS7KC M[:/'IWJ.3?F_O9Q0=:'K7KA[UU3KB_T_QO\`\5]Z;AU=?7K'[H/GU;KWO77N MO>_'RZ]U_]/2A]J>!SUKK,+V%_Z>[C(ZHW'KL>]]:!IUE0V/^O\`[W[V<@=7 MZR^_*>O'KDI_']/;GETRPH>LRGZC^MO>QU8'AUE%R"/];_#W;KQ'7)#;_7'! M_'O?5>I"GZ>[`]:X5'4A3_L?=NM#S'6<JGJ6A_I;Z_P"/^Q]WZJV1\^I\3<\_3Z7_`!;\`<^]J>J?+J6C:3?_`'U_ M=^J$5%>G")N?\+W_`-]S[V#UKRZE@W_WW^^_/MP'R)ZJ?Y]9XW^E_P#??[Z_ MMT'JAX=.$36X-K?[[\W]NJ3TVPJ.I*FQX^G`_P!\?:A3TRPXD]3(W-[`Z<8GOQQ>W_`!7VJ1OV=)B*\>/4V)_]O_Q3VH4T/3#"H(ZG M1M^?];_??7VJ1ND+K0U'4Z-R;#C_`(FWM2C#I*ZDY\NIJ/\`B_\`K_[?Z^U2 M/TFD3B`.IL;'_"_^O?\`WWU]K4?/RZ0LA7RZF1O^"?\`7_V/U_V'/M;')TAE MBS@=3$UL;\"#GHNEBX@CMZEJUK#\'@&_T_P!\/:R.2OGG MHJGA*<15?7J4CC\DD?U!^G^M[7QR<,YZ*9[?);RZG1R6`Y^O^/X_Q_P]JTDZ M+98@IU)6J(^I'_&_Q;Z&_N_B=-F"E<\.LRU?'U'^Q_/\`O?NWB#'3?@GU MZ%GHC$[!W;W?TYM7M3/MM7K+,)JTM:Q0[I)>I`[1K_$X4E13SJU!T8;1:6MSNNV MV^X2^'8/<1K(W#3&7`=J^5%)/RZM>_F)]5=T_#WL+M7&9CXM=/X?X_;A[#PV M5^)/<&TNG^K,CMW`;>VMNZDW%LBCRV^EVEN/*;_J]R;"I9*+/8+>5=4S9:IU M59\])&Z50%Y3W+;]_M+%X][N&W5(2+J)Y90S,R%7(36H0*^4>%0%';ACVR%S MGM6Y\N7FX))L%JNS/,IM)DAB*JJ.&0&30QD+1C3)',Q+GNRH(83OYQ7PB^06 MY_F7\I.V>HND*Z?H[JK8G5>9R^2V['M7!X_"[2V[TSLB+.9W![.3(8O-97;. M`GI*@5U5B<=445$T$PE:/Q2!$7M_S/M<'+NR6%_N0_>4\LH`;426:9]*EZ$! MFJ*!F!-12M1T8>Y/*.[7/,V_;CMVUG]UP11,2NA0J+#&&94J"56AU%%*K0UI M0]5%='_$7Y,?)*CR5?TIU)N#?%'C:',URU$-7@\&F=_N[2I6Y_&[,&YLKA&W M[N##44J356,P@R&1@BD1W@"NI(YW/F+9]I9%W&_6-B0/Q-35A2^D'0I.`SZ5 M)\\=1]M/+&];RKOMFVM*J@FM575IRP34R^(RC)5-3`$5&>G[ICX&_,;Y$;9P M^].G>A-Y[OV=N'=,NRL)NG7A,!M[*;FIZ?*5-3C:3,;IRV#Q\HI/X/40RSB3 M[:*K5:9Y!421Q.FW'FK8=KFDM[[V=]`;"J6%20"Q48H036@/;6I`*)VM\1/DCOK$U&7VQUK4Y#3 MC=[YK&8*;OCW[ENN^OD?E?CCW5B.K*?N7*[1I<9L2LVM1;[HI< MEN[9-!NRMV#D=[P=;8_L"BZVJ]QP]DU>P*[?E5'B8H2%"]%#A=).*]%TFJOKS_L!^/Z^U9;I)I'$]-DDQ;ZGC_C7U_Q]L/)Y#I5 M'"7()&.H$DI%[?[&_P#Q)]I6DZ,8X0,`9ZAR2`7O_B?Z7_WKVC>3Y]&<4-,4 MSTWR2<_7^O\`K?7\?X>T4LG$=&<$.10]0Y'`O?ZBQ(YYY/\`K7]H)'KY]&T$ M0%,9ZA2/T4C\>E\:<`.F^5_K_`+W?_8_[?VC=^ET:`>73=(_-_P#??XGV ME=NE2#/#IOFDMP#3[3.P]>EBBIZ;G>Y)_I_ MC_MO]Z]IF/3P'#J%*]A_C<^V&/'TZ?44%>FZ1CR?Z_T_WOVP3PZ<4>?4-V// MYM_7_7]M$YZ?44^SJ'(W)%OQ_7_'VVQZOU`F:WU`^G/_`!'YX]T/5AGIOD:Y M_P!Y_P![_P"*^Z?/JW4.1K?[U_M_=:YZLH_;U")OS_OK>VSTZ!3K$Y_WW^/N MG5A@5ZCN?]X_WOWH]>'"O4=C?C_6/^\?\;]T/5AP^?6%;W+?U!_WC_D7O76Q MUQ;Z$G\V_P!Z]UZL?3K$?>OGTV?+K%_4_P"V]U)Z<44'7%C8'W0"IZL3\NL! M]^/'KQX=G6^O>_?/K77O>NM]?__4TH?:GY]: MS3K(AOU/6B*CKE[OTWUS!_/O8].K@UZSCZ`_X>]<#UOKD#8CVX.FW& M.L@/O?F.J@^7693^;?G_`!_U_=^K<1UV>&'^/!]^ZKU(4\?ZW!_XCW8&G7CC M/4A3_OO]?Z^[>?53@]9U/_&O>P>O'UZY_P"^_P!]_MO=Q3JIZSH>!_L/]N/^ M->[CJOGU-C8\?CZ'_>C_`+W[WU1AGACJ>K:A[X_P"1W_V( M]['5#4'IP1K_`.QX_/\`Q7W<'K5,GK.K$$>W5X=4-:_+J8C_`$/Y_P`?S^?; M@/5#\NIT;7%Q]1_OO]A]/;RMU1AU(1OH;GBQ/^W_`.->WU/2=AU.BDO8W^GU M_P"1>WU:G3#+7/4]&_/^W_'T_P")]J4:HZ3N,GJ;$X/^'T)OP?\`8>U*,1]O M29U!\NI\;6M_C]/]]_K^U"-TCD2E:\.IR/>Q!/\`B/\`>_:I&Z3.OF1U+1[? M[:W^]>U:/@=)70YZFQM_3_D9_P!?^GM6C\.D+1D@@]3$?Z?0?\;_`.*^UJ/Z M'I%+'Y'J9&_T^EN/S>WY]JTD^>>D$D0:HIU(1C_6WY_PL/Z?7VLCEZ*YH,GR MZEQR'CD$6X/_`!0^UR2U:2?/'1;+"!Y=3$EU M?[U?_??3VH62E!TADB)ZE)(0?K;_`'L(#CU,2IM^;_`.^_ MWOV^KG'29T%2./3A%5?3G_BG^Q]N!QTR8R?/J='5D6Y!O_L?=PWSZJRG\2UZ MFK56_-OQ_A]?]?W8-PSTV8A7AU)6KO8W'XY(N3_L?=Q(1CIOZ<4K4=9Q5\&] MO\/I_O7O?B?/JG@4Z$SIV7JZH[(VS2=T5V>QG6.0ER.+W5FMLT#9;.[<@RF& MR..Q^Y\;B%K\9_&)]KYBII\A]F9T2K6F,3!E_3664PU(.?:)KSF7;>8DVDVC6\(+/E7=.6)-Y6\6ZEA\+ME\.V5'U.U9$5@6HHT1H MP%"0230G@W[\\/AQNKY\_P`P[Y"4/?.&AZX^37P&W1\=^KZRNZ\[I7+1=E;K MV/UGM""/<.*I^L:JHQ&&Q=7UY52U=7&9_P#):ZE\"SR&IBI@Y;*GAJ\C=I\3)/B"@QD&M!0D477,G+T_-7-V[KN:BTOMJ:WC) MCFKXC)&G MV>O]P[([*[!P.T]O=GXSUW-&V5KZ[W6;ZNVDN!(C))(JK(&5#%3L1.[7)I#2N^"-..BY;B[U^/.._ED]C?% M[:??^*R?:K?/[)]M*V?[L6W;OC;2YDUG&H$JH.DD"I( M-`5H2627VTIR;=[)!N:M>_O5KA:I*NI!'X8SH(#,1J`+4`(U$-4`6&R]B[+S>[Z7+319VLS,SS7J1:DJDI%%87)LNXVN[;O')L-I?;?=W!F6:4I6 M(M2JNK*SN%H-`44Q\2U[3-][VR[V?998^8;RPW&RMA`T,2N1,%K1D971$+`D M.7-<_"VGN"9OEQ\?]W_#7,]3?(C<6P^[LYM+XQX?87QB&-ZWWYM+Y1],=J4> M7PTV-V/N'M#%[0RT=)7Y7*Y$HU+!%3&82R*^VU;C!OBWNV M1R6\;W9>>KHUO+&0:N(RS.D[#2I(55XDFE!TG3=]MN-A>QW22.YD2S"6](W6 MXBD!%$:0*L;VZG4U&9FX`"M3U2R\OY)_IP?I?_8>QBTAZ!J6PP6X]19)C_7@ M_P"-C<#^GY]IGDX]&"1&H`X=1))+7!//-O\`'Z?6_'M*\G1A%#CY]09)?K;_ M`!_/^/Y]HY):>?1C%`>(7'41W_Q'_$_4\>T#R$^?1K#`%'#J&[_\3^>?K_Q/ MM'))T9118%!CJ%+)_3Z^T,C\<]+XX^``Z@22?4#_`!_WQ/\`4^T;O\^ER(!0 M4STWR/:_//\`CQS_`,4%_:.1Z]+8TI]O3?*][B]Q>Y_K?Z6_WCVE=NEB)GJ# M*Y'^Q_WCGVE9NE2)TWR/^38G\?\`%3[3.WSZ6(I&.FR1N#_C]?\`7%_^(]IG M;I2JD=0I&_'M.S4!]>GE%?LZ;I7N;6_WW^/MECTX!4_+J&[?4#\?[W?Z^V"> MG5%2`.HDK<_TXM[;)H/GT]CJ$[\7/X_WW^W]MD];I7'39,_)/U_XW[J3TYY= M0V/NI/7N)IY=0I&)-OH`/=">G0.H[&P_Q_XK[;)ZN!7K`Q_WW^/O76SDTZP, M?K_MS[J3Y=;^745C]%YN;7_UO=.K=>-A91Q_Q3WH];`\^L3'_;#CW7_#UH^9 MZPL?Q_7WX\.M+D]QU7KDIL?\/S[O$5I MU.B;BP_V'^/^^/NP/37RZEJQ_'T/^^/NW5?4>?4Z-^/\1]+?\1_A[L.J]3%8 M'\DV_K_Q3W=32G53_+J0C`<$GGCV\#U0CJ;&UN/Q_M[?T]W4]4XXZF(WY_'Y M'^/^Q]OJ>F&&>I2-8BWT(]OJ>FF%#U-BDYM?^O']/:A6Z9=1QIGJIT;W`_W@>WU;TZ3,/7CU-CD)`/\`0?[QSQ[4HWETD9:?9U-1 MP?S_`$Y_I_A_K>U2OTF9/V=2T>Q_I_OO][]JD?Y])73!ZFQR?3\&UOZ?GZ'_ M``/M6CTX'I&Z>1'EU,5[6-_\+?X_[W;VKC?I%+%Y@=2ED`M^?]?_`'WT]JD> MOGGI%+&!4$=2E>]N>/\`>O\`B![5I)\\]%TL`P1\/6='YM?_`(W_`,:]K(Y> MBR:"K4(ZE))]"3^/I_O'^V]JUD^?1?)`0>X8ZE1RG_;?[P/]CQ[?63Y](9(* MUH.I22@V-Q_MK$?CC\<^WA)TE>&AI0=2%E^EOJ#_`*W'_$^WED/F>DCPCR&: M]2$G/^O_`%MW`_SZ9*-YKU)2J('ZO\`&P_WP]W#^IZ;*D#'4A:L?X?\ M1_L+>[Z^'=U0J*_"*GK,*D?ZH\?@$_[Q>_O>OKV@TX'KD*H?U_V_^M_K>_:\ M\<=>\,D"H/\`+KHU7'+GGZ"__(OI[T7'6A'0BI/6(U8']K_>3[T7_9UO1ZGK M$U6/K/=2_P`^KB/S"GK`U2[?0?CZ_3_;\_3VVST_%T\L+,11<=1W ME)O=CQ_3D7_POS[::3I0EL/,YZP--;B]K?F_^^O[8:3Y]*XX0!0#J,\QXY^G M/UX^GM.TG'I:D!-,=1VE_P`;?XG_`%O]A[2O+3HQAMZTKU"DE^O/]?\`B/:1 MY:\.'1A%#3B,]1GD%KGC\?2WY]HY)*^?1E#"%XCJ))*3_C?Z<^TDCTZ7I&?E MU"EEYX^O^W_U_P#8>T3OQZ6QQTH*=0Y)`/\`$_4_T_US_3VDD?I=&E*#SZ@2 M2@`W/^^_PXO[1N_2N-:4Z;Y)+DW/^/\`K7`^O^M[2NU.ED:>9Z@R/]>?\/\` MC?M,S=*U3Y=0)9+D_P!.;?\`(O:9VQTK1:=-TTMOI^;^TSMQZ5*M/MZ;G?ZF M_'^'^^'M@GIT#RZA2RVB<_+I]>'4*1CR/^*^VR>M^74*9P``/Z\_[S[H37JZ@ MY/3:[7/]/Q_QOW3JW461K*;'_D7O1ZN!0=0[VO:W/-_Z6OQ_K^VSTX,=86/] M/=.K#`ZCN?\`>/\`>_>NO#A7J.S?C_;_`.^_I[H3U8>O6)>26)L"#_QK_>O> MNM]<2?J3^>!Q[UU8]83[U\^J'TZQD_[;W4GJZ"@ZXDV!/MOB>K]8"?>SZ=:Z MX>]=4ZXN?[/^Q]U)Z<`H.L?NG6^NC[]UH]=^_=;ZXL;#_>O?NO=?_];2A]J. MJ]>][X<.M]9$-Q;\C_>O^1^[@]5(]!UR][ZIUD!L0?>QD4ZO=< MAP?]?VX#TVXZR`^]\.J@^768'Z'_`&_^\>[=7&>N1])_3P;<_CZ_U_/U][ZK MUF5O]X^GO8ZT?4<>LZFW_$>[]5/KU(4D$?Z_O?6^(KUS_P`?I[O7CU0CK,K? M[[_`>[CJIP:]38F-@>#;Z?[#_>O>^J,//J>K7`^A_'NX/5*5SU)C9K_6UA]1 M]?P/ZCW8'K1X<.I\;WL;?[#ZV_WP]VZIY=25-['_`'WU]N*>JD9!ZE(]Q;\C MZ?[[_'VX.J'J7&_^^_XW[<5NJE:CY]3$;\'D?@_[[\>U"MCI.1^SJ5&Y'U_V M'_%?;RGIHBF/+J?&_%B?]8^U"-Y],R*3D#J;&]B.>?S[4*_"G29ESGJI"O;\D_X#_>>?\`#VI27I!)`*DCJ0DHO];_`$XYX_V'M4LO MSZ0O;`GX<]9U?_$'_BGM0LM?LZ126]#ZGJ0LK"QN3_O7]?R?;PD!\^DKP%:- M3K.LY/UL?]X_WFW'MP/\^DYA\](ZRB0'ZG_;<_[R/Z^[B6G330`^7602_3GC M_'\?X^[^(?7JG@+D4ZYB0?@_Z_)/^]^_"4]5-L!0]O"V!Q7KKRJ/R#_OOZ\>]&0G)/3@MU&*=<#+_ M`$)_WW^OQ[;,H\ST\L)IP'6,RF][_P"\W_WKW0RCIT0$$8ZPM+_@!]/S>]S[ M9:7SKTI2W->'6$RW_P"-G_7_`*>T[S?/I;%:DD#3U&>;G^MO^*6_UK>TS2U\ M\]+4@TFE.HSRGZW^GX]IFD_;TN2$D"O#J.TEP?Q_C_OKW]I'E^?1A'``,#J, M\O!^O^Q-S<_Z_M*\F>/2R./&!CJ&\G^^O_3_`'GVD>7I6D?IU#DE`'UN?\?Q M_P`B]I7?CTLC3@.H,DG^/^/_`"+VD=\]*T2GEU`DDN2/J?Q_A_B?Q[3NWSZ5 MHAQ49ZAO)]>?]<^TKO3I6B'RZ@227_UAQ[3.W2M%Z@2R?4.1^./\`C?'^'^'MEFZ=`\^H3M];_C_;C_D? MMEFKTXHID]1'V6/3JBO4*5CRW]3_`,1[H3CIWJ&[6N?SS^?Z M?3_8^VZ]>XGY=-DKDDCBW_(_^*>Z'TZK]>/`T_UM[]UL=86/^V'O1ZT3Q/6)C^/Z M^ZGJJBIZX^Z,>GAUC<_C^GU]Z'KUOK"?>NJ$]=>_=>`J:=8B;F_ML^E>G/RZ MZ]ZZ]U[_`'W^Q]^Z]U[W[KW6%SO=9>/Q]/;G39%#3KD/?NMJ?+K*I_%_Z6][/KUOK)]1[VIZ\<].:=>0VX/U'T_QYO[]UKJ2I_/T M_/\`K>[@]5X&GEUG5K^[=:X'Y=9U-Q;WL=:/KUS%P>/^1GW<&G'JI'4A'-@> M/]8?7C\_U]W'6J#J=$]_^1_3_>?S[WTVPH1Z=2T;@\_['CB_/^W]V'53\NID M3?V;_P"^_P`+?CW8'JI%/LZFH_T!X^GU_P!L?];W<8ZJ>'4I''U!X_WWUX_' MMT''5".I2-?^GNX]>J_X>I<;_@_3_>/^1^W5;RZHR@C`ZEJWX_/X/^M_Q/M] M3TPR_LZEQO\`UYM;_6_/MY6ITWI)%*]3(Y";`\?\1[?5J\./25EH:>74])+? M\4_V'XY'M]7Z:=,=3%DO^?Z?7_?<_3VH5OGTE9./4I'L;_[[_B?:A7\J])63 MU'4R.7_?7Y%OZ#VI5NF'4@<,=3$<'ZV_Q_-_Z6_QY]J$?AGI*\8/4I'_`,?\ M+?G_`(W?VI63]G25XQ6E.I22?[>PO_OOSS[4I+ZGI*T7$CK.K@V^G_$?[;\' MVJ66GV=)'A#4Q0]2%EX(//\`B?\`>/\`>/:A)/GTE>'B".I"R`VY_P!]R?;R MR])7AJ`",=9UDYN#<<_GG_>_;ZR\.DSV]:^G659>?J?^*_[Q[?6;TZ1O;UJ" M#7K,)1>UP?\`7M_MN/;HEQ6O28VP)IISUE$MR.`/H/P3;_;^W!-\^FGM1_#G MK()?Q^/]C[OXWSZ9-L1^'KL2+_A?\6N/][!O[MXWSZJ;?Y=1_L;M?3'RZZ\PXY_U_H;_ZW''NOB]6^F%`.O&4#^O^WX_X@>ZF7Y].?2TR M!UP,W];"W^-_^)]T,OSZ=%MYGK%YOIZ_]C_7_#CVTTW'UZ?2UX9QUA:;\#^M MO]Y_U_;+2^=>E26],%<=8FD/]2?ZE<'4*1_KS_3\\?Z]OZ#\^TSOTI2/-*'J%+(">+O2J-*=09)+@CZ#_`%_]O[3._2E$X]09'^MB+#VG9NE* MICY=-LCW)_`_''U_XD>V&:OGT\!^SJ([6XN/]B?^(O\`X^V';'3J@D]0F:Q_ M%[\_7C_>?;+'IT#S/4*1^3S?\WN+?[U[:)Z<`KU$=OZG_8?U/NAZ=`IY=0W? M]1_'T%_\/S^+>VR:];^SJ!/+:X_K]1_7G_BGNA-.K@=0'87/^W_K_OA[K\NM M@5^SJ*[V^G)_I>_^\7O8GW6OKTY0>7#J,S"W^\VX_P`?]C[;/SZ<`ZCL?]Y^ MG^M[KUO@.H[-^?I[T>MTI]O4=C_MA_Q4V_WOW0];'#K@HMZB3>WY]ZZV.N#' M\GDGWKK9].L1/O7SZH3Y=8[D\_[;_6]U)Z<44SUQ)L"?;?$]7ZP$_P!?>SZ= M:X=NJ=<7-N/\`;^ZD]7`I]O6/W3JW7O?NO=>]^^77NN+&P_WCW[KW6'W[ MKW7_T-*'VHZUU[W[KW7O?NO=9%-Q;^GMP'JI'GUS][ZH.N8/(/O8].K]9@01 MQ[UP/6^N0X/^^_U_;@/3;C%>L@/O?5`?+K,#<7_(_P`?K[L#PZN/3KDPY##D MW''^MS[WUKY]]O]Z_IS[WUJE?MZD*;'W8'K7''GUG4_3_`)%[MUH<".LX M-Q_OO]M[V.M<.N2FWUY_WW_$>W`>J$=2HG%QSP?][M[M7K1%<>?4Y&XX_P![ MXXX_Q^GO8/5.!^74I'^A]VKU7_!U.1]5OK]?I^;_`.'NXZIPQU+C<`<_['_> M1]/=ACK1'[.I*M_CQ^/;JGJA'[>I4;_3_>Q_3VX#U0]2XW_'X_']?;JMTV5_ M9U*5_I_O!]O!NFB/V=2T>_\`@?;RM3/3;KJ'SZFQR?07/_%+?T]OA@>!Z3E2 M,=3HW'TOS[>5^F6CK4@YZEI)8V^G'^O?_6]J`_25H_(CJ2C_`)O;_'_7]OJ^ M?ETPR4ZEQRCZ'_D?^/M0C])GCKPZEI)Q]3_K_G_"_P#4>U"O\^DS)ZCJ4DMO MK_L2/R/ISQ[?63I.T>,="7UCU/VKW1N)=H=.]9=A]L;M>GEK$VOUILOM\"K"C.3I!/OPW7;_`-/_`!Z'O^'O7N^S.?3'5#MEZ3(!92]O'L;' MVXQ^?0*;,V;O+L3<6-V?U_M+.AR69VO3;6ES>,H*R2-EB MFG@2.1@0K&Q]T_>^W+&LS7\(B)PQ=0"1Z&M#UX[1?M(T2V4ID`RNAJ@?,4KT M&E)U+VS6]AGJ.CZO[%JNUUR0PK=8TVR=RU'8:Y@Z"N).RXL:VY%R1$JV@^V\ MOJ'IY'M9];;B#ZDW"?3TKJU#33UUM--#JK]G'H6*7X7? M,BLAW744?Q,^3-53[$JJNAWQ-3=#=ISQ;-KJJ*&-GECK M#"\:J2P`!]T_?.V@Q@[C!5_A_43-?3.?RZL=FW%A)IV^:B?%^F^/MQC\^@WZ MWZ7[G[CS&2V_U#U+V?VIGL+3O69C!];["W7OG+8FDB\YEJLGC=L8K*5E!3QB MFEU/*BJ/&USZ395-N%K;*KW-S'&IX%F"U^PDBO2.+;;JX8K;V[NPXA59J?D` M>EGM3XJ_*;?F!SVZMC?&SOW>>U]JU63H=T;DVITWV)N'`[JQ,]%,E5'4R1M`\3B0*4:U'W;;X72.6_A61J4!=037@0":FOE3K:; M3?S+(\-C,T:UJ0C$"G&I`Q3Y\.E[B_@)\[,]A\'N+;OPP^5&YMN[FP."W1MS M<6U_C_VMN7;V>V_N7$4>=P>7Q&EK.&44;?]I1 MFCDW:W5E8@@R(""#0@@FHSU8T=IX*FFR%;38O&4]J?&SY(=%X[$YCN[X_P#=G3N)S]4U#@LKVIU5 MOSK['9JM2!JIZ/$UV[<#B*7(U24R-(8X6=Q&"UK"_MVWW6QNV=;2^BE9>(1U M8C[:$TZI/L][:JK75G)&IX%T9:_949Z8-U=*=T[&V5M?LG>W479^S^NM[SM3 M;+W]NG8&[-O[*W=4I!)4O3[7W5EL11X//S)30O(4I*B9@BEK6!/OR;C:S2R0 M17,;3(.Y0P+#[0#4?GUYMLNH8DFDMW6!N#%2%/V$@`_ET%A?^I_VP]O&;Y]4 M6V^71@8OB;\JZC9.+[*I_C+\A)NNLVU(N&W_``=,=CR[*R[5\QIZ%<9NJ/;1 MP60:MG'CB$4[^1_2MSQ[+CNU@)6@^OA\8<5UKJ'VBM?Y=&*[/>^&LPL9O"/! MM#4/YTITB^U>D.[>BLCBO,EFL2E0U+)E,3 M0[NQ&(JC>XLKU#B$EERO:N-ZTWK6];8N. M`L)Y,AOBFPDFV*&.!E.LR52A;<^V'W"U686[748N#^$L-7^\UKTHCL+EHS.E MM(8!^+2=/[:4Z3W6W47;O=.:DVYT]U9V/VQN&%(Y9<#UILCCZ^GQ?=737:W4&3K%5J3'=H]=[OZ_KZE7B$R-3TF[,/B:B=7A.H M:5-UY^GM/'?6]R"UO<)(O]%@W^`GI2]E<0$+-`\9_I*1_A`Z"%Y?KS_R+_B/ M=6D'5UC-/GU%>7_;?[[Z#VG:3Y]*`M/+'45Y?Z\#^E[G_7_UO:=GZ4I%7+"@ MZAO+<6O;_#Z\`_ZP^OM.SBO'I4J<,=09)/\`B+?U_P!A[89_V]*43Y=0Y)+\ M7M_C_3VG9^.>E"IGAGJ$\@M]>!_O/^M_K>T[-TI11TW22:K\V'X]L,W[>G@* M_9U$>2WU/]?Q_A[99NG`/V=0G?\`)_4?]X'^'MECT\!3/4)Y/J!]?]]S_3VT MQ\NK@$Y/45FM^?\`$^VZ\>G@.HLCW'!_U_\`>O;9/IUOY=099--Q_K6'`/NA M_EU8"GV]-KMO#U/6!FX_Q_WJWNI/6QZ] M8"-1_-AQ_L?=>K==L;\?@?[W_O/O1ZMP%>L+-'5:TZQ,?P/]C[T>M* M*]K7K$?>NJGCUU_C^![]UX"O6(FY]MGCTYZ= M=>_'KU:UZ][UU[KWOW7NL3_CG_8>_=>ZX>_=>Z__T=*'VHZUUU[]U[KOWL9% M.O==@D>]CK767W?JAP33KL>_=>!ZRJP'!][(KD=6ZR^_`^76^N0/X]N`UZ9< M4ZRJUN?]N/?NM@UZS!O]C_C_`+'_`&'X]WZM2N>N@-!O?@\?7\_[;W[JO6=6 M)/NP/6CZ]9U;_??T]V'KU4YR.LZM[WU[B/GUEO\`[[_B?=J]5ZYJW('X_P!Y MY_P]W!\^JD>?4Z-_]M_7FY/^P^@_UO=^J'/4Q7_'^QY_XCWL8ZK3UZE1O;Z? MFP-[\I M2M]!_MO\/\/\1[<4]4(ZD*Y^GT/^'MP'JA'EU+C<'@G_`'P^O^]^W%;JC+Z= M24<@CDV_!]OJW3)%#U,CDY'/(M?_`!]NJW#JC+J'4M)#QSS]/\./]O[4*U>D MY%.IB2_@D_X?[#C^GMU6ITTR!AZ'J6DGTM_CS?V\K])66GQ<>I2R7_V/^^_V M/M]7ITR\9K4=2$E(_P"*'_>A[?63AGI.Z#S7J6DPX_'U_P!]_C[>$G#UZ8:* ME>K-?Y.,E_YG_P`*1_W^W!#_`&'V.2]H=Z>NTWX_X6>E>TQG]Y6;>CCJP[K? MY7=C?"W^9+_.[^1O6,>,R&Y>LMP]XYB+;^?2:HV[N&BRO\U3XT[)S^*RE/%( MCQMD]G[OR=%%5QVJ:(UC2PLL@!]H);6+<-JY?M)B0C!!4<12WD(/Y$`_.F>E M,=Q)8[EO=U$!K4L:'@?UT!_:"17RKTEOYA'Q&Z7^2/3DW\U?^7+2,G4N8K(Z M[Y7_`!_QTYEWE\8^U:Z9*W.YN'$4D234NQ*K(50FJ#`!2T>M:^CMBYF3'*MI MW*XM)QLVZM^L/[-SPD7R%?XO\/`YXI]SV^"ZA.[;9_9$_J)YHWF?L_P<1C@$ M>6^6N<^'/\]+O;Y%')5\F'V7\^/D1BM_0ZZFMFR75.8[DWIM'>V&2`+425#4 MVR:J;["+0X@J::G9%O$@"E;1-PY:MK(CN:UCT_Z8("#_`+UQ_/I,;IK'F&>[ M\EN'K_I2Q!'[.'Y=&"^9/Q7VQ\1_YI7<_?%+0X[+?'C8^R?^'$.KI(EBJML; MIDWIFZ:+IO95,-3457MW*_*7-4.(>G7SG^[,,U289(HW7VUMVXR7^R6]H6(N MV;Z=O44'>WVB($U_BQT[?V$=EN\]R!6V5?'7T-3VC[/$('^E\NFO^6EN#,[B M_EJ_SX\_F\K7Y7-9OK3XX9G,Y6OJIJBNR>6S6Y^^:G+Y&MJ)':6HK,E42L\\ MC$M*S$L3[OO)5=ZY55%`57D`'H`$H.F]I#-M/,K,:LR1DGU-7ZK[_ECO_P`Y M94_//^RV?.SC\\?!;Y'GV=;W)6P(_P"'P?\`5^/HHV>.E[_S9F_ZLR='S_E> M.3_*_P#YYI-N.HOB];^G.?[T_H/97OL@.^\K'TDE_P`"=&&S14V;F4'SCC_P MOT53^5!NC.;P_FI_#S<6Y,C)E,QDN[=N?=5]'BZ]&1RU/3;LV?C*Y=)5A-1ISIU`J=I\-]IV4NH+);QE?D?""U_82/S MZ3[HK+NF\!"0'GD#<,CQ-5/V@'\NK@_B5NG9?\X#X)[F^%_R%W/7X'Y,?!39 M&2[JZ*[^JL-5;FKY_CMMW([>Q&_MH;B2&II:G-2X#%5U%CH*9YX&J@,3,'=Z M&K,H;O\`Q.7=V3<[)`;*[8))'6@\0U*L/2IJ:_Z;U'0AL0F_[6VW7CD7EJNM M)*5_3%`P/K04'S[?0]4'_(7NRE[:W/A\?L_$5VSNE^L<)_<3I#KNKKFK9-I; M&ILA69*6MS,Z,*3(;\WSG:^JSNY:^)4CK,U7SF%(J5*>"$5VD7TZ.TC!KF0Z MG;U;AC^BHHJCR4"N:DAJZD$[HL:%;=!I1?1>.?Z3&K,?,D^5!T7[RW_WPM_M M_:CQ:>?2=8CY#J^SLI[?\)O_`(^M?C_AS3-#Z?\`?H.[O81BD_Y&%VU?^(0_ MX^G0J>.O*EJO_+V?^.OT>/'?(SX\_-+;G6_\J+YPU^)V*]+\4_@IN7X4_)Z4 M"GR77'<&_O@S\>MS9#:>^1``X<./#4":":VOXX=FW"BTAA,4GFK&)#0^H M)/Y\.-"*?.[/CAW;\,_B]\V?CMW5BJO;>[MJ_-+X(P5*4=35R;:W=MZOZ9_F M'5^'W7MJM>*EBSNU=Q+C*>IIYC&&66G$<\<553211'<-_;[A>;==P-5#;S?: M#K@J#Z$9_P`F#T3RV%Q96E]:SK1A/%]A&F;(]0,N,AV=YZ"&H> M:"A@R@CB1(D@"%>Q2"]FW#<[D:KCQBBU_`J@$!?3CFG&GV]&6\1BSAL=OMSI M@\(.U/QL:BI]>&*\*_9U2;AODAVEA>A=]?&I]P5F5Z@WQN3:>]1M/+5N0J\; MM7>FT*S(2T>Z-HT3U?V6%R>4QV:K:/(&.("LAG4R7:&(J=20PMD"=014 M>8-,'U&`1Z=%:2RBW:VU?HL0:>A'F/3B0>@#:4<_@?X_\4!_I[VTGSZTL=1Z M=16E`''^^_P^OMAGKCI6L=.`ZAO+];F_^'^^^OMEGZ?5,GTZAO+^?I;G_#\V M]IW?I](QY=1'D']?]]_M_;#.>E")PZA2R_6_`'T'_$_U]L,_'.>GU7AC'4"6 M6X_I;\?ZWY/M@MT\%Q\NHDDEO]?\6]M%NG0,=1'>W)^I^@/-O^-^V2>G0*=0 MI7-[7Y/U/^W_`,/Q[:)\AU<*30GAU$9OJ/\`;G_6O[;)^?3H&*]1W?\`Q_Y% M[H3U8#/4&23CZFX_WO\`/NE>K:>F^60DGGZ_[Q[J3U8`]1';Z_FWT_P/]?=< M'JZXZCN?Z_B_!_WK_'W0GR'5Z9KU&<_7_>?\/^1^Z'JXIU'9O^->]=>XGY=8 M&:WU_P"1^ZDTZWYTZCL3]!]3?W7JW71]((YN>>?K[T>K`=8V/XO]/>B<=:.> ML1/Y]UZ;X]8_]?Z^ZD]/**#KBQL+^Z#)ZMUA)_V_^^_P][/\NM$TZX>]=4ZX M,?P/I[J3TX!3KA[K\^M]>]ZZUUT/]C_L??N/6^'7?OW7NH_UY/OW7NO>_=>Z M_]+2@!!^GM1UKKOW[KW7O?NM=>]^ZWUD5K\?[;VX.JMD=^J=<_?A@]7P> MLRM?_`^_$4ZWUR_UO=P>JL*CK(#[MTUPZRJ?P?S]/]?WL'.>KCKG:X`-[_4? M[S_7GW8'KQ'F.O!B"%-N+6M?Z\6]^ZUU(4_\4X_UN/\`>O=@>JG!KY=2%;Z7 M_P"1^[=:X9\NLZ'\?BW^^_I[V#UXTZY^[@]5ZS1O;@D_[#Z^[#JI^?4Q'N!^ M#S];?Z__`!/N_3;#@:]2T?Z?6_Y`_P!X_P!A[V#3JOR\^I<;?X_[`7/^]?0C MW:M.M$=3$>W'_$GZ_P!3_K>[?/JO4E)/Z_T]W4_MZUU*1O\`8C_D7^V]N!NJ M$4ZDJWX(_P!]^/;@/5*=2HY/H#_M[_\`%?;BGY]-L//RZDJ]OIR/P1]1[>#= M-$4^SJ4DG'UO<_X>W0Q&.JD`CAU+22_)^@'U'^^/MX..F&C(ZE)+:W/T/'^/ M_&O;H:GV=,LH/EGJ8DMQ_P`1_MO]C[=5^F6B(X=2%D_WD>WE?IADJ3C/4A9+ M?0_[8_\`$^WUDZ9*4X='A_ET]^=3_%_YB=(_(CN27L.3:73V[J7>CX;K/:&V MMW;CW#5T%/50P8=8-U=A==8S%4U2U2"]6:JH:(+Q`_M/N$+>S/\`)Y9*IZ+*]74F"22@+AZ>JFK2@=4I?;44 M-['%M486+]"E>]LTC:/'9_2)S]GSZO)+:.^XNS2?K5IVKBKA\]_RI_/Y=`1_ M+\_F`=J?R_.[X>Q-@RMNOK;GLZT:[4[?ZY>HECR&%S..F&1Q]!N& MGQ]5.V+R'CG:@J)75A/2355-4*]QL8=RMS%+B495AQ5O4?+U'G\C0A+8W4NW MS>)%F,X93P8?/Y^A\OLQT"'RM[;P'>_RE^2G>&U*+,8O:WZN9E':\C,/6A8GHZOR9_F79OY%?`OXB_$;(8"K M@WCT/%E,'V7V56PX[[K?^R=FU%71=`;1H=K$KZ*JTTLU?34 M54BM)$&1'9;:MKN5]?*W9)E5]"?C-.%20*$>51TIN[YKG;[2S9.Z/#-Z@?`/ M6@!SY5H>DQ_+Z^<>R_BUB?DSTUW5U[N+LKXX_,#JJ/K'MO$[(S6/P>_=MUF% M&W.RDO6L[B"8)=P/J M4D5!K2JFF:&@R/\`9Z:V^[2S%U!-$6MITTL`:$4K0BOF*G!QTF<)VS\5/CK3 M]D;C^-V=^0':7:.^NN>PNJ=H[A[DZTZ^Z7PO4.V>VMM9G8'8.:I:'8G<_=>1 M[%WG7]:[AR.'H*HU&VZ6@?(2U9IYW2&)'F6]N_!2[6)(5=6(1F^,/S`Z;^0O;]3V54;1Z?WE3 M[Q@PW6^R]K[GW'N62BI,C!3XZ6+<_8^P\9@TFEGB+S"IK2JZ@$8@%EF[)<7N MWW%I`$UR+2K,0!^Q6)_ETEVUX+.]M[J4MH1JT4`D_M(`_:>D%\TNT>L^[/E5 MW]W;U'6[[GV9W3V[V1V[2T78VTL!L_<^WZOLC>^?WA4[;J*#;.^NPL5D*?"# M+K!'7+71-5:2QIX>`7=N$MM8VMM,%$D<:IVDD'2`*Y"\:<*?GTW?>%<7ES<1 M!BDCLW<`"-1)I@D8KQK^71Q_Y3_S*^.'PHWO\@=\]ZMW=DZGN'XV]D?'/$X; MJ;KO8FZH,52=AY?8N8DWGDPN)PVV=S; MIDQ63GI89KK2Y-F%53,WEA,+J>?Z28I(D4^@T8FJJ?(U(&/R_(](+:WA M-U$&1I(-65&&(\Q@FG[?S'2T^?\`M'XZ=>_,;OO97Q.RM1F/C_MS>,6.V!55 M&<33=.'QVY8\AEUW'@MO[TDR-!CLA]Y6&MH*:&8U$QBET5[L4\S0TQ0D4)%!0^0Z?W"VM8[R=+0UM@V//R%17S`-0/4=&YW#\P M_BAN/^5/U5\!ZC,_(;'=C[)^3I^1F:WE!TOUO7[(F6OVKOC:5=L_%M)\C*#/ M5345/O+[J&OEI*<5#TWA:GA$GF0N%K>+O,VYA8C$T/A@:VKQ!J>RGEPK^?2\ MW%H^TP[=63Q%EUDZ13@13XZ^?'HHGS8[/Z![6[/VMO/X^YSN6MPN(Z8^/'5- M92=O]?;+V/F*2?H#H7K;HNDS%#4[)[6[(I,DNY:3KB+).K+1FDEJFA'E$8D9 M58K<00NERJ!C([=I)'>[/3*KPU4\^'2>]:"65'MR^D(B]P`^!57R9N.FOET9 MSY$?S4][_*_^7;U_\1^]Z'*;N[IZH[ZZ_P!Y;:[TG2@GK=Y].;.ZT[AVG1;2 M['R\]IYWL9&Q]=HJ(\C0U%0]4T5;$\^206^V1V>YRWMN=,#QL"GHQ M935?(`A,WXL)$\*4U:-J@:O56`-*^FDC^5'3HWB1BBNM":>A4TK^T?X:EHCW?\`R_NOMO8[;NWMM_(;Y`9+.]K=993L M#>_9.UNMNB9,?TCM?,ME]_=?]<[/VKV)WS68G>^_5$-,=Q2;DB:EIZ<1Q4Z1 MS5*3/,;^1BS-'&`C4"DMW'@22%P/33_DZJBV48"HKN2PJ2`O:.(`!;)]:_Y> M@:^8.\OC1OKY$=C[I^'_`%EO'IWX\96NQ4G7O7N_,T^=W-@Z>'`8JES4E=52 MY[=LM''E=Q05=7%2-E\I]I'.(EJ&155/6IN8[>-;N4/<>9&`5*]17D_V/^\_[S^/;+/\`/I]4/4:2 M4/\`?'VPS]/JG4*28?4G_7'^^_Q]LL_D.GE3AZ]0FEN3SS?@?C_8 M_3FWMEFZ="YR.HS/]3<$_3^@_P!\?;+-TZ%KU$D>Q)-K_P"N/I[:+=.`#J%) M(?I>_P#L?;9/D.KA2K*"17J,S7/^']01_7_$_P!/>B?+JX'6&1OR?];_`!_K<@_Z_MLGJX'45F_/ M^^/NO6ZUP.'6!C_OO\/=3]O6Z>74=V_XU_K_`/&_=>MTIPZX`6]3?4FX_P!C M^/\`7Y]ZZV.NBUC?=>J$^76,FY_P'O1ZL@\^NB?S[;)J> MG.L+-?\`UOQ[V:`4\^M9\^L9]ZZJ37KHFW/OW6P//RZQ'D_Z_MLY/5^NO>OE MU[KWOW7NO>_=>ZQ,U^!]/R??NO=]^Z]U[WOKW7O?AQZ]UF!N+_[?VYU0CSZ['OW6@:=QD4ZOUG!_/ M]?>N'7NN[VY_K[GEUR_4 M/SQSQQ]/>^O''7-6_'YXN/R?S>WX^OOW6OD1UF!X%_S[N#U7ACRZS*>`/Z#W M;K7#[.LZM]/?@>O$>8X=<_=P?/JO4F-^;&XL?K_3_#W<'JE*'/4I'U?X'^O^ M^^ONW52//J2DAO\`ZQY_WGZ'W[AU3J8DE[7/'^Q]W!].O$5^WJ6KG_8#CG\# M_BGNW3?R/4I)`;@_3_#_`&'NU>O$=2E?^AX_P^O_`!7VX&ZJ0!6G4A7_`*GV MX#U2E>I$W%;ILKY]24EM_7_;_P#&O;H; M]G5"/4=24FN0+?3_`&'^]>WE?IMD!^WJ4DEO^*7^GMT,#TP5(ZE)/_7D<_Z_ M^PM^![<#'UZ;9?.G4E9!^#_M_P#BMO;H?Y=,F/RZS+)_7_?'_6]NB3Y]-&/S MZSK*/P?]O_K?X?3VZ)#TT8E].LHDL?\`BG_&O;HDZ9:+Y=2%G(MP+?CW>N_+_`(@_\B_QL?>_%ZT8 M2//'7O,1^;?[[_7][\7JO@DGCU[S7^IN/]X_WOWKQCPZWX('V]?I_P`5Y/MDR=/",=8'D_Q_VW_$GVTSU^WIX)G/462: MU_P+?C_8^V"]>GA&!]G4*2>XL/\`>O;;-4].A<#TZBL]SR?Z7_U^?;3-\^G` MM.HSR?4#_>O][]M,U>KA>HCR\<'_`!O_`,4]MD^O5_D.HK2$DV^M_P`_2W^Q M]M,W3@6F3U%9M/\`K_[?C_BONA/3E/7J.S_DWN?H/]]Q[H3UOJ')+_L/]C_O M'NA/3@6G'IOEE)-A_M_^*_U]U)ZWU#=OJ"/Z>Z_X>K`5.>L+$$7_`,2/]AQ_ MC[T32OKU<#CU&=Q_O=OQ?VV33[>K@5ZC,WY]UZW\AUA9K^]$];X?;UA8VOR! M8J^75N'V]86-S_ M`+[CW7JA-.L;'\?GWX]:45/7'VV3Y=/]8V/]D?[[_>??AZ]>ZQ$^]<>JD^77 M'W[JO7!FOQ_3W35TYP%.N'O7SZWU[WKKW7O?NO=<6-A?W[KW6'W[KW7O?NO= M^F^/7_]329]J.M=9P;B_OW7NN_?NO=>]^Z]U[WOCU[KDK6_K;WL$=:/#K M)[OU0BG7(>_=;!ZR*UN#]/\`>O>SD5'6^LOOP-.M]=@_@_[#VX.F67TZR@_[ M?\>_=>!\NLBM_MQ_O5[GW:M>K#KD0#ZAP?\`>?\`>^/I[WUXBG616_U^#R/S M_ON?>^M?;UG4_P!/]O[L.J_(]9E/NW6N!ZS*;_G_`%OI[\.O$>=.N8/TYY'] M"/K_`(^[C'#JI'6=)`#];?3_`'OFW^'NX/5*>7EU+5[_`)'^P_/XX]V!Z;(I M]G4A'YM_O/\`Q7WOAU[_``=3$E_!-A_7_??TM[L.M$5'4E'(_/%OK]?S]!_L M/=N/V]4^T=2TDO\`GZJD>O'J2K_`.-QW!/^^M^>?=P]>FBI\^LZR`B]^3_3CBU_;@?A MGJA05->LRRG_``'Y^O\`O@/;@?JAC'$=91,/S8V_UA_Q/NXD^?5#%YUZRK+S M]#_O/^]^[ASZ]-&(\:=91,/\1_OO\>?=A(>J&*F:=OK6@]&?3KWF/X(_VX/OVOKWA]C(/7K7AOZ8Z]YC^/^)_XK[UXG5O#/IUP\MO\/\`>_\`B?>O$^?5A%\^ MN)EM^?\`>;^Z&0\.KB(=86FY//\`OO\`8<>Z&3Y]."+-:=8FF_Q_'Y/^W^GM MLOTX(Z=8FE)^M_\`;V'^^O[;,G&AZ<"9&.L+R?X_X_[Q_M_;1D^?3HCR.HSS M;_GG_`'U_;18GIP+Y`=16D)_/_&O^(O[H M6Z<"_+/4=I`+`$?['VTS^G5POKU@:0?6_P#O/^O[:+=.`#J*\OU%^/\`B/\` M7_IQ[H3U8"N.HC/>_P"!?^IXM_L?;9->G0JCRSU@:2UU%_Z_[[Z^Z$^O5J4Z MBO(;?U)^OX_WWU]U)ZL!U#>7ZC^AX_PY/NG3E*8\^H,DMR`+\$7Y(_Q]U)Z] MU%:0#F]R?]]_A[KQZN!U&)O]3P+^]5IUO)ZPNP^ESQO_\`7]U^SJI/6(FWU]^ZID]]=4ZZ9BHXMS[JQZNHQ7K%[IU; MKWOW6NO>_?X>M]>]^Z]UA8W/'T_Y'_Q7W[KW7'W[KW71][ZJ3Y=Z][]U[K(IOP?]A[N#U4@ MGKE[MU3KF/?A@]7!KUE5K\'Z_CWLCS'6^N?U][4]:(KUS!YL?K_O?N_3)!&> MN8/]/?A@];!K]O64-^1_7D?ZWN_^#JXSUR(^C#Z_[W_@??NJD4ZYJW^\<$?T M][&.M8/6<-_0_P"^_P`?=@>M4]>'696_Y%[MUK(^SK*K?0'_`)%[]7KQSD=9 M!S_K_3W:O5>LL]]4(ID<.LRN1^ M3_OOS?ZGWL=5ZF)+]/Z?[`@_\;]WKUZE?+J0KD<@W''^^_/X/O=>J$$?9U)2 M6_U_'Y_WQ]V!IUKYCCU+63_B/^-W]W!^?6B`>/'J0LEC_MO^-\<>[ZNJZ<]9 MU<'Z<'_??3W<&G39`\^LZN?Z^[ANJ%2.LZR?U_XU]?=PW5?D>LRR7^O/MP-U M6G4A)C_6_P!>#_QKW<-U4K\NLZR*?SI-_P`_D_['VZ'Z:,?IUG#D?D'_`%C_ M`+W[<#]4*=9%G8/\`C?NX;S\^M%/,=91( M+_7_`&`_WW]?=@Y\NJ:/4=9!(1]"?]XM_MB#?W8.?/JND==B4\7(_P`>/^-> M[>(>JZ1Z=R_6_#7KB9V/T)_WW M^W]^U_+K7ACUZY>\,=M?6P@ZX^0GD_ M[S_OO^(]TU^75@@].N+2'\DC_8W'^]>ZF3JP3K$91^2?K_Q/^P]U,G5_".#U MB:8`\>VS(37/3@C\^L+5']?KS_K^VRQSGJX4#RZC//?^O/'^M;C_`&/NI;J^ MGJ.TAN;GZ_[[_;>Z%OGU8+@U%>L+2`?7G^E_;9;IP+Z]1VD)X^@]MEAU8#\N MHS2V_P!?_>?^1^VRU>K`8ZCO(3_MO\!];V)_I[H6ZL%KUA9A:[6-_I8_3_`_ MT]MDUKTX!Z=1GD8W%^!]/I^/Q;W7IP?9U$>3_'_8\7)_I[J3U8"O4-Y3;Z_7 M_87_`.)/NI^?5L>74*22_P#O1_Q_VWXY]U)Z]GTZB&0C^G^N"/\`>/=>G``! MGK"S$_4\?ZW_`!3WHGKW'APZPLX'Y%OQ]>?]Y_Q]MDUZN!3J,[_4_P"^_P!Z M]UZM\AUA+?\`(O>B>MX'6!F-[?[S[J3UL"G'CU@N6-A^F_/^M_C[KUOKD3]0 M.`/J?\+?T]Z)ZM2@KUB+?C\?[W[U7JI/6,G\GWKJG$]8_KS[J3TZJT'71-O= M,GJ_6$F_)]V.!3K77#W7JI->NB;<^_$TZ\!7K$3?VUTYUU[]U[KWOW7NO>_= M>ZX.UA;\G_>O?NO=8O?NO==>_=:)IUU[WU0YZZ]^Z]U__];29]J.M=>]^Z]U ME5KBQ^O^)^M_?NO=<_?NO=>]^Z]U[W[KW7O>^!Z]UE!O_P`C]N=-D4ZY>_=: MZY`_GWL>AX=7&<]9P;CWJE.M]=^[`]:(J.N0-_\`7]WZ9(IUD!][X=6!KUF! MM8CD?D7_`*^]CJW'KLAN&4?Z_P#L?Z^]]5IUS1KGZV'Y^G^^_'O=:=>XBGEU MG!_UQ[L#U4BF#UE5O]]?Z^[=:X9\NLP;Z?[ZW_&O?NO8.1UD%OZ_Z_/NP^W/ M6J=95<@V!O\`T_XH?=P:_;U0CJ6C7(-_Q:U[_P!.?K[MU33YCK*&(Y'^^_K] M?S[]U3_#U)CEYYX_H./K_A?W8'KU*\>I:N.#?_8C_B1[N#U5E\QU(23Z7/X^ MI_(_H1^/>P3U7Y'J6K_0@C_6_P`/=@QX=>\NLRO_`(V/^'MP-U4KUG60CZ_3 M_7^GNP/52/3K.KW-@?\`;C_6_P"(]W!ZHR^O699/Z'_B/]O[V#U0J0.LPD/% MQ8?U'NX;K5".(ZRB0?ZH?[[_`%_=PYZU@\>LJRD?D_[?W<.,=5*5ZL&VG\&Y ML'\8]I?,3Y.]H)T#TAVCN7,;3Z0Q>*V1/V?W7WC7[:D,6Z\WU[UO)N;8&WH= MD;7F1H*S,9SQO]%^X-I;OZZJ^J^X-C[BGVU5; MIP]?N?:6/W9V9LMML[DQ^-K%Q]9C]SUQFFHIT>.-HG`=CN)&@/\NFGA0+K5JBM.%#_E'\^BI"0'Z$`?\3^?K[4A_7CTR5].N8D;ZZN/KP>/ M^)]VU@=:T5\^N8F8?GG_`'W]??M?6O#'7/SM8?2]^??M9ZWX8I3KOS_\C_WW M/O?B'TZUX8].N_/_`+[_`'P]^\0^G7O"7KHSG\?\1;WK6>MB->'1@_BC\;^R M/F+\B.J_C/U+_"$W]VSN%\%AJO<%7/18+$4M!B\AN#<&X,W4TE)D*V/$;9SV*.G(H#+(J)0,>E%VIU/\>=N]=[FW M5U/\D<_V%NW9O:N#Z[RW7N^>G<5U3D\]@,UB=_US]G=?U5'W'V-7;EVCA\CL MF"CKHZR@Q-=229JA,L*>0J&TFE9PKQ!5*UJ#7TP<"AS\^'5FCC"DK)4@TR*> MN>)Z+#E*'*X2ICH\SCW=A=32[HVOM_&;IS.&R/8>XJ':6!JX,)E M]Q;5Q]12?Q_+4J5G)(@DCJ.`-.BT-+;Z6^ MMO\`??7W?77JND#K`TI(-^./K_L?]A[;)/5NL+.+_7G\?[[\_3W0MUO2>H[2 M_7_B?P?];W0MU<+UA+?0W_/]>?\`>[_CW0MQ'5PO6!I@+D?7Z6O]?\?=:^75 MPO4=G/U8G_6OQ:WNI/5Z>G4:27\"W^V'^V]U)KU8"F2>H3RC\D\_Z_\`OK>Z MD@=;\^HCO];_`$_'X_/]/S[J3UL"O49W-OK;D?3_`'P]ZKYTZN,=8"?ZG_B? M=2:=>H3UB9OK<_3_`'WT]T)'3@&.HS/?Z^Z];^0ZP$W_`.*>]$TZWPZQ,Q!/ M^M_MO=2>MT]1GK`;L18>F_\`M_Z\>Z];Z[/%PMO\2./?NK4IQZQL1:P_V)_V M'T]UZT3UB)]ZZH_)_V'NI/3BBG7B?Z^Z5)ZOUA8W)][X#Y]>ZQD^]=4 M)KUU[]UH"O6-C>P]MDYZ=`Q3KC[]P^WKW7O>NO=>]^Z]UT387]^Z]UA)N;^_ M=>ZZ]^Z]UQ/O8ZHW77OW6NO>_=>Z_]?27'M3TV#3KE[UU?KPXY]^Z]UF5KC_ M`!_/OW7NN7OW7NO>_=>Z][WY=>Z[!L?^-V]^!/#KW67C\>W.FR*==^_=>!IU MR!][!\CU;CUG!N+_`)_/O1P>M]=_ZWU]W!ZJ14=K<>O$7L1R1]/\>?>^JTSUR1K_3^ER+V] M[K3KW6=3?_??3W8'K5"/LZRAK6'^\^[=5(/$=90W^O\`7Z?CW[KU0>LJG^G/ M%O\`6_-_=@:]:(IUE5F!'/'TL#^!_3ZGW8&G'AU4]2%D%_\`B/S_`+'_`&'N MP^1ZJ1^WK.&'^/XM_K^]]-T(KZ=9DM$5ZDK)S^J@^O4A9..#^>!?_6_ MUCP?=P>O4!ZRJ_\`L/\`&_NP/6J>G659"/\`;6_WW]?=M1X'JI4=9ED']?Q_ ML?\`#_7]V#=:*_GUF$EQ_K?GW:O394=90_\`B1;_`'Q^GNP;K6GY];)'\PW& MS?,'^4K_`"MOD%\>:"?>NT_ASU1GOC1\G=I[3@ERV4Z7WW2X7KRAQV\-YX>B M6?)8/"]B/L:JKY,E/&E#_EE"/+JJ%7V7VS>!=W4F47ETT4,HA-90*^M! M6E>F8(`\B&3^S)_;\NA7V7A^L.Y?Y?7\PKN'Y,=`]*=6=P_$+OOH"BZ)K-K] M68KH\;@W7V#OGZ]O]54.P:S?^*P>V=ERS3/7U-1NK$13R5+9"-(V M<5+NES;)%(Q1U->YMF_P#"=WNS/_%SX^[6ROR]^2/9W1G?NS.L MMFY?KSK_`'_LC:GRFV9TGMRHSF&VYN>ER5?NG&;;RE15-DIJV2:MKG'W@J:9 M?MBH$LD;;G&)F(1`5)-2#I)_9TT8T86;>&H+,0:8!%:="MV+@OC.W]2[AW!MB/![7AFA MP$-51[>2I=E^Q-*$I5JCRZ]N/U$GZJ'5GT`.!2GY\?GUME33=_HIV,*8^9&? M]5.E;7?#OXE=R_-GX4;FR_1'5&VLGW/_`"6MK?-JC^./6V!DV#U-W;\M'VKN M'+8/9./V+@\C!)!B,C!$U;+BJ&HC_B2X0+4&8350FJ+F:.WG42FBSZ=1R0M> M-?\`+\^O>!$TL1*`$Q:J#`)ZK;V-A.F.[/Y9?;WR:[ZZ@Z;V[WQT9\Q>E-A= M,9?:76^W.CL%WGA][5^*J^SNB-Y;+Z6I^L\#N2AVKM:.KS4E?34U/N"AA"0K M7QQ.596SO'=I%'(QB9"34DTIP()KQX>GRZ8"*T#2.@UAA3%*^HQ3_/U:]\@> MAOB@ORL_G?\`PPP7P]^-.T.N/C'_`"Z\S\ENGMX[7Z^GI.W=K=I[&^.W2>\L M/DJ'L#(9K)UV,Q51F=WRM74&.CH:3(^$254M:#K5\^#F\?D!U_\INK.P_BU+%_IWZZFWAV'L6AG MHYLE'N`;$V!NK=NY]H'#TL4E9GFWIL[#Y#$+CH"D^0:M%-')&\JR*;7)B>%T MF_LS0'\S_D.>D,2R+(K1TUC/5R'S9WA\7OE'\/\`XY?S1]L_&[9'QB^5^XOF MM_H5[,ZNH,+39GI3Y%Q[7VX-_P"\>U,?USN?&28+-X2#<%;04.8D>FG66NKJ MR@RLM?-]O4%!!XL,TMH92\/AU!\U\@*C_5YBG2J71)&DXC"RZJ$>1^=.K)OF MKT=MCN7^;?\`//`]M]'[%S6)^-WP@W]W1\%M@_Z#=G;+I_DEW-L;XL=#5E%M M?<&\-L[7VQNGY.8+JK*`K2;;K\IEX\92TWV4<<=#%44DJ2"9H[.WT2&K2`.: MDT!8\`3VU]:#]O3\L:M<2ZD%%6JBG$T'[:=5';6Z7^.'RF^`GPX[D[VQW6GQ MX[LW[_,VPOQ&J^R.N=E;2ZAI.T?C3F,5L_-[^["R77FQ-N;:ZW2JZ?R.\_L_ M[PTN+B4?;)35\LLTJGVK:66*XF2,EHQ%JH36C>0J*-F`5B],8J/ MR].C)T74G=WQF_F>;#^,]=\#>MMG?'W8/\SSXB5/2WR(7X^UF%WEL7J+'_*3 M9&&Z[;`?)*EI\9E>TU[:P60QT>9_O1D=S5)R"U(I11213K$SXB2VS2^.3(8F MJ*X)TY[?*GE2G3E'2<)X0T!Q0T\JXSYU^=>H_P#."^,65ZLV3\J_DWT36]$? M('9_:WSV^3^!^5F]?]#>T]V=M_%;>59OW/X7:'4L&?WKM?);EV-M[)XZI%16 M9ZD^RB_AM1%!/!59+5I,&,43ZE(C73DT;YXX_9Z?RW<1E0[K0@L:XR/E MUJS-(/Z_[;ZV]F1/2,+ZGK$SW'^'YYO[J6^?5POH.L)<_P!H_P"Q!_XGGW0M MU<+UA:4#B]R![I7JP7J.TA;\\#^GO5>K>M.L+2*+\W(M_A>_]?="W5@OGY=1 M9)K@_0?['\_CWKJWV#J(\O\`Q/\`O?'/]/=2?+KU.HKR?U_'YO\`X^ZU].K@ M<*]1G?4?K?\`WCWZO7JXZQ:OZ'_7/X_WOW4FG5@#UB:3Z_XBW^Q'%^?Z>VR: M]7'SZCL_T!)-O=>MT].'6%C];?Z_^M[T3UO@,=86<`?7_7//^P_V_NO6P*?; MUAY:]_TG^GYY_P`>?>NM]Z$].`4ZX?X^]?,];Z][UUKAU[W[ACK?7O?NO=86:]O\`"_OW M7NN/OW7NNB?>^JD]=>_=5ZZ]^Z]UV/Z^_'K8]>O_T-);VIZ:ZY#W[JP/7?O7 M5NNP;$<\7%_?NO=9_?NO=>]^Z]U[W[KW7A_K_7^OO?\`AZUUR#$?X_X>[`_M MZ\1UD_%_=NJ$4Z[O[]UX&G7,&Q_WW/O?'!ZOUF!!^GO61U[KOG_C7X]W!ZJR MUZY@W]WZ9X=9%-C[UU8&OV]9`UC=3_L#[L#U?!X\>N1&KE3R./Z?\1?\^]]: M(Z[#$-8VO]1:_O?6NLP;_;^]@]5-1GK,&_V/NW6J`Y'64/\`X\?T][ZU\CUD M#]_GU0CK*KV^A_P"-_P"^M[]_AZKGSZSI,0?Z_P"N;'Z?[;D^[`]: M_P`/4E9!<'5S^!?F]K_0^[5ZT17K.LMK?[&_Y]^^SK6D^74E9OJ;^[`^5.M? M+SZSK)]?I_O?_(O=P?GUXYXCK*'O;G_#_C?O=3Y]5IZ=9%<_@W_'U^GO8/6B M,4IUD$I_/^\>[:NM:1T(77/;?:'4&=_O1U-V5OWJ_+KK>&X=DYTTI M=)33'+;;R.-KS`98U;1Y-.I0;7`]^(1Q1E!'SZJ`RFJD@]._8?>W=7;V7QVX M.V.X.T>S\]B#JQ.;[#W_`+LWIE\6WDCE#8[)[DRV2K*)O+&KWB=?4H/U`][5 M4445`!\AUHLYXM4_/ISW?\C._P#L+);4S&_N\^X=\Y?8E=#E-CY7>'9F]-RY M'9N3II:*:GR.U*[,YNMJMNU\$V,IG2:C>&16IXR""BV\J1K4!``>../6RSM3 M4>'SZ6*_,WY>)F\NS5S.8P>*ER,^+PV4RHW1]_ MD,3C9\O5O!332/#"]5,44&1]7O"BH!X2T'R'6M;U/>W[>FVG^6'RAI:#9N,I M?DIW[2XWKN:GGZ_QU/W%V)#0[%GI<9582EFV=21;B6#;$M/A:V:DC:B6`I2S M/$"$9E.]$9+$Q+GC@9^WK6ML`2''#)ZY57RS^4M;1;QQM9\EN_:S'=B22R]@ M4%5W'V'/1[ZEGQ-)@9Y=XTLVXG@W,\V#H(*)C6K.6I((X3^VBJ/!(L'PEJ.& M!C[.M%Y,C6<_,YZ9-X_(_P"078E?M7*=@=Z]Q[ZRFQ*E:S8^2WCV=O;<]?LV ML5Z:5:O:E9FLW6U&WJE9*.%@](T+!HD-[JMMJD:U"Q@`\<#/52\AI5B:?/K' MNOY%=^[[W+MG>F^>\>W]Y[PV74FLV=NO=?9>\]Q;EVG5FIAK35;:SN7S59E< M!4FMIXYM=++$WEC5[ZE!&PD:@JL:A3Y4%.O%W)!+$D?/I6#YC_+@9C-;B'RF M^1HS^X\30X'<.<'=_9@S&=P>,:O;&87,Y/\`O/\`>Y3$XYLK5&"GG>2&$U,N ME1Y'O7PX:`>"E!\A_FZL))"?C:I^?0$X+<>=VOF,=N';.:RVW<_AZN*OQ&=P M61J\1F,570-J@K,;DZ":GKJ&KA;E)(G5U/T/NY-10@$=5`8'&#TJ^Q^X>U^X MLO2[@[=[0[#[3S]#1+CJ/-]C[UW)OC+T>/61YEH*7);GR>3K:>B661F$2.$# M,3:Y]U4(@HB@#Y"G6VUL>YJ].6Y._P#O/>6Z=J[ZW=W3VQNG>VQ:+&8W9.\= MQ]C;PSFZMG8_"D'#T&UMP9/,567V]18FW^314DT,<']@+[T%C"E50!3Q%!G[ M>M]Y(+.21\^F3L;MWM/M_,4^XNV>R^P.T=P4E&,=2YWL7>6XMZYFEQZU$U6M M!3Y3.!GJ^J3&3CJ-)\I?DQ++OZ:7Y$]ZRR]KTE'0=I3/VYO]Y>R:''X MVMP]!1;_`'?-)0XC)5%+#'D34I%35$D2@([*:Z8Z+2-<<,#'V>G6P7SW MG/SZ`R?4]>T]8FE'-B?R"2?]X_K[J3U8"G'K`TA/U-O]X% M_>JCSZL/EUA:0#ZGD?4`_P"\?UL?=:^G5@*<.'49YSR`;#ZVL+V_XFU_>OMZ MW]G45Y?KS]?]N;_\3[J3U[TZC-*/SQ]?^-V]UJ>K!2>/4=I1S_2_%K?2P^OO MU>MT%/GU@9AVR> MK\./6!F!OS_OB/>J]>IZ]82;?ZP'O1/6_.GEUA=^/]O;^I]UZL,=8A=_KP!_ M3WKKW79/X%@`/K]/>NK4ID]8RW%OQ[T>/52>N!-_>NJ$UZX7O?\`IQ].";C_ M`(U[T3TXJ^9ZXD_[`>VR:].=8F:_'X_WOW8"F3UKK&3[U6O6B?+KC[UU7KBS M?@'W4GJX'F>/6/W3CU;KWOW7NO>]^77NO>]=>ZQN>+?U^O\`A[]U[K'[]U[K MWOW7NN)][Z;)KUU[]U[KOW[KW7C_`$]U)ZL<8Z__T=);VIZ:Z[]^Z]UR]^IY M]7!KU[WKK?7-#]1_7Z?[S[]U[K+[]U[KWOW7NO>_=>Z][W]G7NN2FW'')'NP M/6B*]9?=NJ$4Z\#[]UL'KFI(Y'^^'O8R*'JW68$'D>]<.O==_7W<'JI%>N8/ M^W_XW[MQZ:*E3US!_P!O[]_@ZV#7[>LBL;WN+_['FWNW5L4H>LGZN/[5K_GZ M^]]>IUQ!8&Q^@_-C_O?^O[]UKK.&!'U_V(_WKC\^]UZT17AQZR`\_P"/NP/6 MJ^1ZRJQ_UC[MUJA'V=90UO?NO8/V]9E?^EK?X^]UZU2G656_VW]/K]+_`/%? M=@Q'5:=9E>_^\6_I_M_=P0>JD4ZR!OZ_[#_??X>]]5IGK,KG^IM_O/\`O/O? M5:$9/6=9O]C_`+[^OO=>O4ZSK*/^1$_C_>/S[W7KU.LPE/\`C_OO\.?>^JZ1 MUG6:YL?K;ZW-_P#>K'WL'JM#Y]9ED']1_4@@@_[U[MJZU]G659"/K]/]B;_[ MQ?WNOSZ]3KD)%)_WW_$^]UZUIS@]9`XM]3[W7KVGUZYAV_!_WD>]UZKI]1UR MUG_#_;^]ZOEU[1\^NPY_%_\`6!/OVKUZUI^?78D;_'GCZ_\`%?I[WK'7M!Z[ M$A_VW]0/][^OOVH4Z]H/7A(3^?\`$?3GC\>_:AY]>TGKHNPYO]>;7/\`Q2WO M6KTZ]I^?7'7_`%Y_V_\`Q3W[5U[3\^O:O\;?[?\`WNWOQ:OEU[3UQ\@M^/\` M;_\`$#W75\^MZ/EUC,@O_4G_`%Q[U7Y]6`\NL9E'X_WW^]>_5^76]/6,R,>/ M^(M_Q7WJOSZV!UC+_P!2!_L?==76P*>76!IE%[?[W8_[:Q%O=:FO5@*=8&G) M_(_WW^O[UCK?\NL#2\W_`-[_`.->]5Z]QZCM(+_JM?DGZ\?[`GWH];IZ]1WE M`^G)_%O]]_C[U^?5A0<>H[.3R?Z?[?WJOIUNI/#K&6_I;_;_`/$'WHGK87UZ MQLY6YXN3^;_X?U_'NC'JP'KPZPM)_C8?2WNO5A\NL+-?\?\`&O\`>/>CUZE. ML3-8?C_6O]./S[J3U;CQZCLXOP+_`.M_ON?>NM]=!1RS#ZF]@?I?_B?>NO4Z M\2/Z$*/^-#_#WJOIU;@/GUC9K_X#\#WK[.JD^O6,G^OO75>)ZX?4W/T_I[T3 MTX%IUT2/]8>Z$UZOUC8WXOQ_7_'WX8SU[K$3[U6O5212G77OW5>N):WT]Z)Z MN!3CUB]TR>K=>]^/7NO>]=>Z][]U[K@YL+?UO[]U[K%[]U[KWOW7NN)/O?5" M:]=>_=:Z][]U[KOZ>]$]6X?;UU[IU7K_TM)?VIZ:ZZ]^Z]UV#[]UL&G7+WKJ MW'KWOW6^LBM]!^?^*#W[KW63W[KW7O?NO=>]^Z]U[WL>HZ]US5@+W]V!ZT^.#U?K,"#]/]M^?>J=>ZY"UQ?CW8'K1 M%>N0)^A%C[N#TRRTZY`^_=>!]>LH/TOQ_0V/('^Q][!ZO7]G62_]1_MO^)Y] M[Z\0#UQ-U_3]#^+7M[WUHXZR*_'^M^/S_B?K[]U[CY=90;C_`(CW:O5LRM_KD$#Z_P"M_O'N MP/6J=90P^O\`B!;_`'KW8-Z]5(].LFL@W_VWY_XI[L".M4I3K*)./IP/Z?[[ M_'WOJM`3US#?XV-_]]S_`$]^ZJ5/6=92!];_`.O_`*_^Q]VKUHCUZRK*+W)M M_MOZ_7C_`%O>ZCKV/+CUE$G]+_[;_7_V/OW7L_+K,LQ%OZ#^G/\`Q2WO=3U6 M@ZRB9;\WM^?]]<^]U/6Z#R/7,2K:_P!.?]8_[#GWO5Z]:TGK()`;6/U_V//^ MQ)]^J.O:2/+KEY"/[7^P/_&C[W6O5?RZ[$I_/_$^_5^?7L>0Z[\S?[[_`(I; MWZOSZ]0==^8_[X>]UZU3KKRG_'_>?]Z'OU>MT^777F:UK\?TY]ZK\^O8].O> M5O\`'_>1[]7Y]>X^77$L?]\?^(]ZKUNA\^N)<`7+?[R3[UJ^0ZW3Y8ZQF5/R M3?\`/OVKKVD>O6,SB_I%[>]=;P.L)G)-[G_??[&WO7V];IZ=87E/)-_]C_K^ M]5IU[K"9?K_3_$V]ZKUX#K"T@/\`6W^^_K[UFM.K4H`>L+3]$]:XXZQZK_X?XF]_]X]ZKU;3UC+`?6X/_(KW_P!?W4MU M:AZQ-)>]OZ\D^Z5QUL?SZPL_U_WOWK_!UOYGK$S?UO[T3UOC@=8R_P#C;_$_ M[U[K7K8%.L)8M^#SQJ]> MK3AUC9K\^]5Q0=5)IUP)_/O7#K7Q''6,\_7GW4GIT*.O$V]TJ3PZMUB9K\#Z M>]@4SU[K&3[\<]5)IUQ]ZZKUTQT_Z_U]Z)ZN!UC///NG'JW77O77NO>]]:Z] M[UUOKHFPO[]U[K"3]]:Z][]U[KL>_=;!IUR]ZZOU[Z]^ZUU[W[_``=;X]?7NN?O8;UZT17KD#_O MOZ>[@]-LOF.N0/\`C[WU4$CCPZR!N!^1_3WNO[>K`]9`UOI]+_3B_O8X=6K7 M[>N[`FZFQYO^;_[S[WUJF>O!B+Z@?\&M_C]??NM=90X_U_\`$'WNO6B*_;UD M#?XW_P"(]VKUJA`SUD#_`$_WQ][!ZU0>760-S_Q!]^].O9''K(K_`-3Q_ON/ M>Z_LZUCRZR^2_P"?]O\`X6_-A^?=@>O$=N8D_'X_(/]?]?Z^]@]>QYCK*)!_P`B_P!?_7^GOW6J5/'KF)!^ M"1^.?S^./K[]6G6M)\NLPD/)//\`O/\`O7O=>M4(ZY"7ZW'^M];^]UZT>N?E M']?]]_K^_:NO4'F.N8D(_P`?][][J.O8\CUR$S?X_P"\V_WJWOW6Z=<_.>+G M_??[Q[W7Y]:_9U[[AO\`5'_??['WJOSZU3[.N_N#_OO^1W]^K\^O4'^H]=_< M'^H'X_K?_B??J_/K>/3KCYV_K?\`VWOU?GUJGV=>,[&]R?\`;>_5ZW0CK@9R M?R2?]?W[`\NO9'V=8S-_7Z_['_C?O5?3KW[>L9DY)Y_WW^/O1)ZWGK@91SR` M?SS?_>/?JU^SKU#UP,E_[1_WK_BGO77J#K&9?Z'_`%Q?F_Y^MO?J^O6Z4X'K M"TAN20;_`-2?\?>J]>IUC+_D\_[`'_C7OU>MT/7`D_ZW^%O]\?>J]6H.N!-N M2>?\?]]]?==75J=8FD`-APW]>;?Z_P#B?=2>/6Z?MZPM(3]?K^#Q]/Z_3W6O MSZW]O6(M_C_L?>B>O?9UC9@+\_['\?7_`!]UKUNGKQZPE_P/5^>/]\?>NK5Z MXZ;V+&W^!%O?NO4Z[+"UA<#Z?[#WKJU*=<-5OH/]C_OC[T>M$_LZQD^]=5)] M.N)/^Q/OW#K0!8]G@`.'71('U]TR>M]8BU_];^GO>!]O7NN!/OQS]G5 M2?3KC[UU7KIB`/KS_O7O1/5P.L1N>?=#D]6Z][]U[_!U[WKKW7O?NO==7M]? M?NO=8F-S];CC_6^GOW7NN/OW7NNB??NM$TZZ][ZIUU[]U[KOW[KP'71/NA-> MMU].O>]=:Z][]U[K_]326!M[>&.FQCKO_'W<&O7CZ]=>_=:Z][]U[KD/?NK` M^O7?O75NO>_=>ZS*VK_#_"_OW7NN7OW7NNO?NO==^_=:Z][WUOKD&(_UOZ>_ M!CUHCK(#?GVYU0\>N_?NM<.N0/OP/EY=7!KUE#WX/^W][(].M]<[^_`D=>X] M=CCZ?ZY'_&[_`./NP/5&4$=<@?=NF\CKF#]/IQ_O//OW#K8->L@;G\*>/]8W M_P"->]@]6KZ]_=>ZR!_IR+?U'O=>M4'60-_2Q_WOW8'JN:TZYAO\;_`.'O?7J`]9`W^P_U M_?J_+KV1Y]J/SZRB07XOS_Q7WNO6J=9@WYX/XM_M[7_ M`*7][U=:IUV6Y_'^PM_O(']/=P:]5(Z[U&PYX][KUK(ZY!R/Q[W7KU?EUR\C M7^I'^\_\1[]CSZ\"//KF)>+$C_;'_B/?NM&AZY"6YX%K?T)MQQ]/\??OSZT0 M*=7C\_X7_P"-^_=>*CKWE_UQ_MC_`,1[]UJ@Z]Y/ MKR3_`(V]^Z]IZ[\GUY_WC_>O?NO:>N/E_'_&O^(]^Z]3Y==&7^A(_P!?Z?[W M[]U[%:4ZX^4#GC_>_?B3Z]6H*5IUQ$M_R!_O%O?L=>\^/6,RD_4?[SQ[]U[\ ML=<-9!/(Y]ZKU[CY=<2_]23?^A]^ZV!UP+$<6L?]O[U7K=!UQ)/Y/'^/'O5? MGUNE/+KCK6UP1_L/]\?==75M)ZX&4?ZQ^HL;_P"M?W6IZW3K`9">3]?Z_P!? M>CUZGJ>L9:_^/^)]ZKUZOIUC+_['Z_[[_'W4GK=/7K&TG^/^P'_&O>NK=<"& M/U](_P!X_P![]^Z]0]>%EX%B?ZWM_L.??NMT]>NF)_)Y_I_AS_L/>J];KUC+ M>]?9U4GK@3[UU6M>N&H_ZWO1/5E3S/7K\$6')O?\^Z%NG`*=<"P'U]ZH3UOK M$3?Z^[<.M=<"?=>JDU^SKKW[K7'KHO;_`!_Q]U)ZN!3K%]?= M.>O>]=>Z][]U[KWOW7NL+-?C\<'_`&/OW7NN/OW7NNC[]UHFG77O?5.NO?NO M==^_=>X]>)M[J3U8FG#KKW7JO7O?NO=>]^Z]U__5TEO;O3778/X][!ZV/3KQ M]WZ\>NO?NM=>]^Z]UR'O75P>N_?NM]=@D?3W[KW653][Z\/GUR5K?XCWX&G6J#K)<'Z6]N#JA%.O>_=:ZY`^_<.'5@:X M/60,1_C_`+W_`+?WN@/6^L@-^1[UD'K?7?NP;K1`/7('^MO]?Z>[@]-,M.'7 M,'_8_P"\^_=:J1UR#6_H?]?WZIZL#Z'K("/K>Q_H.![M7K=?7KO5^&`/^V_W MQ][ZW2N1UWIMRI/^M<O4' MF.L@8?['_'WNO6J4X=<]7]>/];_C7O=>J_:.N0?_`&/NU>O4]#UD$MN+V'^W M_P"*^_=>R.N8<\<\^_5^?7L?GUS\G`!N;?XC_#WL$CK1`\NN8(^H_P!@#_R/ MWO4>O$=]75=->N5S_K_C@'_7X_V'O88'K6GKK4?P/>ZTZU3Y M]=ZC?Z-?_6]^J.O:3UWK(_U0_P!C_P`;][KUZAZZUG^I_P!O_P`;]^Z]0]>U M_P")_P!O_P`;]^KUZAZ[\AM]3_L2/^)/OW7J'KK7_B?]O_QOWZO7J'KWD8_@ MG_??TM[U7KVGY]=%S_0#_8#_`(H/?J]>I\^NBQM_C_AS[]7KU.NKD_4_3ZWM M_O7O51U8#Y=<2PM^/Q_2_P#ON/>M0ZW0]=%KB_!M_L/]MQ[J6Z]I'`]8VF)! M%K?C5P?I_O//O5?GUL?9UB,AO]?]YM_Q'OU>MT/RZQEO]\`/=:]>QUQ9_P"O M_&_]Z]^KUL#\NL9?_D9]UKUZGKUC:0?Z_P#K6_WOWKK?7&S-:X(7_`_@^_=; MIUW95'X/^O:_OW6P.N):][GC^G%_K[U]O6\#[>N!;^G'^-^?^(]ZK^?6B?7K MA?WK[>JD^G7`MS]+GWZM.M!2V>NCSS_O']/>B>G%6G77MLFO5^N#-;Z$?X_X M>]@>O7NL1/OQ/D.M=<2?>NJD]=>_=>`KUP9_P./^)]U)ZO=>]ZZ M]U[W[K77O?NM]>]^Z]UA9K\#Z>_=>ZX^_=>Z][]UH]^J==>_=>Z][]U[K MOZ>ZD]6P.'77O76NO>]=:Z][]U[KWOW7NO_6TEO;O377O?NO==@^]@];KU[W M?K1ZZ]^Z]U[W[KW7(>_=6!Z[]ZZMUV#8W]^Z]UE5M7_$CW[KW7+W[KW7O?NO M=>]^Z]U[W[K77KD?0^]UZWUE!!_U_P"GNX->J%?3KOWOJO78/OW6P?7KF#8W M][K7'5^L@<'Z\>]4Z]USOQ;\'WL'KW7=[?3_`&WNP/5&6O7(-_L#[M7ILJ1U MRO[]UX'UZYJY'TY_U_?J]6X]ZYZW7Y=<]7TN./ZBW_`!0^ M]UZW2M:==6!-U)U?C\"_^Q][ZU3KP+C]0X_V'_%??NM=_P#C_B#[]7K1`/7(,/H#_M_>Z]:H1P/7.Y_WQ][KU[[1CKL/_C_M^?>Z M]:QUS#_[Z_\`Q'O=>O4/D<==A_Z$CW[KU#Z]O8'EGKOR$?0$_['_8>]U/#K5!Z]<@XLM_KQ?\V_V_OVH]>IUWK' M/U-OI_CQ_O'OU3UZG7BZ_P")/_&O^*^]ZNM4'KU[R"W']/I_L.>3;WZIZ]0= M=>3C_C?T^O'^V]ZKUN@SUQ,AOP+C\F_OVHCKU!Z]>,P''_%2/S]+?X>]5ZW0 M==&6_P">/]:W_$#WZIZ]3Y=8M;`W!/U_J/\`>K>_5Z]0XZZ,A/U_WW_$>]5^ M?7J`>?7'4?\`'WJO7JCTZQE_KS[U7K=#UT7_`*7_`-?WJO6P*>?6,O;@DC_; M_P"]^_$UZWUPU$_I'^W_`.1^]=>Z]8\ZR1_K?\4'OW6Z'KN_T`Y_WW^(]^KU MZE.N!;ZW/]?^1<>]?X.MU'Y]<2W'''^]_P"]>]5ZJ3Z]<"??N/6J^G7$M;Z^ M]=:H3UQN3_A[U7JX0#CQZZO;Z>Z%O3J].NB0/K[UD];ZQ,U_];WOA]O6NN!/ MOQ->M$TZZ]ZZJ37KHD#Z_P"P]^ZV!^SK$6O_`*W]/="?3JXZZ]Z^WKW7O?J] M>Z][UUOKKW[KW7B;"_OW7NL3-?\`P'OW7NN/OW7NO>]_/K77$^]]5)ZZ]ZZU MU[W[KW7?X]Z/#K=*`]=>Z=:Z][]U[KWOW7NO>_=>ZZ/`)][Z]U__U]);V[TU MU[W[KW7O?NO=>_P]V!ZWQQUW[MUKAUU[]U[KOW[KW7=_?NK`^O7?O75NNP2/ MI[]U[K('!_P/OW7NN?OW7NO>_=>Z][]U[KP][X\>M<.O?3W[(ZWUD5OP?]O_ M`,5]V!ZT17KG;W;JA%.O>_=:K3KL'WZI'5P:]M]9`P/T^O\` M3WJA'7J]PW7J==BX%P?\`"WNX/5"O78;_`&!][Z;((ZYW]^Z]7KD&(^A] M^ZM4'KD&YY_WC_?'W:OSSUNIZY@FW!N/]C[]UO!Z[U`BS7_V''Y_V/O?6B#Y M=>TV%U;Z_P!3_K?46]^ZUUU9Q_0_[[_8>_=>Z\)/Z\'_``_WU_?NO=Z]>ZY!S[]7K1'7/6/\?]X][KUZGSZ]K'];?[[_6]^KUJA]>N]7^( M/^Q]^KUK(\NN]7^(_P!Y][KU;N].NPW]+_["_P#QKWNM.M$>HZ]J_P!?_;_\ M;]^KUK'IU[5_B?\`;G_BOO5>O8].O:O\3_MS_P`5]^J.O8].NM5_^1'WZO6\ M^G7M=OR/]O[]7KQKZ==:Q_4?[S_Q3WJO7J'KK6/\?]A[]7K=/GUT7_I?_8_\ MC]ZKUJGJ>N!DM^;?[S_Q6WOU>K?EUP,@_J3[]U[KH,Q^@'U_H?\`>_I[UU[K MO2Q_41;^@/\`Q'OW7NN@$'()_P!C[]7K97KVH_[3_O7O76S3SZXEA;ZDG_>/ M^*^_=:KZ#K@6_P!A[U7TZT3Z]<;^_?GU75UQ+#^OO77LGKCNO?NM==%@+V//^Q_K[J3U<"GV]8R2>3[K4]6ZZ]^X=:Z][UQZWUU_O MN0?^-7]^Z]UW[]U[KHFPO[]U[K"6)^I]^Z]UU[]U[KWO=//K77$F_O?52:]= M>]=:Z][]U[KOZ>]$];&,GKKW7KW7O>NM=>]^Z]U[W[KW77OW7NN!-S]>/^-> M[C^?5@//K__0TEO;O377O?NO=>]^Z]U[W[KW78/NP/5J\>NO=NJ]>]^Z]U[W M[KW7*X_V/]?^(]ZZL#UW[]U;KWOW7NN:L;@<6^G_`!3W[KW67W[KW7O?NO=> M][/7NO>_`TZUU[WZG6^N08K_`+'^OO8/KUKKF"#_`*_]/^*>[:AU4CKOWOJO M7=_?NM@TZY7][!(ZM4=/?L'AUOK(&!_/O5".O=O==?FX M]V!ZJ5KUR#?U]VKTV5(ZY7_Q]^ZUD==W]^X=;KUS#D?G_??[W[W7CZ];J.N0 M*VY!'^/-O?J];J>O`V^A'^^_P][KUO!ZYZC?D7_UA]??J]>QUXZ#]]:IUUI6W'^P^OOW6NO!7'T(_WO\`XCW[KW7OW/ZW_P!M_P`4]^Z]U[4W MY6_^M?\`XH??NO=>U'_4G_>?^*>_=>Z[U?[2W^V]^Z]U[5_@W^V]^Z]U[5;Z MAO\`;>_=>Z]J_P!I;_;>_=>Z]J_VEO\`;>_=>ZZU-^%_W@_\:]^Z]U[U_P"' M^^_U^??NO=>L_P#4?[[_`&'OW7NN@G];?[S_`,:]^Z]UW9!^.?\`7/OW6P/E MU[5;@#_??[;W[K=.O%K_`%M_O/\`Q'O6>O8'7&X_U_\`6N/][]^^WKU?3KCJ M/^M_A_R._O1..JU^?7&_OU3UJHZXD_[#WKK52>N-^;#GWZO7@M>NCS]?Q_ON M?>J].!:==?0?\3[J6ZL!3KQ/Y)_V_NO'K?6,O_3WZGKU[K'[V6].O=<;^]4Z MJ6ZZ]^ZKUX\?7CWZO6PI/7`N>0/I[H3U<8X=M]>][ZUU[WKK?7O?NO=> M]^Z]UT387]^Z]UA)OR??NO==>_=>Z][W3K1-.N/OW5":]=>_=>Z][]U[KOZ> M]$];I3/77NO7NO>]=:Z][]U[KWOW7NO>_=>ZQL?Q[L/7JP`ZZ][ZWU__T=); MV[TUU[W[KW7O?NO=>]^Z]U[W[KW7?UX_/NP/6^.//KWNW6J4ZZ]^Z]U[W[KW M7('W[JP/`==^]=6Z][]U[KFKD<'Z?[S[]U[K("#]/?NO==^_=>Z][]U[KWOW M7NO>_=>Z][]U[KF'M8'D?[S[L&ZT0#US^OT]WKU0@]>]^ZUUW?W[JP/KURO[ MV"1UNHZYAB+#\>_8->M]JE` M>'7>K_`_[#WNO5"AZYW/OW6JD=>O[]3KVKY==W][J>MU'7+43_OO^-^_5ZM4 M]=ZA;Z<_[Q[]7KU3UZX][].MZAUV&_WQO_Q'OW6JCKL,?QS_`+?_`'J_OW6\ M'SZ[U-_3_>#[]7KU!Z]=ZC_0W_/'OU>O4XYZ]J_P/OU>M4^?7M7^!]^KUZGS MZ]J/]#_OO]O[]7KU!Z]>U'^G^]^_5ZW0>O7'6?\`#_>?>^M=OKU[7_K?[S[] MGKV.N)/^-_\`??X^_=;J.NK^]8]>O:NO:O\``?[S_P`5]ZJ.M5/7'5_B??JG MTZK4==7]ZZUJ^775_P#8>_=>J3UQU#_$^_5Z]I/75S_K>]5ZL$]>NO=2W5]( M].O>]%NK4ZZ)`^OO63U[K@7_`*#WN@''KW7`F_)]^KZ=>ZXW]ZX]5U>G77OW M6B:]>]^KUZAQCK@7L>/=2>K!:<>L?U/^O[KQZMU[WKKW7O>Z]:Z][UUOKK_? M#_;>_=>Z[]^Z]UP9K<#Z^_=>ZQ>_=>Z][]U[KJ_OW6B:==>]]4ZZ]^Z]U[W[ MKW7?T]Z)ZW2F3UT3?W4FO7B:]>]ZZUU[W[KW7O?NO=>]^Z]UP?\``L?J#_A[ ML.M^8ZX^]]7Z][]U[K__TM)"Y'T]J,'CTV1Z=9?=.M==^_=>Z][]U[KWOW7N MO>_=>Z[^OU]V!ZWQX\>O>[=:(IUU[]U[KWOW7NN[^_=;J>N7O75NO>_=;Z[! M(^GOW7NLH8'\V_UR/?NO=]^ZUUU_OO]]_K^_=;Z[]^ZUU[W[K?V]> M!(Y'OW#KW7,/_7_;^[!NJE1US!!^G_&_=ZUZJ13KWOW6NN[^_=;J>N[^_9'5 MJ@]<@Q'T/O=0>/6^N>L?D>_4]#UHFG7.X_J/>LCK?7?O=3U[KW!_WQ][U=:I M7KOZ?0^]AOGU4J#Y=>!/YY][KU4IUWJ']#[W7K6D^G7>H?U_WW^Q]^QUJC#R MZ[O_`(C_`'CW[KU3UW?W[KU3Y]>O[WGUZ]7Y=>O[]4^O6]0Z[O[]4^O7JCKU M_?JGUZ]4=>O[]4^O7JCKU_?JGKU1UZ_OU3Z]>J.NK^]9]>M:OEUZ_OW7M775 M_P#'W[KU3UUJ']??NO9ZZU#_`!/OU>O:3U[4?Z?[S[]7K>CKC<_U]ZU#UZMH MZ][KJ^?5M(].O>]:OEUNE.NKC\D>]9/6^NBP'^/^M[]0]>ZQLU[_`-/]A[W@ M?;U[KC?WJIZU4=<;^_=5)ZZ]^ZUU[_7X]^ZW3KHL!_C_`*WNI;JP4>?6,DGZ MGW6I/6^NO>NM]=>_=:Z[]^ZWUU[]U[KOW[KW75Q_4?[?W[KW6-GOP./?NO=< M/?NO=>]^Z]UT3[WU4GTZZ]^ZKQZZ]^Z]UW[]U[KW'O1/6Q3!ZZ]UZ]U[WKK7 M7O?NO=>]^Z]U[W[KW7!C<"Q_/NPZWUQN;6][ZM_AZ][]UOKWOW7NO__3TD?: MCK778-O];WHBO52.N8(/T]ZX=5Z[]ZZ]U[W[KW7O?NO=>]^Z]UW?^OO=>MU] M>O$>[]>(IUU[]UKKWOW7NNQ[]UL&G7=_>NK`UZ[]^ZWU[W[KW657'T/U_K^/ M?NO=/SZ]U[WKKW7O>Z]:Z][]]G7NNP2.1[U7K?7( M/_7_`'@>[:CUJ@ZYW!'U_P!@2/=@>JE?3KWO?5>'7?OW7J]>O[]]G5J^O7=_ M?JGK=1US#'^O_$^]X/EUOKD'_K_O'OQ`\CU[KD&!_/\`M_\`?6]ZH>O==W'] M1_M_?L]>Z[O[]4]>Z][MJZU2O7N/?M76M(].O?[[ZGWNOSZ]I'IUW<_U]^U? M/K6@=>N?Z_[U_P`4][KU[0O7KG^O^]>_5/7M"]=W/OU>M:!\^O7/OU>MZ!UU M<^_5Z]H'7KG^O^]>_5/7M"]>N?Z_[U_Q3WZO7M"]>Y_J?>M7SZ]H'77O6H>O M6](].O<>_:AUO2.O>]:L];IUZ_O53U[KB6`_-_\`6M[]0]>ZX%_Z?[S[W0>9 MZU6O76L^_8'6^N-Q[\3Z=:P.NK^]9/6M0ZZO[]UHFO77OW6NO'CZV'^N1[]4 M>O6Z'TZZ+`?3G_;6]U+=7"@=8R2?J?=*UZ]UQ]^ZWUW[WCK77O>NM]>]^Z]U M[W[KW7O?NO=<&>WTY_WK_>_K[]U[K$3?D^_=>Z][]U[KWOW7NNK^]]5)ZX^_ M=5Z][]U[KOW[KU.O?0<>ZD]6P!CKKWKK77O>NM=>]^Z]U[W[KW7O?NO=<"P^ M@^O^^_K[L!UL9ZX^]]7Z][]U[KWOW7NO>_=>Z__4TD?:CK77O?NO==@V_P!C M:_OQSU4CT'7.X/T/NO5>N_>NO=>]^Z]U[W[KW7O?NO==W/O=>MU/7K>[]>(] M.NO?NM=>]^Z]UW[]U[KL'W[JP/KUW[UU;KWOW7NNP2/I[]U[K*&!'-A_L??N MO=]^Z]U[WOK77O>NM]>][KUKKWO76^O>_<.O?/KD'(_`/O=3Z]:IU MR#@_46_V/_&O=@W6M(R>N7UY'T]VJ#U6AZ][]UKKOW[KW#KU_?J=6U==W]^J M?7KVKY=]U/GUNHZ[UG^O^]?\`%/>L>G6^N]9_P][H/7K77>O_ M``_WGWZ@]>M]>U_X>_:?GU[KO6/\?]]_L??M)Z]UWJ'X(_V)M[U0]>Z[N/ZC M_;^_4/IU[KUQ_4?[?WZA].O=>N/ZC_;^_4/IU[KUQ_4?[<>_4/IU[KJX_J+? MZ_OU.O=>+`?\:Y]^IU[KK6/Z'_>/^*^]Z3U[KHO_`$'^W]^IZGKW76L_X>_4 M'KU[KK6W]?\`>O?C3TZ]UQ)O]??J_+K7Y]=7]ZJ>O5'75_?NM:OEUZY]^ZU4 M]=>_=:Z][]UNE>NBP'^/^L1[UJ'6POKUQ+_T`'^\^Z%B>K4'7`DGZ^]=;Z][ MW]O7NO>_=>Z][UU[KWOW7NO>_=>Z][]U[KJX'U-O?NO=8RYOQ]/]@?\`8^_= M>ZX>_=>Z][]U[KJ_OW6B:==7][ZJ37KKW[K77O?NO==@>_=;`K]G7K^ZUZW7 MTZZ]UZKU[W[KW7O?NO=>]^Z]U[W[KW7`M^!_R+W8#K8X]^K?EU[W[K?7O M?NO=>]^Z]U[W[KW7_]721]J.M=>]^Z]U[W[KW78-C]/K;WXYZJ1Z#KD&!X!_ MWOW6AZKUR]ZZ]U[W[KW7O?NO=>]^Z]U[WOK?7?NP/7OLZ][WUKKKW[KW7O?N MO==W]^ZV#3KN_O75@:]=^_=;Z][]U[KFK$$7/'OW7NN88'@'_>_?NO=]^Z]U[WO'7NO>]=:Z][]UOKWO>.M=>]ZZWUZY'T)'^Q]^SU[KL,1_C_K^] M@GK5!Z=O[]GUZ]4=>O[]GUZWJ'7KC_' MW[/KUZHZ[NOXO_L3_P`:]^SUZHZ]_9Z]4==7'OV?7KU1UZ_O MV?7K51UZ_OV?7KVH=>O[]GUZ]J^775_?NM5/7O?NO5/KUU[]UKKWOW7NO>_= M>Z\>!?\`'OU:=;H>NM2_U]ZU#K87UZXZ_P##_??[;W74>K``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`BGO>H=:T]=@@\`_[W_Q3W[4.O:3UZX_J/>Z]>TGK MO_8C_7_'OW6B*&G77OW6NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NN_?NM M@5ZZN/ZCWZO6])ZZU+_6_P#K?\;'O6H=>T^O7BR_B_\`A[UJZWI'KUPUG_#_ M`'W^Q]ZU'KVD==%B?S_MB?>B:]6ZZO\`X^]=>Z][W3KW7O>NO=>]^KU[KWOW M7NO>_=>Z][]U[KWOW^#K77O?NM]=$@?7W[KW7`N;\6M_L??NO=<"Q/Y_V'X] M^Z]UU[]U[KWOW7NNK^_=5)_;UU[WU7KKW[KW7O?NO==^_=>X]>^G_$^ZD];X M?;UU?WJO7J]>]ZZUU[W[KW7O?NO=>]^Z]UU[]U[K@QO:Q_U_=@.K`9ZX^]]; MIGKOW[K?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__7TD?:CK77O?NO=>]^Z]U[ MW[KW7O?NO==6][ZJ1Z=9%-_K]?\`B/=".M<.N7O76NO>_=>Z][]U[KWOW7NO M>_=>Z\#;WNM.M@TZ[]V!Z\>O>]]:ZZ]^Z]U[W[KW7?OW7@:==W]^ZL#Z]=^_ M4IU;KWO77NO>_=>ZY!B+#BWOW7NL@8'@'_>_?NO=]^Z]U[W[KW7O> M^O=>]ZZ]U[W[KW7O?NO=>][Z]U[W[\NM=>]^_/K?7O>NO=>][H>O=>]^H?3K MW7O?J'TZ]U[WKKW7OI[V#3KW7+6W]?\`>![U7KW75SS_`(_7W[KW7B2;7_'T M]^Z]UU[]U[KWOW7NO>_=>Z][W0]>Z][UU[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]3KW7O?NO=>]^Z]U[W[KW7O?NO=<2P'Y]^Z]UQ+_P!/]Y_Y'[]U[K'[ M]U[KWOW7NO>_=>ZZO[W3JI/77OW52:]=>_=>Z][]U[KWOW7NN_\`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`<<^]@5Z]UP-B;_`.'NPQU8#UZ] M[]UNE.O>_=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]'21]J. MM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ZUUVMA_K_`-?]\?>C4]:I MUS]UZKUW[]U[KWOW7NO>_=>Z][]U[KWOW7NO7/O=>MU/7?'O8/7L=>]VKUZF M>NO?NM=>]^Z]U[W[KW7O?NO==W]^ZV#Z]=W]ZZM4==^_=;Z][]U[KWOW7NO7 M(^A/OW7NN8<_GGW[KW7+6O\`B/\`??X>_=>ZY:A_4>_=>Z]>_P!/?NO==^_= M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>]XZ]U[WK'6NO>_=;Z][WCKW71O\` M@_[Q[]CK77OQ_C[]CTZ]UW[UUOKWOW7NO>]UZ]U[WKKW7O?NO=>]^Z]U[W[K MW75P/J1[]U[KCK7_`%_]]_C[]U[KVL?X_P"\?\5]^Z]UC+$_GW[KW77OW7NO M>_=>Z][]U[KWO8%>M5'75_?OMZUJ'77OW5:D]=>_=>Z][]U[KWOW7NN_?NO= M>_'NM>MT%.NK^]=>KU[WKK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UQU`B_P#R M/WNAZV,]_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO__2TD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]UV"1_K?T]^IU4CKD&O\`[Q_L?=2.M=NM=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7@;>]UZV#3KN_P#R/WL'KU?EUZWNU>O4/7O?NM==>_=> MZ][]U[KOW[KW7KGW[K=3UW?WZG6PW7?O76ZCUZ][]UOKWOW7NO>_=>Z][]U[ MKL,1]#[]U[KO6WOW7NN6O_#_`'G_`(U[]U[KL./SQ_O/OW7NN6H?U'^W]^Z] MUZX_J/\`;CW[KW7KC^H_VX]^Z]UZ]_I[]U[KOW[KW7O?NO=>]^Z]U[W[KW7O M?NO==7`^I'OW7NO7']1_MQ[]U[KVH?U'OW7NNBP'Y'OW7NN/D_P_WG_C7OW7 MNNM9_P`/]]_L??NO=<=3'\G_`'K_`'KW[KW75[_7W[KW7O?NO=>]^Z]U[W[K MW7O>Z=:KUU?WKK5>NK^]TZUJZ][]UKKKW[KW7O?NO=>]^Z]UW[]UZG7O>B>M MTIGKU_Z<>ZUZ]7TZZ]ZZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO==$V%_>QUOK M'J;^O^]>[4'7@#U[W[J_7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U__]/21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>'^M[]UJ@].N0//^!_J?I_M_>B.M$4ZY>]= M:Z[]ZZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>][ZWUW[V#U[!Z[M[M7K97TZ MZ]^ZK0CKKW[KW7O?NO=>]^Z]U[W[KW7?OW7JGUZ]?W[K8/7=_>NK`]=^_=>J M/7KWOW6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO7/]3[]U[KUS_4^_=> MZ[N?ZG_;GW[KW7KG^I_VY]^Z]UZY_J?]N??NO==7)^I)]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW77OW6B:==^]_X>O5'KUU?WZG6M7RZZO[ M]UJO7O?NM==>_=>Z][]U[KWOW7NN_?NO=>M[]UNAZ][T3U[`KUU[KU[KWO77 MNO>_=:Z][]U[KWOW7NO>_=>Z][]U[KJX'U/O?7NN)-P;&Q!XL?K_`(^]CK=# MUQY_J?\`;^]]6`Z][]U[KWOW6^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__4TD?:CK77O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[_`&)'^M[]UHBO7(,! M87)_K?\`'^\>]4KU7AUR!!^GO7#K77?O77NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KP/O=>M@]>O[\#UZO7?%O=@>MXI3KUO>Z]:IY]=>_=:Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NN_?NO==AB/]]_3W[K>KKU_?J=;U?+KUQ[]3KU1UZX]^IU MNHZ]<>]=>J.N_?NO=>]^ZWU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^X=>Z][ M]UKKJX]^Z]4=>O[]UJHZ]?WNG7M775_?J=:U=>O[]UXFO7O?NM==>_=>Z][] MU[KWOW7NO>_=>Z][]U[KOW[KP%>O?3WJO6Z4^WKU_P"OO5>MU]>NKGWKK53U M[WKK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7$L!_Q/O=.M]<6-R/\/\` MB?>QCK8'`]=>]];Z][]UOKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO_]721]J.M=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U MZYM;W[K5*]M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[WOK?7K^]@]>].N^/Z^]UZ]0>O7K>]UZ]IZ][]UKKKW[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO==^_=>KU[W[KU3Z]>]^Z] M4^O7O?NO=>]^Z]7KWOW7JGUZ][]UZO7O?NO5/KU[W[KU>NO?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UW[]UL#KW'O51UZ@]<==7]ZU=>X'KU MS[U7KU3U[WKKW7O?NM=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW71-N3[WU[KK4O M]?\`>#[]0]>ZX!C/Q[M0=;`KU[W[JP%.O>_=;Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z__];21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NM=>''T]^X]:IZ=NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7@;>]UZV#3KN_^'O=?3KV/3KPL?>ZUZV`.O?7WZO6J M5Z][WUJAZ][]UZA].NO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO==^_=>Z][]U[KUO?NMT/7K>_5Z]I/7 MOI[T3UZE/MZ]<>]5ZWCTZ]?WZO7J]=>]=:Z][UUKKWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NNB;"_O?'KW71:PXYO]/Z>_`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`(CWL"O7NNBW`(^M_I[W3/6\^G71/-QQ?WOK=.'77OW5NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z__T=)'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7A_M_?NM4Q3KUS?C@?T_'OU!U6AZY!KWOQ_L?>B.O=. M^$P>:W-EJ#`;;P^4W!GYN;:R@ENKRX2*U059W8*JCU9F(`'S)Z8N;FWLX);F[N$BMD%6=V"JH]2 MS$`#YD]"[E?C%\DL'139+,_'[NO%X^G0R5%?7]6[WI:.G0`L7J*F;!I#"H`) M)9@/8?@YTY.N9%AM^:]M>4\%6YA)/V`/4_ET10\X\HW,BPV_-&W/*>"K@1DCDADDBE1XI8G:.6*1622.1&*NCHP#(Z,"""+@^Q*"&`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`V,F,BJ$>&BH&L;54R.'X\<;J2PR1]H_N\;QS]!!O_`#!.]ARL MV4H!X]P/6(,"J1GRE<-7\".#J&*_O5]YO9/;BXN.6^6K:/D MQ4AI)!YPHRE?QR(PTDP';O7,?15)LS)=*4VX-I5E:<[@\[N7;V7S,.X\B:V# M&/18RKR]+5+7?:Y&.GJF:FB,=/(8^8_2MC/[S_M'R=R=RSR:-EY8A_9I7I6Q9K3D12DQ";[K-->G%>AA[^1\E1P[,-F6T7F#Q3K$&@?HZ?]%$> M*ZM'AZLTUTQ7H\_R)^&'0OR7Q=8F^MH4>/W;)`ZX[L3;4%-B=YX^?1IADGR, M4)3.TD1_Y1<@E3``245'(<1+RC[B\T\FSQG;-P9[`'NMY"6A8>=%)["?XD*M MZU&.H@Y4]P>9N4)HSMM^S6(/=!(2T3#SHI/83_$A4^M1CK5E^5OQ3[#^)O8! MVCO%5RV`RRU%;LG>]#32P8?=>)@E5)&6-VE_AV:Q_EC6MH6D=Z=W5E:2&2*: M3-_D7GG:>?-J^OV\^'=1T$T+$%XF(_+4C4.AP`&`((#!E&:')/.VU<[[5]?8 M=EU'030D@M$Q_9J1LZ'``8`@@,&4%>!!^GL:T(Z&77U=?Y?W\I+^69V'\#?A M+O\`WQ\'/C?NK>N^?B-\;MX;PW/F^M<%79G<>Z=S=-[,S6X,]EZV6`RUF3S& M6K9JBHE8EI)9&8\GVT2:G/3@`H,=:7'_``IY^-O0GQ9_F+;1ZV^.G4FQNF-A M5GQ>ZUW55;2Z^P-)MW!3[DR>^^V=WCW319C>^^-A8C.[CR5)@ M^U]UXC$4]7DJN)YYHL=C*2*"($V2.,*.![JQ->/6UX=#=_."_P"$\_Q7[N^& M^\Z[X-_&[K/I;Y-=5>?L785+U?MBBVRW;5+B:&?^\74^:BHE2GKJKZMY M=74='>_X4R_R[/@Q\7_Y;=+V9\>/BITGTWV`_P`B.KMN-O#8&Q\3M[/-@]*37KS#'1T_Y-GPP_E3_/+^7/\`'#OK M-_!3XMY?L<;2'7'VX-WO!4[YZVS\V/H%%,V6SF)I-Q4M34,JLT6-I([M90NU/'JK#K31]VZKU= M_P#\)[/@UMGYW?S)^MME]F;1H-[=)=3;9W7W5W#MS-48K,%GL!MJF@P6UMN9 M:&7_`"6JH\WV+N;#I44LE_N:".I725#$:8T'6P*GKZ'W8'\IS^3UU=L+>W9F M^/@E\5<'LKKO:.Y-];OS=3U7M\4^'VOM'#5N?S^4G/@_S./Q./EE;_:4/NE3 MZ]7H/3K4U_X36?'7X=_S!/E#_,HWGW;\3^E-S[%&1V!O;J;J_/[(PV2VKT_A M-\[Y[:JH-J[.QK0FFQM%B\'1T-`2EVECHT+LS78V:H`SU49/#JX?^>[_`"PO MY>G07\J#Y<]N=+?#KH+K'LW9^&ZKGVMOG9W7^&PNY,#-EN]^KL!DI,9DZ6%9 MZ5Z["Y6II9"I]4,[J>"?=0349ZV0*<.OFB^W.J=;U7_"5SX$_##Y8_#WY#[S M^2OQFZ>[NW7MSY*S[8P.X.QMFXSAJJZ)Y(*`9+(SS^,<> M25C]3[JQ->KKY]"5_P`*@OY>WP@^*_\`+OV#V/\`'+XM=+]+;\R'RMZXVE6[ MLZ]V3BMNYRJVSD^M>YLGD,'-74423/C:S(82DFDB)TM)3QGZJ/>E)KQZ\PQT M*_\`PG!_EO\`P-^2W\L'8O:??WQ,Z.[>[&K^UNW\36[TWWL3$9_<-5C,-N?[ M7%4,V1K(GG>FH*;T1*39%X'OS$UX]>`%.B<_\*:?@G\./B]D/Y<4?QW^-G47 M376U/_`,,Q?RH_^]?OQ<_]%7M__P"I_=:GUZM0>G7O^&8OY4?_`'K]^+G_ M`**O;_\`]3^_5/KUZ@].O?\`#,7\J/\`[U^_%S_T5>W_`/ZG]^J?7KU!Z=>_ MX9B_E1_]Z_?BY_Z*O;__`-3^_5/KUZ@].M43^3GM/^6SV+_,M_F)_P`NGY*_ M$+XX[KRU)\J/DKN'XF9W=?7NWZNNI=N=?]E;KPNY.BL=430>1\=M_9^"@S&! MI0+4])1912^D4\8L0:`@]:`^75_WSR_X3^_`?OKXE]U];_';XL]&]'=]Y+:5 M3E.GNR-C[/Q6U,KB^PMNR1YS;F(R.6I$C$>V-VUE",1E/(LBQ4-=+,B^:*-E MT&(/''6R`>OE2;DVYGMG;BSVT=U8BOV_N?:V:RFW-QX'+4TE'E,)GL)73XS, M8C)4=/ M[9[5ZG,\G3O1FQ>P\)%E]KY_<-#44.6[&[(.*K46&M7;9BH\)C*@>6`U,^50 M@34R%:.WD.M@=7E_S9/C%_)Z_EK_``D[5^1N3^`'Q+K-^BD&Q>CMJU_5FW"N M[^Y=U4E;%M&@DIC%&U7B,"E+49O*HK([8G%U(1O*8P:+J)I4];ZT&OY86W-N M;O\`D-O*LR&V=N[S[*P'4NY-W]([-S>`Q&=QF8[$H]Z["@W5D<5LFMH*S"[D MW)U[T7D=Y;JP6-:BJHVS.!I#'2S/&D+.GAUKJWC^=+BOBKNKJ;?6^^CMTUO: M?5^V=R;$VWTGWEN[F]I;RWK)/VMNCKNBZ.VUMW<6 M6I%&/H\^(J^JU\^O=:L/N_7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K_]/21]J.M=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW1@_C3U1%VOV124.4A:3;&WX/X[N)?4JU=/!-''1XDNMB/XG6.JN` M0WVZ2E2&`/N9O8OV[C]Q.>+:TW",ML-FGU%R/)U4@)#7_AKD!L@^&)"I!`/4 M$_>&]SI?;'V_NKW;90O,=\_TUJ<51F4F2>A_WS&"5P1XK1A@02.K,N^^ZL5T M=M&E>BI*2KW)E4DH-JX.WBHXEI(HUEKZN*`QM'B<6DD8\<95I79(U*@LZ9V^ M[_NEM_M/RW;M:VT^*C? M>YZ;=.+JS6X7+XK+UN'J$B_T54#S-3GKJIRU[=\D\H[,=@V'EJTAVQD"R M*8U=I@/.=W#/,?G(6\J4``!G=@_S(/F-L'*4U?'W!E=WT<,B-4X/?U'0;IQF M1B0@FGJ9ZN!,Y3(]O4])64TW^U\GW">Z^S_M[NL+Q'E^.WD(P\!:)E/J`#H/ MV,C#Y=%6Z>TG(.Z0O$=A2"0C#P$QLI]0`=!^QD8?+K8E^%/S:V;\O=IU_BH8 M]I=F[5AIFWCLIJK[F(TU0WA@W)MNID6.:OV_5U`T.'7ST,Y$4VH/!-/B/[D> MVVX\@7\6J4S[+.3X,U*&HR8Y!P60#(IVNO5E-3?WEAI)L]U]EIE19<- MO;&4\TF(D6H87@HLH6:AK/K>DJ9"!K"D%7M_S=<\E\SV&[1NWT98).HX/"Q& MO'F5^-/Z2CRKT5\A\UW')W,ECNL;GZ,L$G4<'A8C5CS*_&G])1Y5ZTNZJEJ: M&JJ:*L@EI:NDGEI:JFG1HIZ>IIY&BG@FB]_P#ATW9/)_[(^ZF_/_?Q^ZO;J?#U4BO6UO\`\)GNC_%UL8'6PK[IUOKYQ'_``J:_E/#XW=V+\_.D=M? M;='_`"*W-)2]RX;$4EJ#KCOO))/7U&X&B@0"BVYW"D$U=K(:.'<$58KN@K:* M'W=37'5&&>CY?\(LR#L7^85;_GK?C5_[I^[??G\NMKP/5A7_``K=('\J*CO_ M`-Y1=/?^Z#L;WI./7FX=4[?\(Z/F2-M=K_(KX+;GRWCQ/9V#I^_>J:.IGT0) MOG945%MCLG%4$1),^4W/LJIQ==8`::;;4K$_CWMQY]>4^76V1_.3^(O^SM_R MV_E)T=C<9_%-\?W`JNQNJX8H1+7MV=U9+'OO:>-QK68P56ZJG"/A'<`G[;)R MCZ'W4&AZV>!Z^.P6`X)_WOV[0]-]?1G_`.$?WQ(_T;?#WN7Y=Y_&>'$EVZKZ7;(XAZ['SN`8HLUV5FLY352)Z9#A8&8DJH1MN-.KKT9W_A5 M)\R/]EN_EM5_2^WLK]CV%\P]W4O4]%%!-XLA!UAMW[3=O;>4@&H"6AJJ&#&[ M>JULUX=QG@?J'EX];8XZIS_X1;_\S-^?_P#X8GQ[_P#>@[:][;RZJO'K8P_X M4=FW\EKYND_\Z'IK_P"".Z>]U'$=6/`]?)7U+_7_`'O_`(I[=H>F^OHQ_P#" M-ER M>O-PZ&?_`(2H&_\`*"ZY/_?Y^\O_`'KO?FX];'#JMK_A9AF,CM[97\NO/X>I M^SRV$[-[US&+J_%!/]KD<9B>H:VAJ?!513TT_@J8%;1(CQM:S*02/=D\^O$5 MIUKK_P#02_\`SMO^\U?_`&7'XE?_`&AK>[:%].M9]>MS;_A,U_,`^7'\P;XV M_(K?WR][:_TN;MV)WAB]G[4RW]P^L]A?PK;M1L/"9J;'?8=8[,V7C*[7DZN2 M7S5,,TXU:0X0!0VX`..MCH9/^%''S5^37P,^`NU^Z_BAV7_HJ[-R/R0Z\V%6 M;F_N;U_OGS;3SNR^S\ME<3_!NR-J[PV_']UD-NTS\ANZ?>^7S%1A,'28O!18_-9ZKG-5CJ>F@Q\E-/)3B% M8&\?O=,4\NO=?88_E]?-'K_^8%\1>F_E/UXU/24O8>VXAN[;$=2*FIV'V/A6 M.*W[L>N)(J->W]QTTR4TLJ1M68]J>K51'41DLD4-.M]:6_\`PHK_`)+O8FZ_ MYCW0G;'Q>VA]QA_YB/8^'ZTW5!14FP\=4[G MK)@'?[C"9RKE(#*#=6P:^76NMY;XJ_&_KSX@_'/ISXS]549I-B=,[%P^S,/+ M)%%#69BHHXFGSNZOI)*HI*NEGC5XY(V5T=0RD$`^[=>Z7?97<7;O_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z__4TD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T;7X[]PKU+MW<3XS;\&7S6X,W1K M65%;4R4]-3XK$48:E@B$$;RS5%149.H))9%B"J;2:K).'M9[RK[3[3NL>W;` MEYO%]BEU"L57X0(/9+VO/M-R;+RW/<1S[@]]<2R3(I4 M2@R&.!J$DJ3;QQ%DU,$&BHWJ8RLU/1Z8)7E:,K)Z552NK4!/[`>U^U^Y7,FXC?I'_`')80K)) M&C%6E>1BJ(6'FP\;)MK)[8B@K*NC3(Y&NQ M^6Q[5,--4I(F3JJV6FK*>.;R1O&ZJ^@JRDL&6<_>[V"Y)V?DKM_E[TE7XVIDA@W3O'' M==YFF60I#D,5OV>/;;4U4H($L=/D*ZGJXU/`GIHV^JCWS.]UMH@WCD#F6*9` M6@MVN$/FK0#Q*CT)564_T6(\^LTO=':H-WY$YBBF0%H;=IT/FK0CQ*CT)4,I M_HL1Y];D/OGGU@'UI9_-3;E'M3Y8_(+#8^-(:->T-SY."&,*(H%S]:V>:")5 M)5(H'R915'"J`+"UO?1OVXO)+[D3E2XE),GT4:D^9T#14_,Z:]="O;R[DO>1 M^5KB4UD^BC4GUT#14_,Z:]?7I_EE_P#;MW^7U_XI#\4?_?#["]BX\3]O0SZT M$?\`A7M_V]-V3_XI]U-_[\?NKVZGP]:ZVN/^$N7_`&YI^/G_`(???W_OZ-Z> MZ/\`%UOI4_S,_P":[%_+7^?_`,!=K=HY*.F^+/R5V;V_LWN.KG167K[/8W=/ M6D&PNW(I`OG3'[4JLY4TV9B1K28:MGG$]!:@^O7NK=OD/T)U)\O>@ M.R.@>W,12;QZF[GV95;=SL---3RF3'Y***LP^X]O9$)4PTN;P62BILGBJZ,. M::MIH)TN4'O0)!Z]UK??\)M?A%VC_+R[T_FN?%SM6&2IR&RNPOC76[/W:E(] M)B^QNM\SBN\JG9._\*K/-&*3/XI0*B%)9?L,C#4T4CF:FDM9C6AZT.EU_P`* MW_\`MU%1?^+1]/?^\_V-[\G'K9Z^>?\``GY39SX3_,GXZ?*3`M5LW3W9^`W# MN"AH7T56%^YO8V]N$5!'6NOM);:W'@]X; M=P&[ML92DS>VMTX7%;CV]FJ"3S4.7P>;H8,GBE;RU3>E?H&2:DGK? M7S=/^%2'S(_V9S^9GN?JK;V5^^Z[^(&VJ7I'$Q4\WDQ\_8LTHW+V_E4C+,8< MG2[FK8=O58]()VXG'Y9U!0=:/5FG_"+7_F9OS_\`_#$^/?\`[T';/O4G`=>& M.MC+_A1Y_P!N6OF[_P!J'IK_`.".Z>]T7XAUL]?)5]O=:Z^C+_PC6_[(7^47 M_BV51_[Y_K/VV_$=>'0L?\+`O^W7/6O_`(N?U5_[Z;OKWI/BZ\>AI_X2G_\` M;H'KG_Q,_>7_`+U_OS_%UOJL?_A:5_S++X`?^'W\A/\`WG^IO>X_/K1ZT$?; MG7NOHD?$SO^R/?EQ_XLKA?_`'UVW/;3\>MCHPO_``KV_P"W6.RO_%P.IO\`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`@,0SY%*Z>ZH`'0;_`,ZKXC8WX[=][.WM MUYM.GV[T[V1L';.$P=/BH)1B$NGKC"4&TLJMM8W&5_P!Q42-4 MU\\]3*[22)-(6.<]G3;;Z"6VA"64D:@`<`R`*1]ND*:G)))R:GI5[92EJX)8PT4RABAN"K(S*QC[:>Y.]>V._G>MIC2:*2/ MPYH7)"2QU#4J,JZD51P#I-00RLRFONM[5[#[M(586]81!%"74HSZ M/%F+R:"54EPJAB=!;2RL72GQE^478U)1=G]+=8[PS%%MG+P9/#[MQR4&-ITS M6!K$JH9\#4YFLH$S-;C*^F6ZT8J&CF32PU<>\/.9.=.2=HDEV3F/>K>.2:,J M\3:F.AQ0AP@;0&4_CTU!J,=3IS%SCR9M+R;-S#O-O')-&5:)M3'0XH0X0-H# M*?Q::@U&.K1JG^?QZI*+N7!1S83+5N3W%D\%AJ;/TBF">KRV MQJC;XS=!+#4K^]CQD4):]IHQ91"2?=VV>_O8MPV[FUFY=E(=56-7F\-P]@[NW+OG=F0?*;FW=G,EN'.Y!U2/[K)Y:KEK*N1(8PL5/#Y92(XD"Q MQ(`B@*`!DIMNWVFTV%EMEA%HLK>)8T7T50`,\2:#).2EO M6@C_`,*]O^WINR?_`!3[J;_WX_=7MU/AZUUM[)P/6CT=#_A+'_-W_TY]:TW M\N7O[<_G[@Z;VY-6?'/<.9K+UG8G3>#@U5G7;3U+ZZW='4E&H:AC5C)4;8`" M1A,3/+)5U\QU[K<1CQN.BR-5F(J"BCRU=14&-K/7S%?;O6NOJB_\`"8OYD_[-1_+!Z^V+N#*_?]C?$S,U7Q\W)'/-KKIMF86E MI\SU#E/"2SQ8R+8&2I\)`Q/[DV!G/%K>V7%#UOHQGS)_E9[=^4'\SK^75\YZ MJCQCX[XMP[_':5/5-`M=N%]KQ/O+XW&@5K2.VR^V\SD,C+Z9-4;J!HMJ/@:` MCKW1]/FO\F=M_#;XF?(+Y0;J^VEQO2W5^YMXT6/JY###G]T049HMD[4$H9"D M^[MY5M!BXCJ7]VK7D?7WH"I`Z]U\5_>>\-R=A;PW7O[>.5J<[N[?&Y<[O#=6 MLR&QL)&R)-N'>6P9PV8VYE\IM_<.*R6"SV#R%9B, MUA,S0U6+R^'RN.J)*3(8S*8VNB@K,?D*&JB>*:&5$DBD4JP!!'M_K77T4_\` MA&M_V0O\HO\`Q;*H_P#?/]9^VWXCKPZ%G_A8#_VZYZU_\7/ZJ_\`?3=]>])\ M76^AH_X2G_\`;H'KG_Q,_>7_`+U_OS_%U[JL?_A:5_S++X`?^'W\A/\`WG^I MO>X_/K1ZT$?;G7NOHD?\(SO^R/?EQ_XLKA?_`'UVW/;3\>MCHPO_``KV_P"W M6.RO_%P.IO\`WW/=/OR?%U[KYF7MWK77O?NO=3,=D.HI:RDJ8EDBD1E='4,I!`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`S:W`\ MPX/GUEC[+6&Z[?R+:1[JCH7FDDB5J@K$VG3@Y`9M;@>88'SZKG]R]U+/7VB/ MY9?_`&[=_E]?^*0_%'_WP^PO;!XG[>M]:"/_``KV_P"WINR?_%/NIO\`WX_= M7MU/AZUUM[)P/6CUIH=.]O=B]!=J;`[JZDW1D-F=E]8;JP^\]E[FQCA:K%9 MW"5<=722M$X>"MHIRABJ:697IZNFDDAF1XI'0WX]>Z^OQ_*H_F,]=?S.?B)L MCY![2_A^$WU2+'L_O'KJEJ3+/UUVOB:.FDSN+BCFDEJI-M9R.>/)X6I=F,^, MJHUD85,51'&PPH:=;ZJH_P"%;_\`VZBHO_%H^GO_`'G^QO=DX]>/7S%?;O6N MMH3_`(2A?,G_`&7O^8G6?'W<65^RV!\Q=DU&Q5AGG\%!#VUL&+)[QZQR%0S$ MHT];CSG<'3(!JEJ\W"`1:QHXJ*]>Z^G%[:ZWUIA?\+$/F3_T*2FFTSQ];=:U#8[96*R MOGK>W.O='N_EL?.W?W\N'Y@]6?*?8E!_>&#:=568/?\`LAZPT%-V!UEN:%P?B3\4^VMQ2;P[5^,OQ\[,W;,L*2[I[!Z8ZXWGN M*5*=%C@23-[CVWDLFZP(BA`92%``%K>]5/KU[H4-C=<]>]88;^[O6NP]F=>; M?\YJ?X%L;:^$VEAON3''":C^&8"AQ]%YS#$B:]&K2H%[`>_=>ZU3?^%?':G6 M%;_+TZYZOH^Q]AU?9D/RXZWW!+UW3;OV]/OJ+`XWK#NNAR.;DVC%D7SZ8C'U MN5I89ZDTXABEJ8D9@TB`W3CU[HTO_"4__MT#US_XF?O+_P!Z_P!^?XNO=5C_ M`/"TK_F67P`_\/OY"?\`O/\`4WOVGX];'1A?^%>W_`&ZQV5_XN!U-_P"^Y[I]^3XNO=?,R]N]:Z][]U[K MWOW7NOMP_$?_`+)1^,?_`(KUTO\`^^WVU[8/$];Z^:#_`,*F?^WQO=W_`(C7 MH7_WU>W?;J?".M=:[GNW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__U])'VHZU MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]T:'XO?,;O[X?[MEW5TIO.7$P9%X#N79V7B;+[&W=#37$ M4.XMNR30Q331(S+%5T\E-D*='80SQAVN:;7O%_L\IELIJ`_$IRK?:/\`**$> M1Z(=^Y:VCF2W%ONEMJ*UTN,.E?X6_P`(-5/F#3K8,ZE_X4.]:UF-I:?O3H3> M^W\S'&D=9E.JX=L5` MOK!U?UC(8'\F*D?M/V]0]N/LW?*[':MWB>+R$H9"/EJ0.#]NE?LZKZ_FN?S+ M.J_F_@.KMB=1;(W?B,#L;-Y3=>5W/O\`H<)C,Y5Y/(8Q<5!AL-CL)FMPQP8F M*G=Y:J66I5JB=8@L2K%KD#_-?,MKO<=K!:0.(XV+%G`!J12@`)QZYR:8QT,/ M;_D?<.5IK^[W&ZC:65`@6,L5`!KJ8LJY\@`,"N.SF:Q$=9#BW1V0U4LH-#ZBH M-#]G4D2VUO.8VG@1V0U4LH-#ZBHP?LZ:_;_3_7O?NO="=0]V]SXNAH\9C.W. MS\=C<=2T]#C\?0[^W724-#0TD*4])1T=)3Y:."EI:6"-4CC151$4````>_4' MIU[I(;DW7NG>.07+;NW+G]U91*:.C3);DS.1SF02CA>66*D6LR=355"TT4D[ MLL8;2K.Q`N3[]U[I0X#MGM3:N,APNU^R^P-MX:F>:2GQ.`WEN/#XR"2HE:>H M>&@QV2IZ6)YYG9W*H"S$DW)]^IU[IIW1OK>V]Y*.7>F\=U;NEQR31X^3=&X< MOGY*&.I,;5"4;Y6KJVIDG:%"X32&*B][#W[KW25]^Z]TKMK]@;]V0M:FR][; MNV@F2:!\BFU]R9G`+7M2B44S5JXFMI!5-3"HD$9?44#M:US[]U[J;N+M+LW> M&/&(W;V+OO=.*%1%5C&;BW=N#-X\54(=8:D463R%33?<1+*P5].I0QL>3[]U M[I">_=>ZFXW)9'#Y"BRV(KZW%93'5,-;C\EC:J>AR%!64TBRT]715E+)%44M M3!*H9)$965@""#[]U[H3/]/?>G_/Z>V?_1C;P_\`KS[]0>G7ND/N7=NZ]YU\ M65WAN;<.Z\G#2QT$.1W+FLEG:^*ABEGGBHXJS*5-541TL<]3(ZQA@@>1B!=C M?W7ND][]U[KWOW7NG?`[@SVU!R5;A\OCJ@`J)Z' M)8^:GK*28*Q`:-U:Q^OOW7NCBXS^9C_,>PE`,5AOY@'S8Q6,6-84Q^.^5/>E M%1Q1*-*Q14U-ON.&)`O%E`&GCZ>]4'IU[H+-]_+_`.6G:,,]-V;\HOD5V+3U M2-'4T^^^[.R]W0U$;"S1SQ;@W-D$F1A]0P(/O=!Z=>Z+L2222;D\DGDDGZDG MW[KW2^V_VMVCM+&IAMJ]D[^VSB(I99X\5M_>.X<-C8YIVUSS)0X[(TU*DLS\ MNP6['D^_=>Z@;H[!W]O>.CBWIO?=^[HL<\TF/CW1N7-9^.ADJ1&M0]&F5K:M M:9YUA0.4TE@HO>P]^Z]TD/?NO=+/;/8_8>RJ:IHMF[\WGM*CK)Q55=)MG=&< MP--55*QK$M14P8JNI(IYQ$H4.P+:0!>WOW7NL^Y.T.R]XX]<3N[L3?6ZL6E3 M'6)C=R;MS^3R%53K4Q1SNJR!=2J[`&Q/OW7ND+[]U[KWOW7 MNO>_=>Z%*F[S[LHZ>"DI.X>TZ6DI88J:EI:;L'=L%/34\"+%#!!#%EUCAAAC M4*JJ`JJ``+>_4'IU[I#Y_]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M_]#21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1A_B9TOMCY%?)/I MCH[>?8=1U/M;L_?6)VGG.QJ79.<['J=I4.0:0296GV3MN2',;@F5D"+#')$B ME]Q=B;`Z1[)\ M6>QNR]R93"T>Y,MM:/#9/,;&JK?Y M:OS)[G^,?:7RUZXZV(Z_W/!CL9EZK?&0W'ELI08:2':FR:7&5& M;W12X+(9!8\I-2(ZXXQ2^?1XVMZH!IU[HK6+Z:[?SFP,QVOA.J>R^O=;$_2/\@CKG MMG)_`R@K/D9O;#+\P_@)VO\`,K-R4VQ<%5-LG.=Q^M>VL[W1OWY;;)W;N' M%Q&TL#N3,"IH.W:G/G,NHEQ$2&&6DU:'@JZ.66U M>/7NBV[^Z%[SZIR.%Q':/3';'6V6W'*D&WL7O[KK>&SLCGIY'BCCAPM%N+#X MZIRDKR3HH6!9"2Z@]]>ZX;JZ([PV+NO![#WMTWVKL[?.YJ>"KVWLS=77F M[MO;KW!2U32)2U.#V[E\/29?+4]2\3"-X(9%H>@NU=I=H=[;GQ6UNM\+V)L'=^Q(LS49.OHJ"7,M4[CPE$(=KX(5R5&3R M6EJ7'48:>=TC4M[U44KU[I+?)_XK]Y?#SMW=?2??NQFT\UEL)*]31UW M]WMPMA:U\?6Y79NX)Z2FQ^[-OFJ0K'7432T\A^C>_`UR.O=)KWQ'ZX^)':W6E)V]W-L#OWX7]1_*;LO>U/U;EALOJ'-]DX^ M?)5FS.R]P]D; M1ZE[,W3UWM$S#=>_=N;#W3F]E[8-/`E3.-P[IQF*JL'A3!32+(_W,\6E&#&P M-_=NO=&J"N-=2EI;.#[U45IY]>Z+'4]*]R4?75+V_6= M2]F4G4M;4K1T?:-3L/=,'7576/4&C2DI=[2XI=M3U+5:F(1I4EC(--M7'O=> MO=.U)\=_D!7[!JNUJ'HON*MZNH:%LI6]DTG66]:G8-'C45G?(U6\8<(^W:>A M1$),SU(C`!-_?JCUZ]T8;OCX@[5ZMZ`^$7;'7_;F;[=W]\MMN[^R6X^I*3I; M?NTJCK'/;3W+@<#A-N;?W;F!/B^W:G<@SO+8F&-J:6%;++#54TKZ!R1U[H!: MGXS_`"0HM_8[JFL^/W=U)VCE\:MJGJG?<&_LIAQY+Y;';.EP*;BK<:/" M_P"_'3-%Z#ZN#[W4>O7NCD]"?#SXW;_VE_`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`W9NGY8=<=P_%;NG=G]:"J MEQFX*[>.=QF=&3IL8]55U&0R(+H$EDD35/A)7KW2N^-O\P;X88G^7K\7\1U1 M\C?B)AMH]/\`PFW#\=OD1\9N^OE]DOCW/G]Z3;1_@_9N>PWQMI.D>PSW[N#L M3<=-79#'YP.S\]A>DX<)U]O%ZK,QKMW>67EPU6M-C:OQ5?7?P+^Y]XS]-9S:^^^RME;;3.9W:,$6RMG[B@EFK*6*&"BGJ)JIX:&*KJ(?$'N^WK MW1S=U]\]=?%O8?\`(A[A^?OROV7\NL%@ODI\OJ_,_+K''*[IV5E\INC;7;&& MZI["A7(8J#(5.%ZVR.X\+C7K$IF@P\E$M7`[1TL4IU2NJ@Z]TC][?.GXX8GY MP?RL)NSOES\*=^[;ZA^1_P`J]ZIWSMOYY4_R8W1M#KKLGXX=LT)H^WMX[@ZA MZGV_U5A<_N[*X6DQV'.3R"4T]/!0P%HX(M/J&AQU[HFF*_F\[>R'Q[^(O:G< M/S1VYN3N#IO^?DN2S%N0BP.",NZZ[I3+[)W%-03 M3Q4\M/5TLT5.C.1`@WIXX\NO=4X?\*(]U2=B_-"?L_%?/3ISYK=:=@5V_-Q= M-8+I_LR@[,H_CGUC79VAK\)UGN&LQ%15XG;^4GJZZHD3'PRR%(J82.5:3QI9 M>'"G7NMP'^9M\DMF?&3NGY^[@^6OSKZ(W'\6NQ_@?7=4=69[ MPW3@J6/$;SEZS.*.9VEA=PA:F"GR:S244ZY(5=6],E!'(&P*TH,UZWT1[H_^ M:-TGA>Z/Y=_1.9^:W3-)\1_^&0=O[&[[V-F.UNOSU;C_`)%4.QL?M[^YF_FK M\@U%B.SH,?0I0MC*F6*M\.N(Q:7=6MIQPS7K73)\"OGG\=\9T#_*LWSU[_,J M^.'Q$^,_P[^/VYMD?/;X5=@Y:BP':? M35&9CFH?*]$:WS4XGKI:FEC\1\6,]>Z*;F/F]UW\JOY,O;W5G3?\P7K#XGU_ M5OR.^5F;J_C7VMV73=>[][.^#65P':%7UA\4.M=KQN:[=U%G-K[FP^"H:*@2 M:BIYH)(I)4:%4D]2C9'7NK!>S_YBWQ`JZ/OCY&U/\P_XW[O_`)9O87\NQ^B^ MK/Y5V-GQ*=WX#MF?;6+Q&,VG4]%08O\`B6UQ2-35-$,V[BFIQ6+$Y3'T4%;[ MT`>%,UZ]TE/CA_-(Z0VSW/\`RF.B\S\U^EL9\2H_Y.NW]A_)[9&:[6Z]7K## M]X8KJC;^"IMG]G/D,@U)M[L.D?'"A_A]7+!6:?)`8[/(K>(/=C->O=`#\,?G MQ\#.JML?\)^T[7[ZZ>H,_P!3?%?Y]];9K&`>O=:T?\`.@S_`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`9;:V9 M48_/X[+X6NI\IMW.UE'/#4TTT4D%0ZLIO[\17!Z]T+OS`^?WS$^?.Y=L[L^7 M/>NZ.Y^O=>]^Z]U[W[KW1@_DY\J>_OF5VMD.\/DMV+6 M]I=IY3#X7`U^[Z+Y[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO_]/21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_U-)'VHZUU[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__5TD?:CK77O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_];21]J.M=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_U])'VHZU MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__0 MTD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7_]'21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=?_TM)'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=&YV_V#\(J3`X2EW-\7OD) MF]R4V(QM/N#-8CYA;,V]BLOFX:.&/*Y3&8"I^(>X*C!X_(5ZR2PTZ]_I)^`W_>)7R4 M_P#2V=C?_<5^_4/KU[KW^DGX#?\`>)7R4_\`2V=C?_<5^_4/KU[KW^DGX#?] MXE?)3_TMG8W_`-Q7[]0^O7NO?Z2?@-_WB5\E/_2V=C?_`'%?OU#Z]>Z]_I)^ M`W_>)7R4_P#2V=C?_<5^_4/KU[KW^DGX#?\`>)7R4_\`2V=C?_<5^_4/KU[K MW^DGX#?]XE?)3_TMG8W_`-Q7[]0^O7NLM1V!\#J2HGI*OXA_)JEJJ6:6GJ:: MH^:NR8:BGJ(7:.:">&3X5+)%-%(I5E8!E8$$7]^H?7KW7)7 MR4_]+9V-_P#<5^_4/KU[IHW!V#\(JO`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``I,W/\`!7M1 M?CWTOO\`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`W15[N@QV MY/E)OC`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`R+Q^.[5S_+Z]W#4&2@I3@*J&6!4I:M:FECC@7U!CY=>Z0/QB_F" M;H^,?QS^2_QW:7;^Z,G/6>6DACK*AW"S321HB+XBI!Z]U[9'\Q/M?I#LGISM'XH]==1? M$;RZ#:V%WK1]EK\@^V^\D-Z5^_P#K M"'#Y'9'>6R-O;?CVSN;)2S7IL6KUJ$1U;3H`/?J5(/7ND3\5_FEVI\31;,8#^*?W7W%LW>N`SVU\M(] M3B\KA,SB\G03R,\-0K&_OQ%:=>Z;MX?++<^5P6S=G=9]<=8?'K8FR>SX.Z:# M9G42]E5^.RW:F/IJ?'8'>>Y,[W)V3VYOC-UFUL13M28JEERW\.QT555O!3)- M75LM1ZG7NA`[&^>V]=W]3=Q=+[`Z9Z'^.^ROD5O'9^^?D%!TGBNTXJKM[,[` MS6:W/LVCS@[3[9[2QVT]L[?W5GZG)4^(VM3;?QB51C'@\,,42>IU[HBOO?7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U M[KWOW7NO>_=>Z][]U[K_U=)'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=&YV__`#`?GEM/ M`X3:VUOFU\N=M;8VUB,;M_;FW-O_`"1[DPV!P&!PU'#CL1A,)B,=O.FQ^*Q& M*Q]-'!34T$<<,$,:HBJJ@#5!Z=>Z=_\`AR#^8?\`]YZ?-#_TJ/O#_P"SGWZ@ M].O=>_X<@_F'_P#>>GS0_P#2H^\/_LY]^H/3KW7O^'(/YA__`'GI\T/_`$J/ MO#_[.??J#TZ]U[_AR#^8?_WGI\T/_2H^\/\`[.??J#TZ]U[_`(<@_F'_`/>> MGS0_]*C[P_\`LY]^H/3KW7O^'(/YA_\`WGI\T/\`TJ/O#_[.??J#TZ]U[_AR M#^8?_P!YZ?-#_P!*C[P_^SGWZ@].O=>_X<@_F'_]YZ?-#_TJ/O#_`.SGWZ@] M.O=>_P"'(/YA_P#WGI\T/_2H^\/_`+.??J#TZ]U[_AR#^8?_`-YZ?-#_`-*C M[P_^SGWZ@].O=>_X<@_F'_\`>>GS0_\`2H^\/_LY]^H/3KW31N#^8#\\MV8' M-[6W3\VOESN7;&Y<1DMO[CVYN#Y(]R9G`Y_`YFCFQV7PF;Q&1WG4X_*XC*X^ MID@J::>.2&>&1D=65B#Z@].O=%&][Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_UM)'VHZU MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__7 MTD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7_]#21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=?_T=)'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U__2TD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7_]/21]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_U-)'VHZUU[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__5TD?:CK77O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7_];21]J.M=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_U])'VHZU MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U(I*:2MJJ M:CA:G2:KJ(::)ZNKI:"E22>18D:IKJZ:FHJ*G5G!>6:2.*-;L[*H)'NO=6AG M^2]_,7.3ZMP4'3O7%?N+O+KB'MWI/:^*^6/P_P`QNSN+K>IQ]-EZ;=?5FU<7 MWU6;A["Q]5B:M*J)<135DTM-JE5#&CLNM0]>O=%CS/PG^0^VOC_VA\DMT[0H M=I["Z:^0D'Q>[)PFZ=QX+;O9VU^Y'PM7FZO;>0ZOR]=2;UC7%0T;0U,OV?HJ M%E10PI:UJ;U1PZ]T5#WOKW7O?NO=>]^Z]U[W[KW1V>M_Y>'RM[:^.78'RUV' MM'KC*?'OJBHQ%'V9V'D?D=\:MKQ;#K]PU>,Q^WL;NO;6Z^W<)O'"93<&2S-+ M34%+/CDJ*VJG6&%'D.GWJHK3SZ]T2;WOKW0T="]`]E?)#?51L+K+%TM56XC: M6\.Q=XY_,5J8C:77W6?7>!K-T]@=C[ZSTR208'9VS=N8^:JK*AE>1M*PP1S5 M,L,,GB:=>Z.=M?\`E9]M[L[G['ZRQW?GQ$I^M>L=R];;(SGS!R'=4]-\/,CO MKMW:4&\NO-E;?[A3:,U3D]RYW&FIBEISBHOX94X^J2O:E6,.VJ]>ZK3KJ4T- M;641GI:HT=544IJ:&=:JBJ#3RO$9Z.I3T5%+,4U1R#AT((^OO?7NHOOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z7O6'6 MF[.X=^[8ZTV*FWIMW[QRU'@]NTNZ=[[)Z[P];ELA/'2T%#-NWL3<.U=HXR:M MJI5CB^ZKH!)(P526('OW7NA9^57Q"[^^$_:>1Z2^2VTMO[`[7PU/CZG.['QG M9_5'9&:V['E\+B-QXE=RIU9O?>M/MRHRN`S]'6TL5=)3RU%+4+)&K)^O=>]^Z]U[W[KW1CNHOBKV_P!X=0?)#O'8-%M>IV#\4]K[+W?V[49K M>NV-MYFCPV_MSOM/;[[:P.;R=%D]UU#Y.&3S1T4V$W?O_$8/<@V#U[MG+;H MS$FUMETXR>\=QU53!B?M(9XZ%,7'7U-/#55E-Y5;WHFE.O=$P][Z]T93XJ?$ M3OWYL]KX[HWXT;2P._\`MG-4.4R&!V1D^S>J^M\MN*#!XK(9[,Q[;;M/>NR: M+<5=B\%B:JNJ*6AEGJ8J.FEG:,11NPT2!D]>Z%'?W\MWYC]<]2;[[WRO5^`W M3U'U7N>39G:N]^H.Y^BN^L7U7NB+(0XEL/V=#T?V7V%D>O*ALC4Q1*V9AHHW M:6/2Q#J3ZHX=>Z(U[WU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][] MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZS4]/45=1!24D$U5554T5/34U/$\U1 M45$SK'#!!#&K22S2R,%55!9F(`%_?NO=&_WO\!_E-UO@^P,SO?8VU-OUG4^W M*'=O:6Q*GNOHN?N/K?;V1R&&Q5/D-]]%T79-3W-M+17[CQ\<\5?@:>>F-;`9 MDC65"=5'7NB=>]]>Z.3VU\!_D]T[\H]L?#3.;&Q^ZOD+O6/K4[2V3UENW:_8 MR9^H[7P6)W!M"BH%S.UZC[BB\4L+4[PSPSRQ2JYWU[I;_#WX'=W_-Y.\9>F*_K2EB^//3&\^^N MQX]\;^Q>W]]>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[K__T-)'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW6Z+\N=X=.=1]A_\)F/D)WGW;1]-[!^.G\O?X9=U9>&E MVKV/N_>_85/UUA^NMWML+8V+V-M7,8<9#=-1@HL7529W)X2@BI,@\GEFT/"6 MQ7O`]>O=5S_S!^M?C]\Y?B]\K_YWNR\UVGM+Q.R]L_(?=>^ M=N;!P6Y=N56UZW*[@VOELE@Z+%R4E+54M315C"I^_J8JLP8_U30GTZ]T23)_ MRK\/\?MJ_,'M_P"5?8#2=1?%WYGY+X%8"?8>6SNT9NU^[L309W=>8S;[MQO3 M/R&FZ_V=A.OL+!7Z*G;-?-5U^6I:!I:-P\I]6M*<>O=#UT'_`"ROY<'R/WG\ MU\MU3\Q.[=^=-?&;X$;I^:6,K-G]8P1[DP.5V5MO)R;YZAWEENT=O=2U&]=P M[.W121/3U6.VU@\;N#%31NE7CII&6#Q)%,>?7NJ9_DS3_%NE[-6/X?Y'O+)] M//M#9DYG^0U'L>C[$AWQ4[?HY]]4+)UZQV[+M^@W#)+#0.`)FB3U&0!9I-BO MGU[J\;X1?]PW/\ZO_P`3?\*O_?\`/2_O1^->O=%#_EM_!GXH?*?L/XY===N; M^^0F]MR_(_>.8V#FL'\8-K4%!3?$^KK=Q-M#K3=W?6]^QME;CVUN.EWWEXIL M@<-A8Z8T6"ACG?*&KJ30TWB2.O=6;?RF.G^K?C+VG_PHEZ"WWB-Y]ES_`!V^ M!W\P#I_/[LVKO/;O7U5O+JWJ[<66V7O3$;>AS'6?8;[,WGOA]L05-%FIGRV. MQ3*HGPV1TJ5T':_RV_E_==_+'H>EH=G]-8O8>)W M_P!D5<&1V_MSM*)LOD<[1[7EV[5/#50XRHJJBBJJ%ITK:M*E*6#8)-?MZ]T] M?RROY6/Q0^='8^R?CUDNVOD)N/L[MWH_([^Q/=G3FRZ#%_&WH#MRBVODM[2= M%]LR=@;/GW%V=N+$;:H(ERM7@Z_!4M/EZO[.D:OAA-?+XDC/7N@#^+OP<^.' MR8_EB?.'Y';>W][Y6/O3#;>Q\7=^*PN3VYUOUA24^TMI=EMD<'C8Y:&H MJ:BGQ@JY*@_=""#8X=>Z*O[WU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NAO^,O_`&4C\??_`!-_5'_O>8#WX\#U[JVK_A2__P!OM?FK_P"6X_\` MP)70WNJ?".O=`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`,3^5/;ORWIMM;L^:<'Q3[`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`]>ZV-?E=\)OCK_,@Q7S%_F=_P`J7Y0Y MC(;SCP?:'R(^87PH[>QF2VMW3L3%;XIL]NGMVLV-F:&2NQF_]L9>HER4T>-@ M6IH(E9:6#(O4-3T2T!(H".O=%_\`F'\?_P"7[T[_`"L/Y1_9*=*]V;;[%^5] M+\IMY;N[=VIVSL'/[@QF4V7V!T=L_<]5O;9F?Z;Q'^E_!4V`II!L_;^.W)U_ M2[=EJ:EZNKRL]74U,FQ74W7NK#O@E\&.F/Y=/_"H/HGXC;;RO8?:M#LW8FY\ MWM'>^ZLQM3#R4^]-R?"SL;?>X,ON#;5!LBMAS.#CAJ*RGQ=#2UN-J\?5/354 ME=5BF>GJ=$U2O7NJ6]G_`!$Z2^2^Z_G[\FL70=H]-?$WX88W:>X.S,7O'M+% M=G=A[E['[A[C7K#96V,?V)L7XV8.DVAMW=&9?)Y)ZT;"W!-A*#%-%)'7&7[B M'9)%!Y]>ZM)_E+[`^*>Q_D)_,!J/B#W-F.W.OMW_`,@[Y3;GWCCMRTFY?[R= M0]M5F?Z.Q\?MR>*GGH=R4&VL90Y&GJ]"Q)-3SJ-&N*CSZ M]UJ8^[]>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[K__T=)'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U(I&I4JJ9ZZ&HJ:)*B%JRGI*F.BJIZ59%-1#35DU)7PTE1+""J2O! M,L;$,8W`TGW7NK6_YB7\QSK#YT]4?#;KK;_QNWOTSD_AA\>=F_&K9NXLI\A< M)VC0;MV)LG#[>PV-R6Y=OT_Q]ZVJ(=SS4^!+23TN1CIB\YM3V0`Z`I7/7NDA MA?G]LO$?RL-S_P`M5NB]SU-7N;Y3+\KYN[U[GQ4%-2;TAZ]P76U/MV/K`],3 MRR;87"8"*9P=QBK>J=V$RQVC'J9KU[J\G^;;\HNEOBKW7_*#[AD^-^8[,^47 M3/\`*[^%G:W3O868[JEP73F-RF*RG8M3U]3]C](476E?N'?-1UGOG`3Y_&U& M+WKMA:JJK!!D(:VF@CC-0*ZLXKU[JHKXC_S;LCU'L#Y2=%?,'X\;6^>WQY^7 MO9,_>';&P]^;ZS/5N]J7O:LGGJR:>M_CF^L_N[L'J[N#>/;?:;Y+(2S_`,0R-;1420B*CIZ.GHZ>G@B\ M16F>O=5!4.+IMR[LH\)@/#A:3<&XJ?%X7^].>QZ4^)ILKDDI,;_>/<\E%@\4 ML-!%.GWE>U/1TX5'E,<2>E;=>ZV7=_=>[D_ET-C[/J>N^\]P]M]?9"2@HJG=75V*Q&"BQ,^9C@BHH\[6+ M0F3[J*2$4XL".O=$KZ-_F^8+I7H_X%=_LMO?>>)W1G,AVGUIM*AQG][M_P!!C\/!CL1GJK-2Q8Z"&-#03TWGI*C> MGCGCU[I_ZZ_F]=7;$[R_FA=T/\0]SU)_F;]8?(KJK=6V<-\EZ;$Q]8XGY+9& MLW!O?/X[+9KX_P"[9-T[GH=QY:LFHG^WQ>.CI7A@-&6B>>;U,`5X=>Z`7&?S M!NI\5_+)WI_+<@^.O8W*;#8"&:H*Y*EJJBI9RDD*%47=,UKU[IF_F#?/_9/S@V3\-=K8/HG=/46 M1^'GQ;ZK^*&%R^5[JQ/9E%O?9/5F)JL=1;ARF'H^E>MI\/NG+3R12RO%6S4D M:(R+`2XD3P%*]>Z/1TM_/GPO2G:WP+[NP7P7Z^D['^$WQWA^,)DQW\][YGNZJV8E12&BDGJL7-6S&DIZ-Y!'XBM!Y]>ZI"RV6R>>RN3 MSF;R%9ELSFZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H6^A]^[2ZL[ MCZU[*WOM#<&_-O;`WGMS>53M';.],?U]EL[/MG+T>:H\?'NW)[)[#I<33U%5 M1*LS_P`)J7,9(70UF'CU[JT_YD?S'/A%\YOFMNKYJ=V?`[OX9[?O]P9]\]7[ M4^>.SL-L3<57UWLW;6P,5%]Y/\&\AN[%X?*;7VC0Q5T%+D(ZAYA+)#4P&0+' M4`@4KU[J5M/^;SL7S?D+\?;]L;TZ1W%\?][=K M;DR>Z-T8''YSKC#"KW/UU5Y/-5KR8B`X4RO62$SCQT@I?:.KKZ^GQD2S5I:>N>K\1P-<]>ZD]2?S/\`J;J_XZ?S M`?CA2_#F'";/^=>)Z,VHM+U7W;'L;$=-[-^/V>W'GMFTF+IMX=/=K[J[%W;G M*O<]0^=SF>SDU3D)CJCCIHPD*>ID&O7N@J^)?S^V7\9_A?\`/+XCY?HO<_8- M1\ZL/T[A<_V+CNY\5LB'KVEZ3W'NC=.V),/LVIZ8WL^UMZ[-WSN:'(XN;XXPP[3J*7([,BBH)8IJ]88)G$L<[!6]^`R3U[HY>[ M?Y\/7^Z_E-_,9^4S?#K?N)W'_,5^)]7\5-V;>QORQPD=)U=B*WJ?9O4TF]MH M98_%G[[(YZ#';(I:V&&I5(HZIY+LRE`FM.`*\.O=%$^9'\U.#Y[_`!3Z,ZH^ M3G1%9O+Y7?'6GK-J[!^;&/[9AQF[]V=63SQR4NQ>[-AUO5^8;LVLHE7S+EH] MP8FI_B`:K6-)*K)C(>`H<''7N@0_E=_.#:_\N;YB=>?+_-=-9SO+.]5X_>\6 MSMF8WM:BZGQ39/?G7^Z^MLI7;BRE1U=VA5Y6CI=O;QJG@IZ>*A85:QN\SHK1 M-LBHIU[HK_R*[#Z\[9[E[`[,ZSV#NWK/;N_=T[CWA-L[>?8^)[4R>)RNY]PY M7.UM-2;MQ'6O54-1B:9WO@QF?@CVQM_:O?&]L)MN'K.MV]A,-CEZ/V]_<^KVITS@:.LV]1U4^ M*DQFX))?ME6GK:226MFJZZ?GY]>Z(EG_`.8/UUGOY8.%_EOGX\;IQB8'Y497 MY:8[MO']ZX]J.'>]=UQN;K>DVM_H[R/2=?72;*Q^.W'YO')N5\C+)``U8-18 M;IFO7NN/7G\Q?:^$_EL[A_ER]J?&7!]N;L?Q/WO02?RR.F.C^F-L;8?Y-8&L3MG%="B!]K9G/9A?C/2-M?(96J MB+9!*>EJXWC.F'PD:SJF"*\>O=.&Q_YU.RZ+=GSUVCW1\)MN?(GX$J%>OIZ7S#`"M%)C:9( MZB(M5M5>T\,Y'7N@P^*O\TWISXK=K_)??>R_A!A\#LOO?X==E_"[;7676_>. M3VK#L78W:>8P>>W)OW=6^M_]9]Q;T[;[/DRF#1DKJZIH:.*!Q2PTL-'!2T\' MB*TSU[HB?QX[TZIZ7W9N;/Y[JWL_-WW'M3=75.[>K^^J3I?O#J#,[.W#5Y&@ MJ]O]MP=0;YI:B3+8*OEH=8:N$4\E/$@V>O==_.3Y<;W^=_RO[G^6 M?8N#P.V=V=Q[BQ^7J]N;92483`8S`;;PFS=M86CEG"U%AGJ,'ELELG<>-W+0XW-04M1254V)KJK&+%4I'+ M%(T+L%=201X]>ZL,VK_,&ZF^/.QODAB?A-\9MV]#]C?*_J;X- MX8O=V\L0NPHMK97;8W?(^"HJ>FR^0ERM%3I3!OX6S/*)/4R37KW1T MX'JQ2BBU_?1J?/XB8_>M/;IKU[HGWPS_`)G6(^'W;/RDG'QQQ?>/Q/\`F-M> MJV5WM\7>U^QYFK-R;=DR59FL;44/;NT=B[;EPVZ]N9',Y(8W)P;?4TD%>Q6' M[J*&KCV16F<]>Z$?XP_S4^B_BMVG\E=W]:?!''[4Z\[T^(O;/P^VUUKLKY`9 M+'9/9NT>Y,SMS/;KW]O;M#?_`%1VEO#MOL.&MVQ31432'#8:BHE$,&/CN[OJ MA-,]>ZI=JVI7JJEZ&&HIJ)ZB9J.GJZF.MJH*5I&-/#4UD-)00U=1%"0KRI!" MLC`L(T!TBW7NH_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO_2TD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U(I*NJH*JFKJ&IJ**MHJB&KHZRDFDIJJDJJ:19J M>IIJB%DF@J()D#HZ$,K`$$$>_=>Z&3M?Y+_([OFBP&-[R^0'=O@[7[5WWV)1;;HJ"*I@H:/`4N[\]F(,/2T<%9,D4=.L:1I*X4`,U_4'IU[H$ M_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2UI.RNQ:#8 M.7ZIH=_[UHNKMP;AQV[L]UM2;JSM-L'-[LQ%)+08G<^7V=#7IMW);AQ=#.\- M/6S4SU,$3LB.JDCW[KW2*]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U__T])'VHZUU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U__4TD?:CK77O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7_]721]J.M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2EV;4;.I-U8& MI[!Q&YL_LF')4[[GP^S=QXO:.ZLAB`UJNGP.YV)P^2*&\Z]UM7XW^25\!][_+;]?A!M3YF?RZ.TMP]T=3T.WN_* M63:]%FM\]>;X.*^*F4&/W3B77(5,5/BO++2X^@U505IHV]TU&E?GU[JG"/HO MX8YG`R;]VWL/YAY39O8/S7Q72G0NW-N]D=<[T[CW9T'L&'%;E^0>Y)]@P_'7 M:]-GNU:':>Z]N4VWH8*['8T9?/R+5QR1XF05]JGKW0P]7?$SXMY;XZM@[EV;V7LO$[8EP6![ MNQ^SMB5&-R]35PY3'4.3KI/!C(GHP\VJFHZ]TI?YI7P=^-7Q6^4'\RKJKJSJ MKY21[>^.%=\6,;T-N39U'%O;HS9"[UV9UAD.VZKY1;_W-!7[DQ-5NFLWK"NU MOX?44\3YW(+32(E,U/"/`D@=>ZJ3IOCYWY6];X_N.CZ0[?J^H*[4I MNM=YS];Y/=-76Q8ZEVUC]\185]L5N?J]#B,GLO&;EKI]K1TN M"R&[\;N"@J,7#5/%)D(*ZGD@$BS1EO5'KU[H+.S^HNV.DMTOL;N?K#L/J+>L M6/HRJC;7;O4]1A.E7Z*[MVSTXW96# MPE;\<169/9E-1YNHW%FJ2NRD4E!C:.2-:URAF:M3W?+KW0`;(^%'QR@^(O\`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`19\%>C_DML#M/;M=G=O;T*46&S'=C?)7OG/UFR]N;5R>YI,IF]_; MIS.&Q5/%BY94P6.PV/DD^THHY8_`&F>/7NAEW[\J?B#NWKS_`(4);/H/E#L* MER/\PCYE])]J_&.JK^N_DBF/W3L#9ORB[7[TW!N'/R4O1E75;/6CVMV/2T:T MM?#%72Y.DJ42%J<05-1ZA[<>77NC$?/+Y\_!SNT_S^F/\` MY?U;\9<5+UC\C<1D=TU/QCW%L#-]FXG+OF^E,?B]G9#)4^TY(\8V0J:>EJY5 MB$TT"^M?`'MQPZ]T@NR/E3_+ZD^*?\PSX^[#^:65WMN#Y0?'O^7[BNI^R.VN MJOD!2[J.[/BUV#LC/;KZU[)H-L];3["ZYAVOA<;-CMG4^SL1-A(<%2D9#*UM M>8C+ZAJ,=>Z&[MS^9S\6=S_.W^;7W'MOYM,W1WR4_E='X]_%O'#:ORIHJ>F^ M060ZLZ#VICL?1;2DZ>BBZ_JMJ;NZHSM;+F'CI:2-L^7W4P^!?\ MF_H3I_\`F/8/X_=F?$_.?+C,?)E,1MGYCXZDQE!W?WUANT]C4*0;,Z%J]N=I MUF*VI!D**LH)*A\::VK:F\[T<\]2M:9;'7NG7NSYR?`?LWKK^?Y3=,9G`_'_ M``WSDW%\.J[XJ=+U_7G8=#5;LE^._:^![![5W!.-A;#W)L#KYNT,A39'+8RD MR&3HECKJYH*G[6-1*VP#V]>Z5W9W-T7GZ7*=G4W:<>*Z[FV-L7>=$U7-CL31;1V_3X"DVM MC**`Y?*52K%'JAJ#3KW0R?+W^8W\/=XY+^=[O7H'YD8K#;O^:6POY9-+\7,E MMS8ORDV/NR7+?%&AZPI^X,+69Q.E,1_<:NJ*?:=;38Z26LBHZ]617GBC` M.,=>ZU+,MELKGLKD\[G3R%9)-5 MU^0KZN9Y9II7>261RS$L2?=^O=-_OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7J4Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7J=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_7TD?: MCK77O?NO4Z][]U[_``]>]^Z]3KWOW7NO>_=>IU[W[KW7O?NO=>]^Z]]O79]^ MZV1^SKKW[KPIY]=VXO\`CW[K5.NO?NO?;U[W[KW78]^ZV.NO?NM=>'OW7AQZ M][]U['7O?NO=>]^Z]U[W[KU.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7N'7O?NO=>'OW6Q0]>]^ZT<'KWOW7NO>_=>Z][] MU[KWOW7NO>_=>^?7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UZQ]^Z]U[W[KW7O?N MO$4Z][]U['7O?NO=>]^ZWY4Z[M^?Q[]UZGIUZWO77@,5/7K?7_#WOK5.O?7W M[K8%>/7O>NO4'EQZZM[WUJG78M[]UL`?GUU[]UKSZ[X]ZZM0=='WOJI%.N^/ MS[UU;&*]>/O?6CCAPZ]_K^]=;IC/7O?NM$8J.NO>^O4\^N_?NO4Q7KP]^Z\. MNQ;WKK8IY=<1[WUH<>N_?NO>?77OW6NO>_=>%//KWOW7NO>_=;('7__0TDK> MW^O4IQZ]]??NO#(IUZUO?NM@4Z]>_OW7@:XZ];W[KU,]>O[WUJO7K?ZWO77J M=>O^/?NMUIUZU_?NO$5SU[Z>_=>)I0=>^OOW7J5^WKWT]^Z]P'SZ]]??NO<1 MU[Z>_=>&*]>O?W[KU:U'7K>_=>`IUX'G_#W[KU<]>MS[]UZG[.O7]^IU[5GY M=>M[]7KVG/79/X'T_P!Y]^Z]6F.O:??J]4)S\NO'BWOPSUL-CAUX"X_QO_L/ MQ[]6G7B0!\^NB+>_5Z]C\^O`7_V'OW#KQ/`==VL+_D>_5Z\&'IUT.3[]PZ]7 MUZ[T_P!??J]:!%>NO\/>^K5_9UWIY]ZKU6HKPZZ^GO?6ZTX==Z3_`(>]5ZT2 M*]='CCW[JVK`Z[TW`(]^K3K1(].NB+>_#KV*`]>^H]^ZWQH//KUK#W[KU*<1 MUX<^_=;K@]>M;W[CUI?,]>O[]UNM<=>`]^KUK@1UZ_OW6P<]>`Y]^KUHBF?+ MKN]B;?[S[]3K1.K[.NK<^_5ZV?,@XZ[/'T]^&>O:O0=>M<7'^QO[]U4G/71X MX]^ZM7'78%Q_B/?NM$XZ]8@>_<>O`XZ\.;^_<.MDXX=>"V^OOU?3JM:\.NAS MQ[]U:N#7KO2?^1>_5ZI7KVK_`&WOU.M@9!)Z]I]^KUZHKUT38^_=6U==E?Z' MWZO52PZ\>+?ZWOW'K:L:=>M<`C_8^_5IUXL.O&X]^X];#8^?7@+CW[AUXMC( MZZM;W[KPP*^?78YX_P!C_L??N'7B?,CKUK?7WZO7ESGKJ]_?NM@UQUX#W[KP M'7K^_=>KGKUO?NO4SUZ_OW7B:8Z\>??NO4)H>O?3W[KU:8Z]]??NO4KGKWT] M^Z]P'SZ]]??NO<1UX<<^_=>I2O7OK[]UX&N.O6]^Z\!3KU_?NO5K@]>M[]UZ MG[.O7]^Z]7/7K>_=>I7KU[>_=>K3`Z]:_OW7B*YZ_]'22'^/T]O]>'SX==\? MB_OW7O6G70][Z\/Y=>%O>NMBGEU[\^]]:''KW'O76\5Z]^?>^M9KU[CWKK9I M7/7C[]UH]>_U_?NMXH*]>/OW6CY>G7A_C[]UORSUXVMQ]/?NM$XZ\/H?Z>_= M>!&0>NQ_A]??NO5`&.NE^O\`O?OQX=5KURL+_7WK/7@2*=<1>]OH?>_+K9\^ MN_3?_?6]^S3K6:5ZZ(-[?[[GWZN.MUKQZ[-OS]??L^7517\NO-^/Z?CWX=;' M7=A8`_7WKSQU[-<=='Z"WT_/O?GUXM'CCCU[\NQ87TFYM_OO\`>??OMZ]G\NO*#?\`WO\`UOS_`+;W M['7O*@/7A:_'UY_K_P`B]ZS^76J'AUT`=7^-_>^M]_#K=?*O7=@!ZOK_P`1_L/\??NM&M,= M>-K_=;K3KPMS;^G^N??L]>/E3KI0;_0\_P#%#?W[KP/IUW87X_UN?>L] M:J?(=<;'5;Z&_P#MO>_+K?I7CUR-KFY_Y'[]GRZ\:_GUTP-_?AUZGRZY6`MJ M_I_OOI[]UXY/'KBWXM]/Q_OOZ^]]>\_GUW86]1M];?U]ZZ\:XZ\?T\?2_/\` M7W[K0'7E^AO]/^1>_=;/\^O"UFT_[$_T'OW6L^?#KI?\?I;GWOKQ]*]NO9KUQ4$FP_V(_P!;Z^_=;Z[LNKW[_!U7_!UUSJ_QN??NM_:>N1TWY_WC MW[/7L^O7%@;G^GX][ZT.NR``+_7_`(CWK[.M\.'#KQ'`MR/?OMZ]\ZYZ]_9% M_P#8>_?9U[[.O?V>/I_O/^^'OWGUX>=>NA]#?Z#Z^_'^?7C7RZ]Q8V]^]*]> MJ0>O*.>;_3WX];K^?7A;_BGOW5L==`&_OW5:T->N^/\`8^_9ZWY\>NN2?\?> M^O'!Z[(']>?S[UU['GUT?>^O'RZ]^.?>NM^6>NR../I[]UH^@ZZ_'OW6QPSP MZ]^./?NM&E*#KP_Q]^Z\/.O#KOBQM]?^(]^Z]C@.NA[WUX?RZ[%K_P"/X_U_ M>NO&@X==?GWOKV:]=FU_>NMXK\^NC]>/]A[WUHUKUWQ^?>NMFGGUT?\`>/>^ MM'^77__2TDOK[?ZWQ!Z[`(Y]^KUH4!SUU]>/?N'7J^O7>G_>/?J]:!'KUU?G MW[K>K]G787WZO5:@<#UT3S[]U;4>NRI]^Z\2.->NCQ[]QZ]J].N]-^1_O/UX M]^KUJM2>O'T\?GW[K8)`Z[MJ%_ZI6GI MUX>J_P#7\?T^GOU.O=>`MR?\?]]_O'OW'KQSUX&]Q_A_QKWZ@'6CCKP0CD^_ M'K9^S'7@W/(_VPY]^IUZG7M!O]?]O[WU[CUXL0>+>]#KW'[>O%;\C\\^_=>Z M\3IXM]/Z^_4Z]^77=BW(]^ZV!QZ\?2`/K_KC_C?OU.M8Z]^L<<$'Z>_=>IUT M`5Y-N>+?\3[WU[KP.KC@>_=>H.NPNGG_``_'O76R*\.O!M1L?H?]]]??NO=> M"6(N?]M>_P#Q'OW6\>O76KG_``]^ZU0'KO1^;C_8_7W[K>.O%R#86X_VY][Z MU7Y==LE^0?K_`%/_`!KW[KV!UT2!86%Q;G_8?CWKKQ^77K:[$<<_=>QUW^L?X@_["WO77OMZ]8H#?Z_@`W'^\?GCWOKWY=>!U M^FW)^EOZ_P"/O77CUTJE06/].`""?K_L;>_=>Z[#WX('/'^/OW6Z_+KPC(() M(M]>""?\.+^_=:].NM?/T'^O;GWOKP].O%#>]QS_`(W/OW6_GUXO;BWT_P!O M[UUKRZ[*ZC<'C_'@_P"\^_=>&>NKZ;#Z_GG\?TM[]U[KQ!<`C_;>_=>^77K% M!_6X^GX''^Q'OW7NN_U@\6/^QM_L??NO8ZZ`T@DG\?3WOKWY]>!U7%@..+?U M]ZZ]CTSUV$*\W%OS:_X]^ZW3Y]<0W/\`KFU_S_M_>^M==Z#?ZBW^V_WQ]ZZW M\Z]=%^?H+"_^^_P]^ZU\NN1CN>".?H"?Z^]]>ZZ9K>GZ_P")_P"*?3WKK0Z\ M5+`,+<\?7W[K>/+KQ)3C@_U_I_QOW[K77K:P+?4?7\#W[K=.O6T"_P"?]N#[ MWULCKH7<6X!]ZZT*==@:.>#_`+"_^]^_=;ICKRF]P?R#]/?NM4'7@EC>XX_U MS[\?LZ\1\^N(;F_OW7CZ`=^O8ZZ/I-A[U3KWEGKLB]B/S^/\??NM&HX]>/I%OR??J9Z\.-> MO6U+_K'W[KQ)K\NO6TB_]??N/6N/7KZA]+'_``_XGZ^_<.K5`ZZM:Y]^KUX- M0]>O?@^_4Z]PR.'7@O//^^_WCWZO5:_MZZO[]3J^H]=Z??J]5!'GUU?W[J^K MTX==Z2>1^??J]5K4]>/`M[]\^O`D&O7_T])3\&WM[SSU3(.3UTH^M_I;\^]G MK9^7'KL6_`Y]ZSYGK6>NA>]A^?K_`*WO9ZM3Y==\7M;G_>/?O+JN:=<1?4/Z MW_WOW[JU,<.N9TW/UO\`[Q[]Y=:/#KBU[VYM_O'OP_GUX#%.N9MQJ!^GXX]^ MZ]P\^N##^@XX/]?]C[]UOC3UZY<:?5?_``_K[]U[S'7F^@TC@G_7_P!]]/?N MO'RZZ`L/5]/Z?0_G_6]^Z]Y'KL?I.D'_`&/U_P!X_P!?W[KW7EN+W!M;G\>_ M8ZV./7A;G3_3\G_??T]^ZUY]<03J_P!<\^_=>(ZYC3?BX//^L?>^O>7''7#U M:O\`?6]ZQU[U].N9TWL>3_@3;_>/?NM]=.#JM^!:W_%?Z_CW[[>J]>-O26O> MWXX_XCW[K>>O-?BUR+"QY_I]#[]]O7C3KOC3Z_Z\<\_[T??OLZUUT;6]/TO_ M`(W_`#[]U[[>'7E^AU?[S_O7/OW7NNQ;2=/U_P!YM^??NM_EUTE^>1:W-_\` M??7W[KU:X\^NQH_LWU6-N?S_`,B]^Z\#GKBE]8/!YO\`X?[S[]UX'KD-.KCZ MW_V']??NM=<6U:S_`%!^@/T^G^\<^_?;UOY=J]_R!S_`(?[R?>^O`GK MBU[_`.'%K?\`&O>NM5ZY$`!=7U_P_I86_P![]^Z]\^NF^@T\+;_>?>^O=>%M M/J_KQ_MO?NO=>/Z?3>WT/U_V'^P]ZZWPZ[7Z-<>G\_\`%!_C[]U[[.NP5LVG M\?U(^GO?KUH_;UQ2]^>1^;_3_BGO6.O>>.N2A2;#Z_BY_//OWSZWGUZX+JU" MWY/]?Z_U]^ZU7KEZ-5S<\\_7Z_4^_=;ZXL&U'_7_`!]/?NO5H<=O`C1ZOIXUZ[%N=-[V/U_`]ZZ\3CKBE[V_P)-_Z`>]]>KUS`0GB]^"+_`$_QO_A? MWKKPZX_%OI86^O^^X]^Z]7Y]=FUAK^O/\`KV_K_K>_=>KU MTWZ1I''^\_[X^]]>%>NUOI.J^GC_`%[\V_WGWKKW77&DZ;W_`#];^]]>KUY` M>;_2W/\`Q'O77A\N/7)=!OIX//UY_P!MQ^/?ORZ]]G7!+ZA;_8_ZWU/U][ZW MYYZY#1>W)_WKW[KQ/#KASJO^;_T]ZZT<=].NFO<_[Q M[]U[KLVXU7O;\>_=>^?737_'TX^G_$^]8Z]URXTC4#Q_CS[]U[KB?TC3]"3_ M`*_OW7J5\NO`<&X-N#[]CKU.N^+'3S_7W[K5.N*_X_3\WX'OW7O\/7(:>;?>^O'AUR]-[>]'JN>N/.K_8_3W[RZM3'7(VOS_QKW[RQUK/7 M37O_`(>_#K8/79M87_WCWKUIUK/EPZ__U-)3]*\VY_V/_&O;_5?/KP]5QP/] M86_WUO?CU[KP6PN??CUX\.NPU^/I_C]??J=>%?7KP3D?[?\`WW/OV?3K>.O! M^?H/Z?U-O]C[]U[(\\=>*<_X?[[_`!]^SU[\^O%[&UOI[WU[RZ[*ZN0?]O\` M[[CWKKWY]=$Z0!:_'Y'Y_P`/?NM_GUU;4+@?Z_\`3WOK6/,]=_I'TO?G_8]]>QUX#2"3;D?3W[KV/7KRD-=2/J.+<<_P"/OW6^ MN]!6Y;\<^]=:ZZ#7-K6O_3Z_['W[KW78C(()OI/Y_K_4?Z_OWRZ]3'7O)R.! MQQ]/^)]^Z\.O&,DW'T_//^]\@@>_=>Z\6L;?TL/\?>^O#KQ0M9@#8C_>O^-^ M]=>Z\Q*66PN/K?GGZC_6X][Z]UZQ<`B]^>!_O?O76NN^8Q].3_4`\?ZWO?6_ MMZ\/W!;\\<#@?T_UKGW[K7KUX*8[L?J.`/Z&_P";'WKK?IUX,7N#8?[ZWX%[ M>]]:SY\.O",H=3?07/'^'^M?\GWH&O7NO![MI(%B;<#^I^GY]^\NM]=B(AC] M+SUT9+-8*&%^+BYX%OZ_X>]]>Z\8BQNIX/(_J+_BQ/O76N MO,VAM(L;6!)YY``/]+^_=;\^N]!D`9;/ M]M:X'Y]^Z]UX`RB]A=>+?06-S[WUKKUC&I)`U'\<$`<<_P"W]ZZ]UVO[@(X! M`)%N+VM?_>_?OEUOKP0Q^H@<<``WO>_U^GO?7O+KH,7NM@+_`)%_KP/ZGWJG MSZ]QZ[6,J=1^B\\?FW^MM=="2[ZY&(DW6Q!YYO?GGD'W[KW MY9ZZ=M)"@`Z?K?FS?FW^%_\`8>_=>Z[*F2S*/\"";<_X?X'W[K771_;`%AJ- MR;\@] M=>IUY6,@*V`/U'UL2+\?7W[KW700H"Y!X_WDDVM;^A]^ZUYYZ\C:CI(4!N.+ M_7\?D_4^_<.M\>O>.QYX`-^#^SKHN0;6!'(O;G_`!Y][Z]Y==LA:S"YN`3_`*_Y M'U^M_>J]>ZZ8Z;+8<]]>&.O%2X4BP_!Y'U_P]Z^?7OLZ\;Q@ M#\FY_P!]S[WUKKP!D%A8$?@<`_\`&_>N'6^N])C!8_6]K?X_XCZ?CW[K772G M6"MN?J+6YM;^O^'OW6^'#KDL97U-^/I:WU_UN;^_>76LD]<%:YL0`#QO>3U?BWT^GX_V_OW6_MZ[,1)X_US_AQ]3S MQ[]UK/7$M8V`^G'/)_Q_I[]UOKLH6]0MR!P.3?\`UO?NM=>)T@`?4?Z_O?6_ M0]>MK%Q^/K_O?'^'O7RZ]U[E%_U^;?[Q_P`1[WU[Y=>'K!'TM_K6L>/S_C[U MU[KVG0"3]?Z?X?X\^_>G7AUT#J&FWU_I[WU[KL)I-[@_ZQY_VWO77C3\^N@U MS:UK^_=:ZZT&_P!?]C[WUO\`P]=Z['WJGGUH`^O76@DWXM_B0#_MB>??J]>X M#KQ-N+#C^HO[]U[KH@GD?\1_MO?ACKPQU__5TDU^AO\`2W^P_P")]J.JT\^N M_3;C\?[[\V]ZZL/EUY?S?Z6-_?NO#'7(!?[/)_'^]C\>_=:'7`7U?X_X^]]> M..N5DO\`7Z_B_'_&O?NO5ZXFX;_6^G^L/^(]^Z]GUZYL%OSP?S_K\^]=>KUQ M>X/^%N/>^O=]]>\^N0"V8H22`.#;^A^EA MS[UU[KJ,DM:_UO?^EK&_OQZ]US4)JX)+6)'`'-OS[]U[K&NK5_L?]A]1_L![ M]U[KG:/7]?J;VL;7^M@?Z7]^Z]UP?47-[CG_`&WY'T]^Z]PSUS8*""Y(:PU` M`?7_`(K_`+#W[K?IUP?Z@"^FPM_K$?[WS[WUKKG92JESS^+?T_Q_I[UZ]>ZX MN+`:?T_3_&_OWIU[KR@%27N`"`#;F_Y_UQS[]U[KQ"A#H)(#X]8P7UCZZK_`.\WL;_['W[KW^'K(1%JY)!_ M('Z;_P"V_K_MO>^O>G6.2^HW_P!8#_B/J?>O7KW65A'Z2Y(?\A0/]Y_H?>\> M?6^LO/K7^#KE92B^0D6O8VN2!;_`'CWOKPZXL;* MNF^DW_VXM[]]G7L?EUVHNAU_IU<'\W(YM_A[]U[KE90C>,WY&JX^@_WGC_BG MOV*8Z]CKA'ZYJ$LWC)+A21<6_UR/\0/?O\/7OLZX1 MZM8^I_J#<\#DW_-K>_=>^=.LBB+5PQ+`\`C@FUK7M]![]CKU.L)+:R/S?\?U M_H/>NM=*';=/MBIW+@J?>&2S&(VK/E\;%N;*;>Q-)G:MI(YI5"--&"7&_7UZL/Y]7193X`_#_`'9%M?N+JO=_?U%U M#B?YQOC M)3Y7>4&T]BTOR1Z"R/7.X^[O^,C1X/*5.%S=)F\5AZZ2OH:;]J6%S6;KW4\N MO=5<@*4&OCGTD?4@#G_>0?\`8GWOK?7;6">@G3?G_B+\BQY]^ZT:?EUU'8JV ML^G^I/T/XM]?K[]UX=-.N,5R3?].DZO]ZO_K@^ M_=>ZY*([G026"FU[VO\`X<`W]^Z]CK&FHL`/KNMQY][/7AUCD)U?7BPM_K?C_;CW[K7V]MFG M7%/HVN^GBYY^M^+?B_O?7NN7I"MX^3^;\\'ZVM^?>A\^O=<8R;V^JV.K_6_K M[]CKW7)0E_2;FQL#_7_D7OV>O>76-=6H<\W_`#_Q3W[KW633&7MJ/U^EK#_6 M!]^\NO=8SJU'Z\$_[Q_O'OV.O8ZYMIN-1.KZD?C^I!_Q]^Z]UQ>X/%[6X_I; MWOKW7*P(&HV-OZ#Z<_@_XCWH]>ZXN+`6-Q_7\GC^G^%_>^M==BVCU?2_'^V_ MUC]/?NM^?7N-!T_[$_[<_P"\^_=:^?72`D$']/\`Q-N/Z^_=;ZY"UF*?7_6O MQ]?Z>_=>ZX)]=;ZX"^K_`!_W MWU][ZU6G7.RZK?G^GXO_`,1[UU[CUQ8G4?K]>/\`B./?NO'CUVP7B_!M>WYO M;\\'WX=>/&GEUTUQ:WTM_L/?L=>IU__6TE?U`C\\?X_\B]O]5'7E!6Y(^GXX M]^ZWCKP8MQ;Z_P"]^]]>K3KP0@W/'U_']/Z>_=>'78XXXO\`6X_K_K^]=>Z]Y.>`"./J/\+'\VY][Z]UVT;,;J+J;$<@<$?F]K^] M=>I\^O,Q0@?6PL;_`.Q^GOW7O+KS*S@,HO?ZC@6(L+"_X]^Z]UXDQJ%X)Y)_ M(']+6_WOW[KPZ[LTB\`:AP0"!^3_`%^GOW7NN@#&I)')-K$?TY)_I[WU[KP_ MH6'U_J/]?Z>_=>KUVJ%+LP_'`_J2".?Q[UU[KRN6])`%^+@6/T_P!Y MN1[WU[KRQL&U'@"YOQ^`3^#^?>O+KW#KPE.KFQ'];6(_'U^OOW7NO"%]7`N+ M_JX^G];$_3WNE>O'[.O&6S6`!`L!?Z\<$_[&WO5/GU[\NO-&SG4HN&L?Z?6Y M(YM]/>Z=>SQZ\S&.R6!*CF]CR>2+?X>_=>J/3KLHTH#*!]`"`;`$#_'W[KWS MIUT;Q#211Q8`?ZUQ>_OU#Y]>^?GUX:IEL`-2GFUK6/]/\1;W[KW'KVEH5 M)8Y)'Y]^Z]UVK&6Z$`'ZK8``V_!^@^GOW7N/72HT=W86L/I_4GZ# MCZ>_=>ZY+*SDHUAJXX`%OK;Z?CWZO7N..N*1.&!/`'J)!YL.>/Z_3WZG7N'E MUWYCJ_2+:N>+-^K^MOS[]7/7OM'7C!)?TBX_!)'T///]#S[]3KWV=>:4JVE0 MO'`+`'Z?GGZ>_=>^77FB9SK47#6/^M_47_P/OW7NNVN\"@$>IC>QL;!;CZ<_7W[K MW#KKF9;"P9>;#2`0?S:PYO[]GKW7(*T*LS6!-U4'FY^IO^#8?U]^X=>Z\KM* M&4VO:ZV`%R/P?Z@W]^Z]UTD;QW=P5"@_[$_@?ZWO?#/7ORZ[64L=!`4,"MU' M(U<#^M_>J]>\\]="!]0+"POR18V_K]#[]0]:Z]YB6_2I'^MR1_P;\<>_5\^M MUZ-GW-W-TQNW>/QTS_7/QVZ^P^'ZBZ/ZFV#VAMROQ^[MJ[7^0O8FRZC,5FZN MP=]8;:79\NZ,57;NH,E1XG)U.)W)05&7.*.41<7-7/0TG@#GKV>C&;]_FG[W MW7OY-[;5^*GPTZ:I5V;V?5[A[KW M5O@879M!LG&OM:/;^:P/]VZBG$E"8F]ZT_/KW3-LS^9QW'M7MWNKN;(]4]%] M@9;NOXQU?PYJ-J[NH>WJ/9/6WQRJ^J*#I#_1MUABMA]Q[(R6'H:7K/#T6/AJ M\A6Y2OCDION_.:R:JJ)_:>'7LUJ.'1;YOD_N/%]-[LZ2V+U[UKU?A.R\+LC; MW<.XME1]@2[G[P=W;5H(:3=E#C\C,V"Q>&EJZK%TKSM M(1-YO4Z]T6DJTRA@+D7!'`M^01R/K[WU[KW,*6(]3'Z&Q``'!MR#<^_=>Z[! M:9"O&H&X``%P+7_`^GOW7NO*C1!G8$7](O\`DG^MC^/]M[]2F>O?/KR.9-2& MP)'ITJ!2)XSK8:0GJ^OUM^./ZW]^X9Z]UTLQ+6(4`\7`Y M%Q:]_J?K[]U[KW@D#?3CZ7O_`&1Q?_;>_4QU[KQG.K@"P(_`O8'CG\'W[KU? M0=>:%R25Y5N02?Z_UN;CW[KWIUYWT'0`#IX-^>?J>/I;GW[KW7BCR@,J_BQ% MQP1P?KR+V]^^?7NNBQB`2P)_4U[$"_`''^M[]UOAU[2TJ@J!=>&%["WX(N?? MNM'KO285)/ZFX`/TMP2>#]??NO<.N()E!7Z$6(`X!_K^?K[]U[CCKM4:(%V_ MUK<'5<'Z_P!+>_=>_+KROKNEK:N`?\??NM]>2-E(9N%%B2"/P0?]Y]^(ZU0G MRZ\);M]!8_D#D7X^O^O[UU[KKPOJY%A?ZW'T_P!O?Z>]TZ]UWY+/8!2`1]?K M8`?G_8>]'KW731LQU"Y#<_CBYO;FU[>]]>Z\6T646:P^IL>2;\?4<`^]=>Z\ M5,@#+^?J+<*0/Z\?7WL`^G6NNS>-0+`D\GZ$#_`#WKK?7N94%OJI^@L!8W_Q M`][Z]UT`8U)(Y/`!Y']?QQ[]UXXZ[5BX8``,+,+<7MQ;Z_X^]=>Z\J&.[L+6 M!MR#>_`O8G\GW[KW72OJ)4@6/`L`#]>+^_=>Z\L3`W;@#ZFX_P!]S[]UH]=! M^;$<'^GUM_7_`'CW[JWEUXQ,3Q]">#_Q/]1[]7K6.NF>QL+$#C_7][Z]UV49 MK$#@@'ZCC^O]/?NO=>8Z;+];?U/^/T]^Z]U__]?26.G2=%_\;_['Z<#^GM_K M77DYU%OTVY/^PX_V]_?L=>IQZY#3ZBG+`7%Q;Z'_`%A<^_=>ZXQZBX_/UO\` MZW%_\.+^_=>_+KF!%JX+%N;#\7!X_`XO[WU['6(%M8Y-[W_V-_?NM8X]92(] M7-[WY`M8'^GT_'O76Z]8Y-1<@_UL/];\<>]]>ZR,%.DR$AM(O;_6XO?_``]Z MX=:ZX27!4#]('I/T_P!]8^_=;^WKF=)4&2X^H!')(!_UC87]^'7NN+<*-'Z; MFY/!)O;\6_'^\>]]>Z\EBAU_IN+'\W_H.#]??NO=VC2=5[V'X%AS_>9Z]Z]9&T%4,EPY7Z#GT\VOQP;>_8\^O?GUQE-@@7]&FZF]KGZ&_TY!]Z MXTZ]UVH4QCRG2-1T$?7_`!`O?T\^]_;UZOKUT]A'^V25U>HFP-[6`-K>_=>\ MJ]=QD%'\ALEUL>20U^+#G\?7W[[>'7NNP$"/XB2>`Q-@=-_J+?B]K^_>5>O5 MP>N,-R3>Q72=7/T6W)_/(]^''Y=:_/KF@BNQC+&32Q4'CD?7Z7!-CQ[]CRZW M]AZQ1%_(+78Z@+7^MS8_["U_>O,=>^SK,!!Y/J?U<`VTDWL+\7*DCWO%>.>O M?GU@X;5R/\`'41]/>O7KW6=UAU?N%EDL"X47&L@7'-C<>]FGKU[RSUC MFU!_]I`&BWTT6NI'UXM[\>/6C2M.LA$3(AF+*^GBPYT\Z=5^;_[V/>\>?'K? M7&;A46.YCL;$_EN-18?UO_O'O1\O3KWE\NO+I,7[I(`8Z#]2?IJ`_H`??O+/ M7O+KSZ1$/%/#KT7*R+)?QV!)XX>XT!>.23_O M'OPI^77L=<@L8CD:+46"\AK7"WL2+?7Z_P"V]^Q0TZUBG6.&^OU?HL=?(L%L M;DGZ#GWX9ZV,''65!#<^,LSZ3H5OI>W%^.3_`$_Q][%*XX]>_//6!-?D!7EM M7'TY/]#_`*_Y]U'$>O6OLZSE:;RMXZCR%S( MQ/UU'\C^I``_UOQ[UY_/KW4AQ$2#(2LEE+!;&Q_UN+$_G_'WLT^=>O?;UCG) MU*!^A57QV^A3\'_"_O1_EUXT/'KE9#''YB0;>DCDE/P3<_[;W[[>O'KC*0%C M6*_C-R#>Q+B][V/U`]^/\NO>0Z[328CYB0H;T'ZL2+Z@/Q:Y][%*9Z]Y==L% M$3>&Y&H:V/ZO]I^AX7W[RQU[KC#R)-9_;T'5:W!XTD<$:K^]#^77OEUR41A7 M\6K7:_J']F_J(L?Q[]BAIQZ]Y8ZQP%C(!R0?U7/`7^T3]?H/?AQ^77N'69!! MJ]!9G_L!@`I:QL/Z_P"]>_8_/KW#AU'#/Y!^6+?3_'^EAR/>O\/6NL["GUW) M8&YU`6T@_GGZV!]V-/7K>//K#+K\C:OK?^O%N+6M;C^GO1X]>ZRR+'Z?)J63 M2NH"W^P)O^2/>_MZ]]O6.6X*6_1I&BWT(_/TM^?K[T>O?EURLA1?*2IYTVM< MK?F]_P`7]^\L]>^WKJ0611'S'SR;ZBWU(:UOI^/]?WX\...O==H08V$EP@_2 M;_VCO7&$WU!N4*^HW_3_0 MCZ\_CW[KW7-1&`QC)+V-@;?[$C^O'OW'AU[USGK%$6UBW/%B+\%?[5[WL--_ M?NO>G65?#KX)O?@&P!(O:_'TO[]CRZ]QS7K#=M8_U5_]L?Z6N/S[UU[[.LS" M+6=1(-_4!R+_`)L;?U'O>.O'K%+JUF_%CQS86^HM_K>]?;QZ]]O7,A2%,E]6 MD7`_U^">/J1[W7AUH]<9;C2!^BWI/^]C_7O[]_@ZW]O7(`%!Y+CFRD?6W^V/ M'OW6L#B>NFL(QHN4OR3]=5OSP/Z>_=;ZZCL4;63IXL?S?^@'-^/?NO>77+TA M&\8)_P!5JX('^\<7]ZZUY8ZX1?5K_IMZN>`/Z_Z_O?6_GUD73_8_58VOQ_K_ M`(]Z]>O=88R2Z_GGZ?[W?WOKWSIUD41ZN+W!-AQ:_/\`@.+^]>?RZUUC);4? MK>_/^^^G/O?7OMZR,([^HD-87`^E_P`_CWKK?7"2X;CZ?BU_I86Y][Z]QZYG M20ODN&M^+?0?3\&WU]ZSU[K_T-)<`Q@L;?72`?I]";FW^'M1UKKD&\@9;`&U MQ;\V_!_UA[]U[KI4*>IO[-S_`*YXMX!`^E_?N/7N'70 MB8-<_0$DV()M?GWZGEU[KOR^JY``O?@/?NM9_+KMXS(0Z6(87L3]"+`_[S[]3KU# MUYF\>E?J0+D'FQ/_`"+W[Y=>SUV4:4!E'TN&!-A_4$`_ZKW[KW7B/"@!_4YN M`>5"_P!?]>_OW#[>O=>!,JE5`#*=5OH"IX/OW'%.O=>"F%69K7(TJ`01?ZW/ MOV1GKV//KM7\H9+*K$#3I%KD?@F_TX]^Z]UY8GCN[\*MR;,#].`/]O[]3KWS MZZ66[:2J`-=;JMB+\`W%N+^_=>Z\*>0-<@!/J3<&R_4FP_UO?J'KU.N_/Z[Z M5*W^NGU6!^M^>;>_5\Z=>KUR:G=C=>4-F#%@!9A<$@FX//OVD^77J?LZZ>01 MD(H1M``NPN;CZ\_T!X]^KY4ZW7TZ\\3RVEC'##D7M9OH0+GZ<>]TKFG6N/7; M/X%6,!6:VIBP+6N;A1]`#;Z^]M1K=@0&%P`H/-OZD^__9/7C MUVD;4X:20#Z:56X;4S7'-OH`.??J4R>O8Z\DGFU1$*I<74HMCK`^A_P/OPSB MG7NO)3R1GR2#2B>K]0-S]56P)/J/^M[]I(R1PZ]UTE1J8AU0*UUU*NEE#<7% MO]?WJORZ]7KL4DH;FP6YNVH<#F[$7O?C^GO94^G7NO-56#[U0^77J]=O/XB(@J-XQI)8 M7);\\\>D$\>]\.`X=>].NWA>IM+&+ZA8K<#2P%B!J(XL![]0G('7NN+$TR+& M0&`%L@)#:B_`U:3^D?GWZA&2.O>77DE\^J$JBEP0I12O MJN&4$W/I)'OPSBG6O\'7DI7C822<)'ZV*LIN$-[``D\V]^"L*D\!UZO7EJKN M=2(JDL"56S@&X)U7Y(!_H+^_`BOPBG7O\'7C0RZS8>DMPUU_3?ZVOJ_3_A[] MI/"G6ZCKIJD+)98T95LH+*2Y"\7N2>3[]7Y=>ZY/2R2,9(QJC>SJ2R@V(OS< MWX]^*GB.!Z]UYY1!IB"J_C%F+`GU$W(%R.!?WXFF*`]>ZZ:)JD)+&+^G0RBP M"LO^IO;TD'WNA;('7NO,32HL952[$NP<:@%Y`%KVN?R?>N`IY]:Z]8U48*JH M>,D%5]*E6X#+/7KP0TJ,[@%GLJ(;,"`;LQL2#;\>_4(XC MKW72/]PK1:41OU+H!4,5!+:OJ/T\_P"P]^&:CSZ]7KM(&IRTLH("*=*W%V8\ M`<'@>]T(R1U[[.N,5+<-<#AKHCZ'WZA)QUZHZZ=_`%BTJY%R^H7TLQN`#?D6/O?#'GU[KQ MC:I"RH+D#2RBP`*\W%["UC[\:FE.O=>-Z90K`,[$-9K,%`!`M_B;^_O M=>%ZE"%`$B$$*OI#*?J>>`0??N/7CUQ$;4ZL[@$DA`IL0;V)+6_P]^H1D]>K MUW&?.#'I57/,>@:;E>=+<\7'Y]^XU%.O?+KI('C)DDX51<6()))L!8&_)/OU M*9Z]Z==)*';20JJX*W5;%2>!S_2_O5?*G7L=>%-(&!;@`W)N.`/J?ZWX]^H? M3'7N/7ON/7?0FF_^I]5C_C_7WZORZ]UXT[$W'*MRI)`N#]#8F_T]^H?+KPZZ M:4(0JJK!0!=UN20+?4^_?9U[[.O/&9#K3Z,.0S`:3Q<<_@>]TKPZ]UYF\0"6 M!:UVN+@$VM;_`%A^?>NO==LIF4.HL0-++P`/R"/]?W[CU[KUO"A#`%V_'U6W MX/\`KGWXXZ]UT/W4L+!@;V%@"#Q_MP1[]QZ]QX=>53$"[V_U('U'-OK;_`>_ M4IY=>_P]>5O(&2P!/Z2`021S8_X$#W[Y=>^WKI(RAUM:R^KZ@WM^+?X^_9'V M=;IZ\.O+("UF``/%U'(']??NM?;UT(6U+D<\?ZW^/OW7 ML]=.FNS`WU?U-K?[?\>_=:Z__]'273E6#?IXYOR#]/S_`(>W^M8ZY`*J.4:Y M_-^++]3:X]^Z]Y=<8[EC_2S:K_@ZRLL>OULP8VU!1?K^?>_P##UZG[.N,VH,`. M%"C38\%+"Q%OJ;^_''7L=F>NI>%0) M^BW#?0EOH;V]^/EZ=>Z[508KRDA0P"FQO>UV'^(X]^&1UX>?7B`(CXR""UF8 MBS"X](M_2ZGWXTIU[KJ(:EDUDA`H)(N2&!LND&]R03[\.!].O<:]O=8X`QD`/*FX<$FVG\FY^EO>AD]>J.LT:0Z_ MVW+.+E0PT@L+D"_^N/\`8^_"E<'KPZP1F3R+IY;5P./4U[<_U!_/O0.?GUJH M]<]9]$'DTZV_4`5T@*#P"-7UM^+^]T6N3U[Y]89M9E_ M'CGCUOY=9Y%B+*96*R$*655N+V'];&Y%K^]D#B30]:ZQ3WNJC]&A='^U+8G5 M_P`&))O[T<'KW#K)I1HHFF8JQ#6L+ZDOPS#T_GZ>]XH*X/6^N$ZVBB\9+1DL M2;6.NYX8#Z67Z>_&@`H<=>Z[C4-"WE)1`X",%N=9^J@?4@\7_I[\*4SPZ]\^ MNW55@8Q'6NL"0E=)'!TBUSP3_C[]Y=IZ]UQIEU"42<0A`9"0?20?1I_VJ_T' MY]^7-[*!7!SUHTZC M*S^4$ZYK\^O=27CIO*0TA!U>I0MU#']2AN1I#'ZV]V( M74<]>ZP5&L3N"/H;*/P%%PEOZ"WNK<2#U[!X]2)4A.AII"DK(A950MS:P)Y% MG8#D>]D#!)H>O9ZQ50*LBJ/V@BF(\$,I`+$G_5%OK[\W\NO8QUS"H\$33MHY M=8RJEBR7YO\`ZS'CWZ@H"3U[KC,JK#%X3JC+.68KR9+@:2#_`*E1Q_L??C@* M0<=>Z[A4-3R>8Z(Q(I1@/4'/ZE`_(*BY_IQ[\,@U..O>?#KEI5*>0P,7)95E M)4J53FVD?72S?7WN@TDJ:]>J:8X=8Z8:O*'XA\9,I(X6W*$`#]6KZ?U]Z&:^ MG6_LZRQI&/(8',D@C;2K(5X-@Q''+!";"P][&G.DU/7O/K!2ZC,JJ`;W5@3P M4/#EOZ\>]+4D`=:^SK/'%3>8:9"3K]"LI"D\E07)-Q_L.?Z>]@+JPW7ORZB$ MRB4EK^361]"&UZOH.!;G\>ZYK7\77O+J7+'3>4ZY"'+*71%U`,;%QJ)%@"3? MBX]V(6N2>O=8*D.)G5@!IL%MS9;#25/']G_>?KS[JV":];_/J1*D9$35#LDK MH"0%+7%R$9N00Q7W8TP2:&G6NL-2-(A""\6BZ-;]1)]9;C]5^#_3WIA2@!Q3 MKWIUS5(VIXS.='K81E5N2MB6!%[Z0P//^/OU!IJ3U[KJ4*M.OA)>-G.MM)!+ MK8*K#\*`;C^I]^(`44X=>ZZ@75#,)B5A!4AK'6_7K MF%C6&9H&+L-(:X*E48\E1J"A(.>M5ZQTH+,ZMQ$8V,I((TJ/H1; M^T#]+<^_+DGTIUOAUEA2$%C"_DF",45ETBX'U6Y8%@#P/>P!FAJ:=:KU&@\G MF0(+L6``_!!%F!/^IT_7W4$U`'6^I`CI3-82WO)8+H.D^K@:C^/]M[M1=7'K MU:#J,YD\S:@=>LW`!N#^`/Z?X6]U/'Y]:QZ]29HX/(?)(4D-C(B+J"N;:@+G MCW8A:Y/7L]8:H,)2I'I"J(["X,?]DCCFX]Z;C\NO=92D92$S,4;1863460'T M%N1S;_;^_$"@J<]>ZQ3@*L(C]494E6/U9B?5<6%B#[\?*G#K?KZ=^(R>M>6.O2*JT_[1+J9-,C%2""JG0NGU64C_>?> ML`8..MTKUQ@&I)1(;1`*20/TM<:=(-@21>X]Z'`UX=:IUS54$I.BG\O#M^NVFPTWO:VH\VOQ?WZ@K2O7NH\AD\K:N#J/`/`M]/?BM]89@58`?ITKH(XNO!N+?U/U_U MO?CQZ]BO'KF53QH9&*L1P`+L5'"DW`_Q_P`??O(5X]>ZZD%EC\=]!N=7();Z M$'Z4`PDRDA0WI8.0/Z@_U_'OP]>O>773!1%>,D@L-1/! M'Y`X/Z3S[]BG7NO1"ZR:_P!`4$F]RI_%O]?WH4-?3KWKUVH73(8C=@#PP*D` M\%A];D#WNF":]>'7"+47`/T(.JY-M/Y//X`]^'7NN:+%J]#$L-5E9;`MS87N M1?WZ@]>O?GUA77J%KWN+#\$W''^Q'O7^'K1^1SUF*0F0^HWN+K:ZWX)4-SQ< M$>]XZWYXZQ2:O(VKCUO_2TF@3*I4*H8>H!>`1P#?D\CVHZUUTJ/$" M[+Q^D"X()(/UM^/?NO4Z[5_+>,JJE@0-((Y'(!L?H3[]\NO==I`Z'6X(5+DD M$7-OH!:_)]^H?/KW72S7:Q50&N+A?4-7]/\`&_O=?EU[KWV\FOD6%^6XX`/U ML#?_`!]Z`/#KU/*O7)JCU<("`;<@EB/ZDW^O]/?J]>KZ<.NF@=VUH"RN=2DF MQ(;FW/-U-_?B#Y=>_/KMY3$5C`#:!9BPOS]3:_(4'W[\AU[Y#KS1/.!+&M[@ M!A]-+#BW-A:WT][H3D=>Z[9GIT6.P+$!F#`E5O:P!_K_`%L?K[]PP1U[AUZS M5,8*#U(;,H]*V8E@PN;"P%CS[]D\!UX]=A7ID)<`LQTJA`92`;EB+\V_U_?J M%/7:0R4VJ:0%0JV500=;-Q M8V)LH^I][`*Y(Z]UZ.;RDPLJ()!HU(MB#]5O;ZJ2O/O0-<>O6NN,=-(CAY!I M1#J)#"]EYX"D\FUO>]+>8QU['7):J\G,:`$D,R+Z[$$$AK\D?7_'W[4?3'7N MNOLYC)I"W6_#W].G7^KDWM;W[0W"F.O?GGKMZJSV5(V5;*'=;N0O%R?U`\?X M>_%L]>Z[EII96\T2ETD&N[,`1^"A)(MI(M[]I)RHQUNO7GF,!6#1'(4%F,BA M_6QU$+]+!;V]^)TX].M?/KN2%ZI5FB4GC0Z7`",H`LH)%U89FI(A&RJ[N0[*_J5%`TBP!L68_4_@6][RGEGKW7B'K(P$10\37*(`BLL@_4 M`3P5*\_U]ZRXP,CKW7E5Z.-FD4:Y"$2-K,K`>IF(!^HN`/S[]E*D\3U[Y==I M(:I7@"(CD!D\8TARER5;DWX-[_@CWZI:JTSUOKT5-+3%IY5*K&I('!+L?2J\ M&X6[<_X>]A67N(X=>_P]=15'E;PE8XQ(IC#1I9@6M:_)N+BQ'O52V"!GK5/4 M]>CHIE_']/>PC>8H.O5Z[%>3(6:*,*3VJW^'O6O-:#KWEUQ:@G,GH&I&(*OJ7E3:Q(^MP#SQ[WX;>0J.O5_;URDJ_ M&_C2.)Q&%C$CI=F*"VK@CB_T_P`/?B],`"@Z]3KN6EFG83PJ624"3Z@%6/U3 MU6X4_0_2WOQ1F[@./7J@'Y]>DF-*$IPLO&G7=WHH@CHI>0ZS M'(`P15NJFP/ZW)_K]![]E!0C)Z]QZZ]==$0BJLD+7T)9$9'L+^HD!P1_L1[] MEQ@9'6SQSUW''+1))+(H#,#$B$AE>_J8N`2"`%^GY]^H4!)'6N/#KTG M"1QLZW0HH76R7;QL23<,`;7^A]^!+]M,]>X==0TTU*QGE4HL2D\,IU,WI5>+ M\$GGWX*R]Q&!UZH..NXJLR.8F2.,2J8R\:!7!DX4\D@K&UX!*N;J6!/U%^??C&WX1CKU M:=N1`S,4&EB>187^@]^+4P`,>O6^O34\U45J(E+K*+F[* M-#CTL@)(!"D<'WXJ6[E%0>M5IUV\AI%2!D21P#(^L:PA>Q"K9@!8#G_'WZI0 M!:"O7NNGCEK8TEC4:H[QM&ME4#]090QXU`\\_7WZA<5`ZW^?7?KH8@'53),; M^-QJ543B_!%V)_I]![]4H/F>M=>5FKHFC5566,AU2.R(ZVTFX)(U`_G_`!]^ MRXH!GKQ-*D]=1PRTBR3RI:P\:(?4'9[_`*P"?0H!/^)]^H4!8CKW'@>O1S&J M#T^B.-I%]!C73=U.K2]R?2P]^!+54TKUXX'7&&EF@?S3*42+UD@J2Q!`""U_ MU$V/^'OP0CN88'7J@^?7<=:6?2Z1JK@HTD::9!KXU!KFY%_Z7/OP?Y"G7O+K MB,?4>2Q6RAN9-2VTWY>WUM;_`%O?O#<8ICKWY] MJVI@/K_C[\7S6@ZWUU)12N^N(:XY+.KLRJ2&Y]6H@ZA>W^P]ZT,34#!Z\>NY M:CP$0HDDAEJPD\*EM0"NMP%C= M0!I4$_0BQ'O9!;N`Z]7@.O.YI$2$HCOZG<2`.$UV"J+$6-EY]^J5`4C/7N/G MUT5>MC5HU4/&=#1J0B6:[!E#'_#D<^]4+#'$=>\^NP'HXF,B@O+Z1&WJ32A! M+-I-B;FP'^/OV4XC)Z]UT':KC>$*JNI$B*@"JP'I8$&_(O<>_9;`&>MGYGKR M124H:61;?V46X(=GXLUN"H`N??@"G<1UK!Z]'-YBT!5(_*"`R)I]?U`/+7#? M0^_:BV*#/7C7KC'22QOY)5*)&"[,"I/IYLOUY-O?M+<3@=>\^NUJ[OS&B@D@ MLJZ9`&X)4@_50?>M1KFG7J==?8SZ[$>F_+@C]/TU`7N;#\?7WO0WICK=1UYZ MJSV5(V5;!690SG3P&)^H)M[UJIY"G7O+KTE++*WEC4NC^L$D<7%])N?JI_WC MW[2?(8/6J]>DE\!$(2-]"B[.@8ZF]1`)^BK?W[A0=>X]=/$]0%EC`Y`5A<*J M,H`L+D"Q'_%/?C4]P'7NO,S4RB,JK,QUD.`ZK>X``/!8CDGW[*BGGU[KQ#U4 M8TJ`Z'](LJE2/J+D`&X]^RW#CU[KK2],A9E!9[*%/J6PY):Q((O[]0CCUOKP M_<<>?7NNDB>&\CBP7@`$'43P!Q?CGG_#WZA&2 M.O>?'KR3>3]LJJZ[J&5;$,?ISJ^AO8^_5^77L==+!(K:G6RK=F(()%C>%Y&#J+JX!!)MR;W7GG@^_4)X# MKWY=>=S':/3?2.=0/!/X%_P![]PQU[K_T])HZ%B8Q$D$@.3PR@_0<#Z$CZ^U M&*=:ZZA]0'61?$%_#KPZRJM-K]!=FN=*L/23_9!-K_7WO%<=>ZC MAY!)<7U$WMS]3SP/]?WJI]>O#J4Z4WD(+,#J]2BV@'BX!`/`/O>*]>)XYZPS MLXE8?I(-@`>`MN+?3\6/O1XGKWV]9G$+!'G9ED:-3Z!^H']+,+&S$>[8\^/7 MA7K'4$J45&(B"*8R"1<'DDV^K%KW_P!;WH^5.'7NLA\;PQM4%A9G6,K^ME%O MU`J>%/O8I05/6NN,MEA007*,S:VN=?D'T#6`L`/I_7WHTH-/#K>?/KN$AH9! M.3XE*D-_;$A-M*FS$W7ZC\6]^%"#7AUK[./79$:02-3DFY"R,WZE4@VT^D$! MFX)][P`=/7NN--=C(DG^:,;&2_\`9"@E6%SPVO@>]+YCRZV>LT:TXUO3EWF5 M&*+(+"_T8@`H.I4:T9F&EI&;4="O8(S`^D%M(-M7^W][`2HH3UKRSU$,DPFU:G$FJ]KZU:N>->MUQU*E2D$O[C.DATF18[%%M> M1ZPU32+,5_0JZ%0(?2([#1]+7N#?_8^ZM4$];ZSN*=EA:I9TE:($^.QU+R$9 M@1PQ0#_7'NW;0%B=76J^G6.J8QB%8213^,-&03ZRUR[.>/4&-K?C_8^]-Y`? M#3KWI7CUR3QO2@U;,`KZ864DNP()=2"#=5(^O]>/>Q0J-1\\=>SY==3:(Z9/ MM6_&@4:3BO7NO4Y5X)Q4%O""K![G4LI-@$N""64 M&X_P_P!C[TM"&U'MZ\?EUD`B2"9Z1G9@%60MPT<;$W*C2/JP%SS;WOM"L4^+ MKV:_+K#1L[2-&]VB,;^8-O5H/GUGB%(K,:9 MI'J%1S$)``"0G+``'40I)`O[L-`KIKJIUX]1*>2;SQZ69F+VTLQ(:]PP-[V% MKW_I[HI-13CULT/4Q8L?YP`\A/ETA3;Q%M5@NJURE[6]WI'JI4]5S3'4*6:H M\S,[,)`Q#`7L&4VL%^EDM8?ZWNA+5))S7JPZFSI1^0FH>:.,&R.X*FQ(!_P!?_>K44@%R0W6LUQPZPU3>.*!: M9/74K+(UQ(&"H43@#2O/^^_/C0+V' M%>MBM:'KC2GR15"U!;[8*&9B?4DFH"/1>_K:]OZ'WY*$-J^'KQ^761%@2&H> MC:1Y5C&HR6!2)C9W0!1S^";\7_V^^P`E*U^?7J&O6"B+/,4/K3J1`E()&:G:22H".8DE`"LX4G@!02P^H'NR MB.HTDEO*O6C7'D.H<,M1]PI1G>0R6"DDZF)L01_C?_8>VP344.>M^5>IK1X[ MSD-)+?RD%%L(KDBZZM.H+?@\^[TBU4)/'KPU4X=0II)Q/(69E97;TJS!5TL5 M55'`T@6M_A[HQ.HUXUZV.'4VH2C+J:AI(YV1&F2,`J'*W8\@Z38CCW=M%>XD M-Y]:SZ=1ZUG21$0E(EC3PA"=+1E05:XMZW')-C^?=AI*J7K7_)U[[.L=0WCA@6G9_MV#.'^C-*&96#VM M8J`./Z>]/0!0OP]>'SX]9(BDE(?NRPC24")P;R%BI:10"#J7Z?[?WY=)0ZSB MN.O9\NNW\4=(QHVD;7(JSLW#JOUC`L!I5C?GWXT"]E?GU[)X\>L-(Q=9EF+& MGT:I&/)0J1XRE[^LMP!^??ESJ!^&G7C\NLT8@CBF>D9WF6/DR`76-C9WC``% MQQ'4>BDD:=4OK5P4D5R2IC(.O4.;;]EY))?48DD`$;2`$H";`D$B_O:B.HH37RZUG'4$33^<%6;R>2X%VY? M5<#31&\EG4`&(,2-2ZK7T`GG_#VX1'6A)KU MK)ZB5$DXGDU$HRFVE20J`$!=-K?CF_Y^ONC$ZC7CUOJ5.M,?&U4TD=0T2-(( M[&]_TE@02KE;7'NYTXU5U=>S^76&L9D:)(R1"(U,3`GU*W+,2/[1;Z_ZWNK^ M0'PTQUX=9+0O!"U6SJWK6(IR[(#?D$'@,2![W@JNHFO7OLZX5!"01"G+>!F< MECPYD'&E[?7<&EZ>45);PJR%''+B5N"B7O>Z?4 M?T]^6A4ZOA'7O/KMA$E-*U*78ZHUE:3AT0\C2`J@*6`'OQ"Z3IZ]GSZQTA+^ M5);F$H6E)))33E9VF1"5$EA87L64 M6%V53?WOMH=).JG7L]1:9Y3.BB[:KJ58G2R$$/JO?C3?W45)%.M]2HXZ(S*( MVD9]7H1K>-FYT*3IN06M_K^[42N">/6J]0_+/YM0+>37>WJ_5<<:?H.?Q;W2 MK5XYZWU,F2C\I$CLKZKNJ>/=R$J:D]:XC'4:J:3SNINFDZ5 M`-@$'Z/T_P!5Y_V/NK5J>M]9I!`PC:I+K*T8)"`J_UM]/>F\@.'7A\^L@$;0(U066S,(V2Q=E M%B18W]*GWL4TC5U[_!UU+I2!3`249CK<_KU!1I4VM8`$_P"Q]Z-*#3PZV,=< M8K/$_F+&-2"&OR'/%E)O>ZWO_3WX<#7AU[KE^VD,C4[,6)4.6MJ5#<^FUN&( M%_Z>]XH=/7NL=.69F5[F,JWDU'@!0;,+@C4">/\`7]U'\NM?9UD18`6,)=I` MC%`UK:@+7%OJ0#P/=A3R.>O5ZCPLYE0`DZFM8W`()L;VOQ:_NHXCKWV=2%6E M\H"EB;^D$60FUP#Q]/>Z+7CUO_!U&9Y/*220VN_^LP/]/\#^/>OSZU^?4B18 M-9ULRO8%PI!4-I!/)6_^O_3WLTKUNO6&8MK(6X4`:=-_TV])_P`;CGWH_P`N MMU_9UD81%4,Q97TW]-KL.-)8$<$CW[[>/6O+Y]?_U-)U5:"-W=1=K*J,0P:Y M!+,`2+`#B_Y]J:$9/5>NU83J\2HJ/8,H3@,5O<'GG@_GCW[C4>?7OLZ[B@>$ MM+*-*H#874ZB195X)^I/O=",D8Z]6F>NHIE=M#(B>0%-:"Q!-A]+_2_U]Z!% M3CK=.O)1S*X+C2BF[-J6]@+W`#:@;?3_`!][TFN1U[KL5*^2YAC`+7)TC78G MDZB?U<^]:LUH.M?/KS44YD.A=:%@5>XL5:Q#$7!/U][T'TZ]^?7 M]Z2<@5'6J^O7I)/MUC@*1R,BW?R`.$9[-I0@G@`<_P"/OQ-*+3/7CQKUW)$] M7''+"H)`\;QA@`A'(*`D65A_MO>Z%QJ`SUZH'$]>.JDAM(JO)*P8QN-:(JC2 M&(O8LQ/X]^IH%",^G7N/7@?O(6CCC5)8VUA([(CJUE9@";:D-O?J%Q0#(Z]P MZ]'&]'')),@NX\:1L;JY-BQ;22-*@?[<^_4*`EAU[CPZ[CD%2LE.(XXG9=2> M)=(=H[MI8$FX(O8^_`ZJK0`]>..O0TLL#F><%(XAK-BNIB.%4!2>6;@WX/OR MHP[F%`.O5Z]%5*\GC:*&)9`T9DC0+(NL$`@ZB+`VO[\'J76H`5226!#7^@XX_U_?O#<'(H.O5X4'7(UR^;5X(2NN^HQWEL#]= M9;]?']/K[WXG=72*?SZ]Y5Z]+03O(6A7R1N0R2%UY#G4-1+:N+\D^_-&Q-5% M1UNHZ[FJ%A985BAF$*+&7E36S,M]0!UJ0JG@>_,P4Z=(-/7K0%?/KN:EFJV2 MH@0NLJ@E>`49`%*>IA<`CCWXHS]RC!'7J\1UW)(*.**G,<02H'$9>Q" M)R"/3:_]??B=`"T!/6^NY(WKX8Y($&N$F-XE(50#ZE=%)`4&_/YO[]0R`%1D M>76N'76A\?"1-&C2SN+0R6=`D?.HA21K);CW[,:U(R?\G7CDXX=>757PM'%' M&DT3>01QJ$6139&)6_ZAQ_7CWX5D!``U`]>H!UW#3R4*R5%0EO3XXXFY$K/J M%F`-BH`)L?K[V%,=68=;J#@=>@G%5Y*8QPPM,EHVB01W=;,B/R;AB+>]`ZZH M0`3UHXZZ@H:BGD%1,ACBA!E8ZE).C]*KI)N6;C_6]^",I#,**.O5K4#CUU#6 MHTH5X88DDU(9(H],J!U*Z@UR>+\\>_*XKE0`>MYZ\N*JA*%9+1:[&74@&B_+ MA0U^5Y`M?W[PGK2F/7KVH4ZY29!!.2D$,B*RA9)$)F=4``;63?4P%Q<#`>?7*> MI6G9*<0P3F!1$\DJ"0EP2753J'I1B0/];WIGTD*`#0>?7J$YZ]/2SUWCJZ9- M:RH`Z@JOBDC`0IR19;#C\6][9"]'45!Z]6F#UZ0_80Q0/''-,Q::1)0)%BU* M`JK9@`Q"DGWHGPP%*@MQ-?+KW'SZZ:*3(TZ-3QJ)(&,3[W0R@%5R/(=>^'B>NPCXV!C.B-+4,%6"0*T?CC]1=@#I/J86Y_P")]^H8 MEJPR3PZ]QX''7HV_B$,E.D<<4ZD31)$!&DH`(=6%^&`-_KSQ[\/U%*@`-Q^W MKW#)Z]#234*RU-5'I5(RD<;%6$LLH*!2`QN@%R?ZCWY4*`NXX?SZ]4'`ZZIY MQ5EZ8Q4\#3QLJ/"GC_<%G5'.IB4?3;WY6UDII`KZ=>X9Z]3XZHAE$U2IAA@M M+(^M"UHQJTH$9CJ8C_;>_+$X(+"BCKQ88IUZ/((9P9*>!$=F#R1IIF19`5+: MP;AO5R;#WI9!JR@IUZA`X]<3B*LS%52\1DTK-==)0M8.1JO;3S;WOP9*T`QZ M]>U#S.>NY:]%G(2""1$95$LD>J5Q&`NLOJX)T\>]&2C&B@C^?7J'KE48ZIFE M,].AFBGM,C%E#?N>HJP9@UU8V][:-B:J*J>MAAYGKU14+2>*E$<%0T*6DDF7 MR6=CJ94-ULJDV_I[\S:*)I!(]>M#(.>O3T\N16&IID!]/AEC4JJQ/';A`S#T M$-<`7_V_OQ5I`'1?+(]*=>J!QZZ2*3&P2R5"#7-:*.![.CBX9WD"M8A0..?S[\%,:EF&3@#KQS2G7HI? MOHIJ98HHICIEA$*J@E,=PT;X9/7H*2:AUU-2FA8 MXV"+J5O*[@HJ,%)]!OS?WM4:,EV&!UZH-*'KC3U23NU.\4$(G0PK)"C*P=R- M%S(*UT"GV=:IC!ZZ M;%51F.E=4;2>F4NEC&UB'-R'_2>>/];WXQ/4T&.O:AY]>FK4270L$$RQ:8_) M*FMY-"@$E@?R?IQ[\S@-0*"!Z];ICY]=U%#/4O\`]LC,=2"JGK50,'KTL@HUBIC%#-)&NJ0S+KT/)9O&AU*``+$_P!2 M?>B=`"4!/7A4Y'74D$M='%/3H"57PR1+Z1&4)(*AB+*P;Z?@^_:3(`RKU[AQ MZ[:]!`LS^F*$`L>O<>'#KP!KZ?1%&B M30L7\<=D1XWT@N%9CZT(M]?][]ZS("%'/ZGWX!HP68?EUKB>O12"L26G$<44C`/%XE*!VCNVAKL0;K>U^` M1[\#K!6@!\J>?7CC/7H*2:F8U$ZE$A!8693K)]"I=22-9;_6/T_/OP4J=;"@ M'6Z]=0U222>-XH8UD5H_)#%I=2XTJ;ZSQIII`KU[AUQ3'U"RC6H M2-6N\@9+!5N2R@-?Z#CW[PV\Q0#KU1BG7+[Y?/J\$-O)JUB/]T#5FEJ6%1`FI)$4D:@-#+Z& M2S$&RE>/\#[\5+=RC!ZW6F.NI)/M4C@*))(JZW\HUA"_.A!<#A;7Y]^)T@+3 M/7NO/&]:DHK>Q_4*`EAUXT/GGKC M'(*@20^..-G%T\:Z;LGJ"/=B""+_`.V]^!U=M*$]>IQZZBII86\TJE(XKN2" MIN1:R7!/ZCQ[\%(-2*4Z]7-1UZ*H5GT&.*,."ADC32ZZ@1<'41]3[\&]0`.O M#KI:.82>H60?60%"-(Y+6!)Y`]ZT-YC%>MUZ[:J7RDB*,KJ_41>0@'AKB_J( M_P!Y]^U9X8Z\1YUZX24LC.6C&M&]08E?HWJY#->XO[WI)X<.M==R2B-A&$C? M0H4LZAB6%R>>>`WO1-,4X=>Z])"\Y$L2W#*+BX&EE%BHU$<"W%O>Z$Y`Z]U_ M_]72=A]<XTV']2.+?T]J0,'TZUUSTQI%*T#F1QI#W0HRQDF MY%_J2>#S[W04)4]:ZX4EWD93S&4?R7-@J`7UWMP5_!_K[THS3RZWUGBBA#$P MR^254=D5D*78*>06!U,/J!_7W90M20U3UKJ+$TOF322S%P"#ZKW.E@;@VU"] M_P"GNBU)%./6Z\.I0@I#.%$Q/KL(RC6)O^G62%M?_;^[`+4`-UKJ)(\HE?5J M$@?D:F%B".%_-A^+?CW4UU?/K?EU-FAI]8\TOAE*J9(UCU@.5]1!!]))Y/Y] MW*KQ+4/6@>/6"LUK*%`*1!5$0!NI2UPUQPQ:]S_C[J^&(\NO=9C'`\,#U,AB MD92+Z2Q>-3I1FM]#;B_Y']?=J*0I8T/7J_+K'5CQQPK"UX"I9746\CDG66^E MB/I;\>_.*:0/AZ\.N<2K)2WJ7*(LMHI-)9R2"70*.2O`/^O[\*%:N:"N.O?9 MUZ1(XZ8FG?R*TJB9[:'4!?0ECR%)N;_U'OQH$[#45SUZM>/7&D'DBG29M,`5 M6:1C..'69(X8X:B2EE,LJHM[HR-'&QL[+ M]23;B_X'O8"A6*-5NO9ZP4)D>H$?+HP990Q)7Q:3J8_4#2>1_C[JE2WRIG[. MO'AQSU)@@I?+>&8S3!7:.-T*JT@4Z;DJ`=)Y']?=E$=>UJGRZUGTZ@0R5'GC MTEGD,@LK$D,Q)NK7XL1>_P#M_=%+5%./6\>O4]J:@^X*FH:_ETF,(VD'58IY M+6`!XO\`CVYIBUT+^?#K53U"J7G%1(7NC!SZ%-@H%M(2UO3IM;_#VVU=1KQZ MMBG4Z>"F=D>IF:"H>)&E18B]F(_4P`72[#DCZW_WEQ@M1K:CTSUH?9U&KO)' M*D:,3"D2>`J?2Z,H)D]-KEVO<_U]U?!I^&F.O#^?4DQ024M-+72M!(0ZQD(6 M>6)2-#.+'3:Y`_J/=J*54NU#^W'6LUQUCK%\5-3K3,7IG+N91PSS`Z2KV`9= M*C@'W5J*JZ3V^OSZ\..>/7J=$FI'-9*8XHYD$,MB[^1E_<11R2ND`G^A'O:@ M,AUGMK@]>X'KE(D<5&[4]S^38>_$!4)0UJ<]> MXFAZXX\&85,<[-]KX2\SL;^(K_FW2X)\E^`!]1[]'W:@3V4X^G7CBE./4B*& MD2*JDHYS45"0/I!C:,HALLDL=[7=$/`'/NP"`,4:K4^SKV<5ZAT#2R52(2SI M)J297;TF!@3*6)XLJB_^O[;CRX%<>?V=;-*=3::FQ_W`,%5]Q,NMH(I(V1'E M569`7*JOZA?_`!M[<58PPTO4^0IU4EO,=-JRU7W`(:0S^7A>;F1F`"E+#ZL; M$6M^/;09M>#W5ZWBG3G-2XS[IA)5&%_(ODB1&:)'-M:+)H"A0U_];_8>WF2( M,07H?3_9ZT"U.'3?7/,*N926C"/H159M*Q*!XPMB`%T`'VU(2'-?+JPI2O3C M404;^!ZRH-/4R01O-''$TES:RNQ5?3)(H!8<6/MQECP7OGUG6.&:BIWKY6@8-( MM/($,KRP@J3J6S-IC/SZ\#DUP>N5(BST,YK9#'3QRIX9RID< M3,/5&HY9E*@$C\'GWY`&1M9HM<'Y]>8Y%.N;10PT,\E!,9[O&E1)H,0"Y^A^GO9"K&QB:I\_LZ]J).1U@QQ>4U$4S'[5J=S4.[$B()ZDD4<_ MN"0``?4\^ZQY+`GLIGY>G6R?V]2((:6-:B6@J&J:I(&,:-$R%5.D22(".75& M-A[NJH-1C>K@>G^KRZU4\",=0L>T[UD2+KE#MHD1V)1HF!\H?EO3HN?S^/;< M18NH&?\`-UMJ4K7/4^GI<8:I!'5&:3R-XH'C98G=0?&K2E0K`M:WUU?X^W52 M'50/5O(?[/5=34R,=-32U?W)8M*)_,38%M2RAR=.CGG7P![8+-J/\5>KXT_+ MIVJ*7&?WF2+5W24/F*?Y>JU-,+C MIOR#SI5RHP,?C(6-(RRHL:C]K0H-M)7G_8^VY:ZV!QU8?"*]3YX:62.FDKIS M353PJ658S(9$!(AED`0Z7>,#C_#VXRH0C2/I>G^H]4JPK05ZC9$>$4L=.Q-+ MX`T,B$KYF8_NO)P+2!A8@\@#W23MTA3V4_;U9?.O'K)''!-00O73>`K+(L$H M4R22Q_5E*V)9$>]C]`3;W8*IC!D8C.#UHD@FG756B04,/VO`YR,]=4*^>FJEJW*4B&-Q,VIWBG+!5 M$8Y+:U)N/Z?[#WI*,KZSV#S^?6SBE,GK((:>*CJY*&8U$H6-)69&B>&!V];1 MJRC5J(`)'T'O=%".8VJ?/Y#K1R17'4?&:Y9)8I233-3RFH9V.F-%6XD%[C4C M@$?[X^ZQ=S$$]E,_+Y];;`!'4FFIZ-6E>CJ&J:J.&1H(WA:.[@MDBE>G%:3%_>!15ECY["%HV$3'7Q%YM.DJ?I>_P!/S[=T0ZZ" M3SX4ZU5J9'37++4_=,6+K,)F]()X?6;*J_T!X`M]/;1+:B2>ZO5J"GRZ=*JG MH/.345)@F<1O-"D32)'*54R*'`L/4;_ZY]NLL>KN>C>8IY]:!;R&.H.2,T=2 MT7*1(JK`J$Z#`!Z&4BU]0Y)_K[;DJ&(X#R^SKPX=2GBIY8*62NF:"9HK`JFM MI8E8B-Y!;TDC@'^T!?W:BE4+M1J?M'7LBH`QU'KU\24R4[,U,R-(D@N#)(7( ME+@6LZ\"Q^@'O3@`*%/;3KPSQX]98HXI:)6KI#"JS%*>;27D<%2TB:0-31HW MT-_J2/>P`T8,AH*X/7N!QUZ9(X:'512&6-YK3S69'4JH,<=K*0AO>_T)]Z(" MIV-45R>O5J<\>L5&/+%4I4,5I@BN\IY*2A@(]`-[NX)''U'OR"H?4W;_`)>O M'%/7K,(X(J>I>BF,\H557D MG\;7>)T<3AB=*Q6]3DG])0@6_P`?S[K'4O3RIG[.O'UZDTT%'Y2U-.9YT1S# M$\9C5I`ATD%@`2#S:_NZJE>UZMZ=>SZ=-\#S_<1Z"S2>1;(3?4Q8>EOP0Q^O M^'ML%M0IQKUO[3U/^WQPJ0HGO>4@1E&*$W_07TV*WX]N:8M1[_/JM308Z@5$ MDXJ'+ZD'46N+1RA$],2QIX=)X,9%PXMP2QN3_C[ MJ^#CX?+K8KQZS&.*2"!ZF0Q2E2%]#.9(U)".P4$BPX!_(_K[W1=*ES0_Y.M5 M(X=<*L>**!86+4[#4''IUR'AM=@-)4"P]Z?`4*>VG'K8^?7<*K+2M]TY2-)0 M(I+%FU-?R(!8MI/!/X]^%"IU''EU[KJ14CIF-,Y?5(%F>Q0JH7]M;&QTDW/^ M)]^.D+5345Z]7UZXTMY$F68V@"!W<_V&!`1E_))N1;\^](*ZJGMZ\>LJ1PQQ MSO32F:58_P`J5*(6L[*"/4=)_P!A_L?>P``Q4U/7CU&I"[3*OZE8,L@+>GQD M>HG^@4<_Z_NJ5U4Z\>I$,5-Y/VIO+*`YC0QE%+@76Y*D7N?\/=@$KAJGKU?E MU#1YC,EM1L-4&5U53^V(U,?TL5(!U?0>IC]>/K[TW$#R MZ\.O_];2BUM5Q-&B*LB$.JQC2'%M)!!/ZEO?Z_0GVJRXH!D=5X<>O11R4@DF ME739="(W(D9OJ&`/*JHO[\`5JS#KU:CKN.8U(>#1'$9%LC1II&M2&"MZB;-; MCWL'55:"IZ\>/7H:2:)A+,C1Q1'R.UQ_8]04+_5K6]^",#J844=:J#URCKM4 MNEHHD5R4+HI#H'NNK5R;K>_TY]^$F<@`'K?6,8^J\H700NH*7N+`?EOK>UOQ M_L/>O"?@1CKU:]9GR)$HTQ1.@*A7=29"HXU:K_J8<_X>[&3)H!3^?6Z?LZQS M4<\DIDB5YHY;2J]P.'&HAKF]P>/]A[T48DE14'K50.LLM4:713!(IC"H5VE7 M7ZSRRH>"$6]AS[V6TT4`&G7@*^?7":GFK`E3"FL2*%<"P$;H`I4!OHIM<<^] M%2Y#*./\NO<.LAE:@A2%DC>5RTSI(NM8M7I15L5&HJ+GWLDQ@+3NXYZUQKUY MEDR$*O$@$L)T/#&+)HD!*R(&-@;BS.,]=T]-/0ZZJHC:-8T944D7DDD!5%])8:!< MDW_I[TJM'5V%*?SZ]JU8'7*"L^Z9Z5TAA\Z>)9(HRC!_JBOI))1CP1[VKZ^R M@%?3KU*?9UCAQ]5'*LDT;Q11$RR.64Z5B!>PLQ)8Z>+?GWI8G!!9:`9Z]J!X M'K)'E+S#R00)&Q.J1$(F17##6'N?4M[_`$Y][$W=4J*?+CU[3CCUC.'K?+I$ M1*:[>:Z!"FK]=M6JVGG^OOW@R:J:<5X]>U"G'/663)Z)BD4-/,D86-9IH]4L MHC&C66N/U6N..![VTU#A00,9^77M/SZXU5!4U4IJ:9))H:@"56].I=0!:-E+ M*;QMP./H![TT;NVM!53UH,!Q.>LDM8:!8J/Q03/#':5IT\FB20ZVC2S`!8[@ MNJBGGR:PU=-'Y"R"*6)2H$,L(`94#$6C<$,/J1 MS[\R-+1T%?7Y?['6ZA<$]=EY,33)%)&CU$[F9HIAK2*-?VT:RD#R2%3]">![ M]4PJ%(&HYH>M?$3GKIO-EJ<"&)1/32'7#$0D;1S?ID4,;:E9"#S_`(^_=TR] MJC4#P'H>MX0Y.#UW%'-BH)I:B("6NXJA\I!/1B.*&>RS0K`GC2;Q7+QR"Y!8KRIN.1[]J,H*``- MQ%//Y=>II()/75)0U-`[UM5$T,=,A<`LK&60WC2*R:B%=W%S^!_M_>E1XR9' M%`!_J'7BP;`X]O-6[4;PTL'W2-`DT,;1NLD@&BY#&\;L`&X^A][636=!4 M"HI@=>TTS4FG6*GQ%:DZ25$3P0PDS2S!DO''"#(Q72Q(:PXX^OO2PN&!844< M3]G7M8I@BO6=M"1:#/6:HR?V MTWVT<%+.M,$@\T\3/*[1*L;-JU+QJ4@#^GO;3%3I"@@8J1Z=;"US4]<*O&U= M9-]W2QR5$-6!.&NNN-FL'B;4028V!`/Y`'OSQ.Y\1!53G_8Z\&`J"17K+-5O MBTAH?'#/)$FJ8U"&01R36E\,8]/I56%SR"3[VSF(+'I!8<:CU\NM`:NZIZXU M$%1EXX*JEBUNB&GG@B`58FC]2M&&91XW5_H+V(]Z96G5709&"/3_`(OKP(4D M$]>#3X:F5)H8WGJI#*(*A?+'%#&-"OI!`$DKD\@\`?X^]U:%*%1J8\#G_4>M MX8X.!UVWES-):&-144LMS3P+HCDAE4`2!2=(DC9.>?H?>CJF3M4:P>`Q@]>P MAR<'KJF@GQ,,]74QE7=?MX8'LR2E_6[3!2P,<:I<"_)X]^56@#.ZT/`#UZT2 M'(`/7<58^3BJ*'Q00S3()(131^(2R0:I#%("S`ZDN5)L`1_C[V',H:,*`QX4 M^7EUXC20U33KC1T-5CY#75<4L,-*C2?5/W9&'CCA&EF/K=@#Q:U_>DC>,^(Z MT`Z\6#=H.>N=-DQ4S&EE@I:=:E7IQ/31&.2-I1I0W!;4ES8CCCWM9M1*E0`V M*CCUXK3()ZP183("8>:)X8D8M)4:EM&B7+R*58M<*O']3[J+>34`10>O6S(M M,&O6=L[:J,@I*1HED)#F$_<&,-]3)J`$I'YM]?=OJ.ZN@::^F>M:,98]8)L- M7O.[01/-#(Q>*M';4RL#I/-Q]?=6@D))5:J3QZV)%`R<]9ZG)FFE2 MFBBIZA:58X#+4PF21WC4K)8EAIC#W`'^Q]V>72=`4$**5(ZT%J*ZB.N-9056 M0=:^CC>:*H16;U#5#)&!'+$=3*;(4X/Y'O3QO*?$1:JP_GZ=>#*M5)Z[DGDQ M$,%&\,$\]FGF2I0R"G,VG1%'RH!"K=K$BYX][+&$+'0%N)KFGRZW0,=0P.N, MT-1EX(*JFAN\6JGFIX@$CCY,J/&K$`+(&YY/J'O15I@'5%!Y]:P[8.!U M[RRYFED@CCCCJ*>19T@IU\<P MAJ3CKC2TM3BTGK:J(Q%4\,,,FDK42SD#3(%)U11JI8@VN0/>E1X0TCCRH/GU MXD-@'KE!6-DTFH?%3TTDT>J$T\?B$DD)\@BDY*E9!>WTL0/K[V',H:/2`2,4 MQD9IUXC31B33K'1XVKI)ONZN.2G@I09G>ZL6*?IB4*6N96(!!XTW]Z6)T8.X M(5<];+!L`Y/7.#+^6?1+!30QS:XFF@B*SQ"967R+)J^JM8GC_'WM9JM0J`I\ MQQ'7BF,$UZP#!9`SB,P%8_)I\]T\835;R"SAM.D7'%_=?IY=5"N/7KWB+3CU MG;-Z*FZ4U-)%'(`LCQG[AT0@!_(3=9&`N#;@^]F!<^]-#(26454YKUL.`,FAZRU-?]D4H MTBIZG[:-8I):B-I&:5;^14Y6T2.2%!_I[LTF@^&%!TXR.M:=0K4YZX5-+4Y$ MQ5M+&TJRQJLJ!E40RQ@(T8U,`$T@,O\`K_U]U=6EI(JUJ/V$=;!"X)Z[:H?% MT\-*\44L[,\\B5">180]E1$TD69E0,>>+^]DM"JH0"W$U\NO4U9!/7IDFR]/ M%-`@\M.6BFIXO1&JOJ=)8U8@#7;2W))('%O?B&F`*C(Q3_+UZH7!/742RXFG ME>>,>:I811T\@U(4B(=Y9`.#I)`47%B2?>J-"I+#N/E_EZ]\1QUT)I,I3RTZ M11QSQLM0D<"Z%E0620,"Q!9==QS_`%][JTRE0HU#.//KQHI!/7J>FJ,8):RI MC*!8S''&VDB>24%0CJK&\:@$L#;WI5:+5(ZTQCYGKQ(;`/7H*PUGDHGB@@:H M0I&\,?C)D4ZDC<@M>-R+'_7][5S)5*`$CR]>O$4S7KA3XRJ@F6:H1X(:?]Z2 M0E+A8K/9-+L=;$6'''NJQ."&8449KULL#@&O7<65U3`/!3QQNQ#21IIE17N" MRN"1J0->]N1Q[V):G*@#U\^O%<<3UC.'K?,4,;:-=O+J31HU$&3E]173<_2_ MO7@R5`TX]>O:A3CUDERFF]F4@X4:1^WK MU*9\^N%3CZJ>4S0(\T,_[T;WL;2'5H8,1ZDO;C\6]Z,;L=2@D'/7M0&#UW-4 MM1".D"0S-#&!(TJ%[2.=;(AU+9$##^O/OQ8I1*`TZWQR#UQGIYZT1U4$9?6@ M22-"`(GC]+(JGZ(0;CD_7WXJTE'4?ZAUJH'$]_5,:A2.X^OEUX5;SZXMY,C`IB0"6!B&BB&E=$AN)%!:P(*\C M_8^_&LH[1D>77N'$]>19..O?,GKJ"FEI" M]3.K(L2G2I('D=_0J$J6LIU.19)4>**,ZWDN+JJ>HVL M2=1MQ]?>@C`BHH!UZO7-<@&FNT,2HS>IU4B0*W!.JY]5C]?>_$S\(`Z]PZQ- MCZ@RV"DJ6],A(L5)-F/-QQ]1[KX;U(TXZ]7K)+6A'T1QQ2+&%17D2[MH&G43 MJ'U(_I[V7H:`"@ZU2M,]<)J:6>3S0H[QS>L&X)!/!0W()*$6^GOQ5F)914'K M=:=F1CJ9%M863CWHG31:`TZ]QKU__7TI&$<=+(U*S. M2Z+*YU*R(3=0!8'2[6%_Z\?T]J\!3I-?7JOVGKC2$R+.LI8P"/5(Q8G058:& M4&X+:N+#D^]+0Z@WPTZ\?MZS0K!&D\E,YEF6)B-:E="FP=UU`78*?=ETBI4U M:G6OMZP44DK5*+RZNVF12Q*F.WK)!;\+S_L/=4)U"F>MGJ3#%0B=?',TCJ28 MHW4JCN+^-2Y%B"PM_C[LH35AJGK53U`2>H\ZL&8R^0$*2WJ;5^G1<"Q/%O=` MS5U#C7K?EQZ<98:#[E@\[QMY/W(U0E%:X#().!;5?FP`]W98M66/6JG)\^H= M;)**F1;M%H.A45F55C4632+@6*\_XW]UT,])3O6NT3*TD<+J"[RQ+R=2VO:-V('(]V[2BF0T M/E]G6C@XZXU)6&CA%&S/!+*_DFY#M*OZ4DH48.>WU^?6S@T7K): M&&BJ6H)'E9GCBGD8&-XXGU$!0.=,C@`GWLZ51BAKZGY=>'$5ZQXYGE::.8EJ M9H':9G9K1:!>.520?6KD6`^M_P##WJ+)96/93/7FIY<>I%+'1Q^:6CFDGJXH M'>%)$T`$!09%]-G=$)(`Y/NZ!!J*,2],>76JG`/#J#CYIS60A2TOD?0\;N2C MQO<2Z]7&D(223]/K[;C+:UIDGJQ^$].%-3XK[Q!%423.)288701QO(-1B0RD M6Y:WU^OMU%AUBCD^@I_EZH=5.'38U36?=%R\HF$U_$"]ED#\1",-]`PMI_V' MMDL^LG.JO5Q2GRZ=:NGQGW3?<5$M/,Q1IXHH_*D,%H8X@D<"1R'0(%`\;II)'K4AO\"?=)21(1P`X M?9Y=64`@5ZESQT4D=)+73R4]3)3(6$-=7:/+KC4^*GQ\?V$KR12U+?<5%C#)Y$4&*)E])"Z26'X)Y]Z?2L0\-B5 M)R?\G7@:L=6#UU0%)Z*L2ND9:6-HI$G]3R15+-I5$%F+>6.]Q]+#_8C<=&1Q M(>P4S\^O-AA3XNLZ+2T]#6RXR:2HFTQQRNZF*2"FD-I&C4@%@SV#$]T M14D:)B6\_D.M9)`<4'4;$RRRSRPRL\M++3S"KUR.RQP(FHS"X8*T;6MQ]3;W M2$DL5)["#7[/7KS4I4<>I5'%CXWDEHJB6IK(H)I*>&2'0I=4-R+BTC(@)"_D M_P"/MQ%B!)C8F0`T!'GUYJX##'3;CJFL%=3^)GGD>0+XGD+)(K@JZOJ)4*5/ M)/Z?K[:C9_$6E2:]68#2QZ=8Z3!_Q!46JD?_`"G2L#1D0L1)=8O,RF\9/IO; MG_6/MT)!X@`<\>'E]E>J%I--:9Z:*FJKA6S.[RQ3K,W[89K1.K$+&%!L0FFP M_K;VR[OXC$DAJ]74#2*<*=.U=!BWJ&>MJ9:2JD2*2I@B@,J1S21J[C6+@,=5 MR+FQ//MZ182:NY5B,@#S\^J`OY"J]0LO-41U9A0M#!#'$E*D;L$:FT`QN+:= M1EOJ)_J;?CVW,S!RM2%`Q]GKU91VU\^IU0E%44]!/DYY*6K>"VJ./RM/`K%8 M)I%_L,P!L?R!_MG&",D;2L0]/+S'D>J@L"P48KU'R;?;4N/BH9&^R>.25*A2 MT;SSE],WD`TE6BL!I_`/NLM%6,(?TZ2%(JHI2 MSJAFE?5&'FBTV),:-8W_``6L/?ETO$/%8BAP?\/7B2&[5L+7`_V^HCK619#^G3CZ'_/UYZ@J5^+K/%% M0T]'D)L9/+552P*KF2/PM!3R/IFEB7@N0+`D6*W]V41A)&B8EJ?L'F>M=Q(# M#%>H>%DDEJF@F+2TLU/,E4))"(XX!&6:4L;A3&0+'^O`^OND)+/I8]A!K]GK MU9L`$#/4_'P8M:AI*&HEK*U(IY*6GEB,22SQHS(-1`!("D@&US[!_B+(]9)'_E>AH!$1"I\MFA\_T$:GTZA^.;_GV\4MO$(\ M0\>'E_Q739,FGX>F>NJJW[^H:1Y89$G8>%9&"QF-M*(BCBR!0!QR![8=W\1B M20:_LZ<`%`/+IYR%/BVJ(WKJB2CK)(H7JZ>&'RI%*T8+78+9'8$$K^"?;\BP ME@7Y^OX M/T]MSDAPHP@&/\_5DH14C-<]2'2DJ*&@ERL\E--HEB@>.+RO44T;`1R2#DJ% MB-'&96(;-/F.M=P)TBH_R]8,@XIZ.ABH)9/LG$TOW',3S50ID``8_BY][72T)\4D*#@_Y.M-4,-(SY]2HABJZA MD\4T$2KJA0)]5CED)NPL+BW/X\=*1,8F)J:$^G7A4L-0IU&Q3M-'70U;N:'[ M?R3RL2WV[QLO@D0&]W,ATA1RU_R`?=8CJ$BL?TZ9^7IUYL%2./4JGCHZ>"NG MQ=1)55<=,UC)$86@@=@LT\0XU-&/]L#?Z7]W41JLAB8EZ?L'F>M$L2`PH.H6 M'FJ)*Z.&[31SJ\50DDEU-.X)F9BQ.G0@U7_P]TA+>(!Q4\?LZL]*5''_`"]3 MZ&GP_P!XAIJF2IG4R/3031&*.6=(W>)#(RA0=0%KV!-O=T6'75')(X#U/EUH ME]-6&.F5*JN^[6022-.9PV@ES>0OS&5)%U9C8C^GM@.X>M3KK_/JU`%IY4Z> MIJ7"FO82U2+S*+:%WREOXA!<@UX>7[>J`OIK0' MILR4]8*^=9&D@9)#&L*2,%CC4VC5`M@5\=B"!R#?\^VI6;Q&!P1U=*:>G*NB MH)3!-D)I:2MEIXGJ(HX3*"Q%ED>RC0\J`,5_'^Q]NN(R5:1R)"!CJBUR%&*] M0\LSPO2PTS,M(E+&U,ZL0)E>[23L!P':2X(^H(_'NDQTE`OP4Q\^K+YDG/67 M32U%#22Y*:2&0&:.!T4RR301O]7L&(6.0E5/YM_A[V`C1H96HW`?,=:S4Z>N M%<13T5(E`[-2RO*[U()C>6H6ZF.0`@KXXSP/R#?_`!]^DHL<8C/9G/SZV#DU MX]=T96HQ]2,@[K312QM!4_YR5)WN'BC5B2X:/DC\#D^])1HG$A[`<'Y^G7C7 M4-/'KMEIX,=4R8Z62=C)#%42LIBDBA8LRA5%CHDD%B0?>^Q8V,;5-<_(=>SJ M%1UAQCF?[N&J9FI#3N\[N['P:#>.5`=>J02&P`'-[_CW6$UUJQ_3IGY>G6G\ MJ#/4JE2BA%3-0325-7%32/$LL?C"#4%DE3@AWC1B;7^E_K[NBQC6T;5<#S'\ M^O$DT#87J!C)JIJV%%9YA(VB2-Y"4>)O\[JU,0`L=S?\6]MQLWB*..?Y=6:F MD_+J;3T^)^Z3Q54DKB0F&)XM,;R*3XD,MOHS@<_GW=5AUBCDFO#_`&>JDM2A M'37]Q6&J\FJ0U#37T7-S)K!\>C5_JN+?[#VUK?76IU5ZL`*4Z=*JGQ7W;^2I M>%RX,T*1EXXY6YE02@"P5KW(''^P]NLL.ON>A\P,]5&JG#'4')2SBLECNT*Q MD)'&CD*D2@>(``_VEY_V/MN5F\1JXICJRTH"3U*J$I)4II:Z9X*F2G1G"1ZO M(H+K%(]@0KO&H-K_`$]W8(0ID8AR/3]AZU4YTC'4;(.T7V\4#,*80*T#*2IE MU\R2,!:SZ^"#]+>ZR8T`'LICY];'G7CUF40S4-.]<[Q$22QP2JI9YHP58J5L M;I&YL"?];W;M:-2YI0X^SK60:+UQJ=$%%$*)V>&69O--8HYE104C;]-E"FX_ M!^OO34"#0:K7)ZV#4YZX4NF:FG6K=UA1HVCE_6R3-<:4!-SK0$D?@"_O2T*, M'/8/\/7C@]O62T$-)4/0R-*[:$E=E*/%"U[E1:Y#M8$^]]H1C&:GS^SKV>#= M8*!GD>:.74T#POY]1-HXT&I9+GZ%'M;_`%_=8ZDD'X:9Z\>L]/'2*7DI97FG M2&1XHY$T#4%Y9"?U,!>P_/\`L/=E""I5JL!CKV?/J%223FIB"EI-3!61F8JZ MM<.&OQ:Q)_P]MH3J%,UZWCJ9'!0?=F9F602,"FIO0RM;2$N;`?0#D>VRS%B3\75@13J=4149F) MFD>*9@CS1HFM4=T5G`>WU!)O]>?=W"5RQ!ZUGJ+6O*L[)ZN>XCK8IUGF6"2.G>JD:*9XQ<*I8NBG2DCBW#,H_/NQ"D*6-#3KP M_EU__]#2G2%Z".66IC4F0")8'*L).0Q9@"1I2W'^/]/:T*8P69>J5KCKDDBU MTJ#CKU/613/X#3PTQG4P^:%`K*7`4 M:OZJS6!_K?GWY7!.G2!7S'7J<.N,6+JUE#2H8XH_5),'0A4C]3.-)+7(7@V_ MU_>A"X-6%%]>O:@<=:=-3N8QI8@WX35]!_3WMI%4Z0@('F>M:2`U9J:=G6M06H;KP'\)I=%5%'-/52!A32E98XDBN M!*U@REW)L+?0#_`CW[,*T=:L?(^G7OC.*TZ]44\.A(YHWT MH[@-H421D#DVX/OW]LE$4!P:T'GU[X#4G'7=/3RXB*>HK8@#*HIXJ9VC9)RQ M#LTH1F]$87^M[^_!3"&:1%//[>O$::-4TZXTF+JJ&45U:C4\%*#*2'C+ M.P("PII9K&0M8WXM?WI(GC.N045<\1^SKQ=6[5.3URI\I!-*8#14U**D20?< MP)IEC\RE`U["Z@MS]./>UE4M3PPM<5'E7KQ6@KJ)ZQQ[?R"SKYH_!`C%Y*@2 MQE8XTNS2+I;6#8>G@<_6WO0MY:C4*+Z]>\12*`YZS-FZ859?^'4SH)@1.T8- M2RJW$MR+>6PO_K^[>.NO5X2TKQ\_MZ]H-*:CUCGP.0DG,E-&:FGF82Q5)EB' MDCE_<5WUNKEA?DVYM?WIK>0LQ454Y!QY]>\1:4/'K+5Y"GHY$H_LZ6N-)&M. M]14('9G2^M$)!*QQL2`/Q;WMY%0B/0K%<5/6@NJK5(!Z]58NLR;QY"AB\L-3 M&C%!)$A@DC7Q206D>.ZH8_20/T\>]/$\M)8UJI'RQ\NMAU6JDY'7*6H3$04] M!/34];4(&GF2<)*E*T]B(8[7&HJ`6(X-_P#'WMF$*K$RAFXFOE\NM`!\@D#K MTU-)G*:"?'PJKTS-3S44;QQI$&9Y4FB\C*NF6YOS>_X_/OQ5IT5HE[A@C_*. MO5\,D,<'AUTL4F!I'-=3133UDBB.CF*2QK'3ZBT\@0LI8F4!>>/K[\`;=#XB M`LQX'Y>?6JB0]K8ZY+_N>I)*>CIH*6KI9!4+2P:8HJF)P(7>S%5$L1MR3]#[ M]_;H51`&!K0>?6_[,Y/;Z]=TE!485*BOR,6A1&:>&E9HG6KDG4W230[KX452 MS`_6W^!'ORQM!JDE6GD!@UK^WKQ8.0JG/^#KNFK8*Z>XDD#KC1X6OQ\ZU]=$:>FHQ] MQ+(LL+LYCMIA58Y&),SG2;V!!^ONJ021MKD4A%SY=>,BL-*G)ZYTN:I):CQ2 M8^DHEJ!)"U731A)X/,C1^0.-/T+2+0L2G_/Z=8D*E1<`@'^MO=1:S:J:>VO''6_%2E:YZSS M9^D%867&4M1'')&!53(&JY5B"H)F?0/6P6X-KCCW9KA-=1$I`\_/JHC)'QG_ M`"=8JO;^2JZB2KHHFJJ6K(JH)S-`K,DX\FEUDD1@\9.DW'U'O3V\CL7C6J'( M/V]>$B@!2:$8ZS5F3IZ!HL?]C1Y!Z&)*:6IJH];&5"3)%$Q`810N2H!^EO>W MD5*1F,,5%*G_`"=;52U6J0#Z==5V+J\R81<#24]%5TU/6UR1;HL;H&]%3<*IB3*X('S\^O5$9.HX/GUR MCADV]0RG(01RSUTBQPT$S1RP^*G];5$NDR)J#2!5'U'/O8!MD;Q4[F/#[//K MU?$(TG`Z[CE&>HIZ&EIH*.KBD2KB@IPL<-8J+HE5[Z0)HP^I23:W^'/OP/U" M-&B!7&0!Y]>/8P))*_/RZX4>+J\*)\GDH!%%#"\45.\D,HK)JA3$(G$4D@\2 M@EF!^H'T/-JI$\.J65:`#AZD^76RZO1%.>N5+7P98SXU*.CQTE9"T<-131Z& M,J$2I!,0MVBFT6-KDFW!/'NR.LM8A&JLPP1_@ZT5T4;433K'1;?R-)4QUE?$ MU'249^ZEF$T+MIA!D$:+%,SEY"-(X_/^P]ZCMY4<.ZZ47-?LZVTBL-(/<>LU M/N"D>L!?&4M-'(\BM501JM7"DP9#,KZ;:UUW8V_K[V+E-=3$H!\_/K1C.G#D MG^748[4RYJ?&D*O`9-*U?FA\9B)],OC\AETE>=-B?=/I)M6D+BO'_+UOQ4T\ M>I%1GZ2.K95QE%6)"R1+5SHKU-0(%6,3&0J1J;1=?]A[NUP@?$*D`\3Q-//K MPC)6NL@_+K%7;?R%74O64"-64E81403&6%7TRCR>-Q+(A#QBX^EN/P>!I[>5 MV+QKJ1L@_;UI9%4:6-".LU7D*?%+3XQJ.DR4M'$4GFJ4\@CFE8RO!!>Y6.(O M;_7'XM[V\BQ:8B@9E&2?\`^SKRJ6JVH@'TZX5E!49Y*7(8R#4OA%+-3"2*-: M.6GL!''Y7C'AD5PR@7M<_P!;>_/&]P%DB7%*$8Q3K081U5C_`+/7;2#`44-% M64D-75SRO5O35.B6*D0?M1E2A93--H))!L%]^K].@C=`SDUH?+RZW3Q&+`D* M,=>EB?<-#"V/@C@J*!VCEH(BD4)BJ"76HA\C1H&U+9KFY//]/>B# M`X9\^O5$9[C@^?7H*67;U+4562@5Y*JU+3X^1XY8Y[%)GFF"-)&4B`L.2;G_ M`!]^56MU=I4%3@#U^9Z\6$A4*<==PU*9NEJL;3TE/0U3::B!*8+%'6-3AF:" M4L`"P0EEYM<7)`'OP83HT2(%?B*>?RZ\RZ"&))'^#KC0XNKPS2Y+)Q-!#3Q2 M".(2PO\`=S3*8D@(CDZK;2A@7&E!FOV M=>\52,9/65-PTOWOE;%4:HU06-0L?^5JC%M4H<<&:S7O_7\_GWOZE->KP5X\ M?/[?MZUX1I36:TZP/M?*M4GPQ"6G>35'5F:$J\3M<3%1)Y+Z#LU7FJ2"?P1X^DK5IEC@^\J8U:HG,"A"Y:QX)7T_X6_U MO=GF0-01A@,5/$]>"$BI8@GRZXUV&KLE,&21O%C6J-G[/E^77@ZKVL:$==U%3%AXJ;'34E-7SPHTDYJ4$ M@II)[2?;P\7LJV+))"%++YIB"+@_I%OQ[W_8(%=`7)K0\!UO$AJK'2/] M7\NNM)SM&8J.GB@J:20R_9P:8H9XIM"F5=151+&4L2;"QXY-O>O]R$I&H#J> M`X'K7]F:L>T^?7&&BJ,)!45F0@6\JBE@I)&CE6=G;6SR!"Z>.-(R>>=7]./? ME1H`SR+QP!Z^>>MZA)A3UZ"=,O%4T$%-3T-1(HFA6G58UJVIPSF"4``L=)++ M?@$7/'OP83!HU0*W$4Q6GD>O'LHQ)(^?7J/%5F,F.0KXVIH*-6DXDB=YI+Z$ M@'C9K>1WL2?J+CWY(GB)ED%%7^?RZ\6#=H\^NJ7*4]1*:9J.EH15(]/]S3(J MR1&52JL6MRFHB_('OR2HQTF-5KBH^?7BI`KJ)ZPQ;>R:3J9XC!!&X>2H\D7[ M<<9#-*%#EQ91Z>/K:]O=1;2AAJ6B^M?+K?B*>''K,.I, MT(5HY`'5VNX8D*W/'X_UO>C;RD]HJI\^M>(N:FAZRU.2IZ9UI124M;]K&M.U M341AG=XQZRIL2(U:X'^M[VTBJ0@C#:12IZV%)S4CKA5X^JR4@KZ*)IH:B-6( M\D2&&1/VY(;.RDA&3@CBQ]^>-Y2)(Q52/V?+KP<+VL>'7*:>/&Q04,U-!5SQ MJ9)A4*)%IWFTN(8[?I(7EK&Q/OQ81!8RH+#C7R^77AWU(-!UQGIYJD!6EEL\<:1:[RR!21KG?RB"+1'',D@5&>S:5$D=QR2/2??O[9=**`P-:#S'6_@R>'7H*6;%1S5 M5;';4A@BIV:-Q.TER=>EG70BH20?K[\$,09Y!\@/6O6M6N@'7H*B.O6:B2"" MDDG2\;0@(LKQ'R".6P'#`<'Z?[Q[\&$@,84`GAUNFFAKUPI\954DGW53&T$- M.&F8ZXRS%1Z8ETNQO)>W-N/]A[TL3H0[BBC/7M8(H./74-?#-((C2T],)@\7 MFA0+)'Y1H#`VXTD\_P"%^??A(":%`*XJ/+KVDC-<]<%PU8)0)%T1*QU3ZX]( M1>=:C7J^@N+@>]>!+7*T'KU[6I\\]S*NHG0*5_/K=,=8Y<75R2M+`IGAE_<276@++)Z@2&(;@-^?K]?>FB_O18+VZ0:=>`K]G M74])-6%:FF3R)(BEE#(#"ZC2T?J(N`5X_P!]?Q1G(=1@]>KY=?_1TIJ3]^&I M2ID*4RB.0S$,YBEU!%"`79S(I((_I[6+W!@Y[?\`+U4X-1UF\<$-+52T,YJ' M`1)#XWB:&&0G4RAAZM14"X^@][TJJL4:I_P=5J:Y'6+&EYIWA2*05'D8 MZ8XELWEU$D*Z,!8^]1U8Z3E2,];.,]2Z6GHED+TE5]U4)'))#`8I8PTB`LIN MR`,5'(46)/\`A[NJQ@U1]3TP*=5U&@!&.FVEFJ&JXM+-)(\H70Q)$FLV8,#< M68,;GBWU]M(6UK3))ZN::>/3HE#B36+&M;24TD\:OH?; MPCAUT\7SX4_R]4+&GP=-<\]7]U(SL\JU8D`K0=0L,U1/6K3DM M+#,DD=4CNP1::P,LA9OTF(`,#_6W//MN$LSZ>*GC]G5G^&OGTX4=%B14!J3( M&LJXDEEI:62FDB66>.-GB4NX"MZP#;\V]NQQPAJI)J?-!0BIZJS,1E:#[>F: MBJ:T5U.\+/+.TRA8W9F$S.VDHZM<%)`;'_`^V$=]8*DEJ].$"E#PZ?6QF!_B M)A.396^Z$;4BP3:5)D"M"*G0$"@^D,38?UXO[4&*W\0J9?/A3'V5Z:UR::Z/ M+C_L=,V2J*X9"H\Q:"1)BOBC9E2)4LL:QVT^A4`L>+CGVQ*SB1JU!!X=76FG MC7IYKJ/&RR1SY2O_`(?7ST\,M33QTLTP5V4#R'Q*51Y``63Z@^WY$B)#22:7 M(!(I7_57JH9A72M5Z;LRTU/40T\,C)20TL'V;(S!9H)%$GW-UTAGFD+$\?X? MCVU-56"`]@`I]E./5DR*GC7IP>GHZO'X^IS%8:&H9)(87$,E1)54L+*L4DJ1 MK=&4D@,?U*`>?;FE'CC:9]+>6":CRZJ"P9@BU'V\#U'RJ+1T%#'C9FFH)VEF M>L4/$\]4K&,I(A"M%XHQZ5/UN3[U*-$<8C:L9S7U/6TR6)'=Z?+KU"D=;C)1 ME*EZ:EIZN,4M7H>:03S1NTU,J*&9XV1%8V(TD7_)]ZC"O$WBM1`<'C]H_P`O M6F)##2M3Z=99X:>BQ,TF(JFK(YZF.*NJ?&\$L"*A>&$(RAQ'-)?4XX)`7GWM M@J1,87J":$\"/0=>!+/WBA\NL.$#U:9"FK7/\.^U,U342%F-))$28)HOJ3*S M772+:U)^OT]Z@[Q(KG]*E2?3T/6Y,:2/BZG4M)CJ>&OJL37MD*Z"CE94>GFI M3!&Q"3U,?D3]R2*)C:Q%O\>![NB1JLCPR:I`OI2GJ?V=5+,2H=:*3Z]-6$DJ M9\C#3,SRPU*R054CCMRX"2ZG\A2 ME2/GU1GDIE*#UKTG8JW)?Q%)4DF:L:J!$9+7>=I`IC,7IL'8Z2MAQQ[3J\OB M`U)>O#Y^G3A"Z:?AITHZK%[=&2D2;+"EE,R^:B2"9X897TF2!:S0(E178C4? MT#Z\@^U#Q6WB$--0UX4X?*O30:0**)44Z9,U-5Q9.KB=GIQ!+XHH8W=8HX(E M5*=4`*^DPJI'`O>_MB=G$K@XIBGH!PZGJMH<5,::HRN1./R-31P35 M%/'335(9BI5)V\4?[4DR*&9#SJO[?DCA.AYI=$A45%*_GU0,XJ%6J@\>'3?G MVFI):.DIG9,?%1Q/0R1LP%3',HDDJF(T:I)I+W_H`+?XMW%4**I_3"BGS^?5 MH\@D_%U*2"CKL30U&:K&H622>GHJGPRU$M52QZ6LZ(K-H@F9@K?XV/X)N%1X M8VG?2:D`\:C_`&.JU*NP1:CS^WJ/DTCHL;1+BJEYZ&HFGEFK%#PR2U<6F,0R M1FSQ+#$054GU:BW]/>I:1Q1B)R8R34\,^G6UJS$L*-_DZR8R**NQ%6,M4&GH MJ:JB:GKF62:5*B;B:G2-59YD>,!F`/I-C_7WZ,*\+>,U$!P>)KZ?LZ\Y*L-( MJQ'#_+UF>GI*+$5]3A*PU[R2P4U;4^*2GEI*5[N`D;J'TSS*H9OI86][*HD, MC0/J.`32E!_L^O6JEG4.M/3J%@WEJFKJ6KD"35(%]*?:?M'5&+'2'6BUZ:,' M/6OE*:%"U2*AF@GIY7?Q2TTJ'[D2VH&D,J*,UP:^GGTY(` M$)].GNCQ6W#DD2#+?>3+-(8**:GDBAGEC#M%!)5&(PE&=0"0+/\`0#D#V^D5 ML9`%FJ:X%,'Y5Z;9Y-.4H/,])N6OR?\`$7E:2=:P5;,8P7]-0)2/&(KE;!_3 MIL1^/:4R2^(6U'Q*_P`_LZ=HND>E.E%6XS`??R"JRQHJEY$:JHXZ:6:*":95 M>:):E$\(578@7X3Z'Z>U+Q6WB'7-I:N0`:`^E>F@\@7"5'D?]CIGSLU;'E*B M&353+3%(*>")Y!%%31H%@\5M)96B.J_]6_V'MBX9Q*RFHIP`]/+IR,`H#Z]/ M%928VJBQ]5F:]L;D*BC1Y46GDJ34(C-'!4R+&I,HGE&E2LH=0 MN@W**H'UX]MS]GA+&?T]-0?6O'JT>2Q/Q5ZE04]'68:DGS-8U"8ZF>GHJKQR M3R5,%MM$D.0BU%,]8\E''0 M8BF&(J&J**JJ935UZAXI'J(1^U3.A56BC2,EE4\L;MQQ?4H$<*>"U8V;)X&H M\NMJ2SDL*,!@?+KK#J*['Y*/)SM%CJ5W*T\4/[B5*%BP$D4H%N/H3_`*XK;U=W1C6,J:_*GG^1ZM)@*1\5?]0Z MHQ.1.2R--2SST=+)2RP#RH`!,/)&5FDA5BRH.2P']+^W(XX06:* M35(`2!2G5&9C0.E%KGIAQ-37G)THIV>HEDF"&&1V>.9);I,LH.H:"C'4?[/U M_'M/$\GBI0DL3P]:\>G&"Z#7@.GU,3MO^)+",NSM]YXQ1M33:&<2D"F-65\> MDO9=?-_Q[4"&U\4+XQX\*?RKTV7ET5*>72?JJW(C(RR/)+'5)5-^TK,5CECD MLL2)P"J,``+?2WM,SR>(QJ=>K^?ITZ`NFGETH,CCL(:QFKLF<=62K%+5T45+ M-41PSRHK3*LJ+H&IF)M?TD_T]J9(H-??+IU*J//IIW!)4T M^0>E&J"GIHXXJ..-V\9I`MXI%8$!S*#J8_ZHD?CVS.660KP4#'V=.1T*U\_/ M[>G"6FH:JCQU3F*YL?5RTY5---+4/54T3:*>IE6('QNR<7/ZP`?Z^W"L;I&\ M\FER/2M1Y'J@+`L$6J]0LO\`Y'!CX*&9GQ[0O/#4IJC-5.\A6H>065D>/0JZ M3^D?Z_NDW8L2QM^E2M?4^=?LX=63)8L.ZO[.I--%!6X>.3+U+4B05304588Y M)Y95<%YJNJN*"BQ&K$U+ M5<%15>.MK-,D,J&)/)3TWB95>.-B2VJ_)%O>G"I#6%JJ6R>'V#Y=>!+/1A0T MZC8H&KIJ^"OG:+'1I%.]4X>4TM3Y0D.A`&:1IE9E*?4@?XML=)4J,]2TIZ*EHLC48>L:OJ%B2.5FADIWIJ65BL\T(=09&-@"0?0I)] MW"HB2/"^IJ9Q2@\S_JX=5J20'6@ZA8)IZFL-*VJ6FJ()DK!)(VA*8+J:?4^I M4>%@&4_ZKBXO[I`69])-4(S7T]>K28%?/RZ<*"AQ"U)DH,A_$*V**6:DI)*6 M6G26:)"Z>MU"N4(N%%B;?Z_MR-(@U8Y-3@&@I3/6F9J#4M%Z8J.IK?OH&C=Y M9C.H$;,VF5I'TLC*;@J^H@W^@/M.C/XBD&K5ZN0-)'ET^?PS`C("$9,EON1& M*3P2^,L)-(@^X*!"I(TZK_3VH\*W\33XOGPH?V5Z;U2:`='^K[.F.MJJT5\Q ME>2*9)C^VC,JQ&-K(L?T]*!1I/Y%C[3R,^MBV&!Z<7*BGIT]5]'C6F22OK30 MULT,,U33)3RSA99$&HW1"$:3ZE3R#[?D2(M6232Y`J`*YZH"P!TK4=-F8:2G MJ4@A9DIHJ>'[4HYM)"ZZQ.2+`M,[,3_CQ^/;GHZ MBBH)\G5FCG>)TC*Q/,U13Q/IBED"`E6`-KG]2@?T]WTHR1M*^EB/2M1U74P) M"K4=8,F/M::BAHI2]#*CS"I76AJ)]120RBRLAB6P"GZ`_GW67L6,(?T_7U/5 MER23\77*D2.KQSMD9S3T\%2%IJHH\KF21"\T`559G2R!O\&_U_>E`:(^*U%! MP>/VCK1-&`45-.NIXZ>EQ[MCJAJE9:A8ZJ?1)"\81"\481E#!'[!457:)]3@>E*?/JM22`PH.H&,>:6K$/,D4H>.='8Z?MRO[I8FX70H MN#_46_/MN*I<*,@\?LZLW"OGU,IJ3&I.C4U;]U4('D@@D@EA665$+1JSL`+! MEO\`X_2_MQ$CU#1)5O(4/56)I\-!]O37#45?W4;1L[S&860ECJ=GL48?T?D$ M6^GME6?6#G57J]!3/#ITDHL2*MD>N*-Y@&@6)V1#K%XQ/8(%!XN?H/K]/;QC MAUT\2F>%/Y5ZIJ:@H.FRNEJ%JY5DU0E'TB)6*K&BJ`BK]!IT`6/Y^OMJ0MJ8 M'!'5Q2F#U.J*>C=HY*RJ--4R0H\T:PO(-9!];:19&<`$K^+_`-/;C*AH7>CD M<.M`G-!CJ)D3)%+%"A(IXX8S3E20)$9=1F_!)D:Y/X]TDJ"%'PTQUX9R>O_2 MTKA(V2I9:>&"**:)TG$5+&429.8WNMR?)%<$<\B_''M<"9%**H##-!Y]-_": MDXZZI89\8M155,3(/$8(XI%]%1+-]$<7YB14);^O`_/ORJT6IW6@X4/G7KQ. MK`ZR4U6*X348@I:62HC=8I*:(Q:I$(=8I.6O'(!;^M_>U?Q*QA0I(Q3'Y'KU M*9)QUPH\=54\Z5-2DE-#3:IY9#;4!&-7C4$^II/T_P!.?>DB=6#LI"#->O%@ M0`"">LM/EUDJ5#T=)"DK%&J((=%3$)@T?E$NNQ===VN.>?>UF!;X%`/G3(ZT M4-.)ZCIA,CYQ&T#QH)-+5&DB-%#>J8$LOI"\_CW46\NH+I-*\?\`+UOQ%"FA MZE39N,5;/'0T,T:2KIJ)8-55(L>E!+Y@R@2,%NO'IX'X]W:<:ZB-2*\2,GK7 MAFGQ9ZQUN*K:BH>HIHY:NGJ2*B.<:?4LH#A6]7#I>Q''T^@%O=7BD9V=02#D M?GUL,J@`FG6>KKQ0&"@^VHZV2CA6&6:K@$Q6:Y=X83J6T4.H*+\W'^'NSR>' M2/2K%1DD5ZT%K5JD#K'6457E/!74<#S1RP(CQ1`::62`>-X56XTQ']2_ZY]^ M='ETR(M01Y>1'E]GIUX,%J">LDD[8>DIJ.:GIZFHD9JJ2"LB$T=(LEECC07% MI7"ZFYL/]C[V6,**C*"_&A\NO`:R6!('7:L@0RU1ZF/X]^4-`C,ZY8T`/^&G6R0[`*>'GUR2=\U1 MU%)!34M-4PLE5'!1Q"!*N-=4'5 M+(*`#AZU\NO,P8!5->LE#DUKY)<<:3'X]JZ&2FBJ**G\+B5K-'%*P=R\$S#2 MP`_(]^23Q"8RJKJ%*@4SUIET]VHFGKU'H<)D:>JCJ:J":DIJ5C53U!"^B.G! ME;0=37=M-E^O)]ZC@E5U9U*JN2?LZVSHRT!!)Q^WJ32[BC^]1Y,;CJ6-Y'#U M5/3LE;"LUU:9)]3@RQA[GT'5;Z"_O:7`\0$QH`3Q`R/SZTT9T_$:_P`NHK;9 MR_WGA6G=XS-H6JM>!D+6$Y<-PFDZCR2/I[J;:;65"FE>/^7JWB)IK7\NIE9N M&-*MDBH,=710&.%*RLIO-65"TZI&9C-K4`R%"RD#Z>[O<`/VQJP'F1DT\Z]5 M$>/B(/\`+K%D\37Y"K?(T,$]92UJK513#260.`'IWY4*U.ZE`/Z`>]20R2/X MD:ED;(_S?EUM&51I8@,.LM7DOX4M)BWH:"OGHZ=5J)*^G%0T%A(EH MX%D"_FY!_`'NSR>"$BT*S*,U%<\:#[.M*NNK!B`?3KK(4=5G(J+)T$+3*8%I M)Z2$#3034XL8HU)73!(K!T%R>>3]/>I$>X"2Q+44H0/(C_(>O*RQU5C_`+/7 M(S2;>QL-+54M-4U=9.U6:.NB$\%)`BF%'\0*@5$[`\ZC91].?>ZFWC",H+L: MT.0!P_:>O?VI)!P/,=<96FW#CD6CI(8JB@J&,E#11K##)#5#TU$41-_)&\)5 MQ=N#-A++45$-P62$$!>;ZF]^4/;([2+EL`'@?F?LZ\Q$A4*V!YCK)3UK9VBKL M7#24=#5.(ZJGBQ$IHJTTQ)DIIP9&U/H.M/IZE_I[VKF='B5%5^(H*5IY'K3 M+X;*Q-5^?E7K'C,77X>6;+5\$E)3T,#N%D"C[N:93!#2@'5=96D]1^@'^)!& MHHI(29I5(51^VN`/SZVSJX"*P)/7*@S*U\LF-:@Q6.;(02T4550TGVTB33"T M2R-K?]B60!7``-C]>/>XYO$8Q^&BZ@14"ASP_+K3(5`;433RZP8_;N5AK8IZ MN":AIJ5S4SUEU`ABI@97=&76#(0EEL#R?I;W6.VF#JSJ549)]*=;:5"I"D$^ MG4N+=,7\26=L1BXX&J2[5"4G^Y!(I&YE-1Y"KU`5M1-@&/\`3Z^["['BA_!0 M+7C3/VU]>M&$Z::SJZA5&V,PU;(L$,E5#+*/%7%@8Y8IBI2=Y"WU*/=_K8W^ MONC6D^L@(66N#ZU\^K"5-.6SZ=2LAG8Z:J:DCQ^)R*T:14GWM?1>>IJ'IXUB M>1Y/*HT%U.GZ\?GW>2<(V@1HVG%2*DTZTL>H:BQ%<]<,KA\CDZK^*4$$U;2Y M%(ZJ-U"'P%@4DI7MI`-,\946XT@?4W]ZE@EE?Q8E+(PK_L?EPZ\CJ@T,:$?Z MJ]9ZW(_P2GH<1)1X_)5-)"9*ILA`*H4LU4!,*6G*NFD1(1J-SJW#24-=CZ?48(VH:G'TZJL5')$? M+')!'<,()XY+VYTD6N?>I$DNDCEB2M,$#R^SY'KP98BRLW'()\_^*Z$9]N8 MR.GK*.FJ:JOJ6J115\2U$%+#`I@65H@RZ:BH]O?DE\=9(! M&JN14:12M,T/7F41D.6)'S/"OGUCQ.,R&%J7R^1IYJ2FQ\,DI)TJ:F1U-/#2 M*1J_S\DH!-N`/ZV]ZBAE@;QI4*HH)^WRIUMW5P$1JDG_`%'K+C<_'5U)HI,? MBL:M?%+1BLQU%]O40/4*5B;R>1_V_);4/38&T:)J%*J*$5X=:> M,J-0+&F:'J'1[7S"5T0G@DHXH9]4U;K41PQ0$R/,C@DW"QDH?R;>Z)9SZUU* M54'+>@'GULS)IJ""?3J8^ZX1DO.N'Q30BJUBH:B`R#QA^)O-Y`JU+(+@Z>&] MW^L`EU^"A6O&G=]M?7K7@G336>'KCJ'6[9R\M?,U-!)605$OFAK04TSQ5+>5 M)I&)6S:9/7Q8$'\>Z/:SEV*H64FH/J#GK:RQA>Y@"/+J9DL['2U2T,=!C,F, M?##1-6Y"D^XGG>G31(0_D2T*R7"CG^M^?=YK@(WAB-&TXJPJ33CUI(RPU$D` MYZQY;%U^:FBR^.AFK*>O@CD(4`M2S1*(9:5OT<1.GI/Y!_V)U+%+.PGB0LC# MR\OE^77D=$!1F`(_G\^N516-@*.@QD])05]4$EJZB/(0+5+0FJ*&.FA`=/&Y M1-4G)!9A[VSFV2.%HU9^)U"M*^0_R]>`$K,X8@?+SI_Q?7"LIZO<=%15V/IH M]5-Y:&IQ]&B114S!FGCFIX=5UCG22S7G4?;UX,L M;,KMQS4]>JR50LB8VNB$\$$%+J5JF6+4I$TKN`O-K+?\6][ M&JUBTR("['X3D`#SIZ_YNO8E>JGM'F/GUR$TFY,9445+2TU)641IS$GA:BIZ.H52E?/5<>*9+^NFB1"["XN1P?K[U&DENLDTJTQ0`^ M9/R]!Y];8K(516J>/V=9:'(?QN*MQ24>.QM164^JF>@IA3?;[2H8N]X MYE4VM:Q'YO;WN.0SAX`BJ[#&D4J1FA^WK3+H*N6)4'S_`,/6#$X7(XVL7)9" M&>AI,"I/O44$L;B612J+DG_`"?GUMW1AH0@ ML>LM#N.&2N5)\?B\?'4&2%JVBI!%64OW*/&LZS%V%XRX+G2+B_\`K>_1W0,@ M#1(JG%0,BOG7K1B.DT8D_P"'J&NU,W]]X#32+&*C0:PD"$1JY!J`Y<,5"^H# M]1_U_=!9SZ])0@5I7R^WJWC1Z:ZA7TZES;HB7(M(F+Q=1#'4)IJI:13D)HXF M51-]SJ0+/(JZE.GTD@?CW=KL>)J$2%0>-,GYU]>JB+M%7(QU'R.WLI45LM12 M0S5]+5G[JGJQIM+'4@2H6)*!7778@@?3CBWNKVTS.6C4LK9!^WK8D4*`Q`88 MIU)R&73&O#C%H\7DWQU/'23560I?N7,T9)DB@8M&5IX&8H`>?3_M[23>$5B$ M:L5%"2*Y]/L'6@FNKZB`3Y=8LG0UV=-+E,=3R5$4U/'%+3Q!=-#/3?MR0)'< M%823K3^H;WJ5'GT31J2",CT(\OL\^MJRQU5C0U_;URDK),#0T>/J**CK*IS+ M6S19&`5,=$LQ"PPQ!9!HD=8R["_&H>_%C;QI$R`OQH16E>O!?$9F#$#Y?+KJ MJCJ-Q8^DJ*&F19J%GI:C'4B".&(2$S15-/"3Z4E(*OR3J'^Q]^8-!$;$,<'S/7J=*C;N.J'KJ>-I\A-'#3XZMB$L#1TQ622KGBOZ MM+.%0!@;M?GBW@&M8V,B]S&@4Y&/,]>)$C`*<#S'^#KI*E\]055!34=+25D, MD5;'3X^$4T57$G[,JNI8EIH?(&'JY%^+@>_!C<1M&L8#@UHHX^OY^G7J"-@Q M:HX9_P!7GUQQU'5X-*O)Y"!X42!J:&FE`T5T]4&5()4OZX(PA=QQ^D6]^C1X M`\LBT%*`'S)\NO,5DHJFIZR4.37)_\ M4^DH?SR/K?WY)?%U1:%4L*`C&?0_(]>*Z*/J)`]>HV.PF1I:R.LK89J&EH[U M4U2=(*I3CR%8UN2[R%=(%B#?\_0UC@E1P[J55LM-N&-JU M"^,Q=+')*RM54U(L=7`LNI3,DVMAY8]5R=/JL>.?>UN07!,2A2>(&<^=>O&+ MMPQ/RZB?W9RPK/"8)`@GT?=V_9"!K>?5J'H"^K^MO=/I9M6G0:5X_P"7K?BI MIJ6SU,JMPQK6L8H^2Q%?5U;UM'#/64M:!50S``L%F`812`$!'A;TD?06]Z MDAD=BZ`LK9!Z\KJJT8@$>762KK_X6(,:U)05TM'`L)M26B M@\FD?7F_T^GOSOX6F(HK%1FHKGT_+KP&LEJD`^G6.NHZO+K2Y"B@::.6!89( M(5`2CFI@$:%$O=(74AT'^U'WIT>8))&M12A'I3RZ\&5"58_[/7-YGPM#3T=1 M305-5,SU?2.+7)][+&!%C9`6)K0^7E^WKPH[5 M!H.&.NI!+G*",TE/&D]%+(LM%2H(H3%/ZUJ(HR2`P=2K"YYYXO[\=4\:Z%[E M.0.&?/KPHC'4V#Z]<(8ZC"4E1-6TR:ZIHX(*.K0/'((B)99Y(PP)$=P%Y'+> M]*&@1F=9ZV:.P"G`\QURBG;,4M310TU-2U*A*J**CB$*58B],D,C1JH#\<"E:=:(T$-6HZQT%%5XMILA60R4\5/$ZI'(-(JI M9E9(X`#>ZD\L?[(%_P#$>1&B)D<4`'[?*G6RP;M4U/7=)D15O)1_:T-$:N%Z M:.>DIQ`XDDX19&+/>*5O21Q]?\/?DEU$H54%A0$#KS+2C$DTZPT>*KZ>JCGJ M(9J:"G83S36`\:0_N,1RP).FP^MR?S[JD3JP9P0HR3]G7BZD$`YZR19M/NP[ MT-%%&TC%IT@_RI%?5^[YF=]4H!N3I]7/'/O8G&NI10*^0SU[1CXC7J.^$R!J M61(GE1I;)4_5'1C=92P)%BIN?Z>]&"7532:5X^7V];#K2I/Y=9JK*)'/XHZ2 MBJ4A"1"HJ*WFH2`JD#%2,FG7E4G))!ZQ5=!55< MQJZ>*6:&J59HV%F*E@-4+<\-"P*_ZP'O3QN[%U4E3GKP8`4)%>N=15_8K!1- M!354D$5I6JH?+XY)"9&BB(9;*EP"?K_K6][9_#TII!(&:_X.O`:B6KU__]/2 MSE6GI*&67&5,D[O-'%/4!&AD@B*EE4"R.JRNO)'!M;VO.E(R8FJ2:$^G_%]- M"K-W+04ZQXZ5ZL5<-;-(]+X&FEFE9I#3-&0$EC#-UARU_P`V]ZB.O6LA M)2G[/GUMJ"A4=U>I5/#04T=748ZJ:LK(*5%UO$C7XO;W= M1&JN\3ZG`].'SZU5B0&6@KU"QE96RUL,+2354(^77F"A20*'IRI:'"K5`T]<:J=&D>"D:&6-99(U=XX_.T8 MC8:T'T-F^@^OMU(X-8TR:F\A3SZT6>GP4'KTS1Y/)?<*ZU%0\AF#"$O(4=BP M_;\5]-BW&FUO;(EEU@AR37A7JY5:$4QT^U&/P/W[)-7FED,R"6C6%W2)VT%X M!4*IA47)%[V3\D6]OM'!XA!DH:\*8_;TWJ>F%KTV92NKXJ^HB62>D6!S#%3P MS21QQ11^F(*JL%(*`$'\_7^GMJ6202,H8J`:4ZLBJ5!Q7ITJ:?&54='592L. M.K:BC225$IY9_,`S+%4LD*6C:>)02#^/P/;CK$VAI7*R$9Q6OS_/JH++4*M1 M7[/RZ@96IGHWIJ6AGFBH8Z6*2E>"1XA5)*H=ZI]#*3(\MQS^G3:WUO29F0JD M;$1T%*>=?/K:!6J2*MU.5*+(8NCJ)YY*NG30QUHBL[""1R M`YX_')/N]$>)&G>C5(!XUZU4HQ"+4=8Z]DQN.I%P]1(]+533/45\>N"::>&R MI3LOHDB$:-J"G]7U']?>I"(HD\!CH)R>!KZ?+KR]S'6,^G7''R#(T-9'EZF5 M:.!X9HJZ025$D%0[>,0(/7+()HP;J.%TW_Q]^C/B1R"9SH%,\:'T]<];;L(* M+GTZS.M+CL55U&$JY*N22:&FJJOQ24\U)`VN150,$=!42(!J''%OK;W;LCB= MX'))(!/"@_V?7JH)=U#K0?X>L.#JJBNEJJ/(33U&/EHII*N2>5Y/LT@4R)51 MERY#I(`!;ZD\@V]Z@=I&9)&)C(-:GA\^K2`+0J.ZO[>IU#2X>E%758JN?)Y" MFI)9J>"2FDIQ&ZE5>H42(%E>%&)"CG^G/(O&L*ZWB?7(%P*4_/AY=5)402TT\\DL:5$>:-:E(FC7U,>?HO^\>U,D5KXAURE7-*K3@?MX=-*TNG"U'D:]- M>=R&1I,E44D$U1CZ:E\=/34]-42QQ"G1!X9`(V`/F0ZKFYYL?I[:N))%E9`2 MJK@`'R\OV\>KQJK*"14GIPJ:7$5M/CJW,Y&3'9&IHU:55IYJEJJ-)'AIZN3Q MHP1YHHQR3ZK?3\^W&6%UBDGET2%L:"CR+))4SU*/&TLM.Z*'ED2%Q<.>!< M`'ZWN@26`-8<5B*6EF,L M$:F"C(LDT2!)&>Q_5]1QQ[K)IBA7Z=R59LMP..`_U<>MK5W/B+0@8'7L5*,I MCLG%G*J?[*F-//'D9GDJ)J2I=Q&(H@P:205*&Q07`"W_`#?WZ$B:*5;ASX0H M=7&AX?SZU(-#(4'=Z>O4A(L?C<5DJW`5DF0JQX*>:I,,E++04L[.'EAC=%;5 M(ZA"PY7@@C\WI%%#*]M(6?`)X%0>M59F02+0?X3U"P%=6UU9)0UT]164%32U M"UHJ9Y)4IH(T,AK`TK2>-X)%!!_J1^2/;=L[R.8Y&+1D&M3P'K^76Y`%`*CN M!Q_FZ<*"DP5*]15XK)29+(TM'4U%'324DT"F6.(VF7S1J)G@0EQ&/4;7'T]N MQI;*6>&8O*JD@$4S_L=:9I"`K)1"14],N)R^8DR5(GW-77^6=8GI)ZB66*HC MFNDD;I,SQ`%&)U$67]7X]IX99O&C`8M4TH3@UX_ZO+J[H@4F@%/.G2@AQ&T_ MXPL*Y5Y&%8R)CVIYO"9%=@E*:MXC&\9DLM]1U?2Y)O[5+!9&<*)R3J^&F/LK MPZ:+S!"='EQ_V.DY6YS-_P`1J'>LK*65*AKTJ3R)#3O&]A`(=7BT1:=)N#JM MU4L=JSZI9BDI`)4"M"1]G3:M(%HB56N M#7IKW!DCAI:F6.,TJQ@PS7B9?(U0K:R3<\VOQ[8N9) M4E:-6*QJ*``^7D<>O'J\:J5#$`L?\/3I4P8K(4.*K\]7OC,A/3,A=::2H>N@ MA;13U4J11N8RRE:@8!-/]1ZH"Z,ZQI50?V?+J M)FYWQ5+BJ7"U,T>-FIY*I:ZGDD@?(5+/HF,Q0HP:$(HT-R@-C[;N6\%84@<^ M$16HQ4\#7[/3JT8UES(O=7AZ#KE2&DRV%$NX:^6F%+7-!0Y%UDJIY1+%YJBE M**))I(XSI8,0=.JP-N/=H]$T%;J0@*U`W$G&1_EZT24?]):U&1_EZY5K08C" M1-M^LGGAK*]XZ[*():6=9*>-'IZ.Q$4L*E'9N/K8\V-O?I-,-N/I9"59LMP/ M#`_R]>74\A\5<@8'^$]<,'4296DRU+FJF:3&Q4Z5;UU1))/)CZE'$<#1%Q([ M/,&9?&+LUB!]3?5NWC),EPY\$"NHYTFN*?;Z=>D["AC7N]/4=28:?%8_'9:N MP-?)DJZ&GCB\C02TTM#3U$@BGJ85DCC9WT\:UY2_U`^MPD$44TMM,7E`]"-( M/$C_`#^76JR.R+(FE/MX]0-NUU=7Y'[*OGJ*V@JJ>H2M2KJ99(XJ=8VF:IU3 M,ZPM`R!@PL?P.3[:M9)))?#DN(WFBB65HR+JH-[B_P"/;\45JK%X9O$E4$@$ M$5('S]./5&:2E'32I.37I.8_.YS^(T[I65E7*]0H%(]1(T-296"M`8G8Q*DF MJWT&GZBUA[21W%QXJ$.S,6X5-#GA3Y].M'&%/:`*=*23#[1&7:%\NZ/]]H;' MBGF6%9/-9J058AT+$'NM]?`_/Y]JS;V/CZ3<4.JFFF*UX5I3Y5KTUXDV@$1^ M7&O^3I.9/-9I,E5@UE92&*I9%I8:B2.&G$+Z$A2*-EBTHJ`?2S?4WO[22SW' MBO\`J,I!X5-!3RITZD:%5P#CCZ]*'+4&WYJF*HRF0?$9*KIJ>IKJ*&EFG6.H MFCU2,3%$ZQ22-8E"=0)N?K[5S1VK,KS3%)2`2`":$C[/Y=-(\H!")5:FAZ;= MQ5]=CZV.AH)ZBBQ]-2TZT"TE1)%'4TSQB3[IGA9%G:9V/JYY!'UN2S=2212B M*-BL2J*4-*@^>.->KQ!674PJQ.?E\ORZE-'CLGB\76;AKY<=5Z:BGIZGP2U4 MF0HX&C\Y]WI#-##)=2E7R`:$Z@/,T_9UJK([K&E5X^E M*]1LO4-BJ+&4V#K*@8V>.HJOOX3)32UM6)FAE60+XY$%,B*`I`X(O?@^Z3MX M,<*6\A\(U-1BIK0U^STZV@UEVD'=Z>@_V>LU"T.6P<1 MPV[-:R%JM0M0@CT'RKZ]:&IY*2K3&!Z_ZO\`+U&P=7/DDR='EZJHFQAHGJ)Z MFHEEG;'O`08*F'67_Y`/NEN[2^+',Y,.FI)SIIP(_S>?5I%":2B M]]>'KZCJ=208K'TF4KL!7R9/(4])92U-+!)10S.(YZR%98D+O&AL2OZ`;G@V M]N*L,2326LI>4+Z$:1YG-/\`8ZJ6=V59$TJ3Z\3Y#ILV]DLI596"CGGJLA35 M@>FJZ:IJ)98VI9%/GD/D9M!A0%KBS<6O8GVU;2RO,J,2ZM@@GR\^/IU:155" MP%"/\/3MC,9ME?IQ[ M>BAM/$!CF+R"I"T(J0#BI_U'JCO+I(9*#S/'I,QYW."N645M:\YJ0PI_-.86 MD,G,'VP<1F,L=.BU@.![2"XN-882-JKPKY^E.GO"CTTTBE.E-48K:IS!2?*/ M33/5QB7'+#*T,4TC)Y:7[M(S"J"0E20;)]#:WM6T-D9B&GH2/)U49J*N@6"8PQTE//+##!#%9(41(V1&&@`Z@`&!N.#[ M33S3":1=96AI0'A3IQ$0H#0&O3WD:/"58HZW+USXK)U=%!/54\=-+4+*3=4J MF$,3B!YXU!*'GZ71*R@D`$_GP\^FU:12RJH*@FF>F_/5=3C9 M:.AQD]12XZ*BAEHY*>HD05J3CR25DC1&/4\DMP0?I;@#VS M=)Q]7GJ^6CJ1)4TU/5F.2JFKZ6)E-Y`B2.?MY9&4. M3];_`%]W`BEAC>YD*M4@'B2!3C0>7#JM65V$:U%!\J=8LI-_"L;C8L'4S?8U M1GGER4+/3S5=4CF-HI`HCFA6!+60V!!'UM,>N6=98P"5%P@%S;BV MHB)H9!<.?#4BC<2"?+KS]C#0.X^7RZY2)08W#UM5@:V6LFDJ::FJJP1RTLU' M3,"ZK&K+%(JSRQA2PX/T_'O9$<4+M;R%F)`)X$#_`&3UX$NX$BT%.H^#JI\D MU?1Y2>HJ,:]%--4S5$\DIH!`-<55$92[>17](5?U7^A`(]UMV,ADCF8F+3DU MX4\_]7'K<@":64=U?V]3J&GQ%''7UN&KGRF2I:-Y88I*62`4Z%E2:K031`2O M!&Y-N>+\W%OZ>V8))6E122P)H03BAX]7=$"DX%/,=.U) MC=M#(1BGRCUDR3.8*&2GE2.>6,DP4YJ6C\15G50"3I;Z?GV\D5KX@TS$M7`I M@GTK_JKU0M+IRE!ZUZ3XS>:^]$OWE89?N0_V_EF\6LR$^'[8MH"7.G1:WX]I MO&FUZM9U5X?/TI_DZ<\-*?".'2AKL9MLY%Q49%Z&9Y8FJ*!()9(X99%C>:`5 M*Q&)1K<@GE4)M^+!2\=KXI#3:6\Q0FA]*]-AI=.$J/7IHS61R4&2J*=9JBBC MIF6""FIYY8XDIX458"H1AJ\D8#:OS?\`U@&9Y)5E=0Q51@`&F/+IR-5*@D5/ M3A4T^+K8:&KS%?+05]11Q-*J4TLYJ(T9XH*MS'&ZH\\48_UP`;<^W&$+A))I M-,A7R%:^A_/J@9E+*BU%>H68JJBA-)1XZHGAH(Z2&6FFAD>'[P3C5+4R!2IU MM-<%3RMOH+GVW,S1E$B8B/3@C%:^?5T4-4L.ZO4E$I,ABJ6HS=7)2R132T]+ M6%'J)JN%5#LCQHKR,L,A(#_0?3D^[@))"K3N5-:`\21_J\^J5*O1%KCK'6M' MC<72_P`%J)9(*JHE-3D(_)3S/+"!XJ5ELDL2(CEM)_5>X]ZDTQQ)X+DJ3D\# M4>7RZLM78^(M"!P_R]8L?(N2HJV/+U4RTD#0315DIDJ)(*B1FB\48L\CBHC! MNHO;1?CZ^ZQD2)()G.D4->-#UYNTKH7/IUG,=%08RMJW]+(L(U-% M)J<`T%/Y]:+,::EH.FC'U]?)74T9FJ*I995C>"6:22.5)?1(C*[,H!1OK;CZ M^VHI)#(H+$@GA7IQE4`D`=.L./P)K@D>0:>03L(Z-HI`DC*S:(?N&18F5B`+ M_1K_`./MY8[?Q`!+4UX4_E7ILNY7*TZ9)LEDONI&:HJ$D$Q)A#R*B,K?YKQ7 M`"J1:Q'T'/M@RRZR2Q!KPZN%6G#'3O5T6(>H+U=:U#42K%)/2I!-*L,LB*TB M^1(V6Y)O]>"?]A[>=8=57DTOBHIU4,_`+4?ZJ=-V3JJJ&KD@AFFIX8`D4$44 MKJOA55,;^@@-Y%8-1>.`#Y^=>FB0[``]98I MES$%31P4E-256E*B*.E41+5?;ZB\$@^C$*^I?Q]AA,CQJ@5^.,5^76B- M!!))7Y^77''8ZJQTKY&OBDIH*2)I-+%0:B1_VTIQ8MJ$C-S^+?[<>CC>(F21 M:*O\_EUYF#=J\3UEHLG35DS49HJ/'FLCDIDJJ2/QR1R2BT89O^.;MP>?S^/> MXY5&3R355P$CCAO(\BL"2;JGI/ M]>?=$MY0RZEHH/'T`Z\9$(H""W4U-Q4;5XD.*H8XFJ=1J4A7[M(R_,X<+8SJ M#J/]3[N+A!("8E`KQ\_M_P`O7C&:4U'AU#GVWE352)#`]3"\MXJNZ&.2*4AH MY6?4?[#W;ZV_Q_-6M9M9`6JUX_Y>MB5*5)H>IM=F*6DJ!21T%#D5I$BI6K*R M%9IIW@0(YUD7*!A9>2+"_P!/=Y)D1M'A*VD4J>)IU4(2*U(KUCRF)K%IZ+&S45)D*J"$RU'WR+.*62I;RBEAX(70A!:QL2>#[\TBP+'"T89 M@*FOD3Y=>"ZR6#$#KJOHZC/4U%D<93W\<9HZFA@T!*.6(Z@8DNNF*96U?V]:_M6[&H!Y]>9O[Q8Q MX*&D@I:RBJ14&@HE6&&I@F583.(V*@SP,`";\*>/K[]7ZF+3&@$BFM!P(/G^ M76_[)JL:J<5].N-!23[>I*ZORE,`9HUHZ;'U!1HJR1VUNTR!F#10*E^1S.`#Y_;]G6F(D951OS].LU)70YVGK<3!14>+JYXEFI311K`M8 M],3(:6>UM6M+E;D`$7][1UN$DA6-5L.'PF0QE8,G MDXI:&CQT;54DFN-7E*#2E-&`Q+-.QTD<76XN+B^HK>2)_%E4JBY^WY?GUYY% M<:$-2?\`57\N/6?'Y^CJZH4C8O'8T5JS4:UU'`L=13O5*T4;^0*#8-(`UK6' M/NT=PCOH,2KJQ4<17AUYHRHU:B:9S\NH-+M7+BMB6HADHX(Y=4U9Y(PD,41+ MO,C:P;A5NAM:]B;#VVEE.)`'4JH.3Z4\^MF:/2=+5/IU/;=6/&3,PPF/>$50 M85AIT^_9%D'^5:R!:H(&L7L0?S^?;IO(_%U>`I75QIG[>J^"=%-9K3\O^*ZA MU^ULO)732T<+UU-42B>GK1+$1-%4VF221VD!U6?U$@`D7'!'MN2SG+L44M&< M@^H.>MK,FD!B`W^;J;D6CLS1V2%H[+8`6^GT]UF@EG(GBC)1@.'E3%/RZVLBH"C-D' M_9KU(J*R+;M#C\554%)E*U4EK*F.N6.:/'_=%"E)`+-XV**&<`V+&XO<6LSK M:QQP/&KR<37.FOD.J@>*S.&(7@*>?SZX5U-+N?'4-9B:94EHC+256+IC&D-/ MK8SQU%/$WC"I-=1]O6U81,RNV#D$_X.O01 M2;8Q4KY2C@JJG)5*+3XVL5)H4BI$=I*MT'D7R:I@J_0V-_IQ[\H-G"3-$"[M MA3Z#S_GCK55F<:&P/,?/KN_]Z,5/38^BIZ&NH*A:S["B"P0UL$RB!YO&="F> MG:PU$_0V%[^]_P"YD+)%&%E0UTC\0X?M'7L0OJ=R5(XGRZ]BL=5[=BK\MF(# M%&E,U'3T4S1LN1FJN!#*BLX>!%74P(O87^@/OT,+VJR3SQT6E`#^(GR^P=;9 MUE*QHV?7TZS8_*4^%I?42`4R1AF$*,PIX],C%FJ'(0CBX)Y]U@M9X9!--&4C3)/V>7Y\/LZV\L;C0K` ML<=2<=N3'SUR4\F(QN+2J\U,,C111PU5']S&\22K.$4*5U#4W%A<_P"'N\5W M$\@1H$0-C4!D5Q7K31,%U!V)'D?/IOCV7GOOT@>G:*G%1H:O62/Q+$LA'W*! M91);2-0!`)/''MI=NN?$"&,A:_%Y4]>M_41:20V?3_)TY5>[,>F49H\-CJN& M&HB05\T*/7SI`8T^Y\S#F9M&I">?I?\`/MY[Z(2DBV1E!^(CN-/.O55@;3_: M,"?*N.H.6VSEZS(5%;CZ>6OH:YQ64]2'B&N.J59U!$DJ->(OI-P/I[;GLYY) M7DA0O&QJ#\CG_8ZLDT:H%9@"!2GV=3LGF:/$R4V*;&8_,2XVDBI*BLKHDGD$ MZW>2GA=D+"GIV?2`3Z>1;CER6XC@*V_@)(R*`2PKGS`^0X=55#)6365!-:#_ M`%>?6+,8>NW`])F<-3R5--64L:/3H\8&/FIE6"2D57,06(,+K86/)X!%ZSP2 MW12YMT+(RC'\)&"/L].O)(L6I'-&!_;7SZYRS+M;%T./KZ"DR5=422U\M)7( MD\6.BD"PQ*@LX$LYC):QX((/X)L7^BBBAEB5Y22Q#9"^GYGKP'C.SJQ"\*CS MZX5=-4;JQE%48BBBBFQTLU+58ND\44,*S'SQ55/'=%"RV*L?U,P^EA?W5T:] MBC>WB`9"05'#.01]O`];4B!F$CG/F?E@CKG312;4Q%3)EZ2.>IR=2D-/B:L1 MRTYBI-+O63(#(A(:32OY''X/&T5K*!S/$"[D`*V10<21_(=:-)W`1J*!Q'S\ MNN<50FZ<76XVAH:3&U]-+%D(:2A58(3:WT)]V#"^@ MDABB5)0=0"X#>OYCK5/!969B5.*GR_XOK!BK/(LNF.-JL M3^RGGUFQV5I<]]WAH\9C<-49"DDBIJJAC2G9YHRE0*69E0'[>I\)#`?7Z6)( M]VBF2ZUVRPI&[K0%12I&:'Y&E.M,ABI(7+*#D'_#U&P^U\M1Y""OR4,N.HJ` MFNJJKRQZE2F!D:.-8Y&=C*1IL`3IO]?H:6]E<1RK+,A2).XGY#./MZV\Z,NE M"&9L`?;U+HMVXZ3*(9,-CJ"*>:1#D*:%%KZ<5`>,5'F"V\B^2[D?47M_3VY' M?0F;NM4522-0'<*^=?7JI@8)VR,3Z5P>FQ]DY\U[0)3-)3FI*+7,\7B:(O9: MEAY"^C0=1%B?\#[9.VW?BE!&::J:O*GK_EZ<^IBTZM7EP_R=.5?NK'PY%XTP MN-R$=++%#_$*J&.2LJOM@D33F;20SN8R5;GBWMV2]B64A;6-U4TU$9-,5KU1 M87*YD8$^7D.HN9VSEJW(S5^-BER5#D6%;35(DCNR5"^7Q-Y75E:*Y4?C2!_K M"EQ93R2F6%&>)\@_;Z_9UN.:,($=@K#%.I>1RM+@4H<++C\?FJF@I5CJZBOC M$_@FE9IFHX&9"1#`K@?[86!!]N2S):B.V:%)'11)`R`7-N>+^ZS MQ27BQ7%O$2--"HX*1Y#Y'B.K(XA+H[9K7[:]9&G&UL12X_(T%+7U]7/-D'H: M]$GBH81:GB(`UJLLY0FX/TN#_C[4+*%(I85:5B6TMD*.`_,]>IXSEE%#Y@?X>M`B!CK;M/F?EY==4%)/M7&Y"NS-,KR5ICH:3%5)CE MAJ65UF>IJ8U,B&.G'Z3];DCC4#[U%&UE%)+<19;M"G@?,D_9UMF6=E6-L#)/ MI_Q?7*GK8MRX_(XBCQ])C*\B*LIHJ!4IX\C]J6,M+,`%\C*C:HP3;4+\:?>U MD%W%+!'"J2_$`N-5/(_X1UYE\)E8N2G`U\NL.%P]=@):G,YB"2EI:*DF"0L\ M1%?/4*8(J,JK2!DH&.VEF8LA#)6028^CI9?N*FN,T*B& M&F#2NZ.DA(8A/2UB%-B?I[;BL+@2H94*1@U+>@&:]6>XCT'2P+'%/6O4V/=^ M._BOF."QJ0-5LYK5ID^_5&D)^ZUA3><`ZR/R>+_GVX+Z'Q@_TJ!=7&G=3U^W MJO@OIH)&K3UQU`J-G9MLC)'%`\U-+4GQUYDC,MOVWU-P3>_P!? M;3[?WD6U2*W:)7D`J=0K2N:=:"^*6<.0OE3S^?6/(T%5N.F MQ^4Q-*"%A:AJ*"F\:14,U.Q8"%"R!89TE#`"]OS]?=98GNTCF@CQ325'X2/3 MY'K:,(B4=LUP?7K(&&UL1%3Y&CIZVNR%2:K^&UP2:&C@A4PI.8QY%$\Q)L01 M=>/[)'NW^X<*K+&&DDONC$>+&T<%'68VI, MKXVC$<4%3#4A%^X1/0#-"R6)/T!//('O1K>0TAC`D0_".!!Q7[>O"D+U=B5/ MF?\`!UBQ]#5;;HZ_)9:D4B=8Z"GQ]28WBK)9'6=GG16D4QTZ0W%_J;CCWJ.- M[1))9X^/:%/G7/[!_AZVSB5E1&^9/62EK(=PTF1Q5+046+K'B2II4H46!.Q7WT4U&E?0PI%/3R5"&.,Z](] M#2$`\@<_T]VBN(W?P_!1-0(J!0BO7GC*KJUDTS0]-]'M3-+6PB>GDI8(Y@TU M9KC"PQ0L7>9&#Z@0JW4V_/X]M+9W&L:D*J#D^@'GU9IDI@U-.'3A_>J@_B8F M_@V.6$U8?[O[=/OA'Y"34:[&U1;U?Z_Y_/MSZR/Q=7TZ::\:9^W[>J^"VD#Q M#6GY=-]9M7+M72BFADK*::7R0UOEC*RQ3VD261V?46L_J-OJ"1[;>SG+G2I9 M3P/J#Y]6$T=!4@$>74[)9JDH)UQZXW'94T$,=')75T`EFEE@!$H4FY$<;W4` MWL1_2WN\L\<;>&(E?2`*D5)/^;K2H6!;417J/E<179B=,KBX)*JDK:>&0!2E MZ:6-1#+2E25*B)X^+"UCQ[K-#),PFB0E&'[/*G7D=4'ANU&!ZRU%=%@J2@Q= M10T>1K(HWJ*E:V-9EHFJBLBTL/!,9"69P#:YO^>-LX@2.)HU9P*FN:5\NO!? M$+/J(6OE\O/KA7TD^X*.BR&+IQ>%31U./@TJE)(C&19($+*%BG#W-OH>+_6V MG1KE(Y(5X8('`?9]O7@PC+*YXY!Z]$K[`-M$?$0%V.%/H//[>O&DK=K&@\Q_@ZZ9VW%C9(:"BI MZ6JHJ@5+4-&JPQ54$JB$SA+`-/`P`)OPIM^;>]?[DQ%8T`=36@\Q_L=>_LV! M8X/KUPH**HP4%;DLG`54Q?9T]'-I*5LT]S:9/6&AA2,L0;7_`![W'&UNKR3) M04H!ZU_R=;9A(0B'K)25T.9BK,9%14>-J*F+53/1QK"*F6`F7[6<@"ZRK]+F MP(]^1UF#Q!`C$8IYTS3K1!0J^HD#J-C<+7T-4M?D(9J.EH5>JED8A#(8QZ:= M+$ZFG8A;?D$CW6*"2-A)(NE%S^SR_/K;2*PTJ:DXZR4>9I:JI%,^-H,>M4)* M<5E)"$GIVGCDA1U?BP#.`WTN+^]I,C,%\)5!Q4<17KS(0-6HD^GKU$BVUE?N MU2:%X(4E(DJ[J(HXT)+3+(6`L%6X^G/NBVLNH`BBUX_Y>M^*NFH.>IH83P5.I")8YP)%+,S`EAJL3;\7]TD@D+DH-2G(/V]661: M`$T/6>KR$%`\=`:&BKGHX(Z>:HJHA(YE07DC1FU'Q0N=*CZBWO;R",B/PU8J M*5/50NH:JD5ZQ9#'562>+(4$3ST]5"C%$TVI9(P(Y:>UU`2,CC@ GRAPHIC 16 g852944g85s85.jpg GRAPHIC begin 644 g852944g85s85.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1$H4&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!\<`5H``QLE1QP!6@`#&R5''`%:``,;)4<<`@```ESG`#A"24T$)0`` M````$#PD_<^XM2()RHK8&Q`5[I>@`````````IV96-T;W)$871A8F]O;`$````` M4&=0.$))30/S```` M```)```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4````` M`$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$` M6@````8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/__ M__________________________\#Z`````#_________________________ M____`^@`````_____________________________P/H`````/__________ M__________________\#Z```.$))300(```````0`````0```D````)````` M`#A"24T$'@``````!``````X0DE-!!H``````S4````&``````````````!$ M````10`````````!``````````````````````````$``````````````$4` M``!$``````````````````````$`````````````````````````$`````$` M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$ M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<` M``!$`````%)G:'1L;VYG````10````9S;&EC97-6;$QS`````4]B:F,````! M```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`` M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`` M````````3&5F=&QO;F<``````````$)T;VUL;VYG````1`````!29VAT;&]N M9P```$4````#=7)L5$585`````$```````!N=6QL5$585`````$```````!- M'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO7U M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1 M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,' M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6 MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/54E%[V5L+['!K1RXF` M%@]3^L;6.:,2P"N8-D#4S]%N_P#-24]`DJ72^I5]0H+VD>I6=EC6F1/BW^2K MJ2E*CE=$Z9E2;*=CCKOJ[I74K('&/E_I6'^3Z MD>I6W^RE1]8;\6YF+UW'^Q66';7DM.['>?\`C/\`!?U7K<0LG&HRZ'X^0P65 M6"'-/^OTFHWW4DD1/;Q27(-;F%MGU7-[@UF4RD7?G'%=79ENKG]]E=36?V_3 M_FDD>'Q_WD6__]#LF8^5U;-O%EX->/86ENZ=O[H]-L;7;?\`BUL4=+PJ&%HK M#R06N>\!SB#RWCZ/]59EF%?TS*?E4NEM[RYVD#4[MK_WG;?8MC&R69-8>W0_ MG-F2"DIS,K$,-9)?6!K.@;_P!;T_UK24ZB2RZ>N5EK#=662!N=X3^?LEWL=_66DQ[' MM#V.#F.`+7`R"#P04E,EG=;ZYA=%Q#D9+I>Z132#[GN'[O\`);^>]9WUE^M? M[+QG.PJQD62&FTG]&TG^K[KG?U/9_P`)^8L?H7U6ZCU?*'6/K(7N:3NKQK-' M/_=]:O3T:&_FX_\`K8E,&NZVWI5GUJ]%OVRS)9D^G!VC'95;C;O3_G-CFW?] ML_ITEWD"(C3B$D;13__1]3>QEC2QXW-=H05D9)NZ;D->QNZA\_I"0`#(VTN_ MXUN[:_\`?6RJ^?3??B658[@RUP&TF0-"#^:DI?#S*X,])O^#V_^KNDP<_%SZ!D8KQ97,$CL M1V*2GGOK=MZ?4S(QG[;'.L]:Q/LN$QY`8#571H3 MMBO;=8?8_A_JU_S7_@:W_K#AT9W6J*,@$U,Q;'NC^VC?5'I=-/3[W*+CG[G#$"NM]F3@CP<1)MM=(Z&VFJG)Z@!?G[&%^Z"RMX MASO09JQNVS_"K7224K&I))))3__2]55+,ZO@XCW4NL:_(8T...T@O`/T7/;^ M8W^LN*^MW^,2ZO(LZ1T)KCD->:;WEEQ4201I3UOUDP\YM@ZGB$.%=+J;:X]VUQ]SV_Y_P#86GT5H9TC M"`U'H5G[VARNH6/CT8U+:,=@KJ9.UC=`).X_](J41`D9=UAD3$1[)4DDDY:I M))))3__3Z7ZJ?\TOVOU#[)_RU]IO];[1'J?SC]_V3\ST?^*_2_Z==@OE5))3 M]5+*ZK^P_MV%^T=OVG>/L\SS^9ZL?X/U/YOU/\,OFI)-GMTW'S)COU^C]5)+ MY523D/U4DOE5))3]5)+Y5224_P#_V3A"24T$(0``````50````$!````#P!! M`&0`;P!B`&4`(`!0`&@`;P!T`&\`````<@$R``(````4````D(=I``0````!```` MI````-``#GN````G$``.>X```"<0061O8F4@4&AO=&]S:&]P($-3-B`H5VEN M9&]W`1L`!0````$```$F`2@``P````$``@```@$`!`````$```$N`@(` M!`````$``````````````$@````!````2`````$X0DE-`_T```````@````` M`````/_A`3!-30`J````"``'`1(``P````$``````1H`!0````$```!B`1L` M!0````$```!J`2@``P````$``@```3$``@```!X```!R`3(``@```!0```"0 MAVD`!`````$```"D````T````\`````!```#P`````%!9&]B92!0:&]T;W-H M;W`@0U,V("A7:6YD;W=S*0`R,#$U.C`S.C$P(#$Y.C0T.C`U```#H`$``P`` M``'__P``H`(`!`````$```!%H`,`!`````$```!$``````````8!`P`#```` M`0`&```!&@`%`````0```1X!&P`%`````0```28!*``#`````0`"```"`0`$ M`````0```2X"`@`$`````0`````````````#P`````$```/``````?_A/LEH M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB M[[N_(B!I9#TB5S5-,$UP0V5H:4AZDY48WIK8SED(C\^/'@Z>&UP;65T M82!X;6QN#IX;7!T:STB061O8F4@6$U0 M($-O&UP.DUE=&%D871A1&%T M93XR,#$U+3`S+3$P5#$Y.C0T.C`U*S`U.C,P/"]X;7`Z365T861A=&%$871E M/@H@("`@("`\+W)D9CI$97-C&UL;G,Z<&1F/2)H='1P M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*("`@("`@("`@/'!D9CI07!E+U)E7!E+U)E&UP+F1I9#HR,S4T-D8P0S%&0S=%-#$Q0D%&,$8W-38T M0S,Y1D-$.3PO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@("`@("`@("`\ M>&UP34TZ2&ES=&]R>3X*("`@("`@("`@("`@/')D9CI397$^"B`@("`@("`@ M("`@("`@(#QR9&8Z;&D@7!E/2)297-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS M=$5V=#IA8W1I;VX^&UP+FEI9#HV0C@S1D5"-3)&0S=% M-#$Q0D%&,$8W-38T0S,Y1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@ M(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z-D(X,T9%0C4R1D,W130Q,4)! M1C!&-S4V-$,S.49#1#D\+W-T4F5F.FEN&UP+F1I9#HR,S4T-D8P0S%& M0S=%-#$Q0D%&,$8W-38T0S,Y1D-$.3PO&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N M861O8F4N8V]M+W!H;W1O'!A8VME="!E;F0] M(GJN]YLHUQ< M8K?R#-?_`#H^18E_/?OW17(N^.YFC(*OG!!PP#9P>1)UQZ$>6*5#^QX#[\U/ M(-=<1N:^Y<.:%[Y0=8[KLUW3KB6Y'*3],C$RUEA+`[HZH-<#>9G)SVE4:G2N,8'4#A2D=2&W=?_`"H' M?.5.:PJCGENOCS>5N(?(+I2/KFDL;*)24_(_51YN4:5L9LPXXL);T5=`^&Q\D>,VSK"Y1I=F78W\%O,X_N*-,:X)`T.<$Z8('X>2=XQ":Y[FL:KWIY/[G(BX\]!65*PY-?(+`QB77U^H,GK1U8)(Q6 MN6D@5LP,RP?+"$%76,M_L1SP3A>=#D2%'GI,9'04B/%]A#9%'[?>#Y^E*F-Q MBY&T'(7#YD^*:M'E6,3!TV75U9+9*ABL5C!DCEP7(]Q$B2PF8]0D\B09/O@% M(0L9[U@JP^88-*DQU%*.E*.E*.E*X#*<5QO-\=N<2R^CK,DQG(:Z74W=',C'L5%:Y4ZD$J00<$5!`88.HI37%BW-POY1[K MX7Y/E$J1H\^#5O(K0LV\FS+.1A&/91EDO%+?7Q9I_L6$@3L@@V\NJ$B$CQH% M,LV41)FX`X$X4@#*@DDY(`UPZA>0DPK#;`= M&H8JF<:.<8Z<[D>,`ZY^G(GIK@>63SZ M7`T^_OS[?PP7`N(VD<(J5@R,1K,NL35LFIF7F4P(5C./!FL:.9%"-0,AU\:2 MT8U."!'CC,1B'(UQG.>NDR,>N!T`_3UQY$TJ/6SM&7NE;*9L+4DH\&,,@I:0 M8\<0@!,)7H*/*'"8!TP[VJ\3K&>IUFQW"CSO:8(S/V*V^-T@$G0=/O\`,],T MJ56D=U5NTJ,`9ZQ:S,X8&MN*9I$9[B#8WW3*X1'J9\;RK?:0:V-U9. M&]\*BH8+GL)97-B]BBB1!*G^1CO#&$8XU*3I\:^4YYS^Y*;]YZ;7UX#&=:"P M:NXXZ)I#L-(K+;%JG-[/-;2R(L]G>UMJ62Z$&5?0FBK"6.17E7#$/].*$%O/ M<"WMH;>W8@ABS.-"VAR3@#F2`.?PH-=-:V&/WB6265="``-=,XT'I@DC35JD M')U/GW$O<&<[.QF?&G5NV,PM\AM'1X9`P+!TBTDV,./>-<1[I%PE.Y]1.*UP MAE(R):5[`&8;O7[RNN#@'_(/4YY^G/3. M89)-;,:KAFCE\.WF-"L)]>0C6LDB1",1.ZM;I(P>>?.E=W*(1QO"<;"B(WQ> M,C4>Q[5_LYKD5%3_`.I^_P">HI4%-X:IRO`KJOV9J4<>%6UYI4W):^&%S;(" MM`$<-M>X??O6&*US9@$&Y[/9V5R@[(WWOY,(UPWHU[7-3C!@PRI!'<'-:B"#@@@]CSI>W/ M7Y"\0X::UR#(JC'#[.S.LA.*M+5RQCI<=]Q'18]AE=H/V)&CCDHOE6Q_ZA(0 M3Q^4;NTBS4?M5?KCQQJYD_,]MNOWQRTO,FPGBU16C)E75C!(H(.7UXCC>W$= M=XZ?U.K:Z2!K176;$"69(`KW1#NES621N?Y4_>K>.!X)B.L<-QK7V!4-=C&' M8A3PJ'':&JCLBP*RKKPM!&C@$-$3\-;Y$([N0Q7/,5SB/48S+&0)>XI\!3!+-I[`?\LFL ML&"US'M:YCFJUS7(CFN:Y.SFN:O=%:J M*J*BIV5/PO0'&HT(U!'2E)4^3_'X^@=>MW#@EA&@2)-^-"X;Z123R)9!O))G MTD)[D0U>$;5-9UBHD0;E');XKY)U3;?V\-DQ17%W.IA9MPH[@,<#5AO'XACG MII7,V=LR_P!H3LEF9'"KEE"N^[KW!P,GH=>@I25+\L^\=PZACZ:TE2W.,+'H M[&'2R]?U:3MC7-S4DF2[:.Z"!A8%<^RLY+`NIA?[F9&*KP&'YJJ3L?QOX0E9 M8;B11=2J!#'[RBEFD&(V6/=R]-I[!VU;#>*,L:L"[<-M`#E@6)T&#G/3 MKJ*;WPGX2VVU-/:YVKS4I37&7Y%CI)T[2=S7DA8]3G++E1ZZSRZ"9ZR[C(9= M4&%9$#,(H(LB0-ZH0C'M6XKATY6#!@UD.+75L.+75\$`HL*#!CAB0X<8+$&& M/%BQV#!'`)C48((F,&-B(UC41$3I2LKI2CI2M/;\Q;(LRU)F5#B%=5VF5R8, MQ/4=[%1X_R]%*2_CG-_%N/F<1\) MI*J5$LK,L]V14P\>GPP7&70YZ1KR,]OT0-%'IRMDI/R%".'8&5TIB/\`"7ZD M8,J&2/+QC.6`T&[SY]OY[5FD[2!(JM3R1/-J(]O=%1>L$D23>W&#;IP<'.#VH\!( MA0D9`(Y^E*?^3;6%7O/?O&74F0V%E`QRWH\]MK[ M"XW7A;500-["').HYYTU-:W^(GA;@&&X@_9-!3Q:2IH-D9A$J"HCSWV1VE)> M%%^K29CU3]-J7HV/ZH(/8LYB/;(0;.WEU[V?^`[F[O[3Q3M/:4TALY8O=(HY M&Q(]K@*LB%540J#TR6)[:U8>T+;UM$S[(M;5%EECWKABB@1K)_U.,F1L9SGX M1SUTI^G7T%7C]'2E'2E'2E:OV5N/7NIZTMAF6018)DCDD1:<+DE7=@T7BCD@ MU8%?+.B*]GF5!^H37>PKV#:YR0S!5+,<*H+$G0``9)/H*@G&3V&:JY_(-OS9 MW,'>6+:3P+#X.3NR"DLX.K*3#DE,R&%=FF`DVE1M#(`68ZYT.53C'-#3,;'A M13CEK)M5$=_;/:`9M@W$NS2SS2)E"AWB9&4C(*$8!.!SSKJ>M6&R9$X@:9EC M7FY)PJ@-IJ1SY-?:#X>\7"PN;.!;.6ZMH;N* M^2\#O;RRX$L)DN)-V0A\AH8F5@!E0N2/6K;P=9^(-D37EO.7X,,TL4T'QHK1 M+EE;=CP5^'=(9@5.=>E.$YZ56W9#-,;-O+Z"SN[:+B1P*>+N_$5#Y(8 MK@G=`.K8P.N*ZQX(O[&VEO=GWDG#:Z9>&VBJYB(.X&)P&)4$`_,,@:U*'XZ* MY8?$'5,U[$&?(0Y#D4D:?NR199):^QK_`/T;Z41Z+^45.R_MUV#P?:&RV!9Q MGYGXDK`_A+L1C]%!_.J;QE>)>[>NI8_E18XLZ88HN21C3'Q8_*IO==GKJU'2 ME'2E5B_EC_U$&L^)EKEO'KBF.HVQR%I)5GC699E+:29KG4600)!(-G4.&`@# M9YGE2<1XI\=J#MJJ6U8^'>VGZG7S,>)'/!'TYBE+5^,OX\_DTYN[S?S.Y0[. MV+J75>=U0(V2Y-FDE![:W'CZE)858-?8M.KC1<(PP3S-)7'FUE7CPH)A_P`- M4UH`QB1M+&\>\!JN^I7(\USDUQ@%# M4LII$^>"ZE0PVF4R;6V'&'<7$[);!A[>39VS(<1D^1]IB$#%BQ6#'$BQ@"6T M0M;>.VC>0QQJ%R[$EL?B;D"2=>6.PH-.6F>>-*I^?+WEL[+^=V76%CB=IC4" MC/B.*UZ78&"D79:2NAQWV,7TN*(D2]M7XKK%(D7%1CNE0W-=#NZ#)KZ!]G]^+'PU>6V6QRL*V3APKN)DD*``!GL``*RGGDN'XDK;SX`+$DDXZDDD MDULKK=6FCI2CI2D)<-O@^XBX1O;;G-7;4!W(7Z-J8A#SRFABUSJ)M] MM;+[:NAXY@SI=M!R#**DIVJ[-LIDV#V2X4"QQB@Q"8&024Y8\J??UI]B(C41 MK41K6HB-:B(B(B)V1$1/PB(GX1$_")TI7GI2H3\G^`^@^6.4X'F.RJJ='OL* MLH1I,ZB)%AGRRAA&66+&,@,6*&ZB>,QR-+N1F0%79`DB:LI.5/PDX;& GRAPHIC 17 g852944g91q15.jpg GRAPHIC begin 644 g852944g91q15.jpg M_]C_X``02D9)1@`!`0$#P`/```#_[1`84&AO=&]S:&]P(#,N,``X0DE-!`0` M`````!\<`5H``QLE1QP!6@`#&R5''`%:``,;)4<<`@```ESG`#A"24T$)0`` M````$#PD_<^XM2()RHK8&Q`5^[&P`````````IV96-T;W)$871A8F]O;`$````` M4&=0.$))30/S```` M```)```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4````` M`$@`+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$` M6@````8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/__ M__________________________\#Z`````#_________________________ M____`^@`````_____________________________P/H`````/__________ M__________________\#Z```.$))300(```````0`````0```D````)````` M`#A"24T$'@``````!``````X0DE-!!H``````S4````&``````````````!Q M````.``````````!``````````````````````````$``````````````#@` M``!Q``````````````````````$`````````````````````````$`````$` M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$ M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<` M``!Q`````%)G:'1L;VYG````.`````9S;&EC97-6;$QS`````4]B:F,````! M```````%7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`` M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P`` M````````3&5F=&QO;F<``````````$)T;VUL;VYG````<0````!29VAT;&]N M9P```#@````#=7)L5$585`````$```````!N=6QL5$585`````$```````!- M'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R=$%L M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO7U M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1 M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,' M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6 MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/55E=7ZG;AW"MPBFVO1 MX!W3.U\/:]NW;[/=M_/6JL?ZT5%W3#>WZ6,X61XCZ+F_BD%(\&VUT;2?:):1 MX?`?FN_<6S58+&SP[21\5R'3=SCI#N6G\[8[Z2("D%6=3C9+L1[O9])KO MAHNEZ)UJC,<<7=^D:`1//=5_JE]6BI[#'>'5-@R0(,^*(N)^K7UFS;^J MG$SR*Y.P,(UU'Z-VYO\`I'#V_P#F:[9*42*OKJ@$'92222:E_]&YU^FW`SLJ MFEI!"6N`/TF[F_FN5JFFJBIM-+!76P0UC1``1O13- M#OHHR*G4Y%;;:GZ/K>`YI_K-GN_[;7:+(^M..,CHE[2)C:1\SZ;O^@]R?CEPSB?%$A8+5^I&>__P`^>JDL;_%G>?2NI/=N[X;71_Z-24_`/O-=+XF/B/M^.S__ MT_54DDDE*22224I5NHU>K@9%?)=4\#XP=JLIB)!'BD-U/GO^+:T,RLJH_O`# MYAW_`*323?4_I76\+J%MIQW,H=='NC<6ML=6Y^QSF/;[&V)*YX['RL-'A MKQ?_U/54DDDE*22224I))))33/MZB"#]-KMWR],,_P"J?_GI)/\`^461^X[\ MM225*?_5]522224I))))2DDDDE.+]MM/UBLQ3M#*V,V$3)W[-^__`#?8DLVW M+J;]:;R]VVQCJF,K[N=IM&W^4PMV))*?_];U5)?*J22GZJ27RJDDI^JDE\JI M)*?IF[_EJC_BS^1Z2^9DDE/_V0`X0DE-!"$``````%4````!`0````\`00!D M`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%`` M:`!O`'0`;P!S`&@`;P!P`"``0P!3`#8````!`#A"24T$(@`````!+DU-`"H` M```(``````<@$R``(````4````D(=I M``0````!````I````-````/``````0```\`````!061O8F4@4&AO=&]S:&]P M($-3-B`H5VEN9&]W`1L`!0````$```$F`2@``P````$``@```@$`!``` M``$```$N`@(`!`````$``````````````\`````!```#P`````'_X44$:'1T M<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X](N^[ MOR(@:60](EG)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@ M>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!# M;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@ M("`@("`@(CX*("`@/')D9CI21$8@>&UL;G,Z&UL;G,Z>&UP M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AM M<#I#&UP.D-R96%T;W)4;V]L/D%D;V)E(%!H M;W1O&UP.DUE=&%D871A1&%T93X* M("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S8W)I<'1I M;VX@&UL;G,Z>&UP34T](FAT M='`Z+R]N&%P+S$N,"]M;2\B"B`@("`@("`@("`@('AM M;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O7!E/2)2 M97-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#HQ0C4T-D8P0S%&0S=%-#$Q0D%&,$8W-38T0S,Y M1D-$.3PO7!E/2)2 M97-O=7)C92(^"B`@("`@("`@("`@("`@("`@(#QS=$5V=#IA8W1I;VX^&UP+FEI9#HW,C@S1D5"-3)&0S=%-#$Q0D%&,$8W-38T0S,Y M1D-$.3PO7!E/2)297-O=7)C92(^"B`@("`@("`@("`@(#QS=%)E9CII;G-T86YC M94E$/GAM<"YI:60Z-S(X,T9%0C4R1D,W130Q,4)!1C!&-S4V-$,S.49#1#D\ M+W-T4F5F.FEN&UP+F1I9#HX-#-!-S,U13%%0S=%-#$Q0D%&,$8W-38T M0S,Y1D-$.3PO&UP34TZ1&]C=6UE;G1) M1#YX;7`N9&ED.C@T,T$W,S5%,45#-T4T,3%"048P1C&UP34TZ26YS=&%N8V5)1#YX M;7`N:6ED.C&UP34TZ3W)I9VEN86Q$;V-U;65N M=$E$/GAM<"YD:60Z.#0S03&UL;G,Z<&AO M=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O'!A8VME="!E;F0](G/@=CAI'@WU756GZ\ZZDLC:G0CA:&LU]831 M.I12LQ*V[@I97TDVB&/:VUDB:,-Q!-RA04D'F+CH?TF8KLO(ZJIQ2G%*<4JN3\G^ M5(.\;INPP'K]_J+44FP>(V"0A;:J(*92V52L<<,S'1$OL`YR?MH@311)I)/2 M>,:2*[P:R%J1PL>0,IDBY(,05;29BQ`-1.B0%*@BWX;1-P+3TOY\>E7;]?:T>.TKK0W*OI4GT5%1%145%1%147U147]T5%3]E14_A>8JIJYXI3BE<*J M(BJJHB)_*JOHB?\`E5XI5>/GKWEB:WIK6]:5MF#H-/K90\\;3UMHULHHL=J) M)<@3SCR-8ME*-$X&>G^PPP<4UQY8S@X_B)NL*C4YKF`C\25`C\!V"=@P4LT4B_OS);SZV\][3/!OR)(BT3;[1O/F-O0>?`'$[02+MO" M/S/P_==C8]3R70\&IJ0`CJZ,D9T11,?LL8'(_P!4;%&I'I#*/]=&JLD+9$7W MQ1JGHMJ&P/6(%R/GL#^=ZF:V)/\`+OSN1^?6W$5?7@[6"VR]6^,F8F<048,U MQ+8VSQEL%@F=&[XVM:L?PSPO'8A].EU=@`5$B)V)/6X/6 M>=K14U=QY#2G%*HU\O?.RRM]C9]7==V#1*:$JYK*FQ)KRGYG2W5&/!7VM-JK M*.18HY9C#SF!YHV+Z\8D%/9F#M5 MMB'%MQH,$CD`]3L?3IZ;U2?WCY*!4I0\%V3)&P[()2C3JB84LS$Q-!/\`J:R4:CH;9@+1YY%N;NH5DSQ;0C'8UX((0V85 M(*X,P!=(@@Q)/787!"KW/=H&PZ\D_P!?SOL>!7W?R%^#>"\''9'S$\=G%X7( M8BVHJ/796>QM+2K#GMC@:3(1S6IQI>AEH[33$U8S&S'S%5MX1".\LRBNY*VJ M8;%(*7$OW<5W:6E>\(,G59`B3:ZB`.!4#Z'D)UXV`S2*2_=W.QCV([+XW.F6%N/X0(Q`*%IDL!?[QJ07 MCJ2A@J=.EH.$MB#=258C#=HL$YB48-Q8#JR6]1[Q(#ADIW9"+D)%U1"C)!$C M3MSFE;#3BE8FO/K%ZOQU[L[RP^-J[>*:RU-MN4H8[JZ.CLJ"\6`C-7&9&M59 M7SS_`-ON`??VU(#$K=7/>TLQ,SJ".,;,X4A2`0?Z;3QQ^/%CL3:8H_#TTQ\[ MG\[\;\U[;^+;\=^V\J;BC\AO(++`4G4&:TLL`M-H/L6M_P!IG4*03O'"'-'F M`@S$-J]M1H])]N4F:0#092G$@LOMWF?KQN)#:4MI)[PI)V^$?"E4D1N"8$FT M&`9JC!ICO5;@E(!MN`2=CT4.`#-N:U[HB-1$:B(B)Z(B)Z(B)_"(B?LB;'"6..7" MT@>3X2AX"(O9-#&]KD'E)"AY$;$>8KP@*2I)V4DI4)(E*A!$B#<&LC'Y6/#. MV\<>T*[M;JNM*CIZD2VO<%6U,\X[K;KZ$49-IUK.X=\$:%89T[I<\C((R",K M94*J=97-)9FP?3GLK[7X;%Y:YDF)1^\I"$D$K(<`!2E0"&-*0L7&IV4K28$0 M:Y!GG9;$X3,W,P84%813G>I,-@MG?NSWCY6=.Q4$'4GWC=2@+]/QH>:]1YB] M#4UE86XYG9>2KZX#6^K6"D:$1XT25^OB$]Z^DI?JM;I8X49&%IPSG-%!KK*F MBEY![0.R3G9;-4E"0G+\S+[V!`+8[LM*1XA@(2XXH(:+S1;4H)E#B4`$MJ-; MWV:SUO.&'VI4<5@%--XF0J%=Z%EI>HH0"I0;6%!.J-(452N!8[S0JV6HU=_> M(G07DR5D[3MS#QW6AP\Q+LMJ*VRLL_I*L0]T:VE/^K4Y0DYU%:-C;]RFLON5 MZ3(P\:`:SA'-AE;>=:GNUE,[V2?HH$?3@3L*I4A*_B$_,C\B#7N>1R.7P6:I ML=BZ&KS&6SP4==2T-,)$#6UP<:NTXI4?_`":Z M(IO(GJ._Z_L/KBW">V\Q=W/#%*[/["N@)95V"+*.4K!"X2C*.\9%"LQ>=M[< M"-T;BO>W*Y+FN(R7,(PSS M)N'$$1>"H"4S!'/WQ6._H;L#?_CA\W0(6"E4V3U6DN*.;*V,I(U>/HV&1_\` M(O5$DWV/F$7F"4K6KNVO!8;$!TX),^(2\E(00V6BN5<*:?S'LUVEPB,L6,+A< MPQ"E9SA5):<\6G"J4EH:WP\^P6CB%@^&4VI06=>K2`G;=D-70[O*YS:Y<^.T MS>LHZO145C$CFL,JK@.$\$CV/1'Q.D'GC5\4C6RPO]T4C6O8YJ?+F)P[N$Q# M^%?3H>P[JV74R#I6VHI4`190D64"0H002"#7>P00"#((!!N)!$@P0#<7N`?* MNQ,JJ)N)`XD@G?K<3)%9U%U# M-`QLJV9V/'N@[`F655:)DJ!(6M>,LB=M]BN=-X#,LTRUZZ'=6%8%QD'XB\F%&C8C??#2:6!E]&DWM]&L=_=,NQA&%B:P M8"N'"!"B@"''&@L?;3D2,H[5(Q+(/LF M223E.R.:?VEER@KX\,YW1_TD2G^!`W2NP%JMZYR"MJIQ2G%*<4IQ2JZ?RJ]? MC]B>%':=;,.A,H#J(F!BM9Z-AM;8;*7$OOLL+HYFHU?9(WU7F MS=C7%L]I\F6A6DC%0;3(+3@BX/,3;YUC8)U8'%C_+ND1U""1]0*RP?TW. MK@J.P.[\?*Z5/ET`0@RPCL?$BE4][+,R69D3IXXU?FZZ-(?E0;Y(V3R-][72 MI](>VIOQ'9_!N"%%E]3ER9"IPZ"4BR4PVIQB].;+!,!393L.0 MX0"1 M"2-6JQR.:]%]WHK5:J+_``J+R1I9;=;#T/H:QT?A^\6/-;HSO77:LSJ.^S/7USW-#$Z._;1#Z8O)4':U_F; M;1%45I=YN^J!SOFFK#PG,E@*(@C)(J7F?2?:CM1V- M)6)G2VA4KTZG5*4-*5A2M,@E5B8-;)N?-%=$IQ2G%*<4IQ2G%*CM['UGD+!* M-/*^/09_0R73'RR,B2.J&P8=!$V&%61S_IY-G-7\1YY\J<1-C'T((^OZ;6J1_(J4XI3BE.*4X MI3BE5F0=W:\ZRCV[1/-K$;6!_)SVH7>WH]7IJ76=28Z@Q\L1C+S07L+JN8&N'J4 GRAPHIC 18 g852944ibc1.jpg GRAPHIC begin 644 g852944ibc1.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0.-:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M M,30Z-38Z,C<@("`@("`@("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO M+W=W=RYW,RYO7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN&UP34TZ1&5R:79E9$9R;VT@&UP+FEI9#I%-C(Q-38V0T4R,C8Q,44T.$(X0CA&1D)&-C`P134Q12(@&UP+F1I9#I%-C(Q-38V1$4R,C8Q,44T.$(X0CA& M1D)&-C`P134Q12(O/B`\9&,Z8W)E871O&UP;65T83X@/#]X<&%C M:V5T(&5N9#TB(BX.GH1``$#`P,"!`0$!`4#!`$#!0$` M$0(A,0-!$@1187$B,A/P@9$%H;'!0M$C%`;A\5)B,W*"!Y)#)!4TLF-SLZ+2 M@R7_V@`,`P$``A$#$0`_`/P.\]\KGO< M@J223MQI52@S4M2<[_$+\``'_B[A%.S_`+Q,70#!^JD2P;576:AJ-!^87WQ9 M_-W"T(*G^(J+B8#JJK]EI17^I`@'4+W(*/FKC,__`'3+%T(@E0R'1:T%]J*A M-0O:;!=S[0NV3HQKC$$*E:D-_J)J+^]5*CYJO_P",Z<=/#C?2BQ9IL'!JK#=1U&G]?O:@K_69P"%_ M^V*N.S@Q`"P=<7/E>Q_R5IFHZB2@O[XT%1=3A.CXTQV,&*(T"X6?*:U\RT8; M^_[J7]Z*T_K5PE,LI%.6-\8QM$+F9,AN35;%M?:D/_?[P*ZA^:F1`-W%15QI MC`-4+*92U-5OVMYJ"!;Z]J%*(+F<%4R/S$R=2WA'PM6YFSS(7CZ<;, M>*/0+%ERR%R5T=MM'_&7>7>)N92AW_'CN<7C1)L M&\%Y+[ESI0@7)"OQWE\X@?.W8VI\Q-DBI\83B&/4<7B0@`6#-T"^;?=?N,\D MS&)/^?P%T5E+>*T_-W9H%_K$U"N7QX[W'X^,5VCZ+R7*Y61F$B_BNKLWWI#1 M\W=5/_Q$B[:('[1[,=;'Q\8_:#\EP.1S,@<[C]2NJLGWA`_K5SU&XD5:4'?` M`"8Z.'CX_P#3%_!<#D\S(_JE]2NKLWWE%N[GB"DGQY2>BO%NQTH8<>L8_0+@ M)746CKM!_6+FAH/'E%*5^)<;8<:!TCXL%Q.1S,O^N7U*Z6W=>'@ MXKFZ"@%?&D(&[\94URQKAQ\0%@W@%Q,W,RU:S(I6A0\/8J[EPSCPP-8Q9N@5&/)RN1)L#@9,\@TR8B M/^HDE[V+..@MJ]UTEO83M80Z2=&J`3/*'.)/'#;-Z?[F-*/0BRTXK6X:Q6S3BK@USII#PJ@-"0'KM&SMQ091-6B_@%MQX M)PCZIL'U)O\`GW13;7#75EE4D@$22_B`:H/&N7UI@!BU0*=@IRQS$SM);Q.H M;^/^2`^UN`XN?=SG,-+II6\/"6H:.+E`.)[XF.V,0_@J#AE$[YY#M>CDC\%1 MGMKES5;<7`:2X*9I7`DT0.+N)A*$URRQ=&48TE$$L-`N=R8RF"(2D`YJ22_S M>FOX![K#N+*XXW)+<]T$EPN)2%!X07*]P>TA%%%4E<:A+$`Q$?H%P\W&RG(= MIG8N=QN-:DOI2CU+A<]?'QC]L?%@NOBYF1_5+ZE8% MRZ\"@SW2(2$GE]OQ$KC+/#'_`$AO`+K8.7D)<3+^)7-WYO51D#>:3^)6>;V_!0WEVU/B_K,WMJ]=F.7R>-!MVT/X!>B^WFGSEWL4?,RCK3OA,`J(A_!>YX/,DWJIXGZ'\EGS7=^M;V[[+B6 MI=L^,XX^;#$$T#+U'%SF3'<7^:R;BZO\_G+L?_E$R^Z3'+S8HBX"[?'RDCU+ M'GN[X+Q7EV/Q+\S*/?QXPSQ0Z#Z+J83 M'#H&71QY9'6JPKB[O^]_7;NF8^9F3+>'8R3A'H'6Z&23NY6!<75_5+V["?B^ M8G'8Y'[,990CT"W0R/8T7/W-YJ"%;V[&8!^9F_\`:4"8S9("[!:H2)H5R][< MWZ'^NW>U/ZS.57/\>?#C/*$0*`*T3DS+E;R[U(<0%[?$[/ZU-2N57Y=>,LX1 M:@03(ZKG9KW4%X^<]:*N M_4-10)?7HZKF?_MG'$SXF+-1=K!D<5-54DO]1"IJ%X!M6ZG.RH3Q%..3FQQK M2BWQD;A4);_475^>OO\`Z5,5%=\N6.9.+&MUK69+?ZB%_K]XBG_WN=4'_P!T M-#C+.&FBE$LL>XO]24D7]\-E;JXS1$3Q*HN,62#^(5\,Q`5ZSI-1U4$KJ%\5`0"\FZ4)_B*%/NQ5,.'Z*8+Q94SJ6 MI`_XA?IO^;N-W_VS%*!="=J6IJ?_`!&^3XO^+N$Z?_.9X2DX0CJ6I*#^8WW_ M`-+N%(_]*F%>A307ZEJ2DC4+RO\`\W/T*J28I((NFJ[M0U(@_P#B-\G3=W"_ M^7GA)4B%6.I:F/\`]H7W_P!+N/\`VF>!--^9ZE_]\+[_`.EW'_M,"$OS/4O_ M`+X7W_TNX_\`:8$)?F>I?_?"^_\`I=Q_[3`A+\SU+_[X7W_TNX_]I@0E^9ZE M_P#?"^_^EW'_`+3`A+\SU+_[X7W_`-+N/_:8$)?F>I?_`'POO_I=Q_[3`A7= M.U'49-0L6.U&_1]Y:M*7MTQR.F8WN.9*US'`&A!!&S`A:^H,_P#$M1.TWUWN M4M=<29=N-0!)8*`ZE1B;1%514IDA["<:%&1FJ4)VA<:<1E9RCL'OW=*^P5QVL,'-%Q>3DE5[?JKL+"7;NSM/$$V8ZN,-%< M/-D>JV(6`IPA$&Y!WM@WG&F$'\%AE)J&RW+6)4IUTKEQ`8UP!=]%0NEM84*T M2A4E-F1";#BX!RRT@;0P72VL/PCCW=6/3<'`&#A?//O'.()$":]:^-_CHMNT@^':7$`H#U@]:8]%@Q MKP_)S&1)*ZNRMZMI7*@1-YWFF.QAQL`Z\]R>Y.8EZT7765H@"#B)%#LKF4S`)ICIXH`17G^5GBE,\:!%R^JX?(Y!ZKH;:V!1"A"%`@IEM"#HQ:(Z:KD9LQ_=9=-9V7B.`+2 M`[A;Q(0A*\+CEQ`#=M3"D1$4*HP1.68@1ZBPOK^E[&[+N=/TP`,XVU!/\.@# M&$/=(%"2`:Y''+Y&6IV^GJO9?;>&P&X#W`_ET`I8]Z']68+J[;3Z\(80WO$ M(U>\H);4CBXLSL7&(S-_JO0X\0$2(AAHW5:T>GE`YS".[PY=^M"0F;:8K,P] M"M$<1E'SBMGU^/AU:^055:XDJ M>,.35K_&OT5&73RX.:`@X^+NEH)[U"IJX'^3%D9F-=5AGQS)X@T_Q?X_!8=U MIX#3W`JGA)+\BBD#NJCA4G=C1#(\G=@WQU7,Y'',0P%3JY_)Q^/@RYR\TQY< M6M#5<"CN'B>"Y`5"!H:YZKD$.-N/*-H=VZ:?QLN%R^)*4C&&U]),YKVLQ+UH M*VN_(7=F^-S@]@;WG@$:6D!">%*GA(QLBTZ@KS\QDPRVY!YG/AI;Z_#+$N+ M6O"0@*UJ2@-17;@6C%G(K^X+%N;7(H4VY@!10=1`Q60Q9=+#G:ANL*XMP:N& M83+([PZYNYMJ9#:!2H)R)7=LQFG`A=K!G7-W5NA3I98MPSB4(B9`+E7WC&/)2BZ&+(%S]TP%"AKF.E>K/& M.88T6_#(6U*Y^ZC4G/XB@3,;S2HQGD"0VJVQDU5SMW"`2/PBJ;$*T(^K&4]U MH#-2RY2[A3B4*#Q#<0%S(Z\9U)90^[&247HKHW69/&JTZ`0*T+$GC(!!J23F*4R3-`!TXQS@UK M*V,_]2RY6**J/PJ5J:E2$WXI(97`D65"1N8[1C/(,63_`"5=,QUC$4Q="JT] M(PE-"1:N&0S7[!B$@]KH02-AQ4@@$,57>S8O3EU].!-5\"$L"$L"$L"$L"$L M"$L"%>TS_$M/_MUI_>(\"%U-\#^::C6C;Z["IFEP]1[\;X!@_50-(I1M/M]W MT&+(A5K2@8J%"@/U;%7?B_&*NJ)2W+7A9D:UW4"G&N$6J;JH_@M2)A6HIMI] M"%QIQBCJ!6BQJT10B[*=&W/&G'%RJID,VJO1M381T=/VXZ>*'599'16F#[\J M]%>;>5':-_:#U4ZJ'':P8]L5P\^47T5A@RS*%`T>_'7P8_HN'GR MNXU6I;QGXLT7,[%HI39C=$+F9)$EEM6\:N)`ZP5`W]&-4(D!M5EGZBNEM8L@ MF>9-!6M!N&-(#!E+$*$ZKH[6$("`A)0]72,7XQ1U*9(%%TMG#0%`2.C(4&1% M.U@Q[5YGDY7NNNL(#W=O5M*'-`,\=7%! MZ+SW+S"J[.PM6H'.%=]%.Q=U.C'6Q81JO-\K.;"R["RM0".Z7Y+U4VA47HKC MH8\8(7G.3G)U9=596P44KDF14#?M^O&V$/VK@\K,NHM;8H#M3:O[,:(BFBX? M(S"VBZ2VME(0=UN00[![*>[%T=`N+FS-4W6_;6REJ#BX@UJ`$D5`4`)[,CB8 M85EHN9/,92VUB M^TQQP81>0.X]AH_^XD6;]5W5G:-:U@X2A:"@`HT#X"`.$@`C'*G,F1M=>QP8 MQC``!`9]*#H6NWQ==)!"U&!&EJ+F%+0"@I0$IC)(U>)*ZD)DQ$"VVOS9_HM1 MD"C@+0A'"H'P]Z@%.Z4Q49,=L0M`+TDQ;\%;$'"T]:(1DNTUR!]N(#=.3BZ6 M7)''&];-^OQX)G1%>%$:0J`E07(IJ4S'33%HB`+O)ODL<^1.9Z1)[N/CYH+X M75[J`D=Y.\Y` MUU^.JP[NV#F$%A<2*H%*`DAB@*2XC?MQ=CF8GLL&:`G!I`F19_X4&OY+E[W3 MVO<5CC8\]V-Y`;P$'O`)P@J2NT`KC?CS`1JY:I^/P7$Y'%,ID[8B9\H/=ZL+ M=]6KXKE;G3"7.#29'*X]]!0EH+@@1R<2G:-V-7N1B'E0?%UR/Z/*[8G,R==1 M2H^M>EF7-75KPA#7N[DJI4=X(*#$F!#_`!_DC',P(>Y#MT\>ZP;FVJ:4>O8# M0')!B,K.NCBS?4+G[FVS4>S*FU7='7BN0+,+KL8,SKG;NWX5*$!N[/;LW+NQ M1*/^I=C!F>FJYJZM\P&HI<7!`JCW9#&6<-#==K!F-RN;NX,P`.C(4^TXR3CU M7:X^5S&'-!RQ79P9=0N?N817(D?7T9)CF9L;>*[.')IHL:5G" M3L!)HNWV[CCE\C'N'9=KAYYXB\2QHJ[UIN^W^3'`Y./RG;5>W^W\F3C[3/>FS'$S18U7L.+FW"[_P63,P'>-A;3K%:XY67&]%Z'!,:76/ M.P-)ZLALS^W&&9=#')U@7,8J"WK1*5]].S&6?5;\4Z-T7/W$8%$VKW%S"XS3B2S*49!Z+%FC+>($#>H!K0;QD4QBS0W170X^0/=4GM-:^[J M6M,P,<;D8=-5W>/DU?S(#PH*]?N.W'"SXV)*[V#("`%4D:J@C+I3?0CKQR,V M/HM\3HJ$K5KN/8ARR(-5QS,D=I6N,MP=9O8<"D*%D%U!O(^I1DF$FA."U2J*3T;!B MF46\%)"(!"'$4*LX9@[T'M0'WX$(1"%,"$V!"6!"6!"6!"6!"O:9_B6G_P!N MM/[Q'@0NNOVIJ6HT(+KZZ-]DB;\:(ARRSKIK6/ M)R'^D[8*@J,:(ARQLM+;8L%TUK'\-,D&U=@`RVG+&O&*NJLAJRZ.UBHU*U5V MXFI";@F-$.JQ9)M35=+90Y$G+.FPBMEX>&3NOGWWCEQ,3$?@MNRMZ@%:[@N607<"< M>@PPC;C=" M.VJ\_P`K*W@NML[?*F2="KL5"%"8T8Q=>?Y&8_-=1:6XHHS*"BD[>I!MQHBN M%R,W2P71VT"!E-N>WI(.:G%D8[KV7&S9;E=AI>G.D>"UI+F\1!0\(:YOQ.-$ MX25!&9/1BG-DCC%;+1]NX>7DS$X@[AV+,1<]@^GXU;R'IND^$&`,`HT`<)+0 M[:0`JAW7D$QR.1R#/6B]W]N^VC````*#_'X==7!8'@7A):&J`=A-'%Q%"KC3 M&"68`UNN_#C$QZC\>[_HMJ&QX4!0YD@$*F9'#DI3VXJ.3]PZK5#"`P?AD;GOK]64OEP@H$H@R"`_"A/$"$RVX(GH5`-K7LA/MFDD`=6:$FH M09`H,2&204/;B2XO^'Q14Y;8!*#)"0E*J5<$-/MQ:).":LJIP8@%C+M_'XNL MV6U-11H=DG".\I[S5H3TUQ;&99NBS2@(DRI6UO\`+ZE8ES:J2:K5'`FB4*Y< M+4J$QHC(A8!<'%2UO22T@_B)@[ M57J_M/*.X1)I<_Q5.6,(:;2.P[\#-%@5F31BJTV9%&]F.3E MBU5Z3C9&6-/'T_",Z%IIE1,L<[)#;5=C#EU6/.RA5*')!ET[0N,&\5H"F_&;L53C]86#<,^)>DJFW)$_$N,AHM>*;6 M66]J9*:Y@DUS/73'/Y&*E+KK\7.0SE5G?SJK6A5,J^W'%Y&.Y7?XV4]2ZK2, M5?WEIWJ=!V8XV;&UUV,4S*(*IRQU4U.\[$S&.1GQE;<<@*K-FC7,TWI]FW/' M/(:A6E9L\7$H``IGD01E[.C&7)#3161+K%N&=[(D+1HV':0FQ,8LD7JK8RV^ M"R9F%SCT`@TVG>$R3&>2O!U"H2-.T`;"G4B^P8IG']R:J(A3%94HW0GA#UY= MB82EV0G;<@TKO)R_9A$.&307!/8O3_+BA-!!"[34!_P"):@N7SMWT5^8DR]F. MD+JDERZ>%GPG/=M%13;BR(959#HMJW:B**@5H?WLPJ<)#<;81!H;*@FBU864 M3MSKM`S`KC5`:JHK2C:F69S1>Z%W;<\:81@^SV;\=G!C:ZXF?(X?1D>,="] M?M)H,QCL8H;;KA\B="UEIV\>VM*G-.SMQN`9@N9DG4K:MHU(SRV4(W5-4`QK MC':&63=Y]RZ&SB'=V@'K.U.HD8T0](4H1W>:2Z6UB``I50*9^VJXT8P0'3F0 MS:KI;.$)7*A-?WNNHQI@&"SSD1XKI+2(E#U;$WH*)OQJA!Z:+%EE5@NFM8JC MAW\9*5`Z.W;LQOQ1<47,RS_U+I+5ASV5VKV=6.CBC7NN1GD%T%M$$7VG<#FJ M9XZV#&P7G.9FJ:K8C8@SI[J)1-PQZ+A8';HO"_=>=&(D7JRU+6(ERG8=O1LH M0IQZGCXF8`+YQR\QG(RE5=39P9(!_)L7HQV<$+-9>>Y.6[KK;*$=TY*$)3(9 MY8ZN.'T"\_RGVQ[JC8`.H!`=],=3!!EYOEYKLNRLK92`4RXE1",ZKNI MCH8QJO-\G/1UU]C!\*("@ZCV9T]^-L8_M7G>3ENNKM(5+_+9C2%P.3 MEN5U%K#0!%HN:TS[`N+HQ#[5P\^2J['2M/=-(TM#>[PJK2\<)=P@$AP[],@A MQ#+....OZJ'"X\^7F!B8L&)<.&)(TU[4.KW7E#3-/8P,0-[P)7A)XR'54%"> M+KRQQ%XJC=*3B7Q\:*^RU%*$($<"*G:5)-&@' MV89))UM#BX16VJ@D;4(-7 M`K3-J=X`T.#>Q*8Q@Q#(;[10C@G#F`BK^$+7BQ(9!JE+$"*45)]J$VN!&92J M9-R0%JXGO_<]52<9--%1FM1DBE:H"@"H`>FN+(S:A54\>X,-.BSI+(-4R`H/ MP',MW'.@!KOQ/W3Z8*4.-&'FF[#3X_%8]U:@*2@0H2$XAP)2K:U/9B>*>BE. M`J3^'Q7QTT7-W=FUS3PE$-`X(#F20:-JM=^S&K<5SLN`5VT/Q^>MER%]89D\ M+0H#RX-*@*-%*$KC?BSCTERZX/*X8))&T;2')`[6M86O73KP6I6887 M$F7C<]!XD>2`-`+ZM))``-*5QTL<]X:(#-I\?!7E^9@&&6Z MUJ77*W,#5W'IRW'>@P2=E5AR%ES=U`.\A-%2E\A-2B<-#G4;]M#CGY!U7=X^6GBN9NH4!&TFF_<"*9 M?;C%..B[6#)5_ M;N70>`^?Q^*SIV!'9'++;NICAY\8%%Z_B978K)G:-U-I[%"9$+Q8YF:(LN]@ MGHL6>-'.INV9H1MWD8YT[.NOAE]5B3L^(D9TW99"E:@XRSBQ;1='&6*P[B,G MK&W.[BC(- M5=$L77/W<8+3UG90%/M'MQER!JJ^,G7+7D2DH!ENH$._LQGF";*JRB8XG(Q+O<;(Y[JJ]H*@Y]*+V]!Q MR,\'72A)4I&J$2ARZ^JF8QR\T:U6O'+]JSI8O:"NA+194S*5S)`IL/=&ZN>*+%7 MQ]2HO"@E$*`"FXHO;BB08LG*Z"5((&W$4P:H6$I(+_J*5SV^[%4_4FA'+9VY M8@A`P(47`'95?=TG-,"*OV0<"$L"$L"$L"%>TS_$M/\`[=:?WB/`A=QJ*?F5 M^,R;V[H?_M\G53'3C=4(L`R&;E"DI5":[D3%$O=4S(-KK:A:0*C8$3I*[!U M5QLA%O%4RLM2)M31>@%,LDZ2F-40P;50)H3'4Q"CK+(ZJRT'HWTV;SCJ8(?1@4`V(:5(*D-Q>`Y97Q?;YET=K&509 M?%3+.@&Q3C5$;BH$F)86736L9+0OXJA>Q0<\:8W63+(QJNCLX6]U%05-*Y+_ M`+-*XV8X?4K!EF6)DNFMF)F"M*)6GLW^['0QQ_%LX6) MO`+YI]VY$I.'H=/CM^:W;./X<_9F![B3CO8(U;1>/Y,[KK;&)2!L3/(BM>G/ M'8P18+S_`"LC!UV%C;CB"UZ!N3V(<=3#':>Z\YRLI9=M80CN[`:)MSR.T5QT ML40!W7F>7D->J["QARHNU#3V$98Z&*+5%EYWE9&76V461-4*4'=*[PFS9C5C M&J\_RWU7'D^68@/45Y#T:)OAQ4+5!X>`E"A`^((%;E^W&#DD[GN'^/C]%Z7[3& M)Q1%I-1M?$]O\ZKR#81-:&M[I+0,N$L`H'?T"%(7')R%W7L.-%H@4+"@HWY7 M75VT?#P]U"7"CEC"W*9!B7%D/@X40*A+G*!_15555.>[#L*J(B2'"K20-*G+-Q(*Y9<()S*U MPWJR0B!4VO\`%U4FB`-4`#3PIE\(R!Z:]&&&(873VD'=*@T67<1L*GX5VA"7 M%H3(;2,3A)BVB4MI#V)^JY^Z91QSV$[O"KMA"47KZ<:L;[F6/(2([KU^C_' MPZYJ^8.&B;>BCBAH:*,@*KC7B#%M/AE@Y)$HTOV_'X\%R5ZUA`".(#B"6=PA M0.\X(#0Y;,;,8[CX5"9;\NSH7&/)'3JN[QYN%S=S& M%=0#:`*>VB(<8IQNNU@G8KG;EE#T;-G3CG98N%V,$JLN=N8S6F=4ZLLM^V>2]N7M3+'+R1==O#)A18MTWJ M0+LHJ)L3;C).W9='&0+76'HKHXRL2X;N&6S)<\TRKC( MMF(U(6'<-V\.S/MZ/BRQ4M42X=<]=-Z,\BN10^S&8AU;&6U"PKB-0ZB$=F6[(&N,I6O%-KN MLMY4)UT7ZQ6F.=R85HNQQ9$7LJ[Z';1-F7T..+R(+O<>=&5>3,&F[I_DQQLL M779QS<.J:'5:XEU2F;0]@IM[-V.=+JM:RYFJJ4Z,Q54*' M&6<;Q5@[W6-/&A&U.(5H0I:FVJXQY`X?HK8EK763,W,A*_O#^B2@_FXS2"NB M7#K,E:6N5!PY!,QMR&_%,Q1U,,W=4R$*'%2/%#=GD!T#+"4T,A18.KEN$X:=X[%N24^@.83&N$02VBK)(6G$,NOHI]YKC3%05Z-M0O3_+Q5V8W8 M0P669-.,7*RY*C=W706<8`4!#W$H`H7&N`8/U6:9HNEM8P>&F1_F@TZ-^YY6!>X=:$+5=Y,ZGNNTT^-7(43,&OLRVKCJ8HEZKS/+FP<:+L;%@[N MT%VVE?V)CI8Q7P7G.5(A_!=A8L17(`:G?0;MX.-\/V_)>=Y4GIHNLM&@AJ&@ M"[:%,C4(F-(7G^1(N7NNKM65!ID"B+N&W93+$XV7"SR8+J=,C<96EJ-*_%P- MD((("!IS+2X$G-!@D0(NLO'CDEG&R^E`:TL_B]*L%Y'TI@:U@:I7,H&D.C$F];OUZ_5EW%BP-0$G\+6A*GBJ`$"E#7I MQS9DRZ,O28S##$@DOIW?2WS72VU2:@@.X2JBH<$KO(Q3(;0WXJV&8SD9FH=F M^/@K?M@2,G9<->LHI&0!.VN,DQ'2S+?C))KI1;4#>$M7;2F80*I`WXIF=ROB M=I=:T;:($((:2I6H5`/Q"B@4IBDWJM,"&;K\?JK`!"?$6HJT3I6BJ2=F287C M92\O_=^J<@%%44HA4_%MXM^S!8I$^6OI"B[,Y.W@`=X(&G=PGNG+;AAP*603 MOE7U,JK@",BM.(E*`@*#0$4PQ91E%O\`I5&9P0T^*@(*D``M&8(J,3`)+(E* MCCZK'G<2'5R0!*=9"G,CV)BT#0_Y+.978V_'18-UQ&H"AV9;3,)\>:H*XTXQ M$%M>ZRY9$L03M-F^E_S=(%KB`*Y*A0`H`H;53D0:XUXXVTJN7GS@.(N M1;IVK1_\:KEKVW<050=P@DUX@%X7%RA6M14V[<:\4R.PT)IU;M7X*X/+X&&$?= MD!-@Y)\NZC$TL+-2@7#W;`UY`XJ(H-2%:H6B4Z*8V-Y=RX0&V9BN=N6`@GL. M537;BI]%T\,B%S=T`%H`152I6M`"1B$_2NU@+L%S=TVA!&60W'85[,9I!P0N MS@/F7-W;8R0?:@QS,HI5=GCSZ:K$D;P$K15(]NW9ECETS_ M`!+3_P"W6G]XCP(7D.\;_P")7X6GSUT2NTFXD)7/+'7A<+)D)MHKMNU*TK6A M%`OUIC7"(-[*DU6G$W::(AZ*FHS7&O&*NJR]UI,RZ<@*!=J)4A,:(!Z*N18. MKT8J-AZ/^E0]&6.IABQK=9)E7(T)RW`+3^<"!^]CI8H/98N01M1@*[AGG5.S M9CN8(L&%UP^3*)W/9U;:*MH?N4?8#[L=G!!KW7!SDEC%:<(`09$H?8O_`)(Q MMB'LN9DD7VA;=LWO#([-I!K7IH!C1"+!M55+_?\`@NEMF&B;N+\7=)WK7+&I M+'&FY=-;,0#/8,]I"$>S&C&&IJGDLNDM64_=[N^F=-Z%!C5'19_'2P@/V7%SR84706[:!,TJB4S2F8*#'6PQ7G>4:L]RM1A#0G4G9CT7$%`1Z MEX;[K,@2!%+K1M6\1R%>Q2NT'I&/1X`!$>"\!RIO,GJ?AEU5BVJ%16HWT4X[ M.#5>>Y)U'1=?8CX:)5.Q*9!148Z^*Z\]R30KM-/:/X?03^P>_'6QZKS/+/J7 M8V0RW9JN0&6-V(+SG)-UU]D`&@TI3>M*(F1&-NJ\]R3YB%U=F`2T;``*[:@K MVIC1%F<:K@%NY`G"@+D!2 MI:$7=TX,KZ=/\E+@R:9E,L!^`HY^@_/Y^1=/_A\-`YJA&\0*YAH(*$&,$+E3 M'+RO*[B3?'U7KN-..("8`E'H]^GTH2_R"ZVS5Q6JN*`M)5P'PEI&[W>W&20V MA@11;(9)99&4@29&_P`?#?-=1:\2!0T$'A5NX!"2Y>Z2F_9C--GHNEAWL\F? M^&K]*?HM^#A:`UM:Y*.$HA))RS/MQE(:3!;8S&W<+^*V8J#N_NT"Y@?"5/0< M4D&1<66F$R`Q^.BTXGJT$;3PA4H4R45`('9BH@6T6F))#ZHX=UH2>(U%=H;7 M),1:O923%[00-ZGAZNH9$8-M.ZC0G;U0B">LIDI"`$E!_-RQ)..CZH$A6B%` M"@"E=X!W@8B/Q4YESV6;.7$'B;P($#B*D!%!S!`.\98MA$2*HF9!@?45DW"D M5%2A3=52%ZQC3!HF@6;(\C^861.TGXF\11R&N:[\O9OWC/JVXSSB`7"[>"50RYNZ MC14"'Z9YU3&+)KXKLX)];+F+R(DFG7G4C8O1C'EVO5=WCY`P7+W,2EQ2CCO. MWNJN,&05==S!DL%SUS&K8G;LQS-($/JL6=J$@M[,JY MY[:C'.F&HNKB)W46+FG:05KV8PSBX MW!="#$^58,XJ1LS*YDTZ%.,\QJMF-V[+G[MI*G-"I:F6U$Q1-_DM4/2N=NF$ M@\0S4'M4YG&7+=3,9-N7,WD-7(""H"[!L[N\UQGE$`44::+GKACFDU]VZF_& M:8+U]*D"7<76/-&E4&:G8"O3_.QGF!8V6S#DD&=4'YG=^+-.E_&* M8HZMC994X5030A"$V=8_$,9L@-]%9$M0V61*P@G(!$WJ2IS04QGDKHU#FZSI M`X$C+XG5V`E-V*,@_TS_$M/_MUI_>(\"%Y)O&I MJ=^*?\==DJ:@?,29(%H-F.SC#%8IRW65V&H!%.E$535.K&S&*.JB66G"V@%4 MSJ5.6T].-,+*HK1C'P[*D^XXUXA559*`!76"E-^5:='LQU,(I2RS25IB(M46 MO1T>P8ZG'%5SN1.XT",!E10.%/YQ/$G8IQV\`-%PN3($%[NK<.0[=O2=FW'7 MP>GX[KA\B_QW6K"&AHV.Z=NW&F*YN0NMZU"D#AHH(I7*B;2<;8>I0IDGV73V MC>\T;L_WAL*TH5QHAZ@K*1CV"Z6`"@)R-"=W$,ME<:L?J5,RY9=+;M"-0!#[ M]Q.Q4.-,;NLF0R%=5TEDU*#8.@D;BNTXU8PX;J5@RKIK5H`'LZ0"U1F,JK3'7PBK!>9YI_ED=EH MQC;].GWX]%Q1Y:+PWW7(P^:U+1J\/W)MIL"TQZ'#$VU7A.0:%=58B@V;=]:C MZ\=G!Z5P.45U]BCN%1T#VI[ACK8OT7GN4Z[&PHT(4&WII7>Y%UU5H5(13 MD@Z:[,D^S&F'I7!Y`I5=7;$*-H0="$=51B<;+@YUU.GR<+F@;%PR8`[AH4()2E M2#CG9X@,`[_XKTG$Y)S/*;#$X`%=`U.A_%OP[.R>6AM.Z,@THX**E1N(1!C! M,4+^K\%W,,]I#4QBPU_#Z?Q73VSQ1"F[B*9`$,-5I!(+4I\?YK7AE`8*]J(BDKTJF*"!*Z MT@B(\Q^:OME5*B@.11&H0%!)%<5F-RK1D%.C*PV0E`I<31'$]T`U'Q!N0R&( M$=5=&9(I?X[JPU7-`4."%4"@J5!.WNYG$"VJT8XO4%V^/P3N;LJ"%2M5.9H@ M"[\#_-3,2W0E!D!R'$-P%!N':4PMR-DO"BS)VEW&>E%125[K16F8]N+`'("H M,:$U=_\`!OK^BS9(R5:T\-?B%>ZH->E37?B_<`7T;X_P68AZ'U/IT^+K/FC: M&BBJ7.52H`-"K5`:<3$B2]J)''&,0=23\A_`^*Q+D@DEI&:.*4*YD[.'ISQ? M%PS75,P""'K\57,78"'B!JO"@-%=M0TR'2,:QT[+DYF'>)_BN5O;=SFN)X0@ M<02KJN^(D<-2,:,60`OX=ER^3Q9R#28&+GK?IX.5Q&HVK0YP)>0*J6J@*D`* MX$EQ5!7LQT<>3<._C\?5>=Y7$C&@W%CTI\JBI+D"M]%Q=TSA)VU0$UH=G21M MQ:6J=%SX`XY;2N?N6?$B=1^Y:*3BN9HPU71PRLZYZZC%,(X@-Z9*4/>*;2F,4.X"[.$E M@LTT_E3+IV8X7*B*E>Q^V9C0`5+>'Q_@JDC2X=C@3T9BG6<>?Y$6O=>WX.7: M!T=9F MF,4QJNEBDX=8=RWA-F:EQK7=GBJ0<,M:P;B,\)IFIID5'V8R9+*^`(%5S5TQ`1ET@`E=B#. MJXSS]*62/[ES=RW:G2J9KT;!BB0<,JK76/,*.%:+\68Z%.8"8RR6G'=BZRY! M7*N5#W2IR(Z#C!FBP;5=3!*K*N5`[3W=B(14#++')S#5=WCRJ.ZKO`1:53K3 MHVTQQ\T3*B[F"9`VZ*G(T%21TKDE/9CCYX!RZZ$)$U%U0E:#ETH1O&6.;.)! MJM=EFS,&=.RM,`D)T[Z].T(3C)*/[5-9,K2549#(9J` M>C*N,I"T1D_BLZ1JA:*0[XLP0M"N28J4U2>Q5&XK3?GC.I7*K/7<5_EIUX2D M'U07*"H!RSJFW/?A$.&30G"O1LW9#+9BA-`>"J[#]V!"A@0E@0HN'$$&>!(E MJE!P)J]IG^):?_;K3^\1X$+RC>-!U*__`+==!`*4N'J5WC'=A9USRK4``2AZ MLTKWLZU.-<0P90-EI1MR3)*4S7&F(:BK6A&5"9=J'JH=V->&))<*G))PP5QJ ME%[!G396JT&.KB%%DF>JLLV;R@`/40F^F.IA#R7,SS:_5&8BINXLC7MV%/=C MMX8MX+ABX@:]EX'[K,.2->JU MK+)J]&T@5`4^['H<7J7B^1K\=5U-D4X.Z=E*;/5=WI,]&<3G-``C1#QA"7=]R\!XR:[,9,XH2-?I\@NU]NY!)&XD, MPLYI7U&E;G\KKM[&4%P^*G":]XA%4?"&NZ4&W&#(-=5Z;CS%R[4[V_#X*ZBW MD&;LR`A/>``*E#^%`ZBXS%WI9=.,AMK0Z?&E"[%;,$I4!0@R)('\X@KGO4]6 M*)!JZ_@M, MTXB[EM5>VV+Z*N_AJ!4EP2B.1.(J?AS"8D'TLR'B`2.JI35#5J$0)1#M2E`1 MB4:?-4Y.^BRY*$TVKT*4`)=F0X4Q<'L#HLM'8BY63=.9Q5`5,QW:&@:E$WXL M@"U?453DE%J`,N=NE4H4/>XDZQ4[@OMQLQV_[5@R@V%R?C\5@7*\#D>6DD<2 MA>\Y!M3IZ\7Q-6#,LIQ@`ESNI^5OFNZ,\E7+ M%,O25V<'=P6"YNY'XDV9#:NQ*XQS+!=K"77-W34!VHY/853 M+=CFYJAEVN/)SXA8%PT%2=FP;L_9CF97==?"2U%C/V@'K7W]F.1R8L7C=>B^ MW9)";::5^**N]HJ-F_J&?8N.!R8MXKW7!F2S>E9MP,T_I;*#(YIOQQLHHO4\ M:5F6-.U%%5_>V&N_JQS,H8>"[F`GY+'N6A%78OUXQRU74P2M'58%RPE4S"KF ME(>P=5%W8J6N)<.L M"Y!0C8CDR*U"CM7&4K1`T;5ZNQEO^E94@=7*M`=X[WOIC-FA0R72QTDPL MJC@%=O.UPE, MMW"J=F.;DC1=&)5.1J+D?8.CKQRLP8LMN,C;7JLZ5AK]9^[/&.47HK0665-& MBBG]+//XF(J7AT0#Q$(.S"4E7=L&Y?KQ5, M5=`0WA6]5?IV8@F@X$)8$)8$(;@NY0%(P(5K3/\`$M/_`+=:?WB/`A>5[QH_ M,K]:?UVZ+J?_`&>2JYDJ<>AQQ<=ESC16HA1NU#79]2;,:H>I0DK\?T^@KC1& MZK-`Y6A&`79IEV)U[\;<(8*C(7+:!6FCWFN\G)=RUQU<8JVBRS:QJ%8`R'0B MXZO'!<'1UR<\G%;E6&539U>VB8[6``KA\@D,KL("A`FT*=X6N.GCM\UQR%51"F+\>JO+"I71VC07#V`%*T1>S&G'?Y+/(LXBNEMA\*H0@J,J;4 M[<:866/(6BNCM0$R^H.IWD/2N-V/U?)<[,:,5T5H"@S6FS^:<;L5EQ>1M?NM M^WV951>G>AH*XZ6"X\%Q^2:&.BVX-VRN_/*FT98ZV#U!>8Y]8LM!HH3]$::? M5CTG%K1>$^[.#3_+_-:MKLW]FX;\=[$?+1>+S6/QJNFM":$#(IE^T[,=;`=% MP^2'+=0NKLRE5%7#VBA48ZF,U=<'D!Z+KK%0M:9=`W@URQT(6^:\_P`K\5U] MGFW97MS%$QT,9:J\YR%V%E4`[*CJ[V>\XU1.H7G>30LNHM75;TC:[%XD MXW%\KNO8\3)$U@6#?ET^/E==5:3@AJ%"4&]7 M9JXK4%=YSQFD#4+J8C"AC?\`,]2MZW(=4]6*-U`""M37?55.0IBD];!;@[;B25;:_(!$IWG4 MVIN&>($5[JP$LPL%(O+N&O>K04)&6?#LQ%F\%(DF@]:K22=:AHJ,T)*DH!2F M)CM9051[PI-355H4&2D&BU]^)62D6\Q69<.:.(@UH"-YRH37A^W%D'_[5GE( M7'T6'/(%0JA`4"H!5JE`"'.I[,:!$MN%UDG0M]5A7+BY0"A=FJ*AVI6H`H,: M`P8FP6>8G*@H_P"/QHL"ZD+2XFG=^((2C1L8%0C%T*^+_@LO)E*-/VM^+Z#L MN:N5+5/&[(M6G"6Y@@]&W%P+'1\J.*_B/[I:"74 M("4Q=CF8N(Z?'^*Q\G!C($C\>'0W#BJX&_(XG$%H/=*'XD(R(HUHHM-^-T#* MVJ\YFC`S<4+VUM2@H!3\>BY>[.=#3I5%-5^K?B--%?QQ5<]=%RDDK[TSID@- M,0(C+6J[.`!J+GI\W<155K44RZDX<4'NNMBM1N0J[1U?2F.=E'[BNQ@+,5SMRW,9%!+()=D!^?^S4Y;,_=CSW*!7O^"8T`U6=,TUW\-1U$57' M&S1J0O4=O85).U"%^W'-R!B^B[N&3ANBQYFT*T7AR/UXQY!5UT(_@L2X"@MS M"\/PJ%`VIC-(,5JA)P^JYNYC1:$+]%'0F*)!BM(+AU@7+`00B`G]F>5,9IQV MGLI;CNW+F[J(`NI0I[J9%*`XS3]2B%SUPQ"X`;UZ-H7<#C/D'F4XRVK'FC0Y M9[/YJD)T8HG%PQ70X^0`*C(VK@:?=CFY\8%K+K\>8)O5`<*]F9Z!]J8XG(QA M=K!+2Z"\*4_>_P!T4S/U8Y64:KK8I$0\%3D`1*=9*K_LYG'*RAULB:*E*`0$ M`S.Q*[J$#&"06L$$.%FS,"$;:K09;EZ\9IQ`\"K(K%G802"A*FE`C4`]F,,P MX5H)!<+*E;0DA4-#[LJXSR&BOB7#K-D`'%T_>VO MU'%*2$ZAXMFT=B;.C"*D#7L@N!X2-M*9)]$Q7.H!4@@8K06U5?`FE@0E@0E@ M0K&FA-3TY,C?6A'_`*>/`A>6[MO_`(C?[/Z[=%/_`,HD.>W/'I,8U7./9'B` MKL1/?OWXTX]525I1`#LR[5Q?&R2MQ@!*?$G:A"YY@8Z>$,76.5E<:UW[-A7: MO1CHXAJL\RT=VB.-Z9T'7OQUN/%FZKC1(.3 MT"O0_%T*,=''8+CY+_[EKP9@E`5-$!0TKMJIQJQZK(7KLZKH;,<*$IT53*GN M.-4+?-1@7\MXKJ+0@<*%"=@ZO;EC1CU4Y%J"ZZ2S1!F=BHFZA.5/=C5CU6SK! M]A'_`)..OA_1<7D_HNLL\FYJK5H*Y>['2QEPZX'(L?!=98E":A2B50(-M4&. MAC*X'*#^"[*Q)`:?YH7;L7VC&Z,OW+S7)H3XKJ;-V1V#8#U>W&G&:LN#R8Z+ MJ+9P1J+L'5V[L7`D!M%Q,\=2NEM7D+BY#"ZPQ;'D$Y!P#5 M=WIT_<8U3W>)'$\3.(!J]UI"*:UVXP9AYR?CX\%ZO@R$,8@"0Q(ZAQ]&ZUZ> M"[&UE5H<20#\-*9&B@*1T[1C%)GHN_CW$`RH>GZ?'^*Z>VD4@(#0$*ZM0`20 M`4<2=F,\SKKX+K81O(C'IJ>WQ\56_!)2I4(G=(`<451^$G&4ERZZ\(`"GYK9 MAD`XB2#N<$V?A.:XHR._^U:X1)J6W*_'.A%>HU10,C0T(Q40ZNM>ZL>/L'<( MH!Q@'V[PFW"$7[JQP*V^:E\PT@@<-`%7,4)S&WBP;94)4#.-2*H+IP$&TIN0 M@KLZVIAT9BHO4'55);AJ$ER"I[20%H-N&(EV`JH2D]2:?JLFYN&U3.O%D0"V MG=XD`+0?9B^$?3\76?*6=KZK%FE**4*A-^68V`@AW0N+X-(>"SFAN#\EB3O5 M0%:M0`!7-3_-*'%L2(GLL^:;4Z_-8%R_O$N'#F5)79W7.54*)MVXM?=Z9?@L M4A7=,,]?F?BJY^ZD[KEID2JM<6DDDY5XA4[#EBP,%1,@`AFIKXU;\SHN5OWN M(+P\`$FF8`XB"K@>`DM;D=^+(R`+57)Y&Z4-[L';XZT&JX2_+.-_#L`4.I4H M"#Q$<("Y;,;HS)`7FLD![I,7_'\.UJ:?ES-RZO42<_=T8G9EDG M3F!C.2Y78XZYVZ%51"00=]*4WC&>88KLX)49B[7$E(3&WP51U>FGT/":C'!Y$ M7LO=?;I&A=QKH7_P5*5M"-QHNXT^O'$R@"J];Q92+`W65,TU]VRBI]8QS,H: M]UW,$[$K(G803Q;40CZAU+CG2J%U83Z+%N8ZDH=JKVG&;+$D>*Z6#(#=8-Q' M4[%W[,P`3G08PS#Q?HNKCF"'6!.W/+ZM^00;\9IK5C-5AW3>\,KUJ4KD*#&:8<.HD;2RYRZ8: M]J]2^[&>=OFF%B2@+0',[NKM*#%$F5^(DEA99[FA2HV^XXQYH]%U./+0JHX; M-FX9G?[,VF.)R(=5VL!!\55>VA2@S!4K1=P.2XY6:- M'6_&:5NJ3Q3>Y<^E4Z-V.;E'F6O';YJA*F2552=G7M"+C+,.'5H++(N(R5(X M0113^*IXNTIC+,:JZ,C$OJL:1H'$H49A5VTKEF<8I!BK<9T6=(%`VD^[K]F* MB--%8LV0$KLJ37=7&920:D$#/`I#H@N"`E0@SZ>K+"(>A4E5-,Z==,9TT)X3 M+(_77`A0P(2P(2P(5W30NHZ>/_GK3^\1X$+R[=@?F-_T7MU_2_[]Z!$3'I8! M@ZYI1(@H"[T&]/N7&J`HZJ*T&#(YK1$IG5<]V-&,;BH3])5QG#PM3-,LMJK0 M9XZF$,LLBK;`XE-Q3M^AQT<0=8\\F#(XI5,]B;6@57'9P18,N/R9([/<0?<4 MV[L=;#$?M7#Y$A\BKL-"-EG&K$:D*G)HNDMBB#)RU"H,JJ:DIC1`T9<_(+%=':G(;A_)C=BDY!ZKGY@ MX==%;%`@H`16M=@&-V,KC<@5#^Z!G/Q\=EJVA0`'>*]F76 MF.[A/6R\9R!JNGLZI6H/9U=>.KA+%<3DW*Z6R/U#LJ:`9=F.IBL%Q.0NOT\C MC'2![A7HQK@7BW1>>Y8HNLLG%`.KI6ISWXWP+2;JO/\`)C5UU-H_A/8.CH2N M-$;+A9=#`_B;FB44'I2M%3%T9?NBN1E#%UM6SU-%J#PD5*C):%03NQ,3>]8 MK#/&\F8F6C=?Q7;Z6\N$9;W:$AI!+.)W%PFK07$HI4U7?C'FD`2"O2?;X2GM M,0VHI1R?#Y_B6*[:T<>XWB*9YJ#1*`(&AG%2MCEI4U\5:;J#D0/1BDDJ%7+ MA(RSW;\1]L6:OS4_?(U1!?H%X@I1:T&04*CL@>O`81(8V1[[`=5+YZBDA%+E M3A`("@C:A7`(@>FBB,Q9RP43J*-0N4FKGHA0(T;D"%,1]N/=/WV]553DOE4` MJ&F@ID$+BB[2<3``#!1EE4N"T-2.%H`RQ/=2G^2SRB\RY\>_AT^2YF]?QA!5I*JU0BD@@(@`V+7 M:=F+(RJQ]2P9<0R#:!Y?G3XH/KT7%WX8TO#RXEXH2\!H`0%0`'.\:+0[5`5`2=HQDGZ%V>.*+G+D"M5SVK[ MLR:Y8RR:Z[6`K`NA1Q-:F@S]AZ<8LDG%;E=7CW$5SMRJ.+:957;M.Z@QSLS+ MM<>X^-%A3KQ#JH=_2=N.;G;:7NNQQ7$PUU6<%]_[:H43'#Y`N5[?[>0&K1E3 ME"YD5"U&65<CNG&2=OFMV`.L.=M#15V;Z[3W<9,L7/8KIX3 MH+K"NFBJ!3NK1-H]F,3.MD"6JL&X9W2HRW(5%3D3\.*9AZ+5#TK#N6@`JM>@ M)0J$/T7&:4=P97QB05SEXRAWNZDS]^,L_2FN:N8U6ARKEGT;\\4$.&36!*T! MV69Z,UWTR3&>3M160;=59DH3I^*F\YGVKC)DB:E=+"0`#HJ;PE0-F:]:'<:' M'-S`NNWQI!OFA'.N=-_O7'&SQ!#KM\;)6JJN"A.DD?;MR(QQ\\6/==3&52?4 M@;P5ZD]V.5E&JUXRQ94I!F6K39EE7W8S$::*]9LW2J'?T[37IQDG%PVJL!=8 MEU$%)KN/25HG0,9)C53"RI`BM%%5"ASKM3IQFD%I!>RSI6I0KDG0GWXHF&/9 M-530TV$X@I6JAO'>-*.R]V6U<)355XVUKOQ3(,>R:`_(9Y]G\N(H0\"$L"$L M"%>TO_$]._MUI_>(\"1#AEY>O@!J-]M_KUVE-GCR=&S'IX>E6RZ2U*)44S!7+NK]>+H73*Z*W<00549=H1>Q,\:.OAEJO-N['H,,G;HO$D(,C5 M-`DU0N#R8O==/:/`<,@-U?;T9XVXBQ[KBHRV=73C=`O5@YKDE4QHB7'BN1FQ"RZ&WEXD M)3,5RZ=O0,2!,31\8C1J M;F5D5*T'"#4A44=X>[$7-M%W M\%E37:DH:J6AA*!$H0*&IH>G$W#L;J)J-T:E]:?P67+.3\3@40YT)J25:.Z: M9FN!WLJB"0-W^'B^GB5E7%P-K>@&@?M1`BD4)P@#UHHRDX`(>1H+.?XZKG[N MYHYE*D.1Q+\`0/?BV,Y%A(NJO758=P\DILJ>A.P]&(R++I88A8ER[M/3MZ#[<4S!;_:NGAC7LN?N7$N)R4* M!MJ<]N,V0M%NJZ^``!<[1Z\9 M$US=RUM=J$IV"AZZ8SI2+"BP+IO>=P]?7GL5%Q3/U%2A+_U+'E;GT;4[4QFR M!P5OQ%A?HJ+P=W>)%*K0]F[',SBKFR[?'GTL4`Y[0%1:]>.3G%"%V<$J@(+U M/31.DU7MQR,RZ^&3ABL^445ZQ)FU]ON0[=U,8B M-%?$N'6;+397A<794I0#%$Q1U:+5LJ;@:H!D#LV]/3BI,.RKR43=7[,"+>"$ M\.(*[43V_5B$_2I*J[X3]/HF*4T'`A+`A+`A7M,_Q+3_`.W6G]XCP(7F*]_Q M&_S/]=N=_P#]?D*#<,>I'9*@^:S2NK+%0KGLSZ,^+'0P+!GO\D4+['#97<>D M4QV<-EQJST_\`]>OQ=;]H43;E7>G0H3A)Q?CU2AK`KI+3K3ZOIQ#J MQ?"ZM*Z&U*EIITKOSJ.C&F'J6>1JY^07&BZ.S.6_->FHW)MQTH:KD<@%EN6QHTJM5/LQMQEI+DYPX M,0MRW.2;-_2B_LQU\,F\0O/
,=SB2KW7BON@(!%AX.K]L MX@C-3]JUKUX]%@E0$V7@^5$"1"Z2S*;4KUY9G'5PR`%%PN0'JNJLWH0:]Q`% MW'?N"8Z6*0'R7`Y$=.JZ>UD0@#:A"U^K?C=&S+AYX4KHNEM)26@"JU]XHN-> M$[J+B\C'5UTUI,"!7-`HWC8F25QN@=%Q,^-C9=!;2HFPI2O[$48O!=G92HVGWXMC(2\5Q\^-ZK;1`:CJ/3C-*/J!7:Q9XN)`N=-*' MH]NOUT6[!>J5#@$:#Q*H"IDOPM"TQ59;AGH8]K^+'Y*\V]7(\?".\A#J5&>\ M$>W$:"@H2G++&3OYI`5_16XKYH45KG4AO%^Z:"I7+$E'W7?XJCMNF-:$(<4! M^(`-7,@'<<\9R\I4H%KA&$`]Y?3Q_&ZE\ZP;4)2I(%05"E2#[TP*3P])'Q^O MP%$WK4S'$6@H""H)*-2@SJ-IP5?LC?B`8>IK=>WQW4OFF@-)-57O+10$(4K4 MC`9`R;560:$>[_GJ@R7P0#B#>$L1'*37O$%:D"FW"`+5NE+*_P`C_FJKKH<3 MG%SNZ5/0M31JD_<,25S(DOK\?%E1ENPX`#-0X(>\00"B*=N&#(4"B3C:S M%_CXT6=)/Q.SJ.$5)!(*[_7IX+%GE*KQ=]V9:YSFA4:.ZX\+G`9TW8F)^6M@HC# M/W!(C^8>A)NVAH2VK+#N"07<(3@X2KN\2B!O\4DNXA))5Y90DBN:8T#(`/E]?HLIX,X3JQ M@3H2XN#ZF[=R*="NG9BJT)2G2=]<<7D!U[ M3[>2&!_R59XHFT?8HQQ<^.J]9Q92H50E:G%_O9]>.?D#A=S!)UE39=A^P_9C MF9M5UL%OFLB1?8F,F0[1W71Q$$T6) M<--15W&>5W6J%1M6%=-0'JIO392@RQF ME%BVBOC%_!<]..1GC1=S!($B6B"_?TBFSXLTDXBA1P(2P(5[3/\2T_^W6G]XCP(7F2^`_,K M\H?^-NEZO'?7(.LI5UI!1 M/O\`KQTL=@J"WR1V?#7/V[3M[<=#"L.>_P`D8;'<67TW[L=C#9<7(K#*DYH$ MZE(0XZN(G2ZXV<`@]%=A.16B[-AVA<\\;A=MG9?1`,\MF-N(L5R,HZ+]%!^Y8MLZKH+22H*BO1]$ICJXYZBZ\YR(?1=+9R@)T>RO1D<=/#+Z+AA7(S8^BW[>;)*)DIV^Y43%H++DY ML>JV[>XWN_EIV#/$P3<+F9L+U:JV8+A$R3+-2!]F)QDW@N;EPOXK^@+ M7$M3XG'+<$.*M@)W&D@/BZOERI1B<6,[H$EO]1'B.^E*!C5UM07KVAP<2I1. MX0@1A$[,5R`,JV'^*G#D9MI)>MJ5T)>/B[?JMB"[):'DAU.(!I(`: M%X0UP-36IS%3C.?]JZ&)Y0&252SL*4%J_G\RM&*Y+6A055Q"$.!8TT0A`I6F MS%4RYO1='%`PB)-4NU:$4/A7Z7"L"Y/"GPJTEP<05'><12A4D`X@K6E$"!#$ MBOAK:_11-VE07%07<*!3FC07(0GOPZD]TCD,`+FCMUZ`/T^I^B3+MH!<2"Y% M1Z\:JJE0"`OL&6"8E8V=3QY,<(^Z?4U'J7!^H\=+!)U\7$DDA$;Q'B<`C!$P)TVJ68S&)K2'Q?JRIFX+G$*[ MAX:.0-.:/(4@<0IMZQAF40`J,4)SR2B!(1;I\BVCV_4455]P0.%I!:$84+B2 M`AX@XIDJ'HP@1ZCX=S$RV;7(#7O2G7P"YN]V@-&UK9"XD$_"%"=T(:5I MLKB4"M$(*(4"E4(4J6AP&[;BLY-T:GY+H1 MXLXSH#L-'8&X<7-"?E5.40"Q8]NZY^X/ M"?Q.%0ES&/)ZODNIBBQ8K"FV[?=]$QA MGZ5U876'/F%3>N_&#+;YKJX2Q!"`M?INQR,X]0Z+V/VX,Q>B#(#4YJ3_`"8Y M&?3XZKUG$!D&6;-7BZ@?>3CD9?2O0<=Q>_\`DLR8=6[?5#5348Y^7]%U\!:+ M]UC2CXDKF.GMQBGHNCCDQ!DL:<5-%JB9=?U8Q3]!71QZ.L>=E2>C;L&\;ZXR M9/3\UMB?*L*Z%3_O`]J[LL426@%PZQ+EE%/9V]B8SY+A:<9("YZY8O$-J5*[ MLLL9LAJ`KW=?XJ_&?VBZRY!U*5SV#/,95.,>37XTA1J,@$9]"UVCLVXXV:-6T7:PS:NA5X8YF8+?C-6 M5*05/VTJM.(8YF<>9;,=U0>,P!_(!D3MJ,9"'#*Y9\PH37:HK1"*;@`NQ>O&>0 M8LFJY&_V=G[<05J`A5-N!"`]ISS)*4W;,0F'#H0B%H<5)H&!"6!"O:9_B6G_ M`-NM/[Q'@0O,]\#^97V:?.W72#_'>:Y8]7#U+E%]5*%%[?Y/?C0+J*MQ?LR4 MUQLPW^:RE7&Y=/0GV4RQT<3,J9/\U88:;%K0?=C?BJRY^:DBC-12:54]0I[, M=C"7B%Q\L:F**S.A4._G95'NQTL!8@E"QW+!D#KHK9^7\X)6@&[LIC;C-PN=FCJN@MY*"N[Z#9C=`N M%RUEJ!DN66Q$3?CM89O0KRF:%.ZZ2U MERS"T&53^S'2Q3:BXN?']5T=K-ET&O51-N0QT82>BXV?&%T=M-PEM=M>@@9Y M9_9C;&0(7&SXKC5=!:SI5RE@70VUPM5.5*=6SJQJA/=X M+CYL++CJIEU&IQ9467-RX5KPW.XD(,O MO(Z<,2ZKGY,.DEJ07)!S0U4@I0J$!&S$MPU6+)B,:Q6O#=%O>!S[JA"41#[= M^6#<%SYX6%/4MJTN0]W"]7``-*'AGU1A<#N!5!* MCB'=#FYDM0*-G2<+<6)"/8CY1D-36U'%Z?#_`(HGC`@]T(%*J:*?Q!`"HV[, M0$Y:E2_IX#S3@"!777K_`!4O':`\`!7*A*"NP'B0%7&J8>^1+DE6##`.T0Q^ M*NH_,%V1+4"._"Q"@):E:`*.C$"6\IT5N'$9>D4'@S4_*_@Z=UROPN4C:!WB M,S5M0B;4PGZV6J1IY2\F_P`[?JJ3YRXNH0TCA_==W\QPD(GW+A@L1U66&/WB M9-2W0_3Z?FR!)?C-&D9DFB5;WN]]>);I-=7Q MP[Y;I`L`/AOX*G-(I4HT[,@M5<UEKC@?S281!UH_7_`#5">8DF MI#A5>)0M%V!2M1N&$)#Y+1[6XT?W*>'U.O3M59Q_"BP[F,DN5Q`4GN@EE2I*[>]B)S;;?XJ?_`-=ODY)`\"UO$6\)"%"U$4@9%`>DKB$LY`9V"T8_MD#*,MNZ0;Y,U6M^9>E5A7+#P MN+0VM22C2"TD\2E%4MILWXA[M;U_BNCCX1,'$1?M<&]NSBXZK#N(P[-H+2T\ M0)#6*0I0#-PV'9BOWRUV*Z$.#&53$2@QNP'B`+D&QT=<]>0D`JE6NJ$5H*`D M$@@#B:C45!GA^^#97G[?.,7R,`U32@.O9F8-IBY^8DT6H5-YKU8JR>KY+5C9W-EAW!SW[#MIT4QS\ MFBZV$561/LZ^BN?NIC)EL5T,0E9-P&U/7]!NQFEZBNAA+:+(G;FNX]NY=^,4XDAM5 MNQDFXJL*Y;FHVYCJ.5,9C9:H,U%AW(5=G;2O1L1<49!3YK1"3T-USURW.F1R M.0VU^$$5QGR>GYK2&:BYN[J2H`7H*_715QDFWS3J$14DCK*'Z5../G&J[6`^5E7<$:B)4_3I7'*RCZK MJPKYNRIRMSZDXPRNM2SI2#QJ.S+H]F,A"L! M=95PU5(&7N'1EFM<9B'#*:Q9FY'+B6FQ,^U<9)!:`S4LLR04)VYUWY5Q1.[J M051Q[Q[/JQ4K`75=Q/$>SW`8$@25%^;>'=_TD._`I*N01F,9TT!P0FE/V8$* M.!"O:9_B6G_VZT_O$>!"\SWW^(7W]NN?[Q)7L&/68[KE24XMA`V]J=/37%\; MJ!H'*M1T)'8OTWXV85GD&+*XTHJJ:_T5Z,=#%;YJB6JL,5/:.O8N-^&[GJL6 M<#I5%9L+A0H.W,=(QU<)IW7(SAR41NW_`&_^MCJ89,%R,X,I$%7(W<)W4QOQ M^GYKE9(NM.(A,P**,]WU8OB1\EEEM_X8U+.N@M'A0-^]:D;, MDIBZ'I270VSU`*[1P_:F_%^+57RV[:?)=#:R956E0=IW;J8TP.BSS%'706KT M(*HA_P"CL7H7%\2]%BR1^BZ.W>37,[_IU8UXIL%SLPU6];O"#/?D5%`5QN@= M%RLT""25O025!KL`K3K-"*IC=BEM++EA"#V=:I2F.WQ,C+P_W+!N!H7*T+=Z4W(BCB1>CH3'=P3HQ7B>1 MCVR(_P`%OVTP4=299*N77CJ0D]1=MY\@24 M2AW="[%3%T9D>"Y>;$;BZVH+A"$)_P#)'9FJ8NAD-@N9EPT6M!PTJU*OM1:@VO>1P.3B`')3->Z6FJ4Z,9]LR6T M[+J1V,682J^XBK7?HQK3Y!66ZEPHXNC("$$.0E'<3G.1>ZF>TXFSAB[_`!11 MEDV'<\?;'U/61[7I\DGH%MAA$(@UWW\!\=2H_,<1)!*.)5R$;>*CBX-`:2`YB[D@ M!3CQQ*.R()FU>YO8Z?YJG),U(C@' M"`H`K125=Q&HZ,4G*#+H%T\?&$8?ZB&!_P`*_,*H]R$G,N;1KBN*#F+,"NACX1E+>P)U&N MNEN]/FL>=J[@4*M#BH.TDJ,P<1.4]772APGK(-VL?C]5@7+:DUX@H)J#P])* MK5?9A>[*QLM$.'&/FCZOB_X_(+$G8"I*'B<2:&N9)HM%WX#E;Y+;AX)()-02 M7I^/;L]UBW,/=JZHX4"&V-W=JM^/Z67,WT`*FFT#B M4U-,P#Q!>A>K$AF(H;*G+]NB:Q`>U:WI\QV\;+D;NT<2"":H31$0(N?PA*;P M<3_J/+5[P.(3G$V5<>/E MQW!8LQL&6))1W%L!VG8GU][&?(:%;^,);A/0'\56'XNJGM&>.-F('R7K^!!I M@ZH,M4&]??3[,<;.6/@O6\,$!VHLYYZ114Z#E5<?J6[$:`K&N M&J/;^SK(QEGZBNEB)C0K$N=O%MR/M(&,15\7?RK`GH#VJNS(?5BJ8<,MF.RY MVZ*':>Z![*U/3C)D]/S5\?3\USMV*J3Q&J-Z/:$0>_&;);YIEVHN;N@I0==< M]GO3&>8>*CZ@^JPY5W[">IPRR&6*#9782TFT65**.IG7W?[K<9\M`ZZ6,M+L MJ9"^Q1Q>S?OQR\UUV.,3J@$)L3-3O*U..7R`]EVN.6BZ"ZBE,R$K3IQR),&5%^SM^S%13C95I`1[<]N0IU8`B2&[+=T[L)2!I1# M?4+M!0_3LQ5.+50@/%%W?:F()H6!"O:9_B6G_P!NM/[Q'@0O-%]34+[+_C;H MKM[T[Z#'K,=URI?BI19"N9]^Q=]<7Q(U4#V5F/=VIL51[.K@*Y&<%ZV M1Q[C1>NA&6S'3Q%BN5F%2CL-`JY.0,6.BT(W#@"9K]="%&+ MXK'DH&*T[=V600]';3=C3#TJA;MJ\KM%1G_.7/\`FUQ=CU2*Z&V>%"Y(-G4` M5VYXNC+:75VV,8^9;MK)EL'>4JJ9!>W9C4"Q=5+H;>2@(7->%2M-_#L`RQ>% MDR1_!=%;2Y%?9LR[4&+X28]BL.2++H+9_"1_1'#TGI))0XW8YZZKF9L;T*W+ M>2HRKD@0@#+.B*<;(GHN7D%*+:@>'^X<4Q+@46Q;S9;E*;:[SU M8Z^+(XJO.Y<=UOVTW=%4(4@TS%$QOQS(/9W=C="9=C= MMYRF8KNITD*JXU0R!^ZY6;'5UNV]P@HX53H(IN-:#%XF#25%RLV&J MV(9C1"BT]WOIBW<5S\F(&ZU(;A2-A&_/ZL61FRP9<*U(;A$7H(">_HQ=[I[_ M`%6#)B6M#=9*4&70GLSP#,W58,F#HM&.Z(J747>4]Y%=V+1DD0]PLDL$3HKL M=Z0`WB=L-24!&1(/$#PX4I&5U5[9J9"`-:H!!)!2U'-#N%HR'X5:!\1:%!0>_&:1`M M4+IQC.8!`C&;`4[?-K4'XT5UE]W@6EP<%5E`CVDA[2A>.[Q9[5Q631C9:X0+ M[@#N&E*D:&]GOJ[=U;BO`QH(.8VGA"1U[Q4D/).T>_$)STU6G!A$0"P%/`4Z M]Z]/Q1OG02$DX24XLU"U0!:(#]^*A(1K*RT[#D;:P)9V?QI\>*(Z^#64<0`U MO!3)%&1*.S/05Q#?'=^:U^V(XVKM9P1^O7Y('SPJ%'$""@J'-"`@(ZH"U3;B M)R5I9.,-+EQ3MKK5`?>DJKD:2K:CNY5[I-`1G@$@&-Y)D&ND#;L?J?CP5:2^ M:!1"I#G.HB$5(KQ5(^[$3,FR?DB'BW?N]]=?\E3=?<2EI*!>)0H)VA"5*\7V M8#*8H5*!W>;'0:]*?7JW315G72\7>*"@)0$E>(@D.R).*Y9&9Z+7"!EN$7;0 M_-ZULZ#\RWA!*':3^(D]VG[O"T)7%$\U:.NCQ\0$09,9W?5_C_)!?.2:.&?> M1JDN%0"!N%%Z,9Y9.EEU<6$R(`'G>M+^+?FA.D!57<7$-@))0[7$H@7L&*I9 M"S2*[V#B,Y-?#\ZZ'\D&1W$PMI3/X0X[RM&M%Q7O M_!=*/%HU&)^*56%<0JNY=@RHHK3$/=U4Y<6)H/2N9OH6@.1A"D['(E-JA,2C MGZ6^JQ9N("*#7XU7*7T2E"20!0%R$(/Z0*K[,`RT<.L6?B$G:;>/^*Y:Y86< M0"DJ'(E"5):JT(&[$O%&2RUX[+ MG[ER#L[$&7[V,F71:!4/JN:NG\*F@1!70QFM+JH56H0_7 M3'-SAEU^/ZOCL@OS%*JJJ3CEY_4NQQS1CU0GJ3N*#O`=-:XY.:RZF(^5SU5. M39V_9CEYZ.M\+*D_+-2:I[1T!<8)?[EJB-H94)0"HW*AJ$4U`_G8S9-%:#NN ML>9V97.I45%*!$RIC'.3AU,+*F3B*;@ONIV8R:*\>LK*E!KT!#7=4CV8JE&C M*R(W/IPB' M#)JNX;".Q(\"%YHOO\2O?[9=?^NDQZS'= M!-45NT[\N[2HR.:)PXZ6* M2Y6<([#DM05_%U#Z\=3'JN5F%5HQ$.`&6W(9-[,\7`U"Y\P[A7H3^*J#9L0] M&\XNC+:J!%ZFRV;1P4<6>0`)7HI3=C1#U(]R?5=%:O)0;Z;-M4X=M,7=PE/9 M>*W87J,Z@5W'Z\TQH@7"9.Z+K=M9,P46G2FY.G%T#HJ,@UT70VD@7<%;_P!( M+TUQI!H^JP98LN@MY/AVIG6M=F->.;5%E@S1ZK=@D"9J,Z$HE/LQLQG13`2)6M#(3P\1V^SAS!Z<=/#.G9>?Y6&[*^Q MPI6E.GA;0<2;P!CK\?*5Y7G<:)?I8_'=6XI2TBH&8(W;Z':N.UARV!7C.7QA M"1846S;S!.D>]#]6.ECRKBYL3E;EO=)M[V[.G9F,;(9-8V7+S8'J++(.IM!IG[5RQICE[_`%7,S8:,RVH;D.4U">\; M<60R=US,F`B@6K'<"@)7<:#KQ=')(APL$\)6G'<`Y.7V=&PT3$O<.H6*>$]% MH1W()1I*`HBC/?MSQ>"0LD\!`HXG'(RRRQ!7&7'[U5Z1D M1LHE#B7NR"SRP]%:9"$\3`X.:>($N:2$X0"F5>O%4I"!`.GQ_@M6+=E!F=0W=Q4%[ M,S%K5:[A+Y_PW`%U2&A6K0\9(#BTHT-W[>G$2=X\MG5L9^S)[2VBK'Z$V#?4 MW2_,"0'.?Q'B("*C05!/"T[QOS[<5DBH`HM$93E$2)!).FGR%ZB[T-&#%Q.O MG%/Q`?".+AI0GKXJYIB(.TNI`38%B>FC>/\`BRA\V7'@!'#WAQ$M6H7A%"Y230*`U,Q]M<\5F9`O5_!;8X1,OM;&(L]S;0=.OU91%T M5!/=('`"TD@=XD*35P(Q3.>X?%?X+H8,3$."*,X-NE[_`)ZFB7S)<>/BJ`71=O#@!!-S\66?< M1EV:*,BA(7LKD<1&6.JUCC&\?CNLB2(*>\J`\*A#79L&7MPSE)"W2X@S%?NAVU4I8"VZ*Y^[CS)<2=@.\TJ*#KP;R*V5$N.Y<]% MR]W%F@"%J(&[LURP]RS2P48#\%RMY"T%P(0D<1VTJT"H.#=T6:?%$7)#?P7, MSCA<44!V5$`^U<4994\R6&'MS!%(G147DTZJ;*XX^*1M&JYC;M-!G48Y\G;NM6.9ZT67,4`7--Z'/?C,5T,3 MM6ZRIW5)S'L!KU8R2E>2Z.$`CNL6Y?\`$!15S&[LV8Q3+!ET<(U7/W;J'9TG MK4G&KY+7B'7TKG[DYC;1*>\[N%<9)^HK05 MSUR2>(=.7UXS3]2C*E1=8-P?B3,`#HS"(FRN*I>E$8N*K%E[I(-1[-I.=<9Y MFBT8JU6;+0$;1M_"O3U8S9-STZ+9B_1479])[S0?I1,<[+9=OCLY=#=L"_TO MK%-M,$]'V'&53(9` M*UW]._IPE)`<$.8).?MK@1JX4#P[?Q4P)H+_`(C],J?9B@ABR:"\#/:3]F$A M6M,_Q+3_`.W6G]XCP(7F>_/_`(E?E/\`WV[I_P#=Y![<>KAZ@N5*Z9GTZ,OK M^S%RBKC'5`SHU>C-/9C3B.BIR75MC]B[%&SISV#'2QGZ%9I51V'O4W)_T@,; M,9JJ)@[6U9'"K2O8N-V(L*+G98DC;JB*IZ-B9';\66.KCD]0N5EQO>R+&0O0 M[Z)G3'1QGZKCYHR?RT=7H7)0%-_3M^S&ZQ=<_(-5>C)4*I7X2-OMQ8"/DLIC M):<#\D.S+Z;QC0"X=5K?M9-AWA.FI4#%T"X9);\$BHY.Q-A"T3%^,L6ZIA;E MO)PD*50A-Y[M"G5B\%JISB;:K?MYJWX),@IIL7;NZDQT(G59 M[L=FF[9EC9#(]KKG9<`^:V[>Y!0U.\_508N&3]RY6;!HMB M*Z5*A=O4.GJQ9#(77/R8'O9:<-T&_C49)4UJ1TUQ?">XUJL.3CDZ+5BNZYIU M[UW';C3&;"E0L&3CTHM*&ZI4Y'HZ,ZX?N=EBR8'/=7V760!Z>OZ?5B7O'X*R M2XZN,ND0KGFE!EVJ,$&O< MAF9'9E"'`!U#!Z'6X)JI>-PE7 M!O&H0EP4`D```%6N*4W4Q`YG#"H6G^EC`O(".5PQ)T+:6!I1(RO/$0[@1BJM M%XB>Z@``Z\R4Q$Y0U:GX^**_^ARL3Z9`='UT8?G4DLY9+Q@>$N)#5*H`>,!2 MX[#WEZ<5G(W_`%?DM6/A.1*0(QBX85ZGK7H$&6[@B@?+<310PL;Q/DN96QQ- M`!*/>Z@(8.LXKGDV^8E@M>+B>^V'''?(Z=::L[`"I?Q*\?:EYF(KE'"P`FBH,72^U\H1>4\8+6BWK'GZ[G8'S&3::CRB0\"S-V/U=EU&E0 M`#BB60+N\?`6I8_1.YN9S=7(Y9H`*C%)S,.RZ<.,#_U+)G8J[%(S`[3O)3". M5KKJ8\-'`K\?BLN6,[D'2T=62(JTPCFZ770Q\>K:+/EB`!"`(=IJ.$TRZ\5R MS'6RW1PO2"RIX:N*`U)7ZZ5[PQ7[T=5(X@:KG;J!M:!2I)45SJN=#@.9HNJC MBC8BMW7+WMO0@`C8@53F!1`-F'[VTU5,N/`'=$,5R-_$%,.4[B^BW\:1;:;A5).GI/1TT[<8,M&79QR(9EERN4(:C:B4V>W'.R4HM^&3 MGNL^4[5H!]GV'&25BNGQ[?'=8UPY"3THC0[5CR)F.I?90=%,4 M3.BT8QJLR2B[CO/0B=28S3)_=1;L8>HNZINZ$.[,+6M?WD..;F*[7&#>""Y% MV])/T&.5F.V]UV./6+(3]I'3]^S(TQR8 MJZF*66/("'.&=>ZJ*1O[<9)!BVBLCV]2H3?$0E/>0@V[1NQ3)7@EFT5"047= MGV4Q3D]7R4YJH0A(Q4I*N\(56IV+6JKV8:B>NJBZHS0UJ@[:YXBP)?520'#A M/8/J^_%4_4@@$(;LMG;]G3B*:L:9_B6G_P!NM/[Q'@0O,M]_B-^<_P"NW:]M MP\+TX]2N41]$T94TRVXT`N'45<95H]XW]"]6+H':74)#<&5IIRWE.HKL[<;L M)8NLT[*P#V;CG[NK&^/14RLCL(_".P]._?C=C(?L5BS18N-44$YH>DT7(**] M..EBDZY&6`!9$%.G+;[U!SQT,4F7+S1O$=%88X"HW5'77Z\=#')Z:+F98N6[ MJ\QU*%>$UZL7PZ+!-_DM&%X:BTILSKN)SQHC/JJB"%LV\II3:M-N\]&+HD`U M270VTN73L)5?L3%R2VH'UHARRV5`'1B_&7#=%(N];K?MY]G%7($U';3%\9-= M4Y(4HMVUFX4!-5ZT3LHH&+PL.2+>*Z"UER"[*J37'8M>\F\8UXYM1<[+B!>E5IPS#NUW)V5 MJ<=#'DK5<;/@#$+0C>I";2E++SV;`02-%JP7"U&RJ;JXU0R?1ANM:*Y-*A1[-VS&B,J4J%S\F%EHPW2(N?0 M@7=3%L)M:RQ9,&HLM.*ZZ5.Y=B+7),6C(-:+%/`M*&Z%>$A20=H`38%H<6;^ MZQ9,!ULKT=X0*E!4`#-I]BI@!(LLD^/6EU<9=#]G[%.+1.E;K/+#(45MEWTB MG>^[KQ+>(^*HEQQT5EMY\-05'0B[R%.S"WQ5/L`/16&7C6D!2A7(EIR(`495 MZAA[I$>4U4\6*,9C>'CVH_2OYJRR]C"$'8%!<7GO*`UH'"WB`WXKD9DE:HXN M/CC$L;&Y=WZ`,''?\T5EZU>+C+&9F8>Q8% MJ"@;7Z&FMZ*ZR]!'&:D(!DA94(!0T<*YT.,Y+%G_`,UT8&)'N"+RH'`'IZ:4 M?\$47Q`XN/\`'WP.$EK2$H5)<>([<5DM3LMD20"='J`Q(<48W->O^96WAX.) MQ/?)0A2X@*!Q$IF[+%$*)KA[3Q10E4)2J(,/C8^1S@^T_VWR_ MNT]P\N"A)+L/%G),K,`5Z\).(;7 M%7'?C7&7"^VDSY,HYN6/_2/`+]$_VS_XC]S'#9"4,1J9%P3K0/0'Q9?&);`0!O[JC]N('[U/D&A8+[7]I_\`'?VG[;$2E")FW14_G[LJ\2N#B:!: M=F6*O5.:N10VYEM[OF+E0E([ZV#KG5=)C*<)DJ7:A:L%"UQ\1K1W2?\`Q]RN',YN-%I'44B?^H:'_>*-<:J[ MI]U!=V\,]K/'<6\S28IH7*R1JCB:/A<',*@M<`X',#'.RY2)&$G$Q<&A'B"O M,8.+EQ9#AS1,':0>(&BC8F:'&,Y":DKMX,(B&"S9VN+BM` M#10&BE1[L'O!;<>!C2RS9&)5Q1X30V67)@C$;XWLN1NHBT@J1T%I-!F.C/:NS&61VAUJ`= M<_<29[T%/K]V,TBP=6_FL"X.;LPGTIBA#U98MP:G=52N6[I*XJG?Y*6CK)E4 M9(F==@.=!BB1!*OQ`$,J$Q5H*;SO"=*9J,8\A;<=%NP#^8&5(EI*?AJ1_+U# M'/RERNWQ_2H(#G0'B_\`*-/YN.3FEMM==7`/+34LJQ&T9GA.VN:TSICEY"Y7 M5P^D?&JJR*NPE/MVUSQS* MN,*(>QV7:OLQMQ2<@]51,&QNK#3VU/6:E55-^-N,T5)1F'>JY[:D'/LQLQG1 M9;=%; M5O*6A>L':*U48TQD]0D8O&MBMZVD'=*TR)VY[=F+XR>RQY(4/5=!;R\*5'6- MXILWXT0DW@N=DCN"VX)JX_(XX(5]CUS`ZB/ MJVXW8LO1<'D<3:"`"RLAPV'MW?=CJJF9';[1CH0R.O M,YL1!((6I'<%14T%.C:J#&F&0-58)XW#+4AND1#D.B MB[IQ*H%/YJK3O%-I"C$?JUXL,@=KQ(C4ZN'L]'[?HK@OE>_B"?,7GVUY5Y9DNKN\;<:_K`\6ZN9'M+XH2!X-I&Z@8$'$0$2@QZ7 M[OS\/]K?9?9@1_69`SZRD?5,]HVC\NZ_5O\`X_\`_'_%R.Q"^=?=>1[6>Y6T=FJZ_.VUM M[>,22N<02YP:'>#$UQK*G07*\E:3YBZ%-*ZRTO1[(Z>#P.DO(_F'S-<>$\3''PQ0;L>0^Y8SBR$XO M*0OL']L?;?N/)^VPS?>^3/)GF*QC01'0EG=5>8/*FSYG@GUCD33M.M-6D'C7 M&FQ/.G07\OQ4#>*V;.[(/1I7-<82!9HYHAY1\6J1V*XWWK_Q MQBY$SG^WY\D37R3:8!=_+(M(#K$DQK1BO`EU9ZAIMU+INJV%[IFHP'AN+"_A M,-Q"035/@FA)/=E82QP*@[,,^F3F:E>L8G[M&U6 MW'!Z*G(U5%4&P"E31$2F$C,?7 MLHF['-RLO3\*9-"LFY=P\53D/?WDZ,8,A8OT7I.,2P*YZX>E/KV=5:98PY#H MNY@C4!85R]`Y<^&OV)C/*ZW1&AZKGYWYD]=?K[3C/D+ENBU0]86%<$DY@BJB MAVY#&;)=:8W6%<+F2.SI2G4F*9^E6,'=8=QF345K]?NIBE,66'<%*;,T%*TV M]N*IFK=$PLR4[*\2[#0(F0"GLQFDT:Z+3CO7U+,D))W@;-E5:$3&+(6\%T\$ M=0JSJT&PT4#I/75,X;Z;<=U]:4ZKAE M<"%Y;OR?S'4,B#>W=-X%P_9M-,>HCZ0N7*Z49R.W+^DE?JB5<;L7MQ= M&Z2LLJ>C<.A#EC5C-&*SS.XNK+2A`7-:;DVXW8RU-%3)&#N%$RW;$^K&N$F5 M4@C`J%^KWCVXVXI-)<[+"FV2,#1=IVI7K.>9QT<4BRYF6+/T4@=I7W]0/1C? MCF-;+G98F_5'8X'*FT;=VW;7&^$V#Z+EY8&)HKC'4!'1EL(^[&@%BL4XD^(5 MV*0T)WU7[AD<7#H-502Y_P#HIMW5Q;`N&0"8 MEPN@MY:YH?VAL@%;MM,>[WJYG9EO2B8T1EM+JK(`1M"W[:9&9$JJ[CD*C/&N$W\5@G!PM.*8(-QV`<15,\NC&G'D986M"O-\WC%S1%:]%6H MQT<68?)>5Y/!9V?^'U_)6XYN$A2=X*G+9LK7&^&4&JX>7CR#AE>CN%_=.5-W ML*'&F.1K+%/$U%H17/2GN7[R4Q=',LD\`*T([K)75)78ON1,6#.LD^/V5QEV M-]RIE@\4079IN3?O^S#]Q[*!P(HNR M6U)WYTRV=N'O&BB<1=M%/YY$`)`)!0Y`@TKQ+4UP&?1'M2T1&:D11Q5J(6A5 MV!%.PCZL4R+CR+5`L7R/M9J?XOHLCF/G/3^5M,DO[F8![8W.BC<[A+R`]H<0 M:HH^SIQQ_N7W'%P,)S<@UL!U/1>[_M#^UN?_`'5]QQ?;/L\)'+,^:50!&H,R M?@/3NO22_P#.6#4^9[K5-0NVF*+C(/B#A`!/"R,*B`#'BN!][$/N'_V/*D-\ M;`V`%0!^O=?T&_M#_P`=\#^TOL8^W\2$3R<@!RSH\I4OV&@7KUYA^85_SQJ[ MI7/DCTVV6.RMW.(!15G>**YVP'X1G7+Y-_Y#_P#)/+^]_<)8.',G'&AD+?\` M3'LOH/V[[=@X''&'$`(]A?\`P_-<*WB(WC+([:(!LRQ\H'W3E&3G)+=XKI;0 M0P%%IV4TL$K)8W<+V\)4%"@Z5!)QW_MG]R\OB3&\DP4)XA,-"A7FSDKG6:&Y MM[>Z*/+@UKR:.XCW0Y/A>0,EQ]I_MS^Y\7(V2A+^;J%@Y'&]Z!W#S!?1/R&U MRS.K07D[F=Z-O@K4%[2TKM"H?=C]+?8.8/N7VH2)\T#;Q"_.O_E+%FX1CAPN M(9@7/1B*?-U[-^97F>R=EKI5OPFO8NE-AU>T9+<11'Y348>&/4;%Q"\5O=`%_!Q9L=Q,(S&/.;LO%F8`_RS<:' M_'NN=S_MO#^Y83Q^;`3QFW4'J#<'NO37GSRVUKD:Y`NV_-:1<2EFGZQ"PB"8 MN0BVNVBMI?`?A)X),V$Y8!D%POE?WK^V^3]I)SP_F<$FDM8]I@?A(4/9>*KB MV*GB"D"@(3+[,6QRFZX4(GTW"I&!RT:16A#?8AZL(Y*T-%K@/JA26U$`.=5^ M_%)RC6ZF_18EW`0""*;2$HIRQ`90;JLQ>[KE[V$A:)^*HSV9#$MX9]%`P`7+ M7-J'.)#:A05*A/MS[,/?KHJ9X6%+KG[JUX04`4CB(+4&6_?A>\":K#FQ;03H MN)U»!,DK3ZT7MQ=#(Q7'Y.+<>ZX+46(7@<7$NT5[J%0*U?T8UC)1[KBY M<1$B`/@+FI30KEM7[L9,IJNU]OJP/J61=.'"5Z_M^LXYDUZ[CQ)`(7.W+JEV MW;N/V!,8YR)QKPD5I]W7BB4M466=*5VH4)^AV#&;)6+K;$,'6=(:C9[NU M2:4.,&8]%T^.&BJ[B0305*A,Z&BYXY^8AG77QU*$M,]N6Y*CZ\H^W"5BK."$C9^S&=-6],_P`2 MT\!/^-M:;1_'C]V!"\K7KG?F-^?_`)RZ3:`EP_ZQCTT/2N87T3,.A- MV+HR90(5QARHJ`G_`&:>T$XN!8J)[JRTFAS_`)>TXT8S5E3,2N5:'912AV[\ M;,4FHJ9#5':50Y^ZH_;C9"3V59",PKM)IM^O/IQKA(GQ"RY8N'1`X[.GZ^CJ MQOQSLN9F@X)"+TG)-Q*C8O\`.QT8%O%<[)#<41O54IGL"C93-<;<4G^:YV6# MT-%88^M*KL&_V8VP+QK==]>C9[,:HSK5]EBG`_):,<^Y"[:%'1EVXU0RZA8\N(-6ROQSKD-F+,U%Q>1QMSAE>9*#M'\G$6@[1C9CSAR^??FSYMWW-^ MHW$5O,^*Q:]S&M82`Y@/#1#W6)CX5_=O]X^Q,Y)G=R3Z8OZ1_'J5_1'_`,>_ M^/OMW]C_`&L<;CB,_N,JY=_ M<7W#,)3RY2(2T!_!?1O9A(@`.>OZK0S$Y=W,!%V4.,I)=]5.UE;;IEO.#PL$<@'Q-!`).0(J*8GCY6 M;#(5\O16SQ@T`JA,M+BRE89&GAH6R!0`2006N`0]1VX]K_;OWKV>9"<9;9/8 MK+DQ3`(-E[4>5_/;["&*)TQ$D2$%2"OX3L->O'ZS_LS^[!Q\0:7\LBR^<_W= M_;V'[WA]N8_F1*\L7?-3[V9TSYG/>\@ESB7$\6?97'TF/]V>[*A8+SGVO^U^ M-PL`Q@'=U"U=%YDEM[ADC)2&M;R?YZ;=MAC?(0]&M%:@4SS13MQX_P"]8,,SX'CN-U<=P\%YP9;Z7K]E+9WL,%W9WL3XKBSN(FS03Q%5:Z)[ M2"0:C(@U!!QR\F,BA#A4SQQD")`$$,UP>Q[>*]0?-/R2ON4Q61Q MS7$`!GU'0FDJ72-`=)?:9$,I`#+"/CXAWL99SGC&\.T3R?M4?)4RQ:CO#J/]MQH]EX`^7#D>%+7`%KF%KF.:5(+7`HYI!4)3%4 M^4XHO*X\89_CX_)-)9A%0FBKMRVH4QF/(+W96QBWI"Y^]MOB10JH=Q2@[,,9 MY7U4@"::KD[NU<]Q`0KT=&8_FXG_`%#!5RP"YLL.YL>%5K1,A7L7;BN68R6> M>(1KHN7OK?N%6EI7/;MHO3BR.5CV6++BW18+A-4@*.IEQ<-`0:;SMQLQ95S, MW'>P7C?5HB"\A%;^%OQ)U["IZ\;(3-PN/R,>T&VY<7.4);3,J/;15P3+U5O" MW$]P66'='/8@IUUKVICG9#HO:\6--RYVX=\7T3J]N,4[E=G"&BN=N'?$]EC/.9/2W+V>[&:9HRMQBKJA M*57W;U^O/&:[<:5J5HJ5Q@R%SW76Q0-M2@N;4D`JJ?:HVXYV2 M1JNIB]*&\]Q-IXB[IW8Y68OX+JX0Q^?ZH$A0IL`'O4TR3/'-RU)"Z6+]54=5 M5HH^RF:KC#E+CQ6O&U>JJ2YN%6:[Z94QEGZDU0D*H2OL0?4%)Q1DT4X^:551DH510@7:O0J9XJ5P M#!EGR*HHF=-RI]F*U-AN;14'+WEZT-13A/VXHGZRIR0R22OT[,035>0J:;*= MM<,*,DQ(X=O3EOHFY%PDQ55W_$3^W9]>*9^I25S3/\2T\?\`SUI_Z^/$44NO M)UZX'4;ZG_OMT:;?X\I4C,(N/2P-&7-*>)V0040?R#LQ8JU<82F8KPIU[5_F MXT`N'25IKNBJH$RJ4KT@#%D2]%"5!NU5ECDWE/BV4J3TXV8RU[J@JTRM%R-% M`'#^T8VXS1E20Q4QW2`#3N]N5,:82JZSS&X,$?I.RN_;L]N-F,Z+#.#N"B`G M,9FOO%0-JXZ6.6BYLQULIC9D,NH__4XV0FW@N?E#R/5&85RH.NJ^[9C?"?[E MSD(< MZ].W%T#HHUU6]:3*0`:]>U4%=^+X>I"Z*WGI3M3=M/OQ:DMB&9`$)V&M2N+8 MSTDD0_BM:&=$*CKV5Q?&1C066;)CW6NM:"YV**;MY`Z5Q?&7[@LDH:Z+6AN0 M,CL[PZZ=>+HS:RSSQ;B^JU(;E10IG]?1BZ,P158\F+206G!=?A4*4S&9R3MQ MHAD8]US3C@U M9E:CN""3GNR]F]3C1#.U76/)Q!*X5MLX<$)H?ITKC3#.79B+!<7% MW+X-K#-=2G*.VC?*Y3M[C"AQ5/FX\8><@!XT5V'[;FS2$,4)2GT`<_0+JK7D M_G"\89(M&F8P-#N*YEBB+L@.[XCGJ53+'%Y/]T?;>+666*]/P?\`Q_\`W%SJ MX^/(1:Y9OU/X+DN:9;[DQ@/,EN[2S+'))$)WQO+N``O:0QQ+7A5X7(4KB&+^ MZ?MW(@9X<@F1H+E=;@_^*?[JYGW#'P?Z>43D_=<`"YH7HO1+S7\U;OF:[DTV MPEDCTZ%Q:C7.'CN4#B<00*_LQ\O_`+S_`+QEQR0")Z_9W_`(__ M`/'_`-K_`+(^VQX_'B)?<)!\F1JOT'Q0+PC;VS[B3B69 MY')D999+Z1"!]`I!;S!'"SA8$:`%*A7&HJ:+CAY5UJA#:&"*V1Q1.X# M5H'Q=&W%.]7@EJW5J*5P"E[Z%1WCT$4R7$9>I:<<'BQL5N65V>,-E/&PA6D( M'A"M=CAA;0[BZO,"P79P1174(#@)(W("=BE.P%3@C*49C:2)!7>S$AI+1M;. M>P<)823&$1V1%5`.U8_F;6"1KZ@,)*]&]:UQ40ZRF+%I77L_P`J9=.U..ZC$,_"XD<)!^%X(JUV\D&N.?DPD'= MCN$IP!&Z*]?_`#'\B+6Z%WKO(ENRTOW.?/>\N<;8["_:^$ MH@F)_`Y%X_(XDJY./Z[F'7O'H?\`;8Z,;^9^Z_9,7-,N1QVAR]=(S/\`NZ'_ M`'C_`+@15>J-Q:OCDF@G@F@N8)'P7-M<1/AN()8RDD-Q%(&OBF8O\`%[,/W=%"6('TT6#>6H1P(/PTZCV*HQ(9FL[+)EAU7$ZE M"@DXTPFRR3QTJO%^LQH'; MPI/2%52E$[N.IAR.&ZKA\O`][A>.[DI(Y'9G9[U.Q,7SE11X4=LRUE@7A[SB M:T3K39V8Y^4LYZ+V'%]`\5SER[NGIIV&GV8Q27:QL]5S]P[,[=GMV]`QFR>K MY*]JL%@W)`KTE>I?OQGR:+5B;:ZP[I[50]>_ZZ4Q1/TK3#9^ZZP;F05_;7Z) MBE(DFZY^Y>JA*&OL&*9^HI$BY]2S9"0#TTH*@TV;DQ1(O71:(QVK.E-\5[4RV#WDXQ9)5*ZN("0_B7>JU)J.@="8IGZBI1=Z75&:J&$I*(ZEZ M*_9B)?1DQ:J`_)IWJ?:5Q5(5?125O3/\2T_^W6G]XCQ%"\D7CO\`Q#4`:_UZ MY"9(L\@[AA(`OHL$WW%[IXS4??TJ.JN-`54KJ[&=NP;=Q&_9MQ9`Z**MQ MNW[5*#K.>8H<6@LDK+7<)HJ$9KG3+XEBZR9!^Y6HWH[N+`7#J MJX6M;3(47<>')/:N+XRW>*%OV\Z-VIG78:BJ9XLC+;X)+9AG::`M).[9T!.G M%P+&ETEJ1S9%02#MRI7NNZL6C)U43$%:D-Q05]_;EBZ$VJ+*B<"[BZU(KFJD M@YJ=W05-5Q<)"5KK*<;BEEIP7"IL[:$$KD$S.+-Q%U1DBP8K4AN*(M`?L)^H MIBZ,V'4+%EQ/>RT8[DIF$VY=5-V+XY!HL.7"+K1BNT2NSI]^[%T,C++/$?W! M767(IO&1W^_IQ='+JLV6`VDZJU'<`I4[]R?8<7PR%G"Y^3`":JVV=U0I)V+B M^.9BZSSXH*L-N.D@])H?:N+X9SHL.7`&8!&;+D%7:A'%V@9G%\P$+MW;,71S@6=9LGV^-20'4?&'[U.O[-V+QR2*AERLGVT2DX=1?= M,:%+@-U45>W$9<\1N0H'[-+:X!?X[+HM"M=/N"V[U>X2W`#VVHE\'BCJCKB6 MA9&4H!4X\=]__O/C?;`<<9`YF^B]]_9__C+E??".3R(F/#>EP9#J>@U#5/5J M+M'^;W*G+D/RFE6T,TD;2W@M&,AA7U$1`Z"O7ZK'?Z@]48)'V]G9QL,3BV)X=(]X"AJE[B6HY,<[A\?[ MM]\S#''=(DCJP[D]%[+!P.#P`!BA$:"@7HOYY^;VL\YZM+%=3,$K97MFCM>- MD0>X`/HY[QQ\+0"=PQ[;GYN!_9?V[V>/(Y/NF45)N_8?MB-%V<.$1/N1$1F, M=/VCMK7O=GHO7>VMGSNXGJ`O?)RWAH6I1V/C7.YT\N67(Y$C+/(O\=@ML(F1 MVP]*V>)D30QE!T)T?[V.'.-4%ZJKXJN(;DS+MH<3D`0Q5PO5>2])>VX:A8.ZADC(#G`&G$/WHU[0<\0(,#N!8_'XHD` MUG"ZNUT_Y5[96TAE*,<4[K@2>$YTW8]7]H^\Y=PC,_S!^(^+KB\C&,<]P]"\ MJT6S\,LF:.$@C8`2 M<\]PQZGC_="2'-5S\F!A2R]HO+;7982RWD<>%Z``G)J9U_G8]E]N^XPY$=I/ MF7#Y6`PEN7MSRG=7DE[`+5I>I:UR`H5V."E6N]N.CFG",'-ESQ_`TG;DM1UX\UFY\(3\K+GS^X0%(FB\BV/+NHW;>$,+2UJ-?,61 M1/H.Z7RN8Q7=>,<^?Q_WD`K/'GDR(D'BZ\/>;/D6[F6QGU:*S&F[C%RL/$^X>;#DA'FM0Z3;2??I,5% MBXM'F\/C<[$#*DAZ9-6/9OW0ZQTO$@KY\ZKI][I=_=:9J=L^RU&R>&7-J\AS MF$U9)&]JMEMY6U9(VCQN-,>?R>]@R'%GB89!<']#8@W!%"O()E]C,`) MW&HD/]0.H_$6(7.W#`X%6H[+Z;\(9">ZRRB27"YN\C!7B'Q9J.Z!LQ9',0%7 M[>Y^JXK4X0WC2HJBCZSNKC1#,J,G'8+QGJ\0`>,R`>T_NCL..CCR;O%<_)BV MA>)];!1R("%V+ELICI\::XG,%#H5XONU$C@1FI^[($9]6-T_31.;FD_U7K.)E<`:+G;@YURV;C0+3;C)(DKNXI$AUSUR?VIN M3ZZ8S%;,0$O5=<_*]:+LW>_%$RY936#=.H\; MU5,DW)NQ3,L&497![K#F<"XDY*M#3?3<,4$L'3QQVO%^[C)E+!='!!P#JJ^_(I3WBN,.26I74PQ8,-$)>W M-W:IRW`@XYG(-&70P1!JAOR!^F;LDC/[Z+EC!E+K=$:JH MXYG1H#KS2F*C13+/2RIN'=;UGW_`,F,X4Y*OD2.SW_LPE)5Y``XI]*G#4#=1&6$ MI"R&\$CJ6FX9XA.WS3"LZ9_B6G_VZT_O$>*DUY"O_P#$M0J*WUUGL_CR#<,= MS'9E@D7+J;""A%":`(?;MQL!<=E60Q[JXUR$$+7Z$>[$@2*J);17(T*9]6ZG MXJ[5Q>"X=15EE=ASIM`.+`5&40588Y:'/&N$]199U9!!5"N54HC-M%`V[5Z,L\;\<]` MN?EQL6^:(HV="=--F_&S')K+!E@U5-KB#[SP]N\;.+&['-[+FYX$AU;8YK0F M6X!3]9.-49;BQNL$HE^ZM!RTS/:A^K+%@+4-EDE';X*Y;R(4)7I'MIEBV)B: MFRIG=UK0SHB;*YJ@ZDEEG$@]UJQW`("]``K3[%IBT%K65!AT6A'/_.J1 MDO[RU0[\3&1JA9Y8P?2KC+@'^:HJA]FW?BT9)"]5GR8="KT=RF8&VO6M=N_% ML)O477.RXB_=:$=PT-"$4]OMRVXNCE:]"LDL+U-U;9<')1OS^I2<6PRDU6>> M,CP5AD^51L'"O3OK4XM&6K:+&<+ED9LX%20N[0#A'"9 M+N1I)"MB5(PAVE>C'D/O/]Y<+@/",M^4:#^/QXKV7]O_`-@?=?NTAE,/:X]W MD')_[:-3J7[+>Y@Y/TCEW0KR_N'N=%T/C2!S M@2QSFM>0T-)*",`4QX;+RLW,R'+F+R)7U#A<'A\'%'!QXM&(Z66ERZYVKZA! M:F4LB'%-/("%\)A3A`R[SL>\_L/^V,?]P?=HPYE.%C&Z0Z]`_[=>O@O6J:.6ZNI;F8EWB2<9)6I9H.P&@71PC>&#]S\:LK1<(F-#0`0$:`*)PI557/'E\N0Y)F M9N5T,8`M90B:^1X`4U`*;%V;@N*%>`MVUAC@:Y\U&\-`34H.W/$2(^J=^BV8 MJ\@\B\K0:@)]3U-LC;.V M8?!C#:SW!7A%4XF<2#:,:.+Q0C`.3^27(Y6'B8CDRR`(LO,^D\L02PN?+ M"R(/:4CX1PL:<@:5*>['T?[=]CPQXX]T>8BJ^X73:+$^ MSF\&45:X;N\PGNO!IW7"HQ[_`.R?5Y7B5A(?P7ESE63P;ACR2A+0#D!7[3CT'VW[C+%,2!9($D8]!R?O?N8F!T7A>;[LI''"RZWFSU3 MZ?H1DL.7-/AO)X`8W7<[^&V8]M#Q%HXW`;FUZ1CSG)^X8<O_,'GGS_S$PSW.I7-M9SO[CG74.B6!<0>&.%TQ-U* M@;1*E,<4_P!TX,61^/C#C4U/TLN['^TYY(MR\QB^D*?)Q7\5R=CYK\\Z/<_/ M:9SI=Z;>M.`$=IS9I-U::%SQH)<& MMEN])YHTNT?8W_<;Q/LM6L[FQF)`[)$8LT6-98LL0PDS^28]N183("YC MGGDR'EIFDZUH.OP7_`#2;T\H\X6]HW3;J:XL&Q2ZERQS=H(N+MW*W/&AQ M3QNNK3Q9K:YA>R[LII[61KQP>7Q^9]MY1X/W"`ARQ'<#$[L>7&;9<,_WP)H0 M?/CEY9@%B>!C]CD8!R^%.67@F9@3*.S+BR1K+!R,?_MYHBH(_EYHMDQ$Q+#Q M;=`/:0<_WO>*>[%>[;JCVB"U5QFIL`8]N2=WM.[%L)5=0E$&+%>,=9CI)7(D ME!T[ER&.E@R67(Y(%3HO%6L0\1)WK5,E%=F.ECFU0N/GQ"0VE>)M6C\.1Z50 MN[W0Y<\=*&42#+AY(''('4+E+EQJ-W%]I^S&3)==_@2W5ZA4+F[HT>-R@^X?9C//TK=B`OJN?N7$`JX5R3ZTQFE)@ZUQCH+K` MN74BQY=I/1]7WY8IET5V$$&JRY#[ ME(VU"E?=C-*0)?1;\<6#ZJB_Z`;,8LA>]UT\<1&+!`(:$39GFJ@*4V8PY3UN MZZ6(':$,U5<^GZ$V%<^FH&,TVD>RFL]VTY40\5,N'[#C//U*<=?!5I, MB>[O"4S/XNG$"59&+%UG/S&Y?INH<52L58J3D4HJKV=/2JXSI_FA/))K1*#/ M+?A*Q5GKQ=GVG`E5^R@,"`&4'(4%5^Q?NQ&LH]TU8TS_`!+3_P"W6G]XCQ2F MN[U!RZE?[!\]=U_='CO-4Z\=J!8U6&1W%T2,[15$0_8.K&B$@/`J!'U5UCOA M3+8N:BF+PH25R-RCK7W5!'5BR!T4"K+2E%]J5SJ/;BT%D*PUQ%`%0?[7]&J8 MNA(1*JE&15EKD[F=2:4S^G7C;C.BHD/HC@J@(S0H>BONQKC)ZZJF47\41I0D M'X2=M`O5C3CD&K99IP,ZHJ[=HKTA!UID,;83?Q6*<`:&RFUU5&P>VB=JXVX\ MCTT7/G`71/J/01V5QKQY%ARX]O@B-?PHN7;O-1C=#)JN=FPL=P5EKSLV5Z]R M=H7%\9;:&RQR@157(GK[O84W;<6QEJ%BRP8JU'*A"'>$VY98M!!LJ3$A7X[@ MYDE$H-G4<7#)U1O*U8;BK41"M-WU%<6*6YO5=:L5U3<=X7,`>Q<6"?529:<- MRJ5H=F\[QD`!BP$&RB1UNM:&YR7JIX2N="F)"0-KJJ6.EJJ_ M%.1MRK1.]7+WXL$NJRRPN2ZLMN@F) M>X=0LF;"W@K(NV@*5IF>*A[#BWWR`Y67^F&EES^I:^R(.?).(8`H*(7RN&;6 M+D@QY3[Y_<^'[<^.)W9>B]%_;_\`:O*^_3;&\.*]9-4^'\3\EYA\F>5[[G*8 MZF(#!8M),4CFETG"U29C(?A)&/F7/_N7[GSYL9F./H*!?7_LW]D_9?M(W1QB M69>=><^6/+FSDB$UN)X6?Q)G$.E+FM(057B)%,>?RY)&1E,O M)>MQXXXALB&&@7SM\UO.S4^>)9=/T^6:#3FEWB.XR))P"0X-&;&'?NQFGD!! M:LE9"#S!R>D&B\4Z7J!9`YO$B"A.T*$0D("-NW"XV2,HCL5OG']P9;4'.-WH MKG/M$XW,#,R#0J,MA/:2R&6:X>Z1Y<25<]Q)`-:#9CQGWW[[R/NG+GS.2?/(T'^D=%HPXA*L MK?P[*,C@P4S2B(A-1F,>0R9#,N5J&/:*6Z*DT/>[+K/53IVXJ)!5ZT6N;;LX MJAU*N&U0Y!3$#53%`JC[B6\F$;0XJ@:UH+G+T`;3BG(7H/JM6`AFU7D?E;E+ MQI&76J!S(D:Z&`#O2.%4<.(%2!C9P?M^7ES$<8H_X)?] M&TEH:R/P1'&K/!M6`%!^%:5>I\-0N_MWAX8P]65$JC>%.%$.66.IE@)18^E<_C9)8V,;BJS M=3Y)L[YINHHA%XX-);2AS.1R(Q\CS8Q:&-)@E?&R7A;+P.1SF- M`5JC($BIQ'-]VCAQG*2_^D=3_!%]O@(C%B`&(?CUO^+VOV7ZJ/+? M]+;TO>2W+6E2;'(W-G/]]K4UO>:I;_P`NN7+VRNC:NU2> M?R4T26[GGU^VU9VL7$EKJVMVCFZI%S+S/J4\%HPL:_7=2TVSMDM]-D.-G"Y6 M6+"&3)&0_P#W&-&Z/2@![`DZ*&:&.4G(CYOGKV^O^:^,OG]Z*^2-;MI^8O+O M3+'REYEC),=OR[8V9.7+BT@U:UX(W0> M)?7#7QS1@^[^S_?^1BF,7+)S8?\`43YXAQ6)$?,6+[)5-@00N#S>!BR!\0$9 M]A3I_F>J^6UE;WFA:AK7*?,FG2Z+\Y>Q:%S5H=\R1KN5.9HO\'YAAAC/#%<: M;<7"AP:X.MIY6HDA&/N?VZ[Q(I,KC+H20OE MAE#1-!++;S!JEHD@E='+PDH2Q6'A)16H<>*>0)AD&W+$D$=""Q'R-%S)"+;H M%X%B#U!J#\Q5K=B_'*CZK)D&V5%XOU@GC?TA/?GVXVXS3N M"N7R`33LO%NKD#C3BJ2`"B?;LQT\,C9*=;3BD-$()]YK[<='$3;1 MP'%,I?N5^(/$>/PZRYB MJ>_")#JGFBU^F5<8\I9='"-4-V1'4.HT'U8YV:5RNCB#L%`Y M`=%*5*G'+RR9^JZ>$"4A)`>0T``'=MS;T_#C!,T\5T,86W`FC:;_B>G_P!NM%Z_F(U]^,Z:[+4')J=^ M47^O79V;;B1!V+CK@K)*.H2BU.S%T#1E45IQ.V*J9'I&-8K515Q MCSGNH1N.)`L:*!!N598Y$J*!.S;EBZ)<.HJTUP.1Z:CB3)5J#0XLB4D=KJH$ MRZLNE-V-&.4GJL\A%Z([233-`?9^&F_&R,WJ+JLQ1P04!*(:9ITTHN>-49:B MRID"IM3&ZFTKVNR7; MPT_G8UXYTJL.3'H;HE"%%=^\8U0R=%CRXS M4"'^CDO3FO=Q8)G55>SW6A%=_;M-.K9B0F-51*!!JK\=X1M(HJER@;Q[#BX3 M.JJ,`KK+W)>:./`-A!!D>WQ M0+Q/=Z[)?7#7S//"Y[6,:7$!K7.#0`*(/^ECXERN=EY> M/'XX$<<0`PH[=5],^3^9;#DCRA%W;E@G-@*A`XGPU/>"'/%>_;C_`-RW4>EU M\R_,GGO4>:-9O;BXN9)+=DKN"-SR6E[B5<:H>$T&[',S9V!B*%UIQXGJ:A>- M]&NHG7THG0M+`1E6A"*:T.#C96!,O443&V=J(D-P&RSL::-E<0*$(2<@NS%6 M+-LD3W6BFMD1I$\PXD+6U"@G*NPIMQ<.7,EBI>WN#RLKCWA`UI0"B*$HJ=@Q MGG,R.Z2LL$/A#M^S?4BB;\4&8=E*P?1.^2.$)4N M"[U"=EO`QSW.14`>[#J[`*8"\G:7RY;Z++")A'=:E*6N$8'&V( M%%=M3A.TI7&[[?P1I#(@$ M`:`0B#WX^M_8O[?$(@1B-VO^*^/?W)_=`$I3RR(&@%_`+RQI=K%;@$)XAX5? M10AR!W4Q]&XW$P\.-&.3K_#HOD_/^X\C[I-B3'`_I'YRZ_D%UEJM$0,7SR/71&#BD@!=58,)+5)(IMI2B9[4QEGF$5UL>*0#+NK-K'AHS`05(2 MHHJ+7/'/RY`15;,..0+BX6K^30W=1$TN)!?&XT?PA*&B/.P[<>1^_?V_QONT M-X\G*`\LA^4NH_)>T_M[^Z>5]IR#&29\:1K$FW>/0_FG;RT^V,DT##);NB^P:A=3V]I M8V3*ONKZ[FCMK"RB55EO+N5C&KM<,3.G1ZA9>9OG;K-SJ^NV3M3]0_)$W-.J:9;/;YU<; M6\NN=--U;RUYRU./7/*?E;5=2ETWGY_,-GK$3%A4L[5-7ZT`6PPB]`'HS"+]+[;G^+V7= M^H7T_:WYPV/+VJ\F^8^H\EW.F7\M_J>@\OG:!JS]8U'4] M5Y;?IG,6N7%]IUQ%&+C1CJ%W=F.681-;LX'W#'PQ..7!#-O``)<2QUJ8@$`N M*2C*A"QRC*0V[MK?0_-NU^H"^1GG5Y3\Z>3=W+;>9/*^F:-I$EU-%R]SE-)Y M9OY(Y@?<06UUILMK+, MRD`'`W[HZ5\W4L"'J=Q+!8L@,7W"GQ\?5?%GUG9]/U M+E?5+1M]R]Z\3_$XQE M^J^2<4C^CQZ;08GQC(Q_1<5JKT:40"I_D]N,F&1D%#*W[;KQ5K4@!-=^WX2Z MH`%:8W8B?P7+Y'J^07BK6+@#B%5))S/N*Y8Z>$2*Y.8M)A9>*=9F+B0%0N(Z M",E]V.E`[:KE9_/)C9<1=/H4J-GTZQA275X4-LAU9.VJ[\@HQ1D]/S6 MV`VBFA6=)4*:U/91OU8RY-%T,+`*OM^KZZ]!3&+*ZWXM>J$2**4"JOVIO7'- MS^DKIX1Y@-5!Y4G<%VUI0YJ?NQR\M!V74P19^J`XIQ+5.S)?K7&'(?H%O@VB MJDIWMRMV+N[:^S'/R']JU0C^Y59#EVG?^W&>2M51YSI6FQ%"KT5KU8IR:("S M9B`B9"G9F"5;C-DT5L;*D\J$3)=NTKF-JXK35-V83=3[,9[.%;J/`*J\@)Q9 M<.YE22IV!.U.FF,\[?-3JW957_$>SZABI"$_/LPE,%T%Z;JIF MO3NP(_-"I@2H"D[(4VIGG4;,"DC::GYIIZ9?/6G_`*^/%!N?%-=7?'_Q*_1* M7EW[1/(B]1..F+*A/$Y$4&@45S-"J9!2<6QDQ=9R"*%:3'%,\A3\5#L]F-4" MQ91-E<:Y(#.F-<)_58#EU::Y$"T5*]BI79C4,A%ZK$8]$=LE-X%,BN+07#A9Y8 M]0K`?3?]_P!O7A@LJ"'1VR."5IGU_;MQ8""H$$*W'<$$$;"$W<.0*XD"19#4 M=:D5T=_>*;>SCN*,ZG?D/;BR,O]*I5L7B"IIE0[^HDYXG[DE$Q"'>: MO'9P/E%W@E71$.("M=Q9A=RNW8X,IAJ$`KU`QRD-H7L9>^84DGENW1Y)"V:*` MPO9Q$%KFBH*%$7"EEC/&YNK!C!('U7J'JVH,:Z:1SLS12I<-J`9'',D:F170 MB&%5@6%\1<<;:_"NVH*TV[<0C,2<*$HU?NN@A<8WND.;S[T7O&@HF)NR4HL> MRN6MT77#F9`Y=5:`'>?JP`LK(N15:F9H*4V[3OZEP;G+:IJ9D1G"T=X#/W9] M&*Y1#DRLIBH97-,TFXU&8!K#P%S?$E>#P,&VHH7'8,2(E,M#TJ"[Q\VFZ0V. MPT<-FU!W=GND#A&:<2N_?7(#+&GC<:?(R#%'4J')Y,.-C]R9J`NXY8TE[B)Y M^)\SG<4DTCB79KFL`; M$^K"GD8K;@P-0>KJNEM97%"4ZO86KPG&660?MLNOAQ[;W796!HU4)3)%%0"< M]M,8(/HNRT^5>`T`5,@&[TZ,9Y2U-UH,`*!=SI\S:<1R/6:_MQ`EU M$=UV5JYKW->U&R(BH.%PS45#V9@P/<:I\*[CC MY?S/MO)^TH>AG^2U_\`I7D_R+L;75O.?RQM=2N;6UTY_.^B76IW5^+%]M!I M^G7'YA=22Q:HU^FSRB*U2&.X:Z)\Y8UP(.,!!ED:[_%_S[+J.'`LOT,5M?Y+@\NM'M6W)Y9TDE6GF?R MYKEI'J>HQP3!_,]]!-'QR12/9+H^^2R'[-Q?MN(&&*#Y9`@B1G*FX[@\HD>C M]L`S(P1V\J>:1K0"M`!<`:&M=3\@WT`Y:_41]//E;:7?,?GYSI#REK#K8:J[ MDG2WZASIS#KLDFH.*V>\1R#'A, M6#-ER?\`QXF8>X%+ZDT%>_R75E/%CCYR(EJ`FO30.:&_C5>&?-#]?#R4TB"U MTORE\A^<>>+&2V,TVK\[W/AC7K?2I^=>8]79ID'AFS@TRYN+:]T.WN8[N"!L#9K9 M\;(6%G"0XNQZ##_9^?$!ER\F..>C[8#O<[J#HRY>7[[QYG8,M_J]\H_4_Y@^5^F\VL])GG3Y5\E\IZMJ7/VOCF:YU37^7(=(DTR6UTZ M?EIUZ?GM%M].LYGE]C=F66/Q'ADC@2GN/[=YW%^U.?+XF;WH1QDP,1(&, MMQ,ZU<_N&K.%P?NN/+]QXSXL.6$H'S_N#+N^\3(L,>(>+8POC6#H#DR%K$><_-$ M"53_`'2-^_'5P`,#JN3G$@2O%VI3%SB"HQ5-G[JS$P?HLN3*F0=3WXSY#5EKB*^*SI4XR.OL-5IM1,9YFK+HXP& M\M:JNN[;MV=*G&"9#5LNCBC3<+J!S<1D/;6F>>.7GE^U=+%$&HNA',KT_;4A M*`'',R$576@VVB`Y!7ZQDQ!]>*#=6`M54WFFTG-=Q'[,49+_)6"RHW!J$VBCI5G[5R4D>WVYC$5 MRN7;C/DT4P0S*H3Q%?I3]HQ6DH.3?7=[??A*8L@/SSH0J;@?B`H/ILQ>"X=0(8LK\;B`=E` M5V=.-$9;O%0E96@[> MS^<5[<:XRT*J(4D)V9*M=G1VG%XEH57*A1F.6A(/7FE<]^+Q)RQ6/+C844\J MC&N$R?%8\N-O,IM=NJ3P[D.9V[AC7CF66.<'/936B;QQ`+[\LSC=CF0N;FQ_ MM1&O+5]R;T^BXV"?58,F+S=$=KCL-:954USIBX$QLLLH_56!(5W&B=>RE,L3 M$^JJE`&Z.UW8F_I_DQ8L\LBL,E1*GVTZ^BN)@@J"M, MN"WJI[-F[$@2+(5N.YW9]>_WXD)D71IV6A'=$#XOK6F)B0-DE:9==O;EVUQ) M"(Z[#6\1-!13LW=)3!OVU5>1F?5<'K^LNF>86N0`IPD[_%(QS7-)H7!2#6FS&2&2437TE:Y0#5NNBU#6GOCE:'<,4O>+0: M*6-!/:,3E(FINC9(KQQJK7W!:]A<4`))J`IR7/:JXHR1,A16^"CIEI*YRD$! M5I1$&1.\;\*$3$54)6753EK;1C@G$PM5<@A1U.W%FO9E.X[+.\5T%U%.!_#5 M79(B=XD(J#$92VUT2`\K%=&R[9,QIC+3Q!$W;UW=W+"CZB1Z4UU.AZ,[427/ M=X<#/C+DXG&CR&[`4]F`0,I/+TJ0=B>J[9IFOW,T30(>!H1DUTVA;0#A:0G> M*U.-6.#E@6BH2DP877L!I?E'HG+?(,O,&KN\;59VRR@N1TCF-:!'&TE0S^)T M+CVG]OL"(8F-"#NM)`VK4=;: M8^T<<"&,`4#+\]I6_;W04<7X$(W+L/TW8MD=Q<*&*_\`!;]I M>"F5H!`%!(V@U=L';BM7/+:0+LNJLM3`*!R@)E3;DO;AM MH5$N2Z[W3=58X,4[J[]I`Z:XRY`8T"MC6INNUM+T$!"SB#0`IX@X(A#@BECP M4/7CF\WC8N=@.#,/`ZQ/4?J-5OX'*S_;^0.3@-=1I(=#^AT6)K^D/N?Z[I]O M-,^18KBUAC=++'(.\7-:U2YAC"JE17?CYQRHR^W991@-/W`W!Z'X[K/Y3U77^5M=TW7N6]2OM#YAT>5]UI^K6/8;R_U&_OKF^O[B=UQ?WU_/+A@Q;AZ=`%$^8FOCU7LIZ?-:T;E;FFTDYKY?T#6=+-U"'G5[1MY\H6NX MFSQQRDQ.M^,@O:06N(!<"F*8_<.7^V1C`"T:?XJ$N/B-9!SW7Z4O(?S9L;;2 MK&/EXZ?I&GM;#(RUT""TTJS>?#;PS^!IL5M%(HIQ.!045,9LI]SSY'F3K(N? MQ5L&B-L``.@HOJ7Y3>9UEJ5N;#4F6>HV-]$;?4[#48(;^QO[6=A;/!=VMPV: M"ZBE:2'->UPKB!`D&!8W4E\4?U1OT?H;71M=]4GHTT*>]T6&.XUKS4\C=-;) M=W.FVT;7W-]SAYU[2A8]C@A!J#GCZ5QLL91$@:$?(KY-FPRC,Q((D"Q%B#J"-"%XNUN* MDA)R4!1]7=..OCR:A1*\1:S`*Y$-4A6A0NW(8Z6#+HN=R..X7BO5HN! MSDJ*A:FH[$KCIX\KKCY<&R0/Q1<;/V?5 MC+,O)=[%'<5SMP_XC_2I[0,49#HM^,$E@N=NY$)JF?VXI)`#E:)M&.T+GII% M=4U:M3T?T66.3EDTNZZV&+!`<4!JN8*]>\4..?D-UTH0#-H%6<=BG/Z)6J) MC'D-66N(-M4%YVT#=FSZZYXPR+ERM,0&8*G(/6F6X#:G3BC)8*>@5;,[!U8J0+H3\QU? M:<)2%E7?GMR^TX:7U4'U:`H[5WX2:8#NBE21LJ#6NP(#@31]-3\ST]%_XZT5 M,]@D]>\XN"A)66$`E> MS$HRV^"B5::_>:$[*_;D,7)*P",]U5[$*[\\61+J!9MX16O[54@KN_DQHC)Z M&ZI+WZH[3\)!JO5397JQJ@7"KDCCL[-O3C1&6Y5RB]%+=5'.-<^G;NQ?&7T5 MQ6.6+YIU14/7U5]V-$,K762>)K(C92*E M.S-5Q=&;^"S2QAVBK#'[J_7T=A3%L9=%1*#71F2=*[-FSVXL$QK=42Q`VLK# M7JE:4]F7V8GOBL\H$710[H9XYWW3FQXO&ED>H"W? M;^%/F\F.-GB2O'%]J0CXY"[>:E,RH4@5)3'Q7[AS\>X,XFM7@!H&DCA.=4'7OQQS,R.V*Z400KUE;EKO$*AU06D(&O M`V`UX:HN+HCRL5)7;R7^KN0JC.(E2!TC;A`[8^9`M6ZT](MH[RV*@4!`/]$4 M0I7$X^:NB/"R.(Q"]P#0-Z;4H*]&$5">B4CQ(SPNKFN1W@\.$XD\#=6*=D#$\AIX5[O"!0A%R(-<1QA MAN*`NZTG5)IHWPQE[&T:[A)!T*H M7I)HI4G&SBXCFRB*RUOD0*`![44?[ M.*B7HNC#'L\5TEMJ30!WNI"#EUT7%:OHW9;UMJS0`?$&U=F>X8%&1C$.2P76 M:9K3G.:TNHJ@Y=G4<0G&E`H0S0=G7DW1]4<0QKG*109$FBMZCC#(,5MA)XKN MK+46-DBD<9#&[@9F70 M_P`.J[OVG[ID^U\@9L=<9]47N/XC1=AJ_+\,$-KJFGW1U30KL%T%Y$U0UU.* M.X:GBP7$+E$L3^^QV]J$_->1PJ^I\;G1Q1E0?#$B%`SQ*<2=U:TQEEB,@X]8T_-:(9 M0)5])75Z1H%N[0]8U4`Q7]E/90OMVM[TAN971?&H#F.<"*@U1#7%>/%DS/BQ M.3<#PZ*^0WG)#66P\ MOS3_`)CY\>7?+=D/E-/CO)))+CS4Y>L+9H;:V$=PX?F]M$SAA+_F&CPO$$/N M/[4_N#VL@^V\Z7DD?)(_M/0]C_CX^$_NW^W9H0<0`ZCT=N-4IOYNRS\=XY-M@ZY>\-2N1]QK[Z8S=UWN.1K=O09C:B4W[-W%C/(@EQT4\FBYZ5Z%Q39[CLKEBJ9T481$ MC6RS9'`EQXD6ON%4QGR%K^E;(!V!6=([?L)';TGI3&>9JRV8HN=Q58D*5*?1 M*8QY)NM^.()9!-25)7(=)R&S+'-SS9WNNC@#2#IC^$;A]=5]F.9FDY<+IX(. M*]$"0U1,OK5:=>,$CHNAC!`14[3T M="X@2RN'754'',D&F[//;[<9I%RXLI>7NJV(I*#BIZ@GLPE,607H=ZIT`?%@ M1?P07)MRP]$OW*1R&?2J(E-D)V)NN?/%5A= M.UQ`-5"9'/H3MQJADT"S3QC12#B4'U[O^SBZ&30K//']5-?I[1U[,71F1:ZS M2Q#]P2!*"I3KV=IQ?[E*K++#*]T9CBB(37+ZEJ%SQ=&;"E0L\X5+W1VN.=2G MM6I'2*8N$G\Q6>4""R.V3II[4VH-B5Q,9`?2J98AX%%$B;4^@S3#&3JJ-A.B M.UZ@$$9)V8MWCJJI1(*3Y^!I/`4HBU-2:@NH< M@HQX(DS.T>E>^`:@5^UL^$+PU(`>N7%L`]C">)KB"W+ MG$,P6O*7=YST:2KC0`=>+U8@VQFN)`(6N+-.]D,>]^S?V_.;9,@;%U_AU7S7[[_=..,CBP$2S M.:=/$_PJMIEW(]YEN)7/F=5SW5<=XZ,?1^/BA@QB&.@"^8\G+DSY3ER$FW?G@!Z*N>-X]U?MKJHJ20ASVHHVX MA.1%`KL6&@)#GX*Z&VU`TK4Y%4]J8I6L$+>@U%W<(>HRJF?34XCM5QSPQ0BJX!`L^BQYON4',`6726ESW@2^E/9LILP]&64\F4S1=MIM MV`BD$C\0%"*8K97PRF0#KR#IVHB-K7<06F>S>@Z$Q@F&/BNA@Y!B&-1^2ZZU MU=45X%*M!6F_IQ7M#,M\<@D-P+177:'S5>Z:^7Y.YX8;D`7=K(/%M+MHR^8M MW=Q[V_A>$>W8=F,G,X/&YF,0Y$7Z&Q'@?@+H\+[ER>#E]WBR8ZB\9>(_6ZZJ MWURPE>909-,F<>\&M^9LWKF"""YHW@C'C.=_;N?"3/CD3CTL?I;Z+V_!_N;B M^'_#^<\,<4,C>Y=Q#B:C@YHJYG$EFB9F+JU\3*(M`$2P$T/^D]">G1<2S6W6Y;+;O(DB'$PE6M('Q-S#@:)T'I&.*( MDU72$#JOK3Z+/4E^>6\7(?,-_P`6J6D33HDUQ,`Z[M6('6SGDJZ>W0=)"8M$ M1*+FZ&8^*^TGE/YEW&DW=LQTSA&#&@:X!I!%5)S8FC\Z:#-REK[+/5--U>RN+&6RU.""]T^[M;^V=!>:7?6EP'P7EC>P2N9)'( MUS'M<6D(3BB1'J!8C\%*<)'S#UA?AO\`UH_TY=2]!GGJ.;>1-.NI?3+YV:GJ M.I^7=\P33P\@\T.Y>KHFVW&;C2))''YFP/!QOF@GX?KO]H_?/\` M[+C_`-%R3_\`-Q"G^^(_4?EX+X__`'C]BC]NS'[KQ(M]OS2`G$6QY#J-!#)H M+1DXL5\/-1NV'B)(6JDD]7U8]OC=JV7B3%@O'6JS-=QY*X)V`US5,;\)`^JY M>:((JO'FHN"D]J]9IUDXVB5&-ES\D#'(X%%R5XX*=Y^L54[<53D0*+KX6-US M-VX=[J3W9@]N,\I;8OJNIBE5^JY6\RN*`[*4MNZJY^X=0A!38N[ M?M(.*92:JO@.RRY34J=U>S[2<9)>E:8"CJC(ZB$])[-N*)S:G9;L<``VB"X\ M(3]X&NZGVXP9F@" M^_->W%,NBM#O2ZIO<3U#JIT;34XKE+:.ZEL*JR.**O50*<9I':'U4[^"SYB. M(D5+0!0C:J+LQ0FJ4A.1"#>>FF7;BB_(X@K0[5NJ< MIHN2@N<2 MF&HO]$V=-X(7=]N$S!2!D?R',)C1`L6ZJ)H'5P/*H%-%3HZ,7!1DK+75 M`4U^PY=&)1DW@HEE;#@=G30[4^[%RB0"&-D8%"B]/:6XF"Z%,%$=0;BOOKT8 MLC)BZJG$"H1VN*`;T(S_`'=FS&B,M0JB'NB\5:B@.RNPYDG&B,GJ+J!#U%D4 M.6F]*;^S?B^,G/0JN47\5/X@H2J@Y[.BI%3BP2:ZKD&H;*;'!4^[V#HQH@7# M+'EQM*BG2G"??DO_`-5C1')_J666,GS)L7PFPI4*B<"#W1%X=W_2!/U8OADT M"S2ATNGXP<@GTZL71R=53+%7HICK!WD;\7PR,5GR8RRF'(@0;E.[=B^,Q*FJ MP3QG_M16RU0*.M/VXF)&PLJCCZHK9`NTKMV?<,2WR4#$'0(K9,R2O71%]V)> MX&[JF6(2+ZJA>W(:QSG'A8Q25/;OV8X7WKG_`--QS6I7>^S<`9\T7%`O#^J: MG)=W;T<[A:XM`VC/@;PIF<\?'.7R99\QF3%M`1,"D`H4/0H7*H)Q*?I*"D+A48UM-U0-R(E-^&"6 M(VE*F@SH5R"G+;MQ>6=2(%RO)?EAI]C<7+9+QH8]'TVWA;P=PN:-H!K0_$@P$Z"Z40;D5=>/= M%L9;RX9"WB3XGNV,8"'*JU397&KB8M^5[1%UFY>80QD:KRJR_CTJU-M`&A\P M!E*`NX6A&CB5:C'K_M?']_D1B!1UXK[OSCQ>-.<2]#]/XDK'AFH7.^)Y+G=* MJ:YX^G8HQQP$8V"^02.\DFI)JKHNLR#7?09]%,6;NZ(D,C-NSM.6\]'2@.$J MRY-O*B,N%VJ>O-!F!+ M<^E5S!J:XN]NG=<0\H@O3:/C5=58ZAQ$`FM$*[0G6HQ1.+#P6KC\@995-.O\ M%VFGZ@&M:K^\$'OV5KC+)G;JNOAR#:";LNNM-5``(.T)WE%=IR3%7M=2M,,T M92==!;ZL0`?$KFGQ+L^O%.QK1JM>+,0:672Z?JA56/1$4*:C[L4R#%EU\1,Z MA=;:ZEQ`=Y%Z?K*TIBC)%PZUP>X5XWRBJ.KG3?T5QRLW#<[H77:XWW#8-F0. M%H:-S7<);39Q2@?A+@<7(^T M3Y.(F/\`^1'T]^WST^BZO#^^PXF8>X/_`(DBTAT_W#PU[5T6KS?'!&R#F+1Y M1=:1J4?S;9@WA)CE>6&9[&IX4\,P,-U'3PIPN1&/GO,XQQSWQ#!V(Z2U^1T7 MTOBYQD@(DN6<'J.K]M5S?*W/>I&0I'"CD5-R8Q9`T- MAJMF*6\T7T;\\/(_RJ_4$]+?/7D+YJ6D>_F3Z=/./3OD.>O+36W MZ=/>1,F9IO-.A7+1=6/#7M+1^A?M'W'!] MVX./G\;T2'FC_IEK$_IV7Y\^\?;L_P!FYT_MW*\VVL)Z9,9/EEXCTS&D@>H7 MJK?7ZJI&TURS]@QV(#;XK@2EJ5R%[.UQ4$;W*@5,N&IH,6C)("JS[`9.5R]W M.KG(31??7JQ$EZE;<`(7.74K0"#4'LKOSHA.,TB]5U,7E%=5RUR\$KFX[_K3 MK&*I2#*Z+'S#58DS@":5.S.FT=28S3F_@M$`;&RR9'$N792G3N/7C+DR%NZV M8@;BRJ.4%5KL!7;T9XR9)NZZ6.$G'5")6F5<\ZU3I6F.;GDX*Z.&#FB@X[,Z M@<6S(DUQSLDG)(71Q8W/F4'NHAVT-0F0S6H3&298,M\(>9RJCC4-:`36FS?M MW8Q9)@%UIB"S:JL]P:2N]P&_;]^,DI.76D`GQ561V>T9]`-!U*6XKN59^]5) M')14"=A.1Z,L9YR!.[1351Q14W43:$.?2<9Y2W>"&TU5"5X)0N2O>([W#NZ\ M5REM\5(,];*B30M]M=BI]>*#U5D-8E57(IW>[^3$#96*D\\1(&7XNHGIZ,5R M)!8>I2J_=5'FJ;OMQ0A#.1ZC]6!,70?=A*:`E0ZF).130J%X]PCM<*T0#KW4HRN)1F=%1*#7LF1-H3*BYY9KBX9>H5'M]TZA M:D."4.?3_P"5BV&2CBZJGB`%&3AR*-A-=O7C1#)YEGR0)&U3)![HVBN>?4>K M&F.1Z&ZRY,7:B<$;14$MW;%_;@EF`B3T1[3D1`J2L#6)G/MI(F$!Q:0/A^+;2H3'SK^XN;[Q,(' MLO>_8>%[($I"MUX[M-.?\QQ2H0WO5`J07(2F6/%PPG<\EZLS`70.F#49$""0 MGU!=Z8T-5]5$R)18HG2.'$M`M:A=@`I6N%*6T.K`[5NKS6`$*.L`C.@ZQB,) M$T-TPM:"(/C?E5AX3GWF$D#93$Q&_10=B`++@G7,FFZC.^"@+U+5"EKBH!ID MTCH`7&8DQR2Z%2U=:L=U\Y(V1FR3G+!4?-`EYF7..>;Z]GNWNX^-[FM<:N-2"FU%IV8C4R_ MVI2EIHNVT:XBL87HAEE`+SN#2O",Z'';XL&@(Q7$YF4,92/9%DN))I#(\KXA M4@YI2G4$`&/?_8N-[8.8W%!\[_@OF7]QH$_HO M''%((@N!L*9%/=[\2]SHH^V19$%P3^(43K[#B0(-E$P.J.VX1"3]/8JXGN)2 M[$*W'],:(R,;67G,N,@D:+H[*]$:-))!%'`E2[< MF_")F7=)**F[;B)BNEAF;&R['3-1#FL/$05 M)SWD]Y:A"N,>:%:+N<*08"2Z^VU!P'Q*37;7,[MAQF,7#+K0B';1:!U)%[Q" MIM)JRV+F2-C5\UDZ M4$.\-K_#FM9CLGLY`8WC:$.W'S?+C,)&,KCXIXZ+Z*")!Q9>>?3+ZB+_`,FN M?M/U!US*_E_5)(K+6[(/(9):/<`YX`/"9K5QXFG/A&*I!PR3:ZK]+OEMYE6M MU9:3S!H]\VXT_4X+>[MKB$M>V:VF`>PE[*@GB0A*$5QS\H)D0;K9CENK9?87 MTN^>)T^[T]EQ<1OCE#89H`_A,T3@.-C0]!PQY@YDBBC$(,);9?'^2MRQ]R!/ M[2O3[_4$?II6_K8]-\/J<\D]"=JOJ-]//+6HZI8V6DH;[S1\H8G2ZMS5R*^! MD;G:GKG+;_&U318PX2&7YJVC:^2YC:/8_P!H_?3]E^X>SF/_`,#,0)?[3:,_ ME8]KV7B?[G^P#[WP?;QL.?A>6(]?]4#VF+7:3,SDK^M$K0'XNG#)`NI#$[ M%J_HL&XN*N*H"=AZOP]&,\B]1=:H0+L%G2N1=X-.@_>F,9/U6V$ M0JKJ*-H_I(6[O;C-DEL MFB]@QAR2I5=*&,U'[2J[G9G?ED#NH@SKC%DG6BV8X/0(#C5"2AK3/HSKC%DD MY9:8!HJM(6D[LOBR0YIVG%!NK(O<*J\D]XFFP#JW8JG(Q+!3,0JX8HR'12E4Z]D$%"#B22..RN=*]% M<2BA'8Y#TYE-HIGO.)I,'?56X'(%'2B[`-R(AQ;&0`JLZOM>"$%`",B!N]PQ'&1!<*,HMX(X MZNX+LR&+P7#JJ47\40`C+;0&J>_/%HR=5"1JBQFAKW4!%T'O.J&[2`?LQ7$^VIMIHND9S'/)"VUC!!`S!0*=NX=W?B\9'%+J+>9 MUTEC1].T[Y6P-[>%'R#N`K0'(@+ M^(Y8]A]JXDYM(W7B_O/-&)XOY1=4_$4DC+\(!(IQ4Z#3'OL`&'&,<=!^.J^< M,O0K+[(=CT4Q(0M#EDBTWURP][!W4#B@"Q1& MR`(33:NW*GOQ9[I-F59P@TT1VR?NGIKLZMF>'[D1>RIGB`#L4=DAI7-%39_. M&_%@R#U+-*`%K_%%<9,41=V1KLZ-F+1D!NJB.RT(;@,+0K?N)VGHQ9')N6/) M`EV%%T=K<@@5[P&RJTWXM!VEUP\^!G=;4$ZM4(=J+D-I'2,71.X.L7]/KJM2 MWO7`!75"(X9A,URI@&ZTK*49F),?W+?B7'RG^X/M4OMW),!_P$;H'K#4>,#^#KZY_ M;_W*'W/B;Y,,X.V8_P!,VH?^G(+=UZVW&ISV=Q-;S1R6MW;7$L%Q!,.&:TOK M9[HY896H$IQMT/^4G,]^73<)EY9?='Q M`1$UWC:",JX.$N1W.SIB-BQNJ,T#DCO`J%^$K_4=_I=__F6^H)GJ?\GN7C9> MFGU+\RZC=:CINEZ>V#1?*7SMO&SZMKW*<++9C;33>6N>XF3ZKHT8$4<4S+RT MC8V.WCXOL7]C_P!P?UG'_P#J^1+_`.5B'E)-91_C&WT-R5\G_O?[`\C]YXL: M2_Y0!8Z2ZUJ2:U=V`B%^9F>ZS'%O4KT9A<>]),KKYY&/^E8TUT:JX5^G8J8J ME-J*^$-U`LB:X454!/MZ,L9IY%JAC%@LN697$4[4IFGNQEG-JFZV0QZ+/?)G M7KWD95H[8<9Y24MQ[(`94I7(M5:/<=]=XQGF7/92`T"I3%&YGO4W!0G>'7B!+! MU/S`?[2J8)*D)7>!E[<\9C=60]*J2.13L5>G:=R;,)35.1U%KORV(*=-1B)( M(4J;6U5,FBH>@;<9Y%RZ2KXBFAN^(]GU#`5*(U0GN.7U[144Z,)204KAJ#59 M2PE-"?\`:@ZB,53-60%9TS_$M/\`[=:?WB/$$UKZA_B=_P#V^Y_]<[&['Z?F MH$-%#.1Q8+JJ5CX([2M1DM*9A/J7`+IHK,S_`$3]F+$C8JS$X`)M"ITY5Z,2 M5"O1D\*;$IU$^ZHQH%+**OLVG%T9D"EEFG$R45Q8)]52RD]X8PER=T9JN04#:F*\_)&+$9ZJW# MQOM'%*U;]G7A&0T4#`:54VO3)W9[O?@WEF5>WJCA]44>TIOV9 M'`9O751.,&ZDUX&U-Z$9G:2JYXEOD:U54L#VNCL>#F02-F7;V[\2]PWT5,N, M+`*RU]>'+(9]?1^[BR.9I.5FEQJ496(YBH(2I7[>VF+\>&<+AY\%5K17*?"[[1UYXG&;V7/GA(-5>CN@O;7IZ^O%L9$65! MQD%UK6UZV@6FUI(RZ-Z8O_W1NKL<"34>4_+Z+H["[/$T@@@H0"@_G&N:+BK( M:5NNOQ(^8$6Z+L[2^HWO)VYU]J+C'D(?NO2<0"3%;]MJ*!2?W5*BGT7&;(#0 MZ+TN&(C`=%J#5$`!+4K^++WUQ6KHQ,K*O/J0"GQ"%HG%EB<(DFE"%*4-MK+* M?J.94DYY^PA33%\8Z!9\L&J76_R?S[>B=FRX9&X(F,/W;[:/NG"EQ@0,X\V,G28M\I>F6C%]%K^T_< MI?:.:.54\>7ERQ'[H$U([P]0:M"-5YA]1W(EL=/TWS=Y3N1J'+VN:?I=WJEW M$*7>E:DT1\O\TI'W63!P-AJ(_P#-742N-#CXSEQRQS.*<3&<20VH8M*)[Q/U M#%?:<&2.>`R0(D"`7!H01Y9#M(?C=>L/*'/.K6]S#<- MD'QO3/A/"CN@XH3(B#M-05^J3TH>HC2_.7D#1^:+>9C=?@CCL]=TYC MBZ2'4+:-OCSEQ/PW)1P)11EBB4+C0J#F@U'Y+[*^GOSE+S&]._G%IK-5Y8\ MP^6I-$U*X;%&[5N6M=C:VYY9Y[Y?D+F&TY@Y7UJ&&]MGAP:Z6$QR<44CV.MX M?,S\'DPY?&+9H2!'ZOV(<%8.5QL)JQ`.B_DT^LKTM> M:OH@]27FIZ7_`#FLF6_.OEEKCK./5;6.0:3SIRM?L;?\I<\Z`^:*.271N:=" MFANHP0'PO>Z*0-D8YH^__;/NF'[IP8_LL_M//E@J< M!\T),P,>U3:QJ6-#4%>J,UQ4A5W$;-M'9C%\LCE8XXB[&ZSI)U/Q'JSXMN1Q MFED_TK5#"2'+!4GRFJ$TZ-U!MIEBF4GJ;K3#&_@J;I$ZE3(DXJG-:L>(]F07 M*2-V[WG8J8R9GB51CFY@Q3/U)JUIG^):?_;K3^\1XBDP=UKZF0-2U!J4^?NPO29Y"!V)C9C]7 MR4;"B`Q$Z=OO3%JK5AA.6P;?LP(16(#U_:1B8LB_@K#2`4*Y[-F5<3%E3/U* M]&4"(IVH>P9])Q;CU4"KT=,CF@RR1!EV8OC(`525ECJD*B'L2OOIBY0+?-66 MD@J*(%6M$VYBN!11P5V=F+HRW>*2,TE:KV=5:BE5Q))FLIBA#B1\*@CL%=IQ M<""JC&4:J=02=F?2N5/9AJ+%GT4PY/ID56@RQ*,F42`;JR"N?;6M5Z\7`F)< M*N0`LI"HK5%7AZ"C=VS&E14VOV'I6G$@7+K3$A(A1,02Y1.(*1DFP]0]BXF) M@W5>R2DH)5YQS>5-/B.9Z3CQ4_4O1"@6_HVFON'-D-QS,NRHS9&#!>0K2PD8P94"G8HK0I08[N+BR$5SP MIOP8_3\U8#IJN=CU&";C#CPH2!Q#XPJ4VC$!FB2H[?-V0(;]C)>'A[H8V7D>J6$.G1#OO#8BYP M7NA42+;DFVT?E.YU!0+@1O!)(XR[A5@"U578[GVW9[D8 M,*KD?=)2CAG(D`[?S7@-TCGR/>XJ7.*[RAX13>4Q[S"^T!?.YQW%]3=3:\T[ MW>S[?OQJ6>48B*DUW[I4=F:=!Q$2!LH^U3NBB0AJ].\KO]V"(:-548N=MZHC M7J:GA5BT89@K6U!'4!U@]&+A,CRA1$`18NNBLKLMSW&JM`RH2 M%%!BN1`%5U>+C)[%ET=K?J``X+LJG4E<8'AH(KH+?4$:.\A(V;Q]: MIBC5=[''=>RM_F%"%IUNH>S)<61C(2=7[8LVBIS:JUJCB#M_TWKBT`Z*)E'Q M6>=35R<0SWA/8N+=O[OFJ9,>Z&=24_'0=0!W>Q<&S615!8>FR]T_2ES[IW-% MIJWI_P":60WL.N0ZQJ7EW#>.:8KVZO+5[^D9$#)_MG:&0]I>B?7RDKWO]H_=1M_^JS'S0!./O`UECZO M'UPZ!PO3GSBY"U#REYWON5;ITMUI4UN-6Y4U:9K@=9Y8NI7QV\KWN`!U'2;A MIM;MH)X)6*3WQCP=6W,W;H1O/)7S+L[? M4[N9W*FNS6^G:[;";@8&N>UL%^%4<<3BA(KPC$,D'##X[*$Y:_O7ZPO+/S`@ M$^EZSI5ZV:QU".WN+22(E\GS23/%O+X4%[`7N>P12'A=QM+^X3F/W3F<8IQVG=IX*\@3CME M8_'U"]%?]2'^EG;^NWTNV_JN\C-!9J/J:]-/+6HZW96FF1`:CYL>2L7B:SS= MY?RL:TR7NN\MCQM7T5J\?BBZMF->^ZCX?4_VK][/VSE_T^0__"S%C_MEH?T/ M9NB\Q][^TC[EQ3QR`>5"N,_G'N)"W^Z@V[I%?S/OFFRQLECXBR1O$.,%K@RVXN.P?10+@T%,\D^I>C&6Q/VXKR69#%4\5(3.%"=N_P!F M!2#V0W-0.KDTJF75A)MJJX!R%<"`&4'%'414SV9GLP)J3PXM#@(\"%KZI_BFH;C>W94Y?\`$254[L:X M2V^"@2`*JLP@$A>W91=N+@7LJU884*;#GV`X;T31A_)]X]F'%)%3(YY*/K[< M6`JN4=0K<;EJ24&1&9"9C;MQ.)8NJU>8Y".]G52:[\7`@UT42'H5:C>E351E MT^W%T2\4E9:Y14[/:JKV)B:@0R.QQSV5S4&BG;UXG&6WP21VGB1#D@Z=W6<6 M@@APDC"BYH-BJG5FBX=E"?I*G0E>*F[]T[!TXF)#YJ/_`/3^/G=.#TDI]M:# M$U6IM=7J0GHRQ.,FH;)&()?56FD9_B.Y43+VXG>H5#:I\MJ_41L"8M]R79#I M`_#]#T-Q:)#O$S/HHB)9I*8>3 MMRV>S/;EB49/4*N4!:7I49I.$$[0''8B`+0E0N*.1GV0H:I8\6Z;KQ!KNH/N M[J1O%_#8\M:*H0"F>P4QX7FYY9LY.@*]/Q\0A``)]'T5VH2E[VGP6'-/B-.Z MVJ%!@X?%/)G;RA+/GCC@^J\GVFG16[6MC8UH`%&AH!38BICUW&X(C$:17`S< MLR)$5HH`WA2A4UK5-KJ(Y,=3V8#'LC=8?=F2Y65=1*`[(M()V[5I7/'G^9A` M*ZW&R&!K98TDC8W<3MQ/33,_SDQP9QJ8E=B)<`K.CN'SPS\0):KPU,R``7-I MF0W%7_N_'16QI35<_?O@$D;K=H:$`>0`H/X@[V8SY=C^6Z#VNJS'@/"%%0]H M!S]F%'S1VI`470:3/)'<-;&\\)55!.[[\7X9&5"HD,'U7L+Y;V<]_JMHT-=( M22]S0TN)X0`TAHKF<;\`?Q4)2$0\K+V6YHT#5;/EBY?=V=[!;L\63BDAECC[ MS`UB2.;PH1ECN_;PV<.*+B?=91GQYL;!>FX(-=[G*:I\1Z]^/<8YD!@O$2CN MCNU927*JT.]:41#7%HR#]WJ6=G#)ZKB?N1;NEM'=3!(VHNT[.G+(K@$@0Z@0 MQ9%:0*[:TW=/MQ'<7W?M2V^7:'5NV:UTK:T"&AZMHS5<:,>/W"W[5AYI./"3 M"Y77-AC=&$W='[V7LQ*?%C`T"\@9S$V*K30HJ`H,T^S?C,<>@NKL>0]:JC4* M"N60*>PXI,S&NB[''D)BZCX@!ID30#90;$VXMADU)6S8".RD+DA$'=W)7IQK MQY3H:I2XF'(/,/,KL-VB*3F?8NQ2F-D,ZS3^VX";.%IPWBI6@IT4WE<:AG!\ M5F/VP&XHMBWO33(+LJ5/6AHN%+()!@4\7!.*0,!YEO6U\')[MV>?OQC)9;L=^0`CG;*;^CL3$5T<3;4=VI'A)::Y=*;<:`U^J')B\5FRW[B3O MJH7Z&IQ?`!G5$CMNJGSQ4CB:3M"]&W+$U`S&EU$ZB1^/;GO2G5B,BP=1+&RL M6.MZAIE]8:MI%_<:7K&D7UIJNDZI9O,=UIVJ:?/'=6%];O`[DMK=0M>-A1#0 MG&;/CQQL_,C3+B\=-I-NYC(]`\V]-LHW\U\G3&-KG6O+/F?IS67^F* MWACDE8V-H,#SCXQ]QX.7[5SI\7D$F-/,?W1/_'E\?V9.X)-&7V3[;S\/W/AQ MS86/Y>J/9AU7Q?M]5G@N&2L$]O-;R/BEMYF.AN[::VF=!=V-W"27 M0WEC=Q/BD;FUS"-F,1!B6-"ZND0/5Z?T7Z*?TT/5/_G+EJ+RPYEO^+6^6HN/ M0[B68F2\TWB`%N!*X#^J.:0!GBB<`);@HDD#:/2OT&^3'FO+IE_:L;)_#+F$ MLCO^2T8S^PW7W.].WJBY#@TN/E[G/G+0](ED;& M^R;?:Q8&XAGE8`+?Y2.:2Z@\04:"PCBW8SF'[H@[2HYHQE&XWQ_%?A?_`%S? MT4_,KE'U2HG]//R6YS\]?3IYQNU7GOG7DOR+Y2O\`G&_\AO,9SC?S-%B*?.AN*4<.QHJ`K4]E0*GLVXPYLS&EU?BQ/X*)J%-/:N M[&&>1RZWPQM0QJ"YV85$]VZE5SQEGE5\8'U:( M9.1[Q*?<*=>,TLATHM,0`/*J[W%*JHW;!3\0&[%4I:FZ:K2.6NVE,J[4Q5N% M_P!JMB&J57>ZN0!W'< M*B[*[DQ6I^W/HJKE4N45%.%3\*?6N*LAL%;%MBJR.5R9H`%**NU4WXJT2O+L M%4E?L`SV$5[=^>(2+!35)[E.U%X5.:5]HIB+A-ZNJTAKPA>G96H1!BF12O>J>SHSQ7.W="#BM-7M,_Q+3_[=:?WB/`A:VI?XC?\`]MNO_7R8 MTJI5!BZ'I2*LJE=V))(P5`E,E'1NRPQ=",S;OJ1NV8L28.^J-$0VNU*]2_=B M2H5Z,KL45(*T3[:GLQ:/6?!+16HW4#:;U^P>U<70+%DE;:Z@39L3,I5$S-<7 M!1E9&!4+49_:,"@C,*4!IT[*TZ%.)QDW@A'#R15&G=U$TQ:':MU&EE,&C?A[ M:E1NK@4)1?\`Z$0&@"("O%5-F6247$P;R*C*+?\`2G!RZ**N6SH5<6*",QP& MQ5^H[QV8D),E*.[Q4P\CI'=SH*]F2C%@E$J.P(O$"A5:UR.S8:KB8F0&O%0V MD%DY[V9R%!]F)1F(ABHND2GT13OHF+(3W>*:1=PH53NEV>8SKD-N(SRB/BB] M%E7MS3@:I[I!0US5%J%..7R]D?0FJZ']1[<:KM["SBM(A%&T-:`%VJC=V\X]#PN+##%@%RN3GEEDZT@ M5I3AW;!MR%2B8ZP+66#;Y]R0IL&2;,LD527$DMRX:]5<I>1PDY''-RXS&NBQP)`[K)GBX2:*3L&[J.,.1P7%UT,& M5O!47M/>3)1V+FHE<:H28MHMT1*1>) MJIQS!56F:#?[\:8R/S5HQZAU=9.B54;NGJ6HQ9"6VALK#&E5J0W!;MRWA=^> M6+(SW>*!"KFZUX;M*9'9\)&:U1=N'W5NUH@K1BO3^^OV_9B_W(]T.CF\<%JG M5^T(,2!$A1.L3T*JOO"?KS'VA2<3C+:JI#4FJK/NJYD&J?5V##W]E!M=%$W@ M"5'PT4U[:[<*1W)MW43?%*$)543]NW%1G%NJL$#(LZ]IO2!Y_6?DUYH?EG-U M_);>57FC%8\I<_O+GNBY'[^*.[EX02!K.!]5_39);>/E(J3Z)_MEX M&Q[&E674^OSR#O?+CGNX\TM+L66^B*VN&Z27MU;6CP-9 M=7&I:P4N8(KB52+>#PHV-(%2I,Q@C$/*LE49RTH"O?/T_><#K6:SNXY>%Q?$ M9Y0]9Q*W*8REQE!7XJE=],.40:ZJ`+%POT3^F#U`MU*&U/SD-KK4<$,;+F.9 M\,NHPA&,8YS.$\<849H53=CFYL1MT^-5="35_9JJ7ZDWZ5'I9_5P\G;Z'F_0 MM%Y`]2W+NE7K/*;U)\O:3;6W.W+.N06;(]-T?GB6T9'/YB>6UQ+;QQ7NE:AX MSH+=\DMD^WN#QNZ/VC[OD^W9MLGEQI4G#IKN@]I#I:5CH1DY_`_J<)&,@2:A M-0>TAT/4,8W!!7\MCS_\AO-OTN>='F1Z>_/CE.?DGS;\I^9;KE?G'097&>U, MT/\`%T_7M"O4#-6Y6YFTQ\=]IEY&L=S:3-B\M'!L]#[7UN#K$]Q8VZV(7AUSD6M2:9(4)-"=@ZQEBFLGZMN$FJ+W=X)DIRZ`E$Q42'K=-"<_8,LMB8JE)TU6-3LVY=8 M0=>>(E2BHD_3=@03H%7<7%3M0Y+N3"3JJXPT@"$0Y.KPT'_DY5PE)`!`)&U= MB)U5K@0H/)!3H"])5?MQ5,U34,00KVF?XEI^[YZT_P#7QX$+4U$KJ6HA4(OK MOL'S#\:57K\U4C/=%:C,>U/=BZ-V'I3FK5=H0[L25:,PT4G;[,"$9F9ZC]F+ M4C0.BK4#>HV?;AA0R:*S$^@`R(*]%=RXG&6WP52O,<*9>U-@5`>C%H+APA6V M."(#\55Z<@,:5%&:ZJ$T2GM]N&H5)1@46J`YG(?$N?1FB]N+8RT*2 M,URYUW+^]L7$TG<.%,$`IO\`=_-[,"JK*6V:F"*`[*JF:)M)Z<2B=$&(C*OI M4@N\=G_2Q:#J$FD"B`@T7>`?EDZH!FH4U'3F5W MXM2(#/)/Q%H%*;2XZ(9FBLYB]0I-_+)>BN)B?55$`^"EQ! M*U3?]_Q'#W1E0H9K*I*HHE"'!=JJFP)1,PH\H[:J@KM&W',VZ&ZU MIHXQ3O!=H+NVI1:?*6#3SJC&ZBUKH)7O:Z1YX8VN:6EI<[8"T MG.F-?'`#LI!GK9?6[R/]-?D[YBQR7%[&/G'1M>39:RQK63/`61D,
T=`&9 MQU,9`H0%*.#'DXEY:T^S'6X!V9XR%W7(^[<2!XAP%,>F MEDVS([KQV.._%$RUB$@2,MG;7+LH#JH'&9!V3AQ0JJ;3EFO=W?L&)[VNH MRQO5$&S(M"`5ZNNIQ9"0(;59LP)!;JI[.K(>TXM,@9.;+*,PK5/BR3'7Q9-T&-EQ.?Q1*),15=,VC'1B3K=:VHZM MLE*BJC>*'+)=PQ)^J2NQW!!"F@WILRKMPWHZ%HPW-,TZE3:?8%Q(2,31*4R/ M*?2KK+HGNJ,Z;E0*NX8L$P];)RD6I1&^:)-02@.:[?V>[$XSIY4,7;5`?=-H MAVD"M?;N*X-_?\4JJC)>%:%.O-"$K6N)[Y*(#55;YLJO%4K1:;U!WX6\RBVB MMC`$4;QS',>UX#FO8]O" MYKAD6N:X@C;BDRJ^JMV_5?8_TR^8.A>J#TX%S/>XH_E MY"90&@/_`+F,]B^Z/8G_`$KZ)]C^XCE\1LQ_F1`C/K3T9+#P-]`Y)*]%M"Y9 MLO+_`$V31=,O9M3DGN99]0UV:$6]UKKHI7QV%S!PEI)"M+AQ-*5'1U8B2]3="^V/IL\Y+BRNK!T=X M6%KV?+REQ/A2`M?P*2KF'9O";<498N"2I1+%?HB\@/.>WU/3+2Z+6R7(=$Z\ MBC>C^-_ADS!@+2%"E6,HSWZC\5I@8MMO$KXX?ZDS])*#UN>0\'K1].O M*L=_ZI_3URG6O=+" M+BS0\4`'H_LW.WP'!R&Y)Q_]1OC8_P"HUC;S==Q;C?<.-[%X?#*WCC<*<0XD<"T]YDC'`MI$*@_NG$"6J5,#4V0'/&7;U MC,]*XIE*1H:*Q`!-4WOW5/9E]6,ZD M`9%@J[W4H0A/>(JFX(-AQ"*IN MH=Y]F(H41O/6?MW82F`R`]RGH^O#"C*Z&\H$VFGWX2D2R$%4;\)ZLFI.>`T@ MGO5^OIPT$$75=M.]L'T^W`A1L9_9AJ)NI!V)[7<+7BZ>>-X()4E3MVG>%QP=DETG!"G M%9SR(A&>69*$T"5SPQC)37MGZ?O+MG-3KJSG>Z-_`)&(.(N60L>$`+FH*T4K MCI;^LS7.I\E\\V=C!$1+;131S,N0U"1$\V\L8+V&A M<,=".!BX)$4QCR2LRZSG?RD\_P#EKDK7-*YWOWW4%O\`.0,N8YYBR>+P0'/C MXG/+0YN\C=CI\.(CEC5UR?N(S2X\XFGY-_BODE-'X$]Q`ZCH)YH7J$(=%*]A M78O=QWLA_F$BQ*\GB#XHMT4,)24@T*`>GLW5VG$A(@,%5ET4V@`9])Z32ONQ M>"UZ++,5K9.7`9@T'514IUXMQG15&+6LD.BJIDE.A=V+<[B$N)`IOSZ@:UQQN>-D6CZBEQ.!FRYQ`` MLN:D>97EZGO5&03:`=N,V$C'%KKV<,(QQV=DP4IEMWM2N_O+B0R1-Z*K\E89*X-`S44* MJ*+0Y*B8F)B5`AJ=E:;PXDY0R3KDNRV4W)_P!(H5.'NZI@.6"`^=%;LAW03*5:X'/+Z41,+=3NK(@%Y1 MNH>.=A)SW;>W?B!R#JKA$2I8)S.[<:[]W6M<+W(ZFBMCC(N%[A^@K0M4YM]3 M_*VBZ5J5WIS7R:ORO?-C(,^F:VZ6)LT>9\,$(0 MN/._W'D@/M!W8<>&!$J+UQ<&MUX;TO53;7`)*- M#@)03Q%%HHV&,^[$H3,H[-4C0+V3Y"YN?93V\@E"M>T$EY`=L/$!FUX*;$*8 M9.X/\?`_)-?4GR&\SG1NLF&Z1[1$^-)"7$,-&D@DB2,]A`Q7)I1<*,2]5]W? M3/YX36DECCX9VA@(0A(W,DR)R.S&`;L4F_:M)$9Q((J?Q7\^; M_4L_I&/]%?GF_P!9'D9R\VV]+?J/YKG=SAHFB:8Z+2_)?SRUE\U_>6?AVS#! MI/(_F>GA/&S?TU=I
@)<53,5!Z4!&*SD&B>U5R\!=A-5* M]BGBWGVX@9$W39[W0RY(REM0@'$RSZ=V?;B@R,BY5XB(V5660 MF@*D'-*FFT8C9251S@O>Z1[34=F(DT4C%@YNJKW9U7.A*9[3BJY0BY M;$Z=^*D[*`&!2`U2)&1*+A*2KGHRP*)<^"$X]Y1T)]?UX%))K>+JP(0Y5W)F M$ZSQ83AVU0AY,_I=>0P.`'T0"190-2<4DN73382%8TXKJFG]%]:#V7#,"%JZ MG_B>H_VZ[_O$F-*J59JD*:[MXKFN`IQNK#"26]*]N:+TXO%@HHPH0=V&DK#2 M.BHHO4OM3#%T*;37AKWC0[$'\F+>ZK9O)U1@4/61V']N`)3&JM1DCH%0!_ZON0G=7%BK0I[AL3".(KDNY.C. M@Q1ERB(5L<1E>RYRXN7W#^%H)"IP[3N.S(8Y63(9FJU1B(K5L;0L;Q.1\#%T2X5K@!!J%$MHI-TM9$Y\YET^TMK6WMX#*Z1CV-XF@-:**Y,CT;<<;[IF$("#5*['!@&,@&8+ MP9(`!"3L`*8<=U@$E]#/ M2'I%_JS=1\-QBU"TB\2#A/`\A\G"\,*!75%,=;`,A@PH25*)<]V7T"Y!\S?6 M%Y>ZUJ=ARAR+>\UZ+#WH9V06]W'<6I8"'CQF-Y,L\2?ZI*33T$G[3T[C MA@K&0"I+MID"<\O?53BP3(#*.VO9.IJJ!/PK5?VXLC(2M=1((3$K5%.XU3>4 M%3BV,S%18*%/P\7:-G[<7QY)C='LO>RD"[JW*@RW!<2_^PV"B1XD97^:?B)J MYQ*9+5*FB9!U,8,O(R9Y[YE6QPX\4=L8LFXDZ4SSIUU[V'`DARC9T4N+;D*? MA.+8R8N:NHF)](3@D=0RVGK&+XY1;15&)NI^(>).U:8X97B$Q=0T3JS";TQGEG'R6R''I0!-Q#9^[_`#J'VY8HEG=: M!@U-%[.^B[SFTGR"]5'DUYG\Q$,Y0L^8KCE+GM[@'-BY*\P-.N>4M?ND)`_\ M/9J45R3^%L)..3]W$^7]MRXL=<@&Z([P.YOG5=/[68X>9"4W&,EC;4$.7Z`F MU77W2]:_D=%'+>WFGMBNFO8Z_P!.NX`UT5Q:2,\2)\;X2YLT*PY(Y,8R1]$A^:]3E@82,3<%?$36K:?2[^6*5CHWL3OE#ZTO3OYA>G?SKT&VYL\NO-/E/4>5.8]+G$1G M;;:@SBL=7T>Z)+K'F+1;Z.*\L+II;);WD#"UR$@KA5WF'+9NM=/\`-'RJU.ZF;RQSA9'A8&:BQL9L=5MB`^TU.WE82X$. M/>RQ$"#`F6"<=T#J19C_`+HGRR9P['4+C0D9`[@!EB6D.A[=I"H^FB]&GS94 MH3^)4[.W%1G7LI,J[WDU)1%Z&U=DF1.*T(1<,U55ZEZ\EP(02\%14`(-JJO#\6U'9;:IEBN1)*8:\O4JKY50"@VYAVS)U",1-%*AJ MJY=\25._.JB@_$",-38Q#ZJO(^CA0=?0,P11<4RDU2EJZJ%P&9K[\4)H&!"G MA*Q">02"-WVG`A#)0+@0@8$*9+0%%#]2>W`A`>Y31:][LKBL2W2'1"@XA$JJ M-ZLOVX)G1`4,5IIB4!JE#7Z=>!"/IG^):?\`VZT_O$>!"U]3_P`2U#^W7?\` M>),:54JS#1-WVK@0IM)7)$VJI*].+,>J#>BLBH"UH/JQ8H2])\%88538`@7Z M\":GD:)3(IGU]N+(FB@QEYI>I'&8Z_L.&$3M\T6,K5:[#M7>!NQ)5*^TE15` M@7I7^3%XN5%6&%20JD)NV[DWXMQG1+QNC`U+B1L3]G1BU1(U1&N--HIT^SI& M!11VN.SV'?U;\"=T4.(`.\]X]J?5B<9;?!+1A9$Q9&6Y)3!7-/A(K[DZ<-"F MVHVUSW(*9[%7`A#FG;$'%:C(8CERB(HE"#ES=X*@%2*AIR%-_NQ?@P[BY4,DMH[KH0QH!:!45V M*.\5S7=CIQB(AA99"\B9);*D!*'WT%""J8DH,.BDUQ3HV_;P\6&"Q<)&(-T7 MB=M"?T@@ZLL7*&W_`-*D#DG9M`H".+IQG44Y5:%:YE"G[U:9G%GN=D`%Z74A M4=G5BQ)9][(6W5F`2"9VJ6G\%6Y`U'>QS>9)LL'LZU<>!ECD#T74\R7?*\>C MV?SORXN7->&*&FX<\`<2J"XJ3LQ@YV3'N:;4"Z'#A$0?JO"5Y>:?XA^7B0`B MA**BI5M0*]>./OCHMMZA-;ZU'`YI;`TID7+0DJ3047#CFVV0:!>]OI,YIO6Z MK//8,X)88WO="8BX/C1C9&N:?B8TH2>W'5XV8RQ@C1.%"2OJOY9^O[ESRCUC M4^7>=.2]5E>8F>-<6$%RC&RM(CF8'P2P/9(`M"F-<9;Y,0RF.2,0((?IM@R":XA8\03VMNRZ(:7,_B%K0YSN]V8WPD=PZNL.;+CGCD>OA M^:^'7.CXIN<.9;B"+P8;C5[F:"((!'&]ZM&:(@QV\]=I/JVA>,Q#UQ'I&27X MEZLV""7%F2=BTIEMRR&& MS41*$929)3O[=OMSPU7[<>Z2=X*4W?9_LXT&8%U$P.E4X<:]YVX@41=A)Q+N MJ]HD>ZDH<%()ZD)^H)BV.0CQ57MEW"D2NWH"9;SGBR,C&RB(/6B8$JF0ZD)W MH%Q+WH]OJIQQ$V`2J4H@J,U'4@-<1EE,;JP8#$/VY??7%1RLK!%!DX98WPO8'QR,=%)&X`M?&]I;(QV?=< MTH<5G-(%DQ$N[U7Z2_T\O/&#U3^F34O(WG*[^>\WO3WI-MI^FW5X^2;4.;?+ M)SW0\KZJZ:9\DMU/7XHHSF_'C^7@'"YIC"F#*3*/8_NC]:CL>@7I M\.;^JXHD?^6``/<6!_3Z$U*]$/4GY97'+6N7ES%"61/FE\0<(!$O&X%"BD3` M9&H>TA:X790D"/%>H%M<26TR$\)86EI6KFBA"C(U0X`2*A5DZBP7F_DSF9T4 MD;FO#7L%A;Q.[P!%50L<*HE>;GCM-J+? MA\T?+ZOXW7KW^N=^E'R[^JKZ1+N^Y!T[3[7U5>25GJ_.7D)S.\MMI]7U+Y47 M&O\`E7KEU'_$/+?F-!:MA:">"UU6.&?A+3(O2^W0CAD082)`$)V$ MB;;9#RSM1I/Y6/+^X\;VYCE80\P/,`',X:@#_5'U1^E77\GG6M,UGEO6-8Y< MYBTF_P!!YCY=U?4^7N8M!U.!]OJFA3:=K.BZG;R,CEMM1TO4+>2*5CV MM:]0A2@&T@]2!3BR,M"HJTQ`@515"=JI3%H+%TD;%Z2*"1 MPD]G4B]0PPHR16N0IF220A!"=:[\"5045N:*@.?9@24UZ/YV5/A^_$XRV^"" M'1<6!CYDD.:X;'^(-3-2*[42BEV*IYA&BE&+KFKF[=,>%OPDHE>L9&H.,$\A MGX*T!E>L+-S^%[QFG=7^E]N+,6(R*)/&]UTD;6Q-"`;`4&U-QV$8Z<`(AHW6 M29>32LI$@N-1ED`:]ZO7BUE`R)NG4*??LH2%(S(PA9$_4G:=E52N05-O4F&H MHHJ+4[)AXD\4_[(#<_:<=[;E;F6&]MF&2($QW$01I?;2,`>&*H)H"%HHQT,,PWEZHC2VB^P/E1Y MX^GZ^OFQY,0B:[5=&CN0VA[IFC#R8P_*B#=C?BF'`-U-\9#3`7D'F' M2_35KTVIZKR\SELW" M^)?G'::98^8_,5OH\@DL&SPELC""QTKFDRMCX:!H+L=N1$L6.1U"\A&(&;+_ M`*1*GT7C,<6[N[DV)TYXK]ONK)")#P3J*9]!]Q7#A0E5&J<(E>G>@JO5GB8H M7%U$@73@A1L-4V'I3;7$R7"@E4;=G5V]H.`D"@3;I9,IW;^NF[9A_-2V#JF7 M*H7Z*F)J6V*2`J-U$)7MJ%VXKC)KH%*)Z;>C)QIL*Y981D2A/04J%Z=]2,Z8 M-Q2(!JG^'8%_%V;=_OPQ(Z&J@U63TJN?0:=FX5P]SJ.P;G_BMC#=X*!/2N\;>[LQ4?A_JN.<4?^0>:)KZ MA_&Q[+7Q,IPYQ(^@T/A\6[U7Z-O51Y=\L^8?*NC^9?)%S::UR?Y@:%9\R:)J M5EP2P3Z?JEHR_L)P]H+6S21R!XVMD:6G,XXN#+[N,'74=]0?R74S0$9L/2;' MXZKX*\\:!<\NZO=6T\3HWPSO`5H:"CB?A6G&W(8M/X*ACHS+)T?6G6` MU&JUQH6@[0N8!SPE4>R]AN1?,*6SNHG-GXF![6AW$`020K'!M:BH(VXGJ#JI M@NP>J^H'D7YL>((6SW+:-8'L&>*1H=,0%XG![!QM.T@@XSYH;H$?,+1AGMD&M9?I:]-? MFP-=TFP9/=F:"6)D/B.X97>%*QH8XO4N<6%'FZZ>3&.1BV_O MT\5^+7_5E?I*0>6_-UM^IOY"\MQP\F<_ZIIG+7JLT#1+2)EOH/.FH%UKRGYS M?+1NC?!IW-4Q9I>LR@O8R]-M,YH,SWX]%CS?U?&]T_\`Y.&($Z>K'2,9]'A2 M$G9XF)J1)>9.(\;*8G_AG([7_;.YA_W>H=P0`%^(UTB$@@DBA%`5!R+550[% M*F?!U7DD5R4`'8>K//`F0#="<\A>(_$,DWG:<1<*0!-D%TNS;L`0KOJ37&>4GH+(59SA4;5!^T';MQ!-0*FIK[J=FW`I`:E),# MHVA1+@A&VHVC[,)20L"$Q-2-J+].W`EV4`OXOWOL/8BX$P6+H3BK@$5/Q+O[ MPIB,I;4(;RE!FJ'9GL7IQ5>I3430(AK7/([NE,)"A@0H.TS_$M/_MUI_>(\"%KZH%U+4.B_NC[+B3&E5*FTH1N'VTP(1@@"X=)&:4/73VD8:2.J`]E-Z=.S`HRW-Y40.J:(E!T;2$Q;' MTJF)(J%,J%(VY_?UX8*LE'4*Q&Y0F50FWAW#H(3$X>I5*VUXWUR1%Z*4VXLC M+=XH5MIJ5/=V>Q:;\61EM\$D0(M*)[S]BXM!!#A)3:[O#?0=)*5IB2@;HX/$ M`1U9`=IRP)*;32M1N3ZMV>!"!/Q5QSYY#(T6D8P!6ZOV-IXG"]XRJ-H2@[M44'/%^+$9E]%3*41'_`'+I MXV-8TT"GHH"@VK5#CI0CL%%23N\$8$&E#15!.P%#7$P]$E!/J3,Y;NK$_,JO M;/5.'-*!">M/N.)%]%'R=U,@]?\`1)ZQEOQ'?V4'3\3LZ-R"K^'?08D"#063 M)>ZDI)S.:[,\-1\W91#R`J_"HP*1`-U8:XCA5I`H#[2KNA,3$B]5#8&[J]9V M5M>W4;26^-41DD`JY`H)0@E=F,>>$)$R-9!6XO=MH2N*]Y5\<<8AD+C=M*EQV]6>($JT1^B&7`K7MS^]1B@ MSD5,`!0U>O.E,PB8H=E8A/>*H,JE57+MP MMR$(R)4C.@W#H7LPG*F(DAT%\O[N]02A3:37JQ09Z7"EM"^]_P"DIY\VGF1Y M?B[GC4&OU;EZWU/G7R3N;Z5TLMSHDSGSZ_P`FV\MW/+WM"U&0W-O&T`-M MK@BC68XG)`X_*WC_`(LIKVEK];]O$KK<>7O8?;/_`"0MW'^'XUZ+QOZK_*6X MTB_U"Z9:/BN+225LP$9:34^(B9NA=WAMX24Q90T5<@;A?,[4));:9P[P+7$Y M=UW>JU0UOA7MMX MK)[63*.YBC?^$)+[=R?Z;D1F:QM(&QB:$?,$CJ+W63[AQ_<&JN8V5PD*!"U*]>!U+:$Q=P]8V=6$I(1N!"$2N>>_`A-@0KVF?XEI_]NM/[Q'@0M?4_P#$ MM0_MUW_>),:54J.!".4(I7JK7`CP16&K4ID#V[\\719J)(V)I(S"H%5.WVG" M0I\2!N\*J;53%D-528M_U(S2'C>?OV4Q(TLI1\WJ1&(.M-P^)$XCT'#59!!8 MJVQV:E0:41`>O$P3(L;)*PPE$ZVBI@28JO-=-C:5<%!0U_P"B!DM,49,PC978\;U* MY^XN7SN=GPC8JD[:XP3R&997B(C97;*S+R'N&VA"T.8&>:8NQ83(N;*$Y@!@ MNHA8V%H`W9*<]O17'4QP$`RR2+E&:Z$(-4*OT]N+'57M]T1HX@6G,$$=O\F(GR^E5R!B62!2NSH^'L M&>)H4PJ@-H%VTIFDG#0CD@*_,`=:INSP$M$^"8K(!X^$U0P$M!0@\/4"<>=R99^^2#HNK"$=H8*SS3S;S%/*+9T;K>W M;&Q7%A\1ZBC@YPRQERY,@+`,%J7CN>XO)G%TSG\668!(W[!C-(RE4V0@M\4Y M$A>G[E&6$-QLA=ER?:R7>J1VO&UCI6$,+S^)I;1R@CX=F-.`$S`%F0*57OCY M:>GCS4UK@U#E/F'2K.,L;/"[YF[@GXD4M(@D!:6FBBAQTXXFM*O@C;.=867G MG2^4/5-R[=7$-U>236-K:S?,W3KZ>5GAD-8TCC<]Q!V8VX,9W5/E5&666(+` M[EZ+>8\FL37_,-CS%I+VO#!?"UD2_T:Z=X4Q-EK M>GNDMIFAM6O78,9<\!FQ'&;FW8BQ6C%D./()QT/Q\=%^HWSBO.3?4=Y-H M/D$17'+'F7H=M>30`!\NE:XR(LU#2;Y@9'P76FW[);>1I`)+,8\&3W(-+U1H M?C\ET,T120;;(.%\'O-ODB?ES5[AHA<('R/U.$G=BXN*K+* M.B\$V]V^VF#P.$@N!!):A%"U$((.'4C:;*#->@*\T\D\S&TN("V9P>71N!<6 MH&@@-=WR`&M=W4JHPP2:]$Q)C3TKZ;>0GF3X5S8@3L$L6G)7ZB/EAH M`N.9?*2T@Y'\ZG:=;\=WK'E7JM^)-!YBO2QCYY';4UEH%YG,#Q^5NE2&4[3VF+'_`+A3I1U_/)+R M]""H(&U1U@[:8Y^^2M0RY%392N5-@Z<034"YSOV*I7MP)@.F`45K]O7@*<;) MBX!15?=U82DA$J:^S[,"%'ZL"3_1(]!"TVT'7NP(0RX%79]'X1UX$T,NV!_",@+H420,SBFIJFAEP<:J$W;^G[L)(L?*H8$TL"$%RJ:TS1>G+KP(4<" M$L"%>TS_`!+3_P"W6G]XCP(6OJ?^):A_;KO^\28TJI4<"$<9;.S+`A28JNJZ M@H%IF*CLQ9C.B"K#2HV]N_HZ,6**FT@&J]GVX$(X*;^RF!1R>@J0*E`-BY5R MKQ=.+8^E4"R+7,%,`*NE%ZA'B<"FX.4G:@-5ZOJQ)5*X"#M*T*;NSIQ:"(AC M=)&:X`G9NR"YE-IQ9$L725H'@"HJTSV=(.8IBTR`256YO!&*$J5(`0$TRZ*C M&;+F(HK(P$KV6#),Z9RG,Y!*=F7%C$92F:*\`!:%C9E_?(/"E4W'<:U.-&#` M]2JIS`&T6711,\-K6CA";%3MKLQT(Q$0P68DE6'/38I.+?<[*+:*;3T=`79T M[<6"U+(1N(*E5_8N&H^;=_M3@A14`+TTZ!GWL)24B%R1/9GUG/$@6"$JC:GM MKAT[)*+:.*K]^[KSQ(NU%3M\VU$(X6[UW]2][ZL`DY9$H[?!2'>;0)P@"I*T M^[$E%#>X-MY'[FD=F=:[0<5YI;<9/93QUF%R&B3-;K\D[D+(@YR'(`N%2#O3 M'FXGSDKLQ`)8V6US/S?I\\[K:.V+I(F,:7O#0`[A!/"O>H3GB$\\79G5I()H MO&L]^V1[BUH:N0%"*K3HQD,O-N46%]4$7#J_"22II[OG-R8YL.E:#+J=O$!&]DO+,MT& ML:#WA-#P_$-N.ECED<43CGEC]$J'K5>TNB>KCFN]^>L-3Y0N3=W%G*'\%I>1 M,86%I*L4EP77SY\QM>GYFYRUO6[F-L4EY7),ZS/X#\EQ`ZU]GV8BK4Y&]$Z4Q# M?'JAT@!FH"!!M7H]V)H(<,G.=4S*;MN71@1^:;`A+`A.,ZKLJJ?1,"3!WU4E M`RMU8(L'"&7%5`0?O%W[5Q5+(30*R,1Y30B\#//;MJ!LSQ"4FH$U6=(YVT MIM'_`&C15Q4I`&18*JZ2FY">LD%$`Q"4MOBK/_Z?Q\[K[*_I+>H"Q;J_.?H] MY\U$0\M>;'S'-'E/5G. M\]C<6CXIBPMDB<2'*"\!`O`O#XHZQOSQ<79[_P`%*#LTKK[*>G3S7=;76FS0 MRNB(DBFC>7(DS4\6(H35U4-`#BJC55D=%^D_T=^>0TV[T_P;@NL]0?%/+PO= MPLNG-:R>0Q]UC'/H]17B7&+D87#KIC6N5.2O5-Y#\[^5/F3HMCS M3RISYRCJ_*?,NBWS8I8-5T?7M,N-/N&R-`:QLDUM<$L?FQZ.S`Q#[?S)\+EP MSP+F)MH8D-('J""0=6)6?[CQ,>;&7#0R4/:0J#]?E1?QMOU'_11SG^GMZQ_. M;TMZ21TNFGY6Y(#6QWEM* MS9C?S<$>/G;%7!,">,]82L/&/IET((7,PSEDAYJ98G;+_J%^E#<=BO1M*#WY MHN,2O8)J#`BR$YQ.1(]V!!?11XB<]F&D#U3(,)-@F7\*D=(HFW/LP(LHDJ"< MA]9RJFS`F@\5#DA%#5:?R8B9`70F4!,S[RF\]&*B\CW30:FH!*[E(^O"2J_9 M-7:5._`@``,$L"*OV0W&@0@Y?T@<":'@0E@0E@0KVF?XEIW]NM/[Q'@0MC4Q M_P"):A_;KL?_`(^3&E5GJJ&!)3814;_VX$(F1^([SM";4RP(-T=AJ1LS^K&A M11,"$>I%:'Z=>!1R>@IV$H-@%.[O48O5*.TT5=JK]JXB5;"WS1(SPKU9"E5H M?WN!(`"R(T@A1BS'J@D,^B("2[.IV]F[%B1+-XJ?U^]W#^W`F MI;T1?HBX$@[5NI@@JJ=`R'2F0&!-)#FGPYUW?LQ-QJDEQ?A-5)KN'4-F`?ZE M7DT3M56Y(2.H!/:!B9LJT00"X8Z($(XHI51W>(=>(98#)C,#JI0GLF"K_+_( M\EB+C5KMW';/(:"X`,X07$J237//'#GQQ@%LD;4:7`$N)!(ZL:..3N)_:F%]._ M(KU5<@\KQ,L]>T?4BD;8A)#^77+%``5[9'-BLCF$1M(KV7MU9^ M?/DOS'#?MAL["&YO;23PETZTCN'.8.-RNCJJ;CC?BR4`+JJ<\)?<`[=`ODKY MTR6$WF+KMWI$+;;3KJ1DEM$QH8U&JU\B!`KWUQW,KG#BG_M;Z+QV-ARLV,6W M/]1_@O%[2H"=OV9XI_\`Y/E\!6RCMNEBU).AQ#?'JATE0*J$9;JY]6)H2*!$ M*K4M.?84P(27=EL4(>W;@\;H38$*0:'`KE_)MRP(3*B@;SUC;V$X1(`Y4_F[B`A6AZ%Q2D@.>-X`*_#M7;2NS$3("Z%5=+^[4;>J@3HQ2F@N(S M*E`N]"?L"X%/^9W_`!0'N6CWI_>QF5X;Y*=I MJNHZ/J6FZSHVHW6DZUHM_9:KI&JV,AAO=+U73KB*[L-0M)6H8[FUN(FN:6D' M,;<1G$3B8R])"E`F,MT;@K]3OIX\\]`]=OD`WF:X99VWG3R%80:#YIZ%%&R* M>YO8[I/R>EM)+RY@MVMDMR9#PQAID81WPN;7',=(KC3>]"L\H@KYS7D+[. MX?$\%CF.<*T0AR!QS1ZX8W1-%6(LP"[OE+77V\\?%(YI:YK9*E4)4+PJYO"X MK3%H\HVZ&R5=5]#/)/S"N;::U#[JC7Q%926<+VDA"`20T['&H)Q!61)UU7WP M])_G!P26,3KR00ROB8\NE=&62M(>0Q"7AS@$XJ&F(3COB8K1A.TOHOU/^C7S MJCUG3[&Q%V)+F+PHH_$N#"+J)1_"EXR6NF<%X5I4C''RQV%[$%=81&3%MN"+ M?D?'5?%3_5D_IPQ^HWTI:)ZT?+KER:;S9]-$-S=\SQV5LU]_KOD[JCVSAFJVG$)7-`NFQ@"7'>XDCS^!+B1KR<+Y(=3%OYD.I8#>-`0=2 MO-\L?TO(&:1_ER.R9T!_;(V`KY3T@.:H(5I1P%""M<$D! M?LW`;#B,BP[I*!->'8O;4?MQ#U5_+!)&PTD5AHF M[[2<"$0$@]=-R+MSJF!53W_]J*U3OXA[$`Z0*XO/=1B[^6Z(T+[>L',9;$PM M$S62L\88/BH5)2A(Z<@43#,]H1&!E714KB\&PJAH`50G>>K%$\CWNKA$"RI- M89'<1R(6JHF==C68KC$R+E,EJE;%M:Y<0`"J3]C>ZH"&O3C9BPNL\IOX+98T M-:``$%`[>E.SNC&Z(`"IDB@G:XA35-F51DN))61@ZB%/NK4UKLP)*32E%0'< M!]!@0I@@40D4KL7M0#$XRV^"$8%,C]V+4D4=X?>>+^0X%'RB7^XI;!0YHGNK M@3JW=2P)J9-&KF"HILP(25>@;=M:UW[<2!TU0F:3PITHHW[-B4Q8"'[J@F7I M*SM6OY;&W\2(HY%`)*"HJAS7&#GYIXH>2ZT2\LZ.Z?7^1KBUN+WY=[ MK-K@QO=O.K$0+*YWI08SH1(X(E&3E!2H4^_IQ*/@Z%Y]\I+32H[CC MU9MO\G(8I#+<-XXXZ(YI(:4!&-_'$1%SJEHQ7U<\@>0/3)S`\C7X.1Y9Y6AP M-Y=V\(>=1]/_I\M-7-[R_'I MD1CAG?"VTO;=]JR0Q._[LQS2-1=BUQT,9BP-'5$^/C!<&GC1?)7U&Z5I&C>8 MD]GHTPFMOE`]X:08X9"]W#&SA5H5@4C83CM/NXN,BXD0O)RB,?W#+"-7$3^: M\"XRJ]%:5Z:9]/5C2JY!BRE@44J;,NI/=@0E@0E@0GJB=*XCOAU0=NEDY5U7 M5&:9=.Q,0W?L^2*-W4<6H3'W8:L@SUNH[52E?8W;[3C/OEU4NQ3`\6=.C+]X MNJ8H?HK=K>J@3%YZ$H MO85SQ`GHKOS0'NK4H`:+5PVA0%S)Q'P30"X(34`4X57=M553%>0_M4Z_N5=Y M7//+.J4W4"XI38(#W(@SV(>C=U8A*6@NF`JKG$YBGX>CIWXJ4@[TN@EX:$XE M2IKF]QH-V85>'H*H<5SFU!=6;92E6Z&XD*OX10TI52J9IBE6@, M&5.68CA0U*J1M"(E$&W$)%DPJ1?T5*?%4`;C4%5Q$R:Z;EFT7L!Z8O47S?Z7 MO-[E_P`T>5G3W5G;2MT_G#EJ*?P[7FOE.:4.U#3)XI2Z!U[`/XUI(4=',T!2 MUQ!IS1W"GJ5N&8A,$UCK^J_27YO6/(7G)Y7Z+YY^75W!J'(7.&B.UOYA@XCI M3C;.N+NROH@%MYK21KF2,B`0V357YH1C+=`C81\_GW7P;YRM M>5>=8-QU;39>7G13:_HVK36EY-=:1<7'RD'.>BRV<M>K7^8OW%="J#%X;HZ&O9['P-NQ\5X;LIGV=TTN/" M8W*`J+7AK2JBF)CO=1C>OJ7L=Y>2/EEJ.F7'-OF/H.EV1+(;XB^$C[2Y:0\"801S<;96D@<`):6G M:<9,_'W^:-SI\76OC\D8J27Z2_)OUR^ACU>>6=]Y>VGGMY18+#2KR^;K-M)I4NFNT_F$V'YD-49(6AD!D,HD+0`XIC-Q]=7F_Z M>[RQNH^0Y]3EY\\F]7E@\>"QSDX MQCJ?<,&+'F&;C?\`X>:.^'9RTH>,)/'P`*XW'R2E`XLI?-`[3WZ2N3YA6NKK MYC*01PA_1,J`G`4145H`:N!7=DO0B82DF5I/>/4.@]6!"$XJK5* M`]'0!TC$3(#Q0H./X0%/U)7%0(=RFA<5$/8T[#OV[,)1O+L$EHFQ5[<"8``8 M)8$T-SD-#6J^[[L"$/`A+`A+`A+`A,2BG=]?3@2H1V5C32NIZ>?_`)ZT_O$> M!-;NHC_Q'4?[?=_^O?C0HD.J6&H)8$(S?AV_;ELP(1(R$"Y@A1T#/JQ=&0)8 M606>B,UREVZB>_$E%%8:IOS]F!"*A)"9J.T;L"JRZ(X;PAKGD<6X;0-@Z<6/ MM\JC$2):*3IF,"BF[:[MKPXC+(`K8QU/J6=)>'&)EX*$I"-[K9@A:@44/#3:XU(4J`A.->.`LJ92> MI6K'L4*_`A%!5*9D M[5]I")@0B-RV)_VCFGXJX$(C7\77B6^2$1KDJ.KWU^K%RC>B+Q'.G#VK_+@2 M.YZ,R3>OL_=Z-^!-P[:J0W_5]^'=-.2=A%:H=ZI0_AIA(3@D=UN:UW;MM<6] MRJO_`./X^JP-;8^>6VM6J72O:P`+WE()`SJ,8@-5MX\2(NNBU31>>K' M2;?\N@EMK&Z0%[7MC>Z.-"6C-`2*BF.?FAF``B1M6R#MJQ7BN]L=>XW?.F7B M:4<97EQ*YD5R/LQBE')JIK+-K,HXG52J+0]0Z<08=4*W!IEPYS>_7I(`KM0[ M`,3C"6ZB2]KO)7E"RY@M9=,OY9&/[DC!&4>]DA,;T=FK7;LL='#%H;72JS/5 M>[GE?Z'K3FR]>8>?]>TZ,RF5GAQP<8#SQ-8>-G=X047:BXTX\8BQ+E[54QAG M(&M/!>>]0]&/,7*%Q:1V?F7?W-GQMI<.C$Y`!HX,0.+AGC;BA$]3\U5DPY10 M&B^.NQ=B1@DD>'S&2`GC?0#^&1V@X[D:\,$?MDWU"\KFC M[7W&0-I0_$']77KYC.KE+-M=_=Z=XP(4FN(*$T"KN[-JKA*,HN.ZEQ`^[LI3 MW8U*.V29S@W#3C%ZE+B;O]QQ3[G9&U0<5_$O8F*U(``,$P10N6WZ#`@VI=/Q M.:E>E/OP((!NIN)X?\#>A))]^U>G")`#E"`YP*FOX@!N&S;B MF<]U!96QCM\Q5=TG""`K>LDKL5#OQ!3+Z755\J@EN^KN%VTY7\UK_29H>7K:V\ M4N@LK+G#4&QVA+2QC+N1A0<;W!8R,/)CE/\`QDM+L#1_JSG055\);\4L)N0X M\1I\UZ9Q>8VN\GZRU3E:ZN[#5]'OV`-NX8#)IG-'*NL0R,?Q6&K0 M,EM+B,@\+N&1O?C819E!$3"-)Q)KW#U^-%"!8O<'\05YI\Q.37\NZY?VT$$T M5HV82VD:O175\DO\` M.KS7OH[;1)+NVT5TS873.DDL=.C5[8V,:V,-ENKJ5SP&M:'.Z=:ZKIT!E% MJV\U'2[R\.JV%I\[_"$D\4?'(4&*_>"7,)#E"8)-Z1IC#^1B_I,=>,9;HC_1)F.WH)``$6<1(: MKQY`.<^_/_G`:1_U1?\`=UE$EP;D.#HOS0`T'"5"*'4"@U!"@&HPUG`9%#FJ MM>]GV$?%6F!-")0*P[=ER:%D M=_5EA$NH$@AA=-@4@&2)`VX$!]4)Y!(3=@34,"$L"$L"$L"$L"$%Q4YJ-E$P M(``LKFF?XEI_]NM/[Q'@0MK4'KJ>H`#_`-^NE/\`^42=.-"B1]%6PU!+`A$8 M=FS/ZL"$3:-@.>_W8$([&FJ(BAO22=VS/%T3N"2LLC&;BG0W/ZQB22*YX#2B M-`J=Z[QF%P&6VJ@,8N275*2Z2C3O)-%"[CLZ<5&9-E8RJ%SY-J@]@*'-2F() MJY!;@H7%`BJB..9%5(0XNCC>ZK.0"U2M6)C6M'X1L^W/.N-$8@75)))F+HEXIHC2H3: M-^))$.DJ?7[/Y<-01&DC,9[40=&!"*"`X*,E^E>O`A3:F:T.PN[,DKE@0IM< M'=?TRQ9';\TD4%,QUJGVY)BQ"F=GO_>_F]/%@2+?N9DX*EW0@]YP);AMW*6_ MV]E%)[3@4D1M2$#56M*UVY[\,70L:X;<#4()VQO<(")6EHJ4=\.X$XY7*W#- MN:RUX#Y&%W6[JWF]J4=JW2;?2@6P`![YGDO\1P4\#6M)0`[<8,O)+[0*K:)# M:PNO%>HUOD]HVJZQI\D=A/\MJ$9:&3&5T!?KQ5HID:BR?`DI`;^)-G1]V!(D`.4_ M`/WA[OOPE$R`\4SFN%37Z?7@0)14<-338;U?5"?"0E@0G_"F*%]5!W$H<2@0?[-5SRJ<0 M/16Q!)W%`.TDH,PAVDH*';BH]U8ADC(9[%R5%/UXA*6WQ3#Z(!>/A)(3=GUY M(GV8I))+E6*G*\-SVUZ25HBKMQ7,L&354G\78M>E3DVN*E(`R+!5WO0FI3>, MS1=^$2R2$YP3.@4YT`+J+7HQ1,[I*^'I"IF8U3*J$]1W[CB#T=25*25Q530Y MY`GV1DDD,K'MDBEAD=%-%+&X/CEAD;WHY8GM#FN%6N M`.$:AM%*-*ZKWQY(T#2O4ISSY/<^"..'FR?S-\M>2?4'8-B@;'JMU>:WI]KR MUYLV-O%PPLM^?(K$V&MM:T,@UE@EX6B\8,4\F+L>H8]5I MP0C/D0?TF7XL3^+/XOU"]W?4MY7&VU/6[QUJR*<75U*YK6!D3O'N))6MC9L# M6O4``(`E,L=2>VH'I%!X"@"SR><-QK(U7I-Y2>0>J>:_.L$,MG+/I?YM:Z>R M-DT=J_4KJ:1QCM(KFY>RWL[6*)AENKB4MBMK=KI'N:T.(Y_(GMB9$G:!4@.: ML!$`5,B6``J20I\?CRS3$`*R-`:?,G0"Y)H`"M[SK]2EGR@V[\KO33J%II/+ M6E"ZT?7?-_0X3;:WS==LA-E?V?EQ=SQFXY3Y'@F\5D.I1-CUC5FM$SWP0O9; MLB,&L8]!21%9WVQ]4_) M?SJYX\AO-?1/-OE6Y=>:[IUW/^^&9C)6]]C2(9(9'$H2,,T2\978V8C6)!(,3<%48IOS0\Y//[5/4!=ZB>4^=[DZ99\JQVEG?X^K:1!:0\-ZVY!9>F60O:.[P[,T_ZB3SB!$1``Z-T-W>K]2HQG*!>! M+U^;Z'1?>WRBYGT[S,\LI/,&6(6=ES+Y$\[\ZR&5@\+3I;+D37+S5Y8R@;%: M?.0RQ!I/2=XQQ2EX-1OJ67Y/X0?"9Q M4[@'6!EOV)@CZ0LA#%DY<5H@&\*#GVX4I"PNE^2@7`#8>HXJ34.,Y%*]?WX$ MB[4NH5ZNKW'KP)I8$@``P3')=U?=@30G%:43/]AP(4<"$L"$L"$L"$L"$-SD MIMWHE.C`A#P(5[3/\2T_^W6G]XCP(6Q?EOYEJ/\`;[OL'COKUXT)((1!MIAJ M--;IB%VD=6!14F`J$!SZ>LX$*XR-:N0@A43WUHF!".K&BKBFW.JTV=6)B34T M207W30J9A:#,G\(&8Z\!F4V5%TTCR46ONV8@FQ4F0N<:$J:U(J3MV!3A@$V2 M6G%$(\ZO;2A0(41?PDXOQX]2JIR(H%;0(C7-%"B(2 M**0:KB2#<^*L,*U"5*%?8F)CT%1U5@<->C.F)P]*$=IH*FFP(*#?_-3%D9;? M!)':4/1MQL-9TJW@I1,71RD4LBNB]BO*SF;5].9+J.E,#KF+A8(/" M,L4G>XFM=&JD"04.>-N*3Q'9,/I=>VWEQZR?,;E+4G10\@2:E)!,8I(HM`U= MRN8>\GR[7`+O5,:(99>F(*8R"-7#=U[(WGKZA//'U49>B?J`Y\U'G;F&&6^TZ326P&29EO*TLED=,J M2'BJC6MQW8"0X7C(?@O+\F0S?W%.^757.JKG@=*GK"]((503BJ4FIJE^2IO^I"'/?F/VXC*6WQ4BQ/ELJCI"207^+RYSQ%=-O[/C8^]T'6[*U MBFUGEG4W1%_#?:3?>(QX#B',#7@EK@<78G1>K&KLN MN3_([FFPYYUT:'DR#6;:9L+-!L.=)7MYIU%EPQA,>K:AH-O+IUHYB! MK;R4&E#+#")RQE)_*\A_U#RQ)[18$2>D360_[F8]B>J^ M8/,/*YTI\L#KQ9)1GE5!*6QZS+Y5Z7? MP?\`.3S7O[9(3#I6OWEG^0:7('1F>YN;P1B1MI)BO!N]TYG`FH8$)8$)8$)8$)8$)B0`N!%7[(&!"6!"O:9_B6G_`-NM/[Q'@0M; M4`?S/42E/G;O^\/[<:$D)H5*(3FO0N&H$NBM8!5U2F]`.PYX$D96MXE$+A39D?Z1^S$D&Y\45A(/4253<%3=EB4/4HJTTN(/>IM M"=:=>)8]4%%:XTS)`1-[?U<*1:)/9+]P\5S6CPV=UJ,D5V>X9'4X^#B:\H:JK47'!!$IG= MU*ZT;`=5OW?*'*D33*9^"JD270<,B>)'$``8JECPBGZJQAU7$:I9Z##Q_*2L M>6J@#P\$Y(44BN*I1QZ*)9Z+F";8%`6]H!^M,9T@^JL1RVP/$4/]$!=U-FW# MBS^:R#7P7E[RTYL@Y;O/FI(Y'6@0S,80)#P'B4<2,-''//9C;@F(4-$+Z2>3 M?JI\H-!N0_7+74X^)C8W2C2[:Y?Q@([Q"V5KB5V[L;\>:`-#17891B7G%Q\E M["ZSZD?(S6I(+K3X[4=YJ23:9'%,YV7"X<1(*'VXU0SQ?:+JO+[4M&\?S7SC M]0?-.@\S\RQ2Z!&&V[/&?+.8Q'Q![OX<3!2@`4[\=R)`X6UKS'Y?JO*\@"7W M+=&T8'\5Z_"A`RW;UQG_`/<^.BLE%@XLIXL58?6ZDB5!_$@P)I*!3XAUD>[` MA/Q+L[W_`.$GL7`A0P(2HJ*/V=75@[ZH2VT3[/\`I8;US"[FZD[ M4(0G9J&["#T]/;B&317!0XJ:TRR50HZ<5RDRLA`$. M4)[D/7U=E0I*C%2M0'N24%%!3L"!:G%9DX;5"KO M<`*KM`H57>B#=BHE7PA]53>]5"%2=E5Z\@,5FI4R&+*H^0-.1)3VFE=HS;BF M9%WY=>!"]U?2)ZCK+RQ=S3Y4<_7KX_*7S+>RYFN_#=)_D?S`M+;Y30N< MH2S+3+V#^HZNP-+GVSF2@\4`:4/Y<]\?2:']#\OR=6";QV2MIV/Q\47T?TZS MMM0Y8O.1^8'2.L]6LK:*WO;.:*=G`VX-]I/,&D3L>;74&VDK&N:6N+9(WN0U M!%M8R&07CIH0;C^"G"0,#C.K?A8_&BX7GGTZZ)YC^G[FWFJ#F32>7/4=Y/75 MJ9>3;P^%HOJ3\I+QYM[?5O+O4(&.CMO.OD"[<3?Z3?&!VK:6]DD#G2QR#!CR MR&!#N6] M`^1/27Y]>9NJZ;;:?R9<Y8U"[\P-3A\U/4#J.DQ`>6&B7EL>;==N.&*[MK#GW6]/?=VWD/Y6,O7QRW M6G,E?S?K3$C\*V8EU!@;)GG[D2=U1[C4A$T(P1(K(ZYIAA^T$/$]`RP\&!QE MI2?_`(WJ9"KYB#2(TQ1+G]QC0KX\>?GGWYD^I/S.U_S8\T]8AU3F76FVME:6 M6FV;-*Y;Y5Y;TN`6G+W)7)6@P.-KRYR;RSIS6V]C9Q?"QIDE=).^21VV`A#& M,6,".&(8`:!WUW]A&!(``,$,U*G/` MFE@0E@0E@0E@0E@0HEX'2?=@42"::(1).>!238$)8$*]IG^):?\`VZT_O$>! M"Z#5&\.I:AE_QUWV?QY#7&E5U*H<<8#2J$*H`)!W)U=F!`#H;IR5V;D5?;0' M`Z>WJA.>3M.^O[5P.@1ZIVL>36E*J,QNZ,)-P%8:S*F6VJ8:B2_@K3`&D%*! M:#,+]2DXG`!ZW458"4W4]F+DD9I!""B;,)"8'O/&\D^P`_7B]4&Y\40%"5J> MC,H.K`DC\5%J!\70B^S$0ST3&W;3U(C7*F2<7%MW4XMQ"8DDK<;A7)=_%393 M$Q)@VJ2."J$$(-JH4XJH$K7%J2*T[.\NT&H1?NPP2+*/F[(S"0:YFB;$7,'% MP+IHW2<24=7*0)0U%/:%.SLP**("`4K39W:]O;@0I-W%:[RB99D4P(1D`+=R MYK54IV8E#U)&HJB#$L>J"IM((`1*(G\ZFZN+%"<-WBB#(=0^K`C'Z`AS.X8W MD?ND*,QOKLQ'+Z#X*<8[IAKNN5TG1WZU5+VJ5!:&D$YY8\X( M;Y2#M5=6()8!E.Z\O+^%[@_46/+5(1Q$1-DN6(A-,=/'#$#8.KH8HR_2.LC'9OPH0#4_A/UKTC$5<0YK9$!&VF(1D_BJY1(M52%1[U6G[5Q))2#NZ[?FO02! M[\)09F"CDOP_R[O;AJ:;`A(G\5-^X=71@0U64050X%-@Q9(N".&="N!00C1J MBE%!5/:13;BJ6[57AA0(1*.0DU`ZDS0;L134'&BY-V',[=FX$XI))NM`9J60 M"378%]X.RFTXKE+]HNFJ\CB#G39Q(0:5J13%9(TLI[56E?2J\*9]NP]&*9G1 M3"H/<>*JD5%-H&\E%SQ42U!=-5G2;PB!R%:A,@0F*M\D(+G+D0&]A`*TZ<\0 M-/%6Q<_]*I/E*`<**N^BBIW5=BLD@JT4J%1>XN[Q!7Z"@V8SDN7-D*NXJ5]F M(II@,"8#J6$I,`AO3V>]4RP)J`7L504W#Z\"$)YKF#U#+XJ'VX$(7%4J2B*&@!$H5:0*JH1P*["!@27FORY]17FMY6V[- M*Y>UV'4.7XC(^'E?FFQCY@T&WFD#&NDT^WNW"ZTHDL)_JLT+>)Q**<$28^FR M%["V/Z@GF%I]@([?RX\MG:GX:?/W#.99X/':#PRMT\ZV&B)IJ(_$3IPCE#U` M)\2I@R%B/HO'7-WKB]2_-FF'1(N?IN2=&EL_D;K3_+K3[;DV2]@*\;+[6=,` MYAO/$8XL=QWA#V%"",5SD,E9`?3^*?O96VB4MOT_)OQ=>I!1`;_I38%)!UT-Y!*-*@]"*?KP)H>!"6!"6!"6!"O M:9_B6G_VZT_O$>!"TM4MQ(4IB>\FD;J#_P"FI5'%@?521&QN M=T#?AI61FL:VM75380,\\-DMR*U%K].OHP***42B9C+K&!"F*!*-)2AH=KJX MLB-I>5DD<9#H`7HI]>+$D5@%?8G1@0B-^(_];X(#HR/5OZ M.C%Z$JI4>S`A3`5"20/\`=HN?LP()3[,"3%.#3()5>KIS(`P(;5&;D43):_9FBX$5[J8<-ZU0K]FP8$ MD3NIG_TC]^+?+M[)5=.H"5W)]F'OBA%!![P(Z?\`ZGKQ($&R6T`OJBB,2\49 MVA$.W+?LP2COB0JQ,1F2+*C!RUS';/ENM%`D?_$YQWN5$1],"%Y`Y6T4ZP70_,> M`XN;'QAO&6N(*%%S).-/'Q[WJR`.B]Y_*;T:7?..F1:F_GZXL)9&A[8+;3[9 MD+5J/$EG#WD@;C3&_'A$"VZ7X*Z/&RSCN!#?'XKV7Y=]%LUK/";_`)\U.>.! M_'P13B,2<`)X1X;APM?'R2)BX'@%Z9^H'DF#D7FJ*QM[MU MQ%<,E+6R2&6=@A):Y[G4<6.)HN6.T2#PP#I+]%YF<)8ON4\1J/;?\=?%UX%# MA4J4)2N]<9]WE9:$RM.9IVJF:(-K5RPXD"]TFHRFV3.G([OL78<&Z*B<1ND9&]%!M(4+L4G\.#=%+9( M"JCQCK7):@KTU&$9C1,0DH**Y_?U]VN%[BM]L]TW&-J!$%-G=10BJN(C)M#4 M4A`LP0C(*@;N*J*[/]TE17$-P4A"364'2-J"B]72JTJN$9]%(8B4(R#A``&\ M54YU6@Q5*8>MU,!@R`Y[2U!0FNWXO?MQ0IL4%[PB=(HM=X*YC$3(`U4@**K* MYI4;Q5/VH,4DN74E3D&WI/L6G:F(3]*:K/H*R""Q0_10!D;DPCWAW93[#A)@NG,8_G#K_DP)J):1EWJ]*_7 M5<"%`M)S!'2`GW8$)N%*H>U?MQ$Q!0F`*J?AZ,]W5GA;!W0Z@YI=2B*$7Z)G MAB`"'HZCP'+I^AP&,2A2X,BX-IT=E5PM@0*62`:1^%>S]N(F(9PFH MW`DVNJ'@32P(2P(2P(2P(5[3/\2T_P#MUI_>(\"%IZHU-1U`TK?7?_KY*;DQ M=&.T=TF:BH8DA'8\A`3_`$AU%.K`D;]D4$G,!/KPTB!\U++`HU!24Y!1VT[! MLP(1`_-4'4*]AV8$*8=N*Y9U^NJXD)$600CB2H*ID"H7^DY<3$QJDR+XH%.( M$=5.Q,32O=3:_:43910?KRP*/MPZ*7&IH0!M3B"#=G4+B49-X*K9('JI\?\` M/7L^/_\`!Q+?V4'16RMI4_BJ`1LW4PWGT3JI^-4$.!V;EU/YMI1'(3O)3+9W4P>]5J M);$FW1#LU&5#[\\3]SLC:B27[HF&1CN\`2@!J<\TH1PXCDSRC$F-TXP\S&SK M2TCGV^T^VE9\F+O^&XEC#PGN9.H'E!MICFRY,Y`N*K=#;$,%RFH<\ZC?O>76 M+8^+C5.-V=`"X\((ZL999Y2H156F1-UR5WJ=S.3Q1!HJ$#2!4*25)JO3BHR) MNDJ!DD.;1_NXBA3C>XN#2VG0U#5!@0O(O+-EKTK/&T1CC,Y3PAX87%I-`7*T MEJ4"8UX!,AX)#J%[F>5=EZMKB%EMR=?WEM8O`_A2ZG;11<)W-=:2.*KO&-V. M&23.RMCDS`>7=\E[0:)R)ZO;F:WCU35([:)SP9IG3&8EB$N/&QD85!L&.ACP M2%257*>4W!*]*_4#I'-&@\U`\U7;]0O)8Q''>.5"&./'$UKRH1U5VXUY9&'& MB8Z28_1<64".7(S%3$?@O7_YX["3M.P[URR&,7OR5VP.Z7SA(S)_F_6G:<'O MGYI[`F^>>-^ZA)[`BB9Z M[P=A-:8!D*>T)C<.SJ@7KZ"1E3"]R2EL/0IO$G"0H.<"*Y#:4*@FF!""X@Y$GBSS3HP(0G\.W-*?3+`A!=7+WUQ0=S M^:ZF=O[5$A4JB820)!<(#E>B(1V?;B)#*Z,MWBA.:#GF,1,0;J2$YGQ*@*<7 M[<1V@5"$$M*9+Q+4M]M3B)B#=#T?10,;15V9[?OQ`PZ63=1?'D@IM*)7M1!@ M]ONI18FMT$M12:>]3B)B8E!;10Q%),6@E2OT[,"8+)%H(442O6,),%U!#[E[ M,"="F0;@`2AZ-Q7LSPD&@HABI'U;*X M:`=$P`0BJ'W>["3NF+2'$GX2$4%OLPJOV3[I^)N_W'[L##HA11H%0%Z&T^W$ M#"E+H="<$)&*TTV!"B]4ITKU(5P)$L@X$!VK="E"?$D([$ M"#:0#FM![2,"$;`A(%H/0< M_;MVYX$([%RR3/:J_4F-`+ATD5I0KLVX$B6#HN8'8?MP*.3T%"!#?M%>RO>W M8O5*L!RM)W+]^!"E@0GXP`A*=(!*=';@0B?A*9FI']+=@0ED>]^'*E#^][,( M%Q1,$2K)/QMW^X_=AI)PZIKEUT3.O7@0I%Q=M]GT3`A.TT%*A()XE4A4ID,^S$`P M-;)H\3V/HB.*(4SJH6E,2\IBQ]2%Y5K.'4(].=>PM+926LE=P\=2X MF-CE"]&-D-T(.Q*%[@^5?J\YFY1,4-EY?S:H2`#X=KK#RCI#F7F/F7FQMWS+9C3;B%CA;VC0C6^,YSG/*=TR$A M#M`&+>02,($K;OQ7+D=W))ET;Y+UN\1:@[-NVFPG)<8E)1,G\ZM"A"JBT]^! M.WBF\9U-XV?A(/13+`DEXKL]J%*>(?4,MN97/LP//HBB)QM7/WGWC(8>^*$_&!544I4 MHJI7IP;XH3\0HIK1`IV]5,223\6QPIB*M0RW:>][D^]<1VH0TPB&0A.`!]YZ03A(4'`%2-J]W)3U].(2@27 M"D*ED$L!`V':,^K;BL@@L4R&0R$H<))-@0H.ID,S4KMKL7`@%D+`A+`A2&_` MI#JHD"I(7MPD`D^"":UVX:".BCL*U&[`4HW4\)30W9Y99=Y.WH3"#ZH1,-"& M1W4%=U>G%!N?%-!-`I.$:*!F-$%SB>P?R].!/;%-V8$AXH4FSM^S`IH>!"6! M"6!"6!"6!"O:9_B6G_VZT_O$>!"TM13\RU%[`E^2LMR';]9PTB"Z6!12``"#`A+`A'&0ZA]6!"E@1?Q3 M@J!F7&JU^JNS%D9:%)&;45V4]VW%B2,UR4/0!D@&'X(4\Q0YY'"4)#="BBO` M>+\*T]V?;B]5D-463AP(JN\*5RV9;<"2-@0HMN(Q)-[)!-WDXE/\`13IZ\232XDI^[[_P]F>% M5^R2D7(-P:.$H%4D5!&*1&!D\EJB197K[1.68FN=$Z-K@5[TS7)T*253$ M#CP"@MXJ4J!Q=<=<6VGAQ#"TC8B=X+DX`XJG&.E4`FQNJC8[1KD("<1R`0#( M9'(8KVCH?CYIK7L(]-,T3')5[0`6A"5&W8,68Q!TCN--%[A\H:OR[R]H<$FM MVZP-8@5M$!BXOT7M'Y6^HGR(Y:D@-_&&>&` M5;I43LA6O&,L3CFQ@,ZLB8@N0O9'4?63Y&W$$<6B6[+F9PX6G\M9'(WN9->' M/-4QIQYXOL1DGC+'5?*/U)>8-ESWS4V]TRS=:64,L@`D`;++(XDDD!@X0`43 M-<\+EY&Q1Q]W7,I//*8LS47K@'T0CM'W%1CG*2F';1LV=.8^K`A."H7?AN0& MT0DNT*.O[JJ#].O%R2EQ2=/\`N_LQ3ODFIL<` M#M=Q$U"C+-,2C+0H2+N%R4.67XJ%5]B^W/`A3:X%`37A7L&T; MY:X*MW33G/(+D$[=O3@221,_P!M-_;@0"#91<.(4R4+F5&ZF$7: METT$AP[20!5>C\.(M/JBBBX$M&S(UIB:2`0>D=*4^K&=24".KB2HWX+I@LHC M[!VYUZL(J>/51>:)7->C;[\15B`XEP"9C<*GV9X:0+H57(%WY^W=B!&J"[4N MF(V?R'JZ,1302PU-$K3H]F!"CUY*%PI!PR:&>Z*.^GL"DXH302$4G,G(9GI` MW8$`.HN*!?9UX$()).>!"<#`I`:E+ZL),?@FKAJ+&VB9X'#U?:1A*349`*8: MB6T2!/$=VSKIVX2E=(M=4D@#8:4.86F!-2P(0RXMS`)Z%PJ"J%6W:]L[\2@6/91CZ52Q:U732PT)8$*Y&I:*K14HOUX$B^B M?#4$L"$L"%)IWER;`/Y<"$7,;1[C@0D*%I*4V;*A$P(1@4(04*>_;BZ+[:I( MN)I*37LZ,TJ/W4HN6?[1@0B8$)8$*(4(UPV#%4H&'E**FJA;Z'\Q((VR$..> MP(J-S%BNOTWDEK9(YI)GD-(>1Q'O$$'.AQIQ\/:7DD9$KW:Y* MY8Y4YJY6BT;5V6LDC87PRB>81&1AK&YC^($/`=F#LQUCC!CM8&+)1,#%U[$^ M4WI2\BYG,O.9;#1KFV86DG4+^/@"Y`M=,T(N=<.''P0%(Q4Q&,_43]5YLU[D M+TQ\GPW7Y-;\M6]Y!:2AOREQ9RMB_ADM+?#?)P$)UXN@8"S;D2Q88AFH/FOC M5YSWVBWG.U]^0][3V.DK:5'MP(1&EVU2B)0`[LT!H,"$9KB0G#L)4; M3TUJ:X0W$9$BUDU!Q*'-@D!>O+JP(2P(_-1?\`">SZQ@0@X$)8$)8$)8$)8$*]IG^):?\`VZT_ MO$>!"M:BY-3U`;[^Z_O$F76,"4G:ET';BR,_]2B"34V2Q,.U;J26&A'C=5-] M>L`=630,"$=#AJ#%-@2357H3WK]V!"E@0C!U5]F[ M$/0HV3J?Q?O=W[,L/;%-@AM`<[.J+7:=O9AR+!!3[/W>_P#9].C#30YWS,87 M1/X(0=/9W0'&X5H03WJ%2-H3?NQ&L3W3H1V7 M=Z;JQ5I>]H*`%3W33,(:<1..ABR@,]EFD)/NBO,W+',S;7@_B#A[BA1L-"I* M!PV8Z6/("&T51EJ*3LO.&J<\G_)TD=K<^'/*'@.#N\G"FPJ#BQ,O+FZO[F2:[EE>0Z>3NQEQ(:075#6C&7#CE$&>0EW2R3<-%>/[N< MW,\TQ5'./"O[K:-^K&:U?;@0D2J(`,U`"8$)U<"G9PG*N!"F%V\*)_P!'H_FX$(F&`26"$R`;"N\Y M_50820?6Z1%*CIJ-F_JP)J9S"9YTI5=@S3&A116@H"0A&9SVG;TC`A$X5+OW M1NW)7/I&(-/JG1$:U!MK4=HSQ(``,$)PTU&9X00JYK49`KAI$@74F@E%VY43 M+M.!1D2+63!BA$<0"W:!Q;URVX$2)%K)BTC/B!RJ*807-*&F:$&BU-<2207-4(<5,\`5(ABR@@)4&O17VX@@$@N$,A*_RUW]. M#LFQ9T,Y'I.U-A0G"+?-..[_`+5`T4IE[R?Y<+139Y$H1)-3B)LIJ&TH22AI ML_9B)+H%:H3E6ONPD(+J(0H52A^M,*0!%4U$U!);NJ*8JGZDPAXBA(@',8$( M!"4.!"0SP)BZ28'1M*<@%=WOPE)JNJZ8$B'/9*@J:=*?1<"D@N*GJIA%]$)@ M":8`"!6Z$V(9-$B[438K4D*0=Y4IGMSK@48^E1'3A)2=O+9">J=&W+?3IPU- M#P(2P(2P(2P(2P(5[3/\2T_^W6G]XCP(6AJC5U'40I']>N\DH/'DZ\6"%*W2 M5#A(%"?=GU)7+"]LI;8J6)0=JV3KK=/B:%(.0KOSP(5AC@Y?:GUX849(@(*$ MY?1<'@C_`*DQZ*U]V_`HI8$(C#5%[$SSV]&!"+@192CR(SI)38, MSQ)5,E7)!O"XN#Z]4(F!)&;\(0KT[ZUP(0R>%SC_`#@/MQ>J#<^*.``WBWGC MIO.S;MP)*>!"6!"10H%X:J`BH*+[L"$0?50'I^$]?>.!")@0AGB7AW&G5]U< M1H1V3K,IC^%0A5.L8DDI(H/;VG][`A(`E%2A1.K[<#)B1%D_"K2#M!'17"(! M0Y?=JLNY@+2K=ZBH4D9T%`GOQEG%JBRNQRW1;50MKLPO`)3;UYTV8C&6TNID M(M[-'O"!(LFM^PUBZB M(/BE&I4DCNT-*K4G%V+/.)H4IXXD57F*SOY'Z('2W`=Q0ES8EKPN))+G.*CJ MQU\1WXP2=%CF\2QJO&>IW[YR8HRK!"0Z%J-FT?=@0BJ0*JIW<->S#!(LA2;V_9[^\J;\2]7:(210`3 M4]*UJE4[<6H[Z(PC'2.]T$+[C3$=D4(@8`A7;[=R8(C:D2-5,,%02B\.PG+9 MFN)>"'<.$0LW*:9J@]B9X8!)872W?ZKJ8:X;2`G8#TBM,/9+HCRR2X'*WO`@ M?=LJ%Q%'E[)FMSH"[3U8C*+A]4T`E2 M3BN?J0FQ%-0>*+N^U,"$+`A.IP)N4EP,C<5`G/A[>GVU0)A*0#*J225.!--@ M0DWXAUC[,0'K*-$L&3T_-1-NZCBI30Y*(%W43<#5=F!1CZ4/`F6U4'FA!S*' MW[\":%@0E@0E@0E@0E@0KVF?XEI_]NM/[Q'@0KVHN_\`$=07_P".NA3^T2=C M<2C-J&RCNBJN+000X32PT)8$)8$)8$*RR39V`_?AW4?2IDT)&XD8%%.,AU#` MA29\0[?J.!"/@0F`JW7?TX$*P!5>A.O:HZ,70]*2F$6M1].K$DD?`A"/ MQGJ^W%ZH-SXH@(;DNW)>'B6JG"#_`"3EM_[D7#44L"$S`IHT*W]B^W`A&)/$ MA1,P>+B.61W'$1Z4X7"BJ4W57WX?=3_V)S6NW/\`9[,#U1M\O=.Y:=8S^%4^ MK!JH_L^:1#EI_2_VNW#44P:K>G-.C]N!#FVB?+\/^[6M-FS"(=2C+;X*$@+J M%4R(HH_G5:,1(HQ2B=LF*QKJ(->H*"B`JM2E`*=.,LXL:66F)55>&A'4G[<1 M0B1\1"ZG2+:!\K#*O#QM))1&J0M-O=Q.,2:@U4XM>5`ZZ*_NY8H MQ:VLZP@>$K1PN$>;D(5"E=R]E<1V20G+#T4'T&697$]@[H=0`<2*&IH#EUBBXJ32+7#_>K M[O9W<"%$,(+@=X[=N_`A2P(3>&X%4*EVU=M4HOW8ELDDI"(D!V5??N_=5<$8 M[O!"+X)*%!Q>X_[75B6W=YD)Q$2,ME2#0FN_A^'![?=#JPUM:A5J53/91*)B M8`%DB6J4X!"$5'3L&W+]Y<-'_P"I&95`6[EJG$40YY#WC%D9:%"+0)4D\-:= M)V`)BQ)+9V8$M$Y*E?INP5MH@-HGH%Z43,IOWG!5^R:@IV"J$JA7^CG@<7T0 MAE:T(54[=A]F$;%"'53LW](V5Q5/U)J#@2"E.E*D$9#IQ%)P[:JH]I"`EV50 M-B?B&1Q7*.H4E6<'$$G,;.I",5IH9"U*TSK]>!-SU*@4V@]:%,)BI[HFZB1M M0*N]`*YX1;Y)D&46-T(A*KT>S<-V(R+IQB!9-B"D@$$9X$);>C)%&>]<"$.J M[%4HO[M-V*Y4DZ:"Y>-U"@2J4R&*TTV!"$\(57/9]N!"A@0G&`IQNAN04`KM MPE(/JA.%%"]-?LZL":%@0EA/5M4)SD.K[3A3])2+-6RABE20W9)MXB>PK@0A MX$*#S2B_=UX$@[50ER&[+`FE@0E@0E@0E@0KVF?XEI_]NM/[Q'@0K6HD_F6H M$9&_NP<__B'X$*OAB1%D*6+TDX*8$B'4LU!&\Y5[,""^B9%7AR"=?9@32"@J MA/M^[`E0HS'D@`IM3[.P8$B'*+AJ*DVA&WJZL"$51T^P_=@0I-4THF\@@K7W M)BS'JD4<`C;M]R98MLDI@*4PD(R4W=5,"$^!4SA,GJHM!3<%6NWZRBXO44;` MA.S)3GN=ENR3$=L4F")PUHN>0R^Y,%.@5OMQ24N^B<:>S=@VQ53!20;A[!B2 M:8,)*#B'20K<";GJ47A.Q#U'`DH\!W$4R'T1<"$XC*(2`O4#7HRQ+9)).8^$ M$N4!*K4H,NA<(@BZ:I3/XPY`%, M9R)&3%7*/@E:GV`_5F5WXCLDA$CMU2M%^)-U=_=Q*,"?!(R`#Z+7@:8^$@N# M@@(-0X;1M0@XOC#:6T59R=`ML1OE8)$4=&:9UZ5&-48G96RI)`J@%H^VA.W> MA %-3X>D'H!J>JF),]$DN`%`2I!K4_8A7`ENBGX0%1Q';49UJ>GKP)IBP= MZM3O$H0$&'>A3 M40&`IQM/:B'HJ<)AT2<]"IAH`7B&==A78JYHF&EN\S*70TA=Q/[<2V233MX" M*FM%(SR`=T<.(J,@3:RDQH(7BXJ4'VY+3%L8-4W1Y>RF`!M";"AKMJ$]F'&. MWQ0\E,4R0C8$*95J#OPVCT1YE(N:=M:-2M-R8:'"6!-):]"9@+[,"6J0[I4* M>Q`.I#3#NEZ4RK6M<"/JF4<2DKO2IZ>A<"'8H9X3T;Z$;TV9C;B&R*DH$-WI MQ9U.S?1,1,.B;H3@U!4TW(M#[UQ6@$$.%7OI]R[,"$V!"6!"B_/+MW_R82G9!?4=OU`G`FA8$)8$) MSGFO3@0H8SIH#S4&N[NKE45P(38$*+EX0GVK]^%JH#UE!PU-+`A+`A+`A+`A M7M,_Q+3_`.W6G]XCP(5K4B1J6H9)\_=E?_N\B^[`H[HJL"M1@4E/%X+ARDEA MH2P(1&D9.VILS"`?5@217-'#49=55.W/+#42VB@&HA1`4I3KV8$D<>[9U;," M9NG!0K@21R=^6_\`9@1=2'VU/3M78J8L_P#UI61FY?M5.C%@[I%3:4()^A3` MA'P*$]_[;,HA3GV%:&F2=F+/(J_-W_%3KO'M?]^).$]DE(&JT(XMN7P]F[`X M1LDG#BF2=154K793`63B)7"F.K8E:UWUP.`EME)2K1`VGV_5@=/85-H4@'(= M.W=1!3#4$5"-I0#//;TYH,"$@U^U=WX:;RJJH&);))*?`=[\TSV[LL2_F?#( MHIAIW$IGT9YDT&+$4?LJ=P[@S&83.G$%V98SS.GR0J3F\153FO1[,4+2F$8. M>PJ*[LLM^!)P[:J3^$"@'X=X5=N);9*KW)=D@`"O"J94&X[AMQ8&T2EN_95D'D[`AP;7]-0C>%/ MPB!DSA5*;!0$SRPJQ/=(R`/=(L!.03)P05(`J*TX@<3V:Q*EN"F@S)HF07K M6E,2\L4GZI`9`;![AA@/YI72,NBD&K55Z%0T797$DGZIPE*@[>A/K)P,F9)P M@'X2*`;NVE,"3DJ87-&]@.76HP,GN*_]F$5.((O90Y**%"\1J=R?7A2.G[BI;2EBA!?5!?0IOJNU:TZD&!"A@0E@0D>S_ M`&LL!3C=#-*TW]"#.AKA*:KG,]9^O`A-@0E@0HXH-SXIH;S[-^Q0JXC50>?1 M0IAU0\^BBXH%IL^G3@3CZ4#`I)8$)8$)8$)8$*]IG^):?_;K3^\1X$*SJ8<- M2U%`?^-NQ053YB3?@0J;00$)ZZBE.E<\"$8946GM&S%N/T_-0'0W"?$U)+`A M.!_M=`7[L"%9;2GNS7M)P)&RDF:J56G1NH4PU!-PMW>_+WX$*7TR7ZL"$5KG M.H1EF2G8B'`BZF$:N[.O;NKBP3K6R&K2Z(V2E$3M^TXL[:I$$74@^M43M_;@ M21!7)/:,"%)I`)7=]V!",*ITI[\"$8(`GW=[`H^Y#JHAH*H[+.F2=N+6*-\4 M7O?N^\8;*/N=E-K`0IW`'/+;AJLDFZ*.!:9]N!"*!M(4>[VXMC'4W216C+N' M>#O2M32F)MT24P"=@_;L&6$PZ)J8X@H0"A*;^DG><#!FT0LNX;Q'ND(JD;2= MZ9[<4Y`Y4HR,;*IX32:J3T!R=%:C9BG;)6>X.ZF&<+Q M%":G-6U]J``98OQXJJO>_BMQEJ!"0*D%S2JIVDK M@]$S4@9'?ET';BC$3*6TJ9<#<;*,\!8_+A:X;%1=HV+B63=#P1$Q(W((82? MCHF\_>:'$?\`M"EM'5+@S'&>@5W'/-5Q-##JDU@4AQXES2E%WKF#A/5DJ!3X M6`HJKWMY'7E3#-J)74>!E224V`;.DDYX$)&-I3OE=JA?NP(2$;-KB/?]F!.G M=.UL8`/>7ZL"2(&-)XE)]W2G3@3H_9.&@4J>[G]W3@24@$"#[?M)P(3T"E,L M^A:^_`F.Z>F!%'[)DK4%%W[\C5!@23IT'IK[-E,"%%*4^M/JP(21[JI]HV8$40W-:40D$>Q*]66!`NH\*?B0>\]"=6*Y%X*6T(;P\5 M!)IM6JD4.Y,5DDW4D`N<*D#/I5??3O82%%SB%<0#T*=_NP(%J65=X"G-,O>A MWDKBN4=0FJ[P3DB[Q$^_$#1.A'9!+B#EFHSS0]6$A0+EJ0VFW]JX:EMDA%S4 M6CE!H5&U.C$);S0!-B-%%K:+_N_84Q7/U%2D63/R`2G\H3$5!#P(3A,"8;51 M<5HA.Y#[:)A*3@H1Z5[%_P"K@3031QZ^G^7`A-@0E@0HGK3Z=*XH-SXIH3@Z MBN6N7"/KPD**'TS_$M/\` M[=:?WB/`A6=4"ZCJ!"K\]=G_`/'R4(PG5>_LJK!3IVU3:>'VX'3WHN+L?I^: M(V2Q(/JI&J6&A28JT[?IOP(5E@VT]M1G]>!(]%,C#42&2RJ,"2EQ#:T=E,"$ MS7%J#8-E/NP(4^-:`5^KIP(1FMGO>UR$4Q+?/JI.&8(C8]X%=HRHN9& M)>YV4&1@U35"!]1ZL3#&J$4#(!`.DX:2)0(A`.W;]2X%5ET3!RJ%/:T$E>@$ M8N8)&4K%$#B!1A*?BI[^W#445"4J@SV*T.H:"N!"(&M.7$[.M/V;\,`DL$(S M.%IR*IFA0=%=M,6-/J$D=K5=P\)1*..X**HK97T/0,Q15)3'1PX\*5=[L MURIL4IO!P))%=I*_ND47VX$_DHK1-@Z$P))J]"=J_=@3HW=,5V)ETKV;,"8; M5#<*'8"AVT0TSWG`AA?1#1,O?5/Z(WXKG+0*0%$)ZD]TA"=ZHE*[,_9B'E$? M]R1)%T![B,R-U`NP$].1Q%20C(.DGJ*>U,"$-[VIPI[T0H4*U6N(2DU!=-57 MK0`)12%7K0E-O9BIU)B[:JNH=6J'8`.')>M4Q&4F\5$EDG$$("*_3LQ4G'?^ MU5W`5.VGW8%H02`0A^AZ.G`A"+/B'M"_]$H<0]SLK1/JHEH"<--I&P]1)RQ4 MDX-T'B!)+`A.F!,"M4,@@[!U'LWX M2F@O%4`*YGWX$(>!";MQ%I=4)'J7HI]N(9+_`"2EZ4%P"+T(-G5TX@I*(%*G MM^W+"=5[SHHN"@@8:F':MU#P^GW?MP)I>'T^[]N!"7A]/N_;@0EX?3[OVX$) MN`[Z=H/LP(5_3(__`!+3T/\`[]:9T_\`>(^O`A%U-?S'4#3_`(^[!H/_`*]) MT8$*DTE0U&H>A,NH8$(^TXLQZJ,?2%(=O8%7HS&+$TW81V]WV9K@0B,%/N)6 MBYX$(["0J)U'[,"%)1O]^&H5[IE&\>T8$D^!"FUO$MDKEB55+^7\ M.I@=Y%``VA/_`"J8:K1F!I0$%3M"UIQ%:U&+/]B7=6"XT=PE5Z4IED.[BQ)2 M4T(S]IKUE,"%)2H4E?84VIA@$E@A$X%VE"=VT_;A^3NA2X4!JI`I2K5%#D:8 MBHQ)-[("`GI"YBI7/:@3`I*(:VJBM"4#L\L@1A;!_J^/HAT4,&"=YK-P-)/>!*UK$&6+,>.< MRQDRKRY\4!Z7*TS8Q1,XWR.D=W7<3W4'0`:+C9_38XC=D))[KG_U>6>39`;8 MGHL>\=&3W4*(>)J$]E!3&'.8VBNGQA,#SJCQ!.%0G:A^PXH>FU:M73H-X]_ MW8BA1IFHW+@0F+@"A_DP(3.0TVJ,U]V!"3@`E![>'^7`A(4:J=-%^WHP(45' M[SNTJ/\`HG`A2+@$ZA[-F!"D""*%?Y4]N!"5`%4=J_\`6&!"1(`51[_NP(2! MV<5=U1TY&F!"1/MZ5^AP)^*B2=I'M*^ZN!.FCI@3O;VD_;OP**1))-#3<$%-U%Q"4S3:50K4)6N6!""0.JN\UW*I.*=\DU`CO M+Q`^[(;@2HQ&ZE6)[H+SMH0*(M1[-F%V*?\`NC9#2@JE5K[$Q&1HF8>3N@N: MF0H5Z_NSQ6K4%Y*IL^O+VX$*&'X(43PK7A7I3%!"91O'M&!"=1O\`?@3KW4">I=XS]N$I60WK\(7<=VW` MF@X$)8$)NC+JQ5-@-H2EZ4)P&\TI54]PSQ!20UV?8/KSP(3UZ<"CY>R7LPE' M_P!25>G#4O+V2KTX$>7LFP)AM$L""0+J]IG^):?_`&ZT_O$>!#AVU5C4_P#$ MM0_MUW_>),":HX$)]@Z\./J4!ZSX)\7J26!"*P9G833JP(4\"$L"%$YX:@;H MK,MOV9G+`DCL%%W_`&+@0CAR#J'O]N!"E[%3*F7[O5@0DE/W0!D$[.]B7D[I M(Z)P@GN[T4IBY)$#@Q0$Q+S]U&51N"(>*A:4]J[=^+([G\UD$:Z*8) M7::;4SS^O#E(1NHEE99+PCKV[7+G3/B7%L9$*N4-P`%(JS%)S`A10Y$^Y#@0GV9[\RAW[ALP(3([][W#`A(95-,JA/KVX$)(3F>J@SV& MN!"<)53MWC_=R.!"7>![=^Q/8:X$)=J?3MP(34([IKUK[`J$,N0HG6J??M&(29_+9,#K=0)4DX2$%XV]GUX$( M#\NW[#@0H!.W`I!OFGPD[)8$U!Y/9_+3`A"P(2P(4''8H7IQ5,U33X@A+`A# M>79$!-AV[%P*.V*'EF#]7;7`I)8$)8$)U.!1VQ38%)7M,_Q+3_[=:?WB/`A6 M-3_Q+4/[==_WB3`BC=E1P)..J<8LQZI.#9.HW.]C?^WBQ-/3>?8/OP(1FD$4 MV>W`A/@0E@2NHY.!S0KAJ)NC@J`2F_8`:8L4$7>H]OUX$)P0#O2 MM#3H.!".VN0).?Q#_M(F$5">BF6IGGM;^VHP)/%FT20+NZW*,"B[GNGRR('0 M.+[<"2<'W9DN/WUQ;[G93KT4^PY+^SKP_"1B4/2%+S=T9B M`Y`.0=G8F)@L725QD_!\()]W3[L:(S:L5FEA$K65@R32A#W&K7A6M*UJ<6;Y MS[!4[,4"\:E#E8@[R]))KDIZ\1G$"BLQSW2W*F!GEF%H"E*]WQ=^5<"$]?=T(OUX$)N[M_Z2^[BP(0R5VC:B5IOP)BZ=:*.ZO73A*A5`*;CLVU.`FC*.T;MVJ$XK\5 M1UY;-I*8K4D$@;,MG\F>&7U1X*)7L-*C-.W"0H<.?3TGWUKBN49'NF"R"YJ5 M!IWC[,]N*U(%Z&R;`DAO<#2J@X$(>!""0ARILH?MP(3X2L2P(4'-6JGW?LP( M0E&YWL;_`-O`A/3^=V@?8XX$*)Q7,:H";%::6!"$Y%R/7DN^A&!"A@12Z6!" M6!"6!"6!"O:9_B6G_P!NM/[Q'@0C:D$U/414CYZ[*KM^8DI@2T\K*G@33C,G M(^_)-F+(-_W*,?2I*513FF9_EQ8FG[_\[WX$(C014DUV*4[1@0I8$)CAA1E9 M1P**.W((5W'MP(4AN15]O9@0C-4`5K39EE3`A$XG;_$K]!B:1`(8V5EI"9@UVU&7UXE%"*WI0C<,D3$D(T9)JY",P MF[;[,.QHJQYH^93:JA=IZ*[=E<,OHHQV_N1OQ';E1%Q9CLE/U)US[:5[-B4Q M:H([47HZ3]N>!Q;5-(9C9]^]>@X$D9FT]W_9^W"4)?Z0I51#P^SZUSP(_P#4 MGV;,"@Q?ND*HFTX:FU6[(G$E:(*``Y_L`Q9CU3`8,I#=]B+O/:N);(]$O5XI MS4T7HW^[$TB71&`EPS38>L[:(IQ.`ZP;EH:+U;\3,J*`CJ4.2H!)V=*(OX<]F($%G*E$[:A0Q%75R'_8H]S^;[ ML"E_+[?@GZ.&G9]6!0_E?#J'T^G_`-CP*?\`+[?@B8%-!(4$K5*#IKDO3@4( M3W>*@A.2T([4SI2F!32"E!G[.NEK`FHN=0FO62J[LL"$!:JB!:?7B$CY7&JL_V2LA.14:O5D@3,'=B MD/JB6W]J@XD&B=JKMW;,15R$XU*IE0[!N/3@0@(B]X':H*$G93HP2LHU$>I0 MG5!5=E<]OV)BM2!!LAE%H*?3KP(47$&B9C+Z_><0F=$T,_"0B;*?73+%284. M)V_W#`BRA@0@N5:]G4M,"%'`A"S[R=N77@0D5&9/1TIMSSP(4#BO(=%']P43GE_.^'W9_%BM./I4>$&IVH<\U MV88)%D]H4!"7_H\"$O\`T>!"7_H\"%>TS_$M M/_[O_CK3^\1X$(FI@?F6H5=_QUWO_P#B)/YV!)AT5(`9<1ZR/M7`FB<(15)] M_P!0.+(^7U),-%(-0?BW(OOH<6(42T#][>H&6!)CU3\1)HE=Y7[2E<":F"XM MHB]73_O8$)P%5<"2( M'$T0>PGVURP(1!D/LR[,"$5KB2`E.@98$(@7(^[+%L9$FJ2(!U>T4J*T*XFD MB-_V=P3(88NBUD9A&6Y>W%B1I56FE14)V$4[<)-3WT/64'N4G`A2%,U/13KI MV8MA+;X*B?J4@4KEMW>W%FYO50J**#1:C?M^M:+@_?\`)"F#0$>VHQ))$_#^ MZY4VBE,]F!+]WR1`%3?VFO;7`G0#LGIB;0ZE%5('8I*Y*/KSX<2]L=U&5E-K M>';B8``8*+E2PTE-K7`*X-Z5^APT)P[9\*=O8B8E"Z"K0;7B<@4A#FN?3DN+ M@'60L_ELK``94E/UA-QNW^X?=@1[D^J6 M>WK/>!W5/[I<,"LA.`'1,O\`*5%:9$+6N!6J*GL5WA,15BKDIDF6T.7L4)AN5'9%0-:=T=#N@K13GB)LI(;BFX[P<00@X M'(M=";%4C*Q3#(1S M=7ZL\-1UT3\`Z:].$I)BQJ5)'61B,@X9"@YK1D2G8?J(Q4006*:@C=[O?_VL M)"B6@_M)/VX$)N%J+3K4I]>!"2,Z/;^W`A+A9T>W]N!"7"TY)[2?MP(2X69T MW*ON5<"%>TMK#J6GHG_'6FW_`.8CZ<"$?4_\2U`EY"WUUL*?]_)NP(5)M'#O MD]%<2K$H1<7))MF(P](2E91=D>SZQB25'[J((&2#]Y5/U4P*0;6RF%44`&U$ MK]V!"DG35:A!6B?%@0E@0EF1FM$3W^[#"C)%P**<%"N!",UW$%1,"%($BHP( M16$D5()P(1@2*I[1C0HHV65$W8$*=:5J@KD/=LQ,61XW1V.#6C=T)7K)W8E= M1I$(^$I)*A"DI7Z)B05>313%?<5WKB<0Y95(K252@1=B\7L*T7%R2F*T-"-B MG[\"$14"`FN?[,,!RR.Z+N]N_P!_;A(4\:$E,$4J2414R]W3AJ).@4\"BE@0 MI`KU="!*C$H>I"F#6M,LMW01EB0'[HI(X>ZE.I0$P$@!RC_`/J_ M'RLF!V=60(Z]R8COBKDSB02F_P"QN(^OLR+*/>.PGK"?4<5II.+1L_Z7X=Z< M2I@0AD_TB4KU+DF6!"1*8"0`YLA1<0.OZO;\.!,7425W=`R'T.$IH+G;!EMQ M2VO[730G.0`[J#KWXBA0+LW%:9#9U-Z\1GZ4T(NJJ-"*G5O.*Y^HI@M51X@A M4YBB#;6N$292I=2BVVMD-20,CGF0`,\0-U9#TJ#R`VJUILW@>_`+HGZ4$D-% M,_I4X$P``P0CE]MS]HP(2KO'L/WX$)5WCV'[\" M$J[Q[#]^!"O:8OYEI]1_QUIL/_Q$?3@0BZF4U+4$?_[]=_A_^8DPP2"X0J@< M-KE[$_9B])3P(4:='N^+[\"1)_!,ZK3V?6,"`=5$'-2`=A0'ZL":<$+4M/26 M_8F!"FU"M0M<@T47K&!"?`A+JI].S`DP1U4*,"#91PU!%!6I<.D(,"%,$'(X M$(K-N75U;<^G`A%Q>"X=)%:5H55?H/=AI*8SV]7T"XE%"(PH4WXDA6`[8*G57^ M3%H((<(10Y>@C9M&&DIM^75(`!3";#6B=/V8O MJH^5.7%OQ=N2CH_=P@0;)$,G:\[.%J=8PTD[2F7%O"BG1V8$(C2J4KT'HP(1 MP]$S!^FUJ8M$QJLXQ21Q*YU&FE:KV!*98D"#95RBQ:0474"[4VNR_EP..J`2 M"X0E&]=M4_D3$/<[*?MSZ*5-A"=8IT'JQ+?%'MSZ**@9_6F(^YV1[<^B;B&\ M>T8/<[(;)W_%.N#W.R/;GT2X@"*]E*^T'![G9'MSZ)$Y9D=@V;<'N=D_:EV0 ME.YGN^_$=\D_/C'9)>@JN_O999*B8BKU$N.QH.W,T/1TXEODA1+NGV;_`/M8 MBA1)IU%.]]%.!"CQ"FT[\OJS&`D"I3`=(N<54_4$Q"4MMKI_]2&7)L3I4>X' M/$?<[*6WI=0+]R]?T7%::&3F3UG`A#<57)!4NW8%*@C75#>5/1T^WVKBO)HD M$(NX2E$Z,QUXK4@SULHDU-:IN.78F(NK!%B^BB312G115SHF=<"E1#+M_LW# M[`,)-`)6IP(42<]PK]*8@;H0B7$E#2N[+"0H84BP=-1<[;]?T.*B70@N*E<1 M30W$IW2%&>2IMP(0B2<\"$V!"EL.Y#7-.G`I#\$$]:CM^W"38)L":8IMRZ<" M$/M";^']F!"138X'K:!]=,"%-O6O3V8$GJR<(,@!U#$=\4RYNGQ)"$7?S_\` MHXIE+=X)J!-5!7I1,10HX$)8$)8$)8$)8$)8$*]IG^):?_;K3^\1X$*>J!WY MGJ-!_P`==[&__$28$*F&E*AJ[*#M5,2V20B5Q-Y]$J)4V9(F2']F'OBA-P@5 M`"]*IB3M="D`$&1(6C@.G,X$*)!*U"_B[@3H117`DI"@JG8`.WA&W`FD*FF! M)PG0[C[#@33CBWD#:I(&!+P14-!F4V5W882DDA&8(]N!*O=38=E*>W?@21FE M-^S)/>N!"-3%D91%$E*IZ:>[%EZA)$:Y?B(^F_9@0B8D"W@A2#G=?77]N'0H M\49KJ#< MN_$M\NJ1B]E,._G?NG;LZ_Q8?N246/3\5,NVA#V4_P#)3#C*('1(_-2!0[O> M*=&:KBP$&H24N(*%)RK^T8:$8/;L*NWT/VX%7(3D6_:BB4`("=U,AV)B6^2I M,=I8IB4%2/IT9G$5+Z[$/C=O]P^[`K??:<"$(O'PE1GN!P(3*.)53*O>6B=E<"$N+8*'V?\`14@TQ'?' MJAU#=0#>?J7-<(Y`+52=1+J&H'O[".O$-Y5S*)?F*]"'HZ@<\(R,KJ,01=#+ MFU*!%RJ>S/$5)0+LD]XS7=MP(0RZM23NI]U!@30RY.O?L5%3HQ"4FH$*!)7, M$[A5/VXJ39[*#BF1V]?V)B)*M`;_`*5$E-]0AXONPB6JIH;G(.G9B/J0A$G; MG[,-P$*).TXB2Z1`(8H3G`[*#VX2:@2F2GV#[<(D"Z:B24JI08JE+!"C@0EAL7;5"6$A+`A+`A+ M`A7M,_Q+3_[=:?WB/`A6-3`_,M0[G_OUWL;_`/$2=.-"2I`#XCJJE<"52B!?W0.[4]VA.S,J%P(`[I MNSXOYN7]'LP*22G;L_F@I]28$F"D,_A':%V='#@34E``!1:=""NPX$F"?:H^ M_#2(Z*;7+3;]?L%,"BC->10U]O1UTP(10A0T/T]QQ(%DDZG:/J4]0&S$QD&J M>TH@>F:GK/[,3!!LD1H5/C;U?3H7`E:R('(=^_?7#?JA%:Y>O:,.H\$@`*!3 M#D(HG4J=N>&#H4?FI<10+0=J4W#$P5"4=0I`K^'H44^S#4&/0J0=G4+N(0>V MF)N#ZKJ*('D;/8COY,6I)_$V_"=M#[\"$9KAN/M+L"%,.VA1UT]^6`%O%1W- MZKI^(G;UC+V[:X%)&:^H4CM%/KPE40^BF'`;2.WA/O&6!11.-H&X[:Y]*8L& M20O5-TQ<"-B=->W=B.^75#J/&>G_`'3]V#?+JATWB=)S3(Y[LL\&^75#J?&< MEKV?4BY8BDH\?TX?V8*HV=OP3^(?WA[L"$W&-WN?]^"J-G;\%$N2I3H`'#T[ MUP(4>.J(%_I#`A0,I_F]GV(<"EY>Z1>[H[!G[<%%+R(7BG>_Z=N&I>7LHND* MTKTE?V8$U$R=0ZS@0H^*NX_[).!"@7D;$[6C?T].(^3LFH<72!_-^+VHN>([ M](A"@YP0DJ>L\(]VW$2:N$U$OIG38BA.W/$"?JIB!-Z*/%7K%>D$[TVXB2IB M(BH[-@^K[,(EZ"ZD/P4"_K]W[<(]2A#Q%"'QCW]B8K30RXG?[3_`"8$*!(:%.!"$27?=@0E09_6F$I`#YJ)*_N= MI7[!@4D-3T>P?=@0FP(2P(4C4B@0]*?5AJ+/JH_AJ6A,Q^+M`79B$_24Z`)D M[?;]V#9%-*@I3JQ)"?`A+`A+`A0K^X/:,"%&O[@]HQG33([]QOL'WX$)([]Q MOL'WX$)([]QOL'WX$)([]QOL'WX$)([]QOL'WX$)([]QOL'WX$*]I@=^9:?W M&_\`'6FP?_$1].!"GJ8;^9:A0_\`'7>QW_Q$F-"2IC<%]A^W`A/@0E@0E@0H MH-P]@Q!Y]$43KA>YV0R=%V$C:F+$K)^[EPD#*AV^S/$=\4U(!J)POZROV%<2 M23]W;P]E/MPV2W)<(W>\_?@9+<4Q3*B_TG$^Q,)2<)P[A4=.0+N%/Q4P)J>= M1AJ)'12#TH:].W`HH@(.1P(1`_>/9@0I%"I:4(IN`&?7B49;?!2W:%2#R,P1 MTC+W8LC+=XJ.U[61&OZ5&=,^W$DE,.I0U_G?LPW9)%XR,SV9^S:<-WNB_@IB M0;B/IV8'[H3\?2#_`+*?4!B0(*@T^H4FG9Q=@0I[5.).H["I@D;?L/W8'"6R M2?C3\1/^U]YPU%%#Z9[=XSWD>\@XE[G9#)^/Z*W_M86\]D MMH4Q*^$D98EO";*8E*!33:4`[?A6F$_?\$MHZ*8F:&YC_`&0!MWH, M#]_P2V1Z)>.*@=I0'+?52N'OBC8$WC%-B_T&[\\]V$_?\$;(]$O%H*^[LK5, ML+<>H^/DGM'1/XVW(]0H?:E,-^_X);(]%$R#/A!.\Y_:,/>.ZDR;C'0J[JIO M]N$_?\$MHZ)<8V!.MK?M#L#]_P`$;1T3>([HS7(9[\OV8-_9&T)C*X*:UW%$ MZCD,&_LC:%$S&H4UZ0FW><&_LC:$WBT^(=WI&P=&%O/9&T*/B+6A7KIW82$(N)R[WN'7NQ&4MOBF`ZB5S)``W+BN4MW@I4'BHEP` M[OU'$4E`N)S3`A0+@,\"%`OW#V_=@0HU.?UK@=/:4RC8"4VT3VKA*5D(E=_: M57IZ\":=N8^P!?:1@0I4R"='Q'_HX$JIAPE>VAIP[.O[,"'"BBYAW^P2G_E& MN'1+S)(W8UQW$EV[=EA)N$DKDG1M_;@34$&X>P8@\^B*)T`R`Q-"?`A+`A+` MA1*','V.^[`A1X6;C['?=BIH=2G5+A9N/L=]V!H=2BJ7"S),6I*C@0E@0E@0E@0D.DI M@0G`&TIV+@0D@7XJ;T/LP(2<3L<4ZZ^\8$)^\11[5Z:?]7`D0Z5?_K@_Z/\` MV<.J7E2/])I]GVC!5'E1`';3[$^["4DN'M_I)]Q.!"A5I[I[-O[>S`D"ZD'+ MF@KO39]^!-/0Y'V'[L#J)BI\3AN/TZ"F&AFJG#]]-Q&!110\FB@]%#^W`A2! M'[W".A<2WR3\JZ"!^U2#S3B!_FH?L7#WQ2(#TLIB4',KT$ M?=B0(-E%3$PVGV&GL5,`+]4U/Q!TGK3[\,%DDXD&Q1T5^PG#W%)ST/X?Q3B0 M;U^G2#A[DI=@ZGXH_>;[/_J\&Y'G[)>(3\+B?IT.P]X4?;[IP\Y\1[01_P!K M!O3]L*0>$^(#V`>]HP;T>V%(2$!>(#MH!MH-N'O"C[9[)_%=^\/:?OP;PCVS MV3^*[/C;G\--V:IOP;@CVREXA_?'M/\`VL&\)^WW3>([]YOM/WX-P2]LIS(? MWQT=(Z2H*86\)^WW3>*[+B;[?M5$O;/9-XCOW_>,&\(]L]DO$_G]AXC7? M6N#>$_;[IO%7\>243Z@:X6\(]ONFXA6N?55,E[M,&]/VPEXG3]/]S!O1[83< M9WCVOP;T;1T/Q\U#CKWG#[?>[!O"7M]T_B#]_P!S?OQ'/OP.59M/0IC(#FOT[<(ETE`RC81VD??A;AU0H>*-X7>A7`2!=" M7B$Y$GJ'\F!"B7NZ>UP^I<0WCNFR'QG]X#L_EPO<[)^7NF+ATN*_BR[!B.^7 M5'@F+]A(%/IGB*%`O&TJ>M??@0A\9Z/?]^!"7>.W[/NP.I;4R#"38)BX`'(G M_JP(3H/H&_P#9PV4=R5=B$=)^P-&$I**G/B:O M9]:8$G"=7?OM]H^[`FF'%^\/?IV#"3^25%J>U/Y#@33HW][W M?MP(4<"$L"$L"$L"$L"$U=P]I^[`A-W_`.;[\"$N_P#S??@0EW_YOOP(2[_\ MWWX$)=_^;[\"$N__`#??@0KVFS9LP(44=O/\` MTONP(3J5VD;>%/\`LX$*03:#LJB]O=7`DP2XOYWOPW4=I3\9_>'NP.C:5(// M\T]7T.!T;2I>(3GQ>U?NP(KW3B78I[0#]^!)/XO\[W?LP(4A,=A`]H^W#<]2 MA/XQ_>&_/;OSP.>I0G\8='M'W8>^227C#H]H^[!ODA/XS=_U??A[RAD_CC][ MWC[\&\H9/XPWG?F,/N M^+W[\&\H9/X[?HOW8-Y0R;Q^KV'!O*&3^.WZ+]V#>4,EXXSIVK]6W!O/9#)O M&Z=J_B3),L&\H91\8&M0>U4[3@WE#)O'&:Y[5S3_`&L&\H9-X[=_91/8J8-Y M0R;Q6[_J^_"WR0EXXZ$_V?J3!ODA-XPZ/:/NP;Y(3>+TM]O[<)SU*:;Q>D*> MDG[<#GJ4)C*-X";A_+A(3>+_`#O=^S`A1,J[S[!]6!"1DIM3I*#[=N!-B5`R M;B!V@X'1M*;C/[P]V!T;2D7?O.]A4>ZF!T]O5,K=Q(Z`3]:82;!-Q;1Q>P)] M1P(H$RN.]O9]2-&!-+A?^][S@0FX#N'M/WX$J]TB!T#_`&OO&!-2!W\/8<-1 M^2B7`[>G*B^Q<0WQ3\R8D?O./TZ1B=$O,EW/YWNPE)-3O:I!->U-F([X]4,F4[5/;_+A//HB MB>G23UT^I<#SZ(HDN=,\LJ=5,#SZ#X^:3'JF'4O;@>?0?'S0QZIU&P+U_L(P M//HG1+B;^[_TCA>YV0REQ]!_WCB;GH4)A0EQ]!] MJ_7@<]"A+Q/YOO\`V8A[G9#)_$_F^_$W/0H2\3^;[\#GH4)O$.X?3MP.>A0G M\3^;[\#GH4)N/+(;Z'[#NPM\4)^,;BO7]N&YZ%)@EQ]?N^_#?L4F*7'U^[[\ M#]BABF\0[O?^S`_8H8I_$_F^_"<]"I)>)_-]^!ST*$W'_-]^!ST*3!/XG\WW MX'/0II>)_-]^!ST*$O$_F^_`YZ%"7B?S??@<]"A+Q/YOOP.>A0FX^@_[QP.> MA0EQ]!_WC@<]"A+CZ#_O'`YZ%"8N!S:O;]F!ST*$R_S1[_OP.>A0F7^:/:?O MQ%Y]!\?-)CU3K3*N]?;3IP//HG1(D;&IVX'GT11+=VJ=_P!!@>?1%$U-Q]H^ M[`\^B*)<1WGVG#WQ0G7KZB5^[$D)L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L" M$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"%>TS_$M/\`[=:?WB/` MA+4_\2U#^W7?]XDP(5'`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A7M,_Q+3_[=:?WB/`A+4_\2U#^W7?]XDP( M5'`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A7M,_Q+3_[=:?WB/`A+4_\`$M0_MUW_`'B3`A4<"$L"$L"$L"$L M"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L M"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L M"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L M"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"%>TS_ M`!+3_P"W6G]XCP(2U/\`Q+4/[==_WB3`A4<"$L"$L"$L"$L"$L"$L"$L"$L" M$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L" M$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L" M$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L" M$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"$L"%>TS_$M/\`[=:?WB/` MA+4_\2U#^W7?]XDP(5'`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A M+`A+`A+`A+`A+`A+`A+`A+`A+`A7M,_Q+3_[=:?WB/`A+4_\2U#^W7?]XDP( M5'`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+`A+` MA+`A+`A+`A7M,_Q+3_[=:?WB/`A+4_\`$M0_MUW_`'B3`A4<"$L"$L"$L"$L M"$L"$L"$L"$L"$Y!&>!"0!)08$)L"$L"$L"$X"KT`GV8$)L"$L"$L"$L"$L" M$L"$L"$L"$L"$QQ&7I0OM/Y)_P"GA_6']1?E'Y=>>WDWZ0?\X^57FSREHW/7 ME_S3_P`__2[R]^?\J\P6C+[2-4_(^:?.S0^8]*^;M9&N\"]L[:YC5'QM-,5. M>I37H?ZS_0IZJOT]O-72/)+U?^5O_*+S/UWD72?,K2N6/\[^7//WS7)6N:WS M)R[I>M?G7EAS?SKR]!\UK/*6H0_+27;+MGR_&^)K)(W/'*%ZCX'/4H7M-ZNO M17ZFO0CYE:'Y0^JSRU_Y5^8G,G('+WFCHO+W^/G>1>:KW6=/T'7/S;R MXYJYOT.W^?O.7[QGRTMS'>1>"LD3&O87#GJ4+U94[\#GJA+`YOJA+"0G4[S_ M`"98;F^J%[2\V>BOU-_YD MYZY;EYM@UK0_\E:=S5=^8FC_`"W`CLOJ9'^BM^IG+ZB-/]*,?IJXO/W5/3JSU8V/(7_.3R`' MC^G^37I>6&<_?YI=YJCDN)=<@=!^5/U%NM4X_D_#(?AN>I0OEG@<]2A+`YZE M"7\N$A>P'IF]+'J%]9'FOIGDCZ9/*KF;S?\`,_5=,U;7(N6N6VV,(L=!T.!M MQJ_,&OZYK-[I?+G+'+]@)(XY+[4KRTM!<3PP^)XTT3'MR;H7K_@<]2A+"=K( M7M-S9Z*_4UR/Z3?*_P!_YDYZY;EYM M@UK0_P#)6GI0O.?IK]-OG5ZOO.[D/TY>G?DS_F'YS>9MYJUAR1R=_F/E/E/\[N]#Y>U M?FO5(O\`,//.N\L\JZ;\KH&@W=QQ7=];M?X7`PND6_ M)'U&^HW6O)WY/R9])7GE>^FSU!I0E@<]2A>P')OI7]0OF M#Y!><7JFY1\JN9M7]//D%J?)^A^;'FV66.G\H6OIQ\WO//RU_R M/Y=^K;D"?S0]/G,/^I0E@<]2A2Q<+!).AKT9X:$V!"<@C/`E M=-@33H:=.6!";`A.`3E@0D0E".W`A(`G+`E9(@C/`FG`44S7W?RX$K)5;F!V MUP)I`$@]'VT^S`A,01G@2NFP)IT**E,"$V!"DF:[B>T'`DF&8ZQ]>!--@0E@ M0E@0E@0E@0KVF?XEI_\`;K3^\1X$):G_`(EJ']NN_P"\28$*DAW'V'`A(>]* M=>S`D;)(5Z5SZ>O`API#AIOWG+?OP)J)53VG`D*A.C0X+4(%0^W`FF(*[SF4 MK@2NGH$XA7H_EP(_)(A40409?;TX$>*60"]*#=7;D<\"*I$+4?MP(!T-T^0J MH"]W][`FD0$IGN_%[,"54P`KQ;$P(+Z)Z$%&_P`F^O5@1XIFC:!+Q40JCL.!!H%+NG]Y3D3@344.X^PX$ M)%-F!(/JD6GKZ17`FF(3IZL1GZ4+^DQJOF;Z$?+O])[]%-OK2_5*_4!_387G'R+!YPQ6/+/E,.;)_,QOE1Y%^K[]<_S5TC1_.[S;_5Y]+G*/Z;_.>K\O\`/GZD M-MK7GOSS:VT2`VC]6NWP3O M=/*2(7J?YT:EZ3/7]_I[O51ZS=%_3W](_I`\Y?2;ZP?+_P`K/*W7O3!R'_DK M5M2\O>9-7\G=.MM-\S.9G22H06ME*2P" M%^@;UA^>WGIY<0>8?G/RW8 M'EKSTO\`D+EKR>U76;J31_+?1>7+_DVYN+ZYMK5VIW\VLN?%/:264,DPA?*G MT*^COTO>D'RL];OG7YV^G;]-?R[\CM._4&\]O3QY4>K+]3N;F+U5VNJ\B^3' MF)S3H-CY/^17HXL>4]#N+_F2ST/DW7'RH.]\C>8?+#E;7O*G3O,F?S%Y M5T&[YEY)\ON9])U7ESR]OY=%TK@MQI=K:"QDNKAT#8S-+Q"%\F.=M/\`29^I M9^@YY_>J'1?07Z-O1+YR^G3UR^4?D5Y6\\>G?DG_`"'X7E[S]S5Y*M36/TZ?T]/65;? MI*R?HN>6GJM\C;3T:VVKZUYB>5'DBSG;]0KGSS*U/E74.8+GS(Y;\Y(=3CYN MY;Y4T;2>6KRXUJYL4O=+F%Q>6LL-G:FRF$+TQ\L/39Z8-8_2/_0A\T8?3KY/ MNYR\YOUGN7?+/S(YSY@\N?+WF#S(\Q_*.\\^_.[2HO+'S6Y_;R?I6J^97*8T M#2[.RN+"_C&F7,5K&T6D<;&1,$+[#:9R/^GIZ@/U>?U'OTB+O]*CT'\B^3WE MYZ6=<\Q=+\YN1?)W0^6_/NU\QX^2/)C4K_5^5.;M'M+"U\M.7([3S.B9I^F\ MM0:3):7VFOO)+F2/D)Y$>O'T]0 MN5?+VP?S%KOF-YX6UYK/,FF1&T`0 MO:[EZ/TD?I:_H;^@CU4S^@7TD>N/SL]>7FAYA?\`-CGKU.^7T?F/IG)_)/+F MN76JFX.I^6O-\'*^BQ6%K>:=/$;368;Z^FM[E\3+=@A?>WSJ\D_( M+U%_ZA7DOE;SC\AO+;S-\NK3]`JRYSY9\M?.KD/EGS0T?E/6=.\_>:(N7;YF MD\^:5KMI%S3RUIVJ36L=_P"&+R,22@2#Q'J(7PQY*\R/2WZ$_P#3L_IV^KNX M_3F]#'J@]1'G+ZA?/;RFU_GCU(^0?)_/%W/R=:>;?J"O-2OM9U2.RL=?YHYI MT_E_DC3]*Y?GU.YO+;1(AQLAD9$+:00OL+R'^GU^F_Z*_*[]/[R4\W.4_P!# M\>3GFQZ>-#Y]]8_FA^H3YEZ5Y>^N[S-UWGW0;&:ZYV]*>J3O2]Z'/TR?T]_U&/U!O+KR4](/ZE^N\L? MJ#ZWZ8/2YK'G5:Z'ZF?3QR=Y$QW_`"U<\H\PZUI6CZ]_EKFKF?5-#YM/SMY9 MW;9W7'R`AN86&X;((7O3^C#ZC?3/SO\`K-?\`^G5IGG!S MGH7FGY:0I^_]3T'D3Z:_+&:]YYY3YZA\@O*GREL^6O3! MILO*4>A,CY4L/)W4-4UVP_R-S"_0@_5M+GNIX;]UW=!Y#9BT"%^ZW_\`1S^@ MJS]8>M?K7#TT^0]Q^ES'^E/:>LFR\@I_+OEEWE,/43JO*<_)MOY:P^2AY99Y M=J[E.PDO3;2V'AQ\X7#;AEJ+L"XB$+Y?-\O/09+^CI^D#ZNO5+Z?_)_DSEOS M7_5GYZ?ZL?,+R=\FN5>4^==7\CG>9GJ6U77/+^;5>2N7CS]>^4?+FF:1:6\? M+UA/--:Z)IT=MID;;B"TX!"^E'ZBWI9]*OJ-]$7K-YQ]`_I)_1K]4WE!Y;@SFO1/3UZU?3!H7)6DW&O:AS+YOF+T^Z%RO\`Z4MG)GI^\E]!U3U)\D^2 M;O/9W+WE;R)HUSY\:GKG-OI-L;V;S@GL=#M7>9EUJK.9K^*>36W7KI67]P'D MB>7B$+Z(:-Z&O(KDK]6K]:3S4A]$_P"GGI?I>],FG>0G+G+/F9ZP&VO)_HN] M*NL1_)VN:Y-IOI/Y*\L[WE;SVYEYHU2\L[E]@-6Y,;I1>]S-2%[K$`<(7 MLES)Z;_2+Y:_K"_Z<[U%^EKR_P#3SRI=>J3R_P#53J/F)S;Z4_*B_P#(3R"\ MU7\@^G:TNN6>>?+_`,E;G5=6AY,TK4IO,/5'P2R37.HWMA);?-W=V88I,"%\ MJ/-7RN\D]._3,_7C]5&N^0/D3YA>>GD_^N;S+:\E>8?F-Y5MGU?:#S18>C;TR^2'H8Y#\NN;-"YDWRX\M M/TY/3EZNO1Y^E!Y4\Z^I7R;=S3JOE?Y[N_P#,;0.< M-4Y0\M].]*-C^9VUU?R:*\<\6>AZ?$;&&^LKZUF3?1I^B;^N3 MY?\`EUZ5?2=SQY?>C/\`4X\Q?3SR)R1YT>5-]YEZ!YE\^1 MJ?-=OJ7FCS_Y5:)S9!;\KZQ<7,$^FMT'272"=]H72B%R?*/Z7'HV]4W/?^F+ M\J>9_*#RKY`Y4\\_0]YJ^QT[G?FSDW3 MM%YEYSUW5]=N)9+Z]NKJ346:7-J4D,\B6^]#GE=YH>9'IK]1'IZ\K[3RT\PN4/^4^IZUH.G:+ZA-?T[\OA\P]7U MVYY3\>_==&U@?8.U!C8!=1#4"(7E.\YG]%?I#\H/]-ORB/TMO0%YY\X?J!>6 M/DER=Y[^9OG%Y"\FZ[S%/H',I\@>5N8M?LK&WT:#1>8/-;5M<\RAJ7^9N8H- M:N(&61G*=GR)Y5/+/D?S`U/2-&CNIKB2ST6SUSFFZ;9VK7>%:6HCAB#8XV-`A?* M(<)``!XD]Z=>+Q8))@"H4',;.G#2-E)6KE5<]F>>>!%6[J.W/\2+TK]>!#A2 M*+452J9?7@172R8JX[^K+`CP2I11L_D-"-F!'A9.Y21M'1]6VN!`LD40$U*8 M$5TLF-0$5-VX_MP('=.$`KO5-O1NP(U2-1W>L_9GG@0D$`4C;VY8$TC44WY= MFS`A,*<2Y9=NS`D>RDU"'`4I[>K,X$!WJH@9KDE?NWYC`@]KIZ(Y`E/=1<"* MZV3-!6M`A5:>_`BR<(M!5*+E]>!%=;)@"H50N!!LF5FX_3MPO)V2\R2'.D;>O"4DR%M=M0AV8$GT2!)4;2#].C`CN+ITX>([LO:GU8$/HF#MA MJM-V=,"*"J<`BI2B]"YC--N!#@T2#E*'(T3`A@F#4/0.M339MQ'9'HC<$N(K MVY?9EB2&"7`%H0AVDHGOW8CLBFGXD/0*>S[<22H0HN:`J$=6ZO6<0E$"+A`D MY7Z>/2[_`*L7]13TE>G7R7],OEQY,>BO6N0_(OR[Y:\L^4M6YV\NO//4N;M1 MT'E73XM-T^[YCO\`0O4;RWHUWJ\T$(,TEM86<+GJ6Q,%,5*2\8\V?ZF[UY\X M^LK2/7#J?E+Z18/-C1O2US?Z1[7EZPY#\Y(O+R3RWYTYYMO,#5-;N-)N//NZ MYD=SO;ZS:MBM[ENK,L&6I+7V;WI(!"^9?E]^HMYV>6WZ>OGS^FMH7*_E9=^1 M?J'\WN5?.GG7FO5M$YMG\V=+YIY1N/+RYTVPY7UVSYWL.3[+0)W^6E@)XKO0 M;VY<)9^"=G%&8A"]HO,3]FGR[T+RSY$Y3T MCE+S*@\I=6T'E[3?,'2[*[YMT*\\V[_G&_U>6W\R;XRR6>O6$+GQ0%L30V02 MB%Y-\GO]1#ZTO*3D;S<\MK_R?]&7G7R/YG>I7G_U:\M\M^?_`)#ZAYGZ7Y#^ M=_F'S?K'/U_S5Y)6FH\^VD&C3\O^5GI5N_/J\])ESZ/-=C?R-YLP\C\Q\@7?,T/-'\N4-6WZ>OGS^FMH7*_E9=^1? MJ'\WN5?.GG7FO5M$YMG\V=+YIY1N/+RYTVPY7UVSYWL.3[+0)W^6E@)XKO0; MVY<)9^"=G%&8A"^GG)_^J!_44Y0Y+Y7LSY>^C3FKSXY(\IY?);D[UJGMV MN^KSESD.2*QC.F6?F.>=;;E>[;(_3H9[B.\T"YM;^Z;\Q>0W$_\`$P(7I1;_ M`*QGJJ;Z>?21Z<=4Y?\`*'F3EOT<^L3_`//@Y#YWYBT3G_4/,KGOSGDY_P"= M/,F]@\V-=;YE0:/S#RIJG,O/E\ZYBT[3M(U*2,1_UT2!\D@A>1^1OUUO5OY? M_J*>H3]331O+OTYW/GQZE/++4/*GGKE+4^4?,R;RCTKEW4M!\M^79[WE/0;7 MS=LNVL\QV'I=_5H\HM(T"?TM:L[F?6==LO.#TY>:?,7FRS2?,;F0SW5M MS/I45QR3=Z?I^NW]W;/O[5\$@N!"^:'^IG]8/D?ZR/U%^7>9?(+S2T7SNY.\ MGO3%Y2>16K^;?+,CKCE?GWG7EO7/,#G3F?6N7;[A^6U+3F77F`VV=<6[YK9] MS!+X4LC`'D0O`WHW_72]6WHV],EIZ1--\K_2;ZB_)'ECGF?S-\J.7/5;Y'GS M=?Y(>84VHWNOQ__`)!_ZC;UQ>1'E-Y%^6T_E-Z+O._FWTN\ MJ:ER/Z9O43Y_^GMW/_J-\@>5=1TB'E[\H\L?,2TYSY>M-&BMN7K6WT\R3:=< MS7=E;10WC[EC`,"%X'])GZW/K*]*S/4GHVK:/Y#^K/R[]7//6H>:7G_Y/^LC MRL;YR^5O/WF?J]PZYU?G[4.6K#7N3IH]=U600_,QLN1I\XM+8/MG?+0>&(7F M*;_48_J*7/KIY']>MQ-Y(26GE?K_DIR#Y)1^76JV7ITY3\J.9WVMSK7)6 MC\EZ?SC:ZEI]K%UT;6&.W:(7R+]1_G8?49YV<^^=1 M\I?)'R*_SYJ&GW__`"F].'(+?*[R3Y,&GZ)IFB"QY"Y";JFM#EW3[P:9\W<1 M_-3&6^N)IBY9"`(7O%)^L'ZN9/TPX/TFB?+QOIIM^:SS&WF-ND\X_P#-]^E. M\P)O-+_(+^9#ST>4#R(.>9S??*C01=<0#/F?#5A$)^3/UAO5[Y:>E7TA>D_R MQD\NO+O0/1)ZAM9]3/DGYJ\LZ#S*/.!OF'KMWYB75_8\VZEK'.6K\@Z[RC+' MYG:E;OL&<_E3Y_^7&@^0?H2]._-7JL MY6')GJ5]0?IM].5UY=>HCSQY?NK6XL.8+3S%\P[_`)^YGMM=_ MD!/SUYX^3VBLCAT^/0N0^;X.=]#T7EV&/ER(Z1\_:Z5%K3],=X;[USVQR,$* M/)_^HO\`6URQY]>LWSLUGRF](/FARYZ\?\D2^H'TV^;GE%S?S]Z:]7O>0>2- M*\O=%O\`2N1M6\TO\RQ27?+.DLBOX+W7+^SOW.6:%PBMFP"%;YW_`-1YZX/, M7SK]$/J!YM\J?21>>9/H!U3SENO(R[TORQ\P^5>7[G0/.KE4VC-+MS/J+DKRQ]0OE M):^6/INUSE'U,>N_E[]0CS%BYDY+\P]2N(O-_ESS6\O_`#>@Y*T../S7M-,C M\HM0YA\N+*TN]-OK:_U2739[B(:BV1\X/J"_P!3/Z@O57GK1X?*ST5\]^8OIHY3T/RX\O?49YD^ M0&H\T>HB;RKTH:7;:KY8:IYBM\PM/;8\J<[:-HUM8ZY)HUGI.JZA#$V8WC+S M^M8$+P%Y6?KN^I;RO9ZX]"N/3OZ)_-;RN_4`\Y-<\_O.OR/\[O)GG'S/\H]' M\UN8=9_S)J',_(?+VO>:SM4MG0\S16VI6=OK5_KEMIU]96TUK'"Z%IP(7B7G M;]9;UD\T1?IRW7*]UY=>4/-GZ7G(,OEWZ;.?O+'EWF"VYJU#1[G0^3^6[ZY\ MT(^=.;N=N6.;+O5-#Y,BM+R"VTW3=-O+:]NX9K62&8,8(7L%ZH?]0WZV?4UY M)>;OD;9^5_H_]->D^HY[7>ISGSTL^1-QY8>:?J2:_38]+U%GG'SEJO.O.$FO M/UNT8Z.]FM(+"XN;>62U=)\G(^W(A>LWF?\`JV>H[S8MOTS[7F/DKR2LH_TK M-.Y,TST]NT7ESGNV?SC;\C:OY8ZSI+_.4WWF1J3>89KBZ\J-.;<'1!RZU\GHQ-)@EP5Z%RKE[,1V13=+B=ETY?9EB2349)%K ML-5.=>CHP,D))RX@H,A1,"8[I$$UI4#[*_39@0X%$Q*4&S;M^[`BAJEGPD9_ M=M.!#@43D\*`=9Z?HF!%TD+FJB)1=_;OP(H$JL'2?J'\N!-*KAO(/N/NP(2J MP=)ZJ)@0F'>4'K_9U5P)4%4Z<()VY#Z;\"'!HF!)I[ZK@0P%4_"0":4RVY[> MS`A]$P)=0[?LK@1W%T_"X5&S=F<":3220#5:>W`DP3<'2$WURQ'9'HC<$W%[ M-W8F[+!OBC;12X`N=.U:Y>_!LCT1N"8DJ!*NEE`JO7E]F!`LI*!F*T^K`DQTLF- M>$#=0>W[L"?BG4(`17J]FT+3`CPLDZJ)ET#IK3`CQND$`[P*K3J2N!-,?AHJ M*5]R8$DXHVK2BGV[=V!!?1(Y4H-U>([CM[H3`BJ9JH3^$(HR)[P^$F@.(P]* M9[)4J@2GVC$DJI-&:J@%>O(#9MP(3@*J+Q(>>6(_S$44E8M5SV&G2=N>'NCN?\4@"$SA4_=L5!AS])3%%#%*:6!"]_ M/TO/2]R?ZS_73Y'>FKG[D;S^\R>4O,G_`)F?FW)?I>YF\B^3O/36O\G>3_F! MS]8_Y&YC]2O,'*WDGIWY=J7*T-WJ?YU?P>-H\%W%9\=^^UC>(7G3RO\`T5_U M!_5=J7G+S3Z-?2SS_P"9WE!Y;>J3S#],'SVN^9'D'8\Y^3>M^3/F%JO+=GS?H^D:EK'*G-&FZYRU?7E]IT&L:#S7R)K_-/*&N6C=0T MV>"7Y2_F=!/$Z.4,<$P(7L5Z6/T9_P!2[UL^46@>>_I<]+^L^;GE1S+S]JGE MGIG-ND>8GD[HT+=P%P1%@0O%7*OH:Y1OOTG?/KUK-"\J+W4N2/,7RZYFYFLO5K)YRP:ASK= M_P!8TO19>6H8KBQCEF;/%?MC$+SO>_Z:S];JP_S;X_H0YK?_`)*LK;4-8^2\ MV_3OJ/SD%U82ZC%'RE^7^;]U_GZ];;PELEMH7YE'?*G]/ M_0_,;]+GS5]6<'E!ZK=1\]>5?6CRYZ8N6^>-,YS],.A>E#2CK^G>3X@Y"Y_Y M)YPYNTOU2#S@GUKS`G:V^T_2GY9)#?B(0O)W,G^G$_6LY3T?S`U M[6/0CSN=.\L].&JQ?J&EZ3SGI')/-W,NO^76J7\$3VQ6_,%IIDSYXWPAOC,=&! M"\T7_P#I_P#]8;2_(27U+7_H=\Q+7RGM^13YDW,\G-OE/_S#M>3VV!U26_N_ M)%OF"[SMM=0M].!FETZ3EYNI11@E]NU#@0O9+EG])7TY:SZ!OT7?5-==NCV_,?(K>3>5N1+7U%>8/E''JWE7I\GEO+K>BH6-WKGFG;V]OJFG< MJQZ4R-[8Y)S+!;^0CJ//>H\J7>LV.O26/E]:\TW'F7IVD65QH-P!J-]H]KI\[#"^*9[+FV= M*(7M%Y4>BKR_YX_2<]4/KCU'RT]4VJ>8GDQY_5V@>:'*?.7IFLO2=RWH_ M,EWY307>A^:')7-'-5IZI-8Y_O&\\W(L;GEK2+K0HWW5@;F5K8[[PQ"\^0?Z M;/\`6SNF:G+:^A?F6ZM]*Y:T[FV6ZMO.'TYSV=_H^JVMY>V3>7KR+SA?:\U: MRZWL7F33-,?=ZG`Y\39;=CYX6R"%\]>0=4L;SE:]A<_7-&T^W= M*R-C9'.N+<2B%YTB_1S_`%*KCS%]-GE':^E?FJ\\S/5MY7_\Z?(SDBRYN\L; MWF#6_*L6&E:C+SQSM8VO/$S_`"8T.VAUJVCF?SK_`)>?!=/-O(UMQ')$P0A> MJC]'C]2OT5\P>3O*_J/]*/.W)>L>?_.-CY=^3[.7^8/+[S5T_G?S"U:]M=/T M;D*PUORAYPY\T2RYVUVZNVBPTF\N+:_OF-DDMXI(XI7,$+M_4S^AG^JSZ/?) M;4_4-ZA_1_S9R-Y/:%!IMWS%S?I_/?D_Y@?Y7L]6N+*SLK[FO0/+;S$YPYHY M6L3>:A##+/J%E;16\T@9*YCU`$+V)Y^_1<\U/-#D7].;2O1'Z;_5#K?GGZM/ M2KS7ZB.<[#S]\Y_1)I?('F7:@[U9^=_DUZDO4'Y<>3VI:EY.>D2TL;KU# M\[Z]S+R1R)9>7TFH?FHM])&G\_9=9TCESES2-3U_F'7]3 ML-$T'0=$L+K5=9UO6=5NHK'2](TC2[&*>^U+4]2OIV0V]O"Q\LTKVL8TN(&! M"^LGGU^@U^K;Z9/(GF#U*>=?HSYQY2\G.4M&LN8N;.8K'GSR=YSUKE;0+P1. M?K7,O('(GF-S-YBZ!I>DQ2B34Y[O288M)B:^2]-NQCW-$+>\G_\`3[?J_P#G MWR+Y6>9WE)Z-]9YO\O?.GRXTKS8\M^<(O-_T]Z1H.N\BZY::9?Z/J5Y?\P>; M6DQ2?Z6?Z@?J)]2/F7Z1?*'TO^ M8',GJ%\FY=3B\UO+_49^6>3&^7ITJ]9I\LG-O-W/.O\`+7(VBVVH7,K/RZ6; M4VQ:JQ[9+)T\;@XB%]&_7O\`HE7OZ?/Z4/D/ZJO/[0?.CRS];/.OJ_UWT_\` MFEY1'B-2J_$#1G=[DQ)- M2/`".($G\2';T53$3M/E*3'JF>%-*T")6F"4=WBFGH`%!XMM*9E*4Q.BCYDS MMA&1&6X[??A*2>@#2[:*(:I_.!J,*1`%4)B*!,CD-JC,FBX:5D]`"HSRW]>R MF!"8_"H%%KF4.RO3A;O*Z&JG;D2JR:E>%53L/0**N!*HJ4[/Q;DK@33`C(*,@OT.!*HO9(*JU3:>C;[L"=& M3APV!#LZ\A7`CQLHI7M1>E?KP([IU9N^G5A>3LEYDQ;4E#4].S+#3HRD2W:" MOTZ<-(.U%;TPC\ST]/\`XZT_O$>$F""I:FY=3U!30WUV,AMGD^W`B@5'A'[S M>H9_4F([(H)9(.*BNT8DA@4@P*BC/)2J9KDF6([(H!=/Q%=B=7OWXDA@F()* M\30N2KNZ!@2)(\$BXB@.2#V8COCU1$4=.`"AXFL)&1Z=O0$Q-`.B8E*`T'5F M<_JPD[NGX>)"H:[(EV13(@C?A;1NW:IV#)._A@-!5>\2""*Y#IP4B$72`XVK MQ!I!J7`E5RV]&"DAV0D48U`05*\6PD9("J'!2(0DWOM(-.$J"7("N8/3@I(( M23@::@DTID.@@YG"],4*0=XC"PT(^&0Y-6IH.G#I(=D**!G>4/*H"T'NKM-< M!(%4)-)>>$Y$%:@(1DBYXCYI4*$N`"I23A[R`'/82#1,,M'S([)->20URN#N MZ@SK]:9X6X>F5T*0B"GOM<`"2T*"0-E"<\/9%"CQN)J%!.5*U0>S!$DWLA3$ M*N`XV%3\"]ZB]U5*%!@V10H&1V8%`J!!\)!IO7">?0(861#".((]@!0\+J.0 MH$1?BQ(@$,4*#W$/(:H0HA`)H:KEB,I:1NA!Q4FE@0OOQ_I>?_UZ7H<__N8_ M_P`/O4#@0OJ=YA\Q\P/]:`\OZYJVAG7?UWO-WES6G:1J%WISM5Y?U6[ M].`U30]0=:2PNN])U)D+6W%N\NBF8.%[7-I@0O5[_49ZWK/,OI/_`-/US'S' MJ^IZ_P`PZ_\`I:>5>MZ]KVMW]UJNLZWK.J^6WDC?:IJ^KZI?2SWVI:GJ5].^ M:XN)GOEFE>Y[W%Q)P(7D70^:N8>6O]'ES):Z#J]_I,/-WZ@TO*O,3;"[N+3\ MUY>GU;2=9N=(O#;R1FXL+K4-$MGRQ/XHY!&`X'`A?=CS^\Q>?C_JDOT3>4SS MGS,>6;C].+5M6N=!.MZ@=)N]3YU\O?6F>;;Z\L3.;>[NN8Y/+W07WCY&N,\F MCV;W*^VB97+=]KVJW&@\K_IEPZ'H>COU"[.FZ?I M>IZOY7\VZA:6]D9C;1Q7O,5T;N4-:!).QCW`N8T@0OSP>BKF>\\W_P#36>K. MX\]/-WFW2M'YA_64\D9^=_-G4.89[CF+D;3>>.\CM:\J/5MY\6'*?I]\J;CR5YT]%NH\ MM>2OKS\SO5KS1ZJ/7'ZT]9O>6N4^:IN3M)U+S(YTYN\R++RTY$N9=8EU&W?/ M/I4H9HDVDEEH7VUD(7Y<^28)K;]'C_2T6US#+;W%O^K;K<$\$\;XIH)HO7!Y MTQRPS12!KXY8WM+7-<`00AP(7M__`,S>6O,'_4-?K/?I;^:>JQV/E5^IUY,: M+Y5:5+>RW7RFA>=W(OI.Y,YE\N^8;9H;-8V5[!H5UK9BD:_)VC>J3T_?IU^4%Y'-Y)_IA>FSR^]/6@PQ1W7#/YDZWRQRQK MGF/K4EQ2 M'_[U])N!"^^OJ4Y[YWA_U7_Z2W*N/U8_KC?HM> MH6>1GEIY]^L_S6]4_EM':S7FFW-ASEY,^JB)GFA8Z1J=A>07=IK/-/)NB:$( MQ`V)QL-)O0Z4-<&X$+ROZ9?-_P`H/U,/]0G^H!S1)YF:N7.8=6\KM=\P+"^U^3E]DDM MC?V^I0WEU:3VNF36\@A>RGKKC\\/)W].;]+"^Y)\N/0Q^GQYT^G_`/5N\O[[ M5?*_0>;Y^9>D\[ZK=V.E"PYYY0_-]0LM29'8W<# M996Q"%\J/6]ZL]7]"_ES_I+?5AI/S,D7DSZ5V:[S-9V<1FO=6\O-6Y*].'*O MFAH-E&+FT#KSF#RXU[5;&+BD:T27`+E:H(A>Q_Z\W-GI8_3>\@/++TT>4,5A MS-R1^I9^H7??J3>I+3+2U_S#IO-'D+I_.7)?.,/*$.G:K<"T=RES)KD&E2:5 MIWA"Q(7VS\X.>]!T?UCKTS^9_DK>>D'3GM_5`\W M/U9?,#R@\@M2\JQI\ESJ7D1J?IOY2\I_/_3;74+'QIM1M1#RE=Z9=7$KKAUY M!K$LEL!"_FM>@W1/)KS0_4T]-&F<.:N5[GF2RT>SCUV>[U"/5;]T#))83;37(A?"[U=\]\[\ MOG7&MP\Q^D;ER'5[BSL;J"WGU. M#E_F'4+&.=[3(RSO[F%I$=Q,UXA?1K79/^='K6_U0'H1\C^;^5O+KUN>I/D[ MTUZAY#W&J6.0M@CYD=< M2>'%!-*T0OD_^K5Z<_/WTE_Z9G]/ST]>IKF/2-8\X_+7U[WFD\RX0 MOQ:8$)8$)8$([)''A8X-X3W@/W5WD8FA1=(\$\(+0W MNAI14;0`KB#SZ(HIF$$@A[&<0:X-<4(7/LW8>R*'4"XL)8"YH&PYKL.VAV=& M#<(T0G\/Q`QW$UA<"H?F2$4BHH5P;1*J$SG.8C&E`!4YJM01N%<(DCRQ0EP\ M0#BX-.1+@>^AS")B:$C_``Z-(4][B&VJ4Q%F'E0F3C:"2UKE3C<$!78$R3#I M((3D!C0A#G%"7-!0`&@KM7!2([(2"R-0N`0JI!0`]6`AQ5"9.`*'!Q)X5:J# M,U7>!@I$(2!XE:2-I#B@`.\C<<%)!%DR>&"34[.&J"M3NRPA$"R$@Y2CLC0G M;T9"N([OV_)!?1+A`"J#T"M=G9B0B(V0:I*2:FAHY0P!-W$2@`'1@CV]*%-O`X.:QI:Y M">\X.4!%#U<*.[]R$5IB)+6!S'$'@$[I;4DY-3?T848R$G*$1KH":-+231Y<"T'>@`(`Q+R[O] MR$,-<9`*\7'\6=)W$:K0K4?7A2C(R<(<,BN,8 M(IP9IQ.8:XEN#MJFA.9*9""T\;CL"JNT)F,18[GT0B.="'5:YY"<1#@&$@=X MU"HO;@+/:J$*1K^,E"[)"`2.$Y(-P'LP2C+#(\-:"Z-P:``! MP@`YD`YXE35G2KI90E!/`X5:YH#"`$0!.#K"5PI;KA,,418VA@D:YSTV$`M; ML!6J#=AEC0W0AR`D-T%C'1M(:I:69D$U7I!`PM*!)^J30`PF0*'$!HR)3,D[17$ MOV^9-(HZ,F,<*$<35))&_J!PO5&B%$*&DN'=*`5(4YT[!AQ=O-="=&.:>!O> M_%F2YHR`%:`G$:,60F:""210"O2,J+G48<>WI0G'"5:T<)(H2=VRO[V"@\L; MH2C!!4T&144(VCV8(>E!JF!:J-:`30*2@Z`5P#:_ENA,&N#AW30[MV>=,L&R M*%(%@?Q%H534Y`KGU#$DJOV4>%RHA7[\"$[DXLD(SKF6_M&!)BS*+EV_L[," M=&5_3$&I:<#4B]LVE#0?QX]NTC`@64M3:!J>HJ04OKN@))I<25/4,1V136>U MQ!SH:'J.=*#$DF"EX32Y`\(M!^)-QH0#B.R*:@'EHAR^S$B'0HR.<#P`E M&BBJ"=U-@3"E)J:H4B`X!Y(!=["B=X=>&P)="9SBP@`D46A15K[EPI2:FJ%+ M@\2-KB]L9*M)*HXBJ[U"X8+AT)B71-`!!XA5P!0Y@`$[$P$L'2!=(-,C%H.$ MIQ$T.X;U^AP4D.R"64D\&,%I#B]R<3UYX@P.8:-4$]X&H)2F%MVCRW0[GLG:Y\H>QZ.5O M$'.3^&6N#N,Y=T@IAAR&D@L*IVL\-KY.-DC@P`-833Q'<)<1N8,#`%TG>Z:* M1SW<$A+VEI"KWF4`#AD$::G"$MQ929D[(>`EQ?')P-<>&,H2X&CBN31F<-@[ MZI/U46S2%S0XE['4,8*@\=.[1:<6(@R,O]J9`9.+?O)XL3PUWPM)XW!I^$!* M&B;<38.ZB\E`32\?$7DU^&@8YN7`4"H04WX@\^@3VA%-NT2%OC1AH/P5X@<^ M`J:$*F'M+W*'8(3Y7M)0\`:2/#*($*`$N"UP;B?39#`U*(Z`%'>)'&'!KBQQ M1[`2_6GSQKWJKY5]*W+_HV\L^ M5/-#F'F/GGR[NN<>3=4Y?URT\QM2UW4>:.8;+GCE>[Y#T/E'2?+N:ZN;R.PU MI[XI21`WPOX@A?1S4_\`3@>F#3.4/2IY_P`WZRGE'%Z/O6#J&F<@>3?G7?>D M[S8L>?\`G#SPYJYG@Y9Y*\N^7?(IW/8DOI"\T-:]'WH%YI\T--\P?.;TI7/GEKFK M,LFNN1"\ M6>6O^GQ].]_Z>?T\/4#ZA?U6>0_33:_J(Z7IVG^6O(W,7I?YPYXYI@\S>89. M7H^6^3-!=ROYL,T[7>6`_671ZSS3K4G*NE:)<2Z=%()7:BSP1"\@>GC]*3G/ MTPE.Y\\]>N]$USR,YQ\U>4N;/3E MK]YYP^7MSZ9O-^\Y2U:QGCY@=;?-[]53D?R)YG_4M\N^6==\C?*S5_2YS5SCSEJ7F5S+RORKS2/+W1':%YQ6 M^D:KR_I%MS1#:W?,VJ3\OVK+^XL;5MLZ?4(8VB%S//W^FM@Y7\NO7)I7)OZB M'DQYL^L?T`\@Z[YO>>'I6Y*\HO,&+1K#RPM;3F;FGE:Y@\]=>UC2M%F\P>:/ M+OEIVH2\OVFB7HT?4KB'3[V\C$L-W*(7'_I]?H!^3'K@\LO(W5+[]3CR]Y2\ M^_/_`$[6-5Y<]/WD;Z<>>_6!)Y86]G87&K:5IOJ<\T/*7GW3^3_3)S+K&D0? M-"PYP9IKQ&V>.%]Q2ODARWYZ_P"1>5=>YXY7M])]0/D#R=S&_P`L?,;5-&DYVY5Y7YSTN_O' M/MK>XLW36>HRQ7,0=)-'@0O@KZ#/2ERKZS/4;RUY)\]>I?R/](_)%]I>LZ_S M7YW>??-F@;/HP\ MQ[;S*Y\OM?T;DV6Q\OO._7+SF76.6-7YBY>DTXWTD-B!<31/A9<6_BSPB%Y5 M\V_].5Y4^6^A>I+RVTG]6#TW\S^NCTC>1$?GYY^>E35_+?7?+GDSE;EINDV6 MKW=CIGJ4YSY_LN5-7NHH]8TV`NET:S-G<:K9#4F:BORCU?R5YI\Z>9_-UC;RPTG2]9YFU M70N>>2=(\LM+US5M7L!!=7ANM/BM]5T\W%U!=WL5E@0N7\IOT%[NXYC]<_.7 MJK];'DEZ:/1KZ#?,*S\I^?O5YRUR[JWJ*T/S#\P^8(N7M1Y4Y=\J_+?D'7]' MUWF6YGT/F[2)=6@-['J6EWFJV]C':7ERR];9B%Y2Y;_TUGF]SUZ^?)KTJ^7O MJC\KN>/3KZ@_3AJ?JZ\GO65H/*.M76D\Z^0NCOY?T_4;[3?*"'7IM7?YBP:U MS=I+/R)FN/MS9:E#<#4.(36\0A>MWJS_`$?/)_RNN/(*R](?ZC?D?ZL^8_.G MSRY.]/&M>3_F-R!S'Z,_4YY7\]^8NKV>D\D\QF'S>YEUWSD9Y4ZA+?0.N M>8)M-LQ!'=VLT-M=6D_S+!"]I/6M_I[_`"/]'_*'G/R_>?JM>2TOJO\`)+DF MUYWU'T[^?7D9SAZ2>4?-*&/ES3.;-:Y8]._J+\WN?_\`E]Y](T0OJ M=^H9^B[Z??1GY6>:W-/E=^I[Y2>=GG'Y#<['E+S5],'G-Y+\T>BGSNU.R@Y@ MFY2U'F?R`Y4\Y^?-4U;U(\OZ3S':W`DU#ENU?H]S965U-97]W+#\LX0I^?/Z M%G_)'U;?I;^EK_\`.D_S/_\`I*>2?*3G#_/7_)'\E_Y+_P#-+6M-TC\N_P`L M?\W=6_YC?D7YCXGC?F&@_-<'#P1+Q`0O8GRX_P!./Y?Z_P#_`*3#7_-?]1+1 MO)#RP_30\]/^5OF'YDZ[Z8=?YLLN;>2]-T;2.8^9O,2#ESE;SDN>8](UFRT> M_F;IW+EE!KESJVH,AM6743K@/C$+Q3R!^AKZ:M4\D?.+UB>;WZJWEKY(^AC1 M?/V3T[^F3U':QZ;N?.:]3]4G-\-A%+-K.F^4&@<_CFWR_P"66ZI%J-J7NFUF M^@AT34;VYMK>QMOF'B%Y/\U/],1YPI?S M*\X)N2IN2_*OR)\K.2Y^6(.;N:++5&<]\VZEYJZ`Z?FFUM]%NHK;1':I=7EG MX\5A;33W5H(7K[Y^?HA^7&B^4?E1ZF/1/^H#R!ZZ/2_S-ZI>4?2-YS>9O+GD MKS1Y.\U>1GF9SIS-H_+VBZC>>6W-O.VOW/.7)]P-:MWQ7\>I:>V[?>V3K5L] MG=?.Q"%[O^8_^FG])WE1ZS?+?T$\Z?K(\JV/J7\T^8>7+;ECRY@]%G-\VJ1< MHAPZS<-SZ>^4_TKWZWRKS+J-QY6#F^+SF\X+/6^:^7N M7?+'EF36/,;RXBY?EYKU/0M/;;W_`!:FC-?T]S;>03Q>((7Q(P(2P(2P(2P( M5J&$%)..-_""_P`,+QDM0AJ5R.>+HQ`#ZI/HH">0N"ESP75CIWPX_",JUIA1 MD2@@(O@-$B>+&0'?#^(C]VASV8EM#NHN>B$Z>4EY5`"48X!&IW0TA%)&6(O/ MHI,+(I@:Y_\`WS(P2#P/7C:"B@US&)M5T@74))9&/;\)1%#>K!Z11%))AQ2,=Q.JTT>[)#^%V6W+!<53M9+O1-):X<3B6\;2 MJ-_=6J$G!Z8I`N4[7ND:YKC\*/#W9-)/">)/WL`+AT&B0;X0<\.:7=UH>Q>Y MQ)7K*4P,!5)V-;)F.=(K7.+E"\1J6AM>BF%&6ZFJD:53M8&*_B9)PA4:J#I= M7+#8`NE4IF/>XAI!>"""":Y$\2G:/JPHR)NFG$;02[C8_A!+6-7B)0H%VI@V MB-4*`D/?R!(5.(I5"`:$C$FJZ$/Q'DKL7X M:)GEU'$-TV?1%%(L`**G0F>,X-D4U'4FG\SU+,)?7:E#3^L/IA#UE&BJ!P5`UH)VJ*+2 MFS$MP=M4*+8R'\(H>+.J+FH)ZL+9%"D7L7(4)[V2US1*8>X.VJ%$M&EX-0]K20B4!(!J/=B,@? M4+H4G.:T!KF!SVMX7%4+?YBA5`PS+;>Z0J.R4K7.<'MXW,,.KTLFG)#&L9*T/*%W"5!8#\(*A0Y-F"D0Q46>UE%[2\1O8P\(!:&1@GP MB`I:X"JN%53`0XI92>K)4:QC96<=7$,J+14;&JC&"QDQD:>`LX"PCA<]Q(+36HX4 MSQ&,=M39,L:*0X7ME9$P,>0"6@J9&-*EHH%\$)=DF$(RW.4RR>-\1D1L+8W/XFM>74:74"J` M`JX8(>RB13JHLAGXVHQ["'_&6N#6<)JYS@$`088!?LF2&11);^($@`!>?XA) M:A*]_@^$U*UV8-P=M4,60C;3\9!8YSN).,-+F./[W$B$)B.R3N_F3<-V1'RP MJ2^%LKFN`,G$A?PH'.(0@U';B8(?JHU(49HY7/DD`?*'GQ&O:Q_"6OJRK00* M%-V(D'9CN1?,7U;^D'3O M*ST^>>F7.@_F_)_*NOZ'RJWYGG+3HSF/6O^4?GK9_\S/."T].'-_(5QRA^77_E MC:ZMR9X?-FJ06GYAS!!I.EGQ/%%R86ND`A?,CU8?J">D/S+]._\`IO>1>2?- MO\ZYJ]!'YO\`_G9:7_D+S.TW_E1\USQZ7-8@_KVK)IWEUK,G_P## M4VLI\GPE'2P-E$+Z#^:7ZNGZ>?,?K&_U'_FKHWJ#^WZ?/+'D?Z3M>_Y M4>=]O_S6\T=.]&%KY3WG+'Y7=>6L&L\B^#Y@1NT_YWF6WT?3G)X[9S;?QL"% MZ\<[?J>>A[5^<_\`3!ZII_G@ZXTS].[E#D/3/6%-_P`MO-^)OD]J.CCT_#58 M1!/R#'-S^Z`)#QB%YC\NOU9?T_M!]=O^H1\Y=5\_?E M?+;UQ>F?F7R^]+G,G_*OSKG_`.9_-^H>6&I\NV>D?D]MY<3:]R5XVL7#(?F. M8K72+5J\;I`P%P$+W.](GZX/Z9OEWY"?I906WKN\X_1[RGZ5/+7E/R]]2GH* M\JO3%SSKFF^"%\UO5/\`J7^A3G7T2?Z@WR9Y%\_[;FOS!]8&OZJ[4^8_+?1])Y,N>7M&Y9U1LUKS!/I5U/-8.%M M',);M_TD^@OUS\S^;'JZNI^3.6^9O(/G[RY\N//.TY"U+S.O M/(3S,U[5>5K[3>?HN2])TGF+5+UD^A:1J&G.GL],O[N-UVV$Q_*7%X0(7VN] M8/ZU'H\@]"'IYY(Y"_4$\T?U`_5SZ2?U(O3CZL[CG7SG\AO-'R:G]0.C>4.N MMYMFN/+K3KKE;5>3O+CD/2#J<&FV^F:UJ-AJCIM-OKCY:;QX)KL0O7+UA>:G M^FW]3WG5ZN/U%/,[U(^H[S>\Q_4?Y2V.H>O*CU!P:#R]IA MYGN//6VL?^4&MVLPY4BMG65Q=:GI=C%J=[<+JDHLX[00N-Y3]5OZ._ZCGHL_ M3`\K?U%_5#YD>D/S)_31L[_RJYM\O]*\B_-'S:Y6]4_D<1R3$W1>6N<_*+2; M[4O+;5]:T#R[TJS?JEX^"YTVZFU%K+2Z;)::A"(7L9^G=^LE^G=Z5^6OU#?1 MGZ8_41YX_IH>1WFAY]:7YU^BWU8\T>1EMZO-7Y+-OR#Y8\C^8&@>8OE-JO+_ M`#_JVKZ5SI?^6C[G1H9K62[M]+UAT5SJ%E>6C)9A"X'SK_5\])_F]^I+Z9=? MY_\`U1/U+^;_`"<]/ODGYFW%LZWDCAM+F741"[7]37]7CT*^=7H: M\F?3IYD^M+G7]4OU'Z)ZH?++S(U+U@>57H]B]"7FKY/>37+/.T&OK?4^:/,WTK-[1"_75ZY?UC/0US9^FIZO/33SU^HES%^KMYD><<'Y9 MZ4=/\P_0E/Z>>>O3':/FT^+0]2Y^\U;[D;DKE?S)YKY,A@AU!_,.GV-KJ>I: MI9RM\&.VNF-MQ"NV'ZEGZ+OJ*\T/T=/7#Y^^L/S*\F/./T">4_E?Y8\^^E>R M],GFES_'>;>CZ%-RI:\A\D(7K?Y_?JJ^@GG;TK?ZA_RWY8\^/S/G3UT>J;E+S']+&C?\K_`#FLO^:/ M)FF:QY9W5]K/YCJ'EW::3R3X$'+UX[Y?F.?2+MW@HV(E[`X0O&GIK'7/-OR@]9G*?H_\ZO4!Z>_,>'FK4.;;;6O* MZ\YMY%Y4'*&D<]W&M>9VM:9'!J6LZ=':WPTRX;=7#3=Z;@0ON9ZL_P!1CTZ? MI4>O#]'SG3G'2/,SESR)U?\`26OO(35]/O=+T_5//+R5\MN==6\H]0\N.;>; MN2WNNX[[F+E_5_**"RU>V:RX)?;WY@BNI8!;RB%\N?7Q^LSY,\U>4_E)Y,6_ MZP?J-_48N.9O5AY*>8?F3J$_HD\BO2IY!>7'DCY6>: M)YWY5Y:G]-_.'E9YCMY2YWY-=%SWY/7>3^:[J#R_Y*]$OI[\I/*7DG6/*/S!_5)YTY*_4&]5/* M&I64>G2WE;R5H'*W.ND:C+<:CH-WJ'-&D:5,^V@[HU;E&[D=+Q32B M<0OP:X$)8$)8$)8$*Q!#()(GAKH@%=XI:0QK55Q"'IXA:[@#B:NXJ MCAJJXC&,A+LI.&=&,MN)N+P>/OM'BK5X`#2_@W%P7IQ(D/9)CU0I8IN-_==* M7.XA(UIX9.-"UR@$57LPB)/1`(9$D?"UP:^)LLC6M$DK7'A>YM#PH"J`)@)% MC4H`/@H3-D=(YP!D8\!\98TN`811FT*$0C#(D]+(!!4I"QC8XY&"25K1Q%2` MT%>&-$)5BUW8#(1H;I`/4449@7\#XP71E@:WA:2(^!08W(#PN"[:IA%S6-DQ M2ZD2V.-C)HQ(\\;N%QX3$TO[K#0U<*ILP[1:2+EPHO'B-C=&Q`T%IC8KBQU2 M24KPN6A/5A2\PHF.Z=J1P`2MXO$?Q,C<"TM#5#B:*`7'MPQY8U1>R1_BQ'PV M(&/[S`5/>^%PHI!R[,!\PHD*731CPXW>*U0YQ`B^$EPJ7NVM`"=)P@\8^9.] MDCPOC>V./@+7-<6@EQD&]#A("V M-K2Y_$TAKFD%O!5%+R1AU>MD_P`TF/8YQ:V(1.(;L`D#0 M!BD0W@HQ1O#XWHZ,,/$7%IHUHK4A"JH-^(QC+*GO`$`<)JX.H#PYYXBTMSZ)N&1/%C\0.X`>\A M?M=7A#D-.G$MP=M4*#XWB1S>$FJJ`YS:U7B1,1:6Y]$.$Y".[5"J-CB+DXVR$$I&T=YQ:J@$T4(<-AT15#;)(I-7*2>%$SV`8B\^B M&!13%")"TS,H].!.\I-&+4<:G$F#OJD]%"2:0.-2T-*&-*#A)'"12N%(D6LF MBOBA+U?.R'B1QC+7%S.+I:4&'M#OJD[!#DDD:]S6N=$&`-:T4HT('%%)+L^G M!(D4"0`-2B2,8])7R-MR]O$YI:7<1H.(`$4X-(+S)&0!*N3MJ`984CM#!,5J4AP31M=+(V-PJ29.0(5);M MP_5%Y)6-$[CX$;&Q/!+W/<^=A.;3PM8%7A0&HP>D43O=)I\:-QF>&%CFAL[J MCO\`%Q1..TD`'?3`/-&J*`I%((BZ!XD<]P8Z1K4\)H!(`4E'.6AVX"&CY47+ M%-&3.)&2O/"UH?XKW4A*AK`YP2DB(!GA`[@04&A"F&,BCDECE\5X#6\4800A MSQWZJ>]PHNS#8`;A4HN6*:%[YGNAD\I$?!4O!(IPKUX(G=>R#2NJD MV*)C7RLE%T^&/Q&L8TT)(9XB5)#>)T,C/ MM[J*XGL7$C$/4LDYZ(B[]7S]1W]/7D_7_+W MTA>IWF/RHY#YFUF7F/5>3;KDSRO\R>6!K]Q;V=K=ZSI6A^;/(W/6F\OZG?6^ MGP,N)M/CMI+AL31(7(,"%ZQ>J3U9^HWUK>;^L^?/JE\V>9O.3S6URRL-*N>9 M^8_RZTBL-%TH3?EO+_+G+N@V&D+-*]XA M>NV!"\T^G;U#^<7I/\Z>0/4/Z?\`G)_E_P"<7E?JMSK?(W.,>A\M65Q"6R'NJ`0(78>K3UC>I?UT>;UYY\> MJ[S7UGSA\U;S1--Y:/,VK:9RYH,-CR[H\U[YPA>LV!"6!"6!"6!"LPSS<<49+YXR?",!*AT;D:6#< MC30U0#%T9$,]05$@>"L,MK<3<(N8YBQSB(4[TO`I$(?Q$<11.G$HXXO<%+<6 MLJXN[AT@<9'N'$/X5.`UX1$&>Y-^(^Y/T,COMK?QBSYEC%>`8>$\8+D) MA)!(:02BXD8#==NR6X]$&2YG$CRQSX6L>6MB4=P,*-8X)G2N_`92!:P3VCYH MTL,#G\9G;;&5K)#"\=YG&G&A%"'%4PB`9.[$I`GQ"'/+)'(^*-SH61@,X1PJ MX`4D-*EY"KARF7VBD0F*BJD]L,K8YI966TDK2YS7L):_A)`E:`:->*I@(!8D ML4@]@'49G/A(B@>]D;6-<'M(`F+^\9A4@\17JPB91I"R&!O=2X&S11RRR^$Y M71\;Z^,UI^(5:%85;AL"')8IDULX4)"8&0M@>XB1ID\=E!,Y2Q&[1P`)7$9' M;%@@5J4[0R:+Q)9!&YDGAB9PXO%:6\7`0".\T[=F&VZ+FC%*QI5-(/`C889. M(RO$E"V9_"&<+FS/'$A)3@<@4@C+"' MF%5)FLH\+(6/='*R5SG1MXV@M\)M2$4DASSE39AL(APE`O M$CN]X3FJCC4*UV280.X,4,UE(-9$R26*43/8$:Z/B;X/'0N<"NS;EB0#%P2D M7/@H1ODE>8I'.>Q[2UP<1W1\0>J#A0C/"B2:%!`%0I,CB!+F2MG2US#D0_-:*.'W849&52@CHILAB#T;,V0 MLXB(@"'/+`2&EQ/#F*ILPFC_`*C]4.2$+QY>)2YY!=6,9$$T8`BC-,&\[F1M M"+X,(D#3,T#C#?##7<01%9Q!6J#3$V#OJARR&9I`3PJP-)`B'P#A4(6@`E$P MG/0H`8*;H8B[O3,B+@USHW-=W>,`D*#PBF`Q!+H#LK>GO>S5;!C.*-L=]:,: MUU-$N?"73R`=TGAJ<2!CX*)!\5G ML@E#VJUT8:5,A0!@:"2[-:`88!U3W!2;/$)&GP`T<124./$T.!;Q\.\KEA.' MM5+S)C;S!_`A7C02`4*NX?$)W;5VX6T[MR>X(CIH1(?X#7\+D\0N(<\MH9", MADM<2<6U0Q^2'+!,7N+6ND#JM>!1P=D:)D,1,2[BZ`0RG)(P.#'1,F?&UD;Y M5*N9HF/F9(T/!`'=;EP%33A1,(@D[HU3!#= MD[WLC;%%)&)9&,/&2XM,9<>(1A%4-!PR0*$.4#M9/+&^8120L+V>$R/@;G"Y MG$#&04057MPR)&HLAP*)%(8HXYHFR2=Z3PY'%IA:>Z!W05XB"F#TQ:0*!0L5/@^7A_CQ\3I9`66[P1PM M9Q!TQ`V.=08!Y(^85*=2:&B7";B'AMXD=#(2^"-3Q-D`28$Y\)"'`?,/(&9) MF-2F8QUM%(^XC)$G#$RW?3Q"H<7NS0,&>W##Q!,A?1%S0J0++B&2."$0R,+9 M#$QQ<9FBCD+BJQJN$XE$QC0_FE45-0FBC?`)99XWM9X9C\-X07#GD?PMR!.) M5V88&VLK)D@T%T\;HIA)!%"V"65C2PM<3XO`5=$XDJ"14)FF`$2>`#%%15W" M:""6*03S,?!'$Q[W/`O3N%3P\+\L`,"69B0D=Q%2ZC#:7+96.EBDMV1.XWRN`#8VQJI; M0J4"`)D<$83W=.Z#*)'4*<=S:^.'?+,A#GNX9VN=Q1<:ALG"XHJN5!OPQ+&_ MI;N@B370A87GB!AA>U7IXR@1H'?][QJ*(.+![&127#7OXA.UH+'MD/$'D M@_A!KU8A*$W:Z8D$:>:VCE+'6S;QT(CB-P][FOE=$WA/`&GA(8:!<\2E.(-G M(U40"UV"A<6UQ+*^>".2ZBFX9(Y8PWA:'-`$)0HTQ."8)1D2X\T2@2`'F-5. M=\,'A6\]NRZFAA`D>][F^&YU1`.$K_":4*[)L:L/Q.(!(V8E2,0)!S^2+DD4":6-]S%#+:0$L8'0/M81Q"W>/XBBH M/!,"H)J<(@S`,13IT0/*2]TJ6ENV.[@$\DTAECM97%OA-:`PSN+.\'3$H!E3 M`/)'SBYMT2O+RII&B\MV?*6XC,$CA)9Q=ZLP1L["4)5$.[`?/'RBVGZI^FYN ME&PV=O*Z]MW$3O9$RSF!9XOACB=,[A)>UL:@!,UP@-D3*6IL@U--%+N7EO)% M:V[8)(I1<&VB<7_,,#!&7#B[Q=#GVX;#)%HAI?FCTEY&BC!#):-GN+N%\<9B M\)EO*.#YR60M+6C-&Q!I<78408/*0I^:"=Q`%U*,Q744]M;V[+2=[&R,:QQ+ M;IL1XGV[N-2.)M0F9PP1.)C$-)OJ@@Q8NX36UM/;/-S(#'-]MNZ9E%JV1S>V/S)E M-A"6_,%S;FOBFJ"X+`?"XOQ)D,\2WPW/MUO^J1C-J&J!)IUZ97M;%).'2=VZ M:"8Y6R$$2\;J@(:](3$3CF20S]U(2BR-/`]S M);.'^)PB2K+AI=5W&B'=B+;X/`6-OU0"8EBGC8;.WD==P\7S$C616DJ@N=$. M+YEP'>8&@HTBIZL,#9$F0OI^J"7D&TU3(V[MI8[2$0RPO;,^UB[PN&%&"17$ MO+HCV!<+UP:`J#;JBQ"44,EFR>:\AD9&Y@A;;2HTW3W$N09\+(14D5K@C&6, M&4A2S=4&0/E%U)CH+F*>W@MXK:9S62M8QSB+H1@E\)+B2K?B&\YX;B<3"`8_ MFAC$N2X4;>":W>^XN8I(8HHGJ)&\/C.E'`(&\1[QD2N",9Q.Z5(M]>R9+TBG MADMYA)!#;1V4LT)CCDC>YW$0X/=`XO-!*&HN&#'T@,2D015W90M[6YCFCFGB MFM8H"99)7M`'`T=Z($E`9">'MPH0D)"1H`F2&871(+BV=*UHM8[5TOB1BY:\ ME\4D@+62=X"1C7PRPM8_O7"-#&>&5=*'`E0 MC??B`QS$@X9!E%KJQ\Y9FX\3Y-C6_,$MN5/BM:X$FX!W**J8GOQ[W;YI-+; M>JKOT^[\5S&QR2,=-W;H`>$]KG*V4.54<"IZ<0..;]:W3WQ`'RF-`Z0-'=XJ4I7#,HB50[(`+4*'/:7+I'/BCENHIOXT^W8>(RM(DU31M=;LEDN(W!L@$L#Z>,Y0XD57^" M*KTX`-L7E9,ERPNF;PS12Q11-AD5LG`TEQN&,H6KL$\4R#A$74X_5@C`Q\\Q1!+T%T['1O$D4<3;=\D9#'-)_B$ M$.$+N)?C2F$"#0!BBHJ2FAAEC>)9&NA9&/$<]R5;D6BJ*X'(YX8C(5-`$R18 MIHY(G/X!$VV+P]K96.)X"YI`*G(NRZ%P@8DL`R3%JE-'!,'M#FNB#7#^*0.% MH9FZI)+:80$WJ:)N%,3P^,IB:UI*I)`-!(65"K6F6`2B]+H8_)!^7F#RT MM=\:>*G=(+O^\!_=0K@VGU4F/5 M0DBD=([AXI&O[S7H@$2!0U28G6BGJ$48U747,F9.]E]>.9"%;QN;/*@)W"8W.)#@^A4'<#V8C&4C)B@@`41VVT#I>$3AQXG)"003PU: MPOR114[1B481$KI.6L@_,3%QJ0_C_P"Z+J!W$!X?#L!R3$=\G9O,I,&[*P8( M3-PON&Q$O'%!PJ8W$J8R_<"4W@8E*,3*ZB\F0)II622#B,'!W6QM<@:UE&== M!GMPB2_1,`,BR11%X=).VVDJX4C(%A0?%4P`15$DBCD;%)-.+:21BN8X<9D# M3P-ESIQ-&1Q)@0\BQ47:@LH7!,'A0QR<,0B:YDC7(9R]7.D)VUHFS$9>0@"Q M4A6I1`ULL$,D\S87@R1L>]7&XC'>#D"%I8J$Y'!2409%OU2<@M=1F6".)L$J MQOXG&X80WQI&DM+"-C8QD,.3P`VFAU3%36Z=C?'MRZXF\)L4H;%<2*2_C:LD M):G>X2%&2'`!OB\C8W4;&B3V_+VX=!*)!+*DERP\);P@.9!P`JU225VI@)VQ M>)N;IBIJE$#<03">8M9#P2-N']\0O<0PQI\3A(-G0N"+R!W&@U3/E(854S&R M"WEEMYQ.\R,A?*P>&ZVC*$EKX;=2Q14#06&!KB&ON$/Q MF-N0&1VX&C$$Q+D!*M`11!M'RSS"!TDD\4S'B3C>H9&!Q?,*2@,90KTX4"9' M:2X^*J4F%=58MX(6R.EAN8KR6&*26*W$1;Q.8`DA#G$/$2\7",R,2C$`N"Y` MLHDRL0P5:UFN'3PMXW7(>_PW122$MD:\$/\`B4-$2XLY)=3VAF"OOLK(W1B-_'$'3-!M^! MSG,+G-XH?%:C"`5"[,3./'O8%NWZ*(E,BHJJ$]S.R>4B1]NZ*3@;#&\AL0B1 MK(P%1P#0*5!7$)2EN.G9,`$*]<6MKXG%-=QV,TC(I);62-SO!?(T$EJ%&B0G MB`-`N+91B2Y+'HHB4A8..JKWTD\-P^W#I+6.`-CBC8\Q@1AHX94:>$NE7B)K M4XA,RC+:"P`4H@,YNCRP02LM[FZO(;&XGMVOD8]AD\7@=P"& M8QD!*1VR(^"D"105"'>N?;/AMXI7,MV6['PO9(YGS0E)<^X<6$*7.*(51,$S M*)V1I'\T``U-U,Q1W%O;3WETVUE<'Q-ED:7ONHHCPL>X!#QQM/#Q?B&'M$XB M4RWZI6)$0X_)1NUM8K2.WG<8)HWSFZC+HQ=2EQ8[(JWP6MHTU&>%+^6`('RW M?JG%B3NO^2=C&W5FV2[N/E_`N#%!=2!TOCMD!?)`4[SQ`^H.05,`&^#Y"P!N MCTR\HNGG:+2SB^4G\9ES,[Q[R(%A+H0#';!.]$T9FO>."30AY"[FI_1`\TO, MHVW];MIQ=S\$5O)$]E[*XO,4DBM-OM?(R5I5%[IPX^>)W&@U3])`&NBF^..U MLIIK.Y%R^2=MM->%XG$DCG"!C1Q"Y:7DAKH7M'7EA0)F=I),2*]NZ)-$;M4:U MM[=AEGMKV._N+:WDFAA;$6$$#A=.X/!#C`O$&@*N)",8^:)$I`)&1L:`JK9S MW$MS#'QR73+AQB?%(\N9)'("9'E3PL+&JX'()B,)2E)C4'1$@`'LKMO96+;@ M!E]%=OC\5\5HT%KIY(6N='"7GN.'$VO[U<2CCCNI)STZH)D8V99T5Y>?,1O$ MDDLSI@#;B1SF2.D=PN@+%0M(=PHE`.C%8R3W.[E[?HI&,68V5]VGV'SA@^?C M_P"(X39@.\0%0?EA,?X;R3W5R3IQ;[>/?MW:V_10WRV[F5&XO+P3RO=));S1 MRH(&.
Z1O>)R*XCDG(29V`3B'#FI5J>W@E$-S=WD5A<7-NR:2)[" M\/)!#;AO"`&&9K>(M("G$I1B0"2(R(402'#.`4"^?):RQ6T4DD,$=M&Z$LD< MP7+9P)'72L>.(R./8F(3)@=L2T0/KW3BQJ;HKHH;FVM;J[N66DT@DC:^1I=\ M[#"6^'/0J'MX^$G\28;"41*9:7Y]T@2"0`X_)0NRZTBM+>VF=X#V.N!=1$QF M\F+BR1YX2K6P@!H8=M<*9V@"!.TU?JF/,2]U)K&7=E'+>7(MS#.^"&[D5YN& M.'')`Y@'$XPO%'#(8D!O@#,M6AZ_Y)DL6B%&=HM+2`VDW'#S<3^!\JM?:\5 M72,>T<0'X3AP\\/,:`T/Z(=I`#Z*3V1VMC++9SBX,L[(9;R(&-UNSAXV1CB[ M\?C.H3D;\T5L45O;W=S9W3+N5C61.?&US?E8Y7))*&N4 MAQ"`.R`7$@!&)E`N?R0YD0)!D*Q<^YDDM97OFAEMY?%+Y"[Y<1!KVW2NX@QT M+@$R5<0@3(D2K%OIW4B!&HH46""WC\:XMKN.^GM[=\L4(B,?"2[@-SPN)X_" M:3W>W$A$!S$O(#X*3DTD&#JM9233744),ERVXXHIH7/%R."E,TQ.,( M.P+]DMTB*ABL^&ZNC,QS9))GOE`=;N>YS)3(]'PEA/"&E2-B8A&<]UR2]E(Q MBRT!86/S9@;?,I<.8VUX3Q\;2HM?&4QD$CA7;LQ/9#=MW:V_11`)PHE1BLSENNU;*6T,M":SM!/PR7D=HZ1T M;I;1T;GF%\H:Z2(/:]&U.W('%AA`FI9]%'=("@(%HXE2JXA.4]Q%FT3#$=0K%Q!"\LFGN8K*>:)LDT#XW.(D*K* MC$:P2``IV[<2,8WF6)"CND*`.$*\,D$P@8711Q11^$&/02L"`6\H M?',Z1[[F-6^(]G=;`=K?#:>)%J<$GC$;30ZJ0J:W48V_,6[WW$I8R&5H90I.W M+#EY8/$O6Z&)-;)H%N&7#)I/X<;6R>.XDF"10T-K4ME!0C-<1CYP=VFJ#042 M$;(H)Y8)O'?W&&1K2SY9CCWG-XOB,B`+LPV$03$N?R4:DL4UOQ3.EBDYQXC`&59*`=H=3I[,$6D6D7'Y*1#!Q=3BBC8V66"X;]\K8BYTS)`Z-['N4",M5SPM`8VU7$( M$F37"D6`=&B@@:]8[F.Z+&O*:9 MTL0#G3N<]K3&YU)0ZCV'B5%:J;L1C(F3)L&5D6UMX_"+EK^&0@0\/"YR5$7& M%;\5%R/1B6R.^]4MQ:RJ&><2.J>/C+O!)=PAP=_W0:?PKW<0WS=M4]H5B2"W M\8M=<,CXG-+HJDMXT)87@4J3U8F8Q$F=@D"6L@2S2-ED'$8BP\`8UY+6M9W6 MH.D!>G$#(@[;!,`7-5J:?%&=4TV229D#WWED]\)'PET\9)!W'.N_$B!J6+(! M)\$KZ&9FK7TDC)(HXK^[D=(E`&W#_AX5XN):;UQ%B"YH`@D6*IQ73#(.*"&% MKRYOB,'?C\10'9#):XE'(.@"1CU*&+.YX^%TJBZRNG/(;$Z1CW`M MF"\#V2DD/4]Y`#7$3"3T%$]P93DNHVR=V"&X;%PL,TK3XDQC'"YQ2E2*=6'+ M(`+1*CMI&W,$5RZ&-K'R3$N[U28@GQ,C5%VG$I2V^5@2!J@#Q"A-#+W$1(<]T-N+Z)WQ37K8IK>(N1OA20QH6V[F*X)4)'("H.^F"0,@) M1'RZ(#1)"CQ.LX6131-?-*XS_+S#NP19-<$J)92TJAH,!\D6D')JQT382KHG M<)+Z%AMXB'0/>V6TA:7,`E0LN&KO0AQ)IAEYQ>(\PT_5)V+:)-:^Q@<;B%I? MR>YN8BT2-%O#;3``74CN\2]I5 M(X&A22@&W"C"43NF"`*J M1D)4%71(+YCY@QUM;V8GXX?F803-;F4%K7A055Q`$LB9#WG3,*U4-[O2:X0QS>H9M4S*+51VZK";GQGV M-NR(S<1N&M6Z8QRM,Q3N.D:IZ8G%J*Q-J40N#P65M=MA=&SYF977$Y@ M#6.E/X0YQ:>$>W$SD#V!`UU41`[;D.@7&GWLLTL]O#->P7#A/!<-1PD9.CFM M>9V!4;FTN;Z07MI#+/Q.;:.G/& MRUC(J1$PCBV*:8#+:!"0!(ZZ=DP')D[*-Q#<:BVWNK.%TP$?R\EM"U@%G+#P M\3&-)"12!P(SPI1EE:<`]&8:).(.)?YJ9>=,MH;:>WCN+B9SKM]M<-);9L<" MQJ.`+A+,A<1D,2KCB(R#DEV.B;";D&G91F;)JD$,UI;H^V+K>:QMP/#A$A+X MYX%();*B/7(IA$'+$&`J+@?FD/)([C0IX^/2[1_S5NU\]Y,QT=CYQX68=<4/.*G0]M44G+RF@2<7ZI:F.UM8XI[.?QC:6BAD\4P$?C,:X M`&6%X*@[#3"+Y0T!Y@78:]_DG2!)JE"F#=[D#``"5Z:H;:=QJ/R4;6VN=.,M]>020Q1PNB;!*T#YV:? MBCCMBU2K,W..P#"A&6-YS#!K=>R^9S@W=B,(3A+?($1%?\/FB4HR&T,25.UU".:7P#:6FG_-,DMVW M<#2)('3T9Q%S0!&YX#7]!IB4<@D=K"+T<:(,6#N2A0:3J$4\3YH)K.*W>)9K MIP;P11P=Y[V%3QEP:C=ZKB,<602&X$`:^"9R0-'J4:/6(?FA(ZQM+>-\I6Z8 MQ+F*.16F>K1'XHX@X]N>)#,-SL`'OJC:=K.795SHVI>,83;R%GBI\Y3P>'BX MA=%Y6DM)38N)RS#=2((>^OBD(':SD=D"XTN_EFE?;P37L%R[QH;IJ%LT=PCV M.D)(+7,X@U]*)A2QSW/$$@Z^*8G$!C0]$:YOXX9&VS;6TU`VD4=L^ZN`2^9\ M34D:TM5IB8[NM7:*X)9`"Q`D11R@1)#N0Z%>VEW>S&_M(9KR"\8R:-[`%8@$ M;[9]0.*![2*4(P3QRF=\`2#\,E&48C:2Q"+/VA(F? MWHZ%HHL+PX.:?;B,HRR-*`HWT9(&,/*6"Y]R^WN12Q;(" MV-C0%+9)0TN<,L2)]J(A(`RNQT3;<3(?YIIHY=4@MY[2`EULZ2UGL;<`QP.> MXR1SQ-)!\.5H[RU!&%('+$&(M1AI_FD"($[M=4F<>EVCF75LR2:]N`^.RNE< MR**W;P.N'M"ELLKG!H&X5PP#ACYAYB;'1M44F?*:#5)W'JMJ&VMNR*:TF,DM MC;-/!+#.T-;=-5#XD3P0X'8<*N6#0#3!L/S3I"3RL=4T3)=+@N)KN%'W'!!! M8W#1P3%I$LD\K02[@8R@2JFF``XHDS%Z`=>Z"1-A$VZ*0E.IVT]I!;16UPQ[ M+IEO:A&7C(^Z]KR4<98@X.:,C@?W(F,0TKL-4B!$@DT4;6WN-.$][>020QMA M=;QP2AH%[-<#A;`X`N)A:`7/Z!AQC+&\IAJ?5&Z,F$2IPW`O8[BP;;6UG)<1 MM$#K8%K9Y(OXGRTKBWX)F-(;L7//`)B;PB`"1IKV^:#':1)R5"UM+JSF%[=Q M3VD%K&^5SG<+'3.+3&RU94EYE<\!VP#"QPG`[Y`@#X9.1C(;;NI6^H1SO-L; M:TL#/X8<[,,>[NN(K7!#()':PB]'""-H=W9!M]-O89HY)X M9;.&W?XLUR_A:V*.W*O+7*5<\!&C:N(QQS!!D"`-?!&Z)%*HT6K0FX:\V=O; MQ/D=_68@\7,+9.)HF"]T2,\17=J8D,L3*P`>^OB@Q875<:/J(D$;H9.#Q.$W MC2#$&-_ZH]R+.;]%8?JT/S/C-LK>6-LK7BY ME;_6G1L`'CD`<(E;2[UTTKHH)+J*60R1W(+ M>"5DI#V/>0>Z0'][I!Q&6&9E0$@ZI[H@5HCW%^R&7PA:VUZ;9L<1N;D'Q9GP M@!R43@:YO"U=@Q.60`LP+4X;9B.R=!;WDMM$(YGS`D,D<>-T$ M3FJ2R%4Z3@E(1:!`)`U0([O,"0"E<6]S?NBO+6"6:&2$-,<84VDL`X)+6.X`HN+)IHYK^*WFM87.\$/MY;6%M+=P/B"1C*)%,TY_O M##(.0`Q%M`@-`U^J97:?;B*X@;)-+\K<`\%LV)O!XR#_SLBH$.6>$/Y<6 MD*DVZ(]4NP3/#[^W9\M"UDEM([Q+.!4+)@U+AC57B5J.79E3`1[D/**C1`\I MKJDQLMA#*^YA!-PYD4=I.O#*(N)SIY`TT;'DU#4G"`.('<+Z%/RR+CZIO$=? M0/MX8(XI8GMG9!`.%D[/ADH3WI8J$*:[\2?>"`&(JP2;:U:%-%%-8LFN;F%T M8,?@10R!!2/QA>'IP@=]``#\42(:MPGAMKBU<;F>.2&*%I+N-H`E+APMB2O$' MN->C"C&43N(8`)D@T"4=PR4FW,$%LZ9CX631<1+7O'=8I"AKR.'8*XD)"7E8 M`GH@@#S(<=I,(U[5[JL<:]&''(";`#JGMIJ4-EC=M>P>&]C&O1UP5\ M-K&%73!U20@4;S@CCR.QLEN#41#>1&WQ#%"]@9'+(P$QM$A0JH";TQ(1ANH7*1):H MHJ<4]R96$O?)*9@L9)X7O>]'1N9^$$E/YN(B4]];ID`#LKI@T[YDQ^.]#*0+ M<,(B:XE?!\^.5LE(VO*-+3W&!@(:X!`, MJIB!G)WU=-@RN7$5D9GB>XDMIW",SQ1QB2..1S6ND:'!$4&H"<.)R$'>1;LH M@EK.%5O)9&W$C.)UNV/A9'&R5W"R%K1X3APD<7$VJ[<1R&0DU@$X@,]U:FCM MCX,EW/);7$L#))&11"4.50)7G\#I&A41<.0C0S+3(0"?VU"#>N=%+'#&YT4# M((S;EDCFB:-PK,2TM!<]PKM&#(2"P]+41$.'-T9S;:>WM)[R:2WE?&\,?''X MS[F!C@V.61IK'PF@)4NK@:)B)3+2_-*H)$0ZA=N\"*TCMI'BV?$9F3`NC?<2 M$ELIEX>'A=&BZWEFE=-=+X4K[EG"V.&1 MHX>!C(RH6CL$FC`;#Y2;]TQ67FNGMC'WF>Z6TDMI771FE<[Y9D0XX M[IKG<7#(R1`!^)4P0)D3&58M7MW4I`,^JL6T=G$+B>PN)KN\AM'OA9-!X7`O M"U\[&\/\1\<9)#<.(@',"3,!(DEA*D75739YY+N*'C?=,G#XYXII'/8ZW M:(.,3!,X%K\E`_$F)QCCW>0DG0*!E+]U(]50M+R\-W;N;*^>>6=K3!(YSHY' M2./B0NC+D:Q21DC4Q7&<]X%27LID`1Z!:3+/13?B(7DSB;HQMM'-X8'.XCPV MYNBT#PO$'"';ZYW/;]%+;%NRTKJTT@W;A/>S6LKWQ&YM(X3)!!+*( MS)#X[6!H;QO*D?"N+91Q;_.2#J/\5'=+;Y0X5'4;FZ9>W$;Y9;00.\**"*9[ M(XX(O^',08YK7A[`'!R=Y<5Y)2$R"6;X"E$#;U5Z\AL)9(9[^ZEL+VXMH)KR MWA@$H$CVG^-)W4B?+&`XM-=N)S&,EYDB9%0%%Y6B'BZKZI++;7+;6*22VM(+ M:%MFV*5[&S6[H^,71'5&-ICQX3@/PX60F``@?*SOU3@Y),O4 MZ,UMO=Z=:RZE<26[XYI;>TNF,,\]U;L'&YDC7`DQP2/0/.>6)#9*`]TD%R`= M3\=5$O&9$`XU4+US+2RLX].G>;.>6XDFNZPSSWD;@WP)0U'1"",@M90$%:XC M,B$(^T?(7KW4HN23.ZG;>#>:=(=2N98H+>[:RTO`#/+XTS"Z>T:P\3IHPT!Q M*HU<.+3QMD)V@T/Z(.Z)\EVJ%&;PK73'.TZXEGCGO6Q7EZX.@GA,;!)!;!C> M$QLD*GBR><*31QOC+@FIU\$AYI^?I0?JFL7BZM;^*_F>ZQB\")(`TO![HPP(1C*6,DGKT"*RD!,40--E?&2>+W0!5RXCC)FXD28-7MW1.@!CZG^JL6 M\=C;PWESIMQ+?7\-FY\;9[;P?`A<]K+BZB:B2211.RS&>)1$(@RQ$F8'1F[I M$RD0)AHDJMI,]Q->,MW2R7EO<12QW;)IW.C^4+"Z:X>9"YL9AX>+BI6F(8I2 MG,1E6)OX?X*4F$7LKEC;Z6V?BLKN?4+R**>>RM)X1#'--#&YS"'\(\5[`.)K M?QIBS&,0+XB92`+`A1F9-YJ1U6;8WMZ^\M3'-+=RSS!CK>21[HYV3$B9KXG. M+0S@).SA3HQ7"8H/F MBT+#QM0$T<$&+!##O82(6W&_A$WB(+ M;P%#2U>XB5&*3DR;[G<]OT4]L=K:,M:YM-"-_(V>\GMGOG9\S9QQ^);132EI MEMQ=HT\'41*>UP%F:A>7C+ZZ:Z26S?!,8V6T4K MVQP,A:D#&,86M>S@`=EWEQ7DG/>0Y!%&_)2B(F`%PM*^ATQT[);^[FL+R:V@ MFO+6WM_&CBFD8KG\30D3GL`);L)7$I1Q&3S+2(#AE$&;4`,52U:>:&[?:M>^ MVM;>"&.TCAF]F0-7"JXG(0F(RRDQF1]>A2!D"1 M!C%T#4I)+;Y&"UE?'8"T9-:S,D82.T./R4+YXM+.QCT^>7Y*8SS/O0YT4]Q=L<6.AE$986""-$85 MH>C$9^2$?;/D+UZE2CYB=XKT3V_A7FG.=J5Q+'%;W7AV=Z&F6=SYFET]FUCN M)T\;$#B[)AP1:>-\I(`-#^B1\LV@*M4?JFG,5GIS3ID\DD5Q=\%Y>D>!3&^(D@RJ?T0')\UU&R>+NSOH]0FD-E;F&9MX7&: M:WNWN,;(X0X.,HF::QK3.F%#SPD,A\@:O0_X]$I4D-E^B+PVMII]]-IES),LL,[8XY2Q$DT![!,;C,;PP_-`TV0W/S MD%Y+))8?*F:ZD?(Z1UDZ(AT-Q"7%Z2E[N$-'Q8,9,G$R\&KV1,,QCZG^JL0L ML[>"]N--NI;R]@ME8)K?P'6UO(\,N+J)B+(^)@J*$.`#'$2EC+S`U%NZ7G) M`F&BZK:5--/=MMWN?=6UQ!,R[9-*][&VS6.E,+$29;36)%? M!.8`CY:'16[&'3HY7365W-?W<%O--:6UQ;B%CY&,^/B
(^)I+@W,D+B4!C M=X$RDU-$B9MY@T5GZ?>7CKVW:Q\MVZ67@?;S2O!Q*D=W$, M8V&]DN9&W#_`M)8?#MY)8RXQ0NN"T!S7/:`# MDZF)QCAW[1(DO0,H$Y-KD466V_OOFA*)IG7/S*BW\21'3%Z?*F%2.$N[B`?? MBO?DWO\`N?X"FPV_[6^"M2:ST7YY\S?@ZK$I[7:C76;>W=XV\N#)(^TEBF+!!'(YK+<1%HC9&Q MIX'@,`.1#EZ<53G(2))8O96"(,>M%H7<&F.FX[RYEL+F2."6[M8(3*R*:5C7 M/20`N8^1>)P_`3BV<<>YYDB18D*`,@/+6/54]3FFCNI(`]]M#`QD5O%#*6QB MW#%CF:6%H>9@>(FM<0G*0DPH!;P4X@7U5FXCLY8[2XU">:SO9;6-SV0PB;Q8 MF$LAN)&EO$\K`J9G/$I"!`E,D2(\?FH;I`D0#Q=`U&22!UM!!(^*T9:LDM7 M,>Y@N6S(^2YD]D9"\6R@PX^;&^0L`:%%06BFN/#M[&$V,LKX)[EXN M+MS?!E\9C1X5L6M0Q,\.H*H_"DT8?RS0FI14R\V@^"HVW!<6ET+R1S8()('Q M77_>2Q7$A###&UU9/%CJ1VTPX^:)W^D-7NB1((VW.BFX0V]E/+I\TDSGRQPW M-P]ABEMX7!SFL:P)W9G!"[9@+1@3`N7JBI($D*S?XS+N*YD>^T$+9)9G/+W6 MSF._@O87D\3Y'4#=N%C)F")>EDY48B_YHS&VT,%Y-8SON)V1-:72QB-UM!*> M&69C"/XA1!2K<\2&T1)@7E^2*D^:@=`L'R2SF%[W302Q/%R))"\,A8WB-P., MN#71.`W$KB$')VFL42`9Q=&MX[)I?)9W$EUT$%SW,:5# M<\3B("L2\@%$F5B&"IV.1, M@+@J4A1]5=MX-/\`F`(+B6:1CGF"W?$&PR/8'&-AD[RM4#>I&)1CC=@7[)$E MJBBH1SW/CQO:][IW3#^$7$ASWN(=&8P>$"I")3LQ`2F[N;J3!NRNN@T[YHL- MU($GX3%PCP2_B`,0N.$C@X^[Q#$]F/??5)Y-94II[@3RN<]\4C)7?P@YR1EK M@&1M9Q!0`E-O;B!G+>QNZ8`96IXK/QG&>9]O([@,T#(^-L4C@#(/%HT%Q*D? MA7%DXPW>8M)1!+4J$>UDD;K-C&IB9%>V;8FM>0T1B:(M(EA'?#W`4W+@&*0+F@">X6%U-FIQB82.M+9 MD7&KIF-2XCB>K?$!`X3*A4D8/=&YR/XI;9-OZI[XLZF_46"?B9:V\L<;VADSU\=[&$!TA/P^(4)!ZL!R M1>@!'XI")9B4TNF74LCI;5AGMYW&2*9[FJ6S5)>UQXU:7$.I5*8)8IDO$/$_ MJF#1C=2GNV6[VV\=M;W0M6,@-S=`N=*^$(2$0!D;E#=P&'*8!V,"W5(#<'>Z ME<:?X^W/$0"(R*')#A2A*9W0J#5`D(AI7"::X% MB(;$06UV^WB_C/G:XEDLO\1T,2(&QQ\25PYR$&@P)`U0/-YGHZ>6TGU(0WMG M$9`^(130A[0VTD@/#X<2_P#F7@JT;,$HRR-.-VMT2$A`-(U=/)(=+AAM988+ MFXD<^ZFAG'B1VI>`QC(^$H)7M;Q.V'`3[<1$@&5_!-MQ)"DZ";5H;>>SA;XM MMQV]Q:,>&Q1M)\2.:%KT`;(M1FN`CW0#$5%&0X@XDD>/2+?PKF".>>\E\06D MZ200Q0C@$KBU`997%`E6@)@#X8M(>8FW9`\]K`)<+]8MPVU@9%;-%@&D#;L5%_;/F-"G9%+I$$TMY$QTMWPVUO9 MR%KHI`P^)+-.&\0`1.&),AYC0!/<)EAIJG8[\VMY[2.""VN8W-O( M8+8<,=YX9$B8`-(5#:H_X_,:A/!9SZ4R:_OH^`-B-O M;6Y*8(XYXSOR4B/ADI3C,;8U)^'3VNHQ7< MILY;2TL!>PR6HNK1IC?%)*$C:YU!X+W`-<-JX(3C(["!$$,X08F(W.2RA;:+ M>P3QRWT?REK:.^8N+@/8XM9;GC2%C'%_$]S0`H!15P1PSC)YAHBJ9R1(87*) M%K<)N@^6QM;>&9\K'W4#."[@;<<3!,V2HXQQJ[?7#CFB95B`";ZI'&0+GP0_ M\NZD)1&YG!:B0-?><3$9`PAWS`CXO&7@J`GQ8A_39-[:/?MU3]R&W=K\41)- M&=NGVLL#)FIDWU],_4-/B?=6U\UMU&7R,;(U[Z2P/XG-"Q/:BY!J;L*>*Y" MN.5?\/DB,XQ&TW"E.>1LD`X(J.A&B49"+QGZOS2EF_)[>VT^6VM[RZ''>7,=T#)%9NN M$\."%#FZ-O$X@D+AF7L@0(!E+;,-G=V; M',CBMN'^+#+;AY:ULZ^>9VXT`P5PPVR`,R78V`0WN2<%HC7JI&*77[ M2/Y*WBAO-/D+9+&!PC@DMKE"+J,/(:)6O80Y2I`ZL!!SP\@`,3868ZH_XY>: MQ"9D$VA6LTM_;QON=1='!;V$Q9)!)%;N$LES.UKB'%G$`P#>-^``X(DS`W2H M!IXE(MD+1/E&J=CW:[:365M:V]O>VTK;ZWM;8>%!>QD&*?B#N[\Q%Q`@DA-F MW`_O0,(@"8JPU4G]J6XEXFG@F@LKG1([J_U&%K"^(V=G9F1KV7DL]7^.V,N' M@0-87$&I.'&!P`SR#L!U?KV43(9&C#J_@E;7+=7BNM,9:VMA<7$8EM!:M,<= MS/:ETGRUQ4CAD;4=(7!$^\^,`1F;-J1H4Y1V2WDDQ'X*5KIE]I$CM5U*$VL- ME$YT;!(Q[[JYF:88K8>&7(QW'WE0$84,4\1]W(&B!]>R4LD9^2%25&SOX;YS M]-EL[33AJ,+[2*ZM&<#VS/1T$4JJYT$DC0T[R<$,D9_RV$3(,XZ_P3E$Q&X$ MEJL4UIH6H6D[+S48G65G8\5U$Y[P^5Z`4H.G!#!DA+W,H: M$:_1$LD9!HUD5.VUN&2[X;C3[.SM[HR0ON[5G!>6[;EKHQ-XC4[P=*.-,ZD8 M<@12LNBF>8(/G?'&F6AMQ<RVB-Q:2R`PWKWL22"X2.< MUC^]2I'3B)X^0R:(>!-_U1[T`*^KHBW6LPPW7AP6%I?Q68AMFWMVQS[JY^5` MC=)QH"T\32&*M,R5Q*681DPB"(T6ZO07N^8),DT$0:`1;P.<@!INP\DQC/ML)"(9SUZ!`B9^=R'3WFG7 M>L.BU7383-%>0L$L1D8PV=S;@0R6P\1P6(<*L2@!P3QSRMEQAXD?0C1(3CC\ MDJ$?BHSSMT:&VTR2UM;ZZB:^ZNVW31)'9RW?>9:VZ?"`P<3CO."4HX0,9`,K ME]'T"!'W"9@M$_BI36<^N0VM]I\(,D3?D;RQ8]D4=FZ,<44D`>6L,,['Y!2M M=^%*$LP$\8J`Q'3P[(W#&3$_YJ+G.T*TBM;FVAN;VZF-[)9W0$MO90LXH8GM M`):;BX)*D%*89_D0V3`,R78Z)_\`*7!:(2=%+K]I$ZQMXV7>G2/CGL(2(K?Y M:Y/B1W<(?PL:[Q&<,BE3A%\\!L'FCIHQU0&Q'S&AU3M@ET&TE-];1/NM1D;' M#83'Q(!!:$R274Y9Q-,G&\!B*B]>&`>/#S@;I:>&J"?H&737V=IISK^%UO#ZA$ZSM+(&[FE;*QS_`."% M;"P,<7<4ST:IV+OPH89P._)2,:H.2,AMC4E*UUB*6X9'-96EDRZ\6W=;AC`+X0N!!G$@I\P&]XE,J8G[\=VXQ&U[Z^*9@2&3$XD*F0PIX9RENQU!J"G')$!C0A2NKZ.S9F*98V4[D,;W(!7+#E,0.P`2VAG*0@9>9R'376GW6H MO&I:?"ZYAO(F%S7OC:^UN(@(I+4\;F@QL+>XF0I@GCGD/N8PX/X(C(1&TT(^ M'33W#=,CM]/=;6M]/!$Z2X=B M8&_S.R4]K/K#+:^L8N,MB^4N;4/:UMF^!RM;`UR'P)6N4)5:G/!*)R@9(#L1 MT2BV-XR^O5)SSH]M#:S6T-S=SR/O)K>X`D@LXS_"8UA;_P"?D#5<04P'^3$1 M(!D:UT13(7!\HIXIWPR:S!!+901MN+)SK>:RB<&1-CE62.XAXRUHXB$=M]F" M0.:(,!YHT(T\4/[4-4&1[W(U$ MZ<#'%'S!Y2-CVU3W;Y>7TC5-WM8MC!;V\<-U:2_,-M8>[!/#(.!\BN^&>-U0 MIJ#A?\T6B&F*L-44QFMBE';SZ1#/<7L+1)<-%K;6DC@^*<%P?)).UA[T<8%! M\0*Y88C+$#*8J:`)N)EAHF9+^9P3V4=O!:W`X+FW;;AL,=R801)#+F00'*U: M>S`#[L3```W'?LAMM39-!9SZ>)+Z\B,8BB,<$'$UWS,TX+&PR!I.:,^(R"7B^*.3A(`WX<9 M;P8$`$A(QVG<22R:VL+NTE;=WC'6L-JUTSG,>Q[WN;W6P-X23_%+D*A$P1QR MB=\Z`(,Q(;8W*C;W[)9?"EM;:S9->&N2K@]F;MIU3WQ9]$[]2C;.7Q6MO-%&YH;+*";B5D7" MTR.=\+I#PJTFN_#.0`T`(_%+:2&=B4TVFW$TKY+9CIK><^+#,Y[>)S)N\TO! M/%Q-<4-,1.*1+QJ"F)!JT*OV5VR'5=.MV00W(M[JR@,\XXI)',GCX^$\*<#3 M1J[,.4A$[8@%D@'J5.ZBLOSC476LTUQ=,N]1?:PS1".*29LLI8CD5Y:%+1^( MC$HQ@#Y"\M'02=118-D^8W=NV!SI9S*!X;WN1_Q"83-JC>$E:4Q5#<9C;67P MZ981<]%IP0:4;QK([F9[A<.;'"^("!TK23'$)4),(D"*B$8M`Q;F!U^7U2)G MM=EE^->_=7>Z>V+=F6M-;Z2+Q M[)KJ6)WC,\:"./BM62/X3+&)^$EL/&H/[H4;,72CB$ZD@O4-3P403B9[HIF/`9&Q[@(VM_P"'$+`@>UNWPPRWD-O`V6-LKHV%SB>%(W/;5P&1V8LF(/YR1-JL%$&3>0#;HJ>J M$PW1B+A%"R&)MJ&2.;$^T+`6.:X%'&4DEQS4XCE!W-:+4\%*+$=>JNS16`Q,B!B#E)$V_P`E$$@D0K%U M4U1(39QPR&/3Q:M?92-D]XDD9.&AIC,48`:TT0X4VC")AZ"]>_?P3BQF7] M01+86\VF<6HS20VT5Z665Q&WQKETCV%T\,;'*9(`0"7;#@B(G&^4M%Z'\_DD M21-HW:H2NFP0:8/R^5\MK->)?W$C?!N6R-C;\M`]H`,4#:N!6KD7!+:,3XB3 M$FIU[?)*))GYPQ:BCIS8Y[&^;>2.9IS)('LN@7330WSCP!ML#Q.E,L)1[;]$9T=K#IE[+I=Q-<$R6\-]-+$8)[>T?Q$"%H0MBF MF`#W[AT8?E&,G$7L[W`47)F-X8:>*!I3A.-0CN).+3_DW27LKG.?\LYKOZM- M"2O]:XE#1M%,1Q5W"7_$U>W3YISHQ'J>BMP163(-0FTFXN+N\CLU2>'P)8;9 M[@VYEM@UK>.7P^T#+$Q[<8REB+R;Z#5DI&1($PT7_%4M%XYKWP`X36LEM.R_ M;)+Q1-LFL+I)23\,D;N$L(JM,0PDF>W]K5\.JE.D7'JT\5H6$.F"5[M+N[F] MU&.WGDL8KR$0PF8,I*T\#3++&PDM:DR7 M+]1M&6[GSRR2ELD,LCG-,+B?F?F024:V/B+B10XKQ&7N!JGO^+JXF9-)\M:W$(992SQASH8'7!8IBXQW2?B3%D88-[1))>@-G4)2R M;;,L*.XOCJ#7L?*[4S>$^$Y[U-V9.`Q.CX@.`.'"1D&C=B@&?N4?W'_%6$1V M5]++H)K/ET:HZ&:_G9(;QHFM884L6S/'@JA++L7-EJ#X[=^H6]E`)H8[A\8,I,O"> M!WXGAJ!I)3%V2.'=_,D8Y-0+.H1,]OD#QT67KKIH=0F@E<+:&&.*.RC@DD;# M^7MC;\J^(AP,G&U2XU)>N*\QD,A%AIT;12QUB^NOBM2[@TZ2.PFUJ[NK+4YK M")TT5K;-N'2P]YMK/[*$3(2(@'BZH M:W_5Y;&*!YCTL:?`[3'MDW. MDSRSV$U])\_=/;X-P;R)@^5MY@P,,<$<9+F;'.K@F!'$#B+P,JG5]'[(B3*? MG'F:BCIC(+G2K_\`-)I(],@N;=]O>,6:YBU"3NNM[5CN(RLEA*R#)M#A8A&6 M*7ND^T"&.K]ODG,G>!"L^G9&FBL[?1KR71;BXN@^YMH=5N)H_E[JVM4<^&-D M8#.&W?.>^X5-!EE(B/M$X22'`)-"!HH@R,P,@`I3HJ^BAES!JT5[([\G;:,F MO+@R%[[6Z9)_49;5>-;ESU:6CXF9XCA\PD)G^6SD]#HW=/)Y2#$>=Z=^JN1P MV$5AJUQH=W:UTZ20-NYK-@:T/DX0`\YM8:=,Q'$(3.$F4V MU#$#4A1D9;A[@`#Z5KHZH36[WB33I+*Y_-3+*]T45E$SB\?B*T;"WTH.N9=$O+F_U:&RNI+&*] MMOEV%P`;++;D,;XMU%`XEC5SKLQ9".)R<),LNTLX;X+*$I3H)@"#UJLC09;F M75;..V>9S,Y[+B&>5SH)+)\3A>"Z#G%K&>`"5(HX#%.`R.4"-2;]&U=69`!` MFW\=%M:=9\OG48V:=?W%Y=LDF.G6EW;B.RGNXV/-I&ZXX>)\8>`6U[Y`Q?"' M']SR2)EH"*$Z554SE`8@;=3K]%SUI<:B=3@=#)-+J;KP?P9'O)?.>!5H*8TG'QO=;<7W6:E[/T5.[-[;L+=:_1. M'@QR/#HYVR?P&01*&NC`#0RB.:F,TY9/=.YQD?\`R971$-@:L671:E:27I\!)QIR0X_N?S)&.2C@"@.M5 M5&63;Y0\=#JL;7WW$.JW45R1;B#PX[2*"61ENRQ8QAM?EG-+?$8Z.I<`I<3B MC.9C*0:`6:S:,IXR#![G7Q6K>V^FO^3FUR[NK+5IK"W?=QV=JV<.8066TUQW M"674ENT%X6J#%V2&(@'-(QR&(=@_@3T)"A&4JB`>#ZE9^O@P3VMO#)X>ELL; M8Z4Z&22..XMGM#GW$CE:'W,LQ)D_=(`Q#.\9"(IBVANXZ^+W4L3,3^YZJX^' M3YM,TF?7+FXL[M\$K;1UK"+BXN].CZ-]U>.D(O'7@:6M9.TN-$M9-:N9[:&*\N(=)N8(S M<74\/`'7,#F(YKK6*=O<6739KVX=>7CU@N77\3`((+E@X?"BC@!+!DXUSP9-L<8&(DXR:FQ?H?T M1%SD(GZFMHR6FLM[C2+XZK/+%IL%Y;FSO&+/(86E&0R'^4U3T.C=]%*=" M-GK?\-59;#80:=JT^B7ES=73(867+[B'P+FUTZ25+F:U8&#BXZ->X5:W=B>W M'&$I823-JN&(&K*+R,@,@`#_`(JCH9,\]U!(_CTUUARWMF-#F7#' M$O\`#N(ID\/]XE,5\=S(Q_\`:VU[#KXJ60L`1ZGHM"RMM-:+N;1;JYOM5AL9 MWVL5W;>!P!`R>>V`8/%NHH'$M;L-<6PCCJ<))RB)9PWB1W4)&=!D81?19>@O MGFU.VBA=\RR=LD=Y%/*\PNL7QGYHW#CQ>$QK*\2*'`8IPNS:JW)M$ M2;'1:VGVF@NO6?EU[\^/%-$I#(W`N# MZ(T+NQ3`S]P;7,W5LA'8=(LM\6/+?YGX3;ZXI>\`MC;CY'Q6R]VW-WP<7RYG M'#Q?NTQ?LXWN,)%WLU'Z/T56[+LMI?\`58%W/?MU&9TLDK-2;>N_@L>\<%TV M9(XHXEX?#!X6MHA:F*)2G[E7]U_Q5H$=M/2RW;ZTT'Y^3Y^^N+:ZDDA=>VMM M")+2.YD:QUS&VXX`YK>-2Y/A4XNG'![C3)$GJ!;NJXRR;6@'&A[+&UF6XCU* M[;Q6UOXS?$?&>&:5&$,GDC`+VA/MQ;..*ARDB9`=OBZ@ M)38[0\75'6^.&[AA:[PK*.U@_+?"E2.2T?$UWC*TLXY)I%=)M!0;!BO,=IV? ML8-X=4\;$/>6OBK4L=A)9Z=-K%U<6UV^V<(S;Q>/)<63'D6DUTUS'<+^$D`Y MN&+#L,8^Z2)MI5QHZB"=Q]L.'^A5;54@CTZ.UD%GC7 M$]L#Q2->QS7'Y>*;X7;<2&TXP1AAN(T:#;Q%@#2VV>2I/[V"6V.)\1<&53KX>"B"3/SANB' MIK63VFHLNY'-TV-L$KKA?%E@O@\-A^7#^(R22L/"YH_"F%C:49;_`/CZ]#V4 MI%I#9ZOT1O#M(K"_ETJXFNY.&)ET^:,V\UM8N*R.@:P-+FO>`'NW##:`Q2.( MDFC]@HO+<-]!^JJZ4!,^[BE>76'RDK[YSY'$0LC`=!,PDN_C-E^$!%KB./S$ M@^AJ]N_BI9*,1ZGHKEO%9LBO)=+NIKJ^BM)'Q-GB$;HHB@N)H&AH$EPV(D`9 MA:8E$08G$29MK^G=1)D6W!HNL_2C)+>QQ,<)HY(Y&7,MHK(ZQICKR>:WO)+C3GW<,$0F8)G31=XN`1KWM3B`RSQ;(0?SN)M5 M($_MK%->Z7W-VSP[>VO+RYD=%*USW>%.][(VL2/E`N8X&P3ET`SYGP`0WB^8XE\=T84NWTPAF-P`S]*M_%'MC;M3/T& M^?*X0-9);ROXHYWR-8[P9B'A[XW$2%[6OJ,R1B1P3)\OI*C'+$QYI2@08)9C&31`,12O92$'%7=/VO6MNF.EF9'*QTPXG1/+R"[PG4!VM3`<4YG?`/&54HY!$-+U!3N- M0FT]S-.MQ;RML6""26ZM_&>Z>CY?#\3A(@:YZ-&[KP2R'&=D0#M#5&O\$1`E MYNO1/<6%UJIBU.R9XK+N-HF9),V/P+B#^%)$P2HL-%8B@`IARQRR_P`R`H17 MQ"!(0&TZ)I;NXT=EOIL;()9XV_,WAN8O&8R:Y1PAM@Y."-C`.)S?B=VX#.6( M#&`"14OU.@1M&0F9<#XNGDM;K7(H;ZUCC=-$'6=Y!QMABB?$>..6WXB&-CDC MD[S05:1EA2C+/$3CZ[$:?)`;&\39)TMSH-M%:\$+KVZ>Z[GCGC;/;6T06&)L M04,=/)PDO<#3+#)EAB(TWFI?1(-E)E^T44G1W6OVT+#UQTL&.J?EQ_P#24X%UR_:ODF:T7FHR"*." M0-GMV06PXI)Y$/AR3.<\-:`5:VIP1W<>/F;?(VN&'ZJ-,LO]H2;)<\P6TMJ& M0MO;&1EY#'`P06UQ;O\`X4S9`"8V3QD\37.(4$C/`-W)B8@#<*]`?\4VCB.[ M0I16MYR_!<7]W"QMQ,T6%G`7LFAD=(1+++<>&2QT<4;#PL<02[`(3P1,Y>HT M`_BD91RG:+7*E#=W&O1W&ER,@BN'L;=61MH!;QRS6@XGV]UPN(X'L/=<[X7) MAQG+.#`L#<-3Y%!B,9$A;XLFMM.O=%$^K7\)A9:0O9;1,F9*+FYNAX$43S$2 M!;MXED)(#D`&`8IX7RY`S6[D]4S,9/)&Y4K74Y=5<_2KIMM;C4876\,UG`(' M,NFCQ8&RB,N,MM(YG`\4`!K3`,IS?RBPW!G`:O\`!!@(><.6ZI6FAW^G3-U' M4HC;VFGM?>2.MYV22O=`/X<#!$2Y@FD(!=D&K7!'!DQGW)AHQK0_@E+)"8V0 MJ2E:Z_/9;BZ@GC?(+>U/B.D@A:?%\1X8C0 MB@G+!'BY!+S4@#=,YH$-&LCV4V\V3_-B>2UM/D73ESN"`-OA:.)9QBZ4N-TV M(KQ9DTP_ZJ6YV&S\6\>J7LC:SG=^":3E#577#H(6QNLY)4CO7RL:YUM(0X3O M@)$WBB-RN;F7`X#P\NYAZ";]NJ!G@SGU=%*XYHGANG"TMK.>TM9&Q0OO(..] MN(K5(C)+=/<7MEF\,D$A64I@ER9"7D`V#J*ED1Q/%R2YZ6JFN^6]2O9W7FF1 MMN;+4.&\MYKBX9'*6W8#W1SB0MD+3(F6)N+ZT\:>6:&L[FF0M,4`E[K&U1H7=@GFEC M/MP8B(:HN=?DB./>-\B0Y>A2O-(O]<>W6M,A\:'48&2RQS7#(Y+:XA'R]Q;, M=+P&2$%BQD4#3A2Q9,P&;&'C(?0BA'\$XY(X_P"7.A">YU*YT".VT6!EK/-: M1>+?275O\RQEU><,SH+,/X."W@C("BCG$X)998`,,6)`JX>IT'9*,!E>=0#9 MJ?5-<6%]S)%:ZM8PQOE$7R-_;E[;>&WGM/@=9^*0SY:XCD!X6KPO5:XQ'0CIXH$HX9&$W:X^:>6XNN6;2WTWP[>2_N7/U&]BNHQ=V]JR4F&VB@9 M2(RO#"Z1[2BTP&4^*!C+>X:EZ@=&_5``S$RKML&H4I(;WFJS@N+:*,W^FRR6 MES:Q\-K9F"Y)D@NK8%PAAD5O#(U>)R`X&GRH"4!YHT(L*V(_5`,<,MI/E->I M2!O.5+))8X':CJTZBWFX+FS@M+%09'M:?"DN999``A5K,/S\6/F;?(VN`!^J M/+FDX):/UJG#[SFJR?;QQ0MU'2Y?FH;>W8VVLKJTN0(9>)I>8XKNWD:H<3WF MDC/`\^5#:&]R)=A0$'\'""(X2]=IH]RI0VE_RO:W.H7D3&WEZ66%E:.D9<6K MQ_Q$]S=\#O#?X36I&PD$N)PHQGQH')(>ZC7#JPXS/)B<9;=<,&!;0_ MH@Q&(B;DBQ?OT3VNEZARX+C6M0A$)MH'6]C;QS1S-O+N]6)C;KPG%K;6)H+G M!R<1`P0Q9,`.;(+!@+N3U[*,I1RM".IK30)K35;C71/HETVTMSJ,#X[.:PMA M;%MW%PW$,-PR,N\2UG\,M<,AGA0RRSDX9,-PHP:HJ'[*4H;",@/!DQ_P`[*&A" MM#5]!3KJE/)'(-D*DTJE9*N6''B98S?)2$:DCH.G=!SPE'R>HV^:G M%SC(.\80YDM[R`V/H* ML>_5!P`18$[A]$,\EZN;LVXCC=8OF07YGC,GRCCQ_,NME$_B^$5+>%>/HK@_ MH\N_;3:]WTZH_J(;?]S61)N;[B.[,EK:V4ME;2L;";JU#[^:WM@(_$ENW)*V MXF;&2J$M)KD<,\N0F\0-@.HJP[]4Q@CM8DOXT4+OE75+NY?8+ MC3YQIUA':36^E,CL6S7]K\Q<3S6S>"9Y<_A?'%XJAC?PM%,\.>>6,^W``QC1 MR'):Z4<8F-TB036A3WNB:AK4K=:TN'Q[;5(VW+VSW$<4UM<,`@N;#)F/O8@\95O8]*Z=$1RPQO"="$KK5+G0!;Z';QVMS)I\/]7)$\UO:!Y88[2!KP`E'E3ARRRX[8(L3$5X:EZ@=&_5``S2,W.VP;]4\MO?\U6L%[:QQF_L M'26%Y:->-"+#L1^J`8X9;3Z M35]?FEQ7G*EB(YHXG:CJMQXCK>=K;NRM[2S[C9',!\*6\FEDS!):P!4PGGQ8 M,6]R1L:@`?J44S2?E18-[D384!!_5.F&>XOM(O'/;W3>(QAXC>'1O<0`1@$YH/Z)D1PR$ZF)H7N/!1MM/O\`EMESK&H1-BDCA^2LK=DK)X[JZO:? MUGPG%HMH&-XG-RC.4W:TKLPH9Y9)>WD81D&H+$HE`0COBY(+U.BC:\LZI:W,=SJ M+!;6=B3=7,]M<,DF\.U#I!X$<2RA\SF`-**T'#CQLL);LE(1J2#TZ(EF@0T* MR*>'FRXDNP^YMK**SN)7LF-K;!E[!#<%T1?'=,)>Z>(2+Q)Q.(IG@'+D9^8> M0FK"M>_5!P@1H2XZV4/\GZM\T;9S(_DQ,CKT2Q%XM`[B^9^6!,OBF,*&_%Q^ MW"_I,NYCZ'OVZLE[\&_W-92DYLN&W?C06EDZRCE:&"6#COI+6(M:'/N2X$3R M1MXE3NN*;,!Y4MS@#8#TJP[]4QA#,27_``37'*VJ3W4C[%C;BRNY&SV]U<2L M9*8;PB59X9")3)'XA#U'>2F%+BY)2>%8&H+Z%'NPB&D^X?HE=:_/9SFRL8[. M>#3FQV;9KZU$US,ZU`:^1[WAKVATH(:"%:T#$IYI0.R#$1I45HF,0D-TGK6E MDUYHFH:G-^::;`;BUU-C;MOS$[(I897`,EMCXQ:9&Q/9W7`(6HF6%/!/(?=@ M'C(/4_@E')&`V2I(42NM3FT?P='MF6MQ^7PB.YFO;8SDWO;L@0CD\Y)#]$USIU]KC;?5["(3>/$VWO(I)6Q- MM;NT_AR-MS*0UUM*"'-#20TJ#7!+'//$98!W#'L1T[($XXQLE=*:XN>7X;?2 MV-@FNN]?7GS,0N8;>2[1L M&3RV]YS#!;WUI&SYJUX[&\MFN;!;-0&:"XM&O(CC$K7(]@)[P!P&,^1$3CZA M0C3Y)O#$=LK&R@3=\O6K;=[(77VH/-U+#,T7%K;VT*0Q\+>(1R7$KZEP/=:$ MPCNX\1`MOE7J`/XI>7*7T"3A=UDM;KX9&`DQ1W$)@PWBH:@*&CB\VA2BL[O0XY]0O8VL MD='\G90M>)HII;@JY]SX?=\")K5X35SL$8SP1.25[#Y]?!!D,C1'BE%>SZN+ MC3)Q!'+<1^):.MH#"QUQ;.,O@W+6+QQ2M5"2`T@849RS/B-"11NHZI2`QM.M M%&WTZZTIS]3OX_"99PE\<<4S9'S7$J11Q/,?$8X3Q*\FA%-N'''/$?"._C?:LFM+;P9([AZ&!SBQQ+H.-J.`V%P1\P]0ZIH-'N[65EU?1_+VMF'74SX)F22D6_>9'%X;B\.DH@5 M<(89Q\TZ0%:=D')$TC"XBCN5:LY\9<%_ M>P>\2?,`(GH*U1[;>DEPH#E^_$P9,T"V9(2^Y:]KG""$EQD9$T^)XCF-1H`4 M$TRPOZ?(['T]7T0']T)@.4B M318@4J*T3V@CS:J[9Z9=7.KV%Y9QF6VO+VSN8WR2M;(U\D\7B1OXT),;P0"% M!:B8#CD3OA6)K5(3$0TKA4@Z4\Q3B!P>\ZC>MG$CG&/Y9TTINOF`22V-K%)) MR(4X?R[QA(%[V9M/&&=*=&+_P#XWN:W^3J' M\W;I;YK'OI+LZC<.F<\:@+H@-8YP<)2](?!:"!PIP\%$(3IQ1,S]TOZW4QMV MTLMJ^&B"\D.H?.B\2$7XLT-H+GA9\P&J`Y6DGQ.'(JE<7S]G?_,??JUG^+JJ M/N"+0;;HZR]:DE&H3BY=X8#8_EVQ/>V$67AM^5=!4<;'1H51>(D8JS?\A>VC M=-%9#;M\MEIWOY<[Y8ZN;YFIFQMW70LN&BM)A='\5+'8OZGK\=%?G?FRT@?,L*!*CARQ',PA$0_XVIXZOW4L;N=WJ_31&@^3=H]I^Z[/Y6NVOR42^\^W=JJ.H^`S2;(Z89 M6Z6;N?YQ\I`NOS`-:Z%EX6H&L\"L1R.(Y6&('$_MN7ZOW^5DXOO._P!3?@GT MXVS](NSJIF.F-O(?DGPN6[_,',/CLM.,]Z(05E6@7?AXV.$^Z_MO3J^O^*4_ M6-C;VKT93N#9#1+DZ-XXA=>P,U=USPB\;#PK:*6$):.F"'^=UX);/9/LNS^9 M[]OD@;O<'N,[4Z=T+171R6>L_/%SM&$$+[ES2XS-OC*&V;K)SCPF[<`00>[P MYX6!C&>__A:O5]&[HR[G&S_D?\-75F,ZEK;J/2C*1< M2608H+6N+1(=C2N)@XQCG[#NU7NVK)^;'\7LC*P`;U/1:6G_E(;?'01?O MUANG7#K3\RX`>$)\VZS:SNNNV6REH(J%3%N/VO-[.XY=I9_Q;NHRWT]UO;?3 M]>RRN7))W:M:"V>V2-[9A?-N)'N@_+?"<;U]S4^&&Q`D&G?3%/',I90(VUZ- MJZLR-L+WT\=%LZ4.6_S"/\I_,'ZB&W)TD:EPML3>^$_Y5A+!Q<1(_A+146N+ M\0P>Y_)W>Y7:]GT_P54O=V^=MNK77.:9)J`U>S%JZ1^IF\:L]'8^]_\W5LQ'VR_I`72Q#E#\Z8V)]\7_F!$8)9^3?, M>*>!7%)/DOF4KN39C7_\3WOW/N_[7_@ZJ/O^WI;YKFKJ;41JT[IGS#61?D%C M7/#S>MFX86Q1*&N9Q\(9W4+$QDF[:+`YA?=C6;X7KS%,)&"!L$CFPMM6,:;$V8:0'Q^"&EI`JY=N,_(,_>EO MH7_#1ODK,6WVPUOU[K/ZA_>VA]OZ]]MU7'W&/M-L>C_%EE\S/>+Z)HT;6LW\>JGC;;_N>OBM2Y.E.L-%?S M%\^-2=8K&=/1T\FFB1WR$FH>(3_&?&O!FK<\63]KVX?U6[W6HU]NC]^GXJ(W M[C[;;7UZ]E0YA?&R'1663G1Z'\BY^G.\1S'ON#*1J!O'-+?Z\R9`X9`%1GB' M(8;!C_X-M/U?NGBJ9;O^1Z_I\E;B=IS]`TP\Q?-AHN+IFC/LRMZ^Q:6_,>.7 MD_U)MR4B_$3E3$A[9X\3R7N=K7;6^CV43N]V7M,[5>S_`,57UA]JS1=*&CF1 MNB.N;HW+Y'!MX[6`X$1ZCP*`YMHCHD(!:IV86;:,$/8?V7+]=W?Y64H.VVYJ^&B>]-C'R[(>7S<"R=J;&:W+=]W4&N\-=/ M9(6#A;8/>2A!'?0',X4]@XY_IWV;O,]^WR1$2]P>ZVYJ-9!T-\#],UH:HZ5^ MA-;;.>]G&ZY&K&0-M1ISG*U]PZ('C![H8`30X6`@XI^Y_P`%/'=HW?KV4LK[ MH[/^2O@VKJT/RQFBZT_ELWOS']4&J.OP&W<>D2.(E=9B()X/CH)3FUIW)BS^ M6,$SQMV^FY[[>S=[J'G]R/O-MT;KW5'EE_$[56W+^/1?RRY_P[?-^C=WLI9M-O_(]/U?LM33_R=L&L/Y:_,WZR MW2YC!^9!OB"UXF?/OL1%1UXRW)*;OAVXLQ^SLD>-N][;KTU;NRA+W"8C+MV; MM'^3]EC-L+VRVKH+D:JVY>]UJ-);"YUV^*9> M]U@QW/;;JZLS-L\.D,U4,%BZ[$+S"&EJ.,YC7P ME0$YH4QIP_TV_P#D;O=8[=UGT^?15R]W;_,;:]6Z+F]#FU`ZW8?(ODDU!]XU MKHYY'AKN(N-ZV[8\D-B\(/,A0HBXQX#D]^.SUOK^+_*ZMR"/ME_2W^2Z>T;R M9^=QMLG7YG^??\G\P6-T9UUQN^5#G`%_R?S/#PGJ6F-JY(S:I^#X)8Z-,U7&7D>Y[\M_J?3\&[-97XMOMC;Z671ZT M.7_G(CKOYE'K)M+1VKLTH1FU%T8&EWB<2_UKPRWQ>'NKE5<:,W]/O']3N][: M-VUF?^/54X_=V_RV]MZ/=EC5XMG:0^$&WDAX".) MSROB;>,$9`8IY1/NL?3M&UK;6HK,#&#_`+G+^*UKPZ0ZRT=_,WYDW5G:8P_^ M'*NV8NG[.R!Y.[W=NG31^[*N/N;I>TQANU\*M MV6;S*]C&Z.VS<8]!&G-=HYCD+3(_C(U!UT6H?GF7!20*@")F<5W_P#C M[?+^K]WNIXOW;O\`D>OZ?)76_EC]!TAW,9O`_P`2\;I#K`'YQ^F-U_3P/(W7.UK[>[Z/91\_N'VF=JO9U5UM\$>D:,-)=,W0727 MA?)*[AO':QQ?QF:@Y@:/$;;@>&!0M7HPLYB,4/9_X'/CN[_*R>,$SEO_`.2G M@W;]5/3C92V; M@0-LG`$M(IQ@`U7!DVCC_P`E_:W>9[OH_;HB&_W?YC;FHUN_S0]$=;NTC6&Z MLZ1VA-?:$/B=Q7;=7<](F6!>HD>;<$R@GA#`#M.(X6.&?O/[#BU]W;Y74L@( MR1V?\GZ=T=WY:S0]7=RX;WC\6S;J[KU1=LTQSGH;;PR!\JZX1LQ^(#.B8F?; M]B9X[W&Y[[>S:/=0>?N1]UM6:S_Y*GRV]CAJ[+QW'H1TYQU8N<7<#Q(/D76Q M*N=?.G"1BBCJ&*^-)]^__@V^;]&[O92S;FCL_P"1Z?'1:-E^4-L]7?RX=1.J MMTY[@-0:TRLL"]OYC)8"(A;MD"*%'=RVXLC[?MS_`*?=[NW7IJW=1/N/'W6V M/IUT?LLGE=[W:D6-O%7%)]RGH MVG<]MNO^"GF`V_[GIXK8T@:`+F4Z#^8NU@6=V=*9J;6"W-R(G)X'"JW0A:XQ MB@)IB[%[&X^SN.5CMW6?^/10E[FWSM[;AV=USV@27AUBP^2D?)=.G_BMFD<6 MOAYY.1&],9\._WHF%9/KTU?]59DV^V7LVGX,NBL6\I_G$0L M3?NN/FWBP;=\`TE]TKOE`XA7^`Z;AX-],:C^E]/DJY>[L\S;6K MU[KEHYM4.K,X'SG6OS'_`+MSW<8O_&+7L=&'AO`)%:1D&=&,@.7WG#^]N_'X M_!6^00_V,NGN1RB-9D%P+UK_`)Y@N6P^$=';<%[#.UII(;-LY(=T*E,:I_TG MO5W/NJWI?7Y.J0,YQT9F^:YW6);\:Q??-O?'J+;I!%!([A9X;FFT;:-:1Q1< M'`Z*G>4'/&;,9G++=ZW_`,F_16P;VQ;:W^:W]6&@?.KK`U&/5?`M#JS=.#39 M"[,3/':]27^*&)XO#M-*KC3D_I]SYMPRL-S6?XNJX>[M\C;-'NRQ^97RC59& MS/9';-@M_P`L;;R.;;'2_#!M'P<+@'![22[,\2C%'(W>X1+TL&:S:,K,6W;2 M[E_%:E^=*,6FNY@_,6ZN=-B,_P"7<'&8%<+%UZ):-O3;U09#/9BR7M&,3GW> M[MTZ:/W95QWN?:;8^OXMV6;S"6MDT]D#@W1_R^!VCECG-#XG$_-/F)X5O1/5_6]?CHKQ.GNTC27:_\`-BX+;@:&)5\+:6A=^)#VSBB?U[:=&0M,=`[2M0_,W2NTMMS;&W?$0;ENI MN#@8K)SB%+K0K*I0#9A8S$XI&?\`PN&ZOV^5TYON&QM_X-W19763=%OCHGS0 M:;FW9JCKL@7C;1W'X)C+"`+5\RAY7//$Y&`PR]E[AWNW\'2\V\>XW;Q5;17- M?%JHNW%VD?*-=?.XN)[)^,"Q-IQ\0-X^10T9<().S$,+&,M__&U?'1NZE,6, M?6]/U?LK9`+V2RXW[`7%@ MZ#BR'MU]I_=8L_Q=1EO;^8VWM\66/HSYW:E:BU=XDCW.$S97O=$ZU(<;HW*% M.`0J2=CDQ5AW>X-OS\-75DVVE[=EKV8T(WT8L?FG7!EF^0;=<+;1UQW_`)9I M1]VCV?3_!5S]W;YF;5E@V\M[\]"Z)TKM1-T!P.+^+Y MHR))')&YU!Q`AVP-!Q0#,S#?\C_BK#MV5]#?@MUXY=_,G`_,*+WO`<+M,\;Q M*@.J3:>-F?LQ?_\`']RKN_R?^#JO^=LT=EBWK[W\PN/'?(S4&W3@&L7KB&=K[R:U M=:6Q=--\O/XMP]ENLG`R%C>(%_``?W0<./'E&6Z9&T5-:T43E!#`'<4S.9+@ MSB2>"W-G)([Q&,@:VX%O*.$EL[7%YD;&Y5_$<`Y$MSD#:_31,XAMH?,ICE:Y M-QX+;BT%H90%=.UMW\M1R&VX.-MQX5.'-<']-)V<;7^;>'5'O!F8[TTG,ETR MX+K:&V^4A>UL$<\/%$7$`O+EL=S&VZ:).!\&W;B4N/*4G@1M-0 MYK5(91&+2>E.U$.ZUB>QF.GZ?';FWT]K;1KKVV$T\DD*"61Q>0^-KGKPMV#* MB84LQ@=D`-L:5'1$<<2-TKFJ-.'48FW#H[VZ;!)%<@&*X8W MQ&K+!QM5K@Y$7HPYX993[L&:0>I:NJ(R$/+)W!T"5UJ,VA&+1[(6\GR43?F9 M[RV;,9;RY2>8VS'$<%NSB`:1W79X4LDL+88-2[C4W9,0CD\\KE/-IMQS!';Z MM:NMHIIHW6^H175P+:(75J0SQ+-6D&"1A7A%&G#..><#+%@;$&E1T41(8B8% MV^+IYKJ?EN"WTRW%O-=2@ZC?RS1BZMVF8^';QV/&6M=&(V=Z1N;J'!.HKT3`&4F1<"P_Q3FUGYHM(;Z+Y6"_LY'V%XV606EE+"XF>VFMUXXXI M6!Y#V#//=AF,N5`3BPR1H=!V(2W##(Q+D&H3O,_*ME'$SP)]2U65T\KR/FK" M"TM%C8V/B+8Y;B21_>(JP4W8#NXL&H<,NP_,NI-M M[CE6SFO9#;7&HZA(VQM&Q/-U8Q6\7#<7$TZ!D4LQ0!K75`J-N#;+BP,RQR2+ M!JAM70XS':'V@.=#V2@NKCFFWN=,N!:P7T`;J-A+!"VVM'&(>#=17G"7-:TQ MO'#([(X(2/*B<4V$Q4:#N"F0,)$@YB:'KV3V^FW'+,5UK5VZUGN(X_DM.AM9 MS=0&ZO#P.DOG,:UK(8HA\#OC)ZL...7&B(N[K,\$,LN0^";#<*$! MJBM4Y1&)LD7+7KHI66A3Z(Z36M1DM)H-+A=`1*8R-C#^:[]%&QYAN=4G_*=4AM1:ZHQ]D^ M2QL_`N89IQ_`D:8RY\L;9@.)M%;4T7$7(L+L37LC;-96MC@C:'QF25@4CX`NW$L?#ECEOR MF.R-2Q,-[;68T^ZD=%<1VMLV.\9;70,1=%=1 MGQ'3L;("H"O(WG$8\R9GYP-A.@JQZ'J@X`(^4G6/R+9D M>]ERM\;-CR^EEX0?\T8&IP"H?7$AP)[V)C[;]:MX=61_4QV.`=S=-?%0DYWO M6WCIH;:R.GQ3M,<4MNU]Z^T@O'.\07+XF+Q9M=39A'FS$WB(['Z5;QZL M@<>.UB^[\'\%.YY+N[B\>ZQNK!EC?2,N+8WMWX=['!><,J2VLC1(^2/Q"`"5 M>@WXW&@<.:(CA$H[Y$[C6AI5&ON6 M;G6)6ZUIXAN)1PW$?#('.EA;,TEC@4(H*)B4^++,?>Q M&(C,.TBQ!U^3I1S1Q_RYN2*.`FOM:N.7GQ:!IT=K+'I<38;F?4+5MPZ>^E/S M%R^!LK@8;4.E`:!0YBF#+GEQR,&,!HBI(>IJ6?1.$!FC[LGJ="U-$]SHUQS/ M':\P6$EG;R7L/@:A!?7)M6-O;%()'V;GA[9+9\8"!O=9EFH!/!/E`&]'Q-VE2FU2QRYL1ECM&4> M4O0=01^H2$H<Z;#9P<5M;1V_% MP12W#WDE[@I;ENP$RX6,0#'+,N=0PH&[IAN1+=40C0:%.UMSSKI]'6=MJVB3 M\)XC\GIUQ87Q5H7OQP73)HZ#-[1@:7-QOY1F@?`$'\`7^J7EXT]3`CQ+C]$[ M8+KDJPEN9/D[G5=7F;:6X8[YW38+*T`FN))CPLBFNGR/`:PE6@*,B,,1EPL9 ME0Y9E@U0`*E]'[(<AR)W#("R0[:#:I&4N;C.*>T9(^8:#H7_0H(CQI"8S)X-,N> M3[:[UN\?:7-Z\,TO2X;6>T$AP0&J*U;3\DY8QA(RQ<@7>M#T[I6.@ M7/+?S',.I264[-*@,EI;V%X+ETU_#:ASR7$]UV6'CX\N*_(RF M)$!0`O4T#M8*,LHS-BB"-UW#4[=U'3^8[K6YG:)JL=JRVUB*2Q;-IUF89X+E MZ/MI28BYTL'B1H]I"`%30'"Q\@YY>QE`$)AGB&+Z6T>Z<\(QCW8/N%:EZ:J5 MARC<:;?,W4SK)OB1L9&QD;XHW3-'$[\+0A3/#Q\. M6,^YE,3CAYCM+FFE/@(.>.2.S&XE*@<4JAV7.5W>7D<&I6UD-/U![[2Z;96? MAWL4%]Q0\4-Q$\2/EC=("4"O`.TX4.=*>3;E$?;E0L&+&EQ\%$N-&,=T"=PJ M'+BBG%Y?WK;YL%W=Z>_38;@FX,%R)-0DL8"7D-LVM,@N9(8ZM!):S5;QZMJC^ECMN=S?)_#HI3<@7DU\Z.RO+!NGW, ML;K8W-T8[^.UNB)>&2VD9XAN&,D(`X@7D!<+NRO'VFFVMG^7:/&4=TR=QK0L*J=_P`IW6JW'YKI,]E'9:RQ MFHPQ:A>&"[ADNF>).V5LC9'RQ^-Q%COQ`H%%[B,1CF':18UO^.J4 M<\<<=DG,HTH'%$M1U^YY?F9H&EQVK[?2(66LT^H68GFGO7#Q[N1GB.!AMC)( MC&BA`443!DY$N,?8Q`$0#>8.YUOIT3AB&4>Y,EY%Z'1/>Z'<7*;D8S$;A4$M44+=1^24< ML<#XI.=ITK0UKW4+S4[KE**UT&R9:3W447SVJ7%U;F[@==WO#(R*P\4L`MXH MF@%[`CSTKASS2XD1QX;20'D2'#GIV;ZHC"/()R2:R_4+R62/YS3X;6,NM;6&T4, MBFE*[L-I/)DU=D?D7*:">YYSL;G3YA:6VI:8^/4;*:./Y+3Y; M:0MMKJ"[+1)%%*.(%CSF:;\1A*7-QG&=HR1\PT#6(.G@4$1X\A(.8&G4O=/# MIUSR?:7>LW3K*XOI^#2]-BMIA=VC)+D>+%$YI MF)R'RAJBMR?E8(,AR)#&`1$5+T/9E&SU*XYKBO-!O6VD%Q+#\]I=Q:6QM86W M=BTN,>H"+C:ZWFB72V_B1H]OP@5-%P\>>7(E[.1MLPS@-6XMIU3EBCB'N1=XUJ?JGL>5; MG2[C\WU6>RDLM(8_49(M-O/F+J:6U1T,36L:QT+'3IQ/KPM"',G"AQ)83[V4 MQ,8!Z%R6\.Z4N0)C9$$2E2H9"L^;+N]NFVFIP63;#4B^RNOD+00W<<=[_"XH MIHGF1[HW2!0*R-!6N"'+G.6S*(^W*A8,:]TY8(PCN@3O%:VHIP\C7D5TT7MW M8NT^VE=)<&UNB^_=:6G%*X16D;?%;/(Q@!`<2PKF@P1X.03\YC[8-6-6';J@ M\D&/E!WD4I1RA#GB]-[\PZULOR\W'$86V[!>_)EW`@O`_P`3YD0%>+,NIB/] M=/>\A'VWZ!V\>K)_T\=K`G.O70VUY8BPEF:87S7(9?,LYBUXXK M,L,AN&0O0-)!&OBH77-UU;7;X].M MK3Y"Q>RVM67EJ'WDD%E_#XIKF0E[9)7,<13N*-QQ&7,G&?\`+`]L%@XJP[]5 M(8(F.Z;N>AI52O>5;B_N/S#2KBQ;9:HV._MVZC>"WNHC>-\1[96/8Z24-D<> M%Q^(9+ASXD\A]S$8[)5#EC51CF$1LF#N%*"E$U_K]QH\PT72X[\;Y$B4JT* M>\T.?F`P:YI\UG"S4H6RW,%_="V='?0`07+;9TC"9K<\`X2.Z,@<$\$N0W(Q M$`2%02U10MU"<<@Q/CD#37\5"[U.XY;;;:%9MMI9;2+YC4+B[MOF627EZ!.X M6;9.!K+:-A`!;1YKOP3R'C`88,2`Y)#U-:=OS2$!F?))P]F_52FT^XYI@M=7 MM'6D%T&/T_48;F?Y:V\:T0Q2V)D86^')%)5C20T]*X)0ERHC-%A)F+EJCI\4 M0)C"3`OMN/\`%0GN+CE.UMM-@^5GO[OBU*^EEC%U9M8X^!;168=P,>>!A+Y& M[:8)2EQ(C'%CD-2;CLW\4"(S3,BXB*#JDZ&YYMLH[B,VEOJ6ERNM+ELC_DK" M>TN29[=\*@QQW+7M(Y?-)UL&!I<2&ARS/B`!^J=,\M=D?D748WW'-=E-; M/^5@U+3)&WENYK19V,UK<$031S\/%%%<->`6N-7`)OP#?RH&-!DB7&@8TKW3 M(&&0-XGYETF6D_*UK/J,[K6XOKLLTZQC@D^;M8F$B>ZEO*"-Y+6@,C(5:X!& M7%BX=P]*8(SER0<4F$KA@PI=_XH,1B(F'+T.OT3V^E3\OLN-9O' M6D\EK'X%C#:7'S$;KN[/@!UVZ,,$=NQH-#1ZIGA1Q2P`YI,2`P8O4]>R#,9& M@'!-WZ!0M=4FUQS]%OVV[&ZA$8[>:SM1`Z.[A'CP.F:QQ\6W)C(<#09[\$,G MO$X9MYK,&KI\D2@(?S8O3JGM-$N-,D=JNHR6LD&F1ON_"L+L3SS3L'\!O#&& MNCAXW*]RIPT-%P1P3QGW,A&V(>AJB642\D7!-*H=MK\][.VSU**V%IJ/%9SF MRMFPW$9NE9&^-[7%\@CE(5OXAB,<\I2V9&VRI05JI2Q"(W1N/T3PXL"A>Z"5KACC2B7F1M%2QK3LHG,"&` M.X_1"CYGN77`EN+>U^3DE<9610-;=-MI.)I++GB+_';$_,5"4X>-DKFLS-6XB> M1(3\H&T6ZT3&*)CYO442XY?N;F8SV,]JVUO.&Y@;=W'A7,;;EHDX'1/:'N#7 MO/"?Q!,$L$I2>!&TU#FM4O=$0TO4%;MM7EL]9L+&QCB-O8W=E9-=>6[9IGNA MFC\5_$\AT;2]QX6Y`5VX)9C`^W!ML:5"(P$ANEEIMFW9=/PEB%1+PD^'Q4!`VXGC]DR_E/[C%GL_P`63E[C#>VW5ES.F07A MU.S;:QOCO&W*E\D98&@$BZ-P\AK3%P%P?6H*;1BC&)^X-OK?_-U*9CL+^EEN MVQY9_-8_EVW8E-X[Y5\I;^5B?C=X#G-4/^6$Z. MW_:RZ.\_RP-5D^;^<=*+EGS;K<-&F.N06"[(:3QFW,P=Q)TIC1+^F]WS.[U9 MMK_PZJH>[LHWZK$UJWO!JU\+N)\ERZ?B8^&)[HW0O(^3=;/8TAL19PM8AH0F M_%&89/=.X/)_\F5F,QV!K+;U/\CCN6QZTW4)=5;:VHU-^G%C8'7(B;Q"0%%N M6Q)XAR)Z<:$\7'EWB3MQ1R!+>]X,-O1M%/$1M[O7Q6I>,TJ*VTN/ MF%NHOU1NGLXCI[FB6*S<\FPCU`RE'7+8:!*\.>0Q=,8A&(Y&[W=NG31^ZC$S M,C[;;'_S5#F&$/&ER6C#-HCK!K=)$<<>DPK MAVT_5^[IXGKN_P"1Z_I\E<#-.BT721S$+TR.==/TJ.RI=QZ89`$O#)P_U=TX M)B&8!I1<3;&,,/ZAWKM:[=^SV4?.W;YIK^*TET!IT%ER[3X]2)UB*Y!=?&YDA#;"2;@4/LF ML)#``@>5-<2R"!X_\A_;$O,]WT?LG'=[G\QG:G3O\TVBQ01:1J[]7CF9HCIK M1D4<;3'>2:OQ'PWZ>'%@#XH%\4D(6H-^%A$1AF+A^7X%XK1ERAE:BD9TQ)L1P3_IWT MW/?;V[/=1\XG'W6[-9^_Z*ERY"&LUB2^88]!;IQ;JK9(G1F:1\@_+V6H=P`W MS;@K&=@7?B'&BPF<@_D;?-WZ-W=2RFL1'_DW4_7Y,M*S9H\UEK,7+(U)NJG3 M7-X=0X'32V#7M_,8].\+B_K#X!WOYM!BV`P2A,<;=[NW7I^YN[?@H2WB<3E; M8^G71UE\JPR?FCI.`1:VUJ_X=U/,?Y;#_`)'#>*VM&'+\EU*SEX:C%KC[&];I3]4X/`9= M&,HV(MY;M MK_\`.].%E%)!=,F+IY+B&1L<=M&'MU#YQQ8`8A#QM?4=X@4.,_&AD]Z(C2;U M>S:OV9W5F4P]LOZ=/T9=)IIY+.M0MT]M^R[^;E&G27Q8[1V7I\063WM#@_P! M,&^&E51<:8?T7NCVMWN/Y7]+Z?)U7+W_`&_.UJ]>ZY2"UUK\ZCCCCN6:[^9G M^,YCVG\Q,_')*^81EAC,@+W'(L79C'&.;WP(@^_N_%_CY*TG'[9,F]MOP76W M+N1AKTANAJ)E&I-^9?$�W7(D`N'AKG>)\D;I2X;EV8VS/`]X[]S[JMZ7U^ M3JG_`.5[=&=M;_YKE=;M=5&MWXO89Y=1??.X)((I'"0R.:+-UI(T.#8S&6"* MJM0#,8R9XYO?D)C^;NT_!OT5^,P]H;?0W^;KJM:_RLS42SF`:I)K#(+(:S+I M/AML'WO@1?,%'D.=,&`>,6H"?^E&1L^\YF&[;9VK\^JHQ^^8OCV^W5 MGNRP>;+>Y.LSOGC$UM)!;/TN6VA<^T_*#"P63;<-\3PPQJAPH>-3M&,_,C,Y MR36!`VM;;HWQ=686]L`>IZ]7U=;>IMT.&'2HN:1JC]=CTBW;=#2G,#F6ZO-A M'?F8H_4&6Q`)VC/\.-&48(Q@.5O]_8'V]/VN^K*N!R&4CAV^UNU_%NRR^:K= MSY=*FM(S-H+])MQH?@Q2R,BMXR1=1SM_B?UYMPIF<:E0N6*>9$[H;*\Y7:U]NC_.R@^0Y)>PVW5[/V_55.8X8I-+T M&72&3/Y=\&Z9#&\/DNH]7\9SKTZDQ@#:-V5BRCT^'EBW_P`T-O&V9[=OFHZO M'92\M6CN76W;](CU2<:O%=-XM2_,7Q-%C)>"(/8^U,"B)*!Q"]Y46<0/%!XS M^QO.Y[[M'[-9/'N&8^\WN,&:S:MWZJ&APVD7+^JRZ^RX9H4E]:"RAB8&7[]9 M8#QS:;X@9PAMF.&4FA'4<+!&`X\SR'_IMP9K[NS]KHRRD:O1N_Z*Q< M,TN?EK5!RLV^X([^SDUV*_`?J,E@&N^6,(BXP=/BNW%T@3B52:#$I#">+,\3 M/2[UVO&>.2.W M?I;X^$Q?]VWBGEFX?!0@\32<@<4<.)]PDTQ;#O>VW^+LW=69R-H`];AO'XNM MG1!RY+)=Q\K-U2+F)VE7PTQVL&`M,OA?QV6AC?PMU%UMQAA^$5V8TX/Z8RE' MB[QR=AV[FOJW^YG95Y/>8>]M]IP[/^/9<]RE;7XY@T[Y.$P/C=(Z^DNXI([5 MFG,8YNI-O%:&NB\$N:0:\9%5QEX<,G]3$0#=7MM_<_9G5F>4?:+GP;KHNET9 MW)3M9@&C-U*+4G2W(T9^J\+])9?%DHL'.9Q"4L$A!AXN\J<7>QJPG@G.!@WC M*YV[FVO^W_#\55D'(]L[]NS5KMK_`(KCM/L];_/+:.W@N8]=&I-+I9HY`67H MGXKB2XE:"UT0/$Z2I#F+C'BAG_J(B`/O[OQ>K_JM$I8_:))'MM^'9=FY_()Y MB)C?HM..6+V@8M[;?#_JNNUP\F-U>5NM-U*;56&U& MLRZ2<QU^R.)M\0QSN,=]1-PU54[RXVY_Z(<@CD;CFIOV^G=^[OX_@LV,\@ MXP<6WVZL]VT[>"YWF^VO?SZ^=>1&X9((7Z>^TB>ZU=I3HF_EXM.`.$4;8`!P M@@<8<<9.9')_42WAW9FMM;RMV97\B&G18V:1: MMU`Z.Z)02'&SCO3+(6OU&.U+0XJCJ+1,:,XXP$1R]YY&P/M;Y._[FNJI>(Y>#BXC",VMH&@7%?+B#BQG"YXS%NNY_-N[V^2GA??/>WO.'\&HW;]59LX],@Y7L/ M\T,NQ;RZG=/T"&R:R/4V6Q8!?O/B/:FGRW2(U.(OJ*$)/&,4>)$\O=M,CL;U M-K_VO^*C+>97-1?S$RZ9HC]2MFZ=#;Q^'?.U=C"VZDL?%#`(VVH#9E4%"B$5,`@.-(\ ME_8W#:U]VK/HU_DC(9'*/:;W&+]&[_.R+=Q:9/RS?_Y79>&"/4;677X;UK7Z ME):M8?D'HSB+M/BN27$(O%4T&)3&*7$E_2;F$AO?U-I;1_Q1`Y!F'O,Y%&MW M^:J\MPQQZ?S!+JTL$;HKB74C.NG#3A(UC?G8R'$DE.`CBI7%?% M`CCR>\_].P?KN_;M[_HI9B=T!C;WG_#5^RNPLT6?1M?CY3;J`U'Y6!U['J88 MZ\FT42CYZ+3#&XD`OX3,""7-H-F+(CCRPY/Z/=[C!W9S%ZM^#]E63D&2']2V MUZ-9]'_19W*,#Q>7TEQ'X6B,TB[.O&:.6**2Q>S^%'$T-;QWCIPTPD5!!3%/ M#C+?(R_X!`[_``_B[-W5N=MH`_Y'\OC_`)76MI(T"4:C%RNW58^8'Z3=#3SK M!B0CA!O([$QO'#J+[4.#7*@&6W%^$<>6X<3<,^PMN;YMW9U5D.4$'/M]G<'9 M_D_9U@3&G!_1G,!AWC-7;NL[4_P`/Q563WQ!\C;`SM=M?\5R> ME6>K_GEFRTAN8M79J#5EG9*>"=DI-U)=2T$D(:'F3O=YJC;C'AAF]^(@",V[ M7KJ_XNKYRA[9,O0W^3?HNN8_D0\P-\-FI>(=3/AN/"="%R9CP.#&N\7\M%U4 M`?\`DXU#_P"O_J?W;MW_`&O^;/\`#*B7]3[1?;;Y_P":X^_M-8_.YXYX9Y-; M.I.;XL3).(WKIPZ!\$K@C6+PN94<+$QCR0S>^8R!.?=^+_#*^$L?M@C_`(V_ M!=7JQY/;J\S=5&HR:@V:W;JTFF\+=*?>AL8OG-!=XHC,@/BI504KC;F_H_>/ MO;CD<;MOI?7_`!5,!G]O^6VUJ/=M%SO-%M>_GVH_-Q.N'22,=:/MHY)('V,C M&BP^4+6D-C$'"UH7X@=N,O+CD]Z6^KFC6;]K=F96X3$XAMIU\=770:NW0(Y; M5G,9U.376:;:-U1^DF(1^*(_X3+HO<.*^9;!HD.1IC1F_IP0.3N.?:-VW]>[ M,ZJQ^ZQ.)MFXL_Q98_-4,CM0MY&L$NEOTZR=HCH(7OACTML:-8T!CDECFXO% M4J7%=HQ3RXGW`17'M&UK;?X]59@/E+^L$OX_%EJ7+-(ATW0V`VXBTLR..G1ZCQN!,K6+P4HVARK9(81BA_5;O=VT:XCH[_`(=E"/N&M^^4!SCD6Y98CR@ M\OZ-V5J%FG1G]SY MDS>*6I9R7-8QFN5#@B,8X\?ZA[G:UVU?L]DC*1RR&)G8/T?^*KZS%;R:)I;] M%9-)HD=W=MNV2,\2];J[@."34!'Q<7':((2B!J[QA9A$\>!P/[+E^N[O\K)X MW&20R?\`+^#=OU3Z:RUBY>N7:ZVZ&ERZG'^516PHQ.U MJ.[`=J!'AGY!\@83Q6+)%0`?&5.1PIC&>.?Z9]F[S/?M\DXF0RM.[4:W^:!H MD4;--UE^J-FCT/AMHY(VL^WMV>Z1W#)'W&[-U5/EV+AEU&2Y9X.C-TV=NLB2 M.6-LD)(^6CMVG@XKTW*&(BH*XKXX]1E3#M\WZ?-[*64V'[WI\=.JO6+=)EAU M./E]NHLU=^FS"#\R,9>^W4?.QV1BD?AN_K;KE[@T/CX`\2*>\I&>,V*.3W0(OO?7\7_563,=A>S+?MW`V^;(;UWRKIN$Z0)S([Y=Q8#XORGS"$`["%IC1'^E]SRN^ZG1_X*H^]MJS- M\US3X-2.IOB?%-^;F_(\1K7+\[XRMD9*]H:(^)'`JG!T8S[ZLGV<'%9M#'-N9(XPU%5I*[,2' M$EOVR(V`]:MX=4O?&UP^[\%5_P`W:L+HW`>P67C%XL3''2T!#!:^,6^*9'14 MXE7C]F(_U>7=N_8]NR?L0VMJUU0W]S\N#=VQ^7EN+,O#S):W#6!PV--,2EAER`,\3$&0J"6J*$CL M4HY(XGQD$L=/K51O=1U+EAMKHFGS&&6*`7FH7)C9,RZNKW^(76AF86_*0L8& MAS0.,J37"GDR<5L.,L0')ZD].P1&$,Q.20[`=&Z]U.33KSFNRM=69+:P7\7% MIM^^^F%I;WKK?^)!=6<@:6>((WELC6@`.V8>R?+@,P(&04+E@6L1^H2$QAD8 M5,;AJMXIKB:_Y1M+2PLY6"^U`R:E>WC&MN;-T32;:WL[-SV^'+X8;Q2/0.#B M!E@E/)PX#'`_S)5)%1T`'AJB(CR)&/C9X4!I)_0)&8SR$`#L%2]"4/3[_4>:V7NA:C.)99+7]8N#=VNL0/M8W0V M\4WO$MVL=)#')%_%:>[P%=F%BSY>3+^GS%XS#4N#<&FG7LI9,4,0 M]W&&,2_CUNCV'*=WI,S]8U.;3[VVT:"74C;:9>FYN;B:U'%`PM8&.B@;,0Z1 MYR:T@YG!CX17R7MYI\^G6DTLL\=E=<>I3VUH'3>%%9L: MTLN)Q&&D!RL).X8LQ_;L@R?S#$XP:L?,0-`.I;Y*,N5$P8`B1&HI]519S[KC MKUMP^2-^FR70<[3&00N<^RD=P?)LN.%LYF$)1KE!\0;J8K'/Y'N;B?Y3^EM. MCWM^*E_2XMK#UM?NKTOEW>.U(VUO?:='ILEPP1B>[#-3AM)BV0QOLBUSC=Q0 MOX0TGO."E%Q,_;9G+MC*(QDZGS,>W5M%`PL[35FPZC%:ZI=_+7UJ^^:)9( M'PN;(^5L=P\\!57M(%3B>3@SRS]S$8QQS`D!*3$/5F/>W51AR8PCLD"91+4% M"R#JG,NKZ%=NT#1IY+*PT6-FFL^:M8IKFXN(FAT]Z_QXW%@GE>K&CN"-$`5, M0SQ@.W'#RU`#'F'NY`\I5O;L$>_Y3C3Y6WE0VQWAR)%JBA(> MX-_P1'-'`^$@G::,'IW[C5"U/5]4Y1-KRYI,[[<65LR>_NY+>.5E_?:@/F)) MK7QVD"RB!#(RT#B(Z,>/'R"`I>15*8,L\O`A'%B/\R7FE*A! MT`'AJ>J<8PY4C/(/(*`6/4OXZ*0M=0Y[TN.^?/!%J^CW+M/N;N]E%GI]]97+ M3'%R;6/MR#T MJ013Z%*9FH\A:9'\O<6YUC7KEQDO[<-N]/@L--1K;.&24&&:[GEF5YX58R@0 MUP$9?MV$;"/>R&XJ!$:#1R:GH$`PY4_,#[<18T+G]%&V?J//FG75K>3PG5=$ MFCO;2^G++2P=:7K_``;BRO'1L$,,[3&'PO0EP!!VG#A++]QQRA,CWL9<2-`Q MH0=`=0?%*6SB3$H_\QN+"07=EI\# MENKJ6X>6B)]U-X8;$Q[2B<5W[C;_`#NH.:V-L<%O&>ZURM>\C*APX<:?"C+E M3,3*(:.TNQE1Y-H!]2E+-'DD8(@B)NX:@JP4-)UW5>:I9N6M:N3=P:O:OCMY MHK:*)UC?6C?FK:\D^7$?B6O'$DS7`M`(-*JL'(S<[HS%"P#2%02VG7M M52RXL>"/O8PQB>MP:$5_!$T[E2\T&2;7]2GT^_@T.TEU**RTJ^=<37%Y$UK; M4S<$37PV43G\/\`,`8HI[9T+8Y'.M9" M"BGB8'*"<1P\W/FR>SR"98LGE(`#UU#=#7N%*?&QXX')B`&2-0YZ*S9>7][: M7XFU&\L+K3M/?->7$.F71DU.\BL`^=D,-HQ@?'+<.B:'(Y8U-53$\?VW)CR[ MLLH2QPW@#G6=R[PC:03M8R9TS(I$85#G.`7/%T_4;F_Z?\`4VG51_K8>WN8[FZ4?QZ*E<^8.OPZA*ZQD^5TVUN`RWTN MXMXC,RTLR(C;7,LC'3MFECC_`(AXBYKG%#08JE]RY$] M\,DC@Q3Q/``4G%N3[9/)DWXI1CCFQ`E("0W58@UIIU48\N,([9B1G&E`X+=" MJVKJLZARO>\R.M^8].EL; M&/6K6*]N;35KQUK)#>!8+IUMXD3G2V%PZ$/B)(<'Y*,,\<+X9N3$LX#TT?OV0M6UK5N4'VW+.C7#K6/3;6-U[<26T, MGYA?WK1=3W4`N!)PV4?'PQ<*!R.)7"S9\W"(XF$ML%2S[B:DA].G6Z>+%CY` M]_(*R-.P%-->JG6#G1O: MZ.>(I(UJ-9(T@;<.>#)SH1Y(,8Y#Y9;BP)CK%^HN-"E'+'CR.$@F-PP>^A\- M.RA?WNJ74P,W&QT%K##WY&@%[R* MC(QR9,WV^$<&(M.0W2-P7L!V`%QJI0C'E2.7(/**`6(ZD]S^2<6%_P`]Z7;Z MF9K:/6-*G?I-[=7TPM+"_M9`;JV?"Z-ABCO+8OX9&-;WFN!)R&'MR?<<(RO$ M/#@L;=T@\&:ZDDD+I'<(#\XT*X;/:W]PEK8RV6H_PIK*Y=$WP8 M;F.2$/B/"KVA-YPXG)]QPD3(][&7!+`,:$'1WMUJF=G$F-H/MR%KEQKX)ODK M[D32[C4Q/:2ZOJMPS2K.ZLIOG+&PMHF?,W+Y7.8V"6]G,'MY M.!A.9PZB]K&L9'!&$8URM>]P!V84<.3@PERI&)F*1VEP"=9>`MU*)9(:WW'+6L7!NH]3M'_*W#+:*'Y"_LA\W;WX.GCT1-/Y8O.73<BVLE[;VNE7GS4DMZ4@M77/AM:Z&RA=(7R.!R;M"XEBXD^,_)R&,AC#@ M1+UL':P#N43SQS$88B0,BSD-37YH&E.TM88[B) MUT.&&[B="QCW&UD#2YI5IC#E!3$Q#=#^"6.E-GOI[;3+LSZC=C3VNE;!%;M8U['22L:' M(5:%VXECX$\>3W,LHRQPBN7O(=Y=W[I+"[L+73]0?%=01:C=>'J%I%?ALSH);1P MXW2P/D<&@N5Z!2I.)R^WRG-\4HC'*HW%I`&K$=1^*4.5':T@3D%V%**IJ?-> MKZ7?3Z7I$[K/3M(,>FVUO2/N3K.5:'\E9U#E>ZUN2+7=.EL+.#6K:+4'VFIWC MK:>"ZE5MSX0D:YTUG)*WCC?0%KD"`#$LO$EG(Y&,QC&8W-*3$'7Y/9*&<8Q[ M<@28EG`^*H.J:UJG+,T?+FD7!LX-*MV17$DL$*D^ MPON]E%G:7\;4N+::V,:EK$C[RZOH2VZL MFVUHXP6]I:.>WPI95/'*X-#FJ!DF"X9P7MREK97%E?_`!6LTC/X45W#-&'-[H+F4KGA M-/G8CN(]Z!N:`@Z>(/U""8\:=`?;ETJ7'Z).MK[DZP==LEMY=4U6Y%G#=6D@ MNK*RM+5OS$P>\L$;[RY>4#7`\+`3@VY.%BW`CW9E@14`"O@Y3>.>3$':`]:% M[*%I<7_.%K>Z;>SM=>V89JFGWKXVV]I%PGY>YMKUS.&.*.9C^)CR%X@>K"A/ M)S(2Q3/GCY@;#H0?'1.48X)"<1Y30BY^2G%IEWRI9WFM32V]Q>$,TVP.GSB[ MM[1]XIGN[YP8T=R.-(VNHYYKLPQBGQ8',6,[!BX#ZG]`D9QSD1#@7+T^2#8: MGJ/,WCZ%J4YF-W;OGL[ED,<3;.]LAX\4MWX30U]I*%8\N!#2017"Q9A%:]CJG.$,+98:&NKO^J+::%=Z`VYUZ[EL[LZ9;NDM8--NA=.-Y.MO# M+=%@:Z*S@=(7/.3LL*&"6`G//:=HH`7K8/V"4LHRMCBX,CJ/G3NJVGZYJ6L7 M#=&U::2[M-6C?8D6\$;9H)G@O@NX_!8TO;#(T%X/=X%)RP8\^3/+V\I,H3I: MQT-/Q[*<\<(#?"A%?\$6SY7NK&?Y^_FL;FVTQDNH/@TZ\$]Y=/LP9(XXXFM: MZ)KI0"]WX6K@AQ90EOR&)C&K`N2WQ51EF$ALB"":5%%6MN;-6GNHV7\OS5C> MR&"YM((&12.@O28N"VEC:V;Q8Q)W*J4KA#E992;)6!H0.AZ>&BE+#`1<>H?I MU5B/DJ[;>B">[LGV,4SQ((+EK]0EM82Z0QLM6M#A=2QM#2W8XG#'#F)[21L! MT-6';JH'D#:X!W-TH_BJC^<-7%T;ALC&V3)E%@Z.-1:-/!\L^8@RB41!"Y5# M\0/+RF;_`+'MVZ?&JD,$=M?4U^ZLS\G7,EXYEI0P7*2> M#-:R#C=<0MD(`7OH#MQ(\,F?E($#U-0#VZH&>(B'!W?A]56O.8]1M;J6UT^4 MVEAI[_E+>VN(62R".S`B=\S)(WQ&OE=&KJ@M!IB$^1D@3''2$:`>'5$<4)1> M52:_5:=MH$]]JVG:E9R6EO!J5S87[K>_NS#<02SSL,S.`ASY(O$!:I9+=CK7P-2OYKJ>>!\=O#9123 M.O3<<;6M=&(`06JI)&W%.",QE!%&N39M7^2GE,?;)->C==%>TR[Y:=J<7Y=I M]S97DLDS-.O+NX\2Q@N9V/9:R26W&K(W2.`%$87#%^*?&]P#'$B;EB31]**N M</*R0!EVV4.DDFE+.$Q#O.>50L7 M?BC'#+[H$01EW7[^*ME*&RK;6^*+I_S'E`:QXSM/N7.&HASM0;9"UD3VEKF*[NM3=C+DAE]TB0)R[K]]&/Y*^)CL M!%(LNEU2]Y7;J4@U73KJ_P!0A^7CU2]L;H0V4]Y%$QMV]L!D)>QKVD.IWRTC MIQJRSXON?S8F647(-"1>BHA'-L_ED".@-_JL3F2"\EU>[FFC==QW(BN+&>U@ MDDMY--E8WY(6W"'B)C(^ZBJ'@XS\F.268R-7L19M&^2MQ2C[8`H?UU6YJ4^B MP_(VW,=A>:EK5OIMK%?3V5V+9K"CI(+6X_B)-=P0/:)'!54=FC)+#';'D1,L MXB'(+-T!ZD"ZJ$E M:):\R65W?W[;6:6UAM;AUI<6.F3R@V<%[(Z1OB.=P%S&HK&T*;;2<4,6.'*B M99&HQ8B)L_Z=`JP,DIREA($7JX>NK*ES"P7UGH5QI5O)^0LM9[:VLV1R2RV% M]%+Q7\-YPM>77,JM>'E.-GMQ5R1NA"6,?R&8#4%Z@]^_13PD[I"?_)=]&T96 M[:33[+ERQBYDLKF\BGO[FXT2RAD=:7EM:<`CO+A\A&! M&R.^%SNZJJLL6R&"1Y`)PF0VBQW"Y'0`71D0W=[/`^/@LKADC72.ELX)F]]HJUU33-R..?%(XD2(B0 M,@:DC0^`-QU2CNCF!S$$[2Q:CZ_-D'EUC+'3]?N-8MY#H#X+:UN+-['P37NI MOF$EBRQ+VQF.Y@`<]\@^%A&(\7R8\AS#_P",0`1J9:-T(N_12S/*<1C_`.5[ M]!J_57XYM)O='UZTY5T^[T^^?;6\M[%=3F\N[_2(97&]AL)/%/`Z,O:Z1F;V M4K1)@XK%7#&RO76E7<=A-?7HNQ-&T"2ZM M+1WC_P`"]GMFN\-Z;#EMT8Y\:8G#B0E#DF!8DN_4#H2'94SCFB8G-(2Q"0<` M-X$]@5@*NY!B<1C>1H&N^BZ/1-1Y1?J<;=#TJ\TO5[ MEES#HU_J-VVXL;:^GAE;9\5N9W!GBN/`PUX'.`KGC5Q\O$.4##"4,Q<1,I.! M(BE/RZ%49(?^IB(`C,)7.A%R3TZ]EHRRQ^V3)C!K#7P781: MMR$>86W#-)O(Y7:JXPZG+3N$ M)"6_U/Y7>^WH]66P-B9>2QV)E62%DK"'!#XA:0?>A*>0$;I1+1)#.0.C_`%67'#D^T/;D!!J`BK:57+J2\P:E M)=PR7[[F5LUI9#*>3(S\Q)< M$`L0?2W9F8*_!*`PC;1KOH=774:U>AZD"A5&..>0)P M2$<6XL"'^?@]@L+G&&XN]4M[V*)UUI%UI=C+H9MK61UO!I3(^`6O`R)PAGM9 MP\2M)4.*T!`QFY\92RC)&N`P&QA019F\07?O57<<@8S$TR"1=^O7P.BV+JXT M*RTOE^RYNTV\U/6(=-<^-EE<.L[C3]*FE)TVRU!Y?#XD[8@H:>]&U`153?.> M"&/%CYL)3SB&A8B)](EW:O8,J(C-*0CB?4.YU([+.YJC_,+?E^\TBUE? MR[^7.M=,M8X))I-.NH)B-1M[[A:]QO7R!KC(3_$8%"H2:N=_,ABGA!_I=C1% MS$@^8'N]7U#*WCG:9QR'^=NJ>O0CLWXJ]!+I-ARQI%OS?I]SJ+I;R^NM"L[> M5UG?V6EDL9++-*YT);:W=TIBB.8'$%&5D3AQ\.`YL3-Y$P`+2$;$DM8FP^:@ M1DGGD>.1&@$C<$]NX&JK
!J/+VBR/YB]> MPRF=EQ;.2%^302*%`(\G;FXN.7%!'&$B#&Y$^LCJXL?$)X1*&:8S%\I`(-@1 MVZ,;J>D&ST[E:Y;S397%SI5YK$9T;2V.=:ZA\[;PN;J-[;R/,3K>R9&YK'C) MTE*;98#BQ\,_U<3+#*?DB[2<#S$=`S`]2C)NGF'L$#((^8W#:#N7^BGJ+]/U M'E6:/E.RNK2QM-7BFU_3)I3>:A-XL#6:=?.>V5[I=/CE!86`%)$)%"2LIQY. M$1PHF..,WG$EY%QY2_2X;0^*("<>2_((,C%HFP'4>)_1`Y;$>G:/S#/S!:S. MY=ML^_O!=27=K$Z.34+'3W>+(Z"^GM0XL(' M>X3EB_%DXTX9,?!A*'),"VXNXO(1Z$CZU"JG'-&49\F0EA$M`S'0GL_\5@\E MVM_:Z[#>,C=I]A:6MU/K5Q>VLC+0:.V(F[BG;*(_&=<=UD;07'Q$*$`XR_;A MDCR1(>7%&),R138WF!ZO8=V5W*E'V=M3,D"+7W:?2Y[+H]`O^4)K\P\MZ5>Z M/KES:7]OHE_JUY\S:0WTMO*V%@C,DH@GF:"QCD/"XI5:[.-DX1R[>)`X^401 M"4I.!(BG@38'0JC+'DB#Y91EB!!D(AB1JN0Y;TW6V\Q:6;.WN;._AO1)+=W< M$S(K=D)<;^2\D>(VNA;!X@D'$"]4%2,8.)BS_P!5#VWCE$KD%@UR>P#NM&>> M+V);JP:PN>C=^B[*QU;R]/,44MGH]Y;7$FIR_)ZKU[00/#!!HE.ACS?:SRA*&.49&=)$^4$FA,>CL6T"SSQ\SV6,HEHU`%6Z M/U[KAI-)YA/,#H76MX=>.K%OS0AE0ZF;H/;=-N3"V(0F0B4.^$15RQS?9Y7] M5L\W]3OO_N>[^-7Z+7OQ>SNI[6VW9K?HNYU/5?+XW<6H0C4-4M M9G1Z5/>0.C9>74>GB99;47$;BX!KO$`)JM>EFS?;/ZH^]CE*8EYI1/E)%R(] M'?Q62&/F>RV.0$6H"*@:`GJWT7'6\][=7%V)8;JTMI9(;FWN M`PZ:ZRDCC>!%\N8VL`)0CAJ0<8.;CS_U4S/S3,G<"A!])'9F9:>.<8PQV4B! M8WI=^[KK=?ON4X;Z*WYDTF\U;F"UL+&WUR^TNZ^3@EO8[8"2)S6RPBYNH8W! MLCQ\1"41!MY.3AQR"'+A+)R(Q`F8R8$M;N18G4K-@Q\@@G#(1PDDQ!#EG_(W M9<_SM;W5UK(OF1/O-+N].LI=#EM+:1UM'H_@<-O;-8QC_`DMI.(2-*.#RJ`$ M8S?<(SEG]P#=BE$&#"FQJ#LU0>ZNXI`Q,:9!([G_`-3U/ST[+[N0YT,>QH78@N$L&/B8X@92P;L>6</A-S`98I9/)$%I.!YC6T;#N?!&09)\C^00)"/F)J*V'CKX):JZR MU+E4,Y4LKFUTZRU@/UW2Y9'76HNEGMVMTR^E>R21T]@C',#:\$@R0+AYSBR\ M+_X<2,4^'(_GD&9CY384N/&Q0.7!%IVA:]-S#:3/ MY.2RNM:L[J M<7E_J&D1O]_@VMPYKI8]K"N10VF6')Q,D.#$PD"#,$O*4>Q&@+./F MJA'+'/$\@B0J(D!@#W'?0K.Y1B?9-UV\U*WEBY=9I,EOK%O-"^$ZA).[@T^S ML@YT1_,3<$ECQ_W86H4'%7!!@,F3*".+L:0L[^D#_<]1T"NY!^L(I&2:E9:=('RF*[DMU<`` MKP*"BB['+C9,63'P82AR##4N3$5D(]"WU#A53&:$HRY$A+"):!F.A/9UA\F6 M]U:ZS\XZ,VFF6MC>S:W+>6DK;632#$?F+=['M9XTET[A$302>,*A`.,_`C.. M??Z<0B3-Q3:U1\[#NK>28G'LO,D,QUT/RN>RZ#0KWE6:\EMN6M*O=(Y@NK"] MM]%O=3NQ=V[+R2!X9#&TRRBUNIXFEL;R.ZZE50Z>/EX8-+?9P36=S;W1FGNKNVE;!;6 MMNUYU%]Z^2-C71-MN,/!()<>$%2,8>'CS#EP,08S!=R*`#U/V9W^BTYI0.$[ MBX(TU)LRZW3-4Y#.O0/L-(O+*[EO9FZ=J5W<.?I<%Y.9&6=U)IWB!T=L9W@M M"-\-1DE-^+-]N]\'%"49F7ED3Y0="8]'^BS3Q\KVFG(&.VH`JVH?JRXJ+3-? M&NMA9;W0UX:KPFX=%*!\^+DO?<.N3"6&$O)D<[X3%7+'-&+DCDB,1(W\&Z?@NVO-6Y!',$LL^D7=Q.W4XW7>J6UTZ/2I;J.6,7 M%ZVP;,"^U%PTO(`/&`34&O1GF^W#DF4X2E+?60+1)U.WH]666./EC&-L@(M0 M$5;H_71<;K]AK)Y@U$7D%Q=ZA->&2.YMH)3'<-G+#82V$9(_&?`.XYR#BYOM[VYUN:Z>QUY9WEO;7&D3VEO+);'2 M'1-^3AMVL$G@NMVJV1M/XBE*C&7G1G+D&9K$@&)`IM:@'1K'NZOXYC'$PI(& MK]=?JMS4KG0K6#2+3FG3KW5->M=)MV7,EA>_*R6EN]SI+"ROGF1IFO8;9P+W M)11GC1FEQX0A#EQE/D"`=BS#0'J0/I94P&61E+#(1Q&1N'?J1V=9'-C)+R72 M;RRA?+H$FD6\6BQ01OE%E'`K;NRNFQF4"_AN0?%=^*E2AQ3S`9F$\8?CF`VM M5FN#W!OUNKVN#:7EAH M\TL8MV7CW3!SV7$C'.A9^%@V)BW=AQ\?''EQ,IU,0"Q$7H_B:A0VY)Y)'`1$ M4=PX);3]52YB$=_I6@SZ+;RC0(67=HRP:'7%S8ZL)1)=?/&,RF2>YA+7QR)5 MBY+BODMDPXYX`?Z8.&N1)ZOU)N#T4L(,)R&0CW27?J.R)8/LK#EJ&/F:RN+N MSN=4EFT*QAE=:7$BA+-0O!(Z1ABL))'AH80.*12F1#@<<.*/ZH$Q,GA$4(Z ME^AZ:E1F)2S/@($A'S&X[#Q4=5=9W_+EO_ERSFM=,M-3E&KZ<]SKF]%]<1#Y M&\N7L\0SVKXVN8S]UX2NQ9C#)QGXP(Q"1W"YAB"PT'59-=MIY=%NKRTAM-/:U]O>7.K1)))/9RN\(PQV]L$E<:.H.@F`1A@ MF7=2@Y8LKFQ\*ZL[C6[2XD-U M>W>GM6.WDBD;XADM;:Z(,D8R5RUU"U?$^"2_NII@=/M[/B;&1>,?Q.XPO M`S/,'%?&!QQR2RC^1M8CJ2:`=]7T4LSDQCC_`.1Z=NK_`,%>@FTBZTW6[3EF MPO-/U.6Q9)*R[G-Y-?:;#('7UM8/:^0QS^&02T5>RG5;&6&>*<.-$QRF.I)/<2N:(@"O%6J)BCB`PR&9IBC$[G%X]/$FW=6YR#%KR)IX]5K:5< M:%+)F:W0Z9<7]W\S&93'QOMX09$M[J:%KFQO-%IMK=BGQY$C MC1E'.8D`DO\`+Q.A5^:[N+J&2." M*QAC<;XW/B,:U\8@XFEJU<1C/Q8Y!GB8T(N38#5_DK2MD;:3/L_$_AQNE<`T(C"1N7&G%EXGO#VH MF,R2Q)<`FQ;X953AG,?.08T<`57+6FGZN-6@AA@N(]7&H`>-)&\!ETR7BFEE MG(:UT5'.<5(+5V8QPQYO>``(S;OQ[E7&4/;<^AO\EU$NH\G#6#._3;I[VZ@' M/OV7+1IIN!.C[P6?B`FV$XXRW:T+5<:CEX?O/M+[KOY7ZMT=4[,WMMNHUFKX M.N7U.SU7\XO&W,$\^I.OG$3P1R.9-+(];:2VF:'-;$\.;X=>Z$&S&7+CR^\1 M)SEW7_)OT5$0.,$>EETFJ7O+C-0>-5TZYU"^@^7CU.]L;@0VDUW#&QMPYEN M9$EX'#AZ?-8S6T,DMN[3GOA^2\`-:\,8V,<):GQ@XHY`FCD5$!5<6XN M1ER9!CRO+'*A'CT\%')BA&.Z`:0J*H=GRK:0WX,^L:?J4-BZ>XDT^QD,FH78 ML0^46X87(7N=&/$2HJ!B4.+`3>4XRC%RPN6T499I&-(D$ZFU=53@YSUN2\CF MN)3<6,LP\;3&0Q%LMM.X,=:1%K!,7ADB,*J7"I0IBN/-S>YYR^,FL>QT4C@Q MB-*2ZK1/)EI^:?)C7-.;;&\$8T]TA&K>`3XOR/A%];T1=P`GIZ,6?T6/W=F^ M.U[?N;IXJ(Y!,'VEVOIX^"S[GG+6X[V1]I-\I8VUQP6^EO@A`BMK5WA,MIGO MC=*'/CC1]5!)`3$)<[D"9,"T`?3T`T4AQ\9C6I.O?JM"_P"5;2YOA+!K&FZ1 M%J`MKN/2]1E,6HV7SX;(^$PER!)'GPU15`IGBV7%A/)NC.,!)CME MT#B:4MI8$?DHZMK&IRT[7IM1T[1 M;ZYCEL;XZB]L,.ISZ>61-OK-.'B'AN#9$HTA!EB4L<>5CCR)SCCD:'=:1&H_ M51$SAD<0B91%0VCZ%-J-_>P MVEM&Q%`!+DZ<+-DGP80P897&XR%1)[-V"<(QSR.3*-6`U#=5)T'^<-)MM3U# M4;+3=3TRZDTJ;4]0$"]M`XJQH`0J/,Q@#*!JPN#K\BE%/9FVT\^ M#'IUHY[7L<]KWETBU:3TT^H3D?Z?(/;!,9:"[C5(P?Y-TB;4M-U&SU+5=4O&:7#J MVG\$UGI=O`QMW<0<;Q(PWMV0.ZX'NA1E4;^AP'+BE&669VB0J(BY'B?R2+\C M((3!$(AV-R?X!/IVH7O.=GJFD:[>,\2SMVZQ8:Q-%%!;Z6^W<(+F.]=%P,^5 MNHI4!<"05S0(\>3)SH2P\B7I&X2-!%J%VT/YISC#CRCDQ"AH0+E^G@IVVG1< MJ6&JH0MAT[3WZ:X36^D3:@3%)?WO$Y_`?#:61J"TN*'.CCC'$QR MY,)QR9`PCMJ(D_N/RH%$Y/ZB0PRB8P-2^K:#\T/1=:U3FF6ZY!LV,`2!'S!HWCT1M,T.ST(7G,)U;2N8I-%L7WMII^D2.G++IY;#!> M70:X/%C:.D+W.2F91$,L/'AQMW)WPRRQQ<1B7K8$]@[J.3+/,V+;*`E)B3TN M1XFRKZ)S5K6LZC!HFO3RZQIFMAVF7%O#:VS9HWW0/A7L+K>.)Y=:2CC)7A#` M2B@8CQ^9GSY1Q^093Q9/*0`'K8A@+&O@I9L&+'C.7$!&<:CY:?-6]+Y.T^RO M_F[C7M*UZ+2&7>H.TG2Y#+J5^=-:Z5L(B\54\9C3(*Y<-5468N!CAD]S)DAD MC`&6V)>4MM6_BH9.3*4=HA*)DP*V@6 M>UOG>"ZT@='$+B1\;)4C[W$X@*2N*<7W+E2RCW"9XI%C&E0:,*/X*R?$PB'D M&V8%)="-2M6/R_L/SMMB[F/2I+9NH.C=I4SO$)"37T\7Z:K+N/,3F-FH27, M$[+?3H;LF+1GVT#&,LH'^$S3Y)7,=.'NA9PO(/$'DH@08IE]UY8R[HEL0E2& M@`M'K;\5,/2-0D$.K6(U$12? M)F$%!*TRD1-(4J`=^+\GV[%+.\,N/'&1!$9'S1W59NM:*$.7,0K"4C%PXL6U M5+6><]=TS5+G3-$GDTC2M'D9IMII]Q;6[WM98-;$Y]R^9LLH-P]A(''LE/86>/:P\1JA:_S#JO*UTSEGEZYDTRQT:V@@D> M^WMY9=1O)V"ZN-1>9XY`(YW2_P`/A1I"GQU[I0R2XTI8!&4 MX1--N@-=I[_HA:OJU_R3#IG+W+UZV+CLV:QJ&KQPV\S-9N-17PY;02,?&;*" M&(-8\5)"'(JL^?)]OC#C<63>7?*0M,RL1_M`H.[J6/'#E3EES!Z[0#H!U[FZ M*^T'.^BV&MZEJMAHVJV-Q-HEYJ6II;6>L1QM^:M70ECFM-Y:L<0]K0!F:``8 M9A_]CQX\C+..//$F!E*@GJ&[BQ^20G_2Y3BC$RQD;@!4QT+]CI\U"^N;CD/2 M=.M-!OX)[[7I)]0O>8+1D-Q9W%O9O=;6^GV#I62QRM@+RZ4E'-)_G462<_MN M"&/C3!R9'E*<:Q(%!&+]*D^*4(QY624LT6A"@B;UJ2?&P3V[I^>]#GEUK4;6 MQU+EZ^B9'K^HM9::?<6.J-3AQ,ON7',N1,1S8I# MSRI$B7[3W!#BG5,[>)E;%%X3!\L:EQJWX%/+&[D30S>Z1J5KJ>JZW?.L(]=T MUK+G3]-L[%K;B6S:Z03,-_=R/JUP^$%/A7#(/VSC>Y@G&>;)+;OC6,1&IC7] MTOR"0/\`5YMN2)CB@'VFA).O@+*.FW][SWINJZ3KU]&RYTQD>M6&OW,4=M9: MK"03Q`Y\(&%ARY/N>&>'E2\T0)QF:"-6(DVAT[HR0 MAQ,DR-!IT7).EZIS!8ZKI^O:FY\&C6%WI(^9M=#??!S[B M^ON)SVME?$P,B#FEO$0"O$1AQPC[?@GRL17ME+>6.H"VMXF:'>Z8#.R_N/`9`W MY21I+9"XYD`)Q'"X_(S?<-W#Y4C*,HDB5/(8UW%OVLX*,V+'Q6SX0`06(_U` MT8=[,C:9H5KRS#J7-$>KZ3S)<:)8&>RLM&>ZX%M?7;Q:V^I7S0\$65F'. M7^:M;YAU%O+?,-S-K&EZ[%+ILD,5M:Q7%K-(SQH-0@\"!B_)R1AQXCPM8KDI MB/&YO(Y>;^DYNU2?F#2.88]$M[S5CI&C3&6^O'ZI[)9.7.4!",)P,R!ND&`?]>BS=+Y^YBOM4M;;6)_S M72M4N&V-[I$=K;L\:WU)WRYAM'1QNG=)")_X32XE_"A-5Q3A^ZS!^D6\ MX=K5S!9E\SM/\($#YSPX>"0`!`"17%T/M.&/*]LYL+B42=%,4?_<&7(V1S M8X0D0T9'SQ$J[2.H=E7'FS]G=[^8=/U6YLM&N/RK2=) MG&GV6ERVMN\Q0Z:1;\%T98W3M?,8B7@.4`T0UQ3G^Y\K%F./C$X\$#MC$@4$ M:5[G53Q\3#/&)Y0)99!S+QZ=NBO:SRGIVIW46L0Z[H_+;-=L[;5WZ5K,_@WE MK->M+IG,B+ZVL\S2^,N^(DT`Q;R.#BS9!R(9<>$90);)EC$F_P`B:CL5##R9 MXXG$83F8$C=$4+6^8%#W5;7N9=8Y8OARSR[<2:3IV@P0V3N.UM9KB^N9&-N; MC4YA-"_@%V^;B9PE"RNU!#E:O9._,8-7D=;QWMYISOE9-3T]KI M%-MA_-U'%EEQI2X\8RG") MH0'8&HB>X_)`UO6=2Y*CTWEOER[^7CBL&:G>ZJR"VF9KMUJ?\3YJT;-'*WY& M%D89&YI!4(%[8W7,,QT4- M1N[OD/2M*T[0;Z*6[UDR:O?PQO=:V^GZ>Z=LTOY+8Z]IK67.FZ?9Z8&R&P:Z8RQ?/W]+U73M?OHFW>CB+5K'7[ MJ&&"QL897MM+JPOG0MA9'%<-0QFKU!/X<&')/[E@GBY,FGC\T9FD8@EC&3== M.Z%RH:-K&H\YLU+ESF*\^89-92:E8:H^"")NBW6FM\3YJZ\"*- MHLI6O+'N<:9#XL''SY?N,9\3E2W`Q,HRIY#&KG_:10IY<,.*8Y\`8N`1_J!T M'<71M-T2VY6MM4YFBU?2N8KS2;%IT^WTF1T\=G=W[C:Q:E?-$B_*V[7$M.U2 MJ)@Q<;'PX2Y@R8\N2$?*(%V)H)2[#\V2GF/(E'`8RA&1KN#.!H.Y570>9=7Y MFOO\M%"T.%I)#Q/XNZUH79B'&Y>?F9 M/Z/E2,\60$:/$W$AX$5T9U+-@Q8(^]A`C*!?QT(^>B/I'*EAI=U+K,VNZ/S$ M-#L[C5V:3I%QXMU0#$(3QF19Y"@?]38=U1TKGG7]0U.VLM;G=JVE:K+^77FFQ6\# M'20ZD3`EJ^%K9G/A,@,8XCQ-%:UQ5Q_N/*RYACSDY,,SM,6%1*E.XT4\G%PP MAOQ`1R1J#X5JK]GR!ID6M,MY^8])U.UM;JY=)I%I,Q^L7D>G>),=/$(/";DB M'@E:T`@!R5Q;'[9B_J-LLV.8B3Y8GSD!SM;K1E"7,F<3C'.,B+FP?7P68SS( MYC=J+;IUPQ^F.N^,Z,VW@=&;)[^`V+9FQBX+S"[A#E7Q.BF*?_MN7[N\E\1/ MH:FW_3UM16?T6#9M`\X'JU?JM2X\O].=K;K./F32;.VEO86LTFYF'YS!!=<$ MOR!@+RT7;(Y>!@.:@YXNE]KQ'D>W'+",3(>4GS@'0C_5HH#F3&+<82,@+@>4 MD:^"S-0Y\Y@M-2N(M)G&EZ9IT_RMII,EM`\16^G.\`0W+I8OF&/E;%_$'$"T M%!D#BG+]RY4,QC@)AB@6$6%!&C']5.'$PRQ@Y!NG(.3U)U'Z+0U;E&RO;YFH MV^NZ3H#-:@M=3&E:M,8[^R?J(#Y6B)SRL+YBYT:H#Q<-`,6Y>#BR9/=QY(8A M,"6V18C=7Z=.RA'D3A$PE&4S$D.+%OUZJKKG,^L:%J$G+^@7$ND:=H<;--9! M+:VSY[B2,>)-?RB>&0CYR20N:AX7,1VW%?(Y>?C93QN,98\6/RM1R1>1\37P M4L>#%EC[N4"4Y5?MH/EJBZEHMMS%'8'*$>3OABE.+D2+.10R'8LZ4,LL.[`(RG&,F#="' M;Q"%K&LZGRBZRY;T*Z?:0V-E%&1FL7FHL;<27D#IQ,#:-!#8RTHH(* M\(PL^?+PC'C<:1C&,02?]9E5P^F@4L6.&<'/E#DF@Z`:>/53FT^/F[3--U^\ MU&RT34@9M(OKC5?ZO;:P^P#70WMD6%@?(R%_!*`T-!!`3A&'/&.=BCR,DXX\ MM8R,J"36(^5"@3_I\APQB90N&JSW!^=0AZA>WO)EAIFEZ'>,=/J$;]7O];MX MH[BSU!KGNMK>UT]\S96.M[6)O?(#7<1!HI&(Y3.63**"@B;C6OBDR-_.FCQWVIZA;Z=J>D7OY>_6=0X(+'4;6[:ZXBM7 M.C$31>VKZAK0G"5.=&QY^`9,TA'-"3;I4$@:@4U'Y*+_`--EVP!E"0?:*D$4 M?P*>27K%0T?VA]7J4PW)R?S`1&(])H7.OAHHVD\_.FEW]OK=]#!?: M))#>VFMW3(X+2&WO'"WFT^],3(XV"5S0Z(_$2.BJA.7.QRCGD!/&01,V`-#$ M^.B<@./D$L0\LJ$"_5PDVU_RAI5YJ^GZE9:IJ=Y<1Z/:ZA8?Q[/2HWL%U.Z0 M$N;\YQLG.$,!&3$-6(ZOT[J=EID7+5IJ/,,.I:9K5[80,M[% MNFR">'3[C47&W;J%[WE9&QG$&40DH>AQPQXN.7(C.&2<0PVZ&5-Q_3NG*9RR M&(Q,8DU?5M`A:-K>I\QW,G+^MW+[^TU2VDB9((88Y-/NH&.N(-1:8FQK'`Z/ M^(M`$ZBL.?+R9'C\@F4)CH*$5$O`:]D9,,,0&7$&D#]19E/3=!M-*?/K;M5T MK7CH]G-J4.G:7)XLSYHV\,$\X!<66<#R'O<*A`=F'BX\,1.4SAD,(DB,3V4=Q9ST_BJVF+E9LN08\I,\,3\V2$Q%SM%R MVG\57/D2,*1E$EJFP?JLV#G?777K)YY?F+*><&;2HH("V2UG=X9LHGM8)B1& M]&UXBX!/C$&%)=?U6D[DJS_`#4V;=>TQELZ\#!I M[I2=5;!(/%%B6%Z?.>&>`!5V]&)GA8_>V>Y';NM^YNGCHH?U$O;W;2[7T\?! M9=SSEK,5[(ZSD?96%M.([?3)(8"(;:U<(1;3$Q&;B>V)'U):7%,L0GSUKR.O\L6MQ>">#5]-T>'4&VUW'INHO\E@**J4SPY\7'*>Z,XP$F.TW#_%%&.:<8L8F1#AQJR+^?ZIIVOVFDZ9+- MIVGZ5?66GPVLL,1F=\O/&);B5TK7OXKF1Q<*IP$)GA9>1DQS]K$=N.-`&Z:_ M-..+'..^52:K5@ATZZUN^BTGE_6-&U*]EU.#3=2O8[F:.WN;CQO!:;>8!UO+ M*P%@)`'[XD(&)W4D30="W355RAG]MC)PUFKX.N<=R7SB=7=:_D.M&_ M_,"!J(TZ]\)UP9_$^?\`G1#P",N_BJM!3/&7^GS^_M8^[NOH[W?\5;[N/9N< M;6M^C+J+]W+PUN6:\Y8U74)HKV+YS588[J&SN;F#PX[J\;I[0&R1^,PNXN"!0@V M;XHKL>3&,08B+:%=!K-OIEM=16FM\M:QKFKV-E96NJ:C9FZM8YKJ&)HDC)R9HQ`E(%@X%NY%B53CCGE'=C(CC)+`A_CJL MCFGEKF&\U4W]KH^L:IIM]:6EQI<]GI-[-##8&%K(K+A9;N;;/M7,+7,*%:FI M.*N7CR3S;X`SPR`,2!^W0=FLRLPY(1AM)$<@+%^O7NM>_L;73K/1M,YEY;U7 M6=8L]+8)#;?,6;M/M9Y'S66EW,L?#X\EM$[,KP`TSQ?D_I\4,>+DQ,\PA5BV MT&HB>I`^BKB,DS*>`B.(RZ7(N0L[F;E_6-2_*-0T?1-8O-$ETN*VT^TMM+O) MW:2^T)9=V%PR.*7^.9SQ&1W>D4U("XKY6.6;9EP`G`8`1`#[6O$]WJ^KJ>&8 M@91R$#*#4VW/8_X:*]^6LTCE_1K+FOE[5M3NGS7U_86$44]A=Z/IL[VMX;E\ M?!(E[<,=(V)WPUW)B9]G%QH8^9$SF23&+L8Q/76IJ!HH>?)EE/`1&-`3<$]O M#J@:[H>HZMH^AW?+NA:N[1K,WMC+HL-C=7MUI^INF=/+*7MY)1S$>X6.ZSCI\D6PTB?1> M62SFO0-7NK;4=6$NDZ'\K([PI[>&;B:S@1'%#M7$\8CAX? M_P`N),9S\L+$,*R>X!MW49REES__`!R`8QK*X+V'0^*6HZ1/K/+,3>5=`UBW MM=,U9\FJZ'\K<7U]++=PM98ZHYX$L]S%&UCH^%"&*=C5P9(PS\0?TD2(0GYH M7)<4EU(T[?-.!ECSOR"#(QI*PI<>*;0=#U#1M#UVZYDT'5QH][)96<&ASV%U M976H:DR03MN[4R,BDMFV<"\4C:/"@KPI@X\1@X^2?+B?8D0!"QE(5<=&%SW9 M/*3DR1&`C>'.ZX`Z=WZ=E8_+&:QRYK-CRGR[J^F74-S8:AJ>FR13WU[K&GPN MV[M8FNWAME96C)H M8AX[96%PE;WHCN7$.%C.$9,W(!'&$&D"&WO:([O5]&4^1(9-L,1!R[G!_P!+ M7)^5%I:?866JZ?KVFE%S/FC<7DFI65M*R?4-+M9I./Y>2>$51 M#(!44Q;B/&SX\F'AP./D2A1R^X"IB.A(KW9E7,9LW&KRWVCWL,-QISX7QRV#89;<"Z?>O>UH94A%%0 M%JX&&<,OO9`88(1)D2*&+>GN96'U5G*G&6/VXD2R2($6-CU[-=;6A0:/=7=Q M8\OH:=>V6DZE?R7=W%'=2PDMMV\9D%K/1&(GED)XHD$@!J?JUV7.:5>0VMI;6H<^\<^>2!K)VN@:]@;Q=_BS2N,W#XW*'*A(` MX]I MX%W+86EU=>)%:WK]-<>".+Q9&EK2T-C49(HUX.1]M/*!PXSCF9';,EQ$F@.W MH"WA\EGR8>9'"?%,SC".'S/ZH8Q&0S"?JT=_5NLVKNM)Y'']GZN(]4C?<:U!\TRQEN(90V;4AIK"(W6_P`P MQTCFAI#P":K7?/D?:QS#.6,R.^LP6B2]9;.A-6U67'BYG].(QF`-M(LY`_TO MU;5Z/5+;2;U]I>MNWB2VN([GP?EX(C'*T)Q< M$2)DW&'E<3E'E3$HRR3E)]P!(D]B#9C^"TX<^$88D$1B!8FH:X75:\.7;?5! M;:YRMJW,>L6%O9V>K:Q8R3VL%[?VD$<=SQ6\3XXYWP(&.=^,MX3EC?RLWV^& M;9R<N6&I0V]]I=]8:+?7%L-+FA:+2U;X,4D<#K1C/#+*&G$?BQE^X8,\ M^2K`7G($9J4T M="67E0Q@$B6W:#6,#=S$:Z6T5.&.:;^6]>U:?2- M8T;1-8U'0+S1[.+2+>QT>YN&Z+%:-,-SI=RVWCGX)X+E7%Q*O+BB\.*/N&*> MT@^A'T9M%HRZ=;Z M-R[R[IG./+FL:SJ!9>:A8V4#+FQNM"TJ\D:(+.[E!CED?<2L<]L;PL=11`#? M(\?C<3%B^X0E/-648@[3")-`3>I<@:?-5CWLN><^+(0QN`20XE(7(\*!]54Y MFT'4M;TGER^Y8Y?UB70+6WO=-_);;3KB]NM(U1MQ\Q=/N_!9+-,Z_8YKA*X5 MX0I'%6OF8_ZC!AS\*,OZ8`QV"IA)W+M4[@006[:*?'D<4YX^01[Q(.ZPD-&\ M+$*Q9:0[1.4;>#G+E[6KZ+4M7EN]&T%L-Y8W]BRVB,%]?R2O\&6WMKJ0@"%. M%SD<%51+&,7$X$8\^!D)Y"80?;*+!I2>X$J!M6=1GOS&R3WD7@M=$ M,_#5,@4?($>3P8G[?$C%#(=^/U2W2%)O<@@,.GS3Q[L7)(Y,@9RCY96#"\>Q M>O=0T'0[S0N6=;FYNY>UEVCZE>V%K8% MSQ24*UV0!CQ81XW#R3Y\9'!.41&'ID9"NX']HB*$ZNR6:4LO(A#C$>[$$F5P M(G0Z%S5M&5B32X]=Y3U:RY*Y:U?39;._L=0UG1Y8KN^OM7L&L=%;RP3.$CYX MK*Z/&8&E.*J*0MDO8Y/`GC^W0,)1G&4X$[I3C8$'I$WCW=(>[AY,9RI\I\NZOHMGS'J?,>@:Q:W,S3806<;X MHWLGMG@O$XK&M-I%7"Q'C8\V;F1D.'LVF)!!G(GR@/J/4^C=U/DS]R>/'@(] M_48G0ZMJS*N8S MXLN/+RI">(2(H&VDBDCVT[.LODGECF#3=2N]6U70M7TK0K#2K]VMG4='NX(= M1L+F(P_E;(9X(S5>6-:Y+DX.8SP<+'+#RYXY",I2W M!VK$=#(.`>[*K/'D8Q')R)#)@C,$@1:G4]0#4AA&C,FAL;DZ>]XBBC=)(`T<($3G`!,QNXW(^UGE#^GQRP MY9$B$Y2>,9$$1.WQ;POHLV;'S!A?+,3Q@`RB`QD!X:S?@R[9U[R3_F@WKN4-6?)^SICH'E_:/Z[W/:D3[GKW>5W]>RS/7 M;T6,8.>>-LW@';Z6K;T[KOHZXK5^1.?'DY7BUJ1FNTM+^^LH(8[R; MY**1L4O"]A:]0CW-(RJ>ARL_VP7%K-IM MQ"TV,,1M89&1?*P`1<"AW=XOQ+C']QXW)ES)9`)9<1K72$*00JK37R)\+#[?'YV.67EPQ@2,9;6Z1/4Q# M`GY:*C#'D9-V3C2&/!*9(!B[]9![.:LL7G/EG7]5O=.UG1]"UC4M`OM'L&:* MRPT>YN&:3;6C#!+I,T5M#*89[2YXBXN^-SRBH4S_`''#DSY(9^/$SXLL<=@` M?8!0P+.QB7?J[ZJSB3CCA+'E(&:,SN<^HFNX/H1]++5N-/L]&T'ES2^=.6=9 MUK5&6MU>V]G;?.V5QHNEWTX?:V-]*L,DLKBPN;&ZL044`"WR/&XW%PX/N$)9 M6.7]7GY>@L[C3H=(M--N[RXT/48YS+?,O&QQ/EEFO2YLAF([_"%-035SH?U M&'#EX49'B")B(`.82!>0+5.YP=QO;12XTO:R9,?((]]P3(T$@11O"S"U]59M M=*;H7*-A;ZXH^I M5)P&'B\",/N,)3WS,H0!VRB&8R)T$C^WLZ4CESPR6X,8=7P MP4&U%R8PY/!A+@1(PPF1+'ZI"1M,F\@0&'1F4L1EAY,AR2#DE$-*P87CT!!K MW=+1-$N-#Y6U23F_EW6)-+U+4;.+3>7WV=Y9:A-J-HQS[C4HR8V36,4=N\,< MZ@D`0YA5QHPX_"G+GQD<$Y@1Q^F1D+S!N``6/5^R6:4LW(C'C2`R1B297#&T M>Y)J.B+=:4-;Y3O[7DSEW6+#Y#5K6_UG0Y(;R]O=2M)(C!:7<$S63/N(;*X% M8&GA:5<0J*Y##RN#.'VZ$H;9B4X/N,@:1(.HB;Q[NE'W,/)C+ED2>)$9`,(F MY!\>O9E5Y6Y>U31=,YDU'F70-6M]`GL[?3I=(N=,NK2YUK499FRV,=FV1DYQ%,BD>%C/'PYLO,B1Q#$1,"&,Y$O$!Z@Q]3Z6U4N3/W9X\>`C MWW)>XB-2?&S*[;Z?::QH7,FE-R.-FP_;X2QY]H)!EN,XQ+F(.A%"P]0"A(9L6:& M3E2$\;D`@,(R-B1^'9UF2W%Z MR49,/"A+%RIXR(R,MS]8BS&0<` M_+50RQSX]N3D2&3#&0)`#-TEW8U/U7/\GP781W?)IYG%XWE+5HY/S=SF:V[QSI[)W7!8S5/R[B,(M_F M#XH;PT;WLPF-_P#4_:SS=XQ2!]SUOY7?U;+,]6=9_9Y@X^TS!.WTM7_IW7=J M.N,O^1.>OSZYM7Z!KUU?R:I(&ZO'I=^+6>>>YXXM3^>AADBBB>7B4N#NX*%$ M.,&7A%(P21D/'"DI:=ZG=R,_VT66IV6D75/(!+()%Q M(!P0;,UJ4;2ROXV7$,$8T@10@FH(O_GJN@UVVTFQEL=.YEY:UGF#7M.TFQL] M4O[&2\M(FS1Q\;+-Q86B\N+6)[6.E0N=0&H0:^5+AXI1Q MGN8A@2J,,<\P9\>0QX3(D`AZ=>P-P%C\YL:SK%MI\DS8[;YJSDTF MPNY7/LM,NIP&&>6-H)#7*8LA3.Z9X^#!BP\Z!R9Q%Z2;;$EXQ)U.K:.R@!FR M9)Y.-(0Q&6H?<1/Q(0YL#.4I&48NQC&Q)[2.G9TOYF3/*7'(B``";@G M_#JJVMZ'?:QR]HT_+&@ZP-*L;J\M;S0H[2]O;RSU*X<)FW\Y;%+)=QW4'=8] MU(P@&9`CR(C/Q<(G%FD,Y'ND!I6!`T[,I:;HU MQHO+%T>:^7]6FL]3U6`:7H4EI<65X+FTB(O-5C>6QW%G'X3FQG+C1#1PPL48 M8.)(\R),)3\L+%Q>78-3NGD,LF<#`0)"-97#&P[G\DKW2I=9Y9FBY3Y?UBTB ML-49X@MWM+?#'=827'('$LGMY^&1PXF,8S> M4?5(N&$NX%FT=THF6+.#R""9182L`QJ/F@Z!H6I:/I6O7O,>@ZM'HMU#:Z>- M'N-.N;.XU74C/XUM):F:-DT3K*-KG&4#(G/AQ7QH'!@R9.3$CCEH[30RD]&Z M;;O\D\TOZ)H[]!5:3B<.;CY,?#B89*$@ES*(N!X7(U^21]W'EC M/.1*%0"S`$ZGQMV5#E?E[7-,EU74]6T75[#0[;3+B/5;6\TFZ@_-V7;?#M]- MMV3Q1+/)<(YKP5C(%0'8JX>.>(SRY@8X!`[@0VYZ"(?4G71G4\\XS$88R#E, M@S&S:_3ZK0TVRL]1@U?3.6N7=6T/6[[2IHK6>[,]Y\[%$YLUYIL#I2?EY;NW M:0'-`)`.28LQ2X^6,\/%B<>>4"Q)=VJ8CH2/X*$QE@8Y,TA+&)5HS/8_)9'* MG+/,MKK4-]/HVL:/8Z?#IW5[H][!`[3V1.9<6CA)`R.9UTQP8&&M5&6*N M'BRQS#)(&&.()D2&&W45N]F5N><#CVCS2-`!6O7Y=5LZ+'H]Q?FWT?EG5M!U M6]M[VUTK5+MUS!KA\!*#/%V#)Q)9-N"!QYB"(R)< M`FWUL^BKR1SB.[)(2Q@N0UQ_A=,V'V]SC:U MNW1ETNHG0&ZW++=\LZOJ$L5W"R]U.)EU':7-S;AC+F[^09W7QF6,N<`$D0G; M75DS<+WR9P,I"0>0+`D7+?#JF,.1[;"31(MKV#KG^8.5.:9-9OG.T35]5==W M'CP:A;:9>207D%TC[9\.ZF@ HC1CG@%SB$S"8NRY,$9;,T3/,(@2(+5_5K/JHXQFD'QD1@26!&B__V3\_ ` end GRAPHIC 19 g852944ifc1.jpg GRAPHIC begin 644 g852944ifc1.jpg M_]C_X15]17AI9@``24DJ``@````,```!`P`!````J`(```$!`P`!````<`,` M``(!`P`#````G@````8!`P`!`````@```!(!`P`!`````0```!4!`P`!```` M`P```!H!!0`!````I````!L!!0`!````K````"@!`P`!`````@```#$!`@`> M````M````#(!`@`4````T@```&F'!``!````Z````"`!```(``@`"`"`_`H` M$"<``(#\"@`0)P``061O8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V M-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3 M!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H`#`,!``(1`Q$`/P#SV4Q)32F5@%B*\E),IU%HL87@E@<"X")( MGW;=P:G!"2ELE7Z:U9PJNGWM+F,R0`2)(HUTTV[,?Z3?S]J?':'`$@ M-?Y:-/\`Y#_J%8Q`%BRD@>?9-B87K6!KG>G6`Y]MD3M8QIMM?M_.=L9[&_OJ M&/U7H5^0W&.)=56\[1D"XOM$_GOJ^RQA;[I`W;?:_P#JOW?21R2(E$#N+8H@2$B> M@T=G,PGXU]E#R"ZIQ:7#@_NO;_7;[E1MKA=%U"JRW(ONL;MWVOV"(/IM/IT[ MA^\ZIC5EY%#6B7?<.?\`S%2580)47"R&0JRW*J:+#9Z[7!C-L"KTP==T[K,F MN[]U4,UF,VIPJKR&O:6R]]=?IQ^UV[:JLZ!IM1L@'3[6D"I`J">5& MN92E.BC*4Z?-"TO_T/.BF23*<,9;6)BMR&O<;*Z]I``LM%1,_N;J[?41QT]C M*WVFVEWIB?3;D-<]P$?S;&4>Y4677,8ZMEKV,=])K7%H/]9K3M5TY_K4EEFX MV.DG4EDF?=^D?9_U'_7$\6@@?R+8QF$B*GDM/+)+3\V3ML_L+0H;,!9^,`8[ MK6Q[*JJ[Z572W'><@M M%&TB[?\`1]-PV6!W]ERYSI=>-@=HRIHEUCJ:VLK]SFL]E MU[[OYQBAU3K60*Q0V\/$!SJA56*FN.OM8YKG/V_O6;UG9/6ZI MP+6MO,?1]2P.`.NNQM35JYD,UY?V\&_^2?\`]0HUNZ>W#I?DZ/VDVV.^T2?< M[\ZO(;6_V_Z.NM09J!MM8B3&A^+A\>22NW,Z5;8ZQN<029]-M%A`$#:*WV6N M>[_KJKY%>+7M^SY!R)G>36ZK;'T?IN=OWJ`EEI&EV3)3HF]4O__1\X[I)=TE M.&,LF-<]S6-$N<0&CQ)^*V.G-%=7H7X;BYI<77#(L9SM;A7X@HR'AU'K#=0][`T.D3['[G>W99_.;-BDCYK3747]+=-UH]JK++'.FTDO&AWY6":Q2\BUS']8*TU#>RNFV9'3\"ZQ[#D.Q*G6@D`D>Y MM$[?;O\`L[:F_P#"+%;9Z-E=K`X@EPCN=H'J`?YRV^HYS,+#Z8W(Q76.=A5` MN99Z9(9NKJ]0.JN^BUOYBYW*S;CVOZO]YV^BXYSADXV M-++,RFVJA\Q^DDX78MKA]4;6+C6Y#+:W?H_6:W]%=]E>QS6^_P#2>FVWT-_^"]/]&A8+@SI>+NDN;ZK2 MT\SO]3])_9M;[5+@,A+6N$1J!'[H_>_K,/,+CE+BRB7#P^X>+^;X?T. M'A6RP2)D-'8N,3\%G679-8`;:T-9JT")C5O=G\I:5=SOM;'[MI`=[IB!M=_+ MIV_]N*&5U.^UK\>W(R+F/&TL!LM86S.Q^S,VO_J)9CKLG%$U=TY-N3D6B+;" MX3,:`3X^T-0D[MNX[9+>Q=`/]J)3*`LJDNR27;YIG5+_`/_2\X[I)U.IM+GQ M=9Z+(/O#2_7\UNQKF*<,925Y3FEF]K',:-L>G4"1$2YYJ?OV_2]^]%R'X[G- M]#:8YVM#?R4XW_4?VT4='<:_5%EA9#7;OL[]L.C:=P?[6>[Z:(WIC0"YS+&[ M8%C13:=CH#G,/Z;^77[T^-*-]K8TV`M#7\#1KARW_P`DS^1_VVA]6+S5C8S= M=P=;IP7/=Z+(_L5?]-3OJ.-DNI,C;!$MYJE)N%=_R8B*D"!KV\6Q]JQ_4KM>#'IZ_%'ZKE?;.HY&0-18\ND]T"NUS&O:.+!!4,Y<9$AL:W_=9< M>,8B89->$3B>'4>Y4N'_`,<=7ZOO'JY&,T[;->2,]&ZH;'5UXESG,^FUS0'"&BP[F[OH[';M MRK9&-D8MIIR:W4V@-<6.YAPWL/\`::GR+FW0!6VM@UV@,DGS=752A``<**BO MT62[)TNR;6J7_]/SJ%.FZRASG5[9<-K@]C7@B0[Z%S7M_-5MU50.E;/\T(9: MS]QG^:%;X*8!.^C%F98+`Y[*2PN!>T44`D>W<&;J7L9N:S]U6AU#"B/LSO\` MMO#_`/>)5#M_=;_FA3QJ7Y.15C5BMK[7!H<\`-'[S[';3MK8WWO0T7"4E76L MLM<^MNQI`AL,;J!'T<=E-/\`FUK4IN^RT=0MJ(-SO8X>#/;4W_OZH,Z=U)U/ MKBEC6#<27>FV/3+A9NW?1V>E9_F(YZ;U<;FL-;Q8'%^W;#CN+G,=O8SW;F>J MG<<:(/DM,9V)#0@W_P!TY3&^[F/-6_0N],5&LM#"7N>=&P0-ON4AT[.V/L+* MVAC_`$@#MEUA>VAM=>GYSW_G[/8S_B]]FSIW78&.=CZP):`:XB"6^TAMK=VU MVS>U,N&EWH;7`Y`)<->H<,O*^+_N6K5]F8]LM]6#KNX_LL_\FM'J08_+800' M^\!OZ1*B;[_ M`$_2WN],#;M[1SM_JJZ.C]4,`55.,-TFL&7CVMVNVNW>UWT?^MH5N!F4LM?; M2UK:#6VTPPP;0'U;?W_:[\Q(RB55+LTDH1A'[K?\T?W*8##^8S_-"&BK+6A* M-/FKC65GFMG^:$3TJ=O\VSGP"/!UM''TI__4XMX,G0H3@?`_+-@%I81M+@`'N:QSO\([>_P#T?\W^ MB_G$'U'_`+SOO*?U'_O.^\IO"#U7`GL$SW]$?8QNS)%`#P7$R\`FMU+6^YS? M3K=]H?L_X3_#6*+CT.1MJR2-9W&1)#F[V-:YKF[/T;F;W6>S]'8A^H_]YWWE M/ZC_`-YWWE#@'FRK_P7](F]1_[SOO*7J/_`'G?>4>`=U<1[!)_D/T" M=MYMW0T&9@!KFW&#Z7OL]7?6VWU?YO\`X51)Z,;"6UY/I-8(!,/?82-WN#G, M8S9N4?4?^\[[REZC_P!YWWE+@'=7$>P9ST3_`$64"6]G#F1W<7>UK/\`P3_@ M_2KID7=%WN(IR=KI(:'!H:0(:UNYUKG-<[]_^:_X1!]1_P"\[[RF]1_[SOO* M'`.ZN(]@J[T3<_[.'BB?T8?](#^5]))H/@?N3&Q_[SOO*1]8"3O`\9*-(-^" M9H/@?N1-KMO!^Y4B]_[SOO*;>[]YWWE'B&R.`[O_U>`E*5$E-*LVQ4SE/*'* M4I6JDDI;E"4I1M5))2E0E*4K13.4TJ,I2E:J92B4X]ES7.8ZMNPP198UAXF6 M[_I($I2A::;.,ZO'RF6W5C(KJ>TFL[FLL:#N>S<0Q^RQOL^BKU5&-FWN9A7F MNUX>^G&R&[7.(W6?9J[Z=^.YWH_0LM^S[]G\W_-K'W%$Q\JW&O9D4D"RLDM) M$C4%GT3_`"7)<1`T-*X0=V#RTGMIK1__UO.R M4TIBF4UK&4IY4)2E*U):J[;GBNECK+#)#&`N<8&YVUK?Y*>ZN['>:[ZWU6-U M-;VEKO\`-?[E"NSTWA^UKX!&UX#AJ(^B\.1+VH76L#I]=;;L)]1=L%EC:-VP3] M.IS+0ST[ZOI?H_T-BHOSMU+6MDP08C4$AWJ_]+8@ORGECFG3<(@^:E,P8\(' MU:\<4A/C,B2>E^G[$)>!R85G%QS<\-VE[S.UG&@^DYR'1G9>,US<>Y];7'N\S))+OI:F3_6UW.48/\BSD.EG8&'5B8=]%[+7Y3+38UD?H MW56OH;N`]WIWL;ZU?J,647!OTC'9&=DS2RN(+"3N^*:G-R\=KFT6NK:\[G!I M(!,;9]I_=2)L>*@*6QV,L>/4<6U]W`3_`*M_>VJV_'8&F:@6-YL9J/ZPL:JE MF7?<\ON>;'GESB2?^D2I49)JMWP8+'UOCNVQCJ7?]6B)4-D&-G=%8W8\MF1V M/D5&=/FDYQ<9/A";LF]4]'__U_.$D<5P\$\!P)TG2?W3]):'J].+WN-%;9<2 MW]`UVD1]'U:65^[\S_IJ5;37Z7T?)ZB+K6GTL3%`.1D%I?MW?1`K9[G?RW^R MFK_"VJ[D_5ND5%^#F?:+`)%5C0S=_P`5;6][?=^9O_[<0,6\XK`*'N&Q[BRP M$M>)X.YOT'[?W'*T,ZZ]MGJV']$POJ;H!N=8W>UK&AK=UWK.?8AJJ@X'X>2= M76FK[U.I;8;?2_JS?GT.R++#4QK/4%;6[K"SN\;BQG\OTV[[?3_2*IU'I3L-H MMKM&102`7QM181*?$#Q:=8T.'Z?I.0B4T&V3.UHY<=?N1 M*CC-:X74FU\RUP>YH`CZ+FMC>W=_YVK6%U"G$H>P8=&1:YTUVY#=^SR%+MS+ M/[;TP#PMF/@::C\4`36_>1J6G0QY*NMROJCUCV/O]2I_Z'9_UM9E+L1H=Z]#K272TML+(;W9`!2.O2OQ4/$VQP\# M-S[C3A4OOL:TO>&"=K`0UUEG[C-SOSE9R>C68]55INKMKNEK+:B+*O49_.X_ MJUDM]:K=[O\`@_TU7JU>]"9?Z3R[&+\<>T^Q[@98=];_`%-_N>Q_O_,_J+8; MET.+\JQS*Z[[,@9 M1B+(O\T@&1H:/..:YI+7""-"$H,(V0_U;39M:R0!M8(:($>T(>W1*M4/_]#C M_LI\$OLI\%T3>E$O:""`7`$^1,+6'U5P23^LV-@Z;@W7_-8Y26AX@8Q"?[,> MP`^"[#*^KF+31995:^QS`"T$#:=0/W6N[K/_`&8[]U$%3S5N.01IV4/0*Z*S MIF[)KK?+6N&I`U_.\59;]7L-S0XY>TG\UP,C7CVU.:KN+!*H6EQ!(`W1N,2[VHK\&EC7.;ETV%O#6^I+OZ MN^AC?\]R@,'4$]!Y.?L3;%8-<&`EZ?DEP)XVOL3[3$=N8\T?T_)+TT.!7&U] MB6S3YH_II_3T0X$\;__9_^$.'6AT='`Z+R]N&%P+S$N M,"\`/#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI2'IR95-Z M3E1C>FMC.60B/SX@/'@Z>&UP;65T82!X;6QN#IX;7!T:STB6$U0($-O&UL;G,Z&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R M9R]D8R]E;&5M96YT&UP+F1I M9#I#-34P,#`Q-44R,C8Q,44T.38S-T4V04-%0D)%.4,S12(@>&UP.D-R96%T M;W)4;V]L/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@>&UP.D-R M96%T941A=&4](C(P,34M,#0M,354,34Z-3@Z,C(K,#4Z,S`B('AM<#I-;V1I M9GE$871E/2(R,#$U+3`T+3$U5#$V.C`U.C,X*S`U.C,P(B!X;7`Z365T861A M=&%$871E/2(R,#$U+3`T+3$U5#$V.C`U.C,X*S`U.C,P(B!D8SIF;W)M870] M(FEM86=E+VIP96&UP34TZ M1&5R:79E9$9R;VT@&UP34TZ2&ES=&]R>3X@/'!H;W1O&UP+F1I9#I#-34P M,#`Q-44R,C8Q,44T.38S-T4V04-%0D)%.4,S13PO&UP;65T83X@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`\/WAP86-K970@96YD/2)W(C\^_^T=%E!H;W1O)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=7 M9W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*! MD12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7 MI[?'_]H`#`,!``(1`Q$`/P#SV4Q)32F5@%B*\E),IU%HL87@E@<"X")(GW;= MP:G!"2ELE7Z:U9PJNGWM+F,R0`2)(HUTTV[,?Z3?S]J?':'`$@-?Y: M-/\`Y#_J%8Q`%BRD@>?9-B87K6!KG>G6`Y]MD3M8QIMM?M_.=L9[&_OJ&/U7 MH5^0W&.)=56\[1D"XOM$_GOJ^RQA;[I`W;?:_P#JOW?21R2(E$#N+8H@2$B>@T=G M,PGXU]E#R"ZIQ:7#@_NO;_7;[E1MKA=%U"JRW(ONL;MWVOV"(/IM/IT[A^\Z MIC5EY%#6B7?<.?\`S%2580)47"R&0JRW*J:+#9Z[7!C-L"KTP==T[K,FN[]U M4,UF,VIPJKR&O:6R]]=?IQ^UV[:JLZ!IM1L@'3[6D"I`J">5&N92E M.BC*4Z?-"TO_T/.BF23*<,9;6)BMR&O<;*Z]I``LM%1,_N;J[?41QT]C*WVF MVEWIB?3;D-<]P$?S;&4>Y4677,8ZMEKV,=])K7%H/]9K3M5TY_K4EEFXV.DG M4EDF?=^D?9_U'_7$\6@@?R+8QF$B*GDM/+)+3\V3ML_L+0H;,!9^,`8[K6Q[ M*JJ[Z572W'><@M%&TB M[?\`1]-PV6!W]ERYSI=>-@=HRIHEUCJ:VLK]SFL]EU[[O MYQBAU3K60*Q0V\/$!SJA56*FN.OM8YKG/V_O6;UG9/6ZIP+6M MO,?1]2P.`.NNQM35JYD,UY?V\&_^2?\`]0HUNZ>W#I?DZ/VDVV.^T2?<[\ZO M(;6_V_Z.NM09J!MM8B3&A^+A\>22NW,Z5;8ZQN<029]-M%A`$#:*WV6N>[_K MJKY%>+7M^SY!R)G>36ZK;'T?IN=OWJ`EEI&EV3)3HF]4O__1\X[I)=TE.&,L MF-<]S6-$N<0&CQ)^*V.G-%=7H7X;BYI<77#(L9SM; MA7X@HR'AU'K#=0][`T.D3['[G>W99_.;-BDCYK3747]+=-UH]JK++'.FTDO&AWY6":Q2\BUS']8*TU#>RNFV9'3\"ZQ[#D.Q*G6@D`D>YM$[? M;O\`L[:F_P#"+%;9Z-E=K`X@EPCN=H'J`?YRV^HYS,+#Z8W(Q76.=A5`N99Z M9(9NKJ]0.JN^BUOYBYW*S;CVOZO]YV^BXYSADXV-++, MRFVJA\Q^DDX78MKA]4;6 M+C6Y#+:W?H_6:W]%=]E>QS6^_P#2>FVWT-_^"]/]&A8+@SI>+NDN;ZK2T\SO M]3])_9M;[5+@,A+6N$1J!'[H_>_K,/,+CE+BRB7#P^X>+^;X?T.'A6R MP2)D-'8N,3\%G679-8`;:T-9JT")C5O=G\I:5=SOM;'[MI`=[IB!M=_+IV_] MN*&5U.^UK\>W(R+F/&TL!LM86S.Q^S,VO_J)9CKLG%$U=TY-N3D6B+;"X3,: M`3X^T-0D[MNX[9+>Q=`/]J)3*`LJDNR27;YIG5+_`/_2\X[I)U.IM+GQ=9Z+ M(/O#2_7\UNQKF*<,925Y3FEF]K',:-L>G4"1$2YYJ?OV_2]^]%R'X[G-]#:8 MYVM#?R4XW_4?VT4='<:_5%EA9#7;OL[]L.C:=P?[6>[Z:(WIC0"YS+&[8%C1 M3:=CH#G,/Z;^77[T^-*-]K8TV`M#7\#1KARW_P`DS^1_VVA]6+S5C8S==P=; MIP7/=Z+(_L5?]-3OJ.-DNI,C;!$MYJE)N%=_R8B*D"!KV\6Q]J MQ_4KM>#'IZ_%'ZKE?;.HY&0-18\ND]T"NUS&O:.+!!4,Y<9$AL:W_=9<>,8B M89->$3B>'4>Y4N'_`,<=7ZOO'JY&,T[;->2,]&ZH;'5UXESG,^FUS0'"&BP[F[OH[';MRK9& M-D8MIIR:W4V@-<6.YAPWL/\`::GR+FW0!6VM@UV@,DGS=752A``<**BOT62[ M)TNR;6J7_]/SJ%.FZRASG5[9<-K@]C7@B0[Z%S7M_-5MU50.E;/\T(9:S]QG M^:%;X*8!.^C%F98+`Y[*2PN!>T44`D>W<&;J7L9N:S]U6AU#"B/LSO\`MO#_ M`/>)5#M_=;_FA3QJ7Y.15C5BMK[7!H<\`-'[S[';3MK8WWO0T7"4E76LLM<^ MMNQI`AL,;J!'T<=E-/\`FUK4IN^RT=0MJ(-SO8X>#/;4W_OZH,Z=U)U/KBEC M6#<27>FV/3+A9NW?1V>E9_F(YZ;U<;FL-;Q8'%^W;#CN+G,=O8SW;F>JG<<: M(/DM,9V)#0@W_P!TY3&^[F/-6_0N],5&LM#"7N>=&P0-ON4AT[.V/L+*VAC_ M`$@#MEUA>VAM=>GYSW_G[/8S_B]]FSIW78&.=CZP):`:XB"6^TAMK=VUVS>U M,N&EWH;7`Y`)<->H<,O*^+_N6K5]F8]LM]6#KNX_LL_\FM'J08_+800'^\!O MZ1*B;[_`$_2 MWN],#;M[1SM_JJZ.C]4,`55.,-TFL&7CVMVNVNW>UWT?^MH5N!F4LM?;2UK: M#6VTPPP;0'U;?W_:[\Q(RB55+LTDH1A'[K?\T?W*8##^8S_-"&BK+6A*-/FK MC65GFMG^:$3TJ=O\VSGP"/!UM''TI__4XMX,G0H3@?`_+-@%I81M+@`'N:QSO\([>_P#T?\W^B_G$ M'U'_`+SOO*?U'_O.^\IO"#U7`GL$SW]$?8QNS)%`#P7$R\`FMU+6^YS?3K=] MH?L_X3_#6*+CT.1MJR2-9W&1)#F[V-:YKF[/T;F;W6>S]'8A^H_]YWWE/ZC_ M`-YWWE#@'FRK_P7](F]1_[SOO*7J/_`'G?>4>`=U<1[!)_D/T"=MYM MW0T&9@!KFW&#Z7OL]7?6VWU?YO\`X51)Z,;"6UY/I-8(!,/?82-WN#G,8S9N M4?4?^\[[REZC_P!YWWE+@'=7$>P9ST3_`$64"6]G#F1W<7>UK/\`P3_@_2KI MD7=%WN(IR=KI(:'!H:0(:UNYUKG-<[]_^:_X1!]1_P"\[[RF]1_[SOO*'`.Z MN(]@J[T3<_[.'BB?T8?](#^5]))H/@?N3&Q_[SOO*1]8"3O`\9*-(-^"9H/@ M?N1-KMO!^Y4B]_[SOO*;>[]YWWE'B&R.`[O_U>`E*5$E-*LVQ4SE/*'*4I6J MDDI;E"4I1M5))2E0E*4K13.4TJ,I2E:J92B4X]ES7.8ZMNPP198UAXF6[_I( M$I2A::;.,ZO'RF6W5C(KJ>TFL[FLL:#N>S<0Q^RQOL^BKU5&-FWN9A7FNUX> M^G&R&[7.(W6?9J[Z=^.YWH_0LM^S[]G\W_-K'W%$Q\JW&O9D4D"RLDM)$C4% MGT3_`"7)<1`T-*X0=V#RTGMIK1__UO.R4TIB MF4UK&4IY4)2E*U):J[;GBNECK+#)#&`N<8&YVUK?Y*>ZN['>:[ZWU6-U-;VE MKO\`-?[E"NSTWA^UKX!&UX#AJ(^B\.1+VH76L#I]=;;L)]1=L%EC:-VP3].IS+ M0ST[ZOI?H_T-BHOSMU+6MDP08C4$AWJ_]+8@ORGECFG3<(@^:E,P8\('U:\< M4A/C,B2>E^G[$)>!R85G%QS<\-VE[S.UG&@^DYR'1G9>,US<>Y];7'N\S))+OI:F3_6UW.48/\BSD.EG8&'5B8=]%[+7Y3+38UD?HW56O MH;N`]WIWL;ZU?J,647!OTC'9&=DS2RN(+"3N^*:G-R\=KFT6NK:\[G!I(!,; M9]I_=2)L>*@*6QV,L>/4<6U]W`3_`*M_>VJV_'8&F:@6-YL9J/ZPL:JEF7?< M\ON>;'GESB2?^D2I49)JMWP8+'UOCNVQCJ7?]6B)4-D&-G=%8W8\MF1V/D5& M=/FDYQ<9/A";LF]4]'__U_.$D<5P\$\!P)TG2?W3]):'J].+WN-%;9<2W]`U MVD1]'U:65^[\S_IJ5;37Z7T?)ZB+K6GTL3%`.1D%I?MW?1`K9[G?RW^RFK_" MVJ[D_5ND5%^#F?:+`)%5C0S=_P`5;6][?=^9O_[<0,6\XK`*'N&Q[BRP$M>) MX.YOT'[?W'*T,ZZ]MGJV']$POJ;H!N=8W>UK&AK=UWK.?8AJJ@X'X>2=76FK M[ MU.I;8;?2_JS?GT.R++#4QK/4%;6[K"SN\;BQG\OTV[[?3_2*IU'I3L-HMKM& M102`7QM181*?$#Q:=8T.'Z?I.0B4T&V3.UHY<=?N1*CC- M:X74FU\RUP>YH`CZ+FMC>W=_YVK6%U"G$H>P8=&1:YTUVY#=^SR%+MS+/[;T MP#PMF/@::C\4`36_>1J6G0QY*NMROJCUCV/O]2I_Z'9_UM9E+L1H=Z]#K272TML+(;W9`!2.O2OQ4/$VQP\#-S[C M3A4OOL:TO>&"=K`0UUEG[C-SOSE9R>C68]55INKMKNEK+:B+*O49_.X_JUDM M]:K=[O\`@_TU7JU>]"9?Z3R[&+\<>T^Q[@98=];_`%-_N>Q_O_,_J+8;ET.+ M\JQS*Z[[,@91B+( MO\T@&1H:/..:YI+7""-"$H,(V0_U;39M:R0!M8(:($>T(>W1*M4/_]#C_LI\ M$OLI\%T3>E$O:""`7`$^1,+6'U5P23^LV-@Z;@W7_-8Y26AX@8Q"?[,>P`^" M[#*^KF+31995:^QS`"T$#:=0/W6N[K/_`&8[]U$%3S5N.01IV4/0*Z*SIF[) MKK?+6N&I`U_.\59;]7L-S0XY>TG\UP,C7CVU.:KN+!*H6EQ!(`W1N,2[VHK\&EC7.;ETV%O#6^I+OZN^AC M?\]R@,'4$]!Y.?L3;%8-<&`EZ?DEP)XVOL3[3$=N8\T?T_)+TT.!7&U]B6S3 MYH_II_3T0X$\;__9`#A"24T$#0``````!````!XX0DE-!!$```````$!`#A" M24T$%```````!`````,X0DE-!!D```````0````>.$))300:``````,]```` M!@`````````````#<````J@````$`&D`9@!C`#$````!```````````````` M``````````$``````````````J@```-P``````````````````````$````` M````````````````````$`````$```````!N=6QL`````@````9B;W5N9'-/ M8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!,969T M;&]N9P``````````0G1O;6QO;F<```-P`````%)G:'1L;VYG```"J`````9S M;&EC97-6;$QS`````4]B:F,````!```````%7!E96YU;0`` M``I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$```````!2 M8W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<``````````$)T M;VUL;VYG```#<`````!29VAT;&]N9P```J@````#=7)L5$585`````$````` M``!N=6QL5$585`````$```````!-'14 M15A4`````0``````"6AOD%L:6=N M````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T06QI M9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E0D=# M;VQO^"05P=JZO!<-..$))300F```````.```````````` M`#^````X0DE-!"@```````P````"/_`````````X0DE-!#H``````.4````0 M`````0``````"W!R:6YT3W5T<'5T````!0````!0&Q`4@````````````IV96-T;W)$871A8F]O;`$`````4&=0$S%F+P)'*"\25#-%.2HK)C<\(U1">3 MH[,V%U1D=,/2X@@F@PD*&!F$E$5&I+16TU4H&O+C\\34Y/1E=865I;7%U>7U M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_(B8J+C(V.CX*3E)66EYB9FI MNGM\?7Y_(B8J+C(V.CX.4E9:7F)F:FY MR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!``(1`Q$`/P#S])))S8<4-^I)_,?O.%7>I)_,?O.*N]23^8_><5=ZDG\Q^\X5:]63^<_?BAW MJR?S'[SBKO5D_F/WG"K7JR?SG[SBKO4D_F/WG%6O5D_G/WG%6O5D_F/WG%7> MK)_.?O.%7>K)_,WWG`KC+)_.?O.%6O5D_F/WG%7>K)_,?O.*'>K)_.?O.*N] M23^<_><*N]63^<_><5=ZDG\Y^\XH=ZDG\Y^\Y)"X22?SG[SA0O5Y/YC]YQ9* MJO)_,?O.%557D_F/WX55D>3^8_>'D_F/WY(!K)7AG_F/WG)4P)7`R?S'[\-(M<"_\ MQ^\XTMKP7_F/WX:1;8,G\Q^_&E7`O_,?O.&EM=63^8_><"VV"_\`,?OQ5NK_ M`,Q^_&E=5_YC]^&EMU9/YC]^-(MJK_S'[\4VM)?^8_?BMK29/YC]^*K2S_S' M[\:5:6?^8_><%)6,TG\Q^\X*6UA:3^8_><%,@5I=_P"8_>3^8_?D5 M4F>3^8_><"%,R2?S'[SBK7J2?SG[SD4M>K)_,?O.*N]23^8_><"6O5D_F/WG M%7>K)_.?O.!6Q+)_.?O.*6Q+)_.?O.*N]23^<_><4-B63^8_><5;$DG\Q^\X MI;$LG\Q^\XH=ZLG\Y^_%+?JR?S'[SBKO4D_G/WG`K?JR?S'[\5;]63^<_><5 M;]23^8_?BKO5D_G/WG%6O5D_F/WG`KC+)_.?O.*6O5D_F/WG`KO4D_F/WG%7 M>K)_,?O.*M>I)_,?O.*KDDDYJ.1W(KN<"7__T//DG]XWS/Z\SW'6XJ["AV*N MQ5V*M85=7%#L5:PJZN*M8J[%6CBKL*NP*["KL5=BAV%78J["AP&%!7J,*JBC M"E5484JR#"A61%R5*O M"G%"X+BJ[CBK=`-R:#QQ5/\`1_(OFK5D6:STZ06QZ74Y$$1^32<:_1D)9`$T MGT/Y0ZV1_I&HV,!_EY22_BBTP>)Y%CQ#JLG_`"D\Q(/]&N[&[(_9$K1'_DHH M'XX^(.XJ)!C>K>7=;T=@NJ64MH&^Q*ZUC;_5D6J'_@LE&0/)*7E#DD+2F*5I M3Z,56%<56E<56,N*5C+BJF1@I*PC(ED"L89$M@*DPR!;`5-AD2R"@ZY`L@H. M,B62@XR*5%A@5288$+3@5K`EV*M8$N&!6\5=BENN*N&)0WBEO`KABK>*MXJW M7%6\5=@5QQ2U7%78%=BK6*NKBKL!2W'_`'B_,?KQ5__1\]R?WC?,_KS.<=;A M5V*NPJX8H=BK6%78J[%6JXH=7"KJXJ[%6L5=BKL5=A5V*M84.PJWBKL4-@9) M"HHPI5%&*55!A05=!D@A709(,2K*,F&)55&2#$JJC)AJD515KD@P)553)`,5 M15PH5`N%"\)TQ0N"8JKVMG7_ M`"E`MUJOI:AK@'(\@'@MS_+&A^%W'>5_]A_-E0$LGE%ADRB.PYH/6/S,D:0E M6+=JL:Y8(1BX_JDQV7\Q;LM_>'#QQ3X)1EA^8TG(!VKAN)0<<@S#2/.4%W&8 M697BD%)(7`>-AX,C54_=D)80>2QR$)3YE_+NRO89-0\MQ^E*O\`_]+SW)_>/\S^O,YQUM<*NQ5W7%784-8J["KL5:Q5 MK%#L5=7"KL5=BK6*NQ5O%784-85=BK>%#>$(;7"JJHPI5$&%*L@PH*NB[Y(( M*N@R08%649,,2JJN3`:R551DPU$JJ+D@Q5D7VPH*JJ'"Q5E3%5X3"A>(STI@ M5Z1^7NEPZ1HLWF6X4?6[L/%8$_[KMU^%Y%_RIF^`-_OM?\K*9#CEP]`QG/AB MPCS7YEDGN9#SK4FF^6Y)UL&O%CO=A-UJ;,2>68M^4_,C2\`S4-10UZ$9D3B)"W"%Q M*`_,S0(HKF'7K10L.HL4OD`V6Z`KS`["==_^,BME&,UZ2Y?%>[!V3VRYDILN M*J;+BJFRX54BOCBJQEP)4F7`E288&0*F1D"&P%3<9`MD2H,,@6:C(N0+((=Q MD2R4'&12HMD2@J9P(6'`R=BEK`KL"MXJ[`EV*N&*MXJ[%6\5;Q5U<"NKBEO% M#>!+L5=BKL5:P)=BKL5:Q5=&?WB?,?KP*__3\]2?WC_ZQS.<=;7%7=L*NQ5V M*NPH:Q5V*M85=BAV*NQ5V*NPJ[%6L5;Q5V%6L(0["K8Q0V,*%ZC))55&*JJ# M"JL@R2%>-T@66(V*>4,E0"-P>F6MJB\?MBE29<54V7"JDP\<4J;+_9@5388I47 M3`E2(R)#,%28966P%2<9`MH4'&0+((>1<@62'<9%DH,,"%-L"%AR*6L4M8$N MP*[%+>!#L4NQ5U<5;Q5U<;5O`KL5;Q2V,"NQ5U<5=BKL"NVQ2ZN*M8+5QQ5N M,_O$_P!8?KQ5_]3SS*?WC?,_KS-:%IPH=A5PQ5U<5;KBAK"K6*NPJ[%#6*NK MBKL5=A5V*N&*MX4.Q4M85;PJX8H7`9)"HHPI"HHQ2K(,DA71V-%7D>"7\W*0C,#))VD` MELK;G,8MX"G7(VSI>AWR3`IIIV\F9.)Q\CTKRI$>"MX=09`LPAW&12AV&^12I- M@0L.!0MP):P)=@5V*NQ5V!+L5;Q5V!78JWBK=<5=BEU<"MUQ5U?#%75P);Q5 MHXJZN!78JUBJZ/\`O$^8_7@2'__5\\R?WC?ZQ_7F:T+,5=A0ZN%75Q5V*'85 M=BK6*NPJ[%#L5=BKL5=A5V*NPJ[%#L*MX4-XH3O3SY+%G$-0BU!KVG[\P-&( MJU/V0V_3,B'AUOQ7\'#RC5<1X#BX/X>.,N/_`#D6&_+_`+0ZK_P<63O#W3_V M+76M[\/^EG_Q2HK>0>T.J?\`!Q8WB[I_8M:WOP?Z6?\`Q2HI\B=H=3_X.+)? MNNZ?V+6M[\'^EE_Q2LA\D=HM2^EXL(\+NE]C&M;WX?\`2R_6K*?)G:+4/^#B MR7[K^DQ(UG?A_P!++]:H#Y.Z>GJ`]^4?],E^[_I(K6=^'Y267VDO:QK=02"[ MTZ0TBNT%`#_)(O6.3_);_8X>"M^C/'J!,\)'!EC]6/\`WV/^?!#*,+)$(N$( M5D&^28E7C7"Q140VQ0BX4VQ8HR*.N*"GOEFT=]>TJJ_`UW&`WB58,:>/']K( M9#Z3[EB?4&-?G9JDDGF2:('9-J?CF/D-0`;=.+D2\GEAG:K<3\\P91)=C&00 M4BL#N,I(;@5@![9&F5KAR';)!B4UT>0&<`]\R,/-Q\PV>P^4;53"@_WX-LV\ M-@Z7)S>EZ8/1M+DG;A:S'[HFS'RMF'F\J6+]TG^J/U9<64>2B\>+)#NAKA2H MLN*J31X4K&3%5%TP)4'3$I49%R)9!089$L@IB*2618HD:21S1$4$L3X`#($- MG$`+.P'\7\*8OI&F:=_QVYG-RW33[0JTB#QF<_`A_P"*_M8>"(^K_2Q<;\SD MR_W('#_JN7Z)_P#"H?5/^NH.?)7>+4?^#BR)\+NE]C(#6]^'_2R_6H.?(O>+ M4_\`@XLC>+^G]B:UO?A_TLOUJ+-Y![PZI_P<61O%_3^Q-:WOP?Z67_%*;-^7 MW>'5?^#AP7A_I_[%:UO?A_TLOUJ9?\O/]\ZM_P`'#@O#W3_V**UO?A_TL_\` MBEI?\N_]\ZM_P<6-X>Z?^Q_4FM;WX?\`2S_XIKE^7?\`OG5O^#BP7A[I_P"Q M_4M:WOP?Z6?_`!23ZB=--XYTQ9EL:+Z8N2#+6GQ)P\?]#Z$/D&YV!75Q0WBEV*NP*[%6\4NQM78%;Q5V!78I;Q5K%78%=7%78J MUBE='_>+\Q^O`K__UO/$G]X_S/Z\S6A;BKL*'8J["KL4-8A785=BKL(5K%78 MJWBAK%6\*NQ5V%78H=A5O"AL84,M\L_EWJ/F#2+G5;;5M(M+:R^*^2^O!!+! M&7$:RR)P:DXY5'[9AC9ECR7B!?#*J_D+S!"97D6$6L.FPZS]=]3]P]I<,L<)C>GQ223/ MZ"Q4Y>KS7]AL(R!3C3/7ORPU[1+:_FEO--OI-*95U:SL;M)[FUY.(@98J*U/ M498VX<^+_:QAF!*RQTNU/\N/,FE:>][<&UD-J\4>IVD%Q'+ M3'C^UQ?]V_%_AR4!QRBD7^5U[_\27+H&G$SXHY!4NGTRC]C:W#7R# MKZ:06U"M/V1,SL&_WXW'^7,+-9D1_5P+2M5NC=K!?6?JVS_``EE*\UK^T"2*C,/ M'ED#1]0<_)AB18/#)0\S::MF\01&I3VEO,;%'2)EK"T.Z M;X4J#(:],54RF%5-DQ2H.F*5!U]L"0AY%_#`R"O::--<1&ZFD6TT]=FNY:T) M_EC4?%(W^KCPW[FK+J!$$'B9/\`4X_[^7\#:C?6]A8PM<7EW(L-M`GVGD1R6<3V,7K74<\R5]*2&+]XW)?B3XD9ERCQ@Y'A>:$A_+74+NXOEM M]:T62RTV"*XOM56]_P!#B6>0Q1HTO#^\9U^QQ_:3(G*.XI$+O,'Y>>9=$LK M^^O(X9+*P^J/)H#_>?!B,@*#B*K/^5/G6.[ MM[*.UBN+VZOSI<=M#,K.MTMK'>2+)T5%@@F7UW9N,++(K_8R/BA?"*$OOR[\ MQ6VJZ1IT+6>HC793!I6H6%REQ92R(P25?76@0P%OWW,?`G[S['Q8^(%.,VA[ MKR-YBM=1\P:=/%&ESY9MS=ZH/4^'T.4:!X6I^]#^M&R?S(W+'C&WFOAE(,+! MK$I;P*[%78%=BK>*M8JWBEV!6\5=BK=<"NWQ2UBK>!78JU48I=7`K6*KX_[Q M?8C]>*O_U_/$O]XW^L?UYF-"S"KL*'8J["KML5=7%#6%6\5:Q0["EV*'8J[% M6\(5V*M84-X5+L5;&%"X80AD_E?7-/T[RYYNL+DN+G6K""UL0J\E,D5Y'.W, M_L#A&?7B9\8IBW^+^?Y9Z1Y7:ZF,UEJTEW-!3]T+7@IB4-WX3 M-- MT>-BDB'DCJ:%2.X(R88R`(H[@INLMKJ9_P!(*6NI'I+^9_E,7]3^?#^@AI;>:WF:&=#'*GVD/AX^X]\%4Y$,D9C MBB>**Z,;XI1<0W&*"F$`Q8IG;)TQ8%%^7-%F'YA0:N7X6L>F7@"]I)PG`I_K M+$_J?ZN8>:%S!SSZE.`33FU/I.#52-TV:2(X;8S9V-NUPKS MJK*#NA%>7MF)"`NRYDYFMF0>;WGFAL3+NT@4(*4`1!10!V49EZKD'$TO,I$\ MWHQ&`@%3N*[$'L0>QS$E*A3E"-FTO::ZW!E=AX%V/ZSF.26\`*]G*Q8*QV)Z M>^6XRUSB]-\AVA>\@9-B&'W5S:X!LZG4EFOYP7>E6N@QPWD?.YCM9KFP0[QL MY=$=)>_IL@[91D(HELTX/$*MAOE,).D)AC:."SMGB57-6'KW!E0$]Z1KUPX# M9/=$H%#?G(\7^]3R6/?,EQD-)'A9*+)BJDR85462F*5&1*X4J26TT M\HAAC,LK=$45/]F"K1/)&`XI'ABJO%IVG$F<+?WHZ0*?]'C/_%C#^\;_`"5^ M');#S<<2R9?IO%C_`)_^6G_4C_!_6EZDLO[R[O9?5N9"[`41:`*@\$4;*/ED M)$GFY6'##&*@.'_??U_YR`<946\*+C(%MB4T\E^8AY9\W:3KS0^NFGW"RRPB ME6C(*.%KMRX,W'_*S'RPXHD.1BG19+Y8UG\OO*OF&UN--UB^N`\6H+/J<]D/ M2MQ8 M]2UFSL([1[C2(;>R:2WN0TB2V9'H?!"JO')P^*3_`"_BR/ADU_#\4\8M"YF\FZSIEK:W&FPIP:R-H8KF&UMXU"IZ$%U`8XRJ\?1F;]KXL'A MD1V^I>,('R_^:.DP0VEUKB3SWMQKNL7^LQVZ@,+36K!;222%V^$S1,69(_VN M/VEQEC/3N'^Q8B82W1]5_+;RI?\`KZ?<7_F%[:PO80\J-I\5Q-?J+4)$@,KV MGU>T>=Y+GD[2S<$C3X>>`B19<0"<'SS^7VK37C7#S^7DUCRNF@7BK#+J'H3V M=U%]5DYUC>X62S@C5W^%E=6 MO+GENZL1K!DOX+V+E(L+H'C>*<)(4,3NC1RQ5>%F_P"&7XFE&A<6>`B7'C], M_P"*/^3R_P!;^;+^FZ>RDM^,@836S_W5PGV6]C_*W^2<2*98LXGM],X_5"7U M?\>C_27P@UR+:4RM^V+`IM:ITP,2G^D1_P"Y32^,7J.;EHB_>.*ZA:*5Q]T8 M;,?,-K_FMF,\Q_.>/?F#HTMEJDRD'[1_7D-3'JVZ2>U,-LHGN-1M;8.(S/-' M$';H.;`5S!O=V.U,M_,*YNKGS3:0V]H8[9(8([6%!6BJH!!I^W6OJ?Y>961J7MI5F+(&*EF2!W056C;NJ_"OQO] MA?B;,?,2!8S#26]OQCX.(;5+N6.9Q(&22 MC^@OI*W*3^7`,A*?#"3:[/Y!DTIAHUK>0:L9E(::3E;B`-)R`!JWJ,A@ZG[2 M/_/\)'%>["1BQDY)K6X"EV!6L"78J[%78%=BKL5=BEO`KL5=BKL"MUQ2[`KL M5=O@278VAV*6L5;Q5N+^\7YC]>!7_]'SO+_>-\S^O,MI6X0AK"KL5=A0[$*[ M"AV%6L5=BKL5=BAO"KL5=A"NQ5V$(;Q5O"K8PL5ZY)51!A2KJ,(0K(,DAETW MD:>&*P)NU=[VS34/[IA&D3JAIS)^)D]51)\'^KSR`RMWA;-W'D+S';W-[;FU MJUC4R!B(W84=TXQR<9"\D$3W*1**V%L3B[R@-9TG]%:B;/ZU#><4C? MZQ;GE$3(@O`G@W^4N7XY<0MQ/^5A!IHS88Y*O:4?IG'ZX?C^:C5MHI%,UF247=X&W=/E M_.N-=S3'.8'AR<_X:575U=W21++>SW7R/;CZLJTXHN['V45.9V0T'61%R5KO3-/FUF76VMD_2E53X:Y2``WF1.W10GBVR88I;<1[G)A""D3"E#.OWX54UA>1N,:U/<] M`/F<(%L,N:.,7(U_OOZKBT%O_=TFG'^[&'P*?\D?M9+8./PY,OU?NL?\S_*S M_KR_@_JQ05RTDCEY&+.>K'(DVY>.$8#AB.$(.08M@0KC%*&D&^19`H>0;9$L MT.XRLL@572-*75-3AL&N8K,2\R9YS1!P0OQWI5WX\(EJO.1E7DN49#0MRL0L MHL>1-8FO)H(T`MX+B*VFGE4Q.@EDCC$K0-^]X*T\?+;]KX>7VLI.44Y`QF^: M"N?(?F1!>/':KYMW26)XRKMRB="0_P12LP'V/3?E\2Y'Q`G@/>ML/ M(=_<:OJNEWW:Y$S2*2$7TEY%&'/CQ;]K(^(&?A-6WD741,D>KW,.B^J M95B-S1VY6TXMY^<:-ZD8CD;[3+\?!_3Y<EOF+0VT34Q8->V]^WHQ M3FYM&YP_OEY<`W=D^R_^5AB;8RC2686+L"78%=BKL5=BKL"NQ2[%6\!5V*NQ M2W@5U<4NP6KL5:Q5V"U=BJZ/^\7YC]>!-/\`_]+SM+_>-\SF6TK<4.R2NQ5V M*'85:PJ[%#L*NQ5V*NPJ[%6\4.PJ[%780AO"K>%#8Q0J+DE54PJKH,D%5T&2 M"$\'F?7'2)3.M88%M%D$40D-N@54B>0+SD10B<>;-QXX!C"3D*,_QAYG?ZQS MU"1VNE99Y&"L[DTRG\.3&*/].QP\_>X9XL/?DQ?]+,? M_52'^S3>Q7<9"3D1D)"QN$[MD!'C7*BS6^?;8W_E:&Y`Y20?N9O$%10'Z5ID M<6Q(7)T+PC3[F\TJ\N%]8I#*2&C*JZ5Z5XL#^&4Q],C;FR]<=ANE=W=^8#,0 MEY#)&"?2KZ)XU_EYK51?'(E(4'&V1+,(60;Y`LE;1UU M9M3BCTF(SWT@=4A"++S4H?45D<,C)Z?+F'''CE&2JWR97?F'\P8K:Z6 M2YG%NCJ]RRK$RH5DA5`&0'A&LD-LL:(?3_=Q\,Q^&#DW-+X-?\\:I)=VME/- M*;N(?6;>!8XT,4(,=50!$3CZCJQC_P!^/R^TV"48A,3(I5K#^9["YOAJ<<]I M<:W$WUU)X_3:>(S\F)4C[/UB#]G]N/`*/+H@DA3B\Y^:+>*YBAOW2.[1(KE> M*'DD=N;55W4T_P!&9H33[28#`(\0M-YY\U_76ODOS%=.YED>*.*,.[1&!BZH MH5N4+&-A_+_JY'@"^(4IU'4]0U(QM?SM*G+NIZ-_0XF70N,<)B>+'L?XH?P3_XF?\`23FQFCE!`JLB?;C;9A\_ZY5* M--V/*)^1'U1_BBFL)0Q2V\R^I:W"\)X_$=F'^4O;*SWCFV^1>0?F/Y$FT]C= M6Y]>SY,OK1]`PWXO_(_^2<&2(F+'-LPY.$T7D5Y'QE((/7-9D&[M\9V=!#+* M0$!.,8$K*0#,O*GDG5]7NTAM+:29S]HJI-/F>P^>9N/#U.P=?EU(Y#>3U^QL M/+ODVT'U^9+O5*#A80L#1O\`BV0;(H[T^/,NR10],?YS@'HJ?#F-+%?5RO&\DLUKSB+S0M/TJULS:-8$_Z29/49E:!(72A4 M<5D]/U6W^VV`8Z)*3DV8]K.LZMK%W]VX4C2U=8W#UZDM^S3)XS&_5 M=>31G&4Q_=F,9?[9'CCP_.*9_6/R\_ZMVJ_]),>7\6'NE_IA_P`2XG!K?Y^' M_E7/_BV_K'Y>?]6[5?\`I)CQXL/=/_3#_B4<&M_GX?\`E7/_`*J.^L?EY_U; MM5_Z28\/%A[I?Z8?\2O!K?Y^'_E7/_JHW]8_+W_JW:K_`-),>/%B[I?,?\2O M!K?Y^'_E5/\`XML7'Y>U_P".?JG_`$DQX>+%W2^8_P")1P:W^?A_Y52_XM>L M_P"7W_5OU3_I(C_IAO%W2_TP_P")7@UG\_#_`,JI?\6J+/Y`[:?J?_21'_3& M\7=+YC]2>#6?S\/_`"KE_P`4JJ/(UP1#&+_36;[-W*R7$:GP=%HW'_*&']T? MYT?]DO\`AD=SX67^A$'%/_-E(RC_`)JG?^7-2L81=`)>:>WV+^U/J0D?Y5/B MC/LXQEB,=^8_G!MPZS'D/#]&3_4LGHR?\>_K10<=.HR(<@HA!DPP*NF6!@59 M!DPTE$QC)A@KH#DF)5U&2#%44;X4*R#%"(C7IBA'0+@04UM4Z8L"GEFFPRN2 MA,OJJ2\6J8Y4^Q*O4?U'^3@XJ83Q"6_*0^F2)BGD'[JX`24CX7'V'^7@?\G` M1U"QF>4N?^QE^/YK%/S)O[SR]YE2\MR#:WT$:WEO(.<4M%"LLB'X6_XED(R] M(+:87(ABEQ9_EU?L+F[L;BT#[M]3D5EJ>X64&@]N6"0B6<9Y!L+_`!_61MC? M_D]I"E:Q%A_E..1_7EEV3[W&`H!;*O?\<4H*8,P^';W MR3'?HE\\06M.IZD]<-H$0$NN5WKDPJ7RC?))0D@ZX4J#]*8I0[C"J&D&*0A9 M,604&&`I0\BY`LPAI!UR)9!%^67TE=?M8]8*KI=R7MKR9EY^C'<(T7K@?S0% MA,O^5'F/F!X=N;D8"+W9,[?ESJ.HV!G-M:6,L0FU.!3);\)87CL^$4J(Y_>0 M(^H\2.+/)Q^)^*-B'C`_'X_HN='A*3Z=IWY8M=0_7[R0PR6[O*@D:,)-'.(6 M0RPT'VG2!L$C-,8Q;N?*?E>+R[I,\QBM'OH9'EU.XN]C MBQUGN./U+TXI?@XR/[L'B4`,?UBW\GVMYY>;R[=H9"(GU*:^)GMU8>F> M=Q&5/'X_76>W577TU3C]KXB"=[00+":ZKK?DZW3S(=`6S6PNK:SE\NVL]NLE MW"YN5%S"[R(]+A8O5+GGP]'T^#:M-U/2FLXM"M;*Z:993J M40`E*(TC"(A0J<.,O#X1\7I1\OLX1&CS:S('HQS),78J[`K6*NP)=BKL5=BK ML"NQ2W@5V*NP)=BKL"NP*[%+L"NPJNB_O%^8_7@5_]7SK)_>/\S^O,II6X0K ML*'85=BKL5=A0UA5O%#6*NPJ[%6\*"F_EKROJ?F*ZN(;%[>"*R@-U?WU[,MO M;6\`8)SED:O5V5%559V;[*Y&4@&48VK7_DW5[*QUF_,UG=6.AO:)>75G=1W, M3_7^?H&!XR5EKZ;\Q\+Q_MKB)A/`4=;?EKYEEO[FUE>RLH+*UM+V^U.[N5AL MH(K^-9+4/,P_O9E;X(E5G^U_(V/B!1C*#U/R/YDTNUUJZOX8XH]`DM([^DJO MR^OAFMI("M5FBE1"ZR*WV,D)@KX97ZWY%\PZ+:7UW?+!Z.GW-I9W)BE$A]6^ MMOK<'&@^)?1^V?V'^#&,P4'&0F.F_E5YHU+2;&_L9M/FN=3MGO=.T7ZVBZE< M6\3.KM#;,!ZA!BDI&K\VX?`N/B@%/A(?_`E['Y;M]>NM6TFSAO+5[VRL+B[X M7LT,;.E8X.!JS21.B#E\3+DAD%TCPDTU+\IO-&G6EY,]QIUU=Z;;+?:EI-K= MK)?6]JZJ_K20<5/!4D1W*%N"MR;$904G$Q%!EP:4QTO4]0TV8S6,[0.WVPNZ M./!T/PL/GED)F.X:<^"&6/#,<0_V4?ZD_JBG27?E_5#_`*=#^B;UO^/RU7E; MNWC)#U3_`%H\N!C+GZ3Y?3_I7$\//B^@^/#_`%/)Z0\(]&3_4LGHR?\?\`\U"I MB&R2N@RP-)1*#89,(*O&.^28%67IA0J)VPH5T&*$5"N^*$=`NXQ8E-[1-Q@8 M%.[1>F5E(36$=,@4HR*%)F$<@#1G[0/2@W.1)I/"#L6&?F19-J=C+&C&1K8D MQ%MVXG]DGO3QPD#AI$"1*^CRK1Y7*R6LPI0E0#U!S!R9J>@P:+C-A++^WEBN M6C)I0[9A'4[NY'9IKDMDBXP3%(0SXL@AW&`I49!D2R"&E&0 M+,(.096644-*,J+>$)+E9;`A75020-_'(%G:'<9$JI'`5"PY%+6!+6!+L"M8 MJ[%78$NQ5V*NQ5V!78I=@5V!6\4NP%78%=BFG8J[`KL571?WB_,?KQ5__];S MK+_>-\S^O,II6X0KL*'8J["KL5=A0UA5V*&\5:.%78J[%64?E[K=KHVL7%U+ MKM]Y=GDMS%:ZC8P+=QEBX+17ELQ7UK=U'1>?Q_:1LC,6&<"&;:G^;'EZPLO, M9\I1K;:Q?P:1`E\^G6R6]_/9M.;Z[>Q=9K6S]42P\$X-_=^I\+NV0&,FK9<0 M"&U[SWY/\USZ]IVL7MSI]IK<>BW4>L0V8E$5_I=E]6GCDM$,1]";G)Z;1%?3 M95_=\,(@1R7B"R]\\^3-?MM=\N7]S=Z3HMU9Z+9Z3J_U47,O'0HY(@US;1NK M`W0E9APD_<_"K9['S)I]]J=UH4%_JFGWNFW$E MD]XSP:=9-9CU4A=?3DEJ)>/)N'V,1&0(/-3(%=H_FO\`+RR/DO7+O4KV?4_) M=JT,6B6]F4^MSQ74]Q`QNW?TX87]5/5_=O(J\E^+"8RW'\Y>(*=_YPT;4_RS MT_0O\0BPN;2PGAO-(;2$G,]R]U+=+Z6H$>K;QMZB1_`W!?\`9-DA`B5U]JB0 MKFF?FG\V-'U:+S38V*I9Q7^GV-OI>K16<<-]/Z$<*75G>3*/6D@N.#T9W^'T M8OV/AP1Q$45,P\K3,H.,B$R00B(^V3#$ICIFI7^GRF2SF:(MLZC=''@Z'X6' MSRV$C'DX^?##**F.+_=1_J3^J*:K<:%J1_TJ+]%WC?\`'S`"UNQ\7BZI\TRX M&)Y^D_[%PS#-B^D^/#^9D_OH_P!3+_'_`)ZR[T:^LD$KJLUJWV+N$^I$?]D/ MLGV;"8$+BU,,AH>F?^IS].3_`(]_FJ2=!D@VE7080Q*J,DQ5HQVQ4JZ8L47" M.F*$PMUW&!B4VM%Z?JQ+%.[4=,J+),X`30#5[5Q")3O\O72SEEO&/Q1J:$=`:>.;O3/#Z[G3U7R;YN MMKJ%K6X;:M#OOUV(]QF1*/%N'#!X=CR93-$4`<$/$WV)1]D_T/ME0+92#E'7 M)(0$XV.2"I9<#8Y(,2EDXR:$%+A9(63OBD(=\*4/)U.*5!\4J#CKBR4)!D"D M(:49%F$'*-\K+((67*I-\4+*,K+:$))D"R"&?(I*D*75Q5K`KL571?WB_,?KQ5__]?S MK)_>/\S^O,IJ680AV*'85=A5V*NPH=A5V*'8J["KL5=BK.=.\E:=JGEO2)[9 M#:7MU+#%=7=Q.H,SS2S+2S7D+EV@"1$GZQ%+)(TS*VWI^B./IA^?JIRX9*,B6,H@) M[8^0O*VO2Z3'I4TM@-1LHM1O&EGBD^J&6?ZCZ%)&C]2-)XI;N27^]2VEAC_8 M:5X\9'-EP@H'2_(GE^>.V-QK"1/<6;274UT5AMK6:2T6ZB6]G-"WILT;3?5O4#`/\`;!NG]+XN#+;2 M<_B^P?%\E\,(*SD_+>*&:"]M[^2XB69(;F-N'.1?56)I8ZNH4_Z.[K&W[+K^ MUDO4OI8U�<;?[(=/]EA MX:9XM1"9H;2_F2],U)17%N5HQUIBQ1,8WQ0C84-1BA,;:/`P*;6D9J,!*`GN MGVDTP)C7]VOVY&V1?F M369]`\XU75[J>4DN6+&I).YQR290BAM.U.>WO8WZJ3\5,U^9WW9T`2F'G)$O MXHIR*.!2OB,YS6R]3Z1V9A!Q$,8NGDCA6*G)#V/\,P8N;J(4`DFI22.@0"@' M6G?-UI.3RO:XLIC:2FRTGB-F<5/TYO<>T7A=1'BR+O+NK3P7%0]*FN3PY-VO M/C#UOR]YMG1`':JF@93NI]B#F5*`DX()B65Q26=^G*!Q#*>J,:H?D>JY208M M@D"@]0M+FW_OHR@/1^JGY,-L8R!Y)((2>X&QRP,2E M%C_G_P"QDOYK4_ZC_P!+(-?H/R=_U-*_](DG]<'A8_Y_^QDG\UJ?]1_Z60:_ M0?DW_J:5_P"D23^N/@X_Y_\`L9+^:U/^H_\`2R#OT'Y-_P"IJ7_I$D_K@\'% M_/\`]C)/YK4_ZC_TL@DE_#:07DL5G<_7+9"!%=!2G,$`D\3N*';,>8`)`/$' M.PRE*`,AP2_BA]7#_G*&1;6L"NQ5V`J[%6\4NP*[%78$NP*[%78$NKBKJ[8% M=BKL571?WB_,?KQ2_P#_T/.DO]X_S.9+4MPA#L*NPH=BKL*NPH=A5V*NQ0[" MKL5=A5HQQDDE02>IIBAWIQ_RC;IMAM6U55^R`/EBJ:^6/+C^8=932XY4MW>* MXG,KH9-K>%IF`1:%G=8^*;K\7VFXXRE03$641-Y/U(1"XM%^LVY:0%V41,H2 M5X>3JS-0-)$Z_P"2_%/VUQ$TG&JW?D#S18F;Z[8+:^C%ZDAGDCA!)9D]$&0K MRN.44B^@/WG[M\(F%X"BY_RX\R17D]M;Q07P@G%JLUM-&4DX@29IK:5M^4`E#1QNI9)6+P\%X_ M:]5&^SRP^)Y)\,,:CW4'QWIEP:2B$[9((1*#)A@5=,L#659KI5 MH&/NO5/HR6Q:.'+CY?O8^?\`>_Z;^-SV<]O0N`T9^S*AY(?I&"FW'FC/ES_F M_P`2I"O3`S*8VL18@#OL!W.`E#*+7R[.QBZ@SFC$>(05;*CD[D\** M36?(VF"LTSZA.O8_NXO^!!Y-])RLRD>HBS&/R)0.I?F7HDJB*C+"NR1QT50/ M8#)0$1U:IQF>B1OKOEF\-/2=">K%LN$@>K7P2"%GA\DEJW&I&/\`R54L?PR$ M^%E'B3_R[Y;\B:BRK;:J.==A(./Z\P,P=GI,QB63Z[^6:W.G@V<\&84=$7HLW;6(AC4WEI5CY2@ M+O06[3UD91-. M8?6+V6Y<'<0J*?>3DQ&$6!GDGT9'I?F#R"@"PF8,/V90*'Z0Q MK<:R0&M[!_BCMZ[B2X'[4G\D'_(S#*(AN?J_F_S?ZW_$N-'*=02(7'#_`!9? MXLW]##_M?\[+_%_`QV]N+BZN)+FYD::XF;E+*YJS'WS'D2=RY\(B($8CAB/X M5VD>7M=UZ]-CHFGSZE>!#*UO;(9'$:D`L0/V067?*I2`YML8VB8OR_\`/<^L M7&BP^7[^35[6-9KBP$+>LD3;+(RFGP-V;(')&KM(QE3@\@^>KC6+C18/+]_) MK%HBRW6GB!A-'&U.+LII\#5^%OLY$SCSMD,90TGE'S4FHWVF/I%V-1TN`W6I M6?I$RV]NJAC+*H^R@5U/+_*QX@CA*W2?*7FK6=/N-1TC1KW4=/M*_6KNV@>6 M-*#D:LHWXK\3!6,@BN`DD7)D213',ACD1DD#(RO&S*P9<)%H!I&V^O> M9+EOT=9S,?KT;:>EE;1H@>.YG68V\<:*`H>X5'54^R_V<'"&7$2F6L^8/S`6 M:Z_3-S,\MP@M;D3B&8DGD_8/QG^.5O67]]\C*1D%%?//FPAF&H. M.-))N;?%DN`,1.2R#RKYDN[<7T.ESSV\H M:83HG)2H#NS&GV0!%*WQ?[[?^7)<8">&2"CW`(^C+`THB/)!"(3+`P*(3)AK MDK)E@:2B4R88HB,9)B59J=5/S&-M63'&7,)KI]E)J M%S';6L!-W*:)&GV2>I._V0!N3@D0-RU@3CR]?^Z99/>:1Y6T_E;`37Y%)KQU M^(-W6('^[0?S?;;,;)+:Y9=2U:X9FE8J3TKFFU':/0/:: M#V?VLA!IIUW,I>K4[MVRC%JC(N9JNS(XXH233Y0Y)/PCNYEDY$D[YCR+DP"C#J-]"X,P.3)IPS( ME(OKUTYWE8_3@\0L#`-K).3]HGYX;+$@(^UE:HJ=_'+8EKD$^M)Y&0*349E1 M+AS#5S:AOB7OU7&4$QDETUNR@E?I&52C3=&;5GJ<]M*&1R"#MD8Y"$SQB3UG MR;YOMM5L_P!%:L!<6["@!^VA_GC;]EU_ZZS,!XMQ]3KYQ,#_`$4/KNDSZ5?M M:R-ZL;*)+>X`H)8FZ-3L>SK^RV61E89!*I#DDJ+84J9Q52;`R4'[X"E#2#(% MF$*8I)9%BB0R2R$+'&HJS$]``,K+*P!9V`1CR0:%40E9];Z-,*-':>R=GG\7 M^S%^S\6,O1_6_P!S_P`>:,=Z@608X.D?IR:C^E+^9A_H?5-C]DL@+[1+BV@MM3G-I:7$K3P,L$ MLX:)H^2HSU62/['VLQ\P-"N]OQ$!E6J^8?*5DFL17YLM2A3RM8V,F@Z;J#_5 M4GBU-9!:65[2263C%_I4WQ3_`!M(GJ\/LTB)/S_0VF058];\O:CJ>LV5J^D7 M&C3>5=,LO+NFZK?M;PF)+N.YEMKRZ,L4@NX)?K#%?5C^Q'\/IM@((^:V$L\F MZ]Y3\BS7-WJM^MI=ZAK4+R6'EXQ:K!^B[-"9+.662<4L[I[KCRYSN_U7XE;A MAD#)`("IY?MO+]NJ^7]5UK0-2\GZ)J5Z8KF2^GLM3TZWFDJ;BQ>%D^N?6(EC MEC2-+I?57TI/3^+(F^=%D*83J&H:4?RDL=,M;SU+B+S-?7"VTC4N/JKVD212 MO&#\*N4X_P`O/)@'B^#`D4PW)M36%+L"NQ5V!78I=BKL"NQ5V!(;P%6L"NQ2 M[`KL2KL"78JOC_O$^8Q5_]+SI)_>/\S^O,EJ6X0I:PH;Q5K"$-X5:PH=B%;P MH:Q5O"KL5=BKL*MX0AV*&QA5&Z-J'Z-UC3]2$?K?4;F&Z]$GCS]&0/QY#IRX MTKB184&BR[3//FEP:G>7+VUU!'/]:G2:!X4NA-/:_5TC1X8HHX@#\?K"+X?V ME=OBR'`:;O$!11_-B0O:2)HEI%)::@=1"QCBDA]6:41R;HW]9 MYSYMU^XN]2:*-O@4T*]1\LT_:6<@4'L^P-#&6Y7:/I<,[*K?NC^UX'.9WD7T M*(.*-_4R2]2VM[<(``H%*>.;/31IYKM'+Q66*ZA&63FX<()//+4US')<@!#F2F0MDILP)ZY$ED+:#@8VN[3$'$FUW:"I7 M``$DE5Y`#;),%2.6AR0*"$QM;YDIOET9TU3QVF(OE=??+N.VCPZ4C,"=SUR/ M$RX4NO%3D>V4S;H*^AZG-97L;AJ`$9+%/A+'-CXHO;7=->\GO(/BN]+'UF$C MY@N%ACAGNWC6VBC MN(V^L(\LV5 MSN]/6*W*6MJ8T>\N8YE=GD$LZI]57TN7INWK?$F)G+HO`$5<_ MD[:P^7M2*7DD_F?1-7O;2ZLHU_=W.FZ?)#%0+"+OZJ9_K#1FWYK& M'7BUMSY_\78W+BI!`ID7GC\GO+VA6FMO#9:SI\6DB`V&N:A/`]CJC2RQQF"W MC$4O:=H>CS3L& M7C?W,L#27'%1S*"-6^#C_JY+C-`HX`@+^Q_*&WOA%;RZQ<&TOFL+O3Y)88I; MR/=%OK><0LEL%F7C):2I(W"1.$W]YQ;DBA:=>8?RW\I#4/.VG>7UOXKORI-9 M65L;VYCF2XN;S4$M"[<(HN$7IOLGVN?Q<_VU,,\G[H/)/ZL7VN#_#A$S\T<(1?GG\J M-$T"7S-=Z=>7%WHEA9&?1;B0@.+RWU&&PO;.Z^%>4UN9'?@H3X&AD^S@C,FE M,0\ORQK=BKL"78%=@2[%78%=BEV!78JNC_O%^8_7BK__T_.DA_>/_K']>9+4 MLQ"EW?)!#>*M84.Q5V20["KL5;Q0[$*["KL5=A5O"AV%#>%6QA5<,6*JN20K M+A2KID@A$QY,(*(3)AK*NF6!JDKQY8&I$IDT%70')!K*LO7)(1$8Q0B[>-Y) M$BC_`+R5A&G^LYXC\3BPDS'\P-033PFG0'C%8Q+;HHZ?NUH?O;?*!]-_SD#> M?N>0B[(N/485EE8TK[G-1J\/$]EV5K!C9;I4X@(=S64#IV&:R.B(+T6;M@2A M2"UO769F'+,_%@IY[4ZRV+7-^\A-#L^0)9`+2V*7<]\*KU:N&TB!*H.F^'C#+P"ZM.F$2:I0I6B."8U MBD_=2C_(D'%OP.;`>J#JLHX9VE5_:M9WMQ9L*&VE>+Z$8@?AF0#8M("&/^8P MI6'IBJFU>^!DU#:S74IBB`'$3ZOX(?PXO^+R?TO\`2I-- M_F,J+F(*3*I-D4++E1;XH23*RS1N@^8K_1DU>*T@2?\`3.G3:7</@1^\4Q+3E\.53B#3;"5)G8_F9J=I<)+=Z79:C71?\`#M[')?181Q5MI1)`S1*W'ESY`XPGQ$-8_FAYKLM0TC4HY$;4]'U. M]U<7K!@]S/J7I_6DG"D#T95AX%8^/P2/_DXG&$<:M:?F=ZU( M:A-JVG7DT4PEL[F>7UJ(T4L?UB**3BT,=UZWIX#C"1-*;[SIK%_Y9N]!O1'. MM]K+>8+O4&Y?67O'B:)P:'T_3;DS_8Y<_P!K#PT;096$;K7YDZWJ]UYFN+JV MM@/-$UO=7,*ARMMI:GIZ2+/=WMG4P3R"1Y(XN$C-*4@2-'E;DV(Q@).1"^8_S`O-; MMA;KI&FZ4LMZ-4U%[")U>\O`*"25Y7D:./XG(@@].'E(S\,1`!!FW?\`YBZU M>3^;9VMX(I?.,MO/?O'Z@-N]M51-,MLD7K2_$^`0"F:V\_-+S) M>:7YMTJ:.`Z?YPO1J5[!1Z6UUZPF=[6K?#ZO%8Y/4Y\HT7$0&WDCB8ADF+L" M78J[`EV!78J[`KL"78J[%5T7]XGS'Z\5?__4\YR?WC?ZQ_7F0U+<(4NR2'8J M[%#L*NR2'8J["KL4-XJ["KL5=A0WA"NPJWA0V,*%XQ0J)DE5DPJB$R00B(\F M&)1*9,,"KIE@:9*\>6!K1"9-B40F2#`JJ=R`M_#(Y/I+'JEGYB:@TEY*Q;=F:OWY5EV`73BR\TDNS]?C:OPHPS7F?J=M M&P-F9:<)YD>2I(;>N90Q`N-+5R&R4:J)/5(;KE!/$N6U+=,9"@WX<9F:1EOIS.?A%??-;FU M5/2Z3LJQ91C:.ZIRV)S$_-FW:'LR-`MP#XAF=%T MF_EQ=\+T4/@0?IS9Z4">:]0*])F2;_D8B MG+L7TABD!(R:5I.%5]O:M<%FY"*".AFG;[*C_C9C^RN(%M>7,(;5Q3E]$/YW M_'?YTE.\NU>+ZK;*8K,&I4_;D;^>0]_\E?LK@)1BPD'CF>+)_L.=9&Y&"2&5?@'P\69>7PR)QRG)$FG(Q2%4BY/,_D232X[.[T^XNI M(I()0?L*$2"TCND7=CZMX8)T6?EQME^)(_WO[NLQE:1(=5*Z\P?E]_IT::9% M*;F/TQ>)9F#BPM;@+);0B4_5#]9>SY[NS>@\WV7:-QPR3Q`)1JGG_P`PZKHD M^CWOH/;W$J3R2^G6<-&W,(LI)?TN?Q^G]GG\6$0`-L#D+&LD6+L"M8%=BEV* MNP*[%6L5=BEV!78$NQ5V12'8J[`K>*NP)=BKL5;C_O%^8P*__]7SG)_>O\S^ MO,AK6X0@NR2'8J[%#L*NR2NQ0["KL4-XJUA5O%785;PA#L*MC"AL84)Y8ZUH M<%I##<>7;:[GC7C)=/+*KR'^9@-@6;0?\]I ML?%A_,'SDOY//_J^3_2XO^)5DUW0?^I;M1_SUER7BQ_FC_9(_)Y_]7R?Z7'_ M`,2KIK>A]O+UL/\`GK+_`%R0R1_FC_9,3I,W^KY/]+C_`.)5TUK1>V@6W_(V M7^N3&2/\T?:Q.DS?ZOD_TN/]2LD?EW4!^[8Z1=']AR9+5C[-]N/Z>KBMRV_2NWTY1J2VZ0//9G/J5S5D[NT`V>N_E#':Z[#<6+D&[A3F$/5EZ$ MCY9L\&4<+JM5B(EMU0_G7RZ=/OC&1L14')Y(V+###,\F)2P4%"*'*"'*$DMN M(]SE$@W@H0KOD*96[I@I5X<'8X4-&@Q2%T;BN8^I.SN>S*XMT\TUD,8IMG/9 M.;W>G(I&3R#@0-\K#D9);,>NE^-OGFUT9>3[8CLI0K\6;F(>/DG5D@)4'OF5 M!QNI:9I<=GY=L&5KT();[COZ0<#C M&W^61\1&8N;4$QKO,H?B&:X%V1#T'R!.1>IOU&;72EU6L&S/?/M M/\1EOYK:V8_\BP,R"R3Q3 ME]4_]['^;#^B@VR!;T/+WR!9!!RY`LP@Y.^5R;(H27*BW!"2966QD/D/1](U M6[O+;4+=99"D2VT\LXB@M^-7BFDA5/MR0L_P!6_O'AERG(2.3?C`*/ MTWR%Y?\`0TV:\NGN9;^"[#6T,]J`TBVAGMI+63F-S(/2].X5?WGP?WG[O*Y9 M#NSX(K#^77E53"7\QF6%]1DM)9H1`0(8C+RX\G`^LJL*O]KZN_J_`_V&<>(> MY>`)'Y5L/+6H:+JSWL?'4;)H7TYI9Q$DZWLBVBQ3/[2I)')^Z M^-&1(0(A-M3_`"\\M6;7<;:S.LZP@V<1-HY6?T+N5A.5DIZ?*S14]+XF^LQ_ MM<%DB)EEPA73\N?+5]YE:UMM62/3'C$CRV\T#"V=YDA]*MRT;3?5O4$ES(OP MLK#+.[PKZ MX3DL+\?WF$S*!`)>;/R7HDUD+\R:Y#=QM+<-%2-46.\DA`B*/S5Y;>(R?OA\ M#2)Q5E^)GD-:3>D\7[SX'O`QCB?]Q+]M.' M\S?%A.6NFR?""&O?R_T_3O*-CKUYK$JW.HV*ZA:V46GSRP<9':-8Y+P-Z,4G M-&!Y+_+_`#9(9+-4IQ"E]Y^6VJVFD>7K\74$DFO3Q6LENQ]/ZE-=(DUJMR[' MBHGMY!.K?LIRR0RBSY,?"1^O>0-&\NZU!I>J^8&@;G)%?L^FW<;Q,BDK)$DG M`7-O(XX)*CJW^[/3X9*&4R%@?:B6(!#^>?*5EY4UM]&BU4:G?6I*7X6W>!(G MHK*JL[-ZM0WVA]G+<.0S%TU9H"*0KF2'#DF6FZK?V%1;2E8V^W`PYQ-_K(WP MG+82(Y./FP0R_4+/\[Z9_P"G3!9-#OO[Q#I=R?\`=D=7MB?=/M1_['+-CY./ MPYL?(^-'^EZ(DY1(.3$H1H?;*Z;+6F"N"EM8T)[8*3;00],:6U)@4;* M.HJ$$6^;Z(>#F4WL4^(;9DP#BS+T#RK$IN8'(KP<'[CF5'DX63F\R_,^*2+S MUKRRDE_KTQ+'N&;DI_X$C--D=[B^D>YBJ_:&4!N+-/(\O&]3VS9Z0[NLU@V> ME^?S_N=B/C8VO_$#F9CY?$N)']"1101B,7%T2(3_`'<8V>4CL/Y5_F;+0&K) MED3P0^K^*7\.+_CW\V"E7VMNN1*B16-&G\HZ4Z=AD65EH@'<@$CI7WP%5@CC`V4#Z!@96T8H MB*%`1X4&!;=Z<>_P#XOM;=<"VV`!T%*]<5;Q5K`KL5=BEV*NP*[`EV*NR*0[ M%78%=B5=@*78%=BJZ/\`O%^8_7BK_]?SG)_>/\S^O,AJ6X0I=A0["%=BI=A0 M[;"KL*'85=BKL4.PJWBKL*NPA#>%#>%6QA0]4\K_`)N:-H_ES0[&>WUF:XT. MWN(&TV&\BCT:_P#7FEE_TVV9':5*3<'7]M4RF6(DEO&04I6'YQ7<&E6'E\B[ M'EJ/0)-$U'3HY@O.YD:5Q>P4IP='>+9OM11M&WPODO!Z];1XH:O//WE[5/)N MDZ%??IV!M,L8;"2SL[N%-,N/2F:4S26[*29&YTY5_8B_EPC&0;V3X@(1VL?F MU9:[%J]GJ7ERT&G7MS;W5G%:@P3?Z&_"&.ZG4\I0+,O;O_`"Z?3FQO\`/K16AUNPUV-?]'U: MW$6C8YB]7,95Y/DXWBGWS8:0[N MOU8V>L>=)K1M5MIV(E*V-NBPCH7137F?Y5_X;-C`4#?>75<4I>F.VWJG_O8? MTO\`-\S^ MO,AJ6X0I=A0["KL5=A0["KL*'8J["KL4.PJWBKL*NPH;PJWA0WA0O&%"JN$* MSW0$\KOY9T9+IK*.X;4I!K4LIA^L+:^K#Z9I(&FIP]7CZ'P\>?JY4;LN0*X4 M7:Z9^7UR-.=[R/ZP;.(7EKZILX?K(BC^$SD24Y*9I9IN'^],:6J)P?U,E<@@ M`%:R^1M.LH;JQ)U&[A8"1+AP1/',UU'_`'!2D3PK':3']XWQ2_\``S'$3^/) MB>$!`:_K&D:D+(Z=I$>E/#&PO/28L)Y6:O,`_84=%C_9R['$CF;:,DP0EJYD M!Q2KIE@:RKI3)L2K+DF"M'A0B[:>:"3G"[1/XJ:??XX@TUY,<9BI#B#*/+%Y M--/?2)'$DZV!CB52/O&;#3&A;I]0+EL\\U/2U MXRC+LV8EB-0!ATP!ER**@O2O?*YX8R=CINT)X^2JUWS;37J]=++S1 M$$P.949.KE%,+9V#`@5!RT%HE%E?EZ=S(O$[C,B,Z<>>$EGOF/RR?.'D.]TF M-0VI0J+O3#W^L0@D*/\`C,G.'_9+F+JA8L-VD)A*B^80=@:$'IQIO7I2GCFM M+MZ9=Y86.QF0S@->L05@ZB('H9/\OP3_`(+-AI=CYNLU8,P0-H_[K^K_`,4] M+\ZD?I&P*[`Z=;=/DV;"/7^L7"Q@``#N8\3DFQ:QVQ538U^C`E18[9%D%"4[ MY$L@@Y3D"S"%D(RJ3?$(64C*BV`(60C?(%D`A9&%<@RI#LP_S&`J`L+#W^XY M$I6U!R+)QP*U@2[%6L5=@5V*NQ2[`KL5=@2[%78%=@2[%78%=@2ZF*NP)=VQ M0NB_O$^8_7BK_]'SG)_>/\S^O,AJ6X0KL*'85=BKL5=DD.PH=BKL*NQ0["K> M*NPH=A"IGY=TZPU'5XK74+B2TLBDLD]Q#&TK*L43.-E#<49E"O,5984;U65E M3!(T&41991%^56KRW4[MSMK""Y@C(D`DF:WGEMH_5CEC!MG9?KL#*O+XU;]C M[&1\1GX849?ROUHPZC=V=S!)PEM+_`'B_&_\` M=\N:MA&0,3C6:9Y(LY_-.I>6KO54CO+&*:2.[B1S;.]FOKW<;ER7DW\O%V/B).,*\_Y9:M#!82\Z?6FFAF^$R%9;:2=;AT6/D_H1QV MQ822*GJ/S1/[J3BC*%\-5'Y8^8?KLUE&\4DT-P]K7]XJ&19[>W%790J7+,63:+JCZD+B-I+I7C],P-R^")OYGX_:9?@_ER[' M*1YAJRQ`&R6KEX<4JR9:&HJZ9-B593A8%51M\DA$1G%#)/*#\3J[>&G2_P#$ MER,NC"?)Y+J]]=6VH?6+2>2WN$8E9HF*,/I'ZCFKS3(E8V+LL6.,X<,@)1_F MR;?S%9:G1?,5B)YN@U6S`ANA[NH_=S968O\S^/%_N(_P`QD'Y?>6;&[\X:-]7OHK[2WO(3UQ]7^Z_TJ3J:VR#PY?Z;'_FS_XKA?07FN_1KB:9F!!);;WS M('IC3CPCQR>;W6MB2Y95%2#0>&:[4ZK@Y/8]E]E\5+)+B<4,M`#N%[YJCKC; MUD.R8@;(>[GCEB(5:T&9.'5VZC7=F4P77(N+D@4S8PR6\GJ=/PE(@Y)I7)VX M5)SH]BTTA9A\*`LQ]AF3AA9<;-.@QS5)A)=R$=*FGT9@YI67-PQH+[`"56B/ M6FV,-T9-FI$=&(/482*4&UH?`))I,;"-Y&&^$Y*;,6'B+);.S(4,0-LJ.KIV M6+LHR3[1K7GHRI=F)SPEC-1XU7,O M%J!,.A[4[.\+U!XI^Z/,PZ7$7_(B+_FG(?F9_@13_`"3I^Z7_`"LG M^M0?SYYI'2YB_P"D>+_FG(_FLG?_`+&*?Y)T_=+_`)63_P"*4F_,#S9_RTQ? M](\/_-.#\WD[_P#8Q_4O\DZ?NE_RLR?\4L/Y@^;?^6J+_I'B_I@.KR=_^QC^ MI/\`)&G[I?\`*S)_Q2!U;S3KNKVRVVH31R0(XD54B2,\@"`:J`>^59,\IBC] MPWN(CRBFB8HZGQ5E(88K:N=7U MK5Y'F"0W\V&F-E$_ MI35'BCB>\G>*)?3BC:5RJH0!Q4$T"T51Q'\N&@GB*/T>37;_`%6ULK&[F^OW MLT<$#&=HZR.Y"!+F1HW MEB5&9J/Q]290T=-N?+CQQ$H]S,QEWMP:/YGU*94N!-2:62D]X[K$TT,; MH]3A$RK_`#<."_9R8E$,.&1YJFN>5=:T#ZH=4B2-;Y&ELV219!)$KN7AQI*R'PRT-95E.2#`JRGH!_P/ZV:W3_/-/G.[M\')+,QG)>E_D'#"_YD:? MZJA@(+HJ"*@L('IUS(@X^6N$O3/-T_H-)$B$(2?A!Z?+,S++;=Q^S\/JV-?[ ME@5J>%_ZBOZE#7B=F'T=\Y772W?4^QJ$?4*_W*,N;YW#HS4V27JQ&( MCLE@N"'(Y&F9N"1MT^MB)`I+K3\JCKX4S>X3L^?=H1HE)K"QDGG`45J=LV$( M67GLLP&9ZO9IY=\H&XGHMYJ/[NVC/7@/M-\NV9DR,<#WN!C!R9/(/+G-6).] M*Q8<"&6C18] M-`\;T(W&89C13L-$0),C$X*J!M7-+GD0]YHA'A3G38_49 M#6A3<$>V8,LAMZ#%BCP6]%\H`S:HLAW%*LW;ETVS=:"9+POM%`"%,,_YRA$` MOO*M/]Z?JMUS_P",7K+Q_P"'YYL9G=X_`/27DN@&EZGSR_3_`%-6HY%Z[YNZ MZ,YZ/IT8_P"!=AMFV'5U./DQ]FPMBRN"U6,V!*F0[N$12[N:(BBI)/8#`RNA M9Y(UH[72"&N52ZU0;K:GXH8#V,M-I)/^*_LK^UA-#GS<42EF^GT8?Y_^4R_\ M+_F8_P"FDEYZW+$!8 M4/*'DSRWJD&G7&I_6?0FU;4;2],$@4_4['3Q=CA5327ER^+]K[.1R9"/DRCC M"OJOY9>7]-\O><;ZXFN6O+!1>^5?B"QS::9K=%N)13]YZJWD80KQ^..3(#(2 M1]J>`*WYE_EEY5T'2-?GTNTNH)]&GMHK*?\`25OJ+72W#\6^LV<4:3:=0?9> M8_WG"'[4F1AD)(M,H"D+JWY4Z%9ZQY2M8WO#:W.LQ^6_-LDA"\-040O,;5J; M1,DTJQ;-\4#?:P#(=T&`0WYC_ESI/E_R[-J?Z)OO+=Y'J"V6GVE_?PWXU*"C M^K-"(XXGB^K\8S)]M/WO#ERQA,DK.(>8Y8U-'%+L"NQ5K%7'%78$NQ5V*NP* M[`EV!78$NP*[%78$V[%78$NQ5=%_>)_K#]>*O__3\YR?WC_,_KS(:UN$(+L* M'85=BI=A0["KL*'85=BKL*'8JWBKL*MX4.&%6\4-C)(7#"$*J853'1]1GTO5 M+/4[<*UQ8SQW,(D')"\3!U##:JU&^)%BD@TR2T_,+7K*[:[TX1V=P9)9DE!D MF=))HEA=E>=Y7/P1KQYLW']G!X0/-FGUF5?\I>'\N3CC%VQ.0TE?JRN%#NSA11`S$T'@*],O`:92)55RP-) M55.6!J*LN3#`JJG"&)55.28JBMBK)O+'_'#\R-X6T`^^4Y&7,?%JG^IX]K)_ MTM_GFGS\W<81L@!F.&\L]_)RZ^J^?M%GK0?65C8_Y,H,9_XEF5C%AQ\IV+W# MSSI/K1FXB6JR@L/8_M#Y@YDD6'&T^3@G?1Y3=6SQ2U(H5V/RSG]=@-OI/8NL M%`.:Y9E"N!(.Q[_?FF\,@O32D*])X4-)$M>2$]]CU&9>#$;=7J]3PQ(*6W-G M+<2!%&;W!C+P7:.I!)9OY5\I:=ING3:_KCBVTJR7G+(VQ8]D2OVG;HHS;QJ` M\WEYDY)4'EOGCSA<^:-;DOF7T;1/W=E;#I'"NRC^N:_-FXB[/!@$(UU8\3?,EOI]Q]2U+XM-N#Q9^IB)_:'MF?I=1P^F7TN#J]-Q#BC]093YE M\DR1(MQ!26UE7G!/'NKJ>A4YEY<(.X.5!X1^=WF^W\S>?KJ6RD$NEZ6BZ;82K]EUA),LJ^* MR3LY4_R<;48#;W%PZ,[,SO$>*<7]*/@OIHN1\(=Z?$*5WOY@^8KS3VTZX,4T1 MT:W\O(>!YK96LXN(N-#_`'O-57E^TGP\F4SU0%M^<'GXL/ MK]_)KABO[36+9=1:6X^K7-A*9D>$!AZ4;-\S^O,AJ680I=A0WA5V*NPH=DE=BAV%7 M8J["AV*MXJ["K>%#L*MX4-C"A<,*"JIA563"J(3)(1$9R805=#DPP*NN3#65 M53E@:BJHQ%O&/G5FR)YCXM61XUJQK= MO\\TV;F[G#R00ZY2&TLI\FRFWU*"Y&WH2)+7PX,&_AF=IQ;A:B5/I74]9@M[ MVXAN(_5L;AO4],$!E#CDKH3M7B>G[694<=Q!'-UQR<,B"Q74/+>GZQZDNA7* M7$_'](#)_E9AYL0EL>;N=%VA+%OSBQ)_+E_%.4:)U(-"*9@R MT#T,/:$5S3*T\FZI><4CA=R>@H?X9=CTE.LU?;/'R15]8^3O)48N_--XIO`* MP:/;D/[G,;+F)1?S)O?+J?HZ_A_2 M?E^0UDLW-'B)ZO`YKQ/^3]ELS,6H,7$SZ6,]^4GIEOH'DOS=%]9\MZE%),PJ M]C,RPW*'P,;'XO\`8<\RN.$N;@G'DQJ;?E)YBC-([5V'CP.52QQ/5R\.NE'H MG.B?EV]K/&-3GBMV)`$4CJKU]DKR/_`Y3X,;V)43+`A"&.(_L>KR(DD^WQ^%?M9"4?DTXI\1,CN7S80!0`4`V` MS'DWVF.B&E['\QF1I^;CY^3V+SF/]Q_ER4=&LG6ONLI/_&V;<3^=_##^CC_XKZDN< MY6Y*@[9$I46.5ELBAY*$4.X[Y`M\3NSN7SOY.NM8M-0UB"XU)H@QN#)!&(G5 MI(3Z7U;U&BCD]))E>:W]&)V=/W"?$V8?AR`H.9QA+D\X^3V721J.FM?FQB-N M`\,:F%4@DCC/J*Q>Z3U7BF6*7CZ7H\%YE$QU2>X\T^7U\P:%?:?IPT M^QTW4&OKF*&-?6*_7/61%D)+2>G`%2-7;BC?\%CPFBCC#E\WZ!=7/KZI8@R2 M7MY=2S>E]9?TV@5;.+G<222>DD_J22Q\_P!ODG\N1,#T3Q@E4U+S5Y):*\33 MK%H8+J;4)([7ZK'')%'4BG]M_Y(DR/#)/$%/7O.?E1I[JY M\M:+'I=RPM?J,AC#&(P74D[%6+5CD6(P6_J)\4R1M_-R9$#U*F82/7/.GF'7 M-+M-,U*:.6ULI6FMRL863DZ M/\S^O,AJ6X0I=A0["KL5=A0[)*[%#L*NKBKL*'8J[%6\*NPH;PJXF@KA0R0> M0M:(!^MZ;N`?][8^^^9/Y<]\?]-%UQ[3Q=V7_E5->/(>L_\`+7IO_2;'C^7E MWQ_TT4?RGB[LO_*J:HOD36?^6O3O^DR+#^7/?'_3!?Y3Q=V7_E5-!ZGH.I:3 MZ;72H\$U1%;DX-3#+?#=Q_AF."?];AE_#_20R'( MMR(CR005=,F&!5U.6!@513DPU%47)A@553DF*HIPA!55.%BR[32+?\N=3E)W MN;N@^448'ZWR)Y_!KGS`>*Z@W*Y<^^:7*=WU:Y+-<>5='U3]N:RA]2G\T:^D?^(9DX>1'MY3YBO7DE6 M=':.XCZ2H2KBG@RT(RK-1#F:4F*!A_,W\PK0<(O,%VR***DK+,`!T_O5%7'%#612["JY30Y(,2J+3D#T8=&&Q'R(WR8+%-;3 M4=2/&,WMP4'13-)3[N66Q8&9#T/\N;D6^II7[HG^Z>:`GV*JX_5FXZ_!T^(<_>D,=E!;1+=:F&"N.5O8@T MEE'\S_[[B]_M-^SEE5N6J6:4R8XNGUY?X(?U?Y^3_8Q0=]J%Q>2*TI"I&.,, M*#C'&O\`*B]OGD)2MOPX8XQ0_P`Z4OKG_60A;(MJFS;8$J+'(ED`I,@3^4?)^HZS91_6(-(T^1#ZL$5U!+<)'ZD4:SM,TCP7,=)7<.@ MMYF6*1I($1>68?'(!S#`%*T\I^3KM=(,NH?H\S0^G<&.:&7ZS-%!([>FE2]O M(TR10OZ_[MFFY0_9P&3'DUA;+4?2M]*<6NGW!G@+710Q MNTLZ*X]60?`K)$G)IHV8<17ABW'^7WEB:XL((];59+B%)+CU+ MFT5%`N+=)9%D+*O#ZO/+,B-^\_<_M?%@XRDP"#G\I>3(=*M[P:W+/,]C=W4L M,?HK6:&)6BC3G\0I.WH2JZ\GX\X<>(]R\`2[4=8\E7&AW$-MH!M=<=E%O>Q2 M,MO'$#&S?N2SDRMQE3GRX^E)]CG\>(!OFQ,@0QO),6L5=BKL5=@5V*78%=BK ML"78J[(I=B5=@5V*78"KL"NQ5=%_>)\Q^O%+_];SG)_>-\S^O,A@LPAB6\*' M85=BKL*'9)2[%#L*NQ5V%#L5;Q0["EV%#>%6\*%OHQ?[['_`X4V5P@B_WT#\ ME_LPHN7>J)'%_(NW7885XI=Z<:+K$^F^I"(TN=/N*"[T^7^ZE`[[?8D'[$B_ M$N6X\G#YC^:XVITPRT;,)Q^C+'ZX?\5#^?"7U(Z]T>!K5M3T=WN=,6GKQ/O< M6I/[,P'VD_DF7X6_:R9Q[<4?I_V4?Q_.:\>I/'X>0<.3^$_Y+-_PO^G_`#L7 MU(",],@'**(0Y,-95E.3#$JHR0:R%ZG)AK(5%.3#&E13A0K(3A0RG5Y?JGY< MV$)V:Y,]P?DS\1_Q'(3.Q+55Y`'B]R:RL??--DYNZAR6QC<9$)DS;RM:,]LW M$59Z(![LY7MG%'Y1M[*FUFA@)_REHQ_%LOA]1<.?TAX9YEA] M.X<#IF/G#F:<[,4F6A.8,W.BA6RHMH69%D[%6\5=A*&L4NQ0N&%"Y#OA04PL M@3(,OQM,WH_D>V9[^`=N0)S980ZO4%=^=_[SS$:;B.TME'T1`_QS%R#;XN5@ M/(/)'ZYKY.Q"(TR*>:^A@MXVFN)6"Q0H.3,W@`,GB!)V892!$DF@'MKO(LI_>".:0%:@CX6]/\`X'EF\^FOYSS<`1C5B??(DNQC$1%`4%`D9%DL+8$J;-D2D!38Y$M@"FYR M!9A#RM12?`5R!;8B]F57GY=0KKIT>"^,SQ&V6YF"1'B]U(L:A8TD>3ER?^[D M].7_`",QO%VMR3#S2B;\O?,4:7/JQP1SVTA@FM6D`E,D0B,ZJM*-]5^LP?6- M_AY_!SX/Q?$"^&>]IO)-G:74EGK.L6UC*5#VUS$RW%M(M98R2X*O\$]NT+\4 M;[7/XER/'W!!@.I8UK5A9V.K7=E:W*7]M;2M'!?1BB3(.CJ-Z!LD#882V/-` M%5\!]V!6C''TXC)\Q^O%+_]?SG)_>/_K']>9#6MPA#L*' M85=BKL*'9)78H=A5V*'8JWA5V*MC"AV%78JWD@A]`>6QY8_2/D!+F"];S*WD MNZ:RDC:`6'I?5]0_OHF0SM+0/\229_F/YKT[S-KE MK>6*3N+6QAL[G4KQ(H[N^FB+%KJX2&J*[!A']N1^$:^I([9D8H&(PPH3[\S)OJ5A9:6#_O):Q1,/\KCR?_AF.4YC4/>P MP"YDO(Y=VS4R=Q%N$5<#WQAS1)[#^6.DK.TBW(P'UUW/*;#2KW4[ MMH+4*!&.=Q<2GA#"G=Y7Z*O_``S9KXXC,T/^D7/RZB.*-RZ_3&/UY)?S813+ M],V>EQ/8^7V8M*.%[K;#C/..\<`_W1!_R4DRT9(P'##_`#I_Q2_J_P`V'^RD MXPT\\LA/-T^C!_D\?]++_JN7_I7#^'^>]`\D/^D/*6K:A\<@6<62:FWYDQ2&YO9KM);=IHFG+H'#Z:T;2`LIY.T#/#QKR_8]/EF..! MR;D4BFUGS9:Q26P1_NO5@?FE/JH4Q<@PK^Z58O\`@8N7V4P\,47((&\B M\P7TK+2BNL? M'BW(NY*JJK3DQY(R_"/M8DA>`MZCI.J:=/-;WUI+;RVSK'Q@M;+F^IA#II:6)%N/54LJQ,[*KO13R2O)'^! M_C^'(&83P%=!Y$\V7,$EQ:6(NX(E>266WFBE5$C$A=V*,?A'H2_%_D?ZN#B" M\!2`,&`(W!W!]L*'8J[%78J[`K6*NQ5V*78%=@2[%79%78I=M@5V)5V!+L"N MQ5='_>)\Q^O%+__0\YR?WC?,_KS(:EN$*784.PJ[%#L*NPH=A5V(5O"AV*IE MY=\OWNOZG^CK.2*.;TI9RTS<:I"O-A&JAI)I2/[N&)'ED_97$FD@6B]/\D^8 MM0GB2UMP]K-?+IB:A4BW^LNQ1`U0)45V'%2\2X.,)X"IR>3?-D27+OI5P([( MQ"Y=N/)?2M*5NOBY1*WV?M<7B"\!6VWD7SC=20):Z1<3_`%N'ZS:L M@7C)#R1.8)8`?'+$G!OCYRQKQY-AXPO`5,^4M?+V20VIN&U"-)+7@0`Q>/U3 M'5R@]2)/[[]F/[/+EA$PCPRX>5O-@N!!^CKM;E7^KK%N)%F!6J_OTDB MX_9Y*_[.2X@O"43%Y/\`,8D*7T,+PE9YD\K7_`)=NH+:]FMYGN(VE1K643(%21H_B8"@8\>=/Y&7)1E;" M4*2U,FA60Y)"(B=T=71BDB$,CJ:,K#H01T.2""+%'DR)+FSUZBWCI::T12.^ M-%AN3V6>FT")#?ZOYW\[^LZ\PG@-Q]>#_`%/_`"F'^EB_GX_] MJ_A_A2VXMKFTN'MKJ-H;B(TDB<4(/\1X'(D$&CS>5+$7WF"PMV_NO5$DQ[".+]XY^Y<)8R-"TE_,G5S M?:S.]?M.S?>5[J;H MTCI"I]B.3?AFUZ`.FE]1+,='^*.\@_WY$&`_U#O^!P$[A-6"'CGG>U]"_E%* M;G#G"=.6`W:_&Q?EE`KWL(8?"IJ]?`;G-A=0+K);R"%_,*2WU33;&_N)O31 M_66YD`JY*2$*%7NQ7CQR,H^BCR2,E9/2.*1_'K>/:OJS7$0T^VB%II4;/)_/_F_TTSQJ?%0?A/_``-,OM/.B@"<%I`6DX+9`+2H.;Z>`LCGBRLK7X2/ZX49>?I)Q^+*/ M",EC)$D]PS$R274DQ61F+QN[7\W"1/BAXQ\/BY M($)J_P"9&J:EHNH:0;2*WMM0F,K,KR.55C"2A]0MZK$>`P^ MU1D8Y;ZGJEM$(K:]GAB5618XY&50KDEEH/V6Y-482`P!*%I04&P'08J[%78J MUBKL"MXJUBKL"78J[`4AV*NR*NQ2[`KL"NQ*78%=BJZ/^\3YC]>*O__1\YR_ MWC?,_KS(:EN$*784.Q5V%#L5=D@AV%78JWA5K%"*T^_DL;@S)#!)D;K56Z$4JKH5D3]E\2$@TG\OYE^<)9FN9;BWDNY+I;Z6[:VB,KS+-ZZ\V MI1T67]AE^Q^[^QD>`,N-2?\`,'S0T+P"6".W8Q&&!(56.!80@6.!1M'&PBC$ MJ_%ZG^R;"(!>,I7;ZYJ4%W?WD3JMQJ45S;WC<%(,=Y7UPJ]$Y5^$C[&2X0@3 M+(+CS;Y\ELK>\>T6.PJK07"6*QP2-$\,W,,%$;'G90L_'X?W4G\TF`1">(H% M/S!\R?Z*DUQ!=16DM;^J;OZY)=K;1!_5,CS>F9`-H3)+,WH?9^-O\`8OAA>,H"\UG7 M?,4D<#K]:>%I;B&&WC^)!*L:OQXU;TE2&-47]CCD@`&,B2@IK2[M2JW,$D#- M4JLJ,A(5BK$!@.CJRG_*R8+`@CFY8ZS=M<7CN36IS69I678X84$M/7,LOL]^0R?\` M"8_F4BK?N1EF7DC3\W MF5T?B.:^;LHH*0906T*1&"F5K,!9!L;XI#?$TZ8+;.`M'%K+EZX6)5HUR3$H MA$K3PRP!K)333P%<5S(@TSY/7OR[$@2=E(5Q!(PKU`"$YFGZ76FS,`,<\VRL M_E*U<_[JN9%V[!D4TR&8[%MT\0"`'DUS_>'YYJ9\W;P4UZY$,BFN@7K6U[&Z MFA!&9."=%Q\\+B]"\[A;B;3]73[.H6RB4_\`%L'[MJ^Y7@V;"7-PL!]-?S6, MDY"V\!:3@9@+"<":6,B!U"&%8TI&4]7TF%T'V#+#-=2-=Q^E\47%(_P!E>+P'O43" M*_Y65I'UFX/Z.N&L9[JSNQ9D6JH/JRSJ(RBQA&%L+A39L_/XH%^L(T;\5/AE M>,)3KGG=;M(4TNU^HM'/<33SLD/J7'K010"BDC>G-+(BMZ*R3MZ29.,.] MA*?M^9=ENW$3TH\3'_=/X^ICASF1X)CP\H_@_AR?T\,OXH_[.*"!R+<55#DPU29#K M+_H_R58P#X7O.=U)[AFX)]RIC,U`M0%Y:_FO+YR6D<;L?NH/UY$I# MRG\P;D2W\M#4`[9+-R73#=YO<-^\.:Z9=G$*!-J4)_UQQ_CF:-X.OG MM,)/YFA*^5KNW8?%;WG$CPHA7_C7!DWB6>/:8>135Y$'MFJD[>*F,B$HBV8I M(I\",G#FPD]+$AOO(7*M6TZYC?\`V,RE&_$)FSNX@NNQBLA'>QLG(N2`M)P) M6DX"R6$Y%5-SMD2R"BQR)2H.<#(*#'>G4DT`&Y)/8#(I3;_`_F]U#C29^+`, M*\0:'V+5&7?ELG\TNO/:NE'^4A\UI\B^G_-6#\KD_FE?Y6TO^J0 M^:T^1?.7_5HF^^/_`)JR/Y3+_-*?Y7TG^J0^;7^!?.7_`%:)OOC_`.:L'Y3+ M_-*_ROI/]4A\VO\``OG+_JT3??'_`,U8_E,O\TI_E?2?ZI#YM?X%\Y?]6B;[ MX_\`FK!^4R_S2O\`*^D_U2'S0.J:%K.D^E^D[1[3U^7H\RIYM\S^O,AJ6X0KL*'85=BAV%79)6\4.PJ[%784 M.Q5V*MX5=BAV%6;:`OE=O*6GI=M8I?-JSC599C#]96P+6W$@2AIN%/K''ZM_ MQ9ZOPY`W;;&J1T?E?\OXQI+:E>BS>]A-R0;JJS!XI702HJ#ZC%ZJQ1Q/S;U4 MD_8P<4NB>$)9=Q^2]*MXKW3)%U6<75Y;7%K<,KDVI!%E\T=2#&.5WI9/*2(=WB M/66'_AX_VLGP@BQ_I7'\>6.0AE_B^C/_``9/Z.3_`%/+_L9I:AJ-N_3`'((H M[IU^9DRQ2V]BA^"SMH80!V(C%?Q.0U!](#3IA29RW`L-%GNGV>843_47O M]+8P%R]RS-1_K/%/,=]Z\[M7J3E>:3D8(,.N&^(YKY\W/CR4E)R+)LXJI/UP M%D%6#J,A/DY6`;LALXU^K`]SFLR'U/8Z3&!C5+B(%/HS/T[I.T1NQ^]B"R$C M,R8=!+FZV4M\AU)Z#(Q:I(OF`O%.AZMW.6M5*(?C(/;`"RIZ)Y!U3ZO.F]-Q MFPP2L4Z[4QW95YSTXR6^HRQBL-]&EY&?^+$/&91\N7+_`%6R5;&+`2Y2>&7\ M7"=A[YJL@W=O`VAA3(,UR'?"$%Z+Y*D%SH>LV)W,UF[H/\J$B0?\1S8XC<'7 MY-LD2D5:BN+DD+2<"K2<#)83@4*;G(EDHLZVBM] MI_\`EX;_`)YY89"&P]4OY_\`Q'_%.&,<]11R7BQ?ZA_'D_X?_-_X5'_/8])< MW3NSO<3,[$LS&1ZDGMM!7__U/.DG]XWS/Z\R6I9A"EV M%#L5;IA0[%79)#L5=A5V*'85=BKL*MXJ[%#L*MX4.PJN&%"X80A57))5%ZXI M5E.28E54X4*J')!"JIR2%ZG"Q5[>>:"=)X)&BFC/*.1#1E/B#D@6,@"""+B> MC(-/%CK6H6Q<+:ZDTJ>LJBD-PO(%F4#^[EI^S]E\NVGY2_W7_'G7>K3]^3#_ M`-+<'_53%_LX)%^8%\;C6KQS4D'O8A7,%S6N^*63^ M2=/:[U6WB`KS=1^.9FECNX>JE47O44*3WA0_#`F[D=HXQ3\:4S()<,!B?Y@> M8PRF",A5&W$=`!L`/EEA]$:8P!G*WD>H7A=COUS!R3=C"%)7*:YC%O"P8I;. M*J3=GYLITPQB`%X_5X[B.I'+VVS53^I[;3?W;=XRAVX?9_ M9^7AFSTSH.T>98]>`%R6-%'7Q/RS-GR>=ES44P^5=2AUC39M,FXM))&ZV[-^R[+3;PY?9S+ETEW M.!57'O>'^9+1X+Z5&!5E8JRGJ"#0C-?J([NTT\K"3`YBN2X'<84,Z_+:Y"ZQ M!"WV)^4##VE4I_QMF?ICT<#5BA?<@)$,;M&>J,5/^Q-,DY!4R<"K2<"5A.!( M4F.^1+)&Z;HLEY"]Y<2K9:5$:37T@J"?Y(4ZRR_Y*_[+)1QDBSM'^\SZ+;L\QU:6&GUJ^U!4-C;&,$^G]8+/\7["1\L3DV!7@W8- MI&CM>37GUUVL[73())]2E"AGC],^FL2JQ`,LMPR0QJ?YN7[&3)8B+.H_RR\E M7-MY.DL?,&IO+YTN_JFGI/801K$([M;6=Y2MPWV2Q>)5#>I^WZ>5\9W\F?"$ MN\K?EM8ZU,%N=6DLH5UJXTB>80K)P@MK26[>YIR'Q4@XM'_+^UA,Z7@"O=?E M.+/0O.6I7>J\9O+$YCT^V2*HU"%988VG#$_NTXW5LR\>7+U,'BFWP8\?E MLG@3/7_R:TRPMM:2RU>^DU#0M,36+B6]L4@TV>)HXI3%;WBRMRGI.%C5HOWD MBLF`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`-Z^T$1Q> M5=+M=-M$U:YUAHKN.*_+ZM"GHK-&5E?F\F1.*^:?$58/S M(FVI_GCJTE]?ZCH6FVNF7FIZC%J5S+/'#J"CZI;QV]I'$L\;+$UNR3R^NG[W ME/Q^'T\'A=Z?$2/SOYJTW6)+F;2[<6;:[>/K.M6Z,75+ABRQ6PE6UY$VC>7!8Z-ZEH[:;=6*DGR[:^6TF60BGU6Y MCN/K;"GQ22"&.-EK^PKR\;?F;\W=2\PPZ]87MO,=$U:WLDT M[2VN6>+3KK3TC1+B`,.'&0)+ZT2*G/U?B^*-<(QTO&P#)L'8%=BKL"78%=@5 MV!(=BKL"78J[`JZ+^\7YC]>*O__6\Z2_WC_,_KS*:EN(0["KL*'85=BKLDAV M*NPJ[%78H=A5O%78J["AV*NY*#0D`GH,*TV"#T-<*"W7;"AM2"*@UPH(55PA M0O!VPLE6-@0*&N%!5@<+%44X0JHIR2"J`X4*JG)!B60>5B4.I3?[ZL917WWNGV<@#T M9&&]CG^/J7):D2KQ821.?@E'?YCLWMAC'=!D]I_+K2672-OA:[>A;^6*/=F^ M_-C],0'6'U2*9>=-2`MOJ$XQJO%%\%&61],?>UGU2]SQK5Y#ZC5\ M-UQ(*'QS8:<.DUYW2*Y/)RW*6MG$T]P_V47P'4D]%4=V.,8F1H,,N6..)G,\,8_P`7X^K^ MJF9N=/T(E;)DO]9&SWU.5O;'N(`?[V0?[];X5_8R?$(2U@M[E(HVN9XFEGBB$E9FM08YX M6EX?;@GC5;A/W:31-E.0'HV8R*3#3&_+BTM[$F6WGO)8+R"\-R+GTF]:T(@, MZJ&:!DNOAY6YY)^S\/Q9$\39L[A^3J-"R?6)E74)#*LTDJ*;1[AXO4>![EUM[P"BLTB1 MV;/+$DC?NYXTFB_>_:,@;6)"9ZA%^5$?UJ.U`D,L(CA=)KGC!((;HF2*HJ_* M5+#^]Y+^\D_UDB.)3PHDM^4]]YE-S=7`32Y(P;M6$L#&;<)/4^/C@]0"?24'I=K^5J_H^34+KU1*E;FW5YT,*K)=^LR^ MD7_W7]E6PDR0!%!CS#Y=T2>SDT"P2]B>-FU`7W[QI&2]D>&-U="J?Z(L*2>E M]OU).3?LJ$/-'$!R2+7M5CU;4VODLH-.1HXHEM+4<8E$,8C!`\6"\G)^)F^ M)OBR0%,2;0&%#6*NP)=BKL!5V*NP)=@5V*NP)=@5V*NP*[%5T?\`>+\Q^O%+ M_]?SI+_>-\S^O,II6TPJ[%784.PJ[%79)#L5=A5O%!:PJ[%6\5=BKL*'853S M2]6TZVTL03`EE,YN;/T^2W9E`$):3HGH4_:_V'VLNC(`?CU?](N)EPRE.Q_1 MX97_`'?#]?I_I_\`27THNYU?RQ<2JMQ`);=9WF#10M$P62XYE`*BB>D?C3^; M[.2,XD[\K_2U0PYHQV/JX>'U2X_IA]7];C_B05]=Z%ZUNVGPK'PN/5GE](GX M%"<0L;D+Z982-Z/^QR),=J;H0R4>(_P]_P#6_BC_`!?3ZTRGU#RW=">[NV%S M+14>J2)R"0350`RTGIQ_?_8P7%LC#/U/7OC^/#_V MOZE9=1\MH'FC7E=-)(ZL86#4<2*59B>+(0T=/Y-*_ZTH/_&N6PZ^YQLW3^LP*]-9F^>:^?-SH M*"KD&2<>7[.2>\2-!RYL%X^))IF1@A9<;/*@^@].M4T[2HX5'Q",(O\`JC<_ M\$^91-F^@<*((%=2Q;S'Q7D9#5SN1X9K]5KA%Z'LGL66;?H\K\Q.%F(`IWS" MPZSC=GVAV5'`-D@+5S*MT1C2TXJV,0JH#MA8K6Q2%HVR-,@4UTZY^#B3TS$R M8]W?Z+5U"E6XFJIS*PQIP]7ELI8YJ2;C:;Z/B4%INCS7J27,DBVFG0&EQ?2_84_RH.LDA[(N",+WY1_G(SZD M8_2!XF4_1BC]4OZW\R'].2^^UF)+9].T>-K73WVGE8_Z17^RDQQZ8\7B9#QY/X8_Y'#_PN/\[_`&R23&G3*G,6'`E2;`JFYR*5 M)L59'Y$\L6/F"YN[>Y2ZDG401V2V_P`,/K3R^G_I,X2;ZNE/[N1XO0Y_W\L* M?%E621#9CB"F.F_EBTEO9W%_=3`7D%VQMX+=GFCF@M#=0E`"5NTD4?[J9>7^ MK\60.1D,8;/Y27*20I/K=JOJ7SV3E(Y9.$<;2JTU%ZNOU=F>V_O45E_RL'B^ M2?"2SRYY8TG4_+4]_*[&^FU6VTC3>4C1(3=1EEDX+'+ZDBMQ9HFDB7T_V^6& M4B"H@*1D/Y6WEQ;BXM+YKF-]06PMPEI*&GB:XEM1ZN+35X1;6EO-.DT\4T3W/IS7*(WH.!);1NMH?BD'P>I%S^T MW%XUX$,F@^1]-U)M*\Q:A=+(HB>74+.-OW2S6J7`3ZNX_>%)']%W]1?]^+\* M_$\1/)!`&Q8M>BT%[<"R+FR$LGU0R&K^CR/I\R`/CX<>6V38%1Q5V*NP*[%6 MO\Z8I=BKL"NQ5V12WBK6!+>!6L2KL"NQ5=%_>+\Q^O%7_]#SI)_>/\S^O,IJ M6X0AV%6\*'8J["KL*&L5;PJ]`\C_`)0V0!2#.]Q`W_%?IMSY_"^$S`1P(Y?RAUB2X9(-8TZXMD$Z&[A M-PX:ZM)D@N+6.'TQ/-)"TL(M+_D?9PG($>&W9_EI=7=FMQ;ZM:74EVRQ: M-!`2#>2R7BV,:JTWI<"TI>3TR/6^K)Z_I\,3/R7@;OORPO;%KU[K6]-6RT^V M%W=7J/)*JK]:%FT9CC5I1+ZK*R*R_OHF]1,(R>2?#2SS)Y,U'RY)/#J5U;+= M0RR1I;*S^I-&DGIK/!5>,D,O][&W)?W/QY*,P6)A09#)^7NEQZ)#&1?2ZR^D MVFNW6IPF-]/M;>]8%$FMZ"X,$,'QW%[$\GI3?N?J_P"WD?$-LN`4MM_R=UU] M1ET^ZU.PL+J*[BL"MP9B&FN9Y+>TXF.-ZI=O"[PO]CT?WK\4P^*.Y'AJ.F?E M%YHU&RL+B">Q2ZU$HT.GS7"QSB"25X?7/+9D0Q/)*J&$Y0$#%LUI MOY97FIU?3-9TZZMKB=+'1KH?6474+UX3/]5A5XE>.15`5VN!%$LDD:^I^\PG M*!T48D?<_E9-,T4FEWD44=U;6WZ.M;QF^L7M\=-BO[N"#TT*)Z/J\4]=HU9G MCB5W?$9>]/!:DOY7WQL8VCU*VGU>XA^LVFDP\FDF06JWC+&?VY/1>@X+P]9) M(6;GPYGQ5\/9C^L:4-+O&M?KEO>.A99&MF9@CHY1D?DJ\6JNW^3\661E;7.- M(-3OE@8*BG"I55.%BJID@P+(K']UY3U*7H9IXXQ[A$9C_P`2RV/(N-E^J(>? M7!K(?GFNES.`!27H_P"5NB"?4Q;F=W9)B[%"X'"A<<56X$ MMH[(:@TQ(9QF1R5&N';KDALLLA+0-3C;451<(8E3_[KCHWQ?MYM)Q`HR_TOX^ET^+/.9ECPU=^K-+U8\7]7_5,G^QC_`!,: MU35KO470R\8X(1QMK2(<88E\$7];GXFRBK)J$UE.EM%IT"RWLKO(O[J5Q$` M!"LDCAF(YCCQX_$_PY"4@.;9CB2IR:%YDB:V6."Y<.J-9M"9"M'$9`BI3B?W M\6R_[\7!Q!-25;/RAYPNKI;[E9/K<=K1F,<275S0)R:SZ`CTNZ=;DS&U]-25D-L&,S(5-/W2H[>I_(C,K<%P<07A*/ MG\D>9;;0Y]:6ZA?3;-1+(T-VP8,_I?8B/%FD(GC8LH_WY\7P8.(72>$TQMII MV9V::1FE!65B[$NI-2K$GXE)W(.286M)8FK$L3U)))^\XJU@5V*NQ5V*NQ5V M!78I=@5V*NP)=@5V*NP):P%78J[`JZ/^\3YC]>*7_]'SK)_>-_K']>932LPJ MWA4NPH=BKL*NPH=B%=A5--+\S^8=):Q;3+^2T;3+E[ZP,=*Q7$J+'(XJ#7U$ MC1'5O@9'4&C33I5GL)%CA]:%XY#,BI/P]81),[RK M!ZGHJ[,W#'A">,JFH>=/..JI/]:OY98S%`DPAC2)(X;69IH`HA5%@CAGE=X^ M'!>38\("\114OYD>?_TJFHSZI(-1A3C&TEO`.!:03^J(FBX+<-+2>ICP17B*R#\P_/L%E:Q1ZM/]5LYHY;:1HT8B>&5KB+E,4Y2-%++)*B2.W'U M'^'BV'@"\1I$1_F1?V_EFWT6.RMXS9VXM;6_+$M"1<&Y6YB4CE#>K(?AGBF5 M?^*N6#@WMD)[4E>H>;_,>HB[6\NPT=_$EO?1Q0P0)+%',+D*RPI&O(SCU7>G M-W^)VR0B`P,RC]>U_P`PZO;75])I30Z1/#96<$S0R31V]OIX"6\<5Y*I;XO] MV/S_`'OV<$8@,I$UY(2V\[>:+?1QHL=^_P"BO2>V:`+'S-K*W*6U]?CZZVSM M\?HB3TO4_><.>2,!S0,A1=[Y[\TW.I7&JVG5ED# M,6A%>+2-^]?ESY8B`Y+Q'HAQYR\W6\5K:B^D@;3IA-:/Z4:7,+K(9E59BGUA M8EE=Y5@Y^CS=FX?%AX`@SD$2OYC>=Q->RIJKHU^B1SA(X455BC:&/T$5`MJ4 MA=XD:V$3+&[I^UA\./<(K6YMHM4D2&[ACMI5"QDB.&W%H@C8J6A M;ZJ/J[O$4>2'X)&;#X82)ED)_-N_-W:7B:3:QW=B\4UE*'>L$UO"883"U/56 M%:\I+>26:.;@BO\``F0\%D<@8G=7ES/:V$4T*QQVT31P2K&$:4-*\C.[@#UF MYLR\SRXJOI_LY:`UR-J"G)A@O!PJJJ<*%:,Y(,))_>/Z/DNV%:&>>=S_`+'B M@_5EA/H+C$7D'N8"WQ2'->7.')&6D)9QEL(M4P_ MX49E3VH.%'CV'L]IKEQ/(-?U`K&^_P`7M8W,]R+>VB::>0T2-!4D_P'OF$8$F@YQF(B MR:BC8)M.T&4>B8]1UQ31I_MVMH?",=)YQ_/_`':99$C'R]4_]C#_`(J7^Q<: M<)Z@;WCP_P`WZH0I%>VYBEE/IQ2"52/09)$HZ[GEQ;[+9"0!YMN,GHK1^??, M]I+%ZHOV9OA?!P!/$5S_F'YBNKB"0K M:S7$-S'<:>/0YM"R>FHAA4D_NI/0A62-N?/A]KXVR/AAEQGN;NO./FF.U:UD MM8[.+TS;3?Z,\9>)X);>&*1G._U>WFFCM?VE3_?G#!PA!D6,U8"G-B`*4+&E M/"E*O\`_]+SK(/WC?,_KS+:5N%785=BAV%78J["AV%78H=A5V*LI\BWFFI! MYGTJ^OH=-;7=(-C9WEUS%NLZ7<%R%E:-79`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`\3IED^*A3"% M64TL+O\`*91:6>H061/VD^/GZ^1( MG^/ZK*PD_P"8VJ:;>Q^7K>SN;">33[*X@O%TI)([*.1[Z>51"LJH0K1/&_3[ M63Q#FPR'9B"G+VE>#A0JH<*%:,Y(,"G?F5_2\N:1#T_TJE2ZU=F24[[#89=I<3@= ML:JS24G-B\N3;JXH7K3"ALIA1;17%-NIBJI'"[_9RF>41<[3Z.63DT\90T.3 MA,2#1GP'&:+0&3<=>!BAO%6@,574R5(6TR*5>V`#@Y9%C)F'EN;C&X<].,@`_IA#"1KWL#UEI+/ZQ8VBF!:E+F7I++3L6_ M93_)7**I3WD/IC_!#_CW])B9'!P!L!T`S#K=S^C-M/;UO)U^G>*2 M"4?0Q4_\2S-&\'$CME]X2)CD')6$X$K".6%!+P:&X6:K1F2"OV?@/J?`_P`7%LKG&Z;<-\S^O,QI6XJ["AO"K6*MX4-85=BA4M_J@GB-XTB6?(?67A56E6/] MHQJY56>GV0S*N*1S>CWWY16$MY?V&@:M-KZKA M7598TI^W-\*_!\65C)WMG`&-P?EQYJDCMYI%M+2&XADN3+=W<,"PPQSFT,ER M7/[A6NE^K1\_[R;X4R?&&'`Z#\M_-DL-Y-)#!:C3;@V^I1SSHLMOPG2VDDD0 M5_=QRRIRWY,O[Q%9/BQXPG@*$\Q>4=1T37I]':6WO)(K^73(9[>5&62:%UC- M4KZD0Y.O]XOVN:JS>F^$2!%H,=Z3S5/RWLUU.^T70=974-.;+@!Y("Q_+/S=J%I97-E%;SV M^J2K!&5NHPHD:*2XC6*\.+\&R7&$"!5#^6?F7D(%BCFOY+F" M.*2.YMWM7@N;-[U;GURW]T((GE>;^YCC1O496Q\0*8*UM^4GGBYF:*W@M)6+ M)':D7D`%VTUN;J$6A+`7'K0!FCX?M*R-Q?'Q8KX:C:?EAYMO-5ATJW2TENKJ M""YLG6[B,-S'=,TWM[2*T<3RS.W%!+)>B%5/[?!5Y-)@&7O2<:RZ_*[4K32+ M%[F[AAU^]U"\L'TF66)!;I8(IE>60L6+L6!5(U?]VT;?$TR+A\7?R1X>R"O/ MRZ\T:>EW)J$=M:I9S>@1)=0(]PP2.5_J:LP-SPBFBD?T_L^HG[7PY(9`4>&B MW_+77%N=2("+8Z5>M:7Q:6)KF*..Y2UDE,2,RMPDD3[+_%]I/W?Q8/%#+PTJ M\QZ#+HNK75F9!-;Q7-U;V\_).C"00B"#M%&HI]%=7;EY2:?:/`HC+$;YI-7(F3W?96(1Q@H/5XD68D;5WS*T,BZ MOMW&!10`&^;)Y9=QPTAJE<:6UZH<-(MIRJC$J%B_$VV0ML$249;V<[D$`XC( M&?Y>19?Y>TZ6.6)I`1\0H/',[!*W7:F!%IUKSL^H70)V#D`#Y4R=M0C22>8H M/76*\`_OX_C_`-=/A;]6,Q890-%@UVG&4_/,&0W<^)99Y7;UM(U2VZE[1V`] MXR'_`.-\"XT]LD2DQ.U<@Y"F3@2L)P*%IQ9*;9%"F<54S@8LG\D0:-+; M:\;Z*UGOH[6(Z5'=F(#U3.HDX">2&%CZ7+ER;DJ_%&O/*LE[-^*J3%M$\@SZ M7%ZVJPVEZLL!*2T$JU; MS!Y1O=%GM[/RVEAJTDJ-;W\3D)'`&Y/&8JG]XWV/4K_=_#Q_;PB)OFLI!C62 M:FL5=@5V*NQ5V*NQ5V!74Q2[%78%=BEV!78J[`EV*M8$NP*["JZ+^\3YC]>! M7__4\[2?WC?,_KS,:5N%784.Q5V*EV%#L*NQ0TRAE*GHPH?IPJR?_E8GFUF@-X]^HDCY`EX[N0RQN&7C]C[&/`%$RJ7?YH><+RRNK:[EMYY+U;A+ MF]:`"X9;JX6ZD')2$_WH0.C^GZBK^ZY>DO#'PPOB%*O,/F.37;E[ZXLK:UU2 M>YFO+V^M%:)II9N!W7DRKP=&E7C_`+LED_9XJLHQI$IVFFH_F;YGU!+I9DL8 MVU"*>+4I8+2.*2Z>ZC$4MQ.P^U<,B[.O%%=GE]/U9'?(C&$^(57_`)6KYM]" M*$?4P(Q"'<6XK(;:UELHFD'+A5;:>2/]VL:\OWG'U/BP^&%\1#VWYD^:+5;0 M1/;!+);9$#6Z,'BM+-[!8I@=GBEM9I([A/\`=W+GCX87C*K'^:GFD7=G=0_4 MD&G3K/80);KZ,'IVWU1(40D_N$A/V&/)I?WKNSMCX04Y"[2OS/\`-6EP6<-M M]4*:?':1V?J0!BAT^66:WDJ&7E(K7$O+GRC=>/*/X$PG&%\113\Q?,?U-+-3 M;&V@6Y6SC]$'ZNM];R6]V(B35?K22M)-RYNEE M:_KHO)W MMKJ4O?R3":!>,GZ41([E6X%"J<(8UA])H_15?W;8?""^*WJ'YE^9-2@GAO8[ M*;U6#0R-:Q\[4^C%!(;4_P"Z?6BMH5E-.7P2(*$+Q^L+S5N/JG\./A!/B)-K>N-K$_UN>U@ M@OY9;B>^NH5*&XEN9VF+.M2B^GS].-4"_N\G&-,93M`*IPH15G% MZUS#".LLB)_P3`80Q*)\ZS^KJMP1]D.57Y+L/U8=1S:-/R2_1K^1Q19 MY9;/0]+@,5M96_1[B02-\BW%?XYDRV<2.YM/-0U!5U"85V6H&8V>/I^:'/O)]"T4:QA`:O4RYFZ$.D[>EL$`HWS9AY0K^&-( M;50-SDD+2Q)XJ/HRNRX13NR6Q2@"@L.YZ9&.0VSRZ2(#)M($$KB@W#"F;C1R+Q_:N(1.R7:R M:W]S_P`9&_7F>'4%!A1<:;/!U:W<3(/\E_A;\:9./JDJ?HVR#DGFIDXJL.!0L M;`R6$X$*;'%5C8&*P@'KOBR#5!D5:H,4NP%+L"NQ5V*M8%;Q5K%78J[%78$N MQ5O$JU@2[`KL5=@2[%78"KJ8I:Q5?%_>)_K#]>!7_]7SM)_>/\SF:TK<4.PJ M[%;=A0[%74PJ["$.Q5O"K6*'8J[%74PJWBK(OR[GT&W\\Z+/KXB_1,\9&EFNK=X[6XD@A^,<9I7@MG@7T96^&.HD@>EMV/-!V7ES\OE]*W2 M.VO-3ATV2]B2YU'ZM#3]6UW5)/4M-4N!?:W-HVF3W\=E97!.I0J"TJ/"(%^IM+<1?O8UN&C^#EP M]-P"0/DG8MW4OY>Z;I=R=)@L=2T>UTO6+2*5[CC=W[IJL301W`!29&-OQFCF MA2)YHN<<;JG)(WU%(H(#4?*/Y:VT'F(03P26]IQL6.IEIT:" MR:6.Z5FD2*6.ZN:)&(TN/L^E^[_O7>*6R\,4)-HWDZRA)LI[>WM)]'G*:A!J M`FNKM6M[=I'N+4DK;NLSSHEL/3>3T_2]-_3]=SIP MH*;^64#Z[9`]$D]0_)%+?PR<.8:\IJ)2_7YC)=.?%B88A'O%%($C_P!6($?K&2D;8Q%)9Y@OFBNI&!W) M)PY0QPR(+!M3NWFE8GOF#*`MVQU$B*2QN^0:U/`EL#"A40;X4*C)45[C#2`5 MHP*N!-1B>39C^H)_82CT!^.:+,/4^@:2=XPEFHRAI3FPT<=GG.W,ERI#QTKF M>\XJ,R@5.%:M?;VES=D")>,?\Y[_`"RG)E[G-P:2SNG-OI=K:J"]&D[US7Y) MDO1Z73QB&Y+I%V4#*AB)<\ZF$4.;AF.[?0,NCI27%R=J1"8:ZK4]L;;,ITJ=1-'PZ5%3FRQ8J>9U6I.0V5'6-M0NA_Q8?ZY,:K0P3484/%2?GE6<-NG-A#^6I_2O87_`)'4 M_<:Y'`=V6<>E4UN+T=7O8AT69Z?(FH_7C+FVQ-Q!\D`3D62TX$A83BE8<"%, MXJ5IP(6G%+6!6L"78$M4P*[%78J[%78%=BKL5=BKL2EV!78J[`KJ8I:P*[%7 M8$NQ5V!78JNC'[Q?F/UXI?_6\[2?WC?,_KS-:%N*NPJ784.Q5O"KL4.VPJ[% M785=BKL4-XI:PTAV*NQ5KTTH!Q%!T%.F%;=P2E*"G6E,*VWP2E.(H>HIX=,5 MLM\5K6@KXX46X*HIL-NGMB@EL*NWPC;8;84V5X"UZ>_TXHM>H`Z84E>#BA># MA2J`XH*=^4=]8K_+!.:^'[LC^.68_J#3G^@H:^M8I+@BNP/7#.():X2H,E\M M2Z?;:;="(,;V-"Z#KS`':G=3\66QV&S3+>6Z*\KM74H]Z\8Y&K\E_MR)9)7Y MG:MRYR>5AA89<[N(V[O2]J&$:478NU3F1CQ\(IUNJU!R2M4 MBA=OL@DG8`"I)]AEP#B%'6^F1HWJ7AY,.D`.P_UCW/MDCC[UAE[D8]XRBB?" M!T`RF6"W-AK.%"RW,AZM@&GBSEVC,J)D9NIRP8P'&GJ9RZM,EE.AFU_332VC5MI M[:26,?RD_:3_`&+82QZ))YCWG<^^2R,<3$+D?&ZU1;EF:FYW)P');*.(A2MY!ZH(R,3NRF-D5YL7E=6=S_`,M%LM3[QDH? MPICEYL].?3\4A)RIN6DXI6G`JPXJL.!BM.*M8I:P)=@5K%78$NP*[%78JUBK M>*NQ5V!6M\5=BEV*MX%=BK1P)=BKJ8%=VQ5V!+L571_WB?,?KQ5__]#SO)_> M-\S^O,YH6X4.Q5NF%78J[%784.Q5K"AV*74Q5O"AV*M85;Q5V*NQ5U,*MXH= MA5V%#8Q5<,4+AA2N&*5P.^*KP<*&1Z.1'Y;O7[O%)O$5WRHRW;1%$W=J_H17:'E!*/A<=*CJI]QDI1VMA&71D_D>:LR@_:"RBG M@&3K\JC)QY->0;J7F$#UGRW(TXV)70^+,23FA!OURIFIX&38ZX4*HZ84+AA0 MC+28JP(RR)82%LQM+B*ZLPTBAY(QW\,L-VT@;>YM+>UE:AA``\#A)I`%JC^G M$A2-0B>`VPQ*)!(;Z;XCC(I@$JDEWRHEN`0[R5.1MDLY'`K1;%6U;?%43`V^ M3""G^D2\95S(@7%R!E&K'U--MWZE)"/^"7^S!+FB')A.OSO'^8_/(2'"&<3Q%1L+@EQ7K@@4SCLG_F M0!M(TF7O^^2OR*G+)2>5U]1JZO9=3VG\?^,>;K\I_2A_LO^)=-_*)_U+-_L/\`BUO^&$_Z MO%E]UQ_U3Q_*?TH?[+_B5_E"7^I9O]A_Q;O\,Q_]7BR_X&X_ZIX_E?Z4/]E_ MQ*_RA+_4LW^P_P"+:_PU%_U>++_@;C_JGC^5_I0_V7_$K^?E_J6;_8?\6[_# MD0_Z7-E_P-Q_U3Q_+#^=#_9?\2OY^7^I9O\`I7_Q;7^'8/\`J\V7_`W'_5/' M\N/Y\/\`9?\`$K^?E_J.;_I7_P`6[_#T'_5YLO\`@;C_`*IX_EQ_.A_LO^)7 M\]+_`%'-_P!*_P#BVO\`#UM_U>;+_@;C_JGCX`_G0_V7_$K^>E_J.;_I7_Q; MO\/V_P#U>K+_`(&X_P"J>/@#^?#_`&7_`!*_GI_ZCF_Z5_\`%M?H"V_ZO5E_ MP-Q_U3Q\"/\`/C_LO^)7\[/_`%'-_P!*_P#BW?H&V_ZO5E_P-Q_U3Q\$?SX_ M[+_B5_.S_P!1R_\`2O\`XMWZ!M?^KW9?\#[+_`(&X_P"J>/A1_GP_V7_$K^'PH_SX_[+_B4_G)_ZCE_Z5_\6U^AK+_J]V7_ M``-Q_P!4\?"C_/C_`++_`(E?SD_]1R_]*_\`BW?H:Q_ZOEE_P-Q_U3Q\./\` M/C_L_P#B4?F\G^HY?^E?_%N_0]C_`-7RR_X&X_ZI8^''^?'_`&?_`!"_F\G^ MHY?^E?\`Q;OT/8?]7RR_X&X_ZI8>"/\`/C_L_P#B5_-Y/]1R_P#2O_BW#2-/ M_P"KY9?\#"/\^/^S_XE?S>3_4'A MA_/C_L_^)7\WD_U'+_TK_P"+3.WFT:+19+']-6AFDG]7EQGX\>''_??7)1X` M#ZX_[/\`XEJGGR$@^#E_Z5_\6DTFEZ>[$G7;'?\`R;C_`*I94<-P`R]U(]+N,`$ M0?KC_L_^)9RSS(_N#PH_SX_[/_B$_F\G^HY?^E?_`!;AI&G_`/5]L?\`@;C_`*IX M^%'^?'_9_P#$)_-Y/]1R_P#2O_BUXTS3AUUVQ_X&X_ZI8?#C_/C_`+/_`(AC M^:R?ZCE_Z5_\6N_1NF_]7RR_X&X_ZI8^''^?'_9_\2OYK)_J.7_I7_Q:^.QT MU3OKEE_P-Q_U2R0A#^?'_9_\2C\SD_U'+_TK_P"+3C3+S1;4D2ZU:LA%"%6< M_KCR=0KZX_[/_B6OQLM_W.7_`*5_\6CX=8\MQ@UUBWJ>GP3?\T8)"!_CC_L_ M^)6.?*/\CE_Z5_\`%J4^JZ`X(76;:I\5G_ZIY(<`_CC_`+/_`(EB"S_`/5/+(F`_CC_`++_ M`(EIGERG_(Y?^E?_`!2;W_F+0I=):TM]7MQ<,5(D=9PJTK4[1]<,I0/*;7+-PM2$XW!JW:M8\JC&`-\"W'_`%2R`A$?QQ_V?_$LSJLG M^HY?^E?_`!:1G)6?B0X%*?N_;+)&'\^/\`L_\`B6W\WD_U'+_T MK_XMK]'Z9_U?++_@;C_JGCPP_GQ_V?\`Q*_F\G^HY?\`I7_Q;1T[3?\`J^67 M_`W'_5+'@A_/C_L_^)7\WD_U'+_TK_XMHZ9IW_5\LO\`@;C_`*I8."'\^/\` ML_\`B5_-Y/\`4G_P#5\LO^!N/^J6/!#^?'_9_\2C\UD_U' M+_TK_P"+:_1.G_\`5\L?^!N/^J6/!'^?'_9_\2OYO)_J.7_I7_Q;OT18?]7R MQ_X&X_ZI8^'#^?'_`&?_`!*_F\G^HY?^E?\`Q;7Z(L/^KY8_\#3_4 M"/Y\/]E_Q*_G9_ZCF_Z5_\6[]`6W_5ZLO^!N/^J>/@#^?#_9?\2OYV M?^HYO^E?_%N_P_;?]7JR_P"!N/\`JGCX`_GP_P!E_P`2OYZ?^HYO^E?_`!;? M^'H/^KS9?\#;+_@;C_JGC^6'\Z'^R_XE'Y^7^I9O^E?_`!;? M^&XO^KQ9?\#/Y3^E#_9?\2O\`*$O]2S?[#_BW?X83_J\67W7'_5/'\I_2A_LO^)7^4#_J M6;_8?\6NC\KKZB_[E[+J.T_C_P`8\?RG]*'^R_XE?Y1/^I9O]A_Q;__2XY)_ M>-\SF_=0IG`D+3D4K3@9+3D4K3B4K3D4K#@2T<56G`EK`D-'`H:.*K<"6L5: M.!*W%7'`EHXJ[%5N*6CBAV*78%:PJU@5K"KL"NQ5V*M'%+L5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5;&*'8J[%78J["K>!6\*MX% M=A5V*&QBK>*MXJ[%6QA5PQ0WA5=BK>*&\*%V*MC"AL857#%#>%5PPH7#"%;' M3"A<,(8KAA"%PPA"X9)!5(O[Q?F,*'__T^.2?WC?,YOW4*9P)"TY%*TX&2TY M%*TXE*TY%*PX$M'%5IP):P)#1P*&CBJW`EK%6C@2MQ5QP):.*NQ5;BEHD5I_ MM8H=BEV!6L*M8%:PJXFG7;`KB0.N*MLKJ>+HR-_*ZE6^Y@#BI#1Q2U4TZ'Y4 M-?NQ0[%+L5=BKL5;`8L$52[M]E$!9C3K0"IQ6FOP/@=CBKL5=]!'L13]>*NQ M5V*N/R)^0)_5BKL5=BKL5=BKL5=MW[XJ[%78J[%6QBAV*N^CZ>WWXJ[%7?01 M\]C^.%6\"MX5;P*["KL4-C%6\5;Q5V*MC"KABAO"J[%6\4-X4+L5;&%#8PJN M&*&\*KAA0N&$*V.F%"X80Q7#"$+AA"%PR2"J1?WB_,84/__4XY)_>-\SF_=0 MIG`D+3D4K3@9+3D4K3B4K3D4K#@2T<56G`EK`D-'`H:.*K<"6L5:.!*W%7'` MEHXJ[%5K$`$DT`W)Q2]U\L:?:OY+M_RG>!#J_F;0+GS()%`DF74VD%S8PU_W M6/J5N*K]OX_\K*"=^+N+:!M3P=&+*"1Q)&ZGL?#+VIF6@?ET-2\H#S??ZS;Z M3H$5_)I]]-+&TLL9CC1U,,2L&N99C)PC@3^5Y)'6-&;(&5&F0C:&\U^1UTG3 M=-US1=27S#YYOT/!)OBHW".2-&_;R/'UK9EP>: M4^7?RM\R:WJWF'1N4-AJWEI`]_!=,%C%)Q#*S35X)%`I-P\OQ;3)"I:.UY&\,3NP#VCL>$ M36,R:Y+$"RE%QHEUYQOM2\RZWYQ>Z\L:0L%M-YKO[:43RR2CU$L[ M6R!]2256=R%Y\%7XV95;"#6U*8VD7G#R1;Z9Y>B\R:'J\?F#RQ=2-9F_6%[6 M>WNQ'S^KW5O(6,;E:\&5W1_^!R0EO1YL>&GHUS::]=?\Y`>7;7R[?Q:3K,NB MZ>+34)H5N(XS^BBS\HF!5N:!D'\K-RRL?2;9GF'G/E3R7^F['4M2+?3-%M?,>A:O M'Y@\L74YLS?K"]K/;W83G]7NK>0L8W*UX,KNC_\``XB5[*8I-Y=\O:OYCURS MT/1X/K&I7[^G!&3Q4``L[NW[,<:!G=OY<)-;EB!;+D_+'1-3%W8^4O-L'F#S M)81/-+I*VDULERL*\IA87$A(N7BH?A9(_4^U'R7(<=V-G>:G%IDD]Q9JR2R?5(7Y!F$Q')YH^'V./'[.1G9E5,HB@\ MAO[VYN[RZOKR9[FZN97FN+E]WE=V):1O\N0_$->2 M+DN/O"\"2>:_*LGE^ST2_%VE_I^OZ>NHVES$C(%(8I-;L&_W;`XXO3#&5H,: M9EY?\E^:M`U?S+I>FZS#::A#Y0EU+S!"]MS(MIXXYI-._>5XS>G)$3<+QXY$ MR!KWI`ICGE[R-IT_EN/S-YFUH>7="N9FM=+*VSWMW>2Q4]4PP*T8]&&M))G? M[7P_:PF6]#=`CM:I=_E=KX\U:5H&E3V^KQ:[`M[HVKPL8[6:S(8O/)S^.#T` MC_6(Y/WD;+_E+B)BK4P10_+GR]J4=Y;>4O-T'F#7M/A>YGTOZG-:+<1P+RG^ MH3R%A<-$`S<72)I%7E%RP$\"AIWD7R]#H.FZSYN\SCR^FMJTND6<%E+J$ M[VZ.8VN)N#1K%%S7X5Y/*W\F'CWVW1P=Z0^9=!;0M6:P^O6NIPM''<6NH6+^ MI#-#,.2-0_'&_9XI/C1LD#:"*9G^6OEOR1J7E#SA>:SJHM[ZWTY25:PDN38H M;J-5N8I`ZB1Y`?3X)Q9%;[7PME6[G8%HX;:S4\VF9/C='DXPK]M\F95[V(BH^:O(ZZ1I5EY@T?4TU[R MOJ,K6T&J1Q/;R174:\FMKJ!RQAFX_$OQ,KK]G&,K]ZF-)3YW7G,]K)([\RBCGZ>@]W<75VR>IZ-M;H4Y\%X^H[NJKR_UL)E1H-K5%"20R`203JX96@;_8LZ,CY&)N1]S*0V0ES^ M5VD:7>6FC:UYMM=/\Z2F"0Z&]O*UK`TO!XH+J_!].&=PW^^FB1O[QU1N>'CZ MUL@037S]Y1OO-WY_>:="TQECO&,]Q;IQKZC6MHD@A4`K1I:<%;!&51!4QLL; M3\N!?>8[3R[H.N6FK7X@FGU^\57BT_31;G]\S7+5$\,2_:FC'%V^&/[62XMK M*.'S7W'D'0+W3=0N?)_FA/,5YH\#W>I:<]G-8RM;14$EQ:&1G%Q%'7DRMZLL?RUGF\P:I876MV$&BZ);)?ZEYCA+W5L+24J(WBCBK M*\LA?CZ'PNK\N6'CV7@0NN^5?+L&C'6O+?F:+7+**5(+RUGMVL+^%Y*\'$$C M.)H6I]N)VX?MX03R(8F/<4ATVPGU'4;73[=HTGO)5ACDG=8HE+FG*21OA1%Z MLQPDT@"V<6/Y<>3=4U+_``]HWGNWO?-3$QV]JUA/#87%PM:P0WC,:LQ'%)&B M6-V^S^SD3,C;`"&4LKJ5="5=#U#*:,#\B,FUMXJV,*N&*&\*KL5;Q0 MWA0NQ5L84-C"JX8H;PJN&%"X80K8Z84+AA#%<,(0N&$(7#)(*I%_>+\QA0__ MU>.2?WC?,YOW4*9P)"TY%*TX&2TY%*TXE*TY%*PX$M'%5IP):P)#1P*&CBJW M`EK%6C@2MQ5QP):.*NQ5-_)OEF?S3YNT?R["&KJ=U'#,R+R*05Y3R4\(X5D; M!(T+91%EGVH?G5Y:'YA-YI@\F6#R6=XOU/4_K-ZDXM;4B"%A$DGU<,+9%^#A MZ?\`DME?AFJMLXQ;%?S:\N0>7_S#UBTM.)TR[D&I:4Z5]-K2^'K1\">JJ69/ M]CDH&PPF-V3:-Y:U?S#_`,X_):Z/%]2WU>[\UV_F%=%E`]>+3[%%1Y M9HJ\XC,PXHKK\>/U$UW,@*&ZAYS_`"N\YZ[^9VH:EI-D]WY>US4#JEGYCCH= M.6SF<3&62YKPC]%0W-7^/X/A7&,P`ICNF&M>9=/\Q:_^=6M:00=/N-)BCMYX MZ@2I%<00&0?Y,OILW^4K8`*X608G^20]3\P$M591/>Z9JEI:(S!?4GFLW6*, M%B!R=MER63DPQH[\J_+^O:'YFUNQUK3KG3+T>5-7?ZO=Q-#(4-OP#A7`/`LK M*&P3((^*8\RUY5L[SS3^1USY5T.)[SS!H^MIK,FE1$&:XLYK;T3)#'7E,T+C MXE3[*X9&I6BK"S6=(U#RA^2VI:5YAA:QUOS1J=M=:?H\X*W4=I8HXDNI8^L* MO)^Z3U.+O_JX`;ELR&P9UH:.?^C"8I1#-#.4YK#) M'*R?S"-PQ'TTR;6"]9_-/\OO-/FG\P;OS'H%J^H^6/,@AU&T\P5`L8;@,KW8Q8S_`)P:,-0U'4?+^B>3 M;?2[:83:Q=:)9VH8LI3ZM;21H6GDN-XU6'DK+_DX31ZVE#?E=I=AYU\EVFB: MHZI%Y%U=-;G]9R/]P2Y?+%I/JUS MY9^NZ;K6EVB^K/`]Q-]8@G$*DR&*9-O5X<>2\<-U(WU2=PF/Y>V,/D3\QK'2 M]:U.U75=5T2YM)K>Z`DMM+O;U#]7M;FI>/XN*^LE%5?5X28)&PL11YH_29/S MGT/4;N^O-!T/R;'HL,SS^8;C1;.UB3BA3T[:>-*SO/\`W2);<_4Y_P`N1-$< M[9(#RZ?S*MO)&D+I_E_3OS%\J7*2M;V3V37LNF3N]9K1C'PN;9U;XO\`?3Z;%=ZWY?2?ZPMA>,Q4Q!B69.:*) M#"[FQ"N MJKR56P6!*^A6K"%UO3KSRK^38\OZZC6>OZ_K<>IV^CRT$]O9VD'IF>:.O*$S M.>"*ZJSX0;E87D$M_)_R_H.O><6L]8A2],5C=76E:1*_IQW^H0I6"U=P5H'J MS4K\?'CAF:#&'-Z;Y)D_,.6\UE_,?ES2_*MA)I&J1V-DNE0:?=32_5';TK,D M?6Y$B7XY9.3)PXJ[F:1J/FW\E-'T_P`NV[:AK'EC4[J74M)M ME+W36]^B^E5]=N4U:U\S5"Z;':2<7=Y[AJ)#Z`1U>-_P!Y\'P(W)<8S`%=4$64^N/5 M3_G)[S:R\DD%CJC(14,/]Q8*D?K&#^`)'U%AWY`ZO#9ZOK6F<[:/4-?T*?3] M(-\D;VLEY598X)A-^ZX7'$I1_A9OAR>0,8GEZ;K&IZKH6B^3;2QL MYHIM0N=$M;.2X:9?3^I6C1IZDTEP.0_=_N^*_&ZY'TGK;+DUHG_*RK;R9HD5 MIY1->U[S3Y'M_(VNV#6_Z#NK5)+`7TTD@66W^I2EN8],ES M)$/@PQ.]`\2"-MV!_E[I&@:QYYT/2O,,_P!7T6\NECO)"W`$4)2,OMP$L@2, MO^SSRS^2H_S$@_,G3+>^\H:1Y/\M6E^D*R3:;!&"`Q2**VO90T] MS=3D#@\#_P`TOPQKE,JKG9;@\!U-675=05@59;NX!4]01,VV9`:9+\QA0__UN.2?WC?,YOW4*9P)"TY%*TX&2TY%*TXE*TY%*PX$M'%5IP) M:P)#1P*&CBJW`EK%6C@2MQ5QP):.*NQ5I6=35&9&Z3%J#P%>@]L4LA/FX#\NX/**6TB7%OK+ZRFI)+Q`YVX@]((`'5Q M3GZG/(UO;*]F/22RRR---(\TS_;ED9G<_-F)8X6)+A/!`ZCYXH:[@@D$$$$&A!'0@CH<559KN\GD M]6>YFFEX\/5DE=WX_P`O)B6X_P"3]G%))4XWDBD26)VBEC-8Y(V*.I_R64AA MBH+`:O+%;='))'*L ML3M%*AJDL;%'4^S*0PQ6W222RRM--(\TS[O+(S.[?-F)8XJ2M(!%"*@]0<55 M);BZFCCBFN)IHH?[F*21W1/]56)5?HQ6RLJU"O(\3N4J>)/B5Z5Q5K%5ZSW" MV[VRS2+;2'E);AW$3'Q:,'@?NP)M8]9*^H3(3U+DL3\RU3A0J37-U.L:3W$T MZ0_W*2R/(J?ZH8D+]&*22L!85XLR\A1N)*U'@:=1['%#@SK7BS)44;B2M1X& MG4>V*KX)[FVE]6VFDMY:XFFBA_N8Y9'=$_U58E5^C%-ENWNKNU=GM;B:V9Q1S!(\18?Y7`K7 M`H-*5-R=R6-6)-22>I)/4X4+HWDCD26)VCEC-8Y(V*.I\592&&*KS=79N?K? MUB;ZW6OUKU']:O3^\KS_`.&P)M8[R22/+*[2RR&LDLC%W8^[,2QPH6^!K0@U M4C8@CH01T.*JLMU>3RB:>YGFF`XK+)+([A?`,Q+`>V*F1:AFG@E6:WEDMYE% M%EA=HW`/4K&IW8_S?:Q6UPFN!;FU$T@M6;FUL M';TBWB8Z\*_['%;:]27D6]1^9ZR&*JL]S=7`C%S<37 M`B%(A-(\@0?Y(0<$A@W\W(?%R_P`K"A5GN;JYD$EU<37,BBBO/(\I`]BY:F*DVID`BA%0 M>HQ0K275Y,(Q-*MC"K MABAO"J[%6\4-X4+L5;&%#8PJN&*&\*KAA0N&$*V.F%"X80Q7#"$+AA"%PR2" MJ1?WB_,84/\`_]?CDG]XWS.;]U"F<"0M.12M.!DM.12M.)2M.12L.!+1Q5:< M"6L"0T<"AHXJMP):Q5HX$K<59=Y8\HV&K^0O-^MNL\FKZ++ID.DP0&JR/?SM M$ZM$%9I6(7]VJ_M9"4J(#.(L%(M<\L^9-`DBCUW2KO2GG!:`7D+17TPW3D0* M"O88D@4+'1?)7D[5ECN(=7UM=1&KP7!($16.FVLU]?3FD%K;HTLKD;GBB@G)(`16N^5_,WE^2* M/7](N])><$P?7(6B#\>O!B.+4[T.`$'DIB0K:?Y)\Z:C" M*&WD8_5IJF*;I3TY:?NF_P!V?LXF02(E*9X9[>>2WN(GAN(7,4L$BLLB2`T* M,A'(/7]FF%%)MJODOSGH^GIJ6KZ#J&G:=(5"7ES;R1Q5?[(+$?#R[<^.`2!2 M8E#:)Y<\PZ_=26FA:7=:K>2_RT\R^9 M?.4/EJ2PO;%XYTAUB8VSL]BK@D/,C<>`/'X>956R,I@"V0CNE.H>4?-.GZL= M)N]'O8-1*23PVDL#I,]M%RY3A&`/IA8W9G^PO!_Y<(D$&*U?*GFITT]UT:]9 M=6CDGTJD#UNHH5#RR0BE72-"'=OY/B^SAL+PE`V5C?7\IAL+:6[F6-YFC@4R M,(HUY22$#]A%^)V_9Q12OI^A:[J202:;IMU?1W,_U2V>WB>427/#U/10J#63 MT_WG'_??Q8VD`HH^3?.'Z=_P_P#H*_\`T[P]4:7]7D^L>G2OJ<*?W?\`E_9Q MXA5KPE+]0T[4=,OI;#4K6:QO[<\9[6X1HY4)%1R5J'?MB"@BE.WM[BZN8K6U MADN+J=A'!;Q*TDDCMT5$4%F8^V*ICKOE/S5Y>$!U_1KW25N25MWO(7B60CSBTRVM0`L]U^ MZD:LA)D7U.,?IKE?'9H,Q&@\K0.>*BKNQ"J%!)9CL`H&Y)/09:UIWK/D?SMH MEB+_`%KR_J.FV)(7ZU=6TD<89OLAF(^`G_+XY$2!28E*VL;Y;&._:VE6PFD: M"&\*D1/+&`SQJ_0N@(++A13;Z??QV=O>R6TJ65X[Q6=TR$1321D!TC?H[(6' M(#[.-K2*F\L^98+.^OKC2;N&QTR86NI74D+I%;SD@>E*S`!)*N@X?Y2XV$\) M3'2/RX_,#6+:UN].\NW\UA>,!!J#0M':T)IZC3/1$A7]N9OW:_S8#(!(B6W\ MOV%GIGF1+B*;5[W3'M4M-5;C2(#*WQBYF"CU/4_NX"O\`NU6^UC?):JT% MHGD_S=K\,T^A:)?:K!;GC/+:0/*BM2O$LHIR_P`D?%A,@.:!$H+3]*U74K]= M.TZRN+W47+*ME;Q/).63[0]-1R'']JOV<2:12,UWRCYL\O"%M?T6]TI+@E8' MNX7C1V45*JQ'$L!^S7$$'DDQI,_,WEG3-,\E^2]9MC*;WS#;7L^H!W#1AK:Y M]&/TEH.'P_:^)N6`&R4R&P8[:65[>2-%9V\ES*D;SO'$I=EBB7G)(0/V(T') MV_97"QI'WWE+S9I^D0:S?Z+?6FCW(0V^HS6\B0.)!6,AR*`2#="WVL1(%)B5 M'3_+^OZD]JFFZ9=7K7TDD%D((FD]:6%0\J1\1\31(0\G\B_:Q)"**(TKR?YN MU>[NK/2=$OM0N[%S'?0V\#R-`ZDJ4E(%$<,".)/+$R`2(E+;VUNK"ZGM+Z"2 MTN[9BES;3HT9M?EEBT'2;O59(`#.+2%I1&#TYD#BM?VEW874UG?P26=Y;,4N;:X1HY8V'9T8!AB@LQ\H_EEYAO?,WERW\Q:)J5A MY>UJ\BMFOWB>`,LRDIPD93Q9J53D/BR,I@`US9QAWL7?2K]AJ=S:VLTNG:9. M8KJZ5"T<`:5HX1,X%%,G'BO+[;9*V)"BEC?264U]';R/8V[I%<7:J3%')+4Q MH[]%9Z?`#]K"BD=:^5_,]W3ZKI%Y/6T_2(*0N1]2J5^LUI3T.2LOJ?9^%L!( M7A*_0O*/FSS!#+/H.BWNJP0GC+-:0/*BFE>)8#CR_P`D?%B9` M_33H+2>74GD]!+%(W:7^37EB)`\DD$)4,+%O"J[%6\4-X4+L5;&%#8PJN&*&\*KAA0N M&$*V.F%"X80Q7#"$+AA"%PR2"J1?WB_,84/_T..2?WC?,YOW4*9P)"TY%*TX M&2TY%*TXE*TY%*PX$M'%5IP):P)#1P*&CBJW`EK%6C@2MQ5Z?^6FK:GI'Y3_ M`)FZEI<[VU_#^B5BNHS22)99I(I)$;JCA'8+(OQ1\N2Y5,7(-D3L4%Y3O+W4 M/RA_,+3=0:2ZTS2X[#4=/>9WD^K7SW'I?NRQ/%IXRRL/VL,A4A3*)L;H[\X= M;U6WT+R'HD-V]MIMUY9TZ[OA"3&9G8-"/69*-*D,*<8D?X$Y/_-@QCA_F1)IFBWL^GZ7Y9M;)/+L-M*R1P)]6242Q\"JEI)#R9_M/CC`( MW3(FV3Z_IVKO^:>IZQIVK1>5A+Y:M-2\X:NL"L]K];A07/H1J.:W<[<"#$8Y M.7+X_B^*`(X:Y[LB-TN\E_X)E\K_`)@:?HNL:[JG+R[<7%W;:O!'#9EXI8S% M,O":9_K"/_=!U^RS_%A-V.7-%[%C_G.[O=._*O\`+S2].DDMM*U.VO-4OF@9 MHQ3 MO,^LQD:]+Y);69Y!$LTTM[:QO'!=>C(0LMQZ(]6.O'XHT_ER!Y$#E;,,,\E> M;?R_L?,-S>W6N>:O,D6M6]S#K&DRV$+B]2:)@S/2[E-8F/K!POP<,F8FNB.+ M=*]=D.D_D7Y,@TBY>*+7[_5+C7C$Q5I9K218K:.5EHQ6.'XUC)X\OCPC>18V M:3+\NO,'FG5?S&_+.36()$BA.9BX=!:SU0\J_"PVPY/I0.:M^3GF'6_,/Y MQ66I:K=27=Y/::HRAB>*`V$O&.&,?!%&@HB1QJJJJJN,Q441E92G\C8Y'\TW MK1J66+R]J[RE14*IM"H+4Z#D0O\`K8)BK&"33^4B!A\2B3TU63B?CC_=M\&)'J^"W0^*KYE\PZV?R4\FQF\D+ M7MWJ=G=7%2)Y+2SD1[>V:8?O6MXGD+K$7]/GP^'X$P"(XBDG9!?F=>7=_H'Y M=W][,UQ?3^7V6:YD):1Q%>2HG-CNW%=JG&',K-$?E7<2:9Y8_,+S#ITAB\Q: M5I,*:7.H!E@CNKCTKF:(]8Y%C^'U4^),9\P$05ORONIM5\J?F#H6L76,N6].60_`W#^\_:QD*(I,22%+SE6LDN MN"6LC_$!HL2=@QW\N/,1\M>>M'U\::=77396FDL$0N[)Z;(T MB``_O(0WJHQ^%63#(6*1'FSW0M*L==O-63\N?/U[" MZ;^<#>=]0\\6-GH=G+'+C]OFWJ?#D!O&J M9,%\O7$$WY1?FWL+_31;RO$KSW0:6>\JI%96E_;Q@+L^:9&N28Z7<>:+RVM:WEUZR#ZJEO'59?5O\`AZD[I)%%)S^/X,!H4!ZD M@E7LO\)3_DOY_MM"U#6=4MK)M+N2NM0Q1QV]PUT$62V,*0?`X^Q]E<<@`&R8FRI6?F;5M%_YQ^TV'2IS;2ZGKNH6T]]$2EQ] M6$$,CPI*/C1)V6/UN)^/T^/V<:N2DT%OYA7]YI_D3\O='TVYDATB]TM]6N_1 M9H_K&I2SLLTLS)0RR1@!%YEO37&(%E9$@,[\NV&E^9M?_)+5_,LHNM8U.+45 MU&60+/KVJZS%>V^ MI:3.99H[F%T<2J\*LOPVRCFG'CZ7IK^SEAB*8\1MF/F)O*%C^6GD+1;S6M7T MNPO-.;5)8=(M(9HKF\EE*RRSR-<6[/-%3TE5E?TTX_%D!9D6=T$T\M7WDKS? M^8?Y7VTCZE?RV(NH;S6=9MD@_2"VP>>Q0<9)UF]&5?18EV_9Y8#8!1>X8W^5 M'G+SC=?GCI=Y/J-S+>:OJ3P:I&[NRR0U?E&T1)0)"$7A\/[GTUX\>.2G$<*Q M)M2\LU_Y51^;E*T^OZ3R^7Z0FZ_3A/U18RZI=HJ2#\D_-\A4B-MGPEE M20L`?%>2UPGZA[DCZ4R_,KS-K=KY`\A:+:73VME/Y>2YNQ`3&\[+-*D23,M& MDBA',QQ-\"M+(V"`%GWID>2?_F8WDJQ/EK0;G7MU+3 MIZCW2R&Y@9YI9"W.3A]K]K(PLV:22`Z3\R_+=OYX@\PI8:Q<6]WY9_16NZX] MLMMJ7-QZ0U>"CRQJ[1JB>MZB\OYL/`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`L:1VZ*/@CPB(')$C:&\J><=8\L7-S)8K!2I-$2*\3]AU*R)\7%OBQ,;2)4C-9_,*[N_+]SH.E:-IGES2[U@^I0Z7'(); MLQD-&DTT[RRF)&')8E*IRP"&]K*=LV\\_F/IUM9>2]-@L-'\TZ99^7=.>6SO MD,RVFHH&691)"\!%CCA2->"01Q#X/0$9*-$?AD5GY_:R?"*ICQ&[3.[_-343!>_HC0M M'\O:CJ2&+4-8TNWDCNY(W!$B1EY'2U6:O[WZNB9 M(WAL;S1C&-%M+2(1VEG%"2R0PPFO[O=N?,LTG[6/"*I>(VCD_,VZMO-L'FK2 M-`TG1M2A6Z66*S2?ZO,;Q&CD=XWD;B55V]-8^"+@X-J4S8UY?UK5/+VKV6L: M/<&VU'3Y!+:S@!J$`@AE.S(ZDHZ_M*V2(MB#3+Q^<>M6TMT^B:)H^@1ZBMPN MJ0Z?;R*+KZS$T1]5G=W6.(2,\-O$R0++^\9'XKD/##/C+&(O,NHQ^36\H*L7 MZ*?4$U4R%3Z_KQP^@!RKQ]/A^SQ^UDZWMA;5[YCU"\\MZ5Y>E6,6&C375Q:, MH(E+WA4R^HU:$?".'PXUO:;Z-:OYAO\`5=/T6PNEC6#0;1K&R,8(9HFE,I,A M)/)N3=N.(%*96J^5?-FM>5M6_2FD2()7B>VNK>=!+;W-M+M)!<1-\,D3T^S_ M`+)<$A:@TF6L_F)?W^A3Z!INE:=YDK?%QP"%;I,[2W4_-6IZCY:T/R[<)$-/\OM=-8.BD2L;V022^JU2&HP^# M;)`;VQM#:#KVL>7]9M-:T:Z:SU.R?G;W"T-*BC*RG9T=25=&^%EQ(M(-,I_Y M6Q?6QNKG1/+FB>7]8O(WBGUG3K>5;E5E4K+Z`DD>&V:0$_%#&K+^QQR/`RXT ML\L^>[W0]%NM`GTVQUW0+N5;HZ5J:2/'%)XY8Y&0<'XM\:_:PRC:! M*G>:/S"\Q>9K/3;/5/JZVVD7,MSIL-M$((X5E$8%O'&IX);1+"BQ1J/YN3,S M8B("\96R^8(?,OYAPZ]YHF-C;:EJ,$^L7-B&0PQ!D#R0_;=2BIRY?&R_:QJA M06[+UK69?.]]KE[>PZ7^7VKZ1!S\)FF>6*[+\*>H[#UN>5"@ M/XFQY]YR\RZ/I-YYJ\L^3?JDGE?7_P!'M>O")7C2YL@)9%LGD(?ZN+AG52ZM MR3['PY9$'8GFUR/<@M'_`#*OK+2;#2]2T32?,5MI#%M&?5H7DDM5+%S&K1O' MZL',\O0FYI_L<3"U$W6'YJ>:H=7UO4=3%MKT?F0*-F*0D*A1H3 M;C:`Q,OI+B8"EXMUU_\`FCKESY?U'RU:6&GZ5Y9M1U/0]"T6Y6(6?EZ*>&P9%(D9;F7UG M]4DGD>?V:<EZFL%V[A`L[VK"$*S; M(U2;Z+^8=_8:#'Y>U+2M.\QZ);2M<:?9:K'(QM))#63ZO+"\4J1R'XGAY>FS M?%@,+-I$Z0>N^=_,NL^8;;S!<7(MM0L/272A9H((;*.W-88K6)?ABCC/[/[7 M[6$1`%(,BG6I_FSK%Y%J$EKHVD:1K&KQM>T^W>.\N(W7C,!R=HH#<=9V@ MC1I&R(@$F:!T3\P;_3]!3R[J.EZ?YBT*WD::PL-5CD;ZI)(:R&WFB>.:-)"* MO%S]/E^SA,+W43I"ZYYX\Q:OK=GJ[3)83:7P&BVVGH+>VL$C;FB6L0KP`;[1 M/)I/VV;"(@(XBR2/\[/,%MJZZ[IVB:+IOF"22.74-8M;9UGN^&[JX9V2%;AA MRN?JZQ/-^T_%FR/ACDGC+'?+'G35/+U]J4\-O:WUGK,;PZMI-[&9+2XC=S(` MR@JRM'(>44B-S3)&(*!-&ZS^9&LZGY?N/+<=E8Z;Y>FEMYH=+L8FCBMWMBQY M1LS.[R3,_*XEF:223X%^%$5<1``VIF2E&M>8K_6;71[:[6-8]#LETVS]-2"8 M5=I`9*D\GY.=QA`IB96G>G?F1>0Z/9:1K.B:5YFM-+^'2GU:&1IK:,$GT5EA M>)Y(*G^YEYK^S@,.MTR$RL@_,_SG%YGD\R-=QSW<]O\`49[*6)6L'L:4^I&U MVC%J!]F-?LM\?VL>`52.,JE[^8UR^D7VE:+H6E>6K;55]+5)=,BE]>XAJ&]$ MRSR2M'"6'Q1Q<.7[6(AOONDY"Q,9-K=A5=BK>*&\*%V*MC"AL857#%#>%5PP MH7#"%;'3"A<,(8KAA"%PPA"X9)!5(O[Q?F,*'__2XY)_>-\SF_=0IG`D+3D4 MK3@9+3D4K3B4K3D4K#@2T<56G`EK`D-'`H:.*K<"6L5:.!*W%7'`EHXJ[%5N M*6CBAV*78%:PJU@5K"KJ`=-O'`KL5=BK1Q2[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%5A@A)J8UKXT&*VOQ5V*NQ5V*NQ5N@(W%<4.Q5V*NQ5V%6\"M MX5;P*["KL4-C%6\5;Q5V*MC"KABAO"J[%6\4-X4+L5;&%#8PJN&*&\*KAA0N M&$*V.F%"X80Q7#"$+AA"%PR2"J1?WB_,84/_T^0R77ECUV4WMW]H@M]62G6E M?[W.@\3%WR_TH_XIT'#JZO@Q?\K)?\2W7R_R*FZO5I6K&U3B`.]?5PWC[Y_Z M4?\`%(O55].'_E9+_B5..7RS(P1;Z\!;I6U05/\`R-R(EB/67^E'_%,B-6!] M&+_E9+_B6Z^7>+,UW>HJBI+6B#Z!^]Q_==\_]*/^*6]5_-PG_DI+_B5J'RW) M4+>WA(%>/U5*D>W[W`/"/6?^E'_%*3JQ_!B_Y62_XEIE\N!"[7MZHK0`VJ`D M^W[W$C%WS_TH_P"*3Q:J_HQ?\K)?\2T$\MNI9;Z]:A`(%JE=^]/5QK$>LO\` M2C_BEXM6/X,7_*R7_$M-'Y;4*6OKQ>5:*;1*[?\`/7`8XN^?^E'_`!21/5G^ M#%_RLE_Q+A#Y<*AEOKU@?"T0D$>/[W'AQ=\_]*/^*1QZJ_HQ?\K)?\2M>+RT MI`:_O.1%:?54V^?[W`8XN^7^E'_%)$]6?X,7_*R7_$M_5?+M`1?7K!@""MHA M&_\`SUP\&+OG_I1_Q2^)JOYF+_E9+_B5K0>658J=1O*C8D6L=/\`D[@,,7\Z M7^E'_%)$]77T8O\`E9+_`(E=]2\OFG;ZI'7_D[CX6+^=+_2_P#'DG+J M_P"9B_Y62_XAIM/\M@`G4;T5Z#ZI'7_D[CX6+^=+_2_\>7QM5_,Q?\K)?\2X M:=Y;(J-2O3O3:TC_`.JN/A8OYTO]+_QY?&U7\S%_RLE_Q#1T[RV*5U*]J=Z? M5(_^JN/A8OYTO]+_`,>7QM7_`#,7_*R7_$-_HSRY04U&](/A:1_]57Q]5_,Q?\`*V7_`!"W M]&>6JT_2=Y\_JD?_`%5Q\'%_.E_I?^/+XVK_`-3Q?\K)?\0W^BO+G_5RO1[_ M`%2/_JKCX.+^=+_2_P#'E\?5?S,7_*R7_$-#2_+9-/TG>_\`2)'_`-57-_P#_](D?_`%5Q\'%_.E_I?^/KX^J_ MF8O^5DO^(<-*\MG_`*6=[_TB1_\`57'P<7\Z7^E_X\OCZK_4\7_*R7_$._1/ MENG_`!T[W_I$C_ZJX^#B_G2_TO\`QY?'U7^IXO\`E;+_`(AWZ)\MG_I9WO\` MTB1_]5+_`)62_P"(=^B/ M+G_5SO?^D2/_`*JX^!B_G2_TO_'D>/JO]3Q?\K)?\0[]$>6_^KG>?](D?_57 M'P<7\Z7^E_X^GQ]5_J>+_E9+_B&_T/Y<_P"KG>_](D?_`%5Q\#%_.E_I?^/( M\?5?S,7_`"LE_P`0U^B/+G_5SO/^D2/_`*JX^#B_G2_TO_'T^/JO]3Q?\K)? M\0W^A_+G_5SO?^D2/_JKCX&+^=+_`$O_`!Y'CZK_`%/%_P`K9?\`$-?HCRY_ MU<[W_I$C_P"JN/@8OYTO]+_Q]?'U7^IXO^5DO^(=^B/+G_5SO?\`I$C_`.JN M/@8OYTO]+_Q]?'U7^IXO^5LO^(=^B/+G_5SO?^D2/_JKCX.+^=+_`$O_`!]? M'U7^IXO^5LO^(;_1'ES_`*N=Y_TB1_\`57'P<7\Z7^E_X^OCZK_4\7_*V7_$ M-?HCRY_U<[W_`*1(_P#JKCX&+^=+_2_\?7Q]5_J>+_E;+_B'?HCRY_U<[S_I M$C_ZJX^#B_G2_P!+_P`?7Q]5_J>+_E9+_B'?HCRY_P!7.]_Z1(_^JN/@8OYT MO]+_`,?7Q]5_J>+_`)62_P"(=^B/+G_5SO?^D2/_`*JX^#B_G2_TO_'U\?5? MZGB_Y6R_XAWZ'\N?]7.]_P"D2/\`ZJX^#B_G2_TO_'U\?5?ZGB_Y6R_XAWZ( M\N?]7.]_Z1(_^JN/@8OYTO\`2_\`'E\?5_ZGB_Y62_XAWZ(\M_\`5SO?^D2/ M_JKCX&+^=+_2_P#'D^/JO]3Q?\K9?\0[]$>6_P#JYWO_`$B1_P#57'P,7\Z7 M^E_X\OCZO_4\7_*R7_$N_1'EO_JYWO\`TB1_]5_](D?_57'P<7\Z7^E_P"/KXVJ_P!3Q?\`*V7_`!#OT5Y; M_P"KG>_](D?_`%5Q\'%_.E_I?^/KXVJ_U/%_RME_Q#OT5Y;_`.KG>_\`2)'_ M`-56_^KG>_P#2)'_U5Q\'%_.E_I?^ M/(\;5?S,7_*V7_$._17EO_JYWO\`TB1_]5_](D?_57'P<7\Z7^E_P"/KXVJ_P!3Q?\`*V7_`!#?Z,\M_P#5 MRO?^D2/_`*JX^#B_G2_TO_'U\;5_ZGB_Y62_XAWZ-\M_]7*]_P"D2/\`ZJX^ M#B_G2_TO_'U\;5_S,7_*V7_$._1OEO\`ZN5[_P!(D?\`U5Q\'%_.E_I?^/KX MVK_F8O\`E9+_`(AWZ.\M?]7*]_Z1(_\`JKCX6+^=+_2_\>7Q=7_,Q?\`*R7_ M`!#OT=Y:_P"KE>_](D?_`%5Q\+%_.E_I?^/+XNK_`)F+_E9+_B'?H_RU_P!7 M*]_Z1(_^JN/A8OYTO]+_`,>7Q=7_`#,7_*R7_$.^H>6O^KE>_P#2)'_U5Q\+ M%_.E_I?^/+XNK_F8O^5DO^(;^H^6O^KE>_\`2)'_`-5#%_.E_I1_Q2^)J_YF+_E9 M+_B&_J_EK_JX7O\`TB1_]5K_F8O\`E9+_`(EWH^6?^KA> M?](D?_57'@Q?SI?Z4?\`%+QZO^9B_P"5DO\`B6_2\L_]7"\_Z1$_ZJX\.+^= M+_2C_BEX]7_,Q?\`*R7_`!+O3\L_\M][_P!(B?\`57'AQ=\O]*/^*7CU?\S% M_P`K)?\`$MA?+/\`RWWG_2(G_57&L7?+_2C_`(I>+5_S,7_*R7_$NIY9_P"6 M^]_Z1$_ZJXUB[Y?Z4?\`%(XM7_,Q?\K)?\2W_P`ZS_RWWO\`TBI_U5PUB[Y? MZ4?\4MZO^9B_Y63_`.);Y>6?^6^\_P"D5/\`JKC^Z[Y?Z4?\4MZO^9B_Y62_ MXEP?RQ_RW7G_`$BI_P!5<-XN^?\`I1_Q2_X7_,Q?\K)?\2WZOEC_`);KS_I% M3_JKC>+OG_I1_P`4C_"_YF+_`)63_P");$WEC_EMO/\`I%3_`*JX\6+OG_I1 M_P`4M:O^9B_Y62_XEOZQY8_Y;;S_`*14_P"JN'CQ=\_]+'_BEX=7_,Q?\K)_ M\2V+KRQ_RV7G_2*G_57'CQ=\_P#2Q_XI'#J_YN'_`)63_P")7)>>6.:TO+P[ MC_CU3Q_XRX?$Q=\_]+'_`(I>#5_S<7_*R?\`Q+__U.$R)9?76!8A^>\=/@Y> M'+PKFVJ-N!LQ,:D4?J0W@,0;&Z2*.W-MF6.&L#$@M1W.S>P^ M6)-#9`%G=L%7A5IV(HQ".-V([@^V/,;K5'9J1RB((F(C()Y="6[UQ)KDL19- M\VW])E1IF99"N_$5J.Q.)KJHOHU-)(CA48J@`X`'8CQQ)I8Q!&Z]E@,HYL5< MT+J!M7OOAVM`)K9;ZLWK4[\J<.WRQLVGA%+E6#U/@)9@3Q4C:O;?$5:#=+8I M'9J,2RD'F#X8@ID`&UX`,8R6<#:HI0=R,1713?5R-R#!R2@%:]P>U,05([G5 M"H3&2=Z,QV(&/39>9W;!#1UN*@7S=L54N2 M&[$;U&*^YS,10*:+3:G?$E0&VX5!8D,?M`8H%M,[!J#:G08IH+J)RZ[^';%& M[2LQ:AW\0<;4AL<:GB:FFV*M*:U!-13?"I#8(`/$[XJX&HW^_%75H-OOQ5U0 M0"<5;)Z4Z8JXT[]<5<2?Z8JWM7%6JFN*M[8JT#BKMNV*NKBKJXJ[%75Q5V*M MUQ5K%78J[%75Q5V*M5Q5V*NKXXJU7%+L;5V!6L5<3BKL5:Q5U<5:Q2[`KL5: M.*NQ5K!:NQ2UBK6*NP*T<4N.*NQ5K`M.Q5K%+L"M8J[%6C@2[%6L571_WB_, M8J__U>$2VD)NV'JJ`7J8?V]]^/SS:\`OFX/B&N7Q6I>322A6`*.>)0#>AVI7 MQ&(R$E3C`%NCACCM1X_+OB(@&[NE,B155;HYY)R8I2"K*3R`` MXD;U^6(D3L5,1'<.15A1Y4D65Q105Z+R[G$;;J3Q&B*E0:[;5Q)K8*!Q;ESJLH65G6-F&X;O3:HQ.^Z@UMS<\ M[Q-Z:4"H-JBM>]<3*ME$0=RVT*-)4N$YT/`_:%>V-;J)$!WUE_4I3X:TXTWI MTI7#Q+P"G+$BR'XPW&IX#[6W;&MU,K#22O(>#;ANM!2G>N(-J8UNY0$JX8.5 M&P':NU3B%)O9M7,@96-*;AJ4I3QQNUJN3@?34LI#$FE1T&/)>;J^HM6(!4]> MV^/->3BW!0%->6Y;MCR6K;-'`8L%/3?O3%>3BY6BKT'?QQM0+<5!(-0*[T.* MV[U"&H!L-J8;6F^"\NOT=\:6W!V)H>AVQM:<`!O6M/#%7!BU0<;6G#8$@U/M MBKJ\AOV[XH=6@Q5NM=^F*NK3IA5W7?%75.*N[]?HQ5W+?%7;8JZM<5;Q5U:X MJ[%78J[%78JU7%78J[%78I=7%#JXVEK`KJXJ[%6L5=7%78JUBEV*'5P6EJN* MT[%75Q5JN*NQ5JN"U=BK6*78JU@5V*NQ2UBKL5:."UIV*6C@5U<5:)QM78%: MQ2UBK>!6L5;C_O%^8_7BK__6X/)92FZ=@P],N6]2OQ4)K6G6N;3PS;A>(*:6 MZB:A]L0;VY*16]VY(W@5Y)`"".`0&H8GQIB!P[E21+8. M!$\;1QHL;*0X4;!ATW^6/,4OTFRW0V\1$BAS(11#NOP]]N^/(;K]1V<5,\:F M,!2A(*5H!7>HKCS&R_2=W,PA18W42-NQ!Z"O84QY;*!9MSQO-22,"A%.)-*$ M;4'MB1>Z@UL7/*J,$*"0H`"S=:^`PDTH%[MM`[RN MGJUX"E:<_P!KPKCQ;HX33EA='JQ`534L#OMC2>*PY9%V(V4F]G`AU*!0IZBG0TQYJ13@/34EA7EL!U&/)'-WVU^$!2I MZ=M^^/->3B>"@,`Q.].PPKS<07`84'8CP^6/->398+12`Q'CBM6XJ6-1T;QQ M6Z=S`/2M._?;&UIW`U]NM<:6W!@3TI7OC:TX`C<]!BMM@U!%*5Q5PJ*D_*F% M7=108J[H-]ZXJWUZ8JZO;KBKJ5Z8JZN],5=0XJZN*NQ5U<5=BKL5=BKL4.Q2 M[%78J[%75Q5V*NKBKJXJU7%75Q5U<5=@5K%78J[%+6*NQ5V*M8%=C:M8I=BK ML5IK%75P6K6*78JU7%75P):Q0[%6L"78JUBKM_HP*[%+6*N[8JU@5V*M5Q2N MC_O%^8Q5_]?@LL%T;YV`/+U"1+^S2M0:^%,V?#*W#XHU^AM)+0W%8U*N2>$A M/P^(!M)(IM6B)(0%6((4DXBD&^K4:E>18$)2A![^V(4^38 MXE&$8()Z@[DCVQ7WN4<5/,?">@[UQ"^YQ`9*(#0'<=_GA7KN[8(`X)WV'0C% M?(`#`DTQ5I@Q-0*CMBH;)3EON>Y[8KNZCO7%6P5Y;" MA['%6@"#OTQ4MBE#QV.%7#H:]/#%7;4V^G%7=!OBAW;;%+?SQ0X_AVQ5U1WQ M5V^%6ZC%6M\5=48J[%6\5:KBKL5=BKL5=BKL5=BKL%J[%78JUBEV*NQ5U<5: MKBKL5=7`K6*NQ5U<5=BK5<4M5Q5V!75Q5K%78I=@5JN-K3L5:P)=BK5<5=BK M5<"NQ2UBKL5=@5K%6L5=B5=@2W'_`'B_,8J__]#@7J$"/\`9I7I M3PIFRN5N)PQX5R16@N"(W+.">$9'P\AT'+YY("-[,295NLMY)GFX.2RL#ZH8 MF@'?[L$2264@`-FXUA57:!R\BJ>/(4H.Y'B:8173FQ)/7DU"QD602L3$!4L= MRI[4K@B;Y\DR%57-OX$A=H&+&H#L10@=J?,X>0V7F=W)1X29F(4-\#]37N/E M@&XW4['9SGA$OHL>#$\GZ$L.QQ.PV4;G=NB-&C3,5;<*0*DK[X>FZ[@[-2LR M<0C$1\:J1WKU)]\!/K3EO7[--J^%<-"T6:6H\ADH36I^)3T]\`)M)`IM1&"2A+,`2H(PB ME-]6D8MR#$E*;D]O?`%+8XA6*$D]^U!A7WM*>2'F=AT/OBI;)`3X#45W/0XJ M[8H"Y([`]2<5.X&(AN@S)')J*YFG M?TI/B26H(`H1[_1B)DFCU28`;AT0L+]1HNJT\9+L%,9 MV<["A[8\PM<)V<6:"-0C`\R27&X--J"N-T%KB.[F'JHLCL$;=23T-/#$[[J- MMG/(\-(T-`!6O6I/<8DULH`.Y;:,.0Y<(7`)#=<2+4&G//(C\5V5-@ORP\1" MB((=Z*^I3D*5KP_:\:8TO%LY9G9Z'<-L5'6AQXEX0Y4"DMR#%*D`=<:4FW*[ MR55CL16OA3OB#:D4X#@"P(8]-NU<>2\W!C("":4W![8\UJG5*+\)KR.Y'MBO M-WVP"2`1MOBO)Q)4``^]?'&UJW$.*TV-JGKBKJD['[\*NK3%75J,4.W`Q5W7?%7$TVQ5 MO%75.*NQ5U3BKL;5U<5=A5V*NQ5V*NK@M785=4X%=BKJXJ[%75&*M5Q5U<5= MBKL4M8H=7%+L%JUC:NQ2[%#JXI:KBKL"M8VKL4M8H=@2[%6XT>1PB;L?N`\3 MA`LH)`W*90Q10+M]H_:D/4YD1B`XTB9*Q24()"C"-MEF2M'":M;RQ MM%.Y8VM.Y8VM.KC:TLFBCF3C(.GV6'4?+!(`\TQ)')*IH7ADX-\U8="/',64 M:+E1D"%F19-8$NKBK6*NQ5JN!5T9_>+\Q^O%7__2X++>H+MCZ2T#D>J1\>VW M+YYL_$W)46-B.0X[!N/8X@ MWL@BC;E5[=&:10>=%"'<'O4TPC;FDGB.SMYX^**%*&I0;`@]\',+])=4P1A' M4,S'EQ.X`Z?CAY!>9)>%WH/SK7X:UY=Z=<:7B M#A,&<_"%Y5'(=17&UIRQLC;JEU(``(WH.AQYKR=]A:$;MV^6/)>;MW`H*4VIVP\UY.)X@`@$]=\5<06W' M?%#98#:E:=\5IQ4DU['OBMNY[]/I[XVM.`(/R[XJX-7M2N%7`4WQ5W44Q5OI MBKNN*NZ8VKL5=7%6\*NKO@5V%#JXI=7%#JXJ[%75Q5U<4NKBAU<5=BKJXJ[% M75Q5K%75P)=7%75Q5U<5=7%6L4NQ5U<4-8I=@5V-JU7%75Q5V!6L5=BEV*NP M*UBJ90VSV\*,XWF%2W_&OT9DB!B`3_$X\I<1]S/_`,G=$N-7UZ^6TA2>]MK0 MO#ZA0!%D<1RR+Z@9.:QM16I\/+DOQ9B:V1$0!U+D::(NTZ_.ZVO](TORSH1E MB&G0I<2Q6\,AFX2JY`/*.6;"W"IW+&TT[EC:T[E MC:NY8VM*<\0FC*'KU0^#?VX)"Q28FC:5]R#L1L1[YBN4[%6L5:P*ZN*NQ5N/ M^\7YC]>!+__3X++-9B]9BA+!]Y:_#RZWSK@ MCMS92-\N;:M&T3K"A1R!4$\BRCJ!AO;9&]BW1UCC?U5/!B`$.Q+>(^6`;#=) MW.SF(>&D*D`-5TZGV.'F-D#8[MCBD0652:DE%K0@=\>FZ]=FI`75#&I],"G$ M;T/>N`[\DC;FVS(%595+.!O0TH.P.$GO1[FI59GY*"5('"G8>&`I"YGB]0+G510FO%B=JXV$46HPRM4@@"O M*N(26U*$$(*,1W-<4-+L#R'PGMXXA2ZH*D(*;[CQPJX;+1AWV&*MG<#B-O#W MQ5U10!A4]OEBKFJ:4W%-L5;)%145/7\<5;JM?XX5:%:_KQ5NOAL>V* MN'OTQ5U=L5=7%6^VV*'?/%785=7Z<5;/7%75WQ5V*NKBKL4NQ5U<4.KBKL5= M7%75Q5U<4NKBKL4-8I=7%#L5=BKL"NQ2[%6L5=BKL5=BK5<"T[%6L5=OBKL; M2UBKJX%=7%6L55;9`TPKT7XC]']N2@-V,S03.WNE2LX/BOOF5#) M6QWB?QQ1:#'N9#Y,U=O+WF"'48T:^TV16@O(HB!*89.OPU%70@./YLJU&EE. M/I]7=+_BF>+,(G?9Z[?Q>5?/?E3]&V]K#<7\,QFLWL9EMKR-BM-XKPKZG/[+ MQ\O]1N2YKH0R8I7(<`_G$'AIY/'^6?FV62ZACTR]^L69I/;F&LJ[5 M!]($.P_RDY+FRCDPRY3'^<.%PSBF+V2)=%NI)9(8)H)KF%S'+:^H(IU930JT M65_9-QO+:6V)Z&1"H/R8CB?HRP2!Y,#`A0#8;8T M[EC:::Y8VBD%>H!-S'205/S&QRK)SMNQG:E#*V;6*NQ5JN*78%;C_O%^8_7B MK__4X)*EG]=8%B'Y[QT^#EXWN/>N,3?-,@!R7 M+Z:QNT#,S@`$L*$*>I&(H#9=[W:1S)&_K,2@(H_4AO`8@V-U(H[-EE2&L+&A M;XW.S>P^6/(;+S.[JJ\2M,Q%"0C#FZ\CLT[\%01L1&17ET)/>N)-GCBK>Q`+'?^&*N)(Z& M@IMBKCQ[]>^%7$GE^H8H;^&O\,5<":_KQ5PIVZXJX'%75\,5=7;?%6ZX5=7% M75Q5U<5=7%78JZN-JZN*MUQ5U<5=BKJXJ["KJXJZN!6JX5;K@5JN*'5Q2ZN- MJZN*NKBKJXJZN!6L5=BKJXJ[%6JXI=BAV*75Q56L;.ZO[ZVL+.(SWEY*EO;0 M+]IY9&"H@KW9C3!:H[5_+&M:09%OT@5H0#*L-U;7!7D_IT(@DD^/F/B3[:?: M;X<`D"GA(2CF/XT[T`K^K"A%:;IUYJ=X+.R17N&5G5'98P51"['DY5?L*S_Z MJX":2!:-U/RGYCTNQ%_J%BUO9,\,:7!9"KM'$GDKP?'R7X?V6^/X<` MD"I!"4G"JO:;"0^-!_'+(=6N:MRR5L:;61E-58J?$&F(D1N%(;:>9B"TC$KN MIJ01\J893,N9M8BN3*M)_-3SQIUJ+/\`2+7UD``MO>CUN"J0>,N>Z%K!H!JNG<+N.HV'*.3A,1_K229CRTI M'+=M&8)[^5WE>:UU9[;3MM921I6FT<3I\ M/-&C^++HZB8ZL#B#R?7]-CTO5);6"<,A2IX,5-)$K\, MBNN9T)\0MQ9QHI?RR5L:4;S>%3_*_P"L?V9&?)E#FA,K;&C@M+JXJXXJUBJZ M/^\3YC]>!7__U>!2VL1NV7U5`+D^E^WOOQ^>;'@%N)QFN2U;R624*P!1SQ*` M;T.W7VQ$R2O``'1Q1QN7$BRF,%E1>M1X_+$1`ZI,B6HYWGK%(05<$\@`*$;U M^6(E>Q4QK<.51$C2HZR,**./05[G`-MU.^S@YG1ED(7C1@]*`5VH<;M:IU?1 MCJC!BYH6[`#MCR7FXGUD#.P1E/&IZ$=<>:\G,[1*JH001R+4J#\L-TM6Y@'" MR%@C,-P>]-JC`=UY-M*T9X+LJ^.]??"32@6XQJ7^T%Y;\#UWQI;=Z[\Z4^&M M./>G3'B7A<$4-]H&G[/?;&EMI9&<\6W#>&-K3@`M6#!B.E,5;#%@0?G7PQM: M:KQ%0:D[5[#%75Y#G;%7$D;#"KNN]:5[8J[D0=NW M;&UIN@KU^C%7N-K3MO'%7`UZXH=VPJ[KBK=:#%78JZN*NQ5U<5=BKJXJ[ M%75Q5V*NKBKJX5=@5NN*M5Q5U<5;Q5JN%78%=BKJXK3JXJ[%78JUC:78VKJX MJZN!75Q5K%75Q5V*IEY7U2#2?-&C:M<*[V^G7UM=SI$:2%()5D8(=OC(7X<$ MA82&?Z'YT\GIYSCN?6!MK_4M-N9;F73K;3(+>.TO))Y/52W:57K')1I_M2-] MM:]G:"[EN6BDMS,L?HF*6.UC? MUV_=VR>K$T+>DB<97C#'M<\^VEYY8\LO:Z4[@_N/FX'W`G!+DF/-"G*VQVV*M5Q5V*M= ML"KH_P"\3YC]>*O_UN`RVU/IQ$2-U,@=@U'(LH:(1K&SC8K MW(WH?;$&]E(K=R1M"&DD`((XA:U!)\<0*4F^3@?6C*(H1E(;B.A'3?'FO)U# M"AY@,7.RG<;=\>2\W$&9`4`7B2"G0;[U&/-/)S'TT5&4.WVB#T%?#'DO-S(T ME'6E"*4)I2G;$BU!IS.JD*5#E``6/7&UIS1,SO?&EMP=22.(7EM48VM.`*U)^X=\5YN!Y`J``>NWMBKMU&X MZ[`8JW]H;;4[85=]D4(J>N*N-30CY4Q0XFE!2I&*NI4U'0XJ[D*_QQ5U-\5< M#O\`/OA5O%7`]NF*NZ8J[%7=,5=BK>*NQ5U<5=7%75PJ[%75Q5V*NQ0[&U=B MKL;2ZN-H=7&TNQ0ZN*78JZN-JZN!75Q5U<5:KBKL5=BKJXJ[%75QM+6!75Q5 MV*KX9%CF61HTF534Q25XM['B5;[CBJ-_2MI_U:++_IX_ZJX*\TWY-'5;3_JT M67_3Q_U5QI;\G?I6T_ZM%E_T\?\`57&O-;\G?I6T_P"K/9?]/'_57!7FM^37 MZ5M/^K19?]/'_57&EOR6O?03J8H[&WM2?BYP^KR/'?C\;N*9*+&2ARPVAW+& MUIW+&UIKEBKN6-J[EC:L@_+MZ?F#Y9/_`&L[;_B>0R?2? MU]>J*5]?#"KAL#4;>&*N M.X^$;5W&*NV`^+Z,5<=Z4Z>&*M[;5W.*N-2?$8JZHK^LX5=O7^.*NJ,5<*@X MJWBAWSQ2ZN*NKMBAV*NKA5V-JWC:NQ5U<5=BKL5=BKL5=BKL5=7%78JZN*NQ M5U<5=BKL5=BKJXJ[&U:Q5U<"T[%+JXH=BEK%78JZN*NQM6JX%=7%7?+%75Q5 MJN*78JY6*L&'4&HQ!I!"JY6H*_8;=?EX?1TR10&N612URQM7GQ-2M!U8^"CJE`?LKX`;`9$FRD"FL" M6CC:NKBK6*NQ5='_`'B?,?KP*__0\^RR7/UUU%>7,@)^S2O3Y4S.LVXU"FUC MMA/1&+,">$9'P\AT%<-"ULTLA>5Y.+DLIKZ@;I3O@B3:2!3:"-0S0N7D"U6H MI0=R/?"*Z(-]6HV+JXD),8%2QW(/:F`)+?PK&S1,2:@,QV('MCTV7KNTM&C) ME)"@_"W4U/48]-U))JW0U\#BK9XE%,A(.X%-R1[XJT[%:!20E/A( M[XE0VPC)!<\6(!8`85:9G$E!M3H!T]L257<8_4Z[U^SVKBC=:K.6W^D=L4MC MC7X34]JXHN(2X4`)4U/?%7#<&O3QQ5U:+L?F<5=L1O\`1BAQVI3I MXXI=M3?"ALDUQ5VU<5=4U_ABKMJXJX'^W%7?+?%6ZXJ["KNV*NKBKML5=7%6 M\5=7%78JZN^*NQ5U<4.KBEU<5=BAU<5=BKJXJZN^*78JZN*NKBKL5=BK6*NQ M5U<5=BKJXJZN!78JUBKL5=7%6L5=BEWRP6KL5:Q5V*M8JO1Q0HYHAW#?RGQ^ M7\V$'H4$=6FY*W%A0CMVIXCVP'90URQ2ZN*NY8K37+`JZ.::*1)H)#%/$P>* M5=BKJ:JP(\#BE,?,NN3>8?,FH:U)`L$^ISF=[>*I5790&"U_9J.7^3@B*``6 M1ZI:[*J^FI!K_>..A([#_)'_``V2)Z,0.JG7(LG8JUBKL5=BKL"MQ?WB_P"L M/UXI?__1\_2WDPN76GPARHCIO2M*5S.XS;C<(6K;HLM/4#!"2(Q]HTWIAX=U MXMG)<2RMZ;FJ25!`%*=Z_1@$B5,0&D3T^4@=79!L%]]JG$"DDVY7DF#(YVIR M#=`"/'&[4BG#]TA=6#,3QJ.@[[X\EYNJ94JS`%#LQV&_;'FO)Q9HE`4@\MRP MZ;=L>2\W$>HH=F"M]FI[TQYJYG:.B*=@*U\2<;6FBH8ABP4M0D'%6S(RM0;! M=@#C:T[@.744_E[XTMN$C%J'H=B,;6G`4-:@D=`,5<&+;$_V8K3@*`D$'%7< MBPW[=\*N^R-CU[XJ[J*XJZI`%/OQ5QWWZ8JW6GT8J[_.F*NY8J[OBKJX4.Q5 MO%78JZN*NQ5V*MUQ5V*NKBKL*NKC:NQM78%=BKL-J[%78JZN-J[`KJXJ["KJ MXVKL;5V!6JXJZN*NKBKJXJZN*NQ5V*M8JZN*T[!:75Q5JN*NKBKL5:Q5V*NP M*[%6JXJN5Q3@XY)V'0K7^4_PP@H(;](MO$>?MT+\Q^O%7_TO/TMTHNF/IB@8CG3X]M MJ_/,[BW<;AV6+;2I)R8T53R+CK0;_CCPD%/$'),'8J$5#)4!EZ[X@VM4TD;Q M5D<4"BE`:UKM3`!2DVY6]16C50A.XX[`T[''FO)P5HE8N`>6P7J/&IQY+S=O M*M%`!4UXC8&O?'FO)U3&H5@&+&M#T&/)>;1#2`,HZ;%>P^6/->39;B`I4,0- MZ^_;&U:96<\AN#X]L*MF0!N@-.YZ[8VM.X-RK7;K7O3&EMWJ5/2E>XZXVM-! M2NYZ#%7!JU7H3TIBK>Z[GY8JZM10;$8JZI`W[]L5=U&W;%75H*4Q5W7%75[8 M5;WQ5U<5=O7%75Q5W3%75Q5O%75KBKL;5V%#JXI=BAU<5=BK=<5=BKJXJ[%7 M5Q5V*NQ5V*NQ5V*NQ5U<5=7%75Q5U<5:Q5U<5=BEU<"NKBK6*NK_`+>*NKBK ML5=7%6JXJ[%78+5K%75Q5V*M8I=7%78JU\_HP*O$\P%`Y(\#\7ZZX>(HX0[U MF_E2OCQ&/$M.,\U*(K04Z]3W/4X$NQ5V*M;8%=C:NQ2[`KM\5: MKBJZ/^\7YC]>*O\`_]/S[++;?6V)2I#FLE?AKXT^>9UBW'HTI(DRSE.YP`&TDBER/"6;TU*.00C$U%3^K$$((*V(,A)=2$I1@>X\,0DM@HR.L:E6 M(%:FI(\,?M< M4M@IRV%#V.*M+4&IV`ZXJW4;@;'%6AT->F*MU%-OIPJ[H-_HQ0ZH/3%+MJ;X MJ[%#=1BKMZXJZN*NWQ5U1BKNF%75VQ5V*MXJZN*NKBKL5=BKL5;Q5K%75Q5N MN*NKBKJXJZN*NQ5V*NQ5V*NKBKL5:&*NKBKJXJ[%75Q5V*NQ5U<5:Q5V!785 M=WP*ZN*M5Q5U<5=BEK%78J[%78%:KC:NQ5K%78JZN*NQ5K%78J[`EV*'8$AK MJ,5=BKJXJUBJZ/\`O%'N/UXJ_P#_U//DJ6WUMJD\N9JE/AKX5\*YF[6X^ZFD ML[34))))#(>E.XP`FTT*;00AB8V+.`2@84&$4C=;$[L2'8LE#R)/3WP`I(;4 MQJK&-B6'4D4('MBK2MR1O4)*BE#U(/MBK9(5*QDT)^)NA]ABK6S(#(34$A2- MR<5_2IQ5QXD`N2&I_M85*M5Q5V*MXJ[%6JXJZN*MXJU7%78JZN*NKBKJXJVJL M^R*7_P!4$_JQ`M2:5197IZ0/^']]:]M=(*M"X'RK^JN`PD.82) MQ/52J"?<=1WR#)V*NVQ5U<4M8JZN*NKBKJXJ[`K6*NQ5V*M5Q5WX8JT33<[8 M%7QQ32?W<;/[@&GWY(1)Y(,@.95/J%_U^KO3Z/ZY+PI]S'Q8]ZF\$\?]Y$Z^ MY4_K&1,2.89"0/(K`014&N19.K@5JN*NQ5V*NQ5W7%6L5=BK<1_>)\Q^O%7_ MU?/2A%58TX@;T.V#B3PN5%1BP*NK MZ:54UY'[7;;%7$\U!8@$;5['OBKBQ0!5/7N*MM:=N^*N#$['OBKA0;UKBK=:['%7=.^%7=>NV M*NK3%7=<5=6FV*NVZUQ5U3BK>*NKBKOIPJZN!75PJWUQ6G5Q5U<5=7%#L4TJ M6UM=7=Q':VD33W,II'$@JQ]_`*/VF/PY*,3(T.;#)DC")E(\,0SO1/R\LH@L MVLR?6IB*_5(B5A7V9A1I?^%3-ABTD1O+U'^;_#^/QQ.AU':N2>V(<$?Y\O[S M_-A_!_G^K^@S&U6UM(A#:0QV\0V"1*$&WRS-C(1^GT_U749,1F;F3D/]/U?C M_-5?K!/4UQXT#"X7)'0TQ&1!P`\PA=0L]-U&,QW]K%.4L?]7Z?])]'^Q83KOY>-&K3Z)(90-VL)C5Z?\`%4A^ MU_J2?\%F%ET8YP_TO_$NYTW:Q&V8?\E8?3_R4A_!_6]4?YW"PL@JS(RE'0E7 M1@0RL.H8'<',`N\YNP*U7%6\5:Q5O%6L5=BKJXJ[%75Q5?%%+,_"(/>7]\_OLH^0_KF3##$<]W&EE)Y;(P'B*#8>`V'X9<# M320[EC:T[F1[8;6E*:&WF%)4#>#=&'TC(2B#S91D1R*776FR1@O"3(@ZK^V/ M^:LQIX2-PY,,P.Q05?IRAN:Q5V*NQM7'%78JUBKJXJ[%78J[%5:UM)KD_!\, M8-&D;H/8?S')PQF3">0136WT^TAH>/J./VWW/T#H,RH8HCS<:62117,].V6\ M3537+&UIOF?''B6D-<6-I/NZ!7/^[$^%OZ'*Y8XRZ-D*M=<"KHC^\3YC]>*O\` M_];SS+;2&X8U^$L6Y5WI6O3,RFBUHG1I*\`H;8./M;]\;6G)$\;J!0A8;$>V]#C:N"F,%FH=N(6M:UQ5P^-2J@*1O0=#BKJ>FOQ`$L=AVV MQ5WVP"HI3J.V*N)X@*0">N_:N*M%2U"/N\*8JXM0\:`D>.*ME234=#WQ5W(5 MZ?3WQ2T`0=^V*'`]J4KWQ5VXQ5NM=NGABKN@_ABKNN*NPJZM<"N)PJ[W\<5= M7?%6\5=BKL5=BKJXVKL;5V*NKA5NN!52WM[BZN(K:V0RW$[!(HQM5C[]@/M, M?YST6U,4)$MU*/]*NZ;R'^5:_9B7]E?VOM-FRQQ M$!0_SI?C^%YW/DEFEQ2Y#Z(?S/Z4O]L_W'T1_BE,S^L9/B:O#:^L>^/&OAM_ M6/?'C7PW?6/?'B7PVOK'OCQ+X;OK'OCQ+X:0^:?+T>L1FZME"ZO&OPGH+A1_ MNM_^+/\`?3_[!LJS8_$W_C_W?_'G*TFH.`T?[K_IE_2C_0_GQ_S_`.<\[!KX M@C8@BA!&Q!'B,USOG8I=BKL4.Q33JXH=BEU<5IV*KX8GFD$:;$[DGH!W)PQB M2:8RE0M.(8XX8Q'&**-R3U)\3F9$`"@XLB2;*_EAMC3N6-II4@B>5OA%5%"Y M_P`FHKE&?/P#;ZFW'BXO<]:_Y4>=3T=K_P`OK<7+E2(XO6@<^JH/P."8RHDX M_`?V6ZIIE]IEU]6O87@FXAO3D`5UKU5P"P5T/PNM M43%AQY8^$H/EEEL:0&H6@(:>(?$-Y4'*>+4WV_9R<(@[GZ6,B M>G-.EM^-O&R%`&#>G"M:\4Z]J9D>-$'A_P"D?ZK1X1(M3Y99;73N6-K3N6-K M3N6-K3N6-K3BPZ'H=B#TIC:TDU_9>@WJ1?W#&E/Y&/;_`%3^SF+EQUN.3DXY MWL>:%REM=C:M8VKJX%=BKL571?WB_,?KQ5__U_/$LN9=%HM MH-!ZM5!#$GBW:OC3#85;&CJ_)AQ`KR)Z4P!2Y2A#!`58C:IK]&%+2J5#%@0M M*$'OX4P*W560A`1N*@]3BKA0)\0ZG88JT151QZ#J.^*N-`H#"I[>PQ5S`FE- MQ3;%6R5K\6Y[G%6B#6OW'%6ZK7W\<*M`,#7[S@5PI7;KBAP_#"EL>V*NZ=<" M'=>F%+NV^*'8J[%78JWMA5K?%6\5=BKL5=7%75Q5U<5;Q5JN*LP\F6"V]J^I MR#]]='.S/O^%I=HOCQ!/\`$9='01ZDN-+M MPGZ8?Z9ZM^7GY9>4)])-[JUN-2N9G,<*2EO378=%5A5S_P`+FD[1RG'/@AMM M=O3=BXAJ,7B90+,N&,/YO_%2>7?F5H]CY4\W7VFP.RZ>.$MH9#R(61`S1\A4 MMZ;$K7(XM3$Q!D0"W9=%*,R(@F+%AK%AZL4)N42>?^X@;DLCCI4*0-MOAY?: M_9R8U,":!W82T>2(LC9C'G/3UCNTU.(42\)6Y`Z"X45Y?\]4^+_75LAGCOQ= M_P#NG)T,]N`_P_3_`,+_`..?[GA8[F/;G.Q5V*NKBKJX5=@M78VKB<53.RB] M*$$C]Y)1G]AV'T9DP%!QYFRB.62MC31;&UI'Z9IKWDSH3P$*K))R&Q#'X4\> M3T[?97[68V34UM'YML4KE@F8\F'AB7/H\`_,^ M%$\QZTB?W<5Q%XM@_+,RVFG(^@YCY(T6^$K"AD&;L5=BKL"NQM78I:Q5L!F(515F("CW/3$"T)U` MHMT1(F(,9JK@T;EUY`CO7,L``4XQW-I]I6JV--R>Q[4Q5VP4\"3O0GH:8JX;K\9V!V.*M'91Q.QZG%6]B!RZ]OE MBK3$B@'3MBK9XGJ:$]1BK1)K^K%6Z+7%6A6OZ\5;'MBK@?'%75%-L5=BKC[8 MH=^&%75P)=BAU<*MU&!785:9@JECL`*GZ,4I_KODG7-$D@M[YK9M4G,(;1K> M7UK^(W$0FA#VZK5N<3*U83*J,D4BE'4]:,K`,I^>*TLPH=7`KN M+N5C3[(_$X5Y/0V,<'&VBVBME6",>`C'']8+9EDUMW.IB"=S_%ZO M],UZ^"T\*<^7DC#-?3`,L51"&Z'CWR?U/Y MJ(N/-4;,1S9P/Y=A_#,N6HB-B1%KQ=C8H]+0K>91T"O3Y@?QRLZN'\YRXZ"` MY147\QRG[,9^9;(G5X^]M&D'<&0:3^;6O:;I3:;%!!)$6Y(TO,LE?M4*%">? M??-;K8X\NX)$O=Z9.?I)RPV*N)[OX4`WYC^8`Q:W@TZU+&I,=HCL?FTA8YK_ M`,MYN8=9Y,8U@)K6N#7-4/KZF.`]1`L49],42L:#B>';)QT\0;NVN>JD154I MZH@O-*O+?JYC]:(?\60GFOX-#T9A7Y#81-,QC)3FQT=5?U99`\:[J0"!]Q[Y1DSF0H;-D<=,EI(WIEPNXD5S\.W[2O_K+E')L2>[\RZE?GZH0((68APC!C)L=B1\/#_)& M7QPU$D]S`SWH/H?_`)Q^\V:59_EA+:RZI9VM[ZTSQP7,RQM\2K1J'M7ED8QN MF,I4"\A_-"?3YM?U9[.\@O`;6Q,SVSB15E4L&4D`?$-LMA];'^%Y[RS)MA3N M6-K2A?+RM^7>-@?H.QR$]PRAL4ORAM:KBKJX5=BEV!75Q5V*HC3UK<%S_NM2 M1_K-L/XY9CYVUY.5)ARRVVNG5!V['&UID.C^<)+:);748C=VP3TDE!XSI'T] M,DAEEC'[*2JW']G,;)@LW'8MT)ZL?"DAKVTN[*?T+R(PS<0X1B#\+;@U4D;Y*.0 M2Y%!B1S4.62M%.Y8VM('4E^*.4?M`HQ]UW'X'*LO>SQ]0@LJ;';XJ[%78J[% M5T?]XOS'Z\5?_]'SO+/)Z[@=`Q'#VKF7;32T1*'^T#3?B.NW;&E:$KNW%MPW M6F-K3E7C5@P8CI3%7!F<%6/:M?"F*M?8!(-3TV[8JX$L-S0@]<5=4J-CUW)Q M5Q^(`DTQ5Q)78'%7$5WK2OCBKN1!IVQ6G4WZXJX-O3%7=,5<#78XJX;#WQ5U M:XJ[Y8J[^&*MUQ5K%6\5=BKL5IIMU('4^.X^["KT.#\T-'@M-,LCH]]?6-E= M6]T;?4-1-Q]52"-T:'3)1''-;I,\GJ2"5Y$_=Q1,C?$S0X6?$CH/SGLTOH9Y M=+OWB@BTE5:.^2&X>319)Y(O4D2+AZ,YG598DC7T_3_=-]G!P+QJ5O\`G3*K M:'/+I\RS:7GRI8SRSIZ,!A,D,K--^U*T<;>HZI^^XX>!>)YM+ M+---)--(TLTKL\DLA+.S,:DLQJ6/N%49HRA]9L48;&="?\`8GE_ M#)0^H->8U`^YDOUDM\1.[;GZ=\LMQ>%L2.P5,Z+-6/'4?X0\[V8#ES9,TOYWAP_S6+B;;KG.V]!PM^M[X MVO"UZWOC:\+O6]\;7A=ZWOC:\+?K>^-KPJMI+6YC!Z,2I_V2E?XY*)W83CL6 M#(O%%7^44^[;,=V178H=BK,M#\E:7=_E_?>:[M[Z62UNKBU^K69M4CC6"W2= M9I6N&5Y.9D*^G`K/Q3_5Y0,J-,XBPNU3\M+ZUTB74(6<"R9FU5YBC6]M;BRM MKJ*1IX@1ZES)=^C##QY\N$?V_4XHDO"I3?E7YNAD6.7ZDKJLQOA]:4BRDMK? MZW-#>$"D,R6_*3A\7V)(^7JQ.BO&%X%>#R!I5M<-IWF#5ETW4UF>/U8Y(9;/ MTGLUNK.XY;2M!<>K$I8#X4Y/]O\`=X\2\(236=,TW2_,4]EIMX=0LXH(V2\/ M`)&DIP++Q61G5?\G[7Q99C+7D"'#5(%:5-*Y9;72V/2E6^A,D#D0L2[E^ M2LQ.Q5&;0SV%I&LU[-&A'V(F/PI[O[_`.3@*I!KNO37LLD$3%;-6(VV M:6G[3T[?RI]G,K#C`%]6N_(US$!;2$)?:.$FN]1BD*(4!EA'1C4`G)X_J")58RX7]HH&Y M<<2=E#,-3_*_GK%UI.BI=I=V[VT$?Z3N+%5>:[GDABWMVD`$OI%4'+DDO'U/ M@R(FV&(2>Q_+3S;>Z;-J,,,"V\,?J!990CR-Z'UIX(P13UX[?C))&[)QYQQ\ MO5D1,/$&/"B+/\LM2:6:'4=4T[3YX=-N=3EM6N!)<1&W@6X6"XA0%X7DCD1N M7Q(GQI_?1M%@XUX'-^4_G!9XX&^HI*1-]/Q M?8ECY^K%(BO&%X41HODOR3J"VQN/,;Z>7BLY[CU?08%9C(+A(:$,2LQP^L#8TDX!AW"DT/TY=#DTSYHCED[8NY8+6FN6-K3B0 M?X8VM(JVU?4K8@P7+KQZ`GD!]]<@81/,,A(CJB(]?F2XDO/JT!OI126Z4,K- M[L`>+97X$67BEF7EGRUH.K?E5YJUA;%1K=A?P,URC-5+>X*E@J]`HDY'_9Y3 M]$FSZHO.PQ[]1L1[CKF;;CT[EC:TH7P#6P_R9`1]((R,^28\T#7*FQW;%6L5 M=BKL571_WB?,?KQ5_]+SM+,/78\10,?B_:Z]IZ*:\O;&EMH2!B M10+RZ$==\;5RJR$LPH!^.*N!Y`J``?;%7`%`21UVIBK6[#8=.PQ5VZBAWKBK MC5J$8%<2104J1UPJX@DU\<5<6W^6*NH:[X%;J*_QPJU2AQ5PQM7;XJ[MBKJT MQ5U<5=7%6\5=7%78J[%5LS%8G8&C!20?D,5#UGS%Y,\GR7XT>T%IIB:?H,6N MZE<64%Y-J2&/3H;ATG,\@LW2ZEF^'ZO_`'7P<^*\\@)'FV4ED?Y222:=IT\< MM]-J%S>6-G=Z3';Q?6`=2MI+F!H:R>G\*15D]9U7TF];]WAXT<*(D_*_0+@" M2PU=VT6SBU*ZFU5K4Q7%U#9W-O;*4C9W7>2Y^&JQ$/C?XF7B!-/"$LO?*WE MORU;17^HW9U<7EQJUC:P-:.L!^HQA(+FK/',CM<2PJT+)^[XR^I\'VC9**I! M^;;_`/+JYTFU7RSI\EGJOKH]\[B3TS']6$;I%S=J1_6$]?B1ZG.=UY>G&F$7 MU0:8IA8HG3)EAU2RE/19X_\`AF"_QR<#N&O*+B1Y)V[$&C/5&*'_8FG\,D6 M@;[IWY;?T%EU`A6X'BBN`RL`/B!!Z@UXX0R`5=+X:K]>XAQ<102?45YUB1U4 ML!3=R*?"BY?/5SG&NB!AC'?JQU9@5!'0BHS'M:;]7WQM:=ZV-K3O6Q6G>L<; M6G>KC:TKV4P%TC'[*8X?+DFAP:7!J6CR3RW*?6-/^MF*XFC6&5X9@O*-N$<8HK?"R_S9`@6SB32 M-D\X_F-*HCDBG:&DHD@-B_I2B>RCTZ02H%`DK:PQJ.7V)?WR?O&QX0G==?>= M/S'OHC%Z:W_`':W$GQK\3_WCNV/"%LI M'K'^)-8OS?ZA87$ET8H("R6DB#T[:)8(AQ"?LQQH"?VF^+"-F)!4+;3=2A/J&8EW MI7_S/CD1B)YIXD:&S):ZG?7'@ENAI^EFVYRVLQN(I#P79UE)W7]GX/LY'A#99;N/-GY@7*ZJMW:/ M=#6+F:^NOK&G>KZ=U<(8IIK;E&?J[R1?NSP_EC_;C1E:"-UTOG'\PI9;>6:S M,LD-O+:2LVF?%=1SP+:R&\81A[ES;HD8DD;DO'G_`'C,^/"%LK[WSO\`F3>I MPN()6Y17$5RZZ<5>X:[M_JDT]RRQ@SW36_[L3R?&OQ/_`'CNV/"%-L4_0VIT MI^C;KZ;:7_FG)6QX2B(K.^MX9&N+6>W3DO%I8GC!)J*`L!DX'8L)C<-<\**= MRQM#N6-J[EC::=RQM:=RQM6=_EY<7\OEW7]+M[^6QMIY;>:^2`#E/$BL!$Q/ MV4+CX_YE^',;/S#;CY,-U11%J=W&!Q"RM0=J$\OXY?$V`UD;H;EA0I7;?Z.H M_FDI]RD_QQER6/-"96V-5Q5V*NQ0ZN*KH_[Q?F/UXJ__T_.TK1"X8\=^1^+M M7QIF6TJ860/4UZ[GMBK8*5/$<2>AQ5I:BI.PIO7`KJK0A10GMBK0V!Y=#V]\ M5;.XH/'<8J[8#N*NJ*XJX8J[\ M,5=BKO\`,XJ[;"KL"M[8;5V*NQ5V*NKBK1W&XJ#U&*IP;/4'D:9].-L^'S1"2^88U@5/-$"K:J$M5&J2`1**T$8 M_P!U@H?XI@^OQ,S17GZ4D]9&<4E_])@_YIQM>%HZ*]-M4TL-V;ZV-CV/V<;3PIEJ;<;@ M2J\@Y<9`W++9'KWN'"-;?S?3_Q/^Q3?4&%II5O8JU) M*#U#[G=OQQ)H,XBRI^5[R.PU:)C(`C,`P^1R.,@%ED!(2F_`@U"Z@'2.:15' MMR-/PQ8TH>KBM.]7%:=ZV*T[UL5IWJ^^*TNDF]/3;N6N\H%I%[M+\4E/]6)? M^&R0Y$L:N0'^=^/\Y)L@WNKBKJXJJ)BN0.@^S\CN/PR98!;RP6KN6*72!S0]3D&;:NZ,'1F1U^RR$JP^1%",55?KVH?\`+9U#_ELN/^1TO_-6*VW]>U#_`);+C_D? M+_S5@6R[Z]J'_+9<_P#(^7_FK%;70W=S)((YKB65'JH$DCNH8_9:C$[UVR<. M;&9V;Y?0>XQ0[EBKN6*NY8J[EBK7/%65_EO?"+6;NT8T6]M&'MRA82#\.659 MN3.'-)?,)_W-77N0?PIDL9]*)#=+N8ID[8J=VQY)'_OM:M_K/N1]`IC+N3'O M43D$M'%78JUBKL57Q?WB_,?KQ2__U/.TJQ>NV^_(U':OAF4TJ8=R]#]([8JV M.`/PFI'0'IBK2DG8FH[XJX4`)4FN*N%2#RW'CBKJT&WWXJUM3?%7=ML5=U&_ M7%7$GH,5;VK^O%75WQ5VV*NJ:XJ[;%75Q5V*NZX5=BK6*NQM6\5=\\5=\\5= MBK>*NQ5V*NQ5V*M8K3>^*IQY:>WFO(+"Y;B/6]:T)Z&6GQ0GP6:BE?\`BU?\ MO+8;[-&7T^K_`$W_`!7^9_N45JES)<7,SC"+(K-KBM.]7%:71>K+*D,*\ MYI6"1H.['_/<_LKB!:#0%E9J-Q')(EO`P>VM0420=)'8UDE^3-\*?\5JN&1Z M#HN.)YGG+\1C^/XD)D&QV*'5Q2[%#JXI#L4.Q2ZN*JR,7BX_MQ#8>,?_`#9_ MQ')\PQY%KE@2[EBKN6*NYXJC1JS0?NWA:J]_$9BLU:+S"BFK0/Q((/TBG\<( M**2M30`>&9-L5R#DU*T`!+-V"CJ<1N@[** MNQ5V*NQ5V*NQ5V*NQ5U<5=7%7'J MD&E,AU;>B!DFYR2.!0.[,%\.3$T^BN*K?4.*N]3`KO4Q5="LTTJ0PQM+,^R1 MH*D^/R`[L?A7"!:"0!91$LT5K"]O;R"6XE4I=7:&J*A^U#`>X/\`NZ;]O["? M!]J9-;!K`,C9Y#Z8_P"^G_O8?YTO5](+*VYV*NKBKJXJZN*N!Q5U<5=7%7`X MJVK,K!E/%@:J1V.$%"IM("T0HPW>$=1[IXK[?LY*KY(Y!_A_+D@:4BUS`!?40EHNA)ZJ?!QV_UOLMB1U')`*WD<"7*M8JWBKABKJX5=O@5V%78JZN*N!Q5U<5=BK MJXJ[%78J[%78JWBK3*&!!%0>QQ5&?7Q,H2_C-SQ%$N%;A]C_`.,=S6!Q[5/*-C_JO@H="GB( MYC_2^I=^A]5/V+8NO9D>)@?N?#P%?%CWM?HG45%981"HZO+)$H_XE@X"CQ(M M?5[&,5GN_5/^^K,$KQ!KZO,!5PL8\790/P)QX2O$'<85^TQD/\` M*@XK]+GM_JC'9=UK2,P"T"Q@U$:["OB?YC[G`2H"VN^!+L5=BKOU8J[%7=\" MNWKBK6%78%=BKL5;5F1PZ,58;5'AX'QP@TI%KJPM]H&%OYD')/\`@.H_V)PV M"C=L0,WV'23V5@&^D-2F/"MN^JW7^^C]Z_UQX2O$'&!U^VR1^SN*_0%Y8\*V MU_HZ]*S-[@HGW?;/_$<=O>NZUW=V!IKZ\N_"V/'_AFKCQK2&N_R1U-5)LM:M9R.D-:8IKGD?S5 MHB-+?Z>_U5>MY;D3P#YO'7C_`+(800BDC!!%10@]"-\*&\5=BK6*M_YUQ5V* MNPJ[?%78J[%78J[%78J[%78JW&LDDBQ1(TDK[)&@+,?DHJ<(%J2`+/)DFG_E MWYHO%#RQ1V,9WK6S_`)3W M0'^C:M&Q\)867\58XGLX])#[4Q[?'7'+_-,?]]PI%J?D7S1IZL[6HNX5ZR6K M>IMXE*!_^%S&R:/)'>K']'U.?@[5T^0UQ<$OYN3T?\=DD`(-0.H-".A!'8^& M8KL78J[%78J[%78J[%78JZN*NKBKL5=BKL5;17D?A&A=_P"517"`3R4D#FC8 M]&O'W>S2<\1YJXT+QN-_9?ZG)_E?-A^9\EKZ%*/L3J? M9E(_$'`=*>A2-2.H0D^GWL%2\1*#]M/B'X;_`(93+%*/,-L7/+%]K22GP(\FU/4;X5^S M&K9L>*.&),1R_P!/^/ZKH)1GJ9B.27U?3_J,/YOH_P!]--ETG4F@F<*!-:S> MA>6S55X21568D?9>A"TR$M;`4?X9#TR_WK9'LS)*P*XXGAE`_P"[X_XHR0!G M()5@5931E/4',@9`18Y.(<)!HBI!KZQ[X>-'A-_6?`X\:G"#S277_+.C:VI> M=/0O:?!?0@"0?ZXZ2K[-_L6RK+CADY\_YW_%?SO]TY.FSY,'T'BA_J*M8J[%7?/%78J[%78J[%479:<]S220E+?L1] MI_\`5]O\K+L>+BW/)JR9:V'-.88XH4].)`B>`[_,]\RXT-@XLB3S7\LE:*=R MQM:=RQM:<&QM:0=YIT$]72D4Q_:`^%C_`)0'Z\IGB$O(ML,A'N2:2.2*1HI% MXR+U'\1X@YARB0:+E`@BPMP)<<5:WQI7;XJ[%7>V!78J[?%78JXT`KVQ5,;+ M20P$EV-CNL'_`#7_`,TYE8\'67^E:)YND4V6BA410!]E$4?@`,R;IQZ)+/=' M_*?4M0T(WLEV+74I4YVFFRH5/VB`)G:GI^H!^[H/Y>?',:6J`E71R(Z?9@]Q M#/;7$MMH/3&UI++W2$: MLEH`K]3#^R?]7^4_\+F/DP`[Q- M0^+%.Z(R MQ@ZF*'4Q5V*NQ5V*NIBK=,5=3%6J8JWBJ/T/1I-7U!;4,8H%'J74XZQQ`TV_ MRW/P1_Y7^KEN+'QFNC1J,_AQOG+Z81_G2_'U/3X#;VUO%;6T8AMH%X0PKT5? MXD]6;]ILV'%T')T/`222>*4OJ/X_V+;7*$$%A]^XP\2#`/8?+]S;>8?*-M!WUCWQXEX$)JEG9ZK9/97G]TQY)*!5HI!TD3Y?M#]M?AQ ME4APGE_N66/BQRXX_5_NX_S)?[W^;+_.>7WMEH7_FK+<<+._)KR3H;DJ_P!T_O\`RG_).0G'B#*$N$^224()!%"#1@>Q&U,PW*=BKL5= MBKL5=C2NQ5HX%=3%68>2OR\US7K&7688UCLH7]*VFE!"22@@-P/=EKDADC`B M]S^/4B4#+8,VA_)[4#/")=3B,##]^T4;EPU=EC5J!JC]ILF=5MR8#3^;)$7\ MN_(2!YF#ZJ!LJTN;XG\$MQ_P+97<\GN_V+948)%;_F^MQYIM+B^M7M?+RL4G MAA;U9PC[>JQ("NR]2F3.FVY^IB,^_DR'\P?RQMM6TR'S!Y;G-[=R1F5)#()3 MJ4/(\9`X"CZT@'#T^/Q\>']ZOQQPYC'8_P#2**XYMN.5;=$JVZ_=F*W MMTQ2U3%74Q0[%74Q2NB'[Q/F/UXJ_P#_U/.LBCU6_P!8_KS):EHK7"K@!VP* MZG]N%6J>&*MT\<5:IM[8JW3%74Q5W'IBKJ8JZGABK:I([+'&O*61@D:^+,>* MC[SBKU"VAATZUM].@/P62\`XV+2G>62H[N]=_P"7CE99LU\M_G!YOT*W6U66 M/4;-!QC@O0SE1X"12'X_Y+;[5T\QZ+)H>HNOQ7-E3T&?^;8 M%5'^M%_LL%%#`O,?Y2>;/+%N=:\MW'Z5T$CU$DA/,K'V+HI;X?\`BR/G'_JX M@JEGEWS!^EM1@TNZB6WO)SQ2:1Q'&*;EF??9?Y:,S?91>6&U9?J7D_5+.R>Y MAE6_*/\`'#;JWJ+$%J961OB^U\/%`^(*4ANENK2Y>VNHV@N(J"2)]F4D`@$? M(X54OK.-*[ZQ[XJPWSO8JFI)J48I'J(+3`;`7,=!)_R,!66G^MDXEA)CM,DQ M=3%#J8JZF*NIBKJ85=3%74Q5U,:5W34N;@GJ`1^Z M0_ZJ?%_K/F9C'#'WNJU$N.9/2/HC_O\`\?T6:>2;#3=2U*[2_7UOJUJT]O:U M-)75@""!0OP4\N'[65Y\AC'9GIL,9SJ7$!8?1`C2.GV@J=3R(#`O M_=KSC_:R<,9D6&3-&`_WK+M*\Y:;KO%$C]/7'B*O8O14N64;")OLLYZJGP_R MX02?RRQ-4,F9>++Q#S M=?GP<$OZ)^E*_7]\MMIX7>O[XVO"[U\;7A8_YSLUGM(=13^]M2()SXQ2']V? M]@_P_P"J^59A8ON*(Q'T'892=3$>;,89)MH>@:UK4-S-8VDC): ME1+S4@U;?8"NP_:;('60'.V8T\CR7ZAY=U6QD,4RQO<(JR36T,@DFB1Q56EC M'Q1AATY9..IA)C+#()94BE=J[CW[9:)`\FLQKFURPVBDNU*("59ATDV?_7'] M5RK*.K=C/1"92V.Q5QQ5U!BK5!BKJ8J[%5:QL+K4;VWL+5&DN;J0111QCDY) M[*/YJ=,(6WU`_F3R=HWDG3[&*#]'6MK$D<*7;(DJM&:2MQB+LTSOSK_K9B`2 MG*VW:(2#1?/NG^8[J32=/F:PO9%;ZM,\06)?T3JX:Z\K7,G.6(?%):2G_CX@]O]^Q? MM_:7X\HS8N+;?+LD5S=21K=7EM:D/\`7+:0\5O8 M8TJW.NTWP\7^U\,JOD,.6O2662%[AXB'!%0:@]#F5;0[EC:MAZ&OAC:TDMU` M(;AT4?`?C3V5NWT',:<:+?"5A2R#)V*78H;H,4M=\4+H_P"\7YC]>*O_U?/$ MJCU6_P!8[?3F2U+=^_?%74WQ5JF*N(\#OV.%7I5E^5>FZIY>BU+2Y;E[K5M( MAN/+UJQ#>OJT+LNI6A(7XA#'!)+$GPMPDBY,W[4.(LZ"#N?RL6ZNM0N-%U:V M31K6[%LLEZ9>8@%VE@;IW6,1O']9?EQBY\(F_P`G#Q(X4'IWY4^8[Q9S+<6> MGM;LD,J7KF'C%?IOY77U[;:>3JMI# M?ZL]JMC9_$U!=1RREI''VE@C@/K^@LGHR21+)CQ+PM:9^6.I7^F6]Q'<6Z2W M:6MX+B21UBM[*:WN[F9YD],E_0BL9'?4.X(XL"0P/ M8@T(R3!-?*T8;7K>1A46JR7)!Z'TD)7_`(8K@/)(96)MJ5^G(LW>O[XJ[U_? M%4[\M^>?,?EMS^B[LK`QJ]G*/4@)/?@?L-_E)QP$6A&WWFSRYJ6KV^I7&C1V M-W(C0ZA<6H1HPL@H9(8&`Y3"BL'9TX?%PY-\61X4NU?SWKF@>79]2TG6X["[ MU*"2UAB`CE4M%*H?A,`9+>1H7$R),L?+XH_V,B0K&;&:(Z7#/=+QZA M,[317#-U*R$`*:_[J/'_`"85%QH,_=K:6*>/V! M/IR'_@67#'FQDP^F38M4PL%K!@K%1R:FP\3BK/\`4_(.@W-CI\OE2ZDU"WFG MM;6\UJ2XCDCCENHBQ2ZT^*+Z[8LLR2QP_P!_'/Z;?'RR/%WMABK6WY1'T[RV MO=8M+>^9](_0]\S2_4YEU8SJL!!Q?D]YH;] M'13W-C:ZAJ-Q;VXTV::EQ#];E>&*1U'VUYQ_O1%S:&.2.1OAP\81P,.O+>*W MNY[>*XCO(H7*+=PAA'+QVY()`K\*].2KDF!4:;84.XXJOAMS<3PV]*^M(D9' ML[!3^!P@6:1*5`EGD]P#-(1]GD0O^JOPK_PHS))W=;&.P7V6IW5C=Q7EK(8[ MB!N4;C?V((_:5ALRX#1%%D+!L M;=//.7]'W)9ZP'TY;;1PN,QV(8JP(*NIHP(W!![$'IC:F+-Y=0N//FG.COQ\ MUZ<&FCMD^"&_MP!ZA1!M]<6G-V^U+E,:QG?Z)?[#_CCF1EXHX9?4PGUO'8]P M=CEQV-.(84:=ZV"T<+O6]\;6ELR"ZMKFT/\`Q\0R(#X$+S4_\$HP\]EY$'^: M1_Q+!$/)%;^8`_?F*[-Q&^*AJF*6B0#0D`G%6P0>AQ5Q(`J2!\\5<".U,55; M10;F/E]E3R;_`&(K^O)0&[&?)D_EK0SK6HK!-+4?F3M_LFWP0FND_D#,JI+KVHQVR$CFA<1J/B53_`#2?M>&1 MEJCT2,'>R*T\E?ECI/IR>C^D+R(+\"QC[/J%9TYR\OC],!@W',>60GFVB`') M4\[6GY6^8="*ZK:R:);Z>2FE:C:%87MXCN\1)!%PKO\`&8V5FY?89,$3Q';F MDT.;'/R^T[\HA!45O"4JD,*QCZQ^[*3R;$;%8_2]/X. M65<5;,N$%B_YW?E4T5QI7F#0HY9EOGDAU.WAC6/_`$FE8Y3$GP`.M4DX\5Y? M&V6XLA!L->6WF7C-"[1RIX,IH1FQ$K%N(12&NQSMI!W6CCZ#O^ M!QER3'FEU,HIM<:=_IQI6@5(V-1[8JWL/;%74P*T:`;[#"K@0>AKX8I1VD2S M07#W,$C131KQ25"58>ILU".GPY/&.;7,\D26)IR);B*+R)-![5Z9;;"FUE=' M22-BDD;!XY%-&5E-593V(/3`H?1?Y=^=M(_,;1+KR[YD1)=8,)6_MS11>PK_ M`,?4/\MQ&?CDX_8?]ZOP0]3\E:[^C[IC/97*F;2K M^E!/`#3S:I82PD%6,7(\IK;EPD^U]O*F?E%YADTN75-89=*A6(RVUK,#Z\VU0" M@WCYC[/_`#3F+/5Q!J._^Y;HX"=RP+S`UK(T#VT9C1*Q$$[G]JIIWR4>(QLH M-702G"EV!78J[%6\571#]XO^L/UXJ__6\]RK^]?_`%C^O,EK6TWZ8H=QQ5W' M%7<<59)H>J_F#:3Z1;:)]>$^F/)J.BP00-(R&\`22>->#&2.8#A7XX_Y,!`9 M6560_F9%HPT&:RU!-.D@-L+66R(D:WEG$PA$C1>NT1N1SBCY\/6Y?7OKJZN;NXFO=?\`3DF-Q;I,UP\:FWAF@CEC<":-0\$4]NJR+\:*WVL- M!%E--4_,#S1816NFR:4-$U?2ULOJUQ+&ZW-L;%0L3V\=PGJ0>L!_I%9)8I5Y M(J*GPX.%-I4WYA^=WNENOTK)Z\3P.ACCB55^J1RQ1+Z:((Q#'#<3Q>EP]'TI M&1UXX>$(LJ9\^>;C+<2OJ(=KF.&&97@MW0+;(8[.&6)4DCC9 MD5N.-!;2!5```[=.^%";^6?AO+ENXM9/Q=*X"D)QZOOD6;O5Q5WJ^^*N]4XJ M[U<46MD,T<4E: M$D[2PC]]#7XDD3X6R)&RTJ:CY7NM!O-4MI+M+F&UF06D@K6XMI1S@NAVXR1- M$Q7_`"\,52_U??#2VLNWY:9J*_\`+J_WATIA'-!Y,5XY-BU3)-9:*J10C8[$ M8H99<>>/S*AF#SWMU;7&CS1/<2&WCAD28(T,/UUA&C3/Z3/%&+OGRC:1?VFR M/"&?%)#P?F3YWMKCZQ!J[0R>E#"H6*W$:QVI=K8)%Z?I1FV,LC6[HBM`S-#*TD4..5-.NGBEX>E(D,C*_JL$CXD`U M]1R$3^9_@^UC:=V]'C9-Y/1,>(K MX9.VBG>KAM:=ZN-K3O5Q6G>MBM*EM?W-I8Q::]H_^+K");>Y$RVWF"S39([IUK'<1C_?=QQ/^J^.,_P'I]']7^8Y$JG& M^H8CZN&W'IWJ^^*TK6+4PQ.["8])8<%%-NG;,=S[6L-\60:IBEZ3Y9 MTUF_*&_U"PTTW>IC4KV*6>+2X-3<0)91.BRR2D/8PJ[.RW$0=N?/^3(2YLX\ MDQU3R)Y>FT6<++$;^T^L7&GVD7"*ZU!TT:QNO1$D:^DD-J'FN&Y?O;EN4,7[ M^5I$'$4T$%K_`)0T7R7I5EK/ISS7$[W&F7=O<-;W4,CS:<)K>[MGX*C1QW#\ M^<7J1,J?NYG96P@D[*0!NQ[S;YH\KZOI%K:Z5H$>E7T4Z37=XBHOKTME@847 M^[5FC2;TA\'JO/+^WA`+$D,37(LV\IZEJ> MH6NNZ4):RW5FEQ!1A%0VM'Q_OD9>'QYAVY-,:\_\`FZ^\N:RV MDH(M2D$89[IF94Y5*D*H+,R;?`Y*^HO[*YD8L'$+):.U5[6,RP_4D]=O3O?[Z?]ZG']TF5B1;#$(#6ORU\NZ)- M+'9W5Y<.NF:K*+VXBB-G>K:Z:+E;FQD8%:&3X$*>KQ5D=)O75X\1(E'"$9YA M_++R8RZQJ=G!?V-I#'$;.SL>-VEO%^BX[M;^=B!RMKJ=FC%7B3E%<\)/5XPX MB128A)[_`,N^4_*T5OK<*7-V^GW=A:ZE:7#6]Q#<+J>E&^_=(R#A]7E'#X^? M-?\`?;KQ8@DHH!(->\T>6M1\N1V%IH266LGZF;K5%5!ZAM(VB MIAZJ@6[M6VD6OI MS1-O'-$3]J.1=Q_P.949`BPTD44KY844SSR1J6K6WE346EG@_0]K)ZUI#<22 MHZ3J/WC0M$0ZJP/%D7[;9J-?JQ#+&`!E.?U?U?X?Q_-=AI=.98Y3)J,5E^BZ MU8?XAN[>.+1[6UX+%96HMU64R<2'=`>49D/Q7#\Y&^QDI:@<0QDW.?TX[^KA M8C%L9?PQ_B2'6/.GF'5;6"SNKV1K:WC6)1R8LZILH=V/-@H^%?\`)S/Q81'< M_4XLYD^YCUW3ZM\G%/N.6RY,(\T'E38[%6J8J[&E=BJ^/^\7_6'Z\5?_U_/\ MJGU6^9W^G,D-:WCBK@N*NXXJUQQ5G5[K^D-^5\'ER#5Y1KFGB*]29%98YHY9 M6=M)24*LO^@,XNXB[?5WG>Z1/[N)Y(UNRM=YS\_7#?F)YAUG0;WZW9WU[;7- MC>OZG("S`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`@BH/4'"BWJ%OYPT#4K#RO!J^HVZ74%C=R:[+:G?Z?=-=0PW<#0G5;J_MS=+>R M+I4<4'"L3^A:6EU$UO(C)*W*1+OA/Q].)`*3(*L6H_E-/J\]PTVG6D$=WIU] MQ:TG:*<#3)(KVWA58QQ0Z@8Y'CD2*/C^]3[/IXU)1**A;:Y^5T1\NGZGIK6= MJB//%-#<-=+*FGNL\=]2-8YH[C4.#)^^G;[#Q_5TYIC4MUXHL6T/\RO->C>E M)8&"WEC@^K@".BA/K+WE%0'@O">3E%Q'[KA'P^)>62,`6OQ".20F^DDUIBM.]3%:=ZF*TRW\NIAQQ$XHJ]P`#E+EVMD&XQ91:IBR15K:64D7.74TM)"2#"T=P MQH.AK$I3?%*K^C=*Z_IN+;_BB[V_X3`M#O:&F:4.FM0TZ4^KW?;I^QVP[K7F MW^C=+_ZO4/\`TCW7_-&!?BN2QTZ-N4>JQ3/Q(6)8+A2Q(Z!G0*-_YLE#FQD- MN;5G?7EG.MS9SO;7"@J)8S1@&%&'R8;$82`1N@;*EUJ^KW?^]5_:0B M@Z"E>-!VQ``Y*24(*+6@I7KA13=<5=7%:=7%75Q5[;_SBPI/F74SV#653_LI M3F-J>C=AZO/?S8D+_F?YI?IRU&8_C3+,)]`83^HL3<_N9#X@+_P1RWH6%;A" M<V-E:\W?HK2>^LPD4I3ZO=TI6M/L=*]L;7X MM_HW2_\`J]P_3;W9_P"-,"UYN_1NE?\`5Z@_Z1KK_FC%/Q<;:RAB?T-0CNW/ M$^FD4T9`'5JR*H[Y./5A)2KA13JXK3N6*L__`"R_-4^3H[FWNK1;NU*.]K0E M665V4NKT^W&P',?M*Z_:7EE.7&9&QS;(2K8LO\YZOHWG'0+6#6[FQLM6N`'\ MO7TLH:XH6Y,UPD9*VEO(E56%F;U)65U555FS!EJ#AB95+)_0A]7XBY$<(F>$ MD0_I2>)RQRPS20RKPEB8I(O@RFAS91D)`$ZA M")8[73KF:W)Z+/+)P0_3QXG_`"9/\,'QBBT_0+3C#)!`H4SF*GVB/LQAA\,:_[/!V7V)CQS_,3)R9Y^H2G_DN+^;_ M`$N'^+_2\,6C7:PR)QQ]...W]9A-D:8$M^KY=_P"6*\_Z28_^J.'==G>IY=_Y8KS_ M`*28_P#JCBNSBWESD";*[)7H?K,=1_R1QW79WJ>7?^6.\_Z28_\`JCBNS?J> M7?\`EBO/^DF/_JCBNSO4\N_\L5Y_TDQ_]4<5V7176@PRQS1V=YZD3*Z?Z3'U M4U'^Z?;%=E:]],7!DAK]6N!Z]O7_`'W(2>/S0\HS_JX%4.9Q2[GAI%NYXTKN M6*NY8JME;]R_^J?U8J]0\^S-Z5FE?@'E^T-/^>`ZY7'FKS'F`*DT`ZG+%;U4 ME([>R.SQ@SW`\))0.*GW2+C7_7PA!2[CBJPKN?]),?_5'#16P[U?+O_+%>?\`23'_`-4<:*V'>KY= M_P"6*\_Z28_^J.-%>(.]7R[_`,L5Y_TDQ_\`5'&BO$'>KY=_Y8KS_I)C_P"J M.-%>(.,GEP@@V5X0>H^LQ_\`5'&BO$$3=SPW"Q7=NKI$X$,B2,'<2Q*!5F`4 M'U$XNOPY:=Q;CC8D?YWX_P`Y#<\BR=SQ5W/%7<\5=SQ5,/+^N-HFO:?JX7U! M8SI,\5:7C<5'A%$:N?]G)Q3_8MA.P][$; MR_J_[I+>.0;;4Y!N/E@+;!93%F[%74Q5U,5=3%7;@@CJ-Q\QOBJ(<@GD/LO\ M0^GJ/H.3+`+:X+2W7`K5<5=7%0ZN*NKBE[#^1NN>5?+FB:UJ^L>98=&NKBXB MAAME5I;L1PQ.?4CB56Y-(\O&/_4;EQ^',?-$R(`;,9`!>;><-5LM5\UZMJ5B M\TEE=W#26\MSM.Z4`YR_Y;DC_P"J=CDHFB@BPJL"K%3U78X2@-5P M*XL!].PK@E(#FD"WK6E_E+Y9T?3UO?.NJ$W$T19+*R9"D/J1U1GD->97DKG] MC,.>I)-1&W^R;XX1U8CI*>2[?7+>UU&W+)*RK/*A-Y$"311'0Q\EE^TS-R]+ MEPX?#F-J1G&,RQB)D/\`5#PMV'P^("1/^:FGYDV7E(Q&XT/3WL)+9E264L:3 M\C3XD):A7]EN68'8FHU1GPYI#)Q=/]2_JR%AV%>+K_E?%^SCVEAR0RF?\.;T_=Z)-N@RPG", M?XL/J_X\\B>4RR22G_=KL]?]9B&*NX MXJ[AA5W'%7<,5=QQ5OCBKN.*M<<5;XXJ[ABKN&*H^Q99X?J#L%?D7LI&-`)& M^U$Q[+-3X3^S+_KXJH$,K%64JZDJRL*$$&A!'8XJZN*NKBKL5=7%6G!9&7H6 M!%?GA5DWF;SB-8,*P0/#"EC;61CD8&A@C",XX_:Y%?AY9`15)+5$BC-].H:& M-N,$1_W=,-PG_&-/M3'_`)Y_:?)J@',DDC22L7DD8O(YZEF-2<4-<<5"D1N< MN`<*1W+7'#3&W<<5MW'&EMW'&EMOCC2VU3&EMNF-+;N.-+:(LYXXF>**6"5HI:+Z6W-]98Q;PB5F+OZ=O$`]Q-UXKX`=W?[,:_S9;&-M$IURYJ%U.UQ M,92HC6@2*(;A(UV5!\N_^5RP2-E,10I2XX*9VI3#XA\L!;L1V64P-C5,5=3% M74Q6W4Q6W4Q6U2,@CTR:`FJ-X-X'V;".Y![VC4$@BA&Q!\<5=@2ZN*NKBK6* MMXJUWKWQ5BQBS,6;=FW)R)2&J8I=3%78JZF* MNIBKJ8%:IBKJ8TJJM70#_=B#8?S*/XK_`,1R7-CR6"MLTS;L1[>`^651A*9ML,@$3-J-_/9P6FV8VOS^'AE M*N+^'^KQ?Q2_HQ;])BX\@%U_%_I?X61>2XCY@]B*US4]E#][_FE MV?:)_=_YP8CIVH76G7T-]:L%G@-5KNK`BC(P_:1ALRYOI-))Q5/49G*(**.1K11V7)@4*8$V;:!X+R_;8?N_8="W_-.3Y!CS M4J=,@R=3%74Q5U,4NIBKJ8JW&/WB_,?KP*__TN'R+^\;YG]>9#"EO#%:=QQ5 MW#%:=PQ5W#"K?#%7<,5=PQ5W#%7<,5=PQ5W#%7&,$4(V.*HT2Q7:A+M_2NE` M6.]-2K@;!9Z5.W[,X^+_`'YR^UBJA<6MQ;.$G0H6%4.Q5AXHPJKCW7"JGQ.* MNH<5=Q.*NH!UQ0BULD@`DO\`E&"*I:*:3R?ZW^^4_P`M_C_D3%*C\;>U?V6_P`A M^+8#&DQR`^]1WP4RMV^-+;M\:6VU8JP<4JA#"HJ*J:[@XTD23?6=1U#7K\ZQ MJA2V]551IE6ADX_[[3K(QKU_NU_F^'&&.AY+ES\1_I?CZDMN+@2JL42>E:QG MDD5:DL=B\C?MR'_@5^RF2)O;HPB*W.Y4..1IEQ.IC2\2C,/B'RR):.7)ID=3\0I7H>Q^1P$4D M&VJ8I=C2M4QI74P*O$=-Y/A'4+^T?Z?,Y*N]C?N2(1;L5MRLZ.LD;%)$8/'(NS*RFH8'Q& M`@$4>20:W3?7O,MUK*0":%(F0`W#)_NV4"G.G[/^K_-F%I-!'`20;OZ?Z$/Y MKE:C5RR@`[5_LI).`20!N3T`ZYG.(OXA#\8#/VC[#_6_YIPU7-%VM:K$LQJQ MZG(E(:IBEU,5:IBKN.*NIBKJ8%71C]XOS&*O_]/BTB?O&^9S(8K?3.*NX8J[ MABKN&*M\,5=PQ5W#"AW#%7<,5=PQ5OABKN&*NX8J[ABJM!<7$"&-"&@8U:"0 M!XB?]1MOI7CBJ\MI[_WEN\)[F!Z@_P"PDK3_`(/"KO0TX])IE]FB4G[P^*N] M/3%_Y:)3X?NXU/\`Q-L5;%X\7^\D26I_WXM7E^7J/4C_`&`7%4,4J234EC5B M=R3XDG%7<,5=P.*NX8JA'7XV^9S+B-G39)>H^]JGMAICQ.IC2\3J8TCB=QQI M/$ZF&D<3J8TO$ZF-+Q.IC2\3J8TO$ZF-+Q*D$\]NY:&0H6V8"E&'@RFJM_LL M1L@D'FJF:TD_OK8(>[V[>G_PAY)_Q'#MW(L][O3TX])9T_UD1O\`B+#&@O%) MKAIHZO._^JJ)_P`2+8T%XI>38N8H][>W1&'224^LX]P&HBG_`&&'W!>?,_[U M0E>660R2NTDC=78U/XX"D&EO'!2>)W'&EXG4QI>)1G'Q#Y9"0JG<'Z#A!I!#=8CU0K[J?X''9=W< M8OYF^D`_J.-!;+J1?Y1^X#^..R[NYT^PH3WZG[SC?GR\,-K3OW1_9 M9?\`5((_''9=W<8OYF^[^W&@MEW[H=F;V)`'X5..R[N+M0A:(#UX]3\SUQM: M6`9&DNIBKJ8JZF*NIBMNIBEU,"&N.*KHQ\:_,8I?_]3CLD?[QOF?UYD,6N&* MN]/%7>GBKO3.*M^GBKO3Q5W#"KO3Q5W#%7<,5=PQ5WIXJ[T\5=Z>*N]/%6_3 MPJ[ABKO3Q5WIXH=Z>*7>GBBF_3Q6G>GBJ!D3XV^9S-B-@Z+*?6?>UPR5-=NX M8TMNX8TMNX8TMNX8TMNX8TBW<,:3;N&-(MW#&EMW#&EMW#"MNX8TMNX8TFW< M,:1;N&-+;N&-+;?#&EMW#&EMW#&EM#W*T=?E_'*Y\W8:0^D^]1ID7*=3`KJ8 MJZF*NIBKJ8JZF*NIBKJ8K;J8JZF*NIBKJ8TKJ8JZF*NIBKJ8%:IBK=,5:IBM MMTQ5JF*NIBKJ8TEU,5=3`KJ8JZF*NIBKJ8JZF*NIC2NI@6W4Q2U3%74Q0ZF* M74Q5NF*MQCXU^8P*_P#_U>3/'\;?,YD(:]/%#O3Q5WIXJ[T\5=Z>*N]/%7>G MBKO3PJ[T\5;]/%7>GBKO3Q5WIXJ[T\5;$>*N]/%7>GA5WIXJ[T\5=Z>*N]/% M7>GBK?IXJ@)$_>-\S^O,^(V#SN8^N7]8K>&2IJMW##2V[A@I;=PQI;=PPTMN MX8TMNX8TMNX8TMNX8TMNX8TMNX8TMNX8TMNX8TMNX8K;N&-+;N&-+;N&-+;N M&-+;N&*VA;Q:2+_J_P`GBKO2Q5OTL5=Z>**=Z>*T[TL*7>EBBG>GB MK?IXJ[T\5IWI8J[T\5=Z>*N]+"KO2Q5OTL5=Z>*N]/%7>EBKO3Q5WIXJETL? M[Q_F?UYLH#TAYG.?7+^L5O#)4U<3N&-+Q.X8K;N&-+;N&-+;N&&EMOT\:6W< M,:6VN&-+;?#&EMW#&EMW#&EMW#&D6[AC2;=PQI;=PQI%NX8TFW<,:6W<,:6T M#?K25/\`5_CE60;NST)])]Z&IE;F.IBKJ8I=3%#J8JZF*74Q0ZF*74Q5U,5= M3`MNIBKJ8TKJ8K;J8K;J8JZF-*ZF*VZF*NIBKJ8JZF*M4Q5NF!6J8JZF*NIC M2NIBEU,5=QQ6W4P*ZF*NIBKJ8TKJ8JZF*NIBKJ8%:IBE=&/WB_,8J__7YT\7 M[QOFEBKO2PJ[TL5=Z6*M^EBK MO2Q5WI>V*N]+VQ13O2Q2[TL5=Z6%7>EBK?I8H=Z7MBKO2Q5WI>V*A+)8_P!Z M_P#K']>;2`](]SRFH/[R7]8K?3R=-5N]/&EXG>GC2V[T\:6W>GC2\3N&-+;O M3QI>)W##2\3O3P4O$[T\:6W>GAI>)WI^V-+Q.X'&D<3O3QI;=Z>-)XG<,:1; MO3QI/$[T\:7B=PQI>)+M36DR?ZG\EBK?HXJ[TL5=Z. M*N]+"KO1Q5WH^V*M^CBKO2]L5=Z6*N]+%7>CBKO2]L5=Z6**;]+%+O2Q5WI8 M4.]+%:<(<4A*9H_WK_ZQ_7FWQCTCW/':@_O)?UI?>M]/+*:>)WIXTO$[T\:7 MB=Z>-+Q.]/&EXG>EC2\3O3QI>)WIXTO$[T\:7B=Z>-+Q.]/&EXG>GC2\3O3Q MI>)WIXTO$[T\:7B=Z6-+Q.]/&EXG>GC2\3O2QI>)*M86EQ&/\C^)RC*-W;]F MGT'^L@:94[%U,5=3%74Q5U,5=3%74Q5U,5=3%74Q5U,"VZF&E=3&E=3`MNIB MMNIBKJ8JZF*NIBKJ8IMU,5MU,5=3%74Q5U,%+;J8TKJ8TKJ8JZF*NIC2VZF! M6J8JZF*NIC2NIC274Q5U,:0ZF"DNXXK:Z,?O%^8QI7__T8H\/QM\SEZ%OHXJ M[T?;&U=Z.%6_1H*GIWQ5,D\J^8)$61-.G9'`9&"BA!%01O@M6_\`"7F/_JV3 M_P#`C^N-HMW^$?,?_5LG_P"!']<;6W?X2\Q_]6R?_@1_7&U=_A+S'_U;)_\` M@1_7&U;_`,)>8_\`JV3_`/`C^N&U=_A+S'_U;9_^!']<;5W^$O,?_5LG_P"! M']<;"N_PEYC_`.K;/_P(_KC:N_PEYC_ZML__``(_KC85`W-A<6L[P7,30S)L M\3;,*BN^%*EZ/MBK?HXJ[T<5=Z/MBKO1Q5WH^V*N]'VQ5OT<2H2::+]\_P#K M']>;S$/2/<\3J9?O9?UI?>I^EDZ:.)$Q:3J$T:R16[O&VZL*4(^_+!AD18#5 M+4XXFC(6O_0FJ?\`+))^']?<6/YO'_.#OT)JO_+))^']W?A/&8W(J%;K3I7(2@8[%MAEC(7$VI^G@IEQ.]/&EXG>GC2\3O3QI>)WIX MTO$[T\:7B=Z7MC2\22ZXM+J(?\5_\;',?,-P[KLL^B7]9+Z90[)M8G85"DC" M(E!D`WZ,O\IP\)7C#O1E_E./"5XQWN]&3^0X.$KQAWHR_P`IQX2O$'>C+_*< M/"5XP[T9?Y3CP%>,.]&7^4X.$KQCO=Z,O\AP\)7C#O1E_E./"5XQWM,C+]H4 MKXX"$@@M4P)=3%74QI6J8JW3%6N.-+;J8JZF-+;J8JZF*NI@5U,5MU,5=3%6 MZ8JU3%74Q5U,:6W4P)=3&E=3%74QI74QI;=3&EMU,%*ZF-+;J8TJZ-?C7YC& MEM__TB-X/C.W?+T->A[8J[T,5=Z&*M/`>#;=CBKU.R%+"U'_`!1%_P`0&0*% M;`KL51":=J#VINTMI&M14F8"JT4T8^/PGKBJ&YI_,/#KA5W):TJ*^&!5\L>^:8N7F"\/BR_\0&61Y*E?H>V%+O0 M]L-J[T,;5WH>V*N]'VQ5WH>V*&_0Q2X08"H2*>+]])_K-^O.AQ#T#W!X/52_ M>S_KR_W2GZ1R=-'$R_1!32K8>"_Q.;73_0'1:O\`O9(W+G'5;>WGN)?2@C:6 M4AF"("QHBEF-!_*H+'(RD(BR:90A*1J(XBU)!-&D;R(R),O.)B*!E#%>2^(Y M*RXB0-UT08D42/J_Z1_W49*>20B!8WIMOK(@D^KT+>MQ/"BLJ,>739W13_E. MN0\2-U8XOQ_Q+/PI\/%4N'^=7I_F_5_6E&/^=%0`)-!WR;!$?H^^]6XB^KR> MK:!FNDXGE&$(5BXI\/%CQ/+(>)&@;'J^G^E_5;/"G9'#*X?7L?1P_5Q_S?\` M.0V3:W8JQCS(G+40?^*U_6 MEC2\3O2QI>)WI8TO$[TL:7B2#S"E+R+_`(Q?\;',74#<.][)/HE_6_0E=,H= MJB(/[OZ3ED.35/FJ9)BVB.[JB`L[D*JCJ230`8DJ!93/6O*OF30TCDUC3+BP MCF8I&\Z%5+KNRUZ&44L].3T1/Q/HEB@EH>)8"I7ETY4-: M9.PPX#W+05K2N_ABCA*Y8Y'C>5%+11T$D@!*J6-%Y'H.5/AQL)X)=RWDNVXW MQ1PGN;Q0[%5"X&Z_+(3;,:E3(,W4Q5U,5=3%74Q5U,"NIA6W4P4KJ8K;J8JZ MF*VZF-*ZF-*ZF*NIBEU,:1;J8IMU,"NIC2'4QI-NIBKJ8TKJ8TKJ8TMNI@I; M=3&EMU,:5=&/C7YXIM__TPK6_P`3;=SER%OU?VPJ[ZO[8JW]7]L56M;_``GY M'%7H=IM9VX\(HQ_PHR!0JX%=BJ=6.I:?!!IT[RO]9TY;D&U5#24SD\5]2O%4 MW_>5Q56MM9TU95#D1QQ1VRAA;J_-(U_TF'C38S-_NTXTK5U?:6FF0PM&L_J0 M0-%9*O'TV$C%F:X7XN7ITCX?:Q5=!KFGQ+;<5H42TBD5HQ)QCCDD,Z*S5K\# MJ*_MXTK'WX>H_#9.388>6M73>)7_B(RPASQQ9>*6X MX9_TOKQSA'T_S?5ZF06/F?1&NK2ZG5+26VLA"(88.<`?ZW)(ZA6+-5X6V8-] MMFY_!F%DTF2C$>H2GQ;R]?\`=QC'_9NTP]H83*,Y`8Y0Q\'#"'%C_OISGZ?Z M>*7U?SY2XO2A[GS!Y?,HO^A$Q?:^'[&3CI MLM@D^O\`K<7I\'A^CZ?[[U-6368*E$1'AG^'@C"7'^9X_P"\^N/^"_N_J]/T MHW5/.&G+&YT^?U+A(9DMW^JQQQKZEU!*B"/XD_=PQNO)E^U_L6RG#HIWZAM< M>+UF7TXYQEZOZ4Y.5J>U,8'[L^H1D(?NXPAZ\N+)"'!]/HQPE_"A;_7O+K:; MJ,%C!#&T]S<.L;P$ETDE#0/&ZE?1]&.J\/V?Y6]1\MQZ?+QQ,B=HQ_B_FQ]? M%_/XY?CTQ<;4:O`<4XXXQ!E.?U0^J,I_NI8Y7'PO"Q_P?]5)HB]\T:))9:JL M,C!KT7:B'T%#22S77JQSM-7D%]'C&8OV>'^5D,>DR"4+'T<'\7TQCCX90X/Z M_JXOZ3?E[1PF&2C_`'GB^G@'JGDR^)#-XGU?W7##@_H,'S;O.NQ5(-<3E?`_ MY`_6)KTL:7B;]+!2\3O2PTO$[TL:7B=Z6 M-+Q,;\T)2^A_XP_\;',/4C.0$@2]2NOS'\F7>IW$_U-+6WGUK4 M+Z5$@DD6?UH'33]0E]1W(FM99)#+!%P5O5]1$YQ\2-_[[U.7[O[&/@RZ? MS5\6/VH2R\X^2E\L6]OJD;:E&2.*?%M^-D>+#A1(\_>7(Y=3MKJ^?5-/O)=/N+J--.ALX[N*TNI)'M#' M'3C_`*/)&%ED_:B:'^ZX2,/!EMM7/JIRQWW0.O\`G+R])IFH16DR7NLW%E!: MR:M]0BMQ<-];DD=EBI2W:*T>.V]0+SD_V*/DH8I6+Y7WHGEC1]SSK,IP6\54 MIAN/ED),X*=,BS=3%#J'%74.*74Q5U,:5U,5MU,5MU,:6W4Q6W4QI;=3&E=3 M!2NIAI74P4MNIBKJ8TMNXXK;J8TMNXXK;J8TK5,5;IC2NIC2NI@I;=3"MNI@ MI;;C'QK\\2$V_P#_U!36CG)_*?NQ5WIR?RG[ ML5=ZG)_*?NQ5WIR?RG[L5=ZG)_*?NQ59)%(2/A/W9& M3**STI/Y3]V!DWZ4G\I^[%7>D_\`*?N.!7>E)_*?NQ5WI2?RG[CBKO2D_E/W M'%7>E)_*?N.*N]*3^0_<<5:]*3^4_<<5=Z4G\I^XXJ[TI/Y#]QQ5OTI/Y#]Q MQ5WI/_(?N.*M>E)_*?NQ5WHR?RG[CBK?I2?RG[CBKO2D_E/W'%7>E)_*?N.* MN]*3^4_<<5:]*3^4_<<4N]*3^4_<<5;]*3^4_<<5=Z4G\A^XXJ[TG_E;[C@5 BKTI/Y3]QPJ[TI/Y3]QP(=Z4G\I^[%*Y(I.0/$]?`XE7_V3\_ ` end GRAPHIC 20 g852944ifg1.jpg GRAPHIC begin 644 g852944ifg1.jpg M_]C_X``02D9)1@`!`@$!+`$L``#_X1<>17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````;````<@$R``(````4````C8=I``0````!````I````-````$L```` M`0```2P````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`Q-3HP-3HQ M,"`Q,CHR-3HT.````````Z`!``,````!__\``*`"``0````!```"A:`#``0` M```!```#2``````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$``!7H```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B M95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`H`![`P$B``(1`0,1`?_=``0` M"/_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`\[E*5&4\J>UC)1JL%S]E+7V/@G:QI<8' M.C4@=4_2C=AY0RV[7^DPO=4;+:][#[+&[\1U5_L:[U'^G8A*9%4H"V;JLA@E M^/6GAPK='.WP_>6EF]3RL<5^OCU.N9N?5:,K* M>6MM'O\`^U)9^FI_1W>G[[6*/_.'-XKJ#&@0P#+S/;IRW]:_.=[W_P#HM-]V M7@GA#F7[\?;]HJMIWSM]1A;,1.W=_63-<'M#AP>%/JN99U#T6BMM#,<$-8+; MK1+C.X?:K+_3_-9^BV(50+:VM/(_O3H9"3J@Q`6=DU-<6DF08.B;[51XG[EJ M].Z1U:AWVW$LQ1]I9H+V-N]KR'_S>11?6RSV_38K+ZOK#7[S9@$LXC'I$:[O M:!BM;^F_P"S;ZG?\)5[ MTCGKA:6N=]*6DD0?ZP;^ZHRI1*P#W6$42 M%Y32FE*4K4__T/.$DR=3+%T;I]%EU[/3#@6ZN>T26_BWZ2KN,`GPU7?]&Z)1 M2VFD-AFCGD\G3<]SOZR@YC)P`=S=,_+XN,GM&K>/R6-I]7%N`K@;F2."/S/^ M+?N5*I['5[0T%[>\P2.W^;]%7^N97VWJV3;;]!I-=;1((:WVL^BLTV,8XFL3 MM^CY!-!)`[THQ$9'M9&NZG>I\!]ZDTG:)Y6CAXUN0SU,A@8P@[?WCQ[M`WVJ MGE5"K(LJ&@:8$_`%/Q2N1'8+MZ:PGIN*[_@6?]2ED5.-0\7:PKG2 M:)Z5A_RL:LCX[%D=:ZL,9IHH$6NFLO(T:QOLM-?_``EC]S/^#52B9D#N6W8$ M03V95M;DWMO:TL#**J#/)+?4?ZG]2V?8K'V>%0Z=;CU=2]*EYM?D5N]:JELL M[/;NLW;-[/YS^1_;6R"2]C3!%FZ([%OTF.W;7;V_U44P#H5-G5>JZ#[;DP1'\Z\Z]H&Y5^9Q&?#1JK; M'+YACXK%W3IU?5KK#\IQRJ34V3+MP,[C[G>PO=M6IA_5O&QR'NK]2T<2/:#_ M`"6?]_7.W=4ZI?SM7?0W*'VWJVT..7?!_X5__`))1RAD( MKB`\F2.7&/T"3W+V?V+OMU^"Y/K3-G5ZRQ^KGN)E+,^:,X@`$:V][TYQ=T'%#)#V8K-I M'((8L?JW1SE.LIQH;=0/4H:=`ZNR"]DG_A&_35KIY>W`QMKW-'HU\$C\T>"C MDN>&FP.<'@;6O!(('@UWTE!=2-=RS5<1?8,/JUT6_$:_*S*G57N&RNMVCF,. MMGJ,_-??[?ZE5?\`PRT[VDY=-H$!GK;SXN#<=K?\UEBR;K<\Y=3'WNVLPZBT M,]@A[K'M=8VO^?^D4]U\1ZCX$GZ1Y/TN_YT)2!XC9U(1`CA%"@'(^L MYW=5G_@:_P#OZR5H=8#OMQW$D^FS4Z^*HPKN(?JX^0:F7YY>:R2E"4)]+'__ MTO.H3PI`)X5BF.U@$7`Z?8XM>X$./T6\$3XH9&A70XU8K>QWA!^:@YD\(CXV MS_;^9[_`.;WH'5K+GVV.ZC:657.#ACUG=:6S[?W/\^S8J9RY)#AB."MYG_N M`ZL/A\(R.69'MC;7T_X1D\SG]&NQ7D?,>#F\;ZS^CG,$1O^5/7=.IGIV/I M_@*S_P!`)K*JW&NIYV@P#XZZ[6_RMJN8&ROI.):X2T8U8?',;`J_0[6U?6"I M^8PV$V.K8S1PK^AZF_WKE+*S7E8]>D.%L$"):P5_3:/;O;ZB,K,CK=(C\L=*MY?KK-O M42/^#9_WY9\+6^L0'[4,<>E7_P!^69"T<(_5P_NAHY3^LEYEA">%*$H4E,=O M_]/SZ%(!'+:AQ4W[W_\`I11)8/\`!-^]_P#Z45SAKJ&#B\#^".)$+4'5*1'L M?I'AV_M+--K1IZ;->TO_`/2B;UH_P;/^G_Z44<\<)UQ=%\,LX7PC?R=.KJE= M`=]F8ZC<9):!/WNX/U,4\F28HCQZ/28OUBPZL*O%MJN M.RIM;BT,C0;9;N>U"LZW@69#WNIM-5K6DCVAS;&<6,BS_ORP/M3O]&S_`*?_ M`*42&43Q77_T_P#THF'EL!O?7Q/5>.8S"O#PCT>GK^LF!6"7,RK;'?2LLV.< M?[6__HM4'_6/`<6/]&_>TV]F1M?Z.V/TG_`>]:S'?\HMOJ64S,RS?6US6EK6PZ)TG]TE582%P/^#9_T_\` MTHI"P'_!L_Z?_I13QC&($1L-&*4I$DD&SY,(2A&!8>:V_>__`-*)XK_T;?O? M_P"E$[A\0ML]C^#_`/_4X=Q"&XA-]HN_?_!O_D4O6L_>_!O_`)%7"0>[!1[# M[?\`T%/CYU=&+=C.QJKQ>^M[K+)WM]([V5U[?HL?^E9?_I67?\$C/ZOAN:X' MI.'NUK-K?9_H?Z/\`\'6J?JO\1_FM_P#(J/VJO_2,^YO_`)%- M('=(,NP^W_T%NU]8Q*V>G^S,RRRRGU_]&RW_``6_ MUGWN[K>.XR>F8A(C8"!L:0`WVU;-FWV;_P#A7_TO[4J/VJK_`$E?W-_\BG^T MT_Z2O[F_^10X8]TW+M_+_%;)ZO4[&%#L''=Z;'UX[W#=Z3;'7W>UKF_I/1?E M?HM_[GZ;U?U?[,[NLTNI=5^S\;Y_\`.>K]+^ZAOJ[K+,9E3_0?^D54Y%()!?6"-"(;_`.13?::?WZ_N;_Y% M+AC^\KBEV_E_BMT=8PB6.NZ5C6.9MUW%H(;M]CAM=[-C=G_J.OTT3]NXSGML MLZ7C6.9HP/)+0&L-5#(=U;%>T@]-QBX@M]0ZF"-OMVL8UCVM_<_1U?H_LU6/\` MIO7HMT`$SYJ3;MPECFN'$@-_\BG]5_B/\UO_`)%.`'=:2>P^W_T%<$*:'ZUG M[WX#^Y+U[?WOP']R=8JM4:]A]O\`Z"__U?/04\HX`^YGOR/SFG:F=G=,#]IZ'0".S;\@@P?WOM# MU9ZA=AY>&3CNW/98W=#3/YVYK=WY^WW?V$7HO2.E]3W579HQ+9:*7V-)8)U= MZVT_GM_F_P!__!*++PP)HW$=6;%C.0`48S.NIW']US!TS.ZMD6/Z;A,K:T", M6IX+@`-2QEUCLF[W>_\`PBFVB[%:,?(8ZJZJ6V5O$.!F?<%HYOU=S>G19ZM3 MFZEEM;@^HQ'T[/\`M,_W-_GME/\`W:WJADNR#>\Y.[UY'J;R2Z8')>7/^BC@ MD"20012N8PB$!I(2NC?R_I+=/IZEBYXS*Z-]3R=Q+*K9K>?>:Z\IMM/J;/YM MSZUL9%K+*;ZSC936OW;"VK":8):YNVRJAEF+P]K_`+.__O\`4\5%U8QJ_U].(UK6CTG,& M._%IIM8[U*O?^_\`]NK/Q#N)D;B8/BS=^8[]QZN4Y;+G`AP#>'6/] MHCGW?RFN2,I#H%1QQEM;GT4VX]?IW-V/F8/@8\$25/*L:^XEI#@`!(U&G@@[ ME:A+TQOLUYBI&N[.4I4)3RG6MI__UO.92E,DIEC*41K;&6!_+AJ>X`*"K!OI M;3.X"/HB=-WC_+=_+2]WTM-L'=/\IC_P!R MUBEB9=F+^BRV[ZJ]:G[6N=6?I--3R"_8[]UK_IH3'!Q;/N(DD`PKV#C-S+6X MU,-M@/:VW\Z1M#&;?\[])_VXF2(JE$DR!&_X?5Z7ZM]5S\K*?CN?9DXGI`> MJYP+V-:?YOZ.^^IS[-['_P#;OJ>FN-9Y4*B8?2[9N<)^[QC,^L3V/S<,H\35J;<7[_2@-.CX)Y^C[?I>[ M^2H65OH>S<[1K@2S4:]O;[FK0Y^PZ MGB>!O/\`T5?R(#YD?\`2*;[`RAM0>9<]VU[_CPD)#NCA[AKN-<_ MHR2SMNY_!1E&S:&X]_I-F`UIUYDJNK$3Z1Y,,MRSE*5%)&T/_]?S=.DDIEBC MPNJ^KW6?3L;5:&%P'M):"'#PT&Y&>)A/0:'BC\$?OP>A=@X74"UA#@RL6&/ M1:^QO\GU/T?[BV<[ZB85>.Q^%B_:;6G;:TN(?8T@0_%:?T3/3=^__@U0ZIT; M)^V9.7TVO[8_U'`XGJ%CF.'J>ED.8&6?;*-S_P":K?7D,L0_J[U:VTO%MMN% MG8,DG#BKTB7;_`*3REQV[+!^DK)G]'D4N:QS=VUWIW4_ MJ]JP,@1?8-!KVXX7J[LVKJOJ=/ZE13;:VN*QN?#PX[LFQF_])CY.YM-5S/4_ M0_SE7J>HO,^MX0P>KY>&V0VFS:T.^E!#7MW<_FN0Y7/QSE`@\41:N;@!$3$> M"SK&_P#HL*7O8UCF/Y_[O MN5[I/UC=?L>V?S7L-?L_SU:^KOU?QK>J^G;F4L.&6Y-= MC2',N=6YH]"I\M;9ZC+'_F>]&43KKW68IQ!'$"6C;TB^NDWU.=:QL%S#J]L\ MC3;OVQ[V;=ZH/(<\-;J\_F#4^(!>[*I])A=<]FR7G?OAKG6. M_=66KUAK&Y M7ZOK9UNC;Z%E56QC*_;2PRVL;:][7A['N_E_358\KDO0QX?Q;\^=PS$95*.3 MAX9:>CTO9XMUF)U%N,_97;?79;?2YK7EH:6;GV-AK767L_3^[?\`T>E<5];8 M/UFZB02X>J(<23(].OW>[W>Y#M^L/5[GBRRX&UKMXMVC?N_?WJEE9-N5D69- MT&VTR_:-HD`-T:/ZJ=@Y:<,LIDCAE'AH'7B8.9SXIPB,?%8-RX@(LF7W-J]* ML_2$?7!E96YU;0````I%4VQI8V54>7!E`````$EM M9R`````&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N M9P``````````3&5F=&QO;F<``````````$)T;VUL;VYG```#2`````!29VAT M;&]N9P```H4````#=7)L5$585`````$```````!N=6QL5$585`````$````` M``!-'1415A4`````0``````"6AOD%L:6=N````!V1E9F%U;'0````)=F5R M=$%L:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB M9T-O;&]R5'EP965N=6T````115-L:6-E0D=#;VQOP```*````%T``#H@```%>@` M&``!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,061O8F5?0TT``O_N``Y!9&]B M90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P, M#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0. M#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#/_``!$(`*``>P,!(@`"$0$#$0'_W0`$``C_Q`$_```!!0$!`0$! M`0`````````#``$"!`4&!P@)"@L!``$%`0$!`0$!``````````$``@,$!08' M"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21H;%" M(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3# MTW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W M$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P M,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`,`P$` M`A$#$0`_`/.Y2E1E/*GM8R4:K!<_92U]CX)VL:7&!SHU('5/THW8>4,MNU_I M,+W5&RVO>P^RQN_$=5?[&N]1_IV(2F15*`MFZK(8)?CW-!F":W#@;G?]%.*< MDM#QCWEIX<*W1SM\/WEI9O4\K'%?KX]3KF;GU6C*RGEK;1[_`/M26?IJ?T=W MI^^UBC_SAS>*Z@QH$,`R\SVZ]_\`Z+3?=EX)X0YE^_'V_:*K:=\[ M?486S$3MW?UDS7![0X<'A3ZKF6=0]%HK;0S'!#6"VZT2XSN'VJR_T_S6?HMB M%4"VMK3R/[TZ&0DZH,0%G9-37%I)D&#HF^U4>)^Y:O3ND=6H=]MQ+,4?:6:" M]C;O:\A_\WD47ULL]OTV*R^KZPU^\V8!+.(QZ1&N[V@8K6_G*,\QJ189!AE5 MT7!^U4>)^Y+[53XG[EKVMZSZ]3696&]S@,MPJJ:U@<7.;Z5[/LM;7.;_`*#; M9C*3Z^OV4V4OLPRRUI8[]!5(!&UWIO\`LV^IW_"5>](YZW(0,1.P+DLL:\;F M\<:IY3OQ+<)WH6EKG?2EI)$'^L&_NJ,J42L`]UA%$A>4TII2E*U/_]#SA),G M4RQ=&Z?19=>STPX%NKGM$EOXM^DJ[C`)\-5W_1NB44MII#89HYY/)TW/<[^L MH.8R<`'QU>T-!>WO,$C MM_F_15_KF5]MZMDVV_0:376T2"&M]K/HK--C&.)K$[?H^03020.]*,1&1[61 MKNIWJ?`?>I-)VB>5HX>-;D,]3(8&,(.W]X\>[0-]JIY50JR+*AH&F!/P!3\4 MKD1V"W+"H@]"7K>FL)Z;BN_X%G_4I9%3C4/%VL*YTFB>E8?\K&K(^.Q9'6NK M#&::*!%KIK+R-&L;[+37_P`)8_;7Y%;O6JI;+.SV[K-VS>S^<_D?VUL@ MDO8TP19NB.Q;])CMVUV]O]5')?%YK<=<.CRG76[<^/\`@V?]^6>M7ZS-V]4C M_@:_^_K*5W$?UL?_1\X23PE"F6,7_`$'?`KUFH;0V!KM: M!]P7E,`Z%39U7JN@^VY,$1_.O.O:!N5?F<1GPT:JVQR^88^*Q=TZ=7U:ZP_* M<].<7=!Q0R0]F*S:1R"&+'ZMT7MP,;:]S1Z-?!(_-'@HY+GAIL#G!X&UKP2"!X- M=])074C7ZQ[76-K_G+MH_G MG_I%/=?$>H^!)^D>3]+O^="4@>(V=2$0(X10H!R/K.=W59_X&O\`[^LE:'6` M[[<=Q)/ILU.OBJ,*[B'ZN/D&IE^>7FLDI0E"?2Q__]+SJ$\*0">%8ICM8!%P M.GV.+7N!#C]%O!$^*&1H5T.-6*WL=X0?FH.9/"(^-LW+Q$B;Z4DZ3]6,K,ZA M=CX`;8ZNG?:'.:T!KOT;V_I#M^D5I]5^I>!C5,8,JL.:P#++Y(%OT6_9-K6. MMI_,MW(/U?ZAC8^0V\-+LF]KQ994TNL:S<[T6[W.;77OV_F>_P#F]Z!U:RY] MMCNHVEE5S@X8]9W6EL^W]S_/LV*F9_[@.K#X?",CEF1[8VU]/^ M$9/,Y_1KL5Y'S'@YO&^L_G-0:V%M8:="!_%:-T.]E%8QZ)D5@R2?W[':;K/[ M*J/9M<1X*WRID21(WHYW.1Q@WC!$;_E3UW3J9Z=CZ?X"L_\`0":RJMQKJ>=H M,`^.NNUO\K:KF!LKZ3B6N$M&-6'QS&P*OT.UM7U@J?F,-A-CJV,T<*W.DML; M/^C9Z/YBI3OBE7US0TPVMC3+W-#?WOH>IO]ZY2RLUY M6/7I#A;!`B6L%?TVCV[V^HC*S(ZW2(_+'2K>7ZZS;U$C_@V?]^6?"UOK$!^U M#''I5_\`?EF0M'"/U980GA2A*%)3';__3\^A2`1RVH<5-^]__ M`*4426#_``3?O?\`^E%FS7M+ M_P#THF]:/\&S_I_^E%'/'"=<71?#+.%\(W\G3JZI70'?9F.HW&26@3][G.03 MEUO<7N#W.=JYQ@DGS<7*C]H(_P`&S_I_^E$OM1[5U_\`3_\`2B9]WP^/VEEG MSG,3H2)(&P-4&]]IJ_==^']ZKVD/LCTF+]8L.K"KQ;:KCLJ;6XM#(T&V6[GM0K. MMX%F0][J;35:UI(]H*_]&W[W_\`I1.X?$+;/8_@_P#_ MU.'<0AN(3?:+OW_P;_Y%+UK/WOP;_P"15PD'NP4>P^W_`-!3X^=71BW8SL:J M\7OK>ZRR=[?2.]E=>WZ+'_I67_Z5EW_!(S^KX;FN!Z3A[G-<-X#A#W<7M:S: MWV?Z'^C_`/!UJGZK_$?YK?\`R*C]JK_TC/N;_P"132!W2#+L/M_]!;M?6,2M MGI_LS'+7UMJO(<6E[0VIKW2UGLLLLI]?_1LM_P`%O]9][NZWCN,GIF(2(V`@ M;&D`-]M6S9M]F_\`X5_]+^U*C]JJ_P!)7]S?_(I_M-/^DK^YO_D4.&/=-R[? MR_Q6R>KU.QA0[!QW>FQ]>.]PW>DVQU]WM:YOZ3T7Y7Z+?^Y^F]7]7^S.[K-+ MJ75?L_&W.#0+2`Y\M:^OI^C_P`!74HV]7Q;Q6;>G8YLK=2"6C:UU=?J'(J=L#;-V7NH;ZNZ MRS&94_T'_I%5.12"07U@C0B&_P#D4WVFG]^O[F_^12X8_O*XI=OY?XK='6,( MECKNE8UCF;==Q:"&[?8X;7>S8W9_ZCK]-$_;N,Y[;+.EXUCF:,#R2T!K#50R M',<_93NW[/5V6;*UG?:J?])7]S?_`"*7VJK_`$E?W-_\BEPQ[JN7;^7^*WG= M6Q7M(/3<8N(+?4.I@C;[=K&-8]K?W/T=7Z/[-5C_`*;UZ+=`!,^:DV[<)8YK MAQ(#?_(I_5?XC_-;_P"13@!W6DGL/M_]!7!"FA^M9^]^`_N2]>W][\!_58MCI(#&J!C]-S6W-L=B^M76\&RHN@.#3+ZW. M8X/]W\A%!4L#)=BVP';ZW?2`\?%J;+A)B);:[+H@U+AWT2V9&$]S*Z^ATU/D M.,W9'N`/N9[\C\YIVIG9W3`_:>AT`CLV_((,'][[0]6>H78>7ADX[MSV6-W0 MTS^=N:W=^?M]W]A%Z+TCI?4]U5V:,2V6BE]C26"=7>MM/Y[?YO\`?_P2BR\, M":-Q'5FQ8SD`%&,SKJ=Q_="X`#4L9=8[)N]WO_ M`,(IMHNQ6C'R&.JNJEME;Q#@9GW!:.;]7K4YNI9;6X/J,1].S_`+3/ M]S?Y[93_`-VMZH9+L@WO.3N]>1ZF\DNF!R7ES_HHX)`DD$$4KF,(A`:2$KHW M\OZ2W3Z>I8N>,RNC?4\G<2RJV:WGWFNO*;;3ZFS^;<^M;&1:RRF^LXV4UK]V MPMJPFF"6N;MLJH99B\/:_P"SO_[_`%/%1=6,:OW-T8`=1R!!5+JV1DN:QE>Y MM1/N(,%QUVM'YW91&KE.6RYP(<`WAUC_:(Y]W\IKDC*0Z!4<<9; M6Y]%-N/7Z=S=CYF#X&/!$E3RK&ON):0X``2-1IX(.Y6H2],;[->8J1KNSE*5 M"4\IUK:?_];SF4I3)*98RE$:VQE@?RX:GN`"@JP;Z6TSN`CZ(G3=X_RW?RW* M/*=OJV.6`/&2:X:*-L?SE3S7DO=]+3;!W3_*8_\`E^K?5<_*RGX[GV9.)Z0'JN<"]C6G^;^COOJ<^S> MQ_\`V[ZGIKG.MTLQNKY>/7!979#2."(:Z?Q6AZ6'T3.QS=:W)`W>M=4Z*VO, M.IKJVN98]K-KVOM_F]]BS>MY=67U;+R:3-5KY83X;6M_[ZH^7C6>5"HF'TNV M;G"?N\8S/K$]C\W#*/$U:FW%^_TH#3H^">?H^WZ7N_DJ%E;Z'LW.T:X$LU&O M;V^YJW.D]/LZE91@UL<]]U4M:R9]K=_;^JK?5?J=FX&)==F5VF0"ZVQI!`!; M^=_)3N+4^;6X8B/]9YK*;])PG3M'8\H.-4+'D.?L.IXG@;S_`-%7\G#S!+2/ M4WB`^9'_`$BF^P,H;4'F7/=M>_X\)"0[HX>X:[C7/Z,DL[;N?P491LVAN/?Z M39@-:=>9*KJQ$^D>3#+7A MGB83T&AXH_/"7[\'H78.%U')KJ:RM[W@M80X,K%ACT6OL;_)]3]'^XMG.^HF M%7CL?A8OVFUIVVM+B'V-($/Q6G]$STW?O_X-4.J=&R?MF3E]-K^V/]1P.)ZA M8YCAZGI9#F!EGVRC<_\`FJWUY#+$/ZN]6MM+Q;;;A9V#))W`5V;1^GW[P]M5 MVUOZ?TK,>N[_`(Q5N9SG-/W1'@XJ](EV_P"DW.5Y>?*XHX8S]SVKOW(;\6O# M_<<3JO1OL!]5GLI<=NRP?I*R9_1Y%+FL$,'J^7 MAMD-ILVM#OI00U[=W/YKD.5S\Z3]7*LS!KN?U/"I- MC-WHW7['MG\U[#7[/\]6OJ[]7\:WJOIVYE+#AEN378TAS+G5N:/0J?+6V>HR MQ_YGO1E$ZZ]UF*<01Q`EHV](OKI-]3G6L;!]FW>J#R'/#6Z MO/Y@U/B'-"]+HZ;?E=9>QH8=[2RQ\-+7`_1>ZIC6-;]GV^HW^6@_6'ZC=#Z; M30^C)&$7;FV7VDDDZ&6>DWU-ZCA$R!-[&M6SDRXX\`X3ZA)\LR9]8S M,P.>?Q0EJ?6.C`Q^I>G@7NRJ?2877/9LEYW[X:YUCOW5EJW`>D>3GS-R)\5) M)))RU__0\YA/">$H4]+%H5QDN=MYD1_%584Q8\>&NG"$H$[+H3$3J]QT[J[+ M?XW4UX>Q[OY?TU6/*Y+T,>'\6_/G<,Q&52CDX>&6GH]+V>+=9B=1;C/ MV5VWUV6WTN:UY:&EFY]C8:UUE[/T_NW_`-'I7%?6V#]9NHD$N'JB'$DR/3K] MWN]WN0[?K#U>YXLLN!M:[>+=HW[OW]ZI963;E9%F3=!MM,OVC:)`#=&C^JG8 M.6G#+*9(X91X:!UXF#F<^*<(C'Q6#V-8+2'=_ZJ:JU]5C;&P7-X#A(\-6HEV;?<(>*Q_48&J0X9Z[,(R1TW>[QO MKE31D69_3ZFFP,.RIP+)<08KOWW6/9_VXN>^LOUJZIU=T.NEM@]([1#7-)!V ML:?HUNY\;CP01\0F1Y?(.HU9)9X$;&]K8.]4DFUQ M>\ZEQ,G[RFA3<2XR>5&%.(D`!KDZL82A2A-"5*?_V3A"24T$(0``````4P`` M``$!````#P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`FMC.60G/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STG6$U0('1O;VQK:70@,RXP+3(X+"!F&UL;G,Z6YT87@M;G,C)R!X;6QN&UL;G,Z97AI9CTG:'1T<#HO+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\G/@H@ M(#QE>&EF.D-O;&]R4W!A8V4^-#(Y-#DV-S(Y-3PO97AI9CI#;VQO&EF.E!I>&5L6$1I;65N&EF.E!I>&5L641I;65N&UL;G,Z<&AO=&]S:&]P/2=H='1P.B\O M;G,N861O8F4N8V]M+W!H;W1O3X*(#PO&%P.DUE=&%D871A1&%T93XR,#$U+3`U M+3$P5#$R.C(U.C0X*S`U.C,P/"]X87`Z365T861A=&%$871E/@H@(#QX87`Z M0W)E871O&%P34TZ1&]C=6UE;G1)1#X*(#PO#IX;7!M971A/@H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*/#]X<&%C:V5T(&5N9#TG=R<_/O_N M``Y!9&]B90!D``````'_VP"$``8$!`0%!`8%!08)!@4&"0L(!@8("PP*"@L* M"@P0#`P,#`P,$`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P!!P<'#0P- M&!`0&!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#/_``!$(`T@"A0,!$0`"$0$#$0'_W0`$`%'_Q`&B```` M!P$!`0$!```````````$!0,"!@$`!P@)"@L!``("`P$!`0$!``````````$` M`@,$!08'"`D*"Q```@$#`P($`@8'`P0"!@)S`0(#$00`!2$2,4%1!A-A(G&! M%#*1H0<5L4(CP5+1X3,68O`D'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)F:FYR=GI^2HZ2EIJ M>HJ:JKK*VNKZ$0`"`@$"`P4%!`4&!`@#`VT!``(1`P0A$C%!!5$382(&<8&1 M,J&Q\!3!T>$C0A528G+Q,R0T0X(6DE,EHF.RP@=STC7B1(,75),("0H8&28V M11HG9'15-_*CL\,H*=/C\X24I+3$U.3T976%E:6UQ=7E]4969G:&EJ:VQM;F M]D=79W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZ MBIJJNLK:ZOK_V@`,`P$``A$#$0`_`/.]1F>T.Q5U<5=BK=1A0[%78J["%78J MU7%78JWBKL*'8J[%78J[%785=BKL5=A5V*NQ5V*NQ5V*NPJ[%78H=BKL5<<5 M=BKL5;KBK6*NKBK>*M'%78J[%7#%6ZXJZN*N-,5:&*NQ5V*NQ5V*NQ5V*78J M[%78J[%78%=BKL5=@5V*NQ5V*NP*[%78J[%78J[`EK%7`[8JUBKL"NQ5V*NQ M5K`EV*NQ5K`KJXJ__]#SMF%78H;&*N.*M8578J["K6* MMXJ[%#L5=BKL*NQ5V*NQ5V*NPJ[%78J["KL5=@5V*'8J[%78J[%785=BKL5= M7%78J[%78J[%78J[%78J[%78J[`KL5=BKL4NPJ[%78J[%78%=BKL"NQ5V*NQ M5V*NQ5V!0[%+L5=BKL5:K@5JN!78J[%78JZN!6M\4NQ5V*M5P*[%78J[%7__ MT?.V9K0["KL5=BKABK>%78VKAC:MUQ"NKA0[%6QAM7'&U:QM6QBKJC%6\-HI MV-K3J8VM.IBM.Q6G85IV*T[&U=C:NQM78VKL;5V*NPJ[%78J[%78J[&UIV-K M3L;6G8VKL;5V-J[&U=C:NQ5V-J[&UIV*NQ5V*NQ5V*NP+3L5=C:NQM78VKL; M5V-J[`M.Q6G8K3L;6G4QM:=BM-8I=7QP*ZN*NKC:NQM6L"NQ5U<%IIU<;6FJ MXVM.Q6G5P*[%6JXJ[%78%=C:NQM7_]+SK7,UH;Q5V*NQ5V*NPJ[%6\5=A5V* MNPH;&*NQ5V*NQ5;+((XV<]!N:8F5!0$)^EK?P;[AE7CQ[F?AN_2UOX-]PQ\> M/Y?#=^EK;^5ONQ\>/IP.ZHH8%C3<9(9XGHQ\-&9&7?I:V_E;[A@_,1[D^&7?I:V_E; M[AC^8CW+X9=^EK;^5ON&/YB/Y?#=^EK;^5 MONQ\>/Y?#=^EK;^5ONQ\>//6WT#2[G5)X$$DT= MI$TK(A-`S!0:"N*JY\A>=16[.GQ2>D]'NU-&MUV^*4'J@^+%4;K'Y:^?M&N[&SU30+V MTN=2=8K"*2%@9I&-!&FWQ/4_8^UBJC9>1?-EUJ%U8C39H)["5+?4#.IB2VDE M;BBSN]%BY-\*\\57:WY#\S:/J-AIMU;+)>ZF%-C#;21W#2%VX*H])G^)F/V/ MM8J@=2\M>8-+@%QJ.G7%I`T\MH)9HV13<6YXS15(_O(SLZ_LXJJ'RCYH76K? M0SI5T-8NU1[6P,3>M(LJ\T*)3DP=/B7%6K?RIYEN8H)K?3+F6*YN_P!'6[I$ MS![R@/U=:#>7?['VL55O\$>FR'3[@)K%1I M3>FU+GB_IMZ.W[RDGP?#^UBJ:VOY9_F%=:I=Z5;>7=0FU*P"->V:6\C2PB3= M"Z`57G3X<55X_P`I/S/EO)K*/RMJ;7=LD*NQ5V*H74?]Y)/H_7E6;Z6<.:2',)N M=BKJ8JZAQ5V*NIBKL5=0XJZF*NH<5:Q5V*MTQ5U#BKJ'%74.*NQ5U,5=BKJ8 MJUBJO8_[U1_/)X^:)*NKBKJXJ MHWG^\TGRR,^3()%F&VNQ5V*O8/\`G'O7?+VF'S=!K-W96XU'3$M[2/4+B:T@ MFD$RMP::#]\FPK6/XL595Y;\T^4='D-M^:M-U6&>&:2XBLK6VDY37, MDCC]V\RM1H_Y<5;\]?F;Y&\R^1?/LZW$-OYLO+F*Q98_ACU&TM+PM:W4:TWD M%O\`!+_DJF*O$?R^O;2P\]^7+Z\E6"TM=3LYKB9S14C2=&9B?!5%<5>M?F+< M>5O-?D^[6Q\S:9#[@,=IZ4DCQ\>/"-OM\6Q5,/+=SY.\L)Y;L-3\ MSZ3!^)6=<536S_`#=_+V\MY;F2\MK; M4O/NGW2^:O5.UO-9VCP6J]/@:X7O+^DV6H66H6<^I:?Y(L;`6 M4U662[BO6::T9?YC"QY#_*Q5'-YM_)I=:\E:W9:G':Z%Y6TS4M1BTLDO=17M MS.LD-HJ&@:2*25VC!/'A#BJ7W?G[R3J'GW\O?.=GYDD$D?;36=4L);C4M1LY-/BU>_NK.*6&"69BRS MV]9PL88,JCX<51WEF_TP>6?*36_G#3]$3RSY@U&\U=ENY.3VSS(ZB!*>K%>>=7T_6?.>N:MIT7H6%_?7%S:Q4X\8I969!0=/A.*I'BKL5 M5K7_`'IC_P!89*/-!Y)^,SW';Q2[%6CTQ5#:@3]5D'L/UY7E^EE#FDAS";G# M%67Z!^5WFG7],TG4=,6*6WUC4CI%N#)1DN0GJ?O13X$X5?E_*N*JFJ_E/YNT MJWO9[R.)19:N-`,:O5Y;TKSXQ"GQ)P(;EBJ::K^0?Y@:9YAGT"YBM_TE%ILN MKQHDO)9H(/[U(FI\*H/RQ^37FWS%8:5?6KVEM!K)N_J)NIO2)2P4M< M2ML>,24X\_YL56Z=^4FM:CKMWIEGJFE7%IIULM[J6N17:OI]O"QI62>GVZ[< M%7EBJ'U3\L=9LK#6M2@O;#4=,T/ZD;F]LY_5C==0-(#%L*FH_>*>+1XJBKS\ MFO.%F]^DWU:NF/IR7)66N^K$"VX[;_:^/^7%4?YH_(7S;H*O(E[I^J1V]W#I MVHFQN!(UG>*I%YY_+G4O)LPM]2U/3+J\65H+BSL;D7$T# MH*D3(`"F*IG=_DGYPM-*FUJ:2S&@16,6HIK(FK:RQSGBD4;\?CN.?P-%]I<5 M5M7_`"4UG1M"AU^_UO1FTB5KR_9Q5-[G\DO,2:S-HEGJ>EZCJ M]O;7-Q-8VMSSE$ME3U[8*5!-PH/)4_W8JNRM\.*K]/\`R+\V7%I#>WMYI^DV M3V46HW-Q>W'IBV@NGX6WU@!24:X.Z#^3XFQ53T#\D_,&N:5>:G::SHB6NG,R MWQFOE4PJLAA622BD+'*Z_NG_`&\50FH_E-K.F^68O,-YJVDPVUS#+<65JUVH MN;B.&4PL8(BM9/C7X:8JCF_(/\P5U_R_H7H0?7/,EJ;W3V$I],1*G-O5;C\# M*M-O\I<58)K&EW6DZK>Z7=@"[L)Y+:X"FJB2%RC4/AR7%4'BJO9?[U1_/)X^ M;&7).^V9;4[%7#%78J[%78J[`KL5=BKL4NQ5JN*M5Q5V^*N.*M8J_P#_U?.? M7,UI=OBK=<5<,5;KBKJXJZN*NKBK>*'8J[%785=BKL5=BJC=_P"\TG^KD9\D MCFD>8;<[%78JB=/MA=WUM:\N'UB5(N=*TYL%K3VKBKVOS1_SCQI%A>6\&FZO M>\4URRT"^>_M%A1GO:?O[.17*SI'7XDHK8JE.O\`Y0>4-"\YV/ES4]6UFR2] MEDM8KRYTDQ)).LJQ(8.4H$T#,W]ZI^'X<51T7Y)>2/\`$_F721KNIWL/E2V, MFJ?5;&/ZPUP+CT?3@C,I$JT/+E5,50MG^0<,GYCZKY8OM<%GH>D6<=_=ZU)% MQ:-+E4]&.2%F'"9I)5C9.>*I?I_Y/6&GW'F>Y\ZZI)I.B^6+U=-F>UA%Q_++\LM:L?,%]#YLOOJWE^-KJX=-.4\[3U!'&R MAID_>'DO-/AQ55TK\GO)+6^BPZYYIFT[5O-99_+=NMGZB+`TIBMY;QN8],W# M#9(^7#%4T\N?\XZ6>H:5;1:EJ-[9^8KR^U+3XT@M5N+*"32V(D-U(&5XT?C\ M+XJQ;\K?RHM/.%EKFHWMU=^AHAB22QTBW6]O93.Q7U4B+Q\H8N/*0KS;^1<5 M3+1/R2TW5M#M_,\.N,GEBUAOF\RW;P!9K&>RIQA](O5WNN7_+&@ZWJFIZEZ&K1VMW-?VU@)[!(+K)R5_>U_FQ5)=;_)6_P!'_*G_ M`!O>W12\74&LI=*X`<8UD>(39'KBK6*NQ56M?\`>B/_`%AD MH\T'DGP.V9[0[%78JWBJ&U#_`'ED^0_7E>7Z64.:2',)N=BKUC\HOS;T;R?Y M3\Q:5J4$\M[-RO?+Q_,[2=0TZ"^L_).@Z M3<:9I<`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`*/U"QO?K]P[7]S=K,QE$I15 MFJL"8=-MOJ6H^:SR26*4AK-_7$]4/']YTX$-QY+B MJ97G_.0VJHNLSZ'HMKI6J^8KBWNM8O6*WB2-`G$JD%Q&R(LDG[TUY\6Q5?=_ M\Y`1:M?:@WF+RQ;:KIFM06@UFP,[P^K>V2\$O8Y(U!@D9/A=%'^RQ5C$/YD6 MMD?-L6E:'#I^G^:+1;&.RCF=EM(U='JK."TI/I[\N/VL53ORW^=ECI^EZ+'K M?E6TU[6/+`*^7=5GFEB,*AB\:S1)\-PL4AY1\CBJOHG_`#D5YET_3K73KFS2 M_LFFU.778))75-1753RD60*/W9B:IB=2V*L?_+C\Q=)\F:S<:J-$DO;D2++I MLB7\]H\'`D^G(T(I<1,*+(CK\?'%5.;\T-1N-"\UZ5/:1U\UWL-_K;C4KJ2\GN8W>V/+U(+:3] MW;/,_P`4O#%5>U_.N\@\_>7?-_Z*C>7R_I\6FI9^JP658K=[?F7X\D+!^6PQ M55N?SKAA?6)-#T(Z9/K%A%82SR:A:7%%!K\%E"D22MQMGLF+F1!Q')IF9N7V<5>58J[%78JK6W^]$?^ ML,E'F@\D][9G-#JXJZN*NQ32'U#_`'E?Z/UY7E^EE`;I+F&VM8JWBKJXJZN* MNQ5V*NKBK8.*M$UQ5U<5=7%78J[%78JWBK6*NQ5OMBK6*NIBJO9?[U1_/)0Y MHER3G,MI=7&U=48JW@2T<*M8J[%78J[%78J[%75Q5K%78%=@5V*O_]?SEF9; M2WBKL*NQ5V*NQ5OKBKL5=BKL5=BKL5=BM.Q6G8H67"\H'`ZE3D9@2:A>"U6=8Y'!*%@:$_P`N`E-(N?R7?PQO(\J\ M$/&M#NW@,;0A;?R[).I*SKM6NQZCMC::5!Y6NR>*R!F[*%).-K2)_P`#ZD$Y M/(J5[$&N-K2%'EFX+E/64,.Q!QM"!73F^M>A-(L5"0SMT%!U.%5."T]63AZ@ M'@>H.*HAM'D7K(OW'%5OZ*DK3F,46V=)E%*N!7%+CI$H/VUQ5<=&E'^[%Q5: M=)D!IZ@KBJTZ9(.KC%6OT:_\XQ5WZ-?^<8J[]&O_`#C%6OT<_P#.,55(K%TE M1N0-#7#$[H*:9G-+L5IJN*MUQ56L]+;5;J/3UD$33D@2$5`H*]-LISRX8$MF M*/%(!-O^53W/_5SC_P"19_YJS6?FO)SOROFV/REN/^KG'_R*/_-6/YKR3^4\ MVQ^4EP?^EI'_`,BC_P`U8/S7DOY3S6G\IKD'_CIQ_P#(H_\`-6/YH=R_E/-L M?E+:S_E5E MQ_U<4_Y%G_FK'\T.Y?R9[UK?E?!V_')C/Y-R6TNK17BQN(S*(FBW*\NA9 MLC*=&EB+87IWEF2])`G5*>*U_CC+)3;#%Q=4T_Y5]/2OUU?^19_YJRK\SY-G MY;S;'Y=ST_WN7_@#_P`U8_F?)?ROFV/RZG_Y;D_X`_\`-6/YGR7\KYM_\JYG M_P"6Y/\`D6?^:L?S/DOY7S=_RKBX_P"6Y?\`D6?^:L?S/DOY7S=_RKBX_P"6 MY?\`D6?^:L?S/DOY7S-=K((?BX!"*]NMM9#].!E=L*EEFTC5I;9Z^F[AXW/0*QZX4/2M&M=/2V6:$+)(PY>IL2:[G&D MK=2A60*"JR]L572'[)Q5TF[#%*\DTQ53<[@XH* MR4[$XJH*I(Y'%*X]*TQ5KZ,5=BK?<81S057,YI=BKL5=BJ;^4O\`E(K+_6;_ M`(B5H/?%5!QOBA9Q!Q M2L<=L50-T=B,G%@4LN9A#$9N!8H:A1U/;[O'+8BRTSE093H?YBW6GI2]CM[Y MK:W6/1V598A`ZGFDDE"?67?[/P9FN`DOY@^==<\P63:CJLUM<37,CEX[2%XB ME$"A_C9JIXY"4;-LHFF(^6EV.W?*LIV*$#?1,R_9HZ;@$4I]&%4NN$$D?(;G%5&U(RAR%54Q5=Q\<57`??@33J&N*NXGM@6G4Q0XKMAM: M2SS"/]PMV?\`(_B,NTW]X&K/]!8#7-V>;J`[?%78J[%6JG%75.*NQ5V*NR*N MPJ[`KL5=BKL5=BEJN*O_TO..9;4WBAV*NQ5V*NQ5V%7;8J[%78JUA5O%78JZ MN*MUQ5IS^[;_`%3^K(RY%(YH>$5I3,1M53#\5,5;^KCL<5;$`!!!H0:CYXJG M37MT^E2>DQ]0*%E*_:X'9J>_'`JR8Q&%(M.MC!&%`=W!!)[['^.*56QN'DB> MUD;E-;[H3U:,_P#-.*IOHMQIT*L\R5NPW[M@AFD8'M$A'`-_EORQ5+O,5M+! MJY@# MIOV/L1D93ILCB)"L;*4#(^(R&$K3:R#OCXB^$I-#*,/B*<:RD@ZBN$28F"TN M1U4X;8\*WUHJ[U&&V-.,D1&S5]L5=7"KA3%7#KA"J^9C0[%6L5;Q5-_)_P#R MDMC_`*S?\1.8VK_NRWZ;^\#U(9HWPS/#K9/.?S` M6FEV@/5KAR3[E>N!(6>7(*6:&G7?,+*=W88ALGJ**HW28[QY MBT,+/&`>;#H*=ZY`S`9Q@9;@;)U%("*$['8C),:2B^1[2Y6Y05:(GDO\T9^T M/XXJBX[F2WG6>VE:,.*K+&:-Z;]:?1BJ8:K]3O;%+A$>U11PLHY'#%Z?:"(! MR8L=V=L4,7N8ZI4?:73_^4EL3_E-_Q$YC M:O\`NRY&F_O`]37-$[E445KBEL#?%5LAH-L50S-5B,*MH*XH;9<50MR:;85* M72J1D@P*'EKQ)\!^.61_2URY%Z1Y(.GQVGUZ6X2.8Q<8X9`:2<:U4./LDT_: MS.=>=WE_YHLKM9HH"EY6D,:]!R[#!:Q&ZKI,'IVL:TIL,P)G=V4!LF:)X9!D M%4(:;X65-A#VQ6F^!/7`FG<-L"M<*8J[@3BJTI3"Q*5>9%_W!WI_R/\`C89? MIO[P-.?Z"\Z.;PNG#L"NQ5V*NQ5V!78J[%6JXJXG%74KBK>*NQ5V!+6*NKBK M_]3SAF4U.Q5V%6\5=BAU<5<,5;Q5JN*NQ5O%78J[%78J["JV3^[;Y']6"7)( MYH>&M1F(VHH_:&*KB,51.EV\=SJ$$$II$[4<]-AO3Z%3]78\%(0FK`S-ND8_R M?BP)I!ZXMIZ<$D#^HIY"L:\8AO\`$H)^*0@G[9Q5C35AG*5JK;KBJA<)7XUV M-%!5T M0TR-JXQT!PA4',E6R2"@IT^';""Q0,W$?;-%RR'Z6N?(IC8ZIIRVD2F0IZ8K MQ)J"0:YL'7)/YV^K:EJ.ERVKB02!6F"_LN03QI[95(T&S'&RCX$X40].WOF" M78!'1Q]/#`R5_3VP*V(O'%D[TQC:%I0UZ8J[ABK13%5A6@Q0E/F@$:#>D?[[ M_P"-AE^F_O`TZCZ"\VS>$NF')V*NP*[%78JUBKJXJXXJ[MBKJ8I;Q5K`KL4. MKBEV^*NVQ5__U?.&934[%6\5=7%78J[MA5K%6\4-8JZN*MC%6\5=BK6*MXJM M?[#?(_JQER2.:A!VS$;42WVABJ]06("CD3V&`D)`/)D.DZ$8R)IO[[JJ]E_M MS%RY+<_#IZW/-/H+#IM3*#)RN%5N]&-S:NJ"DH^*/YCMDL>3A+7FP\46-*QJ M584(/Q`]CTS.!VMU=4:2>^)A?U8_[R!N0`[CN/NQ5%136C,LLB-+!(E55&"& MI]\57ZKJ]C<(J+:&)HUX04D)5`/!:=^^*L>N'+`-^T,0I6EZJ#7;"A?87/H7 M08_W&&T< M*PQL,446J'PPVN[J84.I\0^>$((1>9KCNIBKL5=BJ<^3!7S/8?ZS?\1.8VK_ M`+LN1IO[P/6`N^:$NX1*+M@+(-LFV!*E*AR0*"@BO[VF28HI5.19.E2B^YPA M!04B[_J&%""N(RS^FN[=6]AA1257OI&4JS<8H@U*;EG`K3Z,LCT:Y1YI0OUD MJ`$:AWZ;9L*=:F/ENTM[O6#'=RK;O%$TJ&38$C:@S%U-CDYFD`ELGWU,D<3L M6_NR=LQK99O"Z8*NQ0[%78J[%6FZ'Y8RY)'-#P=1F&6U&1PR33+'$I:1M@!@D0&48D MF@R[1_+ZVX$K_',>K>'RS#RY>([.QPZ?AW9#;6/M0909.4(H^.T`'3($LQ%, M].TEYVY?9B7[3^)\!D)3V;818=Y\T5=-U5;F%"MK>#D!X2#9OOZYL=-DXH[N MGUF'AE?>P>^KZS#L>N9#B(2P=JR6=?B6KP5[CPQ50F<@FO7O\\50]2=_\]\* M&X;4,KRN_")-S3J#$&B@-;FCN;U)XS M&C*5($9W"C;Y6O7-?, M<,J=G*`(X@I74)AD2Z'2HCN*C[CA!<6D1Q&Q'1L!54X;8$M!<5<4&*K"F*K" MF*K67"J2^;!_SKE__P`8_P#C89?IO[P-&H_NR\NS>NF')V!+1PJZF!74Q5W? M%6\"M;XJUBKJXJZN*N'OBK9Z8JT*5ZXJV#OBKMO'OBK_`/_7\WUS*:F\5=BK ML5=BKABKL5=BKL5=BK>*MXJ[%#L*78JTWV3\L9O0G-DZ=)VN&2YCF79U.U/ M#"A4NI.-:R-<>-CX:":%E/%AQ)WR5L>%8T+#>F&U(4FA'AC;&E)H2,G$[L)!909LG M":Q5V*N'7%4]\C#_`)VW30/YV_XB![`4()KXYH2[M5B4],55 MBE<5621_`<"I_76C?B)9>+>I+NS-O0-TVIEY[FD$'=(]?TL/>&2U9G``^-MOBZ MD`>%Q1WD"WZ*HL[\"H4UXM3PZBN88+=()3;!UB:&3^\A M-/HKL!HU']V7E-F"1V*0#T9SY5\M"RA]:9:W&^=]8DN+F>V,A>7EZEXPZ&7P_P!2(?`N;#!!UFHR M6QB[N&ELHI&^V?A)^7?,L!PI*^FZ?I?HBZO+A4#*U%(+$D#H`,K,C=-D(1JV MWT^VY1RSDHK@$;5#+V*C)<19#&.JYHY8T,T2\(5?@']R-J_1D.(EFA)%_>;; MU[Y)@0M:H(!Q8E45RK\@:$=",%,@Y9*L37?KB0D%6CN9`?AVJ.F1H,K5(&+2 M5!V.1/R1C-NZMO%78J[%60>0`#YQTP'^=_^(',76?W1J("R_WA8CCR_D7(G?,J&(1#B9-03MT6Z?J)B3ZO;H(W/VY@37B>V M6B&]M4LM"@C7(9`*=.9E/[O3DY'WNI11 M!_SS6K9?CBT9#L\,U666,%@E!2%WAFV!9-U!J138UK^& M1;5>9HCIRV_J<0Y]05[.I^R?F,"E*22#DJ0L9JGY80&!=UKO3"A1>54W)_KB M`@FE,WC]A3P.'A".,JRZQ=KQZ$KWIU^>`P#+QBKQZI+0@JH#=AU%?#(G&&4< MI*:Z;I]Q=3AYPP$0Y!*;D9CY#P[!R<4+-EDZ6JD_#R],#X0V^V5`N1+=<\2] M!L,;8D(:ZC`MIO\`4;]63AS#"8V+"AT&;QTC>*NQ5V*LA_+T5\YZ6/\`+?\` MX@![?)'4?(YH2[M21:'%44BU&*NGC_=8JE4"5N&]L506LWAA M41J:LU6^GHOXY*(8DJ]C;HD<=KQ=H8U]6\9!R-":`4_RW^'%0'FWG#S+>ZA> M2P&:7T$?D\+GX?47X:@#PIMF7AQB(OJXV?+Q;,9,@K4F@]^^7`..9)OI40** MPV!ZENM<2P3Q(5Z@5+=ZY%E2*AT*2YZ*0.[8F2:49M&M(+ZWB#AF9QZ@&YIW MQM:#);>X%EK-M662.UED195LQRDX`U4]?',?+"XN7II$';DF6I7MA#=32QRE MH2X:/G02$$D;CKRRD1[FV7-`1W%S=,QB0I$>C'O\L/)C:I';\?MDDXVE1G8* MX\#B@HRV<$"OW9$I"+IM@9J;#%"0^=/^47U'_C%_$9?IO[P-.I_NR\@S?%TH MY-@8%=3%78JUBKL5<,5=BKL5;[8JU3;?%7'M3%7;=\5:WKBK=%KOUQ5V]?IQ M0__2\WYE-3L5=BKJ8J[CBKJ4Q5PQ5O%78J[%6ZXJX8J[%78JWBJ+T<5U>Q'C M<1#_`(<9')]!9XOK#W**WWZ=,YLEZGE]](9)1'R+PP_!"3O1:],S\>SKLVZG(Y9/2`*1#9J]6R9DTB'>B8KP1P MK;\`8`W-T'[;`4%3D&>RG?31R,DD;#^[4.@%.+`;C%D"I>O\-",5)4':FP[Y M,,)%2$B*?B-.],-,.);+.I%1N>V+$R0Q0G?J'SS"RY2=@[#!IQ$6>;((K<5YE>!(W] M\J!;B;5B0JT'PC!2J18GH,*"A[I2;:;_`%&_5DH<<$>]S]*.-/"J66HO<:K:JP)JU];E#@!4I!JP:(`]@>N61 MW8%$Z
)6ZUR,@R"9H-O?(%FYTQ0Q[SLM/*VI?\8OXC,C3?W@:-3_=EX]3- M\72CD[`EO%6B-\5;Q5K;%78JT,5=UK7%#MP,4N.XQ5VX&V*N('?J<5<3388J MV%%1XXJZK5^GIBA__]/S?0YE-3>V*NQ5V*NQ5V^*NQ5V*NQ5V*NQ5L8J[%7' M%#JXJC=$WUK3O^8J'_DX,AE^@MN'ZX^]]!10^V=0!T[5/3)4@E4NHXDDGPEN(.1GD$0V1Q$EE&F>7H4C7UHN4R?%ZA&Q:O\`#,2> M8GW.9CQ1CS&Z=1VP4=V(_:.V5-I-KJ-\_?&T->B3[X;32\6]<+T&="7GPW@5V%78JR/\N!7SMI7^N__$#F+K/[HN1I M?[P/?(UIFA=TI3IU-,4K(7HV!4;,0T!IX83R5(I^$5O/*Y"QCJQV`Q`0=GG> ME?6+K4)Q;3")7+E[@"K4+5^`':O^5F5+8./$W:5>;(K6/2=,6W;E+21KG:G` MER`68_;9Z;Y;@-EAJ!L&*23IZTR\.*96XFJT\,G;%&:9J'"V36<%**5XJ0`5ZB@%2-_GE**Z MI7J>CW6F2R:KH8X.M6N[$5].5>[*O9O'+8D2V+7*-;A,M'UBTUFQ%S;GBP^& M:(]5?K2F53@8EG`VEOF0`6S-W!KEF-A-2\O2%X"/Y33')S6+($7;*FUIQM[X MJQ[SN/\`G5=2]HO^-AF1IO[P./J?[LO&JYOBZ4_?%>%<(5IOVQM>%516I2AW\!4X#MNSB$_T_RE>O:0W]W$T=M.Q% ML.A?C3E^O,?+F[G*A@%6676FAVL")P#*JT8#IO3P'3,,S)YN6(CHBS"!T`^C M&UIWHD^PQM:7"V]L%IX5P@'AC:TV(#BM*-]&?J%SM_NI_P#B.3A]01,>DO*% M^R/EG1%YL-XJ[%78JR/\N/\`E-])_P",C_\`$#F-J_[LN1I?[P/?Z4.:!W3I M$Y"N*4#("AKD57)<<@`3BK"]7NY-?UAM'MF*Z=;GG?2C8L%-*#YM\.90'`-V MB^([)+H82WU*>*G$0R21%?;E4?AAGR1#JH>9H)[C039*L9:PNW5%'PSGU?WB MM7]J/C7)XI5+=CD%Q8#&G*?ILM21\LRY;.%&.[N* M"QZPT9K'6[^2TB41`+-.1L?2EZ;=^#@YF5Q8[ZN)?!EK^%!^;)`MFP\33*<3 M?D0_E2K0-\\.4;KC92@V&4-BV3K7"K'?/`KY3U/_`(Q?\;#,C2_W@][1J?[L MO&>A.;YTHY.!WP*[%78%:Q5L8JUW.*MG8>.*74J/#%7`4Z_=BAVYZ8I;K0;C M%6B"<5=6E!3Z<5;XFM>V*NYK7IBA_]7SAF4U.KBKL5=BKL5=BKL5<,5;IBKJ M8JU3%#8&%74Q5O%78JC_`"\*^8-,'C=P?\G%R&;Z9?U6S%]E-L("'SMK]W+![^&J!XYH2[H*B$=#WP)0EY&.HQ5*+R5H8)7!H0IID M\4;D`UY9\,24L\J6R)#?2%1RED"$_P"H-_Q.6ZD^JFO31J-L=U6+ZCYI9C01 MW8#@]N:['[QA&\5.Q1DK64-TEY>VPN[9HVM;B-CQ`9P?JTU1_(YX-@B67+XO M.M6T34](F=I[9X!SXJLG7D1R^G;?,V$Q(.'E@8E)IG=FJ_7KED:<>5N!Q552 ME148*9*S.`ORQ0](_+7R#J$PN=6:]%J8K59@JT)].1NY-=_^&S7Y\HEL`[/3 MX3#?_`%4'&-?N%3E#8C$0*M!X;GWP,F^?;OBJ_3(H MG\QV<4HK'>136S_.G-/U-F7I3S#A:H518#YT=X)VLW/[R)S&WS4\?X8PC1+* M4K`1GE1"+-2>YRK*=VW'R9*&H*92V*3MA5CWG@U\J:D!_OK_`(V&9&E_O![V MC4_W9>-4ZYOG2CDT1@5L#%6Z8%:.*NQ5VW3%74I6O;%7;$;;8J[AQ5KE'RK3?^.*O__6\X',IJ:Q M5NN*NQ5V*NQ5L8JWBKL5+L4.Q5V%78J[%78JF'EW_E(=+_YB[?\`Y.KE>7Z9 M?U6S%]Z26>RD8K;K-(6'^4#TS90`YNMR=R0W%P%/IJ*D_:S(B'%R26Q(I8`( M/HR36!:?Z7IB[,^Y/8Y$N=CQ=Z=PVP0$`5!WH,@Y(@JPVDL\RQ11EY)#Q0"F M0E,#FR&/=.(/*%\L:7DL"&W$O#@QH7IU_P!CF-+4V-@VC&`=V02Q6\Y@]*V2 M'T!0.*DU]JUZ=LQ@%D;*I'$$'%!3Q8[DUZX2@1;X`#Q."V5-!">V&UI=Z?MB MM->GWQM:=Z?O@M:=Z6&TM*I]A?EG M3%Y@+J8JUQQ5NF*LA_+W;SII9_RW_P"(',;5_P!V7(TW]X'O*/4>]3BES;(I'$GM<0?"O\`E*N6#)6['@XQPO-- M2T^XM+@Q3`"1>0(!!^R2#T]QF="0ER<#)C,=BA:TR36V*G<8A-IGHFC7>L7, MEO`XC$4;2R.U315V``'6IRK-EX!;=AP^(?)[IHEV;#RK;Z5Z"JZE7$@-792M M%B;;MU;-5WNUGL0$9!#Z2$L>4C;NWN?Z8E@NY;T[XI6,P&].^*J44_I:KID] M=X[R$CY,>!_7F1ICZG%U(]#$?S<@]#SU=1+]F4)./]FM#^(S*D*):,4K`3'0 M8?3LXQ3>@S`F=W-B-DV+4!`ZY%*FQ[UQ5(/.K'_"^HCQB_XV&9&E_O`T:GZ" M\=S?.F')V!78J[%78JXX%=M3WQ5H;CV[XJ[:FV*N[;XJX]-NF%7;$`M^'7%7 M$M6@V':F*MGC45^T.N!6ZOSH.G;PQ5U8^7>M?#;#2O\`_]?S?3,IJ#>*NQ5V M*MXJZF*NQ5O"KL"NQ0[%785=BKL5=BJ8>7?^4ATO_F,M_P#DZN0R_1+^JV8O MKC_6?37[67[JPN(88JW,%Q&+@2("Q!85()&9V&8<'48R.0MA/U=UE99%(DJ:J0:BF M9P(KFZS@-[ISI>G;AF4\C3B*;FO3*Y3'>Y^'3^3+/\+ZS';+,+=FY;\!]JGC M3,4:J%N?X5,@T/RA)$EO=:Q&4ANR1&"XJ@4;EXU^+Y95FSF1]/)E&AS35=)L M+;6I;W3X^-J%]."%P2`"*%]_VLJD211+&)I7$'PA6)('V5Z_KR*5ZQ^.P_EQ MM7%23L-NV-J[T2.N!*[AO@M7%,5<(_;%7M<5:*>.&U0VII_N.NZ M#_=,G_$3DL9]089/I/N>((/@7Y#.G+RX78I:IBK@-\53_P`A&GG#33X.W_$# MF-J_[LM^F_O`]QCE\#F@+N;5URM^UE(-%LJPQSS!Y>BUZ,-'9+;:S M:K(-2`)7G(:%)%`!Y"3LN70R M!HU'T%Y%MF]+IP[`KJ#OBKM^G;%74`ZXJ[?Z,"N_7BK@0?EBKM@#3KBK@*@D M],*N)"CX=P<5;(#`$['%6B2*`=/'%7%%+;M3Q&*M\GY_Y2#2 M_P#F,M_^3JY#,?1+W-F+ZX_UGTR&W.OP-C:"-DE.EZ5$;HC2[6:2ZJ9 M))%-06Z\0#MDQ(K0[D.]G'SB,-G;PB$!4$<9/3N:G&[6,B%2X74+L(L[CA&` M%``&P^6^1X0%W:6S1#5JNW8DG#:TN*'HH^G&T->D!N>N-JUZ?(^V!("[AMBM M.X5QM+C&!\\;6G"/VP)<4-,**6\,4.X#"BG&,8JA=3'^XR\-/]T2?\1.3Q_4 M&.3Z#[GA*?8'RSJ"\J%V*NQ5V*I[Y%-/-NG'_+;_`(BTQ M/TS0EW"*C:N!F%8'%*$U%.<&XZ',C2GU.+JQZ$'HX9);VW;JLHD4?Y,BU_6, M&I%29Z8W$+M3A#1,#WRF);BP6X0).\;?9)V^8S(')H/-E&B7H:("0VN8KF*]L6_T^%2()*T$\9'Q0N:?:_WVW[.1OO;!LENI>2+/S7: M/=VK%)BT,"(0!\7*K^J`*\QT../)*/)LG",QNBO*_P"6.B^6I)M2U1TNI;2] MDC6`;*Z(NU%(WWR<\IF-V$,<8#;FCOBN+B29D](2DB&%101Q5J!MWRHI))15 M`HH-A2@`Q0M:O7OBQ:V&YZXJI2F@)\<:6T)Y;B%_YWTNVZK&[3./`(I.9NEC MO;AZH[4I?F%$L_YCW%!_O-;01GYD%S_Q+'42W72C9G\?VAU^G%7_]'SCF4U.Q5V*MX:6W8K;L5=BAV*NQ5U,5=3 M%74Q5L;8J["KL:5&Z+-%!K&GSS,(XHKF%Y';HJK("2?NRO,+@:;,1]]Y7 MS]Y*)(_3=K_P1_IG-_E\G<]*=5B_G+QY]\F4_P".W:_\&?Z8/R^3N1^:Q?S@ MN3SWY,VK_K'^F/@3[D_F<7\YH^IQ<)'$\:044`^ M&=*7FEV*NQ5V*IWY*J/-%BW9"S,?;BO0WL(^U(HW\87$A!2SV<.JV]Q M#,KQ31M#/PJ>/$\D8_JR[4D'<-&E$H[%7N;VP84^L)O[YB`%S"6&ZU;!Y"T) M$AK^SE\2U2!:T>YF@<"52J]#7N,,U&S)[?6-/13')0DC8@B11W%*$-DA$E!F`F4`^N3QR.[W%Q<`.C$,6?G_`""E M/BP>%/N1XL>]3U/4-.TF=H]4N%LY5)1XY@RLI'8U&$8Y=R^+'?="P^:O+4W] MSJ<$G^J3_3`<Q'Z3_3!PE;#1UG2"/\`>N/[S_3'A*V$ M-=:QIW#X+E&(["N2$2@D(G\K-2T>W\Q7^IZM>1686,QVOK$@MR(!(H#VS.PD M`![C$VJRXB53 M\(^$Y&RJ72DPR\UZ=\()5)KN.W^M^I!)R!'(@`BA/:N&RA#!F63E^SWQLJB7 M8&G@<;*'.`*;8V5#;`;;#&RI<0,-E6^@WQLI6M2N"RK3`4K3#953&_L,%E6\ M;*NQLJXC&RKE`]13[C""5*99F-#J8J[%74Q5//)?_*0P_P#&.3]68FM_NW)T MGUO1E&XS3V[9>!@33B*#%*RE3X8%7@$5_P`^F*J#[G"E3*]P,56.NP\<4%`W M5![9,,"ESK'S#/2BFO(]LLC=[-.3D]4\L>;_`"U)+:7\MV;2#0+>V^M17$4B M2R%31EMT`)F8>"YFBW`(W8E^%X&90H`(]0"O3 M*YWQ)Q@;O.?+2#@S4WRO,7*PC9DZ*"HJ,QW)7['IBJ[C]WABJX+4[C`K=.QP MJUQWZ8JV5Q5HJ<4%*?,H/Z(FKTJG_$AF3I/[P-&I^@L,[;9MG5M'"KC6FV*N M-/IQ5Q!KMTP*WL#3&E:"D'?IWQI7#CO0;]L:5R@BO+IC2NH"OP]L"NH`GQ;U MZ8:5S"H!3IX8JV>`H'W8=<"N97+U`.^X\,575A,G^5X^^*K/2FY?9-:_1BMO M_]/SEF6TNQ5V*NH<5=3%7$8JWBKL5=3%74Q5L#"K>-*[&E=3%74PJMF'[I_] M4_JP'D4CF@(/M9AMJJQ4['%4./M,.V*HNTD^'@>HW`Q5;J-N2@NH_P!@T>G4 M>!Q5D'E?5Q/#]5F:K(*J:_LC%+K[5;=.44/[]@=FZ*,%*DD\TLC5D:I[*-@/ MHPH0LX!-1VZXJHON*_YTQ5D!0*9I0[9=3%DL8X$MH*]L5IMSBJ@=S MBAIAA52?%2EET:DC)Q822Z[@$T#(=J$,.^XRW&:+1DWBBC9%R&$LH-%ZM^UP M`)_V39F6X*4^>2L.DZ7#ZCS\A(2LC$B.0FM5\/EA2A/+2'T>7GZ&F_UD_P")#,C2 M?W@:-3]!83VH,W#JW4VWQ6W$'MBMNXCZ<5<0:[=,5=12=^N*N'+EOT[XK;J# M?B=Z8JX;@\NF*VX@!:I7WP+;8IP^/8=O'"MM,2$''[/MBMML$V]0\6.!6F,@ M>BDD#[-.F-+:_C%Z@W^(]NU<56>I-RIORKT[8H?_U/.69;2ZF*NQ5O?%7;XJ MW3%74PJZF*NQ5NF*NQ5O"KL5=BKL563?W+_ZI_5@/(J.:6I7MUS#;EU&/?%7 M<#BK:AD;D.HQ5&F=1`U1\,@XD?/%*']);8$I(Q9Q2@/8XH54D]1`>A78CP.* MHNPTY+JK2.>(-#$GVB/%F/PHON<(4H6_B]*ZDB""-!]E0>0IXAN]<2J"X[E? M'`KE4J1MTQ5%B,D`TV.XP6FF_3:F-K16E#C:\)6$'PPVM-5(ZXH:Y$XJZI[$ M8JM<&F*M&F*M#%6U_O%'OA'-2FV9KCV[%78JU3>N*I_Y'_Y2*+_C')^K,36_ MW?Q_MBKGQ51FH!A"E*IZE MLF&LH=QMOED>;7+Z2S;R]:0374WK01RQQVJN?44-2@ZJ#W_V+9FTZXO-?S!% M;2Q8@!GED)`%/HIBEWER$K:(?'?,/*=W/Q#9/D6H]LJ;554&*:74IO@6G!=L M4NXC`M+@*84-4&!::(Q6DG\TC_<+-_K)_P`2&96C_O`XVJ^@L'S]<56^O+7Z?LT_#%7_]7SE3,MI74Q5K"K>*NQ5O%74Q5U,*N&*MXJ[%78 MJ[%78JZF*%DW]S)_JG]61/(I'-+4[9B-RK^UBJZF*M5\<57H4:L;T(/8XE;5 M4AB"_"NXQ50_NY02:(WPN/U'%45`RI+QD0R1G9H^156\.5.PPA4RU:R>4+)& M\4I@0"4Q&NW@%'V43$H"4/!N"/OR*6S!4HR$F<$4;=:9`-B M'>`#H,*J#QC"$%0D1:;C"Q(46`&V%BILN^%"PE^QPJM]1^XK\L4+UD'RQ5=& M:R+0U^+".:IOF=3CNP*[%78JGWD?;S%%_P`8Y/U9B:W^[^+E:/\`O'H]/#-( M[CJO`P);`-<4N<@8A4,S5.WW86+A7%6F7%4/<85*6R@U)R08%#R]#[5RV'U! MJG])>F>4+$O;W5Q.A6UDA6/ZXJFD?$?ST/';_@LS;=>7D?YF1"-["):E/4D* M$[$@]#@*0B]'@].TC6G89@3.[L8:E_W"S?ZR?\`$AF3I/[P.-J_[LL%W`S=.J=3D,4..PIUQ5Q2 MIKXXJXG>GABK7`\O;KBK?*IXTI7OBK@I6I-.G8XJV#S4BE.^*NH46M`:]NV* MM;RJ#0`@[CH,5;J8E"T#'J:],5N*'?5V]2 MM13K6N].N*N^L?O*\5I7P^*G]<5?_];SGF6TMTPJZF*MX5=3%78JWBKL5=BK ML4.Q5V*NIBKJ8JW3%5DP_I^C*1(N3X8`2YEXN1]QR^)MQI"BLEA#C M<;86*I!&SKQ/VTV(]NQQ5DFCP6ES8+`Y:&."IN@&6..0,?A9WW<_ZBC%"GJ? MEYK..&0*PBFKQ9^(YCLR)]L)3^;]K`D)>EI2JD8JT;9D8,!T-1@2$4U"H8#K MD:;;0DKC?;%'$A)&'AAI'$A9''?&E)4&8'),%A88JM.*K2,*K2N*MQ@B1*?S M#".:"GQ&^9].,U3%74Q5NF*IYY)_Y2*'_C')^K,/7?W?Q#E:/^\>D*-_IS1. MZ5E7%+?&F!5*3IA"H5A\1Q0JJFW3%6RIIBJ!N%))R004',E%R08%!RH2:#M7 M+8?4&N?TEEVCZSJEKIT,$4W"W=.,Y4U!1COR7OUS,IU[!_S$MYGU[3X2>2,` MT0(W*GN,64QM4"H%I0KF`78A'1QU&!DJ^GMBEL1G%7>F?#&U<5^_`K M13%6N.%"WB,"I+YL4_H.>G\R?\2&96C_`+P.-J_[LL"I0;YNG46UN1MTQ5QH M!0BIQ5L@DU45&*NY4-"/IQ5K@W(D??BJ[DI;84KT.*M*A6I84`ZXJ[9U(44/ M7YXJV!P7XA4'HIQ5HCU%'`;+U7%2ZO!55QR/OVQ5SHTE'454C;%5Q=$W0M(Y=WGED>A<+4<1&M/@7"@,?:RY48`X$MMIY.],57 M6-LHE,#J*/\`8)'?(SY.5IB+HK;O2X]ZI3Z,JXG*E@'5)[G3$WI49(3:I:<= M$LGL6%:4.2$FF6`H"6W*D[$9*VDP(42A'3"Q6[]QBK>*NH,5;11ZB?ZPPCF@ MIV1OFP<9U,5=3%74Q5/?)"U\Q0_\8Y/U9AZ_^Z^(DJNX^>^:)W91 M"I4>V!0YDVP)4I$(Q""A"*RX4(E5Z#%72J0N$*@73J<*$%<+2@I\1Z#)!B4" M]K<33-#;BKQ1M/,W\J**DGYY9C:I\BE4>I3I$$25@*4-#U'AF>Z\)OH^D7_F M*66[]0S/IG'BAW+*5I0'_)IF/GE3E:>%HOT7'Q@'E&3R7Y9B%RJ1<(#(&'0] M,2FU=4R+(+BFVV&U=P.!6C&*[XJM*#%6N.*K&3"A(_-RTT*?_6C_`.)C,K1_ MW@<;5_W9>?[4WS=.G<0*?#BKMJ4/7%+3UK\/0],:5LT!WW.-+;@&Y_CBK8]/ MD>(/+%6E#"O+[(ZUQI7?"5;TP0??PQ5RT"GU*D=AT.*N850".H'<=Z_1A0ZJ M!%$H).Y%/#WP*Z3E4<*\*#CQ[8K;;&(,/4!+_M$=/IQL*ZD_K#KN:@C[-,.Z M[.K;N-IJTKOM,-G>M'U1OBC(\#F3`V'" MRPHKH[4$L.Q&28)E96_*.A%678_+%4?%9UIMBA'0Z>7^&A->V)5GV@_E7/K> MG)/9(YE(_>#]A?&IQ9`,5\R^2[K2W:JE6C-:=>G<'`>28GA-I8XL[B($.HFH M"\8.X/?KF#*D22ZLF4FH^[+1(.+/ M3D);/;[&JY,2<3)A/<@);,"I78Y8).)/$AGB9=B-\D"X\HE3*844UP&*TN1? MWB?ZV$?!Z4$W M&<_T=TB8UVQ5LQC%*E*E%\<50*K6;"@(P)O@59<#:F$*@F"@,QV5>IPA"&9. M*-/("7(^!.].PI_,G8F%"TA2(VUSZ7^ZI MASB]CW&$[M8"+5"#0_1@2O\`3VP*WQVQ2MX;XJM9,54RAQ0M*X52/SB*:!.1 M_-'_`,3&96B_O0XVL_NR\[&Z[U&;PNF;Z+MBK1`(JQH?;%7$L"*;#MBKB%+? M%LWMBK?)N=-Z=".V*M*J!J@[]ATP*Y&9B0]2M/B]L*N6BJQ0DL-A\L"N!Y(? M5)VW![XTKB>"#TR:$U+=.F%6V"LBM*2I[4WJ,5=)(T?%4)"`?"1WQ5S+$9`9 M&(8TY*!M7&A:N]2?U^-=JT"=J8V5IOT[;U./-J5^S3^.*O\`_]'SMF:TNQ5V M*'8J[?%6]\5--XXF!60:?8TI&F M['[;^V1,F[#C,S37F/2XY=/6>-0'@;8]W!^U_P`#DM/DWIGK=+^[XA_"D%O! M4@G>N9MNE3S3=/DDDY(A.V^*IJFF,'I0]=ML4,@T3RU=74Z".,L3T`'?%7T+ MY$TR;1-!$-\!`.99`QILP';`2!S9")/)B_YL0MK%O$EG;>O'"DBM(M.7)J4^ M'K3,8ZS'=6Y`TL^=/#;K\I=7XFZU;E9VC#DG$1M#GTZTCGGX7,P"0T^$[#H2:_%WW^UFA_-RXR7I[H4([081Y MG\DWFD/*$83P`D^H-B`.O-3T([TS98=7&2G#Q1L!BFIZ?%$$-`K$_$*U!!%0 M13,S'D+A9=.$LNM+F1`Y7X"`P(WVRV.8.%ET:6W%D035=QE\9AUV73E+Y(N) MH1EMN#*%+#&,+&FE0^HO^MAB=V)34C?-F7#=@0ZF*M4Q2R+R`O\`SL\'_&.3 M]68?:']U\0Y6A_O/@]-X],Y]WA5XOLXJJ<,54YEHG3`E+T7]^%=N!)[G!+5$;!E^5!!)>B6GG?6; M4M#8+VTU6XN+IB1=7$:1F0]>,=2H`^9 MWP2RFTXAP[L)E6&.22WN:!UZQ,-C7O49C9KNP[6-+]Y M;MX@;TQA.W'R8Z*A"XEA20=>C#P.2:PK@;8$NXXI=PP*L*'%#13"JFR8JD/G M($>7[@_Y4?\`Q,9EZ'^]#C:S^[+SD;KF]+IFC\(V-<5<145)H<"MLW$4Z_/% M7%%Y5)I7>F(5KF>5`,*MB-58D&I7<#`K2LSGBVX8?*GSQ5L*$5G!#'I3P&&E M:'[Q34\:=#3:N`*V/W2#COR/Q$;@4PJY@'579@C=-^_RQJU<\K141`***U.] M:[[8JVT2.]2X4O0E>]03<`!QKQ"]Z9(GH@@R3%-[_`/**)]7>2V:.#3V;D&8U*@TJ*8K;)M(TO0="I#:0^I,F MTERXW!]CVRJ6:(;HX35I!YFUNYCU22!WY1TW3[5.ZYJ=1F-T[S1:6)@"QFZU M.6@@G=D8R*ZG_)&^WCFMF79QP@VTNIJQ/.S$#-)!("(N5.C*=]_;(8 M\E2LN,<,AC`&T^+G'ZF`7U\MO*S6[?NA*3%&PWBH:@*3^SE4H\1Y._QXMJEW M*3^9-.DN)FU&-;MY8BG[HBBCO48!IY[<.R/"H5$T'GS^6QJUW,NGLD4)J\*2 MM6I7JH(Z9M9:CPXCB%M4],9;CDQ^5I;20I*A`5N,BG[LR]CN'"R1,-B@7:*6 M[2/[25(8C8D#?)"P-G%%&==$/JFEQ*@EBW1B2H[TR_%EMPM;I!%)6MMZ#,@2 M=0<:P0,'6NV^2C+=KE#9&YMW7.I@5V*NQ0R3\O5KYJ@'_%4OZLP^T?[KXAR] M#_>_!Z@\=,YT.]*I$M,*JP0X"5"V=/W9QM*6PI6XIDF*,D`&QZ`&ORR*2DMP MTU]>FT@/`4K<2#]A/Y1_E-E@V%L#N45=>C&OH*.%K`*24[D`4C'_`!ME4YTW MXH7OT5K/46N&)D'[I/L0@]#38C_5S%E*G-C$2Y,S\JV*B1/4/JR.*)&"0%J2 MW/;]GVR..\A\F&>?!"NKT.+3K=+=4`Y&E2S;EO2PHL8,@YH?AJ*'?J"7+@_P"5'_Q,9F:'^]#BZS^[+S6G('L?#-\736X`J.E: M[X%("]:=:XJV8V)K78^/\,-+;C(.738[5PZ_9 M???J*^V1HK=.^L()JM=Z8\*\3__T_.^9K0[ M%74Q5O%785;IBK>*NQ0[%78A74PJV,5=3%6QA5V*%RH'8*>C46GSR,SL4QW( M3F&`*!04`Z#-*[FD7'%[9$L@%=(L%LE:.,LRH.I/X8%9#ID(KRI\,8HGSR!< MC"-T7<,#2([J1ZEP?\@=!_LCE9+N-/#B2"]NT!GN96K4$(!^R1L!@@#*076Y M(PQR)06DW?INK$[U!-?$]XY)UJ&J7%Q=QVTW*..1F`8;V>*B'_9`FF6QTDY;57FN361`1MKY M_P#)D$L)6TGA$@_?I&:-&QVY(>_CE,^S\YZB5-4^U,1C5H`ZCY2O6N:F>XF& M\32@@OOTV_:R\8LT:ODW^+AR#TBY)%=Z/=^HDK*8(V-(S("I8$;4VIF0,@Y. M!DTY,K0FH."WI1[JO?+L8<'6Y;](2YXP.F7.J*DT>3QG<-.0;-9O2Z9V12[% M7859+^7(KYLMQ_Q5+^K,'M'^Z^(KR1'8YSH=Z5L:T^_"J)"U7`5: MG3]V<"I9;*?K#'PR2J6I7:P1&O5JD_(8@6I*'M5-A9%CO>7578=Q45^Y1C*7 M>L(6:2&:[+2&-0S(K%N7+D&!ZU&4D=7))Z!/=*@=0IW`Y47B*U+=%S%R;FG, MQ@1C9>P>4-%E@2.6>,^M*JD47I3L/<#KF9@Q\(`=/JLO&6:"T-:&E&("#H>F M9L8.%:&NM*>4&BU.`XRR$V+Z_I4MI:7/+[3`;=*@FF4R%`ML#9#RS4XU6X*^ MGZI?X*;BI[]E,3L@"VG@D>7D@JIH5;VP5:;7F:W];=*M7^] M\#TK3'B7A*SZM/ZGV=J_;_CDN'=>(*KH`?7C]W'ZQDDGAL4#&3*;[4C!:Z9()9#%<1MZ)8@J#3=:_(9.>4C' M$VN'`)2EL+B4MO/,\-T%]2Y9+BV;]VT5>15MJ@]_\I08M#>QS3(D\AB$Q#3R?M",; M[>YR^<:&R.+OYM:[KD,*_P"X>0PQ(31CNQ9MCOWVR.#3F9]08&1B-F!:KJ$T MEQ)(\AEFD-7)H*FE,WF'"(.!ER@A_O?@]> M:.HSG0[TJ/#XL*HF-=A@5==R)%@K2-"-^WVF`[XXX M`&VK-JI2V')Z;I%M%]6XQ'[).]:U^DYGP`Z.NE(IW#9AF`\.^71BU&26>8/, M5II2?5;5!=:HX_=VZ[@'^:1A]A,!]1X8\VS%B,N?)AVK6>L:A93-+(T]S(*A M5HD8H:T0'?[\EET1,"!ZIN7`QB7C'F=M72_2&ZM2$B)>YCDK%/0=#&NRO[YJ MY8^$&,MI.?@,KX@+@EED;G5)FB2Y00)2L2`B4`5V<'?,@#A`*13NTTF" M(,J[_P"5WKD3)1%TUH4W7IB"I"3W[E&6O6N3#`HZS?DBG(29!,`"0,BV+'0U MQ"&.^>%IY;N:].4?_$QF9H?[T.+K?[HO,*?#\/TYT)=';J#C\73M3K@6W.#0 M<>G8X5L./"@YUY=_"F"DVY@Y?X>G[/A@I7?NB^_VOPKAI%N57]3X@:5^(]J8 M$N01[^G7E3X:XJT@^%O4KP_&O;$*6V"F(^C7J.7C3"@M!0(_WU3O\`[T[X!Y MI]SI%/!##7AX#K7WQE?11SW7.(J+ZW(R4WX^':N&P.;$7T6R"42U2O&HX$=, MB;9"E]+87`K7F-B?V>62L(`(4N-UZG[7.M:]JUZXU*_)?37F_P#_U?/69K0[ M"KL5=BKL*'4Q5L#%6Z8JZF%7$;8JV!MBAU,5;PJ[%78JJVP_TB'_`%U_6,AD M^DLH?4&5I'OFA=XB%CP*N*;8JBH(PM%'T_/`E-&D*V9X]@0/F10?L1H`?'IE41N[W%$4$P\E:D\>H7$!C%Q:RQ,\R-UY(*<@>WO_DYB:L>D M4G%#BO=F'[J*P2>Q$444;[Q1@)Q/VB`-N0.:XR,I>K=S,4(Q](&R;0W]M/;0 MNDC0AB1/&1S:1J;T`KME1!#1P$%-+[2[FWT%0]RPB9@]O:LZFHI4@"A9*Y?, M&,`27&P98SS$"/\`6DH>9A81^6;"?3X/2N`E)JJ=W_:^(5+9=DEC/#P]WJ71 M#(6ZW>W2\&NW4EQ^Z5=E*KL&.V9FFPB0VV:)7:4ML%'V1[U.61A2)Y($5%NTT."6C-L:?9/7Y MX3D9X>SQ+=7_`$2/51%CYG]D`59J>`&1,]K)IO.E$2+#)+SR[8Z-HEOJ^IW* M+*S!QI3#D30_"C^'/[1_R33(OI) M,:R*`!R]@H^%$'[*KF5BPA M_O/@]D1-M\YP.]*'DCXDT\/\`-D<< MK)IRC"@+9WY;GM1JUDB@&W:>-(_4`#`@;T]LP>&Y-LQZ7O4T"R6D1A/Q"FX] M^N7F#K;I.=(G%M.>8_T=U%-OLL-M\OPW'FPR;MZ_YD=+?T=/\*O,M].M_.0]S.KU#-X`$'X5R./CCR+*65N;R_K;' M_CK2I3IP1/U4R[\QF[_L09`O&//VHS2>9)8I;KZZUO\`NA<%`:>FO2H`4?%F M#J,GB'?F]%IHB&$5W).VB6U\49^4=VO'A=0GA(K`5V/?Y-EL94*=3,625--5 MOM'NDMM9I/;2$+!J2#B"?Y9%[-CPWN&`D0=T_D*O&&0\D8`JPW!![C(-C&O, M2<$#>!RZ#5)5T63U+9:]1D9AE%.D7;*FQIQDD,:\]@?X:N:_S1_\G!F9H/[T M?%Q-;_=EY=3BM5/?HIBMN8 MNK``T`Z#%;;X()*%J'^7W^>*6@SLY!Z&O(>&*'(BBI1N3`&@]L:I;:0EU82' MX1^T>Q[8C=2&_L1EHS6OVF[CZ,:I>;O[R.LC<>)HK$5K@JUY%IW:-$]-CQ-3 MR'5N+L/B4"M?#)$7NKI))DD"(?@6G!>S8F[6A3?HV_KTY;U MJ8]^O6E<'"O%04_7N?5IR-:_9[?+#=X%8)3I] M^*6POQ"N*HB(4-<"E$AN2QH!L7`/T;Y7-S]*DVKSA+DR5J[DA1X4R$`[L2KY M)IY*L[V>\^M1J!#Z@MW)W')ARH:?S4IF%K<@$:ZMVEH660.M[;7,X#!)$^&A M')0I-.WAF,.$@%RKL6B_*UM/=ZC#!`Y6X9P)&4\F4U^)U&&>/BD`N?+&&,R+ MT%M,CTV6/ZY=+<04=3=3;.C'?E'$:\Y-L$8BR)/+*+B.`_S(_1+^M)@_ MF[7[>$K':&3@2S%9J"1VI2M!6F'3:/BE?\+M]."![;'+.*F(T75,++3(G!,A)>GA3Z,I M))<_%I(C?JF]G8VP19)YEMK,.LF8XPRR2LFHO,:OM"5W(W_M4? MI_TSS&\O;J[E:2>0N22P!)(!^1S-ACC'DZ;/J)9#UOI$]<4%OTL- MHIL)BM-,@XG##Z@QGR0=,W[I'4P)=3%74Q5E7Y9@'SA;_P#&*;_B.87:/]U\ M0Y>B_O/@]E4;TSG*=ZLGCJ-L*H16X'?!:HGZQSCXUP6K$O,NKS1NFDV%)-1N M3N>T:TJ6/R&6QCU:IRZ!B_E8,)I%-$>:-)/4/2I`)I3PIE$]FN` M,C1Y/4ORYU_Z[HT)N'$CRLR@CJ0IV8CMEF"70M&IA4MF=V4Z-/)&R[*?@:G4 M4S)CN:<603%].L+A0[1@%?B#=ZC+N`-7$0MD26):Q/11VH",!%!E=I+JNI7" M6D[3R^A"BLS.GPM0>Y.4&6V[9"%D`VLEK=*'BE!5J]CV8'VQC+A0 M8\3'_+$=YI[3:7=3^K''(P@#"C*1N1_JL/B&7YCXN M+K3^[+RRG!:@[G\,Z#HZ-U"XZ@$=^V*N),8`7?WQ5MDYT:H6HW!QI+C(R-Q& MZB@H1OOBM.]'XS5J=Z=_EB%MRR.[\3T-13PQ132Q^G\88-Q&RC$!0;*NQ5V%78H;&&E=3%6\4*UGO=P#_BQ/^)#(9?I+/']09P%SG7?+ MP,5;`WQ557;KTQ0JVIJ5KT%3E3U(_VA*J_`2,U>N''*AS<[31/!LHWWGC3[F[N4]%V>!Y(U9/A MY*22#7YG+\>@E$"RTX];$V`.26:?YD\P6NH_7;4JDLFP:E*9ESTL)"BRC/)/ M8CTEDT>J:]?MZMS=L9"-V78[]0N0Q:;'`[!V<-.``*7#3P)>;(2S?:=R78_2 MQZ9(4.;$F,1=+M6 MN_+NBQ212R6^HWW$!?3=_3A)^UTIZK?\+F/*9)J/)UN;M,C>_!C'_3Y&$:OK MMWJ;+1?0A4%5"[,5(Z;?97Y9*&(#<[EYS6=ISRDB/IBE14`4`VRUU16<*X4- MB,>&*M\,5=P&-JV(Q@M"QT/!OED\?U!C,;%+:9T+HW4Q5V*78JRC\M/^4PMO M^,4O_$
T?[KXARM%_>?![/X9SI=ZJ!584[X$I?=Q<37!2H&6Z,$3R']@$_ M=AC&R`PG+A!+'_+.GVX<5"SQ[.@]V-#E,CPD2#E M8"#<2A;6XOQ<)I\X:>U53+$(5J.,A+&I/V2C'T\&:%\F8,8FRS3R7?S6-[!Q M'IEY0?3!K1`*4.0ACIQLV42.SW;2;N-@'\>F9D).#**=+>Q\?M9;;"D+>:BB MJ:'(2DR`>;>?_,+-;/8P-ZAE(6ZC0\FX#M[5S7:K.:H%W'9^FWXI,!B",[O$ MO".1N,"^$:_;;?\`F;!AAP!.JR<4_CA9SPS$@P/S?&2X]^2.'9__]#SU3,] MQV\5=BK>%78JW3%#>%78J["KJ8H;Q5O%785;IA5U,4*]D/\`3(/^,B?\2&5Y M?H+/']09P!G.!WQ7BF%7*-\55#]G%"^%N,;L>JJ3]^1F'.T?-ASSCC)`$_?E MV//Q'O@`<_CVI-HM6MK/RZD<R.CMH@.0(XMU)V!^DY>(4U'(52[C2PA]2X^`<>:!J+R^1.1E MFC$&N;C'/$\BPW6_.!0-%;+')(X(=.)9$K[G[3>^80C+)O+9T^L[1C`^CU28 ME/)+/*9IVYR'H.PS(C$`.@S9I9)<4SQ%38'OA:BMXUPVAW#%:=Q]L5=QQ5KC M@5P7%:6R+\#?+)X_J8S^DI3G1%T+L5:Q5O%63_EN:>;K?_C%+_Q','M'^Z^( MQK)51\\YSH[SJJI)BR4KH<(&MM0AU.,5X'C.!WC)_XURW'N*:\F MQM7FM?KUK&L3JLK,)+28]%G`V!(_9D'PG($="V`UN.:$E1YH!>V4!M7MV*7, M#'=)!]J-M_LMVR$)1L,M\@II]W"UU%,))`0)5;9X_P#)(_CAX3%P M0HD?\J#H,S0ZM$;=,*K*T:O7M3%43H%P8O-FDOT#2/`WN)4/\1F3I M)>HN'JH^D%YS^9$36GFZ_L`*"&9N(_R7^,?@V7<-6Q$N()UY?CX64?RS$F=W M+AR3GE0;Y73*U)FWKXX4%CGGFI\MW('7E'_Q,9F]G_WH<36G]V7F('%?CW!Z M#.A')T9=3DM$%-_B48I+1H@"NO)QN!BKG5GH4%5I$';"BUS%`1S7D13D??( ME+0CE,M=Z5KR[8BUVDE`I^)1OOX[Y$BQ MLGD=VV*QQJLJ(%HJ`+3]GQQD+Y(B0'/)"KJ)(^;J M0&;^S$UW)J^3C#<_6`XK2O(2=J8$*B8=ZMKZU?2%*UYU/WX\4;JEJ5N*ETC4!Q0V7*6LS#JJUH).(D!R:M$MUFM(8)2_\`O^1P[-7P"\?3 MRJ4Y9([>ETV76G'*YD'^AC87J&M7U\H1SQB!)"@DTK[FN2QX1%T>J[1GDV'I MC_-2Y5`.PW[G,AUUNIBAHK4XJ[B,5;X8J[CBK7$8JWQQ5HKBJR51Z;_ZN3Q_ M4&$_I*2@;9T9=`ZF*NIBK=,59)^7A`\UP'_BJ7_B.8/:/]U\0Y>A/[SX/7(Y M109S;O599*8LFY&Y#%4FU=*B(?Y8)S+T@W+A:T[!;I2_[CX_F_\`Q,YC3^HN M5C^D)7YB@#Q?$*H:AAX@Y*!1.*1^79!&9=-GJT?^ZB>I3V]T.3F.YA`]Z;7] MK-%(-2C7U;FW4"_B7;ZS;=I`!_NR+*I#C%'HY&*?`?(I/?1SZ?>Q:QILZIZD M?J1N@8[*?M?Y7^4C8X,E^F3E9L5BQR9]Y<\SC6;!;@E%N5VGCC<,*_S#>O%L MLEC(==*-\G^4V60CP MAP,N0SEQ%'LU%_CDV"GM2OM:6U?LW41_'?,G2_4XVJ^ MAC/YL*EQ^9$S)OZT4#D>]"#^K,K+LX^!-K"-D@50.@&:\N>-@BSTW.!5%V-< M4,<\[,3Y>N*=>4=/^#&9O9_]Z/BXFL_NR\U%.)$A/7;.A')TC9'P#T]Q7XCW MPI+FX\5,E>7:G6F*'2B9"4)Y"O'PKVQ7=;$9"2'KPH>=<1YJ:Z-C@$?TJ\Q0DGJ![4PBE][0_NF$Q M/&H"GO7VK@'FD^3GH(5]$D"OQ^-?HP'EL@<]W'@8T]8MS-:4ZT]\3RW4<]G3 M&0%!'41<1PX_QIC*^B84N7Z"SQ_4&;@YS8=\NPJV*C%2M<5H!BA7@ M"'DC[HXHWR.`MV*9CN.:I9"VBU"*XO2SB"GI2(JNPX_9JK_"EW<=;C MF/6$.+?R^;Z:\NT#O(S.8XT:)26]EV7^;;+!DRU3*&;3CD=T3^F-&A4)!:`A M1LYYDC[V%3D:R'FY4>UH1V!D?DH7/F0EUDMDD$ZT)=FH*CP49''IY#F7$R]J M@\HW_605SJVH7*A9&"(I+`(`I))W-0*Y='%$&^KK\FOR2VND&P!))W)[G??+ M7`E*RMH3\L+`M$>&*N"#%7<<5=QWQ5OCBKN.-JMXG%74.*NXXJLE4>D_^J?;P(=BKL59!Y"-/,\!_P"*Y/U9@]H_W7Q#EZ+^\^#U:)^F MWFB/VH9I$(^9J/UYCY=I M%OPFX!#:S"7@=:;TP0+.7)A=6CN%=326)MC[=QF15AI'-FFERK<1QT;C*N\# M^_=#_DG,XYN7I$\D MAU+RY>0WCWVG73VER"D?JJQ57+G=2%%,G@U>U2;]1I`=XMZ/Y+NKRY]?4Y%< M)(?B4!5J#6K4IOCGU>U!=/IJW++;.W$8*QDM'&Q6-VV+-W;*<./>SS:M5J.+ M8?2F,:A$"@_,^)/4Y>XC;G:G;%5@K]&*J\YN?T!<4_FC_P")C,WL_P#O0X>M_NR\[W=2&-`#]K.A')TCB>"` MH>IW;$I<0KHK.>)ZN)4%MEC9QR;B32J^],!4$N]67U M*?LU`XT[82H#E1%D)5N17=4_S\,:7B/)J.222J2&J$5;V]\?>I`')R!8XV>) MN;=/"@/7$1`222Y6]6(F4T"D%7I7?PQ&_-!H;;QP/(#))P M9J%DI7K[^^)`/-0:Y.:XG$_I]J\?2Z_#C9Z)X16ZWT;;U>/K;D_\`JG)8SZA[V,_I+'P- MLZA_O/@]/BE&V@WH:D9-#^R1V.5RB MR@65))'_LFZ:)#[0@)_#*,\K+E:>-!?4<0A/7$(*A(U` MV="`Z6Z<08P"M#R. MY[8%.[17U`&J%/3!5J"VSF,A`!0#J>^%7&+F0W("H!H>N`A0:=Z["2E!Q!I[ MX5K:W"$(W(L#QJ>(Z[8`%,FHY6E)C8`!@?LBE",-J8TY4]%#)4.?LT'3?K7` M``I)+A6XC8-1"I!#=!X8_4M<+53;QCC1F[]+ZI_RTO]^/Y3%_-7\UD[W?I;4CUN'^_'\IC[D?FU^ MD]0_W^_WX?RF/N7\SD[VOTC?_P"_VQ_*X^Y3J[Z_>_P"_F^_'\KC[D?F< MG>[](7O^_P!L?RN/N7\SD[V_TA??[_;#^5Q]R/S&3O=^D+[_`'^V/Y3'W+^8 MR=[OTA>_[^;[\?RF/N3^9R=[OK][_OYOOQ_*8^Y?S.3O=]?O?]_-]^/Y3'W+ M^9R=[OKUY_OYOOQ_*8^Y'YG)WN^O7O\`OYL?RF/N7\SD[W?7;S_?K8_E,?VD,4H!`=>M#UR,\<9BI"PRC,Q-CFCQYI\PCI?RCZH-1\7<81H\0_A"G59"*MJ;SAYIN)(Y9=3F>2+EZ;$BJ\OM4VPRTN,\ MXAC'43CR+F\X^:C]K4YC](_ID?R.'^:&?YO+WH.?6M6N#6:Z=S[G"-)B'*+' M\UD[UD6JZE`1Z=PZ$=P<3H\1_A"?S63O1:^:?,J[KJ,P_P!E@_(X?YH7\WD[ MUY\X^:2R_P"Y*:J@A37I7KC^1P_S0G\UD[W+YO\`-2?9U.<`;#XNV/Y'#_-" M_F\G>[_&GFH[?I.>G;?^S'\EA_FA'YO+_.=_C+S6!4ZG.?\`9?V8/R.'^:$_ MFLO\YH^9)EH=0E*]P3B-%A_FA'YK)WHG1O/?G#05D32-5GLUE8-*(F`Y$>-0< MLCIX#D&!RR/,H8^9?,9E>4:A+RE8O(Y;<6?YK(.1=_BWS"3 M3Z_-X?:P?DL/\T)_-9.]K_$OF,-5M0E*C?KC^2Q?S0C\UD[VO\3Z\]5-[("= MU-:X_E,7\T+^:R=ZA<:OJT\#QW5R\T34K&Q!!(.3AI\<#<1NQGFG(42@N/J* M0H`X]NV7=&J]W4$:<6'(G<#L,"\W,AE`*"@Z<<:2#6S;L$HI7DP&YPJ-W&&1 MWY#[)Z$]NV-*"[UD]3[`_EYGK7`BCS7-JGH1!9%# M,QV4]!\L;H;K5G9S1M.JL@`X_"5K0`^V)WY*#1W<[I&$1T$C(!R+=CUH,)(' M-:ODY[:2642)]EZ$5.X!_I@,;*@@!LW$7K`>F.O'G^UX5QL#:D<)(M9]3F]7 MKM7[517YX.`VGCV?_]7S]FS<6W8JZF-*WAI6Z8TKL46W3"K>*NQ5V*NIBK>* MMTQ5V*MC%6\*NQ5V%#>*VX8TKJ8TANF-*W3"KJ8JWBMNPTKL4.Q5U,5;IBK= M,5=]&*NIBKJ84-TQI78TKJ8TKJ8TKJ8TKJ8TKL:5U,:5U,:6W4QI;=3QQI#J M8JT=AC27=ML:5W;&E=OVQI7&G?K@5Q&^V*NVQ5U"#7MWQ5H4.PV.*M`4Z]/# M&DVX[@\<4-``#X@<"N920..XPI;/$4Y"I&-*TZL6!%=\"VW6/GT^([5]\5:" MNK$L*"NY/?%;#DX'D%%">F*N"$*2P/&G3WP4M@M4#1D(""#5E[XT5V=Q"H!( M#N31<5Z[.=&9%,:DKX>^.Z@T7.8Q0.I+@;_KQ46T\AK6G+M7$*+I:D4B2?)/+FUQX1<9@35JJHV-,>0W M7KLZ2-I(T,2DH!3CW##QQ(OD@$=6Y#$@5906D`^(KMAE0YIB">2V6&9Y><8J MK4*,.@&`@WLH(ZK^=M]8%5/*M`X/PUIUP;?%`NCW*7H77JUXMRK]OMAJ5IXH MT__6\_9LW%<,*MX%;IDE;IBAPQ5O%78J[%6QBKL5;IBKABK=,5=3"K>*NPH; MI@0[?"K8&%6Z8J[%6\5=BKL*'#%6\4NPH;Q5V!6\4-8JW3"K>*6L5;Q5V*NQ M5V*NQ5V*NQ078H=BKL5<<5=3;%(:IMBKJ;8JXBE*8I<:=\5:/44Q5PI7WP(M MPK7?Z<*NV%0.O;`K0K3XNF*NI\)*_3XXJT=U^(G#:MM4#X2:>V!6F*?M&A-* M@8JYN?+X3MVIBD.HG/Y=NU<%(:7F7H:^_P`L4FFU"[\#5^W]F%BTH)!YUXCJ M>]<%,C3C01UC)._Q>.*+[W44I60G_)/?&D]=G2`A5].O#Q'C@6//=SJGP^HQ M#TW`&*`6I#)SHE:;<:=*8D)!%-\8/6^T>502*;1("=Z\E+E M<^KU?GRK3>F&C?DNU/\`_]?B_P#@SS3_`-6Z3[U_KF^_)9OYI='_`"OI?]4C M]K?^#/-'_5NE^]?ZX_DLW\TH_EC2?ZI'[6_\&^:/^K=+]Z?UP_DLO\U/\KZ7 M_5(_:X>3O-%?^.=+]Z?UP?D\O\U'\KZ7_5!]K?\`@[S1_P!6Z3[U_KC^2S?S M2O\`*^E_U0?:[_!WF?\`ZMTGWK_7'\GE_FE?Y7TO^J#[7?X.\S_]6Z3[U_KC M^3R_S2O\KZ7_`%0?:[_!WF?_`*MTGWK_`%Q_)Y?YI7^5]+_JD?M;_P`'>9_^ MK?)]Z_UQ_)YOYI7^5]+_`*I'[6_\'>9_^K?)]Z_UQ_)9OYI7^5]+_JD?M=_@ M[S-_RP2?>O\`7#^2S?S2O\KZ7_5(_:W_`(/\S?\`+!)]Z_UQ_)9?YJ_ROI?] M4'VN_P`(>9A_TKY/O7^N'\GE[E_E?2_ZH/M=_A#S-_U;Y/O7^N/Y/+W+_*^E M_P!4C]KO$>9O^6!_O7^N/Y/+W(/:VE_U0?:W_@_S-_RP/\`>O\`7'\GE[E_ ME?2_ZI'[7?X0\R_\L#_>G]7N7^5]+_JD?M;_`,(>9O\`E@?[U_KA_)Y> MY?Y7TO\`JD?M=_A'S)_RP/\`>G]<'Y/+W)_E;2_ZI'[7#RCYE_Y8'^]?ZX?R M>7N8_P`K:7_5!]K?^$O,G_+`_P!Z_P!7N7^5M+_JD?M=_A+S)_RP/]Z_ MUQ_*9>Y?Y6TO^J1^UW^$O,G_`"P/]Z_UP_E,OO\`7!^4R]R_ROI?]4'VM_X1\Q_\ ML#_>O]/M=_A/S%_R MPO\`>G]/M=_A/S'_RPO\`>O\`7'\ID[E_E;2_SQ]KO$^ M8_\`EA?[U_KC^4R=R/Y6TO\`/'VN_P`)^8_^6!_O7^N/Y3)W(_E;2_SQ]K?^ M$_,?_+"_WI_7'\ID[E_E;2_SQ]KO\)^8_P#EA?[T_KC^4R=R_P`K:7^>/M=_ MA/S'_P`L+_>G]/M=_A M/S'_`,L+_>G]/M= M_A/S'_RPO]Z?UQ_*9.Y?Y6TO\\?:[_"?F/\`Y87^]/ZX_E,G/M:/E M/S'VL7^]/ZX_E,G/M;_PGYB_Y87^]/ZX_E,G8NOU%Z]:57^N/Y3+W+_`"MIOYX^UW^% M/,E:&Q>A[53^N/Y3+W(_E73?ZH/M=_A+S&!46+D_-?ZX/RF3N7^5]-_/'VM# MRIYD84:Q?[U_KA_*9>Y/\K:;^>/M;_PEYC`^&Q7N7^5M+_JD?MY3VMI1_&/MB_ROIA_&/M8>7+ZDX%:\*KU^_!^2R_S4#MC3`5QC[6AY6\T MLU'L)"C5#"J]_IP_E,O\U/\`*NEK^\'VN'D[S''5ULG9@*(*KU/TX_D<@Z(/ M:^F/\8^UR>4_-$H9);%P#N"2O4?3@&DS?S2D]JZ4%/W5D[.QW M<%=A])P_D\H_A7^5],?XPV/)_F>9*2V3JRF@8E=P?D4\XK_*VE!VR1^U MIO*7FF)52&RDIN68%.OTG'\IE&W"H[7TIYS'VN/DSS'-Q=K)T8#(&^I M/P^T4JM?&G7"-#E_FE?Y8TU5QQ^U9_ACSC6OU"6G\M5I3PZX_E,U_2C^5=)5 M>(/M?__0XJ6?^=O^"/\`7-ZX%#N6EG_F;_@C@30[EI9_YF_X(_UR)10[EI9_ MYF_X(_UR-IX1W!:6?^9O^"/]<;*:'<&B[T^VW_!-_7!:T.X+2\G\[?\`!'^N M"UX1W+>]:'<&N3_P`S?\$W]<;6AW!HL_\`.W_!-_7%:'<&BS_SM_P3 M?UP6M#N#7)_YV_X)OZXVM#N#7-_YF_X)OZX$T.X-%W_G;_@F_K@7A'<'$=P=R?^=_^";^N$E'".X-%W_G;_@F_K@6AW!KF_P#. MW_!-_7%-#N#?-_YV_P"";^N*T.X-(5PQ06QBK>%#8Q2WBK8PJN&*MC"AO"K>%5PQ06\*%PPJV,*%P MR2KAA5=A0__2XH(5PQ06QBK>%#8Q2WBK8PJN&*MC"AO"K>%5PQ06\*% MPPJV,*%PR2KAA5=A0__3XHV\US9V-Q=6]M_O1-#$[I'0V_TXJG'F3R?YD\M/8IKE MBUDVI6ZW=D&96YPMW^$M0[_$K?$N1$@61%)-DD.Q5V*JD$$UQ/%;P(9)YW6* M*-:59W8*H%?\HX%#./._Y27OD_3&GU'7=*FU:`P_7-!MYF>\A$]>)*D#DHI\ M5,C')?1D8L#R;%V*NQ5.)O*'F2'RK!YKELF7R_17 MAR^'!8NDUM:3_A[X4.Z=NO2F_P#7%7=O;%78J[%78J[%78J[%4;HFBZGK>KV MND:7`;K4;Y_2M;=2`6:A/5B``%!+'`2`+2`MU?2M1T?5+K2]2A:VO[*1H;J! MJ,4=#1A5:CZ1B$%"85;&*'8J[%4X;RAYB7RJOFMK)AY?:X^J"_Y+Q];I0K7F M%K\/+CQY8+%TR`V2?"AL8H;PJ[%0R70/(>JZWY3\P^9K:X@CLO+:QM>12%A( MXEZ>E164]/VV7(F6X"0$'=^4?,5GY:L/,US9-%H>I2-#97A92'=*_LUYK7BW M'DJ\N.(D#LM)1DD.Q5L8E5\<;R2QQ1J7ED81QH!NS,>(`'B2<*IGYE\K:]Y8 MU5M*UVT-G?K&DQA+*_P2"JL&0LOXX`0>2R"5C"AO"AL8I;Q5L857#%6QA0WA M5O"JX8H+>%"X85;&%"X9)5PPJNPH?__4XHZB$T.2)-3TW5%3EQD-.:. MM.WQ?\%D1,\5%/"*L*EG^6OD?0/+>D:KY]N]4-]K\1N+/3-'A]0V]L=EFG7`8)9#>RB`3&W_(?2/^5@77E6?4YY(;W1VU;RO>*!&9B/]US*1^S1^G[* MX/%/#:>`722>0_R?7S)^7?F#S'9-2'FCU6M8]4DA3]'27BU4P@#?CS''E7(\BZ3^7GF#6+N^%GYE9WU M)80CM&\;#TA$I`^!GHK\OV9;XP27T7FU;>S].T6)% MT_TBHJ2PHW+TJD_Y61Q$K,!(?/\`^6VIR>:/)&@:;J5YJE]Y@TRW>!]1E,HM MPP!*J?V(8UY-QPQG0)4Q1P_+G\E#YE_P,/,NI_XG]7ZH-6]*/]'_`%RE!#3K M3U/AY5^UAXY5:$M+?)?Y/6=WYB\W:7YNO+BQC\H0F>]%BJL\RKW3GT5H^,B M?ZV&4^5+&*I=^0/RT\Q>1M;\R^1+[4XKKRZD+AE,T"$"/>Q7SNGY>"^M M7\C37\U@$-T-34+*DP8TX\:55EH>76,2&&6*: M&43"Z!^RT?#]U3]K(RF3%8@`O-?-FA?E]J?Y@V>C>5;S4!+J>K26FKO>Q(JP MO+<&RI`M'?F7Y/_*+RJ=0\OZ?J6KS^;].EBCD>>-/J M;AF0R?9Z<8G+C_*^'!"4B%(`33RS^6GY1>QC>->/9F27C_L?Y MLD)62"@QV9*GY7Z5H_FK\O-$.I7MKYE\P*EWJLD#JILUD0M$("OQ)+\)KR_9 MP>)8*1%G'Y::!Y'L=9_,_3]2N]0OM3L4O8=1N)U29C91R$"=)&W:Z)Y\LA,R MH4F(#SORG^7WY<^.TN;K^7]?FDL-.\NQ7<^MW45`\:6Q*K3D#]L_%_JI@E/;9EP[JU[Y8A/Y))YDM M-2OA;2:ZUK;:1--_H@4FB2M&-O6XD>;ORQ_+'R9I]M8>8K[6 M1KUY9"[AU6"%3I@F="4AZ&O)_AKRR(G(E>$!BT?D/36_)N3SR9YAJ2:L--%M M5?0],A/BI3ER^,]\GQ>JF-;6MUSR-ING_E-Y>\Y033/J.L74UO/`Q7T56/E0 MJ*3ORZ_)[SC=?X>T+5M:;7GADD@U66W5;!Y(HR[(%H:` M4/VF^+(RG*+(1"_\MH);?\EOS:MI:>K;^A%(!]GG&S(U#XSMORF\F:_?:KJ#V&HZC+#=::).<%O$';U7MHCL)>*&F2$O4:1T#*O+'Y9?D MAYCT?5M9L]5UZUTG1HR]WJ%['%#!RI41HU#SD_R!_P`;9`SD#3(1#S[R;:_E M;)%/+YLNM6DN#.T=EIVE1*SFW`!$\CD-3_4I^SEDS+HQB`]'T/\`+?R=Y1_. M?RQ;7E]=WFE:O%;W_EP^DO-IWD`$5VK#:*E36G\N0,R8ED(@%C?YV6?Y?IYY MU"/0Y[\:\^J^GJL$L:1VL08J#]6*[_"35H:I^H7'EOR?K MVI#S+$DK6,U_&@LKUX:DK&10H#3X?\GXL>.0W/)1$'8)9Y`_+GRUJ/EWS/YA M\VW=]9VGE>5(;JSL41I69J*0"W<.>.&60@BD"/>J>9_(/D:Y_+Z;SSY'OKYK M*QNDL]1TW4E7U49Z#DCK2M"RX8Y"#14QVMYKWRU@V,*KABK8PH;PJWA5<,4% MO"A<,*MC"A<,DJX85784/__5XH2=/T?4/-^DVVM7<-AH[7"/J%U.P2,0QGFRDGO)3@,C,D1*8C M=Z=YX_YR#-UYHO?T?Y>T/4M,M)#;Z9>WML\TK01;*W/FH"%OB6@RJ.';=F9[ MI5^=/F;R]YTT7RSYPMKJV3S+)`;+7])B;]ZA0DH_IDDA`W/B?Y9%PXXD&NB) MFT'^6'F'1--_+_\`,6PO[V&VO-3L8HM/@E8*T[@/58P?M$/VBB]6XXS!,@5@=F=Q?F$_F_RKH2Z+Y^ M3R7Y@TJU6RU'3+YS#;7`B`59HY:%>5!V_P!DJY#AX3N+9`V.;"9_.UYH?YK^ M7=9N?-A\VC2S"MWJJ@K$L:9N4A!'<(J,&K+&9[DN_*1[R&]O MKK2O.UOY.UI/36V6^^&UNXR2761C^[_=D+Q5E;#/W+%G7F_\T?*^D?FEY0\R M6%1_E8RAR";YH/R]=^5O.'Y, MZ?Y%NO,%GY=UW1M1DO(6U+DEO<1RF0[2[!?[X@_M?#DI6)6QYAK\VM6\N6OE M#\OO+^FZU::Y=^6V.1C"P67$L7RQ^5*>?1YY7SW8GRVMZ-6&E\7_ M`$EZH;UA;^G]K^\H.?'_`)JP\4JI`YVN\M_F9H>J^8/S3U[4KF+3/\0Z:T6E MVT[JKR<$].*,=FDX*I8#^;$P($5!8S^5?F#1=+_+7\PM/U"^AM;[4[&".PMY M7"O,Z@@B,'[1%7(KW]*PZ4JR'4C*']9;8Q?:IZGP\Z?\U8+/#PT MNW-WDO\`,O0]1\U_F?Y@U:YBTL>8=+FCTVWG<*SMQ,<<2]FDX!>0_FQE'DHE MN7AT8(C4'J`!^&7,'I>LZ_HLW_..NE:!%>Q/K4.L2W$NGAP9EB/.CE.O`URL M#UVRO9$?GYYCT+7;CRD='OH;X66A0VUV86#^E,IW1Z=&&#&#NLCR9OK?YE>3 M+?\`YR$\L>94U**YT.UTN.SN[Z`^I'%(Z3I\?$$_!ZB\_P"7!PGA97NP75=% M\N>7/S.T?6(?-.G:Q:W.NB]F-DY86ML9Q,'G?[`:C4XC^7)`DQJF/(H7S_KO ME:^_/&]UJ9DU3RS)J<$URT!YI/;(L8D"D?:'PL*88WPJ2+>XZ3^8&F6_G2[U MD^?M$'Y>O:/#INA1,MO<0N8P$#0>FK_#1OBY_P"QRCAV&V[+B>2^2/,'E'7_ M`,N-5_+OS'JRZ#-^D3JFA:M*I:W+EC^[E(IQ^T_VF7[?^3EIB0;1?1+M+T'R M'Y+\]>6[C6]>T_S/IPN'?58=/5I[>V11^Y9V^+UOB;DR*O[/[6$DR!V1M?-Z MVGGJ*VMO.MQK'G[1=3T'5=.NH/+6EV\@5?]CSR>6-&PQB0E M]IY_L]9_YR#L_-VHW"VFDIJ8$4\IXI%9PQO'$6K]D$4/^SR7"1&D7NR;R?YP M\H?\K5_,B*]U>"ST[S5'>6NFZLQK;$;,@1;S[2KJ MW_+/\P]$U#3M:M==33FC>_NM/Y&#TW)CGA#'[?[OXB?YLF=Q3#D7HW_.0CZ) MY5\OVGD[0'_.@_87]G_`(PID,8LLI[!X58W]WIU_;:A M9OPN[*5+BW;_`"XB&'ZJ9<1LUW1>]_F;^8'D3_!NLZGY8OHI?,GGX6::S:Q$ M>I:PP0CUE:FZF1ZJU?\`?CY3&)O?HV2(85<>8-#/_..L/E_Z[$=9&NFY;30P M]80[?'P._')T>-;V>C^2_,ND:%H\T7F7\P=,\T>0FL6CCT*=/4U'U&0`0K&U M9%X_%&/BX_ZF5R%\AND&NK"O)6I^4_,'Y2:C^7]]K=OY=U,:J-2TZXU"OU:5 M/A_=F0;*5X<6^+^7[63D")6Q'*D3YZN_*&D?EKY+\J'6['S#-H^JFXU>+37, MBM;LQ9P&VZJW'&()E=)/*GIND^?]%A\[6VLZ?YYT.S_+B*V]*+R\I6VN8W,! M55:$IS8B7XBW/_)XY48[0?+$NKV]K>1:K)^E*LK/:02NX,TB'HJJ M_+!&Q(H_A#+O/VF^1]8T32_*GEKS_H>C>3]*C5A9.[O+<7/5I[AU*K(U?B5? MY_\`A80)!LC=E*J2G\OM=TFV_+>;0_+/F33/*_GA;^0WFJ:BH1;NV#-Z9AN' M60(G'@0N2E$F6Z(D4BOS%_,#RX?S2_+[6_TO#J\.AP6XUJ]LCZJB5)09"*`5 MK0O0#!&)X3LB1W8M^;FD>6QYNNO->F^:=.U:+6-3ANH+"U8M-%"Q4N\Q^S&$ MXY/&354LJYLSU?\`-;RKIGY]3ZXETFH>6]2TN+2[Z[M2)/35XUY,*=?3D1>8 M'[.0&,F-))'$E7DW0_RV_+WS(/.,_G2RUNRTU)GT32K`,;V=W7BBS+OZ9530 MU^U]K_)PSE*7IJD"@;2ORWYPTF7\L/S+AU"[AM]8U^ZBN;.Q+`/*6D1V$8_: MXY*4384'9"Z'Y@T6'\@_,VARWL*:Q=:G!-:V!8":2-3'5E7J0.)R4P>,%`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`WPA6QA5=A0__T>.&[\J_ MSW__``,6;_CP_P!/['25J^[#\YN^M>5/]^7_`/P$6/'A_I_8M:ONP_.;7UGR MI_OR_P#^!BP<6'^G]BUJ^[#\YN];RI_OR_\`^!BQO#WS^Q'^%]V'YS:]3RH? M]VW_`/P,6#]SWS^Q-ZONP_.;N?E7_?M__P`!%C^Y[Y_8MZONP_.;7+RH?]W7 M_P#P$6-8>^?V)O5]V'YS=_SJG^_K_P#X"'&L'?/[$7J^[#\YN_YU3_?U_P#\ M!#_7!PX?Z?V+Q:ONP_.;5/*G^_K_`/X"''AP_P!/[%XM7W8?G-KAY4/^[K__ M`("''AP?T_L7BU?=A^GY4_P!_W_\`P$./#@_I_8MZONP_.;O2\J'_`'?? M_P#`18\.#^G]BWJ^[#\YN]'RI_O^_P#^`AP<.#^G]B\6L[L/SFUZ'E3_`'_? M_P#`0X^'@[YIXM7W8?G-WU;RI_O^_P#^`AQ\/!WS7CUG\W#\YN^K>5/]_P!_ M_P`!#A\/#WY/]BOB:S^;A^#OG]B^)K/YN'YS=]5\J M?[_O_P#@(^?V+QZS^;A^%@[\G^Q7Q-7_ M`#%@[\ MG^Q7Q-7_`#^?^Q1QZO^;A^^?V+XNL_FX?G-WZ.\J_\M%__`,!# MCX.'OG]B^+K/YN'YS;_1OE7_`):;_P#X"''P+J^[#\YN_1OE7_EIO M_P#@(^?V+XNK[L/ MSF[]&^5?^6F__P"`AQ\'#WS^Q?%U?=A^^?V(\76?S^?V+XNL_FX?G-WZ/\`*O\`RTW_`/P$6/A8.^?V M(\75]V'YS;^H^5!_Q\7_`/P$.'PL/?D_V*^)K/YN'YS=]1\J4K]8O_\`@( M5""3/?BG7]W%A\+#WS^Q'B:ONP_.;OJWE2G+U[\^/P0X^%@[Y_8O'K.[#\YN M]#RIQJ9[\5Z#A%CX>#OG]B\>L[L/SFV8?*H`/KWY!Z'A%CP8.^?V+QZO^;A^ MW"+'P\'?/[$>)J_YN'YSF'YS7>EY4#\/K%]7_4BZX\&#OG]B./5_P`W#\YM*GE4N5]:_!WK\$/;Z,]^>.].$6^'AP=\_L4SU@_AP_.;D'E4AF]6_`4`U MX1=^V(CA_I_8@RU8Z8?G-W_.J<.0FORH-#\$6WOC6'^G]B;U?=A^4U\&85IPBZ8?W/?/[%O6=!A^KKEA^*'8JZN*MUQ5U?#%7;8J[%78JXXJUMXXJZN*N&*NKMBK5:#%6^N*N)I MBKCBKBW;%6J4-:X$AW(DT/3%7"@W&YQ5KD6!#=/'%75*@TW]\4NV8>!Q0YF* M;+TQ5S"M#6AQ5S.0:#M_'%7<5YUK[TP*Y9"Q*GH=C@M.S2@+5J\B.F'9:)<' MY@J3[UQ""*=7TT)!Y$]_#$%-6T3S2I/$CH3TQ0!NXN8T4(=CO7`D!M@KT8L$ M+#H<:0-G&9T8*O04H*=<>*DQC;O10S?;'CP/6N-J#0:6=Y'XL/A:HXTZ?3CQ M(X=FD58ZNK!RHV`'XXQVY*27+(TRNDAH!1@U*`'WP7;(CA<&]&-F1@Q8@M,: M'-D"0M^NS^I7;K]F@K\L>/>F-;6__]/S[7-BXSM\*MXJ[%78H;PJ[%6P<5;K MA0ZN*NQ5O"KL5;Q5V*NKBJZN*NKBKJXJWA5V*'8K3L4-UPJ[`K=<*N!Q5NN% M75Q5V*MXJ[%#L5=BKL5=BKL5=BK@<5=7%75PJZN!75Q5V*NKBKABK?7%6L5= MBKJXJ[%78JUU/MBKN0.U,5<-M\5=6M1BKC\*D]<"::/Q"M*'%75*[=<"',O+ MX@>O;%+F:AI3884.X4-3OWQ5RN&:E-CM@27*O`\C3X>PQ075]12M`/"FV*TM M_NTZ`D]!U&*>;9K*HIL5[=L"C9W(1*$IR[FN$K5N:,R%7%`"-ZG%=@VTO!N/ M$,%H*GKC:@6T(#ZG*HXDU]\:1R#2RB1B.(4/4!AUKCQ)X:%N2(Q$R,0>/8'K M7QP`%;!*@@#B:DB,X61*!6'V2:4(VVQE&UB:=)<")^/ M!6]/8L>II@XJ41O=LVC&7D&'"O+K\5.N)C9M/%6S7UM?4KZ2\:UK^U3'CW8\ M#__4\^9L7&+L5;Q5V*MX5=BKJX4-@XJV,5=BKL*MC%#>%78J[%6Z[8%=7"KN M0Q5NHQ5NHQ5U<5=48JZHPH=48H=48JW4#%7V*M!EK@5P/CTQ5U00:=<*NJ%&_?MBKCN-MO;%7$A0* M[G`K3;]!MBD-ED!Z?KQ0&J-RKVQ5L,M2%6E=JXI:0<22>@ZU[XH+@58$1BAZ MXJ74*H>:U!Z+@M6BO-!P6@'VE^>%7-10JNM3OMTI@6G,C/1D%5(Z>&-*#3F> M-6`9:L*`MBH=Z4GJ7H;5^U7\:8;%HHT__]7SWFP< M=U<5;KBK8PH=7%6\5=A5PQ5O%%.PJW7%75PJV,5;Q0["JC=.R6\C*:,JD@Y" M9J)I,>:1?I2]_P!^?@,PO&DW\`=^E+W_`'Y^`Q\:2\`=^E+[_?GX#^F/C27@ M#?Z5OO\`?GX#'QI+P!WZ5OO]^_@,?&DO`&OTK??[]/W#'QI)X`[]*W_^_3]P MP^/)'`'?I6__`-^G[A_3'QY+P!O]*W_^_3]P_ICX\EX`[]*W_P#OW\!_3'QY M+P!WZ6O_`/?GX#^F/CR7@#OTM?\`^_?P&#QY+P!WZ6O_`/?GX#'QY+P!WZ6O M_P#?GX#^F/C27@#OTM?_`._?P&/CR7@#OTO?_P"_?P&/CR7@#OTO?_[]_`8^ M/)>`._2^H?[]_`?TP^/)>`._2^H?[]_`?TQ\>2\`;_2^H?[]_`?TQ\>2\`:_ M2^H?[]/W#!XTEX`JV^J7[SQJTI*LP!%!_3)1S2M3`,DKFP<9K`AV*NQ5":G- M+#:/)&>+BE#E>:1$;#/'&RD9U?4/]_'[A_3,+QY-_`&OTOJ'^_3]PQ\:2\`; M_2VH'_=OX#'QY+P!WZ6U#_?OX##X\EX`[]*W_P#OW\!CX\EX`[]+:A_OW\!_ M3!XTEX`[]+:A_OW\!CX\EX`[]*ZA_OW\!CX\EX`[]*:A_OW\!A\>2\`=^E=0 MK_>_@,'CR7@#OTI?_P"_?P'],?'DO`'?I34/]^_@/Z8^-)?##OTK?_[]/W#' MQI+X8=^E;_\`W[^`Q\:2^&&OTK?T_O?P&/C27@#?Z4OSUE_`?TQ\:2\`=^E+ M_P#W[^`Q\:2\`:.J7Q-?4K]`P^/)>`._2M_3^]_`8/'DO`&OTK?#I)^`Q\>2 M>`-C5K_?]Z=_8?TQ\>2.`(C3]1O);I(VDJK=10>'MD\>61-(G`4GJTX?%6AZ M>.9KC4T:%1Z=:5-?'`FFSQX+ZE:]J=:>^*6I.7P\*E>U,44&SZ7)>?7;EX8A M::XR>KMTKOX4PE(;'H\SPKSW"D],&R#;48?D3)7TZ'G7%330X%&]*O.F]>M/ M:F-]RD=[:@>D3,#QK\/CC[UON:85B'H5I6C?S5[?1B>6RUONX^F(U]>I;>E. MM/?$U6ZB^CIED)7TJF.GP4_C@E?1((/-M_JX<";EZFW+C]FM,)(ZH%]&B+CZ MQM7KL=^-,!OX+M7FU_H7JUHWVNO;K^K'K2W+X/\`_];SU7,]QV\5=C:MX50^DLH4Y_I9X M^;&SFO:KJRGO-7:PM_+S>83ID=O%^F$(E$0M7AJT1E:O-:'_@<5:M/^<>- M(;S#YBLI+[5+FUT>QT_4;>UL;-)=2==0)_<26[.JI/"!61>>*L;/Y:^3[+2X M-:UC4=3M=+GUR]T4QBUB^N1BWC#1-)"SA5D9CQE3U/W?^5BK)#^1/DE_S$U# MR79ZSJMU=Z+9SWFJ&.TA+L8T1XX[51)^]=Q)T;ABJ`T[\@HM MJ:58:J/0D%M-"UTC-+`00R_"P&[+RQ5)_*WD?3O,6C>;-7CN9;:'0!:26L)5 M6,B7EV+>DAKL8U;EMBJ=P?E!92?G!J_D(ZC(+;38KJ5+W@ID;ZM:FX4%:\1R M(XG%6/:7Y'MK[\N;[S8UTZ3VFK6NF+:A04*W,;.9"W6J\>F*O0(/^<:!IQ$V_P[)Q^'%6[;_G'*(C\OTN]4EAE\X&5;Y! M&A-HZVQN8U&^[,G'ERQ5`Z9_SC]+J?E+ROYCLM0::/5KX6NKVJJIDM;=[PVB MW*+6KQJP_>;?"S8J[R?^0MIKVK^:;.YU@V$&D:A+HVB3.JUO=0#2>E":GBO) M8JMQ^SRQ5!:!^7/Y;W7DK4]?U?6=7L[K09(;;6[.*S@<+<7#M&JPEI5YHK+\ M9?T\51GFW\EM%T/R_HM]'/K$\^KQ:;.MV;.,:8@U$KRC-T'KZJ*=E]/%6_/W MY.>3=-M/-(\K:U>W6J>3'B&MV.H01HKQ2N(_5MY8CN%=A577EBKQPBF*M8JB M]+)%]$1XG]1RS%]08SY,D!Y1@OVZ'-@XKJE4!0UJ=SC:7&C*I<\6Z5\<;0YV M=*!"0*;4[XVFFRJ,PYM0M2JX%=ZDOJ4WI6G'M3#:.%I5C#GBU6%2J_+%)MT; MN_)7-4(^+V]\`)6A3E"JC-$Q+4I6G0>V/+DIWYN#&2(F5B*'X6/6N-WS4@#D MXL8X@8F)JV[#8[=L'39>9W:<*\:-*Q5MP#2I(PD;;J+')TLDL958R5CI52O? MYXF^B(@'FVRQ/(ID?@S4++2HK\\2`3NH)Z.,US]8X"M*T$==J8RD0?)(B*6^ ME:^K3U32M*4_"N.UIWKEL__7\]9GN.ZN*NK@5OIWPJW7"KJXJW7%#>%#L4NP MJ[&T.KBM-C"KL4-XJH7I_P!%E'^0J^;FECCTG1]1O)K"*:`H3(;>6(?%=\OLJ_PXJR?\MOR!LM:_+Z M^N=5TF\;S#JTE_%H=RG,Q69T]6'[\JP7]_.KP)R#?$N*JOE#\L/(E_\`E7IT M]]I,,GF"_P!/U:X$JW4R:H]U8N1$EK:\O2F1>/[[D%XXJEGFOR/Y!TSRAY36 MWTRP&J:U8Z/=7-U)J6C6LNFZIH"RRCZWJ[E192JX)=8I4=I90I^%H\53;SM^1&FZ1^4"ZE; MZ;=0^:-'M[34=8U!^?U:>*\YC1>OIFF M:-,=313!O\I.:8JQSS9^5ODGR[^7;^;DT\W\L^AZ.L M%BDTI^KWU_$TDU]<4:JQF@6&/^[9L57^8_R&L-._)@:E'IEVGFS3K*VUC4K] M^?U:2"Y=Q):IN4]2UB].66@^SBJ"U3\L_)T&L^:K:.R*PZ9Y,AUJR'J2?#>M M%$QEW/Q`L[?"?AQ5,O-GY??EUIUUY/TFVTK3UFU:?0_KLHU.9M19+TJ;@&P( MXK$_*GJJ_P`.*J?YS>5/*7D*&SU6R\O66G:G-J5]96>F>NVHVMUID2%!=2B4 MR>C<)*R*8P_PMBKQ/S-KT>MZF;Z/3;32E**GU2Q0QP`K^T%)8\F_:WQ5*<5: MQ5V*JUK_`+TQ?ZP_7DH8DLUOS;)-&UHTC1!UGB:)OC4,R[/X8JS.?_G(3 M6(KB1M&TQ-)@BT>;1-,"7$TMQ;)/.L[3_67_`'DD@=/AY<57%5T/Y^LVI:WJ M%_Y;MKM_,EK:6^N1KG)$\AX\U1^/PXJQ?7OS&_26@1:#:Z M7%I^G0:O-K-M&DTLQ0S(J>CRE+.ZKQY>HS<_BQ5.K7\\+V+\QM=\Z3Z1#<-K M]J]G=Z;ZTL<8CDC2-N,J4D&T?;CBJ$N/S/7X[6.65V*M']3N!<`K3KS*\3BK-9_S MYLW\\1^*SQW#%YOC!^-&Y+BJ-G_YR&UXZM>ZE:Z;!:SW MVM6>M3!97(/U*(1);'85C:G)CBJI%_SD5KJZO'JDNEV\LMOK;3;>*/_#:74#QEF*7D%[/Z\DY\N0KJVE6]C:V^K+=W5>&GE>-;?D+:K\34F/]O%57SM^=T>O66NPZ M1Y;M]"NO-$DAKBKF^ M*N:/DW*H6N]#UQ5WKMZE/>G'OBM-"+@Y/('C4T[[8JY)7DJC=''84H1XX`5, M0&P&A5G#`]@1N!\\(%*3;0)FC/)@I0U#'IOCSYJ=N3F9H(_@(;F:ENHV&`;! M>9WJG&O2N_R^>2K?FPO;D__0 M\\YFM#>*NPH=A5NN!785;&%6\5=7%78H;PJ[%75Q5U<5;&%5"]_WFE_U#D,G MTEE'FQO,!O=BKL5=BK*?)_YE>:_*$-U%H16:*0 M`_:3%55OS7_,`WVE7JZQ/'/HRJE@$/%%"L7JZ#X9&=B6D9PW/]K%4RB_//\` M,6'1Y-*@O((8)&N&$R6T(GC^N,6G$4W'G$)"QKP*XJA;C\X?/=QH-MH4]W#) M86<4%O:EK:`S1QVI!A59BGJCAQ_GQ5!:O^9?G#6-/U33]2O!<6FKWOZ2O(FC M2GUNE#+'0?NBPV;A]K%4!IOF_7=.T>31[6<+ITMW#?R0,BL&GMJ^FQ)%=J_9 MQ5-9/S9_,"75-5U*;5Y99]:AFM]1CDHT+Q3KQ=1"?W:;#X>*_#BKE_-CSXNK MZCJRZFRWNK6:Z=J#!5"RVR1B)49*6*MW M?YV?F%=V-E9W%["Z:>UJ]I+]6MQ,ALF5X/WP3U*(R+MRQ5*-8_,+S7K&DW&D MZE=BYLKF_EU5D=$JEW.297C:G*,2%B61?@Q5C>*NQ5V*NQ56M?\`>F+_`%Q^ MO)1YH/)E8Z9LW$=@2ZN*NKBJ"U@_Z#)]'Z\JS_2SQ\V.',!R&L5=BK*ORK@A MN/S)\L0S1K-%)J=JKQ.`58&4`J0=M\5?3VIZ?H]_Y\\BO/'9:XDWF+5('U2" MRBMX8H8H9%739T`_>2Q,O(-(OQ7M,N+`2:9K;0V5PFJZ M#:Z_EMK+:XWFBXO[O2]%N%\R66DV]R^F MVSQ/;AY5%IZ84(K3J.'JMBJ$_+SRMY;TG7_-_F?6=,T[2K#4=;;1]-TO6Y(K M=8;1)N5\T(<,'E2-E6%4_:_:XXJEEEY0\R^0_+VO0>2-#AUGS59^8GL[]Y+9 M+^>/2FB62S9(G#4CN`_[V11_Q'EBJ6:'YV\RZ=^6/G&XO=*TNWUCR[?6EI;) M)IUJ[0_69)/71B5;GT_:+<<59;H>D7_U[RQY?T_RY977Y4:CHL5SK.L/;1MR M9X&>ZN);PCG%<12_8BY?L\>&*K]'L=(;\H["TB%MJ,7^&-0NE\NBSC-[=LMR M\<-]'<$!U:W'%G1/C_R<58A^1-C^F/(&I:%8V4FG:O=7%TW^(9=-COK&>&.U M!:SN9G5C:\/[Q6!3DS+\6*J4.O\`EM?RB3SR=(AE\W11KY1KZ<7U9Z4CZE/M?O,53?\U;_4-)TCR]YST2S32K.UOCIT/EO5](MX9;:26THXC+ M)2\MBO)O4;GQE;DK8JR&.^2^_/[5/+TFFV0TW1=&N+G3H+;3K>1Q-)9Q.6$8 M4?67#L?3C?\`:^'%4#Y*TW1IM>\[7GG"P=H-1&DZ%:RW^EQ:7-&VHJT7JBT7 MDD++RC;FA^S\>*L<_.?RGH.D?E!INCZ?;PG5_)VHPZ?KM]&B=59``.A6M!B03R4;%SR^G2,J'*CXF;?[L)E M2`+<\$DLG->CT(-:$?1@JTW07?65$].(H#QYT^+PP\?1B('FI_4Y>?:E?M=_ M'I@X3:>(4__1\\9FM#>*NQ5O"KL4.KA5U<5;&*MUQ5PPJV,4.KBK>%78J[%5 M&\_WEE_U6'X9&?),>;':"N8#D-4Q5U!BKJ#%7;8JZ@Q5V*NIBKJ8JZ@Q5U-L M5=3%74Q5V*NIBKJ8JZF*NIBKJ8JZF%74&!56VI]8B_UA^O)0YH/)E(.;-Q&Z MXI=7%78J@=7_`-XG^C]>4YOI98^;'C3,!R785=3%5\,TL,J30NTL0U]*^N(^4IG/&5Q64@@R;'[="?B^UBK<^N:S/2A/4CD3UIA5$6WF;S':7;7EKJEW!=N@C>XBGD20H-@I=2 M&XC^7`J#^O7GIS1&>0QW#!YTYMQD85(9Q7XB*]\*J\>NZU%IKZ7'?W":;*>4 MEDLKB!CXM&#P/W8%6PZQJL+0M#>3QM;H8X"LCJ41MRJ4/PJ:_9&*MVVMZQ:V M=Q96U]<06=W_`+U6T4KI'+_QD0$*_P#LL*J'UNY^K?5?6?ZMR]3T.1]/G2G+ MC7CRI^U@57O]:U?4!"NH7UQ>"W7A;B>5Y!&O\J(_U<5:36=72\-\E[.EZ MPXMI^)A_,<"H;%78J[%45IE/KL=?$_JRS%]3&7)D M-:I0#WIF=;CTV#1?C%?Y1BK3*64$"H&U,"N+*M`PY$=2<*',KLU5!(VH1[8I MIOG'ZFXJ:_:]\"M(KJ_)ME`/(^V&EL.1E)943BS#8^.(4M*K(K&040T'$]S@ M"DAO^\C*Q*5-02!O48GR6N]U`D0$JUJ:JI/;!RYK5\G.K21H8P>`ZJ-Z'";( MV6-#FZ1T0*LJ*N.*'8J MZN%6ZXJW7%6\*N!Q5U<4-XJJVD<A!ZURO-]!;M.+R#WIGK^ MGZ5;QQ<+>(N-B47J#FKT6??U.U[0TPJXK;&STIN+-:Q%3UJO?-_&$3O3H"9` MT4T&CZ2*4LH=^AX]C+Q*2RYTPVLP5U#1OO$].HS"S8S`N7B(D$;96EFK5D$9W!H17 M]>8\B[738X`V:3R*#0S)ZTPM1MU8`T_V(IOE),G0F"UC@B[*-S])R^((=)GR0F?3'A"7S M6R$$A`,F'"E!2AC0DAD%1[86("*2&$;F-3]&`ML:'14]*T;K&%^0R-MH$3T5 M4@A7I'&X\"*'`VQC70)QHVM1Z=*";*V=0=UF@253]^1D#TI*1B(6(GZ?^)D\Y'0?*M?GF\+Q`;P)=BKL516EPPS7\4*'M^P,TO&>]VO!'N7?H32/^6*'_@!C MQ'O7@CW._0NCT_WBA_X`8\1[UX(]S1T32!_QY0_\`,>,]Z\`[E1-&TQ@K M_J##QGO7@CW*XT+13_QX0?\``#'C/>O`.Y:VAZ/_`,L$%._P#;'C/>C@',]Z\`[E";1M'4;64(_V./&>]>`=R#?3=)'_`!Z0D>/'#Q'O M3PQ[FAIND'[-I"?]CCQ'O7ACW-_HG2_^6.+_`('!QGO1P#N4SI6F#_CTB_X' M#Q'O7@'.&O\`JC!QGO3P#N4I=%TL M'_>.(?[''C/>O`.Y0?2]+'_'I%_P./&>]'`.Y472]+*`BTA_X''C/>G@',]Z\`[ MD-J&GZ?#9R21VT:.M"&5:$;Y?I9$S`+1J8@0)"35''X?'KWS],*7.7Y?#4+VITQ0W^ZY]Z^':N-K32L_J&M:?M`], M"N4)4^G4O2BUPJU&3Q;F3P]_$=.N`$]4FFP0(SZ5>OQ>/T8^Y>?-U5,7[VNQ M^&G7'WH([G2,W!/2)"=Z=2?>F)Y;*'/Z1"^K7F5W(\/?"?-0U(TPEI&6X[<* M=*=JXTFEY-O]8W!Y=_Y>6"@@VI%E:A)IT$\7HSK5":JW\I['&>,2%%ECR<)8G=6US; MW+V[J%>-J'CT(\?IS43C1HAVD38L*8C/+??*[9\"X(1N=OGUR)9"("^B]"=_ M'`RV;>GI5"UID@5D=D-&*U/\[>>_+9_P!Q=^UQ:$;VKGU( MV'@4>HR/A]SD>-D_B`R?C^'*QZ^M@2/Z.7U?[-DD^H7#^5M2;RGYS_2%@]I*MSIEVW[P1%3R`62N]/Y M<.,D2&[+5^%DQR,H5Z?KC_QUX''3TUX].(I\LWCP@7X%=BK5<51VB4_2^;BW54ZM5^+;P.*M%BNPZ>.*MFC$$FA/48TKC(RD*.@Z M#%%.XQ\]SWKQ]\=DN61F?B>AZKV`IC:N14`+*>3#H,"N5V=664_#2I/@<=U= MR$<1,;$DFA8=1BO-P(D0&1J4.S'WPC?FIV::0QJHC8\#OR'<]\!\EB+YMN(W MXM*W!F&XI6OOA]Z!Y-/-*DG&,GB*!!XX+*:7F*W]?[=&K7T_?PKA-6MFEGUN MY]7J>OV:;4\,;-K0?__4\[9FM#L5;KBKL5;Q5U<5;KBKJXJZN%78JWBKL4.K MBK8.V%75Q59^8(WG#$,#US.B7#D$:`&'(=1F%3D'(2O@C= MAR(PB;">,Q7QQI)T.%G&`*I]551\2\A]V-AGX:TV@?^[D`(Z+)L?H/?#0 M+$XCS4G26(TE0@>X_41@IAN'1S,AJC4'@)H>V2B!Q.-EQR MA&7":2P';-D\T'5P,G5Q5U1A0CM#/^Y2'Y-^K,;6?W9)^+;J<:3:-<@BHW4C;`J5W8-O,LZ[K7XADANQY(_FDD:NO0BN" MF0*T$TWQ5U=L!5":H:V,OR'ZQF1I?[P-.I^@I`2%!IO7-NZIVS+OM[XJV3Q` M`WQ3314-OTKBKC(0:#J-L5;"5:M=JU`[XH:23D_$C8FE/#%:?->7)IG,2JB4 M-:L6(J-\2:6FWC$M).07D*'EMA(M%TV\[QN$4`JA`Z5)'MD;Z)'>[ZNIF!Y@ M`GD5_:R1`MB"M^N/RK04KTIOUI@O=-=7_]7SMF:TNQ5V*NQ0X8JWBKJXJW7% M6P<5=7%75Q5U<*MXH=BKL56RG]U(/\D_JP'D4QYA+PAITS!2T]QUR8+">"8\P@6C@?N8G\*?"<+CF(/]%3D@EBW<57J"-QBQX"Z(L/LL M5/AVR)#+'(CDCDO+A5X2`D$4#=13#C^IOGFEP&PMKFU>>#JX&3L5=A0CM#_X MZL/R;]68VL_NRWZ7ZPRE>F^:7H';M@TQ0N#;8JINV^*K5.^*N=Z"OW#WPA4I MUZ^-K:"-6I++L3X#OED8[MN9(#B&5J0'*E?V<*%[$ M!?X8TMM1_!T[XH3#2[HPW8#'X&.]=PC/L02$9OVA[Y$Q8728^I#=)4=?VAW7^S($,@;0DZ21#IR M3LPZC)!!5+"_1OW3FE>AR,@HDJW2*RLC?988QV4H'3[EH9&M9-M_W9PD(!1] M20,BRMW+%;0FIFME*![?KS(TO]X&G4?04BW`J:&N;5UC1^(;;4Q5W+CM2N*M MLO+<;5VWQ5W,`@$5IW.*NX,7K7;K7$*X.K/0"E:@'%6E1D);L!X]<>2\VU(= M64`*>NW?"#:TX#TT-0"6Z+U&V(V7F[^]3X0%XG=.V^`FUY.9A&J*5#GJ0>WL M,-TM.>-I>+INK"E":4Q.Z\FS*B.%*`E:`L>N"PM-F"0R\P?A)YD*5K7OX5PVCA+__6\ZC,UI;Q5V*NQ5V*NKBAU<5<,5;Q5V*N&*KABKJ[ MXJWA5V*M,*J1XY&7TEE$60M2TY*"!3WS"=MX-M3100QFIK(3MBB<(Q&_-"KO MR[').-%%QAU=9`>/I`!3X$]3E]D"TF-[,AT[6()9!$Y"2;!7Z*3_``S)PZH$ MT7$S:8]$_CD*[-VS.B;<"<4;`X;IDFL+;BZCB%0:D]"-P/GFOUFL$!4?J=OH M>SIS/%+:*5>9/T9K.G&1*6^JVRL>5GTZQ#SP M\7E7:W=Z$(?Y@/$9JXY.$V[:>(R`BG&E^5-*UW4>5Q(LK,2\LA.[D^.3Q7.7 M-JU$S@C=-^VGBDM+J,TDMYAL M:?+9ES)$FJ$Y1V3:W'DSS$/2U%?T/J35I>GE!(A!%,WP4AF/^ZS]DGV."VGPA M+EZ9*D?.+E'*IJ.QZC##ZF.9&(.-F*1Q\=O;J^,HVUW2<0:C#.G%Z1R4^('[)R'"RXDJO);<3_`.CR#U*_9'3[ M\F!MNCA).R*FU"XB1$F0.Y`(<'`(VW2QF/-=;VPO)%9Y1"Z[B@+'`6R&E$NM M)\FDLT8:.X#&G[2TRLERCH+Y%!7$,]NU)D*UV##=?OPC=P\N"4#1"!U%O]#D M`V-!^O+]./6'#U!]!2444?%7?MFU=YQ5W%^5:^]?;`K89"U%%":T)Z8III%*[L#Q`W]\4-KQ92(Q0]=_X8;6G M`<8SS'PGHO?:F*VUSMO4KP[UK7&U?__7\Z9F6TNKC:MG M"KABK>*NQ5V*T[%78H=BKABJX'%78J[&U=C:M@BN^1D=BV8C4@MN-1CC7B-V M[+F&[7)GKD@*S3R&1^W0>&%Q23+=4`HP-?;"H1L;D+'(!R"D54],OEO&V05+ M62))^4Z5B:M0H\?5]1M&_T6X=(Z[*3R%/IRR.:4>1<7+CB5,>9]6> M2D]T[1'8J-OU9*>>9YECCA&)Y,IT&6:YB%J'JK;QN37KXYBF.[N<>;;R41*E MO-)8WQ])>1"S#K&Q[_ZIP$6QR)!J=E=V2+ MM<,A5@[IC;>:=:T_4$]>3U++D*T%*CQS'GAC(;.5CU>2$M_I>M:3YFTQGMIK M6<1EP.;K\N^8%2@7<0,4GFUQQ"/(;H[]+6/E MX0W.G3"YM;M3%.!M(LE*\LRAECCWCU<;P9ZGTS'#."1?4O+'F*^C_3=HLT#; M.YZU/^5E.#/Z[);=3IC&%1WD\9_,?R=8Z1KDZ:,'ETTM^[0FKH.P'MFPQ:D2 MV==DPRB`9!)-&\U:UH4PC#,\"G]Y:2]/N.97N8PSD<_4$XFTCR]YM_>Z6Z66 MJR5Y64@X*3_DR#;?Y8`6V6*&2-ACFI:?J6BRS:?K-HP8`A/4%'4]C7]I?]7) MPVDXF:QCD)>L4D8.V;0O*AU<%IIU<;6G5QM:16FW$,%XDLS!(Q6K&IZ_+*=2 M"8$!NTYJ=LFM[J&XA26%@T;5HP^[-.13M1(*A88$VM+BF*VAY;I8^W)S]E/' M"`RA$R-*#/-)NSFA_94T`PN;#31'-2-N@K1>NYW.-LSAB.B"O[>)(>?`?"0= MQ7O[Y*):,2F.G0KLU-MJ?3D9.1C@FSZII MUBO[^=$8;\%^)ON&1X)%MGJL<. M]?#%#E)*GU">-?A/>N!:;-`@].I%?B(ZUPI:/$HIF-&[4ZTQ]Z^YTAD!4(3Q MI\-/XXJ0N<1%OC8AMBP'2M.^)0U6<3T%>NP_9IBK5+7U/M&E>G;`N[__T/.> M9;2WA5U=L*N!Q5NN*NKBK>*NQ5V*EV*'8I=BK>*'8J[%5LE?28+7E0T(]\C+ MD64?J"R/3/13U+C[;=$[T/?,0NQ&'J7-0"@VR-I*D*\O;)-2)M`2WIG[+[$Y M="5[-@BC6M[BV$EK(M.A([TZ@C*)GAV;A`A!ZG8,D8)_;'4>(P8Y6TYL="TA MD4@TIT[C)EQ*3CRWKEQI]V@47LDYW62GT8U3D2/ M$G7Y?645[/?Z=>[V-S"\+,WV5;@60CW4KET!0IQCOLP*UGEM)EEC;H:&O1A7 M<'YY6TB5,TM-&M-:LOK=CN0*2PC[4;=ZCPR)E3F1QB0L)?/I.IV3$1EU"]0# M^K`2)((E%.X_-FG36:6EU#1E7@Q(H:YBC#(2MSAJXF'"5+1+R[CO.-G<_N*T MHQV`R.:(K=GIIROTG9Z1:Z+JL]NDOUGCRIRXDT/RS63H<@]!IYRY2+*O+'E; M3)Y2+NXG!3^[1V)C9CW`R$!Q[%MR@XZ,=PB]6TW4-,AD:)P"-E#G9AD9XQ'F MV0/&>**`\HZ'%>ZIZNJ<3PJR1MNK?3AQD=&.M@0+*MKGD+R93ZA^7'F6P]6ZLR)X8"&CFC-&8$[$# MQS80U,9BW"R8LF*2Y?/+W&B3Z!YCM_6,4;_5)F3]_%+3X?B;XE%?M#,C&2), M,N:,L+S!:M_>HT9\1\0_#(G"0Y4.TL9Y[+KVZMKBSWA._B$IEF/DXNK_O/A^A(HQSO$'AU&6%UY*>K<%1Q2*N(D MA2GN)RA'I]>UE-CD`6=;((*"Q4]LL:PZ2`TJHKC:F*F#04!/N, M4+9.@;^7?%41'@IVQ6V@2Z'D>G1L;6FR?34&,UY=6&*\VMG16=J-X MGN,>:W3;R-&55#10*[=\;6K9;2[%7=L5=BK=<*NQ5O%75Q5V%6\5=BKL5=BAV*NQ5?# M)ZFV1ER;,7U#WKII&9BTC5)ZD[Y@V[690A/?"T$K#UR3!,+1XQ M'O\`3\\%N;@('-.[.[6[O:3`5FCX5)Z%1ME.:^;EDQ)2?5I/C2VH*Q[$^)!P MX8]7!U$[-=R3W%J:%U%5KO[9>X4H4@HWD@F25#\2FJGY8@TUW13^RU+1YA6Y M4Q,3OQZ9:1$MHR(J_P#,2"T^J:4AMX@#5P?B);8DGN:;8F<0*"";8JR2!"3L MH-!E+441I6K7^EW0N;*4Q2#K3H?8CPP$`LX3,=P]&T#SSH6I1O#K\"P3-0PW M4=>!\0RCIE1@1R#>)6WFO>:M$@#*X MN-/K\%W"28S3NP_9RG\M$LSKK-P0`4('?,/-HI`W%V>D M[4@14N::ZM^9&FZCJ$<%I*SQ`U/AF/+3RJY.?A[0A=19M8WVFR:='*KKSH"& M4T(-,QKIS03(^3=U9RW5J)#*7"]R:XH,@)4&/7NOOH\'!X.<1-'K4U\-LLQQ M)Y-6>40?4\[UB.SU-[^]>`O5&9'Z<2!MOFTTV4B0MTNMPQ,)2'BR&2[Y-NP!^61DD%/SQ MC`?E\Z#??*DM.3RZ_%78CP^6%*7W:A6JNU1DJ4%`R(:W MVABS$@0A&-6)'BN*N]1JT[=/?%7!2IY5K3%7!V>HVH>E!BKE!12=CVQ5U3(I&P MIO7M@5U3&O9JFM>HQY*X@R!3L*;5.PVP\UNFVD:.BC>F^XK7%>;FB+L#R4!M MZ'8X*6V_782<:;`T`IOX8VM+?J_QTY#CTI7>G]<:7B?_TO.5C%30;"N+(%%+*R>G+W!\=\C,6&X24KMEDG+@[$[ M]]L8;-63:;>26MRG"6,T/<'W&0IQY1HJ=N[%N+&@[G%0I2,6/@.PQ05F^*%>VN#&:$ M_`:5'RQ9QE19WY;@L;Z1KKEQ:#BS1U"K+W*A*D[91D-.[T6.,][WC_LDSDCN M((>34$C2,P@8@>DK[`BG)6'T9`%R)@B._5JR-]IHEDA6ML?@N;>4!HI02/H6 MOMD[Z.-/`>:CJ_DBPU.U.H>6"5GY$7.D2?:5@&9C&?Y=OA7&,^]PLF#J&/\` MEB^CM[SCW((.P)Q$B.3$\, MSNPW5$TZ.+5K5(:,UE)(A'P\>*GMF5@)\2/]9HU4*QSC_0D\40_`OR&=>7S> M*ZN*75.*MUQ5IIHX1ZCU*CL,KR%WUR$[BWF/RIBJ MF]P*']Q(H^0)Q5%6VIL+5A':SR1J#R<+L/G3"$)4UW$S5J17QQ5PEC/1P<5I M;*0%P)0AHS4/2HQ32.T^W$<[?%0,"*Y&3)D$4J^F*_$JC(4E3ECY.LZ>%"OX MX%0,R2"9RVX<57V]LDJEZ1*5(\148"68W2TADE<`T4]LL:CLW4`;X549EJ.0 M/MB@KX&VQ2',0'-<+$MFX5>@+'`BE>SBN[UZ1@JO=OV1\S@);(P)3J#RS:@` MRRLS]Z=/QP6VC&&[S3;6W@,D9;D.FX_ID\1]3'+`"*`K7,TN"ZNV^^*N._3% M7F*N7DH).X\,5=NZ\0NX.X[8 MJV:H*$5J>G;%6BID4,HV&U/`X%;9PM%8!RHW)QM:<8Y'8,HV;IO2@PJWZRA_ MLCPY=ZX$K?0EY^W7E[85M__3\Y9EAJ=BKL4.KBK=<5=7%78J[%78JW7%785= MBK8PJZN*NKBK1.QR$^190^H+H(.7Q-TS"=ICAU59:'M11T]\6<^Y8L7!"YW. M$,>':U!EXD>/7&V%(Y)$2W((JP8$?(X953+H@FSG%U'.%F55XR0' MB>7*C?#T8;Y&F4P.]COF*V#W#WB+\3L?K``V#$[-_LLO!=7FA1V5/+.KW^FW MDUEURR6[:3T)4`*T-#[9I#L7JL?)E MF@WS-;FTNHN4D9HDGCAB0QRXZW!83Y_\OSR6=_>PCTFBBD?D"!5>/Q*Q[0CQX"0=XP+P-""JT\!G8%\ZCR;P*W7%6L54+T_Z,_L*Y#)R90YI1&\ MO(B,GY#,5M`M%Q"['VW`'@=\B68'>BD?EMS%._PC`V``IG!IL[1ADV5U#?`Q M0&NQZ'*_$I*`/Q.'B+&6"(+3Z"IIR2(GQ!!_%<3,LHZ: M,N2"N=$DBW3X%W[\EPQR-6724@I]+EC"-ZD;EAT6M5(\6XA1>4X7@H`IOME6,DAR]3`"0H(Q8H8 M*1(H%/M'I4Y.G&%-W%Y;P1ASOV`'4GPR88F8"6S3O(/'P&*&RRU42"K@;D8I:?FS@K6 MAW4^&.ZE=SA]6I!Y=W[5QV0LX3>I6AK6M>V-E7__U/.6934[%78J["AV*NQ5 MV*MUQ5V*NQ5V*NWPJ[?%75PJWBK8'(A?$TR$_I+9C%R`\TP2'BG`F@S!>@CC MZ--$*[]!TQ8G&AW_`'C")>@W-,+1+U&ED\9!-.U!B&,XT5:[A]/B*[-&&^G) M21((#B58L/I&&+B@;JG-XJ,-T/486SB(")#!UV/P,-CX'#;+F$*)SSX-]KI7 MWR0+C<28Z63ZRT')CV[4.V^%M@6[RVLC-+#$>$H`:4I^.-J8%4AU2]A MA,"2LL1IL"1T.WW8#$,AED!5IIH=[ZEP3.[22NPY!C]H=.O\,A(.5I<@XMTQ MU*]B<'TV]`U`XU[+T)/3:F0$7(S9`>6R(\O`74KV<[>I%?$QK,S;\^H.^,MF M$=PF_D_RS)?:I-I[Q_O825DT5C8G9E%EK/I\3+!Z;CKE<9[MV337R*"\^7,%QY;U&X!$9 M-JX*$TJ2N9F.I9(^]P]1$QP3']&3YE7["_(9UQ?.X\EV*M5Q5U<54KM2UNRC M>O;*\G)G#FAK>T<)S%5J:9A\3D"*86^D,Z\B22=\@9,A!7_0PXU!-1^O!QI\ M-OZW/;6P@1NO?N#TIAX7*.4QB(A4M]&NYT$DI"AMQSJ3]V1,P&S'I)R%E3FM M+RQ8/OZ==F4_#]V$$283Q9,1L\D1/="XMN7MN/`X`*+=*?'%*H7B$C13*37[ M+#J#EI#AP(NB@7_=WH->II3)#DX\N:=6A0IQ+4![^&5E5>98>G4;%C7K3(I" M&EE(;X=P.E>WRQ9";2R(-, MFP;`*N2/VA\6*A3D_O1BA,ZT]/W497(N7`IEY?F-UYDMC,:A240>'%#Q_'`1 M0;,4N/(+16KR^A,P(J:D4^6$-J,24>AP-,EBYAKR)K3(3^DMN&53!\TRC8ORD MEHH/2N8+TH-[E0FN/5/HP;_S-DG&RY>+:*+L[$(`QV`^\X+;\6&@A;H`'M4G M$-&4"U^H#U)8!2C\-_?#,M.2.X"7S*!*:FC=ADHI@D M*$_NST]L#6;!W49R5?FFX[C%JD$RM9&CL)ITV=J1I]/7)6V0Y*=K2AYHF_O1.%CEJS$EFDH*)ML"?&IR`#/+EXJ04EHR>5M=A@UV#5T("7UN!/M_N^/9O\`@AOFOUN,D.Q[.G'B-]7H MFBZ])J8*L5"*U:'KMFJ(WW=]#AK;FFFI6[74(DM6",FS"G4@Y*9',)QRX=BD M'G26VG\HWRO5;A;>0,IZ@@5R[32O)'WM&LQR\')_5+YR7[(^0SLB^:QY-XI= MBKL51&GJ'O$4BH-?U93G^EMP_4F-S8B0J!T!KFM!=@8HVV@5$`[@=(4A)[6WBDU<)(=A5@/$@G;+)RJ+?@@)91:E,J!H;NR)E*5#:,5*ZB>)&]63U;9_A<.`"M=@01D@>YJRCA&^X8Q#*/795 M-5;;YCMEQBZC'+(ID:9^ M(KVS207@=&*-5)8W'OWQ(1"75,M5G>:2DU#*I/)QT8'O@IL$[2LCBW%M@.AP ML"THJZ[].OOEF/ZFN?)6J1F6XSNN*M8JXT/?`KJTQ5O:OOBK7(UQ5L4&]=\5 M=7E4-TQ5K902-SXX5;KR6IZ^.*N+%0./3OBKB%:C,:$_:'B<5".,64/<79=J(I`I\(P6U9,W$2=E290K M)%$C3WK41#L%!?8';J?Y<04S/(`>I%ZAZNF:A9V44S2O`.4P)-"[BI)]STRO M(!*!7%(C(*9?:0>9TI=:=(T:R#F$(J-NN:DRQG8O11Q3KBB6;^6+W7/J8O+J MLD4O]X*="-LPYT#0=A$<4=_J1WF:]L;SRMJ3`4E^K2UVWJ%.6Z;^\C_6#3J! M(89[_P`$GS=']A?D/U9VA?-0NQ2[%78JB])WU&+Y']64:GZ"W8/J9"4!S5NQ M=2F%6N5/NPL2D=[&PN^<9*3)R*D=R#4?@3UH&=GH28BH)8 M"E37(G&&[%K9CI:$UC6IKA?1"&&'8E"0SG?O3)1A31J-3*>QV05M;LW448[[ M=EZ5R9+1$;)N-/%L@`'*-NK'K7O7!;"F/ZU";6[%!6-TK]YR<6!1&DWSV\`` M/H`Z9'B+*@H2W%V?M*!C;%UJ?CI*_$;TJ/'*Y#=LA M)3NQ_H[$;KR(5CW&&*S2@`UKX9:U%SR;T'7"AHQR.-]NP7%0F,ECZ<2U'85^ M>5@LC&FI:_5K=R=EK%TZ=QDBL"%6Y,C11S@(ZX$O_U_.%P2PVD9<4+=%![;9KR]:)1Q#S0QDEN&J:L#TKXX M&B4I9/2]62A[J=OD M<"005"9*`@_-6Q#7()KIVG3S:/%=P1!9H68/(3]M2/LD'Y9$Y`"VPP7&PI06 ML%Y4VY"W2BC6\AH`?$4PGO8"B726$JSI'(C#ZO1G%*5#$?\`!9$EL$"9!-(X M%N-@7"CF?A7L!7J:9"W,\,22^^AXQ1AXZQGXD7]H@]"1X807'R1(YHW38K=8 MWY,I7C59!7E[4'6@RN3DX:X390T;27"A/48PQ_:51RY$'H`WV1D^32)&7N"$ MEO[F&0MOZ3$!DH5)IL%IX5R5`M9RR!9+Y:T5T]+4)7$^HR!A:6/1HS7^\;(7 M>PY-N#$9&R;*5ZC8W,6LVT4B9[/5B'#!/O)%)]/DT^H)4DH6VV)\D"4)#33E2H:G1$!WI@9SE$"@G*0AE*N*ANH." MVECVNV"1742N.4*L*^^1+*.SKR5?1*"AKL=NE,8LII/,Q`XKU\*NQ5V*MUQ5U<5=BKJXJWBI=BAV*785=BAV*NQ5M&XL&\"#]V" M?TEGC-2!",@5YOWDG3]D9@/08H&9N2,62O[J(?ZS9!S0;-11$O/\``?WHWXY$=S;*8I#S6>K/22&`#BIJ5DCIO2@^T21_*HPV!S M82G*7)%0>4/,H*?NHXDD%3(98V(#`G>AVP&8/)8PD+O9UAY2UF179)+>",(1 MRDD:M!X*@Z^&^,IA8PEWA/\`RGY1C&HQWW#1*0]W'$JP*P'P^G]8,?-A M_/\`$N)LM^+`9'DS#4;/]'+-<6MK':SSKRFO&)DF>O3U)V"+O_)"G^RP&5;! MWFFTP$27COF74KB;61=/*9)HV%&&P4+T"@>&2`N)=#K,Q&8$'Z7JFB7DVH:( MCM+\16G7VSG,D>";U.+/QP%L@\OZM;65NH>)SZ1XO*HJ/IR!L2)> M==BDT&]6%3)!-`]&VH#2F6Z>(.6/OQR007'2Z_LU'@U=\$_I+9C^H(]93(>(^", M=\P"'?1R6?YH7_70B>E$*L3N1X8`&PZH1%15+6TDN']20[#PB)K:U/&%1\;_P`S8TTZO4`QX8I(K[^`[?3E@=3$K2'#DH=NO'MDPM$' M95!$@J-I5ZCY8&RE221)8O\`BP'%E(V%B`?:^TO<=Q@8KW4,E5;<=#_`X;9$ M`A"S1A1RKP<;E#T;Y'`=VODFTGKS:=%>S0+!"%(A(-2U.I.8Y-&@Y@'%&SLD M\5X78+QK'UH+D](\BZIY4@06_F2.4VK'U%A+,D):E`X=!RJ,P\IRP M/I'$':X<>*0J9X"R.P71-2E>/RKH(U2"W8O)_I!Y,#M2CNI?_@5OK,@):,1W9@2.-S4*RI3D1W^+,J,>'I;CGPN? M%P'W,MUG4[K18?J>FZ/:VURRT*(9;B7AQ`&[_`G_``V"4G-TFFC,\1F2'C/F MFXU^_9GOK@(D=0L2GI7K3*@;+L-3$\-`[//[^Q948\&9C6K4S)C)YG5:8U:8 M>6/--W;1FP8FB_?3,34:8'==)JR/263Z7JTYF>2*Y>(_MK78_,9A3@`-P[K' MF-[%5\P^88ET62S,G.656'PTV%,EI<'K!:NT=3>,B^CS04H/;.I>(#?TXJ[% M6JXJCM$/^Y.+Y-^K,?4_06[!]3)6\,U8=B5C8516@1^IK%N`/B+J.0Z_:'?) M!K+U9-&)/V<(00B%T%B/LX;8M-H+4^S^&-I05QH[`?9PVA+;BP(J"-L;2POS ME`8&LY`-N;*?I&*%"V5'C'@1TRLM@4[G348B;UE)^0VRN61NC!.X8(XD"H*#P M&5$VV`4N9:XJAYX_@.2#$L?9RETOS(/T[9=T[1,&'_ M``M<`YLIA,(_LY)K2_S`/]Q4W^Q_XD,LQ?4QGR8>!MF<7&;P*[&E:K3`K>*M M=\5=0>.*N'2AZ8JW2E:=<5<-QOBKCMTQ5QH14]<5W88JWP3EUVKTQ5__]+S@,RFIV*NQ5NN*M8J[%78JZF*NQ5V*EV*'85=C:MX MJZF*M%J?1@GL&<>87!Y)!Q^R@[9A.Q!,D5$(H@&<\1^.1(BI0!`VPIF*>=N1C^FBQV%)HYG,:MHR%G%*>W\#@LNRQYHEZ+HNJ?E]J,<8U6PA>0`5K&)3H^IZPJ"@55NVX?(;Y[ MCX`]V]?M&>Y:0L!VHG'($VY\*BELVK)%\$[;*B[#W.61BX6?46&%33-;WJSHP=U-6`WJ/HRXBQ3H,OIEQ!,+;7 M;E&=H2*2>/;*3A'5(U,AR7()FC>64U9@>N&-6*022"2@LVSJ&\"NQ5V*HW1/ M^.G%\F_5E&I^@MV#ZF3&AWS5AV)"FW?"$)SY'@]?S/9Q#>KK^+`9,,"^D['R MN\E/@W^6!*=0^3B5'P8:8$AJ?R5RBDE?PP+3$=3T4H3\/3" MKS7\Q[+T],@G[0(QM#%K-_P!WQ[9$MD2CHIROPG=<@SI;+'&X)_#` MJ"FLP-P-L-JA_2*MTPL:5T!`P,E1=S_#%7&OABJE,1P(R08DL8O%(F)\#7\< MN#CGFG6BW`BU*UD/V&<(Q'\KCB?UY$*N`Q5QQ5U,5=VPJ[%"I;*K7$:R;QE@&7V.)2.;-['1M#F0 M.EJI9?M+5NGWYEZ/%AD:E$6QU,\P'ID8IY9>5/*%R*36",_B6DW_`.&S=0[- MTQ'TO&:[M77XY?7+Y1_XE,4\D>4T96_1D;*I!X,TG$T[&C#">R=.?X7$A[1: MT'Z_LBR"Q\@?EC/$+V?0;=IRQAM-'M9+@O+)_-(S.Q"?+-?D[-A$\('I_BF[ M?%VUFE'C)]?TPQ0_WR+O/RF_+FST^:$Z-!<>8F0L]BDTS+"#5BR@-N8U_99L MCBT>.4OIK'_._GMN;M/-#$0)\6;^*/\`J?\`TBP^/R'Y0I3]&I3_`%I/^:LV MG\EZ?^:'0_R_K0?[P_*/ZD!J7D'RY$`\-BH`W^T_]F/VE!)H?I.<[J]-X4N3W>FU'&.:1-IBQGX(B037N!7,$ MESX8ST=^CA7D4X_25RLR;?!*[]$I*P?TRY'[0K^O89$S'5L&GD>A1DEE-+$L MBKO][=,''%D=-,,D;+38E20?UY/PQT:_SN4'5#]*MAX0TRR3O?<*IL/+TR#G9O;&GQ/$6=/N._XX>% M?$!V"R'RSILS5LYXC(33A(Q0G[S3&F`CW%3O=(OK-)!+"550?C!++]XKA$8V MQEQ@;I,.F93AMX%=BKL*HC3Y'CNT=#1A7*<_TMN'ZDW^NW-/M?@,UM.=;OK4 MYZM^`PTBT5I6N:GI5]'?6,HCN8B"CE58`@@C9@1VPJS.'_G(#\V(MDU=!_T: MVW_5/$((M$I_SD5^;QV_3*?](MM_U3R7$Q\,*@_YR'_-P]=93_I%MO\`JG@, MD^&%*;\^/S2G6DNJHP/_`"ZVP_YEY%L$:2^?\U?/=Q7U;]#7K^XA'ZDQ9B*2 MZSYFUG5K?T+^<2Q!@_'@B[CI]D#!:>`)6MW,FP?;Y8&0B%07]R?VOP&"F8B% MPO+DBO/\!@IF(!HWMT?V_P`!C2\`:6XD;=C@2,4>Y65C2HZXVR&&+3R3#H?U M8VGP8J#W,X_:_`806!QAHSR,M:_/"Q\,(5[:"4DNM3WW(R7$6LX(KEC2.G`4 MXFH[[CYX+0<<>Y$S:M?O(\AD^-R68\1N3]&2$FLXP@-2O[N6T=)'JII44`[@ MY=@/K#1GB!&TE&9[@NQ5WRQ5U<5=BKJ8H=0XJXXJUTQ5L[B@Q2U6@Q5W6E,5 M;Y4([XJXJ":C%6^9KBK7'[_QQ0__U/-^934XXJ[%78J[%78JV,5=BKL5=BKL M5;IBKL5<,5=BJI;_`-_'_K#]>)Y)AS918:GZ,H5:!12I]\C"5-\J+)K2\#4F MCW'5P/UC-_H=9?I/-T?:&@&0#U>EEBE13;3+S4;. M^273V*W3`QQE0"3SVH*Y7FA$QJ7)CILTX2N&TF6Z1H5WIVE7]SJ5S%I^HWR^ MDCW+U=(6_O'H*MS?PS6YLXG,"`XH1=Y@TAQXI')(0R9/Y_U<#%]5LM&@"_HV M]:\]/:=G3TQ4].%=VS/PSF?J'"Z?58L4?HEQI>P61"I% M(JM4/,_LDU/T*,K` M^7";@Y,'WF2*Z8QE"'B?I2F2!8S$@.;'0/AS(<)O`K ML5=A56L_]Z%^G*L_TMN'ZDR&:US2N!PH=MA5VV*5R'?`JNE.G3`R"\$=SBS; M>556IP,K0,EX6;BN]>@&_P"`PUWHXFPMRZAA#(16E>)I7(F0'5E4NY0>>6)J MLK*!_,",D`"@R(Z(FUOHI!U^>1,6R.2T92N^1+D+2/#`R"I%(`=\"410,*X& M00\T34VPA$HH>([E3U&2:"X['"Q:Q8E389(,"@[W_>=_H_7EV#ZPXNH^@I;7 M?-@'7MXJT1BKL5=BKJXJU7%7#?%#NF*NJ:8I=4`;XJZA(VQ5Q(%-M\5<:UVZ M8JW45Q5KB]?XXH?_U?-^934[%6M\5;[8J[%6Z8J[%7;XJ[%78JW48JZH.*NQ M5V*M;XH7Q`F1!W)&)Y,AS3*`!&^+XF/11XY4W@4GVF:BT3A216GQ#L!X99CD M0F4;9)9W00K*A^`[FG[)_IG1Z+5B0`/-YSM3L_CB:YLGLKH3(&4T==P1UV\, MVHHO"9<74@^&<;VW&L@?7^Q MM48X]A"WJBRS[RMO6N]=JYSYIW9UF4\RR?R+I$R:?!/, MH:25F>24?$5J=J^&1C/AD"1Z769\LI'F7H3Z;"R1&"8M.-VF&W$=]\IU0.6? MH#1`B.YW=ORR6UTMT* MAVJLZ,.H'V6W[Y#3R-47H=)E`])5]/UD`*PIV((J"/EF6)4[*6,%/(M;L)HO M0U6V^OV9I\#$I(ONKC;_`(++HY1_$XT]+,;XSPG_`&+%/-?E_2HV:\T-VELV MW>UD%)8Z_@Z^XR,O3N.2C#*<:R#AG_NF$R16CUXL8G!Z],OAE=5J-'10UQ;R MA:3H)XOYUV;^W+Q+N=?DQUS0!L%-?JK[]XWV.6";BG%_-4&#H?WL94C]H806 MD@CFODG;ZK*H8.A4@ANHVPQ"3DVHI`.F93A-X%=BKL55K/\`WH7*L_TMN'ZD MR7-:'-+>%#>*M'%5Z8&85:FGOBS`;KL!@9%9;6\VI7)AB/"WB'*>;I0#>@)V MY8)SX0SQ8C,^28PFRM1QM;3L>3L.WRRK@D=Y%V$81`V"+L@[EUD0?$ MPX;U&YZGWRB=6D%/]3@BNF^H6L"-*M%&PXT[EC[9>RB13'9O*%G)<-#$_HW$ M9-94%5(`K7C@.CS7DFXR)2%$C_[SO\`1^O+L'UAQLX])2S-@'7-UQ5U<5:Q M5V^*NIBKJ8JW3%6N^*M]L5:Q5WRQ5QIWQ5JIQ5LD$C;%6MZU]\4/_];S?F4U M.H<5=BK=,5=3%78J[%78J[%78JZF*NQ5L8JZF*'4PJOAWE4#K48#R2!NF(*Q M+1/BD/4Y2Y-B(VYKDEX\5_:8U;"H/1D&F:H$F,;?9Z$9?ARF)L->2'$RFQO# M"Z$-6)MU/\,Z;2:H3#R7;'9A(XHL@BGCE0$'-@"\=/&8G==3[L+%V*I7K%XJ M0F/D/\HY"4J=KV=I#DR6J^3]-,MF][0,)&8@#[@",X3MG)QY+'1]3[/APPID M6G^7+B[F`X5BY?$>YJY=Q5'`%0:9;J\8H&(]2<&>4"\6U?RO=Z M,W&$>O"!\:5^)3WHCT?:8.TDM347@*"0-"6W42@J#]^V3X@[;'EC/ MD;9#HXT*_D$5W?-IDK;++(G.(_,J?AR['PR:LV;+C%QCQAKS3^4.J26WUVWM MH[V`BJWFGMS##K4H-QEDL,AN-W%CKL&;TR_=S_I/*KW3M2T^1N#3>CZ7'U6BG`6/5%#+/:SGC*O"0=2-OQS)=1(=[6Y6K-,D& MAM#I8@,7HQVS] M,ADS5LW2QB(14$$`LQP^)AO78U.8A)NU$17-D'E^UCCM;O4K@/,%X1I`/A>1 MW-%2HZ"OVCF9C]0MJS1X9;6USI=R\ M3@M"&98YB**X!I]^9(((=%EP2Q'?DV#%.M>_?Q&)1$@J$LV)Y)'-&AU!-!OXY2V\MU\"GGZS]`?A'^78M6<9L,ORGB;,A#7EFHE!+VY_;738FI/-]J^SQY@(Z#78F7>C?+-N,@YO)9>RLD3R67.NH%^&B^YP'* MV:?L>5O3M!N2QWD/@/;-)VCVD(`B)W>V[+[(X>01EO>C2=2 M-HIXVTC!64[!6[,,Y/+(3%]7HQC.,T0]*\E>8K(RB&4CFIH?;*<.8@U)IRXR M&:WM]%.\<:,`K#'BRDCU!6GPGK3,//D,<@,>21OS1JQ MV@(`DH2*$'H7KG3IS/;>JP0\%'C_`).4ZC31QP,@2WZ?42$A1IY)9^2/ M,2/-':1^K%$QXQ/UX]A7,;#DX]Z>D':48T)(O1?-GF'RU=-!`TEJ]?WUG(/@ M:G^2>G^LF9F/,8MV;28=2+VM;Y[ETWS'IWZ2M0+76;>INK-T`$H.Y*R+N2/\ MO+0SF)V*R+QWZGK]XR6.3K=3BCUYK([BY@V!]2+] MI"?B'R\A1;8MJ>4A'9>N+.U.TN M>-_)<^F)"B\80>@8GK@F+#?HQ?^21 M`R0!1J%-:UZYOIN,=XI#+"#\)-.)/O\`+,N,AD%]6N6(X^7)&R6JVEV\BJDM MN&*,JG:%U-2A]SE4X<)\G9:?/XD*OU)9K&EV.I,S,(Q$P!(6H52>WQ5;?("5 M'9O./CCPEY_K.BRZ9=DVY+0&I`ZE1[^V9,,@D'1ZK3G$=N2RWD65>+"A[J<) MB>C5#(.12[4/JD$G))5Y'_=8-2/NRR,26K+*(Y%1.L1H%#(Y?H"*9(XVGQZ7 MQPM?RJR$0N.I<]?NR!/"YF'32S;@B*:#R_><:I)%)[`D?KROQXN=+L+-5QE& M277-G
*N(!Q5HD],5=2O7%75[8J_P#_ MT/.&934[%78J[%78J[%78JWBKML*M]L5:/7%#>*6CBKABAO%6XUY2*O4DBGW MX)(/-[1Y%M=.FF6UOT=HF6AD`JH M-.F^:7%J:R;GA<[M/%4=MT#YF\J:)!?2%*+'\3EE)0_#VH-LWFC[8S<)'%LZ M<]FPF+(IA6IZ4D8$EJXD3@'*5JP![=>N9$NT\D]B68[,A#M*^!^C,3$>A<[M'2B0$HIKH6N MSO!%>7T;02!OJ[7\*C@TBC[,J#;I3C^TV6Y(6Z7PQ+E_I69P>;_JNGK>.KWU MBH_WJMOWO$CL1]H?)LQ1BF#1/%%HEBLU])5(/S7MWDCC+NL#TX>HI4_CD>*8 M"?RWS94NO>M!ZQ8@$5$BD$=.^4>*.[=J.+HE%EYRG349(KEU])2O'W4[5RR& M>1(L[-F33U'9Z%IFL6%$1I`.?3N,V8U..)X;<3PBFUU#'<0TCF]($?WFS4^6 M4ZF?'L3Z40%&R&,SQ7FB:E;"0+/IUZWIM.M`5;Q8#*XR&"8%^B3D<'BQ/?%3 MN?*GES7[B99XUD$=>#GX>G4J>V61&/)*1OZ64,V7%5%Y/YATE](U1X;)OK=I M7:*3XI%[4#?:.8F/5Q,N%Z33:LRCZ_2P[S#Y;L[KU984-I?1[O;L"*^]#F>- MMQ_I6_)@CFCL=_YS!+F"YADXN.]-NA^1[9E8R"'G-1CE`T4-<%3%)RV<*:,- MF^3#+AS<&8%;)(!F6Z]NF*M#%6Z8JJVQ5)@S'B/$Y3F%Q;,1J29(H8`KN#T( MS7N;:_T3X8K;9@.*K6"Q*6?Z!W.!LB+0[33MT^$>`&_WY*F\0V4OWU31V%>N M^!'"M'JQT9&848$T)\<)Y)@#$A.]>O[ZRU=A9R-$I@0$'X_MJ"WVNG7MD,`N M.[F]IY#CSD0^D?P_!/\`R=YNM9XUT^_@*7R4&GRQA3$Q&Y60$\E8]CF'J-+P M^H%EH]8PZ9Y:U>^T^WO_TAP2=.20^F3QY=CFPQZ82B#?-U>0\),>Y3 MO/*5Y9--?UCNRT963U%*%%'5DIWRC5:&@9#=S='JZ(B6&W-J)$DFLF:.>V/J MQ[<9`3X$=1FJP2HN_H51Y%/_`"[J=QKB""%!')"GI?HV%=I>0^*5B?B+L?VO MVS@9L?YW\Y&:OY9]*41Q$)=LH,EG*P]16'\K`<6'_`Y5ET];,2=N2V;16VD"[-O]/?)(E6Q4I]+8*C<33OD&[J$TT_2: M,#0^V8N23T6CQSC#7$JQKWYM0_=7,4QE+D+=X=1CPBYRC'XH*^\P:) M+"T(ADN@VP*CB`?$,V9&+2Y`;MTVO]H-+D@8B)R%BNHF4VDIXA4\*U/7QS9X ML=2#Q>7+=I+F87%=@2[%78%:J,*NVQ5V!74Q5K%78J[%75IBKMSBKABK=#BK MJBOTXJ__T?.&934ZN*NQ5V*NQ5V*NPJ[%78J[OBJ[%78H=BKL5=BK:UY"G7M MB>2>J*$)K2GQ'MW&4EN$4TT^R'J+RZG>N4R+EXL=*U\X=JK^?O+MR%+&)GY$&.-7*DNH_:(_GS:894>%AI,MPK^:\JUV:: M!%*JDD<9"+Z*D5D4_8-:'HWQ9E4W\7IW8Y'),EQ]:@B8*RF66)1]A5'Q.`/V M`=LR(EQ)XP5M[?3W+AY&)1UHI^7?*91W=A#*3$1+TO\`+FS^O_EYKBW2;3/, MHD85!>WMVE20>\;*M3F3"%QW=3JLI&05S#$_(WG:XM;A;B<1FVN%')%`1&Y[ M%77I\CE4H".S(2&2-GF])O\`RUI>IV:ZA9#G;,#0`UX$]5>G@>^42B0UB1&S M&&&M:6P6&61K9#5X2:[>`RJ6($,R`4Q@\X:3/*HFCXU7@[,-P6U01T^>8FMP>"-CS;-/(Y)#R8EY,\LKJ.L37LZEX[5N2AMP:_9 MZY5V5I3.7$?IBYO:.?ACPCJF/F/RGH=W/>3:@WH:D%/U6?\`9V&RM3,Z>IA' M)(2/#-JTF;)"N#Z7BFO_`)8^9)H9=2TZ%;F)06N($ZT'5E'0Y+1ZSC%D4YNK MS1G*NKS2]MRL4@"\"BGG&]>2D#H"=\VV.8)#J,^"@6.#[(S/=2[%78J[%7%> M0I2M:-M9+I$XI3C6HVS#,;;A)&))>$_L_\#CP!/&53E>'LI_V./`$ M^(6Q;SS_`!L5%-@`,?##9'4D(0R,I(:/8&E0F/F2Q8ZDK4KR@B/W*,C@/I:((WY.'I9\)L/I0>;_+]I$L-O')*D:T`0;` M98-1C&P8&,CN@[WSYIK6TL:VDA9D8+4#N".AR&35PH@PNK M,W(E:$V]$F4;%PVXZ]/\HYSXQ]2]'+.15?Q,;C$MCK#SV9,#Q2;<37@:[$,. MJG,K!DZN?#AR0X9O4/+[Z=J4+R:CR8L.4A&U6`[TS:XR)#=Y[6Z>>.50Y,8_ M,:*5K6'2XDX)/[&3#BDV*5CY0?T M2#'T((PL8S]*3W^A".(H4)-=MLB8-GCBDHN1?!>$5(5`H2H^(_3@&&-VW2[4 MRU43PA)VTUW3*/-.+6W)<#[1[YCR+G8XIK"E`%7Y2Q8F+L.X-`?8Y,M`CN]B_(G699-/U70@0LH(DMV)H0'-'IFC[1Q@3 MXOY[L<4N*()_A>F:TK3Q`4`^KI\-#4?#2H:O[5,Q]+$[R;#I;895/A+#+6_O='U.#48X4=HSQ>(J`'CW#)_+ M3C]K+(<[8Y8\42&8V.K_`)3ZG&'D:UM'&\UG=RM:O&WW%'7_`%,S*!=5X^0" MDN\^_FCH%MY>)[:2>T5EM;:"3^]6)F`::>:GQR_95 M<:(8$TJ-F6J1R,LK-LJJ_1=_B9J#?C]G(9>3F:,CC\F6^7_-6N>6KA9-/G$^ MGRT#VS?&A0;DT)4JI;<6&&0.MO4;++L"?FK*+KUK56Y,`U5)ZTVS3Y\LISLN5IX5`T/4RJTUFTL=,+VLJ( M74$,A'4C;-EBUQPP(#A'"9RW"1WT5]>VQN)I6D[ECWS3:B4LAXBYF.0B:"%T MG5Y[.)XHH:\U9926K7Y#MENGU,L8('5.7$)2LEXKYRT1F34+F:$Q%1)P:E#X MTKF]T.HW`!=CK<$,F"1_BC%Y*O0?+.L>!#>V*NQ5P&*JMJG.X1:?V M=D6`VS%#8$TBTZJ],4JT>EGKB$+QII"$TZ>&%4EDL/B;;N>N*M"Q]L55HK)@ M:KM@(M(D0;!91H?E+7O,4[):H]W/'&6X_M<$'8>PP"(#;DSSF;D;3GR3Y8EM M_.5I!=PTX"5N#"E2%V&4:@$1;,$NCU8Z?#8J+MW0*_VY*"BUV"9@RC3E`H>Z M;BX>6*+D7"J*0<[2 M:@`B,O\`-22W6%8*I;K,Z(1+P^$$`TJ:]BQ^R+LH&9T0\KDG9)9YI'Y=V MJHKW("@C[`&^&FNT^3RAH,.^;_*J0WDP5``">@IW M]L5>>:AHE&/PXJE#:0>>RU^0Q5'V'EJ[G($4#-7P&*KO/OD;6+'R)J>J3VS) M;P+&7*6MZG%7?#BK__3\X9E-3L*MC%6\4-8J[%6\5=BKL5=A5V*NQ5U,5=B MKL*JEN"9XP.I8`??D9,5WN7H(F7$]RU"5D%W'.1&)*A'&Y!ILY'AVS`T&4RB0?X79X8T00 MEGEVX$FHM%*H$`^8_+,]GJ4MCJT#VUY"35D%:#]3)W5 MLE"8Y%LS82?4.10=OY9M)(I%ANS+-Q)W`58U`JS,!N?\E?YLE(@-4,9.P2IX MKFT].%N<=">0<$J*[F@_RN^5\0ENW'&<=!,=-UQ[8A$(%20\$F\;5_E/497* M%[N7BU-&F4^5/-XLKUK6[1H[:=E:,A0X6A_9Y?$1_,F1E'9)R$RY/<]$LM*U M!!JCM-*]H`#:/^[CE`%0JQU9GH.O[+?ZRY`C9QR3Q4>J%U>S>'2I)3'&+@R2 M\[4J`T:RH%12=Q(%Z(W\W^5@#8=R?-"6%_J.C0+97=N=1T&0+%-:W7Q."2!5 M6;Q)^S_-B=VJ>+J.:6>9ORTLI]+_`$SY39KRR/-I+%A66,I]H+7KQW^'*)XN MH;\&K(/#/FPWR]J5YS6V;V32;;3[K1(X.!,K" MI9=J'QKFH)!][K9SE&=GZ5>SM[A)?T;/,?0(+(U-R0.AR_3QB;C,IE.)]022 M:XU#3;\IZ2R6[$@,/M4\GZ M1Y&UBYC5XK=RI[A3_3,5L9+:_ECY@85%K(?]B<51Z_E=YC`VLW_X$XJIS?EY MKUO&W*RDJ1V4XJQ6_P#*.HV_+G;LO^L,522;3I(6HZ\:>.*NBA7PQ5[?_P`X M^P1C5I'I1A&U#]&*O0_.WE.TDOH]5M$$-VZ21-(M%^(C[7SRG,-F[$4JFL[+ MZJ([E%:.)%+N?LD@=3[YBF(/-O!+%]?TR?\`2EEJM@X-@B,DT()`JQKT_P`K M*,D:Y-^.5BF$W:ZBGFF\CN^3I<1A[%@M42$$?`/DV('3HSZ;4BXAZIY M;T2*SMTD*`/38?QR]UR>C"AV*L*\\:;&S>J!NXJ?GBK#;'\NKG5I2U.$5=W- M0,59/9_E-Y9L4]:]DYD;L20HV^>*JZ:WY`T5^$$:%E_:`!Z?/!;(1+S[\_/S M$T?4_P`K];TNT0\KA80I\.,Z-_#)8SZD2A0?(>9C0[%78%=BKL5=M@5V*NQ5 MJF*NH,5=BK>*NP*[%+L5:[XJ_P#_U/.&9;2W3%6\4NQ0[%78J[%78J[%780K ML*NQ5V^*NIBK=,55;2HNH3_EC(RY,X3^:I!^61;B-E;RB\J:XK(#S< M`+0]RPI^.8?:,;QN7V0:G*_YI?1>N23K8Q^H`TH+&X(ZTH`I'^2-\TVBA43( M]7::8#B*0W=8)%O[3[10?6(P:@\:4=:>(S/C/AE8'+_-9%HWF-9XE M!;Z#FRAE$A8>4SZ:6*9B7>9-(T;6+%FN;`7TR_"@1A'*`=FXO[?Y65Y87N`R MPY90.QIANM_EG?VEKRT:?ZS;MQ2195598U!!^-OLMXW1+18KL3']X9`2$%=S4[HE1\>5,`0F6 M?\S)DA8&[`Q!E_25H]0OO+UU#/;W"LKI`LL=OT9G?@ZNA^#CR8_$/V<'$$Y, M49<^;$_.-@MC=_I>"%HX+MW%Q&N_H3AR*5'\U,QLV.V_2RXMCSBF/EGS;AD-O+;M10>YIW^>8<8$[N/(B! MX3N&VN5N[1TN+5"[`KL5=BJ8^7) MFM]:MIE%6C)(^8&1R"V0QEC^K_G=: MW2LBZ9;2#?\`O8P_Z\;7@>6^9]?M=6E9ULK>V:M:P((\%LACMCT8(;8T^>^& MT&'<]7_);S!::1K:&^E6."8,OJ5K2H(WITP@L98R!;VCS7KMC+I:+9744TKL M*!6#&G>OAE>7DRQC=B4%VHNGMRX=3'R1`?B;>AZ[9ADN52E>S"0"-SZ?$KD\.*&A1:?L@9L\1%;.KU`]5EGZJ%`4=%%!EKC+L5=BK#_.M_ M&@X[?`,!9`/.M0\^ZCIS!8)#QZ!:Y&VTQ#&-;_,'6+NL4MRU#L1RVP6V0B&- M3:[&I+22U/0GKOBDRB&+^<-6-YH%ZH-(P$`7N?C&6XOJ<;)*P\S%*>^9CC-4 MQ5V*NQ5V*NP*[%78J[`K7;%6\5=BKL5=BEV!78J__]7SEF6TNQ5V*NQ5V%78 MJ[%74Q5U,:5PKBK=,*NIBKL5=BK>*JEOM/&?\L9&7)E#Z@FO)E/P]6Z^V8U. M;:^O!?30_$W4]\"?)>.-O"X/]\_0>`/;'JR!$!YHI9.-D?\`(3;Z>^1K=L)] M+>AN8)K6<=>3&NYVV&=$L1U*XN=&OWCF/K6$]"&7]D-W4^'BN/(NYCPS`*R*[>U M8NK;=4(.Q[C_`((99BR<)<;7:*.:)V]3)-"\RP74L=LS4N63FBG[+`;'?VS. MCEMX^>(QV/1F.C/+,\<82L\@`>,;CXA3?VVR?3=I.VZ1>JW]V6;MZ;?:;]K,6<79Z74&(W>&>;_+-_I>I3VMQ$BSLBAXU/-2.-3( MI[_&#@!X78@\8L.TG3>$),W%$=:>HE2>5!0;Y`MW%03NSXV<*^G$RR@<:L*1 MR5/0]AA&[1D*O)YBU.[A326OY]*CA'!(8`M0@W5E#;-P.[4R=^3B\!Z&BR#R M5IFGV\ADO)I9KBXEY74EU(?4G%#2;E6GI[5X+]C*\ALMF.-1/\Y*O/&I_69/ M]Q\HMXY;A4]-BI56B4#F[#[$?'BQ_:^'_*R48L)R(":>08XM6L=1T&\_>QZ@ MS?5+HMRYS1J2S+_Q+GD<@MIE(PJ82_RCH5R^N7-F\9$UNQ25/`J:?CFJSQ)- M.=FSU$$=7H5_8WMC9Q36X/K1$405'->G$YKYXS&7DUZ?)&>TD=%YAMN"B2V, M,JD`JW6A%*?+&&40F*#&>G(ZV%GYBVL2?E]>I"P5S;W#,O0D%"P!SI]1C`\, M#^=%UO&3Q^Y\;Q_W:?ZH_5F_/-TR[%78J[%41ITP@OHI6^RK;_(Y7DY,H6-L@$//J\D2E>7TXLB2$ODNY MI#5CL?YC@M1$E0:]DC8;T'AVPHWCNB1J`900<%-A-HFQUA8W(9RCC[#C^.&T M0X38DG?EGS9>)YIT\23GTY)1$U2:<7%,CE'I8XQZGM-@ZGE$EPH7I$RC=/$$ MG-=SN;7`=G2:GFR',AQ75Q5`:IJ<-G`S,1SIL,5#R/SCYC#,WQ?C@+:`\RN# MJVHFXU&"WDDT^Q%;FZ`/IIV`Y>-3D2V1/$6#ZMK#(Q;?K04VJ3B$2)#=II>I M7?ERX\TW-U;VNE6LOU>UADD`EN9P1RCAC&]5!Y%VPTU))Y@U6RN8=02QC>"T ME8-;PR,'=5Y#X2PZG;+,7U(GR8I[YEEQW4Q5V*NKBK6*NIBKL5=BKLBKL*NP M*[%78JXXJ[%+L5?_UO.69;2["KJ8JZF*NIBK=,*NVQ5V*MC%78J[%78J[%78 MJWBJZ&GK1UZ#&1E0^]`:97D%ENTY(B"]H_+ M@M<^3I)WE_?VJY="3SG:FE`/$.KVW3KB]MO*EQJMB`;RX?T+:2G((BBLLA!\%#9D2G MM;H\<+R`%(+WS)INF:+L#/J#W"36]A&K-3DP,DK%EX'C[NC4+ZWBE59KF(/+<7@6,QH'81QIS'5ZGC_K8>'9MQY#$TA(=.5.Y29(+>+X28>%&8E%_P!THOP,?VL;M!%CA(YLKBN["#S'#K]F5-CK M%J):]!ZRK\0%?$','5S&,\33#$9C@/\`"R'0M4_2DZ&[41VP:I)&YIE.ERPR M3N?TL;79% M78J[%56VIZRUW'@TF%#UI7`QGS:.IO!<1W";M$PD`'X%%/TY&.FB&9%HRPDT[3N"V[?$YJ6:K%0-J'-;EF M#+9V&/"1'=Z;Y&U!W/HN2(RM8@1US-TTK=7K84682RQQ1L\C!57J3F8X`W2* MZ\SVH9DA:M-B9^;O.),\L:2@C=B0M2@)-`QZD=JG"A:;II'"D[G8@=,GC^ MIKR*&\5;B_O5^8_7@ER90YI M@`3[?+,8!R0O```KDDMJO(CEL!D26P1[U2[N6D"1TI"G;Q;(QBRR3XMD9,7M M])MJBC&3DR_/ID.9;R>&$7H'DC68;>REMW4@W)#)*K%2IH!O38Y@Y)[T]1H< M!.(23]KUE<)*:J6^"8=0?!LQY1<\!#ZQ9"^C8CX9D'VO$CO@"0:8R+B:&[CE M=2MS:L#/&?VT.W)??+8;.%K(<<#WO9]+U.VO/RX=&:>1=(N&EG@M06DFAD!X MH%'4,6^+EE@W%/+1N$SWL-6Z;5(C=74TMO"MR!:P%RQ<0"IJB4Y.K4X+\2XF MARPIS6:0'U M&4#C1.50PKA"2#U10TR99X8XH)"I++"B'F:UJ0-MO]E\.*@[>:MK%E':B"XG MC+73G@K@KQX)4MZO/[''^;_8Y$CJRCD)%7L$!:Z7>W%ZY$DX@EIZ7.J*J2'E MPY$LWQ]>+_"O+$E)C:5:W:6^GZDEK9V\M_YBE14B'`"*W,W1Y-R'DY[IS^'+ M([AIG,@VFFL:A-Y8FT>]\F>8$(!E6RF8$=:JA*G.C[*X,D1'J).KU1G$?!\ MB1G]VGC0?JSJ"Z!=BEJF*NIBJI!M*,IS_2V8OJ1@E/;-<"YA7K<%=\*%079\ M<52JZE83\E-#N:_37)AG(5N%L>HJQ8N""?Y17'A90SJ-U?LPXJ"J]R>IQ$6J M>0E9`Y.YZ]LF6J*(#%>M-^^17FHSR,A6G1NGAA"UU>]_DIYQGTGR?#;W"B6- M)93;[T(0MLO_``64Y-?''Z2'9XM%QP!MG-W^9^>KBAC@(W MRPVC+2\W^RGQ'PR);,8W5;B=KF"1&WJZ\3X4KD:IME+BV3G3+ MF6+TS$VR@4'RS79XV;>I[.RU#A9Y:SK=VR3*I5B`)4I4$CN,1"XV'8F5<^JJ M)E)%6KSJJR#I7^4Y&,+8DI)K\+R6[R(.-S`A,1_G3NOS';+#$-&21`)#U?R7 M:7.G>6;+7+*S(MI+4QZG:%J>HM`0PKMSKXYA2U0CL0\KP\4COZE*[\O6&MVY MUCRHZW,L86W@TV1OJ_U('[:\5HU6)Y'E]K]ELRHD$6.38,O#Z9\V)S:"H\P1 MPW$,IMM-"07*QGBH9FJ#)7CR3JS;9,'9G]1#+QI<=];R31W+P1"*5W$45:1H MQ4_&:<>8'P_%D.9;>(QV8QK%M8P7.G3ZC:&*`45"2"3')2C/1B_&F_+A^UA` MHLI$'<W+TR?B^U@(Z,[H>]*&\TZ^MXUR"L=@[+(?MHT M@H%"\34_"WP\J_&RXF+,S`&_1F'E_P`M7]@\7FOS!(&N?286-D2`>8W624B@ M?;[-?LY.,''GD\20C'D\WNI=0U#S3R>3E=W1=W=M]U^("GA3IF'JMHDN_/!C MC&(Y4];@L[BZTR*.4?5BD?Q%=CL,U$HCAMU?$(2V9%^7=J]]HMS:SKSA@=HC M(:5\`9,9XAZ7![0R''D!'-BWGQ8=,TC7H710#:3)')']DU0C,?%'P-4 M(CE*2Y+GC)M\GQC]VGR'ZL[4AYT-X%=3%78JOA_O!E.?Z6S%]2NO_EQYL\OP:/!IDEG_IEG'Q<= M?5%:\T\3_,,PLN/>W)$O33.F\U:9`7:UL%BCH%25E7XF(K\5.F5V#A"0HC6[66UM[:YWF:A!7\?OR&4>ERM%*LE'D MF-SKFGV=C+'<4^.-@JH2O`J#O0[?%E.$^ISLT-C[GDR:Y.[B**KNQ^$#WS>7 M0=!&!G*@R%;:2QACFEDY3RH"2=B">P'A_E9"91_,<2S?5+K:*2@(.]#XC*<9 MX)4?I+O\.;Q8_P!()K?VITO6)(&?E:7?[R$]02>WMD"6SDQ-T@KR5+E#: MRMQEZHXVJ#MUR%WLM,J\L>;H+'2)+76YGBAL$`A"[B0$T`85S3:W0DG;B+J\ MNGX97$;)P8(X5'F31M26UN&"F8H08WKTB=:_&M/^!S'T^IGC/"6J>+CV(91; M>9]%UR"U_3$+:;J$;+(XW,;^G\(J_P"W'\7]V_V&[*Z\]D;T_@XY>#NW#)"J(X9,/[.#S9#-"MRNT[R'YS47BVFGK!:")H(IY;D0@A?]V) MR^+K]E&7TN.2,26`U,+KFF&CZ+Y9TK41=3S2ZMJ*B-6CBC:6WBDB!ZN?W;GD M?!%1LF!WK+'/)M7#'^DUYFUN]D,TSK_I'\S,&`4[4V_=1U'[*EFPY)T-G9:3 M1BWE.H:M,OF6TN7?]\6XLR[!58<:4S"S#BB7,S`"0%;/7[9=2N=,65I3R916 MG?.;E(WY.,3`31.E:VNEVGIEI84<\9I%!*%CW-,MP:B<-@6O/@XS?I4O/&739\IQ_87Y#]6=I(/-AO(J[% M78JOC^V,IU'T%LQ?4K'-;W.:6CX8JMB7E(_CX9,-97F(G:FV%5IMJ]0#\QA0 MM^J(/V!BE=Z/:E![8JL,17%5\$89BK=^F0FWX0K&.>`AT8J5W21205^1&0-% MN(9)HNN1W5U&+VPV5K,I=X7,D:U MB/+E7O7=U<2+\\! MY,H\TP!Y5[`9BN0M+"M,*VW^KOD5"(T\QK=+R%6(-/;!-OP5:LU^8;D*IJ.? M)@>]=J9#AV;?$]5*$[M!>R^D:J6Y`=M^V'HHF8RV1EO@7E[!K?EJ!X9/3OH"*GNK#^!&49)V`'H\9XQ82A8>$(,_5A<$LO`?:DV_ M5FCR:*4*[Y.NPS,I'?Z4GTK7+::5(KFU9-.BJ\5Q%55=VVK(R5*KF6.SK_=,^T[4]-=!%JDQM5`Y0LKE5(`JI]3=&&9PU4\0K+&_P"DZ2>G M,SZ.:K!J]Y=AX],AGN+9:H9Q)R!#;;4K]^`9M1F'HCPQ_G-IP8L5<4O5_-4M M(T#6YH4AU.ROI3'R51%.`G`L2.?3,[3Z9-271+,6T M&EI]8=6/I22_6):4I4*!Q4?ZV6RD8CDY&ATWC&Y2]+Q_6M1UJ_`T0ZG)AWM&VM\TL]U]7FXQ$D20,*I]QS!X:#DY( MU5A!^9)XH?*5];RNO)K:81@=/L^&9^CWG"S_`!1==JP>&1I\UQCX%^0_5GH! M>3!78*6W8TMNQI;7Q_:&4:CZ"VXOJ53FL[G-*TXJMC2LZ$;,2`?I.2#"2;BU M\!A0N^ID]L5::R]L;0I-:D=L*J+14V(PI40!&X/8Y";?@*8H%9`.H/;*7*0] MQ9KOQ`H>N&V!BNM]2OK0+&:3V\;@'3+*`:IYY3.Z!AB5!7]KNQW)P%@`O9CD61*&G-0K6E:DVPN$'^5;.'V_YYE\DP MKK'07$8K]D]&IFORQ>J[/)J^C)H;/3XXOKMN!Z,P_>A=P#_-3``'86AI+06\ MS.L9-O)ORCJ0*]3Q&$#?R4"T-?VZ32680+,%G3@:?%U^SO\`JRG-7"7#U4:C MSI[6NCWESY?#3VOID($C24@#T_VA'7NPS0Y,&7&/$ER#J<>6/%PQ]7]5YS:P MZ_Y?F:\6U=]+61HXKE`6`CK_`'<@!SH\.21@)UQ`N?CQXLWHOU,YT7SAY5N[ M6BF.VE0$26\H_@!JIK_+EXS1(_6Z_-V9FB:^I.[31?RXU!([B`/ID[*3 M):=6N8^G$D2*P\. M1X`Y"1X>LG,T^GEF^K'CB?\`2L0N_-8TU&H=9*QW$=:DJ?&G2F0U&+CA3K=1A!9S8>:X&^ MLA8(Y!<;P-R``/N"Q_87Y#]6=R7E5V15V*NQ5=']K*=1]!;*?S$DWT?SAJVDS^ MM:K"U5X-'(G)67P(RO\`)PNW.P]L9L?T\*(A\^ZY"TGI16ZQ2$MZ/`E`3X"N M1&A@')_T1:CNA_I4.?..N*Y>%U@!WX1UX_0#7!_)\/-B?:#4'I#Y-P>VL=M+!IPBB-4X M0L#7I6O+!JNR\6:(C+BX1_-<7!KIXC<:233_`,WO.VGW2(J7B M:O4,C$K3)XNSX0%`RX6_)VK.?.,+_G5ZE'5OS*U?4Y#+)IVGVTK5+-;1-&"Q M_:X\N.&79^*3=A[?U./D01_2"%A\^Z_`K"+TDY5K0$=?IR/\FX_Z7S;9>TFH M/,8_]*VWY@^963@TB%-J+0TVZ=\![-Q_TOFF/M)G'*./_2KHOS"\Q1&L8A4^ M/`U_7A'9N,=9(E[2:@\Q#_2N?\P=?DWD6&1NQ8,:?CC_`"=C\V/^B+4=!#_2 MJ$OG76YJ^KZ;(37A\06ORKDOR$/-B?:#.>8A\E)O-NI$$"&W6HH>*'H/IP_D M8=Y0>W>-H758Z41A0TWQAV;")!!ELXL];.5W6[#P``!X;9L+<1O`KL M5=BK:L5-1D9P$A191D0;"XRME'Y.#;^8DM+DXC1P1^8DOMYY+>99DH64U`;I MMDORL$>-).X?.NK1_9AMS3Q0_P!<'Y2#+\Q)$#\P]>'2*V'_`#S/]7[45N/DA_KC^4@DYR4))YBOW^TD? MT`_UQ_*Q8^*4'<7LTXHX4;UV&)TL&0SR"U+F1104^=,'Y.#,:J:[Z[-[?=@_ M)P3^F\!@_)P7\Y-QOICU"_=C^3@OYN:PW,A[#[L?R<%_-S:%S(/#'\G M!?S5W% M#^&2C@$3809DJ9&7,'8%<<5=C2;:P4KL%*ZF%6J9%78J[%78TKL5=@5V*M'% M+N.%7__5\[9G-#L5=@5V%785=3%6P,5=OBKL*ENF*'8J[%6Z8J["KJ85;P*U M3%6\5=BKL*'8J["KL5=BK6*MXJ[%78J[%78JUA5V*NQ5V*NQ5V*&\4NQ5V*N MQ5V*NQ5V*NQ5V*NQ5V*M8J[%78JW@5V*NQ5V*NQ5V*NQ5V*NQ5V!78J[`K6* M74Q5O%6L5=3%6L"MXJU3%74Q5U,"6M\4NQ5JF*'4P*XXJ[%78J[`5=BE_];S MMF GRAPHIC 21 g852944ofg1.jpg GRAPHIC begin 644 g852944ofg1.jpg M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D M``#_X0./:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B`\ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M M,30Z-38Z,C<@("`@("`@("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO M+W=W=RYW,RYO7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN&UP34TZ1&5R:79E9$9R;VT@#IX;7!M971A/B`\/WAP M86-K970@96YD/2)R(C\^_^X`#D%D;V)E`&3``````?_;`(0``0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@(" M`P,#`P,#`P,#`P$!`0$!`0$"`0$"`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,# M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@#<`*H`P$1``(1 M`0,1`?_$`0@```$$`@,!`0`````````````"`P0%`08'"`D*"P$``@,!`0$! M``````````````(!`P0%!@<($``!`@0$`P0&!@8%!0L%`A\!`@,`$00%(3$2 M!D%1!V%Q$PB!D:$B%`GPL<'1,A7A0B-TM#7Q4B06"F)R,R47@I*B0U-C-$14 ME!C"TG.STV2RDR:W.'@9.8.$5;4W=R@Z\J.DU$5U-D:6MB=8N"EY&A$``0," M!`,$!@4&"0<(!P8'`0`1`B$#,4$2!%%A$W&!(@7PD:&QP3+10B,4!N%28G+2 M,_&"DK)3<],D!Z+"0V.3=!7B@Z/#-)34%K-49(3$)35$I&5UA94(\[3D5:4V M_]H`#`,!``(1`Q$`/P#X*[A<;BBX5R$W&X2165*1JK:I:I)?6!J6MU2UJD,2 M22>,714*.FYW*0_UA7?][J.?_I(=(<4^BYW+2?\`6%=^(?\`6ZCD?^G_`/SXV6P."R7"?8K1FXW#/XZL/_T4_P`_\^-E ML`T989R(`6&'] MI>[/\N-]L!A08+F7C)R`3BK9BNKR4SKJN6/_`%E[CB/U^,;[8CP"YUXRU8G! M7#%?7R_Z;5^\/^TO9Y_UXVVHAQ0+EWY%I%\:*Z8KZ^0G6U<](_ZR]G/+\<;[ M48\`N3>,@U3@KFGK:[`_&U>.(_M#W_G]D;X"/`8+F7)3`+DL3Q5[3UM=B/C* MLDX?](=X_P"[C;;A&E`N5=G)S4EWS5_35M:9?VRKR)_Z0]GA_E]L;(1BV`7, MN7)8N<\U?4=978$UM60/_=#V?^_S,;(PCP"YDKDVU.:#B5LM-5UON?VNJR)_ MT[N>(_KQIA"+8!8+]RY$AI'`YXK9J.JK5$?VNJ[OB'I< MZY`6&[=D^);#'FMKHZBK]T?%5.`$_P!NX?3^ M/&<:HVXG(+GW+LHU)+-Q/-;/2/U@`!J:D8_\NX/U?\Z-ENU#%AZER[UZ8%20 M>WDMFI'JO,U51++_`$[F6?\`6C5"W'(#U+FWKTP_BEI[<<%L-.[5F7]IJ,<2 M/&=.1Q_6RC9"U`UTA4[E4`":FHQD1^V=X']IJ!QGXSO_G1>+,/S1Z@L4MS<)\,I#O*E(Q4G=70?G)]90MRJ&=14#O>=^L*P@Z$.`0-S<)I(^U1G'*O' M^TU../\`IW?_`#HKE8A^:/4%?#95:^[58_P!IJ!QP?=/'_..,S%$[ M,!D/4%JM;BX26)PXE4=2]53_`.DOXRE)YWGF?>QC/*U#@/4M]O<7''B-6S*U MZJ=JI?\`2J@F*:C[:+6JM^LD0*JHPSF^[P'^=G&2 M=J&)`]2Z5J]/`$TYE:M6/UF,ZFI,R`77L7)4J7`X\U0U-=78_V MVK'#_I#V9Q_K\(YUZ,:T"[&WF2U2J!^OK\OC:O#_`-TO<)#^OQE'-NPCP"[% MB1H'.H*AJ*^X>]_;JS!4_P#I+V4A_EQS[L0^`P75M2+8G'Z%2/U]?C_;JO&< MO[2]Z/U^(,<^X`NK:D:5*IGZ^X8_VZLE+_M+W_M(PW`!DMUF1:JIGKC<)?\` M3JS#/^U/N-PU*_MU9G_`-J?_P#/C%,!:XR-"]%5/7&O MFK^W5F:A_P!)?Y'_`"XRD!UNB2]54N7&X3/]NK<\_B7Y?^LC+,45\"55NW&X M>]_;ZWCE5/B>.4_$B@LM#EU5NW*X2_F%;G_VI_\`]I%$@%H4)^YW#3+X^MQ' M_:G_`/S^R*9`*R*I7KE<0?\`I];E_P!K?RP'_*17@%9DHCMRN,D_VZM/_P!% MOC*6/^DBDXIQDJUVY7'_`+?6X8?]*?XX_P#*15DK(X*`JY7&1_M];D?^M/\` M;_SD0<5*CJN5QE_T^MR/_6G^7_I(KDGX*"Y<[EC_`*PK>'_6W^S_`)R%3@EU M'__`,J)2G!2T9^C[8L&"0J8C(]_V0^:DXJN-UL!G7*N2(H>?L5]3">)'$$>B< M;;8&`7+N.=3X@T[%?TJ>..7LP^V-D%S+CD'@P]JV&D3*7HPX9G[(V0JN;,`! MGS6S4B?P]@RX`D*(^J-,,U@O?5)R?VX+9Z1(&(SSRECIPC7#FN;>Q+?-^1;3 M1(Q$@#[H/8#A,=V$:H5Q6"[0EF=G[UM=&@33A^MQP^@$HU0"Y]V7#BMMHVIR M'$2^HSYQKMTQ7-O8L_Y<5M5(V,^[M.(E/G&R`P"Y=Z0`)K_"MHIFY`#*>/T, M;+8#T7*ORH7],%L=*W(C#.7?(',WT"JGFY`X9^T8=L9Y MQ6RW<:3*BJVP,`/O6I5R/Q MB4P3QX3G.,DV71MDLV2U2L3G@<@9#GB)2]<8IA=6T21JJS#XK5*Q.*IR7V?=&"XS$B>T^S$1 MDFML0[`JIJ,U=_V&,AQ[EKC4A5+@Q[R/M$9)K1;Q54]^M+E]/;%!Q6C-5;F, M_1+OF(SR6@?!0GI:3V"*I*V&*IG@)J/=]D5'DK,VR41S(=Q^R*3[4XR58[]> M,5Y*R."KU9'NB#BI3#ASER'Z8K*?ZR@N\>V0]@,*F&*BN'/OEZOZ(4TB@8J( M<5'O^J$5HQ48PI323*LS].$(I&"C',]Y^N(4IE?XCZ/J@0HR_P`1]'U"!"2< MCW&!`Q3,)+%6*=;/YE;_`-^I/_7MPJ#@BY_S*X_OU7_$.0T4*,G(?3C#I#BG MT?A/^B8^H1;`JLX.K%HX2[O:(N"K*G,Y9'[ M/Z<8MBD.*LF#EQ/'V_48OC1525FU@1W`^V<:8+-/!U8L<>X1IBLT_E5HSD3S MC9!8Y?*K5C]7T?9&NW\5DNXJV9PE]G;/[XV0Q6*X%;T^!EPF/6,HVP6":M:? M\0^F0C=#!,O1A]\;+>*Y5YF(#\/51;#2N-,!@N?<(J:UI[%M=%@?IQ*8U6PY7/O%@6],%M=" M,4_3]:-<`RYUTXGTQ6WT(_#W>GC[<(V07.ND.#5F6TT:0`.1'_DD'TQMAP7) MOGPDY$?"JVFF21(B4TC`=A$L1+"4XV6P#3BN3N"8N1B%LU*G`)YB7U?;&R`S M7+N$D&)X?0KQA'X4RP$AZ!F9^F-=NH=?,3_SOL)C),>M= M&W+/+\JUNI`D<)2P[92)QC'<"ZNWD!W!:Q6#/M&1SRY1CN"JZU@TT^F"U*M' MXN0F?1G&*X%U;)9X_5=:E6C,2_5)GSF9^F48IMBNI:)=CP*U.L&)/(*^T_7& M.Y@RZ5C*7)EJE:,%3SFGV"8^N,G&.?=Q*[&W#P"H:C,GDHF.9>HNSMZX\515(Q[]4_J MCFW5U[%/4J)\>ZONP]9C!_P"V,<\. MY;88^G)4S^9':1[2?5&.:VPR5149GO\`L,9)+7')5+DI^GZ@8RSP6BW0JI>_ M$9\2M6#%0GLOIS$4Y*P8JL=S/>?KA#@K!@5`7EZOKA3BI&2C+^OZ?9%94_64% MP\/\I1A?K MB%*97^+N_I@0HRC,DP(23D>XP(&*9A)8JQ3K9_,K?^_4G_KVX5!P1<_YE3F.[[(<)C@I",SW?:(E(IK?+_)'V??#FH=5LU%+1D>_[H8*#4*8C/T_8 M?KAXI,E-;^_ZH?@H/T*:@^Z.S]$,DEC16#)E(\2!,\.8],XMC5)+!6#1)X\3 M/TX_7%L<55+!634](/*7LG]46Q59P5@UEV?;Q,712'%6#)P!/(^R<7A5R5FR M?P_3(QI@LT\%8L_9A&F)62?RJT9.$OI],(U6UEG\JMF,TXQKMK)<#JU9S3]. M,;8%8[F"MZT_9]@C7#Y2N??'V@;"JVFD.`':#ZL?:(U07.G@1S= M;51Y^KV:3]D:;:P7PX(],05ME#FGN_\`*C9'VKF7:AQZ5*V^@_5[O;C&N%%A MNB@[5M-)P[O:=4;;:XU]])'IFMIIE<.)EW#\.'MC;;R.2Y6Y^L!B?R+9J;A( M\/MC9`T9L*EIXRP,I<3&NVS,N;=X\*JX8((EW$CC(!,\(T1P6. M=1WJR201V19$T8JF0/;/[(K)5T!PS M*IWR!J',I'J&,9I8+;;P(XGW!4-001W3'_"_1&::WVAX0%K55*1^F0/V1CN% M=6Q'T[EK%89DGDD@S[HQ3X+JV1J.K)F6I5WZPY@_^2#]<8YKK6OF('I@M2K< M\Q(`^C^F,,\.=%U;;ZN3%:G5G`]L_J5&.XNG8'@].:U.MG(D\QZ?=EA&29%> M%5TK0)8\Q[EJM83I(&!`$^R9&<8;F+KKV?DTG$,M8JQB>Y7UQS[F"ZME]8XU M^*UNJ]I$_:91ANE=G;`,`%N2U^H_6[S]<T MQCFML,`J>IP6J?+#TSC)+!:XBO\PJ88*.*%&3D/IQATAQ3B,_1$24)]'XAZ?J,1%"DH_%WC]/V0R%)1EW$_?\`;#*L MXIY.8APF."D(S]'VB)2*S$1=%)+XJR:P,^[[8M"K(HK)HX>SZY8=T.JU M.:P`F>?IF3%\5606JK%G(]\7QJ57-6;!XY]G+NC1`U99IBBLFL_2/MB^*S2P M5HP3*X9,I8< M9_7'0M8KEWV;M5S3Y^H^B<;[1HN5?C4G+%7=.,9_#[XWVRN1<@\B.9]JO MJ8^\.$\AR/&-L#1\@S^J-,"L-V+N5LU&<.?VB4:X$+FW(G%ZK:J)6*1V2["9" M-4%@O.Y[/X5MM$9%./&4NR9]@C5`KG7($>O#TX+;*-P)'(2'US MG&B,J/;C&>[P,^,HQW#2JZ=B.&GE[N*U M:L(/ID,1PC',AZKJ603`-G\%JM:K\?'&0],ICT2C#<-%U[,6=_3#W+4J MQ6*N(Q!QRQ/?&29]:Z5H5Y+5*LX$%7:.['U3C%F,5R MBZMFM6KZ46MU1SX2&79-6/HCGW2NQMVQX>GP6MU1P].?[MSXRCF73FNS8<$#.BU^H.8XD_9]I$S14-1,3^G*,%S!=*V&\*I'C@8G&22TPQ58Y^(^H>V,L\%I@JE\^\J?TF9 M_5%)6F*K'2)B7?/OB@JX*O=GIG]/H8ID5;&E55.F9&664LI$C/CE%,C2BL'% M073]?U8>V*SDG&"K7,">_P"J*RK?J@*&KM[/KBL\$V:A+.`Y@3^GJA2@8E0% M\>P?9/[84JR."C+E[Q[,.V8$(<5(#!1E?A/H^N%*>*8.<*4'%,G,]YA4PP4= M6!4>1,0I496(4>8,"%'@0@Y'N,"!BF826*L4VV_S*W_OU)_$-PAP0<%FY_S* MX_OU7_$.0\4*,G(?3C#I#BG$9GN^T1!P4)]'XAZ?J,1%"D)_$._Z\(9"D(.) M'TSAE6<5(3P]$.$V2D(S]'VB)2*:W_Y(^R&R2'%2D:LVCE/CF>.&$:(E9IBE%:,?A[C&N&(628IS5JQF)Y3_`*/JC7;-5EF.*MF3 M/T<^"Y5\9#%75.92[1C].^-]LKFWQPP(JKRF)F M,AEZ><="V5Q[@:3]BNZ96`,\IC#F9"-T%R+V%,`X6P4QDKLD.';C&V!*YEZ( M$J?*M@IE249F60ERY`=\;(&@&2Y=X`3D_P`U.[L[5LU&H^[C+5@9>F6$:8LL M5P%F&!6RTBLL9XY=P`(]8C7`T7,N@.ZVBC7(B1XR$\SB#CC&J!>JP70`<3CW M\5M=(L31CA,'OR^V-4#ZUS[L1J8"CK:Z-T2!F.S'OG[(UVSQ7.N@-@&6TTCN M`,Y"4N8RC7`U9&9(!YSDGQGEV$8SP[8S2EQ6^ MW;X+7:I[W<,QA/(REQ(Y",DY+HVHNP&-/5S6LU;GXL9`3].&@`'AG&&9IS77@*_HT]RU2K7BH89`@C.*Z]F-0.?Q6O51,^>)E/LF(YMW`KMV1XA MVJ@J3+LS,^//[8YMPE=:R*@JAJ%2"CW^F.=<->:ZUD4?)U1U*L\"VV@J9XXGTGVF,=Q;H9*F> M_$>SZ?68RR*T1Q=5CIQ/9EZIQFGBRT1P'%5#Q]\CM/Z(HR6J*K7#+'+`R[>R M*)8JX8*O>/N_7V(BDJR."@/$RF)\2>4^6.&4*4X5C[(56#!1G,CW)^R*SBI4 M9>0]/V1"<8)DYPAQ4'%,G,]YB$PP497ZWIB%*C'(]Q^J!"8@0@Y'N,"!BF82 M6*L4VV_S*W?OU)_Z]N$*@X+-S_F5Q_?JO^(*3-2D'VD?5^F&&"@J8@S]D61*K;)3FC+ MTD?6#%HR5>:L6U8I[)R]9SBP*N15@UFGT#UX1:$N:L6SCQD9CU19%(:*Q:5) M/,RG[1RY"+XXJJ>"L&5?88T0R5$\%:-G\/?&B)62:M&#P[`?J^Z-4<'6>0<, MK5D^\/JC9;99).>]6K)$^_\`1]T:X+'=&*M63E],3&VV5S[KNZMFCZL#+'#* M-ELK#>"MF58B7&4_JCH6BN9N!2BN6%"8^J-]HKEW@Q5RRK*6>`/='0MFM5RK MT6H/3-75.K\/TX-,5RKWRUP=;!2J_"<#CD>\X^C[(V0EEFN72E"I[,N/ M+*4*9JR-L`45:]5)D9FV,DRNC:B3CB2RU>K=$SZ^/,RX1CN'@NG8CXN0'\'Y5K%8Z,1/. M67I)]L9)E=&U&H?-EJ]4N>KDB6/9, MQBN'CDNI:CPQDM=JE@3)G(#ACCV3CGW)+LV(")!."UNI5V_JF7>3@.^,%TT[ MUU=L*AL66NU9$\^X\AE'.NRH5VK,`&?%4%2K`RPXCT#ZXYMTKL6(Y9A4%0K] M'T],0Y*BJ3(2PS./IY2YQS[A#KJ60>]450?29S,8;A72@&`'%4SY M^N7ISPC#,K?!V5.^<_7]D8YFJW6Q6N+*F=,IXC$X]WJC)<.)6R`J`JAPS)]? MUQE*TQ#JK=,@KO\`TQEEBRT15.Z:CK.'? M"$54C!0G;X=BON,.H4YLR]!]G'ZXD)#BIB2)CZ9X3[L8:*AZ,IB M3@.8P^Z'"4T4A!R^G+[#%@4?64QLX?3Z<(<8JN5"K!LR/H]LQ%@2%3T'V'#T MXQ8,%4<75DP,:8&BID%:-'WAEPG&R!=8 MI!BRM6E&8[,/IZ!&NV:+-C6N!]"KZF7D)GEZ,9B?;&R!S7+NQ8F/,6=3BJ3M^&2R:L M_P!8_P#"/LD3`;@4QL'T=,+JC[Q)RR(U8#/#F3"&8P&"M%DBIQ[U7/58$P#. M6($S.6&?&*I3?%7PMY1Q[U4/U1G,]F'O3G.*)3#+=;M2$OX515%3A.<_2KW< M#F.,XS3GZET+5JCY\>':M=J:B95[W"7&1DG@,HS7)4Y+;:A7G^1:U5U$^^9E MV8S^R,LY8KH6HX-B3ZAS6M5;TB<>,SGGCCGP$9)E=.W%F`P=:S5O3.9[.[[9 M\8R3EF5OM1+@+6JMW$\CZ>[T",M=6Q" MH;`%:[5+E,&*O1P],S'.NR77L0H&Q=4%0JZ!`Q3,)+%6* M9;?YE;OWZD_B&X0J))5S_F5P_?JO^()4*Q1SEP]4Y?5%H4%3FE"8Y'+MYGLE*+PJ M)*T1P[A%T2J9`JQ:4)`3X`=D:(E9;@JK)E67/`>J-,"J9BCJT;5CW$3^WOC7 M;-%CN#Q.K9D\>4OMC5`K-<&?!6C)Q&.)X]_Z8UVSZEBNQJZMF58?9W_<(VP+ M$%8)@L0K5A6([MZ27S+]RNZ9>7HG_`)O"4;X2R7,N M1K[^Q7E.O+',=IQ,;;,;;99I`R.'"<\L,<^8B^,V6.Y:'=EZ M.KMBKRQPG+Z_K,:(S"QSLEVR].:MF:O`$$2RF>_+UF+A.O-9C9+9-ZE.162S M)&7=/E+.+1.JS3L#-Q[OR*2FK)$Q(CD9S^V<-U%7T#B&(Y_#B@UG<.^7VP&X MI%H8A@5'G%0':H@9\\#+#F?;.*Y3&2TPLD9*K? MJ_\`*.,N7/'C/"*93>IQ6JW:.`P5'45,YD83Q.$YR!EF8SSN9.M=JS+$194% M149G`F1QY>Z!SQC/.7J6RW:8.0\F^':M>J'\SE.?#@93.<9;D\ET;-IO&<3^ M1:]5O_BQYS!X8SSS,XS3DMT+>9]*K7*E[OR&$L>($C&.Y)UT[,&`XLM=JGL3 M.>,P/3RQE&.Y)=.S;S.:UVI,YF7T]$8IE;H!ZJH>(*B.`&)YY3C)<*VVP6JJ>H M5[TAACZI']$9+A6F+JK>5A+F3&:16J`50^J?>R?UX>@"*Y)U#6J4Y]_I,P/;"%-%1%'''M M,^_/ZH62;-15_A/TXPJE1E\.[[?T1!3C!1UGW>\C[_LA$JCK/#N,0G&"C+S] M'VF(4ILY'N/U0(3$"%A64"D8IJ$EBG4RV_S*W?OU)_$-PA422KG_`#*X?OU7 M_$.1*E1DY"+!@DEBLQ*A/(_"/3]<"$^@X2Y9>V!"E)Q`[H$)_EWCZQ##%(,4 MZC\1[ONAU!Q=26^'^=]T2$DE-1EZ?NA\PD(S4MKAWGZIPX424M&?H^Z+!@D* MF-DY=LOJB7S42"FH.$NR+`4A%%8-Y@#(:?6!C%L<%65/;41GP$X<4JE*M&B2 M"3E(?5CAV$1:#@D.%%+:)P["/:<8NBJRK5M0,L\\> M_P!<:(%9I@'%6;)$^_U<8T0*IRJK-I6([/H9]L:X%8YBJMF%>SNE*-,"J)`% MU:-'A+ZN.67.-<"Q6&8<*T87B.$QV1LA)8ICQF2NJ=SV8C+''VQNMR7-O0?M"NZ=P^Z9]^ M4L3CF<<#&R$@N5=MFIR_*KVF=(XYY992^H1KA(+G7(F)Y9=BO*=Z4L<,C]_; M.(?*S?E[UL%*_/`X3]6$N)[(T1DL4XEG;W*^IWP)'.?##,JS'. M-,)+#>MT=O1U?4U1^''T82.V-,9<5AN6G9L>'K5]350D,1B.SE%\956.4 M01AZ,KQBJXS&/+3+(<(OC)9;EL''/L5RQ68":A_P>??%PFLTK5'%?4K-JLF, M%<<92.?"6,6QGD5FE9!#UQ]**:W69`D'D,)ST@3Q[8LUA4]%\6]7+FGTUDLS MGSD#]AANH^"3HF)Y(56'@?1-./KG$]3)U'2)PP[OBFEUA)EJ&(EF)\NZ4(;B MN%FK%O3V*"[5Y@GLS`[C%V*C-ZK2+>3,53OU M0EBO*>.&6/O8SQX1FG++-;K-L$5^7\JH*I\XXS M'HPS]<8YR74LP..5%K]4]G]^9EE[(R3FU%T;5MZAJ-[E05+N!QY\I#T^J,%R M?!=:U;&=`J"I=&)F,>/=D<8YMV2[%B!?DJ*H7.?9GW\O9'/NR76LP&/)4=2K/&0.9RY?7'/N M2S73LP5'4+QY3)(R^G",,RNE;C3F53/KSEF."O`<@!5E0H<>7USC-, MK5`/BJA]7O2$I>W@/1A%$EH`]2@+.?=Z?I,Q1(YJV.#9JL<,\IXSP].$5%6Y M.%5OGZ#B>(/=%,C4IVR4%:CEV$^H'[HK/%,,56NFX_5`A,0(2%9^ MB`IHI$)+%,IEM_F5N_?J3^(;A"HDDW%9-QN9('NUM6<,/^L.=\0ZARH:7#B) M#@>/$#MAA,A0:I7B*Y#V_?!K*&2P^H23(<>??SB1,E2`"G$U"Q/W4^L_5A#: MD:5(35+`'NI]O'TPR52$U2E2]U(F1Q/.)=0P4I#QD3I'+,]D3J*@A24NJ&0' M/&?WPPDD(=3FWC(8#/'/LRQ,.]4IB&4QMP@H$AB3//NYQ8"D(=34N2&J64@> MWGQAP4A4MI?'ME+MPBS$)5.:)F9\A$O1058M*GEPD#CCQQ![8M!95EBIK9F0 M>?W8^B8BS)DBM&5"4O8>,6#!*>"FMF1X_=,B+8%5D*R95,#LD#/CC+"+P53( M*Q;5B#S//B)QH@5GF/4K!E6`QQQ]`X$CE]GWQMMR7.NQ$@QR5PRL"0!RR_3QC=;EQ7-NP& M62MF%@:3W3[\HZ%N2YEZ`QR*N6%$@3(SYX2($YQNMS7+O6BKEAS+'CAVXCLC M="7K7+N1<PXS[I#+OC9;DZYMZW4@XY_D5U3K,P)\N(Y&-L)#%'HG+EE&N++F7'J**\IG92QSP'LEZ8T1K189O'T=7K#PF)J[>1 M_%EAPC3%8;F+TK]*O:=P&6,NZ7K],7Q)6:<0:LWTJ[8<$D^\9]_^2>[&+XR6 M2Y;;!J*X9>3A[Q(EV9^@3B^)62X*58A6S+P,CJ,LY`B46Q/%99`O0!6+3_)9 M!RE,3[^Z+`1W*DZG)'`=V$09#/%2+9:BKW7A(S6 MH]F!.)XX8B()J^2D185#]B@.O#'WB.&8R^J*926J$"11@#P52\ZF1)6>^8,I M#AA*4QWQ1*2UVK8'`E4U2\`%'6>&7Z(Q7)^M=2S:%%0U#N*L?;[#PPC%I4+[O;SQ]>2I7EY_5Q^F$8 M;DET+402JAY>9Y#V\XQS*VQBJA]<@3].$8YE;;<1DJIY>'&4L?3E&696J`95 M#JL?1C++T1GF5V#),,"H MZS-4N7UF*Y*8XJ*X?Q9RREVY0J=1SP$++%DV3)DF9/9@(0HBHYS/>?KB$Z97 MGZ/M,"$V"M65Y"?+],;K<\US[UHC#!6S"SAC,'+E],(WVY ML5S;ELD$9%7+#A`P.(^H9CCQC=;FQY+F7K9(IB%<,.9. M'IGGRPC7&2Y=RWQ"N67&,:H2X+#=MT8Y=JN:=[$8Y9\9R5Z8U1D6 M7.N6^'I7%75-4F:9DSPGB1AGA%T2&60B6KQ8]ZO&*G(S,N\F>'#E%T3Q5-R( M;P@^@R5LS4Y&9_WQ(Y1?&5%DNQXJS:JLL<,YS4>/USBZ,LSBLDX-0.W?Q5DW M52$YY3$\?IQAQ(8*HVY8U]JF)JQA)6'83Z<<<(;5EFE,#CDG/BYY$=N)_1#" M7%52CPQYK/Q8^DX#(\5(A'%BFU54YB8XD3*O1C/"%,N*LC:?"@[U!=JI_KX9 MX3YXB%U<,4_3R/Q5>[5RG(^O5C]D52EFM$(48/3M54]4X?B.7&>'W3BF4EIM MP<]W-4U14SXG#&>.8^^*93HP6B-NH)>G:J5^HS&J>,YXRSX8<)1FG)EOLPU= MF*IGZC,`\9SQGG.9E.,DY\5TK5K"(P]N*I'GAB)G,DXF7=QC'<^/H'HC' M.3EUOA`@,JAY4<<229_0SXQ1(T5L`YY*JJ%&&?VQ5(Y*T* M`\O$)P`!$R?7+V1058,56/*Q.8Q)',]D52.62M'O5X^V*RI'%0E# M\7HB"<`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`-\$&K/,^H??$.>2G3$Y>Q,KK3B)SPR'VB<0H=J" MH41RIG,^J?,"7,PIDG$7JQ].]0':J6!./I^_`1422KXQ`:)Q)],RJQZJ)GCV MRQ[<)8>N*)%:H1?PJK?J,2#,3Q&8_5EG,R$42DMEN`<"3@-\%35%0,<>V!C+.171A$9T'8J9^HS$^?>1/VQEG)UOM`#!U2OU!,^'T/&<8KLF70LP)(I M54S[YQGEQSXB,-V7`KL;>#8CT94C[^?#EQRD)\I8Q@NR75LQ+L*.J9]Z<\9_ M?SCGW9KKV8N>/TJE?=)GCZ,>WF8Y]R>2ZEJV148JE?=G/'G+F>W",$YKIV[8 M-525#F9)GS^G&,-R?!="W#ZTE3/.<<.[G_3&.Y+);[4'(D54O.8&?]).$8YR M6Z(52\X`#W1DG):[<0[9*K>7AG.>?LC+(^M;(A5+JYDS[?T8SBB1=6A5SZY8 M9PP([HID5:J]1PSS]@!/UF*Y8I@**`\HB?.7UX2]1A)* MP#BJ]>?TY16GR452LS].Z%)4\E%<5[?JX0B91EGV_9_3"BI4J(O];N^R%D:I MXX*(OAZ?LB"GBF_UAWB*SB@XI@YGTPJ88*,3F>\P*5'@0FUGAZ?K@0FE90*1 MBFXA.L16A3+;_,[=^_4G\0W"E*5'N(8I%+2<`?I.!"F).8]([.*IE@I;)Y]P/;%E/8?8?Z8U6Y<%EE%W5JTY+[1 MAZ)1MMR6"[`Y<5:M.8`\O6.R-MN2P7XN'&2M6G)R(X88=P^Z-UN38KF7HZBX MQ5LPZ,#/M.'+*66,;K<\BN9>M/6*N&5R"<21P.!QX\9QNMS7-NVBW'@>:MF7 M)2':.6':,>4;KA5BU4Y3(GQ,L#PP6.0'U ML>/Y59-5!YS`[I_=%H*SRB*_F@\E-;JL/>U3PY#+NF9XQ8#P5,@U"#Z=BD"K M&4__`'LOOPAQAS5$R"*G30,:=BPJIEFO#D92@>M$IA M)JFG&.(/VX3F8P79E=>Q;\(` MJ53/N9XX<^WMCGW+F2ZMFSGQ5*^Y(X'$G`##Z8QAN3R75LVC'#%4S[N<\N)^ MSU1S[DADNG:B?RJG?>XDR'#[HP7),NI:B[<%3/N3GCA]?],8IS9;[<`3R"IW MEY_T>GN$8YR70A%@JIY>8!P'M.$S&26,XHD:*Z`<\E5OKQSX8^N4HH)6@WG%)/L3@O1 M0'#RQEZ/I/.*SQ5P5>XJ9,L!F>/TQA)'),*U41PY]WZ(0I^`4-PR[L3ZHK*8 M"KJ(J<\>.([C"2.29,*,R3PB<`@5*C+4,>V)[?7.46*LXJ6A4CWR]<,,$&HJ MIK2C-(X$XCT18"JB,E8(R[9SBP%5$%36EXS'`B8["9"''L1S5D@^H'ASQ^V+ M055(%^2FM*(D>0JRL6EX@@B1E]#RSC1&2JG%6+2\<>`^AC1&3%UF(<,K-I MP&1Y?HQXQHA)9;D%9MN<1V3$:[$NPQMA+FN9>MM&@5HT_*4^?H M(G/E&N$L`N==BQ+JP9J1F#(3RF,\9YC`1KB>.*YLS'$8*Q:J`D``Z9<"03^& M6$:(R?'!8)1`I"A&6.6"L&ZPB8GEP,I3P/*4:(@4)6:Y.8)@!7AZO3M5BW5C M#$"9,R#.?L,616>9#X-7(J8BK,IAU$ M823.?W0,>Q'4`I\Q'`?2FU50,_=)F.(^X@Q!?BF&F3O`UX_D*CKJ\P"!C('/ M&8PD`/;G%9"T1D#P`['4%RL[2#?%5[KX][&0$ MSGV]T8[DBNK8C$'DJMZH!.^,%V3+ MKV(.:<%3O/`F^<99 ME:[8;%5CJP![<.)E&6?KY$Q7(C!70#5*@.*P/9QGS[8SR*TP%%6N+).8`Q';.4QV\8K) M5C*N?5,]V>,\<(JD49.H*E8SR$Q%9+#FFB*J"Z>78/KBHJX#+-5ZSG//[(7- MU8`HRS].R%)4C%U$>R^G$B*CBF419D.W#ZONA<2I491D)<_JXQ$BFBHJSCW? M0Q%`$P=1U'VPA3F@9,J.0'IA"B*CK,S+E]<0F491F3ZO5`A-K_"?I],($)F! M"2K+TP%3'%-Q6<4Z(A"EVS^96_\`?J3^(;A$BCW/^97#]^J_XAR!"@F4\,H$ M)\&8G`A9B4)<,G1$BA0GTXZ>\19DJSBGX@8(4])!2)J)0GTY`=@AXE)R4 MMA?ZO$8C++C]<6Q*0J!X#V0W-1FI[1D$\P!##%(1Q5@A6`([P>>&.$6Q594UI0GAE,2F&? MU1JA.JR3'K5FR[ECW@<_Z(V0DLL.\L6]2G(>E(*$AG[QF)X\91LMSX%MD.X&'/AQ4Q%5*1!!]?*6&$:H')?\'T*8BL!D`0,`9`',SGPF)PXXE4F?U0P# M/1\:OD_HZD)K1C(X<.R6>)&46`<<50;@!\+Z>/!.?'8`A4YSR)/U"42R@WL" M[^U'QV$RI/'3(G+M.F0,2V04]6FHL^6."877)Q"E3.,\3P&&$N?HA2#DHZD, M)OJ[?A\5$778#$D@XC5@)G$XRRA)!6QNT:+D@U#_`,"C*K-4^.4O>[3V3`'M MC/);[4M8.0$Y3EQ/$#*,UR3+H;:W*5,P!V>Y1'*B>9EAG, MCZ8QCG+,+JVK9+:N&+D*$Z^<Q:EP)/I15[CW&>9PGSF>.,8+ MDUV+-EB"M=.S`$MDJ6H>&(Q^DXQ7 M"NE;B`&5.\X,9$Y'T#F>R,5R2Z%J"J7G,R#@,NWM$8YDK;`4HJM]P#O.0XQE MF:K7`556XY*15X'J5:XLXC"442* MOB,RJ]USM[OISBF1S5L:FJKG5<9C.7M[I13(K1$.H*UR!XCC[4N$5FJG%0EJQEP_\`*^ABHE2%`=49J5Z! MAPR!Y0AP96#%0G#*?H/H^^%)5N3*,HXS.'?AW>R*Y%,%%6J<^T^SMA4X&:C. M?;]D(Z,2H;A_%/M`^R%Q*=1%G(7?^DQ8D(S4QM6` M';]PRB1P59"F),P/T9PX*13&SD3Z>Z''!2SCFIR%9=T,"JS6AQ4QM1GG.8/+ M@,/3A%@*@A6"#),QQ,^Z1$.JCQ4MI9.)X$>GOE%D2RK(]2L4*)'=]7`>F+.: M&4U!P202/PSX&7T$6Q*26'-3FW,_7^GMG%X*H(4]"\!]"#R[(MB55,*:AR8R MQ$O5P/''"+HE9Y`G!367/1^G[HOB651B^*L4.Y<_7]#&F!>JSS>-`K)IW"4_ MIS[,XOA)9Y1<.%8-.$2&./#Z9B-<)+'#]?HC9"16.Y;X*U9>E+*7#U_7&VW-<^[;5NR],#A+#$]L;+3W1OMS]2YEZW1\)*R:>G.9,^.>/+NC9"3-P7.NVG)Q=633^7#MQ/ MLQC;;FN;=M8N*J>AX9S](&&?'MC;;FN7>L"I-.[FIK;TY#/#"<\/6`8CG[E(#I[#PGBF6.'$YQKA M<"Y=ZP1S[*,GTO*3E*69F9S).,IY1JCI.)J`")J,QP! M)PGG/*4:!,G#!ZE67;V3BT3.)]ZSRVT<(M7 MD?I2P](?BE+@)@'GC/"&ZCE)]T,0[T["L*>)&"CC+"<^W,@Q/4*66S)%":Y? ME(2/&5_65,XRGC+G/`\(KE<&.2OM;.0H\M1YCWY)"J@F9`!&.,I9G,<)",\I MCBNE:L2-1$$%_>FR]@!/E/#'E^+!,XS3F,0M]BP0-)Q[*^O!1BZ,ID]N)R'` MXSC+)] M1SQ'"?9&&Y-\%U[%A@!($GD?@H#KV>/KGQ]48;ESBNM9LYA5KCQSPG(?3.<8 M+DPNK9M$9!5;STIB??GPGE&&Y+-=.U;`RJJAYW/T_01S[DN"Z5J!Q*IJA[ES MRC#.6*Z5N.#*H>K/A&*Y);[4.Q5#SLY\N)XGZL)QCN%;K854Z]SGV#U M>C",15T0 M:*"ZN0.(F>$4FIY*\*N=7CG].?**B5=&(4%U4L3W>V*"5?$-55Y7/5,\,>$S MCVF*I>Q6A5SRY3D1/E/'[\(ID45JP#UJ*Z?9AWX3]AB"G"A+.0GVY\8K3A1U'C] M,H4I\`F5<(0HCQ4)WC_G??!@$RBJS]$*4\<$R\_7`A-KR]/V&!":@0D+/"%DFCQ2(1,D'.%*4XJ=;/YE;_WZD_B&XA0H]S_ M`)EF4L^^)4*4A0SG%@*7$KI%,:/L'M!'V1:$C,>2F(/U>O/ZH<%!I4*2VJ1EF#[(=+(9A3VU8`] MLHETOQ4]I1RP]DN/HBX%9Y`XC!36G<1]/69QH@3W*F0>JGM/2S,_KG^B-, M3F%E+C%633N4SCP[HTP*HG%6#3N7]/TG&J!6.<:\U9-/">?=Z?7&R$EDN1KS M5HR]V\$I9B7]/MC7;EP6&[;HTL%8-/8SGA+CGZ.V-D)KG7+68P5@V\.?HX M]TN<:X7%AN6"2IK;X//#F98YQLA,BJYMZS&1P-.:F(?'?_FXXR[9I/AQ/'43AE*6<^>)PC1"Z*,)'MP./=E]D:(WEAN;$T;V?P)279SG/'T2[L)SBT7FS6,["4G< M8]H^&*5X@E^MWZE>P"<.+XXA4_\`#6R/K1KF<$X@WV%$\?*R2 M"13*OO22\,I8#LP]'NPAO9NM$-AEIP]."274YR[,.?:2,!&>5TYK=;V%OMX, MF2[*6/;+5Z<9D11*X"MUK9F##+M3"Z@2,]7`X'#CEBW"6<8[D M^*Z-JW4-BJYUX8XS[8Q7)+HVK8*K7GN)R]'+",-R2Z-JVP'!5+[\YXB,5PKH MVXOC@JAYX#/#E&&970M1XXJG>>`QG+LSGR]4XQS/!;K<54NO3S/=(]^'JC'- M;(1<T\\2)13(Y*^,6KDH;RYC M3QGC/E/AZ8ID>"M%0JUQ>GEC/"6,A[,8J)5@5>ZX#(G/L'9]L4EU8/:HBU2! M/W^KNA#P3J`\2)GL]G.%D74@<5&40GO^G9%:91%G/Z8PI3X!0W?M'U0@3`T= M,$YF$/!3BF%J],YCN^DX&3C!0UJF>Z?T]$*5*CDXSA"G%`FB9#V0B@8IE1`2 M>9P`^G*(3IB!"8.9[S]<"$VLY#TP(34"`'31,S.*Y8JP4"Q$(2#G"I#BIUL_ MF5O_`'ZD_B&XA"CW/^97#]^J_P"(<@0H,"$##&!">29@&!"5`A$2A.(S'TX0 M\35,<$\(F0S4`Y)Y"B)'O@!4'%3&S/(X18E-%(;)Q'+[8E(I2%98X\,XLB4' MBIS;AE,^SB.>><.RK(X*8E9`!$^!X=G.'BQ'-*5,0N8SD93EE(&&!2\BI;9G M+Z8RRAPH8X9*6A9&$YXY?IX0P594UI8F.(.79CC%@/!(0ZL4*P(PG[9#(Q8, MDA#%2FUS/+&?HAQ3#!1DIR7)@2X=N&&>`BV*KES4MI>&0QGW>F<61*1E.;6. MXX3/;%T2JYCABIB')"6.1G/AVQ:"JBV:E((P^F,:HME@LAX%63+TY<3A+Z<#&F!6:8 MS5BT_P`\I=DIR'U1K@666X*JQ9?[1ZY\?9&N!6.X'5LQ4#":A/T3SR$:X%8[ MD6JK5E_`8Y>DQL@5@N0!5HT^,/T?HC9"2PW+8*GMO98Y_6,>$:H26*<,E-0_ MVR]7,QKA-8;ELER%.0^!*1/HEAGQ$:836*[:&04QM\<\9=GK,XTQN'N6*>WB M,/F4M#\R?>G@,.WL'*-,;GJ6*YMR:O7A]">%0`9XX<&<@!ZY0_45/W>;U'LHE?$YS/MR]4A M$]5J!1]U)Q9UCX@_UL#W'ZXGK*1M#@`"$%]6>H?;"&\%8-K-L@F5/R&.(Y"4 M5RN/5/#;R'A(\/!F3*GQ+`Z1Q!E]\L(IEU1EU'#5,892X1GN36 MVS9`H2ZB+?XB0[,/J&<99W"MMJR!X@WTJ"Y43G-1/9,>OA&6.<_1GZ8R3DZW6X-V*`X_+(G++"49+A6ZW$"N:K'GQ].T99]L9+A.2W6HC/ M%5+[XQ,_JC#<*Z%J("J'ZCM'=/MC'<6ZWRP50\_V^WOC)-;(<%6NN@SF<.`' M=&.:VP]BJWGY"4Q])?48S3"T1*JW7OMG/OS/HC+):(\\5"<W'UX>L$Q3+%7#E M@H+JSI)F9S&/IRYQ22V*<8.J]Q84?7GV?9%,B5:*U4%TXGD#(?3LBHE.13FH M:E@@S,@/I[80XLG`([5%6HJ!GEQ[`3A**\T[%U!6HG`^KEW>J%3`*.I68]4( M2IQ[%'69S'(3].7U&#"J;DHRU2[I3/MBL5KFI&*BJ7Q.!QD,_JYQ*=15GAQ/ MT]L))-$9IHGA%9*DG)-*.)`R!PA5(&:CK,SW8??$)DV3($@B8($OIW0(3).9 M/?`A1R9XF!"2HR$@<8$P&::BLXIE@F%)4$I,*E4ZV?S*W_OU)_$-P(4>Y_S* MX?OU7_$.0(4&!"($):%2PYG"!"=@0B!"6@D$8<>/JAA135F3_;]46XA**%*2 M<>^$P+)S4.I"%%!EAF9_5ZH8%DA#J:A4L>!AU6GP<(:)4Y,I;9F>\?=%P+I5 M-:5A(R'Z,(EZJLT*F-GCVGZH9*:J:AS2)$9^O*'B4KJ2E0(X"7;%@I@E-5+: M7].T7/'"'B57(.%.;>:EIEB#/[!&J%5DD6"L&GY\?;CP^R-<%GE7!633TI>]/TGG M&J!62X'5FR_PF.&''/V1K@F-<"L,PZMV7\L9>GGR$:H% M9)CAP5@V]ECC+T<(UP*Q7('O4YMXXZ,DW6RWI)5 M0\_C@?KYQDFMULN57.O9X\)\,,XRS6N!953U3PS[9C##U1DF%HC-5CKTYXYY M]WV"<99K5"BA..\?OEAG[8R36JV%`<>PPPQ]![O3&>5,5K@[**MS,GF2!Z(S M2]JT0&04-:^./9//^B*)8.M4?8HJUY\>WZ<(HD5:/8H+J\%">`X=QX\HID?6 MFC[%`4N9!.'`=O=SSBF2L&*CO',=D^RTPKA6)),(3F@T281(B!"G6S^ M96_]^I/XAN!"CW/^97#]^J_XAR!"@P(1`A$"$\#/$0(2H$)8S'?#I\D\#A*) M@:LJSBZR##2&:8'(IZ<\><*H4EM>&./LQ_HBU*P*DI7*1G,?;.!*>.:E(7*7 M?F/MBR)4$9J6AP'.6/M.'O0W-5G%36URRRD/3#@N*I,"IB%@RQ[I\.$C#@I2 MV*D()GZ/N^^+`4I&8Q4UM?`YX>GG[(?W(9RI2%\L\A/AVRQP,,%$ADIK*^'' MLQQX&?(Q8"JR%.0K#M'L'=%D57+V*6A>$IF6?U9<9Q:.)51#J4AP@RX_7C[# M%H2$*4AVW^GGZXTP*RS#OQ4A#IPF9'"?"><:8++)W4Q#W&?*7I]D:X%8[G$*>V_ MQGQE],991KA4K),XJR:J)#/[S&N"SS((5FR_/CCV'KC1$JLVV%/F3Z7QAGSX_3"+1*JJE;8.I"7\<^_'V1 M:)<%1*#J0FH`//Z=HE%@D51*V'3OQ':H18)MBJ^B#@2/4E?$=I]9^^&UI>F0 ML^.>?M_3!J4],H^([?;^F#4$=,K'CG^L?7^F#6HZ12#4GZ?2<(9*P6N5$PNH M'$D>DQ69$*Z-L*,NHY&8]<5R/%6QC2B84^<,1VX149*X6W%<%'6^><^/HY11 M*0R3"!!JHCC\AGZ9YXXS$42*T0!5:\_.>.)Y1FD5K@ZJ'ZC_`"I_?($S3JM M5O)E4//S)Q]7>/1E&2:VVVQ"JW7I<9=W?WQFF%LA)E4NU$Y@3D<3Z\XRW`KH MW'*KG'I'$\^W/C&*86J!=07'&?.,L@RVV^*B+?U9R[Y0AJ4PQY*,M9E)79/F$L9PCU=.`HRC,]@B"73`9ILGB';A]/1`A.0(2DYR[9Q(P4C!.GZL8F)8H"$JG@WUB'!."5LLE.;5*4L9>V?;V2A@4I#*2E0.1'H/ MJ/9,"+0(RQQ[(L!59&:D(7(C'MGC/&+HE(5*0Y/C MP[L>W&+XE52'%24K]4_KC1`K-,9)]+@S'#O[QVQKB"GM5';Z.3FJM6JK#.?T]L:8NLLV/-6355Q MGP]>4CPB^)6204Y%5,#'"6/IB^)58CJ.:E)J4M,]0(Y0XNQ%'4C: MWYQZD+R7V[+.2;79;K<%$G(#X2C>GZ(8WH1^8L5 M%O8W[@^RB"/UHCV$AU_YKK;VO*IYJWD+<:\LW7AQML:G%#I9O`!"9D37J MM8*1,2[XC[_M1C./\J/TJO[B26U0!''4_JTJ%5^67S.T31>K/+CUTIF49NN= M+-Y^&D$3!4M-I*0"G$$YB`;W;&HN0;]:/TJ3LIGPC23R$OV5IEPZ5=7K0DFZ M])NJ-L"9S57]/=VTR1IEJ]YRT@8#.&^]V)82B>PNKH>5[UFC$-SE`>^0*T*O M;N5L)1_$1EE+M[(QW"M5NA<8*$MTXHRW.W#GGEV81DF5I MB..*BK7A+G]6<9IE7BHY*&I7;.)Y) MEE%9.84C@FE*GG@GNF84AJ9IP'3*U#2>`G(=N/*$(JI-%#<5CAGP[OZ8AGQ4 M@4412OQ<<2)GCC++A%9*8#-,J40._P"GMA"4PJFE+X'C$*6X)E:\.`2,\#,Y M?5`I`317G+U_HE$*4T5@YDS$$?;A".Y4L4TI4\!Z88!0FR0(DEE(#IJ*DZ( M$)!SA3BE.*(A0B!"F6U0%SMP_P#=M)Z3\0W]D"$S<_YE'&'Q2D-4)]"C//Z^R%K' ML06/:I2'!/'`\>6??#`NE(4I)EZ8E1B$^E0^[OSQA@4V+XX.JL<58-JP MD5&9&`GW&8X"+`57(*0EPY'NQ[._"8BP-DJR^"D(\?0QJ@5FG%/)7]0XX8Y8QK M@5CG'UI]#IR)GAZC+ZHU062892$/=O#[!G&F!R6&Z,\U*0^,Y\LV-EN0*PW"14JP:J^>>1YQLB5F,^*LF:OM.B+0>*SRJ:*0* MKMY#]/HBP%5F#GFA6X;38"Q=[];ZJ]6BCK;>*JRT52NBJ;ZJIKF*6FLK=:TE M3U%^9U#J6U.H&I+95*1D1A\T\PM^5["YOKORPT@#,F1``'K?L!70\L\MW'F& M]M[.PQN3>I^6(`),CV-3FR[7/>=GS=[9K!;.D/2?H!TXLM(I+-DI-O\`ELV# M?*ZCIJ924,)>W'N2@NM]N%1X0'B.5+JE*<))),C'S/=?BKS&Y,](1$'HY)_) M@OH>V_!OET8`[J]N9WC4D3T@GC3FK-GSE_-CW:A"+?UEW[MZA8+I:I]HV.S; M+HV6W7)^!2M6.WI2EID@A`2`9`^\091SY^?^9W#C;`_56P?A+R./S0N3/Z4G M^":N>^/FH;Y0@7GS)^8)Z@J6W!5T])ONX6NG6TI"&I!NDIT5-5XID#XBCB") M2BF7G/F9.KJ,&P``"T6_PUY#;CI&VB9<29/[Q11J'9OS#FBIX=9NK527662K MXOJ-N"L13)05-AE-&NK\6B<2CW?%"5C&2A*'CYYYC$N;E6X#Z%$OPUY-(,+` M`_6E[W65V?YD5OJTUEGZ\=;+*XI]2WUV?J'?64K2I*@A2FGUO4U05`:5$@"8 M&`E"3\Y\RG473$\@/H3P_#ODL0TMO"8;"1D?CCS2E]3OFO[>=%=0>8[S`J52 MJ3J_^'2[N-/%M8*`JF?94R4H/XBVI`)R3+")_P"->9@ZA./\D5[57_Y7\@E$ MQ.W#9>*5.QRD_P#C!^:VPR:2[=9>H]_HR5L/L[QV]M[=E.^M51.I36B\VMP. M.._A4E8(4F6`SBZW^(?-;=1*'\D*B7X/_#\OEMSCV3(;T_@77_?'4/=.\=Q5 MC?46P;?M'4.FH+1>[G=-NV"@VI37VTWKXZB;_,+%:FV+6W<**X6Q12\RVE2F MW2E95[LOH'X6\^N^:F]M]Q^_M0C(-@8DF.&3%G[5XC\1_AZ/E`MW-K(G9W92 M`U5E&08UD<1(&G`A:6JJ_P`K`<<,)?5./6&2\L;4HUQ"875D<9X9SG"$IHZE M&763GCSR(]O?.$)5L8N&90G:NJ29X]L9ID!61,C10''YX3X=F1/",=R2VVH$L MHCCV??SR[>R,4S6JZ%N.'%1%.<)\Y<.!P[1&69S70MCM4=3G'D>[A[8S3*V0 M!3*G!//(\^9$9)E;K8!4=:\3RD1+/#OC',\%LB%&6X)'&7*2T14=2_:3/@/1.*2K`V"C+<`Q&([M0$^\GV MY=V,523@.HRE3F3AC(=IE+VF*B5<`F%'43/&?#(?0&*929/B5!<5*8RY=\H@ M5JF`&"C*<(PGA^M@#W<(@IL%'4L$XGNPX44DIN032B,,><*I%,4PLY>G[(%(+IE9P(XX8>F(4IF$))0F3F>\P`'% M,2&28=*FCF>^*R:JP8+$0A))G"DI276(A0B!"($*3;_YI;OWVD_B$0(2+G_, MKA^_5?\`$.0(4&!"($(@0B!"4E4L.!,"$]EC$H&*<0J?=PB2F/%+.(B`6+I0 MDC,=\7!,<$Y$I$\E4R.8Q[,^^!D*4VX9$'''U3Y0*$^E0PEGR/=$H:C*0E1$ MCA#`I7R4E#AD!V8CZY&0BT%TJD-N9X'MDJDMOD?K8?HC9"YQ7/N6C6JF-U1YCVY>R<: MX36.8,5/;K9#!6(]7*9C1&7%)&0=N"FMU>`F9RYGV]F$61+HD=55-15SQGAW M^V8`BX%5:'*EMU4\U9=O*+!)/IC$*RL-+2W[?O2BPW!9_++IU+L3UQ2A(*G: M3;]+7[A4A()2"5OT+8D9@Y&/%?CN^8>56-N,;FZ![H1D?>0O9_@BR9;^]N/J MPVY'?*41[G7NS9KST[I:&G8;MEO:!0E&J20LH2$J2ZFI9(=01*1,\3V1\PUK MZ*MMI.H6R:525-4U*DHD&M`4D^$D:"AC2X$I!.8(QB-0*G2<%;,]7]MLZ0A# M:7$D@.%EM!)./AG0`=2I2$ID0AG13I.04^FZT[?UO.ANF6\K4A6I:5%LJ'X4 M..4Z5I01F`<#$:JHTDX*:>LVVW@G66@$Z1I<2V05:22$:L2$^V)UJ-)Q3?\` MM1VA5);\2FI7&S,I=*4*`U3TS"`DMSQQQ[9P=2JDQDJRY[NV/4H2^W34+%4I M02XXXEAT+9QF0L*(03GJ"=7">$2)LH8KQO\`.M6V&IZX[%NED99IUW+IINFB MN;M,9-5KUIW-;7Z-:AH1J<89JEC(R"L#G'K_`,#W]'GQAE=O[5SGC]DOOBF4V0^J@4 M%RHG/G^C[HS3GZE?;MDJ(MZ?'[?7/&<8KEQ=&U:(J,%&6[CF)9]_9E&64G6Z MW!1E.GF>/H]F,42*V6XFB9+F&/TF.Z,LRMMN(R32EG#U9]T8YR"VVXEDPI>> M/?ECV1CG+@MT(J.I?;+T\S&2`!EZQPEA%4C16Q%5$63G,`=OV8142K`.*A+6,SZ.V*I45P# M*$I>H]_W??%,BK!P4=2S^J2,.ST\XK+#%-7),N8CCV_5]1A32BEZJ$M13@,I M\>S#[8K)HG%:E1BYF9>V$U,$^E,+7F2/1/TV(0FUK$P9'^C^F!2F]8Y'OF/JE"Z4),IXSS)X1.%%!DFUD` M2[90NNK)HIJ%3I),05!*Q"I40(6"98F!"1K'`'Z>N!"EVTSN=N)_[=2?Q#<" M%BY_S*X?OU7_`!#D"%!@0B!"($(@0B!">"I@RG$H&*P%$$8F4,G4A*@H=O&% M*4A*EB/1]8X1(-4A"DI0X<09#+'$?T&+0JS4*0% M@2)F9>>.<7PDJ9Q3Z52XX9>GZ9QKA/BLTXIU*O MT<.'=&N$PLDX>I.!6'IS^^-<)+'<@V`3J7)9^GEV>F-4)9+).!>B>0Z<9=TR M#/`REB(T1DL4X'+%/I=[3/V\>S`1?&1&"S7+8(KBGDNF69]?+LXQHA<;%8KE MDD.R?\<@`'`9YYREPC3&ZL=HA2TUI`'LQ^ MR+Q<9(QS4MNM.$_;]D6";I"2%K]WWBC:F\.F]Z>=4ABW7BZ5YTJ+:VW#0)H& MJC6D&3;*ZO'+'C'SO_$*^!]RMO1[LB.Z`!7TC_#^T3;W_-L*Y1U?>`QK5'5B0<$$\ M"![VE2N,B)YQ#J3"*=;ZP%2EZZK4E29*DXL!)`D-2BXKPU88*D3R(@)0(Q"E M#K$?=*ZFJ4I"0E#CCI0?#Q(U-)=<*TC^LHD$<(5U.D,V2>'6=TIPJFT:00"A MPS2DYA(.K!7=!J08C)._[;ZM(5X56ZVHR)6RM*%F>2U+!;2!V`1.I0(Q>JKJ MGKG5AM17<%'P_>4XX\5#6@?C*'-(URQ]TCB90:N:D1C@RZ*[WZOG?G5VU.M. M+>M]JM=UL#-4X3*HJ:S575CK:)E*&RY3I2,!,I/9'=_"6ZC:_$FW?Y9"<.^4 M#\67"_%6WE<_#^XC#YP(R[A(/['5V:TE."CWSX=G&/MAF%\.\0+%W3"JQ6)* MO;@9-$RMXX MY$X>X]T9)SXK7""86L9X\NSMC'.2UQBHJUDG"7M]49I%\5>!ZDPHS'?ZY122K MH@)E1EEGA/T\.^*9%6A1E+QD3CG,\3.6'"4525@CEDHBU8R_5$SW@F*R5:`H M3R@#($X]L@#V15(IPH2E9_3CG%1YIP&"9*Y8S/H[LY3E%1**IE3ID1(2!Q/. M7+OBL\59$44-2IS)^F.402&5@&2C'.*BF.*863CB<)@>C+T0JD%,$\28A,FE M*G@/3VP(3"E2F!GSPE`A-DDYP(6`1/.(D0`@@LEE0^GZ834$HB5')F9Q"N`9 M))B'4$I,*E1`A8@0F29F?J[H$+$"%.MG\RM_[]2?Q#<"$7/^97#]^J_XAR!" M@P(1`A$"$0(1`A*23EP,_7*)0LPR=*2HI/9Q'/EC`0@AU*209'NA4AP2R)18 M))158AU*<0 M22,>W'C@/JA@4=J?2LY@G+*?/A#@^M*<%+;.)PEZ(L!2D!2$JY]W"6`GC%H*I(R3P7SG/[/H M(MB4D@GTKXF8/.66/#'&+8G@JI!2$KX3EB,.>/LC1"2IE$)Y*^8&.&`/+OYQ MIC-EGG!TZ%X9>CV3C5";K+.VG`J8)&0GWGE&J%S(K+G&-$9NLDK/UD\EW*9PS$\YC@.R8BT72,<%GG:BS:?OG+!^P>LKZE^$MO\`\-V+SC^_TRHY+&((+?QB"!C3$E>)5GW9 M?MIE-%FHD-+B4\M$R1_DZIX#C(P:G0R0K=%8$F;R@)S_5 M21/A.?&<0Y0RIZ_?C%"@FKK5`8Z6DJ2HDRX)0H>W`1!D!B4PBM`KMU[CW@I5 MJL33K5&LE+M1J6`6QBM9<)T(0@"9E.4L2(KU3N%H*6C&LE[6^4GY/G4F]>2_ MS0^<#J]LF]6:G9\N._\`=GE3LU[HZZWUN[;CLURBW%N7K324Q535(V]:+)9J MVW6E3J7&:]VH>>2E2&TD]CRC^Y;ZWNC("<)@=FH,3VL:+D^878;FU]W,#+;S M#R_2B^`K@3GGV,5Y0T%P;K:)BJ;_``/--O($S/0XA+B"9XXH5'VFSN!@/3XIM3N&)_0/MBJ4E9;MX43!>X3PYY^K&*I36F,"0FBL' MZXHE<*U1@_:DD@CTX284N?&1[N'?C.,LIK7&`3"E9R]1[XS2DZNC'C@F5*`F?6!]>,42.2 MOC$*.XN4AD#/*<\)S$^8BHE6@!15KEB<9F>''[HK)5D63"U&8)`D0/VY`0$)2%)3(CV^B`)22"E34)2/'L^V&=326" M=0ZK(]F,L3ZL(D%00GTN<@>$YXSSY8PX+I<.Q/IC].!BT%5F/!24+!Q.)GG(<9Y\)0X*K((3Z5G]:+8EU64\E4 MACCR/9QF>^+0560Z>2N78)B66/*+HE4R'K3P4!DG0L<)?0\A%\;C*B4!P2PL?:25J/>EZ^`G&F% MSBLL[8R#T60J?Z,<91IA<99)VB:`42IF?H]?=W1;&ZYQ54K):H2M9,AW8?T2 MQBT7'+*HV#S=.!Q(PU?T0QO1C0D.JQMI'Y04M5;34[:G'7`E*05+4K!*$C%2 ME'``)''E"3W^VL0,YR#`9%$?+=UN;@MPB0_$+](O_#^=&E[-^7SY%'W&E4E? MN/9W5'S%W):4%!7>=^[YW:Y9:I2I:VPY8Z.W+;4#.24F))A;H.+?5'<*=RTSYFO^'5\NGGCOVX>M/0BY6#RR>8G< MBWKAO&G&WEU'0CJ[N!U4G=P[GVY8JT9$\0SYNP7QL>:?Y!'S#_`"O/72X[ MK\N&_;OM*WA3R>HO2%M'5KI]4TOB*0U4INVS$W&KH`]H)+=72T[K6%ZZ)=2]KU#E+Z,'93]XLCYB`>=/>J/_9_U#GH^-I4XS"2 MXV%X_K+0%X3GS,1T;WH$?>+'YT?6%=6OH?U'O[J*=EY^H6LI0EF@;?K7UJ49 M)2EBB#[JE*X`),3]WNG%U`W-@EHD&7:O2CRM_(_\\WF?N%"OIYY<>JE_M%4Z MT'=W[EL=3L7I]0H4DJ4]<]Z;T38;&Q3I;25&2W5:4D@&&Z$(![A`/#-3U9RI M;@6XF@]M?4"OL#^7-_AG.B?EWN=@ZG^<2X;3Z\;YLBZ:YV3HGM6GK'^CEFN; M3;=12O=0-PUS%!<>IWP%6I)-KI:>DLSKC`\9VK:46S)NQB--H=Y^'!+TC,O> M.JN'U>_\[EER=>^?F:Z6L=0-CTFSG*1H,;YZ>]5.C*:1BE8IZ*EM.^=AW';5 M#;Z.FIFFZ:@H*!%S"6*9A"&66TA*$I``AK&-,7'K=5;L,TI9?"J_'FLRW[2J MJL-Q"45]BJJNPUC23BA^R5C]K<.A7OB:J0D@Y1]#\A\ZM3M?=[AH!1_4O%?B M3R:Y.[]ZM!Y$N>^OL5T7TXE*@1CPQ[YQZ3[Q:D6$@05Y<;:]`5B:>CIOQ5<. M(PX02F.-%;&!3?B&?$'Z8F*Y7%9&T_%8*Y]OZ(KE<5D;7))U83EEPGGSG,QF MG=R6F%D9"J1,\Y<^)]N<9YW!FM4+/"B23F9C#*?+U1EG=6J-I-*41CAWCA]) M1GE<=:(6RF5+S)XY2[1[(SSFKX09,J4>SUS[\(HE)U<(C$)E1X#$X9\L_;%$ MI*X1JF%*)$N,^S"6,NZ*Y25D8^I1E$RG/$9@Y3[.^*C+U*V,2F%*&<\1B/IR MG%4I*V,0HKCLM6$CPRR[)'G%1DK`%!6J4\.P\,1%9*;$J,XJ0*1QS/ M.?(CE%9+J6S412]/;+/GRBLDIF?'%12HGZ992],5DNG``":6J4Q/'CG@)9Q6 M2RD545Q?;/EGCW]T(2K`,DSF<85,:"B#@/3$%(3J/&)[AC%H*K,4^E:3Z_5.?W19&2KE`Y)\$ M82Y9S],71DJ=)=DX#S5VS^K##A%D9,JY03P/;CPY8\I\8NC/BJC;?M3@5@,> M7"?TPB^-Q4RM'/%.`CB?Z)9>R+XW%1*V'3@4,L.&'V=IC2+N:SRM1)69G@#+ MF!EW\I2BR%T'%+*T&$\2;<(S4?JCQ?F'G-[J&,#5>MV?E-F,!*86DW._7&K9<0\ M^H,K0I"VT#2#K24A),IE.HXQPKV]W-X-.1T\%UK>ULVB#$`%?LN^13I[3]*_ M+_T&V"W2-T*>E_E)\N^PO@T-I9%)=*?IKM)%Y8+*4@)7^84[Y4,"%E4\8:[2 M(CFP]P]JHL>*.[Y6_+*]4'.HD>S7VR"A[:?2S86W MWD$'#PW;5MZE=3+A(S$`E+$DOVE2[AC@M]JEU-<4_'5535>&M2VQ4/.NAM2I M:BVE:R&]0$CIEA"X?*R"74!QEIN<@FV&R=`KBM&WQ5MTM!M*YN`* M39-]V*J7,`E++JU)B7GH\WO3 M(*--_<;S+=:]O4S2$%"$T%'U#W!^7#PU!,DJH%M*E*6.&$)KN;:Z1`D$%6CI M[BU&<@XD%U[I=WUC:D_$I2ML$:U).G2GBI0.$N<=&SYSN;9&LDA9+OENUN#Y M0ZY!H+K25K2'45#1"P#+Q$$^]V3X3QCVWEOF1W%L.77D_,?+18D2`P4[QV1_ MQ[/#)Q////(QTYW>/9AV&8.0G%,KE%?&% M4T5?:<^9BF4W5T8LFBN0^G+ASBF4E:`R:+F7$G*68';Z8K,E;&-%'4[C+U\O M7%4BK0HRG>W$B7#CAPSBHE.%'<F<(2RD!TPIP&>(]405!*Q$)4$R$XA"9F>9]9 M@0L0(1`A$"$0(4ZV?S*W_OU)_$-P(1<_YE*6E9$B<\P"@#D>PSECQ$*D(3R7`<"?L@=*V82L.<,Z<%^U M/-$]OU1(2E36U2D)]^'`18"_:JR&4E*@0>WAQA@3@5&*>2]/`S,L#F/J`BT M%*8IY+APY?3G#@I6'>GDN`<1Z_IC%@*C%24.Z?&+0561ZU(2Y,9RP$L2)?TQ8))"[\E)2Z< MCR&7*6,.)52$4=/)=PQXXC'A*+!)5$%/A9YSPX&+1-5F*6%]O;A/AZ.V+!-5 MF)[DZ'!P[I\O9%@N*N5L,NQ'E(Z/V[S#>:/R_=#KW5W"BVYU.ZI;=V[NRKM# MXI+M3;-9-3>=VNVRL4VZFAK38+54(0^4+\`KU@$@1-[<&U9G=`UTN,4832U%OWI>/AZ9 M#9:1<*U^Y;OJ:RI0\VT%+4H_MG"5)(GIC@QW_F(IU">P1^CU574=_K2?M*AG MY>'RZ2P^[4=->@]L8#0=6\WTUW%<'FZ=%8FB;JFQ5;D0Q*L?5X'_SFO+)Y<>B>PND-]Z'[%V;M2$ZH;YV-NF MX;,L%QVLS<:!.T=M[CM%%>;:_=+A2UU2P^MUZGJ$A"TM/%!FD)">;O[<8PA< MC$1E(ER#C_`MOEU^Y.[PF,-H:[D8<9!="Y,1MRGD(E?M&V>IMM'?MX M)M_@MLO;C?IJ<-($OX"U!=-2-I3DI+:'`!R&4:;^HE^_P!:R;240"'X+D>E MK$E(F1W2.(PC,8@K77$*U15`2)(/IP]D0(M08HR4D5'(Y=LNW+*)<<0C2.]. M"I.&(]402Q:B.U(-4<>S#B/8(G#%D,_:HRZK$RD",R<\,^427'%E%'4-ZI!F M5'TGA/LB(AL,%/)<;;XJV7-O5S+H;6$5-OJM"Y*2"Q6-R7I.$T!9BVV/%R5- M\CID/6B_)]^?[M8[0^<=Y]*-#(8IKWUD8WO0Z4A*':7?^SMK[S;?;`_4=-[4 MW)0_D]]"NB_6CK;UBNW7':MJWQMOI- MT+JM[[=VMN-I59MFMWG=^I.P-@VNMO\`:4/L?G=#;+?NNK<13NE3(?*%J2=` MG?L[4;EPZ@X`PRQ99]_?G8L@VSID98C&@?\`A7TZ[9\B_DN"4U;?ES\L;(4I MUQ:*OIE8JL3;6=;+:'@'IN:=3;92/V#S M.IL?0E-JV<1'U+YD/FZ^7K8'EV\U]LI^E6V+-L[I_P!6^E.W M^IUNVOMBG70;6LNXF;S>MI;R9VY:%K=_([17W.SMU3=$E1:86\O0$I4$CL;' M=3O;9[TC*\)$$G$Y@ELV(=8=U9KJ`H&KR(+#^*QJ:U`P`7EZ5@S,_J^WCAC& M@W%1&V$V5SRRY9'TF0G%'HEQG/**I2"9]D5DNGB`]5&43,@9I0HRB2229Q*<8(!.6,N4"$L90J0K,0A,',]Y^N!"Q`A$"$0(1`A M$"%.MG\RM_[]2?Q#<"$7/^97#]^J_P"(<@0H,"$0(1`A$"$0(61F.\?7`A/P M(6!VF?;`A!$XEU(+)N4,F1`A/(7D#SE]/7$$9I2$Z1.)C)J(Y9)LQ:%!QHEM MD@GN^V!*0I(/&%2FBE2][LY>B)2O1\TN9'W1+J0=62=0ZJ?#V=GMB05)BI"7 M#G/T`R([^8Q[)RBQTO:GT.RE,3$\9`]D^,.)>M08N:) M\*GEP/M],6`NJU*2YQP]D\X8%#53Z53'"8BP%!"?0XB<6B20Q7?SY8UYM MNU?.+M7?MU44TO3WIIUBW0E00I6BM7M!6WZ!8TST.^+?#H5P(Y3BO<:IV91& M!#>OT*D&-N!D6U:XMZI+UNWUY]-OOM!%)?MPTU0X"MA)16-J0Q,C0U4M.*%2 MWX>*$N$%LB0D)"*+>W#`D46&[NI$L%Q&CS^;2HVJQ5[OUS0BM33^,XFTOW6L M=515"*AD`*JT.(>#8+66DA4S,B<6]*$31Z=B@7+LJ-BNJ'S$^K-FZV^4JV[Z ML]?<+A3H\Y#E!2O7:B;1TV+8_ M3E\%V?)B3=NR..D+JE\GW:R-Y_-&\AUA6WXR/_$OTWOSK<@?[+M&YG=56LSP MTM,V07-M&FKA)PF1[(S2A MP6V%XX,MLIK@9?B$CVB7MG%2U!CBK1%:3+,\9CZ2SB.8`01ZD[\9/B1+($_8 M,(5SP"&9(55X<\CGACZH:G>AE&8X@9 MXSAA$FJ25P17$._+QHLEX)(3IHEJR)TAMQIU)(!G(%,:(1`/:L%VX\3(Y+\S M;_$QVP4?S8^I5W\)+?\`?#H_Y>=S%24:!4+'2NQ6!Y\XDE2WK(03Q*3&;2PY3H*W5..=?\`I25H M;(4C0Y\.VM222$ZT@'.-GE=;DZ9#WK'YP6MV_P!:7\U>N-M\X?3:\5WPYWOO MME%54>&FL;V@V:Q#:EM)<=>=8O=.@.("5%3J`E16```F9CLBT]#$>M<"5X#Y M25S%MCKYMRE?2^CJ'O.HI'J>I\)VMM"U.IJE.%=/5,M_'O3=;;TI)0$J2!VF M=AVHD*`:E1][E`_,67G5\X#==AZB[7\FN^[+75-QN%LM'63II?ZJH853A1I+ MO8=X6XA+A4X25U]2HZB9ZYQ9MH=&,AQE\&6VU=-\2AE$"7M8>\KQ4)QG.7TE M%IEQ5@&21K'9SSPQXS]$5F?%.(\$PIR9EC],<<)0AFK!!JI@N$XD\AZ>!XX` M17*2>,0F2OEC[)=L5F:<1XJ.MSF)RBHS5@B MF%+GB<@,\3A%9D4X&0493G:`)^F7#/G"&2D)A2C/ZI:;(]XGNP]402H>C)E2YCD.,0H49Q9G('`CLQSB0$X":]L2F9+`G" M&092]6620`<<0#]45@*%&4K5[89,`R3`I2P)0I+I272HA0B!"8.9[S]<"%B! M"($(@0B!"($*=;/YE;_WZD_B&X$(N?\`,KA^_5?\0Y`A08$(@0B!"($(@0@9 MCO$"$^#/$0(68$(@0L$3B112"R;ADR,H$*4A6I(YR^K"<*0E(99(GB,X:,FH M5"$Y^C[HM"F224E4 ML,>^<2ZDAZC!24KED>\3E_3#@\561FG@01,?T&'!X)4XE>@]G<#/[8<%#/VJ M4EP&6(GZ!^F'!2$-V*0E?/\`IAP4N."?"\)2GWG#VPXD@IY*\N[+/V80P*AO M4GT.9<`,A@?I*+!)DACGDGPYGSQQ$L1ZN$61FZK,63Z5G.<^?T$R(M$BE,0_ M-/)$OZ<90PF,"D,4\EV69.8Q&&'<#*'$DAB"O<7Y'WE@V_YD=]^;*NW M1?'-L[?V3T>V'MVKW)I=*+/4=0-]5":BH.AIT+4+'8GYIDHS4DE)$Y1.Z_*%\A#B*>Z;D\XU58D+>32-M)>6^A]UM MO4*AJII['5HJE*"=7A-G4R2/=GA&N%V<8@=$D^G-<6?2U.+HTO3`_!:I=/E# M_*CJC7&K\_-GI:ACQ&'Q=Z?==&E%=3-"XU9%W:VJS1U+SM*X52$PK3)&HS$3 M*[=/^@+>G-/`Q!_>@?R?BO)'YM?EWZ,>6CRF=+]N]#M_4_4C9O4GS.W7>]#N M=F_HOJ:NFL'1JVV)A;*$L4SEH;<_,%%=.ZVVZ52*DY1PO-[HNV;;18"9]WP7 M?\G!C>N1D03H!RP)S9<'?X>+;+-_^:]Y?+N\VEU.P=M=;-_2652;>L?2#=U- M2N^Z#-3=5Y=+?$PVQ(_.CZG7Z,U@W::*GL5L46P*6W M(JWTA4INW.JJJY:MB3@H`@>[B,9GWB4\ MN$XT1@!VK%.X9GD%Q!O6[>)0W)E:I)=M=G4C;3BB2![_`(%`R"!E M+MC+NQINCL]Q9:]C+58(&1'M#KJ1\F7I38>N_4SS*]&-R5QH;7OWRY,T%2^+ ME56C13T_6?I>Y5/&X4;%344_@TSBU)*4*)7I`!)$:?*Y"$[DS4"(/^4%F\VB M91M`8ZY#UP7MDYY,?E4=/-YIL6^NOG6S:=5:*E]%QI'NE/62I-.JF=2D(9<_ MN)3M7)E\LE+50UJ#@('N@B/0PNW36%H$'F/VEYR[;@)-.1$OU9?17MS7<2A\ MN/R5*JF80QYE^MJ*JO26:=D=+^JXK%']F!4MLN;7;%*PT^[J6=:2&@2$E((- M_4W;/]WIW?MK,;>U=C?.H\I#_-HO+OYR/0+RD;#\FW2C>/E.ZUU?6VBVIYHT MV7>-?56O=%M384=0^FMYIJ.F8_O%MG;GQ#=55;72XI;:5@+U`^].,NN>H]6) M@V`+5.'$KJ;.%IY"S,7-4*D%VTE^`X>U?-&ISD<9=\Y^F(,EL$$R7,,5`\A) M(D?JXPAD$XCG1,J7C@`.T2YX890ADFTA,+<_23^F><(9)@,LE'4Z.TD\APR[ MN$5F3JR,4PM4\_7SBLRXIQ%NU,J7++$^CE[(0R4ADPI?K_H[(0ETW-1U*`F3 MSY]L*3P17!1UNY@8#F<>.>$5DIQ'(XI@DG$^Z`,AQEQ)$5N2FPHFU+`!Y)4**HS,,F`98@4I03.(=0Z4, ML8@J"LQ"A8)EB8$)@YGO,"$0(1`A$"$0(1`A3K9_,K?^_4G\0W`A%S_F5P_? MJO\`B'($*#`A$"$0(1`A$"$0(602",3*<"$\"#E`A9@0B!";/*0$,G"Q$H3R M,$CT_7`A/`S[X4I2&60,3W19$Y)23FLPZ$M"M)[#GG`H9U)2H$3!^L8PJ4A. MA4\\#/A$ND9D1*LB00V:RDXX^@\1W1*"."?0Y+B>_P"\<88%DACZU("A+WOJ M,6`\%6G$J4)2.'_"&,YGG`"5)`S4A#G`GTDRGF3AG%HDD,>"DI42`9]V/#NA M@5`;`XIU*^W[(<%E#<$\E?<93[._"'!4,$\%G"1P[,./=#`J,4^EP8"1R,.) M'$)#'A@GPY@,ICB93`Y918)<4C53B7,9`J$^T2GEZ89TI`:J]^_E-79W9_D_ M\XU\I;EGT+SD(2F7 MB/#VT]:XWKKSOS;#M/?[@Y=%;?J6VZ>AN#MTH=S68*?84IJB;K:"ZW"EMCGQ M2@M`K$L.E*I--K(E%'A)(!\7#AZUI,+D(@SCX#F""/6';OS717S@[CN0Z"=" MK#5U%=4"_P#5'KAN]1JJI=4C7:Z/8VTVR5N`*"QX3H0D%00V`/=_#'GOQ#2- MF.9,C[@O0_AV/CO2'M)7>_P#PUEKJ5^?W>^YVF]3>U/+!U-6ETS/@U>Z- MR;%V>R9`&7B4UZ?23RSPCE>6PU792X0^(73\VF8[8`8RN`?%?:G:NI51<-R7 MT%"4.45[K+0A"4I+3E';`S2L>"-02V\A2"%@#3)1`D<(ZURV`&&&/>N-9NDX MXNRYBMW4/Q$S6\I"TJ2E;0'AN#W9:PV)J*3*1.&(C$8E=`R*Y,M74&IIO##[ MQ01I+8T*27)'4$@J`"=<\1E(0FD'!,)D+DF@ZJ:M(44*<&!;29&7`HG(*G/+ M"%Z?8F%PC`EUNM#OYRVC6ZL)5I.F:2H25*1T@DG$\)PP`P%$KE MZXK1[CO)M/BJ;=;?0)DKEC,Y)0F85('UB&TG/%091Q"Z^=3>HC-OH'JU;J/$ M$D.(`<2HMD%"DI)4$ZEA7;@(T6;6HMD/>L]Z]H&K-E\5O^*.8<>ZW>3G<#J5 M`UO0'=MB;<(P6S9NIMVNK.EIZ6BHRPRA@U%XO-TIK4BIHTG3X!?EMPC$O2(7EYDR#`$GM7 M-U+U+WUMM;-=57*K52TZ':=R[45Q9O%NIWG%^&Y_:K;*QRCI+3#/@J/S)=0KIN_Y?WF,VW6O?+-$XTEW MX8L;EW/8:FK+JUK<:>6WNA?B.-CPRB07B4QS/,(`R$XXX^YUUO);C7S;D<8$ M-W4]:\'E.''(=T@?Z8Y[E=YDP5COEB,IS]'"4+J"SAQA#,IA M&J94O$XR`R!^^*S+BG$6*94X!CB>P3A24S5?!,K=EV]AX?T0ADZ$R5GN].,( M2%+<4RIR0/$]LL>>>,*9*1%15+)/"7$((F>!SPPRAN80^13R'"..`S[Y<.R'$E!B%)0K4,LI>N'$DAB0GTJ($^&0 M'(]T,"%!+I:5]LI=PEW#A#.C*F"?"\N/IQA@5'9BG$N<)D=F'LAW]:@XI]+N MY6*R[ M=VM8:.DN%T'A&T6VIN+ZDOU`6$I:2H&1E'3\MUW)PX:I>_THN#YX80))Q%N- M.-%K6\*G:U$\A5`[05%;04I6/RNZVRXV&QV:LJ$-.6BNLS%55L43;):0EAQ$ MEMN.CQ4DHF?4@0B&CCZ5],%Y/5.9>1!]*`<"M(L*::CK;G2\%+0M2:ACPWVD+C/=A;N`ZFQQS!R8^_ MBM=BYJD6FX M=8'Z2U,5#Y"55%316^W)IG75)2MUQDJ4`HD#QGX@U2NVA+YNF?7J9>T\@$!: MNFV^C7%N+:2SXN>)S7J#_AD+>'O,IYCKL/&2:+H?M2TEUH*_9HO/6#:;KFO3 M-.E2;7(3$B<(P^5CQ7'_`#![P5I\Y)Z%OG=_S2O>+:_5536ZMV7A]FOJ@O?V M[ET]'6-KIVC2N7NL!KJ=Z@JBY35"_AP4%;7AJQP!()[]R#@1S8+SUNX8R,N9 M7;JQ=36;P&Q(U:G`':6;"UU1<7J'A!]E+13H;6%3(P`$XY\X:"V"Z=N[U`XK MZ>II7 M>)LW]:VJAW)6-E+;M2IW2E"EGP7Z*5* M)_&F21)0[Y`<(C2YHFUC!\4W5[THU)_:U;C3N@D+IG*A1T?K*3J`,B,!E,Q( MMRR"@W8#$T[%QE>^I%OIDK+%X4M+2G"]\92I;*$8'Q%.J6V1H!E^+`&+8VC* MA%>155R\(AP:=BZ/];.M=E>VY>R+BGP"VXVV/#:4EY]DZD:$N514B1]XRU&0 MX&4;[-D@@-1L=&ZXXA"$DJ=Z479 MGPRDJ44_ZQ<,B<"<(XGF<6,"?TA[5Z#R:3PN1Y17B1\O"PT&[-\^83;MR<4S M37?RI=2J1U]M*/'IV$[KZ?/UM52NN!0I:RFMS+SC+NE10ZE)D8L\C?[W)OZ, M^\*//I".S@3_`$\>>4NWW%=_K9:MO[K4FO;N#UCLEO=J4;/VY14]NI+'M?;R MG5,45HL-'<+F[75=TU.MJK:UTNU]T>53SX;7>0\BIJ>FW3+XE1$W#3J2A*!($CF^9B0V^J.`C)_8WIVKH M^37`?,@[UE`#UR?U47B*MP#4*CDSQ42.0)]><*2G=L$DK`P'#"9R^AA20%#$IA3@F>?HE] M<(2Z<14$*G9JK$HA09HF!$.E+R39(Q)('?$*0$PIR8]WV_P!,2`G`9,Q* ME9`G$2(&*AV6%X>@142Y4Q31,X`&5@#)"_PGT?6(E"9@0E)&,X@J"4N%2K$" M$TLS.'#Z>J!"3`A$"$0(1`A$"$0(1`A3K9_,K?\`OU)_$-P(1<_YE4"%F!"21QB05(*R@XR[_`%_T M"&3)R!",H$)Y"^!B,%7*.82B.461E2J4V0GW8Q!" M0A.A7/T1"4C,)0QQ$,ZG4&8H@3XX):5R[\IX1+I2$^E61F)CCA[(82;L2&/! M/I4",P/4)]OIAP04I=+U&7NGVF7LA@?4H3R7#AQ$L<3/A,PPDE,:)]*P02,N M9G[(=TK$)P*RQ]<,ZFG>GDKGB9#AAGW^F&!45&%4ZE>./KG]F`AA)067N[T. M>MVU/)%Y&]N[JKJ&V6OK7O/S!7:N7=/C#9TT-'ONGH**NO+5(DOOVMBLT*>3 MBGP$N%25#"._Y/+Y3"I$=3 M.GB[)54;**9Z[FVW!:;E:GJ@7.BO5DW10T=?8KC8+C5+#=)4MU#]%44Y:4FH M2=2$>AC.%^+Q8@AF)8\P1BO/MJW`UI)24H MPQTF0R#'+/ES*MC&6G4=488N0Q/*/YQ/(4%211_,?SE-MG8OE(?TNH-YZ/=0 M=PE+R];LKKUQWJAGQ))2V'`Q1IU:9@D$SF3'C_/8C[Q:%#]G(^N97LO()&6V MN%F/4B/\A_BR]C?\,50L(ZH>;NXO+4%T>U>B="T$(4M:D5NY-XW59"DC]F@* MLB9DD`$C,RC)Y?;,8W9\XCV$K1YQ-[=J.>J1]09=KF[VZ0^FIO5<\VFHH'*5+C-735"R5+FIM32@$R(CO3UNP-*+SMO2SG!S M[USM9^N%JIWZ0NW5YSW6:5-!7.W$4YID'Q4,O5-(A)4AQ3A6@Z)@RQ(&%,HN M,G5@EXLV[<%SO;>OUB5\(IYYQ,G%4I?:OIK&WE(]UJH:0NE#].%,_LW$K!47 M4S&!C/*U+(C'@KHW(_6U>M M!,@I4B<2<,83I3:C%/UHC\X#N7-FW^L]O?0V?SKXAEU2,7`LH6,B4:S,`A/X MM.,(;$ M1H+X>Y0;\&<%SWE:%=>LB@XVE;C*:M25D/!ZIIDN"8D#AI:('ZO]8XRE%L;- M&2G<%G7"N[^LM4+;5-ZG35.U`2'%NBIHETQ]Y'NE#S50H*GJ"L`!RC3"R`7= MEDG>G(,RZ:[YW[=;E0W1A3B6T-4]P<\1YNC2TX%LKT/.H10AFB0I(Q`"7"D9 MRE%\6B:*J47CQ*Z6_P"(Z<%WZ/?+KN&MIXO;K\12DMM ME;:W&SH)`)2#'G?,XOH_6E\%Z;R:3=3AIC[RO&'Y=#;=OW_Y@ZYQ^F8%N\GG M7&]H%40$U+FW'=HWYN@:&AW745ZZ$,H3(#4O$RG%ODT=.]'.W+X*//YF7E[\ M+L3[)8MW=>*MEFII*!BC744*76R*^L0XJH;6$47@$>&XX/ M#*R3(:HNE*-N&JYX8CCZ56>,9W9#I`R?ARQK@/9VK1=V6NR[I=\Z/3_9%VI] MU45C\L>YKK<;BRZR:%=]VO<;;5;J;L573#X>Y6G;5R=#ZF(_BX<,LEX54SRG:6F<4!- MRG9<5.?XEMI4?:8\V).'7N94D1S2RN>F%?BA-*5( M3./=G]T02$8IA;A&(/W#'(G@8K)XJ0'3"E*4,\9^B7T,*9<$X`"0HR$SCR[^ M$*3F5-4RI7$]N'UPAEP4@%,*7R/H^^$=.(IHDG&(3T%$"!+*34&*"0!A$)*D MU32E!(F?5Q/=$)P%&4LJ)Y?9/"?;#!,`R1`I60/5$$@#FH65*"1@8J))0`24 MPHS,2K`&"Q`I2%D2(XX??`A-@3B"5!+)<*E68$)M2N`^R4I0(3<"$0(1`A$" M$0(1`A$"$0(4ZV?S*W_OU)_$-P(1<_YE\,,!#"3*O`K$HL!!P4K$"E/H<`$E&4@`,.401P2D<$^#D7K?][86I MY;B'*O>W4^MNCZF420BE**5M&N6K5KGG'H_*(Z-M&YQ@/>5Y#SJ0N;^=MOEN M._\`%%.W\JE=,?.+YB^BUH;L_3'KKU&V)0MM+:--8MR5C="BD#NKPFZ2L54T M3-,RO%*/#&DXQT;G2N![L8R.-1\<5S;=J=N3V)2C@'!^!<>Q<:]5.OG5;J_= M%;CZI]5]]=2[DEBGHQ7[OW%7WOP:4*7X(IZ6H<7340*FI*TM("U:2"3,A7C" M&FV!&'`!ORK79LB=TSFYN<37U9`=@#K@?S4[F7A5-3:4 M.MJ98N753?UW^'4APR!;=JC^#]F`9#*/.>>G^]6OZG_/*]'Y%!MO>X]?W0`7 MN!_AQ*EVV4/GEOI\55-;ML],J@(0EQH(J:/;G5NI;?-4T0I2D--JDWC(^]A* M<+Y9XK5P?ZR/\TI?.Y$&S'CJ7'MFW92MVRWN5CCZ'*L.N(:;>J+2&*=RF6E`(Q44@3P.$)C@K`_>MVH=XT=02T*MQ+KC;BDTM+4-T#2EI]Y M(0W56U.FE3IF=)/881_6GJ`MXLO5&EM?@IHFT$-EU:U5-U=NC044F94BF?0E MI!)E[R!,<\(AG+42D/BZY0MW7.J<9%/;6[%35:4I4E3*'J>I5.0*_P"UZ7U> M&/PX`JSG$B(/%(=3,$H]>+D67$.5=V"4*3X]0V\I"'@A?AZ0PY4*4I)5^(Z9 M#`R`$3I')*Q'%45?UEN3GQ**&MITL.^\XERMJFPZ"9H2M5.\AL.-F?O88SPA MHQXBBB5:+CRX]2;BEHGXVF14*;7K=;>=4PRCWE>%)%2IU3CC:M145#W,)0Z! M$#`57&M;O*KJVZEK\PH%"J2ZTXQJ<>;4OPUC!7CS"U`$IU%:BH2@CB.U3(%C MV+5OGGW@;@\JGRX+O-E;B+1O6E4MD.)FA.PNG3;2EI<2-"U"C)4F?NG#A'$\ MU&FY$9=2?N"[7D4M<;@ST0_G%>+GDZW-4;:W3UL>I32!5W\J?7VP/_%H\4"E MK]OVQ54FF&I(36/LL*;0HSTE4\9"(\I`GOP#_1S/>`X]RM\\$O\`AQ$?Z:V. MXD@^PKG[H1YL.M_EXN";]TCW]5;8><13*K;+74-OW3L^]EC%EO<.S]P4];M^ M\>&0UO+RJ^8S9 MC#3#S5,TXZ_LA5PH6JD>"\':=+E"?7A+P`\@O=SI&)AC)(Q3* MG#+L.$\OOA#+UIM*9*B9\!RGAE"ZDS))7+`D^V%0FEN883E/.%,E(#J.IR8E MQ[SCV90A*L$4T53[(A,`V*Q*(1J")@8&(=(227"258J7J/Z89PE3@498'#Z>J)0R:><6VP^I)EI8=4DCF$$CVB),BQ[%,8Q)#X MNO2OK-6.T.SO*Q:%%DFP^63;K0*9+*U7"Y"N4I:22XE6M?N@RPRP,>OV30V4 M1PA'XKPN_'4\SN#\ZX5UP?K%K4D.*DHJ2O$`%2%$*3K(T^_AEA#2E@3BK80: MD4JKKJFKG4N/-I=46$*++7A:W/"4&R0D)904D`G2`)XCC$&1D-6"OLQ`HQ8K M5?,`X[+H*RM8=::\O>VUTU0D.!-33U&\M[.I=2'4A025DR&6$>?\[/\`>X!W M`M>^17>\ICIV]PMI/6-.#`>U?0__`(?BV(8\L_S#=SHIWE5-';K/3HJFUJTM MMTG1'K/7AE339#BUK>6@H(]T$'5@8L\I_=3YW8^[\JR^>?/9Y1D?:%UH3J="*=AIOXA?\`9WWJI[4W54P2$^&VRGP?#4A^4RET(4DZ5"8!BJH) M5K1(?)/,5ES>K0EFRT]$\PT).L.UE0D.M@N*4X;@IQI2T25.:U:01`\E!$14 M+?['O1^F=-+4W$+53I#WP=S8:2E2RD*+J*AQVKIEI0#,I04$#A#@I#[%?*WB MW5T:EBUTM0NJJO`1^1U:7G:EP.^$T7VFZBJ0VJH=>3H0L)"TR42!!J'$LC3R M3%055V30)S M5A\Y2GGY"?EKW%;YJ'5TNZJ=*BVXU)I.T;4P`6UF6I)HI*)&LR$YX1Q/._GC M_6S_`)L5V?PZ7U@X]&W_`#I>G%>'OED,]U]04$-*#W07K2V?&7I2@#:1<\1$ MUH2IUO1-`)D5`"*/)C_\P']5<_FE;O.Q_P#+S_76OYZ0BH6&&4I5-OPD&9'O ME10`"H@R!(Y9M[)<=0P3TTZN.,A;[C`6L[)KT_#%;22?$J`N24'W5D`&0,X@ MOTY#-C[BJI@:[$H\?$^`#DO>3;63FZ= M.)B74&J3K`$@F%2@<4@GB3ZX$P"86YP2<)9X@SQ[HD!,`FHE M,B1,!+*$K`#&*S(J*DII2SP]F7UPK)Q$)N)3H@0FU*X#[9SG`A)`GB8@E02E M0J5$"$DK$L#CW&!":)GB8$(@0B!"($(@0B!"($(@0B!"($*=;/YE;_WZD_B& MX$(N?\RN'[]5_P`0Y`A08$(@0B!"($(@0B!"($(@0B!"($(@0LI5I@0GAB`> M8@0LP(6")Q(4@LDI)2988D?3VPR9/0(1`A9!E`R"'3J5SPB,%7**61/*'$LB ME=(ATR($)Y+IR5B.?'TXY1#)2$^E4Y*'TX1&"4C)+UK[HE*0D/+FQ4`9?#O9_^C5P@E(Z3 MV(C'Q#M"]'O,&MRGK^DC2@DJI>@G3AM&I*5)0T[;&G4!7!9*D3,\I=D>RL$C M:P;\V/N7A;T1+S&X]*G^<5UK>?;U245*2"B4]4RH`DE1)D2>^(E*.!6JW"XS MQ";54)4@A)F%*+BDK4$JTH"M(U!0FB>,H@S!C3M5]N!B1K[.\JIZ^UQJG>B2 MR9NL>7S8U.],A0\5=XW55*T)0`EI$GA).,A'"\Z)EO8DX]*/O*[/E4(C;W(Q M^7KS^"^C7Y%3]);OE^?,GOJEJ37TJ*AEE!;<"%TZ^BF[J9S14A2&T/I-7@-0 M*9\C%WDQ+Z^"HD<2 ME+8*0?[2ISWDA7"93QB7&8*2N6"2MVWU00T*BG6XI9:/Q5*[3J<*M+``50/, M4S;R=02%RU`'$Q.J+J6D5R,Q>6;(\Q0BTE:_@V*5*JTUEN:618*135=0NOJ[>:.H"J=%0_3TZ::K M<#I;:2@,U3)6E%(D)*WTJ)4"0E,IJG'4M6],>U'.,GD]-\&_H M[G\PKI^;_P#T\_UMO^>$AE\&EICI"2&4'PTR"1J2")"9X".T;@Q/%,NSZ5EO-$0_K`O-^A<)HV3D`DIPS]U:D_9'C!) M@O=RCXRGRN?/TP$NHTA-J<.7U\QQ4B[=,M87K<\OW25_Q'B2I0%HJ$^\!I2%.%`E(9"/;6BVSA^I'^:%X20? MS.X:MK(]I^*ZJNNDS5A.:)#E.9GVD$QAG(FN:[=N(!9J*.I?[$!6KB"9`J`( MP["F?"*R3TV6B(^T)RHJGJZHJJ+ M*HJKPIRJ2RW?*NF#[[B54Z*:I\-Q;@1XC3J6*MM;:O$&G7I*4RF)91SB2"NG M"(;Q,#V)%)=ZX5E*&W5%2*I.FD6&5J4`"E:5U&E2AI2.(D1F08'"4QI3%;4U M>[FZKP&UH)4"VAMMUEM#+/B:TM4+CE(ZXVD&869E6G.8B'#\TIB17+L5BBK< MJ/B&G:@AEQ9%2_4,H*&%J>2M?@K;TAE)G)(T*`'O''"&RY)7X"JN:>JJ*=Q; M)N[%/I00E'Q0:4L.R2A2JE!T*#;8,B="B#$=JDOPKV*X;KJ]50FH5=5/5::2 MHI6JBEKZ9CPK>XVIEZF0VZXA*DO)62I4O&4HSG.1C;MK;D."ZQ;F9C`L0KYJ MH;:;72J=_'4,5%0X-RI11.OM4SC3KE=;2EQ;CGPSA1X@6$H_JJ5(CL"#1<@O M[%QY3).7IQ7*WS87J>H^4+\L]]AUC6WU!WI2^"RLO)80TQO5(2'2D$)EP65+ M,]4Y$`>0\^_>,,.L?YH7K?PN=6K40_0A3O7@)Y?G?#Z@U(4E:TN["ZC-%+;J M&5*2K:5>3[ZP4@#3.69E(8QA\I(COXFOR3_FE=CS@/L"!3[2W_/"71:E4=.5 M8R98!4/=3H\%!.).K.6$=AB7<9KG%A,-GDK!M0UI!&F29$3QGQ,\HLB09`84 M6:X"`2"277:_R4A#GF1VBVM8;#VTNIS9.L)F%[)N(\).LI"E+!(E,$G`1IMA MXR7-W9TQ@3CU!\5YH4GNTR$XS!<$R)9.K&(.1CQ(^*]_)B73YF"@1P!Y3@0E0(6(E"3(C$?5$NF!2DJ,Y'CQRB5*<@0B! M"R%$90,H(!3P4,CCW1`)%4ACP2I`Y0XEQ2N<"5@E!0.<2Z*C#!)>(\%['_BG/\`WBH@X'L1 M#YQVKU`\UML?8W!TP#P4AW_PU]$W!XZDF;3ECJ]`2?U`$JP&>J/>1MG[I%L- M$/;`+P1NMYGZ1-+7=)4IIVZ< M/=`.D]7)O44NFJM-6^:B:@)^,5SCG>=EM[$!A]A;P_55WE9/W>X[O]YNXX_, MOH*^4=\3O\`P_;)G;D[#KC+&BXGXHF!$Q;Q';3J^'8%U;N%&^P^]J:I:A/^ MA6V&JEQ7@-J)2X2II#A=4H&7!(D"3'O(Q)C5UX6+HJK'Q*-F ML\3]HM+2'U*0X"4-A#H0VM:E)(U*.G49R$>N8-1JK*5R3DYJ9 MJ"V:?PU-RJDN()%6HF:4,@!:YSG(&)&*G0&3S;AK2MJEIJFUCXWQ&WD+;J'1 MX3JW$EY];2B=6F:DI`.,AC%L`34FBJNL`PKP6PT-JK*VJ832K27:]:5!U25- MO*?4OPRDK%`L2#6DR252"TS(Q,=_96C0N,%Y[>W6=G8%6KEANC?C-NN+;8I! M)Y:J5Y*J-UM81X513^#);R'`9360[*:=4=0Q&EES(S)DV2["?-7V[6VOY.OR MY7JW6I^CZS[YM%22ZVXE#Z[;O6M0U)"ILJ\$@Z%`*3QQG+PGXAD]X@8B[[XA M>Y_"L3&)EQL1'J*\!_+M9:B^]1W:*E'[1&P^HU6"%MH(31[2KWUXNK0C%*92 M)$YQA\EB;GF$8YZ+G\PKJ^>W!;\KE,_TMO\`GA#;+K=-3M+0GQ6&TMN>&"9J M#3>O%0$P@X9#`1VYPE$F+.Q7/AIKO,UL:G9I@ZM=CZC-MZTYJ_N=<2E9)G);< MIIR$^,;;4=,9<*+C[V[J,(?6U/ZEY@E'A+?;)GX=35H))'ZM4\F*CC]40Z@E*`E$.H)=9B%"Q`A-*5/N^F,"$F!"($(@0B!"($(@0 MB!"($(@0B!"($(@0B!"G6S^96_\`?J3^(;@0BY_S*X?OU7_$.0(4&!"($(@0 MB!"($(@0B!"($(@0B!"($(@0B!"($(&&,"$XE<\Y<)9P(3D"$0(6")Q+J066 M-2D]HYG'[8D%,"Z6%`RQQ],2A*@0B!"4%$1#*"`4Z%@YR@P59B0E2$-K*ARL M2,-J"EUB&4H@0E!:AQGV'$0,H9.H[:FS7"W;(MMR?8OBF+E3JM]X\6YKIG:-UM*F7F"O6M"@8]-8 M\\^[1Z9M]2+1Y-IB(]^#KRFY_#\MS=-ZW= MZ4[%OU1YMNIB]]=*.F]/M7<=PL/3*W71OJ#:;!<&&-L-6S::[@XJU7*Q6FO5 M2*=;J7/C&V4*+"5>(M6.=^UYMNWN/;N$"(J-+`,');UCU9J\QO\`E6WE,:;E MHSE.0TRU.2\M#._8:\RO1/H9\AKH[T<\C"_+CT&WG<;#7;W8W=>]Y=7NJ%J= MN.Z>H&X=\?W<8=OUUVUMQJFHMM4>V[+MBFH*"STQ>;IM#BWGGGG''E7[+S&/ MEU^,)`RM0F),"SD8ESB3QP;#!8_,O++GFNW-^,Q;NRMF(,@2`#AX0Q#8D<<6 M==?=S?X:^N;O?A'>PNF,-W8';;D3SJ)`+2*[_#'[JJ5+?J? M,WL$N.3/CJV;OSQ5*TZ05%*PN6D2E/@,<86Y^)]A=\(L7?Y<5-K\->:6JG=; M=OZJY^TN/Z[_``RN]55C##'FSZ<(0A*U*0[M#J47E&<]:0W3*3^PD-!*SE&. M?F&TN>*-F\WZ\%T+>PW6VZ25.*\2F2TEQ2@2D#3?L_R)_2M\;_`,+C MN[0&T^:+9;S:VD-U!=V=N,NN#0E+JDK^'U!94F:2,1(9XQ0/,]F[RA<]<5;_ M`,)\P;PWK)'ZL_I35S_PNVY'*#PJ/S$].+16B@2XU,-IFIO2NVSO]@) M/*U>([8?2L%_R[S`1:.XV\3^IQ)#\*>9=01GNMN=7"W7+S1=8;DU1;$W6]U&Z8;YZ&4MX?VO,-P86H&)E($:B`79A44`XC/DO5 M^4[*[Y58^\7KHN6A$CPB3,"Y.DU)R!RYKS@^7M_AH_+517GKJ[O/J'U>WS7; MAZ:W7872K>6\-E#IY26P;O=+%PZ@6;IZMH&^FW6RE^!JVZJ['X4UI++;BTH= M0&)\EO1OQD)WF.H/$@`T,3I)J1@?8F%Z/XBVL[`C.U:<&)(D"2*B0$Q%P,PV M)%53[P_PAM;9Z$*MWG9Z>4C#50*=NOW'TMW+15+S!:+:%/-TM_KPNJVBXZO'^%%OUMIFVK?YX MND=;=@FA9/Q?33=E,A]](2NI2RXPXIA*G$*2$E4DA/\`I,3#CSW;Y[:3#](? M1ZU3+R'?$Z?OD"7PT?\`*]7Q7,?E>_PUO5WHGU5M?5H=?.F?4JAL5HWC0-;< MVM8;S:JRK>O&UZVW5"55=S4L)-$E];B6V4.K?(2E(&8B[Y[9NP%J-HP)G$N] M.S#FEL_AS=V[O7G>%R`C(,(L:MB=1P;(9K\_F[4QH[M=J0A2337:ZT^E8*5C MP+C5-$*20"E0*,00"#'E3B7Q<^]>T&`X,/<%6+5I$Q(XR]AY0"JD#BF5.*4) M8#NF/MRAF3,$B9YGUP*40*$2,02!BATH#G"F7#!02@D#D#"$DH`)31,O1_3$J5G6.WV??`A+ M@0B!"6%D89]\0R4Q!3@6#GG`E,62XD$A(L$ M]+@[\#[E^B#\S/SI>:+H5OC;W2GI9O=RU[+NVW&=VVS<5LV%YD:G?]4UN*V[ M3NJ::Z[XZ/[KL-N=N%`AQ5L<:J_%J44=,VTV61X@/I+.VA=U3T:K@D0<"!4Y M-1PR\U.^(W3;G<,;60J)2P=Y`U8NX9\."\KZ'YC7S(&6"Q9/,!UN9H6'4/I9 M3M/SBU],PIAQ094$7WKU:/$2AQPJDHF:B)]EL]M;=Y68/^K%66YVB/!=(CP, MIGXKDK;?S/OF84=P-QN'F8Z@O.:6J1T7OH;U.N;:U,K"V@Y3[D\W%*SXZ9:E M+D#,8SG"&QMY`B5J+?Q1_FJ_4&>%PZCF=9]?B"[W^7SYN/S'"E5%=^N#6[;1 M5[A%`^-S>5#8-P104R5,)4FBN-;YLTU(8!)0NE<<<<0HZ]9*A(GY?L9X6B)- M^<0/9$NLGWCS*$R;=^)MZL[8E_.NANRIS?)?1'Y;/.MU%W&_=;-UAL*KW?== MKK=O7:W=+]K=.+:U9ZLLT]2W<;=4>8?=S2GG'EEYMY&@%OW2%8$<[<>6V](G M9(C',/(UXC[,+19\UO0F8;@"8+&)`MQ8<#]L_M1D(F-.V%/\MUN--U# MV[4(U-JH1G,+J]N(.I)_"?#W`Z-8'MBK[O<%#[I?0K?OEG`"O;']I/C=-H<) M7HM:B))"?&VZZX4F9"TE%Z_#PSS@%FX,"?;]"C[S:)=A_D_M*]I[[;7$@I32 M`\`'[0#+N:N3@!],4RA)\O:M$;UMOX/I4U-TI58A%,`G&?C4)D<\=-4=)GVP MND]Z?J1'H%E5SI#BH4_:0[0J5AV&JE`(R*.I`YJ%472C2$DHI5DB924VU15/ M"?OW%N4SG#PC+#\B6=V`QP[OI6&KQ;PT"*=@322='Y8$@@R`4$7!0!G!*$M3 M?2EC=ML&%>3?2J2Y[PM=&A1-(TMU(DD%-G4V%G'EC#QLRD6)IW_0DG MN+<105?]']I=`/,)YNM[[)J4VGIGLBMJ+XRNN^,K'^F-;O"V_`T2?V#M#2VC MJUMFG?2Q43+JEJ`2G!(!,XZNU\MC,&=Z0T,])$%_Y!7$W?FUV,Q9VL=,W(), M8R#"C?O8_3R7SW=??FL_,293\XS;U7 MIKS%NE-*7%F;>K]I.2!J)5'8AY5LHC2;K?\177'>%*DAQQ"*;RT>82UM%"6E!.M.W>N-T`2H* M*A+/,'`2!Y=MF<60W,@_YH5XWU_5]KN@3^C"X''^T++BZK^;7\QELI9N773? M'A/):25JZ7^?&SEP(0DA27[3NJ^);-1I,@G\4\3G##RVV?\`0Q;^+]`43\RM MCYMQ)N#7/>Y7;KRI?-'\XU[1UF9K]QVK`<>- M*-G3BJ_^*SE&X+$R91MD_P"DD:"C``GNB#+\T.O@2WU4.5&]=XU#J$MN/[OW M2ZMMM#R&VUN7^X..(0BI2BI0A*ED`.`+`P4`9QY67SR_6/O*]@[@'/2/<%J* ME@X2PGR&?K@9,Q3>`@0EP(68$+$2A)*>42Z8'BE!)E%ELDW(O^$$M$D_FGW%?;7 M\U&@V5<-\],47RLZ>5=19-A-T;+]^J/*6BO8:J:_Q7J2GI=SV;=M\I*--13X MMZ/`0X)$J)`P7C8RM2G$&8$C$_7`+4RC$R[:@=J\? MW;9TUJ7-#*NETVU%6KQ_*(^VX]XI(=`H_*I?5-A#:0@(;F,B9SA3.41\AYT' MQ6T61(N+A(=P-5RGJ%5R3L_;NRD5"2Q3=/'$*5H_8L>7A;RR0-!;-+\OZZ,A MN9E[I.`B(W'^J7[(_2B=FX*1G3G*X_N-%W=Z/V;;;-71TK%GL585.I=):INC MZ0ES!WPRXU\M5U(:04?@"BC3@)1JM#4:1KW?V@6.["]&+ZAG4$GWV9>I?0=Y M<]R6*Y7W;+=';;!05%92VBG>326CIS3U'BT3C:=-/467R!;7?4XMIL*46W4J M*<)@SBK<0,+)/U1S/_B/@L8C=G?#N26R/L_NJ];=UWUBCW.ANF6$@4=*E&EI"U$R\N*Y)=,@DAP$`&0!CAVHGIE^.?_`/-7;OS:Z&?`9$?]0?>N0K+> M7WZC]W]H5;" MZI"4_P!K<&DM:R!N@C20"`5CI2V2LD=N)X141DP]G[:T#4*E_P#*_LEME#N) M],E>/4#5(@*_O&G,G%7_`/+9B6`X2B@@9?#]I7QE+-_\K^S6WTFZ%%LA3SDP M4D!3&YL04_B01M!HS5(?JF*I0:OT?2KXSES]O[(4:LW8XT#[[J"`I25>'N-L M*;29:IC9;YU$82D92B8C,^\?2@S(])?L*A>WHG2'"I+ND:2A7Y[I$U8$%SIP MX9A6?"+8P8M]'[2SRN$X?'^S5<[U#;IV7"?`;UI)5H-Y"DHD=)2@]-!BJ69G MA%G2U%J^S]M5&](1.'M_LEQ5=.H:*VO;HT+IB7U%"!JJ"M1][!**CHI4:U`3 M4<981JC9`#C$>G](L,[TI'3D?3#H+QA\U?4/;U'O[=;SUNV)65#;=925;E?: M^@U?4O)?"VE.!W=OE!W+<6:A+H$Q4.%12DB92H$>CV5B9VT3XL>,_A?`]B\S MN9ONI%XL>4/6YVA/>2Z\'>JAZ>W.Y/6R\(Z1VRFK:RG3P,T5*_4!M M54XV/(NP^^S0M!3KE.T?&<"2E(*E)CIF$A5C_EEN[K%40M1,=&L`XXVXOR$O MNT3RR70S?M%TEI*RX4]'6](JQMFIJ:>FKOR_R0T])<:=I]3;=<*6M\L6WZRC MIZI@>(AM[2ZTE02N2@J*B+SMHD>X^XS*?I[:/BZL!Q>46[R+8P7!PH>E_P`8 M4,5?0\G]HT0[4>11"II$T%,[!MALJUG_`$@*2!^'&%E'H.PK MD@NKM/6S:M6EE3](E*U.KI:-1EXKR3I2M9V[W4MQ(F_4CE(2-W;K2DI4D;FW"$J0IA2%#\[KY%"J9U^ MF4D@8%M:VR/PJ(D8^?7215]-C^[B1^:/<%KD5DDXJ5B8YCUP*6*07! MP^GM@3"!S3>M1X^P?=$LGTA)@4H@0L3`S($"$DKS`G/T0(2)%6)^Z(=0X2I` M1#J'68A0L0(6"H#CZ./J@0FU*GE.4"$F!"($(@0B!"($(@0B!"($(@0B!"($ M(@0B!"($(@0B!"($*=;/YE;_`-^I/XAN!"+G_,KA^_5?\0Y`A08$(@0B!"($ M(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($)041VCE`A.`@RQ$^4X$) M4"$0(6(E"Q*6(B04P*-9E(Y\_P!$HE2EA0P!(RG.?'E`A9F#D1`A9@0B!"6% MJ'&(9*8@J[VZ/B+]9&)`%V\V=N9*I>_=*1..A#BP,>`)Y`Y0]O\`>1_6'O"2 M<=,2?T3[BONS^9^]ONDZA6RFL%3U`93;[974BW;"OS+T5,CP:^J8IJQM>S;_ M`+/LZU*I4)2`IH.I0=)(3I2/;VC&/4D6'CP\+XE\*^U>'MVY7KD8`R8@Y3;` M5Q;!Q@_->,]1>>J356\BZ=1.M+-"$N-M!I7G$N0+BV0IM6ISS/;=;4A#P3X@ MU)$DE(Q$,;\';I@\]0'Q70CL+H@#&Z1RZ9('+$*^L.Z][J>#3F_.I=>VR6C_ M`&^BZ_H0ZH*TK44[B^8?93K4#*2@)#E$1G8)>5J+_K?PHN>7[LAX7[A_B_\` M*C[UV]Z:[JJW:FB167.X%X*8TN5UVO-*J22E/PC#%Y^9_-XJD73-!4#,'W0( MTVS;,GMB.'I]0K##!>VWEFWDBP5FW+W67:DK&PH-TX> MNS%.RH5#@\[K#N7M?MOK);;OX%4_;K`77VBV^EE6UG/A5:OV:"6_-#6MJ&D: M@"#H3GB#'ECL+T`VH^J8]]M>G'F%B?BTP_E6S_URYPM&]K=X2E"ELX*@)A2- MKEH$B?O.+ZWU>DR$SC(SPBB6VN.SR?LE^PM,-W;`?3#MU6_[0K8U;_M0TI^& MMBL$R*3LM,R?Q:4+ZQ:L)XX0GW6[F9>J?["M^^V\A#^5;_;5@C?5D`&MNVE2 M@0$(?V(2G3A^TU]7"IN>!`,\HI.VD`_B?]67[*M^]VW9H_RH?MIW^_MBT:YT M*1,(5(;$<2#*:1XB>K>E.KAC,Q6;,W;Q>H_0K!N8-A#^5']I5SW4G;[2'&0U M2+F)IPZ?^&I2@9%9/61#B$`\<(CHS-`_\D_0C[S`/2/\J'[2TRX=6+&D@&FM MQ6`4ITL[$<`,\%)T]>&%J1/.0G*-$-K6QE#^5#W:PM;N75RS MK8<";1:B/PZ4L;;4G5I*IK^&\Q#9``&,CJEQBZ&SN`UE+U2_8*RW-]$P+0AZ MX?VH77W=O6"UT=.[4(LE"U4M(4EM]@_#NZEA2II%+YLJ$!"1EID2#RCHV=G< M?2)2;LE\;17.O;N)B9`0$^V-/5?'O7DIY@^H[][N=UNC-9N>A=#;324VZ_[J M9;T(*B@E5#Y_;49(4!I3H0DC"/2[2WTH@$`]L?\`^W^*\]N(2O3<2(/*0]K; MM>4W4/=VXUU;S]MJM^.+2O0JKH]Q=>ZSXE2M:D@-[:^8[4!&HDRTHD!@!*-\ MA"0\0``Y1'OLA%G9;C5JC*9)#8R.&&&ZRR76J_;PZAOU2F6[QU586M7O>%>O M.\RV24$+\9=M\Y&Y02L*``"2!B(K,(81C'M)A^P%L.TN.]V<@>4;A_ZXK1_S M+J56O-)5>>MM20%I2INK^8"\`B
@NR.K-P-QZ>53B_$:\YY=2^U?MN*HQ;G+GT5 MWHXW=5OM&0;9>J-&HI0L%937?E&,(R)C$B8SMGWLJ;5HVY$`7)>$TT7XY',: MB3V5X+XR>H84SOW?+:@X%-[SW6A272^'0I-_N"2'!4L4U0E8/XM;3:Y_B2DS M`^>W?WTA^D?>5]"@'A'CIC[AQ8^NJTPN'AA[81E8(#--DDQ*9D0(6"0,S`A& MH8'K^@@0D0( M1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(4ZV?S*W_`+]2 M?Q#<"$7/^97#]^J_XAR!"@P(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$ M"$0(1`A$"$0(1`A$"$X%Y`^OZ"!"4%`Y&!"5`A$"%B42A$AR$"'*)KL@=&I9F('0X6V;%:\?>FTF-(5XVZ-MM:3H(/B7VW(D0O MW"#.6.'.++9\O7EYZKOI0PX`$AA\4Z9D!"3-2O;6S("=6>X:.>)Y_#O7A]O M"T;HU!R(,"T3D,S`^P]R\0'[!0+?*[=M2G8J'*E86^_LS8Z:4).8:8V_\NBO M>2IM1!`"U2'">,-JB344_C?$A=00E&/@E7^(/=:*Y'V[M*O2Z4HVZ*Y*5HE\ M)TPWK4)0A04$NIJ+5\L023*>*2,>Z<$8CZN';],E,Y7`&-#V/_U++N!TGVGN M$5%,[06N_P!$XVM&FHM^PNME$^XTM,PAGX/Y>-K<`*1(F821&ZW:>!)8C.L? MC<"YM_@#"1!C*96GD`?6;=/7>!^E8[UV_<`+3%3E>_S;"]6^GV MRKA1O4C3]!=5TRD!QQU.WM\H0ZX9$E]ZL\K]"RV0K\"E$F7?'-N2MF.K5%_U MK?\`;.M%H7Q,1TST]EYO_0`+M'9]I7(,J+%-5M)3J2D/4FXVU*"I:L5]"J=: MWFY^X`)",,F?(]A@?^N71AU6H)`]EP?]2%MK.T[J4O-BV5Z0TCQW7W:/MPDW9<^-M0ZK:=T;;FH5 MB@M:M2$)W*DI44@`H1_L47(MSP.)`.<5B,":,?Y']HK#U`*B7:T_[-:G<-I7 M7]K^PKB9:M1:W8I($L%*">A3GX93`QBR$84=O\C^T54C<#CQ^JY_9KCF\[/N M0FI;5;I"B0A=OW87M$@2"!Y>I]*7DMD>3FXN!MM9"4 MZD"9G*8QC7;E:$F<:ASA_P"("QW!N1'5XZ\!>_\`#$KS>ZP[*W'3)NNNS7?6 M[J"BO9G4:J::*/9JM?^)6&=S>0PC<[X MW_>=HO)3JGLO<'CO*-AKGAK=U)J.EV['@4`Z/$E M_EH4:"B2<25:B1"S,`*$OVGX7BM-NSN)'4=&C-]+^J6S'O6J4&V]FLOME_:N MV$*<2DJ^,V5T&\'6%R297CR.;<=\(3QU*2>)PC.;ET_*2/XTOVU;/8[0#[2$ M9=MNTW_].%Z&^4;;6SW-V[[^#VYTX74N]'+TW6Z:+RM6.FI6TW_;JVEI=5LS MIOXB5*:47$U"_AD^Z2DJ4@BB_P!4VW>9&J.<\7Y2/IFLO3V=N[$Z;0I*FFT* M-SMQ]O<.'QX=3VPSU+ZC,)TZ6=^[P90&RP4:6]Q7%(T&E<>I=/+PUK;E^$D2 M,?.+O[Z?Z\O>5]%LUMP(PT1]P]*+1)CZ8_5%;A6N%@J/`3[9P.$.%B9[NR<0 M2E)6")S^OEV0.AU@)EVP.@E9E`H68A"($(@0FRL2PS](],"$W,G,F!"($(@0 MB!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0IUL_F5O_`'ZD M_B&X$(N?\RN'[]5_Q#D"%!@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"( M$(@0B!"($(@0B!"($(@0B(@0LP(1`A$"$0(22.1/KB7 M4@H$^,%$%EOW2I'C]3NG3(!47=^;-:`!TS+FY;6D)GK;(*I\%)[QG#VQ]I'] M8>\*)`Z9?JGW%?<[\WY=(/-)U:MK]]I:9ZTW55M<:JMP[4M@14,IJ*@L"GW1 MYKNF:]#;52F3CEN23_77G'N+`$[!F1X3,D4IB?T<.SU+PEJ4H[DPB?&(UK4% MA0_:CVCO7@76OV&FKU4]7NFP*47%GPO[Y]"ZKQ`#[ZPA7G)OJ2<"/>3.68E# M]%R\1AP'_)75%XBAD!)LR!_UI6\;;1T^J'0FKJ-F5#B4(*O&K?+?5>*I12"G M15]7=PMD%"IZE`CV1;"W('"3]A_923OVV8F!CS,?C<7?#H=MOIQ5W"T-4MJZ M:,AYQ)-0+#Y6*]S2LZ/AUZK1?G'FPW-9]_`X`B<=.W&[*D1(<*SIZF7-W$MK MI9[;-@UK'M)EE1FQ7T(^6/IALZJ?L3K.V=@+I;D*0-45-9>@RTUR&WELH`J+ M1MN@>82\XT5#3)8(D!(3C%O-U?MB33N:P,7NTYMJ(7,L[+:WK@!A:,2<#&P: M\'Z:]OMB=,+734C#C-#04"6F62W2M[>VDL,8R\%+E*DH=+!R4$R/(1Y&]O9D MD&1)XO)>LL>6VHQ#QB!PTV_52/J78"W;,MS;3:C1,NO-K6XE\VRSMZ@4`-I# M#5^+"? M9`-S/\XMW_0H.TM$/IB^=!]"X_O&R[2VY,4%N0EU"Y)$K0@I":#;NEP)]W42+ MJT3[Q,PJQLD-H@1^K;7!F\.G6W%4%0V;3:3J2DR72; M0():*E)4!6[D82'`5$I!5@2<8NANKVH2U%N1E]"IELMN8&)A`]UM>5_F%Z>[ M2I?S,5%MVBU4%2UK56L]"DO*4EA147OSC>VA!)(E,F>J*X>YVVVL3:4;0D3G&Q[>U>(G6[:73^F>J2Q_L]HO?=7XC5T\LU(\L-: M2ED-JZSV;2`LDX*FK.6$>@C&_MJ*QDTV\*!"TX`TF]NGXU2)T(2JR_ M,JH5^^I4IR`&W-[/TK+MC?G>CU"X:5-6>G)MV5E;TA)2L*G M.7X59Y&'M_O(_K#WJ)?)+]4^Y???\YNT7Z@\W?4Q%@.[T4]50V>Y/"R,=5&: M45M:W5?%J2[LJFLUJUK4@3/Q"WE!/[0I5@/;>7C5M7'YYX?2_O"\5=EIW9!< M^$4\6/\`);+@"O!/\YWK05JV7;YU1IF2M;;Z/CO,4R%-N:DEE:3U[VHHH6H^ M\0X@@'$B-E07I3T_.6P2.EAJ(_C!O\GXK>]H7J^/U&E=_P!\H4C00[7;SZVT MOB%.DJ8=_,_F`;<"TA(!`S(`C1:F)!I%FP8#Z"JKD9C]V)DOF;GL>07I;T!J M&':ZUJN.Z-RK=-2VT]0CJ%NAMHTJ@EU3BW;C\TAUUIMY].E:4L*4`)RE%LWD M"(1!EBYBX]0L26"Z+L:EP]&$R_>^XC[%]!GEIN"Z5JW*9NU]6ENM9<^'7NJ^ M/.(I@P7WV$5KWG'WLH,A2O?6K6I*0`!*9CC;X/\`5%1^:U>P;:/=5D;,S$P\ MRP/YV68?[Y+OH5Z\;9OU=7T5,ZD.,MN);<:0FKN:FRR4@:V@O?\`+24RQU2$-I@ M!3\GN59,WS?C\/F5BQ5#]5;RFR```ITF83D-5Z<"C/+.$('I_`K(.,<>_P#: M5DV\M:)E:P$XA/B$.2..+:KB5:B?1**WCAFKA&>+T[_I3:RM0.EQT$B8)<.H M#'5/^WG'U1((08GC[5K5R2J9(74$@*)TO/A:E@$ITH1>6DE8X#"'A(`\O3DJ MI1(]#^TM1J?BBIT!=:B2`MQ`=O#BUJTB3FC^\O[NZJA5Q=;NFZ]:PIDN4]UZHN)2EIM*%H=V+>D>&+]EOX6` MLD+=TFD[F/Y]RO\`]Y/IFO-[>SF_@^X$UG5&HFO6L,7#S2U#23.*%HT)G(I6KOB`!];2#_%_:2WKC0^N1V7?[(E>DGDUM/4 M"V]0=PO+LF^&::IZ-;U;:%[VSUV%,_74IM56VEMR^>4B]-U:UOI(0V!5U$R0 MTRZHX8]Y&WTPYB/''.''^L'O9<^%^[1U8ZBH=9#;S0:<3NV[!;8;J*"U5#>A0(TKI:98E)339]P?-]R&W- MP?ZR7O/!?1[+]"V^/3C[AQ`]P[`N+8H5B($(@0L0(6"H#C/NE`A-ZU<_8/N@ M0DDSQ,"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1` MA$"$0(1`A$"%.MG\RM_[]2?Q#<"$7/\`F5P_?JO^(<@0H,"$0(1`A$"$0(1` MA$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$ MH+/$X=P@0G-0YCUB!"S`A]1(@0D^&D^Y?<3\V2[V;?GF=ZI[CJ+5:-P"I#3-% M7*L73VXNIME-<;E3VJD+MR\J?4FM"*>F:`3XU8ZJ68!/O?0?+K=R.WT`5=S7 M,XYGX+YUNNC%U9:Z15Q6PSMFQL)><(0$[*V>I M_-7AJ6W9_EJ5SS@6O)*9`DXSC<=&$LN4O@M%N-S3J``#4!T?L'N7.G3S;-^J MWF6Z/;MU:J-,T.4'3;?*B\=4@FGI]O\`RNV@P$N>Z3K*9\91#P+D/I[V[O$% M:.K$``1,OXK_`/H5ZL>7[;.\;9^%<<\0LO.W+RQ6IGX@ZPDA2=)"=)_"(Y6ZZ,@9O! MOUK?NZRKM2OZA$"XSY1N\>/W?VKUTV/4U(L5F4NEKT*-*@*<=M.Y&W%)*C-+ MHJ.EM$X9'`:DMR$L!'C[Y'6D'SY>QI$>]>OVVKHQE)]3<#\;8(]07,=+K#8T MTU8X")$FANJ=.$P#_P#":WB2)912PY^SZ5J)I_#^RI#GBH5I2U5X`X?!WI:D MZ0D$3:VD0K%0D!,0-3^#Z4K@%FKV']E3:=%2A+:BS6*.IM13\+><)SD"%[7; M/KE%`45M5(6%24%TMUU%&$A-5B0%2[,`(0N,75D2" M[>GK">>=\-OWFW$B9!(I;D7`3A(J38ED)!]$H7'M34[EJ]:X5CW6Z@K&!!HZ MY*2%8)4DJV:],@\\8NAQ+>G>L\V%`#Z?Q55U"%)2LEI2@4#4I=)6DSF0H`_W M$][E(3)BQGP]/:D+YBGI^BN&]WM:Z=]M#3L@E9]VAJUF8F4K*/\`9%<-66,P M?7%@EI(/I_.5MT% MGR@[A:=TMDDJDH`C"<>IVDX1B#JHWYX'=7<`KQ.[CI5K4XLMUO2W_*ZM:6&7UDA2TJ6I*LN<:#*,9$1E(@=M?5?+.GC8OS MA'7"W&1_JZ/V[0!<>T-!TW:>67=J],4IU^-3NO[!\N#3GAE);"&G;GY%]O.O M*;2)*6O3JG/`DR7[-GN].7;';E^7[J)7>?RI4^PZ+J-># M3IV#0Z^C'4AIQ#;?EOMK-.T^Q1)<8;IZ39/39::5Z8\1*WTT@S>:6B0/-W9O M2B'U$:X_GY'E,_`\T^WAL;,@+8M1D`:-:``(KA`?0OBLZ[H0WUSZU-M^%H;Z MN=1T(\!5(MC0C>%W2GP5T"ET*VI#W2R2T1^`E,H^9;W_`+9>'^ME[ROI>VKM M;1_UK*ZMJG3I;IZ6EIT+>?>6<@!&C:;3=;_=6]ELK=R]O+TQ" M%N$3.2Q.Q+3;^H/F.-\3M85U!356P.G-?;T[Q?=N-%6U= M$W=MT7*W73;NVJ%-30%BK6VS7OI4ZVAM.I96W]"_Q`_P<_'GX$_"&W_$/FYV M^SW>\OBU;MRC/<&T3"4]5_IRMVQ(QB=%L7]9\1+:)!?)/P;_`(T?A7_$W\0[ MW\+_`("OZ]SM-OU3N;UMK4P)P@38L2N6]Q=C$S`EPVTXO?V>JT=-R M`G$2M3G=B+T`0)VS<%-,Q("8B/#SKKT#ZH^6_J'=>F/5O;-5MK=%K0W5-A13 M4VN]V>I<>:M^X]N75F=)>;!;<8=2V^TZTC[=Y!^(?)_Q1Y9#S M?R2]&_LIT<4,9!GA.):4)QL/R=OD<=7/G&VSS`7+I9UPZ<='AY?*[IE0WUG?]CW M->%;@5U.8WY46UVU*VZTXFG1;4[#?2\'L5%Y!3QEV2^2[$8Q9Y+BKKE\H_J- MT+^:[M+Y3UZZN;'O?4G=O4CH7TUI^K%LL]_9V/17+KOM[9FXK'7OV>J;%^=H M[(QO-EJJ"1K6MM11@!,?UJ=`>GRKTV\_'^$\\YGD<\K/4SS34767I=Y@['T@ MMZ-T;]V-TWVYO2W;OMO3VD*SNG?5$W>:0TMQMFQZ*5PNC04A3%J9J:K5HIU` MCE28Q.&*^=?RK=`;QYJ?,QT#\LNW[_;-J;@Z_=7NGO1^Q[FO5/55=FL%UZA[ MHMFU[?>+I2T"55M3;J*HN:7'4L_M%(!TS.!E)$.:X+W+^91_AQ.I'ROMG^7S MJ#UY\X'1.X;*ZZ^9#9/E^K;Y8MG=1$(Z;T.ZK5N"^7CJIN%A^WN&Y;5V5:]N MN.UM)2J_,'@ZCX=MV2],.4^F!P=_%7JO_ M`+C5="RC<7A4#"FJ2EOU%<6:EJG6?&IPOPW"5I,0Y4F$!BZ^=OJ[T_?Z2=6. MI_2JLNM)?JKICU#WIT]J[Y;FJFFH+W4[+W'X[/3:7*FM-;8Z?\`+W:: MM:N[:FP)*3(A6,#G)&B(Q=ULWR_/\,-U\^83L;KQOS8'FAZ-;'MO0?S4=7O* MM=6-S[6WU6O;CW!TA9VN_<=WVDV^D0::PWUO=#2J9BH2BI:"%!P`R@M?W9_@K?-9M#:NYMV5_ MG5\NSE#M?;UZW%6(1LKJ8%+I;);:FY/H2443JP5M4Q$PA9$\$G(CE`C`EJ^G M>NI/R_?\+QU0^9!Y4>G7FQZ"^=WR_M[9WS27&AO&T+[M'J$GD^_>A/5/J)T M7ZI[?J]J=1^E.]-R]/M];=K@/B+-NK:-VJK+?*$N#2S4MM5U&LM.MJ4T\TI* MT*4E2292&+29?49TX_PE'F7O/E&VUYP>M_FSZ#^6G957T5'7SJ!M[J+MG?\` M<+UTDV`G;+N]ZUS>K]GHO`1=[)M!`J:^E:07:9\+IR"Z@@PY3Z88%W7B'Y/O M([M[S.GJ3=J[JDSMK:.SE[KI;!SU>XG-I;;K=ZUU95IW-=*.BMUSNVU M;>K\@V^TY4W?X;G8 M7:UAEZE34JMU4M@.N4-2366RK4E(\>CJ`FIHWM;+R4NMK`9U5*+28+2X$J)D M9$P(78WR?MFK\VOE:I0E2E5'F.Z(,@-ZO$47>I>VFPE&E;:M1*\)*29\1%EH M/=C^L/>HFXMS(_-/N*^W/YI%R;>ZY;M5=+Y:&54MFM-.BGJ[_M&B=2TX]<*M M3CK-[\WVWZY0=4Y-*G:5O4,$K6D$Q]&V%N,K6DT\79[XQ^/O6Q7:7QUK6BLW9T762A&IO0U^8^&C/^C]"T;>[<,-1,L*N3\;M`N6]GUVSFGD%^MZ)5"W5,+2ER MY^4:X*\.:5N)G=NL&YSJ"CC*:1(YB$C:$2\2>[\D5K%\X38^G.[^1>CG0V_[ M?IZJ@>:INA-2RR\%TYIZ+R0A-(5U2*MP!;'3[=+ZWGJLI6DEQ:DJ``FG").L MQ,2;NGMN>QB.]1.%BX-1Z1F,*6Z/QZ>R,'2F":''FM_WEQB.=8?0HE5?;6'$A3]H0MPS`6-IRDJ4EA2P2H$<( MMC9.GY9?Y7TJHWXF6,?7`_YJMZ6[T*`$_$6HMZYD^)M`3,L4D-OA?O`#NC-< MA^:#_E?%:K=QJEF[8_`+8V+Q0!(4A5K)2J4DU&VL`"#^+XP8#N,4&T M#^'WCZ$^J^V_2H*>M310*P'(]T3TI9`^K\J.NU:>L?0M9K]SV M5'N//6>0!.-9M\:4KP$THN2<5'LC3:LS-0)-V'X+%?W4!0F/KC\5&5>K.M+A M#UJ5J92OQ!6[=1I;RGH5N-B>@C(G5AE$SMR&4CZ_H46[\30:7;C!<,;VNMN# M-8LUMCIT(:5J<(T)R492,N!A[5H$AX$O^N/=%47;T MB"08AOZH^MS3O7COUCW#L)-?6*JZSIFRQ\;5)**NY>6]*WJALI:7)ROW]25* MEMH<][]II*3(G&/<[.U?%L/U7_5O4Y4@O#W[VVZI(C9)>OBVU>?SC*F)7E7U MGW?TB;EXMRZ:>(E:_&I:*]>59&A:U.MR34L^97;8;?DE*BDX*"I"1!CMV-MN MI#5IF!Q/6^-L_D5/_$MG:(A`VY'A$[:G+]_&O:NCNY]Q["J`[1V^IV$`Y7KJ M6:E6\.A&@N-T1IF*9YK;_P`PNQUJ%EY2O#<1I1,C4CC%ALM2\]><_C:3_P#$ M;KOM](88'IDMG6.\`+Y9OP6E6;EG[^U>A?E7W#<* M[J+?30U-R8J/]C&]WE5%MWQU8JPM]-#2.L)U6GSX;T/B%+>O4&VGFP@>%4TA MF^G!N[E,B]J),",9QQI3^]%O6_,8KX:_,=K1YA M>O2%^+XG^VCJCK4^NI6^5?WWO>HO+K;A=JQ;BB)DNU=2X2?>>=5-9^8;^F^O M?ULO>>0]P[`OJ&T_['9_JH^[M/O/:5PQ,\SZS&17K$"$?I/JS@0B!"($(@0B M!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($ M(@0B!"G6S^96_P#?J3^(;@0BY_S*X?OU7_$.0(4&!"($(@0B!"($+UG\B^Q] MJ].>EN\?,KO)""\S1[@:LM1H^(=M>V-NMJ%\J+, M@Q&F5O5INS"_"'_\4?XD_$'XR_&WE7^!GX6FT-Q.Q/<@2(C9@O$ZXW##5:@5U>K_-5YG.I75NR[FZ=;EWC8-R6^[5#^P=J]/GJQ`L7 MBLED-,4U$RAV]5;5$%&IK*Q"_P`2U`--20G\[?C[\;?C/_&_S67EGF<+^[V. MYF19\MLB=RU$!S&,;,`]VX(N9791,S6L8`1'Z)_!W^%G^&G^#OX4N1NC:6X" MR!O/,=U*-JY=,AT;,IB(MV(3$`1%]=PRG+T)\JOS9/,AT=ZLT'3WS<7 M&Y;OV)Z['1V??G3]VYO,MC0'SO\"2VXW,X2N6;FWN]7;[D@G5$R$IQURD)`SC) M^I2XY=O7'YL'EQV]UZ\IV[=YT]#35&^^B=JKNI.S+[3-)?JEV"B:9JM[V)-0 MU^U>M%YVW3*JO#09*JZ*G7DD@_GW_!/\4[G\._C2UY7=D8^6^8RZ%V!HUVO1 MDV4Q<^S_`%;DGJ`WR;_!W\3;G\/_`(OM^4WY&/EN^D+-R)H!,DBU-C]:-PB. M7AE(9KNM_@;?_P!6?F6__I[RE?\`U.\QT?NI?M)F#'%=,_F&_P#W97T9_P#D MKOET_P#Q,N@D*F'P*_1GW;O?IG;MP;2Z5[WW#M2GW#UBI]W6G9FQMR5-!\3U M&8VW857C>EGL]GN$V]Q&V[8<O0ZLK7BIY5PZ6 MUUQ8^`4ZIYRIV[76]UQ]VJ%6&HY*6?Q!>T?^-F_^,#\J4\O_`!A4DY9__67Z MJ1*C`+TP^2MUUVA\V7Y'NR=@=6JI6XK@[T?WUY'/,0VMMAZM>N&U]GIV%^:N MN5!J6JB][DZ57ZQWQ;ZD`"OKU$)&D1"DXNOS#>EOD$ZJ;W^9'M?Y;UWIWK9U M/J?-0?+3NVJ13NI;LB[%OU_:V]MW):0FJ6Y9+'8+967?Q6PZA=$SXB"M)!5. M2C3X^2_2@_Q+GFJVW\OSY.VXNB'2EQG9VX.OMMVOY/.D5AM-:Y3U&WNF/]WO M!ZB.4;`\2L=L=MZ0;=J;"MT+3X#]YI2I94I*5QR4\9%:)_@^O_F/M!P_^V;Z MWXM-=56G;F\JFVV6B71[8M%CM*6Z"C0$)4FG2L MC\1)Q@4RR[%^>QUM_P`0K\Y:FZ@]7MC->>C?J-KL[SZ@;5;M2=B=&0VBPHOM MWM*;>BH_V;FM0VFWCPTJ#OB)&2IB<0`X=1*6F1`:B[N_X3GYHZ?)[YR'O)WU M4W":#R_>="\6C;]A>N-846G87F18:_+>G5\0EQ+J::EZH4^G:M;X:4J?N#MG M=?<13T:R)P0#J#9KZCOF$_X>K:/F_P#G*^4;SS4EALKG02XZMP>>':SU1:J9 M.Z-W]#;;;ZOHO4BSU58BNW)2]7_!H-N;C:IF@U2VJPAY9+U8I<0I!&.87GS_ M`(Q/YI"-C=/-H_+`Z0[BT[LZHTEDZI^:.KM=0/$LO32BN7QW3/I=5U%,^54] M?OO<=J-\N=*KP:EFU6VWDARENB@9Q4.P?-?GV[#ZK]2>EM5<*[IWO7<.SJJZ MHI$7%^Q7!ZB54KMU5\?:JQ24$H3<[+B2$L9&-`M$ MJZFIKZA^MK*A^JJZIYVIJ*FH=6]45%0\M3KS[[SI4Z\^\ZHJ6M1*EJ)))))@ M4.7JHY"L,9\\2^MJD\RO0JI=;IZ=VKJ M%M,=4-KNN)8I:>FK'ZEY24R2VAIU:U$!*%$R-VV!EN(1&)D/>JKS0L3D_=I&4P:P!J)9\B.=:+Q8K% M[_14EX574NH99>47Q\1YHJ5K!9.E:Z?<%E=6CBH)4D$C.<=%[F?']+WZAWI[ M9@0-#X8,P/\`T97+VPKOO`KM[KM\ZF,$-J*'U[B\U+#QI]+B=1^+\WVRFDK2 M$J2A(#7N@88R*RG*)Y\,/\XJ^-GJ1`>38O7`_P`02O5U M:JU$(Q3+43JYQRYV2,`WK#("RE,YS`[(2%F1.K3[!_9)Y78`:=1Q?YC_XA2[7=UO(<0BX7 M)80X#-5PW$H`)P2G4WU4JIS3F)C'A"7;-R-=-.P?V85MF[;D&UE_UC_;E;:W M<*E)E\1=2Y-((35[FD1($:?_`(>7.?HC)*$\@!W?\E:GA@22>T_VJ8JKC<$H M+J';P`5*"'"_NB9*3(@*3OIM$PK`R5G#PA(R8@-V?\E+.40'$B_ZQ_M0M*K+ MO7.O(0:V\MR40HFOW8D*QF3)'4]!P5(8@QMC9.E](?L']FN==NC4VJ7\J7_B M`I*JZZ*86VW57IP^"HE*:K>:EE/ZZAX>^GW",,3/TPDK=&D(_P"3^PGA<88S M_E3_`+8KA3>FZ=[T%,^_:KIN)AJG0IVG_L_4:I*'&D++4UTG4^@:6=4O2W%^>HSNDNYKN!QX;GX=R\Z^H]PZGU04D[AZPNTJU5#I:IKEYSJEE+. M@EHN"BZV;E]UMS\*@E\E]2BHNINO5JKKGGZEY;9IO.36.%MI(4%5/QFQ]VK2M\HF5+7@D`C&&Z0&4 M6'.#>R0*M.[TAP;E>%N])N3]"5%Q]1;:ZHUU3\7467J,\S4>)6E][;WF3*FD M/.G0V$UWE0OCCZ?$,DA2S.FNMGO037=(^H#19KMN;[=+:F[6E+B%.;L\C1IEO`ITA"EN**L$L5 M9(IUY-WH%H%XG[2-7BV/]:/;[,4D)WYWB\2/"?SN/^[#,<>XY?$7YJ&44GF8 M\P=.E`;#76GJ:D-);4T$#^^-WD/"58]L%I0GBG\MM^DX?#,2\)/ROS$@[^\1 MAU)>_D3[SVE?5-@#]PLOCTH^[L'N'8,%P&5?U3[/OC$M;!8`5@<9=_Z8$%@E M@/MB4BM::P7RLME9>:2S7:KL]O7X=?=J:W5E1;*%PI0L-U=P9972T MR]#B3):P9*'.(=/I.("JR"DR(E@#Z"`01S!!F#Q$2D1`A$"$0(1`A$"$0(1` MA$"%L=OV=N^[4:[C:MJ[DNEO;2M:Z^W6.YUU$E#6KQ%JJZ6E=8"$:#,ZI"1@ M<)A&1J`M]/]K4]9;;>_N+>.[[O26+;ED9K[Q66ZTT3MSNM978%7TPZQ;,IMOUFYMEUMXV[?JBUTVZMOVS=5@= M7=-J7B^V.H%QL-XIJ@!JI<*$NA*]*PI($$,N`0)F4Y>L[[VZ-_P#3S;&_%]*[#8:K=-QWJWTY MOFYJ'=S=!_=JCL&\KMO[86R>KNR7^@-I8;>7[N]6W:N6C8#U$=-PP?4W3E`R MF(MXKD2P)J/FWG_XTV?D7XHVWX=\QV-G[K?O6KPW,B&CK,H"YI,7ZL+HC`S$ MFC;D)$CY3Y'^4GKGM[H)U'K=P[ILK]SLE^L+NWZJNMM.P]>[*A^OH:Q%?0I? M?9;?I%*I-%6PE:7%ITE)*F]"O4?X(_XD>6_X8_C"7GOFVVN;CR^_M)[>9MZ3 M=MB4[=+KC8[9T+Z;;GW-< MZ/;ZK'9[9:[*NX;MW!2VVJK[G77BX4MM55"BM-&W4GP@ZN3#6I;BTZ]",7^/ MW^+/X=_''XF_\V1C'R[R+:[2WMQ< MC$1(CJE[%=4/FM[1V5Y5]P=`-]='NINTO,U3=*G>C>XMC[LLK5KV[:+M5[.5 MMA[=]7=*VN9NM18:B@=%PIZ5-*7Z@NH:2X65?&'\#>5_X-;W>_CFW^+O+_,- ME>_"DO,/OENY:D97)`7>J+0$0;=)CIF8N,P,M(EX!QO+_P#"+<[O\8V_Q3LM M_M+WX8EO/O,+EN6J<@+G4%L1`TZ@1H,M3!M3?47M=_@;L=M?,N(R-_\`*5V? M_F_S'<)F4?J4K]*$ZO%Q)]ZZ9?,-_P#NROHS_P#)7?+I_P#B9=!(52/@5[6? MXOCK9U,\MW0?Y>?7OHUNBLV5U4Z2>=NEWSL;=%#)3ULOEBZ9;LK&$53"DK9N M5FN"6S3W"@?2Y27"B==IZAMQEQ:%&:`6B3V?%>GWDZZZ>5/Y_GD:\M?F$O-J M9M743H?USZ1]9[AMZPW`)W-Y;O.1Y?+U:]UTPMKE>W6)N.U[LE]9IA5MNMWC M:-]\-T,5BE_"GO1AV%>0?^-F_P#C`_*E_P#)A4G_`,1?JI$YJ/JGTXKR-_P8 M?G3/3+S=];/))N:Z*;VUYG=ACJ%TZHG0%MM]7>B]'<;E=J&A2'$?#*W-TKN% MTJJI92OQ/[NTZ1IEB9J(EX]B^I397RCF-I_XB+J1\S)K:J4=+-R>4JCOE@O% M([:Z*CMGFQW"\CHGO2G%J;<=KW_B^AUD5UO3WR6[#8VA7T]/6FIME1UIZELVO>?4FX4X: M0VP*BU[>3MZQU#9+BZ>MM-2@J2HJ0F1BEE2+9E?4)_@[KG05_P`H1VEHZEM^ MHLGFIZUVRZM(4"JCKW;-T[O+=,\`24.*MEWIG@#CH=2XMF;SL:JEIOX_; M6\-M7&FN%!4HFAVG?2<%!20#!$@3/4,%^I?L$ZO\-7:5:7$:ODLUQTNMN,N) MGY+:PR<:=2AUM8XI4`0MO_`-3]B0!-++L^)7YH M7G1_^/&\V?\`\DQUW_\`BI;IAA@%7<^6?S<]7&:"\]4[WT%W#>=Y/TCCE*SN[<'2VZ;MV:_N&L6I#@HKGO8[* M3<*X-(\!BKK'0R@-)0D+DK6\3+\>+S0^9'J?YOO,+U?\S/6:\&]]2^M.^+SO MC=%4DN?!T;MQ=#5LV_9FGENNT6V]J62GIK7:Z4K4FDM](RTDZ4"&"KD7/)<" MP)4@R!F9P)@[,$G"?&7'+V1"FJQ`I78/RFTM/6^:+RZTU5X'PKG6[I<7_C#; M!2EIO>EF=6*DW@*M(IR$>^:E*F`F?B)4F8.WRX/YA8&?5CQXC@Q]1!YA9/," M(["\9-IZ4G=N'-QZP1Q!"^TKYD-)M5/6J[T_Y9LY]VGZ;])/>-JZ(O*0PGIY M:#3L_P!J\O.XJARG2R06PFI$>HF_;]2NCNS"!:)#1Q#ESP(C8N,W$+TAZ9]/:] MDT[HME^J*=:T.V]*-E]:DH6&W5DHK%5?RYMNH6Z`HD'4$`3X&,\IB,G.AQ^E M:_\`&>Y53ORE;:,9Z36D+_JILC[<5[#](]HRL%B=?I:UJH0VYXZEV*KI5-@+ MF'5KO'0':E[DPD81;1^L:]T=W(-[^"V[;;W;T1WP$)_L=,%21(+HK,OQ)?B3J.S MD&1EQ`C$=R78`$?QO[1;AM"6,M3^G&T%`J]O*4V$FG`0D+*$II[$4H&HK(0G M^Y+I&.>$/;W,0OHK>FP%J]W_`$3@(X1T-ONKD91TZNZ=P`]PW`]ZP;C91E&6 MJA_5MGU$[,BO%EXZ]6MK[;:N=6V[MMEQ(6ZRXM&S-HD%!?D4ZJ[Y<=^IEDIQ M6`^M,I`$SCU]BY<,*'Q-G.Y\=[\'7C[EDDF,HQ,'SC#U?_3@#VNR\VNL=IVN MQ2WJH1MW95,S3JIF4L779O0@NEITONMCQKU\M*VJIE,-,E*@M0#BE3!]TQMB M;_3U2E(D-75<:O\`[U+N4V]GMS>TCIZ226,;#L,/_LD/>%Y_[ZIMATMT52&D MZ2TJ*:G:15.NV7RDL:EH'Q=2\I-1Y/=J+13NOKT)5-101/44Y4@W*DB1&.,J M^N4O6NE-K',_O,^6: M[W>3!&UW>L;5-:J_IK3:]@;Y><:I[IY9GJM=OI]OO+=I$T]FZG6"H?IJAU/[ M=QEM)::)\0ML!;@IW!N"RX$JR&&OCC0/VF6MU13J0O==S4GX=ZSW:_6ERG`/N*IJVL8 M*9:'G4R6?D_F8(\QO@N_5EQX\Z^NJ^L>6D2\NL2BS&U$T;ADU&X-1=>!+C.? M9*,*V]B5-,I8R'=`HKFG&BUXC0=#BF2XD.);*`Z6]0\0-E84@.%,],P1.)0! MXE^K;?=S^;2_>6/RP;M_P];/R\>O/D+V5T0VU:.IGD[WI36NEZB;^NM;251O M%AW%>6JRW[>LF[KEMJG:H[K27^MLUY&X4UC]Q-Q\1332JVF?IV>E%\4^P_E( M]..IOR=//[\T/?6XNJ?3#KQY8/-%N+I$UY?$4&W:'9-K>;WMT%LUQLFZJ6XV M!C=EOO6W:CK#7TSS#;E(&W+>TDM(_:),I2SLU5SGY@OD,="^F6\?D6[*VAUU MZL.5?S8K7LZLZG73>[S@[L\Y7E4VON3<'6S>%/L?8Z>CU MNN6S=QVK9&\K!;+)<-C6T7&Y[4WC?:>CJZ)CX]@=!>D7DIZ-W/J=U&_(]O7? M<.W*WJOU(>H]D]2:FT[>IKCM*ZU;E"U;6=-NI*=;554U5>U0MR2B,'IFMTV_ M_AN-FT'SOW?E<=1.O^_&.CE]\O\`5^9GISU;V]M"R4'47VOUZ&:MM_\`+6WQ2,&I73T\.C3'');)T;^4'\D/SF?,5HO( M[Y2_.UYJELW+HKU8?HUNMJDONRWK=N#I+T\;OFVKOL`5] M_I%T2@%-66J:55H6ML`Q4]2/,MM1UK:MWVEN=K=ULJ[L-O6_J1NRQTU4[;T-5 M3-LI+N^EMQ=+I3+J-,10XKY^?4>[+T=D2J3BOTXO)YU`^:7T_P#D)_*#K?E4 M]+=D]5^J5TW56VSJUM[?[&TT;29Z2'>_5^HK:F_7+5B]=*.CF_+_Y;D]3_ M`#_[@Z5V^BO>W>G-_P!I[BO#5UNU5MBTO6J@J.KE\LM;:;>JD>^!==-=;JVO M2A3SSSA50P(2K;/D-\POG1\@/5KS>U3GDRWKMS9?7+8WG)Z17 M'IP.JMBO&X[/M(=4^AMPJNFO3JH%AK:^_LU]-3U354I5OIWP_P#"5`IVJL!4 M2@U#BN[GE$^3G\N+Y:'F-^5VCSZ^;?KK1?,NZX]6/+MUGZ+=".C>T;94]+=D M;J=ZF64[)VIU3JZW96Z;KD7EL\JG0ORY]6>O^]MD[4J]]=17+8_Y9]@U M-CV9L#:M#176HK=S[@H-NW.K0XFAN+J&KS:/6WSH;#^7QU3\Q%9T"\P>TO,)T4IJ#S1](]Y(VMO.Y=/KO;MJ5 M>RMHT&Y=D[PWSLQFVW65KJU4-!=6JBF57*#[-*.FT`28X^G)?2#\W'H+Y,O. MC\U'H#Y1.J_S$_/-Y=O,KU'Z`';73+H)T%8K:+HW==E[F'5NKW7>;U>UV"MV M^Q=>H5@VY=+9>F:MY2*ZVVZFIGDEI2$$S0/E_*OF6\G/R"/*3UH\UWS>]A=< M_,QUJZ>^7;Y5>[*MNZ7O:6U-K7?J%OOI]9D=8+EN?1CY M,?E,8\E?4_YCWS9?,=U&\OGEJVEUGW'Y?]@["Z$66BOW5/J;U"VI=;EM>]KM MEUNNV-Y43-.K=MKK:*@I6[6\7$6FMJJRHHZ5@..RZC0!0XKT%_Q.%JZ-6/Y7 MGR([/Y=MT[JWOT&MO2O?%'T=W?OFWMVG>>XNFS/2OH$C9UVW5;6K;9VJ+<%7 M8@PJK;32TZ4OE4FT#`0,42^4]R^)R&5*S`A$"$0(1`A$"%.MG\RM_P"_4G\0 MW`A%S_F5P_?JO^(<@0H,"$0(1`A$"$0(7K#\ISYF-Z^7AUANSFY;5>]Y>7[J MF+-;^J^T+#5ML;FLU=9*EYW;/5'IX:VHI[>C?6S36/H33/.-4UUH*AZD>6TI M3-33>G_"WXCG^']Z9W(RGL+K"Y$%I!CX;D,M<*L#20)B6=QXG\<_@ZW^+O+( MV[4XVO-K&HV9R#P.H>*U=H3T[C!R/%"0$@[&)][^I7RQ/E;?-"NU5Y@?*MYE M[%TPW;O2H>OF]K+TU>VA6VVYW^Y^'5UM?N#R^[VONQ]Z],-WU2EIZJU M5#[BW6605*6OV^X_#7X6_$LOOWE.[A8OS7SW.VM`1A.>L$1&`&XMPNPNP;Y=0C,,!(EPO&GIAOK9OR M;_F!]?>D&ZK_`&?S#;&M%NING=SZC],&J!%ZIFZT;;WC25-);Z^[.VYNZV9Q MPVW<%F%PDS<&%!%4LTNEW\T_XU?X:;G\4;*7X]GNQ=A,N;5PBW*.F M>ES"0$ZD">B0,6(+CU?XF\DW/^*WX'VE[::MAO3/K1MWGTD@2MF,B`XC+YK= MS27@:Q&JG3+YA_FWL'G*Z^HZF;4VC4[1VO8MGVC8UA:NPH_[RWJAM-PO%U5> M]Q_`.5%(Q7/U=\=9:8;??0S2L-#65%1C/_AI^"[_`.!/PR/)MU?&XW<[\[TS M%^G&4Q$:+;L=($022`92,I,'8>B_P_\`PE=_!?X='E&XO]?=3O&[,A]$92C& M.BVX!T@1!)(#R)+,O:3_``X7SL/*S\H:S>;VW^9#9'6_>#_7RY=#JW9ZNCVW M-F7]J@:Z:4W5BGOB=P*W9OW92J-RI5ONE--X`J0L-NZ_#DG7[\NO=18AB5P# MYI_FM>7?K?\`/^Z??-/VKM3JU0^7S:G6WRI=1[EM:^6+:M-U7=L?0S:'3+;V MZZ>CL-'O.OVPYMX_*/\`-;_M"N5-N;>?ELZJ4%)M M'S'=*]O5%,;E?K);TU[FT=][3H[G74%F7U!Z;7:X.O4/Q+K3=9;:NOMY>IA6 M?%,24L3D5ZH_XB+Y^7DZ^;/Y7.BO1?RZ[`\P>T]W=./,!3]3[Q7=7-K[#L%@ MJ-LL].]\;4_M7J+O2NJ+PY<]R4ZTMN,LM)9;<.M2BE,0F+`,Z^8[RC>8 MW=_E#\S_`$$\SNQ%+.Y^AG539G4BAHTN>$W>J3;EYI:R];9K%A2%&V;JL0J; M;5I"DE=-5+2""9B2D@6/)?HR7+_&F?+-8MMQ?M70CSG7"ZLVRM?M=OK-D='[ M91W"[-43KMOMU7G7CJ[U0ZV]1[HY>M_\`5WJ!N_J5O.ZNN+<57;GWM?Z_<5Z?25J5I:-?<%AM M`]U#82E.`$2*))%SR7K_`/)2^>+UI^3SU"WJU:MF476CR[=7ZBRU/53HU<;T MO;5>W?;&EVDM74#IWN@6Z[M;H+S1AMFI2EUBBJZ."."D2 M#,5]E!_Q;GR6>IUNL.Y>JG0_S`JW=;;>UX5MWCY?>EV][E8*IY*'ZV@LFX$] M0[E3FE;JYZ74KI?%D%J;03I$=R<&%MSU":J'B*DU72+Y"_\`B,/)#\KWR'TOE@Z^=//,ENG?HZT=1>H-1=>E M>SNGE]VJBQ;MI]L,VQ#5;N;JCLZYN7)L6ATO,FD2A'NR<45$(&922)>I?(#Y MAM_67JMU_P"N?5+;5/<:/;G4KK%U,W_M^DO"*=J[TMDWEO2];BM5/=6J1^JI M&KDQ07%M+Z6G'&TNA02I0D3(P5JV:%\)?:72(2AU M)TN*!]V$[@CN7Q8]2]Q4.[^H_4#=MK;J6;9NG>VZMQVUJM2TBL:H+Y?:^Z4; M=6AEQYE%4BFJDAQ*5J2E8(!.<2*!),@R)&"TF!*ON^^6E_B:6]=3^GO2CJ9L?<-\V3LOIG<-E/WC>&[>H%^MJ[5=+QU8LUX>H$4FZ M*9+SKEN;6VX'-+;@2DK5C@K@8OJ=?"`!(2/U@^T80RJ.*S`H6#CWCV0*7*2) MF>(F,OMB$S>I)(S,Q@?3`I79_P`E'BCS<^6YQCQO%8ZT]/*A'PYK`_.FW)0U M$V56^[V"M2Z`U[I:KZ)8.(?:EXB=_E0!\SVX.'6C[QR/N/85A\T)'EFX,<>C M/W=H]X[1BOM.^8Y>6CUVW.^Z\BH#&QND(=I[AN2X(2^E?3>P5"&JAO\`\8MA M4^4(?3E34JEGWE.5.H5C_P!/V;1MS`8?:W,*?6.'[L>H>K`?,=P;FN!+G[.. M.=,VE<)'>/BO(E=YM5.YJ=H;2[[TQJN]EK!X8U`K4;EY^J1!7K][`C3(&?/J M1A;(?4!VR'[950N;BV:"4NS5]`'P6[[>W!LSXAD.,;70@M@^+67;H7252%D+ M2?$.C#-4AM#A1<=Y>0FDT52%(<6U4F_P#G8O3SC?AH)]_4%*)! M`QBB5N_:D3!R!^:9R;U0/L<+3#S/8WK0A*W'/%_^';Y;Z%!3RBE;?Q#77^ZN,(*?>&F93A+.(GO&B\HWFR8[ MA_\`)LK%/[C^.I*;#1BVV_;5R0L%LILF]/)HZPV MXE*`:=MVR=1;HBI4VA"5:@5:_[U$Z\M5S'/W&P(`D"W.Y?^-I66+.X`,H MQ@#R&U^%QER%:MZ;P*D,+8I:1"E**W5WSHK5"F;*5*\93=-NQ3CB5*$L,9F> M4XYURYY=*I`D1_K+WJ_=KIVQOXEF,8?J[?U_O$W6[QW:ZTE:J.C_`&DT*G?. MBH]]&HE`6=X-!:D3Q`4,X:V?+7I$`_KWC_U:6'`7/=_.^A2CIDA>K4[U&'XU3&([3'0A>V8#,P_6O?V"Y=R.YE)Q$$]FU M_MPMB_O3NM3#`7N2"-+_G MW?C85K>84&B6H@FD=J3ZAN!1<-=0M\;Q8LM639:@,U%,^W4NBY^7U2$LI2?$ M4HW'KG8DI1QFEU'?&FQ/RP78L8:@?Z2Y7N.V/N6;YV]VP(Z8:^X73[]DWJ7B]=Z)?3%_UK'KIYBNJ-Y;M#5UMZ7*7:5TIK>B[ MWMYNFZA[);>>524E56.)<[ M.I%P=74N(;74U*ZJQ?,WNH<9#J"&V`"AMDR"228!$92+`\`/^JB5JZ6ZE6]$ MFX<_M*=C7Y#TPS7#9K-TJ+#M&UU*\12WU,EFI\R+BB)E*$RM/G4W"$AE))`T M=TX'B2P)/:WKPQ1T+L`YU`'^M]3.:+NUY-KAU&9ZST=<[;^JE:Q3]-NH[2FZ MVW^:2X-*2=O/*00S=.J6XK:*GXE(^&*W%NFJ4CP9/>&M-&ZMQ.V&HQ$3D_TC'G\T:_QNXY?$]YY%/*\X?F854-7!BH7UMZBN/M7 M9F[,71MY>XZU3J+DS?D-7MFO2X3XJ*Q(J4KF'??G'R?S4"/F>XC%M(NRP9L> M0`]0`Y+ZKY27\KVY.=F/'AFY)?M)/,KJJ!/##TQ@7069X2.6,NPP(2D3F)*T M*204JF4E)G.8(Q!$H%&!=?9WY3?FP_X>+R2=1K3YZ/+IY0?.[L+S?6SIY7;> M1T$LF\K11^7S^]U_VJ-I[HJ&KK7=2;P#MJ[I>J:E#E50UK-&Z^*BGL[50S3I M9@!6&0+X-[5US\D_SNO*+O#R[_,M\FOS0^E_65GHQ\Q3S4;_`/./>M\>5%=@ M>Y-J,V[>%SMS%%8+3?^FEHJ[75C\S\3344]72NM.ZTS5*# M'$+EGSH_/(^7SU%\TOR1=P>739/FB_\`#]\JF^VBFW==.IE@V"WU"W=L+;;? M1>Q[:H=JVN@WU44VX=T4VW^E"W*VJN%5:&:JIJT!+;:0M8%+@+I#=/F<;JZG M?XBJT?,-\@?3[<.Z=Q=7O,%TTV[T=Z/=6GMO[*OO4ESJ!TTVCY?+[TOW)76Z M_P!_VYM&MZ@KN-=;[?<%5M73VUZKI:MW5X2DB,`H:SJKYG;UMVU^76MNM;N2T]0.H]1TM:I-X78[ MMJKY<=KU&XKMN"EHZ2U,-T3J@FG57!#PF.0#8^F:^5GY=7SW?+%M'Y?.P?ET M^=/9WY=?66X=*NJ5TVGN#<^X-U#8?4JGH=U[6364M' M7;NKFT+4S=*"JIFJ.=)35=(:VHEE#A\GYK7_`"S_`#H_)!YG4>FM=IVI555Q=+5 MM9O);I#J=;:07U,(ABC5%FS;XKPHZ#>:'?72#YB_3_S:=`+9>;EO*Q>:MCJE MT\VKH2W>=VTU^ZC/5K73ZXT]"\_J.^;!>'++7,,N*UMUKC:58A43@%&K5<)& M!7UN?XLOS;]$=A]7?*3Y#+3T[:I.E]/U08\^'G?Z8]/KK;=H77J#NOJ+?5VM MG;MVO]DI:ABV=2KUM1G=%;5W%Q52I;E[M];I44-+7'8F=AXL/@OF&^;GUP^7 M/U[\S=GW=\LCR[;G\M_02W]+MJ;?W!MO<[;=I=W9U'HZR]55XW;0;18W3O:G MVPPBQUMNMCP;N2DW"HMZZLLI<=<=>D*N9![5ZN6K_$)4?0#Y;_RK>@'E%KNM MNS?-%Y&>LC>]^L/YXS;+'T&ZP=/':CJE4W_I==ZC;V^ZJ^[UVMNQO>%%35=/ M76NA^'"7*BF=;JF*:H3#)]0Q[%R3O?Y[_D4Z/_-=Z8_-D\C_`$(ZS6+XMA>?SRY]0[-L?:&W]UN[LI=OU-TZ@]'M^;8WANYFHWH]?+12U=R%=:+6Q= MZZS-5*TMO72O>9&1J&!6E?,I^:E\M_K[Y9NO>U/+SY@OG:=3.JO75VT_D/2/ MS8>:G<>Y/*CTF9?WO9-U7_QMD5'5+==5NBGM-IMU106>BJQ=VV7'VW?&;4P@ MD8H,AR[EV>VU\]'Y1WG&W)Y&O-1\R_H9YK]F^?GR'O\`31^P=2_+75;6OO3W MK!4]*MST&][`_NBV[AW)8*VGL%SWM1OW5ZR_"LO4CERJJ9%UJ&')0(<$9+1] MI_XECHGT_P#F^^>3S:6'I-UNN'DP\]G3/H]TFZ@V:WWFU=./,GLYWI#TPLO3 MO;_5?8]=M?=U7;K??K8E5Z^&HZ?<%OK$MW)BJ:KZ:II`VN5`,<%TT^9E\Q[R M&]8NDW3CIYY7_,#\X+S$W^EZ^[$ZH;QN7S!O,I=>IG3O9^QMG4VX'*K;W3[8 M55OF]T%;O*Y76Z4BF[A54R'J:FHW&TU2_B%B(9U.H#AW+LEYF/GN>3;K%\_? MR;_-$VOLGS"4GEZ\O_1ZAV'OC;EZVGL.DZKU]_I+5Y@:$5.VMNT?4:X;9J[7 MXO5"V8U%ZIW%!JH,DR;"AE#C#E]*I>@WSR_)[TPZB_X@?=VX=E]?ZFA^:?;= M\T?ES3:=J;&J*G;/]Z-L>8.S4HZNTM3U#I$;>**[JC;%+5:WKSX;3-1)+A#> MN64F074QKYN'1O;'R/?*O\O_` >I]N\VOET\YM!YH*?>%TVYM=[HXEJP=1 MNJ.^+`*"],[P7Q7L=U*_Q$WRW_ M`#9-[:Z^]>>H?SJ_+5URM>S+3:=\^6;R7^;2][)\KF_=PV.E5^THF6.I.W1; MK7N%T^!5U+%#9:Q5.=3R*I])>=*H>.3-[5YE^2'YOOD9O_D9ZE_*_P#FG=#^ MMF_O+)>.M>Z>NG1?JQT*OULKNKW2OMK[XK*RY;BKML;`?%6ZLV%%0M\-, MNT^LNLC(U#->*_S2NK'D6ZU><3?&_P#Y='17W M;0V*FIMX;AMFUJ6_;HI]G6:ZW)`2S0(N-4%J97528^)^$IY"29![5YWQ*1$" M$0(1`A$"%.MG\RM_[]2?Q#<"$7/^97#]^J_XAR!"@P(1`A$"$0(1`A$"$MMU MUEQ#S+KC3K9"FW6EJ;<0H8!2%H(4D@9$&#GFI9.9/,P*"7Q1 M`A$"%B!"S`A$"$0(5QMZU?GU_L=C\5U@WJ[VVTA]FE=KGF%7*L9HTO-T3'[> MM6TI[4&426Z1I202#`5,0Y9>C/4KY3?G/VQ<^N5[Z<=$.K/5'H=T.ZY7[H)> M.M[O3NY=/;15;OL>\Z/852;KM/=UD^X?+KN?&[5::^K=I&V**I<:-04=,Y8+M M'U"^2E<-@;;_`+S'S)4VZ:50#R*/:?1'>&X;I^6+^6?LWYD`W"NWV/<-S?;V MU36/>"=L5E#;S3JNU3X=.KX=(Y9TW3CQS72E_Y6_S"*:FZ&UM7Y3.KMOI M?,DQ55G19VX66FHD[OHJ'9M5U(N-8^JJK&!M6BM73:B>W)5OWH6UFEV\V;DZ MI%%)\CA+TY;_`-GF\=N( MLU1N.S7.A=>;N-<;IG4.D=1TY+;>NGRE?/IT M`\W6S_(SN;H==-W>93J+M^W[IZ=;%Z6W*V=0D[^V_5[:N&ZZZ[;6N=BJ7J.M MMVW+99;E^9ON%EFC-KJUJ46&2\1T&%:%IM)UAMM>WN-MF_;7H[?L%INE8LM)=G M+JUJJV&TWYBA>_*Q6*04@=0+ M9-M.]:*U4EYV[L?>=AJ[70; MBME3:N@MRJZF%2\U\0UK'"@VY!:?HQUD\M+EI\JG73S1[`_O)TDW#N\=1+9T'I=KU6Z]L/?W7JG1L5%L1NZ MB-YN5T*$;<14TZZYA":EDJ'X)A;Q7OY5?S#=IWFZ6;>/E(ZP;6J]N=& MJ3S"[NIK_:;=9'MH]'JZXU-JHMR[K=N]RHJ;:ESNEPHGJ>AL]S52WFLJ$:&J M-:C(CA0+ME.;`W-LW=/3NGHFZ M84SFYZFZ>-M^Y.7BH=7\.+;4U(0T@%_P75>$`.B48@."NN,2JTDR'9.!2*K! MD)$9_7]T"E\D@XF<0F7:;R1LMO\`FW\N[3JZ9ML]6=GJ<8,`V+S!CQ!%%]C_P`RZ][8I.OW4B@5>=AT MU1;[-T[MSA?ZM>4&BK:7X#IOMM+0?H*CI%<;E1>,PM*@W4ONI\,I<94*9;#; M?TKR^,C9UF#:KDS4-]8YW#(^MO6OE^ZN6Q?Z?5U:81#`QDQT`UT"+?G5X@X$ M`>/=-N7:QN;(J^I.Q*.B54H56%'7/R>4`<2PTXIA/CTGEYK7U)#L@-*)&>7*TH\-M/Q*D2L7D[O#S3:7$E.O\060`#Q;IQG\T'?A('Z$T[W2#B\( MB+4(M1#XU+''#MHO6?R^=:-CACXFK\SM@86B254*/F`7.W%Q"D("F5L;.^79 M6H(2M94-+@"E*'`$QBW&SMZM(M7,JBS;EWUO0]R+?F6^\4H7MI*VQ=]WTY#D MT-MUZKUFZ)==.GSS]N4]YGG*EMI2`BFN'G?ZP;M9JW53#39MC7D-L=OJ& MEDZ=)=P6)SPCS6[\OOD2T6)`OE:M@COZ[NN_M_,8M$SOVJ!PVYN%^;=!B%[; M]*[]MVX[:M-?2;V=N1?9<6M\=0J"^-J6ZI.@"LO/33;=QJ$--R""Y3MJ0G`B M/%;^S>C=-LPEI#,:Q^,J\5['RS<6YV1/J@RJ_B$O;IB2.#@K4I MM*D7Q,\`0-V6-E)QQ*I[2>_6P&!B^&WO@_+(C^,?B%5=W5EFUQB>T#OP*3;[ MC;WRLHO*:A25Z?>WEMQY.K@F;VTJ>2)'"0($3>MWAB"/Y0^)2V;MN0:,@3V@ MO_DA7AN%`@D+KJ9)*@D)_O)M+3.1DD#^[R4)2K/#"<91"?`^U:3<$<2/6/0J M.[54(9<>-Q;#39]\C=&SY-E7N@@*VZ9$F66,-",M69//5\$7+@,"20(\7C[: M%5!NMG(6?S.B7-6CW]T;%"TR`"IA>V`0>0]L:NC?E$&,9@;$)$3G M`GF8$^K2KEIVU*#6I^VN)T'7XMWZ?5*)D:?>UVA.H3(Y"<9S"\'I' MW7;?73=-TKZ6IZ@=.K8B`,+6XNTK]EN/A?&'%E\D\T\T\K@XN[[;;?Q4_O.RH?XVU.(R MCM;+?2A&)V]UA4DV=T'QTN3>(85<]BX,/./*NM(?\6VYE*D M0-QY;,/02``V\9ZC1@Y:K,['RSZDW/:-14NE-_Z8UNEQUQ!;ZM_*5OKLW'%? MZ9;?2VQ^([J2"H@)"Q^J(Z'0N".H!F&?4%>\E/*_MI3`F3<'W''`5:TII6K0ZXVH)QTR`.$5R-P1`U`8_G? M0FC9VLI$C;SN&GU-M_:!=]_)/M6U-]9;=HVMM-]FJZ;=1J/Q*?9/R]*UQ%/4 M[9KVJIL&AZE4`>;<0I873T@"ZEK4T\6Z13[J,V^G/[C2XY<4'5X\+8?'^+2M M65VTM6X;\$;4P#'Q:=M%J'&4[A'*@,JTIJ7Q\^=FC9H/-MYC*.G:988I>L.^ MJ=EBFH=N6RF99:O=0EM%/;=H7&[[4H&4ID$LVVJJ:%M("6'5MA*C\=\Y?_BN MX=R>M+%^/Z7B]=>*^U^2M_P?:@!AT(TI2GZ/A_DTX475L8$'D8YBZBR)@4$.G.7:)Q*4AD0*$0(4^U76YV*YVZ]V2XUUGO-GKZ.Z6B[VNKJ+?= M+5=+?4-UEON5MN%(XS5T-PH:ME#K+S2T.-N)"DD$3@4@D%PNW?5_YB?GU\P/ M3YCI1UQ\Y/F8ZM],V/A"=A]0>M._]U;5JU6].F@7=++=[[545X/2_>NU.H_3OV[N"Q[@IVFGZBPWBVWFG8?"RP M^_:ZQFN99?#:VW/!==8"5Z5!023+&`U"F)8NO9'J3\\#S`]4;9UDM=]Z0=$* M)'6NQ_,'L6XZFV4?4!%3;&?F+]2.D74WJE56?XC?CK!=V!>^C=`SMMJI0^T* M:LJA7BL4II;4,K.I3N6]7OY_'F$NQ\S/P'0?H5L]/FHO=1U7WZ=C77KAM>NL M?F@O'3/>?2/>?F-V5>Z'JT;[8KWU#V+OFJHKWMP5"]KU+3:4MT327ZY-6,IZ M@]BXZJ_G<^8BJM?YS0[X14M45^^7)MSY:3KH2G>B*JOF1>W] MO_JAYT-]]9^EE!TOZ=>89_K)Y4=G^5KJCL_=G3_8_6KJ&F];IW#MZP.N/[IV M\_L2A/P]-4(LB:JIKRN&3&X`/4O.C=WSBNO.\:N[5%SZ?=.ZI%<[YZ6K>[>[ MOU-W9>[79O/CY6^GWE)WU97-S[IWS=[]>6.G?33IM;W=N.5C[SC5:"*LU-*A MJF;D!DAF"77*O0[YM.R:_P"9#T%\]'F=Z";9HF^GGEOWUT0ZS4?0RFW$U=?, M1=%>3C?_`)7=E;CWK:-V;_\`R?;3VXK3<;%:K^=M.65FFM+%1645-^8D*=&4 MZP2_-0*;YZ/F&M>^.C^YK%T9Z$6#:OE[ZP^3SJ=T.Z56RGZE/[(Z:[=\D/1W MK%T:Z/\`2>VW"]=1+UOK<.TKC;NM]ZN]^N%YO-QW!<[RXET5[36II0R.IVJM MVW\\CS+[2LW1I>WNF70ZW=1^GO43R8;\ZI=7!9]]5.Z/,Q0?+Y1=*#RH[&ZK M;??WXKI]M_;VQ;#=ET5?5[2M&WKU>TTU,[5UJWF2MP9&L*$Q\Z'JCMWHW=^C M?3;RW>7/IM0V7;GF3Z9^7O=UCI.J%TW7Y7N@_G`O5)N'S&=#^FB=S=2+SMC= M>V-\W4W-=#=MX6W<6Y=NMW^X,VRX4[7P::09'4&3IG<'SK/,#N"Z=<;RYTKZ M,VVY=<^I/GBZL72KM]'O;7M/>WGKL/0ZR[XNFV&JG>+[*D].W^@=HK=N-5PJ MT?$/U(N'QK2T-H&=`N-AP6QV#YV^_P#:O7#KUY@]N^4?RO6[?/FBZ>;@LGF) MV]5KZW[GZ/\`6OJYNNZ[EOU]ZY]2^BV\^KNY.G&Z;TK<&YG+G1;?>H!MBV76 MG:K*6B;?"U+&0+@&2\2)#(3(X$X&7=,R[HE5XE).($IY_?`I##%),\)Q"D-D ML9SGZ!P@0A(GW09YND\Y?EOJW*QFW-T757;=>L!3\3J%.*BJD'/&0H M)>#37U+RNW&&U`(,?'/\VV_C(PEKD69G)?U5^5;Z[*>Y?5"0C&&$A,CP1+2I M``EW:M"[C4P\C$]67FJMUT=6+@TM54R9N> M*9I`PQ,=6,H:?FSRN#]EEGE,`L\7TYQ@&[!4GZ%O^TNLMZI:IERAZ]W^TK<# MZ7%TGG8\QMN>32-.!33)&U/*BLKIW5*,BT5`$35)69*5F;DS)'.3^OP^F2OM M_9B(=I9-&U4D2A&Z9,6 M`NW[3?K=$2-10!C$GF'7I7TO\PVX&FD,O^9Z^LE`9IG&7O.Y\V*ZL-AMX-T[ M20]Y.D-!S3(*4VH-@'&8G''WFSLW)&0M1GI_U&RS[;P>JOV&ZW=F+2%RUK'_ M`*YYA(4/^ZEJ8?UTQ[K16FU75&U3?GU*;:2V<5-]<]\-:4 M8344N="O=4)C`:L\XZ-O:$AQ:)_YD?VJYMSS&V),=P`W_M%S_P`.5;TW5:@` M82G?E&\E:5ALN]:K@I3@0/?416](:W+_`&1^%PI[7F4" M0VY'_>*^VP/:N".L'7^FL%@J*YSJM26=I]MX,OM^:EC:CGC(2I"4T]0?+]N% MQN9$RM31TG$`\9VNRE])O/,(0VYN'=1B'Q^\QC[38/N7 MA]U:\U9JZFO6/,M7-EJM;:I:3_Y:)6T#J"L**GM-?Y%#2MA*R04SDI1!.`,? M2=EY9"$8B5B>IJ_W.)&69W*^8[OSW=QG+3N]CT]7AU^:2B3CB/N!]0[VP72W M??F)=KVG&U^96H?"D5/A-+^:#T?O?@J4I`=4S3[E\DK()6I!UID/$ERCM6=E M:ML>A,%L]KI]VX-.?L7-M^97KZG[;K#3K#*Z=7F)^71 M=W7WJI(8>N71VW!VG\9L)4W^)LD'41,Q3*S,1U1CGSI^5-+6 M:OP`9=65#(Y=TWG$*662D'$'U]L2H=*X#L`$"@ MUJNYWR[GOA?.]Y9ZDW$6GX?JC9:C\S.Z!LDT)8;J715(W>JTWW^[3K13-%:* M*J-.J2PVH@`]C\/1U^>[2+/]O&C:L^!(?L<+C_B*1M>0;R8(!&WG4RT`4SDQ MT]H!(R"^P7YF_4#P?,=UI99ZLK:5:[EMFU,TJ_-=U%MK=J^&V+M]#E`WM^AZ M/UE/M_X9Q1+K-&_4T_B+4ZVM1=4E/U/RF!ALH2!,'E(MX88REA21/>77RC?7 M8RWDX1,9D1C]8R(\`Q=@`V0%,6))7CFCJXU;ZUUVJZMTCK**M!J4->=+S`41 MJWR`H)^)V[T=%65^[/W2%'@#+#K@R$2(W"/XY(]D2L@O6Y3'6TZ@,6` MR>DBQYRH6Q^4*T[C:P`&J!F#G*R7#X!R7]^>*]%^EO6;X=I%4/,"IAMZW/N6 M:X,^<'YM;W]X4T-Q11/"V+L/2UI5'1TWQ#B%JJ`D@MJ2$A:TSB>V%R($(SE$ MX@QM%G%?G(SRYNZIGYG.,I:Y[?5$>$QOS!<&@^RMN`02Q?)F#KOOTIZ@/W5^ MQ'_;PFL5<*=RJ9ICYI_G9.FEIVWRV[2O+;ZF4I3($K*BI8F9#"/F M?F]V$-P6A:B_&S8Q[;4B%],\C@3M8@7;DP,&W.[-!2O7B)=IXO#^:%+M.U72$!>Z=UJ64I4RE/7CJM4)(E):GC<[67"-4I` MXDWYEMS&WW04@7[.J8']=,>M@M%J-O77Q MEM#>%_T!S5-/F#ZHM/`^("H%0V=Q*0I6)5)=1L];I2!D5`&,MS< M6WI&V_\`5M[!);+5B;?/=I_KYD>V"Z]=:D7.W;8KZA74_S*&K0T;[MZ9@':$,SO4+HUOSS!L4Z&BUYDKFFL:0LIU_-9WQ6O\`AZ`I M*5?G/E-:990M)($B!B=6)CK0V)MQZ87!3:FTZF%)U+=<]ZI=TW?R]T:4IK*M0=TG45GB,XKE;B08QB) M<')[LU7=E?MD7+UZ[;&8;;U(H2\K8^;'FU`%WS\E&[+/5]GQ*@FD0^A6'>VH2V M$P+<3(2!I&1;,RD9D[>'B)B M2:8DQ`B2<28@!\`!1=1XY2ZQ#).F9/;^C[H$.DE/J@4@K!$I=HG$)DX,AW") M59Q68$(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!" M($(@0B!"($(@0IUL_F5O_?J3^(;@0BY_S*X?OU7_`!#D"%!@0B!"($(@0B!" M($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($)) M.'?A`I`+I,ID$`RF(A.G(E(0LR@4M3FN\ORTM?\`X]/*XM%95V];75&VOBNH M-P6;:E92_#T5<_X]/N7<+%39+&XV&YBJJFULL_B4)".U^&QJ\]VH9SUA1GXY M9KC?B60C^']Y(EAT)55!V_O0JK%N.=1*\(\=QUQ+WS#J"UM*DV7$,%R MW=/W%I47$@I<`U%8F99QK`F'.N1;_6@_#V*(&5ZEN,F>K1B#Q%!ZB'17K50TES0VUUKL#'B MH MP:B&[0O.>8;[9;6Y$B]&$G(CU?-MWLXU+$GI1GJ`.,9`]H9?3GY5NJ]#N79U MO?9WQM[<3E/2T267J?SVTG6:1:932_"&[77;-LKT!'AK<)=9UNK(G,XQ\C\] MV=ZS?/@N0C(EP=M&VY?$B)()[."^O?AOS';[FP";UFY*`#&.^-X`,PB)3B#D M34.2>2[YTUZ?<25$4!I@VD^*CJ79WL2)^\?R](`SQGC'F#$@>&4S+]0_2O:" M]!VGHB`/Z6+UXT55,S7^C,E1>W6W=A=MBG]/&/MQ3EJOOB%"6Z^@=(*IAGJ]:+DL]A"K8@J24 MG#*0B+\+@_/_`-F8IMON;!H)6B./7C+X+<&KBYI!!940#@-Z6=8DE\]Q;'P5LW?U%DNH>;,T`A;74[:# M@.0)#RZ66)&YVOW4@2@X_P#:+4&_C2!`?L7@+UIZMKIZM^H:ZQ5EG>45T;E)1_.#\L$E M.H6HH<52.[##GQ""B9).@G,91]7V&SW5V`'W>]/-_N,A[Y/]"^-;_P`_\NVE MXB7F>TM%\#YI8)IR-MBWM70OJ%U)O=I8H>;6=X1"UY MG;.`CIW6SF`YH`#:NGA6CX&KI=LLL/L!"PDK2G2%`I,C!*T`"8^$'*L3V$2%.QUV;&[N:A&X)7)1H M)-8E&3C$&W,/P?2`[\EI=MN?4&\/E@7?K?4:W1J2OJ#Y"+H/$*AH7*JMU,"" MM0F)IU`YQ1.(`=A5EQK. MJC;M;8.H=L:HW]O^0C<3=74-[,NC>FO19JZG>:MGB.)\-IH*J*QU"63^Q<=4 MG#O8VY;.1^STN"?#,9_H5'NX\%7M!O;>]B)PW`D=4:_=Z4XNS.&.,LQ0$KXU M?F0T[])Y\/-=357YA\2SUKWDFH_-K+MG;ES\?XX%WX_;^S''=I62KUSUTEM6 MJBIU30R2@`Q\A\\8><;D1;3U3@[=VKQ-VU7VCR'7_P`$VO4U:^C%]6EWYZ/" M_'33@NDA$B:KGZM?4D*IV;9 M:=M7VX.NM6"].H126C>+C6UK@^HMX-UZA2G]?#".W^&P#Y[M@6;J9NV!X5]2 MX?XE)'X?W9CJU=$_+I>I&&KPOVT7V0?,,3NA?7GK\MNAZEEIKJ4NGHS1V'RL M4+3E"U:+8AA-I;JUO5E91(+9#57P]J^0^:2N1\TN:I7NF(@$-:T`:(,7'B%79W))+D1$0O'F]T>[JMYE3= M#UD\)VI#*BG_`,(+2RZP5+=!+K`2R&T.#2MP$%1.4"/$#B_$)=J*<)5I=F! MDM*CCF!&T0,"0-0-SBYX/4\3P!7;?8M\ZJM!+- M3<_,0IEYNF9"*+J)Y(*8+98FI;0^)M3Q8\.K*5`F8E-)!G,$;$)3+@$\XR./ MZOHZY^[WUZW9B(1E%PPT"V"T31A+.NZ?1V^]5&+BRW3WOS'))>2[6LO M=6?EZ43;Q\%;07"4-A1FN0.4+N+&VT>.%@@`U-N_\`YI7'&X\R MZQ-J]YA;!J8B6Q`]M]2PL-+;?OF[?(AN M9+BFU)96I-;L-BWOO^(E(US;F"G#./DWXCL;>U/3$V(RX`;J//"3C\B^L_A; M<;VZ)&?WJ4!4:I^7R(.'U2#7GF*!>C]$]N`L(_U;N[+44O*Z.F9`_$I-(X:< ME)XUW2N_0O=ZMP7,NN9#C]U^DJANK^X$$D4>\I8HDQ<.A-&DDDJ M))K3/5,R$Y8`1=;C8;&U_P!,?<%FO3N"0_?/PU;./O*DV5Z^N*1XK6Z4&20I M-14]#*\G#%:E6U14I1[(6_&V1_HAP;K#WA/8G)P";C\Y;0^[WKD%@7$@ZA=Q M+2D`T.PE+,I2)+"]$Y>B.?*`!U$Q?ME]"ZD26;QN>`LE0+@W=])#2MP-3X,6 MOIQAA^/56S23AQPE%ELU8B)'%Y_!4W;@Y&8(!E'3MQM1B7C;KQZX]H*Y%TWC.D[O<-@0W80 MK-FGOKS0`1ODA66O9'1MV0G/7*FJ2VH'*B+@L")/UKFY;_`*,:ESO,X;VSMY=".[-QJ=.SY?JY-U9"'K!7 MAMU3M'795SK5?W6\WI)6M"?_`+4_Y4%:P?%4K2$-FYA]4U?\:LE4B`91]-V\ M/*A;#?<"6REYD?>P=?)Q>_%,KDI2_P#,,!J8"7_EML6#:7D0H9H:3[.Q<#4VSKNU5.MN]-2^4@^(;E\NOH M[6+74M(4%H4;'NJM'4Y+C;?R\Z:WNK54=,=P)44-VC=2Q34@*O#=J4D5 M"VE_#,)#E0"GF;TS^YW)`M(&.,S;(\0JY%/57.@6C9VK-O?V;<+=L1D2/!M9 M2=HDLVIF#.#*@H!607QN?,BM+-A\]OFBLU/:6K$S;NJU[IFK,SLZMZ>-6M"& MJ730M;"N5577#9C=-/2FUOO//4('@K6I2"H_'/Q!,W/.]U,DR,KTB^K6[U^? MZWZPH<0ON'X8LC;_`(=V5B,8PC#;PB(BWT@&#,+1)-L<($^'#)=)(XZ[B)0* M&"Q`A8*0<2)P(31P)D?IR]$"$Y$I%F!"($(@0B!"($(@0B!"($(@0B!"($(@ M0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"G6S^96_]^I/XAN!"+G_,KA^_ M5?\`$.0(4&!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!" M($(@0B!"($(@0L$R[N,"D+&H<_K@0Q2AB,0.SNX&(38+(QSP]'&)4.2L^K#L MQB%(%>:($(@4KT3^4S;_`,S^8KY6:55L%W:_OS>_%?\`_P`[ MNP0"#;9M)F[R'U003V=Z^OSY@UD-9UM\R%2=IOOO5/5R[5J$*\H(KUW>HJ:6 M@;J*^J=3>F7[W3/-@*;O("471$EZ`28^J>3EO+]O$5B;9'UIMXC]:@QQCB,5 M\K\PMB6ZW-P`"0O1(:.@2>U$'P_,6`'VA\!`TBJ\C;GL"\5CI;I^DKRENU(4 MTJF\B0?JJA12ENG0HJW$AING))FE.`/O&9.'=M&(B&#E\.F>.+.N7N(N\;D( MQ<&KXAG'`,SX9U5YMCHUOFKJ5K1T3WM44B?[,Z;1\NFQ5BFO';F/:0NX6PN M@W4)]+!1T2ZU4@1\(&GJ+Y7?32N;"V&G`X5&NWP%(TS`.?BI49R(`)+>;>,M M(NVA+@=<7]7H%E_X5O9Q$CM+IB&`D(0DV>W@TI]AA14I!!3[BDZ@5))C+=WVS`+WMOJ' M^NNPQPRQ/-)#RK?B(B=MN!$U(Z&WGR.,FTCER7NAY4]J7ZSVRB8NO3'?UE4P MTC]ENCY7FSNF=0-"$AOPZS;&ZZ]@!`P29))Q)GG'SKS[LRR>._D1 MWQE`>PLO;?A_R_=;,:96+\<_'Y5;PX"<+CGDX=>FUL:>:HAIL=P;.@>ZGR__ M`)?($`Z11_F)2F8PESCQJ:K4M M:$[=OKHFD@L^6FUW)H@XE)+UP!5PQPE&F$;#`CIQ_P#>?H"R7;-YR#"FU5"AI5()Z6)KB`?U4I76I"\>&(@MQMC(?[4#X(OPD1\ MCG_==7O*X@NM`^:D'^[]Q*9G7I\L+-RU#(GQT7+6)G'`8\HZ,#:$6!'_`'IO M8RXM[;2,M73'_P"W"7^KV'=IV^O2XTX5(J?(9U-ZEK M6!-)1\!0;DI/$(29#2H3CL>478V[XG$W8G_?;=L/Q?22O/\`GVQC>V\H7+5B M42,_)[U__)$PO"/J5T?VT;C5FLZ3;5=JO%=<-14_)%\P%6I2'26D)J*JCZB) M:=P`TE*.1);,NX/#! M=(MX=)NF5!47!JLL_3:VOTKE0R]2UWRV_.+MU;%0PI@.4]2FEW2_\*L%1FG$ MI*>W!QO[K!C%B,1<)]N?)=4^2[(DB1&N)PE%O9B#4N]:+CNGVGL.G56BB_V+ M)F4^^ORM^>+;#M*PI3X<>:>;N56S2T[&E`+9"E*+J4IQF0YNBX')@)-5[A'P MKW+GWMN-L"16`F`&M7"0*AP8D@`4-15P,5Z!>1RMVK0=?>CJ:L=&6&JM>\Q1 M"KVWYP;,VXI72W=&NMHD.E8#[*&G$!ZKG3TVIQPU/K5.VEIW]LR83C.0`G&\WRS\7AY?6+Q!+8F*^0/YG#S55Y^?-)5L M5-JJZ>IZEU-335-BK]S72RO4M1:K6[2KM5RWHAO=];;RPM/A.71(N"D2-0/% MU1\:_$,3#SS=1((/5.(`.6(CX1V"G!?<_P`.3U^0[23Q(-B-8F1&;,9^(]LJ M\5T1CC+M(@0B!"($!)*0>PP*'30)$"&2P9YRPB4I#)4"A$"$0(1`A$"$0(1` MA$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(4ZV?S*W_OU)_$- MP(1<_P"97#]^J_XAR!"@P(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$ M0(1`A$"$0(1`A$"$0(1`A$"$V9DDR)2 M$NDR$$A,`B!2B!"4E)/=`CL7HC\J%5K8^8/Y:7[T]8Z>V,;NO"WW]QWGS5[VZZTKS%>W6KI:A5:*9F=MN#3S1#0`;42X#XP' MA<.O+NJK]E.@+J*GI(ZANI1K9J=Z>8VK:<&LZ0ZJWU3;B'%`?J2`!YQU[1MZ M2TH,_P"?/Z%S)S>;U)TX%C\:*ZHKETW`\,VWR\5*VD>X[5U7G/>==]Y26]2* M"[>"T)G4EU24X)F9QOMB.H2,H`,&^TE[*9K)=O``Q`,CJJ=/O`(;BYP&-%RK M8*_IRY4+>19_+LI.LN,T3-H\\E52 MEIJM39?;NW3;YDM526=\H=:50A-JOOQ54EU`"TN-A;9*A)4@8JF),T9R)R(O M6@3SK%AWK/U8.7MQ`+O&6UW$HQ_0`$A*8.1C0EC@"_NYY.M]](+=1V]JBNOE M1HWTH#;B=M6/YD^VJY2PHS<=1OA-9;'$%6`(.DD2GE'B//MON;KD_>YV^4]C M./PGZ\%Z/RC<;.U<%/+X73^?8\TLS(]L&Y@L2O9?;N\-H5=`A;5TZ?_W?X$A?0+6\LSB^K9__`'X> MPAU5;@O^S`L>+7=-`7"5(^)9\QZ]222E95\`@)0J8PG%]FU?B/"+P;GMOBJ; M]W:3(UG9L?T=^?T]0#-9TU$ESE3,>8RG)R"3*YH*9]IF#"[B%YO M'UO7MC[E-B]M(GP':`?J[^/O7.5MO-C$&FKVGBE)_9575%(,S(2%4R5$$Y3 MCD3LW"6`F_9:^"[=K=62QU[6OZ6Z^(4*]7[;3;*_&K]FI!U3#]RZI@3SQ^#8 MU``C$`806[-T&D9]T;2+V[VC>.>V;]?;_NG8J:U09 M6G7A/\9MS"F!C'7LV[\HL!>]6V^*X=^_LW.J6RT_K;_X4],$]2[TV0TVDM7_ M`*2^&E.*O[_>8^D,_P!707J)]2<>TF+#M]Q)P(;@C^KVQ^*R?>=E"0F+GEX/ M^\>81^"ZI>8/J=TN9M%*,H]Q;L;X0 M&B&]TOGL]C[P22O%#=^5&^>O>\J%Q@PCY_YL#R.@PB!V>W)=?[]U/Z8,BH\# MJ5Y6G%>`%*J++\TOS\TREOJ0$@LKO-E60ZRI05[Z2F:/KTC!>S\NW7ET):+5S;RDP(,=_NKV(Q!N?,7+UI3$KK'N'J1:E/OKMO6CI MFPYXSKCZK5\UKS$L.UP=::2IE(W#MQ0<#:T*7J5(DK.)$@'\<9`#7I:@U0#> MQ='4)1,IL9B3DL[T%>9.+\VR5%:^H5R4'6J7KE:VU/L/N)-+\UO=9#3+;BG/ MA'*>[;:2V^\J0\-!/[10'&471G<.5PTR%N5>_#M7&W9`B(ZX1,I$^*_.TP?` M@`@\@5WZ\C74;<-;YA^B27NJ&ZKA3*.[J);#WS!+#5J5;T=-]UNFW)J+A87? MS>G<6`XS:FFTE^H1\09_#D')O1*6PNPE$ZBQK;C<^M%B0&-,R"X["LVSN"7F MEB8N$VXR-#N)08=.;BKZG_,(TR(U?-`+XV/F:U?YAY]_,_7FNM#U)>KE5=BL]0JJ>Z@6QBEMV]77U.:E7-EIMNM42ZE*0J0^-?B6'3\^W4& M8BZ::3!J#ZAK'L."^Z?A>Y&]^'=G=A(3A*P")"X+H(JQ%P`"8.4FJNB.D$33 M,_3T1PUWL4B!"($(G+&0/?E`CL6)]TY_0=T2EP[4DI&//@!E$*7JR;Q!@4IP M9")5:S`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0 M(1`A$"%.MG\RM_[]2?Q#<"$7/^97#]^J_P"(<@0H,"$0(1`A$"$0(1`A$"$0 M(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(39,S(9<(A.`W:EH2`D)>OO@4< MEZ;?)WNBK'\Q3RZ7L+;:_*;SN6M+SF]-O]/4M(1M*\MJ5_>[=#3UDM2BES2G MQ4*4^I0:;!=6@'TGX2`/GUD$.&G329?4E]45/H5YW\5QG+R&\($B9E;K&0B? MGB]304?MP%2%]-_G?WON5O%QNS2&.JV]D#P?,KTK8E]U>!(:4AB M7(IEIH*4]]5YON;P49-U%]NS+C:BLE?F4Z>T;B-(]Q;CK%N6C0C+`>_PCMV+ MMR-").^<[:Y=V,9S,G)D(L*&E.SDMHLV]6"%$[_NMO==`;J'W_.-M"D55L>Z M%,+:8MB`BD.J7OZB0".R.G:N2!ZIC0EWK\_P9WSY+L'MO?M` MTPPIOK766UIEE3**4?,&L5(IQ*4-I*&D-V-+-.UDI(FJ021AA&K4,!`ZC^A: M^G'FN7,RSE$0%2]VXW!N'"@"[![!ZH4R[K1JK?,?>V@DTSR*M7S*MOV?PA;T M!RD2FL7:7BAVG>3)KW0"KW`(HN6[A'@L$@TI:A*IQH,7S]JIEOH1)-[O8?AGS[80NR`\PM M]7ZP_P",L.?@N`L'>@SHR]:+'Y@.G":1OXCK1L502A.MQ_S@=.+JL)3@-3S: M4>,I>1*0)F/GD_)O,1+_`+-N&/\`[)(+ZC;\^V&G_M=FF/\`\SMGT=(NGF+Z M-LN*:=ZY]-J=2Y+DKS=[)H=4S,+.DJ"""#A,'F(MM^7>9"IVUVG':/\`0J+W MF_EU1][M!_\`\3B/9Z%3;=YA.DFM`1UUZ;U)<`*1_P",+8E8I1G@`A2TE9`$ ML,#"W-CO2/\`LMP?^YD>Y3;\TV<6_OD2_'S2)]X7(M'UUZ:%N2.JNPG`$A:" M/,3L*J)2H?CU_%#W>1,XPS\OWCUL7/\`N\@NG#SG:B/AW%J7_O\`:/M3=9US MZ<:"H=4MD)2$K4I3?F*Z?TX`01K5K762`3,3.0GC`-AO!_H+G_=I?0B7G&VE M_P#:(4&6^M46CUO7_IBV^!_MBV5XV/A:?-=TQ8*\`%!#+U?\`W0K%/S+;@ZX[G_\`V-KX\%$/7_I^65+8ZI;?<7-2),^:GHRXI6.( M\5^Y:09\,XL/EV[+?82;_=+@]P2#SBQ5MQ(RY>8[8^\KKQUCZ]V6ILU>W:^K M5SHW'3X2!8O.KY6K`\7/#44K;>O]:^EM39]W'&?"4=/R[RZY"Z#/ MT!,>WL6-J?WFVVX('UMKN/A/#L7D+EWSZ4? MLMUYPQ+O#=^6S..'CM$5YX+JCN;>G5AQ*W*O?WFXN3[3M0^7FO-C\M#U`(PZ&X!_P`HD?1Q6,7//.J) M7SYU)JZI7/*I184=H`2S[Z^%=1-]WCJ`_7*JWW_-;0#9.H;^*^'2E_ISY*;]4_&5+@>?4VQ2O4B*AM8(T:E M)&KW9B(>(07H=Y&*'=B?,)T M3>N&V>LM#1T][OIO-PNOEQ\L*J2@34;0W13.N5M9;;BM=BHM1;2]4TX\=#A" M$'PW5QCW>C[G<:,=1B&^SN0KJB14&CX=CO5/M^M_Q"R7O"W&Z0N[7L+H: MNFU-F5%7M+;U;)B8[HX2[H/J390<2,N M6,XA,D2(S$"$0(2@0,YSB0EE[%@DJ,L988$0)0DJ3P([CC*(3N$U^$X]OT$" M#4)8(,2E(99@4(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"( M$(@0B!"($*=;/YE;_P!^I/XAN!"+G_,KA^_5?\0Y`A08$(@0B!"($(@0B!"( M$(@0B!"($(@0B!"($(@0B!"($(@0B!"Q`A9@0B!"($))5+M],"D!`$Y*.)/# MMX1"8ED\@$3P(R^V)2)>'$@0*6HZ;5(GV0*0`L1"99$^$\($)X8R)&(^W.!0 MLP*5Z7_*&MM==?/WT1IK=;[WII M=O5[%&A)=>6XOQJ5I*GV07FT`^G_``:0/Q#8)(`:>)D!\DJ/&MH-/2O]8M^*4:CR MJ]-?&?`O]0IMT5KUS;N-S\=(+R*FH2AVI;4EY?OK,?5MBWW2R0!I$/Z,S?\` MC/XE\DW0/WBZ&D'E^C#+\W)\>>.:\]7]JW-<_"L75`U"EM+;;I_*OTC4EQME M:TE57R_UKC"*@!FE\!NZW4,BJJWCX:0")("E),Q&R-IZB,-60.W- M?559)7(@'J&Z(9Z+L28O0&N!)&E=B]K6#=[BJIM>WO,FA"F4//.6_P`G?E)J MW@:1U!8><;KKHRIEM+147%)4"K`&8G%TX1+-&T"#G9N"O<5SVN&4H&YNR)"N MFYMJ`5%)84J6['7->RK7OA=;;TTUE\TBRRIQ#R:?R>>26M0M=0`RP6$U]S`< M$U2`<24MJ`*,3,62%B(8QVV&=N_'O<%QW8A<:5W>OX9^9?,2#&>P.(8-J&/: M/"31>QOE8V%U3JJ>G8:VYYIBVYX"V*B\>0OY?]4$^'@XT'D77XI;(G[RBL+0 M,2,8\SYS?V4(&4QY>#_7[ZU[8T<>I=_R6UYW*X+=N?XA-L$5.W\FOB@R#&3' MG5>D=/T\ZL,,)>1:>MR4MH1HT^2GR74SB1J!7X9_O$AI(7IQ$Y7FC M[-_]\WI^"^@6MMYS'Q$>;'_]/\M!]BTF][MZ:=P]JLE'SB(;3YQ4Y;'R MP>^GQ4W;>Q.K54*=:]M^8A(3-LN7'R*>1ZWA12H@K3\%N`J901AA.9RY13=W M&PB6?9ORW6]^(3PL><2QCYMW['RWX+FVBZ?=0T,@5%DZG+6II)*JCR@>5Y*Q MP2A2:"_%H*1Q3CGAV8Y[G9D^&6W[MSNOB%NM;?S(!ICS#OV6Q_S5K.XMD;\0 MUI3MGJ>LE#C:DTOD6\NM\FE9&H:1?R@I*TA4ID*(XQ,+^U_.L-_O=\?!5W;6 M]9NGO79O_IVUD_M9<-5'3[>SM65O[`ZONI6ZH?M/EF>62HIVY)"5'4+\NL*5 M9ZM2IS('9JC?VH%)[9_]]W`^#+G2V^]);H[YC_\`A6T(][^]2U]+=TE#B%[# MWV$DH)\7Y8/E^J`D(QT(33W\I6DDXX*/]4B-=K>6147+/_[C?C\%@O;+<$D2 MV^Z-<_)-O+W'TR76'K-TNO[5!4N*Z1[YJ]3;C87_`/*7NA.[$ZU'4E8=3NA* M5K6M&F2A@%3E'7V>[A.3=:T?_P!3O%NYO0KDW]F(2$I[6_6E?(+<7_C`^E5Y M)]2]JUM&I]NMZ-W%O1J2@WOY$W2I@ZR[XE0%U-EW4I8;04B>F<@,A'I]N8S# MB9/ZN[N2'*A7$WL+%N0?;V!+]/RECS&J)HS9+K->K':6VEK1TGVE6O.,5"ZI MNY?)7J;,S15+C*:>G0VY:-V/IJ67RM6@J2D)6D*""92:=J,B=9IE]M(GMRKR MQ6C:;NW;C",8V3(%R!Y?<@!D(DZI#27<&@)%`5U]WMMVWN-U#3W2#I33(IRO MQG7OE:]3-NO,OT+9%8P^JUWDJI"PI?[9(5(`"8!PBD6K(:1,2>!+'UKCUK;FP[=='&;KT^Z!TKR*5-2&;WY"_,990X:NF:6@ M/(MFXDR93XA4VXDE/N@G.4+*%O48GI@_K7!W9XJF6ZMB,9AI@C4";1(+TY8% MP]';@O1WR,;7Z7,]?/+\:.G\NSM0_O1RG;-N\LWFJVI<*=51MF],-.TM5>*Y M5FIJI)?6E`JTE@)0KQ`/$;BF_(_=[FG2[#"Z7+$4`E3\E"1!,AAPKB1IQE%?(K\R>VVBT>>?S%VRPV^PVNT46[K4Q0T.U]J;RV M-MYAI.T=O$_E&SNH2W=Z[9H77"I:**Y*54TX5H)(`,?(OQ49'\0;J4R92-P% MS.-SZH^O'PSX:A0K[9^$^E_Y:V71$8V^@&$;<[4<2[6KOVEL$UT3\4<#@NC\ M>?7H"L&?Z8E0Y"0KM$\\9 M/U_;$*660)X"!2LA).;@JAV M[YDKBI11OFXMOI9O8JET]RJ`X'%.+90FF6\E2FB6?#$?4]C*!V=G4P$K42=4 MR#4?FC#L'>ODVZT#<78CIZQVUUV4F3DQI4M^2T^$@>]J)U&>2YH#[:=C>8"L25-3;3\0U0J*UNOI5J5HS&,AC&R(MB+ M&5L$_P"MGW+%>F93<0N-@6M@OQ)`[7]JY=M6W]BO4C"U6CHB^\_^R*U]%_-+ MA-5GS2W$*=4XUJ;J&G;K2.FC#96D+ M2%.+!2`$$3E/$$$81X2>_O$N+^X(Y^8[?X0JOK,/+=D M`!*QLA$Y#RK=U]=RBU"Y]%[+>*AMJBZ6]!776*:MKUJN7RZO,.I"J:G1XCJT M*7ORFI4NI`/AH2/%?)D`3(01WUT8W[S4'_U&R?:(9\,$3\MV<_#&QL2P)+^5 M[S+EU&IQQ5AM'I5L^A6V_4],.@3!+@UNT'D1\TNV*HM*6VLR"]V5#;.*I_AT MH)&$A&;<;G1_P`\M\%R_P#[--DM M"L8_N1T7:1\1,(3Y8O,DQBVM125%N]J%2XF9]YL@!4S'..ZON_4OD?[U8/P7 M3'E]G"-O9O\`[ENX_P"?_`N.MT=..GB6W0]M/H(VB:UA5=Y=_-LEH`#41KMU M[2E1`&.DCNBZW?W4SIC+<$\MQMR?YJR7MCM(1>Y'9`<3MMX!Z]:Z^W#8O29- MZNZJ<"M M)P3*9X1JM[B^"^K>=U[9'VF*S7-CM#$@6_+:?ZOS(>P%UU#\P^W>D]!;'UW& MD\EM%H<2#^??_+(.G]05$#Q$MNVJL?IY+:P'(3E'<\OO;N;^D6V M$>)XK"3<;:EH^.E("IZI`C21,P]R-XEFN-V1"?:;O:&D;U@R+%QO+DL'<,14 M-QP:BXUN.X-KU;S2&=R=*&&7$%56W3_,*Z^4].KXHG4[5KN5O>73JIUJ2%ZQ M($"?;#BJ.F;H_&H_F#]1GVEBF6YX[E/\795MH0\%"2$22G\0!U0K7`:FYV: MH(E=A,"L):1I<7)-X>#!@W#(,R]7?(E<*:IZW]!J:CW8U755;U"HVV_[O>?] M[<2W4JV_=DAC^Z=WL3(W(7*AW4:5;S:JB6D";$0-,N+$TQ^:(7QW?->2!\P_S0E+[=4W M_?*R%NI:ZAW'JRAY!V3M@!?^TF[M,W+>*I@A58\G6I0*9G3./CGXJ!_X]N'Q MU#Z@M_5'^C%(=@IFON/X71Q']:>?H@4K,2E.*;4DDX?=$*00DD$9P*43QG`H9&HSG[)P(9@@G5+@>`SG M]THE**%RDE,\.//,Q"=-`R[>S[8$)04#$I"%F>$^$"CDB?JYP(]ZS`A8@0C. M!"S`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(4ZV?S*W_OU)_$-P(1< M_P"97#]^J_XAR!"@P(1`A$"$0(1`A$"$0(1`A$"$0(1`A$"$0(1`A8@0@SX0 M*0V:,<,._P#1`BBS`H2%<.?*!,/8DSD<<>_&(4I4E<..6/U8X0(HLA/,S/;V M9CUP(IAFEB!`+I4S*4"&JZQ`I1`A.@``<_%U/(Y-G?LCYM/ M^ECGG^K];Y]]OEMY7A)I/-AM1 M09-(T=(^(P>MJ! M;38]V;HI&IM;TZBT-0TM2D+/F_VI0I::42E320Q;55+KFE6)S"00!D(W>-JF M9&=(%REQQEN:FTI2%C6DF*Q$AS(2U$U(M0JSMCB&/T% M4W[ER(C;,H].`$Z\P(@L3\N!,JD5:G- MU.7_`+W?*WN1[PF6;OONRH89?9I/A]U_-0OM73KJ=)?IT M>%8;<6:E8HG$DAI:@$'WB#A'G/-X$V]4879._P`GE]JX>%7+BN6)7;\DO7([ M@V[UR($9,1/SF[:B^(#")>F-3VKTEH=P;7=HF@-Y=)'W2VB:C\P7J/4IT)FI M014LT8*`A(QUXJ]<>*N6=Q%P;>\'_P"FV![S5?2K%W:2@)=7:F3?_P"8OR_S MM2E!`0H^&`2DJ)D3 M+`A"Z!JE;W1)HQ\NLD^PJV>Y@/!;O6``V'F]P=F,/BK';^[]LM:0K?W3)96J M:V:?YE6\+JR"E6ME`^*H/%<=+DR9G21(17=M7I5Z6X<"C^6VP?86P5EK<6L) M7X&)-0/-YD=@>#X\URY4;VL-:ME;6^MHJ84UX:7Z/SVWJFF`E)?TM,4!:=4P MO)04"`!/&,'W2[_17G__`"^'[2Z$=U:)'VT7Y>9R/^;DN-=Q[QH`F='OVB<> M#;@\.C^9+5V@^&F:RZ#56M2"4IQU$8)&,7V]K)FE:FV-?+A$8+-=W,7^SOD MRY>9MWU&*ZZ7O?ZVJQP(ZF7(#5I&CYP5CM:)*DJ?P[UC*TK!.`QPR.,HVV]M M%JV8]_ELC[I+GW[MX4%[<..'FMH8]H],E?TN^W548#74:^.NH3HTL?-@VO6@ M:C+4*RHM27'%2R*TC'"-%O;6A*MJU7CY9_N76'KSNW>-7:7$6SJ)UL6RC]H1M7YJG0*Y*(2E6M":'=ED4@N%,Z6ML#_^7WK?M=>;\QEYC*((O>:R@/S?,-C?[6$HX]K_``7EKN;< MO5]VNJ&4[O\`.#&%!:IB2@?> M(EZ&-K;"()AM@P9^EN`6X#26`].*X$I^9WKW3!\YE*32)B?*B-3."\P):A0' M+YL]*ZN;MK^N;BF'!5^;_P","DFK??ZR>2C<;3U8JL6ZARA8H:1A!27U`R"E MR7,SD91>.B8D"%D'+3&Z*`?I?!E3&UYT+@N[B>_+@/KM[&A)=GMXUK6N(J%P M7N"Z]7DJOM->+EYOFP_6M-W-+E/Y1+PIZX#QWR:Y]#R2\B3)42-06I..(!B@ MB)8Q`#_ZN1X8+LPI"<+XW!TD96&?Q&E:4R53MZDZL5UT#WA^9.L;I+73/,K5 MM;RG*K$6ZE=3^7U%:@OBF%,&UD.J!4[D#[HA91#Y.!_1R8GLQ^">&J1^6_I` M'U;)D(@^$D/I;B0\NY>MWDMINI=RZS^7VX7S;?72H10=1::GKG*SH-Y<+G86 M$/[?O:ZIZ_779[;-U8HTTA;>54TJ?BJ5$E,B9QR;[H_<[C],2,<6D*ZHYNT7 MPF]S[3_,Z?=_]V3N=FJ7T[VDKP[V=FLTVUS7);*9_!MH0E,DK2'0L1\F M_$IMS\XN2M:>DT6TB0BS9"?B;@_:*,OLGX;C=CY'MX;C5UQ$@ZHQC)W.(CX0 M>S'.KKS**9"?&<7J^J!#IT)ECQXSMB648IR8@4,O;3_#U6 MEF^_-&Z*T%0VTZT;3N110[M-K>(]XVUI1%N=4E%M7H=,KD3_`*N_TXQ;$>F_ M")T>\?FTU%N35&-6\.>&"\S^,(B7D9@:ZMS8#:=3O=B.ZGULL5]/?F M5L>T&=U=2'D;)VZXMGJSU20ERA\E5\L;;XJ=[7MKX+P:FJ6$II5-I<^-20FL M)4_CXQE]Y$-,`><5XL]M9K*MEO;-H;2V\%I7_`.%2N>IVW`E* MZ70VA\I:=VY9U//(59$K!=\)QE/D_K:UYFL.I+=)-5=.C)J"M*9%6I*9@9`7M98$"R#^ MN1143E(2D-5R46'^CD22,@?JY\0P7.MCVM:*=-&Q6V+X=:Z5ZLMSP\C#-2]5 M)J-/P.L?FJEM-51"O?\`>4SIQ09D15X1739;/[4L.>&7M66Y.T'$;MP-&A%B M9))^JPP[<(YXKM)TZL5&MNHNU'MCXNTVQVVE^N=^7?:W4U-3XK5OIZ93KU2X MP:IYMWQ?!*G'*@@NE(TE0HN2@PC]D+AP_O!#<\';)\%23?TRE9URV\&))VDR M[M$"N,JN8UD?F8"H]LO*5:+)1T]$JGV_=#4*?4DT5-Y'=L[,`I4:UM5B[E4. M.)^*K'W%-EH`%MM`PEICPGX@E=G&0C.T(-C]YECF&88<7JO?_A6%B`C.8N2O M:_E&RB*8B;RSD28Z6!B!7)>I5)2,"G;#.U[Z4+;!4&ND&TF#-0Q"V=82E6DX MCAVQ\]E;NZCJO6AVW)KZO&;Q!A;W!IE8L_P+6[TEQ#+BO[F[TJDDAA+#7079 M]T6$M*24J*?';;73GQ#I$\""<..FS:JQO;=V=^O./H53>E=TZNGNB79ONUJ1 MXO1J9#FH-KH:%XAU?3R_MDG1X57Y<-M43@T)!#FM%24@%6`Q./`#&)NVY`-& M_:[1N"?@IM2!&J5F]BS':1![:?E[%N[%%;BT$*V1` M!)&/#",9A=!_?P;E=*WQ-K2QL7/^[Q"H;S;K$TA2E;`J)K2X@J_\/MINFE+B M9*"DM5"5*2L9B9U#.++5J_(TOP)_KF^"JO3VL!XK$P/]V!'LJNO]\MVQD5B6 MW>DK;Y"ES;5Y'K7I+E0;@CW23.:<3SCKVMMO3%^LW/[VWJHN'>O^6"> MDVH]AV#BG'"F=%84=MV:EE*O]E]@I_V1T?&^3>DHPVWI,DA%/4K]P@Y`]D0; M.\K_`'F?=NHU]9577V(`:Q9Y/L9!NP`8+I1YF[9TCJ+)5(O/3'HUH0V^XP;G MY%][WQ7Q"43\'_X6JEM+:%)!5-6I*2!/G'H_*/\`B&L?WB]*.>K=VP&]I=>! M_$EGR>Z-=S;[:#.S>67YN>#1#`/ M6X*6E2QX*E)%\8KYE';;87NKMK6 MRU`N>IY+N&+XMXHES]6;Z0>+KJM=K;T*K'ZX5EE\HMB15TQ0A5=Y'O,Y3-)= M<(3*W-VAUUYBI:*<%$%$R1(F%E.!'B$I'GNX_L_1VKL;7;V]9D);.TX8_P#R MR^<6/A`N."!2NJN3KKSN(=&:6F?I&]F^4RL=J':1]ZK;\OOF*V[76TLJ<\2G M;775R&VZ=12`^="O$2O`C&$,=N6=O]O(^X?P+L6Y7(0,--F4BQ?[L82!'ZTC M1J'B#BKG:-1T7J:FI14;$\G%!\2W;DLOU?2[S"L)ID_$ZGJFW(9JJA"&T(&F MI#P4762`@:H648`O`EQEUC7D7`?NP6FW&W6)=JI?*/:[DCJC:Z>U5>V&O,ALW<-3>%VR\"AKK)279+EF=NK MR7M+`K4"CTL>\`,3@WVJ/E]\P%XCI$D"4)BA#@AZOP?$A;]H;(\RVL)_=X3- M\`&4I0KHG4,]0'R/A!*^.GYU]MLMK^9IYG:/;='8:&QMWG99MU-M=B]4^W@R MOI_ME2WK.SN);E[31U51K=2:A1<45DSD1'RO\71E'SZ\)F1GI@^HB4OD&)CX M21@6IEDOLWX2E&?X>V\H`"+2PU,^J3D:O$Q-0]5Y6S_JS]/Z(\RW%>A(0J1& M,Y=D0RADWD<)R[W[HE*]7"PI!(]N']$#*=2:(49`RPPXP,C4%C2>R!#A9(),"`61I, MI"4IS[$"C!$"%F!"($(@0B!"($(@0B!"($(@0B!" M($(@0B!"G6S^96_]^I/XAN!"+G_,KA^_5?\`$.0(4&!"($(@0B!"($(@0B!" M($(@0B!"($(@0B!"($(@0B!"($(@0B!"4D3.(PE`A.P(68$(@0B!')$"$1*$ M2,#%2Q2M,\I_3NB0%+#-9"">!].$3I0P3R6EF7(92SRX3&,3I10)X4VK.4Q`Q^] M[?-L+L?7V9KZ;O,I6V:HWGU-N%8NV7IFIZB[WNBV[OYX=PN5#=0_NJ]J"GWT M4ZR&VEJF*1N::5(^'3I2C#Z]L.J-M8B#>C*-B`I;M1%(1RH],2]<<5\7WML? M>MQ*8$X3W%PL=S,GQ7)$^,N8@'"#-`?9Q:(#="W*&TOU=2FDN?3ZR^*VE+^O MS?7NNF.Q;-TBO4_D1]!S7#NV8Q!-J4&S^W)? M)ZBK9<%MMFM-B:?0T_NS8=:B@HJJJ;9H/.I=;*?=,P`;HV[TJQC>!_JH'V$][FGZUIIW*E:6Z=T%-J:37O):U3;!FJ>N>$1 M,W&8"^X/]!;KWO[X,U==2.M-550VTFB0TX\^O4AMM*9M@Z`2$F,M[[S& MV#(;AW_]7M.!D']I.:JM0VYD19G8Z$0]/,+LA*69$<"U/E*IK4 MTIIX7';RTT3333@I/,EN7=KX4M3G@DL5C22^I*S)0&+:1CPCYW^(9W39(,;A MU&CV8>IQAQ=?3?PG:B+XN$Q,(,[7R2YP^:I/N7IS2)I4T[2T&U'3I.O^\-R? M*5"2D*0J8Y3GQSCY_(R$JZF;@%]4A`:`P&/%VX9T6LW5NC6M;CC>VEN*#BW# M4[WO=#^T0O4E8-.ZG3))$TB>HY1IM3N1($>H!RA$^M\5EN6XUG*,-9?&X8U& M=/0IRS?E0#*FQ8$H<24*+747<-:G6#[R4%Q2@H))RX0FXE<+B6O_`&48J_;P MMZ08B.EJ_;D]RW^G%"$@!RW!)F0IK=%V43I$])4XI1)`CGRE(5;_`"`NG;A; M9O\`K"?>J6].T:&5J\6F/NE*4CJ#76D&0DL^(M&E,N"IX&+;,O%4`5_HG]Q5 M.X@PPD:97=/O7`UZ2INY33<*)ML.%+2CYE:ZF6\EM/[5/PB65#0@JTE,\9QV M[5V'2+B#Y_W5Z]I*\YN+5\7@1U(@8?WH8+9[0ZZ*;(?>(^_)=5O,55W/\@N;%-= M=VK4*:K>4BG\].V>FU.MH4ZB^'&Z^B0]4!:$R#:5:SPRCN^2&/6!B(`NU-E. M1^('::`+S?XAMW9[:8C]X,V)8[^W;#-XJ!C*F0J5X!=7:6\"^/!VIZ@+9^*=*)@MME))TZ0-67TVR9&U0U_P!U$?6&KV]Z M^5RVMZ-X0O0W&AG`^_F9(`!H0EVGHNO]9^8LN-%+GFYZ(7FM M?I'4J-4VI^K4T%:VV%E2'QEI$C@%20!C,L#^86]0%>T+1:A?O2UVK.X,YC$R MMF1CFQ,P.):1!9F4_9]37-*+2*'S1T]/2>#5H5:.N/1>K=&(,47HTK.+\[1)88"A]_R' MD4MO4N[=4.B%W0OS;5MGMW4JST^X'+C>.CVX=NHMUQ;NU-5_WBKPEBZT-A"7 M'/%51MJ?UG`R,AR/,19M[&_7;C[(L]J<2X,2#3AQ-&PJNIY?':=ATW8E-=T]*?SNJM];=4M M'IQM@-(K*NUSMU0XVVD)U,^X0,(^9?B@`^-5]D_" MP,?([43JI*X/$VJDY8M1Q@6IPHO'+P`,BH=\ON$>=TE>AH4R6URRP&/TF!!I M:J$W+.8,SEG"D*"$F1B&4,5B(4(@0B!"($(@0B!"($)M2>('?G.!";@0B!"( M$(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0IUL_F5O_`'ZD_B&X M$(N?\RN'[]5_Q#D"%!@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0B!"($(@0 MB!"($)24S[OIA`A.@2P$"%F!"($(@0B)0L@*C4I35)JE+5R.!AA'@H)=6+-N*L=)(G(YDS,])["#%D;4B ME<*X8LP4E)42#Z>Z67],:([8%09]BM:>Q-F0*">7:>W/$"-5O9/E55&\R^@7 M_#3;.K+G\U+9_P"6_'I>H^D&[ZE;5NM@N3]2T-Q;5\6G=UM/-V^G<;;5XE4H M#P$:E@@I!CTWE.TALX7=W=`$>E.+DL*QEF6]0KDO-_B&Y+<;6WMK;FY]XMR8 M`DD1N1=F=N))H`'*^A[S!V:_JW+OQ"$71=0=\[K\!+GE?V_:JFH15;LO9;>1 MM_X5VH;>=2X5(*0I+H2%DS7'O]G&V-O;(T,+4/KZ@/!%V/OS&&2^2;V4_O5R M,8'6;LV:S*+^.5=+.YR.$FU#%=3:79V[[C5+72(W2IPK27%4GE6VFFA;&E:A M4"Y+ITLI>33I<60E*0MQ*6Y\1UH]*-2+6/Y]?5CV^MZV?#MHI]3]/Y;>DS=*A2?V#/AJTM)I$O58\)"4Z4K,TC'`UDVW`(L`G M_62?\M*DX@56&Y&(#X"I&>`XFB[%["%[9?IE?F/66J+:V&:85 M?EFZ/43#-2`V'&7D(#BDU+64P-2P`LDX1@NQLF)CIVPQPN7#3CP^A:(F4;FK MJ;F4J,3MK,0"U1@X;(C%>Q_EXMM7-MY3^Z75>(PMP7+I?M';A<<;0V7"\NW- M`I9\0R2 M*[V)8?#6*G??"IA35.G\1,R$(9DD`G#E'B#(`^$%^2^DF/A>6CU-\/8M2N=$ MI1U)J:EI22`"S:&ZR9&(!*Z0MD^F8G&VS(?6B>\B/Y5SK\;>$#$,-=##C%Q[EQ-=:)DU8"ZVV(/B3T/[&M M[1Q&"4U#-N6HZ1PX1T[1)MN!+M%PGV$KB7H1-UI=$G%C:T_Y2NZ.DIFJ;1*V MOI"E+#B+92-B:\2E3!HTB4ARG&:JHJ>@MMZBJ:FDF9IE4[2C^&07.0G+C'H/(IW>L-)G+EUY0 M^/L7C_Q+8VDK+3Z4"1\QV_4;O`^++YZ>MVW+&F\O/.[@V`^BH7\6^W_\KTJU MBGJ@/!33EZG=0I]`*1,IDVI2@1C'UG:ZC;`8Q;_VL8<<*=F*^+;ZWMK=X@3V M\XR(D6\NO%I8"-)^)F%0&)8A=(=RV[:#GQ])4/\`11P.R:J';EY#=S6RMU!) M2VNG+%;K9JG%DA8`#DP%'*4;G(PUODVX!'L%>U\%5;MV)4_NAB<2=A>C)\7! ME(WY5-U6_2TD@M/.2JB7END34`"YI] M\X0CE@TR""W[US[!3T"W6[%BIG:L5S%B<:\6)+D\,<^"M=EVWIT]>:AF\W;H M+:J5%!4K8K7_`"Y]36`FK::+S%#;J2W79+E*[7524LN5#AT-LJ4H`F28HNQF M01$2E7#K:?:U>++I;<;0BV=/:#K!Y?:]F MN\N%T>5ORT7%DG;W66CO5JN(H;JE--8F6E(I%[F6VA12*UMV@;;D5&,;D6-1CJII[6*Z7ELMF/,=M.4MK.8N.-49Q,3IE0"/UV>M0 M8DKY&_GRV:I/S3?,D*BMLET>-NZ1U1KMN43MNM%2W6=,=O.TZZ2A?=>J*32P M$I6VXHN(6"%24"!\Q_$M@W/-)7(QE$&U;I)W#18N_,8X'$4*^U?A><8>2VHO M`^.XQB=42-99CWX&HP-5XX.VE:98*G+$F8YX2[8\W*S(+T(F&<*`ND6B8*3R MD0KNBHP(Q3"95>XQ(G`D#+`\>`,\<84Q"D24=3?>)=A^V%TIM02"D]XB"$." M'2)#E"LA@L$"&`2PA7`1(B4.%(2PS[\( MU)P"SSO@*[I[*07.O^81@6!JMIMVWWJE2=+92G#&1FMO62P7JJ/3)VU7.FW%U'I^F=*QMZ];_V;;[U7 MT-?4-K.[+O0TSX=I[`W)VZJ26P93C;NK=NQL9RNZP&D`8V^KXC"3>'(?I_5Q M7%NW;N[OPC9JUR!)-SI`1$AJ.ICJR^S^O\KAW7OKYC;#U8IM[[Z52=->@+]I M:WIN$6"X7/SXV&W7>XV@;JOE305]U;J+VNZMW:Y4M0''F@I'P[399D/"48W> M6[JS]WLE[^KI#4]D4\(!``#,#VOWK@>9V-S/=WI].VPO>$QW4BX$I&)?3J8\3X^Q<4V)V6D8>$@F9.YNC55@(C10"H MDQQ#OBM\V_LF[S?33J\K=+?.I\,BJIUNMEL4'BW-M3SZ%N)"])UZ MS(2QB);N.!CNC'"EG#MI0<.Y8CL-S*4C8Z.L5\6[(9\-+Q\1;$!L^:Y=8V-O MNM92RBX>3*HMBTL4SS`\\"$-`488>:%ZI:?=<4HIQQBC_B%A MR\=WK!+'H5?#%F+\LF=1=V&_Z9A$;:6UF`"/O) MENQ_S`[,68GO3V/(]]("<+%B3U_[5(TQ=FH.>2]=.B5CW#8F*1I>U^CK)\,. M.JLW7UV\ZB4A2/`365CBW&B#/5*1$I9QX?S;)'WD4['4OWE[_9%>QU>9LPVT>Z_'Z%J];>=U-J*DT.S4MA12I;O5NFIDHQPFE- M2$@@1KMPV@PE=?E8)]ZRW!YM*IL-S^\Q`]@5Y:=S7UJ0?1L9L@'2A/5%BKUH M_6.E;Y!'.*;UK;R^M?\`]BRNLS\QM4%B!'^\CXA;JSNNXZ$S&T`.:=\T2D_[ MDZCA&&6TL?G7?]F?I6^&ZWP%;$/]O']E0*_=M]"%%I.QPH9>-U`IJ>8E.94` MH3!YP\-IMLYWA_S1^E5SW?F!I';P)_KX_LK1JC=V\E/E9=V*&]12L_[7*)4Y MR&*'6PD$:>^6$:X;?91BVJ\3_4GX%9)WO.)2?HC2]7W$#ZGBK1G=%_2Q_I-D M*=)*RV.I-I4E0(Q!61.4LHK.WVVK5&=W!OW4J>U,-SYH(Z96(DN];]K#U>I= M1^O-SZ@7>VU;%%:NFE6DH4EL/>9NS;+*DDDH"G=.M(2J7..[Y7]ULS!E.[(O M_P"KR)]:\KYSMO--U`M8@/\`WJW%^[\B\5NJFR.M]5B=Q6^I;@/@H35WEKQ'5K`]V1D8#O-O(UJW&U+X15T-EN]/AA>C*3NQMU]< MOH"]:O(C8_,/:>M_0IKI MM-PJ;LS9UE8+[=,HNN"24F9(CB^;WMK/RV_![1)MT$H70[2%,`QR#AEU/*;' MF,/-=L9QW<&O>-ONYT`QDQE]I(D&GR.7(=AJ7Q^?.YH=P;F^9;YA-R[AV=O[ M8UVKK/TE;K]J=3Z.S4>^;4_0]/K72(-\9V\]4V=2J^G:14L*:<5KIG6U+.LJ MCC[S9VMW&-^S*%RV0PE#5I(&0U5IA7#`47NO*O,KFUVT=E>C=M;B,I&0NZ-5 M9,'Z9,:LX(-002Q=>/\`66:1.I!F,@01SYG"//W_`"N0P"]-8\SA*DJ*@J+0 M.*?KEB9SE@0(Y=S9D49ET[>YU5!=:]4VM$IHP).&6/'C@!&65J05H(*K7*4SP2,5&-:I@64-;,OU53G++] M$*P4N4PI!2,/&V271JR*MF+:IPXH,LP1A*7IYQ?&P3 MBD,E=T]I22"42&'^Z/&8[XUV]L^"JE<`5]36L"7N`8F<\YB6(C?:V9EDL]R^ M`KRGMP3*0,Y#F>>&'.4=G;^5RE5J+FW]_&%7J%L-'977RD);D#E,">8X&.]M MO*3'"+E::Y:;;MQ M78;:'2*MK5-!+(]XC$@$R[N`$=*UL--&=@_!XV_F'FUZ-^`G&W8A*.H M`@2,Y#`Y@8')?35U@Z(^6>KW+?KA7]`DWBKJS<67:NQU-FM#2V*U#U-^`I7];GN#42'ED$!9!X/ED/-[NTM@[NW`,*2@9'B"Y(U%F;;T+0VJH>VXITJ;*$@O3U:$@`X1U91\[A/P[VS($_T>'-A)NX9KG=;R*Y; M(EM+T3I`877=@&N5M0B8Z=B_&6DA]0J^():K^JBY_P!M;,V?0-M_!/;P;"`I#8JS87%I2E*$!M&F MQI6EG0D:9$``F6$<3=7=Y,GJ"P>S6/9J7=V?_#K40+(O@C!Q$^TQ=NQ;^Y:+ M*I!6*[<#`4``&6;2"E(2``V#:5`:1E'-!O#YHVB:XF5>WQ+JF]8+F)O#L`IV M>%:_6[>L"P4.;AWLD8$AMG;J@0#.7[7;S@)D,1G%T)WY5%G;D]L_VE3._MXC M3*YN/5`_YJ33[?VN2A/]Y-UZVE+6%5-)M8N*2YI'@E7]VB2TF6"<,SG!*6YQ MZ-AB,`;C=OSXJ([C92QNW00U=MEQ0.Z[BDGWBEW:?3AUM1QQ6%[.5XDQ M@9XF4:(SOD4L6_Y=U_\`TBJ-_:8&](5_,M_L*R;VCMU:?YRPZ)`:G-E;`QD, M2=&V$"?/`"*S>W$9,+(?^LN_MJP'87(_O(]$?LK1-X],MAW.E=1<*]A3+@D MIJDZ9=)ZYZ>DI)0;GLRJ,Q,D=L;]GN-\+@$+406^M=O-[+BY&_AY7*V1])_JK->2$:'_P#89T*4DI03X7B--[30EU2%*)5A[X,E3D(U_??Q%(!ON@%?]-?_ M`&O5P6$>5_A$4_OS4'[NS5CV<<5H5X^6[Y!J]YQ==LK<:B]K*S2=$>E%(VVH MNEY(:32VA@LMI42$I2)!'NPT=Q^),`=JOWB?7JJIGY=^#C)Q]]!))<6K3 M#DVFG`)BC^6)\N!ZHIW5]-[FMMIY*O`J^EFSV$529`!BH71J8>TJ.)*2V3SB MS[S^*142VY'*_=^)2_\`"/P5-M<=V8C(VK5:U!:.>>"[M^7CR)>0WIIN[:NY M-@],J.GWCM:ZLW?:=V?H[I:&K;>*="PQ5LTE)7"V5-2WJ44!Y+C>HX)G*/.^ M<^9_B@[6Y"\T-O*!$],]1(/'421[PO2^1^1_A"UO+4]N;L]Q">J`F-,8R&%( M1B":FA<8NZ^+#_$!>5/I_P!/OF"]2:/IA;#M_;]7L7I?>E;<98JGZ"WW2[;? M>=N/P%=5U=74NL5#S/Q&A1"65/EML!M*4CVWX:%_S7\.6O,-[<$]U*]'4*YM@`OG/W-TV MJZ-3FME1`)QT889$SB^]Y<3@$UGS.4`[O'@N'[CMIYA:_V.8[HX.X\K-907H]OYGJ`$ M\51U%KF,4@\@1D.W$&>,<>]LI1-0NM;W<9"AR5!4VF9(PQP!EC(`X>J.?(^^(T%#@I!3+"$,64L"L2@90 MRQ*(9#))2#B9Q"A8\,<"?IZ($)!21,X80(28$(@0B!"($(@0B!"($(@0B!"( M$(@0B!"($(@0B!"G6S^96_\`?J3^(;@0BY_S*X?OU7_$.0(4&!"($(@0B!"( M$(@0B!"($(@0B!"S(\CZC`A9"2>SOF($)80.6/I@0E@<,I1+*6*)=_H$_1W0 M,ABLR,#%#%9E#:5+!*"3P$-I*'&"<2CGGWR^Z)`&>*@DY8)Y+1Y8?IYQ->Y1 M[U*;8QF1SPS,QWSE#".2AW*F-TQ5@)#C^$'/"7HBP6U!("LF+>I6F85.>&', MYG#+"+X6>*0R`[%L+%N3+\($L@D`3/?+(1LMV/4J93`-<5=4]`F6*?J)D9&- M]K:N,%GG>C'-7+%$D#\/`#ACCC..QMO+]1#AEVOE<``X7G]WYI*+@+>;5MHNJ22W/(?A]4L,NV.]8\OC%>G%*I3:E$82E-LDG$& M8!P"CPCHV]HRP7=]I@6+`>LKO%TLZ7VYZHI0O3(K0#^Q4<`<)B0&,:#MC%8! MO)37U%?*1=L/E_WU?MSE=$FBW;LO^[5V0ZPI+KXI[@W=_S,8W9^M:+>W\J(I9@&5NS8-IH(+=HI$', M$()EW$KG*,YW&_(K.7K6F.U\L?PVXA^2N&:"T-G]C3L()$O=U#`X8XX11*Y? M/SF3$5&4S4NKA:M8`!'P-)_R"/;] M\`G,8$HZ%DXQ"Q^7T4Y_#HGVE1R["J43U;GYQ1T+/YH]2S\#2'_B&_4?O@ZD M^)1T+/YH6#;Z,YT[?J/WP=2?$J#M[)QB$C\LH,_A6IY3TXRSSG$]6Y^)S:9RQG(S'*7W8Q!N7'Q*GHV!]6*A.6^S*U)SZ%FE:\F'S;>VM;JKITSI2=>W;/J[7W9 M2.=RPOS/J^A9I3\CA7[O:].]:U7=7.F^U4_%MV>U,_#2<2I%:\ ME22F9!0"524!ZHN'D_G.\!C*Y,N*N,57_P`6\DVA$HVK88T;$>]?)S\WFDM/ M7KS";KZF4]-:J=EVP[>VS1&E><=4_;]N4E0W1U5:MU()K7!5J2L)`0E*$@<2 M?K/X5\MGY=Y+:V,W,XRE(OQD0[8TH&S7R3\5>:1\P\[N;ZVT8Z(6PQQC#403 MS>9#8!AQ*^6/U1R+VR;)=>UO!(.%15- MK2"3*0/$<>0CFW=L05NA?C+.JIJBUDXC\6>4L^?+`1DG8*T1N!4SM`L$X>]Q MP![@2A&4ODHZF M)8XX^S[(5JU3:DR6R#A[8#'@I!2-$OU?5^B%,4422D]T*8E0W!).&<0R&*(% M#%)(''/OE`ABL:!CGEQ_1$(2-!QRP]O=`A)D>1]4"$0(1`A$"$0(1`A$"$0( M1`A$"$0(4ZV?S*W_`+]2?Q#<"$7/^97#]^J_XAR!"@P(1`A$"$0(1`A$"$0( M69'D?48$+.@S`QQ$YRR[($)00../L^V!"7`A8*O3$LI8E+3B`8EDS)42A9`G M#:4$LEA'TE^F)8#M2N2GPS(_2?MRB:GDH=.AG+Z2]&1@TA#E/H9[`)=L\>R4 MH81S2NI3=.3B1.8W?F9JN3++M^>@:.4L)RY3PCMV-NPYKA7]R9N'J>*YB ML&V9E$P!IE^I//T8YQV-OMLRN-N=X(#3;J13^!=@-J[522WBG40)$M3(X2D4 MR$XZ5NT>YI"A-G#`XXZ.R'-E\J*D[G2P!JO3_HWNZOV^Q2AFN9``1J'A MR&&.4N$*]"MF]7[XIID)NZ")($@A8`P`TDZ9<(XE_R MFU,N8!=FWYU=C\LCZ<5V?VIU,NKY;#M>PHJEB`L#A*>&,<#>>26!6,5V=KY] MN7:1Q-.:[$;>WE7/)034LF>/XE9X9`\"3'E]WY5:@:`NO3;3S>[(.X9J0)F!+CC(Y1YV_L8Q-7!7H-OOY7!DRY%H+P\X$R<1JX@*!QEC@5 M8]T'G,?M)'U<(QSL@],D2S!!G&6=F+\%KC?N-7!2D/K(F$IE.1`5(SEG**C9AQ]BNC>F>SM4GX ME2!*B1RX#5.1C?:VD'J3Z9KGWMU,@G-<7WS*!A+`X*S ME'8VVQMRJ79<7<>8WH#P@+@W.LXS$>HVWDNWB'#NW)>5W'X M@W4P=98/DNIN_.JNXE-N)\2E4%)5,%U1G^*4AJRERCM6?++0J`N1>\[NCF"O M-'K955^XWJA;[=`X5ZYJ41F4B>9GD(Z]G:0A%@"N1?WL[DM6+^H+SCW[LQ:U MOGX>@4#JD1H./.8$XT1L.&:JHZ\H\XY+J#O'8Y*G!X-*DS4,`G&1)R/$2BNY MMZ5"TVMV3IC%P>:ZR[GV0$K_MC!Y?#!5# M]#C^`$'CV]\KL@9#)6!Y'LB%"QH3R^GHB%"3X?;[/TP(2"D@RD3VR@0L2]F< M"$0(1`A$"$0(1`A$"%.MG\RM_P"_4G\0W`A*N:97*XS/_7JN4C_[H&>1]@^N!D,$H-F>7M&'H@TH9.:) M\5>N)9319$\U>L1(`S446?#[_7$M%#A+\/M3[?_`#8-(X%1J"/#X33[?_-@ MTHU!*#)YI'T[A!I*-82DL<=8XX`''TCMAM);!0[E.BG/9+A@/MB=!0_-/"E5 M*0TD\Q+VRX0PAQ03S3S=(HB>$^.`/$YC.-4;`!PHJ97058-4PG^$"?*8'>)< M3[8UVMN9$`*B=T`$DJT;8&`D<<>9ED>^.K9V9+`!>O;F;U7,5AV^GW%%LRPP`/.?+/G'6LV@*!SVQ,@=),4>4WE_+467KMEMB`X'B7+UIW(A(3.G"2)9N2GV2$\N$>:W4R322]-M M[((K%N:Y`M^ZFP$GP5)E+$/#.6)%'"[5FT&9BMC9W@V92*AQ/[0$C MNF.,8)`\5T+4,@"%<,;R;`P+@F.+HQ/&6H%G#+9&`;`NIZ-Y(.&MP?\` MSQ)^N*9&1Q97QAVIS^^:3_QR_P#X)]LY0OBXA6"`-:LL_P!\TC_CE_[\3]!. M$#RXA!M\BD'>;?%U??X@)^Z)\1K108CA)TPO>3>DC6[IS!2Z`>0AXZQ@0JY0 M=5KV\629E3V>7B^T\HOCJ%00LT[<F?29"7WQIMB0S MC18;L(/02=:C0\QVEDD^"YZRNM6[:BD<2Z?RJOD)@3J%SQ)X%/O2$>JVUZ18:XG MU+R&YVX^8QD_`XKK'NYJF<4XK\HJYZ3*;[HX$2D!'4M7`]9/ZER[]@D,0ZZF M[UME.Z7BJRU,Y&7[1PX2QQ(C?&Z&^98)6CI+.*+J7O&QM++\K0ZF4SBI9SRD M>,7QE$C&J41.3T75G=VW$%3O^K5(GJE+5SSQR,XM$'-`U@M*@76S<^W$J4L M+IE)/O`:AR/##'UQDG`#!;[5^3^-B<`<%U_W'MI*2OW"#(R(!F!VX8F,ERUJ M72MWNF&Q"X0O^VTIUE+9/XL99X3G*.==L/DNK9W$@&C)P5P]=[$4E9#9&?"1 M)G'+O[4+I[?=S!`[)<1%$K0X*T34!RV@`G3SPEGEZI8Q M2;(X*S4,U`702F<)3X@GL]L4FRIU*(NBEGVG*7WPAM)M991U4F.)3V=W#&1A M3"F%$PEQ3"J;$@2EP,A(^G"$,."9P"?ZP]HA=! M1J&:3X1&92)]^/J$&E3J"QX?,I]OW1&GBAPD%N?,=Q$2T4.%CPCS5ZQ$$#)% M%CP_\[Z>B(931)*#.4D]Y^WMB&4,$CP^8/H(@9#+&@\E?3T0,AEC3WP,A@B0 M[?IZ(&0R)"!D,%.MB?\`65ND?^O4LY_O#@?U?8(E@HU)7ACL$NR(HH=*T'.1/"4CN/VSRB=(.+I=160T98R'+C/VP:8\ M$.E!DG'ZQ_3$Z0A.)IYX9GL!R]8AF""4\E@IQ($I2_")_3")TJ-3T3HIQ_42 M2J&$"H)'$)U-,#^J.V0QAA;*'YI]NF3,@I(D.*1]ISAQ;*@R"E-T@!! M4#E.6,_:F46""4DJ8W3`@2Y\021+E+3G#]-*9$%36Z0S$S/LTX#L.(.$6QM< MDAGR4UNF.`TA7$`8>.79]4;[6W=9;E_3CBIS;,R)=G#(<^P M1U+&T:JY>XWC!@:JWIJ,K4DG$=V'TG'8L;<#*BX>YW>-5ME!;9R]T^KE+(RC MK6-N,2N!N=T6TU=LF-6O2')601& M079#:M/1H#]=F M:.&36K<0TEV;VK4VY(:5\143`&$LN[L$8;ER8#.%MM68DN'783;=UH4:/[;4 M)GRQ'?,RCGW[LFP6VU:J2#BN=]N7VD0$`7%Y/&BV.WA MI!UKF2T[G92$D5Z\A^*1/;Q'./-;DR)8Q7J-M;!J)57(UOWC7Y5WMO@/$ZW*CWC(#^WZLL)_TQR[L1E%=>R)$5D%=M;S/"K&$CB9' MU^F,<,(1X%5D2_."AO;S=()%6E,L#^']$7 M1A'@2L\Q/B'5:]O)R9_MR=4CC,8S&!PPC1",,HT6.8N?G!U05F[Z@@@W)M(( MRPX#CA*-UJ-O\PK!=C=_/"TJY;J?4%?ZV9QF93/MPSG'4L:!]0NN+N(W:C6% MQG>=Q/K"I7AM,P<1/U8C`1W=K<@*=,KSNZL7,>H%PEN.[/*"RJ^MF9GIF=69 MD(?SM))!_KSRS![HWV[IT_+18)V-)+EW76O=5,E1LGHN"=P6A,UA12J4Y*EWYXY$1GF,LEKM&1( M,Z2?U+A*_60'6$``"9$QA@.S];",LF.*Z,1(,QP*X8YMW:,[A=6UNM9=U$"WV]R.*KW*[ARC M/*TKHW'JH3E(!,R$Y@REZ".Z*96E8)`FK*$Y2#E/+).)]$XJ-KDG$E$728?A M"2#CA+'C.8/**C;3B2A.4HG(@2GQYRY2,5FVF$PHRJ:4\$\LN)[`?LBLVTSA ML5'73?#]!B#&/!#E)\)7%.7$GZHC3'@C44V4B9F!.?TXQ M&A-J*QI']6?=/[X#;.2D26-$\0"!W&$9BQ1J22@=A[Q_3!13J6"@#@/0/T0, M$:DWX*AZU3J6O7P'H[P(?1V(U#!.ADC\(';,"4,(<5!GFGTL2.(`PXCT MPX@$NIT^A@G/`3&$Y<8<0"4R*EHIN20>&!GAGVRAQ`Y)7&>*E(IYC\/(>GAG M(90XMJ"5*0P#+LD`"!D`,R8L%M)J=2T4_#3@1/"?:<8OC;2&;8*6BF'+L$Q+ M/MBV-H%(;DN*F-L`2D)^C'GAV1?&TJ9702I:&0HS_1CVF-5NP>"IG='%E,;; M.(X_=]9$=&WMA1*EMLS(EQ.6,R1+'G'2L[<#)[5 M;4G1[I]../+G(1T;<'7.E..`KVKDVSVL33AB!]Q]9C=;`"PWB'-0[>G>N6[) M;1-)*<"!+`"0F#AQC7`LL4F)?)&<71*RWI5('HZY?L-.X MC0?`2HX8$8``9]D:1B<5(MGO7.V MW'WDZ#\(G`C-/<1D(JG>C@"F%HRE4+L#MJY.H+?]D2QWU:$('PJ0?=F`F1.!PR!E&*=P<5NC8&F@JN7;)N?3I)I4X#'W M53]B.9=A/\ MY=:QTZ>%BMGI=],X2U@F0G-4I\QA+TQSKD)\5U+1AD%:M;Y;$M3BN\*5.6/& M7*,TH3."VPT*>UOEG`AY?<5+^Z*90D]5IATW`]/6IG]^D<'U_P"^5]1BLPDM M`Z7>G1OEO/QEXX8E1'U0AA-..F4H[Y;_`.75W35(]TX71-3X,D@[Z:_Y=?K, M-IN9`)2+;)M6^6O^64>S6K'M(D<8<0F]56>FH2]\4LC^U5.>86X3W@D<(L$) MO142Z/-U7N[W8Q(>7+C^T5/LG*471C<6:?1-535.]J#'6XXH\1K7,X2Y1LMQ MO\0RP71MSQ6L5V]+<9S\69R]]7*.A:C>;$+EWH[=Z@NM+N.[[:K4#XDI8CQ5 M2/\`P8ZMCKBKAUQ=S;VTB007/-<:7G<]H5K)8=5+_G5GB3A-.'ICM[>YN1A( M57F]Y8V9<&)8>E/RKB6\;AM1+A%,]Z7E<9XGW91VK5RZU9+S]VS8=X@_%'BK)]>D&-\+DR&U+#WCW+@W<#]"HN*11D8F?O*`XF9GQC5"Y3%9I6@"0S!UPG?TTB@N5* M9$&1U$XDGC+*+A<8T*2=@$5!7"][IV5%?[`C,`SXR./=A#&0(<%TL8'4TJ#( M_%<0WJC0=+6)+)2`1A.0]7",DUOMR?$,5QG<[4E,YI''@)B?/F8Q7(#$+=;-&*T.N MM^G5A]L^1`X1ANVG[UOM7Q`.?3L6KU5#[T@.8YX^GC'/NV/"NKMMT!(1)S6O MO4A!.$I&6&7?EG'.N67HNQ9W4@.3JO6SC(X?=WQ@N6`NE9W)>I4-;8R`GP([ M/NCGW=MP%%U+6Z$BRBJ8`)XYX??/A&&=C@MD+V;J&JGS[YCW9S[S&:5DK1&X M,RH:Z<$D8SECACW$Q1*TK8W`HBZ:8EI&'/$X#]$4FV5:)@E1'*<9&4\29`8? M;(14;:<2Y**JG./8<\N.!X<8K,$PD5%53B1E@,R3Z9&>1$5&'K4ZE$53X8<] M0X$SPP.)PG"2@&=DP)49;!GW889YY>.<%4 M)T(YX]T2RC4G$IQP$L1GQ[AG$L49<$O29SEACRX]D,(A0<$O0",O:!]PB6X* M,DZ$3X9F7*'9%`GTM*ECE(Y2P[881`*4D<$\AK#&9';+V3RAQ&J4G@GTM$C` M`CO'++.'TJ-14A#)X@'D,)^T3PE#1B`E.+!2DLSE(2$N'?Z,X<0=03F<%)0S MV89DD`@=@PGE%@@D?,*2AD'APD3/2<3[)18(*#+UJ4AJ4I]F.?ISBT6U7KS" ME(9GFF8QGQ]N$6QAZU69/V*2AI,AAB>'<,>PSB^-LJHS'&BDH:YR(GAW'G&B M%EU3*ZW8I*4]@ER^OOPC9;L+-.]'%/I1E*9'"?9D.V4XWVK+!SBN=>W`%'IP M4]IC$$C'`=G/`1MMVWHN;>O!W*N*>E&I*I99X2G/ZHWV;;GDN;?OM''T^"V2 MDI)E/NX'`<\3BR58M'%=Z+]*@2FXGZ?;',N"'%=6T)T,AX@MCIM\O\5)GRX1 MAG"&172MF1`<*]8WVZ9:E)X8@_I$HR3A'BMUN4GPHK!O?:A+]HGTSGZ,>/&, M\K8Q6R$I#ZJG-[\5_7`P[?5GE%1@%IC(\&"=_OY_SLN$IF$Z;9J[4^1"7_?H MYEX'O)^^(Z:D%EG^_F2P!VSQBR-KFLER8RC15 MSV_93]T*Y$@2^N<:(6OTEDN3XQHJ.IWXJ1DAO,R]W#],;(6OTJ+GW9$^Q:U M6;Y69D(1A/#1Z,>S&-UJ,134?6N=>U5(B'[%J%QWHZI*I--F<\=&?;'3LB(^ ML5QKX-?![%Q_<=WOJU?L&N,OV7UQU[)@/K$]ZX&XMD_48=BX[NNYZA6O]BW/ MEX>>'=G.-$P.:Y\K+$L*+BV]7ZJ7K_L[\5KY*QX:,9_J#NXQHA=@RS&W)V*XLO M#KR]0+:,)_J'@#Z,A%L;D0D-DEPRXMNX=,_<`$C+W92/JXPTIQ(41A)P#@S+ MC*ZL%6N:0..6(]@BB4P"V2V6Q1<87>BGJF`!CRSF9=PBLRX*_1QP7&MSH1[T MQ+&C$RRQBB9]2U6\G^8>Y:#<:"6KW1+,<)]QC-,!EJ@"[8A:;6T,]4A+G MD.,991R5X-5K#]*`5`SP)^@[(Q7;3Y572L7S&+$EP52/4ND$RP),L)]QDM=3;WZ.]%5O4Y$Y`F8X<)1BG;R*Z5J^1ABJ];4AD.W^DSC)?JE&2=GDM<+PXJ*MKT3'' M[QW1FE:97QF^"BJ9&)(E/LX=\42MJZ,^#*,MF>8[N.$\)#NBF5M.)\2HRV)C M$3ED)#*>&?`14;:L$WP*B+9EPSRE[1A%9@&4ZE&4QG@)C+GW2QXPA@0F=RRB MJ9$C[)@#T@Q68)TPI@&>`Q[H0Q/S#[`8315-J3"FR.!PY2`]
$IR[L)XYC'&% M(4X!-Z4\R#V_0&((4NFBW+@1VCZ&(4J5;4G\QM\P#_;J3(?\^CL$"%*N8`N5 MPPF?CJON_P!.YSPB0"H?@H@'81V#Z\##`(YY)P()S]0_1@(9DKY)Q*.0]'WF M&`4-Q3Z43G(2YB>?*1[(;2$43J6P",]4\Y$S'U#"&$>"@DJ2E!)[L>/V3`AQ M$E*Z?0WV2QG/$Y#]$.(I73Z4$Y8^OU3D/H(<12D@%/);!.(QR$CQ''MBP0HE M,ZJ2E'`8<`,<.WTF+!%(9.5)0@8=_$=D@,1#B"C4"I*$2E[N.(F!/E(3SEC% MHBJS(=ZD)1.1ECEE,RPX]\6""4D\5*2WEAC(2$N_EPBZ,%7*;8IY*!A,=O?] M\C%\(*B4@5)`/'[YS]4:(6U5.X0GDIRQXR$YX=G*-ENV!V+)SNC;"E%SKNJ=P!IU<_ M0)3X3SB^,^"I-O3CQ6]VU`FG[L^7JB\7&6^G.6?:#(9>F+(WG*SRLENU;U;7@-(\4#*6/TG%AOD"BJ^[DFJY M`ME2$:3XZ<.WL^^$.Y*8;9A0+D.UUY3I_M">'&UW9 M8"0*EL9?K2PSYQFEN#WK8-KAP7(ULO[B`@?%(.`&"LI>GE%$MQ1:X;;2'(JM MXH=T.)`_M2/7A_[Z,D[X[EJAMR:9K;J+=SJ2/[4C#M'HD>V,-R_$KI6-K<"V MFEWJZD`&I1Z#[9\,8P7;L2NM:LSSQ5ZQOQU)']J1D.XXCVQ3*,"/]HW_NA'M^^#0%+E*'48C_K#1](B-(4N>`23U&./]I3GD#^F4'3! M456/]HQ_[2F)T`(>20KJ,O\`[0CNX?68D1BDD9<%&7U&61+QVY#AGAQ[IQ8( M1R*IG*1Q"AN=1G!^%Y![@>`XXQ=&$3ZNS+.4IQH@(<5 MCN=0O14]1U"J,3XJ<1RP[?3&F`@,"L-R,R[BJH*O?U2H&3J3/+#M/JC;;-L5 M=8+L;C856L5F^*TS_:C&>0^ST1OMSM<5R;UJ[6BT^OWC5KG)T2[A,^W*-T+L M`%RI[>7"JTJX[IK%A4GLQCA],XU0OPIP6:>WD0S57']QW!6*U3<`G/('VQHC M?BLB+!N!W)#M:4%5H-R=<4%`GOPGQYQ$KSE$;) MB*C\JT.Y8A05]G;E+MBHW?4MD+42*AR)*F. M)X=W$$KE<=6QMF(%*@K3ZVE!U>GT\NP&*I3#U6CHDQ<8K4ZNF$UQ;++Q##%4SS&!]GTX1DG&JWVY48JK>8T\ M^W/UGMC+'!1%HD9`^F79&:<`RUV[A4=2 M1Q'I]!GA&6=M:83XNHZT9\[M$(8Y)G3* MD3X`>T'V80A!%%/8FE(GEE[,_9"D)GR3)1+#*?I].<00IYA2K:`;E;Y8'XZD MPR_ZPWP,H0A2Z>N*?]97'"0^.J^&?[=R+&2.HX2.[M^G.)`14IU*9$=W'LG M#B*B@PQ3Z4#+C(F7=B<88!*Z>">0[ND.%L]&F4N&661E*+A<5/3:A6U4)&`GR!_H[8LZGK59MZL5N5" MX/=]'&7")%TC-(;#K<*)X3`"@!AW=F$,+N95,[6(&"VVCJ0)`+'?/"?.7HA^ MN0%2;#G!;31ULM(+F',G+CAZ84WZN%/0+,5MM%<3_P`IECF)Y7PVRVRBO:TR(=[?Q"<42W"T0VY*VVDW&XF7[: M>7ZX]442O^M;(V"S%;'3;I=$AXTSA^N!+UQGG?"U0V\CABKNGW:ZF7[4GG[X M^G&,L[H*WVK,PKEK>;J9?M3_`+\$>H9QEE.)6ZW;/>K%K?#HE^U/^_Y]T42D M,,EJ$#3BI[>^G>+I[PN7UXQ03'):H"6!4UO?KN7B^G7]F)PBJ0CWK1#6_)2$ M[^<'_&JG_GY^N45$`XJ\:AS3XW^YQ<5_OQ_1"F(5H).3)7]_U?\`*J_^"#[C M$:4[E*_O^K_E5?\`P3]$+I3.4?W_`%?\LH?[J<&E2YS"S_?]7_*'_?8]\^$# M*#6K52#O]?!U7^__`$0VD)3(Y"JP>H"_^4/;[_"#2$I)X)E74!S_`)0_[^0/ MHQAQ$*HRD[7GZ,_VBO0OGGSG%PTA9IN:*M=WR^9R61WJG]D:(&(Q62<9&BJ7][5)R M6J?#WA]T:82AQHL-R$\&5%4[QJ3/WE<\5#EW91JA<@N;429JPG^MAC[(N&X#*@[?DM5K+FZJ''[#&>15D+=:@LJ-]K`\<3Z#P!YQ3* M0/:KXP;!5;K8YY2S$XSRJM<*-R58XUCV@R,9IA;(DC!0EM_B&?LSX13)EHMF MJA+1GR`^O[I11(+5$T4923F1[)\OMBB4:JX3`"CJ3W]P';&>4%>)%U'4G'&4 MA]4S(2SS,42BKXR'>F"B6$QWRF>0,C.*91=6@Y8*,I',2..9XX#G%4H^I.#G MFF5(G/"9,Y<$J,63B2C*',?7A+D<"8K,4PDF%H!D)3&/!0Y<9Q60G!X*,MN M64R/>P]!X9X,L8K,63@C-1U)S.1).?I,LY1U-$8G+.7,Y80A'%,"F%(E/GRX9YXPFG-,#Q3)3AB#QSX<`1%9"EV[$] M;D@7.W3S^.I)'_Y^W$,I?UJ57^G.>'*'`2$J0E$ MY#[,1]T6"*4GUI\)E+/`2RGERXPX"5WJ<%(2D"4AA(&>?J&$.(E(2GT)XRPX M46 M"*0GUI](E@"MZ<`=^$\^`[(NC*BJE`N`KVFX<@0?K MBV,_6DE`LKZG7*0QSGZ.4.+G-5&V>"V*D>`ECC],(GJ#N2]'-;'2U($L>T8R M@ZO-(;>2V&FK)2]Z7IEGSE$BZV:0VAWJ\8KR)>^>V4YGUYQ)O)19TUV4"/VDNY1^R*S?'%,+!X,KVGO2A+]J<<,S%1O*^-@ MY*]IK^M,OVW+(F*I7:J^%@@.5@5BUNM8_P"._P"$8IE,+7",AABIS>[E_P#*]DM1,4&0*TQ$ MADI2-XF?^F.')1]N,IQ665X!4I&\U?\`+8C_`"C/OBLLKH/FI*=Z&0F]_P`( M_9%1`Q5T9'`IU.])?\?_`,(GU0I#JZ,FP3@WI/\`XX_[XS]4*0K!)*_OG_S_ M`+3$,FU\0L_WT/\`R^6,IG#ME`P1JY+/]]CQ?]JA/ND8C2%.OD@[VY/R_P!T M8-*-?)8_OH.+W_"./;Q@91JY))WK+-WTZE?H@;FH,^"0=[#_`)8^LGVSAA%( M9TP31WKG^UG+_*,.(A5&?),+WK/_`(WL_$?I.'$0J93XJ,O>I,Y._P#")$6@ M!42ER45S>:L?VO\`PE18`%1(U4)S>2O^4/\`OC+U1=%N*SR/`*N>W@L_\;+C M^(Y_=%\=*QS$CDJM[=CAG^U_X1BX3"RR@6P52]NEPS'B'U\.0E.+A<"SRMG! ME25&Y'#.;AGC+$Q9&X%GE;Y*EJ+^LS_:>T^V+!=5$K)%6HJ1^]K)/OGLQGC% MHO#!)T#D%1U%V6J8U2S,YF'ZH2=!\0J.HN2B#-1Y?'(?Z8JD0RN`+*`L#4>/TE%,EH@#FHCBCTQ25/.*B*JT23"@)\)\R)]W+A%, MHE7`NHRDC&0GGB1EAE%,@G'$)E0Y@'C//[LHJ(X)Q),*3+/$<#+$X]F9BLA. M#FHY3+'AP)Y''[(J,4X*84B9PY?A.(^@BLBM<$X/%1EHE/L^G="$*1)E'6F< M\)'LSR].$(8JP23!0<09R$CV^OCG%9"8'@F%CF,^1S,^&&4(17FF!HHZT'#]<6` M,'*4E1@`)>TCGWF&`?L2^Y.@=@[!RSQEPQBP!0[]BD(2,R,/3/O[A#@)20Z? M0DDSEEG^CTQ8`JS[5*2G$8=OIEVXPP]JBC2F>':3Z(L"K)>JDMI[OT\8M!# M,J9!W(P4M`Q^OU18"JYAU*&>$N$6Q*JG&E%,1AI$LY,DIC6@HK1E67;Q!P$6"224,U:LN2(&6./IXRR,.)*LQR5PR^!+$CUCCA MZ8G6EZ:MF:F4L?:>WD8GJ*.FPJK9BLE(ZLE"7O\`M_2)90AFG%NJLFKZH?K_`/"/WQ69K0(,IS>X%#-?M/WQ69*V M,:*8C<1'Z^7^4?:)Q62KH..Q2D[D4/U_6?TQ466@,I"=RD?\9RXG[X0A7#@4 MZG?_G!ZS]\2HUK']YO^H^>/Z(<%4RB%7N7RL_?%@DJS;&*KG;U/B,^?9W\X M<359M<%7.W>8,C[?MG#B:3I\,56.W.>9&?"?HGC#":4V\%6NW`D''GC/ZH;J M!`M^I53U=.>/UY]F/9$:TP@JIZIG/'GQ,3K3=/U*I>>SQ]IA3-.(*K==!/+A MB9]T09<4T8U95KJP21PS)R]4(9JP6P[LJ]P\3Z.7Z8K,@<$X@0J]PDS$LCS^ MF4(9<4P@6HH3@$_M]$5D\5=$9J*K,\.^*B4\02&R=1%B)XIE0S[O1S'JBLA-@>284#CD.V M>.?U17(*P'BF%#D.&.?JG%1#=B<5Q4=:(SQ,5D9YIT[;DD7.WX?]>I)__!V^ M$5D43@Y%/W(?ZRN`GB:VJX9?MW#[8>/L"11DB7"8X]\N4.*J#P3Z!,CGZ^.4 M6`*LE2$C@!D<>R<.`D=24"7#/NRATN)3R1[1+NSA@.*"GT\Y\/6,(M`59X)T M"B#4E,:J:W7REB#ZQ^B#4C2IJ+BK#''G/\`3RA=7J1HX*4F MYRX_>?;C$:E.CBI2+K(9GLR^^%)]:D0&&2EHN\I8G#FD?>(-+HU,C\]/]<^O'TXP,%.JB/ST_USZ_TP,%.H#`H_/3_7/K_2(-(4:J M8H_/3_7/^^_3`W8C4L&^G^N?7]D\(&4&0[T?GN/XU>L&!E!/%)_/!C[Y]?UX MX1+9*'"2;X/ZY]8^^)JD.G'-(-[']<_[[],,'2$#O2#>Q_7,O\Z?VPP!"K(! M39O2?ZY^[UF&!*4Q!3:KTG^L9=_Z1$@E5F,2F%7E']8^@S/L,."528Q[TPN\ M)_KGZOK,."568C/%1U7=.,U$^GZ\8<$I#%U%5=4S_%SEB,/;PA@2JS#L45=T M3Q)Y8?0PSG)(8#`J*NYI,_>/=A+V&&U)=`P915W%)X^B<-J.2C0HCEP2>(]< M2)%1TZJ$Y6@SQSG(3^AAM2!!0G*L8G&7I$1J3::J`Y4S,Y\3],X#)2(54)Q\ M'MQRGAA,'"(U%DPB`5#6\#D>SA]\(9,F9RP4-QR9SP&79^B%)HG`XXJ&M?9A M"&03B*C+.'.6'VXXYPA/J4@9$*.L]F8]&45DJP"JC*,\I89F?TPA"58`<$PN M4AZ_1SBLE.SALU&W]$(3F$\0HZ\"9\_P"B*I*P*.H#4,>!E].Z%.:= M1U<.()([_H(K*DX!,G`^D_7%4DX*84/J$^4\9X>F*RK,DRH8>ST8PA3#BF5= MW/T_T15()PF5I^S`<\_;%2<,0ZC*&/898\B(@J0HRP3[/6/Z(K(3Q*CJ!Q)[ MCV'@80I\"I%M$[C;^8KJ6?\`\';X\8J-''),/:E7+^9W(\JZJE_WAR&C@H>C MI@"4@>.)'U?5%@`2\U(0,I9_=/*'"0\%(3CC+$^V0BP)20GT\>4_OAF"C)/) M$O21(^N<61"0IY)`[N[A+ZHL&-$I;2YQ3R9\.$6`*MV%4]#QQ2'!/($P,.>/ MI.$6!+[D[+W?]U]D61Q4&F.*>$Y&0SP]D,&2%/I,C/#TQ8`Z5/))(![>$.,4 MO)/H,IG#*7KBP4HJB`],$\DR`/9]8E#@I#Q3J29D1(_27*&!2R%<%)0_ MZ3+Z8&&!2Z0>U24U!PF1Z_LX1+J-/%2$U4NSER]LH@E0!2J?3689X^@>V(36DV4+5,`$^FXD<9^F(Q34QS3@N?;Z,#]D*4P9*%S(E)4O][],HA,$ZFZ'^O,\ MB8_IB=)1K/!!NZN?M'VF!D:EG\W5 M+.7I_3!I1K2?S<\_3AC[8-.:C7ZT?FZOZT&E1K23=U?U@)=H^^)TH))6#=S_ M`%I>D?:8EDM5C\V6?UCZTP:4I)6#=5']8S&>(^K5*&90_K2%711S5EPPX]QB M69+4]J0;FJ/M'WQ+HTC@FE56>)]D2Y0P4=52<9D<\YXQ+\$-Q4=502 M?1P@)9`#GDR84_B1@/1],84E2P"C*>Q(Y>G[90I/%6-2B94X9B&$*<$XH63"E<)SY\_7"%,*)E1]HX MR]7#&*R4V::)GV82E"2*?-1G%"8GP4/KX^B$JFP3*L9G/.$DG"84)R/?EZHK M=.$PH2(!'=[)_7"$IBHZA[WI/Z822EL$TL8'MG[816`E,D?5%9Q3#!^:84,_ M7]<5R5@3*IR/>/9**CBG#8)A8P^G.%4_691U\?1]0G%94C%1E<>Z?MSA"K,G M3]M'^L[?R574H/?XZ/NBN7R\T_-9N'\SN!YU]5_$.0PP'8E/!1P)JGRF/IZX M<8)2I2<"`?9W0\56<5(1E/D#[9Q8`Z@T*>2,!WS]8PAABA/)X#T^PQ9%)(9I M\"7JG#A(?EKQ3R/L^V+`DE\M$ZD$F0]L/%*73H$@)\)Y=IBP)7R3TIIPSG.7 M9*461-5$A5.C`F)#8)"$ZF.7LRA@:I#4Z0G03,2/?+E#@I3'3VIQ*S[Q/&6/TG%B4A^U.A9PX=L MX9+I*<#N7O93^F,,E9L$ZE[TX3G/]$-V)$M+PG,&6';]W;$AVJH.+Y)T/]OV M$Q*.Q+%1W?3U054,EA\B(=2S9I0J3V^@Q#H;)+%4H<_6/N@0RR*I7$D>K[H@ MA2R<%6>?M'W0(8NE?&'F?6(%+$4*4*X\%'_?"40R8,L_'>)/K_1!I4:T?F!YG_??H@THUK'Y@>?HG^B#2C518-P//\`X7Z( MG2E,BD_F!Y_\(?=$Z5#G%8_,%8^][?Z8-*74>Y8->KG_`,(0:4.D_'JGG_PA M]IAM*5RZ#7$YGVC[X-*AZND_&G@3V^\/TQ(`4$DI)K#S/K$2HJD_&$YD^O\` M1`RAI)LU:SS]GW1+(98^*/,^L0*-(2?B3V^OZ^<2Z&"27SP)'T],#J&#ILOG MF!].[.)J4-FD%Z9EJ'TY81!P3!LDVIT88_9EZ(AU'8FR[B9!A:)NY-J7QG]/5"E,(\4V5JQQ[B,C[(4E2(EVS396[[N^&%<%&D+(69'//AE*+$AHG-9G(`Y\M9U]GMADC)27)$^ M[/N/;W0V(9(U013/% M9^(_SO;$-Q0QR9'C]_T],%$,>2S\1W^L_?`R&&>*/B._U_I@931'Q![?IZ8& MXH]R/B#S/T],0RFB/B#S/M^^!AGBA^"S\3W^O],#!#GDL_$#FKV_?!IXH<<5 MCX@]OK/WP,$.CXCM/M^N<#!#^M'Q'?ZX-/J0_8Z/B#V^L_?`P0ZQ\0>WUG[X M&"'6?B.\=LS]0@9#]B/B.T^W[X&0ZQ\29X3]OWQ.E#K/Q![?6?O@8,OJ$0HP MJ$G7S'?CQ]D*GJL%SWB)9<81,?:D%PF8E*4L..>/JB%('K6"L@\YQ6<$\<4C M4>1^_\`3%:."8,IGT^J$DF32L1Q!'M&,(4X M%.295QER/VQ6<>2>+::\4RKCW8^V%DRD)I7X3W''T144Z8.0],*<5-.]1R,! MWG[(0J3BHJLAW_?"%6C%/V_^94',5](?_P`81%9P/8I#(N'\SN(Y5]5[:ER( M&`;@@BB8&9$N9G%@P4%2DXD<`9'U"<.%6<5(29B4LY^S^B+`4I#%.I,^'&1] M`SB12B,>Q/)G@<^?=RBV*0M5/)/V#T#+VF'#I"`R>3^@^R'!2M1D\.).7"'! M9+1G3B9R/J'HBQ(0W8G!.&B45S3J200/9RPG%G-1S3F)]<_LAHE*:ETZ#,98 M\X=V[$C)8*N&8^KZ"'=*S%.C&6'TE#`J,2E`RGVP[LH9^U*!,@.[ZX<%*0XY MK/O:N0_I/?$@I2!B$H<9XX8=F>,."H8G'%9&&0QY]G=E#NDTA9&J>&>$2_J4,"CW_`*2@+'%`X!'O\AW_`$,&I#!'O88?5C`XQ0P" MQ[_TE`XQ13!9&OZ2@+9H#8!'O_24#AWS11D>_P#26'J@<%#`(]_].$#A%"L> M_P#242X44P69J.0Q[Q]L#\T,"CWL,._+&(<%2R"5GZ&)? MFA@L>_\`24&H(8+/O_24#A#!'O\`TE$.'=#9(][D('&*BF"/?Y9=WWP.'=2P M;DCWN0^GI@?FH8(]_E+U?;`XS4@#)8FHGN^G&)#`*"QJE35REZ85@F=8]_Z2 MB:*$>_R^J)U!#!'O#A]4#A0P1[_TE$.,67"8@?FA@CW^7HP@IWH1 M[_TE`"`A@4>_])0.$),SJF1,R[L(@FC9(`<\U@G5Z\.SL[8AU+!![L>/?Q,( MZ9DB2M79Z.4*ZDCUK!)D1Z?M$*3ZDX%'2)Y0A3`-VK!PGV?TPA.29DT5'UXC MNX0K\%#52"<,,YC'V90A+]B<#U)LSQ[YPLBFH&*;)F>SCWPG/--SS3),\>9^ MK]$5R3`43:YR'M[>4(I`'>FI\>'&$)3"H32C.??[,80IL`FC,3)[O7.$348` M)@G/U?7"23@8)I61^FG[0(<*HXI]&`[C%@42"D)PGWQ-5%&88IU)X18$DAFG MD]O!/MF(L!2G'O3J9^P?9#Q4$5/!/),Q#I"/4G$F1Q.''UPYB)"4'AFEC"6[#Z>F)=*U$H!S`^DX88*#4TX+/OSF?7`Z$>]G,^N!T-7FC$GC/O@0>!62%83^O*!PAV6 M)JYGUF!&*R=6>6`XY^W$P.AECWAQ/K@=#-5$U:`5'(GUP8*%GWN9]?Z8'"%B:LYGUF!#9H][F?7`ZEBCWCQ/K@=!'%'O]S/K@=`%'&")JYGUF M!")JYGUP(P1[W&?I@=1GS1[TN,N_],#A37-$UYGUP.@CUK$SS/K@0V2S-0YXX8F!T4."Q/$3Y>N()HIB*U0HY M#MEA"]BE@*K!F/5]TH5TT@P6%3PB'JF`XILSQ./*$4C#FR23A,\_5F(0IJLZ MQB2>6'JD(507?DFE88S.9'W0I*8`Y)HG\7H^R%*?"AQ2"J4L<^_&*RFX)O$# MM/K[84D99)@*IK#$7)-* M,O2GVXB8[80X*1CR=-*X>F*S@FBF5'[SW16GR4=6.&9/V1!4ADPOCZ!]0,5E M2,7R4=6!/^;]9A"K&HQ3]M,[I;1RKJ4GO\=&?/.*Y?*G6+G_`#.N/.MJ_P#U MSD1$T0HX,A.0PG[?Z8L"5JLGT&?JF/IZ8<*LA24GCSX9B'"&1$N$,#BB??$.$,B9YF!PAD3B=00P1,\S$.$,B9@<(9'V91.H(9$ MX'"&1`X0R)P:@A@DDXC/*0]>?MB"4`(5*7IX9PKIF=84F`23F?01W'$"$*8!,J,CVD?HA M5#.7R31.(^G=[(K)3^](498\L^V>7HPA2I%`Z:[/3C%9+E,'9TRKCV'[8@X* M0*.F"<\\S'ZIPZ MCW)\'VC[(!BH(3J9''O^^+@4G).IR)/=W80U%!=F3J3+O'T^V+`4O).C@9_2 M4,EP*F''L4&@<9E+PD<\\/;[(8%DLL$Y-(TB6F&'%(6[DL9GV0P*C/DE"7 M(_IA@5)J&"/JG#`D)6+L@@DX'+[H<8,@BO)*PY&(=%$3'* M)=T4X(F('0X=T8=L0Z*&M5CUP:@H:M,%G#M@=31$Q`Z'")B)=%$8N#4H;U+.'(P.IHB8@=%$81+HH48M8,I#OQ]0A22"I&%4DRPA M2(17--F6$IY\84ETP%.209=L*>28!QR39P/J'KBLE..* M;7RYR/M,_;$.I:J;/W?5"*4RH^PD0I*D"B;.`^K[(12U4T3P/&4*4U,$VHX3 MYX#NA%(?#),*RF/IC"2*8<$VK+N3/TF*CBGC\4RHX#F<^[^F(4J.S],2$%.C##TSAP4AXI].M+[(:)4-EDG4F7+NYPP*E+23I!S,_ MMA@P2XT3@XPP*2=&"7F!],\8<44%.3!4D2E(<^67JA@4AHER//NP$,"HS2P9 M#G#`H(+.,5GA],X8%RI(<J!#K,X$.C#E`AQP6($.."S.!#HGV0(!1/G`AT3[($.$3 M^GTE`*(=$^R!#A$X$/P1/L@0Z)P(=\43@0Z)]GM_1`APCT0(<<%B9^[Z2@Y! M!*/JXCG`AUF<"'I1$X$.L>CVP(H@83^DH$.RS/&!#YHG`R-2P3RP@0]&1]#` MBG!9GV0(?DB<#(='H@0X&2)P88(=8]7T],"''!9G`AT3@0Z)]D"'&*)P(=^Q M$^R!#A8$^)GZ.,"'HDGGZH'8(%2R#.4SV0KN64M58$NZ(=/A%T@XC##'O^L0 MI/%`!;O1]D*2%*;)DO*BG$IK*?9P]D*2]$T<62#]?T^V$)9-#$C) M(5^$\PK`]RL,(4I@FB9R)'`?;V0I+*4V3(`RX_8<(7`J6[&$D4P& M297D/IE"OD@#,ILPAQ4\TVLY#D)PKIDR<3+F)^V*R4PI5-'AQG,=P^ABM/@H MZR<>S#VQ",TR>`Y")_3]D(5:*!-+.)X3,$^S'OBP)3@I`!P,^`^J)4/DG4<2<GE$@\$M6JE)G,8 MF7+T18Z@C-/??$X%`P3H!!SPE[9\H9WHE*<$Y'MXPSLH9RE"GN@U(;DB2CSX?/MA25+>M,F>)F>7=C%'=@(K*:(4<@S'*7WPI5AP9,GAWX^J*S@F3]O\`YG0? MOM)_Z]N$."D8HN'\SK_WZJ_]>Y$#!!Q3(X]GVP\5&:=Q]T_YLX<*,W3Z3@>_ M[HL"22?$S*67Z,(<*M2$_A'TRAE"<293[IQ(Q4%.@Y=LO;*+0ES3R#AV_9#1 M4$)8PGW8>L0XQ4)Y,Y<9SXPP452Q.9[,9\8<%017DG4SE#):O1.@DD]PE]<^ M^4,$9IP9#'^F&Q2YI:9S'*)2EDL3Q[X:KI:LZR">V'2IX9"7+^F)"@@A9$Y" M&&*#@E`F&4``A9$Y2[8EZ(*SCD)_3MB7'>BF)6?>^DH'B$46)GM^S[H*8*:( MF8"0%%"$3.7.!PSJ:(QRQS@WLQ@>*,^2SZ M3]<#AG"BKX!EC'F>V"BD]B)XYF"C.C*N*,9\>,'N1]5\UDZOH8AP@-FL8CG/ MOB:HSY(QE.?MB`1AFIH[(F<<8FB&"/>S^V`D(HC$9S]<0""$4=EGWL_9`XP* MBBQCV]L2X11J(QX>R!P*9H'/%$SS,`JI",>!,!49.<48Y3^GV0(#$.LX\SVY M^R"A4/R6)GF8FB9&,N,H@XJ*(QYF!QCD@T1CCC$.$=H1CQ)]<2""@X4Q6)GF M8FBEEF9GG*(<9*,D$GU?;$.,E-%G'Z&`$,Z4-GQ6)GF892.:)'G"N!BH?DC$ M8>J)<$.I%:E$SVP`@J:(Q[90.,%!Y8HQ,0\0@T6#WF<#AJ(J_)8,Y?IA0@MW MI/#T0IQ3`46#.1^G9$(`)Q31)XDY\^,0312S%),_I].R$3Q#FJ229RYX3XPI M*@-CFFU8`^F4"8531U8$'LS[80I\T@SQ],*C.N";(D!QU2[Q*7&$)3LFE9'Z MST3B4K49.@D$8B4L.^<,"H:C)[->'TPBP&CJ&RS2QACV^V&"5/@X MF4I2F3VY?5#!0EC'TRERE#HJG0<3_5EARPPSAA[5"6"98'TYPR@BB7Q!.&'M MAXI,/1JI=*S,Q+!#!8G*!PI9UF9@H4,$3,%$,$3/T`@4,$$GC M!12P1C^F7VP(6)P40RS,\X,5#!8F8**669GZ2@HA@B9@H$,C4>?U0!LE#!$^ M,"ED3,%%#!$SS@HI8+`,LH*%#+,S!1#!&H\XBBA@B9YQ-%+!$SS@HAEB9@0L MSYG[XBBAD3/T$31#!$Y\L.[ZH$+$"E9F,02F`)QP39[^'VPJ9-D_BQ&6'JB)* M6IS39R)/`8]V4(]4V`3:CC@<"!,\..?*(/-3@D$DYF*W3,FS^('A+/UQ&2A- M&9Q)^R$*9B$R<">W+U#[85Z*12F:03/"?`S[\(KD4V3)E4R3V3`^R%4Y)E>* MNX?;$'!2!5,JP![3]LXK*88J.L\CPPESQA2K!Q3*C[O:93^G?%9Q4A-&$.*E M.VW^96[MKZ3U?$-_;"2P3!8N6%SN6&==5D?]X7]\$<$'!,)Q2/IQAE"?1F1V M?T?7%B@C).C`"6[[1#)"G4X2/(S]LXL!HE9/Q*5.C'2>4 MH8)2[\DXGF/7[(L#8(YIX<)\A]4,."4X\DXD8*$\Y?;#!0:=B<3D)\OLAG0$ M\G(B>']/&&""!W)2`9`8YY>F'HD+]R=D22,3(3PSX0P*C`)8PRP^GZ(D5-4I MJG$G#.<,[)2^"7+C#.H8LLR[89Z/FAJI4U#+GV?5#!$@GAB)\X'0RP!+AAC] M_;$NE8K,_I_1`Y0>:SI/T^KO@4+'9]!`Z&S6=,Y8Y\\($5X+!^K"!U+'%!R! M[($8(F9`2[<>/U0.RAJ\T9]GI^^!WJBHQ0<,/;],('*$<.T>VF! MV4YT6)3]'M^R!W45!1(C'TM&)@=2LR(R^P_?$((28ET(@0B),""%CCR@ M4X5TS.F=1E*>?8( M"I`:B3+"%>E5#46#WR)B'0Q-4A1PQA15,">Y-G'NB":J4VH`$=L(2F!3:LE` M=HY\W+ZH0FJ8!Q5-GEV2]D*5)3:IID`>^%)0`Z:.,^X M_5"DY*<3R31&"3/G"$U9,V::,DS(S/T]DX0E2$V?KQA4V"CGCVF%."8!DTL\ M)X9GOQA%("C<#].(A2FR3*\QQPR]<(G":43(F>.'T]45H3UMQNEN'*MI/XAL MPLL$^`14I]DH<8**IZ M!X_3&'!49I])G(XX2G])PZ4C-/@XSQD0"/3/#OA@0R5/)R`[/T?7#!(Q3 MJ3(RQ(X#T\IPRADZ"`.(`E/CQG#@^M+B$]SP,L)####E,1(([T$)P&1&>7T$ M.#FH:C)T&8G(\X8%0U$J(F/5.6 M8.!A@5':E@^Z02>!F,9X'#TPP.:&S2TD2P*IGA+'/'C#`I2^:<2H3.J& M"*LEZDDX3)[HETK9XK/'CZI_;$A!3@4)8:AAQP$Y<.\Q)]B!4.A"N'O3)/N<#H8H*I&6.''AC M$.%+%&H3`,_IZ/9AF('4,L%0$ISQ`.&,L,C`ZABLE0PSEPP'T MF('3,Z"H``F>.67/CC`ZAD!0E/WI<<,H*(`/C'LS@=#%9"P1[NK#,2QEV'A`X158"AC^+3Q,O9WP( M8Y+(6D@RU3@<('!82H3XRXGL[<>,#A!!60I,Y>],Y3R'?`X4,!@<(8X+&K&6,YP*6*R5HF(,_UI3SY@2@4`$H4H`Y''$2EEZX$,4%21*>J>,YF4N7,SB'"&/,#H8]Z-0GA//`F7H@4,4:O>E)4Y\!Q]<0X0Q1J$Y8G&42X0Q25JS$C. M?+MG`@!9U"4B"<,Y^@SA.].01@FB<4AP]$060!Q1,9J?`?0Q!/!`HFYS3(3P/K[L80J6.*0>!,Y=O],*<4PP23@= M0G)7#B#VB%)4@9)K@>>'VSA24S%(G@3CAAP^PF%*@!-$@DY\\N/K[(@\4PX) MOMQ])PEW"<5DY9J0*)DF<\Y3,I]_JB"I32B%2X2[,(K4@)I1S`G.6?*(<*6* M9)&>.'&7=E"DIL4PL@%7.9]N(QA$X&:8)&>,AF>W+#$G.%DFS3)XGOE@>,(2 MI3+DI@`SX]D(I3]M/^LZ!6,OC:3/#'XAL=L)+!-DRQ<9&XW`?^[JO^(/MD8LR2E/HXC,'V<,/7$@J"G4IS$Q*^?+$=D/AV*,J)\$D#&6(GP$O M1##FB5$L8??#.V"6*6G$$$@9&9P$N,SSG#`NH+`IP8`2()RF,][I5F)S)P$N/MA@:J"*) M24R,]252!,DF>(RB20H"7.9TSSP/T$2Z@NZ7(F)0Y/%822)!E/F,>\8Y&"N.:CFA2BDZ4D@`>L\\N,",4$`@'4$SQD29$\2. MV#%""=&D).$M1/`D^T"0@0R#)8!)"3E,Y'N'&!Z(6)E`&DYYD98<,H"AG6<5 MX*(!YG`2^R!Z(9$M`)2H$\QEVC&>,#H9U@$KF%*RQ!.0EGE`AF69:`2#.>`E MPRQXX0(R0"53"C,$9S$AZ>R!T8("=$U!0,LL.,%$`("E&>HS'HP)XD#&4#C) M#-VK(2!,E04$SPSRRE,D80/DA8"U',DC+AGW0/D@-B$!`!_$.T8@R[X*.CFL M:SZ)G.1PGR@,I8XXY MY1#H05*!"4G+NQ//&!T,ZQ(*&HD)G.D<0KD?48'0RQBB029'$DX`'LD>,#\$+,RM.*I2.9R/9(2Q@1V(_` M)@^\<)CEG+L,&2AJHGK!2HB8Q"CD.S#G`I69%()G,Y`SRGQ(QS$#AD=JP%%4 MTJ,\)SPPE]A@=T9K.G0"J85AA('U]T#H6`HJFE6(.'##TP.AN"`G3[V,02@."V20L!1GJ2)XR)S[>Z!WQ4LDJ.DR!!P!F>)EF.S&%)0`B'8\ MDVHZ0)$$XS4,>)X\X4E@GQ/)-Y\?3]\)53B*)!&D*(())(F#@._MB"64@O1, MJ]X8G+&9QE^B%2:(EC,&0), MN7T,*4SX*.5$S!EB,H4XILDA0',$@_A''*6'$0JG-E'6HE1!RY'#_ M`*2W%9P4YI-Q(%TN&$IUM8)S_P#=#F<0,%+549(.J7&<\>?T$6!05(0H'@9S MP,^SB(E*?8G4ZI@`$SEJ.].IFB>I/=PGW0P+A M1I+I:3/5+`G,<2`/;#.&4:2]5E((*B,N([H MD$59*01BLH"DJ43,"4R#D1REQ.$`(4@')*$BK"8)[>,O9#@ADC$FB4$J!G(B M6?=QB=0*EI#)+1W&05*9X=W9$B04,>"S)4Y$Q(8_9Z(@R08RX)7 M8I.J0Y]F422.]&F1RJDJ!P($P0%"6,O\GL@)0TLA19D0!.B!V0(EJH(.GW9R&8S(X`] MQ@U4H@@Y8H`D#J&!(`X$GC*?*`$-7!0Q9B@B8DG#*8)QP^Z(<,AC@,4`$`DS MTR`[R<@,!G.1SPPS,`(R3%^"P`J>1`YD90`YI0#@LX3D`4SR,Q*?##.`2"8 M@I("M7$8R)ER,IGTQ#J&Y52L)Y<E<%#',+)Q3[H(YC.?(^B(<9((.020#B2,,I93]$YR$2#F MAB[L5D"P\(`5#2>JS_FI()$IS^KM,`,4 M:3D%A,YRR`S.6!YQ`*`)<*+*2)B4QGI.?IB=04B)R"2$K&!!!GC,92B'JH:0 M."4#CE(>P82G$Z@ZD`I.E1.1GSY]O&(>O-1IEBA>`F03B/29REZXG4'4Z9)! M2LGB>1&'JB-03&,N"2J0,B)JXF?LD)Y0."H8@U6%@Z@98$8=V&'?"$\%.DLD MJPEJ$S+V<`85QFIBZ;4"2D@82(]/*`D,I8O@DKD`-0G/(8S^L0KC!2Q3:@2` M4XCB!P/;WPI*EBD2P][(D@#"1D>$*2I;UIHXI5I!`!F1Q[R(@D(JU4@`R).` MG@.9]&6$*2,U(#)LC%0&B%)!%%(!S34C[Q((`!G,<(1ZH`",JVCF9RE^W;^J$."D8I-Q!_,;@HD&5=6 M$R..%0YP@""HZ5DR5,D=I]'.&CBE)*>0@ZA)23,9`X\\NR+`H=.A:M0D<,<. M&&6'9`#5%`*J0!_E"?+C,\#RBP8J'2M2Q,@RR$N4I"4CSAG44-%)&>8&J6': M98]T2E3A40=(X=T."W8H-4\/>`5J$CS.)E##VJ"R&!HH*<$T) M*@029`2S3^G")02,,TIM2E3!.>,SPE#.HP'-.`%.I06%2RT\.1,QPB1@Z4D' MM2D%2I@XSPGA,=L#U93@$I"5`S*PO2"0$#&?`GL$.D<9("U3D25`X2$IXYR^ MR!W*8$$43B$*RUI(!F0!CAC+OPAE#NDAQK`E(GEAD.!PB702.]**,9ZACC(X&9Y>F%YY(<+"E.). MD$@``2YRXG#MAE.H#'%+Q5(E002)@$RGV\(C%0XQ6%K6DZ0<-.>'O'^L.R!& MH-59$U)"M029$3,I*ED>^!#ATE2EM@!*LYJ*Q+'AAV0(<+/O.H.I0!21BK)4 MYSF>8,"'ƕ*;0`%`E1/O`X2'!/;CC$X*!('$(25.)(4J13CK4!(`G%/JQ M@02'Y(.IM.I"@HD@:DY)ECCGBJ<1@IU!"%K7J2HYB85(221Q/9C$I2?4L@%" M5J"TK(&&F7NDX3,XC!&IZM580M:U:5E2@H2G_5PGJR[)>F#DFU!92"C4H.(6 M4IF$@3)(RGGA$MFHU524..*6D*45`F4CR.4L,)0(<-S2DMR/^D2K22K2D8G2 M#QSG`P0)#$!D@.N3SFDG\&$L.",74`J4$D$C4PS@[5!(X560DH2I84E1P`*<0,1B9P8(!!R6$*<6HI* MI@@F?]66,S_DP.I>.26`M(4HK2HI!P''@#V">/H@0XQ&*;2XLR225:AI*1VX MD@95,_AYS.(YXS@09`]J7H*52"T MR!_#AJ.&4&2*.R;4XN9D2`#^$@8=^$2Z-0SQ2EI*I_M$I!QTJ_$D\CQPB,,$ M.D^*L&0)2`92PQEQ/:84EJ*3+CBDJ23)25)1J&HI4)XDFU)Q6D*40)835QXC+C"FJD%(6I3:0$G,XJ''/`3Y2B#1&.*0I2EXDZ=.&I6 M(D>!],+0A2$VHEL`I5-1,M292`(_#EQB%))*;"E*!0HRD-6M60)($ASG"8XJ M2?4F_>2%'6E1Q"2D2`[9YPN"G),A2E`I,R2#CF1V\1*4*7S4X5S2#[H*Y@Z> M"<93XGL$0?:I3`6M2I$DA0'KQQ':)1!*G--R,\5!6F9TRQ40#*4NWV0CYYJ> M:B^(LZ=1F"0")8&8.7KA7346%)QP4"=67$C'"7.%(4NF%+5//'.68Y>C"*R2 MZAG":6B:I!29#($R5V]F4#)G8,\LS,_888.ZB(* MD:T3(4DJR!,Y&8E,@#.'=0W!+5KU3D5!4BDB,X8%*V>2<)42%)25)4)B0)E+`ID`9$&&=\$I`S3Z5!*4I6@*5B98C2#B! MQQ(SB260V8P2E**TH4E)(`E(`DH/*0!.(AL,$C.GTJ#:0%IU$DJ2DS20``)G M#`$Q+\<4$,62RHJ2%(!`&I)2#/$R(5+$G#"&=U#-BE(6$(,QJUD229IFH8$S ME,81(/%00G/$!20$RDH'3.<\,"#G@8<')#):5E*5$@R,D]JS+#2",-,2.*@@ M.P3FH%*DI3I.!PF=0!_#Z,XEU!"R@J3,D$`)]Z8(U`X!(!'$B&!IR2Z>"4A8 M*2E*0E1$A[Q..9Q,I"642"ZD@)32E:@N12E.))!RX@&7XCRB03FDT`)P.I)] MU`23,!15B"K`3G@,3$@U4Z9,L(EZH9+4^@*Q1KD0"L$`JEF0)'C`2$:4E>K4 MHA)4,PH?ATG+'NB'*`&[DI3B4D)6@.*"0%*!*9GT8X1.H*-*PZ5$ZM)4E21I M(!,@!^'`'$1!.>2D#(K)<"`E+B=:@"93EHG(A!SQ`]42_%1I6'"5:5(22@B0 M`'X2,P9=L#\%.G)'B!*$AQ.HDDI&`*4GG,3F2,H'I5&E"E:T)*$F2204#]51 MQG/B"!Z('S"!%"5Z$$K3@H^ZV9@X9K,QA/+ME!J;%&ET%86CW$RTF:D#$D'` M*$I$R@U.**--70A10E:EH(09)"5`C6H&;+D_#"23@N9XX` ME.0G$:@ZC2R;DLKTZ5:M0][2K3.?XBJ6`GQB:J=(2U/-^(9HU>\)KG*9!Q4$ MC`XP:@HTE(6%E1FE2R3J24@Z5`Y25])0/52P`Y):W4`A*D!:@D)4O41,@2(X MSES@,F[5`BL.E2E!02HI4`4R&2>4A@)1&KA@ITK*G$I"4K0%J"?ZRDZ0<0G# M.)U!1IKR6%DJ"5H22DB02D3T$8*20)D2/K@=2U*K.L(0E*T:B22D$E.E.6)' M.4Y0:D:>"PI>M*2A!T@J!0)G2K`ZCF2%<^<#NAN*R%Z&SK3/4J:4'`B4QJQQ MDM`T)EI42I`QG/`*P&,OM@?@C2E)7H2HJ1[ID-"IXJ&,QAD!` M^94F/!`6%H4E"=!F"4@DE2>,B<<.4&IT:4(44%2E"20D@@B6N>21,<#CZ('X MH;)"7$K"DH0$+*3+&>OFG$``F(U/A1&E):*DJU:2E*02I120)2D$X@`E1P`B M00`EC*402`F`)'!(6HJ"5`3!``D)A)3*:9`9B()X(`#L5@J`2E*DE1]XR,Q MH!(PRGB<90K^M,(\,$A2BL#2GW0"DI1,D*$\<)F9&,0>*`&-4C5I2`M.HDS2 M#@1+];LQB":)FX)M:M:1(2""=21C^+`*PSG*4(2XHI`8IM*I))4DZ29!)PF0 M<\1,`"(J,5+.D*6%H(2"F1"E)$U:ACE(3)3"DO@@!Z)I"]`4M8]R6@I(EJ4H M8#$3X1'-2S)M2P4J2A(0200-1][3,E,Y88#TPH+]J9DR@D$DX)`),\)C()QE M,DF(=2P"3K3,A*`A2DR2J(@F01IG@#.Y/W@3^KWQ8P=0'9+\5>,Q+"'8.E>3/DG%.J"R`2A*2$H1P`2`)F0G,G$\(9\E`#X)^ M2%:%J4EM2DZBE4_?X%:<_P`4,H?).*6IM24(44I2F8TG\6HS*U',S.42Y%$M M"G1):4+6L-J/NJ4K)>F?O`3!),\89GQ0^02RLH2A#:B$R*E.#_C"JE6I:5^X05"1!_6'+3G$NH9+"4`DZTN%.H^$`024XRGB#(B)S1E1"7EDI)!7 M,@EN*DXGW)&9XZ)Y3X1+*'2#4.!1.(D?PX2$L` MGF?MB'*E@E*0UJF7$HU$>YF4E4B03E.9]$!0DK>6E9"=2$H.D(&0`RGS)$&I MNQ##/%*6EM12LJ#16D+4D@F1,YJEF`J64&*C!84XIM6A`*`D!(EF@XP8ARHP*-7@H*FU:M:]!<3^H4C4$'B"K M/T088(H3590LNI6EPF0`6'5'!!G(I/\`GC*`5Q4E`DTA:T*#BII1J2#)H*.* MI']8RP.0B:`42NYY(0ZIPJ0N9!25:B1^S*<0J8EASB`7H<$QXE"0AL+<0M+B MDI)2$C\,\/$D<2$CZX!2N:AUAMY3BPVHJ6ES4DI)G(2F7!P]S.`%S7!!]:4V MA"5:TK2Z4!2@A&:M(.4^6<##BATAJH<*D8J6%'24F1"@O"4I#*<0"74X=B6& MF_$`\0+]XCPQ+62"?'*!@^*5^2PM]P+4$ZFPDZ0@2`3IPRQGE`Y[DPP2 MEI0I065I9*DA92>!/'#GGS@HH!]2PXZMM?AIU(2B24RE[PP.LG'!L?M$KQ/N"/B8S!&(_#.4XC&JE MRFUK$("#@I)6IQ)D%^]*29SD$Q!?)&?-(FE:0MQ6DZC)P\0H:M!`XB6<+C1 M2[)"EAM(*%:O$41K2)2TC\&,Y$`SA33!2X.*;"RM*@LR"9*#BN!)EI5*1((@ M=Q5%`7%`D$I0DJ;5K4HA&M,QH`!.1GBKZH0T"D5[$V%E84VXHRTE6LRDT4F6 MHY8&<0[XIFI1()2A"UH6EU21AI_5U#3JD2\ M4D)(DH+G(2D1C$/5E-`'2))&I86EPH2HA*)SF,C,YR^R%HF`!G`P=0YQ9,+=5J)F4!)D!* M0`!E(IRG%9D73,$VM+<]2G$ME0!*#,$$B2ZSK'[/3B=+DS,3&"]/\`6A]0)P5;$4*6 M&7=92$G!7X_U3Q*@>(XQ(!P4N%)+S)7/P@K00"Y,@J_RAP'.&<.ETEN!2U-K M4I7N*6%$$*D"%!67+`91)!=PH?#L3RG6PH`M)>4VE*5N$XDI!!3(2GIRAR1G MBAC6M$ZL%:BXVE2T+Q3I$Y"0>91-24H8)W4VV$)6T'5I3)4U2T3).C_&DF M0`EQ4<]E$@O1!BU4E+3@4"4*;2DZBLCW4A.)D_TA_"GB5SR(`B&DZ5HXI1J&=>HLA0"@ M?%U'4H"7[21]WT1.H.C22'2%-.%:BE*EA2IA:924%'!66&$07=2T4M;K04$E MD/%`2@N%1!5I`F1Z>?*),@[8J&>H6'4+6LN-H6ZA?OI6)?AE+3V$$2@+O3!` M9F*4M:&PAI;275H2`HDD!,\0V-/%'&`EJ&I4Z0:B@6'$J>DXTVMU)2,$X^$4 M3"FSEWP%S48**=ZR5H90VVXVEU8FLH4I0$*S,`:92*LS`[!CB@!ZY+"DEY* M%LMS"?V:FD8^$3[TQ/$I5$%R'"&&!600PV$NMZUN*U^$HD:4I`25&61)RB78 M54LYI@A7[=M/@MR+:CJ909DZ\`XF>)Y&!R110P%$`AEM?C-3\0I0EE9D5:?> M+AED$S@!8.4,,`C4EYI2&F]"DJ2LMI,PXF6G`JQF@XR@=Q3%#`&J&TJ8\1QU MLI3IT!M6'BJ5B$CL&8*?#`F<53QY0#4*G!22"LMN-+):2TAE; MB="'`2<')+2^R5R#*&=1(#NHGPRK`&1PE.`2!.#*=+"J;%.]K2"A:4A0!=,M*=,CX@ M,P2!*<`$G4>$)P5#!*))+FH@K*``2!*4!D'91I>J;=:<4M2T) M6ZA9"TK3+W@H`R_W.4!=WQ"&BU<4IQQIH(;4TA];:`E2RJ4CC[B2/ZG.`R`I MB5.DD+#J%/%+K*%N(6A,@@?Z,I`26R.8(PYP%S4*`!WK*EMLH;;<;2ZX`5*2 MHD>$%$$(P.*C*?(0/I#'%2SFF"%I+R6UL-J4E*"@MH()94#,S$\E@Y]D!$!AJGG-9Y0.0*H8$L"@_MVT^"W(MJ*5,(Q(U M`%+J9XG4,#!B*(88%"?V+:_&;)UJ2$LK,M6C$N\9!,Y"`'2'*&@HI,0* MG!):;6A:5K2II#?OJ6<@D9IY35E$!W?)0P':E(?9*I!E+*E:DI<"C-*EX3D1 M(3)B=0=2S52$LNZT^XIO2H$K/X4Z1,K'&6$XBKU0TV(8NH\+)3CS.H_L@Z4R!< MU8N:1(JPXF))`+*=+AZ,FE-N*7-"5.I7[R%B1U)7ERRX\H60+T4C3IJAUQI$ MD*:2^I"0E2U*(D<3H$L?(F0@MJU%H&>H*$@L2.85"XA&'8F@/"0I3J2`?=#:C+Q%9SF)G]G*<0'% M3@I+2H$WJ0\A:&T!"P->D8EP)D)3SF"84FG`J0.*;0E3)<==24(2VI!09?M2 MX)!HRG@HF(KB4$/@D!:'0M"&0TM2-*2%3U2.K1C,>\)PO).P&*90A:5I6XA3 M:$8K4H8`"D'=1P)P\33[8@D/R4L6 M493#NLHT*4"N7B?JG'%9=4M6E*G`HA2%X>^%`$$\LX4@DNG!B%,MZVQE3:7E)K*%)62 M1[P?;G.6<+(C!`6:]ML76XJ0ZEU2*VL4EO3*:DON_CG_`%\79K`()F%ZL".P8Q()=10#)3$LL!X)#X5I7(-@$*5+'1J)ECSXPX`= M*7:J3X[NLG60K7BV"=(.J7AZ[($+PPFJ<^R<2Y!Y(9P^: M?T(4EIQUU+*W$35J$_$`)`=,I%)5#T-<$KEV"6XI37A-MJ*6P@+2XA4O%+F* MEF7,C+E$G@,$!R'*<`2ZVA;C@;5J*`I0*O%3F#*0(*1QXF)H15+G1*7-I+26 MU>XHZE.IP+BQ@4XSD$"&<`40*XA/H(<:475E(2L)0\<=14/>0>>DX]D2"XJH M=BT5DR:;!:5J\1E#>E8=7CH4H MZ=!E(D*!G+LB8EP7P42<%ABG@D-LK6VX'"5AM2TS!;2H3)`SFHX3R$2[!PBI MQ"*0E*0XXVZAY;:9I`24 MZ`HR+LE'WM/#E.<30!QBI&I14A:5)7J).E(&KQ03D42G.&B7H:I M9*0RA"9+;=2^M*5.(:TJ25%(GJQ&.@8RXQ-,BZ"2<63+;CA>;Q+@60DH4HR6 M%X&>>('J@B25,F9\E*0PSX@2'DN%)5)F1!7HG)!49I&4C##2^*5RU!11P^]J MUZBI?B3*3JD2HRT%/*1E$:BZEF"DJ88+I0:A")N`*04DZ9RFT%_A..`,2T7Q M2F1:BC./.^(KWBV4*DEL3TMA&"4@2Q$A[8@R8\$P%'3[C3162IY+"W$I6MK2 M5>&I8Q,\A,XRX1)TYT4`RX)#ZUI<4VDEH-A*6TI5DF7NK!D`2O,]L02Q;`*0 MY3BD)6&W774LNN-A2DE)7KT^[XN!&DJX@YRB:&I+*'(H$AXEM2&VU%+:&TE! M"C^U"YJ4\2)`E2L.,@("6HH`)QQ2M(<::<>=#2CJ0%*&HO(;(`60G&:`=,^, M%"*ED>(8)+I+26D-+.A8+GBIFCQ5@R(&,P$)X<("6`;!3B:BJRD!YD*><+6A M90VZH%6H9J:EF=&?9."A#DYJ""#0(6/":1X+FI+KAUNIFDE20-#/-(X]I@)8 M4]:G'$9+#?[5IQ+J]"&E(6E]4U:"H&;4OQ*2L8R!PE`""*X*&(-,4H@-,J4P MZ'"IP-N/(F@M)EJT@'$%1XP4`>)JI!)+2"PP2\'D.K/A!'B*>4HDLJ20$K$_ MQ!6E($DI4@LI6HA3I"IDX8#TP!@"07**DL0 MP6*=2W%EI1*VUH4'-2I^&E(U>+,X@H(],X@&K'!$@P<);;;:=;C;J'W6FEN( M1I*03ID7)&<]`,Y<(D-B"Y4.30A,LN.*=;3-3@\0+" MBM:EC]F3,*U'%LIX@`D=T1J+J6&E2#3L>,6_'22')>#I5//%HK)TSGA,PS1U M,Z'EBR8\1=2RLA205)*O&2DR# MA`D00<)\8"Q`,BQ144`HD/3:2RAM8T%)7XJ24EU9)2HF66@2$H"6###WH9ZI M03XK"5O.!O0X4)>4-1=2<2V1@3HG@8'!#R*C#`)*QX+*/!3-)4IO M!+0&:0D&?;`2``V'%2Q)JLM#QFG"\YI0VM!0\J:BE2\%-+Q)*07P3"'WBM)"E M.*4H#PB?=63@4*'(PHE5,U%(%.SXOA^.D_M"GPY$$RF?"USEB1*>42T7Q2O) MJA1E/.ZBO46R%R#8,DI*5:0V`1D)2B-1=,SA2'&62X07DLE1&MH))\-2I%2` MJ1`&.'*<2=+XU4.6917G'4NN`E32&_<#844A"`#I)EQ(,\X61:F"F(<.GGD( M5);CR:=QQ`6MLH)$S@%X`RU2G*`MG1`)&"8>*FW`VE10A#:=,C+Q$''Q3VK) M]$+*34&"F(?'%"DI4EMQUP,K4@YC7XJ4F27=(E*>1YRB"Q#E23(4"0^?##2$ M$^$I.L.#`O$D^_V!,I2X1$BV&"(X^+%)]UUA*G7$MD.+0VXHE1=2)'$#$E!, MIQ&(G`<0X#*79$.XK@IP-!5)DE#3CC2PXKW4E: M0I)92J?O"8FHJ]D06`H7*'+UHF&E%PK;6I2FRE:RHXAO0,%@RD/MA07IDF(: MHQ6$H0E#JVWD/.(;)2$H(*0?=4YB>`.$105%4>(EBH[*W%NI;4I3J'"4*253 M`1*:E_[A.,X0$DIF8/FA#3.O6A]NI6D+4VSI*?$*4D@&<\$YGG*(IQJASPHH M:'W"XGWUN:EA)053"@HR((.6!]$()%^*8@)?@L%W0*A"P'"`T`?>(G)O4<)3 M$NV!HNSJ'+.H)><+A5J4%:S[@)D#J(T!)QD)RBO5(GFG;U)2V62X`IY+9)&I MJ2IIU'WDA>6!5Z(DQB[$J`3D%$>==2ZL:E-:"4)2DX)2DR1+,3*0#/C%9+%. M&(4^@;;_`#2WE;B&%JK*)2VI$E*B\W,\O>S],1(`U-"@%)N#+J;I7N.-N-(; MKJQPK(E^&HH[=2"X-333062G6D'4@KFG5PGB<8>,@3 M@&4&!XDT2FZ5\K"5-K2$KDIS-*0DS+FKB)"8B1&3J20W-2&ZQ*G=7@ME)6"' M/^-*9R\7$2URQAM8?`,DTY.4KX.I4KW6U+"U'2[CI4E1F%DG$"6<,8EV"74% M(-4C6),-O>&I*2ZO!2R@":Q(2D3E#:@"ACBEK9?<4MQMM;[3DW&U)`D0K-!R MDI)PB3$DN,"E##M"?4^&M+);;?4R@(6MP%4UYJ;'-")RGQAG:F*#%ZBB6ZAU M^3[+9<2M(&E.*6BB22UB1@G,890S$U&"@,"R=+GPZ4,K0VXM.I2@Y_Q17_Q: M>T#/OB7:A01J\0P2R%U"4.M-S"1X:VD8AE29D:0922X,>^)-<%'RFJ<2I5.V ME+J$K6X0[X2\0TG%*28*D.,-@E*->*'4"8GK3@>1@K(/%'RFN"4E2Z1H^,TDN/K24,.CW4H;D5. MJ3C)9)D(/E'BQ*EA(T6"M56T4,M(0XRO7X+4Y.H7@7)'-;9S[)0/J%,1DH;2 M0^"&_$I$../MD%T!E##D@EXB2U+6D8Z&QZ28/E!,@@G40`A+IJFW&&VD,NC2 MXA#/_60C\3$H`#'Q2")$2I%9:J/B`NF2RS3K>;TMK;)&IQ/OAI>J7N.2([#`)"0 MT@,2HTL7R266GFG$O/(=8;8!=4H@`D@2$2)"E.3ERE!$$%S0(D1(:1BEMU: M%J+?A,T_BI6T'6A)2%.?AQ(P03@J7.`3!+,`Z#%@[ND-4M4EQ!=;6PVVH+6] MA)"6R"I25`D2,L.)@$9/P"DD&@Q2DW!OQ=:J=IM"EJF\D3=0E9(\8`@)"Q.9 M],`F'P':H,*9I'P59XFCPU2U$!^7[.4YATJG+3+&<1HD[9*=46YIU=<@/%0I MV74I4G2XI,G7$I`3XAEAK.F8$N429A\*<5&@M3%-.TU4MU1;;&IM/O>`MK-$@<&U`S$!!EXHA2/#22"[\*TVRZRVXZ2IXM.@GX<*F$)(Q( M<:U-.4[8$FYDK0ZF9!T+$YSXP%Y!XA2& MB2"Z`I5(R0^RE:WUI4EAVI3+0P6V[[H<'-:2)*GCR@^>-,1D@-$UP6$:Z5IQQ]H`ND--L.Y.:9+4M2< M3I0,NV`/%S)26E0+/B_%-N,MM(:=24O);:``J$IFE0).(6W.8QD8`=08``\E M!&DOC1);2[3!Q]]M2$A!;0A0`#RW,$H5C(H$IF``CQ2P4R(-(I2'Q4!;"6FF M%N(&A3?N^(I$E!I<_P!5^923K5*8@,P^`;BHT\72'&*E2U%#: MG4+5-MS^NE>(4HDSXXP:2],$P(%,UA=4E*BE+++_`(8"/$<'O.J1@J7(`B0B M)28LP+(B'#U"34-O.K+S*%O-NC6A8&4\"@@D2*")0[4*0_3MJ<2M`2I*1@RM`D6 M0"0$CBGACC"D&0U!./#0K"G#3H2RXTE;F#JT.B89UR*6$C44B:I83@)8,:E M*SGDFG/$J4MK:1,(!;6T@22T1[R5)'!+@/KA3XA3'@F%"DZE4K>AQL*<=6I0 M9=$PA"3+7+@M?U1'RACBAGE0I"RJH;2&D`*94=3+8P*5Y.I'%292,XCYA08) M@-!X\T@%=,A2GF_>>(2EAS$*T8EU8!R3@`><*VD50?%*G!-J6:EM3;38;<0H M/!ML8/)&"D_YZ9X#(Q'S!@SJ0""Y=-I#E,''GFRD%/AH0J7[9:R)@C'W$C$G M.(8QQ0:T&*:2_P#$)6PAMMIUQ(*='N^)X9U%M4\R1.0A7<-AV*=.D@XA-LH= MISX[K:VD-!1.K`N3FE+8E.843CR$0Q%2I)!+)**@.?L?"9IE/(6TAUL$%"CD MDX8(61*<*"Y92Q%\1++F8324VH(76-^(7/`;T!S4%F8>T@R"\)C7+&4+K#NR-.574=VDJ=2@A M#CFI4TNA,DJ2LA07,2D)'&64*8EZ8)P1I3;E0E*U)2PU4:)(#B_QNE'NDD2D M,1A`9`'`%D"/:I5"R\Y=:!YI#CS3U=1N(<`*IA3[?NJP$E((EZ(KD)$N*@J0 M0`U'3=2ZZJ\5R,7=5?5H6E2CI4@ONE9429)`2"9P0)U-B@@-P26$4?C(\)U; MZPI1::6V4)<6@$H1XARQ$P3@90\1!Z$NE)D1444=A]_QPH*6IY3@]PJ.E2U+ MD6R@'3QEV0.74D!E8>#0BH*?&7B[+P=!#8)/^B#TL$:L"8L`AJ9ZNEJS^U-. M/OAU1*UMN)69-A2I(*3)*0@$!0$N6,+J.JM*H8*>ZW1^-^U>6PXK07F4("VD M.*`+B=629_\`!)BTB+U-4@,FXA-U#BTON)UK:#9"$)2M20EM(&A0D0%:AC/C M!(EVR4@!GS4QQ+"_#0PJ'2:E: MFW$M();90TV6="RGQ4+2%%TZ2)E:CQF1$R+%A@I`!%<74B33K3#M4M33BD+2 ME24>(IYI!`0X1+#3.4\=4/0Q!EBD)()$<$JH66TT[3"E!@M%SQ$DI+KA)2X7 M)$$+21^$Y0&@#8*8AR7Q3Z-#M,A54M;>AU3;#J05J<1(*<04R)TMJX\X:A'B M*@D@M%9=4&:=KX92EM..+\6I)\-PN)/NM*2`%)T(,^V&P#1P48RKBR<84ERG M<^)6M#3;J"V^"5+\10DID),RM)2)RX9Q(J*FB@T-,4X2VW3K52N+<"W4MO.J M&A;:=.I"0F0*0I7'G$X1>)4"LF.*4PKQ4/H?6KP$)2ZITS4MEP'2A2)SFI2N:'$+<.E39! MUJ4I4PG2,9P`DEL5)##@G&4TOBH++SC[B=:F6EMZ$.N(!*0%'.68'ZTH:,8O MX2Y1(R(K1-,U#WC(T+6XX7!^S4I0"U*4`I!224I!GCRA09:@5/A;FI(:H/B? M##ZU$O$)9*)-E0.#?CF0(\3"?HBS3!\4NJ3*(NJJ/&4K6L.^+,MZE:4J"I>' MHF!*>$N,(\M3YJ1@V;*8\BB\<^*\MEQ2T>(RAO6VVM025M^(```"<>4,8PU5 M)!4/("C,H]2\^*AU)4ID(5H"&UD(0VD#PBD)(2L+3(SE[T+(D'@IB'#J0\BF M4I+E2ZNG?6TA;S3386`HCW7%`":5K0`2(8B)J2TB%`,@[8)FK<<;=\)M10RV MTV&`VLI2MHHU!TE)`)<,Y\LHB9(+8!3&HXE/*2PZU3N5;JV7EM?J-APNMI44 MMNK&&DD8#^M**RTI#U*KXM:TM-O)#-1_I5AQ8FXPE)FI8TB9_JS@'BCX\`@T+1Q65EMFD)I M'5K0NH":A\@MN(DG4TRE(Q2A6<_UH"PAX<\T5,FE@DTZP\S4)J%J-.G0X7U3 M6MAXD);2V%8J+H/X>R<$7((E\HS1)@QCFEGPF:=]=(XMYSW$.N*3X:V&5D@K M0D2,E$2*@<(F@B3`N4/)P)8)%(X7"ZTXM:Z=;*E/+4X3X(1BAU)42$KU82&* MHB!=Q(^%D38$-BG&TL-(?=I7%OOMTY4D.MAOPT$I2\\E.:RVA67")&D`F!>3 M>A07^M@F:-YQQ\-%1>;<0M#R5K44>#H)6X2HD)T#&<1`DR8U!1)A%Q0I^G12 M)I03(T-`HM-45)?9T M*4ZM;@2&E+)0ZE9]\%!]T`IF>R4+&4M0J2F(#.I:&;>*D(0^MTAU7ALJ;DRI M:22ALO2(TZA('C#@6]5#G@EU2;"BA?%U'CZO$<#_`(T_"UJTAP*_T.C\!$_= ME*45ZIN^;IFBS#%E.<8H#4$./K947$AUE+>II"U$%;8>E+3J)!/ZL.1;U5*4 M&;.RB5%14"H>*E+84VOPPTE2DI;2W@VD)!`5[DC/C"S,A(Y)H@$8.I-0BE*D MJJ7G*9]QMM;S++?BI;4I`))*1[BUB1(GA#R$7\1(+52@RP&"9K'7$/>"E2FF MVVT(82VX0"R4!27)I("E.3))A)DB3"D6P^XSDTUXG MC-H)2T\L`30I2<@`EQEP**2\5G]HZ MLI*?>UB6G]6(D2&`P]Z(U)?%.?L7J6G,S4HJEJ\!LM MN!\_M'&7C@$M@C4LK3FGD)P1K$B1+<42<$:<5D^"U2ON4;BGE%2&W75H\-;# M1)EI&!DZX)%7")I&),27SY*')DTL$BE<4]X[;ZU*IRR5O*6O7X!09MNHU:O? M*C*7'*(BY<2^5E)I\N*<;%.TW4.TKZWWVVI#Q&_"4TVHZ7'FQ+WUH&+@UJ5_I=4BSX?X9!1T MREE":I:G>J:FGDI:V:#XDH6^XVHO!*V4M@LI<4J2F?%*2`@K,I$=H/4U],T MCSTJ(_4OBH="U+96A9`;"B`WH,DH2D8$2'IA9&3OS3!F3SZ*3Q"JH>44D:EE4YCA"3+%A@R> M+D.:I4V7*=ARK<6TOWT-*2DNJ>92?=6L$>[I5@#C.)H0#(I:@EA1,/+#;5.B MG6HL*UN!X:D*=>)DX%RE)38$M)]4+*@&G!60\1\6*2"VY3:ZIQ;:4/E#+P!6 MMR:9N-Z<2M+:N/ZN4`K'Q<5!#2.E-OE+5,V:5:U-NO*#CYFVOQ&TS2SI`!2D MI,_\H0K`#PFBD.35-LJ#S+Z:A1#3:VE(?$UN(=5[OAH!G/Q$8D>GC$8Q+X.C M"5!5"BVW2NKI%K=U+;0\\I*FULIF5("1@=+BC(JX0M`'BF#F0!4>F<\9#[;J MU+ITMZUN*45EE8P;4C43[RCP&<0"[ZL%)&DAL4)%.TW4.4JUO.H:2%%:/#++ M3A*5N)$O>5APQ$101)B7*AY4?!1J1:G'2TM2G67&G`^%+*M#:0"705$@*09< MIPL226."<@##%TII%,@J>+S2$E3_B*T+0M9DMM0/B$E15HDF9GPA(DZDQ`9\$^VU1!Z33RW MEH*_"86WI;6I,RA/B'`@8`$YQ`$7IB@F3/@%7IJ:DO)4''%.J<_T>HR4I2@% M(TSD,<.ST17JEJYNF8)Y;-`:K0JH<_TH26PF;043BWXTI:"K"8AC&&K'-*\B M'Q5?4U%3XRM2W&W$K($)4`@I5(-AO5B``!VQ627YNK0`R=J&Z4NJ\5YQAU6 ME3K3;>M"5K`*QXDA*9Q,LIP2$=52Q4`G`)QAUQ%XH6]192W74;;24**0EM+[ M92I)F`K5G.$D3J;)3$!GQ3M95H0A1(\08:0Z$F9(/.+!,/A1+I#.'2_RNK4OPPD*; M*](?U"1;S\72/>,D8GC.#IS?EQ0919/_`)@GQB4T[#C;:TA+K@/BK0B2?$)D M1K,IB&Z@?"GM4::>C):[=5.+4IA)>;>)<;>4I(U)=]^:@53*DDX\Y80VB1K& ML2HU1%)4*=T2'^C2K!(/"&,FHSLH`>IS3K MM*_4*^)ID%UJH2'9*6D*0N6E3,B1@G3AP`,282D=4:A*"!0Y)QQX4B6J7PFJ MA;*`'5.@G2MPZRVW($I0@&7;PAM6GPL"R*2J]$XIARM+=53I*@MH(>;U)_8+ M:]T(1,B3:@9@<(EC/Q1"5Q'PG).:_@666'&FGGE%50ZEWWD,E1DE",QXBDB: MLQ#.8AC4^Y%)%P6"<4ARO::=IT^^SJ9>82=*&P3J0XT%`#2OB)SG$L9UB$`B M+@^M+FJ@:T/-(=>J5A08=.MIEMKW0XH`XK=4<",><3\@8_,5%)5&`2R%W"GT ML-H;?IEZE4[9TM.-.F7C)23^-*A(G.&#SPQ"@EBG$("/<6E8)Q M6E*@0,,`Q42:)U$T3K;#E"ERIJ$:=*%M,M%25)?6Z)2<"21X0D3WQ(C* M#RD%!,)%HK+3PJTN4G@LTZW4`LK:!'BNMG7X+L\="AEVB)B=;Q9B5,AI8Y+- M/2OTRQ55*%--TZ2Y[JP5N.RTH:D@G!95CS&$3&)CXI8!(3$T%2G&:M+ZBPME MBE%0@LAY@%*T.+(T3U'_`$:E8'G.`2!+,`Z"&KP26J"J;=0NI!899/B.NI6D ME(:DH:`DS!41AR$-&!!*4B8.4-U`).P;VJ=%'>J%VZI6LEE'C-. M*"VGBM)U(I*BI6JIID*>:J`'4%2P%)4H26TK5+_`$:A M(=D1*$I'5"L2@2B`QI)8>J4TA12!EFJ53HT../C5I=7[ZFVR)$-MDR^J),M/ M@8%D"(EXGHLN4[U=HJJ9LK2ZV$N-ZTCP76@$*90%$3:`$Q+G$2C*;3A_`@&, M7B5A;OP+;-*MEI]Z2GG@[[R*8O2T,H`R.E,U&))T`1(!/-0`)%PLK:=N#;3] M,VGQ&A\,[3I4$H:D2M"VM4@&W$G+.>,!B;H$HXY\D`B!(*%%5O92T\TAVH?7 MXRV'#J:9:;!0E>$TEU:CACE!^[BQ#DG-!\9I@L@+N3"?`:2A^E40JF;(0VMA MT@^,C49!:5),YFJ5);:IG%!;90T0XI] MT))$@2`GCC``;0>6)R44F:8!82HW%E=.TTTS4,K%0VRU[C50F7ANS&1=0""" M3E`YN1TAA+&F:DC07/R^Y90R[;TO5-6V$S1\.Q3J4%)J5NXJ\0`D>$VA,^HTLM4SKB4N-%D%"7G&/?\)W,@*&6.8A@=?@8`Y( M;202[)3-*_1*-95I4PVP@E*=:2IYYS]FVT-.H:258SP(A8PE`ZYX#T9!E&7A MB7*33U2*A2J5;%-2_$MJ82]3I((63-M"YG%IQ0"2,,3$B8EX2`'4&+5Q9#-! M4LN(?JT*IV*>;SSR5I)'AXA""DE6IQ4A.66<1&W.)U2I$(,H$4Q*PS+$R6PZ%!^1^(+8('C>( M3+Q='O3E#=4.[!G[U!C3-87::Q2UI:2'F5J!:?*T@+:<,PZX"K45`*F99PIL MS>GRE3K@!7%#UP;0X4-4S-2A@I:2^ZDJ>=+!"5*QEF4$)GRB3<`-`"!QQ*!" MCDU*R]05+[JJBE0JI8J0'VW%+2%?M!-3:]9!);5A/E*(E;G(ZH5!4"410XH> MJ44I12!FGJE4K8;<=?3J_:GWUM(('NM(*I2D88R$?"`"W%2!JJ7"R[3/UQ36 MTJ"ZAY`"TE20IAUKW%L>\4S0D_@EPA91E-IPP(]2AXQI+%8<=%O;:I%,LU+Z M`IU\/36BG<>Q##4N(2)JQEC$DZ`($`GGS0/%XA@AQEVX-LOTK:26P:=ZG2H) M13K1[R5-!1`\-P*RSG`1*X!*`Y$(<1.DK"E*MK*&GFD/5#[A?6P[[[3"$`MI M(`(_:N'.1EAV1/[N.F0!D>.2*3+C!9DNY4[9IVD(>I7%(72MG0T$/'4EYO5A MJFF2L<8@@W(^'YADBD#R*-*[8RM52TE;U4XE#=*LZF_"9.I3[H!D5:B`F1@` M-J/BQ.10XF:9+(4;BRMEEIMJHIU?$(99]QI]L@-K)U&7BMS$CR,N,%;@T@`2 M&0S4GP$$FBPAEVW(>?JF@"I/@,4ZE`H?4N2EES1/W6P)R,`$K8US%<%!TR.F M*PV]\>AZE0TU3/*2EY@,@H2^MI4RP[,S(*3,<`>Z!]8,&`/+-2VGQ%#5*]1: MJNI;$#*"$-ZD:GWG9MI9PG[A_6[!!&,H>.>`42,3X8K#-2BI*Z4L4]+\0T6 MT.LI*?VB??0A?$M+*92PQ@$M7AH'X((;Q9(9H:AAQ-34H+#5.%/.+2L%1T"8 M;1I,]2SA.(C"43JFXB*J3*!#1J2AFO0MP(:\8%"2#*1TE4 MCSB1-RQ``*#!J@U0BV527$I='AMH7^T?"A)*$$DN(`.K$)PY>B%%J;UI$*3. M&6*!OL256NK*RA"0MI2 MP$5&I$BTLS#RD$SF$&9'.(Z4WI\O%&H=Z4Y7MH=]RF9?2TI"$O.@J?=\*0*R MH3]XZ<)Q)N,:`$!`@X=TT]053KRG:9)?8?(=0ZM8!4'?>DJ9G-!,C[(B4)'Q M"H*D2B`Q-4IZI33D4R&&:L4R$LJ=?U:U+3BXE/)"%&0'"%E(1\+`LH`<.D5% M,_5N?%TR%/-OH"B"H!33J`$+8QD-*=/NRX0&,I^*.!0#$>$FH277A1MM4G@L MU#C:5*>+WOI:<=DYX34L="0<>$XB1T>$U3`"8<&B2MEVX):J*=&HA'@/,)(" M:=3>(T`R`:6%>O.((,P)14@QB3&13:U&WM(8=:;>?=6JH<:J/>0P@CPT!,C_ M`*103B1$$Z``0Y0/'@?"D+0YZV\TX/#6H!7X76U`9\,HCYPT14)OEJ<"D);=M MS;K]0VD+=3X##"U`H=)(*G'`F84A`3AVSA6-L$RQ*"1,L*`)"5_&H>IT--4[ MTDO,I9]UM\M3U-N$_A,C,&<*^L&(QQ102$B4TW3O4?B5=2DMAM!2TWJ2?'== M]Q+:@DG]E+%0.<0(F'BD%+B7ABD-OIK`NE+3-,I]N3:V`I`4Z@A2&E)/XD.2 ME*(U"7AH"5(#5=TTS25%.L5-4@L,TP+RBE:%*4I`DEE(!G[Y,IY2A1&43JE@ M$$@T%7335:AU19<89IDOA32GJ8%#K9=$@H$C+49&4IQ&IRQ``*G2U07;BFD6 MRJ;='C#PF6R5.OI4DA*&S-2D!)*IJEARG"].7UJ`9IM0RQ*Q^9-^/XBJ6G2T MM9FXE)%0E"YI\1*\`'1J"B>^%Z@=R`C12A-%&-IK0O0E(+6N0J-0D6@0?%DH MA4]&/.<0;4W;)2)ADERX-A]:D4[+K2%8.K&M]Q*-(+FLB2EJTS23*7&%-P.X M`93IHYQ3+M!4N.+=82'V7SXK3Q4!J2[B->HZBI),C"RMR).FL2I$H@5Q4JCJ MT,W6VTZ&6:@4]51,J>=F5+6FH1KTS!DE),A."4P/"`"P4B+^(YI=4U1_G%>: M5YU^J35W!=.R\T&VEO)=<*9*E,E(F4#]8B(ATP7B29(EJSP5/1K>74,!I2G7 M5.XH4LR7,J\4.`J("=,]7*(@3K`&+J3@>Q6C+5L55I2W4/.*#Q#;"V@EA3B2 MK0R72G%K6)3R(BV(MZL:OW)'GIP4!#M2*H@+6*HU!]S63)\K_`4DRTSPE+*$ M>6K])U+1:N"MGV+6*M27JEYE7C(\1EIO6PA9TEQ`>D2EK49'^K.7"+B+>JI8 MO7@D!N-0*-6.NHK'_&4IIU"T@(0L@(2F7@!H)(FG2!*69A9&0E6BD`:12BLJ MAJBUI56OO4]4IIM=4TRSXB0X4)*E%1$D+5.:APY19+0_B+2:J0&7U11,7!11 M4*:4KPF4--II@%E*#3%$T+0J8U%PS*CS@F2),<,DT11QQ4Y::9;=*NO??8J5 MTH40VR75.L@D,O/)()0ZI&$N(AR(D`S)$BJ_$"0`\735>H-"E;:612&G2JF6 ME9272H_MW%R*?VY5@1P$H)%F`^5J)HAW?%3$"G714JZYYQI4W$4SC:/%<=IA M+%T$$Z$.3TJXY90]#`&9(X)"")$1#\>216%#5-2?"N*51K+JB^=3;CE4"4K# MR<"VIM&"4Y2Q@(`B-/R_%3&I.H53U-X3M#KKG'$,HJ--+4(`<<4LI/C-IS*F MT\>"50P8Q\18/100TVB,DM_PFZ(*I'7'*=RI(JGW!X3R7$I`894``4M9D<"< MXDL(>'!ZI16?BQ:B51^&[2U0J'%IHT*:(?!4ZXBI*@$H92=167$?B'+&)C6) MU?+\42#$:?F3W[!NBJG*!UQXZVT52W4%EQJF,_\`1:92;6Y+6KD(;PZ288Y] MB4N9#4&X)N@4'DU:'EE5**>I_:I:+?HLK1QFU"K4ARI>2KQTI<90U_9DK)`4R'].H-:\)S MP&$6$6M;$G'#)1XQ'"BK:MU]-4^'E*;?2[+PT*5)!20&4-(24@H"9:0!CZ8K MF9"1>DG4Q`;)E853=!XROC*EZGJEI:75,TK(=90\I"2Y->@Z5*G-0&`),6R$ M-7B)$J)8F34`,5#N3BVZMQ#BO"2VAM+*$.*#?PX'[);9!&KQ!B3SBNX2)-EE MV)HU'$J8\BE4BF77U#]/6+I4%Q#+(>U-IF&7704D(>6W^KQSBPB#`S)$R.U* M-51`/%U'N2@TNG;0LHI!2MJHRE92EQM8FZZLB4WU.DZOZN`A+E&`^1J)H\\4 M_IIW*.B=N#SK+I2ZBG6R@.N/4J5@-J>20H@-DD)5Q$-X=`-PD'WA+XA(Z!1- M5Q2TQ1"G6HT2TNK0]_HU.U)4`[\0`0$NA,@$9`90LZ1&D^#XYIA4DR'B"4P& M';>A=<\XTRFI6BB?;3XSZPI.M]E*3JU,(4)S/X3@(F+&V]PL'I\5!<2$JU4 M5099H&C1N+73.U"Q4OJFT]\0A`\%IU*=.EI*"2DX`F)DP@\"3$FIYY!`)+<%.U05"[>\Z\"\TBM=<1X+[+$BMM"4!(/@N.#WE3[(DZ1;)MDFM$XQ2K7*H=8"4C6M21(G-(Q$.-.F1MDF3>S-E!U M$C4&#J+:U>*^XT5>)2JIG#6:W"4-TZ1/Q=9*]+J5@:)9F$M5DWU&KV<4TV9_ MK/13*5%&"ZNWU+U57-TKKE,U4M!D:]("EIDD%3R6R=(YPT!#&V29@4<)3J8: MV$5`MCCKE:PAE1>+I4EQMQ:E)53*22_XH),@&\9D?BE"6R3,`5^CFFF`Q=6- M(S:C4H%+5//OI4[\(S4LA##E0VE7@H+FGWT@I]W^L1%D1:UM$DG+AR2RUZ:B MBJF'JE56UH6XNM-0)-J4J:GBLAQ#C6H@-B9"A*03.*XF>NCZW]J&/A/$*Q-@OZ?]`7<"9Y81:UG6Q)QPR]?!*]S3ADJJI>J? MC7O%<6BK%006T+4-#B5`-(;0%)FB6G2.((YF*92EK+_,ZD`:?T5:UC5K^)7\ M75O4KZO#-4S3M!;#;RT(+R?%"2I*E$G4!^'.+I"V)-(D2S`&"4&;>$/'(JON MCCB*VH0^KP?#"$-(;<4EL4P2/`4U)0U)6C&?%4XKN.)D&@&'9DFB(L#BIM2W M2*\!RXU#U+7.TK:GT,,^+-/O):<=FE6FH4U(*'&'EIH;A(FV0]J6.ICI`(?L M]2BW10:=9:2O12)I6O@5)\XRA-0XW1/-I\5UUO3-UM22%380L>ZJ>>42&-L&X2`]/3@BHE MX*EDBK$JA851.K72./O?$OJFT\:E*0&FW4C3H;0T?='ZQ,1-A;&@^$G'GP1 M%S+Q?.V"S2>$[0U!K'7$4C;[1IWT`.NBI70/.NMJJ&T5KKB/">:;TZF$`)`*6%N?B,\3G$G2+9-L MN'J@.9`3&2:H%(>8K4U#BA1);0X\\%%:V*A*P*;P`HJF\K41IEBF(MUC+7\C M8\^2DT(,?G^"?":9NCKG+<^\\^AMM+RGV@RXS2K7)Y;("05:I2)&($2!$1)M MDDMZ@E+N-88*-;5>,Z\RM872&E=-;K65):82/<=2J:O#>2Y+0>.(A;9))!^5 MJ]GI@FF&#M5U*IT4B0^NWU#]36HIW%L-OLH:X`..M>[I6ZAI1($-$0J8$F;* M):BPF&BZA6UQ;E8RAM?C)<"DOMN.E3:J8I_;*=)*M*4(QU9@RYPEO49`"OT9 MJ9``$X%3Z1JV^.!25+M14(#II6*AH-L.O(2KPQXLIF1Q3/\`%%D!;?PDZL@> M*4ZFJ**LIW:@U3/A+<!:?C`V*IP_P!H`0SX?]EUA9CA15;[ MM0*IWQ%K36"H,VPM4TO)7)"$(21)($@D2_#%1,M6>ITS!OT59U#5M%2M-14. MLNE2/B6F&PNG;>6$*=0'`D%*9JQ,Y"9BR0MZO$2)9J!K;PCPJLN+CB*U]+BO M"*2`A"%J"$LH3)GP@%)U(*9$9(FU5`U"D`X=0[F2V^AO5X=,EAHT92LI2N MG*$DN$S&IQ:YE>>.$+<43XRGI: M3XJ2):?U1"S8`"/RLF`J=0JG`&'*&F$P&LMP4!Q(Z0F:OPFZ.F^&<6JD===6X^9LN+JA_Q;J4Z2WX30]T92[86 M5(C3\O'FI`4"'V6TG5K:4D`JQDDQ$6, M#JP>B"^H:15DFH#+5`I=$ZMUE=2$UKJQX3Z``"PV4B10PI1GVF(+"'@-'KZ< M$P#R\0JR8HREVGKA4K4*)"&UE[%QQFIU'PO!2=16XM!(*1PA0QB=7R?%3(,0 MV*6I-.FDK%T#SC[@#2:@N(\)UBF425*9"1-06K!1SD(*"),"YS[%`?4!(*); MU!Y50AQ9-&JF<56*4X2&TH$VG6YE4GTK_#*4\82-7'U6JG(84^9/-II4IJ5V M]]U^J;I5J0'FO"*$&0?=:$OVCR6YR'"<`$0#H),F2EZ"0\)*@6Y2EU3:$$.M MN-K2^E:RIH4JD:G%K))"0A,B#G.$MDF3##-/)M*?I6K?XNJCJ'JFJ2VZNE:J M&2VVMQ*3H.L)DM0&*056,%I2G*A3LO"6LR62 M3XR'4$D!.F85,>[%,3(R`&+JPB(%113&V+4JL2ENI<<4'E)0PX@"F6L*5H;^ M(T@>#KD)G.':UJ9ZOW)2;C5"IG'J@U)FMP58J<6RM0(?#D@WIGD#@,)2BGQ: MJ_.ZL:.GDRL'VK7\6M+U2\VXI:/&9::"F$.J*2XVEV4PWK.,LL8>0MZF)J_< MH!GI=E65[CR:JH#JBTZAS2EMM9`;;3+PDM)$@4Z92D,8IF2)%Z%/$#33!7%* MU1?FUM76/NL5BZBWN5+3#7BI#JGF_>4922XM,M21D<8:X(/XR1-J]JB.KZH\ M+T6*RUU+-VKJFJ06Z>GK*NH<4VXDK/A/+6AI&@E0+BA*?`9Q`MRB=4@T17%1 MK$J#$J(Q=W%O2J&Z=+3Q4TM3+"4OM)>FG4VZDS);GCS[X<7235F/!!@PIB$I M-CJTO:'DI0PVJ:WTN`J##9U!Q+:)KUJ2F8&,^!) M"E+6OWDZR@RY#&&-UI>$!@D$7#G/U)QZVU-2LU=(A3M/6)%0TIUT(<27<5-K MUG40VN8"OZLH8VYR.J%8FJ82A$,<0G7K@Y0J%`PEET4:`TXY4L:U%T^^OPPK M20P"J21E(1)F8>`-3BD$=0U'-./4M1<2BOI$>(BI;"7&UK#?A/-$M.-H\33- MHZ9HE,#$0QA*YXXX''M0\8#3(X):ZAVUI:H4)96ZVGQZDOM^*A#S\E!JG"I! M#:$@3()U'TQ)F;8$`Q.;J&$_%5O3%..,/W5#%8PVDNMA5)5-ZDMMMJ;]]MQG M4K2&W$+Q&8(B=,KH$HXX'\B!(0>)P2BX_:&44^ELU=0LU+J'4!UEEH#PFDH& M"5N+E-1!PPAG-H:::BH`%PO72$Z`_=Z="VT(-51K\-YI/[%A33P*FW6DGW$. M!2=*A^L(GQ713YA\5!^S_5/K2T^/:&2IU"?B:M82AI4G6$,L3*G5X^&IQ:E` M)QF!C$A[4:MJ/>C]X:$L,TI+CMW94P$-BJI5BI90TD--/,KDTXE0_`'4$Z@3 MGD.,2";@:FH501H+U(*6VS46EMVIJ&D!YW12T[94'6W%+]];CX02CPVTIP22 M)JB0)6AJEC@$CZRP=LTIJH>NB7J%Q+275)%13EEL,H6Y3XJ;?D532I)]TG\) ME$B$9I5-7N5I50OAE`K$*9;73T_@D/@:VPX$ZE+864R(. M`S@$S+P&CC+B@QTU!H$MFW55(OXRL06:>C2:A:FG`IQ2FQ[C3?AE2DEQ9D3P M$$83B=<_E%4:Q+PQQ*&+LXZ\EJI0RVQ4%3#BJ9D-OM?$#0E:7$G4O0I0GA-0 MAHW3(M(``\,5$H`8.6XI:+)6H=2'TI:IFE%3SS:T*(:9FLJ:0"5ZEA/NC,$] MD`M3!>5(C-!G$X8K(OJ_&#RF&/ARY,Z60*@,*]W4'YZR^E!GJS)P@ZY=V&GV MLCI-'$O[$E5BKBZIIH)-,IR2*DK"5%ISWBZIHGQ`L)49C,J';$FQ<)I\O'DH MUP:OS);MY=;?(IVF%,,%+31J&0NH<2Q[A4X\5!25N%)D3BF,GQWSXA;I]$D*>>L[+-+H:55/*55U"'FP^RRA0\-IMH>ZE3ATZEJ293PB3*5F M(A34:E_8WQ0!U#J#L*)2D5-[8;>82V:FC6Y3OL@AEGPGCXK+[(/N-K,I+3F< MX&E?B\?G%&P#(<6RTGTGUNL3J+)3R<;;565KH/@NI#].U34__&*2#X:WW5+D M"#-*8/%8C5M0VVD,L/,/_LES!.EM MYI0U3/XAA`\K\=(;6*L*`CZ5!`M%S\JPAJILK+]54-M_$5)324K,P\R0!XSS MU0$^XI+8$D))F3C`!*Q$RE\QH!EWJ7C<.F.`JL-U#]X:>H5(:14@"LI!3H\% MIY;'NN,U$BI(.A4T*,I&",Y7@;=!+$-FV14&/3\6,(.6XHI[=5T+IN% M4<`D01MSMGJ3H(U_)1!G&8T0Q**>[N MU#HIJMNG:9K`JF6[1TY;>;74`MH6E:27%H"R`1+$&9@C>,CIDPB:4YH-O2-4 M7IQ6&K)7-/(56)2S2TRB\\\RZA2_#IIKU,H1-2HJ4^A)!F!,G*#[Q+4Y`T\A M7U\4=&E"7]BQ_=ZX>,&0E!I2[I%5XB2OX*@7(`-+Y@E5-U=I7!1TJ&'6:%M-*ERK9+SKKC(TN+4I9U);*\$B4 MP!/C!*\8G1%FC2HJIC;U#5)Z\%FHM]9<5_F-"V'&JU"7E)==2AUI](\-YB:Y M:T(6CW",-)@E;G<^T@'B1[>"@3C#PRQ"'JUVU^';644[RZ5L_%+J6/&`J7Y/ M*;I]2@4,-)7(2P)R@E7(*8PZGCJ!DAZEJKNABX4C:5+6CX:J: M4L(0P_3'3_9]>!IW$J!`'X3`8RO-J=JH M80W\52*52U#(DPQX:OVK3K"5$MME0,E(!G,`Q!$K\1*/S"A&7(J:6R1+`UYK M)5462G2AQ#7QEZAQ]Y:^!FA(@>5B+%M1.!J&^E%+II M\H'>L3J+W3E#:&Q643OBI:;`8IWJ:H`0IR1FA%0TM,IDS4@P/*_%@VN)[`WT MH;IFORE"6ZFR,.U%0A'Q-64TM,R3XS(0B;SKSX3)"I2DA),\S`!*S$RE\QH! MB.:BEP@1P`?FA#[]X9>HBAE%4WIK*5++89;>+8TN-/RF)A"P4*5@#$"1O`PH M)8AJ`\0?@@@6SJ.&?I[T-4U5:$NU]6VE"D(^'I6TN!Q+[]0=,G_#F$L-H3.1 MEJ,HD0E9!N3[!VGB@D7#H@L,UKUS2[;GDL-JJD?V=;#'A#XAB;Z45`2I6MEU M*",I)(G!&X;OV98$BC4KP/)3*'3\8?&J*>@JK>HU]& MTR?#GI:4I?OJ.$H(VYVSU)X"M./!!E&0TQSHBGN;M4LT=2BG9:K4JIB[1TY9 M=:6Z`&U`I45+1X@DH2Q!GA$1NF9TR8`AJ!$K9B'#N"DLVBL9>2]5H#--3$O. MN-.I<6$L?M`&DH)6"X42&&`,`LSB7G2(J6/!!N1(\/S%9;OKJGPI]AA-.ZM0 M=\%F54AIXE.I#Z5$EYI*IS`]XB`7R9>(#2>`JI-H`4)<)/Y!7^+X)#8IPX4F MI"T$_#@S\8-3\0N%KA+!4'0N:F/R\>7%1U(L_P!995?7`^IUMFG53)7-O6S_ M`&@L((`4JHGJ\52$SG+`F1R@-\ZG`&D'O93TGBSG5[%AZS5SCJE4J4O4SZ@X MR\\ZE"U-5$G-3S:Y.!;86=6&,NV`V9RD\:Q*CJ1`:7S!(J+JXP\::E##C5*$ M4R%U3'B/N*8]U;BUJ(4@*6#I!$P!W1$[ICX8@,*5%41@)5)+GA@LO4%36K-= M1-^,Q7)%2GQ'0A;;BA)QE074,^+_:'!XKB&DK(+;#6H``328"B$-I6%>\@',3@(E=CJ&(H1]"5Q`L<,DA3C M]F82TM#9JZMSQG&W0'6&6&AX:)#\"WW59D?A3A"DFT&IJ/>$T1U"^`";5X]Y M92&T-_%4BSJ;;_9,.4S^2T`GPT.MN)D<9E,!U78T;4#[T4M'-BDA#]GIW''4 M(^)JU!AEE8#K"66AXBWG)'2XHDZ4IG,8G*%.JT'/S%2"+AY!-I>>N[+U+H:3 M5,*35L)90&FG4R\-YMR1(#H!FE2L.$0YNC0/F%>#IF%LB7U2FT,5%H2_75*$ MI5I%-2MZ@ZAUU[\2W@B8\)M"3@9:B85I6@92%?7^S;:5H*@EN:IK*I"6$*(2M^.0H%)E&8TAW*0Q<7*Q?P M=0EAENK;6P':9GPUH=(U-3TDE;)4)*3+(S.$X@3,CHDS&E%)CI\427'%-,VJ MK8=34U:/`IJ754O+9=2XX?`]]*&M!*@IQ4O>.29PHMSB=4Z1%5)G&5!B4VW> MG77PE]MA##ZE-N&G8TOM-O32-#B?>6M!4)F7O1`NDFK`'AC5!AF,4T+'6I=# M;R0AA#GOOI6%*##2BHN):$UA90G!(&!,+T9NQ^5\4W4@SC%(5?72^'O!853) M<"@/!`JC3Y8OZM0?+>.K,&`WB[L-/M1TN9=-+LE8M]7@(\1AU>IIYQ8"U-/' M7J<;40LJ2%8R$S*%-F9+!M+J1<#5^9(?NSK+H;IDLN,T^EE"ZED.U#O@#PRM M;JR%)*U`R'ZHB#=(+18@<>2D0?%W*ETELJ:FZT%92(\6GJZVCJ$*=<2AQ)3-GQ95E*Y5&M9\%2U7#XJ8;4I05\ M25J\5+@U8)U%05P"Y_H2'J"&6'?\`PJJJ7*O\P>\8J%<*HDMH69AT+_9AD3EH M(`T<"(21EK+_`#O_``)@(Z:?*RO*S\G^+4:TU::H>$*[X30:05&A!?&H^]A. M3@&`,Y1=+I:O&^K-L'S5<>II\+:A5I4FA)9_-?B_S$T;)JQ1Z"`9$M^*%#W:GP MI%0&$6RT4-Q];5;TQ2Q$ZZ&TOFHMV4?B&`%!-"*5G\OT*4&U4Y$UJ.4WR[,+ MY&(N%B/S6IV*8$$'\YZJ+Y?D41!,R9?,R#!5,%OP_ M])C@9Q,".F=?R/1L7^CBID^H:?F9.O+IDVQY5K+P:^*91<%5!E4);TGX<30` M!3*<.?\`6AB8](FV^EZOCR[DH?J?:<*+%N6V:>X"K4HVU+32GU)5J<16%832 M_"B9G4J2#AEID8+?RRU?N\^W)N:)_,-/SY*2VJC^"N*K6:DOI;:-07\'D4)6 M0ZNF*)8!0&LYA)G#/#1+I/J:K\.2"^H";-\5&M"PIZJ"U!=!\&\;CJ7-"*<) M)94B>K]N7B`WE,F"T:E_D:OIQX*)X/\`6>BL:(T`34*M2:LW!-$^JG^,TDZ1 M)+ZF`@R54I:)D.,/$P8])^HU']O>D.HGQ_(ZK[.MPU].FG4EU*D+34I<<):^ M!*#\2MZ9.D)1C//5+G"623,-AGV9JR8&DJRMYLYJD&@^+56:7C0IK"D4JZG0 MOP$SD535_P`7/C*<76^EJ^S?7D^"KEK;Q_+FV*K*)RJ^-IA3J<77*J9!"U&: MGBH_$(?3/3HD5:P<`)\HIA*9N#3\S^CIR(B)!P973:MO_F`"55))K"$3E\`7 MO$5H&J7B?#%Z4CW2PBX=#J4=W[G^AU7]KIJS-W^C*D?=K!6N^(MQ%Q%5+P_$ M,_BDN#PTH0@@*05`:1+%$IQ293ZE?WC^U6>'13Y65U6*L?QSHJS5)>\9OXP4 MI!H@_I1\0!DHMZYZY83GVQ?/H:_&^K-L'S5<>J8^%M.7'DJJ[.O"X50J5E#J M5)#2&5J#::?2!2FF`TZD%N129$ZIQ3>,NH=6/PR960$=`;#T=6EZ5I4/^E%H#6!C/ME%L^DXZK]1@[>F/%)#6'%MM#T=0;R MX4U:!J2BC^%85;0VX4M*H2B:74S(!67"H.9R($X2\6E3Y&IV>F/--;^5S\SU M4QU5%\-;E7CXM-::6:#22\5=%K/P2ZT+Q#JD@Z1F4S/9#DVS"/5U:VRX9.D& MH2(MMI?/CFHMV6A#=M%.I2;8:91H3K*5K>+A^,^)Q3_:TN2F.1[X6Z6TZ?W; M4^+\TUOZVKYWJI#:Z0VNB5=C4:0\^FVKIE`U+E&)!PNE6!IDOF2"9DF4,##I M1-Y\2S8MF_)\%!U:ST^_@FJ]3";=0FWE:;8I^I\9QQ6FH-RU?@K"GCX)FWC( MC*%ND"U'IOTW/:_/NP4P),SJ^?V-R2J)RG7:G#*!3_'JJB`^B@*B%*8T"7A!R7B',`]T,\.G(V7>COBW+XJ/%KCU M.[MYJ+9W$JJS_$#\K-8NX!BI_+DU^CX9=0&E>$ M-0!7XQ1,MSS/;%MOHZ_LM758L^#_`$\$MPW-/VC:'#LJ6UNU*KC2"D<6Y6FH MTEMY9]_WC\6FJ020A`;U%9E[LHHM2EU8Z/G?^%^7%/(1T$'Y?1E>4QVW^9(2 MPJJ*OBE_#!W"W*?U*#,SBL4Q?EI)P$QPE%X^[&[X=3O1_E?+N=5GK:&+,W>J M%3M9^8*)<<%U^,_T7B+"_C?$P:")@:)X#"6C'*,^J?4_UNKVJ[P&%&T-[&5[ M5?W=%Q<%2:M+GQ*?BQ325;Q430:E*"1J53AV>LC#.-$_NPN$3U.]6P?/N5,> MKH\+:6SQ5/=7JA%QK!5N%JI#Q"$-.*`0UA\(*4`C4@MZ2B69,4793ZLM7SO_ M``,K;>G0`/E;^%6UQ5:@\D77XQ%S--3FXIM\BPA\M"8*CC\1IEKEEA%]PV=7 MVNKJL';C]/%5PZK-`C0]'5?>W"FN*%+0U2"FIORT-N*2P;>IK]DMI0*9J*M6 MOCJ]$57R1.OR,&X-Z8IK7R/C17FB$OA-/B*I`N5&JL"Q M)-0IO$=F<62-O3'K/U-.7#)^?P2C6\NDVA\^.;$FSF1*&!@;43>?-FQ;GR?!+XA,BVV%7X\DS%&:Z5Q M,$S$67M/HU5?'EW(B_4\?S-3AS2+8XRN@N/QQ<5:TKIY+0LJ?3<5*'A(I"29 MDM8K!.D)QYP6R.G+J?NJ=K\OBB?SC3\WL;FG5*HQ;+BJTFHU!5,+BJI(%0B@ M5JDJG*)@4_C8.G,9Y0/#I2-E\G?%N7+B@&1N`7.[@ZCV=Q*A7AY15:Q1*5<% M%2EE!G*D+&)G5J=_"!B1W"(LGYM7[IJ_!N?!%W+3^\>GQ4M@T(9N"K/\6JX) MHU:16%(6BEU)%:JCT`@OI;.(SE#Q-O3+HOKTY\,VYJ):G'4^5_;S4&RNE59I M;<0Y3?#/_F`<<6IE-O#>IU:SJ,BDI3H)_6,5V"3/]!B_9Z8)[C"/Z3T[5/H3 M:_&4;9\8JX_#5!H$UVCPB^&R4A(S^)T3T3S,XLM])_LM748L_'Z4D^HWVC:7 MJRJK6[4&XTGPRRM];TEH=4K26_>%5\1.92V&PHKGD1%-J4C<&G%_X73S;0=7 MRJVIC8?CVTTQJR[\0X*3QY"A+X*_`"B)'P"N01/F(NA]WZ@TOJ>CX'=:"Z$*`U&F\4F9Y3B^7W?J>)]3U;#^!5CJZ*8 M-WJHN+M2*^J%0I::Q+\M#:\$&8^'%.)Z2WI"2B0][OBFX9]0ZOF?T960TZ0V M#*SN'Y2*J=R^+37EIC\P30E'PXJ2A/B3,POQ`F6N6,6W.EJ^TU:V#MZ8JN&M MO`VG)\577EQ8KG4.K2VR&FA1AM92P:`H_LRVC,`ZQ/4<]6?"*;Q/4K@U.S)6 MP`,>?M=3:SX`M4BKK\8+B:)LNBDT:BR"H4IJ=4DHJ5-8R'"4XLD;;#JOU-.7 M#)^;*N.H/H;2Z@7A80Y1I:4$6[X1HV_2J06T9!]3N(!J0]@X,TX MFGIQXIK>;_,]4^I5(;?;E7552'3XXHU4Q"GG*!*QI55%>3?B$AL_B4!WQ#PZ M<>J[Y-BWI@I8DGIMS[5'N*VQ26WX-2Q;5A\H6I1#JZ_6?B!5&?\`ITI`T@&1 M3.6$1<(T1T?NZ^O-T0'B.KY_@LL*IU6Q'YIXQI_BUIMJF#.I4-$ZO1J)"J1* M^)R5ARB`8]/[1]+T;'GW(KK\&+535:IA-J;_`"TN)HE5C@KENF52FI"4&F2^ M4Z4BG4B>CFJ0B)&(MC0^AZOB^28/K\7S-1-4*VE6^M_,%+7;TOTY96V=3Z:\ MS"DTQ,YS8QP6>&1B"8BV3:?$.^+?0F#F0U\*,H]L4DM7$5*BNW"F2J MJ4E>I:']7]D-.9J_M2ES`&&`/9"6RXD_[MJ_!N:FYC'3\Z?;-$*:X*M)JE58 MI05JJI!X46O^U.4VG-:4RU<991(,-,ND^IL^&;*"")#J-I?)5MH4553R=25T M:J5\7$+62TBBTS+BN.L+EXQ-<(`K\ST[5,I?RX*6;7\6;B* M1\T8K0G05Z`5%"4SG4^$"4C/.)ATW/3?6Q9_3%1+6PUMH>JJ;6X\JOIA3+UN M*)\9+JE%M5-(FJ-0)X(#9))S!E%5HDS#>G%6381+X9?!3Z3\E^-:^#^*-07' M?@A5:$T:GPEPTZ5$>\$%4@B>&4X>/1U^!]63X)9"YI\3-GQ5"R[5FO;+96JN M-7@V5$J-1XLG$+$S).J85R3EA%`,M=/WC^U62$=%?E97"_R'\Q,S4`_&>_I( M_+_&U@*`)FKX8/#Z"+3T->>/=_`D'4T4;#O_`(525KE2*]_QU*37BJ4-"%&: M7I@-(:2#I(TZ=/,&,\]8F7^=U;%M(;Y595WY/\8KX_XH5A#)KDTNGX05!;3X MPQ]Z8_7ED9\8LGTM;7'U4=L'],4D1<$?"VG)\4PZMX;BI0ZH('QU"*<-J(9^ M$#S7PRV!,$H*,9_UIQ7=?61+N;ADF@QB#Z^U3JJ\.U5XKJ.L;9^%K*VMI'%4 MM,&WT%]]:$.)4DZW-+DICB##B[*1T3;3*E,:I3``:HXBJ88V_4-/A=6]2*I: M8K>?^'?#KZVZ?]II2R@:DJ<*1/\`JQ,;$A)Y$:1SK13U!(>$'45A&XZ@U(<= M9IC2..?M$)ITIJ0PY[A"7T**RZEM68GJ(D,XF.XD2Y`T$\*LH-H,P^8)_P#N MU4%_P144AI?%2-7CI%2*;!4C2E.H/^%AISGCV1/W:6IG&GVMV*.J&>KK+FX: ME-2M5,S3JI6ECP4.TX-0IIHAL!;RE:PZI*29_JY1/WB3O$#0/6W:CHC34ERG MG+#4//J=HG:;X:K4FI8%54ANI0BIDO2MIQ.M7AJ493_$.,/*Q*1>!&@UJ:UY M)1<`#$%TNINS]$[\%0(IPQ0I32H-53^*ZXXQ-+KBU+(<0A3DY)X#'B(B5XQ. MB#:8TJ."(VQ(:B[E./VQZYJ%RHE4Z&:YI+ZFJNI%.MJHQ0\A.M)*F-:9A0F, M3#RMFX>I!FD'J6J@2$?"7<<$X_7O6CP[52AE?P;8^)>J:<.EVJ?D^YX`604, M(U@`C!7")E<-K[.#4Q<9_0H$8S\XV&S)#;KZUK_%FD>B)K8@U#.7>&'Q1$"Z7 M#Z1W%*27MPTRT'X=JOMS@<0L?V2C>HZHA*T.'WVVJA+K?,I)2>&(XPP! ML1,BVLT&8].25^K)@^D8K+50]?F:B@=##=4RD5M&XVV*:F.C]F^W5Z=2$@I7 M[JU##AE!&1O@P+"8J,AS?Z4:1:(E4Q-"$ZS1O6)A^Z5"F''4(^$H44[HJ&R_ M5$I4Y5%(0E+2$#\)_$9PP@;(-R3&6`JX<\42(ND1&'T(IKB]>"[:ZH4Z/BFP M:5VFIBSX=73S=:#X;4=5,L)(5/W4^F)C,WGM2:HHP:HXJ)0%OQQ=PG:6V/6K M5X(71K52TI:?0\^)-*"D*4M;:7![R998\#!"\9RZ M=QM,J4#'E[4QMB$=<'U"M2E4MAJ:=\5-<_2FEH]52^*.H\:H<%,?$"4,MI#B M/$6D3D9I$^^'C8E$O-M$:EC6GIW))701X7U'EQ2FMQU+E0DU35/$^XI#[=/ M3A%2EFH);_9U"5E2G$!8Q_6E$#"JHI M!2!PI4M%0/C#2I]XE-+H*_B"T): MJ%0I]IFD^"0X"VARGG5&D:(2`JH*BL/+:3.9$TDR.40=U(2<`:'X5;MXJ18# M,2=?L?L3S^VZEZH4JC?I!2U"T/,&IJ=%4VU4R4I> M`C0<'+%CR]'2B]$1\3ZARHD5%]?I7ETMO;IC24.FD8^-I?%J'/AO<675N*2M M`6XDR&:1B(66X,)&-L#3&@<.:*8VA(:IDZC6F%4NJM#]R6+G;W*1-/<&4U:6 MZZJ-.ZV^X).MZ5H4I;06/=4,QEPAI697#U;;:95J6(XJ(W!#P3?4"U!18J[H M_:5(M%"&%(M[0:?=K*7QR[6.`//*:2M2`W3I\0:4@2/"(G>-D]*#-$5)#UQ+ MW)RV%'H4/5E1M]NGM5/\.NH\/XVO=>9-2P M7JHS0U1Z]"?!0E&*T_B/;."4SMP+46U8EPXKP^G-1&(NDW).!@*\.*RNGJ-Q MTS%>R:9JKIB:"N0\X:2E6$`O4SE+-*T).A?O(&4\3A`8G8]4!, MMM`1#&Y(N`P,3&4MS`VRPN1J,AP+_2@@69 M"83(:I']O,5-SJ%4KU2H)H+>AATU5.'JF1==K-*4(\-#:,$$^\1G,B M0(2V\3=DQE@&+BO%09"\1;#Z<3^19IKA47T5%HJA3-N5#)J*%VFIS3H15TG[ M735!"E!5,M'$X)(YD1$+DMP#9FP)%"`U16K*91C9(N0=@:O6AX+%-;'K-XMY MKE4CJ*!HK88H:LU"G*M\>`SXY0A`;IDE9))]U7&4HF%HV7O7-+1%&+U-`[9( ME,7?LX?6-7&2Q1WBHN;IM-R%-X%T:3UZFCH?!JMVXOS3?=XD:23J[:/V)QW:E4Y4J12U%% M\&\ZA3"WZG16)IG]*_VE*MO6I]"5$`$S60)YQ)V7'WJ!?CI< M@ZARS"34[DJJ>I6S;V:3X.C4FEIA64OBU2TTA$1=><6%H4XI!TS!*,#V1$] MU*,M-L#IQH'%:>G(,N`B9[>5P]6T8Z95J6-5$;L8C1^ENCUZ!\.V@?B'XCZ86=R6W`LQ8R`>X21%V&1IQ0Y2O[C MIZ>XL*I6:QDJM]P0^X:.D6ID>(P]2:@Z@:T.>\A)]V>.(B3&6Y@+L6$Q0O0< MF^A`E&S(Q+Z,1GVNL./5&VZ9BD;^&++NLFDH7:.K M_:-J23XC;50VMN1'XE@`TFIH_>6BL"%*!8<2K\1_#ZHB-PWP;4F$L0P:HX\F1*$;33#L[%ZX\%FGM MU19`_=ZQ5*]\&U*D8HZKX@.UE1-EHU*D(26:9.HDSF%<I<;3&M"Y*)7!(:8/J-*A@D4^X:FH? M;8KVJ44E:54M0*2E\.I:35`MI4RZVI2W%(6H`X>^,3$1W)E+3<`T2H6%:H-D M1#Q^8<<*)3.V:INI2*EZC-(PXI;ZJ>JUU9IV"5@-TR&]:7U(2`0"=&,LA$C: MR$O&8Z`:L7+#DH-Z.GPOJ]B;&ZJLU/CJ9I!1EXJ+0IP:KX4DID*D*UFH#6.J M4RK#MA?O<]6H@:.RK=O%E/0BS.=7L]2<7M:I74EIE^D^#<=3X:W:@"K%*[)? MO4I1K\<-J(TDS)$^,H;[M(RTQ,=)/&K=G'DCK!JOJ`R33^XJANH<31M4WP=, MM+-.FII_$J%MTI#9*WEJ"T*<*#+#W(66YE&30`T"@<5IS1&R&&HG40^-*K-5 M8JBL>%9;WJ04U:E%4PFMJ?!>;-4-2TK;6DN+2EU1D9S4,(:5B4CKMMIE6I8U M41N@>&0+BE!1(JKN];G#;*%+!8M[2:776TI>>>J$#4\Y-:TJ0TI:I)'+'*4) M.[*V>E!M,:5#US3QMB8US=S6AR2ZFVO7;1=:)=.A%_9`Q::7P'5T[7BUKM M0QXR7*FJ_:J%,E9`13H20`1@KUQ$IFRUJ+.,7#U/!-&`N>.3L?2J':1^_L4] MR873-5(2:*O;?=^&8\6F]YMVE*DK2$*0J10/P\<9Q$HRO@7(MJP+EJCAW*1( M6B8%VQ]:0Y4/[?8IZ!OX=VKJ9UU8M;9J:5"%`LL-4I5I0X=*"5.)[B,1"F1V M\1`,9FIS')D-U29%V%.!6%-O[BI$/H-.U6V]U5,^%GX6C=IGYO,K:_&AM]!$ MBD8D8\H&.X@X83B6.08XK[D\92_M5$S149$Y?@; M=J7'7/\`.0#V0I?;QR-R1[0P]Z8?:RX0`[R4E*WMP4[K2BPU74#@J65`?"T; MM,_)EU#TM3;;J5B:5'$Y05W$=-!.)<9!OI1*(M$&ND]Y=(##M@IWJQXT[U74 MJ%#1I86:FF0"D/U#E40`A1*422@\I\873+;Q,Y,9F@S'-T`BX=(?2')?X)MF MK>OJ*BV5`IVJ@(%91.,L_#L^+38NMU93J0&UI7@L_A/#*(C*5X&W)M3."S!^ M?TJ2!;.L.V>:2U;ZBRHJ+M5JIG%4[?A4C5-4?$(55U/[%)J2A*0AA*2<\%3E M$"V;(-V3%A1B]3Q09"X1"+UX_!(I[D]=RNTU@82FN:4VR]2TP:6W5M?MV5.) M0H^(P2@Z@(XEMPB:BK**D2JKIDNON*9J&PZLJ6K4 MA)<)TIX#&`W3$Z(-IC2H0(`C5+$IU8LZKW7IMGQB+FNIN8MZZXI-.FK*GM$M M)DEV4PWJP![8+9LF36WZC%GP=1(7`/&VEZLM:M+5;^:4@I6UHJOB9J<<;4$H M2"14JJ5D!)9T:@YP(/=%=L2UQ$?G?^%T\Y1$23@ROZ<[9_,T>`*M+GQBOAU/ ME)M@?*U^`5I!U_#!XC2.[A%T3MNKX7=^Y_X4GVNBK85XJC\&O-Q6TIM[\U%; M(N%LZ_C?%!"RYI*0@KD1PT13IN:V8]35[4Y,1''PLMCJCMI-R<-6*M3OQ2!5 MKIL+>JH!0*A21^+X;QIZI89QHD=MU/$[O5L'^CBJAUC"C-SQ5-=V*H7*L%4V MMVH6]J2MII:D.-+(^#-.I`DEKPPA*)$2.$5W1(7):GU/D/4RL@8Z'&'HZO[A M^2H?"+Q\L$@FH\.6N69[8ON=$%KVHW``[8?P\54. MHWV;:V$OOU*UB MP;LR3VB-/Z3U[59U`MR&+#B.FMK3X?B_/BFMD^+52X]?3@IS::!JT6S\\35:U?%*MJ*4:* MEJW*4G"IUD2IR]BTDR*1+MBP=,6H]9WJS8MSY<$AU]2739L^93-U#+EOM3EM M0ZNT)74(4E;954(N6LAU5!5EF(:`@+/VSZ- M7A;%\^Y1+4;G@;4U?3BE5:*1VSC\I0^JA;N$[HT^/$JS4*;3\`X\$:@NE2#[ M@`]U,3/2;+V7T:O$^+Y=R@&0FT_F:B+6AENW7-5R0XBTJ=I4(0VA3=2NY M`S;51A03(I8_TBOPE,AP,3:TBU(W7Z5.W5R[L4LS(R&CY_AS3ZDV]VT7(61% M45)W=ET=6FVJN1FPFH4 MU_Q8F2*LM:@W.9SBZUT3)K.KJL=+X/\`3P2SZNE[C=-P[>F"IK"S5&YT/PC2 MF*A#Q+JWV5H0W3HF*WXM2DB;?@ZDJ$YE1YQ59$C>CH^9\^&;]R>Z8],ZJQ:C M<R+[9VO5'3U"3T M?Y7R[E7+[QTSJ9FKQY]ZUUNGN/YFAM#-0F[BO/[1;;@7\?XI*W5/:0/#*AJ) M!D6\,L(S@7.J`'ZVKVNK28BVY^1O8MC?7M075SQA6%0KQ\0IF0MIJ/$2'E!( M.KX7X@$J'?F)QI)V?5\6I]56^5\^YU4!N.GX6P[U071FN_-*U-6PX[7JJS)Q MAE:@M2U)^$72NA.D(#91H,Y)ECD8SWA,7I"=;FK^!O@K;9@;8,:1;#WJ^NAV M\BL6F[FM7KO$ M4[D$73JK%@S8:K4LX3Y>B+;G1$8QW&KK:1\O#)^;*N'5))M-T]1Q]K*OO[04[0.4[9=LZ MK8S^3EMI:T-L`2J&W!)135^-BX3+5,X%8F-;)CX>S,'F^*LLFA!I=>OP M]BFRMS5ILZ+\FL^)\*H5;D48T5+5I4XGP$U>L@>&5S+8,BE.&8,6-:%J'WG5 MK8LV.G)^_!(-9N2Z+:*.^#\OBHUY0TY06=RWH==LH34(90I"G'VKGXA-7^8A M(5_:5HEI/X0F?,0E\`VX&T_0JW'5F_/X)K;ZY"?[WX-G;IDJ;KD@-RKEZ5Z=%`M[(*`&K$9B&ATQMP=P^G4=+8_I=S^U++6;QZ3. MWB)PY=Z1<4TKMDIE69+[EK;N+HN;3R/$K?CE(1\&[5!&H*IO#P:ED2DB"Z(& MP#8?I:O$^+Y/R;!3#5U2+U)D4;!OIXHM::9NT7)=W;>1:%5E*FF;:0MJL5=4 MCWW*%*@G2A-.9/'(@&>1B+.D69&\_0<,V.KEW8Y(GJ-T"U6XU>#<_@G7Q0.V M2X_D*:M2&ZRE5>FJL:ZQVA+:A3>$$%0-"U4F:Q*9(/`0TND=O+[OJ8$:GQ;+ MN?%0!<%T=9L#IX/]+8*-8VVT4]Y=KVW&K(*-"*]/A+;==JE.)_+TT`4$'XYM M4R%#($#E)-N!IN2N/T`*]N3?I?!->=XB'[YZ=F?4;>%=\?\$V:A M%:=3[UL0[.M:MQ;)D\H`:Y8E)',19'I&W,;;5U&J^.G/3\>20FZ)QZS:'HV# MY.J_;K1%<\XID,VQ%OJ3>%/,+:8;O/YB/VSC+@TUJ7B:EQ]X("" MQ@M2S.2T9'$1DMQN]8"(/6U<,\W5\NGTWE^[9;,5[/\`SA14*XK_`#(:E)D; M3\3XHFO3JU?`_%`S&7HC63L>O];Y_P"*[^O2ZS@;KI?5;3_&9O>RUNX4]P%V MJT5+#SEV_,#^U:9<.JJ4XE5*Y3O!"@E`04%LSDA,@%V^.M-6S\0%!I5(Y3 ML+L$\8S[H2%Z6NKX-AI:C=RNL?NAI[^+YNK:XF MSM"B;W!^8KO2+93"M_+5"8$E?"HJB3)RN13D!1&>'9%]SH#2-SK-_0'T^Q^; M8JJ'6+]'3TW+/\.2K=PM:JFC6TUX]J7;:<64M,N.MHHDI`=;6`E935>/,NDR M*B1RBK=?/$QK9,!I;AGWOBK+#:2]+FKQ=O\``IZ_RQFV61&X16_&&D>71-T7 MN5#-J4[_`&5%<%E.1)\,'WDIF.!BP](6H?>=6MBS8ZKD")PFXT].!M?\` M9V+<0/29V#OAR[TBYII'++1J MLZ'W+4BX5":]IY"G*P7)03\,[6I1KFR6`0SA(8'E"W1`V(FP_1$B[XZLGY-@ MIMZQ>(N_O&#-@V;=Z+8BD:LM7+@VMFQBG936)2VME]VX*<2JW_`!6@?&-R,U2E(@$\EL- MHF;G[AJ\7R;FFNOKB(5N_#-^2EI%K>MMY;V^*T5HIF%5B*R:JEZTAV=6B@T$ MI)Q'BC\2DR'*'`M&U/[MJUL'?$Q>K?%*>I&<3>;0Y9N.3_!0MOMA-36..M!B MUHMM0;R7&EMLKHE)DVA(TH)J%/2+1$],CS$5[8>*1-+(B=79]+X!BG;`]8::#-\-.;]RMO-TV-?IR5Q;#MM5>TFU?'MUZOB1 M:E7$@T"*LH<^%.D$+_\`1:CRXQ?:.V-QK.KJ5TO@^7Y/:J)B_H>;:,VQ;TQ6 MOV]BO_-*5-.R\U'JU?""JE+GW1H? M9]9_%\W\5_H=4?WCIY&G>M;JZ>X?F;R'67EW?X_%UMI4U5JGAX#C3@20EH$I M*#/!`QXQFF+G5(D#UM7#-7Q,-`(/V;+8;@O;*;B^FX?&N5:761 MF-)#9]N:MKC^3MN4Z+X:]V\-4%,FX*MJ@&RX&_<2Z2?>K4L:0LCLBV[T1("_ MJZVD.WIBV*2WU"";3=-RS^F"K]P-DUC*PVEVW+H:::T^EOKO7B[^C*6^+8U1VE%]36JN'P1+0 MHQI=;MQ<)H6Z[41-U*?P\0F8YQ:>F(0%]^IIHV.G)_AR2CJ&4ND1I?VYLH-Y M0A35H71-KFV%>#_2FKFFGJC8OFW+B@F1N#I_,U3D MV2S5IHW;(]^3)J54J*]M5V;J$E=8J:!\&I24:@JC0X,`,`HS.1B)Z#9/1?1J M\3X\N[XJ8ZA<^T;4U.'/O42T):10WA5P;=;LTF&W4I0MNH7F;HS/3M5?8VPE= MP\G'G%=@5EJI:T^+X=_!/=.# M?O'IZ<%,I1:W&K@BPBN3=E6YX,_'J05E@:?C4410KW:Q3&$\Y'#C#PZ1$A8? MJZ:/PS;FEEK<=1M#Y>QU5V!ES\Q96TT&*=MAU5>I]AQM@VP((JD/:TI"M:2` M`3/5(\#%-A^I2D6+THV;I[I&C]++M5A;E6%56&[3^8-W)3-4BV*N.E5,FJ+: M@T9`E7CE`(:U9=\66Q9,VM/U&.E\';T9+/J:?&VBCMBWIBJ"U4]:;I1BE:6U M7)JP2X\TL);*%'XM52X0D*;*-8G+.49[8EU(B-)OP];JV9CH)."N6#M8 MW1'@BM2Y\:H4ZGM)M@J?$7X!(GJ^$\:6D'"4N$6Q.V-WPOC1_E?Z'59ZVABV M'>RUQQJX"Y*;+3RKN:V7B)2K7\:79I<2[ITA$Y*G.01V1G,;G48@]35[5:#' M33Y65[6JVTFY.BL%6MX5+?QBZ;2+<:B:!4J"2K4*+8FZBL7=4NVL5YH-/@FHU-&2]9D7TH("R MG`F++G1$@+NKJ,';C]*2/4(\#:'HZQ46"HI;O<:ZM=I7Z:@JJ^M^'H:E-155 M"J9];C;24("5-HUI!6K,)$HBWMS"6N9!C&K`N:8(-T2&F+N:5]ZK*7<=RJ*I MIJM7\315CGP]32L-(0M3-42T?AW$)#NMH.33C[TLANE2`H5+K:`")^X23PAAM M):VD1H!XU;LXH-^.EP/$W=5,*W9=!4E_4V*0.A0HBVC_`**"!\.7B`[XI:'X MISUQ'WN[J=_`^'+AV_%'0@0WUN/-3U[3JE5112U-&S1O.H+2:JI"*YABHDZ6 MGJ925*54MH<*9$^_A/.'.TD9-$QT'B:L>27K@#Q`ZO8_:F*K<=SIJAVGMS@I M:.B<^$I:=]I*WDHH_P!F34J<25A;Q02H$X`Q$MQ"0)(I18K;Q<+34?D]N>534]M:12%3S#;CM15:/%>JR'4G M2VXMP:`)#0,,X)W9VI=&T6C&E14G,_0B%N-P=28J+34WU%->:=RDIU5[ M)^+:K:CX=*JRF(IW7Z,K"O%I7]`.&"3EG#2MRO@7XF(U"KEJBCCD4HG&T]N0 M)8T(''BE5-;7;=33VBC>#3C3*:RN?4A#J*JJK25DTIHI%:2@J*7"'$)`DKNAM$]Q`700)BA]9==K-L4 MM-1T[R45M>IROK*I`%13%M!-,S34BECPG-`$W%R!"I#C$RE/;0$(D:Y5)Q'` M`?%1&,;TC.7RB@'T]J4VW7;HH_&4ZPFX6NH^&74U!^'I*FCK$^,ELJ"2TW64 MSB,@/>01S@&O=0U..I`LYH"#7UA!,;,V^I(98N/@G"BLVK1!Q#S1N-U?\+XF MG4FIHZ:DHP7/!2I0#3E74.+)((FA$^4-X]K!P1U)G$5``R[2E>%^;$'1'+-R MLL.UVZ:6IHZAUI5;;EMW"DJG`FFI/"=_LM135:VTE#2E`ZFU2F3AP,$93W43 M"1'4C4$T'`@_!21&P1(`Z30C$\0GD457MFDJKFMRF=KGE-VZAE+P# MK]14'2E`>6EL);0J8)[XD1GMH&[36?"&+@/B3\`@SC>D(,=(J72:2MK]QBJM M%8\EQQQCXV@J0TEI%+541U%-5X8"125"5Z2I7X2,,8FWU!N1ND6PX!-7#4Y.*E:FU4)>*U M4`925FC<5H%*ET#QB^&52!G,N0GWZ]JU$^!\.7#B_P`5)VUIF`\;8\_J0+BW2.E*E-KI%()-4TTHI"9DD@$YF'.RGU-$91Z9.9 M\3'EQ4?>@(/(2U@5I1^W@H]5NNZ,5+PH7$4M#1N%BGI*EE"E)8HE>%IJ75ZG M0MT-'7C-,^R$EO+L9GIEK<2P!X#B>>:F.WMMXP\SB>94BKVO5UM0*VW.T5-2 MW%+5>UE.6NT8B$V($BQ#\C[ M.*B.XC`:)@F4:4%"R:KKY<;34N6>U/&EI+2VW0-BI80X^\\VV%.U3GC!1"7G M%S2D2`3*6<1K<#F54[562JOR:>^T2Z*F_- M*=-14L5]4:658R/AWW:8J0YXE#4>&%)4)!/;.)E8G?;<0TC6'(E)JX$A\0<4 M1NQLO:D)-$X@/3FV:Q6W*X;<4Q8K<^&?@V$OUM0XTE8K:ZO/Q#CU/XNH(HVA M[J",%&?*"Y=N;4C;VRVD.2V)/!\N'%1&$+[W9AW-.0'Q2G+;6;HIJ.]-.4K% M:0Y;K@JL=-,Q5N42I,5=&HI4@A:%D+0G!*@>V)Z<]W`7P8B?RRFHE+'AN-L M(0"XM(!*I3SB)SN;.,;4#XY>*1%0<@(Y4S/%$1#<2-R0\(H!GQ<]N06135V[ MJ%NK+K"+G:JA5#45-4KX6BK*2I`J&4MKD6VZRG4`%)`DL8F6$I$9[RWK)`NP M+$DL"#4AMY]VF M96H>$]5U"W2I4Q-*9C@(#U-E;&DCJS.(J`!EP\W:Z)VC6*RE MHFE(-34OU*BE+1J7?#"6T*20)`\3!HN;*V;S@W9'2""X&9)YG`!&N&YF+;'0 M`Y>A/9V8E(I*RX;J;K+-7NH=J4L?FELJM`IV*:HHR$.M5RFQH12U2'I!:@2E M4Y8RD0N7-Y&5BX?$!JB<`",BV1?UHE&&W(NP!TNQ&)+\.Q.L6FMVS3UM\J%T ME0_3-(I;:W0OFJ::K*Y7@?%UVA*-##"/P@DA2CC+")C9GM8G8X=O!.4> MWZRSER]7%=#5,V>F](DCPPHFN8;ABFE8M0& MNV&G&KD\.WBGZ/9M93UC;M?4T-31T2W:I]N@J?%N%2BAF\A#-,E"2VX\MH:L M3HQ`X&'AL9QG]I*)A%R=)!D0*T'/V)9;J,HM$$$T#B@?G[E$8WK>7*AI^I6A M^@?>'C6YIE"5KHZI11\,P\D)>+Z&G0$*S6L#G%8\PO&0E,O;)J.1R!Q=2=I; M$6`.ML3QXGDI9V+6_'&D%90"WJJ/#,ZG_68H2=7A_!Z-7QHIU:-,\5>]V18? M+I]3IZH]-^/B;]7%^2@;R.C6QU-PH_;P42HWG>&ZEYRD<;IZ"F?*&*!]I!6F MEHU>$:>I>6"\'EH:(6HF:%$\L:SO[T9DVRUL&@(R%&)Q?BF&UM2B!,$W",>9 MX#!2ZO:%9559J+=44--17`MUK#5RJBS74B;@0^XV[3J0I;JFG'%:)F;@D,,X M>>RG*>JT8QMR8C46(U5J,_BECNHPCID"91I0."W`J/<-PW.UU+MKM3QHJ&T) M1;*=JIIT./*72HTN5-0705I-0M4PF<@W(C.%N;J]:F;-DF-NWX0"*TQ)?CP4 MPL6YQZEP/.=36E>#<$[5V"KOA9OU`NAI4WBF16U%-=82I5;6ULJEZJ8#P5II$E6ELI]U4E.`&&&+\RCX6NW=0-5P>IV[E;7EV MRKJ*M8I*2MI74?%,+94$%I-8P3I6E(`4#/D!.FYO;8NDCJQ.DDE@0:ALG&80 M)1VTS!CHD'#5(_(L/&X;/H6&6'6?S*\/.//U;)%50LT="?#9I&%K2&G*IU;N MM9TZDIF)R`B)&YLK8$2.K,DDBH`%&!P)X\$#1N9DR!T1&&!G++$N/@L_"5VT:!VN\6GO6A.AMFJ0[[BR"4J!EE!"=S M>"5F9>8&J)P`;$'D1GQ08PV\A\HKE>&NKKE)2D)::0`$)."EGN@%J>UB=Q(Q,Q2+%P"N[HG;7"^H4+8$5!+9<>")6[=D=:`8C&N(-&[>"726*JLI>OM>NBJ4V MFG=K6:>W59J7'*PI\%HNE*&RW1M%PJ6OB!PQB86)6'W%PQ(@':)>N`=LAB42 MNQNM9@)#46ZNWIBS>)E"?A+#C@1V%3*S;A$W+8:4:U/#).TNTJREJ4U%> M_15%';O%K'V;=4EZNJ!0DO--LL(0E:"XXV-6)*!,8YP\-G.$M5PQ,(N2(ER6 MJS<\U$MP)1TP!U2#5#"O/W*,QN^[/532JMU%10U+^A^A98;"UTU8KPO!IGD2 M<+K2'1H(,UE(YX5QWUXS!F7MDU`&1R'P4G;6HQ:(:0S/)24['JQ6BE-70_`) M?\)034C\Q51)5K+::31J^+4R`B6J85[W"4/]PGKT&4>F_$:F[./)1]ZB8/IE MK;A1^W@HCF\;NBH:1J32TZPW\,\\H%X/*2V0LDS2X2.$)+ M?7=6J):`.#9#+BZ8;:T0!($R(QYE2ZG:-4]5JIE(45O,ETA()]\``PTMI*4_LS$0DQ#D`@'B.7M2QW($?&"9`9"A91J_ M<-SH:AZ@MCQHZ&V::&F9J*=+CQ^#_9K>J/%U.#QU@F4Q)$I0L]SO;,0)AV)9CGCEP4PNQMCI3$B8EJ!Z?3Q2:^Z5]B= M39+<^JG:MK+;;SCK*''*NL?3\0_5(\5*M-.5.2;"9)P,+AX\TU5UE?MI M%+::)X-O>#^8W"I\,/,5#]82EMNB+@T*IF&VM)4`"I6<+.Y77;5I:>F8=; M%PNCCM;4UC6FHI$TU,13LT=*M0\-QT@(1(ZDRY(J&%``? M>H`C?D9D'1&@R-:N4E":W==$X7'6A<;0^G35OD4U$]25V)IG%I!;;JV'&PI. M$U)PXQ`U[N!-B0+>"0[W'TI*FJ[:M$:D.L+N-SJ!1LU%* MOXJDI*2E2:AY*E$);565*C@D@Z$B?.<$3VEO4XZDRP(J`!7UE,#&_-F.B-:T M+IME^NW33U=!5.H564810N;:S,A0/`2B(RGN MHRMS(ZD?$#@.!![Y"*"LVU2U=V==IGJLA%NH/@WOBF*9V MK_TU56%*4I"DH3I:0H2*CVB4=.>VB;Q(,\`U0'S/P"C7&[(6PXCB7H[9!,T= MQKMP^/9JYXNBJ94_1O)8;;%+64IV:"J^)/Q;\Z=IZJ4E* M"U14_B%2E8A0]L1LRL@WIZ3I#@`O7"O((,XW&MQ!#G/X5 M54ET;50K\!E"'67E)+C56T&P%*2RMN:DG#3.>4+"]HZFFMR7:Y;%NJ?&K*E='^T;;;:0D.-I6Z`5D8I2". M,$=O*$M5PQ,8U8%R6]*J)7A,:8`N:5%*J)2[HNK]2TBN<%51U;A8J:6F90AU M;-6?"TTKC8#GBM!P%!GCIQYPD=U'P3&S`1\-)#-/(V?5"K##U M71KHVGE>*&:@+KW*5DE?AHI0G5\6XVD)*9S"B3$_F1CH!XU8"@JW?=?B34)6A-&E[6*$MMX4J3I^&4[+Q?%\(2)G,+BL[N[JU#Y'P M;+AV_%/T(`,?FX\T_4;0JG*M2*6JH6J2H>0IE-74!-I%)*E5+8< M(`G[T@>,3+:2,_`0('B:@'EQ2B_'34'5[%#J]Q7*EJG::WN?"45"H4E/35#* M%K#=')D_$N.`NZW2@E6(T@X0L]Q.$C&V6A&@!Y<>U-&S&0>=9&OKX*R8L-17 M7:V7&B724S%RJ:&M--7U89J&'*A]!=0E*TJ*V"X"IM6$TGL@GMY7#U(&(A(. MQ+&N*B%P0&B3DBE.2JJ2GJT;I=;<33.*I@X"A"EJ`3_`%"1RC1:N;8W1TXF,ZL2:.<**NY&[I\1!&8` MJM>HZ*ZB[,-LLOMW1-G:W!5"-_IL",,,^SM6MU]'$0"Q9N1Y@8JN$;I M!-H@6WHX?O[%`W$VJIK*.J:9+UJ>MU-^4%BF=<:IZ1"-"Z5:$IO;]"L7'[;2VVRTVX*&LK:Y-*\[3- MTK_PU30VRH=!HF*Y:W$%:U)22A.:`)'MMU6H6X1W$3*;%@"Q$<@?@$C3E*1M M$"+US<\E&OH354MEJ+?3O*LB*9VGI:1#;E0Y0U[3I^.;K2@.^)4N324N9*3/ M'FM]IPA*V/L&8#%CF_/FIM`@R$S]H]3Q&3KZFHLM% M3K-'64U*&]%74+6I;112/U).A!SF#+*3Q-N&W`W$209'2!0@9GL)P42$I7"; M1`8!SB"NS4K[5IIJZJ16V]P.558U,VC&%B1O`FT9!@*'4, M2.``QXJ)@RNCID:P"YR;)^*=J'*&LL-6BPT=32LL7&G?O5%4+-76U%.IKPJ. MI0MI;RG*1JH2`I.:2)D2S:4K<]L1MXF,1(&0-20U#V`XA3$3C>!O$$D>$X!\ MPD6/PZ2BO;]QIG?R-3+%/44BFUT[M=F?K&JI M_P"+J:^TL.J-8S0K0ZX0IO4"M`$U).&)PL$K4K-R.VB8S8.Y0_3.--5-*Z"VQ1MH<0V':M^I(#4 MIZ,><5[7PRE.0:R('53$9`EQE%UJ5F0E#;1E#<&!8R+]H'` MD.DG&X")7R)6A(.`&[#V`JDVRS4MWBC>8870LTS;SU<_54KC-.U:VVC\8BH\ M1#84EQ$DA$YE&2$X3E&FQ/:FX!9 MC*%TOI)+@$X4RY<%3O$0!%X2Q(P(Q<\,75UR4.D3(O M;;+/@W-;.U<]FF]I?;M=8A1N:E-7)=4DVI+ZW5)17&A\?_H9J#K`TRD0J0SC M9&]L?O`D(2'C^9_"_'3P>K*@V]UTB#($-@U6X/Q6K55#=_S9]EZFJ7;VJXZ? MB&F'R%URW@JGJFJ@-J0*#;GZNG2RFK?11^/J=9:<00L: M3XF@C'CLO7=EUSU82E,$:I1+1)&)`X<>*SVH;GI#IR`B10$5;(.J#I*BCI7G6:BA=0DV_X)2$+"$AHA*1JFE8)PGCEW49G<2-P:I$N M"!0@_*W`-EDKK!CT@(EF%0>.;J_N]78FGJ:FW#;:Z[7RFMM&Q=*JV5R:1CQ_ M"4L4[H^(9\6J996D+6`)D^@:;T]N)"&ZA*>X$`)&,FKP[0*$JJW"]*)E9E&- MDR)`(?O[%4;H0JHN#=8&E55LJ;=2.V5;%(Z[3M6M+00*8(;;<#=0RZ%!U.!) M(PBG>/*Z)L]DP&AA33P[0<>:?;D1MF)I<$CJ-TY686[<-W&4[PAD6,8 MD^$2XGW!)"-R'QQ7I.LDZT@R)Q)JW33C;G;']VTM$8F)'S`\WSS">QX3,3/VNJI MP<9$MM'MZU4^XZ"LK/%JZRILM%2NFBK:*VR#;CK[CCC)125-1,M-'A( MRPPLC*U#:PCNHRD\B8`'21'F>!.`2&-R5^4MN0*#434$\N8&:CWDTU;9+.Y9 MJ2H;LE+5UK-3;UA=;64EZ<)<#])&W$B M#'$B7&1S<8%39$H7I=4@W2`0<`1P'?BEVQ='0;>J!?Z.J?M=5=6S9[:T54=> M:VG;6;C64RW%,&FH@A24K!D'%SSU8S9-NWM3]YB39E/PQ'ADX'B(X!L>)1<$ MYWQT2!<$?$<0QP';BE5RZ&NVXZWMVAJZ6BI;NT]?;<^LUM<\'60BWUJEM./K M>H&GD:=('NJ`G@DP7#:N;0_=8F-N,P9Q)>1?Y3S`-.11`3AN/MR#(Q\)P`XC MM.*9L8:H;7?GKM2OFP/IHZ95!H[0T-,AT,ZZYQ\GPU">@$SS$5;/P&=R8;;"!UAFU`_+$(1A$O> MU>$N[-B3R;'BK2WU%FJ:>[4FV;;7VN^/VAU-.NOK!5N55*TM"Z^BH'4U#OPU M<[3@Z5?KR&"KG&]&49;F0E:$L@S'( MGB%3;3:=I[PQ5M-&AHJ2DJG[M455&^Q2)LP9(JF7@XAI#A?FD(1B=8F,L:-D M#&^)Q\-N,29$AAH:H[\`.*MW)!M&)\4B0S$/JR/=BZO++7[;X3IGC(Z=OII+@U7!QRIJJ5 M]"&$M%2KD[7/N-AM;99#@7-1UJ.&)!C'MH7?O,.F#&Z)8D%@WS$\F=^*TWI6 M^E+408-@#7DW>S+:**Z;(-^:>IK374SKER=^$N=15>+:D5;[CB*>L50"I5II M':AP*2G2-`4%82PVV[_E_P!X$H6Y`F=)&7A!)H3'@]66:=O=]$B4P1IJ&KS# M\>:U%5OO'YNIDTM4=P"Z$?%"F?E^9_$!0JA5>&$"GUR6#KT^#A.6$8#:O_>- M!$OO6MG8_,^+\,\<%JUVNCJ<"SIP<8-@WI5;=<+ILI-[>>K;575;[5>S\?.Z[>\O^\$W;2VM#3?@%"4`*&A8,^9Q[N%W[S/J@RN&3N!0@_*W_# M/"0V;BYM8ST[J$I[F,0)F,F!+8=HH"?IDVDL@,TR`AMP-O,.A8<09&9!R(EGWH,K^LC M5:E$&!`)&AJ#NJ".*LVQ$;6G"8D=5?K9GORY*VK:BSTM%9:3<]MN%RO3%K!/ MP-9\(_0T#[BG+=17%U3[/CUJ&!,G'1CE/&ZY*Q"W;AO(2GN!#ZLM+1-8B7$M MZA1)"-V4YRV\A&T99AW.9'`.JW`3Z<[8/W;0T0SZ6^8'])\>*>QX3,7".MJ\1P? M@1R934/6NAL%FIMRT%97N+=K:NRT=([\'76^TK4E`^*<4\P?AJAZ9:9,BD`8 M>[A8)6;>VMQW<)2)),`"QC#F3D3@,DH%R=^_AZZSV M-VS4CZ;#2O5M.Y;RA59645Z4XIQ;UP4T7U/*J:56IMTS`2<_>$)N=-RQ;EMX MD;8$C3B1/,RXN,"IL@PNS%TCK$"N`,-=DMS M*E45P2^RRK\RKVENK953T))""#+6LG,*`B;1MV]I_>8F5HS\$123CYB.`RYE M$Q.=_P"Q($Q'Q'$4JMN"G7FD_EM:XM MI;RJBA2I)2$XZ%RX)@O&WMZGBP6#2TJ9NNY:0)'` MQ&VTV[%R5^)^[$@:<"9XTX,,2IO"4KL!:/VH+G`*4MZV5MAO+&VJ" MKH'4.455>:.L>%;75]I05(G2K0Z\2Q3U!!=:`.I).$U8L96;FVN1VD91((,@ M3J,H\N0+.$NF[&]&5\B08Z2`P$N?,AV."A;;":(7JKK:=QJQ)M:V+LPY3N4Y MN#M0K1;Z.D#@9U5JG=6E0/N<#J3N#^[:&D,-3_`"@^\C",#]M MJH<6XD\F]JL:.HM%51WFCVU;Z^VWA^V'3\?6"K>K:%EQ*[C1VYQNH<+-:MB9 M!P*^V6%MN5F=NY#:0E"^8?6EJ<#YA'@6]:KG&Y&49;B0-H2R#,(!53M5M MRGNB:M+1H[=24-4]>7JBC>8IE6CP2AVG4EUML+!G3L@8WM8&F MU&),G%-+5'?@.:LW!$K>DUF2&8YO3U9JXLM9MYRI53V"UUUHO5105E/9ZNZ5 MB:NF15K:);ITM)J'/#?=0DI0LCW$=5^0E:$@2`&I]'%:[M^DKDWJV&BIG:*J8J2Z]4U=(\VS1TK(4;DNK<6VA M*T>!K205>\I0SSC+M8W/O$.F#&X"Y)%`!\S\F=^*NO&'2(G6)&`YX,MDM]RV M<;U3N45JKJ1]RM?^!N-75!=L9JG_`!44M4JA-02VPXZL%`E^SU#`<-5J[L>N M#;A*,C(Z9$^$$NQ(X/DJ)V]R+7CD#$"H`JU'`/%:HW0W?\U0TFFJ4WT7(H%0 MJG?`3<@]-RI54Z`CX8*FM1U:2UAV1B%N]U]`!^\Z\6^L^+\,^Q:3*V+;O]DW ML^G+M6TU=RV:+VZ\_:ZZH<;N;:JFXL583:W*EIQM+U<*'QTE5(V^@J4G3[^D MJQGCMG>V/W@RE"1.JL@?"3F1'@ZSPM[GHM&0`;!JMP?BM;O5);K8;S6[<16*9O=KKKK=:>FI&+Q66RK33TKM8TRCXEL,& MH;+KC:2$K,O?(TSPD-5^YM1<:_"4[X`$C$L"0*TSYG-4V[=XQ>U(1M$E@0Y; MTP5%NAAY^[U%2ZTJLI*JGIG;8]2TCSU,JTEJ5*RSX:'`DLDJ2I&87CQ$9MX# M*\92&J!`,2`XTM0#LSYJ[;$"V`[2!JYJ^9[U<5]3:*>GM=)N.VUMSO5/:V14 MJH:P4JZ5EPK714E:ZI]OXBM;IS[QQTD\)Q;#O"K+=8WK73.BQ-(JZ9%%H54U% M#=DK*ZD7`H\53K]0T=3;F13/^L#%>XTSM6Y6@?NX<-B1+-^)(SX)[+PG,7". MJ^/$7ITD#4 MLS&!$$#;AMA]XB90,G@!0CB>Q_642$I72;1`D(^(XCD.U)N2J6LL-.+%1OL6 MRFN;@NEO=)JZQ-94(2JBK'U(+Q?I%(!2B4]"Y92PBZ83VX-@$6A,Z@:ES@2< MQPX%$-<;WVA!F8T.`;,=J9M/@T=GNJ[S2ON6>HJJ1FEMZ4JI*RINK1\1VHHE MK+)9;IZ>7B*R5*6>:VM,+$S>!-@D,,"9<1V#%3,&5R/3(Z@!KB&X%./NV^ML M-R9V_0U5)X551U%XHZETUE95V^1;9<86E;FJF8JI%QL3(SECB2-N>WG';1(8 M@R!+DQR;D#B$#4+H-V0-"QP`/YK1=Z%RE:Q7EMK]K&Z,?E]MJ MZ&K<>>1;JVLJ0Y0,5;P<32.KI/%FTVIQ0"J.G&49DG227#G`M M[N"KE&]H\<@8Y@"JU:DH;L+LPVTQ4HNXKQ^W<96$HJTOE3[CE1I""T"%*49^ M\B?9&6$+G5`B"+VK'GQ)5QE#0Y(T-Z46RN7+9XO*G56VJ4L7`*77(J`+:JH2 M\`JJ^#\0'X45`UE.,QC&@W-IUGTE]6+^%^+<'51A?Z;:@S89]CK5KG170W>J M34,OOW)5:9/L-N%+SJW`:9VG>2"E+:DE)09^Z)#A&:Y"YU2)`F[JQ'')CZE; M&4=`8@0;^%;'=*W;B+BM-TH*FX5[(IVKG6T-0&*1^J9;0FI*6"O]KH4-*C^N M4F+KUS;=0B[$RN!G(+`G.BKA&Z8^"0$2[`ARV2KZYBJ7NFG=>3\2V_6V]ZA? MIV7':==N6MGX,4X"5A"$-#24\%@QGW$9F\20X.!%0V2MMD:`!0Y\7S5FO<5T MKK_56VYNKN-ON-QK+?44C;#:5D5-0ZVAUDMI0L+IUR4!.4@>^+;6XNSN"W=) ME;E0AJUX=BKE:A&)E&DA5^Q-46V*1BOU/WBW7-JB4_4+MU"X7+A6?`I6Z*=+ M>J7B*6V-G*MM]]SXBB< M?!>MB66BEVEJ%%"J-M0;#I7X;DD&6Y-,JK#8H%.'\U#"OVAH2WKE\8&CX>?;V1=]SCU.F)QTOA M]9N';DJQ?EHU&,G;'+M[,U$?WG>FZQU5([\'0TSY336QQED!JFI5^$*1]2FR M[K6VU)>,TDF645RWEX2,H%H`TCP`HWTIA8MD#567'FI];M>EJ*X.T]XMEI9N M'PU6BV7!PMW"C->$N+8\*9`/B.$MSE.8$6RVL93>,X0$F+'$/Z42B\0&,92( MHXP+)NY;CNENKG[7:'5VRAMA1;J:F<896Y.E$EU#Y=2M6NI<.J4P"B1XSB+N MYNVYFS9)A;A0`CAF>W%$+,)Q$[GBG*N/'+NP4BNLU/=S37Q%RMEC7=Z1NMJ* M&Z+4TKXG%M^I8]X*725"F]0.`XC.'N6(WFOB<+>L.1+CF1R*B%TVP;9!D(E@ M1[$7.\7#;SS5AM%2NCIK?2->-4%AE;EQK*QL53UQ274.`LN:Y-D8&1GP@N7K MFVD-O9)$8BI_.)J_9P40MQN_:W*F1]0%&3K]`CJ2%U-/^;UUU:;;<9NCE4?#9^"4X'`:2E:;E/.>F?&9.Y/ M:1C9LFI&HR&$B<&Y!$(B^3&,,`=W:%VY*,;L3I).$AB.\)3]A(QB"8&K#+^% M+J'7MI6VD;M=:Q45UZ>>J*F]4B4/49IZ`AEJWTA<#B2YK<*G"<1CE/"9&6SM M`69`SN$DR&#"FD<\RH`&XF3<#0BS`XNOLU2P[3WFK2E MBC^%N)#;EMJE-EM/C>*@*;EB1IGQG,2=[:/5D!ZZ>XVN[U2`Y2, M"[V^[/-MMT]L53D,/M5Q:#:4TM2V[($@D^]R$-"Y$&P:9)2`X58).G^L8+5Z[NI';7R90 MD"Q_-,:B79Q1(22`99G*"W8C8$MR9PN=.+@1XX`GD'1*X;K6!&4-18D\,QV ME,6KD(F3^&)L[ MJ]>F+&X)G:N>$AN.!#<,47+%N$3=M#3.-?5EWJ=0;8IJ:L^(JKU:[TU;$U%> MNUVP%RX5R[:"ZTWX?C$8/("G9`XB61AK>SA">N=R%R,`9:8_,=-6^E+*_*4& MC&43)@YP#^E%`I-[7QVLIUUSPK[?65*6ZBUML-2>I:]?@BFIUH;2ZMQI+XT& M!&:L4;)I/S5-`N_VIRD M36*:-K23^;.4J-3@MV@.E/Q?@I\,RQ(!.!BP>76^MTC=@8:FT_7;\UOSLDGW MJ73UB$A)L3@_'L5<]OR_(JG:MET4]`S4*4W:54[`\.BIE!'Y>\K2IU+Q;:*5 M^]-+A(X2BJ7F6Y$]<2UH&D6P`RXX>U6#9VM.F0>X14\3Q5E6;0I7;BI-/?[7 M:Z>N>IWV[96DHNE$FXE#JJ0H+NGQ@MX^$".(!!E%US86S=:%V$(R((C(^*.J MK=M:*J.YD(>*$Y2B&<8%LPH=QW7>J"NJK=9GS:K=:7!;*.A?IF5%"+>`UKJ0 MXA;J55*DE1`4!X:DRE,F$N[W<6KIM6";=J!TB)KVXE/;VUJYN6R[J*'F:A])2^\V`Z@FE?<1J3AB9GC@]W:P MOD;B,X6NI$2TRQ!.)[":A)"]*V#:E"4S`L\<"!EV\4S=KY==NU8V]8ZA=OH[ M/3,TZUJIF''KC65#8JW[DHO(6/">6Z/#T@`^].>$HO[B[M9_=-L3"W``?K$U M,NPO3DIM6;=X=>\!*X71MEIUJ\5%P*@A=(IT.(-#3-MA*2G MWOPB>!G%V]=V$8[;;2;PZI2&$S+,/]4"G:B%N&Y)NW0]6`/U0./,I1IE;NME M'=ZZXT%KNE&^]9:NX7%/@4=Y;;1\52K8T+;U5M(%J2XE/NI)7AE*='W^S'<7 M)QA>C+092H)C$-SC@5&K[M<-J$3*T1J`&,3@7Y')%7456S;=04MHKF'ZZ].5 M%PK+[2M-NT;]/1+%*Q;Z'Q"Z@AC6"X3-0/\`G81:F,8[N9E>!T08")Q!-22WL6&%/[RM3Z[I<*6BN5AK&TMWNN0EB@?H;I. M=L?+1;0FK:=;2I"4B9`03^(Q,3+S"P3?E&-ZU(-.5(D2^J>>8XHD!M;@%H$V MYCY1B\<^S)96AW9MI-;;KA1W&Z7NN^`1>*!L.T%OHZ!LU*Z-/B*=2JNJ5:B0 MJ7NX@>[B$'R^QU+,XROW):=<:B(B',?UC[E`_O5S1P+%%6U MF\:.YVV]5K2*BVH;O5NO=0TVS26U((I*FDKRT6D)IZQ"CI5^(G5+\(@MW+GF M-N=G<2&N`$XS.$$Q&)S<=B4W1#:=NN5^I;I;[S$A@X.4@W`X\E-VQ:M1-^R!&Y#Q9L1F#VY*1;=LTM!5*N% M5?+3N!%F8JKH;5:"7*^N=MJ2MH%DO*'A-/A*W-.2@`#+")L[*W:F;URY;NQM M@RT0'2+;0'E+I_'!;Q.I*<<3.$M>9;JY=`ODSLS+2B`*B5*MR@)'P@^,@/X0/SBS>M*=Y/IZQ;F)$8GY1 MS/)59ZA[A^+^-#P3;A5ZQ9E4[.GX%+@;_+=>CXCQRR-$]4_%,LL(H_XMN]?4 M!^Q?Y&^K^;QPIVJS[C8T:9`=1OFY\?77L5K5[(HUW95-3[CM5NI*JI8\.UU* MM%YHV:[PW#1!'BZ452`]H:!!D-,YF+Y^66S?T0O6X0D1X9?/$2KI(XAV"JAO M)"WJ-NK5M]%ZI&+NJTW@ENLHGJU)6\H-AY/]G??"EHU8DD\(>]LX M79"_;N6[0N1$M,S6)./<34)+=^4`;4X2F8$C5'`MAWM0\TQ>-P7;;]:K;EAJ M7;50V1EJA`73L/5%94K;34OW-TOMKFBH6_-N6"@"3F)1N-W>VEP[/:R,+5L: M835SNMQVE\#MZQU980W1(N=PN:&&%IO-;#DE@#]4#( M\TI=*=VVRWWNMN=#:+HP\_9*^MN8\"DO8I4_$4[]*&UH!J:9#BDN)2`E)U#@ M(#;^_P!F.YN3C;O@F!,J";5!',8')1J^ZS-F$3*T?$!&IB]*]N12:RKJ]F4% MMH+/7,NU=X+]WK[[3-(=HZUIA7PE-0T'BEY"FZ5)'B&$1.(.))[T75.H-<^ZM2E!6(3J(_"(@ZO+K&NQ,2OW9-KC@(QJ8CF27/)``W=S3=!"V$5*" M?#/XB2?ZL%N=SS"U.WN)#7;:49G`/0B39'+FB<8;6<9VHO&7A,1B6J".Q*;I M?[IVROOE)=*"\7-]YBQT-;;4^/1V450\9^HJ0I3@%4^AM*6TJ&E2M(XF)%O[ MA9EN+1P*FY:AMFO6@Q!8C\X'(<\TNDM;6W*>X;C%TME]J;72(^!I[65.M457< M%_"MW.OFXI:*6F2HR(E@53@MV([2,MWKA=G"/A$:L94$I` M!!PEC%C=7]U<^Z;DF=JX&PJ#B)4X-7DINV+=B/6L@1G`OVC`COR3]NVY36Y] MR[5-XM6X$66EJ+J+5:"'*JJ?H@"RM2"ZK^SL/$+5+(@1-K:0M2-^=RW=%N)E MICB2,.X&I43ORF.G&,H:RVJ6`?X\%#MN\+Y65U+2W=[\UMMS>%!6VUJF8)=9 MN)\$?"J;2'5JIBX%(F3-M)GCC"6M_N;EP6[Y-RU,L8@8B5*=F2:>ULP@96P( MSC4'LX]JFTFRZ1NYHIW[]:[C2TE0^IRUTSFN[UC5"''A1:/$*55*@T$N@#$: MI2G%D/+K8O:9783A$EXCYB!D.=*I);J73U1A*,B,3\H)S[%6)W_?S4IK5OA5 M`JJ#BK0FG9*30K7X?Y>A81X_C^"H)'O3+N&6$4CS/=&>LG[-_D8,WYO'"F.* MM.SLZ=#>-OF?/CZ9*T?V32*NJZ-K<%KI*5ZK:2BV/JTW:GIZD(>^`T)="$50 M:=LO+H=?IQNPC`R^4_,`?J_K#!5C=3$!*4)&8&(^4D4?L5?7;TO M=/65*;:_^76^@?--26UUAD):IK\`EP@S2#AB)FNYYAN(7"+ M1T6HEA$C`"C'U53PVMF409C5.0J>9S"F7#;=+6U2:ZEO%KL;=W9I;DFUW.;5 M=0N7!.MT!HNIFAQ]16V%9DD&0R>[M(7)]6%R%H3`EIEC'57U<$L+\HQT2C*9 MB2'&!;TJH-WW%=;-6NV.QO.6N@LJ&[O7=H1MMN6C&()+?,95U#EP4V[<;X-ZZ')+`?F@9 M'FL/4(W30T%\J+C06>X$OVNX/7`>%379R@,V:NDTN)!=;;6I+@2)!4QP@-O[ MY;CN)RC"[6),L)-@1V8%1K^[S-F,92AB`/JOB#VXA(K:RKVE26ZW6>L;4_<& MUWBOO%.TV[2W$+4:6FIZ`N^*DT](A`"E8*GI_K1$YSV4(VK$O%(:I2&$L@(\ MAGS30C'L4:=Z@K"WX:`'5HU-\299Z<2,I;VW*-Z0%RVQ$C@`:&)[+A)^&.T[75W6BN%)<[E6U+-IIJ^@D]26EM:/BGRYK*T_%U24`("L#[O M;-3#[G:-Z$A.[(Z08X1&)?F<`I$NO,6Y`Q@*L<3P;LS3=NN5;NINOLUXJ@HI MIC=:"Y.---MVM^A4`XJK+:6T"DJ$.:23C.8XB46[ES=B5F^7IJ$OS2./(IIP MC8(N6QFQ'%^"*:VM;XI4VE'[-E3?OSF!A"6KUSOKZ>W75Y=UM M]U6JWU5&U3LI4H5@+:7:)G;F6(`X\.83 MSLVXQ,X>&<:@D\%)H]ITC-Q_M%[MMT8HE5-0Y;:%1]\56-/ON_$43[X4]:FV M&-+M+4**/A&EI0'2H-N23[VI2@`V3\K9'+TS3G;VV84F,ZX\5 M-7LNC_-C2"^VUNG55A`MZG/]:)87^T%$&]8'Q?AGPP/3GA#G9PZG3%R.G5A] M9N';DD&XEHU:2[8Y=O8JVKWE>&:QU5&Z:.BIJCPJ>VK89TM4U(H-)IWE+:+P M4M+$K4RMKQ)S#BR4`D3F!AG$W-K"5S5&<8"3'2<0_I11&Z1%C$R M,7#C`LGO[P7.V[@I+5:G7K?06NNHK>S2N,M*=7\.^V''WB\A:RJI<458&121 MSBN[N+MJ9LVGC;A0#LS/:IC;A..N=92JK6F;M]7?*]FU;>NUFN5:NZ,6RY5B M*MYNGJ:GQ@T#3O)!IG74^XDF10I4HLLSV\IZ;43"Z00"2X!^'+@EF+HB\R)0 M!J.2UFR[2W6F\4*6[)>;:[35(=T.L;8NU,XNX*--@.1TJN4+_38R>F&?8ZUQ M6S=X&ZFE_([R:]5>4FO_`"^M#*JDOE?YA\:&?#\+4/%U:L,HS_=[_4Z9!ZNK M'F^+^U6=6UHU`C3IP^#>Q;/7JL";TX[5;8NMZW+S<2Y9+Q=55=1XS==3VRK=8JV:F1I'$/(9+3#89*4R)_9Z>49]Q9O=:3 M@S)+@@4(.#>E%=;N6Q;%1%A@3@K^\T]MIJINEO6V[O?+M1T-%276X49J*9IZ MJ8:3K;6A!2*A]ALA"G,2J4C&B_/;1D(7HRN7HQ`E(%@2V'-L"JK8O2CJMR$; M9)(!#JLW/MS<%7=#<*:S7:Z6^OI*6IM;]'::UUEJ@\%+;-`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`%<6VX%FQKE>;'=J6R(M:Z.OHZBUU=.Y>7JM:445#2H=;:5XZ7)D.#\!.>)DNU@;0 MN7MQ$C;"#2!#:R<(A\WKR37Y:]$+9!NZG!QTMB3R93Z*BI[G0WRV[;VY>+-> MJNUS;%7XU8NYT=(\EZNME*\M;@8=J&C(X@K'=A9;EM[UNY9VD#;W!AG)]0!< MQ!R)]N"20N6Y0G?D)6A+(-I)%">(5;M?;NX*2["YUEFN]IM=NH*NHNS];9ZU MAE^W+84VY;@RZRD5#E6LI`2)Z=,\Y17LK=R%[JS!A9A$F1(8&+-IKF<%9N;D M96M$2)7)$`,<#Q[E:6-BV554[0V+;5YV[>:VVU]%:;E7*J*QIJI=9FFG0E2W M0P\^V@I2O`IQ`Y1?MKFTN3-K;0E:W$H$1E*6H`D8CN(Q$[LA.T"" M0`U/R8JFV[M+=:+U:U)L5YL_P-1\345]5:ZMJGHJ:D!57%UYQI+;Z7&$J;`! M([%DZYB4=-8@5(S#]BU9G9>]?S1JC38KVUU%7O\`XLF/3TX/DV#>Q;75/[83N!Q][:5YJ5MW5M=3>6P^U;W*EAU"'K ME^7%Q*33IJ6RXI.G2H`JQGCNGN?+1NC*5N4FG68-"0:RT\'JRS1M;SH,)@>' MY6J'R?BU'6LWK9V\57BY-.V"\W6IJ:];C=Q8M=)B493G*7S`%I/@0?5V+19O6>E$Q(A$1PHX;$'TJMCO M@LM/<%,7G:UYW#=:&FH*2[W:@+U+3UU;2L(%1.F2XVA]34M"S(^)+2MMM906:LJ6%VU;"44M&VEEI;;2J8)*/#P!GJ_6,4;ZS=GN) M7(@W+4P#$@.-)%(TPTX,K-M2XV:NHHZ=)B,\L%5;%^Y*5W;R$+)D6!#NV)Y`E0-S;?O=QJ+7=+38[M76. MKLU(U:F*2T53WY,U1#PJFTOML-N^"^U4'42?><,QCH$5;RW*]*%^Q$RVLK8T M`!]`%#$@8$''CBK-M,6XRMW2U\3.HD_,^$@^3>K!2UT#5GL>W[?NG;5YNUP\ M.MN%%14Z7Z*JL5IK'`&*2K<*F7%&H6"M+*O]'(@?A$[#+;[?;6K6]A*Y>\4A M$'281)H">9J!DD'5NWISVTA&W0$LXE(8D=F#YJ-?['(PD[E MVQU4.KN36)=.Y(ZY8ZL-4:UNX7AVLLMC;IZJ@ MKZ%NG8\"NN3JUEERE8JGC+P\$J*@9349/;Z6WV0&^A*6NX3"#Z91`#2D^($L M&S2S-R]N"=M(1,8C5)G!=N4*]K;>N[%!:[Q4_FUA^$J:VO M175S2545V>6E+SM8UX$VTRF&@O\`R,(O"&YV<9;*$A:A<.NW\TM4L)OF&IP" MFV96;Y&YD#.4!IE@&&,>1SYK%GLU;9[!>:C<^W[PNU7*NH*6AL2Z*KHZZLNE M(5/.7&G+B65TC5-3)"2N8"PD\)3C;QCM]K))P&2>=MOYSMJZ4NT]MW>WO4ERH+E>+.\S4UM;= M:'0IEA]AP>,MUJAJ$^)X"29J3.4U";2-G<;*<-A"4)1G&4X$ZI3C@"#PB<8] MZB/5M;B,MS(2B8D1DS")S';(9J/MVPW6U4VXKCN"PW>EL*K:BVUMNJ;;64KU M\K*EX&@IJ-+C;:T.TQU*#PEH*\\#)=G`V(7K^ZC(;71I,30W)$^$!\",7&"; M<2ZDK=NP0;^IQ+'2`*D\C@V:F4M#3WBT[BMFU=M7FS7BHM[+[C-9X]6]>;91 MOARNME(\7'?!6M*P5)!!L[&$K>X,`6,M1G&)>4(\#GS23ZM MJ[;N;F0G:U$4#:210GB/WK]07)^[W*R7:UV:W6JO=O*ZZS5C"*Z@J&2 MT+4EAYE'CNU;I"@`"4%'`J$ZMA:N6KQOW1*&VA;D9N&$HD-H#XF19N&*?=3C M.V+4")7I3&EC4$5U=P]:M;+36VN76VS;>V;WMN_5]GKJ&U7"O!NVUS9W3*SM+CN( M:;E^0N6(S!D`&[^8!J1P5%M;:FZFK]:Z@6*\V1FW.+K*VXU]FJZ>FH[?2-J^ M-9<6^RAM_P")8)9")G5JU#\,XS;';[B.ZA,"5H0.HR(81B!XG>A<4;-U=N;M MHV)1)%PRH`#4DX=C8ODM@LKFVUWNG%KVG>K)6U3M8Q:;U5!ZHH:&MK6GFZ*I M-`MW2REQ;@2@%`#2EA(`C7MMQY9+\C M9/4F+D`!JB`Q(&-?1UJ5OV3O?\XHZ-NPWRCN35S0A5V=M5<:>GJ*=[74W5=: MZREMYG]FIS452>U:?UI1AM;/>?>(VHQG&\)_,06B0:RU8-F^:U3W&WZ1F2)6 M]/R\0<`WPR6W*JMI#=WY3]\UFU(CJ?/J\+O\^C@]=*RBSO_N^GJ!]/RM7]75QR=:G=-E;U-YKZ M1VP7VX5[]R6$75JU5QI:IVK>"Z:X(K6V5-LM)0XA1(,F0F6&D1@O[3>?>9PE M&4[IG\P!:1)I(2X%P7R[EIM[BP+(D"(VQ'Y<&`Q#>CK:KXK;S5X>;O&U+S?K MA1FBIKQ>:0.TM%7UE$TRBK=^!0ZE+V@HT.>Z?$*"DSE&W=;CRV.X,;]N5Z[% MA.<9,)2`&HMGP)^LLUBUNS:!M3%NV7,8D.0#@'/L&2H=U[6W0]?;C5_D=YOE M+<0U74%PH++65--4VZH:!HJ=D-,N-M*I&1X?AS``3K/XC&7?V+\MU.XTKL)M M*,HAP8D>$!J!A1LF5^UNVQ9C%Q"47!!-7!J3Q+*'N&Q7.ZT.W+AMVP7 M=^PLT-1;&;73VVJJZBQW)A]2ZU-8&T..O.5PDKQS.>C,ZA.O=PZ]JS>VD9': MB)B(#Q&$@7D)-CJ=]1QP36)=*=RW?(Z[@ZL!(,P;LP(RQ4BFMBK+MBB8W7MR M\5WQ]VJKA9+(TQ4T-=;*9MI-/65CJUAA=.S6U"I^"3B5`RG.30Z.VV,8;Z$I MZYF4(`Z91#,9$Y"1RY*)&=[<2EMI".F($I,X)R'=QYIJ[6:JO.W;6[M;;MX; MMMKN=:UO#M MMN=THV[9854=315]1274VQ5YVQ74^T]N7F@- M#=J2X7NS.L55=7W.E6VIFCJV7$^.NH8HZA$RRDF123*S;BMVU=MWFSW1REI: MNHIJL5%:_?+51/E=9;Z1W4\6U)"PI38EXFH`X$RLC+;[G;WK.R@;=\Q!(,M1 MG$&L8G)L2,TAZMJ[;GN9"=MV!`;3(X$^[DH&UMOWVWUM;=;I9+O;;)16BM-Y M^-L]6RW=*6J;++-I;:?907WZE^2@0"IO3_E15L;<[5R5^\##;1MG6X(U`T$` M^))P:HQ5FYF)P%NV=5^4QI8NQ'UJ9#U'!65II:&O%RM>V]LWK;U^N%GK*6VU MU>Z_6)=6D(>?MS+I=>535-:PV4AP#5('E%NWN;2Z)V-I"5G=3MD1,I:GXQ'` MR%'SP5=V-^&FY?D+EF,PX`9N$N8&+*FVMM?<[%\M]:JRW>R4MO2]6U]=6V:L MIZ:GMK#1%;3+\5E#;JJEM7A!N9!GJ'X08HV-B]'NK+-IVI>K#<*H5M/9[O6>-4TE!6UK M3J*5TT:W%)9UE>A&H?LBH)&<:-M?\OE?$;%N5J[)Q" M[C:)NR%R`8RB`Q(!#@'W\5K%JV9O,7>WTS5@O5NK6+DDFYNVRO%+2.4CRG*F MN76.-!#S*D-K,RK]L%2_6,8[&UW7WB,(QE"X)_,06BQK(GA[UINWK/2E(D2@ M8X<7P`'L6TMU.USN)-2C:-Y;*KNIQN]*#QMP?4^IM-U%M\12/A34'Q0G3I`] M_.<;!N?+/O>L6I`=1];^%W^;1P>K+,;6\Z&G6/E^5JM^;JXM1UJE;LO>OYK5 MTB[#>JJXN7)8_-46NN--453[P6S2VB\.;>1>JC\RVI>;Q54S] M,W=+Q3!]BAK*NB0RBLJ!0)<`>0AQHA8"3XI01C&S<;CR\;@]6V;DP0)3$F$B M,9-GSXK/:ANS9&B8A$CPQ(K$'`/[N"H=S;5W4[>[F\;)=[RU<'45E)7T=HK' MJ:KHJIM/P3;:VF7&6/!9DT4$@)TZC@9QFWEF\=S.1!N"1<2`<&)P9J!A1LE? M8NV^C$`B!%"":@C'VYYJVO=/;Z-RDMVX=M7G<-\H;10T=UN%`NHHVR\ELK31 MN%"FOB'Z5EP)4N6H@B?(7[BYM+9B*.JK4;\P;EB0A M:,B0"'SQY`\%7;IV]?JZY-W6WV6[72SU]LHG;2NBM%6\W24##0:%M4TTRHM/ M4CNHD$`K*Y\#*C>VYW+PO6P9V)P!B0'`B`VFF!B?7BK=MZ#, MHD>&=EP[>Q9M6=Y"5S<"!-):3")+QB>)SY*N/5N7)W-O(0M&68=R,2.7O4'< M-@NES8L%PLECN]18Q;%4%';Z>W552Y9:JD=5\?358:;<4IRH7)7C*GK*<\IU M[J!O1M7MO$G;:&$14P(-06S.+I[,]$IPND"]JW(C$``G$$Y-V<4U=[/77:R6BHVY8;NFUT-774M9 M9$T5765E'*:9E=O#H$:A M&LL0QP'/X)-7;'[OMQUO:VWKQ2-4%U;JKO9ET]56UU:A]D,T5>E8#KE0Q2N@ MI"!@@@J_5Q)].]M"-I$Q$)O.#ZI%PPEQ('#)1$RMWWW!!)C26`#&H[3[4S9; M'IW*0N(;<950M!1+PX$B?NPNWB M+-JYZ#;.W;Q: MZT)HZZMHGFWZRJO%LI75!VGI%@N+!IW%!:FD_CP&.J)>S>V]RWM(F%VA()WV*!MNP7NW.W.YW:S7:BLM-:JEJZ,55JJZ M<79%4"U3VYA#S3?B/+?`4%#%LR_K17M8&V9W;P,=N('4"/F?"(?-Z\L5;?F) MZ;=L@W3*E<&Q/IBIUOHJ>X4]VMNW=N7>QWJMM+S5*_5J?K?C&6E(=K+:PXM2 MC3O5;""`L2*@#RA[4MO=C.UM8FWN)0+.7=JF(X$C/-5S%V!C82AY=4%!`1B9X_ MJQ3M+=R-X7"#"W$$R)##3F.;X,GOS@;9@")2-``7KQ[E;V9JU5%=\/9]M7>Q M72LIZRFM=SK?B*IBDJZEAQ#$F%*6&7'0="52]PJD,XML7-K*YILPE;NR!$9$ MN`3A3+@^2BY&\(OE5K=GVAN]-YH$-V.\VQZGJTNNW"HME:ABB% M*LKJ7UU"F?">1X:%`>]I=U2GC&6Q8O\`7B`#&0EB10-B7]'5MR[;Z9)(D",` M<5L-,[MXWY#S&U[M3..7%Q5/=G6ZE=$S4/.+0Q7_``"O=#'C+"TI(`2#/"4: M(7MCUQ*,#$F5)$TXZ;:@0U0U>QUJSFS-XBZN4IL=Y57JN&D7 M`6ZM#"ZA51K%>*Q+!;#2B?%*IX#",DMON.KH:75UXY.^+^U:(W;6C4XT-AR; M!ELEQ-A3>7%5FV+M<'FJMKXVZ,IJFJ2JJ&-"*FK%"@:5M%ULE0`DX03C/'1< MO;+KDS@9$2#R!8$C$MZ.J80O]-A)GY!UKU^VINER\UREV:[W5=6_X[%?3 M6RL<8JV*H)52K;=2RIMI(:4E&F0C-N+-XWY%C-RX(%"#A[/4K;5R'3%1 M$C+@RV:I:M]'>;93WG;MVO5UH?RNGN=PH_C&$NU+!:*FO"9255;S#9"%*`*E FD2SPC1>EMHR$+T3.]&($B"P?XD8/FJH"]*.JV1"V22`ST]*K_]D_ ` end